PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Achour, M; Jacq, X; Ronde, P; Alhosin, M; Charlot, C; Chataigneau, T; Jeanblanc, M; Macaluso, M; Giordano, A; Hughes, AD; Schini-Kerth, VB; Bronner, C				Achour, M.; Jacq, X.; Ronde, P.; Alhosin, M.; Charlot, C.; Chataigneau, T.; Jeanblanc, M.; Macaluso, M.; Giordano, A.; Hughes, A. D.; Schini-Kerth, V. B.; Bronner, C.			The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression	ONCOGENE			English	Article						ICBP90; DNMT1; methylation; UHRF1; vascular endothelial growth factor; yeast two-hybrid system	UBIQUITIN LIGASE ACTIVITY; ESTROGEN-RECEPTOR-ALPHA; CCAAT-BINDING-PROTEIN; GROWTH-FACTOR GENE; DNA METHYLTRANSFERASE-1; BREAST-CANCER; CELL-CYCLE; DOWN-REGULATION; DNA-METHYLTRANSFERASE-1 DNMT1; G1/S TRANSITION	Inverted CCAAT box-binding protein of 90 kDa (ICBP90) is over-expressed in several types of cancer, including breast, prostate and lung cancers. In search for proteins that interact with the set and ring-associated (SRA) domain of ICBP90, we used the two-hybrid system and screened a placental cDNA library. Several clones coding for a new domain of DNMT1 were found. The interaction, between the ICBP90 SRA domain and the DNMT1 domain, has been confirmed with purified proteins by glutathione-S-transferase pull-down experiments. We checked whether ICBP90 and DNMT1 are present in the same macromolecular complexes in Jurkat cells and immortalized human vascular smooth muscle cells (HVTs-SM1). Coimmunoprecipitation experiments showed that ICBP90 and DNMT1 are present in the same molecular complex, which was further confirmed by co-localization experiments as assessed by immunocytochemistry. Downregulation of ICBP90 and DNMT1 decreased VEGF gene expression, a major pro-angiogenic factor, whereas those of p16(INK4A) gene and RB1 gene were significantly enhanced. Together, these results indicate that DNMT1 and ICBP90 are involved in VEGF gene expression, possibly via an interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 and an upregulation of p16(INK4A). They further suggest a new role of ICBP90 in the relationship between histone ubiquitination and DNA methylation in the context of tumoral angiogenesis and tumour suppressor genes silencing.	[Achour, M.; Ronde, P.; Alhosin, M.; Charlot, C.; Chataigneau, T.; Jeanblanc, M.; Schini-Kerth, V. B.; Bronner, C.] Univ Louis Pasteur Strasbourg 1, CNRS, UMR 7175, Dept Pharmacol & Pharmacochim,Fac Pharm,Inst Gilb, F-67401 Illkirch Graffenstaden, France; [Jacq, X.] Hybrigen, Paris, France; [Macaluso, M.; Giordano, A.] Temple Univ, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA; [Macaluso, M.; Giordano, A.] Univ Siena, Dept Human Pathol & Oncol, I-53100 Siena, Italy; [Hughes, A. D.] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Natl Heart & Lung Inst, Clin Pharmacol, London SW7 2AZ, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Siena; Imperial College London	Bronner, C (corresponding author), Univ Louis Pasteur Strasbourg 1, CNRS, UMR 7175, Dept Pharmacol & Pharmacochim,Fac Pharm,Inst Gilb, 74 Route Rhin,BP 60024, F-67401 Illkirch Graffenstaden, France.	Christian.Bronner@pharma.u-strasbg.fr	高, 雨莉/HGU-8187-2022; Hughes, Alun D/C-6636-2009; Alhosin, Mahmoud/H-8101-2017; Hughes, Alun David/N-3781-2013; Alhosin, Mahmoud/AAD-5782-2020; Bronner, Christian/R-8488-2016; Giordano, Antonio/F-1927-2010	Hughes, Alun David/0000-0001-5432-5271; Alhosin, Mahmoud/0000-0003-2147-1445; Bronner, Christian/0000-0002-3101-9279; Giordano, Antonio/0000-0002-5959-016X; ACHOUR, Mayada/0000-0003-1044-824X				Arima Y, 2004, GENES CELLS, V9, P131, DOI 10.1111/j.1356-9597.2004.00710.x; BARTEL P, 1993, BIOTECHNIQUES, V14, P920; Baumbusch LO, 2001, NUCLEIC ACIDS RES, V29, P4319, DOI 10.1093/nar/29.21.4319; Bonapace IM, 2002, J CELL BIOL, V157, P909, DOI 10.1083/jcb.200201025; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bronner C, 2007, PHARMACOL THERAPEUT, V115, P419, DOI 10.1016/j.pharmthera.2007.06.003; Caracciolo V, 2006, ONCOGENE, V25, P5294, DOI 10.1038/sj.onc.1209681; Chen Dao-Rong, 2006, Ai Zheng, V25, P308; CHENG CH, 1993, BIOCHEMISTRY-US, V32, P8568, DOI 10.1021/bi00084a025; Chuang JL, 2000, METHOD ENZYMOL, V324, P192; Citterio E, 2004, MOL CELL BIOL, V24, P2526, DOI 10.1128/MCB.24.6.2526-2535.2004; Crnogorac-Jurcevic T, 2005, GASTROENTEROLOGY, V129, P1454, DOI 10.1053/j.gastro.2005.08.012; Espada J, 2004, J BIOL CHEM, V279, P37175, DOI 10.1074/jbc.M404842200; Fournel M, 1999, J BIOL CHEM, V274, P24250, DOI 10.1074/jbc.274.34.24250; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Gabellini C, 2006, ONCOGENE, V25, P5326, DOI 10.1038/sj.onc.1209631; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Hopfner R, 2002, ANTICANCER RES, V22, P3165; Hopfner R, 2000, CANCER RES, V60, P121; Hsieh JK, 2000, ARTERIOSCL THROM VAS, V20, P973, DOI 10.1161/01.ATV.20.4.973; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jeanblanc M, 2005, ONCOGENE, V24, P7337, DOI 10.1038/sj.onc.1208878; Jenkins Y, 2005, MOL BIOL CELL, V16, P5621, DOI 10.1091/mbc.E05-03-0194; Kimura H, 2003, NUCLEIC ACIDS RES, V31, P3101, DOI 10.1093/nar/gkg406; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lorenzato M, 2005, HUM PATHOL, V36, P1101, DOI 10.1016/j.humpath.2005.07.016; Macaluso M, 2003, ONCOGENE, V22, P3511, DOI 10.1038/sj.onc.1206578; Macaluso M, 2007, CANCER RES, V67, P7731, DOI 10.1158/0008-5472.CAN-07-1476; McCabe MT, 2005, CANCER RES, V65, P3624, DOI 10.1158/0008-5472.CAN-04-2158; Miki K, 2000, ONCOL RES, V12, P335, DOI 10.3727/096504001108747783; Milutinovic S, 2003, J BIOL CHEM, V278, P14985, DOI 10.1074/jbc.M213219200; Mortusewicz O, 2005, P NATL ACAD SCI USA, V102, P8905, DOI 10.1073/pnas.0501034102; Mousli M, 2003, BRIT J CANCER, V89, P120, DOI 10.1038/sj.bjc.6601068; MUKHOPADHYAY D, 1995, CANCER RES, V55, P6161; Naumann K, 2005, EMBO J, V24, P1418, DOI 10.1038/sj.emboj.7600604; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Oak MH, 2005, J NUTR BIOCHEM, V16, P1, DOI 10.1016/j.jnutbio.2004.09.004; Oba-Shinjo SM, 2005, MOL BRAIN RES, V140, P25, DOI 10.1016/j.molbrainres.2005.06.015; Ohta T, 2004, ONCOGENE, V23, P2079, DOI 10.1038/sj.onc.1207371; Papait R, 2007, MOL BIOL CELL, V18, P1098, DOI 10.1091/mbc.E06-09-0874; Peng DF, 2006, CARCINOGENESIS, V27, P1160, DOI 10.1093/carcin/bgi361; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Salimath B, 2000, ONCOGENE, V19, P3470, DOI 10.1038/sj.onc.1203672; Schaaf GJ, 2005, FASEB J, V19, P404, DOI 10.1096/fj.04-2104fje; Suzuki M, 2004, CANCER RES, V64, P3137, DOI 10.1158/0008-5472.CAN-03-3046; Turek-Plewa J, 2005, CELL MOL BIOL LETT, V10, P631; Uemura T, 2000, CELL STRUCT FUNCT, V25, P149, DOI 10.1247/csf.25.149; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Vallbohmer D, 2006, CLIN LUNG CANCER, V8, P39, DOI 10.3816/CLC.2006.n.031; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Wang G, 2000, EXP CELL RES, V254, P64, DOI 10.1006/excr.1999.4743	53	128	134	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR 3	2008	27	15					2187	2197		10.1038/sj.onc.1210855	http://dx.doi.org/10.1038/sj.onc.1210855			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	283FE	17934516				2022-12-25	WOS:000254621300009
J	Llobet, D; Eritja, N; Encinas, M; Llecha, N; Yeramian, A; Pallares, J; Sorolla, A; Gonzalez-Tallada, FJ; Matias-Guiu, X; Dolcet, X				Llobet, D.; Eritja, N.; Encinas, M.; Llecha, N.; Yeramian, A.; Pallares, J.; Sorolla, A.; Gonzalez-Tallada, F. J.; Matias-Guiu, X.; Dolcet, X.			CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells	ONCOGENE			English	Article						endometrial carcinoma; apoptosis; death receptor; casein kinase 2; FLIP	PROTEIN-KINASE CK2; LIGAND-MEDIATED APOPTOSIS; C-FLIP; CANCER-CELLS; DEATH RECEPTORS; DOWN-REGULATION; TUMOR-CELLS; SIGNALING COMPLEX; MOLECULAR-CLONING; PROSTATE-CANCER	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has emerged as a promising antineoplastic agent because of its ability to selectively kill tumoral cells. However, some cancer cells are resistant to TRAIL-induced apoptosis. We have previously demonstrated that in endometrial carcinoma cells such resistance is caused by elevated FLICE-inhibitory protein (FLIP) levels. The present study focuses on the mechanisms by which FLIP could be modulated to sensitize endometrial carcinoma cells to TRAIL-induced apoptosis. We find that inhibition of casein kinase (CK2) sensitizes endometrial carcinoma cells to TRAIL-and Fas-induced apoptosis. CK2 inhibition correlates with a reduction of FLIP protein, suggesting that CK2 regulates resistance to TRAIL and Fas by controlling FLIP levels. FLIP downregulation correlates with a reduction of mRNA and is prevented by addition of the MG-132, suggesting that CK2 inhibition results in a proteasome-mediated degradation of FLIP. Consistently, forced expression of FLIP restores resistance to TRAIL and Fas. Moreover, knockdown of either FADD or caspase-8 abrogates apoptosis triggered by inhibition of CK2, indicating that CK2 sensitization requires formation of functional DISC. Finally, because of the possible role of both TRAIL and CK2 in cancer therapy, we demonstrate that CK2 inhibition sensitizes primary endometrial carcinoma explants to TRAIL apoptosis. In conclusion, we demonstrate that CK2 regulates endometrial carcinoma cell sensitivity to TRAIL and Fas by regulating FLIP levels.	[Llobet, D.; Eritja, N.; Llecha, N.; Yeramian, A.; Pallares, J.; Sorolla, A.; Matias-Guiu, X.; Dolcet, X.] IRBLleida, Inst Recerca Biomed Lleida, Oncol Pathol Grp, Hosp Univ Arnau de Vilanova,Lab Recerca Biomed, Lleida 25198, Spain; [Encinas, M.] IRBLleida, Inst Recerca Biomed Lleida, Cell Signaling & Apoptosis Grp, Lleida 25198, Spain; [Gonzalez-Tallada, F. J.] IRBLleida, Inst Recerca Biomed Lleida, Dept Gynecol, Lleida 25198, Spain	Institut de Recerca Biomedica - IRB Lleida; University Hospital Arnau de Vilanova; Institut de Recerca Biomedica - IRB Lleida; Institut de Recerca Biomedica - IRB Lleida	Dolcet, X (corresponding author), IRBLleida, Inst Recerca Biomed Lleida, Oncol Pathol Grp, Hosp Univ Arnau de Vilanova,Lab Recerca Biomed, Av Rovira Roure 80, Lleida 25198, Spain.	dolcet@cmb.udl.es	Encinas, Mario/B-5600-2009; Eritja, Nuria/M-1347-2015; yeramian, andree/B-5936-2009; Llobet-Navas, David/AAT-4676-2021; matias-guiu, xavier/C-3039-2009; Llobet-Navas, David/B-5660-2009; Dolcet, Xavi/B-5665-2009; Pallares, Judit/A-6635-2010; Sorolla Bardaji, Anabel/C-6614-2011; Eritja Sanchez, Nuria/C-4465-2011; Sorolla, Anabel/E-2546-2012; Yeramian, Andree/P-6724-2019; Eritja, Núria/S-3700-2019	Encinas, Mario/0000-0003-3509-7431; Eritja, Nuria/0000-0003-1018-6649; yeramian, andree/0000-0002-9569-6316; matias-guiu, xavier/0000-0002-7201-6605; Llobet-Navas, David/0000-0003-1443-7003; Dolcet, Xavi/0000-0003-1921-0449; Sorolla, Anabel/0000-0001-8238-8763; Eritja, Núria/0000-0003-2131-7915				Ahmad KA, 2005, ANTI-CANCER DRUG, V16, P1037, DOI 10.1097/00001813-200511000-00001; Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Dolcet X, 2005, LAB INVEST, V85, P885, DOI 10.1038/labinvest.3700286; Dolcet X, 2006, J BIOL CHEM, V281, P22118, DOI 10.1074/jbc.M601350200; Droin N, 2001, BLOOD, V97, P1835, DOI 10.1182/blood.V97.6.1835; Dutton A, 2004, P NATL ACAD SCI USA, V101, P6611, DOI 10.1073/pnas.0400765101; Galligan L, 2005, MOL CANCER THER, V4, P2026, DOI 10.1158/1535-7163.MCT-05-0262; Irmler M, 2000, FEBS LETT, V468, P129, DOI 10.1016/S0014-5793(00)01206-0; Izeradjene K, 2005, ONCOGENE, V24, P2050, DOI 10.1038/sj.onc.1208397; Izeradjene K, 2004, CLIN CANCER RES, V10, P6650, DOI 10.1158/1078-0432.CCR-04-0576; KIKKAWA U, 1992, MOL CELL BIOL, V12, P5711, DOI 10.1128/MCB.12.12.5711; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Korkolopoulou P, 2004, UROLOGY, V63, P1198, DOI 10.1016/j.urology.2004.01.007; Landesman-Bollag E, 2001, ONCOGENE, V20, P3247, DOI 10.1038/sj.onc.1204411; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Lavrik IN, 2006, BLOOD, V108, P559, DOI 10.1182/blood-2005-07-007096; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Lee SH, 2003, APMIS, V111, P309, DOI 10.1034/j.1600-0463.2003.1110203.x; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Liu X, 2006, CANCER RES, V66, P11115, DOI 10.1158/0008-5472.CAN-06-2471; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MacFarlane M, 1997, J BIOL CHEM, V272, P25417, DOI 10.1074/jbc.272.41.25417; PADMANABHA R, 1990, MOL CELL BIOL, V10, P4089, DOI 10.1128/MCB.10.8.4089; Palacios C, 2006, CANCER RES, V66, P8858, DOI 10.1158/0008-5472.CAN-06-0808; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1998, FEBS LETT, V424, P41, DOI 10.1016/S0014-5793(98)00135-5; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Ravi R, 2002, CANCER RES, V62, P4180; Rippo MR, 2004, ONCOGENE, V23, P7753, DOI 10.1038/sj.onc.1208051; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Shin S, 2005, EMBO J, V24, P3532, DOI 10.1038/sj.emboj.7600827; Son YG, 2007, CANCER RES, V67, P8274, DOI 10.1158/0008-5472.CAN-07-0407; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Srivastava RK, 2001, NEOPLASIA, V3, P535, DOI 10.1038/sj.neo.7900203; Takeda K, 2007, ONCOGENE, V26, P3745, DOI 10.1038/sj.onc.1210374; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Wagner KW, 2004, J BIOL CHEM, V279, P35047, DOI 10.1074/jbc.M400708200; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wang GX, 2006, CANCER RES, V66, P2242, DOI 10.1158/0008-5472.CAN-05-2772; Wang GX, 2005, MOL CELL BIOCHEM, V274, P77, DOI 10.1007/s11010-005-3077-1; Wang GX, 2005, MOL CELL BIOCHEM, V274, P201, DOI 10.1007/s11010-005-2952-0; Zhang XP, 2004, CANCER RES, V64, P7086, DOI 10.1158/0008-5472.CAN-04-1498	52	43	48	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2008	27	18					2513	2524		10.1038/sj.onc.1210924	http://dx.doi.org/10.1038/sj.onc.1210924			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	289LW	17982483				2022-12-25	WOS:000255057000001
J	Fruscione, F; Sturla, L; Duncan, G; Van Etten, JL; Valbuzzi, P; De Flora, A; Di Zanni, E; Tonetti, M				Fruscione, Floriana; Sturla, Laura; Duncan, Garry; Van Etten, James L.; Valbuzzi, Paola; De Flora, Antonio; Di Zanni, Eleonora; Tonetti, Michela			Differential role of NADP(+) and NADPH in the activity and structure of GDP-D-mannose 4,6-dehydratase from two chlorella viruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-GLUCOSE 4,6-DEHYDRATASE; UDP-GALACTOSE 4-EPIMERASE; CRYSTAL-STRUCTURE; L-FUCOSE; ARABIDOPSIS-THALIANA; D-RHAMNOSE; IDENTIFICATION; DEHYDRATASE; PROTEIN; EXPRESSION	GDP-D-mannose 4,6-dehydratase (GMD) is a key enzyme involved in the synthesis of 6-deoxyhexoses in prokaryotes and eukaryotes. Paramecium bursaria chlorella virus-1 (PBCV-1) encodes a functional GMD, which is unique among characterized GMDs because it also has a strong stereospecific NADPH-dependent reductase activity leading to GDP-D-rhamnose formation (Tonetti, M., Zanardi, D., Gurnon, J., Fruscione, F., Armirotti, A., Damonte, G., Sturla, L., De Flora, A., and Van Etten, J. L. ( 2003) J. Biol. Chem. 278, 21559-21565). In the present study we characterized a recombinant GMD encoded by another chlorella virus, Acanthocystis turfacea chlorella virus 1 (ATCV-1), demonstrating that it has the expected dehydratase activity. However, it also displayed significant differences when compared with PBCV-1 GMD. In particular, ATCV-1 GMD lacks the reductase activity present in the PBCV-1 enzyme. Using recombinant PBCV-1 and ATCV-1 GMDs, we determined that the enzymatically active proteins contain tightly bound NADPH and that NADPH is essential for maintaining the oligomerization status as well as for the stabilization and function of both enzymes. Phylogenetic analysis indicates that PBCV-1 GMD is the most evolutionary diverged of the GMDs. We conclude that this high degree of divergence was the result of the selection pressures that led to the acquisition of new reductase activity to synthesize GDP-D-rhamnose while maintaining the dehydratase activity in order to continue to synthesize GDP-L-fucose.	[Fruscione, Floriana; Sturla, Laura; De Flora, Antonio; Di Zanni, Eleonora; Tonetti, Michela] Univ Genoa, Ctr Excellence Biomed Res, Dept Expt Med, I-16132 Genoa, Italy; [Duncan, Garry] Nebraska Wesleyan Univ, Dept Biol, Lincoln, NE 68504 USA; [Van Etten, James L.; Valbuzzi, Paola] Univ Nebraska, Nebraska Ctr Virol, Dept Plant Pathol, Lincoln, NE 68583 USA	University of Genoa; University of Nebraska System; University of Nebraska Lincoln	Tonetti, M (corresponding author), Univ Genoa, Ctr Excellence Biomed Res, Dept Expt Med, Viale Benedetto XV, 1, I-16132 Genoa, Italy.	tonetti@unige.it	fruscione, floriana/AAA-8747-2020; TONETTI, MICHELA/AAF-3404-2021; Tonetti, Michela/F-3039-2018; DI ZANNI, ELEONORA/K-8643-2016	TONETTI, MICHELA/0000-0002-8829-7173; DI ZANNI, ELEONORA/0000-0003-4564-2202; fruscione, floriana/0000-0002-4054-645X	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635, P20RR016469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032441] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR 016469, P21 RR 15635] Funding Source: Medline; NIGMS NIH HHS [GM 32441] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albermann C, 2001, GLYCOBIOLOGY, V11, P655, DOI 10.1093/glycob/11.8.655; Allard STM, 2002, STRUCTURE, V10, P81, DOI 10.1016/S0969-2126(01)00694-3; Allard STM, 2001, J MOL BIOL, V307, P283, DOI 10.1006/jmbi.2000.4470; Beis K, 2003, J AM CHEM SOC, V125, P11872, DOI 10.1021/ja035796r; Bisso A, 1999, FEBS LETT, V456, P370, DOI 10.1016/S0014-5793(99)00982-5; Bonin CP, 1997, P NATL ACAD SCI USA, V94, P2085, DOI 10.1073/pnas.94.5.2085; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Dunigan DD, 2006, VIRUS RES, V117, P119, DOI 10.1016/j.virusres.2006.01.024; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; Fitzgerald LA, 2007, VIROLOGY, V362, P350, DOI 10.1016/j.virol.2006.12.028; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Glansdorff N, 2000, MOL MICROBIOL, V38, P177, DOI 10.1046/j.1365-2958.2000.02126.x; Goetz H, 2004, J BIOCHEM BIOPH METH, V60, P281, DOI 10.1016/j.jbbm.2004.01.007; Graves MV, 2001, VIROLOGY, V285, P332, DOI 10.1006/viro.2001.0937; HAN TM, 1992, SCIENCE, V257, P232, DOI 10.1126/science.1631544; He XM, 1996, BIOCHEMISTRY-US, V35, P4721, DOI 10.1021/bi952706p; Hegeman AD, 2001, BIOCHEMISTRY-US, V40, P6598, DOI 10.1021/bi010441a; Kallberg Y, 2002, PROTEIN SCI, V11, P636, DOI 10.1110/ps.26902; Kneidinger B, 2001, J BIOL CHEM, V276, P5577, DOI 10.1074/jbc.M010027200; LABESSE G, 1994, BIOCHEM J, V304, P95, DOI 10.1042/bj3040095; Lakowicz J.R., 1983, PRINCIPLES FLUORESCE, P44; Li B, 1996, EUR J BIOCHEM, V235, P180, DOI 10.1111/j.1432-1033.1996.00180.x; LOWRY OH, 1961, J BIOL CHEM, V236, P2756; Ma B, 2006, GLYCOBIOLOGY, V16, p158R, DOI 10.1093/glycob/cwl040; Maki M, 2003, GLYCOBIOLOGY, V13, P295, DOI 10.1093/glycob/cwg035; McCracken JA, 2004, ANAL BIOCHEM, V324, P131, DOI 10.1016/j.ab.2003.09.025; Mulichak AM, 2002, BIOCHEMISTRY-US, V41, P15578, DOI 10.1021/bi0266683; Nakayama K, 2003, GLYCOBIOLOGY, V13, P673, DOI 10.1093/glycob/cwg099; OTHS PJ, 1990, CARBOHYD RES, V198, P91, DOI 10.1016/0008-6215(90)84279-4; Rosano C, 2006, BIOCHEM BIOPH RES CO, V339, P191, DOI 10.1016/j.bbrc.2005.11.009; Somoza JR, 2000, STRUCTURE, V8, P123, DOI 10.1016/S0969-2126(00)00088-5; Sturla L, 1997, FEBS LETT, V412, P126, DOI 10.1016/S0014-5793(97)00762-X; Sullivan FX, 1998, J BIOL CHEM, V273, P8193, DOI 10.1074/jbc.273.14.8193; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; SWAFFORD DL, 2000, PAUP PHYLOGENETIC AN; Thoden JB, 1996, BIOCHEMISTRY-US, V35, P2557, DOI 10.1021/bi952715y; Tonetti M, 1996, J BIOL CHEM, V271, P27274, DOI 10.1074/jbc.271.44.27274; Tonetti M, 1998, BIOCHIMIE, V80, P923, DOI 10.1016/S0300-9084(00)88889-6; Tonetti M, 2003, J BIOL CHEM, V278, P21559, DOI 10.1074/jbc.M301543200; Van Etten JL, 2003, ANNU REV GENET, V37, P153, DOI 10.1146/annurev.genet.37.110801.143915; VANHOOKE JL, 1994, J BIOL CHEM, V269, P31496; Vogan EM, 2004, BIOCHEMISTRY-US, V43, P3057, DOI 10.1021/bi035547f; Webb NA, 2004, PROTEIN SCI, V13, P529, DOI 10.1110/ps.03393904; WELLING GW, 1989, HPLC MACROMOLECULES, P77; Wu BY, 2001, BIOCHEM BIOPH RES CO, V285, P364, DOI 10.1006/bbrc.2001.5137	45	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					184	193		10.1074/jbc.M706614200	http://dx.doi.org/10.1074/jbc.M706614200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17974560	Green Published, hybrid			2022-12-25	WOS:000251940300021
J	Grumbt, B; Stroobant, V; Terziyska, N; Israel, L; Hell, K				Grumbt, Barbara; Stroobant, Vincent; Terziyska, Nadia; Israel, Lars; Hell, Kai			Functional characterization of Mia40p, the central component of the disulfide relay system of the mitochondrial intermembrane space	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFHYDRYL OXIDASE; PROTEIN IMPORT; SACCHAROMYCES-CEREVISIAE; BOND FORMATION; CYTOCHROME-C; SUPEROXIDE-DISMUTASE; IN-VIVO; COMPLEX; YEAST; TRANSLOCATION	Mia40p and Erv1p are components of a translocation pathway for the import of cysteine-rich proteins into the intermembrane space of mitochondria. We have characterized the redox behavior of Mia40p and reconstituted the disulfide transfer system of Mia40p by using recombinant functional C-terminal fragment of Mia40p, Mia40C, and Erv1p. Oxidized Mia40p contains three intramolecular disulfide bonds. One disulfide bond connects the first two cysteine residues in the CPC motif. The second and the third bonds belong to the twin CX9C motif and bridge the cysteine residues of two CX9C segments. In contrast to the stabilizing disulfide bonds of the twin CX9C motif, the first disulfide bond was easily accessible to reducing agents. Partially reduced Mia40C generated by opening of this bond as well as fully reduced Mia40C were oxidized by Erv1p in vitro. In the course of this reaction, mixed disulfides of Mia40C and Erv1p were formed. Reoxidation of fully reduced Mia40C required the presence of the first two cysteine residues in Mia40C. However, efficient reoxidation of a Mia40C variant containing only the cysteine residues of the twin CX9C motif was observed when in addition to Erv1p low amounts of wild type Mia40C were present. In the reconstituted system the thiol oxidase Erv1p was sufficient to transfer disulfide bonds to Mia40C, which then could oxidize the variant of Mia40C. In summary, we reconstituted a disulfide relay system consisting of Mia40C and Erv1p.	[Grumbt, Barbara; Terziyska, Nadia] Univ Munich, Adolf Butenandt Inst Physiol Chem, D-81377 Munich, Germany; [Stroobant, Vincent] Catholic Univ Louvain, Ludwig Inst Canc Res, Brussels Branch, Cellular Genet Unit, B-1200 Brussels, Belgium; [Israel, Lars] Univ Munich, Protein Anal Unit, D-80336 Munich, Germany	University of Munich; Ludwig Institute for Cancer Research; Universite Catholique Louvain; University of Munich	Hell, K (corresponding author), Univ Munich, Adolf Butenandt Inst Physiol Chem, Butenandtstr 5, D-81377 Munich, Germany.	hell@med.uni-muenchen.de						Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Allen S, 2003, J BIOL CHEM, V278, P38505, DOI 10.1074/jbc.M306027200; Arnesano F, 2005, STRUCTURE, V13, P713, DOI 10.1016/j.str.2005.02.015; Banci L, 2004, J BIOL CHEM, V279, P34833, DOI 10.1074/jbc.M403655200; Barros MH, 2004, J BIOL CHEM, V279, P31943, DOI 10.1074/jbc.M405014200; Beers J, 1997, J BIOL CHEM, V272, P33191, DOI 10.1074/jbc.272.52.33191; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Coppock DL, 2006, ANTIOXID REDOX SIGN, V8, P300, DOI 10.1089/ars.2006.8.300; Curran SP, 2002, EMBO J, V21, P942, DOI 10.1093/emboj/21.5.942; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Endo T, 2003, J CELL SCI, V116, P3259, DOI 10.1242/jcs.00667; Farrell SR, 2005, BIOCHEMISTRY-US, V44, P1532, DOI 10.1021/bi0479555; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; Gabriel K, 2007, J MOL BIOL, V365, P612, DOI 10.1016/j.jmb.2006.10.038; Herrmann JM, 2005, TRENDS BIOCHEM SCI, V30, P205, DOI 10.1016/j.tibs.2005.02.005; Herrmann JM, 2007, J CELL BIOL, V176, P559, DOI 10.1083/jcb.200611060; Hofhaus G, 2003, EUR J BIOCHEM, V270, P1528, DOI 10.1046/j.1432-1033.2003.03519.x; Hofmann S, 2005, J MOL BIOL, V353, P517, DOI 10.1016/j.jmb.2005.08.064; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Jensen RE, 2002, BBA-MOL CELL RES, V1592, P25, DOI 10.1016/S0167-4889(02)00261-6; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Koehler CM, 2004, TRENDS BIOCHEM SCI, V29, P1, DOI 10.1016/j.tibs.2003.11.003; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Lee JE, 2000, FEBS LETT, V477, P62, DOI 10.1016/S0014-5793(00)01767-1; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; Lu H, 2005, J MOL BIOL, V353, P897, DOI 10.1016/j.jmb.2005.09.002; Lu H, 2004, J BIOL CHEM, V279, P18952, DOI 10.1074/jbc.M313045200; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Milenkovic D, 2007, J BIOL CHEM, V282, P22472, DOI 10.1074/jbc.M703294200; Nakamoto H, 2004, BBA-MOL CELL RES, V1694, P111, DOI 10.1016/j.bbamcr.2004.02.012; Naoe M, 2004, J BIOL CHEM, V279, P47815, DOI 10.1074/jbc.M410272200; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nobrega MP, 2002, J BIOL CHEM, V277, P40206, DOI 10.1074/jbc.M207348200; Rissler M, 2005, J MOL BIOL, V353, P485, DOI 10.1016/j.jmb.2005.08.051; Sevier CS, 2006, ANTIOXID REDOX SIGN, V8, P797, DOI 10.1089/ars.2006.8.797; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Sideris DP, 2007, MOL MICROBIOL, V65, P1360, DOI 10.1111/j.1365-2958.2007.05880.x; Stojanovski D, 2007, METHOD CELL BIOL, V80, P783, DOI 10.1016/S0091-679X(06)80036-1; Terziyska N, 2005, FEBS LETT, V579, P179, DOI 10.1016/j.febslet.2004.11.072; Terziyska N, 2007, FEBS LETT, V581, P1098, DOI 10.1016/j.febslet.2007.02.014; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Vala A, 2005, J MOL BIOL, V354, P952, DOI 10.1016/j.jmb.2005.09.076; Vitu E, 2006, J MOL BIOL, V362, P89, DOI 10.1016/j.jmb.2006.06.070; Voronova A, 2007, BIOCHEM J, V408, P139, DOI 10.1042/BJ20070804; Webb CT, 2006, MOL CELL, V21, P123, DOI 10.1016/j.molcel.2005.11.010; Westerman BA, 2004, GENOMICS, V83, P1094, DOI 10.1016/j.ygeno.2003.12.006; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; ZHANG RM, 1989, J BIOL CHEM, V264, P18472	51	74	75	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37461	37470		10.1074/jbc.M707439200	http://dx.doi.org/10.1074/jbc.M707439200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17959605	hybrid			2022-12-25	WOS:000251833600021
J	Nakata, S; Fujita, N; Kitagawa, Y; Okamoto, R; Ogita, H; Takai, Y				Nakata, Shinsuke; Fujita, Naoyuki; Kitagawa, Yuichi; Okamoto, Ryoko; Ogita, Hisakazu; Takai, Yoshimi			Regulation of platelet-derived growth factor activation by afadin through SHP-2 - Implications for cellular morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; FACTOR RECEPTOR-BETA; E-CADHERIN; ADHERENS JUNCTIONS; PDGF RECEPTOR; C-SRC; TRANS-INTERACTIONS; EPITHELIAL-CELLS; SH2 DOMAINS; PDZ DOMAIN	Upon binding of platelet-derived growth factor ( PDGF), PDGF receptor is autophosphorylated at tyrosine residues in its cytoplasmic region, which induces the activation of diverse intracellular signaling pathways such those involving Ras-ERK, c-Src, and Rap1-Rac. Signaling through activated Ras-ERK promotes cell cycle and cell proliferation. The sequential activation of Rap1 and Rac affects cellular morphology and induces the formation of leading-edge structures, including lamellipodia, peripheral ruffles, and focal complexes, resulting in the enhancement of cell movement. In addition to the promotion of cell proliferation, the Ras-ERK signaling is involved in the regulation of cellular morphology. Here, we showed a novel role of afadin in the regulation of PDGF-induced intracellular signaling and cellular morphology in NIH3T3 cells. Afadin was originally identified as an actin filament-binding protein, which binds to a cell-cell adhesion molecule nectin and is involved in the formation of cell-cell junctions. When afadin was tyrosine-phosphorylated by c-Src activated in response to PDGF, afadin physically interacted with and increased the phosphatase activity of Src homology 2 domain-containing phosphatase-2 (SHP-2), a protein-tyrosine phosphatase that dephosphorylates PDGF receptor, leading to the prevention of hyperactivation of PDGF receptor and the Ras-ERK signaling. In contrast, knockdown of afadin or SHP-2 induced the hyperactivation of PDGF receptor and Ras-ERK signaling and consequently suppressed the formation of leading-edge structures. Thus, afadin plays a critical role in the proper regulation of the PDGF-induced activation of PDGF receptor and signaling by Ras-ERK. This effect, which is mediated by SHP-2, impacts cellular morphology.	[Nakata, Shinsuke; Fujita, Naoyuki; Kitagawa, Yuichi; Okamoto, Ryoko; Ogita, Hisakazu; Takai, Yoshimi] Osaka Univ, Sch Med, Fac Med, Dept Mol Biol & Biochem, Suita, Osaka 5650871, Japan; [Takai, Yoshimi] Kobe Univ, Sch Med, Fac Med, Dept Biochem & Mol Biol, Kobe, Hyogo 6500017, Japan	Osaka University; Kobe University	Takai, Y (corresponding author), Osaka Univ, Sch Med, Fac Med, Dept Mol Biol & Biochem, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ytakai@med.kobe-u.ac.jp	Ogita, Hisakazu/AAE-4416-2020	Ogita, Hisakazu/0000-0001-6750-1668				ALONSO G, 1995, J BIOL CHEM, V270, P9840, DOI 10.1074/jbc.270.17.9840; ARVIDSSON AK, 1994, MOL CELL BIOL, V14, P6715, DOI 10.1128/MCB.14.10.6715; Chiarugi P, 2002, J CELL SCI, V115, P2219; Chiarugi P, 1996, BIOCHEM BIOPH RES CO, V219, P21, DOI 10.1006/bbrc.1996.0174; DeMali KA, 1999, EXP CELL RES, V253, P271, DOI 10.1006/excr.1999.4669; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Fujito T, 2005, J CELL BIOL, V171, P165, DOI 10.1083/jcb.200501090; Fukuhara T, 2004, J CELL BIOL, V166, P393, DOI 10.1083/jcb.200401093; Fukuyama T, 2005, J BIOL CHEM, V280, P815, DOI 10.1074/jbc.M411099200; GONZALEZMARISCAL L, 1985, J MEMBRANE BIOL, V86, P113, DOI 10.1007/BF01870778; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Heldin CH, 1998, BIOCHIM BIOPHYS ACTA, V1378, P79; Holgado-Madruga M, 2004, CANCER RES, V64, P2007, DOI 10.1158/0008-5472.CAN-03-2886; Hoshino T, 2005, J BIOL CHEM, V280, P24095, DOI 10.1074/jbc.M414447200; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Ikeda W, 2004, J BIOL CHEM, V279, P18015, DOI 10.1074/jbc.M312969200; Izumi G, 2004, J CELL BIOL, V166, P237, DOI 10.1083/jcb.200401078; Jackson DE, 1997, J BIOL CHEM, V272, P24868, DOI 10.1074/jbc.272.40.24868; Kakunaga S, 2004, J BIOL CHEM, V279, P36419, DOI 10.1074/jbc.M406340200; Kawakatsu T, 2005, J BIOL CHEM, V280, P4940, DOI 10.1074/jbc.M408710200; Kawakatsu T, 2002, J BIOL CHEM, V277, P50749, DOI 10.1074/jbc.M209846200; KAZLAUSKAS A, 1993, P NATL ACAD SCI USA, V90, P6939, DOI 10.1073/pnas.90.15.6939; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; Kodama A, 2001, GENES CELLS, V6, P869, DOI 10.1046/j.1365-2443.2001.00467.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Markova B, 2003, BIOCHEMISTRY-US, V42, P2691, DOI 10.1021/bi0265574; MCCORMICK F, 1994, CURR OPIN GENET DEV, V4, P71, DOI 10.1016/0959-437X(94)90093-0; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Minami Y, 2007, J BIOL CHEM, V282, P18481, DOI 10.1074/jbc.M611330200; NANBERG E, 1993, J BIOL CHEM, V268, P18187; Ohnishi H, 1996, J BIOL CHEM, V271, P25569, DOI 10.1074/jbc.271.41.25569; PLUSKEY S, 1995, J BIOL CHEM, V270, P2897, DOI 10.1074/jbc.270.7.2897; Radziwill G, 2007, EMBO J, V26, P2633, DOI 10.1038/sj.emboj.7601706; Sakamoto Y, 2006, J BIOL CHEM, V281, P19631, DOI 10.1074/jbc.M600301200; Sakisaka T, 1999, ONCOGENE, V18, P1609, DOI 10.1038/sj.onc.1202451; Sato T, 2006, J BIOL CHEM, V281, P5288, DOI 10.1074/jbc.M510070200; SATOH T, 1993, MOL CELL BIOL, V13, P3706, DOI 10.1128/MCB.13.6.3706; Stein-Gerlach M, 1998, INT J BIOCHEM CELL B, V30, P559, DOI 10.1016/S1357-2725(98)00002-8; Takai Y, 2003, CANCER SCI, V94, P655, DOI 10.1111/j.1349-7006.2003.tb01499.x; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Takekuni K, 2003, J BIOL CHEM, V278, P5497, DOI 10.1074/jbc.C200707200; WATABE M, 1994, J CELL BIOL, V127, P247, DOI 10.1083/jcb.127.1.247; Yamada A, 2006, ONCOGENE, V25, P5085, DOI 10.1038/sj.onc.1209525; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Zhong CL, 1997, MOL BIOL CELL, V8, P2329, DOI 10.1091/mbc.8.11.2329	53	37	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37815	37825		10.1074/jbc.M707461200	http://dx.doi.org/10.1074/jbc.M707461200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17971444	hybrid			2022-12-25	WOS:000251833600057
J	Fongmoon, D; Shetty, AK; Basappa; Yamada, S; Sugiura, M; Kongtawelert, P; Sugahara, K				Fongmoon, Duriya; Shetty, Ajaya Kumar; Basappa; Yamada, Shuhei; Sugiura, Makiko; Kongtawelert, Prachya; Sugahara, Kazuyuki			Chondroitinase-mediated degradation of rare 3-O-sulfated glucuronic acid in functional oversulfated chondroitin sulfate K and E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTGROWTH-PROMOTING ACTIVITY; CENTRAL-NERVOUS-SYSTEM; EMBRYONIC PIG BRAIN; NEURITE OUTGROWTH; GROWTH-FACTOR; HYBRID CHAINS; NEURITOGENIC ACTIVITY; L2/HNK-1 CARBOHYDRATE; NEUROTROPHIC FACTORS; BINDING ACTIVITIES	Chondroitin sulfate K (CS-K) from king crab cartilage rich in rare 3-O-sulfated glucuronic acid (GlcUA(3S)) displayed neuritogenic activity and affinity toward various growth factors like CS-E from squid cartilage. CS-K-mediated neuritogenesis of mouse hippocampal neurons in culture was abolished by digestion with chondroitinase (CSase) ABC, indicating the possible involvement of GlcUA(3S). However, identification of GlcUA(3S) in CS chains by conventional high performance liquid chromatography has been hampered by its CSase ABC-mediated degradation. To investigate the degradation process, an authentic CS-E tetrasaccharide, Delta(4,5)HexUA-GalNAc(4S)GlcUA-(3S)-GalNAc(4S), was digested with CSase ABC, and the end product was identified as GalNAc(4S) by electrospray ionization mass spectrometry (ESI-MS). Putative GalNAc(6S) and GalNAc(4S, 6S), derived presumably from GlcUA(3S)GalNAc(6S) and GlcUA(3S)-GalNAc(4S, 6S), respectively, were also detected by ESI-MS in the CSase ABC digest of a CS-E oligosaccharide fraction resistant to CSases AC-I and AC-II. Intermediates during the CSase ABC-mediated degradation of Delta(4,5)HexUA( 3S)-GalNAc(4S) to GalNAc(4S) were identified through ESI-MS of a partial CSase ABC digest of a CS-K tetrasaccharide, GlcUA(3S)-GalNAc(4S)-GlcUA(3S)-GalNAc(4S), and the conceivable mechanism behind the degradation of the GlcUA(3S) moiety was elucidated. Although a fucose branch was also identified in CS-K, defucosylated CS-K exhibited greater neuritogenic activity than the native CS-K, excluding the possibility of the involvement of fucose in the activity. Rather, (3S)containing disaccharides are likely involved. These findings will enable us to detect GlcUA(3S)-containing disaccharides in CS chains to better understand CS-mediated biological processes.	[Fongmoon, Duriya; Shetty, Ajaya Kumar; Basappa; Yamada, Shuhei; Sugahara, Kazuyuki] Hokkaido Univ, Grad Sch Life Sci, Lab Proteoglycan Signaling & Therapeut,Fac Adv Li, Frontier Res Ctr Post Genom Sci & Technol,Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Fongmoon, Duriya; Shetty, Ajaya Kumar; Basappa; Yamada, Shuhei; Sugahara, Kazuyuki] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Fongmoon, Duriya; Kongtawelert, Prachya] Chiang Mai Univ, Fac Med, Dept Biochem, Thailand Excellence Ctr Tissue Engn, Chiang Mai 50200, Thailand; [Fongmoon, Duriya] Minist Publ Hlth, Dept Med, Lampang Canc Ctr, Lampang 50200, Thailand; [Sugiura, Makiko] Kobe Pharmaceut Univ, Higashinada Ku, NMR Lab, Kobe, Hyogo 6588558, Japan; [Sugahara, Kazuyuki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Atsugi, Kanagawa, Japan	Hokkaido University; Kobe Pharmaceutical University; Chiang Mai University; Ministry of Public Health - Thailand; Kobe Pharmaceutical University; Japan Science & Technology Agency (JST)	Sugahara, K (corresponding author), Hokkaido Univ, Grad Sch Life Sci, Lab Proteoglycan Signaling & Therapeut,Fac Adv Li, Frontier Res Ctr Post Genom Sci & Technol,Kita Ku, Nishi 11 Choume,Kita 21-Jo, Sapporo, Hokkaido 0010021, Japan.	k-sugar@sci.hokudai.ac.jp		kongtawelert, prachya/0000-0002-5963-2796; Basappa, Basappa/0000-0002-8844-468X				ARIGA T, 1987, J BIOL CHEM, V262, P848; Bao XF, 2005, J BIOL CHEM, V280, P9180, DOI 10.1074/jbc.M413423200; BLOCH B, 1992, DEV BRAIN RES, V70, P267, DOI 10.1016/0165-3806(92)90206-C; BOHLEN P, 1991, Progress in Growth Factor Research, V3, P143, DOI 10.1016/S0955-2235(05)80005-5; BRONNERFRASER M, 1987, DEV BIOL, V123, P321, DOI 10.1016/0012-1606(87)90390-3; Calabro A, 2001, OSTEOARTHR CARTILAGE, V9, pS16, DOI 10.1053/joca.2001.0439; CHOU DKH, 1986, J BIOL CHEM, V261, P1717; Clement AM, 1998, J BIOL CHEM, V273, P28444, DOI 10.1074/jbc.273.43.28444; DEBUS E, 1983, DIFFERENTIATION, V25, P193, DOI 10.1111/j.1432-0436.1984.tb01355.x; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; ERNFORS P, 1990, J NEUROSCI RES, V27, P10, DOI 10.1002/jnr.490270103; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; FONGMOON D, 2007, 19 INT S GLYC CAIRNS; HAYNES LW, 1988, MOL NEUROBIOL, V2, P263, DOI 10.1007/BF02935635; Hikino M, 2003, J BIOL CHEM, V278, P43744, DOI 10.1074/jbc.M308169200; IIJIMA Y, 1971, J BIOCHEM-TOKYO, V70, P75, DOI 10.1093/oxfordjournals.jbchem.a129628; ILYAS AA, 1986, BRAIN RES, V385, P1, DOI 10.1016/0006-8993(86)91540-4; JUNG W, 1994, J CELL BIOL, V126, P485, DOI 10.1083/jcb.126.2.485; KEILHAUER G, 1985, NATURE, V316, P728, DOI 10.1038/316728a0; Kinoshita A, 1997, J BIOL CHEM, V272, P19656, DOI 10.1074/jbc.272.32.19656; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; Kinoshita-Toyoda A, 2004, BIOCHEMISTRY-US, V43, P11063, DOI 10.1021/bi049622d; Kitagawa H, 1997, J BIOL CHEM, V272, P31377, DOI 10.1074/jbc.272.50.31377; Kitagawa H, 1997, BIOCHEMISTRY-US, V36, P3998, DOI 10.1021/bi962740j; KUNEMUND V, 1988, J CELL BIOL, V106, P213, DOI 10.1083/jcb.106.1.213; Li FC, 2007, J BIOL CHEM, V282, P2956, DOI 10.1074/jbc.M609296200; MARGOLIS RK, 1987, BIOCHEM BIOPH RES CO, V145, P1142, DOI 10.1016/0006-291X(87)91556-7; MARTINI R, 1992, EUR J NEUROSCI, V4, P628, DOI 10.1111/j.1460-9568.1992.tb00171.x; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Nadanaka S, 1998, J BIOL CHEM, V273, P3296, DOI 10.1074/jbc.273.6.3296; NAKANISHI Y, 1981, J BIOL CHEM, V256, P5443; Nandini CD, 2005, J BIOL CHEM, V280, P4058, DOI 10.1074/jbc.M412074200; Nandini CD, 2004, J BIOL CHEM, V279, P50799, DOI 10.1074/jbc.M404746200; NEEDHAM LK, 1993, P NATL ACAD SCI USA, V90, P1359, DOI 10.1073/pnas.90.4.1359; Ohtake S, 2003, J BIOL CHEM, V278, P38443, DOI 10.1074/jbc.M306132200; Plaas AHK, 1997, J BIOL CHEM, V272, P20603, DOI 10.1074/jbc.272.33.20603; SENO N, 1974, BIOCHIM BIOPHYS ACTA, V343, P423, DOI 10.1016/0304-4165(74)90107-X; SENO N, 1982, CARBOHYD RES, V103, P190; Sotogaku N, 2007, J NEUROCHEM, V103, P749, DOI 10.1111/j.1471-4159.2007.04849.x; Sugahara K, 1996, J BIOL CHEM, V271, P26745, DOI 10.1074/jbc.271.43.26745; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Ueoka C, 2000, J BIOL CHEM, V275, P37407, DOI 10.1074/jbc.M002538200; VIEIRA RP, 1991, J BIOL CHEM, V266, P13530; YAMADA S, 1992, J BIOCHEM-TOKYO, V112, P440, DOI 10.1093/oxfordjournals.jbchem.a123919; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0	47	27	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36895	36904		10.1074/jbc.M707082200	http://dx.doi.org/10.1074/jbc.M707082200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17951579	hybrid			2022-12-25	WOS:000251646000015
J	Lo, KWH; Kogoy, JM; Rasoul, BA; King, SM; Pfister, KK				Lo, Kevin W. -H.; Kogoy, John M.; Rasoul, Bareza A.; King, Stephen M.; Pfister, K. Kevin			Interaction of the DYNLT (TCTEX1/RP3) light chains and the intermediate chains reveals novel intersubunit regulation during assembly of the dynein complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-S-TRANSFERASE; SLOW AXONAL-TRANSPORT; CYTOPLASMIC DYNEIN; DIFFERENTIAL EXPRESSION; SUBUNIT HETEROGENEITY; FUSION PROTEINS; MOTOR DYNEIN; HEAVY-CHAIN; LC8; TCTEX-1	The cytoplasmic dynein 1 cargo binding domain is formed by five subunits including the intermediate chain and the DYNLT, DYNLL, and DYNLRB light chain families. Six isoforms of the intermediate chain and two isoforms of each of the light chain families have been identified in mammals. There is evidence that different subunit isoforms are involved in regulating dynein function, in particular linking dynein to different cargoes. However, it is unclear how the subunit isoforms are assembled or if there is any specificity to their interactions. Co-immunoprecipitation using DYNLT-specific antibodies reveals that dynein complexes with DYNLT light chains also contain the DYNLL and DYNLRB light chains. The DYNLT light chains, but not DYNLL light chains, associate exclusively with the dynein complex. Yeast two-hybrid and co-immunoprecipitation assays demonstrate that both members of the DYNLT family are capable of forming homodimers and heterodimers. In addition, both homodimers of the DYNLT family bind all six intermediate chain isoforms. However, DYNLT heterodimers do not bind to the intermediate chain. Thus, whereas all combinations of DYNLT light chain dimers can be made, not all of the possible combinations of the isoforms are utilized during the assembly of the dynein complex.	[Lo, Kevin W. -H.; Kogoy, John M.; Rasoul, Bareza A.; Pfister, K. Kevin] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA; [King, Stephen M.] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06030 USA	University of Virginia; University of Connecticut	Pfister, KK (corresponding author), Univ Virginia, Sch Med, Dept Cell Biol, POB 800732, Charlottesville, VA 22908 USA.	kkp9w@virginia.edu			NIGMS NIH HHS [GM 51293] Funding Source: Medline; NINDS NIH HHS [NS29996] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029996] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; CHANG JH, 1995, METHOD ENZYMOL, V254, P430; Chuang JZ, 2001, J NEUROSCI, V21, P5501, DOI 10.1523/JNEUROSCI.21-15-05501.2001; DiBella LM, 2001, J BIOL CHEM, V276, P14366, DOI 10.1074/jbc.M011456200; Dillman JF, 1996, P NATL ACAD SCI USA, V93, P141, DOI 10.1073/pnas.93.1.141; DILLMAN JF, 1994, J CELL BIOL, V127, P1671, DOI 10.1083/jcb.127.6.1671; Dillman JF, 1996, J NEUROSCI, V16, P6742; Douglas MW, 2004, J BIOL CHEM, V279, P28522, DOI 10.1074/jbc.M311671200; Espindola FS, 2000, CELL MOTIL CYTOSKEL, V47, P269, DOI 10.1002/1097-0169(200012)47:4<269::AID-CM2>3.3.CO;2-7; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; GILL SR, 1994, MOL BIOL CELL, V5, P645, DOI 10.1091/mbc.5.6.645; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Habura A, 1999, J BIOL CHEM, V274, P15447, DOI 10.1074/jbc.274.22.15447; King SJ, 2002, PROTEIN SCI, V11, P1239, DOI 10.1110/ps.2520102; King SM, 1996, J BIOL CHEM, V271, P19358, DOI 10.1074/jbc.271.32.19358; King SM, 1998, BIOCHEMISTRY-US, V37, P15033, DOI 10.1021/bi9810813; KOHLER G, 1975, NATURE, V256, P497; Li MG, 2004, MOL BIOL CELL, V15, P3005, DOI 10.1091/mbc.E04-01-0013; Lo KWH, 2007, J BIOL CHEM, V282, P11205, DOI 10.1074/jbc.M611279200; Lo KWH, 2006, J BIOL CHEM, V281, P9552, DOI 10.1074/jbc.M511721200; Lo KWH, 2005, J BIOL CHEM, V280, P8172, DOI 10.1074/jbc.M411408200; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Makokha M, 2004, PROTEIN SCI, V13, P727, DOI 10.1110/ps.03462204; Makokha M, 2002, BIOCHEMISTRY-US, V41, P4302, DOI 10.1021/bi011970h; Mok YK, 2001, J BIOL CHEM, V276, P14067, DOI 10.1074/jbc.M011358200; Myers KR, 2007, J NEUROSCI RES, V85, P2640, DOI 10.1002/jnr.21213; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Nikulina K, 2004, CELL MOTIL CYTOSKEL, V57, P233, DOI 10.1002/cm.10172; Nurminsky DI, 1998, MOL CELL BIOL, V18, P6816, DOI 10.1128/MCB.18.11.6816; PASCHAL BM, 1987, NATURE, V330, P672, DOI 10.1038/330672a0; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Pfister KK, 1996, MOL BIOL CELL, V7, P331, DOI 10.1091/mbc.7.2.331; Pfister KK, 1996, J BIOL CHEM, V271, P1687, DOI 10.1074/jbc.271.3.1687; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; Sakato M, 2004, J STRUCT BIOL, V146, P58, DOI 10.1016/j.jsb.2003.09.026; Salata MW, 2001, J NEUROSCI RES, V65, P408, DOI 10.1002/jnr.1168; Samso M, 1998, J MOL BIOL, V276, P927, DOI 10.1006/jmbi.1997.1584; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; SHARROCKS AD, 1994, GENE, V138, P105, DOI 10.1016/0378-1119(94)90789-7; Susalka SJ, 2000, BBA-MOL CELL RES, V1496, P76, DOI 10.1016/S0167-4889(00)00010-0; Susalka SJ, 2002, J BIOL CHEM, V277, P32939, DOI 10.1074/jbc.M205510200; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Tai AW, 2001, J CELL BIOL, V153, P1499, DOI 10.1083/jcb.153.7.1499; Talbott M, 2006, BIOCHEMISTRY-US, V45, P6793, DOI 10.1021/bi0600345; Tang Q, 2002, MOL BIOL CELL, V13, P4484, DOI 10.1091/mbc.e02-05-0245; Tynan SH, 2000, J BIOL CHEM, V275, P32769, DOI 10.1074/jbc.M001537200; Tynan SH, 2000, J BIOL CHEM, V275, P32763, DOI 10.1074/jbc.M001536200; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Vallee RB, 1996, SCIENCE, V271, P1539, DOI 10.1126/science.271.5255.1539; VAUGHAN KT, 1995, BIOCHEM SOC T, V23, P50, DOI 10.1042/bst0230050; Wang L, 2004, BIOCHEMISTRY-US, V43, P4611, DOI 10.1021/bi036328x; Wang WN, 2003, J BIOL CHEM, V278, P41491, DOI 10.1074/jbc.M307118200; Williams JC, 2005, J BIOL CHEM, V280, P21981, DOI 10.1074/jbc.M414643200; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Wilson MJ, 2001, CELL MOTIL CYTOSKEL, V49, P229, DOI 10.1002/cm.1036; Wu HW, 2005, STRUCTURE, V13, P213, DOI 10.1016/j.str.2004.11.013; Yang PF, 2001, J CELL BIOL, V153, P1315, DOI 10.1083/jcb.153.6.1315; [No title captured]	59	18	21	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36871	36878		10.1074/jbc.M705991200	http://dx.doi.org/10.1074/jbc.M705991200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17965411	hybrid			2022-12-25	WOS:000251646000012
J	Ha, SD; Ng, D; Pelech, SL; Kim, SO				Ha, Soon-Duck; Ng, Dennis; Pelech, Steven L.; Kim, Sung Ouk			Critical role of the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase-3 beta signaling pathway in recovery from anthrax lethal toxin-induced cell cycle arrest and MEK cleavage in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; T-LYMPHOCYTE ACTIVATION; BACILLUS-ANTHRACIS; DNA-DAMAGE; PROTECTIVE ANTIGEN; IN-VIVO; EXPRESSION; CHECKPOINT; RECEPTOR; KINASE	Anthrax lethal toxin (LeTx) is a virulence factor causing immune suppression and toxic shock of Bacillus anthracis infected host. It inhibits cytokine production and cell proliferation/ differentiation in various immune cells. This study showed that a brief exposure of LeTx caused a continual MEK1 cleavage and prevented tumor necrosis factor-alpha (TNF) production in response to lipopolysaccharide (LPS) in non-proliferating cells such as human peripheral blood mononuclear cells or mouse primary peritoneal macrophages. In human monocytic cell lines U-937 and THP-1, LeTx induced cell cycle arrest in G(0)-G1 phase by rapid down-regulation of cyclin D1/ D2 and checkpoint kinase 1 through MEK1 inhibition. However, THP-1 cells adaptively adjusted to LeTx and overrode cell cycle arrest by activating the phosphatidylinositol 3-kinase/Akt signaling pathway. Inhibitory Ser-9 phosphorylation of glycogen synthase kinase 3 beta(GSK3 beta) by Akt prevented proteasome-mediated cyclin D1 degradation and induced cell cycle progress in LeTx-intoxicated THP-1 cells. Recovery from cell cycle arrest was required before recovering from on-going MEK1 cleavage and suppression of TNF production. Furthermore, pretreatment with LeTx or the GSK3-specific inhibitor SB-216763, or transfection with dominant active mutant Akt or degradation-defected mutant cyclin D1 protected cells from LeTx-induced cell cycle arrest, on-going MEK1 cleavage and suppression of TNF production. These results indicate that modulation of phosphatidylinositol 3-kinase/ Akt/ GSK3 beta signaling cascades can be beneficial for protecting or facilitating recovery from cellular LeTx intoxication in cells that depend on basal MEK1 activity for proliferation.	Univ Western Ontario, Dept Microbiol & Immunol, Siebens Drake Res Inst, London, ON N6G 2V4, Canada; Univ Western Ontario, Infect Dis Res Grp, Siebens Drake Res Inst, London, ON N6G 2V4, Canada; Kinexus Bioinformat Corp, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Med, Vancouver, BC V6T 2B5, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); University of British Columbia	Kim, SO (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, Siebens Drake Res Inst, 1400 W Rd,Rm 119, London, ON N6G 2V4, Canada.	sung.kim@schulich.uwo.ca	KIM, Sung Ouk/A-1309-2008; Kim, Sung Ouk/AAO-1795-2020	Kim, Sung Ouk/0000-0002-0282-6661				ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Bonuccelli G, 2005, AM J PHYSIOL-CELL PH, V288, pC1402, DOI 10.1152/ajpcell.00582.2004; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Chen ZH, 2003, MOL CANCER THER, V2, P543; Comalada M, 2004, EUR J IMMUNOL, V34, P2257, DOI 10.1002/eji.200425110; Comer JE, 2005, INFECT IMMUN, V73, P8275, DOI 10.1128/IAI.73.12.8275-8281.2005; Cordoba-Rodriguez R, 2004, J BIOL CHEM, V279, P20563, DOI 10.1074/jbc.C300539200; Cote CK, 2006, INFECT IMMUN, V74, P469, DOI 10.1128/IAI.74.1.469-480.2006; Cote CK, 2004, MICROB PATHOGENESIS, V37, P169, DOI 10.1016/j.micpath.2004.06.013; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Drysdale M, 2005, EMBO J, V24, P221, DOI 10.1038/sj.emboj.7600495; Eapen AK, 2001, MOL CELL BIOL, V21, P6113, DOI 10.1128/MCB.21.18.6113-6121.2001; FALK LA, 1988, J LEUKOCYTE BIOL, V43, P148, DOI 10.1002/jlb.43.2.148; Fang H, 2005, J IMMUNOL, V174, P4966, DOI 10.4049/jimmunol.174.8.4966; Fang H, 2006, J IMMUNOL, V176, P6155, DOI 10.4049/jimmunol.176.10.6155; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Ha SD, 2007, J BIOL CHEM, V282, P26275, DOI 10.1074/jbc.M703668200; Hu HJ, 2006, CELL MICROBIOL, V8, P1634, DOI 10.1111/j.1462-5822.2006.00738.x; Kalogeropoulos N, 2004, CELL CYCLE, V3, P1196; Kassam A, 2005, CELL MICROBIOL, V7, P281, DOI 10.1111/j.1462-5822.2004.00458.x; Kim SO, 2003, J BIOL CHEM, V278, P7413, DOI 10.1074/jbc.M209279200; Kim SO, 2007, BIOTECHNIQUES, V42, P493, DOI 10.2144/000112390; Koo HM, 2002, P NATL ACAD SCI USA, V99, P3052, DOI 10.1073/pnas.052707699; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Li Y, 2007, EXPERT OPIN BIOL TH, V7, P843, DOI 10.1517/14712598.7.6.843; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; MIKESELL P, 1983, INFECT IMMUN, V39, P371, DOI 10.1128/IAI.39.1.371-376.1983; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; Muehlbauer SM, 2007, CELL CYCLE, V6, P758, DOI 10.4161/cc.6.6.3991; Paccani SR, 2005, J EXP MED, V201, P325, DOI 10.1084/jem.20041557; Page K, 2000, AM J RESP CELL MOL, V23, P436, DOI 10.1165/ajrcmb.23.4.3953; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Piatelli MJ, 2002, J BIOL CHEM, V277, P12144, DOI 10.1074/jbc.M200102200; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Popov SG, 2002, FEBS LETT, V527, P211, DOI 10.1016/S0014-5793(02)03228-3; Rmali KA, 2004, INT J MOL MED, V14, P75; Salles II, 2003, P NATL ACAD SCI USA, V100, P12426, DOI 10.1073/pnas.2134042100; Sanchez I, 2005, SEMIN CELL DEV BIOL, V16, P311, DOI 10.1016/j.semcdb.2005.02.007; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Shaw M, 1997, FEBS LETT, V416, P307, DOI 10.1016/S0014-5793(97)01235-0; Song JX, 2004, NAT IMMUNOL, V5, P150, DOI 10.1038/ni1030; Takuwa N, 1999, MOL CELL BIOL, V19, P1346; Tang JB, 2006, P NATL ACAD SCI USA, V103, P11964, DOI 10.1073/pnas.0604987103; Tournier JN, 2007, CELL MICROBIOL, V9, P555, DOI 10.1111/j.1462-5822.2006.00866.x; WELKOS SL, 1986, INFECT IMMUN, V51, P795, DOI 10.1128/IAI.51.3.795-800.1986; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060	53	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36230	36239		10.1074/jbc.M707622200	http://dx.doi.org/10.1074/jbc.M707622200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17951252	hybrid			2022-12-25	WOS:000251458300013
J	Zhang, Y; Liu, C; Zhu, LY; Jiang, XH; Chen, X; Qi, XQ; Liang, XY; Jin, S; Zhang, PX; Li, QG; Wang, DJ; Liu, XF; Zeng, K; Zhang, JF; Xiang, Y; Zhang, CY				Zhang, Yan; Liu, Chang; Zhu, Lingyun; Jiang, Xiaohong; Chen, Xi; Qi, Xiaoqiang; Liang, Xiangying; Jin, Sonia; Zhang, Peixiang; Li, Qingguo; Wang, Dongjin; Liu, Xiaofeng; Zeng, Ke; Zhang, Junfeng; Xiang, Yang; Zhang, Chen-Yu			PGC-1 alpha Inhibits Oleic Acid Induced Proliferation and Migration of Rat Vascular Smooth Muscle Cells	PLOS ONE			English	Article								Background. Oleic acid (OA) stimulates vascular smooth muscle cell (VSMC) proliferation and migration. The precise mechanism is still unclear. We sought to investigate the effects of peroxisome proliferator-activated receptor gamma (PPAR gamma) coactivator-1 alpha (PGC-1 alpha) on OA-induced VSMC proliferation and migration. Principal Findings. Oleate and palmitate, the most abundant monounsaturated fatty acid and saturated fatty acid in plasma, respectively, differently affect the mRNA and protein levels of PGC-1 alpha in VSMCs. OA treatment resulted in a reduction of PGC-1 alpha expression, which may be responsible for the increase in VSMC proliferation and migration caused by this fatty acid. In fact, overexpression of PGC-1 alpha prevented OA-induced VSMC proliferation and migration while suppression of PGC-1 alpha by siRNA enhanced the effects of OA. In contrast, palmitic acid (PA) treatment led to opposite effects. This saturated fatty acid induced PGC-1 alpha expression and prevented OA-induced VSMC proliferation and migration. Mechanistic study demonstrated that the effects of PGC-1 alpha on VSMC proliferation and migration result from its capacity to prevent ERK phosphorylation. Conclusions. OA and PA regulate PGC-1 alpha expression in VSMCs differentially. OA stimulates VSMC proliferation and migration via suppression of PGC-1 alpha expression while PA reverses the effects of OA by inducing PGC-1 alpha expression. Upregulation of PGC-1 alpha in VSMCs provides a potential novel strategy in preventing atherosclerosis.	[Zhang, Yan; Liu, Chang; Zhu, Lingyun; Jiang, Xiaohong; Chen, Xi; Qi, Xiaoqiang; Liang, Xiangying; Zhang, Peixiang; Liu, Xiaofeng; Zeng, Ke; Zhang, Junfeng; Xiang, Yang; Zhang, Chen-Yu] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Diabet Ctr, Nanjing 210008, Peoples R China; [Jin, Sonia] MIT, Cambridge, MA 02139 USA; [Li, Qingguo; Wang, Dongjin] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Thorac Surg, Nanjing 210008, Peoples R China	Nanjing University; Massachusetts Institute of Technology (MIT); Nanjing University	Zhang, JF (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Diabet Ctr, Nanjing 210008, Peoples R China.	jfzhang@nju.edu.cn; xiangy@nju.edu.cn; cyzhang@nju.edu.cn		/0000-0002-0420-4508	National Natural Science Foundation of China [30225037, 30471991, 30570731]; 973 Program of China [2006CB503909, 2004CB518603]; "111" Project; Natural Science Foundation of Jangsu Province [BK2004082, BK2006714]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program of China(National Basic Research Program of China); "111" Project(Ministry of Education, China - 111 Project); Natural Science Foundation of Jangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by grants from the National Natural Science Foundation of China (no. 30225037, 30471991, 30570731), the 973 Program of China (no. 2006CB503909, 2004CB518603), the "111" Project, and the Natural Science Foundation of Jangsu Province (no. BK2004082, BK2006714).	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Brown JD, 2007, CIRCULATION, V115, P518, DOI 10.1161/CIRCULATIONAHA.104.475673; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; Collins AR, 2001, ARTERIOSCL THROM VAS, V21, P365, DOI 10.1161/01.ATV.21.3.365; Crunkhorn S, 2007, J BIOL CHEM, V282, P15439, DOI 10.1074/jbc.M611214200; DAVDA RK, 1995, HYPERTENSION, V26, P764, DOI 10.1161/01.HYP.26.5.764; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Egan BM, 1996, HYPERTENSION, V27, P723, DOI 10.1161/01.HYP.27.3.723; Esterbauer H, 1999, GENOMICS, V62, P98, DOI 10.1006/geno.1999.5977; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; GALIS ZS, 1994, CIRC RES, V75, P181, DOI 10.1161/01.RES.75.1.181; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; Goetze S, 2001, J CARDIOVASC PHARM, V38, P909, DOI 10.1097/00005344-200112000-00013; GORDON D, 1986, CIRC RES, V59, P633, DOI 10.1161/01.RES.59.6.633; Greene EL, 2001, HYPERTENSION, V37, P308, DOI 10.1161/01.HYP.37.2.308; GROTENDORST GR, 1981, P NATL ACAD SCI-BIOL, V78, P3669, DOI 10.1073/pnas.78.6.3669; HAOURIGUI M, 1993, ENDOCRINOLOGY, V133, P183, DOI 10.1210/en.133.1.183; Hennes MMI, 1996, HYPERTENSION, V28, P120, DOI 10.1161/01.HYP.28.1.120; Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070; Hsueh WA, 2001, ARTERIOSCL THROM VAS, V21, P1891, DOI 10.1161/hq1201.100261; Kashyap S, 2003, DIABETES, V52, P2461, DOI 10.2337/diabetes.52.10.2461; Larrouy D, 1999, INT J OBESITY, V23, P1327, DOI 10.1038/sj.ijo.0801106; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lu G, 1996, CIRC RES, V79, P611, DOI 10.1161/01.RES.79.3.611; Lu G, 1998, HYPERTENSION, V32, P1003, DOI 10.1161/01.HYP.32.6.1003; MAJACK RA, 1984, J CELL PHYSIOL, V118, P253, DOI 10.1002/jcp.1041180306; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MARSHALL NJ, 1995, GROWTH REGULAT, V5, P69; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Oda N, 1999, J CELL PHYSIOL, V178, P121, DOI 10.1002/(SICI)1097-4652(199902)178:2<121::AID-JCP1>3.3.CO;2-6; PEIRIS AN, 1989, ANN INTERN MED, V110, P867, DOI 10.7326/0003-4819-110-11-867; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Richardson DK, 2005, J BIOL CHEM, V280, P10290, DOI 10.1074/jbc.M408985200; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sarkar R, 1996, CIRC RES, V78, P225, DOI 10.1161/01.RES.78.2.225; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Staels B, 2005, CURR MED RES OPIN, V21, pS13, DOI 10.1185/030079905X36440; Staiger H, 2005, DIABETOLOGIA, V48, P2115, DOI 10.1007/s00125-005-1895-z; Sylvester AM, 1998, J CLIN INVEST, V101, P940, DOI 10.1172/JCI1630; Wakino S, 2000, J BIOL CHEM, V275, P22435, DOI 10.1074/jbc.M910452199; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2003, DEV CELL, V5, P73, DOI 10.1016/S1534-5807(03)00170-9; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang PX, 2005, FEBS LETT, V579, P1446, DOI 10.1016/j.febslet.2005.01.046	49	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1137	10.1371/journal.pone.0001137	http://dx.doi.org/10.1371/journal.pone.0001137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987121	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459000021
J	He, Q; Luo, X; Jin, W; Huang, Y; Reddy, MVR; Reddy, EP; Sheikh, MS				He, Q.; Luo, X.; Jin, W.; Huang, Y.; Reddy, M. V. R.; Reddy, E. P.; Sheikh, M. S.			Celecoxib and a novel COX-2 inhibitor ON09310 upregulate death receptor 5 expression via GADD153/CHOP	ONCOGENE			English	Article						COX-2 inhibitors; TRAIL; death receptor 5; prostate cancer; colon cancer	ENDOPLASMIC-RETICULUM STRESS; INDUCED APOPTOSIS; CYCLOOXYGENASE-2; CANCER; ADENOCARCINOMAS; CARCINOMA; CELLS; SULINDAC; PATHWAY; COLON	Cyclooxygenase-2 (COX-2) inhibitors are promising anticancer agents but their long-term use at high doses is associated with adverse cardiovascular events. The molecular mechanisms underlying the anticancer or toxic cardiovascular effects of COX-2 inhibitors remain unknown. Here we report that COX-2-selective celecoxib and a novel COX-2 inhibitor ON09310 upregulate death receptor 5 (DR5) and cooperate with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), the ligand for DR5, to induce apoptosis in COX-2-positive and -negative cancer cells. We also show that both agents engage GADD153/CHOP to transcriptionally upregulate DR5 expression; GADD153/CHOP is a C/EBP homologous transcription factor implicated in cellular stress response and apoptosis. Based on our results, we propose that (1) these agents appear to mediate their effects, at least in part, by engaging GADD153/CHOP to activate DR5-dependent apoptotic pathway and (2) their regulation of GADD153/CHOP and DR5 expression appears to occur independent of their COX2 inhibitory effects. Our results also indicate that ON09310 is generally more potent than celecoxib and, at lower concentration, strongly cooperates with TRAIL to induce apoptosis. Taken together, our findings form the basis for future in-depth studies to further explore the utility of TRAIL and/or agonistic anti-DR5 antibodies in combination with low-dose COX-2 inhibitors as a rational approach for cancer prevention and treatment.	[He, Q.; Luo, X.; Jin, W.; Huang, Y.; Sheikh, M. S.] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Reddy, M. V. R.; Reddy, E. P.] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19122 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Sheikh, MS (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA.	sheikhm@upstate.edu	Reddy, E. Premkumar/F-6233-2011		NATIONAL CANCER INSTITUTE [R01CA109820, R01CA086945] Funding Source: NIH RePORTER; NCI NIH HHS [CA 109820, CA86945] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Gupta S, 2000, PROSTATE, V42, P73, DOI 10.1002/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G; He Q, 2002, ONCOGENE, V21, P6032, DOI 10.1038/sj.onc.1205897; He Q, 2002, ONCOGENE, V21, P2623, DOI 10.1038/sj.onc.1205345; Hida T, 1998, CANCER RES, V58, P3761; Huang Y, 2001, CANCER RES, V61, P6918; HUANG Y, 2006, TOXICOL APPL PH 1216; Liu XG, 2004, JNCI-J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; Marnett LJ, 2002, ANNU REV PHARMACOL, V42, P55, DOI 10.1146/annurev.pharmtox.42.082301.164620; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Prescott SM, 2000, BBA-REV CANCER, V1470, pM69, DOI 10.1016/S0304-419X(00)00006-8; REDDY EP, 2002, Patent No. 6376519423; Ristimaki A, 1997, CANCER RES, V57, P1276; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Wilson KT, 1998, CANCER RES, V58, P2929; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Zimmermann KC, 1999, CANCER RES, V59, P198	18	31	32	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2008	27	18					2656	2660		10.1038/sj.onc.1210894	http://dx.doi.org/10.1038/sj.onc.1210894			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	289LW	17968315				2022-12-25	WOS:000255057000015
J	Cho, CH; Parashurama, N; Park, EYH; Suganuma, K; Nahniias, Y; Park, J; Tilles, AW; Berthiaume, F; Yarmush, ML				Cho, Cheul H.; Parashurama, Natesh; Park, Eric Y. H.; Suganuma, Kazuhiro; Nahniias, Yaakov; Park, Jaesung; Tilles, Arno W.; Berthiaume, FranCois; Yarmush, Martin L.			Homogeneous differentiation of hepatocyte-like cells from embryonic stem cells: applications for the treatment of liver failure	FASEB JOURNAL			English	Article						coculture; endoderm; animal model; bioartificial liver device	IN-VITRO DIFFERENTIATION; DEFINITIVE ENDODERM; GROWTH-FACTOR; HEPATIC DIFFERENTIATION; SANDWICH CONFIGURATION; BIOARTIFICIAL LIVER; COLLAGEN SANDWICH; ENDOTHELIAL-CELLS; CONTROLLED-TRIAL; GENE-EXPRESSION	One of the major hurdles of cellular therapies for the treatment of liver failure is the low availability of functional human hepatocytes. While embryonic stem (ES) cells represent a potential cell source for therapy, current methods for differentiation result in mixed cell populations or low yields of the cells of interest. Here we describe a rapid, direct differentiation method that yields a homogeneous population of endoderm-like cells with 95% purity. Mouse ES cells cultured on top of collagen-sandwiched hepatocytes differentiated and proliferated into a uniform and homogeneous cell population of endoderm-like cells. The endoderm-like cell population was positive for Foxa2, Sox17, and AFP and could be further differentiated into hepatocyte-like cells, demonstrating hepatic morphology, functionality, and gene and protein expression. Incorporating the hepatocyte-like cells into a bioartificial liver device to treat fulminant hepatic failure improved animal survival, thereby underscoring the therapeutic potential of these cells.-Cho, C. H., Parashurama, N., Park, E. Y. H., Sugamuna, K, Nahmias, Y., Park, J., Tilles, A. W., Berthiaume, F., Yarmush, M. L. Homogeneous differentiation of hepatocyte-like cells from embryonic stem cells: applications for the treatment of liver failure.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med,Shriners Hosp Children, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Shriners Hosp Children,Dept Surg, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Tilles, AW (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med,Shriners Hosp Children, 51 Blossom St, Boston, MA 02114 USA.	arno-tilles@hms.harvard.edu; ireis@sbi.org	Nahmias, Yaakov/AAM-3872-2020; Berthiaume, Francois/ABD-2139-2020; Nahmias, Yaakov/H-4725-2013	Nahmias, Yaakov/0000-0002-6051-616X; Nahmias, Yaakov/0000-0002-6051-616X; Yarmush, Martin/0000-0003-4986-8444	NIDDK NIH HHS [R01 DK43371, K18 DK076819, P30 DK040561, P30 DK040561-12, K08 DK066040] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K18DK076819, P30DK040561, K08DK066040, R01DK043371] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANG SL, 1993, DEVELOPMENT, V119, P1301; Asahina K, 2004, GENES CELLS, V9, P1297, DOI 10.1111/j.1365-2443.2004.00809.x; Ball EMA, 2001, DEV BIOL, V238, P1, DOI 10.1006/dbio.2001.0399; Berthiaume F, 1996, FASEB J, V10, P1471, DOI 10.1096/fasebj.10.13.8940293; Bhatia SN, 1999, FASEB J, V13, P1883, DOI 10.1096/fasebj.13.14.1883; Cathey JC, 1998, EVOLUTION, V52, P1224, DOI [10.1111/j.1558-5646.1998.tb01850.x, 10.2307/2411253]; Chan C, 2004, LIVER TRANSPLANT, V10, P1331, DOI 10.1002/lt.20229; Chinzei R, 2002, HEPATOLOGY, V36, P22, DOI 10.1053/jhep.2002.34136; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; DEMETRIOU AA, 1986, P NATL ACAD SCI USA, V83, P7475, DOI 10.1073/pnas.83.19.7475; Demetriou AA, 2004, ANN SURG, V239, P660, DOI 10.1097/01.sla.0000124298.74199.e5; DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628; DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007; DUNN JCY, 1992, J CELL BIOL, V116, P1043, DOI 10.1083/jcb.116.4.1043; Endo D, 2004, J HEPATOL, V40, P399, DOI 10.1016/j.jhep.2003.11.019; Fair JH, 2005, P NATL ACAD SCI USA, V102, P2958, DOI 10.1073/pnas.0409840102; FONTAINE M, 1995, J PEDIATR SURG, V30, P56, DOI 10.1016/0022-3468(95)90610-X; Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004; GRESSNER AM, 1993, LIVER, V13, P86; Hamazaki T, 2001, FEBS LETT, V497, P15, DOI 10.1016/S0014-5793(01)02423-1; Henderson JM, 2004, ANN SURG, V239, P667; Hisatomi Y, 2004, HEPATOLOGY, V39, P667, DOI 10.1002/hep.20063; Imamura T, 2004, TISSUE ENG, V10, P1716, DOI 10.1089/ten.2004.10.1716; Ishii T, 2005, EXP CELL RES, V309, P68, DOI 10.1016/j.yexcr.2005.05.028; Jang YY, 2004, NAT CELL BIOL, V6, P532, DOI 10.1038/ncb1132; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jones EA, 2002, EXP CELL RES, V272, P15, DOI 10.1006/excr.2001.5396; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Lange C, 2005, WORLD J GASTROENTERO, V11, P4497, DOI 10.3748/wjg.v11.i29.4497; Maguire T, 2006, BIOTECHNOL BIOENG, V93, P581, DOI 10.1002/bit.20748; Maguire T, 2007, BIOTECHNOL BIOENG, V98, P631, DOI 10.1002/bit.21435; MATSUMOTO K, 1992, BIOCHEM BIOPH RES CO, V188, P235, DOI 10.1016/0006-291X(92)92375-8; NAGY P, 1994, J CELL BIOL, V126, P223, DOI 10.1083/jcb.126.1.223; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Novik EI, 2006, TISSUE ENG, V12, P1515, DOI 10.1089/ten.2006.12.1515; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Park J, 2007, LAB CHIP, V7, P1018, DOI 10.1039/b704739h; Popovic J R, 2000, Vital Health Stat 13, P1; Rambhatla L, 2003, CELL TRANSPLANT, V12, P1, DOI 10.3727/000000003783985179; SCHMIDTCHEN A, 1990, BIOCHEM J, V265, P289, DOI 10.1042/bj2650289; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Sharma NS, 2006, BIOTECHNOL BIOENG, V94, P1053, DOI 10.1002/bit.20936; Shaw CN, 2003, J MAMMAL, V84, P123, DOI 10.1644/1545-1542(2003)084&lt;0123:ARMMOG&gt;2.0.CO;2; Shirahashi H, 2004, CELL TRANSPLANT, V13, P197, DOI 10.3727/000000004783984016; Shito M, 2003, J SURG RES, V111, P53, DOI 10.1016/S0022-4804(03)00048-9; Skrtic S, 2000, LIVER, V20, P157, DOI 10.1034/j.1600-0676.2000.020002157.x; STORY MT, 1989, IN VITRO CELL DEV B, V25, P402; Strom SC, 1997, TRANSPLANTATION, V63, P559, DOI 10.1097/00007890-199702270-00014; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Wells JM, 2000, DEVELOPMENT, V127, P1563; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yarmush M L, 1992, Cell Transplant, V1, P323; YASUDA H, 1993, J CLIN INVEST, V92, P1491, DOI 10.1172/JCI116727; Zaret K, 1999, DEV BIOL, V209, P1, DOI 10.1006/dbio.1999.9228; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837; Zaret KS, 2001, CURR OPIN GENET DEV, V11, P568, DOI 10.1016/S0959-437X(00)00234-3; Zhang BM, 1997, J HEPATOL, V26, P1348, DOI 10.1016/S0168-8278(97)80471-0	61	58	62	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2008	22	3					898	909		10.1096/fj.06-7764com	http://dx.doi.org/10.1096/fj.06-7764com			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17942827				2022-12-25	WOS:000254143700028
J	Skarpen, E; Flinder, LI; Rosseland, CM; Orstavik, S; Wierod, L; Oksvold, MP; Skalhegg, BS; Huitfeldt, HS				Skarpen, Ellen; Flinder, Liv Ingrid; Rosseland, Carola Maria; Orstavik, Sigurd; Wierod, Lene; Oksvold, Morten Pedersen; Skalhegg, Bjorn Steen; Huitfeldt, Henrik Sverre			MEK1 and MEK2 regulate distinct functions by sorting ERK2 to different intracellular compartments	FASEB JOURNAL			English	Article						proliferation; survival; hepatocytes; adhesion	ACTIVATED PROTEIN-KINASE; CROSS-CASCADE ACTIVATION; GROWTH-FACTOR; NUCLEAR TRANSLOCATION; MAP KINASE; FEEDBACK PHOSPHORYLATION; TRANSPORT; COMPLEX; BINDING; RAC	In this study, we provide novel insight into the mechanism of how ERK2 can be sorted to different intracellular compartments and thereby mediate different responses. MEK1-activated ERK2 accumulated in the nucleus and induced proliferation. Conversely, MEK2-activated ERK2 was retained in the cytoplasm and allowed survival. Localization was a determinant for ERK2 functions since MEK1 switched from providing proliferation to be a mediator of survival when ERK2 was routed to the cytoplasm by the attachment of a nuclear export site. MEK1-mediated ERK2 nuclear translocation and proliferation were shown to depend on phosphorylation of S298 and T292 sites in the MEK1 proline-rich domain. These sites are phosphorylated on cellular adhesion in MEK1 but not MEK2. Whereas p21-activated kinase phosphorylates S298 and thus enhances the MEK1-ERK2 association, ERK2 phosphorylates T292, leading to release of active ERK2 from MEK1. On the basis of these results, we propose that the requirement of adhesion for cells to proliferate in response to growth factors, in part, may be explained by the MEK1 S298/T292 control of ERK2 nuclear translocation. In addition, we suggest that ERK2 intracellular localization determines whether growth factors mediate proliferation or survival and that the sorting occurs in an adhesion-dependent manner.	[Skarpen, Ellen; Flinder, Liv Ingrid; Rosseland, Carola Maria; Wierod, Lene; Oksvold, Morten Pedersen; Huitfeldt, Henrik Sverre] Univ Oslo, Rikshosp, Radiumhosp Med Ctr, Inst Pathol,Lab Toxicopathol, N-0027 Oslo, Norway; [Orstavik, Sigurd; Skalhegg, Bjorn Steen] Univ Oslo, Inst Basal Med Sci, Dept Nutr Res, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo	Skarpen, E (corresponding author), Univ Hosp, Rikshosp, Radiumhosp Med Ctr, Inst Pathol,Lab Toxicopathol, N-0027 Oslo, Norway.	ellen.skarpen@medisin.uio.no	Skålhegg, Bjørn Steen/AAZ-2976-2021	Skålhegg, Bjørn Steen/0000-0002-3481-8084				Adachi M, 2000, J CELL BIOL, V148, P849, DOI 10.1083/jcb.148.5.849; Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Belanger LF, 2003, MOL CELL BIOL, V23, P4778, DOI 10.1128/MCB.23.14.4778-4787.2003; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Burack WR, 2005, J BIOL CHEM, V280, P3832, DOI 10.1074/jbc.M410031200; CATLING AD, 1995, MOL CELL BIOL, V15, P5214; Chaudhary A, 2000, CURR BIOL, V10, P551, DOI 10.1016/S0960-9822(00)00475-9; Coles LC, 2002, ONCOGENE, V21, P2236, DOI 10.1038/sj.onc.1205302; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; Eblen ST, 2004, MOL CELL BIOL, V24, P2308, DOI 10.1128/MCB.24.6.2308-2317.2004; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Hirsch E, 2002, J CELL BIOL, V157, P481, DOI 10.1083/jcb.200111065; JELINEK T, 1994, MOL CELL BIOL, V14, P8212, DOI 10.1128/MCB.14.12.8212; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Lenormand P, 1998, J CELL BIOL, V142, P625, DOI 10.1083/jcb.142.3.625; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Rescan C, 2001, MOL BIOL CELL, V12, P725, DOI 10.1091/mbc.12.3.725; Roovers K, 1999, MOL BIOL CELL, V10, P3197, DOI 10.1091/mbc.10.10.3197; Rosseland CM, 2005, HEPATOLOGY, V42, P200, DOI 10.1002/hep.20762; Skarpen E, 2000, MOL CARCINOGEN, V28, P84, DOI 10.1002/1098-2744(200006)28:2<84::AID-MC4>3.0.CO;2-X; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Talarmin H, 1999, MOL CELL BIOL, V19, P6003; Ussar S, 2004, J BIOL CHEM, V279, P43861, DOI 10.1074/jbc.M406240200; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Xu BE, 1999, J BIOL CHEM, V274, P34029, DOI 10.1074/jbc.274.48.34029	30	35	35	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2008	22	2					466	476		10.1096/fj.07-8650com	http://dx.doi.org/10.1096/fj.07-8650com			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17928366				2022-12-25	WOS:000252822600017
J	Ishii, K; Hamamoto, H; Kamimura, M; Sekimizu, K				Ishii, Kenichi; Hamamoto, Hiroshi; Kamimura, Manabu; Sekimizu, Kazuhisa			Activation of the silkworm cytokine by bacterial and fungal cell wall components via a reactive oxygen species-triggered mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-1,3-GLUCAN RECOGNITION PROTEIN; PLASMATOCYTE SPREADING PEPTIDE; PATTERN-RECOGNITION; PARALYTIC PEPTIDE; IMMUNE-RESPONSE; IN-VITRO; MANDUCA-SEXTA; ANTIMICROBIAL PEPTIDES; LEPIDOPTERAN INSECT; CYTOTOXIC MOLECULES	The insect cytokine paralytic peptide ( PP) induces muscle contraction in silkworm larvae. Here we demonstrate that bacterial and fungal cell wall components peptidoglycan and glucan stimulate muscle contraction via activation of PP in the hemolymph. Anti-PP antibody suppressed the muscle contraction induced by PP, peptidoglycan, or glucan. The contraction was also inhibited by free radical scavengers and serine protease inhibitors. Moreover, injecting live silkworms with peptidoglycan or glucan generated the active form of PP. The active form of PP was also produced in vitro when peptidoglycan or glucan was incubated with hemolymph containing the PP precursor. Generation of the active form of PP was suppressed by free radical scavengers and serine protease inhibitors. Furthermore, PP activation in isolated hemolymph was inhibited by potassium cyanide, suggesting that cellular activity is involved. Stimulation by peptidoglycan promoted the generation of reactive oxygen species by silkworm hemocytes. The addition of either the active form of PP or anti-PP antibody to Staphylococcus aureus injected into silkworm larvae delayed or enhanced, respectively, the killing effect of S. aureus, suggesting that activated PP contributes to host resistance to infectious pathogens. These findings suggest that immunologic stimulants such as peptidoglycan or glucan induce reactive oxygen species production from larval hemocytes, followed by the activation of serine protease, which mediates the PP processing reaction and leads to defensive responses.	[Ishii, Kenichi; Sekimizu, Kazuhisa] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Hamamoto, Hiroshi] Genome Pharnaceut Inst Co Ltd, Tokyo 1130033, Japan; [Kamimura, Manabu] Natl Inst Agrobiol Sci, Tsukuba 3058634, Japan	University of Tokyo; National Institute of Agrobiological Sciences - Japan	Sekimizu, K (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	sekimizu@mol.f.u-tokyo.ac.jp	Hamamoto, Hiroshi/G-6397-2019; Ishii, Kenichi/H-5469-2019	Hamamoto, Hiroshi/0000-0001-9315-7442; 				Aizawa H, 2006, INTERNAL MED, V45, P1, DOI 10.2169/internalmedicine.45.1491; Arumugam M, 2000, EUR J CELL BIOL, V79, P513, DOI 10.1078/0171-9335-00068; Bach JF, 2003, ANN NY ACAD SCI, V998, P161, DOI 10.1196/annals.1254.017; Bergin D, 2005, INFECT IMMUN, V73, P4161, DOI 10.1128/IAI.73.7.4161-4170.2005; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Canto E, 2006, CLIN IMMUNOL, V119, P156, DOI 10.1016/j.clim.2005.12.005; CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Ferrandon D, 2004, SEMIN IMMUNOL, V16, P43, DOI 10.1016/j.smim.2003.10.008; Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; Garcia-Lara J, 2005, FEMS IMMUNOL MED MIC, V43, P311, DOI 10.1016/j.femsim.2004.11.003; Gorman MJ, 2001, INSECT BIOCHEM MOLEC, V31, P257, DOI 10.1016/S0965-1748(00)00145-4; Ha SD, 1999, PEPTIDES, V20, P561, DOI 10.1016/S0196-9781(99)00008-X; Hamamoto H, 2004, ANTIMICROB AGENTS CH, V48, P774, DOI 10.1128/AAC.48.3.774-779.2004; Hillyer JF, 2003, CELL TISSUE RES, V313, P117, DOI 10.1007/s00441-003-0744-y; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Ji CY, 2004, J BIOL CHEM, V279, P34101, DOI 10.1074/jbc.M404584200; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kamimura M, 2001, BIOCHEM BIOPH RES CO, V286, P67, DOI 10.1006/bbrc.2001.5365; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Kanost MR, 2004, IMMUNOL REV, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Khan WI, 2006, CLIN EXP IMMUNOL, V143, P389, DOI 10.1111/j.1365-2249.2005.02979.x; Khan WI, 2001, INFECT IMMUN, V69, P838, DOI 10.1128/IAI.69.2.838-844.2001; Kobayashi KS, 2004, J LEUKOCYTE BIOL, V75, P428, DOI 10.1189/jlb.0703321; Kurata S, 2006, IMMUNOBIOLOGY, V211, P237, DOI 10.1016/j.imbio.2005.10.016; Lee WJ, 1996, P NATL ACAD SCI USA, V93, P7888, DOI 10.1073/pnas.93.15.7888; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; Marcinkiewicz J, 2007, INT J EXP PATHOL, V88, P155, DOI 10.1111/j.1365-2613.2007.00530.x; Marmaras VJ, 1996, ARCH INSECT BIOCHEM, V31, P119, DOI 10.1002/(SICI)1520-6327(1996)31:2&lt;119::AID-ARCH1&gt;3.0.CO;2-V; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Miura K, 2002, PEPTIDES, V23, P2111, DOI 10.1016/S0196-9781(02)00254-1; Nakahara Y, 2003, ARCH INSECT BIOCHEM, V52, P163, DOI 10.1002/arch.10080; Nappi AJ, 2000, BIOESSAYS, V22, P469, DOI 10.1002/(SICI)1521-1878(200005)22:5<469::AID-BIES9>3.3.CO;2-W; NAPPI AJ, 1993, PIGM CELL RES, V6, P117, DOI 10.1111/j.1600-0749.1993.tb00590.x; Natori S, 1999, DEV COMP IMMUNOL, V23, P317, DOI 10.1016/S0145-305X(99)00014-2; Ochiai M, 1999, J BIOL CHEM, V274, P11854, DOI 10.1074/jbc.274.17.11854; OCHIAI M, 1988, J BIOL CHEM, V263, P12056; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Pereira LS, 2001, EXP PARASITOL, V99, P66, DOI 10.1006/expr.2001.4657; Sekimizu K, 2005, J BIOCHEM, V137, P199, DOI 10.1093/jb/mvi019; Siwik DA, 2001, AM J PHYSIOL-CELL PH, V280, pC53, DOI 10.1152/ajpcell.2001.280.1.C53; SKINNER WS, 1991, J BIOL CHEM, V266, P12873; SKINNER WS, 1993, COMP BIOCHEM PHYS C, V104, P133, DOI 10.1016/0742-8413(93)90124-4; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Strand MR, 2000, J INSECT PHYSIOL, V46, P817, DOI 10.1016/S0022-1910(99)00171-7; SUN SC, 1995, EUR J BIOCHEM, V231, P93, DOI 10.1111/j.1432-1033.1995.0093f.x; Tanji T, 2006, BIOCHEM J, V396, P127, DOI 10.1042/BJ20051921; Ujita M, 2005, BIOSCI BIOTECH BIOCH, V69, P1178, DOI 10.1271/bbb.69.1178; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Wang Y, 1999, INSECT BIOCHEM MOLEC, V29, P1075, DOI 10.1016/S0965-1748(99)00086-7; Whitten MMA, 2004, J IMMUNOL, V172, P2177, DOI 10.4049/jimmunol.172.4.2177; Whitten MMA, 1999, J INSECT PHYSIOL, V45, P667, DOI 10.1016/S0022-1910(99)00039-6; Yamakawa M, 1999, DEV COMP IMMUNOL, V23, P281, DOI 10.1016/S0145-305X(99)00011-7; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854; Yu XQ, 2002, INSECT BIOCHEM MOLEC, V32, P1287, DOI 10.1016/S0965-1748(02)00091-7	62	65	79	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2185	2191		10.1074/jbc.M705480200	http://dx.doi.org/10.1074/jbc.M705480200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	17947232	hybrid			2022-12-25	WOS:000252501000046
J	Owen, D; Campbell, LJ; Littlefield, K; Evetts, KA; Li, ZG; Sacks, DB; Lowe, PN; Mott, HR				Owen, Darerca; Campbell, Louise J.; Littlefield, Keily; Evetts, Katrina A.; Li, Zhigang; Sacks, David B.; Lowe, Peter N.; Mott, Helen R.			The IQGAP1-Rac1 and IQGAP1-Cdc42 interactions - Interfaces differ between the complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING-PROTEIN; RASGAP-RELATED PROTEIN; BINDING DOMAIN; CRYSTAL-STRUCTURE; INSERT REGION; CDC42; EFFECTOR; RAC1; CALMODULIN; IDENTIFICATION	IQGAP1 contains a domain related to the catalytic portion of the GTPase-activating proteins (GAPs) for the Ras small G proteins, yet it has no RasGAP activity and binds to the Rho family small G proteins Cdc42 and Rac1. It is thought that IQGAP1 is an effector of Rac1 and Cdc42, regulating cell-cell adhesion through the E-cadherin-catenin complex, which controls formation and maintenance of adherens junctions. This study investigates the binding interfaces of the Rac1-IQGAP1 and Cdc42-IQGAP1 complexes. We mutated Rac1 and Cdc42 and measured the effects of mutations on their affinity for IQGAP1. We have identified similarities and differences in the relative importance of residues used by Rac1 and Cdc42 to bind IQGAP1. Furthermore, the residues involved in the complexes formed with IQGAP1 differ from those formed with other effector proteins and GAPs. Relatively few mutations in switch I of Cdc42 or Rac1 affect IQGAP1 binding; only mutations in residues 32 and 36 significantly decrease affinity for IQGAP1. Switch II mutations also affect binding to IQGAP1 although the effects differ between Rac1 and Cdc42; mutation of either Asp-63, Arg-68, or Leu-70 abrogate Rac1 binding, whereas no switch II mutations affect Cdc42 binding to IQGAP1. The Rho family "insert loop" does not contribute to the binding affinity of Rac1/Cdc42 for IQGAP1. We also present thermodynamic data pertaining to the Rac1/Cdc42-RhoGAP complexes. Switch II contributes a large portion of the total binding energy to these complexes, whereas switch I mutations also affect binding. In addition we identify "cold spots" in the Rac1/Cdc42-RhoGAP/ IQGAP1 interfaces. Competition data reveal that the binding sites for IQGAP1 and RhoGAP on the small G proteins overlap only partially. Overall, the data presented here suggest that, despite their 71% identity, Cdc42 and Rac1 appear to have only partially overlapping binding sites on IQGAP1, and each uses different determinants to achieve high affinity binding.	[Owen, Darerca; Campbell, Louise J.; Littlefield, Keily; Evetts, Katrina A.; Lowe, Peter N.; Mott, Helen R.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Li, Zhigang; Sacks, David B.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Li, Zhigang; Sacks, David B.] Harvard Univ, Sch Med, Boston, MA 02115 USA	University of Cambridge; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Owen, D (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	do@bioc.cam.ac.uk; hrm28@bioc.cam.ac.uk	Mott, Helen/AAV-3873-2020	Mott, Helen/0000-0002-7890-7097; Sacks, David/0000-0003-3100-0735	NCI NIH HHS [R01 CA 93645] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA093645] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; Brill S, 1996, MOL CELL BIOL, V16, P4869; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Collinson AD, 2004, ASSAY DRUG DEV TECHN, V2, P659, DOI 10.1089/adt.2004.2.659; Elliot-Smith AE, 2005, BIOCHEMISTRY-US, V44, P12373, DOI 10.1021/bi0506021; ELLIOTSMITH AE, 2007, IN PRESS BIOCHEMISTR; FELTHAM JL, 1995, PROTEIN ENG, V8, P33; Feltham JL, 1997, BIOCHEMISTRY-US, V36, P8755, DOI 10.1021/bi970694x; Ford B, 2005, J BIOL CHEM, V280, P25697, DOI 10.1074/jbc.M502240200; Freeman JL, 1996, J BIOL CHEM, V271, P19794, DOI 10.1074/jbc.271.33.19794; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Fukata M, 1999, J BIOL CHEM, V274, P26044, DOI 10.1074/jbc.274.37.26044; Fukata M, 2001, MOL CELL BIOL, V21, P2165, DOI 10.1128/MCB.21.6.2165-2183.2001; Fukata M, 1997, J BIOL CHEM, V272, P29579, DOI 10.1074/jbc.272.47.29579; Geyer M, 1999, BIOCHEMISTRY-US, V38, P11250, DOI 10.1021/bi9904306; Geyer M, 1996, BIOCHEMISTRY-US, V35, P10308, DOI 10.1021/bi952858k; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Graham DL, 1999, BIOCHEMISTRY-US, V38, P985, DOI 10.1021/bi9821770; Graham DL, 1999, BIOCHEMISTRY-US, V38, P14981, DOI 10.1021/bi991358e; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; Joneson T, 1998, J BIOL CHEM, V273, P17991, DOI 10.1074/jbc.273.29.17991; Joyal JL, 1997, FASEB J, V11, pA1236; Karnoub AE, 2001, MOL CELL BIOL, V21, P2847, DOI 10.1128/MCB.21.8.2847-2857.2001; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; LANCASTER CA, 1994, J BIOL CHEM, V269, P1137; Li R, 1999, J BIOL CHEM, V274, P29648, DOI 10.1074/jbc.274.42.29648; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; Linnemann T, 1999, J BIOL CHEM, V274, P13556, DOI 10.1074/jbc.274.19.13556; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Mataraza JM, 2003, BIOCHEM BIOPH RES CO, V305, P315, DOI 10.1016/S0006-291X(03)00759-9; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; McCallum SJ, 1996, J BIOL CHEM, V271, P21732, DOI 10.1074/jbc.271.36.21732; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; MOTT HR, 2003, HDB CELL SIGNALLING; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; Owen D, 2005, PROTEINS CELL REG, V3, P31; Owen D, 2003, J BIOL CHEM, V278, P50578, DOI 10.1074/jbc.M304313200; Owen D, 2000, BIOCHEMISTRY-US, V39, P1243, DOI 10.1021/bi991567z; Ren JG, 2005, J BIOL CHEM, V280, P34548, DOI 10.1074/jbc.M507321200; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; Sokol SY, 2001, J BIOL CHEM, V276, P48425, DOI 10.1074/jbc.M107975200; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wang SJ, 2007, J CELL SCI, V120, P567, DOI 10.1242/jcs.03356; WANG ZX, 1995, FEBS LETT, V360, P111, DOI 10.1016/0014-5793(95)00062-E; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Winkler DG, 1997, J BIOL CHEM, V272, P24402, DOI 10.1074/jbc.272.39.24402; Wu WJ, 1997, J BIOL CHEM, V272, P26153, DOI 10.1074/jbc.272.42.26153; Zhang BL, 1997, J BIOL CHEM, V272, P21999, DOI 10.1074/jbc.272.35.21999; Zhang BL, 1998, J BIOL CHEM, V273, P8776, DOI 10.1074/jbc.273.15.8776	77	48	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1692	1704		10.1074/jbc.M707257200	http://dx.doi.org/10.1074/jbc.M707257200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17984089	hybrid			2022-12-25	WOS:000252282700056
J	Baranov, SV; Stavrovskaya, IG; Brown, AM; Tyryshkin, AM; Kristal, BS				Baranov, Sergei V.; Stavrovskaya, Irina G.; Brown, Abraham M.; Tyryshkin, Alexei M.; Kristal, Bruce S.			Kinetic model for Ca2+-induced permeability transition in energized liver mitochondria discriminates between inhibitor mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; BRAIN MITOCHONDRIA; CYCLOSPORINE-A; IN-VITRO; MEMBRANE; TARGET; HEART; RAT; INVOLVEMENT; DYSFUNCTION	Cytotoxicity associated with pathophysiological Ca2+ overload (e. g. in stroke) appears mediated by an event termed the mitochondrial permeability transition (mPT). We built and solved a kinetic model of the mPT in populations of isolated rat liver mitochondria that quantitatively describes Ca2+- induced mPT as a two-step sequence of pre-swelling induction followed by Ca2+- driven, positive feedback, autocatalytic propagation. The model was formulated as two differential equations, each directly related to experimental parameters (Ca2+ flux/ mitochondrial swelling). These parameters were simultaneously assessed using a spectroscopic approach to monitor multiple mitochondrial properties. The derived kinetic model correctly identifies a correlation between initial Ca2+ concentration and delay interval prior to mPT induction. Within the model's framework, Ru-360 (a ruthenium complex) and Mg2+ were shown to compete with the Ca2+- stimulated initiation phase of mPT induction, consistent with known inhibition at the phenomenological level of the Ca2+ uniporter. The model further reveals that Mg2+, but not Ru-360, inhibits Ca2+- induced effects on a downstream stage of mPT induction at a site distinct from the uniporter. The analytical approach was then applied to promethazine, an FDA-approved drug previously shown to inhibit both mPT and ischemia-reperfusion injury. Kinetic analysis revealed that promethazine delayed mPT induction in a manner qualitatively distinct from that of lower concentrations of Mg2+. In summary, we have developed a kinetic model to aid in the quantitative characterization of mPT induction. This model is consistent with/informative about the biochemistry of several mPT inhibitors, and its success suggests that this kinetic approach can aid in the classification of agents or targets that modulate mPT induction.	[Baranov, Sergei V.; Stavrovskaya, Irina G.; Kristal, Bruce S.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Baranov, Sergei V.; Stavrovskaya, Irina G.; Brown, Abraham M.; Kristal, Bruce S.] Burke Med Res Inst, White Plains, NY 10605 USA; [Brown, Abraham M.] Cornell Univ, Coll Med, Dept Biochem, New York, NY 10021 USA; [Kristal, Bruce S.] Cornell Univ, Coll Med, Dept Neurosci, New York, NY 10021 USA; [Tyryshkin, Alexei M.] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA	Harvard University; Brigham & Women's Hospital; Cornell University; Cornell University; Princeton University	Kristal, BS (corresponding author), Brigham & Womens Hosp, Dept Neurosurg, 221 Longwood Ave,LM322B, Boston, MA 02115 USA.	bkristal@partners.org	brown, abraham/R-8823-2019; Tyryshkin, Alexei/A-5219-2008; Tyryshkin, Alexei M/GQH-9902-2022	Tyryshkin, Alexei M/0000-0003-2625-6250				Andreyev AY, 1998, FEBS LETT, V439, P373, DOI 10.1016/S0014-5793(98)01394-5; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; Brustovetsky N, 2000, J NEUROSCI, V20, P8229, DOI 10.1523/JNEUROSCI.20-22-08229.2000; CROMPTON M, 1985, BIOCHEM SOC T, V13, P667; Dedov VN, 1999, BIOCHEMISTRY-MOSCOW+, V64, P809; Dolder M, 2003, J BIOL CHEM, V278, P17760, DOI 10.1074/jbc.M208705200; Friberg H, 2002, BIOCHIMIE, V84, P241, DOI 10.1016/S0300-9084(02)01381-0; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; HALESTRAP AP, 2001, MITOCHONDRIA PATHOGE, P177; Hansson MJ, 2004, J NEUROCHEM, V89, P715, DOI 10.1111/j.1471-4159.2004.02400.x; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; Krasnikov BF, 2005, BBA-BIOENERGETICS, V1708, P375, DOI 10.1016/j.bbabio.2005.05.009; Kristian T, 2002, J NEUROCHEM, V83, P1297, DOI 10.1046/j.1471-4159.2002.01238.x; Massari S, 1996, J BIOL CHEM, V271, P31942; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; Matsumoto S, 1999, J CEREBR BLOOD F MET, V19, P736, DOI 10.1097/00004647-199907000-00002; NICHOLLS D, 1982, BIOCHIM BIOPHYS ACTA, V683, P57, DOI 10.1016/0304-4173(82)90013-1; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; NOVGORODOV SA, 1992, J BIOL CHEM, V267, P16274; Paradies G, 2004, CIRC RES, V94, P53, DOI 10.1161/01.RES.0000109416.56608.64; Pokhilko AV, 2006, J THEOR BIOL, V243, P152, DOI 10.1016/j.jtbi.2006.05.025; RAJDEV S, 1993, NEUROSCI LETT, V162, P149, DOI 10.1016/0304-3940(93)90582-6; Ricchelli F, 2005, INT J BIOCHEM CELL B, V37, P1858, DOI 10.1016/j.biocel.2005.04.001; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Schinder AF, 1996, J NEUROSCI, V16, P6125; Stavrovskaya IG, 2005, FREE RADICAL BIO MED, V38, P687, DOI 10.1016/j.freeradbiomed.2004.11.032; Stavrovskaya IG, 2004, J EXP MED, V200, P211, DOI 10.1084/jem.20032053; Zhang SZ, 2006, LIFE SCI, V78, P738, DOI 10.1016/j.lfs.2005.05.076; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A; [No title captured]	33	29	30	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					665	676		10.1074/jbc.M703484200	http://dx.doi.org/10.1074/jbc.M703484200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17962193	hybrid			2022-12-25	WOS:000252128100003
J	Gahring, LC; Osborne-Hereford, AV; Vasquez-Opazo, GA; Rogers, SW				Gahring, Lorise C.; Osborne-Hereford, Amber V.; Vasquez-Opazo, Gustavo A.; Rogers, Scott W.			Tumor necrosis factor alpha enhances nicotinic receptor up-regulation via a p38(MAPK)-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-SITES; ACETYLCHOLINE-RECEPTORS; BRAIN; PHARMACOLOGY; SUBUNIT; SUBTYPE; ALPHA-4-BETA-2; EXPRESSION; CELLS; NEUROPROTECTION	A response by key neuronal nicotinic acetylcholine receptors (nAChRs) to sustained nicotine exposure is up-regulation. Although this unusual receptor characteristic contributes to processes ranging from aging to addiction, the normal physiologic reason for this response is unknown. We find that up-regulation of [3H] epibatidine binding and function in HEK293 cells stably expressing alpha 4 beta 2-nAChR is significantly enhanced by co-application of the proinflammatory cytokine, tumor necrosis factor alpha. The mechanism of tumor necrosis factor alpha-enhanced up-regulation requires transcription, new protein synthesis, and signaling through p38(MAPK) as demonstrated by complete inhibition using SB 202190. This finding extends the possibilities for nAChR-inflammatory interactions in normal physiological processes and offers novel insights into endogenous mechanisms that can modify up-regulation.	[Gahring, Lorise C.; Vasquez-Opazo, Gustavo A.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84132 USA; [Osborne-Hereford, Amber V.] Univ Utah, Dept Pathol, Salt Lake City, UT 84132 USA; [Rogers, Scott W.] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; [Gahring, Lorise C.; Rogers, Scott W.] Salt Lake City Vet Affairs Geriat Res Educ & Clin, Salt Lake City, UT 84148 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Geriatric Research Education & Clinical Center	Gahring, LC (corresponding author), Univ Utah, Sch Med, Dept Internal Med, 2C132,30 N 1900 E, Salt Lake City, UT 84132 USA.	Lorise.Gahring@hsc.utah.edu			NHLBI NIH HHS [P01 HL72903] Funding Source: Medline; NIA NIH HHS [AG17517] Funding Source: Medline; NIDA NIH HHS [DA015148] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL072903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015148] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BENWELL MEM, 1988, J NEUROCHEM, V50, P1243, DOI 10.1111/j.1471-4159.1988.tb10600.x; Carlson NG, 1998, J NEUROBIOL, V35, P29, DOI 10.1002/(SICI)1097-4695(199804)35:1<29::AID-NEU3>3.0.CO;2-D; Carlson NG, 1999, J IMMUNOL, V163, P3963; FLORES CM, 1992, MOL PHARMACOL, V41, P31; Gahring LC, 2005, J NEUROIMMUNOL, V166, P88, DOI 10.1016/j.jneuroim.2005.05.007; Gahring LC, 2005, NEUROBIOL AGING, V26, P973, DOI 10.1016/j.neurobiolaging.2004.07.005; Gopalakrishnan M, 1997, MOL PHARMACOL, V52, P524, DOI 10.1124/mol.52.3.524; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hogg RC, 2003, REV PHYSIOL BIOCH P, V147, P1, DOI 10.1007/s10254-003-0005-1; Hommes DW, 2003, GUT, V52, P144, DOI 10.1136/gut.52.1.144; Karihaloo A, 2001, J BIOL CHEM, V276, P9166, DOI 10.1074/jbc.M009963200; KELLAR KJ, 1987, BRAIN RES, V436, P62, DOI 10.1016/0006-8993(87)91556-3; Kishi M, 2006, MOL PHARMACOL, V70, P2037, DOI 10.1124/mol.106.029298; Lukas RJ, 1999, PHARMACOL REV, V51, P397; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; MARKS MJ, 1985, J PHARMACOL EXP THER, V235, P619; Orr-Urtreger A, 2005, NEUROREPORT, V16, P1123, DOI 10.1097/00001756-200507130-00018; Perry DC, 2002, J NEUROCHEM, V82, P468, DOI 10.1046/j.1471-4159.2002.00951.x; Rogers SW, 1998, J NEUROSCI, V18, P4825; Rogers SW, 2001, GLIA, V33, P306, DOI 10.1002/1098-1136(20010315)33:4<306::AID-GLIA1029>3.3.CO;2-N; Ross SA, 2000, J NEUROSCI, V20, P6431, DOI 10.1523/JNEUROSCI.20-17-06431.2000; SCHRODER H, 1991, ANN NY ACAD SCI, V640, P189; SCHULZ DW, 1993, J NEUROCHEM, V61, P2225, DOI 10.1111/j.1471-4159.1993.tb07463.x; SCHWARTZ RD, 1985, J NEUROCHEM, V45, P427, DOI 10.1111/j.1471-4159.1985.tb04005.x; Vallejo YF, 2005, J NEUROSCI, V25, P5563, DOI 10.1523/JNEUROSCI.5240-04.2005; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wu J, 2006, J PHYSIOL-LONDON, V576, P103, DOI 10.1113/jphysiol.2006.114645; Xiao YX, 2004, BIOORG MED CHEM LETT, V14, P1845, DOI 10.1016/j.bmcl.2003.09.105; Xiao YX, 2004, J PHARMACOL EXP THER, V310, P98, DOI 10.1124/jpet.104.066787; Xiao YX, 1998, MOL PHARMACOL, V54, P322, DOI 10.1124/mol.54.2.322; Zoli M, 1998, J NEUROSCI, V18, P4461	32	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					693	699		10.1074/jbc.M707330200	http://dx.doi.org/10.1074/jbc.M707330200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17977823	hybrid			2022-12-25	WOS:000252128100006
J	Reibarkh, M; Yamamoto, Y; Singh, CR; del Rio, F; Fahmy, A; Lee, B; Luna, RE; Ii, M; Wagner, G; Asano, K				Reibarkh, Mikhail; Yamamoto, Yasufumi; Singh, Chingakham Ranjit; del Rio, Federico; Fahmy, Amr; Lee, Bumjun; Luna, Rafael E.; Ii, Miki; Wagner, Gerhard; Asano, Katsura			Eukaryotic initiation factor (eIF) 1 carries two distinct eIF5-binding faces important for multifactor assembly and AUG selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							40S RIBOSOMAL-SUBUNIT; C-TERMINAL DOMAIN; TRANSLATION INITIATION; START CODON; PREINITIATION COMPLEX; CRYSTAL-STRUCTURE; EIF1; BINDING; YEAST; RECOGNITION	Eukaryotic initiation factor (eIF) 1 is a small protein (12 kDa) governing fidelity in translation initiation. It is recruited to the 40 S subunit in a multifactor complex with Met-tRNA(i)(Met), eIF2, eIF3, and eIF5 and binds near the P-site. eIF1 release in response to start codon recognition is an important signal to produce an 80 S initiation complex. Although the ribosome-binding face of eIF1 was identified, interfaces to other preinitiation complex components and their relevance to eIF1 function have not been determined. Exploiting the solution structure of yeast eIF1, here we locate the binding site for eIF5 in its N-terminal tail and at a basic/hydrophobic surface area termed KH, distinct from the ribosome-binding face. Genetic and biochemical studies indicate that the eIF1 N-terminal tail plays a stimulatory role in cooperative multifactor assembly. A mutation altering the basic part of eIF1-KH is lethal and shows a dominant phenotype indicating relaxed start codon selection. Cheung et al. recently demonstrated that the alteration of hydrophobic residues of eIF1 disrupts a critical link to the preinitiation complex that suppresses eIF1 release before start codon selection (Cheung, Y.-N., Maag, D., Mitchell, S. F., Fekete, C. A., Algire, M. A., Takacs, J. E., Shirokikh, N., Pestova, T., Lorsch, J. R., and Hinnebusch, A. (2007) Genes Dev. 21, 1217-1230). Interestingly, eIF1-KH includes the altered hydrophobic residues. Thus, eIF5 is an excellent candidate for the direct partner of eIF1- KH that mediates the critical link. The direct interaction at eIF1-KH also places eIF5 near the decoding site of the 40 S subunit.	[Reibarkh, Mikhail; del Rio, Federico; Fahmy, Amr; Luna, Rafael E.; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Yamamoto, Yasufumi; Singh, Chingakham Ranjit; Lee, Bumjun; Ii, Miki; Asano, Katsura] Kansas State Univ, Div Biol, Mol Cellular & Dev Biol Program, Manhattan, KS 66506 USA	Harvard University; Harvard Medical School; Kansas State University	Wagner, G (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	gerhard_wagner@hms.harvard.edu; kasano@ksu.edu	del Rio Portilla, Federico/B-4351-2015	del Rio Portilla, Federico/0000-0001-8672-0567; Reibarkh, Mikhail/0000-0002-6589-707X	NATIONAL CANCER INSTITUTE [R01CA068262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467, R01GM064781] Funding Source: NIH RePORTER; NCI NIH HHS [CA68262] Funding Source: Medline; NIGMS NIH HHS [P01 GM047467, GM64781, GM47467] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Asano K, 1998, J BIOL CHEM, V273, P18573, DOI 10.1074/jbc.273.29.18573; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; Asano K, 2001, EMBO J, V20, P2326, DOI 10.1093/emboj/20.9.2326; Bieniossek C, 2006, J MOL BIOL, V360, P457, DOI 10.1016/j.jmb.2006.05.021; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Fekete CA, 2007, EMBO J, V26, P1602, DOI 10.1038/sj.emboj.7601613; Fletcher CM, 1999, EMBO J, V18, P2631, DOI 10.1093/emboj/18.9.2631; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; He H, 2003, MOL CELL BIOL, V23, P5431, DOI 10.1128/MCB.23.15.5431-5445.2003; Hinnebusch A.G., 2007, TRANSLATIONAL CONTRO, P225; Huang HK, 1997, GENE DEV, V11, P2396, DOI 10.1101/gad.11.18.2396; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; Marintchev A, 2003, P NATL ACAD SCI USA, V100, P1535, DOI 10.1073/pnas.0437845100; Nielsen KH, 2004, EMBO J, V23, P1166, DOI 10.1038/sj.emboj.7600116; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Qiu HF, 1998, MOL CELL BIOL, V18, P2697, DOI 10.1128/MCB.18.5.2697; Singh CR, 2005, MOL CELL BIOL, V25, P5480, DOI 10.1128/MCB.25.13.5480-5491.2005; Singh CR, 2004, J BIOL CHEM, V279, P49644, DOI 10.1074/jbc.M409609200; Singh CR, 2004, J BIOL CHEM, V279, P31910, DOI 10.1074/jbc.M313940200; Valasek L, 2004, MOL CELL BIOL, V24, P9437, DOI 10.1128/MCB.24.21.9437-9455.2004; Wei ZY, 2006, J MOL BIOL, V359, P1, DOI 10.1016/j.jmb.2006.03.037; Yamamoto Y, 2005, P NATL ACAD SCI USA, V102, P16164, DOI 10.1073/pnas.0507960102; YOON HJ, 1992, MOL CELL BIOL, V12, P248, DOI 10.1128/MCB.12.1.248; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244	30	49	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1094	1103		10.1074/jbc.M708155200	http://dx.doi.org/10.1074/jbc.M708155200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17974565	hybrid			2022-12-25	WOS:000252128100049
J	van der Velden, JLJ; Schols, AMWJ; Willems, J; Kelders, MCJM; Langen, RCJ				van der Velden, Jos L. J.; Schols, Annemie M. W. J.; Willems, Jodil; Kelders, Marco C. J. M.; Langen, Ramon C. J.			Glycogen synthase kinase 3 beta suppresses myogenic differentiation through negative regulation of NFATc3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; SKELETAL-MUSCLE; CARDIAC-HYPERTROPHY; CALCINEURIN; ACTIVATION; EXPRESSION; PATHWAY; KINASE; PROTEIN; CELLS	Skeletal muscle atrophy is a prominent and disabling feature in many chronic diseases. Prevention or reversal of muscle atrophy by stimulation of skeletal muscle growth could be an important therapeutic strategy. Glycogen synthase kinase 3 beta (GSK-3 beta) has been implicated in the negative regulation of skeletal muscle growth. Since myogenic differentiation is an essential part of muscle growth, we investigated if inhibition of GSK-3 beta is sufficient to stimulate myogenic differentiation and whether this depended on regulation of the transcription factor nuclear factor of activated T-cells (NFAT). In both myogenically converted mouse embryonic fibroblasts and C2C12 myoblasts, deficiency of GSK-3 beta protein ( activity) resulted in enhanced myotube formation and muscle-specific gene expression during differentiation, which was reversed by reintroduction of wild type but not kinase-inactive (K85R) GSK-3 beta. In addition, GSK-3 beta inhibition restored myogenic differentiation following calcineurin blockade, which suggested the involvement of NFAT. GSK-3 beta-deficient mouse embryonic fibroblasts or myoblasts displayed enhanced nuclear translocation of NFATc3 and elevated NFAT-sensitive promoter transactivation, which was reduced by reintroducing wild type, but not K85R GSK-3 beta. Overexpression of NFATc3 increased muscle gene promoter transactivation, which was abolished by co-expression of wild type GSK-3 beta. Finally, stimulation of muscle gene expression observed following GSK-3 beta inhibition was strongly attenuated in NFATc3- deficient myoblasts, indicating that this response requires NFATc3. Collectively, our data demonstrate negative regulation of myogenic differentiation by GSK-3 beta through a transcriptional mechanism that depends on NFATc3. Inhibition of GSK-3 beta may be a potential strategy in prevention or treatment of muscle atrophy.	[van der Velden, Jos L. J.; Schols, Annemie M. W. J.; Willems, Jodil; Kelders, Marco C. J. M.; Langen, Ramon C. J.] Maastricht Univ, Nutr & Toxicol Res Inst Maastricht, Dept Resp Med, NL-6202 AZ Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	Langen, RCJ (corresponding author), Maastricht Univ, Nutr & Toxicol Res Inst Maastricht, Dept Resp Med, PO Box 5800, NL-6202 AZ Maastricht, Netherlands.	r.langen@pul.unimaas.nl		van der Velden, Jos/0000-0002-2451-3180				Abbott KL, 1998, MOL BIOL CELL, V9, P2905, DOI 10.1091/mbc.9.10.2905; Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Allen DL, 1999, MUSCLE NERVE, V22, P1350, DOI 10.1002/(SICI)1097-4598(199910)22:10<1350::AID-MUS3>3.0.CO;2-8; ALLEN DL, 1995, J APPL PHYSIOL, V78, P1969, DOI 10.1152/jappl.1995.78.5.1969; Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Beylkin DH, 2006, DEV BIOL, V294, P541, DOI 10.1016/j.ydbio.2006.02.049; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; CORIN SJ, 1995, P NATL ACAD SCI USA, V92, P6185, DOI 10.1073/pnas.92.13.6185; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; Delling U, 2000, MOL CELL BIOL, V20, P6600, DOI 10.1128/MCB.20.17.6600-6611.2000; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; Dunn SE, 1999, J BIOL CHEM, V274, P21908, DOI 10.1074/jbc.274.31.21908; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Friday BB, 2001, J CELL SCI, V114, P303; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Horsley V, 2001, J CELL BIOL, V153, P329, DOI 10.1083/jcb.153.2.329; Jefferson LS, 1999, INT J BIOCHEM CELL B, V31, P191, DOI 10.1016/S1357-2725(98)00141-1; Kegley KM, 2001, DEV BIOL, V232, P115, DOI 10.1006/dbio.2001.0179; Langen RCJ, 2004, FASEB J, V18, P227, DOI 10.1096/fj.03-0251com; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Miyazaki M, 2006, MED SCI SPORT EXER, V38, P1065, DOI 10.1249/01.mss.0000222833.43520.6e; Murphy LLS, 2002, J IMMUNOL, V169, P3717, DOI 10.4049/jimmunol.169.7.3717; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Neal JW, 2001, J BIOL CHEM, V276, P3666, DOI 10.1074/jbc.M004888200; O'Connor RS, 2007, J CELL SCI, V120, P149, DOI 10.1242/jcs.03307; Olson EN, 2000, BIOESSAYS, V22, P510, DOI 10.1002/(SICI)1521-1878(200006)22:6<510::AID-BIES4>3.3.CO;2-T; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Schols AMWJ, 2005, AM J CLIN NUTR, V82, P53, DOI 10.1093/ajcn/82.1.53; Schols AMWJ, 1998, AM J RESP CRIT CARE, V157, P1791, DOI 10.1164/ajrccm.157.6.9705017; Schulz RA, 2004, DEV BIOL, V266, P1, DOI 10.1016/j.ydbio.2003.10.008; SZASZ G, 1976, CLIN CHEM, V22, P650; van der Velden JLJ, 2006, AM J PHYSIOL-CELL PH, V290, pC453, DOI 10.1152/ajpcell.00068.2005; van Rooij E, 2002, J BIOL CHEM, V277, P48617, DOI 10.1074/jbc.M206532200; Vestbo J, 2006, AM J RESP CRIT CARE, V173, P79, DOI 10.1164/rccm.200505-969OC; Vyas DR, 2002, AM J PHYSIOL-CELL PH, V283, pC545, DOI 10.1152/ajpcell.00049.2002; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61	49	54	64	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					358	366		10.1074/jbc.M707812200	http://dx.doi.org/10.1074/jbc.M707812200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17977834	hybrid			2022-12-25	WOS:000251940300040
J	Li, LB; Xu, KX; Bonini, NM				Li, Ling-Bo; Xu, Kexiang; Bonini, Nancy M.			Suppression of polyglutamine toxicity by the yeast sup35 prion domain in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; SACCHAROMYCES-CEREVISIAE; EXPANDED POLYGLUTAMINE; MUTANT HUNTINGTIN; TRANSGENIC MICE; PSI+ PRION; PROTEIN; AGGREGATION; DISEASE; INHERITANCE	The propensity of proteins to form beta-sheet-rich amyloid fibrils is related to a variety of biological phenomena, including a number of human neurodegenerative diseases and prions. A subset of amyloidogenic proteins forms amyloid fibrils through glutamine/ asparagine (Q/N)-rich domains, such as pathogenic polyglutamine (poly(Q)) proteins involved in neurodegenerative disease, as well as yeast prions. In the former, the propensity of an expanded poly(Q) tract to abnormally fold confers toxicity on the respective protein, leading to neuronal dysfunction. In the latter, Q/N-rich prion domains mediate protein aggregation important for epigenetic regulation. Here, we investigated the relationship between the pathogenic ataxin-3 protein of the human disease spinocerebellar ataxia type 3 (SCA3) and the yeast prion Sup35, using Drosophila as a model system. We found that the capacity of the Sup35 prion domain to mediate protein aggregation is conserved in Drosophila. Although select yeast prions enhance poly(Q) toxicity in yeast, the Sup35N prion domain suppressed poly(Q) toxicity in the fly. Suppression required the oligopeptide repeat of the Sup35N prion domain, which is critical for prion properties in yeast. These results suggest a trans effect of prion domains on pathogenic poly(Q) disease proteins in a multicellular environment and raise the possibility that Drosophila may allow studies of prion mechanisms.	[Li, Ling-Bo; Xu, Kexiang] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Bonini, Nancy M.] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania	Bonini, NM (corresponding author), Univ Penn, Howard Hughes Med Inst, Dept Biol, Leidy Lab 306, 415 S Univ Ave, Philadelphia, PA 19104 USA.	nbonini@sas.upenn.edu						Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bonini NM, 2002, P NATL ACAD SCI USA, V99, P16407, DOI 10.1073/pnas.152330499; Borchsenius AS, 2001, EMBO J, V20, P6683, DOI 10.1093/emboj/20.23.6683; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Chai YH, 2004, J BIOL CHEM, V279, P3605, DOI 10.1074/jbc.M310939200; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Deleault NR, 2003, J NEUROCHEM, V85, P1614, DOI 10.1046/j.1471-4159.2003.01819.x; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Gokhale KC, 2005, J BIOL CHEM, V280, P22809, DOI 10.1074/jbc.M500390200; Goti D, 2004, J NEUROSCI, V24, P10266, DOI 10.1523/JNEUROSCI.2734-04.2004; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Gsponer J, 2003, P NATL ACAD SCI USA, V100, P5154, DOI 10.1073/pnas.0835307100; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Jones GW, 2005, BIOESSAYS, V27, P823, DOI 10.1002/bies.20267; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Osherovich LZ, 2002, DEV CELL, V2, P143, DOI 10.1016/S1534-5807(02)00118-1; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Paushkin SV, 1997, SCIENCE, V277, P381, DOI 10.1126/science.277.5324.381; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599; RAEBER AJ, 1995, MECH DEVELOP, V51, P317, DOI 10.1016/0925-4773(95)00379-7; Ross CA, 2003, P NATL ACAD SCI USA, V100, P1, DOI 10.1073/pnas.0237018100; Salnikova AB, 2005, J BIOL CHEM, V280, P8808, DOI 10.1074/jbc.M410150200; Shewmaker F, 2007, GENETICS, V176, P1557, DOI 10.1534/genetics.107.074153; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Thakur AK, 2002, P NATL ACAD SCI USA, V99, P17014, DOI 10.1073/pnas.252523899; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Vitrenko YA, 2007, J BIOL CHEM, V282, P1779, DOI 10.1074/jbc.M609269200; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; Zhou P, 2001, MOL MICROBIOL, V39, P37, DOI 10.1046/j.1365-2958.2001.02224.x; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	45	11	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37694	37701		10.1074/jbc.M705211200	http://dx.doi.org/10.1074/jbc.M705211200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17956866	hybrid			2022-12-25	WOS:000251833600045
J	Yamada, K; Fukao, Y; Hayashi, M; Fukazawa, M; Suzuki, I; Nishimura, M				Yamada, Kenji; Fukao, Yoichiro; Hayashi, Makoto; Fukazawa, Mitsue; Suzuki, Iku; Nishimura, Mikio			Cytosolic HSP90 regulates the heat shock response that is responsible for heat acclimation in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS TRANSCRIPTION FACTORS; MOLECULAR CHAPERONE HSP90; DISEASE RESISTANCE; BINDING-PROTEIN; GENE-EXPRESSION; DNA-BINDING; FACTOR HSF1; THERMOTOLERANCE; YEAST; COMPLEX	Plant survival requires the ability to acclimate to heat. plants are subjected to heat shock, the expression of genes is induced, and the plants become tolerant of higher We found that transient treatment with and radicicol, two heat shock protein 90 (HSP90) induced heat-inducible genes and heat acclimation in thaliana seedlings. Heat shock reduced the activity exogenously expressed glucocorticoid receptor (GR). Since activity depends on HSP90, this suggests that heat reduces cytosolic HSP90 activity in vivo. Microarray revealed that many of the genes that are up-regulated by heat shock and HSP90 inhibitors are involved in protein and degradation, suggesting that the activation of a maintenance system is a crucial part of this response. Most these genes have heat shock response element-like motifs their promoters, which suggests that heat shock factor (HSF) is involved in the response to HSP90 Several HSF genes are expressed constitutively in A. including AtHsfA1d. Recombinant AtHsfA1d protein the heat shock response element motif and interacts with thaliana cytosolic HSP90, HSP90.2. Overexpression of a negative form of HSP90.2 induced the heat-induciblegene. Thus, appears that in the absence of heat shock, cytosolic HSP90 regulates heat-inducible genes by actively suppressing function. Upon heat shock, cytosolic HSP90 is transiently which may lead to HSF activation.	[Fukao, Yoichiro] Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4008511, Japan; [Fukao, Yoichiro] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara 6300101, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Nara Institute of Science & Technology	Nishimura, M (corresponding author), Natl Inst Basic Biol, Dept Cell Biol, Nishigo-Naka 38, Okazaki, Aichi 4008511, Japan.	mikosome@nibb.ac.jp	Yamada, Kenji/C-4336-2018; Fukao, Yoichiro/E-7137-2013	Yamada, Kenji/0000-0003-4872-3729; Nishimura, Mikio/0000-0001-7960-9721				Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Baniwal SK, 2007, J BIOL CHEM, V282, P3605, DOI 10.1074/jbc.M609545200; Barzilay E, 2004, J BIOL CHEM, V279, P6847, DOI 10.1074/jbc.M312799200; Bharti K, 2004, PLANT CELL, V16, P1521, DOI 10.1105/tpc.019927; Charng YY, 2007, PLANT PHYSIOL, V143, P251, DOI 10.1104/pp.106.091322; CHENG LL, 1992, BIOCHIM BIOPHYS ACTA, V1132, P26, DOI 10.1016/0167-4781(92)90048-5; Diaz-Martin J, 2005, PLANT PHYSIOL, V139, P1483, DOI 10.1104/pp.105.069963; Duina AA, 1998, J BIOL CHEM, V273, P18974, DOI 10.1074/jbc.273.30.18974; Fu SN, 2002, PLANT CELL, V14, P3119, DOI 10.1105/tpc.006726; Hong SW, 2003, PLANT PHYSIOL, V132, P757, DOI 10.1104/pp.102.017145; Hong SW, 2000, P NATL ACAD SCI USA, V97, P4392, DOI 10.1073/pnas.97.8.4392; HUBEL A, 1994, PLANT MOL BIOL, V26, P353, DOI 10.1007/BF00039545; Hubert DA, 2003, EMBO J, V22, P5679, DOI 10.1093/emboj/cdg547; Kamada T, 2003, PLANT CELL PHYSIOL, V44, P1275, DOI 10.1093/pcp/pcg173; Kamauchi S, 2005, FEBS J, V272, P3461, DOI 10.1111/j.1742-4658.2005.04770.x; Kim BH, 2002, J EXP BOT, V53, P371, DOI 10.1093/jexbot/53.367.371; Kotak S, 2004, PLANT J, V39, P98, DOI 10.1111/j.1365-313X.2004.02111.x; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Liu YL, 2004, J BIOL CHEM, V279, P2101, DOI 10.1074/jbc.M310029200; Lohmann C, 2004, MOL GENET GENOMICS, V271, P11, DOI 10.1007/s00438-003-0954-8; Lu R, 2003, EMBO J, V22, P5690, DOI 10.1093/emboj/cdg546; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; McLellan CA, 2007, PLANT PHYSIOL, V145, P174, DOI 10.1104/pp.107.101808; Mishra SK, 2002, GENE DEV, V16, P1555, DOI 10.1101/gad.228802; Molina C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-25; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; NADEAU K, 1993, J BIOL CHEM, V268, P1479; Never L, 1996, CELL STRESS CHAPERON, V1, P215, DOI 10.1379/1466-1268(1996)001<0215:THWCAP>2.3.CO;2; Nishizawa A, 2006, PLANT J, V48, P535, DOI 10.1111/j.1365-313X.2006.02889.x; Nover L, 2001, CELL STRESS CHAPERON, V6, P177, DOI 10.1379/1466-1268(2001)006<0177:AATHST>2.0.CO;2; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pratt WB, 2004, CELL SIGNAL, V16, P857, DOI 10.1016/j.cellsig.2004.02.004; PROT M, 2004, PLANT PHYSIOL, V135, P1457; Qbadou S, 2006, EMBO J, V25, P1836, DOI 10.1038/sj.emboj.7601091; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Queitsch C, 2000, PLANT CELL, V12, P479, DOI 10.1105/tpc.12.4.479; Reindl A, 1997, PLANT PHYSIOL, V115, P93, DOI 10.1104/pp.115.1.93; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Sangster TA, 2005, CURR OPIN PLANT BIOL, V8, P86, DOI 10.1016/j.pbi.2004.11.012; Sangster TA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000648; Schoffl F, 1998, PLANT PHYSIOL, V117, P1135, DOI 10.1104/pp.117.4.1135; Schramm F, 2006, PLANT MOL BIOL, V60, P759, DOI 10.1007/s11103-005-5750-x; Soldano KL, 2003, J BIOL CHEM, V278, P48330, DOI 10.1074/jbc.M308661200; SORGER PK, 1987, EMBO J, V6, P3035, DOI 10.1002/j.1460-2075.1987.tb02609.x; SORGER PK, 1989, CELL, V59, P807, DOI 10.1016/0092-8674(89)90604-1; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wandinger SK, 2006, EMBO J, V25, P367, DOI 10.1038/sj.emboj.7600930; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; YABE N, 1994, PLANT CELL PHYSIOL, V35, P1207, DOI 10.1093/oxfordjournals.pcp.a078715; Yamada K, 2005, PLANT J, V41, P888, DOI 10.1111/j.1365-313X.2005.02349.x; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	55	156	176	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37794	37804		10.1074/jbc.M707168200	http://dx.doi.org/10.1074/jbc.M707168200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17965410	hybrid			2022-12-25	WOS:000251833600055
J	Elliott, E; Tsvetkov, P; Ginzburg, I				Elliott, Evan; Tsvetkov, Peter; Ginzburg, Irith			BAG-1 associates with Hsc70 center dot Tau complex and regulates the proteasomal degradation of Tau protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; PHOSPHORYLATED TAU; ALZHEIMERS-DISEASE; NEURONAL CELLS; CHIP; RNA; AGGREGATION; EXPRESSION; SYNAPSES; SURVIVAL	Intraneuronal accumulation of phosphorylated Tau protein is a molecular pathology found in many forms of dementia, including Alzheimer disease. Research into possible mechanisms leading to the accumulation of modified Tau protein and the possibility of removing Tau protein from the system have revealed that the chaperone protein system can interact with Tau and mediate its degradation. Hsp70/Hsc70, a member of the chaperone protein family, interacts with Tau protein and mediates proper folding of Tau and can promote degradation of Tau protein under certain circumstances. However, because Hsp70/Hsc70 has many binding partners that can mediate its activity, there is still much to discover about how Hsp70 acts in vivo to regulate Tau protein. BAG-1, an Hsp70/Hsc70 binding partner, has been implicated as a mediator of neuronal function. In this work we show that BAG-1 associates with Tau protein in an Hsc70-dependent manner. Overexpression of BAG-1 induced an increase in Tau levels, which is shown to be due to an inhibition of protein degradation. We further show that BAG-1 can inhibit the degradation of Tau protein by the 20 S proteasome but does not affect the ubiquitination of Tau protein. RNA-mediated interference depletion of BAG-1 leads to a decrease in total Tau protein levels as well as promoting hyperphosphorylation of the remaining protein. Induction of Hsp70 by heat shock enhanced the increase of Tau levels in cells overexpressing BAG-1 but induced a decrease of Tau levels in cells that were depleted of BAG-1. Finally, BAG-1 is highly expressed in neurons bearing Tau tangles in a mouse model of Alzheimer disease. This data suggests a molecular mechanism through which Tau protein levels are regulated in the cell and possible consequences for the pathology and treatment of Alzheimer disease.	[Elliott, Evan; Ginzburg, Irith] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Tsvetkov, Peter] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Ginzburg, I (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	irith.ginzburg@weizmann.ac.il	Tsvetkov, Peter/J-9878-2019; Tsvetkov, Peter/D-6458-2011	Tsvetkov, Peter/0000-0002-7577-2342; Elliott, Evan/0000-0002-1630-969X				Aranda-Abreu GE, 1999, J NEUROSCI, V19, P6907, DOI 10.1523/JNEUROSCI.19-16-06907.1999; Aronov S, 2001, J NEUROSCI, V21, P6577, DOI 10.1523/JNEUROSCI.21-17-06577.2001; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dickey CA, 2006, EXPERT OPIN THER TAR, V10, P665, DOI 10.1517/14728222.10.5.665; Dickey CA, 2006, FASEB J, V20, P753, DOI 10.1096/fj.05-5343fje; Dickey CA, 2006, J NEUROSCI, V26, P6985, DOI 10.1523/JNEUROSCI.0746-06.2006; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Gotz R, 2005, NAT NEUROSCI, V8, P1169, DOI 10.1038/nn1524; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hatakeyama S, 2004, J NEUROCHEM, V91, P299, DOI 10.1111/j.1471-4159.2004.02713.x; Kojima SI, 2004, BIOTECHNIQUES, V36, P74, DOI 10.2144/04361ST02; Liman J, 2005, MOL CELL BIOL, V25, P3715, DOI 10.1128/MCB.25.9.3715-3725.2005; Luders J, 2000, J BIOL CHEM, V275, P14817, DOI 10.1074/jbc.275.20.14817; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Mandelkow EM, 2003, NEUROBIOL AGING, V24, P1079, DOI 10.1016/j.neurobiolaging.2003.04.007; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Takayama S, 1998, CANCER RES, V58, P3116; Thies E, 2007, J NEUROSCI, V27, P2896, DOI 10.1523/JNEUROSCI.4674-06.2007; Xie HQ, 1998, BRAIN RES, V798, P173, DOI 10.1016/S0006-8993(98)00407-7	26	81	87	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37276	37284		10.1074/jbc.M706379200	http://dx.doi.org/10.1074/jbc.M706379200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17954934	hybrid			2022-12-25	WOS:000251646000053
J	Hines, JK; Chen, XM; Nix, JC; Fromm, HJ; Honzatko, RB				Hines, Justin K.; Chen, Xiaoming; Nix, Jay C.; Fromm, Herbert J.; Honzatko, Richard B.			Structures of mammalian and bacterial fructose-1,6-bisphosphatase reveal the basis for synergism in AMP/fructose 2,6-bisphosphate inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRUCTOSE 2,6-BISPHOSPHATE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; LIVER FRUCTOSE-1,6-BISPHOSPHATASE; ALLOSTERIC INHIBITION; DYNAMIC LOOP; RECOMBINANT PORCINE; NEUTRAL FORM; 1,6-BISPHOSPHATASE; AMP	Fructose-1,6-bisphosphatase (FBPase) operates at a control point in mammalian gluconeogenesis, being inhibited synergistically by fructose 2,6-bisphosphate (Fru-2,6- P-2) and AMP. AMP and Fru-2,6-P-2 bind to allosteric and active sites, respectively, but the mechanism responsible for AMP/Fru-2,6-P-2 synergy is unclear. Demonstrated here for the first time is a global conformational change in porcine FBPase induced by Fru-2,6-P-2 in the absence of AMP. The Fru-2,6-P-2 complex exhibits a subunit pair rotation of 13 degrees from the R-state ( compared with the 15 rotation of the T-state AMP complex) with active site loops in the disengaged conformation. A three-state thermodynamic model in which Fru2,6-P-2 drives a conformational change to a T-like intermediate state can account for AMP/Fru-2,6-P-2 synergism in mammalian FBPases. AMP and Fru-2,6-P-2 are not synergistic inhibitors of the Type I FBPase from Escherichia coli, and consistent with that model, the complex of E. coli FBPase with Fru-2,6-P-2 remains in the R-state with dynamic loops in the engaged conformation. Evidently in porcine FBPase, the actions of AMP at the allosteric site and Fru-2,6- P2 at the active site displace engaged dynamic loops by distinct mechanisms, resulting in similar quaternary end-states. Conceivably, Type I FBPases from alleukaryotes may undergo similar global conformational changes in response to Fru-2,6-P-2 ligation.	Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA	Iowa State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Honzatko, RB (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, 4206 Mol Biol Bldg, Ames, IA 50011 USA.	honzatko@iastate.edu			NINDS NIH HHS [NS10546, R01 NS010546] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS010546, R01NS010546] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BENKOVIC SJ, 1982, ADV ENZYMOL RAMB, V53, P45; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choe JY, 2000, BIOCHEMISTRY-US, V39, P8565, DOI 10.1021/bi000574g; Choe JY, 1998, BIOCHEMISTRY-US, V37, P11441, DOI 10.1021/bi981112u; Choe JY, 2003, J BIOL CHEM, V278, P51176, DOI 10.1074/jbc.M308396200; CORREDOR C, 1984, FEBS LETT, V167, P199, DOI 10.1016/0014-5793(84)80126-X; Donahue JL, 2000, J BACTERIOL, V182, P5624, DOI 10.1128/JB.182.19.5624-5627.2000; ELMAGHRABI MR, 1992, J BIOL CHEM, V267, P6526; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Erion MD, 2005, P NATL ACAD SCI USA, V102, P7970, DOI 10.1073/pnas.0502983102; EVANS P, 1992, PDBSET; FRAENKEL DG, 1966, ARCH BIOCHEM BIOPHYS, V114, P4, DOI 10.1016/0003-9861(66)90298-0; FRAENKEL DG, 1965, J BACTERIOL, V90, P837, DOI 10.1128/JB.90.4.837-842.1965; FRANCOIS J, 1983, EUR J BIOCHEM, V134, P269, DOI 10.1111/j.1432-1033.1983.tb07561.x; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; GANSON NJ, 1982, BIOCHEM BIOPH RES CO, V108, P233, DOI 10.1016/0006-291X(82)91856-3; GIDHJAIN M, 1994, J BIOL CHEM, V269, P27732; GOTTSCHALK ME, 1982, J BIOL CHEM, V257, P8016; GUYNN RW, 1972, J BIOL CHEM, V247, P7325; Hines JK, 2007, J BIOL CHEM, V282, P24697, DOI 10.1074/jbc.M703580200; Hines JK, 2007, J BIOL CHEM, V282, P11696, DOI 10.1074/jbc.M611104200; Hines JK, 2006, J BIOL CHEM, V281, P18386, DOI 10.1074/jbc.M602553200; HUE L, 1987, BIOCHEM J, V245, P313, DOI 10.1042/bj2450313; HUE L, 1984, BIOCHEM J, V224, P779, DOI 10.1042/bj2240779; Iancu CV, 2005, J BIOL CHEM, V280, P19737, DOI 10.1074/jbc.M501011200; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KE H, 1990, J MOL BIOL, V212, P513, DOI 10.1016/0022-2836(90)90329-K; KE HM, 1991, P NATL ACAD SCI USA, V88, P2989, DOI 10.1073/pnas.88.8.2989; KE HM, 1990, P NATL ACAD SCI USA, V87, P5243, DOI 10.1073/pnas.87.14.5243; KE HM, 1991, BIOCHEMISTRY-US, V30, P4412, DOI 10.1021/bi00232a007; KE HM, 1989, P NATL ACAD SCI USA, V86, P1475, DOI 10.1073/pnas.86.5.1475; KEMP RG, 1990, FRUCTOSE 2 6 BISPHOS, P17; KITAJIMA S, 1983, J BIOL CHEM, V258, P7352; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kurbanov FT, 1998, J BIOL CHEM, V273, P17511, DOI 10.1074/jbc.273.28.17511; KUWAJIMA M, 1984, J CLIN INVEST, V74, P1108, DOI 10.1172/JCI111479; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEDERER B, 1981, BIOCHEM BIOPH RES CO, V103, P1281, DOI 10.1016/0006-291X(81)90261-8; LIANG JY, 1992, P NATL ACAD SCI USA, V89, P2404, DOI 10.1073/pnas.89.6.2404; LIU F, 1990, J BIOL CHEM, V265, P7401; MARCUS F, 1984, BIOCHEM BIOPH RES CO, V119, P1103, DOI 10.1016/0006-291X(84)90888-X; MCGRANE MM, 1983, J BIOL CHEM, V258, P445; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; MEEK DW, 1983, FEBS LETT, V160, P105, DOI 10.1016/0014-5793(83)80946-6; MIZUNUMA H, 1983, ARCH BIOCHEM BIOPHYS, V226, P257, DOI 10.1016/0003-9861(83)90292-8; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nelson SW, 2004, J BIOL CHEM, V279, P18481, DOI 10.1074/jbc.M308811200; Nelson SW, 2002, J BIOL CHEM, V277, P15539, DOI 10.1074/jbc.M112304200; Nelson SW, 2000, BIOCHEMISTRY-US, V39, P11100, DOI 10.1021/bi000609c; Nelson SW, 2000, J BIOL CHEM, V275, P29986, DOI 10.1074/jbc.M000473200; NODA T, 1984, J BIOL CHEM, V259, P7191; Okar DA, 1999, BIOFACTORS, V10, P1, DOI 10.1002/biof.5520100101; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; PILKIS SJ, 1981, J BIOL CHEM, V256, P3619; PILKIS SJ, 1981, J BIOL CHEM, V256, P3171; PONTREMOLI S, 1982, ARCH BIOCHEM BIOPHYS, V218, P609, DOI 10.1016/0003-9861(82)90386-1; Radziuk J, 2001, DIABETES-METAB RES, V17, P250, DOI 10.1002/dmrr.217; REYES A, 1985, BIOCHEM BIOPH RES CO, V127, P373, DOI 10.1016/S0006-291X(85)80169-8; REYES A, 1987, J BIOL CHEM, V262, P8451; Roden M, 2001, RECENT PROG HORM RES, V56, P219, DOI 10.1210/rp.56.1.219; Sato T, 2004, J BACTERIOL, V186, P5799, DOI 10.1128/JB.186.17.5799-5807.2004; SCHEFFLER JE, 1986, BIOCHEMISTRY-US, V25, P6659, DOI 10.1021/bi00369a050; SHIRAKIHARA Y, 1988, J MOL BIOL, V204, P973, DOI 10.1016/0022-2836(88)90056-3; TAKETA K, 1965, J BIOL CHEM, V240, P651; TEJWANI GA, 1983, ADV ENZYMOL RAMB, V54, P121; UYEDA K, 1981, J BIOL CHEM, V256, P8394; van Poelje PD, 2007, CURR OPIN DRUG DISC, V10, P430; van Poelje PD, 2006, DIABETES, V55, P1747, DOI 10.2337/db05-1443; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P3483; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P2861; VANSCHAFTINGEN E, 1987, ADV ENZYMOL RAMB, V59, P315; VANSCHAFTINGEN E, 1980, BIOCHEM J, V192, P897, DOI 10.1042/bj1920897; VANSCHAFTINGEN E, 1990, FRUCTOSE 2 6 BISPHOS, P229; VANSCHAFTINGEN E, 1990, FRUCTOSE 2 6 BISPHOS, P65; Wright SW, 2002, J MED CHEM, V45, P3865, DOI 10.1021/jm010496a; XUE YF, 1994, P NATL ACAD SCI USA, V91, P12482, DOI 10.1073/pnas.91.26.12482	78	16	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					36121	36131		10.1074/jbc.M707302200	http://dx.doi.org/10.1074/jbc.M707302200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17933867	hybrid			2022-12-25	WOS:000251458100071
J	Holloway, AK; Begun, DJ				Holloway, Alisha K.; Begun, David J.			Rampant Adaptive Evolution in Regions of Proteins with Unknown Function in Drosophila simulans	PLOS ONE			English	Article								Adaptive protein evolution is pervasive in Drosophila. Genomic studies, thus far, have analyzed each protein as a single entity. However, the targets of adaptive events may be localized to particular parts of proteins, such as protein domains or regions involved in protein folding. We compared the population genetic mechanisms driving sequence polymorphism and divergence in defined protein domains and non-domain regions. Interestingly, we find that non-domain regions of proteins are more frequent targets of directional selection. Protein domains are also evolving under directional selection, but appear to be under stronger purifying selection than non-domain regions. Non-domain regions of proteins clearly play a major role in adaptive protein evolution on a genomic scale and merit future investigations of their functional properties.	[Holloway, Alisha K.; Begun, David J.] Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; [Holloway, Alisha K.; Begun, David J.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Holloway, AK (corresponding author), Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA.	akholloway@ucdavis.edu	Holloway, Alisha/H-9574-2013	Holloway, Alisha/0000-0001-9810-389X	National Science Foundation [0434670]; National Institutes of Health [R01 GM071926]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071926] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This material is based upon work supported by the National Science Foundation to AKH (0434670) and by the National Institutes of Health to DJB (R01 GM071926).	Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Begun DJ, 2000, GENETICS, V154, P1231; Bierne N, 2004, MOL BIOL EVOL, V21, P1350, DOI 10.1093/molbev/msh134; Cooper JL, 2004, MOL BIOL EVOL, V21, P1712, DOI 10.1093/molbev/msh179; Eyre-Walker A, 2006, TRENDS ECOL EVOL, V21, P569, DOI 10.1016/j.tree.2006.06.015; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; NEI M, 1986, MOL BIOL EVOL, V3, P418; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Schmidt PS, 2000, P NATL ACAD SCI USA, V97, P10861, DOI 10.1073/pnas.190338897; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Welch JJ, 2006, GENETICS, V173, P821, DOI 10.1534/genetics.106.056911; YANG ZH, 1994, MOL BIOL EVOL, V11, P316	14	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1113	10.1371/journal.pone.0001113	http://dx.doi.org/10.1371/journal.pone.0001113			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971876	gold, Green Published			2022-12-25	WOS:000207458700030
J	Liedvogel, M; Maeda, K; Henbest, K; Schleicher, E; Simon, T; Timmel, CR; Hore, PJ; Mouritsen, H				Liedvogel, Miriam; Maeda, Kiminori; Henbest, Kevin; Schleicher, Erik; Simon, Thomas; Timmel, Christiane R.; Hore, P. J.; Mouritsen, Henrik			Chemical Magnetoreception: Bird Cryptochrome 1a Is Excited by Blue Light and Forms Long-Lived Radical-Pairs	PLOS ONE			English	Article							DYNAMIC NUCLEAR-POLARIZATION; DEPENDENT MAGNETORECEPTION; MIGRATORY ORIENTATION; ELECTRON-TRANSFER; MAGNETIC COMPASS; DNA PHOTOLYASE; RED-LIGHT; MECHANISM; PHOTOACTIVATION	Cryptochromes (Cry) have been suggested to form the basis of light-dependent magnetic compass orientation in birds. However, to function as magnetic compass sensors, the cryptochromes of migratory birds must possess a number of key biophysical characteristics. Most importantly, absorption of blue light must produce radical pairs with lifetimes longer than about a microsecond. Cryptochrome 1a (gwCry1a) and the photolyase-homology-region of Cry1 (gwCry1-PHR) from the migratory garden warbler were recombinantly expressed and purified from a baculovirus/Sf9 cell expression system. Transient absorption measurements show that these flavoproteins are indeed excited by light in the blue spectral range leading to the formation of radicals with millisecond lifetimes. These biophysical characteristics suggest that gwCry1a is ideally suited as a primary light-mediated, radical-pair-based magnetic compass receptor.	[Liedvogel, Miriam; Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, IBU, VW Nachswuchgrp Anim Nav, D-2900 Oldenburg, Germany; [Liedvogel, Miriam] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [Maeda, Kiminori; Timmel, Christiane R.] Univ Oxford, Inorgan Chem Lab, Oxford OX1 3PS, England; [Henbest, Kevin; Hore, P. J.] Univ Oxford, Phys & Theoret Chem Lab, Oxford OX1 3PS, England; [Schleicher, Erik] Free Univ Berlin, Inst Expt Phys, Berlin, Germany; [Simon, Thomas] DIARECT AG, Freiburg, Germany	Carl von Ossietzky Universitat Oldenburg; University of Oxford; University of Oxford; University of Oxford; Free University of Berlin	Mouritsen, H (corresponding author), Carl von Ossietzky Univ Oldenburg, IBU, VW Nachswuchgrp Anim Nav, D-2900 Oldenburg, Germany.	henrik.mouritsen@uni-oldenburg.de	Liedvogel, Miriam/S-8341-2019; Maeda, Kiminori/A-3500-2012; Liedvogel, Miriam/HDM-7933-2022; Hore, Peter/R-1923-2017; Schleicher, Erik/C-9951-2010; Liedvogel, Miriam/D-5418-2015; Mouritsen, Henrik/A-5401-2010; Timmel, Christiane/GLU-4087-2022	Hore, Peter/0000-0002-8863-570X; Liedvogel, Miriam/0000-0002-8372-8560; Mouritsen, Henrik/0000-0001-7082-4839; Timmel, Christiane/0000-0003-1828-7700; Schleicher, Erik/0000-0003-2953-050X	VolkswagenStiftung; Deutsche Forschungsgemeinschaft [FOR 701 TP6, MO 1408/1-2, FOR 526 TP6]; University of Oldenburg; EPSRC; Human Frontier Science Programme; EMF Biological Research Trust; Royal Society; Engineering and Physical Sciences Research Council [GR/T05424/01] Funding Source: researchfish	VolkswagenStiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Oldenburg; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Human Frontier Science Programme(Human Frontier Science Program); EMF Biological Research Trust(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding: This work was supported by the VolkswagenStiftung (Nachwuchsgruppe and Lichtenberg-Professorship grants to HM), the Deutsche Forschungsgemeinschaft (FOR 701 TP6 and MO 1408/1-2 grants to HM; FOR 526 TP6 to ES), the University of Oldenburg (HM), the EPSRC (PJH and CRT), the Human Frontier Science Programme (CRT and KM), the EMF Biological Research Trust (PJH, CRT and KH), and the Royal Society (University Research Fellowship to CRT). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; BLISSARD GW, 1990, ANNU REV ENTOMOL, V35, P127, DOI 10.1146/annurev.en.35.010190.001015; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; BROADHURST RW, 1991, BIOCHEMISTRY-US, V30, P405, DOI 10.1021/bi00216a015; Brocklehurst B, 2002, CHEM SOC REV, V31, P301, DOI 10.1039/b107250c; Byrdin M, 2003, P NATL ACAD SCI USA, V100, P8676, DOI 10.1073/pnas.1531645100; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Cintolesi F, 2003, CHEM PHYS, V294, P385, DOI 10.1016/S0301-0104(03)00320-3; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; GHISLA S, 1974, BIOCHEMISTRY-US, V13, P589, DOI 10.1021/bi00700a029; Gindt YM, 1999, BIOCHEMISTRY-US, V38, P3857, DOI 10.1021/bi981191+; Giovani B, 2003, NAT STRUCT BIOL, V10, P489, DOI 10.1038/nsb933; Henbest KB, 2004, J AM CHEM SOC, V126, P8102, DOI 10.1021/ja048220q; HORE PJ, 1983, BIOCHEMISTRY-US, V22, P1906, DOI 10.1021/bi00277a026; Johnsen S, 2007, J EXP BIOL, V210, P3171, DOI 10.1242/jeb.007567; JORNS MS, 1984, BIOCHEMISTRY-US, V23, P2673, DOI 10.1021/bi00307a021; Liedvogel M, 2007, EUR J NEUROSCI, V25, P1166, DOI 10.1111/j.1460-9568.2007.05350.x; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; LIN CT, 1995, SCIENCE, V269, P968, DOI 10.1126/science.7638620; LUCKOW VA, 1988, BIO-TECHNOL, V6, P47, DOI 10.1038/nbt0188-47; Moller A, 2004, NATURWISSENSCHAFTEN, V91, P585, DOI 10.1007/s00114-004-0578-9; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; Mouritsen H, 2005, P NATL ACAD SCI USA, V102, P8339, DOI 10.1073/pnas.0409575102; Mouritsen H, 2004, CURR BIOL, V14, P1946, DOI 10.1016/j.cub.2004.10.025; Mouritsen H, 2004, P NATL ACAD SCI USA, V101, P14294, DOI 10.1073/pnas.0405968101; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Rodgers CT, 2005, J PHYS CHEM A, V109, P5035, DOI 10.1021/jp050765z; SALIKHOV K, 1984, SPIN POLARIZATION MA, P22; Sancar A, 2000, ANNU REV BIOCHEM, V69, P31, DOI 10.1146/annurev.biochem.69.1.31; SANCAR A, 1994, BIOCHEMISTRY-US, V33, P2, DOI 10.1021/bi00167a001; SCHNEIDER T, 1994, J EXP BIOL, V194, P255; SCHULTEN K, 1978, Z PHYS CHEM NEUE FOL, V111, P1, DOI 10.1524/zpch.1978.111.1.001; Solov'yov IA, 2007, BIOPHYS J, V92, P2711, DOI 10.1529/biophysj.106.097139; STEINER UE, 1989, CHEM REV, V89, P51, DOI 10.1021/cr00091a003; Thalau P, 2005, NATURWISSENSCHAFTEN, V92, P86, DOI 10.1007/s00114-004-0595-8; Timmel CR, 2001, CHEM PHYS LETT, V334, P387, DOI 10.1016/S0009-2614(00)01436-6; Weaver JC, 2000, NATURE, V405, P707, DOI 10.1038/35015128; Weber S, 2002, P NATL ACAD SCI USA, V99, P1319, DOI 10.1073/pnas.032469399; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko W, 2004, J EXP BIOL, V207, P1193, DOI 10.1242/jeb.00873; WILTSCHKO W, 1993, NATURE, V364, P525, DOI 10.1038/364525a0; WILTSCHKO W, 1995, J COMP PHYSIOL A, V177, P363; Woodward JR, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.077602; YASUI A, 1994, EMBO J, V13, P6143, DOI 10.1002/j.1460-2075.1994.tb06961.x	49	142	145	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1106	10.1371/journal.pone.0001106	http://dx.doi.org/10.1371/journal.pone.0001106			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971869	Green Published, Green Submitted, gold			2022-12-25	WOS:000207458700023
J	Qu, J; Liu, GH; Wu, KY; Han, PW; Wang, P; Li, JM; Zhang, X; Chen, C				Qu, Jing; Liu, Guang-Hui; Wu, Kaiyuan; Han, Peiwei; Wang, Peng; Li, Jiangmei; Zhang, Xu; Chen, Chang			Nitric Oxide Destabilizes Pias3 and Regulates Sumoylation	PLOS ONE			English	Article								Small ubiquitin-related protein modifiers (SUMO) modification is an important mechanism for posttranslational regulation of protein function. However, it is largely unknown how the sumoylation pathway is regulated. Here, we report that nitric oxide (NO) causes global hyposumoylation in mammalian cells. Both SUMO E2 conjugating enzyme Ubc9 and E3 ligase protein inhibitor of activated STAT3 (Pias3) were targets for S-nitrosation. S-nitrosation did not interfere with the SUMO conjugating activity of Ubc9, but promoted Pias3 degradation by facilitating its interaction with tripartite motif-containing 32 (Trim32), a ubiquitin E3 ligase. On the one hand, NO promoted Trim32-mediated Pias3 ubiquitination. On the other hand, NO enhanced the stimulatory effect of Pias3 on Trim32 autoubiquitination. The residue Cys459 of Pias3 was identified as a target site for S-nitrosation. Mutation of Cys459 abolished the stimulatory effect of NO on the Pias3-Trim32 interaction, indicating a requirement of S-nitrosation at Cys459 for positive regulation of the Pias3-Trim32 interplay. This study reveals a novel crosstalk between S-nitrosation, ubiquitination, and sumoylation, which may be crucial for NO-related physiological and pathological processes.	[Liu, Guang-Hui] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; Chinese Acad Sci, Grad Sch, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, GH (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	ghliu@scripps.edu; changchen@moon.ibp.ac.cn	Qu, Jing/ABB-9088-2020; wu, kaiyuan/AAD-6635-2020	qu, jing/0000-0002-3988-5067; chen, chang/0000-0003-1008-1062; wu, kaiyuan/0000-0001-7395-4524; , Xu/0000-0002-8103-8486	National Basic Research Program of China [2006CB911000, 2005CB522804, 2006CB503900]; National Natural Science Foundation of China [30270352, 30770512]; Knowledge Innovation Program of the Chinese Academy of Sciences	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	Funding: This research was supported by the National Basic Research Program of China (2006CB911000, 2005CB522804 and 2006CB503900), the National Natural Science Foundation of China (No. 30270352 and 30770512) and the Knowledge Innovation Program of the Chinese Academy of Sciences.	Albor A, 2006, J BIOL CHEM, V281, P25850, DOI 10.1074/jbc.M601655200; Boggio R, 2004, MOL CELL, V16, P549, DOI 10.1016/j.molcel.2004.11.007; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; DEPAUX A, 2007, ONCOGENE; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Hang J, 2002, J BIOL CHEM, V277, P19961, DOI 10.1074/jbc.M201799200; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Iwasaki K, 2007, J BIOL CHEM, V282, P22335, DOI 10.1074/jbc.M701477200; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jakobs A, 2007, NAT METHODS, V4, P245, DOI 10.1038/NMETH1006; Jang HD, 2004, J BIOL CHEM, V279, P24873, DOI 10.1074/jbc.M313018200; Jones MC, 2006, P NATL ACAD SCI USA, V103, P16272, DOI 10.1073/pnas.0603002103; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Liu GH, 2006, MOL BIOL CELL, V17, P1822, DOI 10.1091/mbc.E05-10-0979; Lyst MJ, 2006, EMBO J, V25, P5317, DOI 10.1038/sj.emboj.7601404; Man JH, 2006, NUCLEIC ACIDS RES, V34, P5552, DOI 10.1093/nar/gkl691; Matsuura T, 2005, EXP CELL RES, V308, P65, DOI 10.1016/j.yexcr.2005.04.022; Navarro-Lerida I, 2004, J BIOL CHEM, V279, P55682, DOI 10.1074/jbc.M406621200; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Qu J, 2007, NUCLEIC ACIDS RES, V35, P2522, DOI 10.1093/nar/gkl1163; Saitoh H, 2002, J BIOL CHEM, V277, P4755, DOI 10.1074/jbc.M104453200; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782	30	41	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1085	10.1371/journal.pone.0001085	http://dx.doi.org/10.1371/journal.pone.0001085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17987106	gold, Green Published, Green Submitted			2022-12-25	WOS:000207458700004
J	Kawamura, N; Kugimiya, F; Oshima, Y; Ohba, S; Ikeda, T; Saito, T; Shinoda, Y; Kawasaki, Y; Ogata, N; Hoshi, K; Akiyama, T; Chen, WS; Hay, N; Tobe, K; Kadowaki, T; Azuma, Y; Tanaka, S; Nakamura, K; Chung, U; Kawaguchi, H				Kawamura, Naohiro; Kugimiya, Fumitaka; Oshima, Yasushi; Ohba, Shinsuke; Ikeda, Toshiyuki; Saito, Taku; Shinoda, Yusuke; Kawasaki, Yosuke; Ogata, Naoshi; Hoshi, Kazuto; Akiyama, Toru; Chen, William S.; Hay, Nissim; Tobe, Kazuyuki; Kadowaki, Takashi; Azuma, Yoshiaki; Tanaka, Sakae; Nakamura, Kozo; Chung, Ung-il; Kawaguchi, Hiroshi			Akt1 in Osteoblasts and Osteoclasts Controls Bone Remodeling	PLOS ONE			English	Article								Bone mass and turnover are maintained by the coordinated balance between bone formation by osteoblasts and bone resorption by osteoclasts, under regulation of many systemic and local factors. Phosphoinositide-dependent serine-threonine protein kinase Akt is one of the key players in the signaling of potent bone anabolic factors. This study initially showed that the disruption of Akt1, a major Akt in osteoblasts and osteoclasts, in mice led to low-turnover osteopenia through dysfunctions of both cells. Ex vivo cell culture analyses revealed that the osteoblast dysfunction was traced to the increased susceptibility to the mitochondria-dependent apoptosis and the decreased transcriptional activity of runt-related transcription factor 2 (Runx2), a master regulator of osteoblast differentiation. Notably, our findings revealed a novel role of Akt1/forkhead box class O (FoxO) 3a/Bim axis in the apoptosis of osteoblasts: Akt1 phosphorylates the transcription factor FoxO3a to prevent its nuclear localization, leading to impaired transactivation of its target gene Bim which was also shown to be a potent proapoptotic molecule in osteoblasts. The osteoclast dysfunction was attributed to the cell autonomous defects of differentiation and survival in osteoclasts and the decreased expression of receptor activator of nuclear factor-kappa B ligand ( RANKL), a major determinant of osteoclastogenesis, in osteoblasts. Akt1 was established as a crucial regulator of osteoblasts and osteoclasts by promoting their differentiation and survival to maintain bone mass and turnover. The molecular network found in this study will provide a basis for rational therapeutic targets for bone disorders.	[Kawamura, Naohiro; Kugimiya, Fumitaka; Oshima, Yasushi; Ikeda, Toshiyuki; Saito, Taku; Shinoda, Yusuke; Kawasaki, Yosuke; Ogata, Naoshi; Hoshi, Kazuto; Akiyama, Toru; Tanaka, Sakae; Nakamura, Kozo; Kawaguchi, Hiroshi] Univ Tokyo, Fac Med, Dept Sensory & Motor Syst Med, Tokyo 113, Japan; [Ohba, Shinsuke; Chung, Ung-il] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Tokyo 113, Japan; [Chen, William S.] Univ Kansas, Transgen & Knockout Mouse Lab, Lawrence, KS 66045 USA; [Hay, Nissim] Univ Illinois, Coll Med, Dept Mol Genet, Chicago, IL USA; [Tobe, Kazuyuki; Kadowaki, Takashi] Univ Tokyo, Fac Med, Dept Metab Dis, Tokyo 113, Japan; [Azuma, Yoshiaki] Teijin Inst Biomed Res, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Kansas; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Tokyo	Kawaguchi, H (corresponding author), Univ Tokyo, Fac Med, Dept Sensory & Motor Syst Med, Tokyo 113, Japan.	kawaguchi-ort@h.u-tokyo.ac.jp	Akiyama, Toru/AAA-5887-2020; Kawamura, Naohiro/J-8372-2019; Ikeda, Toshiyuki/GVS-5588-2022; Tanaka, Sakae/Y-3061-2019	Akiyama, Toru/0000-0001-9493-4768; Tanaka, Sakae/0000-0001-9210-9414; Ohba, Shinsuke/0000-0002-6874-8539	Japanese Ministry of Education, Culture, Sports, Science, and Technology [17390410]	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (#17390410). The sponsor had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Akiyama T, 2003, EMBO J, V22, P6653, DOI 10.1093/emboj/cdg635; Akune T, 2002, J CELL BIOL, V159, P147, DOI 10.1083/jcb.200204046; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; CANALIS E, 1989, J CLIN INVEST, V83, P60, DOI 10.1172/JCI113885; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Huang BK, 2000, J BONE MINER RES, V15, P188, DOI 10.1359/jbmr.2000.15.2.188; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793; Kim R, 2005, BIOCHEM BIOPH RES CO, V333, P336, DOI 10.1016/j.bbrc.2005.04.161; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lee ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211, DOI 10.1016/S0006-291X(03)00695-8; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Liu XM, 2007, P NATL ACAD SCI USA, V104, P2259, DOI 10.1073/pnas.0604153104; Niu TH, 2005, GENE, V361, P38, DOI 10.1016/j.gene.2005.07.016; Ohlsson C, 1998, ENDOCR REV, V19, P55, DOI 10.1210/er.19.1.55; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Rosen CJ, 1997, BONE, V21, P217, DOI 10.1016/S8756-3282(97)00143-9; Sugatani T, 2005, J BIOL CHEM, V280, P3583, DOI 10.1074/jbc.M410480200; Thrailkill KM, 2005, AM J PHYSIOL-ENDOC M, V289, pE735, DOI 10.1152/ajpendo.00159.2005; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Yamada T, 2006, NAT MED, V12, P665, DOI 10.1038/nm1409; Yamaguchi M, 2005, ENDOCRINOLOGY, V146, P2620, DOI 10.1210/en.2004-1511; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200	40	194	208	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1058	10.1371/journal.pone.0001058	http://dx.doi.org/10.1371/journal.pone.0001058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957242	Green Published, gold, Green Submitted			2022-12-25	WOS:000207458500005
J	Swirski, FK; Berger, CR; Figueiredo, JL; Mempel, TR; von Andrian, UH; Pittet, MJ; Weissleder, R				Swirski, Filip K.; Berger, Cedric R.; Figueiredo, Jose-Luiz; Mempel, Thorsten R.; von Andrian, Ulrich H.; Pittet, Mikael J.; Weissleder, Ralph			A Near-Infrared Cell Tracker Reagent for Multiscopic In Vivo Imaging and Quantification of Leukocyte Immune Responses	PLOS ONE			English	Article								The complexity of the tumor microenvironment necessitates that cell behavior is studied in a broad, multi-scale context. Although tomographic and microscopy-based far and near infrared fluorescence (NIRF, >650 nm) imaging methods offer high resolution, sensitivity, and depth penetration, there has been a lack of optimized NIRF agents to label and track cells in their native environments at different scales. In this study we labeled mammalian leukocytes with VivoTag 680 (VT680), an amine reactive N-hydroxysuccinimide (NHS) ester of a (benz) indolium-derived far red fluorescent probe. We show that VT680 diffuses into leukocytes within minutes, covalently binds to cellular components, remains internalized for days in vitro and in vivo, and does not transfer fluorescence to adjacent cells. It is biocompatible, keeps cells fully functional, and fluoresces at high intensities. In a tumor model of cytotoxic T lymphocyte (CTL) immunotherapy, we track and quantify VT680-labeled cells longitudinally at the whole-body level with fluorescence-mediated molecular tomography (FMT), within tissues at single cell resolutions by multiphoton and confocal intravital microscopy, and ex vivo by flow cytometry. Thus, this approach is suitable to monitor cells at multiple resolutions in real time in their native environments by NIR-based fluorescence imaging.	[Swirski, Filip K.; Berger, Cedric R.; Figueiredo, Jose-Luiz; Pittet, Mikael J.; Weissleder, Ralph] Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA USA; [Swirski, Filip K.; Berger, Cedric R.; Figueiredo, Jose-Luiz; Pittet, Mikael J.; Weissleder, Ralph] Harvard Univ, Sch Med, Charlestown, MA USA; [Mempel, Thorsten R.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA USA; [von Andrian, Ulrich H.] Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA USA; [von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Pittet, Mikael J.; Weissleder, Ralph] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Swirski, FK (corresponding author), Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA USA.		von Andrian, Ulrich H/A-5775-2008; Pittet, Mikael/ABD-6300-2021; Swirski, Filip/AAF-1340-2019	Swirski, Filip/0000-0002-3163-9152; Berger, Cedric/0000-0003-2086-7392; /0000-0003-0828-4143	NIH [U54 CA126515, P01A154904, U01 HL080731, R24 CA69246, P50-CA086355]; American Heart Association [0525866T]; Novartis Foundation; Human Frontier Science Program Organization [LT00369/2003]; NATIONAL CANCER INSTITUTE [U54CA126515, P01CA069246, P50CA086355] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069259] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Novartis Foundation(Novartis); Human Frontier Science Program Organization(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH grants U54 CA126515, P01A154904, U01 HL080731 and R24 CA69246 (to RW), P50-CA086355 ( to RW and MJP). FKS was supported by a post-doctoral fellowship from American Heart Association (0525866T). CRB was supported by a fellowship from Novartis Foundation ( formerly the Ciba-Geigy Jubilee Foundation). MJP was supported by the Human Frontier Science Program Organization (LT00369/2003).	Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Hanson HL, 2000, IMMUNITY, V13, P265, DOI 10.1016/S1074-7613(00)00026-1; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; LEHR HA, 1993, LAB INVEST, V68, P388; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Mrass P, 2006, J EXP MED, V203, P2749, DOI 10.1084/jem.20060710; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; Pittet MJ, 2007, P NATL ACAD SCI USA, V104, P12457, DOI 10.1073/pnas.0704460104; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123	18	52	52	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1075	10.1371/journal.pone.0001075	http://dx.doi.org/10.1371/journal.pone.0001075			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957257	Green Published, gold			2022-12-25	WOS:000207458500020
J	Tsutsumi, S; Scroggins, B; Koga, F; Lee, MJ; Trepel, J; Felts, S; Carreras, C; Neckers, L				Tsutsumi, S.; Scroggins, B.; Koga, F.; Lee, M-J; Trepel, J.; Felts, S.; Carreras, C.; Neckers, L.			A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion	ONCOGENE			English	Article						heat shock protein 90; cell motility; cancer metastasis; molecularly targeted small molecules	FOCAL ADHESION KINASE; CANCER CELLS; METASTASIS; MIGRATION; MELANOMA; EXPRESSION; GELDANAMYCIN; PHENOTYPES; SELECTION; ACTIN	Heat shock protein 90 ( Hsp90) is a molecular chaperone that maintains function of numerous intracellular signaling nodes utilized by cancer cells for proliferation and survival. Hsp90 is also detected on the plasma membrane of tumor cells and its expression has been suggested to correlate with metastatic potential. Given the abundance and diverse functions of the intracellular pool of this protein, the precise contribution of cell surface Hsp90 to cell motility and tumor metastasis remains to be determined. In this study we utilized the small molecule DMAG- N- oxide, a novel cell- impermeable Hsp90 inhibitor, to specifically examine the role of cell surface Hsp90 in cell motility. We observed that, while not affecting intracellular Hsp90 function, DMAG- N- oxide significantly retarded tumor cell migration and integrin/extracellular matrix- dependent cytoskeletal reorganization. Concomitant with these findings, targeting cell surface Hsp90 significantly inhibited tumor cell motility and invasion in vitro, and had a dramatic impact on melanoma cell lung colonization in vivo. These data indicate that cell surface Hsp90 plays an important role in modulating cancer cell migration that is independent of the function of the intracellular Hsp90 pool, and that small molecule inhibitors of surface Hsp90 may provide a new approach to targeting the metastatic phenotype.	[Tsutsumi, S.; Scroggins, B.; Koga, F.; Neckers, L.] NCI, NIH, Urol Oncol Branch, Bethesda, MD 20892 USA; [Lee, M-J; Trepel, J.] NCI, Med Oncol Branch, Bethesda, MD 20892 USA; [Felts, S.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Felts, S.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; [Carreras, C.] Kosan Biosci, Hayward, CA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; Mayo Clinic; Bristol-Myers Squibb; Kosan Biosciences, Inc.	Neckers, L (corresponding author), NCI, NIH, Urol Oncol Branch, 9000 ROckville Pike,Bldg 10-CRC,1-5940, Bethesda, MD 20892 USA.	len@helix.nih.gov	, Fumitaka/AAO-2957-2021; KOGA, Fumitaka/AAM-8739-2021; Koga, Fumitaka/AAO-4655-2021; Koga, Fumitaka/AAO-2779-2021	, Fumitaka/0000-0001-7888-0085; KOGA, Fumitaka/0000-0001-7888-0085; 	Intramural NIH HHS [Z01 SC006659-25, Z01 SC010074-12] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC011032, ZIASC010074, ZICSC006743, Z01SC006659] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arlander SJH, 2006, J BIOL CHEM, V281, P2989, DOI 10.1074/jbc.M508687200; Banerjee S, 2005, ADV MATER, V17, P17, DOI 10.1002/adma.200401340; Becker B, 2004, EXP DERMATOL, V13, P27, DOI 10.1111/j.0906-6705.2004.00114.x; BRUNSON KW, 1978, NATURE, V272, P543, DOI 10.1038/272543a0; Cranmer LD, 2005, MELANOMA RES, V15, P325, DOI 10.1097/00008390-200510000-00002; Entschladen F, 2004, LANCET ONCOL, V5, P254, DOI 10.1016/S1470-2045(04)01431-7; ERKELLERYUKSEL FM, 1992, J AUTOIMMUN, V5, P803, DOI 10.1016/0896-8411(92)90194-U; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Fidler IJ, 1999, CANCER CHEMOTH PHARM, V43, pS3, DOI 10.1007/s002800051091; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; Heath Elisabeth I, 2005, Clin Prostate Cancer, V4, P138, DOI 10.3816/CGC.2005.n.024; Munster PN, 2001, CANCER RES, V61, P2945; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; Neckers Len, 2005, Expert Opin Emerg Drugs, V10, P137, DOI 10.1517/14728214.10.1.137; Nguyen DM, 2000, ANN THORAC SURG, V70, P1853, DOI 10.1016/S0003-4975(00)01810-5; Owen BAL, 2002, J BIOL CHEM, V277, P7086, DOI 10.1074/jbc.M111450200; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Sidera K, 2004, J BIOL CHEM, V279, P45379, DOI 10.1074/jbc.M405486200; Solit DB, 2002, CLIN CANCER RES, V8, P986; Stellas D, 2007, CLIN CANCER RES, V13, P1831, DOI 10.1158/1078-0432.CCR-06-1585; Tian ZQ, 2004, BIOORGAN MED CHEM, V12, P5317, DOI 10.1016/j.bmc.2004.07.053; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; Whitesell L, 2003, CURR CANCER DRUG TAR, V3, P349, DOI 10.2174/1568009033481787; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Wu JC, 2001, MOL THER, V4, P297, DOI 10.1006/mthe.2001.0460; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x	29	130	140	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2008	27	17					2478	2487		10.1038/sj.onc.1210897	http://dx.doi.org/10.1038/sj.onc.1210897			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286KN	17968312	Green Accepted			2022-12-25	WOS:000254844900012
J	Zhu, S; Bjorge, JD; Cheng, HC; Fujita, DJ				Zhu, S.; Bjorge, J. D.; Cheng, H. C.; Fujita, D. J.			Decreased CHK protein levels are associated with Src activation in colon cancer cells	ONCOGENE			English	Article						cHK; src; colon cancer	HOMOLOGOUS KINASE CHK; LYN TYROSINE KINASE; COLORECTAL-CANCER; BREAST-CANCER; GENETIC PATHWAYS; FOCAL ADHESIONS; CSK; EXPRESSION; FAMILY; BRAIN	Src activation has been associated with colon cancers but the mechanism underlying Src activation is largely unknown. Csk-homologous kinase (CHK) can inhibit the kinase activity of certain Src kinase family members in vitro by phosphorylating the C-terminal tyrosine and by a non-catalytic mechanism. CHK was previously reported to be expressed primarily in brain and hematopoietic cells. We report herein that CHK is also expressed in normal colon cell lines. Furthermore, CHK protein levels are significantly decreased in various colon cancer cell lines and the decrease correlates with the increased specific activity of Src in these cell lines, while the level of the other Src inhibitory kinase, C-terminal Src kinase, is not significantly changed. CHK is also expressed in normal colon tissues but its expression level is decreased in colon cancer tissues collected from the same patients. Immuno- fluorescence microscopy shows that CHK colocalizes with Src in normal colon FHC cells. Overexpression of CHK in colon cancer cells results in inactivation of Src without phosphorylating Y530 at its C-terminus. In addition, CHK suppresses anchorage-independent cell growth and cell invasion of colon cancer cells. These results reveal a potentially important role for CHK in Src activation and tumorigenicity in colon cancer cells.	[Zhu, S.; Bjorge, J. D.; Fujita, D. J.] Univ Calgary, Hlth Sci Ctr, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Zhu, S.; Bjorge, J. D.; Fujita, D. J.] Univ Calgary, So Alberta Canc Res Inst, Calgary, AB T2N 4N1, Canada; [Cheng, H. C.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia	University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Calgary; University of Melbourne	Fujita, DJ (corresponding author), Univ Calgary, Hlth Sci Ctr, Dept Biochem & Mol Biol, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	dfujita@ucalgary.ca	Zhu, Shudong/A-1741-2011	Cheng, Heung-Chin/0000-0002-4965-7148				AVRAHAM S, 1995, J BIOL CHEM, V270, P1833, DOI 10.1074/jbc.270.4.1833; BENNETT BD, 1994, J BIOL CHEM, V269, P1068; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Bougeret C, 2001, J BIOL CHEM, V276, P33711, DOI 10.1074/jbc.M104209200; Cam WR, 2001, CANCER, V92, P61, DOI 10.1002/1097-0142(20010701)92:1<61::AID-CNCR1292>3.0.CO;2-D; Chong YP, 2004, J BIOL CHEM, V279, P20752, DOI 10.1074/jbc.M309865200; Chong YP, 2006, J BIOL CHEM, V281, P32988, DOI 10.1074/jbc.M602951200; CHOW LML, 1994, ONCOGENE, V9, P3437; CHOW LML, 1994, P NATL ACAD SCI USA, V91, P4975, DOI 10.1073/pnas.91.11.4975; Davidson D, 1997, J BIOL CHEM, V272, P1355, DOI 10.1074/jbc.272.2.1355; ERSHLER MA, 1995, FEBS LETT, V375, P50, DOI 10.1016/0014-5793(95)01154-7; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fincham VJ, 2000, MOL CELL BIOL, V20, P6518, DOI 10.1128/MCB.20.17.6518-6536.2000; Fincham VJ, 1998, EMBO J, V17, P81, DOI 10.1093/emboj/17.1.81; Hirao A, 1998, J BIOL CHEM, V273, P10004, DOI 10.1074/jbc.273.16.10004; Hirao A, 1997, EMBO J, V16, P2342, DOI 10.1093/emboj/16.9.2342; HUNTER T, 1987, CELL, V49, P1, DOI 10.1016/0092-8674(87)90745-8; Ilyas M, 1999, EUR J CANCER, V35, P1986, DOI 10.1016/S0959-8049(99)00298-1; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Isozumi T, 1997, ACTA NEUROPATHOL, V93, P438, DOI 10.1007/s004010050637; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cellbio.3.1.31; Kim S, 2002, J BIOL CHEM, V277, P36465, DOI 10.1074/jbc.M206018200; Kim SO, 2004, CANCER-AM CANCER SOC, V101, P1018, DOI 10.1002/cncr.20442; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KLAGES S, 1994, P NATL ACAD SCI USA, V91, P2597, DOI 10.1073/pnas.91.7.2597; KRUEGER JG, 1980, P NATL ACAD SCI-BIOL, V77, P4142, DOI 10.1073/pnas.77.7.4142; Kuismanen SA, 2000, AM J PATHOL, V156, P1773, DOI 10.1016/S0002-9440(10)65048-1; KUO SS, 1994, J NEUROSCI RES, V38, P705, DOI 10.1002/jnr.490380613; Levin Victor A, 2004, Cancer Treat Res, V119, P89; Nakayama Y, 2005, EXP CELL RES, V304, P570, DOI 10.1016/j.yexcr.2004.11.027; SAKANO S, 1994, ONCOGENE, V9, P1155; Samokhvalov I, 1997, BIOCHEM MOL BIOL INT, V43, P115; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Smith G, 2002, P NATL ACAD SCI USA, V99, P9433, DOI 10.1073/pnas.122612899; Staley CA, 1997, CELL GROWTH DIFFER, V8, P269; Trubert CL, 1997, EUR J HISTOCHEM, V41, P169; WATANABE N, 1995, JPN J CLIN ONCOL, V25, P5; Yamaguchi N, 2001, J CELL SCI, V114, P1631; ZHU S, 2007, IN PRESS CANC RES, V67; ZrihanLicht S, 1997, J BIOL CHEM, V272, P1856, DOI 10.1074/jbc.272.3.1856	41	13	15	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 27	2008	27	14					2027	2034		10.1038/sj.onc.1210838	http://dx.doi.org/10.1038/sj.onc.1210838			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	279MK	17934522				2022-12-25	WOS:000254359100007
J	Frolov, RV; Berim, IG; Singh, S				Frolov, Roman V.; Berim, Ilya G.; Singh, Satpal			Inhibition of delayed rectifier potassium channels and induction of arrhythmia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; K+-CHANNELS; GASTROINTESTINAL TOXICITY; GENE-EXPRESSION; DROSOPHILA; KV2.1; CYCLOOXYGENASE-2; ACTIVATION; MUTATIONS; CELECOXIB	Selective inhibitors of cyclooxygenase-2 (COX-2), such as rofecoxib (Vioxx), celecoxib (Celebrex), and valdecoxib (Bextra), have been developed for treating arthritis and other musculoskeletal complaints. Selective inhibition of COX-2 over COX-1 results in preferential decrease in prostacyclin production over thromboxane A2 production, thus leading to less gastric effects than those seen with nonselective COX inhibitors such as acetylsalicylic acid (aspirin). Here we show a novel effect of celecoxib via a mechanism that is independent of COX-2 inhibition. The drug inhibited the delayed rectifier (Kv2) potassium channels from Drosophila, rats, and humans and led to pronounced arrhythmia in Drosophila heart and arrhythmic beating of rat heart cells in culture. These effects occurred despite the genomic absence of cyclooxygenases in Drosophila and the failure of acetylsalicylic acid, a potent inhibitor of both COX-1 and COX-2, to inhibit rat Kv2.1 channels. A genetically null mutant of Drosophila Shab (Kv2) channels reproduced the cardiac effect of celecoxib, and the drug was unable to further enhance the effect of the mutation. These observations reveal an unanticipated effect of celecoxib on Drosophila hearts and on heart cells from rats, implicating the inhibition of Kv2 channels as the mechanism underlying this effect.	[Frolov, Roman V.; Singh, Satpal] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA; [Berim, Ilya G.] SUNY Buffalo, Dept Med, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Singh, S (corresponding author), SUNY Buffalo, Dept Pharmacol & Toxicol, 102 Farber Hall, Buffalo, NY 14214 USA.	singhs@buffalo.edu	Frolov, Roman/H-8099-2012; Frolov, Roman/I-3889-2016	Frolov, Roman/0000-0002-7431-5297				Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; BATE M, 1990, DEVELOPMENT, V110, P791; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; CATTERALL WA, 2002, IUPHAR COMPENDIUM VO, P86; Chen QH, 2005, BIOORGAN MED CHEM, V13, P2459, DOI 10.1016/j.bmc.2005.01.039; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; Chopra M, 2000, J NEUROGENET, V14, P107, DOI 10.3109/01677060009083478; Clancy CE, 2003, ANNU REV PHARMACOL, V43, P441, DOI 10.1146/annurev.pharmtox.43.100901.140245; Davies NM, 2000, CLIN PHARMACOKINET, V38, P225, DOI 10.2165/00003088-200038030-00003; Er F, 2003, CIRCULATION, V107, P485, DOI 10.1161/01.CIR.0000045672.32920.CB; FitzGerald GA, 2004, NEW ENGL J MED, V351, P1709, DOI 10.1056/NEJMp048288; FITZGERALD PT, HEART RHYTHM, V2, pS3005; Flower RJ, 2003, NAT REV DRUG DISCOV, V2, P179, DOI 10.1038/nrd1034; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Ganetzky B, 2000, KIDNEY INT, V57, P766, DOI 10.1046/j.1523-1755.2000.00913.x; Graham DJ, 2005, LANCET, V365, P475, DOI 10.1016/S0140-6736(05)17864-7; GU GG, 1995, J NEUROBIOL, V28, P269, DOI 10.1002/neu.480280302; Hegde P, 1999, J BIOL CHEM, V274, P22109, DOI 10.1074/jbc.274.31.22109; Herrera VLM, 2005, CURR OPIN LIPIDOL, V16, P179, DOI 10.1097/01.mol.0000162323.77666.5e; Hodge JJL, 2005, J NEUROBIOL, V63, P235, DOI 10.1002/neu.20126; James MJ, 2006, CURR OPIN CLIN NUTR, V9, P89, DOI 10.1097/01.mco.0000214565.67439.83; Ju M, 2003, J BIOL CHEM, V278, P12769, DOI 10.1074/jbc.M212973200; Kalgutkar AS, 1998, SCIENCE, V280, P1268, DOI 10.1126/science.280.5367.1268; Kang JX, 1997, P NATL ACAD SCI USA, V94, P2724, DOI 10.1073/pnas.94.6.2724; KIETER JR, 2000, NATURE, V405, P97; Kositprapa C, 2000, MOL CELL BIOCHEM, V214, P47, DOI 10.1023/A:1007160702275; Kozak KR, 2001, J BIOL CHEM, V276, P30072, DOI 10.1074/jbc.M104467200; Kraliz D, 1997, J NEUROBIOL, V32, P1; Kraliz D, 1998, J NEUROGENET, V12, P25, DOI 10.3109/01677069809108553; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Leung YM, 2003, J BIOL CHEM, V278, P17532, DOI 10.1074/jbc.M213088200; Liu WS, 2007, GENETICS, V176, P937, DOI 10.1534/genetics.107.071688; MacDonald PE, 2002, MOL ENDOCRINOL, V16, P2452, DOI 10.1210/me.2002-0058; Melman YF, 2002, TRENDS CARDIOVAS MED, V12, P182, DOI 10.1016/S1050-1738(02)00158-5; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Mitchell JA, 2006, NAT REV DRUG DISCOV, V5, P75, DOI 10.1038/nrd1929; Nerbonne JM, 1998, J NEUROBIOL, V37, P37, DOI 10.1002/(SICI)1097-4695(199810)37:1<37::AID-NEU4>3.0.CO;2-9; Nichols R, 2006, PEPTIDES, V27, P1130, DOI 10.1016/j.peptides.2005.07.032; O-Uchi J, 2005, P NATL ACAD SCI USA, V102, P9400, DOI 10.1073/pnas.0503569102; Ocorr K, 2007, TRENDS CARDIOVAS MED, V17, P177, DOI 10.1016/j.tcm.2007.04.001; Ordog B, 2006, INT J CARDIOL, V111, P386, DOI 10.1016/j.ijcard.2005.07.063; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Petersen CI, 2004, P NATL ACAD SCI USA, V101, P11773, DOI 10.1073/pnas.0306005101; Podlowski S, 1998, CIRCULATION, V98, P2470, DOI 10.1161/01.CIR.98.22.2470; Psaty BM, 2007, NEW ENGL J MED, V356, P328, DOI 10.1056/NEJMp068286; Roberts R, 2006, NAT CLIN PRACT CARD, V3, P276, DOI 10.1038/ncpcardio0509; Ruiz-Canada C, 2002, J NEUROCHEM, V82, P1490, DOI 10.1046/j.1471-4159.2002.01092.x; Scholle A, 2004, J MEMBRANE BIOL, V198, P103, DOI 10.1007/s00232-004-0664-0; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Singh A, 1999, J NEUROSCI, V19, P6838, DOI 10.1523/JNEUROSCI.19-16-06838.1999; Singh S, 1999, INT REV NEUROBIOL, V43, P191, DOI 10.1016/S0074-7742(08)60546-2; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103; WU CF, 1988, INT CONGR SER, V832, P311; WU CF, 1983, SCIENCE, V220, P1076, DOI 10.1126/science.6302847; Xu HD, 1999, CIRC RES, V85, P623, DOI 10.1161/01.RES.85.7.623	58	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1518	1524		10.1074/jbc.M708100200	http://dx.doi.org/10.1074/jbc.M708100200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17984087	hybrid			2022-12-25	WOS:000252282700036
J	Beeton, C; Smith, BJ; Sabo, JK; Crossley, G; Nugent, D; Khaytin, I; Chi, V; Chandy, KG; Pennington, MW; Norton, RS				Beeton, Christine; Smith, Brian J.; Sabo, Jennifer K.; Crossley, George; Nugent, Daniel; Khaytin, Ilya; Chi, Victor; Chandy, K. George; Pennington, Michael W.; Norton, Raymond S.			The D-diastereomer of ShK toxin selectively blocks voltage-gated K+ channels and inhibits T lymphocyte proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN BASIC-PROTEIN; SEA-ANEMONE TOXIN; POTASSIUM-CHANNEL; AUTOIMMUNE-DISEASES; NMR-SPECTROSCOPY; STICHODACTYLA-HELIANTHUS; MULTIPLE-SCLEROSIS; CHEMICAL-SYNTHESIS; PEPTIDE INHIBITOR; SELF-ASSOCIATION	The polypeptide toxin ShK is a potent blocker of Kv1.3 potassium channels, which are crucial in the activation of human effector memory T cells (T-EM); selective blockers constitute valuable therapeutic leads for the treatment of autoimmune diseases mediated by TEM cells, such as multiple sclerosis, rheumatoid arthritis, and type-1 diabetes. The critical motif on the toxin for potassium channel blockade consists of neighboring lysine and tyrosine residues. Because this motif is sufficient for activity, an ShK analogue was designed based on D-amino acids. D-Allo-ShK has a structure essentially identical with that of ShK and is resistant to proteolysis. It blocked Kv1.3 with K-d 36 nM (2,800-fold lower affinity than ShK), was 2-fold selective for Kv1.3 over Kv1.1, and was inactive against other K+ channels tested. D-Allo-ShK inhibited human TEM cell proliferation at 100-fold higher concentration than ShK. Its circulating half-life was only slightly longer than that of ShK, implying that renal clearance is the major determinant of its plasma levels. D-Allo-ShK did not bind to the closed state of the channel, unlike ShK. Models of D-allo-ShK bound to Kv1.3 show that it can block the pore as effectively as ShK but makes different interactions with the vestibule, some of which are less favorable than for native ShK. The finding that an all-D analogue of a polypeptide toxin retains biological activity and selectivity is highly unusual. Being resistant to proteolysis and nonantigenic, this analogue should be useful in K+ channel studies; all-D analogues with improved Kv1.3 potency and specificity may have therapeutic advantages.	[Smith, Brian J.; Sabo, Jennifer K.; Norton, Raymond S.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Beeton, Christine; Chi, Victor; Chandy, K. George] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Crossley, George; Nugent, Daniel; Khaytin, Ilya; Pennington, Michael W.] Bachem Biosci Inc, King Of Prussia, PA 19406 USA	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of California System; University of California Irvine	Norton, RS (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	ray.norton@wehi.edu.au	Smith, Brian J/F-8282-2011	Smith, Brian J/0000-0003-0498-1910; Beeton, Christine/0000-0002-2500-5874; pennington, michael/0000-0001-5446-3447; Norton, Raymond/0000-0001-8893-0584	NINDS NIH HHS [NS-48252] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048252] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIYAR J, 1995, NEURON, V15, P1169, DOI 10.1016/0896-6273(95)90104-3; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Beeton C, 2005, MOL PHARMACOL, V67, P1369, DOI 10.1124/mol.104.008193; Beeton C, 2003, J BIOL CHEM, V278, P9928, DOI 10.1074/jbc.M212868200; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; BEETON C, 2007, J VISUALIZED EXP, V7; BEETON C, 2007, J VISUALIZED EXP, V6; BEETON C, 2007, J VISUALIZED EXP, V8; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; BERAUD E, 1993, J NEUROIMMUNOL, V47, P41, DOI 10.1016/0165-5728(93)90283-5; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BONTEMS F, 1992, BIOCHEMISTRY-US, V31, P7756, DOI 10.1021/bi00149a003; CASTANEDA O, 1995, TOXICON, V33, P603, DOI 10.1016/0041-0101(95)00013-C; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Dauplais M, 1997, J BIOL CHEM, V272, P4302, DOI 10.1074/jbc.272.7.4302; DEIBLER GE, 1972, PREP BIOCHEM, V2, P139, DOI 10.1080/00327487208061467; DINGLEY AJ, 1995, J BIOMOL NMR, V6, P321; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; GIBBS SJ, 1991, J MAGN RESON, V93, P395, DOI 10.1016/0022-2364(91)90014-K; GRISSMER S, 1990, P NATL ACAD SCI USA, V87, P9411, DOI 10.1073/pnas.87.23.9411; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Hubbard S. J., 1993, NACCESS; HUMPHREY W, 1996, J MOL GRAPHICS, V14, P27, DOI DOI 10.1016/0263-7855(96)00018-5; JOHNSON BA, 1994, BIOCHEMISTRY-US, V33, P15061, DOI 10.1021/bi00254a015; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; KING DS, 1990, INT J PEPT PROT RES, V36, P255; Lanigan MD, 2002, BIOCHEMISTRY-US, V41, P11963, DOI 10.1021/bi026400b; LEONARD RJ, 1992, P NATL ACAD SCI USA, V89, P10094, DOI 10.1073/pnas.89.21.10094; Li L, 2003, PROTEINS, V53, P693, DOI 10.1002/prot.10460; LIN CS, 1993, J EXP MED, V177, P637, DOI 10.1084/jem.177.3.637; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MILTON RCD, 1992, SCIENCE, V256, P1445, DOI 10.1126/science.1604320; NIELSEN KJ, 1994, PROTEIN SCI, V3, P291; Norton RS, 2004, CURR MED CHEM, V11, P3041, DOI 10.2174/0929867043363947; PENNINGTON MW, 1995, INT J PEPT PROT RES, V46, P354; Pennington MW, 1999, BIOCHEMISTRY-US, V38, P14549, DOI 10.1021/bi991282m; Pennington MW, 1996, BIOCHEMISTRY-US, V35, P16407, DOI 10.1021/bi962463g; Pennington MW, 1996, BIOCHEM BIOPH RES CO, V219, P696, DOI 10.1006/bbrc.1996.0297; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pohl Jan, 1995, Letters in Peptide Science, V1, P291, DOI 10.1007/BF00119770; PRICE M, 1989, P NATL ACAD SCI USA, V86, P10171, DOI 10.1073/pnas.86.24.10171; Rauer H, 2000, J BIOL CHEM, V275, P1201, DOI 10.1074/jbc.275.2.1201; Rauer H, 1999, J BIOL CHEM, V274, P21885, DOI 10.1074/jbc.274.31.21885; RIVIER J, 1983, J CHROMATOGR, V268, P112, DOI 10.1016/S0021-9673(01)95395-6; Soler D, 2003, BLOOD, V101, P1677, DOI 10.1182/blood-2002-07-2348; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Tudor JE, 1996, NAT STRUCT BIOL, V3, P317, DOI 10.1038/nsb0496-317; Tudor JE, 1998, EUR J BIOCHEM, V251, P133, DOI 10.1046/j.1432-1327.1998.2510133.x; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Yan LZ, 2005, MOL PHARMACOL, V67, P1513, DOI 10.1124/mol.105.011064; Yao SG, 2000, J BIOMOL NMR, V16, P109, DOI 10.1023/A:1008382624724; ZAWADZKE LE, 1993, PROTEINS, V16, P301, DOI 10.1002/prot.340160308; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	59	51	58	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					988	997		10.1074/jbc.M706008200	http://dx.doi.org/10.1074/jbc.M706008200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17984097	hybrid			2022-12-25	WOS:000252128100038
J	Wong, J; Quinn, CM; Gelissen, IC; Brown, AJ				Wong, Jenny; Quinn, Carmel M.; Gelissen, Ingrid C.; Brown, Andrew J.			Endogenous 24(S),25-epoxycholesterol fine-tunes acute control of cellular cholesterol homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2,3-OXIDOSQUALENE CYCLASE INHIBITOR; LOW-DENSITY-LIPOPROTEIN; LIVER-X RECEPTORS; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; ENDOPLASMIC-RETICULUM; LANOSTEROL CYCLASE; OXYSTEROLS; BIOSYNTHESIS; ABCA1; METABOLISM	Certain oxysterols, when added to cultured cells, are potent regulators of cholesterol homeostasis, decreasing cholesterol synthesis and uptake and increasing cholesterol efflux. However, very little is known about whether or not endogenous oxysterol(s) plays a significant role in cholesterol homeostasis. 24(S), 25-Epoxycholesterol (24,25EC) is unique among oxysterols in that it is produced in a shunt of the mevalonate pathway which also produces cholesterol. We investigated the role of endogenously produced 24,25EC using a novel strategy of over-expressing the enzyme 2,3-oxidosqualene cyclase in Chinese hamster ovary cells to selectively inhibit the synthesis of this oxysterol. First, loss of 24,25EC decreased expression of the LXR target gene, ABCA1, substantiating its role as an endogenous ligand for LXR. Second, loss of 24,25EC increased acute cholesterol synthesis, which was rationalized by a concomitant increase in HMG-CoA reductase gene expression at the level of SREBP-2 processing. Therefore, in the absence of 24,25EC, fine-tuning of the acute regulation of cholesterol homeostasis is lost, supporting the hypothesis that 24,25EC functions to protect the cell against the accumulation of newly synthesized cholesterol.	[Wong, Jenny; Brown, Andrew J.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Quinn, Carmel M.; Gelissen, Ingrid C.] Univ New S Wales, Ctr Vasc Res, Kensington, NSW 2033, Australia; [Quinn, Carmel M.; Gelissen, Ingrid C.] Prince Wales Hosp, Dept Haematol, Sydney, NSW 2032, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Brown, AJ (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Biosci Bldg D26, Sydney, NSW 2052, Australia.	aj.brown@unsw.edu.au						Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Beyea MM, 2007, J BIOL CHEM, V282, P5207, DOI 10.1074/jbc.M611063200; Bjorkhem I, 2002, J CLIN INVEST, V110, P725, DOI 10.1172/JCI200216388; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P2209, DOI 10.1161/01.ATV.0000148704.72481.28; BLOCH K, 1965, SCIENCE, V150, P19, DOI 10.1126/science.150.3692.19; BOUTAUD O, 1992, BIOCHEM BIOPH RES CO, V188, P898, DOI 10.1016/0006-291X(92)91140-L; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Costet P, 2000, J BIOL CHEM, V275, P28240; DOLLIS D, 1994, BIOCHEM PHARMACOL, V48, P49, DOI 10.1016/0006-2952(94)90222-4; Eisele B, 1997, J LIPID RES, V38, P564; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Janowski BA, 2001, J BIOL CHEM, V276, P45408, DOI 10.1074/jbc.M108348200; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; KANDUTSCH AA, 1978, SCIENCE, V201, P498, DOI 10.1126/science.663671; Kielar D, 2001, CLIN CHEM, V47, P2089; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Mark M, 1996, J LIPID RES, V37, P148; Morand OH, 1997, J LIPID RES, V38, P373; NELSON JA, 1981, J BIOL CHEM, V256, P1067; Nguyen AD, 2007, J BIOL CHEM, V282, P27436, DOI 10.1074/jbc.M704976200; Ory DS, 2004, CIRC RES, V95, P660, DOI 10.1161/01.RES.0000143422.83209.be; PANINI SR, 1986, J LIPID RES, V27, P1190; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Rowe AH, 2003, CIRC RES, V93, P717, DOI 10.1161/01.RES.0000097606.43659.F4; SAUCIER SE, 1985, J BIOL CHEM, V260, P4571; SAUCIER SE, 1989, J BIOL CHEM, V264, P6863; Schmitz G, 2005, BBA-MOL CELL BIOL L, V1735, P1, DOI 10.1016/j.bbalip.2005.04.004; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Song BL, 2004, J BIOL CHEM, V279, P28798, DOI 10.1074/jbc.M402442200; Soumian S, 2005, VASC MED, V10, P109, DOI 10.1191/1358863x05vm593ra; SPENCER TA, 1985, J BIOL CHEM, V260, P3391; TAYLOR FR, 1986, J BIOL CHEM, V261, P5039; Telford DE, 2005, ARTERIOSCL THROM VAS, V25, P2608, DOI 10.1161/01.ATV.0000189158.28455.94; Wong J, 2004, ARTERIOSCL THROM VAS, V24, P2365, DOI 10.1161/01.ATV.0000148707.93054.7d; WONG J, 2007, IN PRESS ATHEROSCLER; Wong J, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-10; Wong J, 2006, BIOCHEM J, V400, P485, DOI 10.1042/BJ20060914; Yang CD, 2006, J BIOL CHEM, V281, P27816, DOI 10.1074/jbc.M603781200; YANG JX, 1994, GENE DEV, V8, P1910, DOI 10.1101/gad.8.16.1910; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883	47	67	71	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					700	707		10.1074/jbc.M706416200	http://dx.doi.org/10.1074/jbc.M706416200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17981807	hybrid			2022-12-25	WOS:000252128100007
J	Kawato, M; Shirakawa, R; Kondo, H; Higashi, T; Ikeda, T; Okawa, K; Fukai, S; Nureki, O; Kita, T; Horiuchi, H				Kawato, Mitsunori; Shirakawa, Ryutaro; Kondo, Hirokazu; Higashi, Tomohito; Ikeda, Tomoyuki; Okawa, Katsuya; Fukai, Shuya; Nureki, Osamu; Kita, Toru; Horiuchi, Hisanori			Regulation of platelet dense granule secretion by the Ral GTPase-exocyst pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-INDUCED ALPHA-GRANULE; BINDING PROTEIN; GROWTH-FACTOR; COMPLEX; ACTIVATION; MEMBRANE; EFFECTOR; CORE; IDENTIFICATION; DELIVERY	Non-hydrolyzable GTP analogues, such as guanosine 5'-(beta,gamma-imido) triphosphate (GppNHp), induce granule secretion from permeabilized platelets in the absence of increased intracellular Ca2+. Here, we show that the GppNHp-induced dense granule secretion from permeabilized platelets occurred concomitantly with the activation of small GTPase Ral. This secretion was inhibited by the addition of GTP-Ral-binding domain (RBD) of Sec5, which is a component of the exocyst complex known to function as a tethering factor at the plasma membrane for vesicles. We generated an antibody against Sec5-RBD, which abolished the interaction between GTP-Ral and the exocyst complex in vitro. The addition of this antibody inhibited the GppNHp-induced secretion. These data indicate that Ral mediates the GppNHp-induced dense granule secretion from permeabilized platelets through interaction with its effector, the exocyst complex. Furthermore, GppNHp enhanced the Ca2+ sensitivity of dense granule secretion from permeabilized platelets, and this enhancement was inhibited by Sec5-RBD. In intact platelets, the association between Ral and the exocyst complex was induced by thrombin stimulation with a time course similar to that of dense granule secretion and Ral activation. Taken together, our results suggest that the Ral-exocyst pathway participates in the regulation of platelet dense granule secretion by enhancing the Ca2+ sensitivity of the secretion.	[Kawato, Mitsunori; Shirakawa, Ryutaro; Kondo, Hirokazu; Higashi, Tomohito; Ikeda, Tomoyuki; Kita, Toru; Horiuchi, Hisanori] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan; [Okawa, Katsuya] Kyoto Univ, Grad Sch Med, Frontier Technol Ctr, Kyoto 6068507, Japan; [Fukai, Shuya; Nureki, Osamu] Tokyo Inst Technol, Dept Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan; [Fukai, Shuya] Univ Tokyo, Synchrotron Radiat Res Org, Div Life Sci, Tokyo 1130032, Japan	Kyoto University; Kyoto University; Tokyo Institute of Technology; University of Tokyo	Horiuchi, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan.	horiuchi@kuhp.kyoto-u.ac.jp	NUREKI, OSAMU/G-4960-2014; Higashi, Tomohito/AHE-7942-2022; Fukai, Shuya/X-4838-2018	Fukai, Shuya/0000-0002-1241-1443; Higashi, Tomohito/0000-0001-5616-1477				BHULLAR RP, 1990, FEBS LETT, V260, P48, DOI 10.1016/0014-5793(90)80063-O; Bos JL, 1998, EMBO J, V17, P6776, DOI 10.1093/emboj/17.23.6776; BRASS LF, 2005, HEMATOLOGY MOL BASIS, P1889; Brymora A, 2001, J BIOL CHEM, V276, P29792, DOI 10.1074/jbc.C100320200; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; COORSSEN JR, 1990, CELL REGUL, V1, P1027, DOI 10.1091/mbc.1.13.1027; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Feig LA, 2003, TRENDS CELL BIOL, V13, P419, DOI 10.1016/S0962-8924(03)00152-1; Fukai S, 2003, EMBO J, V22, P3267, DOI 10.1093/emboj/cdg329; Gerges NZ, 2006, EMBO J, V25, P1623, DOI 10.1038/sj.emboj.7601065; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; HASLAM RJ, 1984, FEBS LETT, V174, P90, DOI 10.1016/0014-5793(84)81084-4; HASLAM RJ, 1985, NATURE, V313, P821, DOI 10.1038/313821a0; HASLAM RJ, 1984, J RECEPTOR RES, V4, P605, DOI 10.3109/10799898409042576; Hofer F, 1998, CURR BIOL, V8, P839, DOI 10.1016/S0960-9822(98)70327-6; Horiuchi H, 2006, ANN MED, V38, P162, DOI 10.1080/07853890600640657; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; Kondo H, 2006, J BIOL CHEM, V281, P28657, DOI 10.1074/jbc.M603227200; Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4; Mark BL, 1996, BIOCHEM BIOPH RES CO, V225, P40, DOI 10.1006/bbrc.1996.1128; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Nesbitt WS, 2003, J CELL BIOL, V160, P1151, DOI 10.1083/jcb.200207119; Nishi E, 2006, J BIOL CHEM, V281, P31164, DOI 10.1074/jbc.M601316200; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Padfield PJ, 1996, BIOCHEM J, V314, P123, DOI 10.1042/bj3140123; Palmer M, 1998, EMBO J, V17, P1598, DOI 10.1093/emboj/17.6.1598; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; SARGEANT P, 1994, PHARMACOL THERAPEUT, V64, P395, DOI 10.1016/0163-7258(94)90019-1; Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Shirakawa R, 2000, J BIOL CHEM, V275, P33844, DOI 10.1074/jbc.M002834200; Shirakawa R, 2005, METHOD ENZYMOL, V403, P778, DOI 10.1016/S0076-6879(05)03067-3; Shirakawa R, 2004, J BIOL CHEM, V279, P10730, DOI 10.1074/jbc.M309426200; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Tsuboi T, 2005, J BIOL CHEM, V280, P25565, DOI 10.1074/jbc.M501674200; van Dam EM, 2006, INT J BIOCHEM CELL B, V38, P1841, DOI 10.1016/j.biocel.2006.04.006; Wang L, 2004, J BIOL CHEM, V279, P19875, DOI 10.1074/jbc.M400522200; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wolthuis RMF, 1998, CURR BIOL, V8, P471, DOI 10.1016/S0960-9822(98)70183-6; Wolthuis RMF, 1998, MOL CELL BIOL, V18, P2486, DOI 10.1128/MCB.18.5.2486; Yoshioka A, 2001, ANN NY ACAD SCI, V947, P403; Yoshioka A, 2001, J BIOL CHEM, V276, P39379, DOI 10.1074/jbc.M102933200	48	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					166	174		10.1074/jbc.M705340200	http://dx.doi.org/10.1074/jbc.M705340200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17938170	Green Submitted, hybrid			2022-12-25	WOS:000251940300019
J	Powlesland, AS; Fisch, T; Taylor, ME; Smith, DF; Tissot, B; Dell, A; Poehlmann, S; Drickamer, K				Powlesland, Alex S.; Fisch, Tanja; Taylor, Maureen E.; Smith, David F.; Tissot, Berangere; Dell, Anne; Poehlmann, Stefan; Drickamer, Kurt			A novel mechanism for LSECtin binding to Ebola virus surface glycoprotein through truncated glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; RESPIRATORY SYNDROME CORONAVIRUS; N-ACETYLGALACTOSAMINE BINDING; DC-SIGN; CARBOHYDRATE-RECOGNITION; ASIALOGLYCOPROTEIN RECEPTOR; VIRION GLYCOPROTEINS; STRUCTURAL BASIS; LIGAND-BINDING; PROTEINS	LSECtin is a member of the C-type lectin family of glycan-binding receptors that is expressed on sinusoidal endothelial cells of the liver and lymph nodes. To compare the sugar and pathogen binding properties of LSECtin with those of related but more extensively characterized receptors, such as DC-SIGN, a soluble fragment of LSECtin consisting of the C-terminal carbohydrate-recognition domain has been expressed in bacteria. A biotin-tagged version of the protein was also generated and complexed with streptavidin to create tetramers. These forms of the carbohydrate-recognition domain were used to probe a glycan array and to characterize binding to oligosaccharide and glycoprotein ligands. LSECtin binds with high selectivity to glycoproteins terminating in GlcNAc beta 1-2Man. The inhibition constant for this disaccharide is 3.5 mu M, making it one of the best low molecular weight ligands known for any C-type lectin. As a result of the selective binding of this disaccharide unit, the receptor recognizes glycoproteins with a truncated complex and hybrid N-linked glycans on glycoproteins. Glycan analysis of the surface glycoprotein of Ebola virus reveals the presence of such truncated glycans, explaining the ability of LSECtin to facilitate infection by Ebola virus. High mannose glycans are also present on the viral glycoprotein, which explains why DC-SIGN also binds to this virus. Thus, multiple receptors interact with surface glycoproteins of enveloped viruses that bear different types of relatively poorly processed glycans.	[Powlesland, Alex S.; Taylor, Maureen E.; Tissot, Berangere; Dell, Anne; Drickamer, Kurt] Imperial Coll London, Div Mol Biol, London SW7 2AZ, England; [Fisch, Tanja; Poehlmann, Stefan] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Inst Virol, D-91054 Erlangen, Germany; [Poehlmann, Stefan] Hannover Med Sch, Inst Virol, D-30625 Hannover, Germany; [Smith, David F.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Imperial College London; University of Erlangen Nuremberg; Hannover Medical School; Emory University	Drickamer, K (corresponding author), Imperial Coll London, Div Mol Biol, Biochem Bldg, London SW7 2AZ, England.	k.drickamer@imperial.ac.uk	Pöhlmann, Stefan/H-2395-2011	Pöhlmann, Stefan/0000-0001-6086-9136; Drickamer, Kurt/0000-0001-5026-5996; Taylor, Maureen/0000-0001-8300-4987	NIGMS NIH HHS [GM 62116, U54 GM062116] Funding Source: Medline; Wellcome Trust [075565, 041845] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Chapman-Smith A, 1999, TRENDS BIOCHEM SCI, V24, P359, DOI 10.1016/S0968-0004(99)01438-3; Comelli EM, 2006, GLYCOBIOLOGY, V16, P117, DOI 10.1093/glycob/cwj048; Dominguez-Soto A, 2007, BLOOD, V109, P5337, DOI 10.1182/blood-2006-09-048058; DRICKAMER K, 1991, CELL, V67, P1029, DOI 10.1016/0092-8674(91)90278-7; Drickamer K., 2006, INTRO GLYCOBIOLOGY; DUBUISSON J, 1994, J VIROL, V68, P6147, DOI 10.1128/JVI.68.10.6147-6160.1994; Fadden AJ, 2003, GLYCOBIOLOGY, V13, P529, DOI 10.1093/glycob/cwg068; Feinberg H, 2000, J BIOL CHEM, V275, P35176, DOI 10.1074/jbc.M005557200; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gramberg T, 2005, VIROLOGY, V340, P224, DOI 10.1016/j.virol.2005.06.026; GRAYEB J, 1984, EMBO J, V3, P2437; GREENWOOD FC, 1963, BIOCHEM J, V89, P123; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; IOBST ST, 1994, J BIOL CHEM, V269, P15505; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; Jones AJS, 2007, GLYCOBIOLOGY, V17, P529, DOI 10.1093/glycob/cwm017; Kolatkar AR, 1998, J BIOL CHEM, V273, P19502, DOI 10.1074/jbc.273.31.19502; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krokhin O, 2003, MOL CELL PROTEOMICS, V2, P346, DOI 10.1074/mcp.M300048-MCP200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai WK, 2006, AM J PATHOL, V169, P200, DOI 10.2353/ajpath.2006.051191; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Liu WL, 2004, J BIOL CHEM, V279, P18748, DOI 10.1074/jbc.M311227200; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Marzi A, 2004, J VIROL, V78, P12090, DOI 10.1128/JVI.78.21.12090-12095.2004; Marzi A, 2006, J VIROL, V80, P6305, DOI 10.1128/JVI.02545-05; McGreal EP, 2005, CURR OPIN IMMUNOL, V17, P18, DOI 10.1016/j.coi.2004.12.001; Pohlmann S, 2001, TRENDS IMMUNOL, V22, P643, DOI 10.1016/S1471-4906(01)02081-6; Powlesland AS, 2006, J BIOL CHEM, V281, P20440, DOI 10.1074/jbc.M601925200; RINI JM, 1995, ANNU REV BIOPH BIOM, V24, P551, DOI 10.1146/annurev.biophys.24.1.551; Sanchez A, 1998, J VIROL, V72, P6442, DOI 10.1128/JVI.72.8.6442-6447.1998; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Simmons G, 2003, VIROLOGY, V305, P115, DOI 10.1006/viro.2002.1730; Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045; SUTTONSMITH M, 2005, CELL BIOL LAB HDB, V4, P415; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; Varki A., 1999, ESSENTIALS GLYCOBIOL; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Ward EM, 2006, J BIOL CHEM, V281, P15450, DOI 10.1074/jbc.M511502200; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Wragg S, 1999, J BIOL CHEM, V274, P35400, DOI 10.1074/jbc.274.50.35400; Yang ZY, 2004, J VIROL, V78, P5642, DOI 10.1128/JVI.78.11.5642-5650.2004	51	78	86	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					593	602		10.1074/jbc.M706292200	http://dx.doi.org/10.1074/jbc.M706292200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17984090	Green Accepted, hybrid			2022-12-25	WOS:000251940300064
J	Weixel, KM; Edinger, RS; Kester, L; Guerriero, CJ; Wang, HM; Fang, L; Kleyman, TR; Welling, PA; Weisz, OA; Johnson, JP				Weixel, Kelly M.; Edinger, Robert S.; Kester, Lauren; Guerriero, Christopher J.; Wang, Huamin; Fang, Liang; Kleyman, Thomas R.; Welling, Paul A.; Weisz, Ora A.; Johnson, John P.			Phosphatidylinositol 4-phosphate 5-kinase reduces cell surface expression of the epithelial sodium channel (ENaC) in cultured collecting duct cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANINE KIDNEY-CELLS; CLATHRIN-MEDIATED ENDOCYTOSIS; NA+ CHANNEL; SORTING SIGNALS; PLASMA-MEMBRANE; KINASE; TRANSPORT; UBIQUITINATION; TRAFFICKING; INSERTION	Ubiquitination of ENaC subunits has been shown to negatively regulate the cell surface expression of ENaC channels. We have previously demonstrated that epsin links ubiquitinated ENaC to clathrin adaptors for clathrin-mediated endocytosis. Epsin is thought to directly modify the curvature of membranes upon binding to phosphatidylinositol 4,5-bisphosphate (PIP2) where it recruits clathrin and stimulates lattice assembly. Murine phosphatidylinositol 4-phosphate 5-kinase alpha (PI5KI alpha) has been shown to enhance endocytosis in a PIP2-dependent manner. We tested the hypothesis that PI5KI alpha-mediated PIP2 production would negatively regulate ENaC current by enhancing epsin-mediated endocytosis of the channel. Expression of PI5KI alpha decreased ENaC currents in Xenopus oocytes by 80%, entirely because of a decrease in cell surface ENaC levels. Catalytically inactive mutants of PI5K alpha had no effect on ENaC activity. Expression of the PIP2 binding region of epsin increased ENaC current in oocytes, an effect completely reversed by co-expression of PI5KI alpha. Overexpression of epsin reduced amiloride-sensitive current in CCD cells. Overexpression of PI5KI alpha enhanced membrane PIP2 levels and reduced apical surface expression of ENaC in CCD cells, down-regulating amiloride-sensitive current. Knockdown of PI5KI alpha with isoform-specific siRNA resulted in a 4-fold enhancement of ENaC activity. PI5KI alpha localized exclusively to the apical plasma membrane domain when overexpressed in mouse CCD cells, consistent for a role in regulating PIP2 production at the apical plasma membrane. We conclude that membrane turnover events regulating ENaC surface expression and activity in oocytes and CCD cells can be regulated by PI5KI alpha.	Univ Pittsburgh, Dept Med, Div Renal & Electrolyte, Pittsburgh, PA 15261 USA; Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland Baltimore	Johnson, JP (corresponding author), Univ Pittsburgh, Dept Med, Div Renal & Electrolyte, 3500 Terrace St, Pittsburgh, PA 15261 USA.	Johnson@dom.pitt.edu		Guerriero, Christopher/0000-0002-1046-2300	NIDDK NIH HHS [DK 064613, DK 57718, DK 65161, DK-54231, DK-63049, DK47874, T32 DK61296] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054231, R01DK065161, R56DK065161, R01DK057718, R01DK063049, R01DK064613, T32DK061296, R01DK047874] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; Bairstow SF, 2006, J BIOL CHEM, V281, P20632, DOI 10.1074/jbc.M601465200; Barbieri MA, 2001, J BIOL CHEM, V276, P47212, DOI 10.1074/jbc.C100490200; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Blazer-Yost BL, 2001, AM J PHYSIOL-CELL PH, V281, pC624, DOI 10.1152/ajpcell.2001.281.2.C624; BREITFELD PP, 1989, METHOD CELL BIOL, V32, P329; Bruns JR, 2002, J BIOL CHEM, V277, P2012, DOI 10.1074/jbc.M108571200; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Coppolino MG, 2002, J BIOL CHEM, V277, P43849, DOI 10.1074/jbc.M209046200; Eaton DC, 2001, J MEMBRANE BIOL, V184, P313, DOI 10.1007/s00232-001-0098-x; Flores SY, 2003, PFLUG ARCH EUR J PHY, V446, P334, DOI 10.1007/s00424-003-1027-x; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Guerriero CJ, 2006, J BIOL CHEM, V281, P15376, DOI 10.1074/jbc.M601239200; Henkel JR, 1998, MOL BIOL CELL, V9, P2477, DOI 10.1091/mbc.9.9.2477; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; KLEYMAN TR, 1994, AM J PHYSIOL, V266, pC1105, DOI 10.1152/ajpcell.1994.266.4.C1105; Krauss M, 2006, P NATL ACAD SCI USA, V103, P11934, DOI 10.1073/pnas.0510306103; Kunzelmann K, 2005, FASEB J, V19, P969, DOI 10.1096/fj.04-2469fje; Lebowitz J, 2004, J BIOL CHEM, V279, P41985, DOI 10.1074/jbc.M403923200; Leung SM, 1999, MOL BIOL CELL, V10, P4369, DOI 10.1091/mbc.10.12.4369; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Ma HP, 2005, J AM SOC NEPHROL, V16, P3182, DOI 10.1681/ASN.2005040434; MALIK B, 2005, AM J PHYSL RENAL PHY; Padron D, 2003, J CELL BIOL, V162, P693, DOI 10.1083/jcb.200302051; Pochynyuk O, 2006, AM J PHYSIOL-RENAL, V290, pF949, DOI 10.1152/ajprenal.00386.2005; Pochynyuk O, 2006, J BIOL CHEM, V281, P26520, DOI 10.1074/jbc.M603716200; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; Rohde G, 2002, J CELL BIOL, V158, P209, DOI 10.1083/jcb.200203103; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Rotin D, 2001, AM J PHYSIOL-RENAL, V281, pF391, DOI 10.1152/ajprenal.2001.281.3.F391; Sakisaka T, 1997, MOL CELL BIOL, V17, P3841, DOI 10.1128/MCB.17.7.3841; Shibasaki Y, 1997, J BIOL CHEM, V272, P7578, DOI 10.1074/jbc.272.12.7578; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2002, ENDOCR REV, V23, P258, DOI 10.1210/er.23.2.258; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Staruschenko A, 2005, J BIOL CHEM, V280, P39161, DOI 10.1074/jbc.M509608200; Staruschenko A, 2004, J BIOL CHEM, V279, P49989, DOI 10.1074/jbc.M409812200; Swift Pauline A, 2004, Am J Pharmacogenomics, V4, P161, DOI 10.2165/00129785-200404030-00003; Tolias KF, 2000, CURR BIOL, V10, P153, DOI 10.1016/S0960-9822(00)00315-8; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Wiemuth D, 2007, BIOCHEM J, V405, P147, DOI 10.1042/BJ20060747; Yoo D, 2003, J BIOL CHEM, V278, P23066, DOI 10.1074/jbc.M212301200; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200; Zhou RF, 2005, J BIOL CHEM, V280, P4518, DOI 10.1074/jbc.M411053200; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	51	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36534	36542		10.1074/jbc.M703970200	http://dx.doi.org/10.1074/jbc.M703970200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17940289	hybrid			2022-12-25	WOS:000251458300046
J	Sakaguchi, M; Murata, H; Sonegawa, H; Sakaguchi, Y; Futami, J; Kitazoe, M; Yamada, H; Huh, N				Sakaguchi, Masakiyo; Murata, Hitoshi; Sonegawa, Hiroyuki; Sakaguchi, Yoshihiko; Futami, Jun-ichiro; Kitazoe, Midori; Yamada, Hidenori; Huh, Nam-ho			Truncation of annexin A1 is a regulatory lever for linking epidermal growth factor signaling with cytosolic phospholipase A2 in normal and malignant squamous epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN KERATINOCYTES; ARACHIDONIC-ACID; PROSTATE-CANCER; FACTOR RECEPTOR; LIPOCORTIN-I; PROTEIN; INHIBITION; PHOSPHORYLATION; EXPRESSION; BINDING	Regulation of cell growth and apoptosis is one of the pleiotropic functions of annexin A1 (ANXA1). Although previous reports on the overexpression of ANXA1 in many human cancers and on growth suppression and/or induction of apoptosis by ANXA1 may indicate the tumor-suppressive nature of ANXA1, molecular mechanisms of the function of ANXA1 remain largely unknown. Here we provide evidence that ANXA1 mechanistically links the epidermal growth factor-triggered growth signal pathway with cytosolic phospholipase A(2) (cPLA(2)), an initiator enzyme of the arachidonic acid cascade, through interaction with S100A11 in normal human keratinocytes (NHK). Ca2+ -dependent binding of S100A11 to ANXA1 facilitated the binding of the latter to cPLA2, resulting in inhibition of cPLA2 activity, which is essential for the growth of NHK. On exposure of NHK to epidermal growth factor, ANXA1 was cleaved solely at Trp(12), and this cleavage was executed by cathepsin D. In squamous cancer cells, this pathway was shown to be constitutively activated. The newly found mechanistic intersection may be a promising target for establishing new measures against human cancer and other cell growth disorders.	Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Biol, Okayama 7008558, Japan; Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Bacteriol, Okayama 7008558, Japan; Okayama Univ, Grad Sch Nat Sci & Technol, Dept Biosci & Biotechnol, Okayama 7008530, Japan	Okayama University; Okayama University; Okayama University	Huh, N (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Biol, Okayama 7008558, Japan.	namu@md.okayama-u.ac.jp	MURATA, Hitoshi/B-2327-2011; Sakaguchi, Masakiyo/B-2280-2011; YAMADA, Hidenori/B-2639-2011; FUTAMI, Junichiro/B-2578-2011	FUTAMI, Junichiro/0000-0002-0020-2855				ANDO Y, 1989, J BIOL CHEM, V264, P6948; CROXTALL JD, 1995, BIOCHEM PHARMACOL, V50, P465, DOI 10.1016/0006-2952(95)00156-T; Cuervo AM, 2000, J BIOL CHEM, V275, P33329, DOI 10.1074/jbc.M005655200; DAVIDSON FF, 1987, J BIOL CHEM, V262, P1698; FLOWER RJ, 1976, BIOCHEM PHARMACOL, V25, P285, DOI 10.1016/0006-2952(76)90216-1; FUTTER CE, 1993, J CELL BIOL, V120, P77, DOI 10.1083/jcb.120.1.77; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; HAIGLER HT, 1987, J BIOL CHEM, V262, P6921; Hsiang CH, 2006, PROSTATE, V66, P1413, DOI 10.1002/pros.20457; Hu N, 2004, CLIN CANCER RES, V10, P6013, DOI 10.1158/1078-0432.CCR-04-0317; Kang JS, 2002, CLIN CANCER RES, V8, P117; KIM KM, 1994, FEBS LETT, V343, P251, DOI 10.1016/0014-5793(94)80566-0; Li JL, 1997, BIOL REPROD, V57, P929, DOI 10.1095/biolreprod57.4.929; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Lo HH, 1998, CANCER RES, V58, P4624; Mailliard WS, 1996, J BIOL CHEM, V271, P719, DOI 10.1074/jbc.271.2.719; Movitz C, 1999, BBA-BIOMEMBRANES, V1416, P101, DOI 10.1016/S0005-2736(98)00212-0; Nakanishi M, 2006, BBA-MOL CELL BIOL L, V1761, P1335, DOI 10.1016/j.bbalip.2006.09.005; Ohuchida K, 2006, CLIN CANCER RES, V12, P5417, DOI 10.1158/1078-0432.CCR-06-0222; Parente L, 2004, INFLAMM RES, V53, P125, DOI 10.1007/s00011-003-1235-z; PEPINSKY RB, 1986, NATURE, V321, P81, DOI 10.1038/321081a0; Radke S, 2004, FEBS LETT, V578, P95, DOI 10.1016/j.febslet.2004.10.078; SAKAGUCH M, 2007, IN PRESS MOL BIOL CE; Sakaguchi M, 2005, P NATL ACAD SCI USA, V102, P13921, DOI 10.1073/pnas.0500630102; Sakaguchi M, 2004, J CELL BIOL, V164, P979, DOI 10.1083/jcb.200312041; Sakaguchi M, 2003, J CELL BIOL, V163, P825, DOI 10.1083/jcb.200304017; Seemann J, 1996, BIOCHEM J, V319, P123, DOI 10.1042/bj3190123; Shen DJ, 2005, BIOCHEM BIOPH RES CO, V326, P218, DOI 10.1016/j.bbrc.2004.10.214; Sonegawa H, 2007, J MOL MED, V85, P753, DOI 10.1007/s00109-007-0180-7; Vishwanatha JK, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-8; White IJ, 2006, EMBO J, V25, P1, DOI 10.1038/sj.emboj.7600759	31	46	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35679	35686		10.1074/jbc.M707538200	http://dx.doi.org/10.1074/jbc.M707538200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17932043	hybrid			2022-12-25	WOS:000251458100028
J	Cable, JM; Enquist, BJ; Moses, ME				Cable, Jessica M.; Enquist, Brian J.; Moses, Melanie E.			The Allometry of Host- Pathogen Interactions	PLOS ONE			English	Article								Background. Understanding the mechanisms that control rates of disease progression in humans and other species is an important area of research relevant to epidemiology and to translating studies in small laboratory animals to humans. Body size and metabolic rate influence a great number of biological rates and times. We hypothesize that body size and metabolic rate affect rates of pathogenesis, specifically the times between infection and first symptoms or death. Methods and Principal Findings. We conducted a literature search to find estimates of the time from infection to first symptoms (t(S)) and to death (t(D)) for five pathogens infecting a variety of bird and mammal hosts. A broad sampling of diseases (1 bacterial, 1 prion, 3 viruses) indicates that pathogenesis is controlled by the scaling of host metabolism. We find that the time for symptoms to appear is a constant fraction of time to death in all but one disease. Our findings also predict that many population-level attributes of disease dynamics are likely to be expressed as dimensionless quantities that are independent of host body size. Conclusions and Significance. Our results show that much variability in host pathogenesis can be described by simple power functions consistent with the scaling of host metabolic rate. Assessing how disease progression is controlled by geometric relationships will be important for future research. To our knowledge this is the first study to report the allometric scaling of host/pathogen interactions.	[Cable, Jessica M.] Univ Wyoming, Dept Bot, Laramie, WY 82071 USA; [Enquist, Brian J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Moses, Melanie E.] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA	University of Wyoming; University of Arizona; University of New Mexico	Cable, JM (corresponding author), Univ Wyoming, Dept Bot, Laramie, WY 82071 USA.	jcable1@uwyo.edu	Enquist, Brian J/B-6436-2008	Enquist, Brian J/0000-0002-6124-7096	NSF CAREER Award [NSF DEB-0133974]; IH COBRE Center for Evolutionary and Theoretical Immunology [NIH P20 RR018754]; University of Arizona, Department of Ecology and Evolutionary Biology; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018754] Funding Source: NIH RePORTER	NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); IH COBRE Center for Evolutionary and Theoretical Immunology; University of Arizona, Department of Ecology and Evolutionary Biology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	BJE was supported by an NSF CAREER Award (NSF DEB-0133974). MEM was supported by a subproject of the NIH COBRE Center for Evolutionary and Theoretical Immunology (NIH P20 RR018754). JMC was supported with funding from the University of Arizona, Department of Ecology and Evolutionary Biology.	Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Bartholomew G.A., 1981, P45; BROWN MF, 2007, AM J PHYSL REGUL INT; Calder WAI., 1996, SIZE FUNCTION LIFE H; Charnov Eric L., 1993, P1; DeLeo GA, 1996, NATURE, V379, P720, DOI 10.1038/379720a0; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; DOBSON GP, 1995, P NATL ACAD SCI USA, V92, P7317, DOI 10.1073/pnas.92.16.7317; ELSE PL, 1985, AM J PHYSIOL, V248, pR415, DOI 10.1152/ajpregu.1985.248.4.R415; ENQUIST LW, 1999, PRINCIPLES VIROLOGY; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; Harvey P. H., 1991, COMPARATIVE METHOD E; KLEIBER MAX, 1932, HILGARDIA, V6, P315; MATHIEU O, 1981, RESP PHYSIOL, V44, P113, DOI 10.1016/0034-5687(81)90079-7; Nee S, 2005, SCIENCE, V309, P1236, DOI 10.1126/science.1114488; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Savage VM, 2007, P NATL ACAD SCI USA, V104, P4718, DOI 10.1073/pnas.0611235104; Savage VM, 2006, SCIENCE, V312, p198B, DOI 10.1126/science.1123679; Savage VM, 2004, AM NAT, V163, P429, DOI 10.1086/381872; Schmidt-Nielson K., 1984, SCALING WHY IS ANIMA; Silva M, 1998, J MAMMAL, V79, P20, DOI 10.2307/1382839; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Tella JL, 2002, P ROY SOC B-BIOL SCI, V269, P1059, DOI 10.1098/rspb.2001.1951; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026	29	41	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1130	10.1371/journal.pone.0001130	http://dx.doi.org/10.1371/journal.pone.0001130			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987117	gold, Green Submitted, Green Published			2022-12-25	WOS:000207459000014
J	Iwami, T; Kishida, O; Nishimura, K				Iwami, Tadashi; Kishida, Osamu; Nishimura, Kinya			Direct and Indirect Induction of a Compensatory Phenotype that Alleviates the Costs of an Inducible Defense	PLOS ONE			English	Article								Organisms often exhibit phenotypic plasticity in multiple traits in response to impending environmental change. Multiple traits phenotypic plasticity is complex syndrome brought on by causal relations in ecological and physiological context. Larvae of the salamander Hynobius retardatus exhibit inducible phenotypic plasticity of two traits, when at risk of predation by dragonfly larvae. One induced phenotype is an adaptive defense behaviour, i.e., stasis at the bottom of water column, directly triggered by the predation risk. Another one is a compensatory phenotype, i.e., enlarged external gills, for an unavoidable cost (hypoxia) associated with the induced defense. We identified two ways by which this compensatory phenotype could be induced. The compensatory phenotype is induced in response to not only the associated hypoxic conditions resulting from the induced defense but also the most primary but indirect cause, presence of the predator.	[Iwami, Tadashi; Kishida, Osamu; Nishimura, Kinya] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido, Japan	Hokkaido University	Nishimura, K (corresponding author), Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido, Japan.	kinya@fish.hokudai.ac.jp	Kishida, Osamu/B-7970-2011		Ministry of Education, Culture, Sports, Science and Technology [16370008, 18657006, 19370005, 09035]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding: This work was supported by Grants-in-Aid for Scientific Research (nos. 16370008, 18657006, 19370005) to KN from the Ministry of Education, Culture, Sports, Science and Technology, and in part by a Grant-in-Aid for a Young Research Scientists (no. 09035) to OK. The sponsors did not have any role of the scientific activity itself.	Andersson J, 2006, P ROY SOC B-BIOL SCI, V273, P431, DOI 10.1098/rspb.2005.3343; ANHOLT BR, 1995, ECOLOGY, V76, P2230, DOI 10.2307/1941696; [Anonymous], 2017, ANIM COGN, DOI DOI 10.1007/s10071-016-1007-0; BOND AN, 1960, DEV BIOL, V2, P1, DOI 10.1016/0012-1606(60)90013-0; BURGGREN W, 1983, J EXP BIOL, V105, P191; CLARK CW, 1992, AM NAT, V139, P521, DOI 10.1086/285342; Crowder WC, 1998, J EXP ZOOL, V280, P121, DOI 10.1002/(SICI)1097-010X(19980201)280:2<121::AID-JEZ3>3.0.CO;2-Q; DODSON SI, 1974, LIMNOL OCEANOGR, V19, P721, DOI 10.4319/lo.1974.19.5.0721; Edmunds M., 1974, DEFENCE ANIMALS; FEDER ME, 1983, J EXP BIOL, V104, P79; IWASAWA H, 1991, Japanese Journal of Herpetology, V14, P39; Kishida O, 2006, ECOLOGY, V87, P1599, DOI 10.1890/0012-9658(2006)87[1599:RPPIAP]2.0.CO;2; Kishida O, 2006, J ANIM ECOL, V75, P705, DOI 10.1111/j.1365-2656.2006.01091.x; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lind J, 2005, BEHAV ECOL, V16, P945, DOI 10.1093/beheco/ari075; McIntyre PB, 2000, OECOLOGIA, V125, P301, DOI 10.1007/s004420000451; Schmidt BR, 2006, EVOL ECOL RES, V8, P1301; SKELLY DK, 1994, ANIM BEHAV, V47, P465, DOI 10.1006/anbe.1994.1063; SKELLY DK, 1992, ECOLOGY, V73, P704, DOI 10.2307/1940779; Stoks R, 2005, J ANIM ECOL, V74, P708, DOI 10.1111/j.1365-2656.2005.00969.x; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; ULTSCH GR, 1976, RESP PHYSIOL, V26, P357, DOI 10.1016/0034-5687(76)90006-2; Ultsch GR, 1999, TADPOLES, P189; Vonesh JR, 2005, ECOLOGY, V86, P1580, DOI 10.1890/04-0535; WEBER JM, 1983, CAN J FISH AQUAT SCI, V40, P1583, DOI 10.1139/f83-183; WEST NH, 1982, RESP PHYSIOL, V47, P165, DOI 10.1016/0034-5687(82)90109-8; WHITFORD WG, 1965, PHYSIOL ZOOL, V38, P228, DOI 10.1086/physzool.38.3.30152835; WOOD SC, 1980, AM ZOOL, V20, P163	28	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1084	10.1371/journal.pone.0001084	http://dx.doi.org/10.1371/journal.pone.0001084			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971850	Green Published, gold, Green Submitted			2022-12-25	WOS:000207458700003
J	Schooling, CM; Lam, TH; Thomas, GN; Cowling, BJ; Heys, M; Janus, ED; Leung, GM				Schooling, C. Mary; Lam, Tai Hing; Thomas, G. Neil; Cowling, Benjamin J.; Heys, Michelle; Janus, Edward D.; Leung, Gabriel M.		Hong Kong Cardiovasc Risk Factor P	Growth Environment and Sex Differences in Lipids, Body Shape and Diabetes Risk	PLOS ONE			English	Article								Background. Sex differences in lipids and body shape, but not diabetes, increase at puberty. Hong Kong Chinese are mainly first or second generation migrants from China, who have shared an economically developed environment for years, but grew up in very different environments in Hong Kong or contemporaneously undeveloped Guangdong, China. We assessed if environment during growth had sex-specific associations with lipids and body shape, but not diabetes. Methodology and Principal Findings. We used multivariable regression in a population-based cross-sectional study, undertaken from 1994 to 1996, of 2537 Hong Kong Chinese residents aged 25 to 74 years with clinical measurements of ischaemic heart disease (IHD) risk, including HDL-cholesterol, ApoB, diabetes and obesity. Waist-hip ratio was higher ( mean difference 0.01, 95% CI 0.001 to 0.02) in men, who had grown up in an economically developed rather than undeveloped environment, as was apolipoprotein B (0.05 g/L, 95% CI 0.001 to 0.10), adjusted for age, socio-economic status and lifestyle. In contrast, the same comparison was associated in women with lower waist-hip ratio (20.01, 95% CI 20.001 to 20.02) and higher HDL-cholesterol ( 0.05 mmol/L, 95% CI 0.0004 to 0.10). The associations in men and women were significantly different (p-values, 0.001). There were no such differences for diabetes. Conclusions. Growth in a developed environment with improved nutrition may promote higher sex-steroids at puberty producing an atherogenic lipid profile and male fat pattern in men but the opposite in women, with tracking of increased male IHD risk into adult life.	[Schooling, C. Mary; Lam, Tai Hing; Thomas, G. Neil; Cowling, Benjamin J.; Heys, Michelle; Leung, Gabriel M.] Univ Hong Kong, Dept Community Med, Pokfulam, Hong Kong, Peoples R China; [Schooling, C. Mary; Lam, Tai Hing; Thomas, G. Neil; Cowling, Benjamin J.; Heys, Michelle; Leung, Gabriel M.] Univ Hong Kong, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China; [Janus, Edward D.] Univ Hong Kong, Clin Biochem Unit, Pokfulam, Hong Kong, Peoples R China; [Janus, Edward D.] Western Hosp, Dept Med, Footscray, Vic, Australia	University of Hong Kong; University of Hong Kong; University of Hong Kong; Western Hospital	Schooling, CM (corresponding author), Univ Hong Kong, Dept Community Med, Pokfulam, Hong Kong, Peoples R China.	cms1@hkucc.hku.hk	Janus, Edward/AAU-8652-2020; Leung, Gabriel Matthew/C-4336-2009; Thomas, G. Neil/A-1879-2013; Schooling, Catherine Mary/C-4386-2009; Cowling, Benjamin John/C-4263-2009; Lam, Tai Hing/C-4317-2009	Thomas, G. Neil/0000-0002-2777-1847; Cowling, Benjamin John/0000-0002-6297-7154; Lam, Tai Hing/0000-0002-2033-9971; Leung, Gabriel/0000-0002-2503-6283; Schooling, Mary/0000-0001-9933-5887	Hong Kong Health Services Research Committee (HSRC) [411026]; University of Hong Kong Committee on Research and Conference; Hong Kong Research Grants Council [407/94m]; Hong Kong Society for the Aged	Hong Kong Health Services Research Committee (HSRC); University of Hong Kong Committee on Research and Conference(University of Hong Kong); Hong Kong Research Grants Council(Hong Kong Research Grants Council); Hong Kong Society for the Aged	The study was supported by the Hong Kong Health Services Research Committee (HSRC# 411026), the University of Hong Kong Committee on Research and Conference Grants, the Hong Kong Research Grants Council (grant 407/94m) and the Hong Kong Society for the Aged. The funding source had no involvement in the design, collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	Adam CL, 1997, J REPROD FERTIL, V111, P121, DOI 10.1530/jrf.0.1110121; Arslanian S, 1997, J CLIN ENDOCR METAB, V82, P3213, DOI 10.1210/jc.82.10.3213; Avendano M, 2006, HEART, V92, P461, DOI 10.1136/hrt.2005.065532; Ballantyne C, 2005, EUR HEART J, V26, P2224, DOI 10.1093/eurheartj/ehi373; BERENSON GS, 1981, AM J EPIDEMIOL, V113, P157, DOI 10.1093/oxfordjournals.aje.a113080; Butters H.R., 1939, REPORT LABOUR LABOUR; Campbell BC, 2004, ANN HUM BIOL, V31, P213, DOI 10.1080/03014460310001656604; Dahlman C.J., 2001, CHINA KNOWLEDGE EC S; Donnan Stuart P. B., 1994, Annals of Epidemiology, V4, P46; Dorgan JF, 2003, J NATL CANCER I, V95, P132, DOI 10.1093/jnci/95.2.132; Dorgan JF, 2006, J CLIN ENDOCR METAB, V91, P3992, DOI 10.1210/jc.2006-0109; Ezeamama AE, 2006, SOC SCI MED, V63, P2533, DOI 10.1016/j.socscimed.2006.06.023; Freire RD, 2003, BRIT J NUTR, V89, P705, DOI 10.1079/BJN2002824; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Gonzalez MA, 1998, INT J EPIDEMIOL, V27, P350, DOI 10.1093/ije/27.3.350; Goran MI, 2001, DIABETES, V50, P2444, DOI 10.2337/diabetes.50.11.2444; Hauspie RC, 1997, ACTA PAEDIATR, V86, P20; Hero M, 2006, EUR J ENDOCRINOL, V155, P453, DOI 10.1530/eje.1.02226; *HONG KONG GOV, 1955, HONG KONG ANN REP 19; Janghorbani M, 2003, ADDICTION, V98, P215, DOI 10.1046/j.1360-0443.2003.00268.x; JAROSS W, 1981, ENDOKRINOLOGIE, V78, P28; Kim MH, 2005, INT J EPIDEMIOL, V34, P1266, DOI 10.1093/ije/dyi175; KIRKLAND RT, 1987, JAMA-J AM MED ASSOC, V257, P502, DOI 10.1001/jama.257.4.502; Lam TH, 1999, ATHEROSCLEROSIS, V143, P405, DOI 10.1016/S0021-9150(98)00294-9; Langenberg C, 2006, AM J PUBLIC HEALTH, V96, P2216, DOI 10.2105/AJPH.2004.049429; Lawlor DA, 2002, BRIT MED J, V325, P311, DOI 10.1136/bmj.325.7359.311; Lawlor DA, 2001, BRIT MED J, V323, P541, DOI 10.1136/bmj.323.7312.541; MADDISON A, 2003, DEV CTR STUDIES; Manor O, 2004, ANN EPIDEMIOL, V14, P453, DOI 10.1016/j.annepidem.2003.10.011; MARMOT M, 1992, CORONARY HEART DIS E, P3; Moran A, 2002, J CLIN ENDOCR METAB, V87, P4817, DOI 10.1210/jc.2002-020517; Morrison JA, 2003, J PEDIATR-US, V142, P637, DOI 10.1067/mpd.2003.246; NGO TW, 2003, HONG KONG READER SOC, P543; Nikiforov SV, 1998, AM J PUBLIC HEALTH, V88, P1348, DOI 10.2105/AJPH.88.9.1348; NOLAN CJ, 1990, J ANIM SCI, V68, P1087, DOI 10.2527/1990.6841087x; Ovesen L, 2006, ANN NUTR METAB, V50, P317, DOI 10.1159/000094294; Pischon T, 2005, CIRCULATION, V112, P3375, DOI 10.1161/CIRCULATIONAHA.104.532499; Pollitt RA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-7; Roemmich JN, 1999, AM J HUM BIOL, V11, P209, DOI 10.1002/(SICI)1520-6300(1999)11:2&lt;209::AID-AJHB9&gt;3.0.CO;2-G; RONNEKLEIV OK, 1978, BIOL REPROD, V19, P414, DOI 10.1095/biolreprod19.2.414; Saad RJ, 2001, J CLIN ENDOCR METAB, V86, P4881, DOI 10.1210/jc.86.10.4881; Schooling M, 2004, INT J EPIDEMIOL, V33, P1219, DOI 10.1093/ije/dyh221; Seidell Jacob C, 2005, Semin Vasc Med, V5, P3, DOI 10.1055/s-2005-871737; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; SLOB AK, 1979, BRIT J NUTR, V41, P231, DOI 10.1079/BJN19790032; SMITH GD, 2004, LIFE COURSE APPROACH, P77, DOI DOI 10.1093/ACPROF:OSO/9780198578154.001.0001; SRINIVASAN SR, 1985, METABOLISM, V34, P861, DOI 10.1016/0026-0495(85)90111-8; STOZICKY F, 1991, ACTA PAEDIATR SCAND, V80, P1139, DOI 10.1111/j.1651-2227.1991.tb11801.x; Tsang S., 2004, MODERN HIST HONG KON; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; *WHO MONICA PROJ, 1988, WORLD HLTH STAT Q, V41, P115; Wickman S, 2002, EUR J ENDOCRINOL, V146, P339, DOI 10.1530/eje.0.1460339; WONG SL, 1992, J EPIDEMIOL COMMUN H, V46, P148, DOI 10.1136/jech.46.2.148; Yu ZJ, 2002, J CLIN EPIDEMIOL, V55, P143, DOI 10.1016/S0895-4356(01)00451-6; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	57	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1070	10.1371/journal.pone.0001070	http://dx.doi.org/10.1371/journal.pone.0001070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957253	gold, Green Published, Green Submitted			2022-12-25	WOS:000207458500016
J	Treweek, TM; Ecroyd, H; Williams, DM; Meehan, S; Carver, JA; Walker, MJ				Treweek, Teresa M.; Ecroyd, Heath; Williams, Danielle M.; Meehan, Sarah; Carver, John A.; Walker, Mark J.			Site-Directed Mutations in the C-Terminal Extension of Human alpha B-Crystallin Affect Chaperone Function and Block Amyloid Fibril Formation	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; IN-VITRO; MOLECULAR CHAPERONE; KAPPA-CASEIN; OLIGOMERIZATION; FLUORESCENCE; BINDING; PHOSPHORYLATION; IDENTIFICATION; SPECTROSCOPY	Background. Alzheimer's, Parkinson's and Creutzfeldt-Jakob disease are associated with inappropriate protein deposition and ordered amyloid fibril assembly. Molecular chaperones, including alpha B-crystallin, play a role in the prevention of protein deposition. Methodology/Principal Findings. A series of site-directed mutants of the human molecular chaperone, alpha B-crystallin, were constructed which focused on the flexible C-terminal extension of the protein. We investigated the structural role of this region as well as its role in the chaperone function of alpha B-crystallin under different types of protein aggregation, i.e. disordered amorphous aggregation and ordered amyloid fibril assembly. It was found that mutation of lysine and glutamic acid residues in the C-terminal extension of alpha B-crystallin resulted in proteins that had improved chaperone activity against amyloid fibril forming target proteins compared to the wild-type protein. Conclusions/Significance. Together, our results highlight the important role of the C-terminal region of alpha B-crystallin in regulating its secondary, tertiary and quaternary structure and conferring thermostability to the protein. The capacity to genetically modify alpha B-crystallin for improved ability to block amyloid fibril formation provides a platform for the future use of such engineered molecules in treatment of diseases caused by amyloid fibril formation.	[Walker, Mark J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Treweek, Teresa M.] Univ Wollongong, Dept Chem, Wollongong, NSW 2500, Australia; [Treweek, Teresa M.] Univ Wollongong, Grad Sch Med, Wollongong, NSW 2500, Australia; [Ecroyd, Heath; Williams, Danielle M.; Carver, John A.] Univ Adelaide, Sch Chem & Phys, Adelaide, SA, Australia; [Meehan, Sarah] Univ Cambridge, Univ Chem Lab, Cambridge, England	University of Wollongong; University of Wollongong; University of Wollongong; University of Adelaide; University of Cambridge	Walker, MJ (corresponding author), Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia.	mwalker@uow.edu.au	Walker, Mark J./F-6940-2011; Ecroyd, Heath/E-7140-2015; Carver, John Adrian/J-3825-2014	Carver, John Adrian/0000-0002-2441-8108; Walker, Mark/0000-0001-7423-2769; Ecroyd, Heath/0000-0001-7574-0044	National Health and Medical Research Council (NHMRC) of Australia; Australian Research Council; Australian Postgraduate Award; Royal Society	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Australian Postgraduate Award(Australian Government); Royal Society(Royal Society of London)	This work was supported by grants (to JAC) from the National Health and Medical Research Council (NHMRC) of Australia and the Australian Research Council. TT was supported by an Australian Postgraduate Award, HE is supported by an NHMRC Peter Doherty Postdoctoral Training Fellowship and SM was supported by a Royal Society International Fellowship.	Andley UP, 1996, J BIOL CHEM, V271, P31973, DOI 10.1074/jbc.271.50.31973; ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Aquilina JA, 2005, J BIOL CHEM, V280, P14485, DOI 10.1074/jbc.M500135200; Aquilina JA, 2004, J BIOL CHEM, V279, P28675, DOI 10.1074/jbc.M403348200; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Bera S, 2002, BIOCHEMISTRY-US, V41, P297, DOI 10.1021/bi011010v; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; Cambillau C, 2000, J BIOL CHEM, V275, P32383, DOI 10.1074/jbc.C000497200; CARVER JA, 1992, FEBS LETT, V311, P143, DOI 10.1016/0014-5793(92)81386-Z; CARVER JA, 1995, BBA-PROTEIN STRUCT M, V1252, P251, DOI 10.1016/0167-4838(95)00146-L; Carver JA, 1996, EXP EYE RES, V63, P639, DOI 10.1006/exer.1996.0158; Carver JA, 1998, INT J BIOL MACROMOL, V22, P197, DOI 10.1016/S0141-8130(98)00017-8; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; COPELAND R, 1994, SPECTROSCOPIC PROBES; Das BK, 1997, BIOCHEM BIOPH RES CO, V236, P370, DOI 10.1006/bbrc.1997.6950; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; Ecroyd H, 2007, BIOCHEM J, V401, P129, DOI 10.1042/BJ20060981; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Farrell HM, 2003, J PROTEIN CHEM, V22, P259, DOI 10.1023/A:1025020503769; Fernando P, 2000, CELL STRESS CHAPERON, V5, P148, DOI 10.1379/1466-1268(2000)005<0148:FCOXSH>2.0.CO;2; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Ghosh JG, 2005, BIOCHEMISTRY-US, V44, P14854, DOI 10.1021/bi0503910; Giese KC, 2005, P NATL ACAD SCI USA, V102, P18896, DOI 10.1073/pnas.0506169103; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hatters DM, 2001, J BIOL CHEM, V276, P33755, DOI 10.1074/jbc.M105285200; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 1998, METHOD ENZYMOL, V290, P365, DOI 10.1016/S0076-6879(98)90032-5; Kamei A, 2000, BIOL PHARM BULL, V23, P226; Kammerer RA, 2004, P NATL ACAD SCI USA, V101, P4435, DOI 10.1073/pnas.0306786101; Karshikoff A, 1998, PROTEIN ENG, V11, P867, DOI 10.1093/protein/11.10.867; Karshikoff A, 2001, TRENDS BIOCHEM SCI, V26, P550, DOI 10.1016/S0968-0004(01)01918-1; KATO K, 1991, BIOCHIM BIOPHYS ACTA, V1074, P201, DOI 10.1016/0304-4165(91)90062-L; KELLEY MJ, 1993, J BIOL CHEM, V268, P18844; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; Kreil DP, 2001, NUCLEIC ACIDS RES, V29, P1608, DOI 10.1093/nar/29.7.1608; KRONMAN MJ, 1971, PHOTOCHEM PHOTOBIOL, V14, P113, DOI 10.1111/j.1751-1097.1971.tb06157.x; Kudva YC, 1997, FEBS LETT, V416, P117, DOI 10.1016/S0014-5793(97)01180-0; Kumar LVS, 1999, J BIOL CHEM, V274, P24137, DOI 10.1074/jbc.274.34.24137; Leroux MR, 1997, J BIOL CHEM, V272, P24646, DOI 10.1074/jbc.272.39.24646; Liang JJN, 2000, FEBS LETT, V484, P98, DOI 10.1016/S0014-5793(00)02136-0; Liao JH, 2002, BIOCHEM BIOPH RES CO, V297, P309, DOI 10.1016/S0006-291X(02)02185-X; Lindner RA, 1998, EUR J BIOCHEM, V258, P170, DOI 10.1046/j.1432-1327.1998.2580170.x; Lindner RA, 2000, EUR J BIOCHEM, V267, P1923, DOI 10.1046/j.1432-1327.2000.01188.x; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P8397, DOI 10.1021/bi0105983; OCHI N, 1991, BIOCHEM BIOPH RES CO, V179, P1030, DOI 10.1016/0006-291X(91)91922-Y; Pasta SY, 2004, MOL VIS, V10, P655; Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339; RANDALL LL, 1992, SCIENCE, V257, P241, DOI 10.1126/science.1631545; Rekas A, 2004, J MOL BIOL, V340, P1167, DOI 10.1016/j.jmb.2004.05.054; Sathish HA, 2004, J BIOL CHEM, V279, P16425, DOI 10.1074/jbc.M313402200; Sathish HA, 2003, J BIOL CHEM, V278, P44214, DOI 10.1074/jbc.M307578200; Smulders RHPH, 1996, J BIOL CHEM, V271, P29060, DOI 10.1074/jbc.271.46.29060; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stege GJJ, 1999, BIOCHEM BIOPH RES CO, V262, P152, DOI 10.1006/bbrc.1999.1167; Studer S, 2002, EUR J BIOCHEM, V269, P3578, DOI 10.1046/j.1432-1033.2002.03049.x; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; Syme CD, 2002, EUR J BIOCHEM, V269, P148, DOI 10.1046/j.0014-2956.2001.02633.x; TAKEMOTO L, 1993, BIOCHEM J, V297, P653; Thampi P, 2003, BIOCHEMISTRY-US, V42, P11857, DOI 10.1021/bi030129w; Thorn DC, 2005, BIOCHEMISTRY-US, V44, P17027, DOI 10.1021/bi051352r; Treweek TM, 2003, AUST J CHEM, V56, P357, DOI 10.1071/CH03031; van Rijk AF, 2000, OPHTHALMOLOGICA, V214, P7, DOI 10.1159/000027468; VANMONTFORT RLM, 2001, NATURE STRUCT BIOL; White HE, 2006, STRUCTURE, V14, P1197, DOI 10.1016/j.str.2006.05.021; Young JC, 1997, FEBS LETT, V418, P139, DOI 10.1016/S0014-5793(97)01363-X	69	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1046	10.1371/journal.pone.0001046	http://dx.doi.org/10.1371/journal.pone.0001046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940610	Green Published, Green Submitted, gold			2022-12-25	WOS:000207456100014
J	Wang, H; Zhao, Y; Li, L; McNutt, MA; Wu, LP; Lu, SL; Yu, Y; Zhou, W; Feng, J; Chai, GL; Yang, Y; Zhu, WG				Wang, Haiying; Zhao, Ying; Li, Lian; McNutt, Michael A.; Wu, Lipeng; Lu, Shaoli; Yu, Yu; Zhou, Wen; Feng, Jingnan; Chai, Guolin; Yang, Yang; Zhu, Wei-Guo			An ATM- and Rad3-related (ATR) signaling pathway and a phosphorylation-acetylation cascade are involved in activation of p53/p21(Waf1/Cip1) in response to 5-aza-2 '-deoxycytidine treatment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE-INDUCED PHOSPHORYLATION; CELL-CYCLE ARREST; DOUBLE-STRAND BREAKS; DNA-DAMAGE; IONIZING-RADIATION; P53 ACETYLATION; TRANSCRIPTIONAL ACTIVITY; ATAXIA-TELANGIECTASIA; TUMOR-SUPPRESSOR; MAMMALIAN-CELLS	Most agents that damage DNA act through posttranslational modifications of p53 and activate its downstream targets. However, whether cellular responses to nucleoside analogue-induced DNA damage also operate through p53 posttranslational modification has not been reported. In this study, the relationship between p53 activation and its posttranslational modifications was investigated in the human cancer cell lines A549 and HCT116 in response to 5-aza-2 '-deoxycytidine (5-aza-CdR) or cytarabine treatment. 5-Aza-CdR induces p53 posttranslational modifications through activation of an ATM- and Rad3-related (ATR) signaling pathway, and 5-aza-CdR-induced association of replication protein A with chromatin is required for the binding of ATR to chromatin. Upon treatment with 5-aza-CdR, ATR activation is clearly associated with p53 phosphorylation at Ser(15), but not at Thr(18), Ser(20), or Ser(37). This specific p53 phosphorylation at Ser15 in turn results in acetylation of p53 at Lys(320) and Lys(373)/Lys(382) through transcriptional cofactors p300/CBP-associated factor and p300, respectively. These p53 posttranslational modifications are directly responsible for 5-aza-CdR induced p21(Waf1/Cip1) expression because the binding activity of acetylated p53 at Lys(320)/Lys(373)/ Lys(382) to the p21(Waf1/Cip1) promoter, as well as p21(Waf1/Cip1) expression itself are significantly increased after 5-aza-CdR treatment. It is of interest that p53 phosphorylation at Ser15 and acetylations at Lys(320)/Lys(373)/ Lys382 mutually interact in the 5-aza-CdR induced p21(Waf1)/(Cip1) expression shown by transfection of artificially mutated p53 expression vectors including S15A, K320R, and K373R/K382 into p53-null H1299 cells. These data taken together show for the first time that 5-aza-CdR activates the ATR signaling pathway, which elicits a specific p53 phosphorylation-acetylation cascade to induce p21(Waf1/Cip1) expression.	[Wang, Haiying; Zhao, Ying; Li, Lian; Wu, Lipeng; Lu, Shaoli; Yu, Yu; Zhou, Wen; Feng, Jingnan; Chai, Guolin; Yang, Yang; Zhu, Wei-Guo] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100083, Peoples R China; [McNutt, Michael A.] Peking Univ, Hlth Sci Ctr, Dept Pathol, Beijing 100083, Peoples R China; [Zhu, Wei-Guo] Peking Univ, Hlth Sci Ctr, Canc Res Ctr, Beijing 100083, Peoples R China	Peking University; Peking University; Peking University	Zhu, WG (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 38 Xueyuan Rd, Beijing 100083, Peoples R China.	zhuweiguo@bjmu.edu.cn	Zhou, Wen/A-5763-2010; zhu, wei-guo/E-1334-2012	Zhou, Wen/0000-0002-5496-5815; Wang, Haiying/0000-0001-7729-0649; Yang, Yang/0000-0002-8737-590X; Zhu, Wei-Guo/0000-0001-8385-6581				Abida WM, 2007, J BIOL CHEM, V282, P1797, DOI 10.1074/jbc.M609001200; Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Andegeko Y, 2001, J BIOL CHEM, V276, P38224; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chao C, 2006, MOL CELL BIOL, V26, P6859, DOI 10.1128/MCB.00062-06; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; COVEY JM, 1986, CANCER RES, V46, P5511; DINCALCI M, 1985, CANCER RES, V45, P3197; Dornan D, 2001, EMBO REP, V2, P139, DOI 10.1093/embo-reports/kve025; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; HAAF T, 1995, PHARMACOL THERAPEUT, V65, P19, DOI 10.1016/0163-7258(94)00053-6; Harper JW, 2004, CELL, V118, P2, DOI 10.1016/j.cell.2004.06.015; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hekmat-Nejad M, 2000, CURR BIOL, V10, P1565, DOI 10.1016/S0960-9822(00)00855-1; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; HUPP TR, 1995, CELL, V83, P237, DOI 10.1016/0092-8674(95)90165-5; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Karpf AR, 2001, MOL PHARMACOL, V59, P751, DOI 10.1124/mol.59.4.751; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KHANNA KK, 1993, ONCOGENE, V8, P3307; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Liu L, 1999, MOL CELL BIOL, V19, P1202; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; MAYR GA, 1995, CANCER RES, V55, P2410; McKinney K, 2004, MOL CELL, V16, P413, DOI 10.1016/j.molcel.2004.09.032; Nag A, 2007, J BIOL CHEM, V282, P8812, DOI 10.1074/jbc.M610443200; Ou YH, 2005, MOL BIOL CELL, V16, P1684, DOI 10.1091/mbc.E04-08-0689; Pandita TK, 2000, ONCOGENE, V19, P1386, DOI 10.1038/sj.onc.1203444; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Roy S, 2005, CELL DEATH DIFFER, V12, P482, DOI 10.1038/sj.cdd.4401581; Saito S, 2002, J BIOL CHEM, V277, P12491, DOI 10.1074/jbc.C200093200; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shiotani B, 2006, MOL CANCER RES, V4, P125, DOI 10.1158/1541-7786.MCR-05-0104; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Unger T, 1999, EMBO J, V18, P1805, DOI 10.1093/emboj/18.7.1805; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0; Wong DS, 2004, J BIOL CHEM, V279, P55667, DOI 10.1074/jbc.M408174200; Wright JA, 1998, P NATL ACAD SCI USA, V95, P7445, DOI 10.1073/pnas.95.13.7445; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; Yih LH, 2000, CANCER RES, V60, P6346; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006; Zhu WG, 2004, J BIOL CHEM, V279, P15161, DOI 10.1074/jbc.M311703200; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	73	43	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2564	2574		10.1074/jbc.M702454200	http://dx.doi.org/10.1074/jbc.M702454200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	17977830	hybrid			2022-12-25	WOS:000252622300013
J	Amir-Zilberstein, L; Dikstein, R				Amir-Zilberstein, Liat; Dikstein, Rivka			Interplay between E-box and NF-kappa B in regulation of A20 gene by DRB sensitivity-inducing factor (DSIF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; UPSTREAM STIMULATORY FACTOR; P-TEFB; TRANSCRIPTION ELONGATION; PROMOTER; REPRESSION; COMPLEX; CELLS; SPT5	The NF-kappa B target gene A20 serves as a paradigm for gene-specific control of transcription elongation. This gene is regulated by the elongation factor DSIF (DRB sensitivity-inducing factor) under basal and NF-kappa B-activated states by two distinct mechanisms. Prior to NF-kappa B stimulation, the A20 gene is occupied by polymerase II, and elongation is inhibited by DSIF. This inhibition is mediated by an upstream promoter element termed ELIE (elongation inhibitory element). Upon NF-kappa B activation, inhibition of the A20 gene by DSIF persists, but now NF-kappa B and the core promoter regulate DSIF instead of ELIE. Here we investigated the regulation of DSIF by ELIE and the regulatory switch from ELIE to NF-kappa B following NF-kappa B induction. Electrophoretic mobility shift assays revealed two distinct protein complexes that specifically interact with ELIE, one of which is the E-box protein USF1. Interestingly, USF1 is displaced from the A20 promoter upon induction of NF-kappa B. A mutation in the E-box section of ELIE diminished the binding of USF1 and DSIF recruitment. Consistent with these findings, the E-box is crucial for DSIF inhibition in resting, but not NF-kappa B stimulated, cells. These findings reveal a dynamic regulation of DSIF involving either E-box or NF-kappa B depending on the physiological circumstances.	[Amir-Zilberstein, Liat; Dikstein, Rivka] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Dikstein, R (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	rivka.dikstein@weizmann.ac.il						Ainbinder E, 2004, MOL CELL BIOL, V24, P2444, DOI 10.1128/MCB.24.6.2444-2454.2004; Ainbinder E, 2002, MOL CELL BIOL, V22, P6354, DOI 10.1128/MCB.22.18.6354-6362.2002; Amir-Zilberstein L, 2007, MOL CELL BIOL, V27, P5246, DOI 10.1128/MCB.00586-07; Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Chang JTC, 2005, MOL CARCINOGEN, V44, P183, DOI 10.1002/mc.20129; Goueli BS, 2003, ONCOGENE, V22, P8042, DOI 10.1038/sj.onc.1206847; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pinaud S, 1998, J MOL BIOL, V280, P785, DOI 10.1006/jmbi.1998.1905; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; ROUGVIE AE, 1990, MOL CELL BIOL, V10, P6041, DOI 10.1128/MCB.10.11.6041; Selva DM, 2005, J BIOL CHEM, V280, P4462, DOI 10.1074/jbc.M409616200; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; SPENCER CA, 1991, ADV CANCER RES, V56, P1; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wang XL, 2007, GENE DEV, V21, P1031, DOI 10.1101/gad.1521207; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8	23	21	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1317	1323		10.1074/jbc.M706767200	http://dx.doi.org/10.1074/jbc.M706767200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17962196	hybrid			2022-12-25	WOS:000252282700014
J	Gallegos, JR; Litersky, J; Lee, H; Sun, Y; Nakayama, K; Nakayama, K; Lu, H				Gallegos, Jayme R.; Litersky, Joel; Lee, Hunjoo; Sun, Yi; Nakayama, Keiichi; Nakayama, Keiko; Lu, Hua			SCF beta TrCP1 activates and ubiquitylates TAp63 gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-KAPPA-B; UBIQUITIN LIGASE; TRANSCRIPTIONAL ACTIVITY; PROTEIN STABILITY; P53 HOMOLOG; P63; DEGRADATION; GENE; E3; MORPHOGENESIS	p63 is a member of the p53 tumor suppressor family that is critical for epithelial differentiation and also has an important role in cancer progression. Currently, the molecular mechanisms governing regulation of p63 function remain largely unclear. This study identifies a unique E3 ubiquitin ligase for p63, SCF beta TrCP1. SCF beta TrCP1 is able to bind p63 gamma isoforms, with a higher affinity for the TAp63 gamma isoform. Strikingly, co-expression of TAp63 gamma and beta TrCP1 leads to the stabilization of TAp63 gamma. This stabilization of TAp63 gamma leads to up-regulation of p21 at the mRNA and protein level by increased binding of TAp63 gamma at the p21 promoter. The up-regulation of p21 causes a subsequent increase in G(1) phase cell cycle arrest. Last, SCF beta TrCP1 is able to ubiquitylate TAp63 gamma, and this ubiquitylation, as well as the increased activity of TAp63 gamma, is ablated with the expression of a ubiquitin-deficient mutant of beta TrCP1 (Delta F beta TrCP1). Therefore, our study reveals that SCF beta TrCP1 is an E3 ligase that activates p63 through ubiquitylation.	[Lu, Hua] Indiana Univ, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Gallegos, Jayme R.; Litersky, Joel; Lee, Hunjoo; Lu, Hua] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Sun, Yi] Univ Michigan, Ctr Comprehens Canc, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Nakayama, Keiichi; Nakayama, Keiko] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; [Nakayama, Keiichi] CREST, Japan Sci & Technol Agcy, Kawagoe, Saitama 3320012, Japan; [Nakayama, Keiko] Tohoku Univ, Ctr Translat & Adv Anim Res, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan	Indiana University System; Indiana University-Purdue University Indianapolis; Oregon Health & Science University; University of Michigan System; University of Michigan; Kyushu University; Japan Science & Technology Agency (JST); Tohoku University	Lu, H (corresponding author), Indiana Univ, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	hualu@iupui.edu	Sun, Yi/K-1025-2014	Sun, Yi/0000-0002-5841-4287	NCI NIH HHS [CA 079721, CA 93614, CA 095441] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA095441, R01CA079721, R01CA093614] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Belaidouni N, 2005, ONCOGENE, V24, P2271, DOI 10.1038/sj.onc.1208418; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Iordanov MS, 2002, MOL CELL BIOL, V22, P5380, DOI 10.1128/MCB.22.15.5380-5394.2002; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Jin YT, 2004, J BIOL CHEM, V279, P20035, DOI 10.1074/jbc.M309916200; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; King KE, 2006, CARCINOGENESIS, V27, P53, DOI 10.1093/carcin/bgi200; Krappmann D, 2005, EMBO REP, V6, P321, DOI 10.1038/sj.embor.7400380; Kulesz-Martin M, 2005, J INVEST DERM SYMP P, V10, P142, DOI 10.1111/j.1087-0024.2005.200405.x; Le Cam L, 2006, CELL, V127, P775, DOI 10.1016/j.cell.2006.09.031; Li YP, 2007, J BIOL CHEM, V282, P6936, DOI 10.1074/jbc.M603822200; MacPartlin M, 2005, J BIOL CHEM, V280, P30604, DOI 10.1074/jbc.M503352200; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Moll UM, 2004, MOL CANCER RES, V2, P371; Nakayama K, 2003, P NATL ACAD SCI USA, V100, P8752, DOI 10.1073/pnas.1133216100; Osada M, 2005, MOL CELL BIOL, V25, P6077, DOI 10.1128/MCB.25.14.6077-6089.2005; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Peters JM, 2003, MOL CELL, V11, P1420, DOI 10.1016/S1097-2765(03)00233-8; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Sil AK, 2004, NATURE, V428, P660, DOI 10.1038/nature02421; Tan MJ, 2006, NEOPLASIA, V8, P1042, DOI 10.1593/neo.06568; von der Lehr N, 2003, CELL CYCLE, V2, P403, DOI 10.4161/cc.2.5.484; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zeng SX, 2002, EMBO J, V21, P5487, DOI 10.1093/emboj/cdf540	31	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					66	75		10.1074/jbc.M704686200	http://dx.doi.org/10.1074/jbc.M704686200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17965458	hybrid			2022-12-25	WOS:000251940300009
J	Galuska, SP; Geyer, R; Gerardy-Schahn, R; Muhlenhoff, M; Geyer, H				Galuska, Sebastian P.; Geyer, Rudolf; Gerardy-Schahn, Rita; Muehlenhoff, Martina; Geyer, Hildegard			Enzyme-dependent variations in the polysialylation of the neural cell adhesion molecule (NCAM) in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; ST8SIA II STX; PERFORMANCE LIQUID-CHROMATOGRAPHY; DEVELOPMENTALLY-REGULATED MEMBER; ULTRASENSITIVE CHEMICAL METHOD; POLYSIALIC ACID SYNTHESIS; MASS-SPECTROMETRY; MOUSE-BRAIN; COOPERATIVE POLYSIALYLATION; HUMAN POLYSIALYLTRANSFERASE	Polysialic acid (polySia), an alpha 2,8-linked polymer of N-acetylneuraminic acid, represents an essential regulator of neural cell adhesion molecule ( NCAM) functions. Two polysialyltransferases, ST8SiaII and ST8SiaIV, account for polySia synthesis, but their individual roles in vivo are still not fully understood. Previous in vitro studies defined differences between the two enzymes in their usage of the two NCAM N-glycosylation sites affected and suggested a synergistic effect. Using mutant mice, lacking either enzyme, we now assessed in vivo the contribution of ST8SiaII and ST8SiaIV to polysialylation of NCAM. PolySia-NCAM was isolated from mouse brains and trypsinized, and polysialylated glycopeptides as well as glycans were analyzed in detail. Our results revealed an identical glycosylation and almost complete polysialylation of N-glycosylation sites 5 and 6 in polySia-NCAM irrespective of the enzyme present. The same sets of glycans were substituted by identical numbers of polySia chains in vivo, the length distribution of which, however, differed with the enzyme setting. Expression of ST8SiaIV alone led to higher amounts of short polySia chains and gradual decrease with length, whereas exclusive action of ST8SiaII evoked a slight reduction in long polySia chains only. These variations were most pronounced at N-glycosylation site 5, whereas the polysialylation pattern at N-glycosylation site 6 did not differ between NCAM from wild-type and ST8SiaII- or ST8SiaIV-deficient mice. Thus, our fine structure analyses suggest a comparable quality of polysialylation by ST8SiaII and ST8SiaIV and a distinct synergistic action of the two enzymes in the synthesis of long polySia chains at N-glycosylation site 5 in vivo.	[Galuska, Sebastian P.; Geyer, Rudolf; Geyer, Hildegard] Univ Giessen, Fac Med, Inst Biochem, D-35392 Giessen, Germany; [Gerardy-Schahn, Rita; Muehlenhoff, Martina] Hannover Med Sch, Inst Cellular Chem, D-30625 Hannover, Germany	Justus Liebig University Giessen; Hannover Medical School	Geyer, H (corresponding author), Univ Giessen, Fac Med, Inst Biochem, Friedrichstrasse 24, D-35392 Giessen, Germany.	hildegard.geyer@biochemie.med.uni-giessen.de						Angata K, 2003, BIOCHIMIE, V85, P195, DOI 10.1016/S0300-9084(03)00051-8; Angata K, 1998, J BIOL CHEM, V273, P28524, DOI 10.1074/jbc.273.43.28524; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; Angata K, 1997, J BIOL CHEM, V272, P7182, DOI 10.1074/jbc.272.11.7182; Angata K, 2002, J BIOL CHEM, V277, P36808, DOI 10.1074/jbc.M204632200; Angata K, 2007, MOL CELL BIOL, V27, P6659, DOI 10.1128/MCB.00205-07; Anumula Kalyan Rao, 1993, Journal of Molecular Recognition, V6, P139, DOI 10.1002/jmr.300060306; BIEMANN K, 1988, BIOMED ENVIRON MASS, V16, P99, DOI 10.1002/bms.1200160119; Bruses JL, 2001, BIOCHIMIE, V83, P635, DOI 10.1016/S0300-9084(01)01293-7; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Conchonaud F, 2007, J BIOL CHEM, V282, P26266, DOI 10.1074/jbc.M608590200; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; El Maarouf A, 2005, P NATL ACAD SCI USA, V102, P11516, DOI 10.1073/pnas.0504718102; El Maarouf A, 2006, P NATL ACAD SCI USA, V103, P16989, DOI 10.1073/pnas.0608036103; Franceschini I, 2001, GLYCOBIOLOGY, V11, P231, DOI 10.1093/glycob/11.3.231; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Galuska SP, 2006, J BIOL CHEM, V281, P31605, DOI 10.1074/jbc.M606516200; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Geyer H, 2005, J BIOL CHEM, V280, P40731, DOI 10.1074/jbc.M505985200; Geyer H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh131; Geyer H, 2001, EUR J BIOCHEM, V268, P6587, DOI 10.1046/j.0014-2956.2001.02613.x; HALLENBECK PC, 1987, J BIOL CHEM, V262, P3553; HARA S, 1987, ANAL BIOCHEM, V164, P138, DOI 10.1016/0003-2697(87)90377-0; Hayrinen J, 2002, MOL IMMUNOL, V39, P399, DOI 10.1016/S0161-5890(02)00202-X; HE HT, 1987, J CELL BIOL, V105, P2489, DOI 10.1083/jcb.105.6.2489; Hildebrandt H, 1998, J NEUROCHEM, V71, P2339; Hinsby AM, 2004, FRONT BIOSCI-LANDMRK, V9, P2227, DOI 10.2741/1393; HIRN M, 1981, BRAIN RES, V214, P433, DOI 10.1016/0006-8993(81)91208-7; Inoue S, 2000, J BIOL CHEM, V275, P29968, DOI 10.1074/jbc.M004150200; Inoue S, 2003, METHOD ENZYMOL, V362, P543; Inoue S, 2001, BIOCHIMIE, V83, P605, DOI 10.1016/S0300-9084(01)01307-4; Inoue S, 2001, J BIOL CHEM, V276, P31863, DOI 10.1074/jbc.M103336200; Inoue S, 2001, GLYCOBIOLOGY, V11, P759, DOI 10.1093/glycob/11.9.759; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Johnson CP, 2004, P NATL ACAD SCI USA, V101, P6963, DOI 10.1073/pnas.0307567100; Kitazume-Kawaguchi S, 2001, J BIOL CHEM, V276, P15696, DOI 10.1074/jbc.M010371200; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; KOJIMA N, 1995, FEBS LETT, V360, P1, DOI 10.1016/0014-5793(95)00059-I; Kojima N, 1997, J BIOCHEM-TOKYO, V122, P1265; Kojima N, 1996, J BIOL CHEM, V271, P19457, DOI 10.1074/jbc.271.32.19457; Kudo M, 1998, GLYCOBIOLOGY, V8, P771, DOI 10.1093/glycob/8.8.771; KURAYA N, 1992, J BIOCHEM, V112, P122, DOI 10.1093/oxfordjournals.jbchem.a123850; Kurosawa N, 1997, J NEUROCHEM, V69, P494; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liedtke S, 2001, GLYCOBIOLOGY, V11, P373, DOI 10.1093/glycob/11.5.373; LIVINGSTON BD, 1993, J BIOL CHEM, V268, P11504; Mendiratta SS, 2006, J BIOL CHEM, V281, P36052, DOI 10.1074/jbc.M608073200; Muhlenhoff M, 1996, CURR BIOL, V6, P1188, DOI 10.1016/S0960-9822(02)70687-8; Nakata D, 2005, J BIOL CHEM, V280, P38305, DOI 10.1074/jbc.M508762200; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; Nakayama J, 1996, J BIOL CHEM, V271, P1829, DOI 10.1074/jbc.271.4.1829; NELSON RW, 1995, J BIOL CHEM, V270, P17171, DOI 10.1074/jbc.270.29.17171; Ong E, 1998, GLYCOBIOLOGY, V8, P415, DOI 10.1093/glycob/8.4.415; PELKONEN S, 1989, J VIROL, V63, P4409, DOI 10.1128/JVI.63.10.4409-4416.1989; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Sato C, 2004, TRENDS GLYCOSCI GLYC, V16, P331, DOI 10.4052/tigg.16.331; SCHEIDEGGER EP, 1995, J BIOL CHEM, V270, P22685, DOI 10.1074/jbc.270.39.22685; SIMANIS V, 1985, VIROLOGY, V144, P88, DOI 10.1016/0042-6822(85)90308-3; Stensballe A, 2004, RAPID COMMUN MASS SP, V18, P1721, DOI 10.1002/rcm.1542; Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; von der Ohe M, 2002, GLYCOBIOLOGY, V12, P47, DOI 10.1093/glycob/12.1.47; Walsh FS, 1997, ANNU REV CELL DEV BI, V13, P425, DOI 10.1146/annurev.cellbio.13.1.425; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Wood GK, 1997, MOL BRAIN RES, V51, P69, DOI 10.1016/S0169-328X(97)00209-X; Wuhrer M, 2003, BIOCHIMIE, V85, P207, DOI 10.1016/S0300-9084(03)00043-9; YOSHIDA Y, 1995, J BIOCHEM-TOKYO, V118, P658, DOI 10.1093/oxfordjournals.jbchem.a124960; Zhang Y, 1999, J BIOL CHEM, V274, P6183, DOI 10.1074/jbc.274.10.6183	71	45	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					17	28		10.1074/jbc.M707024200	http://dx.doi.org/10.1074/jbc.M707024200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17986444	hybrid			2022-12-25	WOS:000251940300004
J	Hayashi, M; Maeda, S; Aburatani, H; Kitamura, K; Miyoshi, H; Miyazono, K; Imamura, T				Hayashi, Makoto; Maeda, Shingo; Aburatani, Hiroyuki; Kitamura, Kunio; Miyoshi, Hiroyuki; Miyazono, Kohei; Imamura, Takeshi			Pitx2 prevents osteoblastic transdifferentiation of myoblasts by bone morphogenetic proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR PITX2; PATHWAY; GENE; DIFFERENTIATION; INHIBITION	Muscle cells are often exposed to bone morphogenetic proteins (BMPs) in pathological muscle and/or bone conditions. Because BMPs function as strong bone inducers as well as myogenesis inhibitors, certain molecules likely prevent muscle cells from converting into pathologic bone; without these molecules, de novo bone would form as observed in myositis ossificans traumatica. When C2C12 myoblasts are exposed to BMPs, they differentiate into osteoblastic cells but cannot mature into bone cells. As the Osterix gene, a transcription factor for osteoblast differentiation, is only transiently induced upon BMP stimulation in C2C12 cells, we hypothesized that unknown transcriptional repressor(s) inhibit Osterix expression and prevent complete osteoblastic differentiation. Gene microarray analyses were performed to identify putative inhibitors for osteoblastic differentiation, and the paired-like homeodomain transcription factor Pitx2 (also termed Rieg), which plays an important regulatory role in left-right asymmetry, was identified. Pitx2 was induced 2 days after BMP stimulation in C2C12 cells in concert with Osterix down-regulation. Overexpression of Pitx2 repressed Osterix expression and subsequent osteoblastic differentiation, whereas Runx2, the most upstream regulator of osteogenesis, was unaffected. Conversely, the induction of short hairpin RNA for Pitx2 in C2C12 cells enhanced Osterix expression and osteoblastic maturation upon BMP stimulation. Moreover, mouse embryonic fibroblasts containing myoblasts from Pitx2-null embryos showed enhanced Osterix expression upon BMP stimulation. These findings suggest that Pitx2 suppresses osteogenic signals induced by BMPs in myoblasts to prevent their osteoblastic conversion.	[Hayashi, Makoto; Maeda, Shingo; Imamura, Takeshi] Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Koto Ku, Tokyo 1358550, Japan; [Hayashi, Makoto] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Aburatani, Hiroyuki] Univ Tokyo, RCAST, Genome Sci Div, Meguro Ku, Tokyo 1538904, Japan; [Kitamura, Kunio] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Kodaira, Tokyo 1878502, Japan; [Miyoshi, Hiroyuki] RIKEN, Bioresources Ctr, Subteam Manipulat Cell Fate, Tsukuba, Ibaraki 3050074, Japan; [Miyazono, Kohei] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo 1130033, Japan	Japanese Foundation for Cancer Research; Tokyo Institute of Technology; University of Tokyo; National Center for Neurology & Psychiatry - Japan; RIKEN; University of Tokyo	Maeda, S (corresponding author), Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Koto Ku, 3-10-6 Ariake, Tokyo 1358550, Japan.	shingo.maeda@jfcr.or.jp	Miyoshi, Hiroyuki/G-9808-2013					Dahlqvist C, 2003, DEVELOPMENT, V130, P6089, DOI 10.1242/dev.00834; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Gage PJ, 1999, DEVELOPMENT, V126, P4643; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Katayama K, 2004, FEBS LETT, V560, P178, DOI 10.1016/S0014-5793(04)00100-0; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kitamura K, 1999, DEVELOPMENT, V126, P5749; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Logan M, 1998, CELL, V94, P307, DOI 10.1016/S0092-8674(00)81474-9; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Onishi T, 1998, BONE, V22, P605, DOI 10.1016/S8756-3282(98)00056-8; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shafritz AB, 1998, CLIN ORTHOP RELAT R, P46; Shih HP, 2007, GENE EXPR PATTERNS, V7, P441, DOI 10.1016/j.modgep.2006.11.004; Shirakawa K, 2006, MOL CELL BIOL, V26, P6105, DOI 10.1128/MCB.02429-05; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Valentin-Opran A, 2002, CLIN ORTHOP RELAT R, P110; Yoshioka H, 1998, CELL, V94, P299, DOI 10.1016/S0092-8674(00)81473-7	21	23	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					565	571		10.1074/jbc.M708154200	http://dx.doi.org/10.1074/jbc.M708154200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17951577	hybrid			2022-12-25	WOS:000251940300061
J	Shen, XH; Franzini-Armstrong, C; Lopez, JR; Jones, LR; Kobayashi, YM; Wang, Y; Kerrick, WGL; Caswell, AH; Potter, JD; Miller, T; Allen, PD; Perez, CF				Shen, Xiaohua; Franzini-Armstrong, Clara; Lopez, Jose R.; Jones, Larry R.; Kobayashi, Yvonne M.; Wang, Ying; Kerrick, W. Glenn L.; Caswell, Anthony H.; Potter, James D.; Miller, Todd; Allen, Paul D.; Perez, Claudio F.			Triadins modulate intracellular Ca2+ homeostasis but are not essential for excitation-contraction coupling in skeletal muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUNCTIONAL SARCOPLASMIC-RETICULUM; RYANODINE RECEPTOR; DIHYDROPYRIDINE RECEPTOR; CARDIAC-MUSCLE; FOOT PROTEIN; CALSEQUESTRIN; CALCIUM; BINDING; OVEREXPRESSION; LOCALIZATION	To unmask the role of triadin in skeletal muscle we engineered pan-triadin-null mice by removing the first exon of the triadin gene. This resulted in a total lack of triadin expression in both skeletal and cardiac muscle. Triadin knockout was not embryonic or birth-lethal, and null mice presented no obvious functional phenotype. Western blot analysis of sarcoplasmic reticulum (SR) proteins in skeletal muscle showed that the absence of triadin expression was associated with down-regulation of Junctophilin-1, junctin, and calsequestrin but resulted in no obvious contractile dysfunction. Ca2+ imaging studies in null lumbricalis muscles and myotubes showed that the lack of triadin did not prevent skeletal excitation-contraction coupling but reduced the amplitude of their Ca2+ transients. Additionally, null myotubes and adult fibers had significantly increased myoplasmic resting free Ca2+. [H-3] Ryanodine binding studies of skeletal muscle SR vesicles detected no differences in Ca2+ activation or Ca2+ and Mg2+ inhibition between wild-type and triadin-null animals. Subtle ultrastructural changes, evidenced by the appearance of longitudinally oriented triads and the presence of calsequestrin in the sacs of the longitudinal SR, were present in fast but not slow twitch-null muscles. Overall, our data support an indirect role for triadin in regulating myoplasmic Ca2+ homeostasis and organizing the molecular complex of the triad but not in regulating skeletal-type excitation-contraction coupling.	[Shen, Xiaohua; Lopez, Jose R.; Allen, Paul D.; Perez, Claudio F.] Brigham & Womens Hosp, Dept Anesthesiol, Boston, MA 02115 USA; [Franzini-Armstrong, Clara] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Jones, Larry R.; Kobayashi, Yvonne M.] Indiana Univ, Sch Med, Krannert Inst Cardiol, Dept Med, Indianapolis, IN 46202 USA; [Wang, Ying; Kerrick, W. Glenn L.] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33101 USA; [Caswell, Anthony H.; Potter, James D.; Miller, Todd] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33101 USA	Harvard University; Brigham & Women's Hospital; University of Pennsylvania; Indiana University System; Indiana University-Purdue University Indianapolis; University of Miami; University of Miami	Perez, CF (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	cperez@zeus.bwh.harvard.edu			NIAMS NIH HHS [P01 AR47605] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR047605] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Beard NA, 2005, BIOPHYS J, V88, P3444, DOI 10.1529/biophysj.104.051441; Beard NA, 2002, BIOPHYS J, V82, P310, DOI 10.1016/S0006-3495(02)75396-4; BRANDT NR, 1990, J MEMBRANE BIOL, V113, P237, DOI 10.1007/BF01870075; BRANDT NR, 1992, FEBS LETT, V299, P57, DOI 10.1016/0014-5793(92)80100-U; Brown LD, 2007, AM J PHYSIOL-CELL PH, V292, pC1156, DOI 10.1152/ajpcell.00397.2006; CARL SL, 1995, MUSCLE NERVE, V18, P1232, DOI 10.1002/mus.880181104; Caswell AH, 1999, BIOCHEMISTRY-US, V38, P90, DOI 10.1021/bi981306+; Flucher BE, 1996, P NATL ACAD SCI USA, V93, P8101, DOI 10.1073/pnas.93.15.8101; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Glover L, 2001, BBA-BIOMEMBRANES, V1515, P120, DOI 10.1016/S0005-2736(01)00406-0; Goonasekera SA, 2007, J GEN PHYSIOL, V130, P365, DOI 10.1085/jgp.200709790; Groh S, 1999, J BIOL CHEM, V274, P12278, DOI 10.1074/jbc.274.18.12278; Gu W, 1996, SOC GEN PHY, V51, P19; GUO W, 1995, J BIOL CHEM, V270, P9027, DOI 10.1074/jbc.270.16.9027; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; Hong CS, 2001, GENE, V278, P193, DOI 10.1016/S0378-1119(01)00718-1; Ito K, 2001, J CELL BIOL, V154, P1059, DOI 10.1083/jcb.200105040; Jones LR, 1995, J BIOL CHEM, V270, P30787, DOI 10.1074/jbc.270.51.30787; KIM KC, 1990, BIOCHEMISTRY-US, V29, P9281, DOI 10.1021/bi00491a025; KNUDSON CM, 1993, J BIOL CHEM, V268, P12637; Kobayashi YM, 2000, J BIOL CHEM, V275, P17639, DOI 10.1074/jbc.M002091200; Kobayashi YM, 1999, J BIOL CHEM, V274, P28660, DOI 10.1074/jbc.274.40.28660; Komazaki S, 2002, FEBS LETT, V524, P225, DOI 10.1016/S0014-5793(02)03042-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lee EH, 2006, BIOCHEM BIOPH RES CO, V351, P909, DOI 10.1016/j.bbrc.2006.10.115; Lee JM, 2004, J BIOL CHEM, V279, P6994, DOI 10.1074/jbc.M312446200; Lopez JR, 2000, ANESTHESIOLOGY, V92, P1799, DOI 10.1097/00000542-200006000-00040; MARTY I, 1994, P NATL ACAD SCI USA, V91, P2270, DOI 10.1073/pnas.91.6.2270; MARTY I, 1995, BIOCHEM J, V307, P769, DOI 10.1042/bj3070769; Marty I, 2000, J BIOL CHEM, V275, P8206, DOI 10.1074/jbc.275.11.8206; Marty I, 2004, CELL MOL LIFE SCI, V61, P1850, DOI 10.1007/s00018-004-4196-7; Meissner G, 2002, FRONT BIOSCI, V7, pD2072, DOI 10.2741/meissner; MOTOIKE HK, 1994, J MUSCLE RES CELL M, V15, P493, DOI 10.1007/BF00121156; Murray BE, 1997, BIOCHEM J, V324, P689, DOI 10.1042/bj3240689; Ohkura M, 1998, BIOCHEMISTRY-US, V37, P12987, DOI 10.1021/bi972803d; PAOLINI C, 2007, J PHYSL, V583, P676; PENG M, 1994, FEBS LETT, V348, P17, DOI 10.1016/0014-5793(94)00556-7; Perez CF, 2005, AM J PHYSIOL-CELL PH, V288, pC640, DOI 10.1152/ajpcell.00407.2004; Rando TA, 1997, METHOD CELL BIOL, V52, P261, DOI 10.1016/S0091-679X(08)60382-9; Rezgui SS, 2005, J BIOL CHEM, V280, P39302, DOI 10.1074/jbc.M506566200; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; SOMMER JR, 1994, PROC ANN MEET MSA, P192; Takekura H, 2003, J MUSCLE RES CELL M, V24, P439, DOI 10.1023/A:1027356912404; Thevenon D, 2003, BIOCHEM BIOPH RES CO, V303, P669, DOI 10.1016/S0006-291X(03)00406-6; Tijskens P, 2003, J MOL CELL CARDIOL, V35, P961, DOI 10.1016/S0022-2828(03)00181-0; Vassilopoulos S, 2005, J BIOL CHEM, V280, P28601, DOI 10.1074/jbc.M501484200; Wang Y, 1999, J MUSCLE RES CELL M, V20, P645, DOI 10.1023/A:1005559613516; WANG Y, 2007, BIOPHYS J S A, V20; Yuan QQ, 2007, CIRCULATION, V115, P300, DOI 10.1161/CIRCULATIONAHA.106.654699; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389; Zhang L, 2001, J MOL CELL CARDIOL, V33, P233, DOI 10.1006/jmcc.2000.1295	52	59	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37864	37874		10.1074/jbc.M705702200	http://dx.doi.org/10.1074/jbc.M705702200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17981799	hybrid			2022-12-25	WOS:000251833600062
J	Bhandari, D; Trejo, J; Benovic, JL; Marchese, A				Bhandari, Deepali; Trejo, JoAnn; Benovic, Jeffrey L.; Marchese, Adriano			Arrestin-2 interacts with the ubiquitin-protein isopeptide ligase atrophin-interacting protein 4 and mediates endosomal sorting of the chemokine receptor CXCR4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ARRESTIN; COUPLED RECEPTORS; INTERNALIZATION; TRAFFICKING; MICE; AIP4	The chemokine receptor CXCR4 is rapidly targeted for lysosomal degradation by the E3 ubiquitin ligase atrophin-interacting protein 4 (AIP4). Although it is known that AIP4 mediates ubiquitination and degradation of CXCR4 and that perturbations in these events contribute to disease, the mechanisms mediating AIP4-dependent regulation of CXCR4 degradation remain poorly understood. Here we show that AIP4 directly interacts with the amino-terminal half of nonvisual arrestin-2 via its WW domains. We show that depletion of arrestin-2 by small interfering RNA blocks agonist-promoted degradation of CXCR4 by preventing CXCR4 trafficking from early endosomes to lysosomes. Surprisingly, CXCR4 internalization and ubiquitination remain intact, suggesting that the interaction between arrestin-2 and AIP4 is not required for ubiquitination of the receptor at the plasma membrane but perhaps for a later post-internalization event. Accordingly, we show that activation of CXCR4 promotes the interaction between AIP4 and arrestin-2 that is consistent with a time when AIP4 co-localizes with arrestin-2 on endocytic vesicles. Taken together, our data suggest that the AIP4.arrestin-2 complex functions on endosomes to regulate sorting of CXCR4 into the degradative pathway.	[Bhandari, Deepali; Marchese, Adriano] Loyola Univ, Stritch Sch Med, Dept Pharmacol, Program Mol Biol, Maywood, IL 60153 USA; [Marchese, Adriano] Loyola Univ, Stritch Sch Med, Dept Pharmacol & Expt Therapeut, Maywood, IL 60153 USA; [Trejo, JoAnn] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Benovic, Jeffrey L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Loyola University Chicago; Loyola University Chicago; University of North Carolina; University of North Carolina Chapel Hill; Jefferson University	Marchese, A (corresponding author), Loyola Univ, Stritch Sch Med, Dept Pharmacol, Program Mol Biol, 2160 S 1st Ave,Bldg 101,Rm 2721, Maywood, IL 60153 USA.	amarchese@lumc.edu		TREJO, JOANN/0000-0003-4405-6228	NIGMS NIH HHS [R01 GM047417, GM075159, R01 GM075159-02, R01 GM068857, GM47417, R01 GM075159] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068857, R01GM075159, R01GM047417, R37GM047417] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angers A, 2004, J BIOL CHEM, V279, P11471, DOI 10.1074/jbc.M309934200; Cheng ZJ, 2000, J BIOL CHEM, V275, P2479, DOI 10.1074/jbc.275.4.2479; Diaz GA, 2005, CURR ALLERGY ASTHM R, V5, P350, DOI 10.1007/s11882-005-0005-0; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese Adriano, 2004, Methods Mol Biol, V259, P299; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Sachse M, 2002, MOL BIOL CELL, V13, P1313, DOI 10.1091/mbc.01-10-0525; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shenoy SK, 2005, J BIOL CHEM, V280, P15315, DOI 10.1074/jbc.M412418200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Slagsvold T, 2006, EMBO J, V25, P3738, DOI 10.1038/sj.emboj.7601267; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Winberg G, 2000, MOL CELL BIOL, V20, P8526, DOI 10.1128/MCB.20.22.8526-8535.2000; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	24	155	158	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36971	36979		10.1074/jbc.M705085200	http://dx.doi.org/10.1074/jbc.M705085200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17947233	Green Published, hybrid			2022-12-25	WOS:000251646000023
J	Kim, HS; Park, BO; Yoo, JH; Jung, MS; Lee, SM; Han, HJ; Kim, KE; Kim, SH; Lim, CO; Yun, DJ; Lee, SY; Chung, WS				Kim, Ho Soo; Park, Byung Ouk; Yoo, Jae Hyuk; Jung, Mi Soon; Lee, Sang Min; Han, Hay Ju; Kim, Kyung Eun; Kim, Sun Ho; Lim, Chae Oh; Yun, Dae-Jin; Lee, Sang Yeol; Chung, Woo Sik			Identification of a calmodulin-binding NAC protein as a transcriptional repressor in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGET RECOGNITION; SIGNAL-TRANSDUCTION; PATHOGEN DEFENSE; CELL-DEATH; PLANTS; GENE; CALCIUM; PROMOTER; SPECIFICITY; ACTIVATION	Calmodulin (CaM), a ubiquitous calcium- binding protein, regulates diverse cellular functions by modulating the activity of a variety of proteins. However, little is known about how CaM directly regulates transcription. Screening of an Arabidopsis cDNA expression library using horseradish peroxidase- conjugated calmodulin as a probe identified a calmodulin- binding NAC protein (CBNAC). Using gel overlay assays, a Ca2+-dependent CaM-binding domain was identified in the C terminus of this protein. Specific binding of CaM to CaM-binding domain was corroborated by site-directed mutagenesis and a split-ubiquitin assay. Using a PCR-mediated random binding site selection method, we identified a DNA-binding sequence (CBNACBS) for CBNAC, which consisted of a GCTT core sequence flanked on both sides by other frequently repeating sequences (TTGCTTANNNNNNAAG). CBNAC was able to bind to CBNACBS, which resulted in the repression of transcription in Arabidopsis protoplasts. Interestingly, the transcriptional repression mediated by CBNAC was enhanced by CaM. These results suggest that CBNAC may be a CaM-regulated transcriptional repressor in Arabidopsis.	Gyeongsang Natl Univ, Div Appl Life Sci, BK21 Program, Plant Mol Biol & Biotechnol Res Ctr, Jinju 660701, South Korea; Gyeongsang Natl Univ, Environm Biotechnol Natl Core Res Ctr, Jinju 660701, South Korea	Gyeongsang National University; Gyeongsang National University	Chung, WS (corresponding author), Gyeongsang Natl Univ, Div Appl Life Sci, BK21 Program, Plant Mol Biol & Biotechnol Res Ctr, Jinju 660701, South Korea.	chungws@gnu.ac.kr		Yun, Dae-Jin/0000-0002-3638-6043				Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Blume B, 2000, PLANT CELL, V12, P1425, DOI 10.1105/tpc.12.8.1425; Choi MS, 2005, J BIOL CHEM, V280, P40820, DOI 10.1074/jbc.M504616200; Collinge M, 2001, PLANT MOL BIOL, V46, P521, DOI 10.1023/A:1010639225091; Corcoran EE, 2001, J BIOL CHEM, V276, P2975, DOI 10.1074/jbc.R000027200; CORNELIUSSEN B, 1994, NATURE, V368, P760, DOI 10.1038/368760a0; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Delessert C, 2005, PLANT J, V43, P745, DOI 10.1111/j.1365-313X.2005.02488.x; Duval M, 2002, PLANT MOL BIOL, V50, P237, DOI 10.1023/A:1016028530943; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Gadgil H, 1999, J CHROMATOGR A, V848, P131, DOI 10.1016/S0021-9673(99)00338-6; Grant M, 2000, PLANT J, V23, P441, DOI 10.1046/j.1365-313x.2000.00804.x; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Jin JB, 2001, PLANT CELL, V13, P1511, DOI 10.1105/tpc.13.7.1511; Kim MC, 2002, J BIOL CHEM, V277, P19304, DOI 10.1074/jbc.M108478200; Laser H, 2000, P NATL ACAD SCI USA, V97, P13732, DOI 10.1073/pnas.250400997; Lee SH, 1999, BBA-PROTEIN STRUCT M, V1433, P56, DOI 10.1016/S0167-4838(99)00149-1; Liu ZB, 1997, PLANT PHYSIOL, V115, P397, DOI 10.1104/pp.115.2.397; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Meijer AH, 1997, PLANT J, V11, P263, DOI 10.1046/j.1365-313X.1997.11020263.x; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Mitsuda N, 2005, PLANT CELL, V17, P2993, DOI 10.1105/tpc.105.036004; Motohashi H, 2000, CELL, V103, P865, DOI 10.1016/S0092-8674(00)00190-2; Nakamura M, 2006, PLANT PHYSIOL, V141, P1363, DOI 10.1104/pp.106.077388; OLIPHANT AR, 1989, MOL CELL BIOL, V9, P2944, DOI 10.1128/MCB.9.7.2944; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Onions J, 1997, J BIOL CHEM, V272, P23930, DOI 10.1074/jbc.272.38.23930; Onions J, 2000, BIOCHEMISTRY-US, V39, P4366, DOI 10.1021/bi992533u; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Park CY, 2005, FEBS LETT, V579, P1545, DOI 10.1016/j.febslet.2005.01.057; POLLOCK R, 1990, NUCLEIC ACIDS RES, V18, P6197, DOI 10.1093/nar/18.21.6197; Raghothama KG, 1997, PLANT MOL BIOL, V34, P393, DOI 10.1023/A:1005812217945; Raventos D, 1998, J BIOL CHEM, V273, P23313, DOI 10.1074/jbc.273.36.23313; Reddy VS, 2004, PHYTOCHEMISTRY, V65, P1745, DOI 10.1016/j.phytochem.2004.04.033; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Riechmann JL, 2000, CURR OPIN PLANT BIOL, V3, P423, DOI 10.1016/S1369-5266(00)00107-2; Robatzek S, 2002, GENE DEV, V16, P1139, DOI 10.1101/gad.222702; Sato N, 2001, NUCLEIC ACIDS RES, V29, P2244, DOI 10.1093/nar/29.11.2244; Sheen J, 1996, SCIENCE, V274, P1900, DOI 10.1126/science.274.5294.1900; Shinozaki K, 1997, PLANT PHYSIOL, V115, P327, DOI 10.1104/pp.115.2.327; Snedden WA, 2001, NEW PHYTOL, V151, P35, DOI 10.1046/j.1469-8137.2001.00154.x; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Yang TB, 2003, TRENDS PLANT SCI, V8, P505, DOI 10.1016/j.tplants.2003.09.004; Yoo JH, 2005, J BIOL CHEM, V280, P3697, DOI 10.1074/jbc.M408237200; Yoo JH, 2004, J BIOL CHEM, V279, P848, DOI 10.1074/jbc.M310709200; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697	56	93	108	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36292	36302		10.1074/jbc.M705217200	http://dx.doi.org/10.1074/jbc.M705217200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17947243	hybrid			2022-12-25	WOS:000251458300020
J	Muller, P; Ewers, C; Bertsche, U; Anstett, M; Kallis, T; Breukink, E; Fraipont, C; Terrak, M; Nguyen-Disteche, M; Vollmer, W				Mueller, Patrick; Ewers, Carolin; Bertsche, Ute; Anstett, Maria; Kallis, Tanja; Breukink, Eefjan; Fraipont, Claudine; Terrak, Mohammed; Nguyen-Disteche, Martine; Vollmer, Waldemar			The essential cell division protein FtsN interacts with the murein (peptidoglycan) synthase PBP1B in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENICILLIN-BINDING PROTEINS; LYTIC TRANSGLYCOSYLASE; Z-RING; MEMBRANE; LOCALIZATION; CLONING; MIDCELL; DIMERS; 1B; TRANSPEPTIDASE	Bacterial cell division requires the coordinated action of cell division proteins and murein (peptidoglycan) synthases. Interactions involving the essential cell division protein FtsN and murein synthases were studied by affinity chromatography with membrane fraction. The murein synthases PBP1A, PBP1B, and PBP3 had an affinity to immobilized FtsN. FtsN and PBP3, but not PBP1A, showed an affinity to immobilized PBP1B. The direct interaction between FtsN and PBP1B was confirmed by pulldown experiments and surface plasmon resonance. The interaction was also detected by bacterial two-hybrid analysis. FtsN and PBP1B could be cross-linked in intact cells of the wild type and in cells depleted of PBP3 or FtsW. FtsN stimulated the in vitro murein synthesis activities of PBP1B. Thus, FtsN could have a role in controlling or modulating the activity of PBP1B during cell division in Escherichia coli.	Univ Tubingen, D-72076 Tubingen, Germany; Univ Utrecht, Ctr Biomembranes & Lipid Enzymol, Biomembrane Inst, Dept Biochem Membranes, NL-3584 CH Utrecht, Netherlands; Univ Liege, Ctr Ingn Proteines, Inst Chim B6a, B-4000 Liege, Belgium	Eberhard Karls University of Tubingen; Utrecht University; University of Liege	Vollmer, W (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Inst Cell & Mol Biosci, Catherine Cookson Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	W.Vollmer@ncl.ac.uk	Breukink, Eefjan/I-3039-2016	Breukink, Eefjan/0000-0002-7311-0660; Ewers, Christa/0000-0001-6167-1340				Addinall SG, 1997, MOL MICROBIOL, V25, P303, DOI 10.1046/j.1365-2958.1997.4641833.x; Bernard CS, 2007, MOL MICROBIOL, V64, P1289, DOI 10.1111/j.1365-2958.2007.05738.x; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Bertsche U, 2005, J BIOL CHEM, V280, P38096, DOI 10.1074/jbc.M508646200; Bertsche U, 2006, MOL MICROBIOL, V61, P675, DOI 10.1111/j.1365-2958.2006.05280.x; Born P, 2006, J BIOL CHEM, V281, P26985, DOI 10.1074/jbc.M604083200; Buddelmeijer N, 2004, MOL MICROBIOL, V52, P1315, DOI 10.1111/j.1365-2958.2004.04044.x; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Chalut C, 1999, J BACTERIOL, V181, P2970, DOI 10.1128/JB.181.9.2970-2972.1999; Charpentier X, 2002, J BACTERIOL, V184, P3749, DOI 10.1128/JB.184.13.3749-3752.2002; Chen JC, 2001, MOL MICROBIOL, V42, P395, DOI 10.1046/j.1365-2958.2001.02640.x; Corbin BD, 2004, J BACTERIOL, V186, P7736, DOI 10.1128/JB.186.22.7736-7744.2004; DAI K, 1993, J BACTERIOL, V175, P3790, DOI 10.1128/JB.175.12.3790-3797.1993; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Dougherty TJ, 1996, J BACTERIOL, V178, P6110, DOI 10.1128/jb.178.21.6110-6115.1996; Draper GC, 1998, J BACTERIOL, V180, P4621, DOI 10.1128/JB.180.17.4621-4627.1998; Geissler B, 2005, MOL MICROBIOL, V58, P596, DOI 10.1111/j.1365-2958.2005.04858.x; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Goehring NW, 2007, J BACTERIOL, V189, P646, DOI 10.1128/JB.00992-06; Goehring NW, 2006, MOL MICROBIOL, V61, P33, DOI 10.1111/j.1365-2958.2006.05206.x; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Goehring NW, 2005, GENE DEV, V19, P127, DOI 10.1101/gad.1253805; Heidrich C, 2001, MOL MICROBIOL, V41, P167, DOI 10.1046/j.1365-2958.2001.02499.x; Jobling MG, 2000, P NATL ACAD SCI USA, V97, P14662, DOI 10.1073/pnas.011442598; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Mercer KLN, 2002, J BACTERIOL, V184, P904, DOI 10.1128/jb.184.4.904-912.2002; Nguyen-Disteche M, 1998, CELL MOL LIFE SCI, V54, P309, DOI 10.1007/s000180050157; Pastoret S, 2004, J BACTERIOL, V186, P8370, DOI 10.1128/JB.186.24.8370-8379.2004; Piette A, 2004, J BACTERIOL, V186, P6110, DOI 10.1128/jb.186.18.6110-6117.2004; ROMEIS T, 1994, J BIOL CHEM, V269, P21603; Schiffer G, 1999, J BIOL CHEM, V274, P32031, DOI 10.1074/jbc.274.45.32031; Spelbrink REJ, 2005, J BIOL CHEM, V280, P28742, DOI 10.1074/jbc.M501617200; SUZUKI H, 1978, P NATL ACAD SCI USA, V75, P664, DOI 10.1073/pnas.75.2.664; Terrak M, 1999, MOL MICROBIOL, V34, P350, DOI 10.1046/j.1365-2958.1999.01612.x; Ursinus A, 2004, J BACTERIOL, V186, P6728, DOI 10.1128/JB.186.20.6728-6737.2004; van Straaten KE, 2005, J MOL BIOL, V352, P1068, DOI 10.1016/j.jmb.2005.07.067; Vicente M, 2006, J BACTERIOL, V188, P19, DOI 10.1128/JB.188.1.19-27.2006; Vollmer W, 1999, J BIOL CHEM, V274, P6726, DOI 10.1074/jbc.274.10.6726; VOLLMER W, 2007, IN PRESS BIOCHIMICA; vonRechenberg M, 1996, MICROB DRUG RESIST, V2, P155, DOI 10.1089/mdr.1996.2.155; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999; Wissel MC, 2004, J BACTERIOL, V186, P490, DOI 10.1128/JB.186.2.490-502.2004; Yang JC, 2004, MOL MICROBIOL, V52, P651, DOI 10.1111/j.1365-2958.2004.03991.x; ZIJDERVELD CAL, 1995, J BACTERIOL, V177, P1860, DOI 10.1128/jb.177.7.1860-1863.1995; ZIJDERVELD CAL, 1991, J BACTERIOL, V173, P5740, DOI 10.1128/jb.173.18.5740-5746.1991	46	103	106	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36394	36402		10.1074/jbc.M706390200	http://dx.doi.org/10.1074/jbc.M706390200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17938168	hybrid			2022-12-25	WOS:000251458300031
J	Li, J; Zeng, XH; Mo, HY; Rolen, U; Gao, YF; Zhang, XS; Chen, QY; Zhang, L; Zeng, MS; Li, MZ; Huang, WL; Wang, XN; Zeng, YX; Masucci, MG				Li, Jiang; Zeng, Xue-hui; Mo, Hao-yuan; Rolen, Ulrika; Gao, Yan-fang; Zhang, Xiao-shi; Chen, Qiu-yan; Zhang, Li; Zeng, Mu-sheng; Li, Man-zhi; Huang, Wen-lin; Wang, Xiao-ning; Zeng, Yi-xin; Masucci, Maria G.			Functional Inactivation of EBV-Specific T-Lymphocytes in Nasopharyngeal Carcinoma: Implications for Tumor Immunotherapy	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; LATENT MEMBRANE-PROTEIN; ADOPTIVE TRANSFER; SOUTHERN CHINESE; CELL RESPONSES; BLOOD; INTERLEUKIN-10; INHIBITION; EXPRESSION; SUPPRESSION	Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus (EBV) associated malignancy with high prevalence in Southern Chinese. In order to assess whether defects of EBV-specific immunity may contribute to the tumor, the phenotype and function of circulating T-cells and tumor infiltrating lymphocytes (TILs) were investigated in untreated NPC patients. Circulating naive CD(3+)CD45RA(+) and CD4(+)CD25(-) cells were decreased, while activated CD4(+)CD25(+) T-cells and CD3(-)CD16(+) NK-cells were increased in patients compared to healthy donors. The frequency of T-cells recognizing seven HLA-A2 restricted epitopes in LMP1 and LMP2 was lower in the patients and remained low after stimulation with autologous EBV-carrying cells. TILs expanded in low doses of IL-2 exhibited an increase of CD3(+)CD4(+), CD3(+)CD45RO(+) and CD4(+)CD25(+) cells and 2 to 5 fold higher frequency of LMP1 and LMP2 tetramer positive cells compared to peripheral blood. EBV-specific cytotoxicity could be reactivated from the blood of most patients, whereas the TILs lacked cytotoxic activity and failed to produce IFN gamma upon specific stimulation. Thus, EBV-specific rejection responses appear to be functionally inactivated at the tumor site in NPC.	[Li, Jiang; Zeng, Mu-sheng; Li, Man-zhi; Huang, Wen-lin; Zeng, Yi-xin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Li, Jiang; Mo, Hao-yuan; Gao, Yan-fang; Zhang, Xiao-shi; Chen, Qiu-yan; Zhang, Li; Zeng, Mu-sheng; Li, Man-zhi; Huang, Wen-lin; Zeng, Yi-xin] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China; [Li, Jiang; Mo, Hao-yuan; Gao, Yan-fang; Zhang, Xiao-shi; Chen, Qiu-yan; Zhang, Li; Zeng, Mu-sheng; Li, Man-zhi; Huang, Wen-lin; Zeng, Yi-xin] Sun Yat Sen Univ, Ctr Canc, Dept Biotherapy, Guangzhou 510275, Guangdong, Peoples R China; [Li, Jiang; Mo, Hao-yuan; Gao, Yan-fang; Zhang, Xiao-shi; Chen, Qiu-yan; Zhang, Li; Zeng, Mu-sheng; Li, Man-zhi; Huang, Wen-lin; Zeng, Yi-xin] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Li, Jiang; Mo, Hao-yuan; Gao, Yan-fang; Zhang, Xiao-shi; Chen, Qiu-yan; Zhang, Li; Zeng, Mu-sheng; Li, Man-zhi; Huang, Wen-lin; Zeng, Yi-xin] Sun Yat Sen Univ, Ctr Canc, Dept Radiotherapy, Guangzhou 510275, Guangdong, Peoples R China; [Zeng, Xue-hui; Wang, Xiao-ning] Technol Univ So China, Sch Biotechnol, Inst Mol Immunol, Guangzhou, Guangdong, Peoples R China; [Rolen, Ulrika; Masucci, Maria G.] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Karolinska Institutet	Zeng, YX (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China.	zengyxi@mail.sysu.edu.cn; maria.masucci@ki.se	huang, wen/GXW-0661-2022; Masucci, Maria/AAC-6666-2019	Masucci, Maria/0000-0002-5541-2809; zeng, musheng/0000-0003-3509-5591	Guangdong Province Natural Fund [04300284]; International Joint Project grant [2005B50301007]; NSFC; Research Grant Council of Hong Kong joint research fund [30418003]; NSF of China [30170872]; Swedish Cancer Society; Swedish Foundation for International Scientific Cooperation (STINT)	Guangdong Province Natural Fund; International Joint Project grant; NSFC(National Natural Science Foundation of China (NSFC)); Research Grant Council of Hong Kong joint research fund; NSF of China(National Natural Science Foundation of China (NSFC)); Swedish Cancer Society(Swedish Cancer Society); Swedish Foundation for International Scientific Cooperation (STINT)	We wish to thank Zhan Pen for assistance with FACS analysis, and Dr. Lu-lu Xiao for HLA typing. This study was supported by grants from the Guangdong Province Natural Fund (04300284), International Joint Project grant (2005B50301007), NSFC and the Research Grant Council of Hong Kong joint research fund (30418003) and NSF of China (30170872); and by grants from the Swedish Cancer Society and the Swedish Foundation for International Scientific Cooperation (STINT) (to MGM).	Ansell SM, 2002, BLOOD, V99, P67, DOI 10.1182/blood.V99.1.67; Asselin-Paturel C, 1999, GENE THER, V6, P606, DOI 10.1038/sj.gt.3300841; Blake N, 1997, IMMUNITY, V7, P791, DOI 10.1016/S1074-7613(00)80397-0; Brooks JM, 2000, J VIROL, V74, P1801, DOI 10.1128/JVI.74.4.1801-1809.2000; BROOKS L, 1992, J VIROL, V66, P2689, DOI 10.1128/JVI.66.5.2689-2697.1992; Burgos JS, 2005, MED ONCOL, V22, P113, DOI 10.1385/MO:22:2:113; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Chen WH, 2004, CELL MOL IMMUNOL, V1, P328; Comoli P, 2004, ANN ONCOL, V15, P113, DOI 10.1093/annonc/mdh027; Dolcetti R, 2006, PROGRESS IN VIRUS RESEARCH, P191; Dukers DF, 2000, J IMMUNOL, V165, P663, DOI 10.4049/jimmunol.165.2.663; Fang CY, 2004, J IMMUNOL METHODS, V287, P21, DOI 10.1016/j.jim.2004.01.021; Favre N, 1997, J IMMUNOL METHODS, V204, P57, DOI 10.1016/S0022-1759(97)00033-1; Feldman AL, 2002, INT J CANCER, V99, P149, DOI 10.1002/ijc.10292; FRISAN T, 1995, BLOOD, V86, P1493, DOI 10.1182/blood.V86.4.1493.bloodjournal8641493; Goldsmith DB, 2002, CLIN OTOLARYNGOL, V27, P61, DOI 10.1046/j.0307-7772.2001.00529.x; GUSTAFSSON A, BLOOD IN PRESS; Herbst H, 1996, BLOOD, V87, P2918, DOI 10.1182/blood.V87.7.2918.bloodjournal8772918; Heslop HE, 1996, NAT MED, V2, P551, DOI 10.1038/nm0596-551; Hislop AD, 2002, J EXP MED, V195, P893, DOI 10.1084/jem.20011692; HO JH, 1978, IARC SCI PUBL, P99; HU LF, 1991, J VIROL, V65, P1558, DOI 10.1128/JVI.65.3.1558-1567.1991; Jimenez R, 2005, CYTOKINE, V32, P45, DOI 10.1016/j.cyto.2005.07.009; Khanna R, 1998, CANCER RES, V58, P310; Kis LL, 2006, BLOOD, V107, P2928, DOI 10.1182/blood-2005-06-2569; LEE AG, 1993, LIPOSOME TECHNOLOGY, V2, P1; Lee TV, 2000, J INTERF CYTOK RES, V20, P391, DOI 10.1089/107999000312333; LEVINE AM, 1994, ANN ONCOL, V5, pS29, DOI 10.1093/annonc/5.suppl_2.S29; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; Linehan DC, 2005, IMMUNOL RES, V32, P155, DOI 10.1385/IR:32:1-3:155; Mould RF, 2002, BRIT J RADIOL, V75, P307, DOI 10.1259/bjr.75.892.750307; NAKAGOMI H, 1994, INT J CANCER, V57, P240, DOI 10.1002/ijc.2910570218; Ogino T, 2007, INT J CANCER, V120, P2401, DOI 10.1002/ijc.22334; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; Shao JY, 2004, CANCER, V100, P1162, DOI 10.1002/cncr.20099; Straathof KCM, 2005, BLOOD, V105, P1898, DOI 10.1182/blood-2004-07-2975; STRANG G, 1987, EUR J IMMUNOL, V17, P1007, DOI 10.1002/eji.1830170717; Tatsumi-Tamori A, 2000, ANN OTO RHINOL LARYN, V109, P1125, DOI 10.1177/000348940010901208; THORN RM, 1974, J IMMUNOL METHODS, V4, P301, DOI 10.1016/0022-1759(74)90073-8; Vockerodt M, 2001, VIROLOGY, V280, P183, DOI 10.1006/viro.2000.0768; WALLACE LE, 1982, EUR J IMMUNOL, V12, P1012, DOI 10.1002/eji.1830121206; Wang HY, 2007, CURR OPIN IMMUNOL, V19, P217, DOI 10.1016/j.coi.2007.02.004; Wang RF, 2006, SEMIN CANCER BIOL, V16, P106, DOI 10.1016/j.semcancer.2005.11.004; Wei WZ, 2004, CANCER IMMUNOL IMMUN, V53, P73, DOI 10.1007/s00262-003-0444-1; Whitney BM, 2002, J MED VIROL, V67, P359, DOI 10.1002/jmv.10073; Wolfl M, 2004, CYTOM PART A, V57A, P120, DOI 10.1002/cyto.a.10116; Yin Y, 2003, SCIENCE, V301, P1371, DOI 10.1126/science.1088902; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zeng YX, 2002, SEMIN CANCER BIOL, V12, P443, DOI 10.1016/S1044579X02000871	49	78	79	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1122	10.1371/journal.pone.0001122	http://dx.doi.org/10.1371/journal.pone.0001122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987110	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459000006
J	Guezou, A; Pozo, P; Buddenhagen, C				Guezou, Anne; Pozo, Paola; Buddenhagen, Christopher			Preventing Establishment: An Inventory of Introduced Plants in Puerto Villamil, Isabela Island, Galapagos	PLOS ONE			English	Article								As part of an island-wide project to identify and eradicate potentially invasive plant species before they become established, a program of inventories is being carried out in the urban and agricultural zones of the four inhabited islands in Galapagos. This study reports the results of the inventory from Puerto Villamil, a coastal village representing the urban zone of Isabela Island. We visited all 1193 village properties to record the presence of the introduced plants. In addition, information was collected from half of the properties to determine evidence for potential invasiveness of the plant species. We recorded 261 vascular taxa, 13 of which were new records for Galapagos. Most of the species were intentionally grown (cultivated) (73.3%) and used principally as ornamentals. The most frequent taxa we encountered were Cocos nucifera (coconut tree) (22.1%) as a cultivated plant and Paspalum vaginatum (salt water couch) (13.2%) as a non cultivated plant. In addition 39 taxa were naturalized. On the basis of the invasiveness study, we recommend five species for eradication (Abutilon dianthum, Datura inoxia, Datura metel, Senna alata and Solanum capsicoides), one species for hybridization studies (Opuntia ficus-indica) and three species for control (Furcraea hexapetala, Leucaena leucocephala and Paspalum vaginatum).	[Guezou, Anne; Pozo, Paola; Buddenhagen, Christopher] Charles Darwin Res Stn, Puerto Ayora, Galapagos, Ecuador; [Buddenhagen, Christopher] Univ Hawaii Manoa, Pacific Cooperat Studies Unit, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Buddenhagen, C (corresponding author), Charles Darwin Res Stn, Puerto Ayora, Galapagos, Ecuador.	cbuddenhagen@gmail.com	Buddenhagen, Christopher/J-3942-2019	Buddenhagen, Christopher/0000-0002-3016-1054	 [ECU/00/G31]		This work was accomplished with the support of Project ECU/00/G31 Control of Invasive Species in the Galapagos Archipelago, a donation from the Global Environment Facility (GEF) to the Ecuadorian Government, represented by the Ministry of Environment. The Project is implemented by the United Nations Development Programme (UNDP) and is executed by the Galapagos National Park Service (GNPS), Charles Darwin Foundation (CDF), National Institute for Galapagos (INGALA) and Ecuadorian Service for Agriculture and Livestock Sanitation Galapagos (SESA-Galapagos). Funders did not play any role in the study design.	[Anonymous], 1995, PLANT INVADERS; Buddenhagen C., 2005, Galapagos Research, V63, P32; FOSBERG FR, 1972, CARELESS TECHNOLOGY, P869; FRYXELL P, 1992, FLORA ECUADOR BERLIN, V118; GRAVEZ V, 2004, CONTRIBUCION CONOCIM; HUSSEY B, 1997, W WEEDS GUIDE WEEDS, P218; *I PAC ISL FOR, 2004, PAC ISL EC RISK PIER; Jorgensen P. M., 1999, CATALOGUE VASCULAR P; Mabberley DJ, 1997, PLANT BOOK; Mauchamp A, 1997, CONSERV BIOL, V11, P260, DOI 10.1046/j.1523-1739.1997.95356.x; Nel JL, 2004, S AFR J SCI, V100, P53; PROANO ME, 2007, INFORM GALAPAGOS 200, P31; Randall JM, 2000, US FOR SERV RMRS-P, V5, P64; Randall R. P., 2000, Plant Protection Quarterly, V15, P109; Rejmanek M., 2005, Invasive alien species: a new synthesis, P161; *SPEC SURV COMM, 2000, IUCN GUID PREV BIOD; Staples GW., 2005, TROPICAL GARDEN FLOR; SWEARINGEN J, 2005, ALIEN PLANT INVADERS; Tye A, 2006, BIOL INVASIONS, V8, P201, DOI 10.1007/s10530-004-3574-2; TYE A, 2007, INFORM GALAPAGOS 200, P101; TYE A, 2007, INFORM GALAPAGOS 200, P137; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Wang X., 1996, J PROF ASSOC CACTUS, V1, P49; Wiggins IL, 1971, FLORA GALAPAGOS ISLA; WITTENBERG R, 2001, ESPECIES EXOTICAS IN; *WWF, 2006, NAT LIST NAT INV POT	26	10	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1042	10.1371/journal.pone.0001042	http://dx.doi.org/10.1371/journal.pone.0001042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940606	Green Submitted, Green Published, gold			2022-12-25	WOS:000207456100010
J	Sporns, O; Honey, CJ; Kotter, R				Sporns, Olaf; Honey, Christopher J.; Kotter, Rolf			Identification and Classification of Hubs in Brain Networks	PLOS ONE			English	Article								Brain regions in the mammalian cerebral cortex are linked by a complex network of fiber bundles. These inter-regional networks have previously been analyzed in terms of their node degree, structural motif, path length and clustering coefficient distributions. In this paper we focus on the identification and classification of hub regions, which are thought to play pivotal roles in the coordination of information flow. We identify hubs and characterize their network contributions by examining motif fingerprints and centrality indices for all regions within the cerebral cortices of both the cat and the macaque. Motif fingerprints capture the statistics of local connection patterns, while measures of centrality identify regions that lie on many of the shortest paths between parts of the network. Within both cat and macaque networks, we find that a combination of degree, motif participation, betweenness centrality and closeness centrality allows for reliable identification of hub regions, many of which have previously been functionally classified as polysensory or multimodal. We then classify hubs as either provincial (intra-cluster) hubs or connector (inter-cluster) hubs, and proceed to show that lesioning hubs of each type from the network produces opposite effects on the small-world index. Our study presents an approach to the identification and classification of putative hub regions in brain networks on the basis of multiple network attributes and charts potential links between the structural embedding of such regions and their functional roles.	[Sporns, Olaf; Honey, Christopher J.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Sporns, Olaf; Honey, Christopher J.] Indiana Univ, Program Cognit Sci, Bloomington, IN USA; [Kotter, Rolf] Radboud Univ Nijmegen, Dept Cognit Neurosci, Sect Neurophysiol & Neuroinformat, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Kotter, Rolf] Univ Dusseldorf, C&O Vogt Brain Res Inst, Dusseldorf, Germany; [Kotter, Rolf] Univ Dusseldorf, Inst Anat 2, Dusseldorf, Germany	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Radboud University Nijmegen; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Sporns, O (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	osporns@indiana.edu	Sporns, Olaf/A-1667-2010; Honey, Christopher/C-3105-2015; Honey, Christopher/AAF-3616-2021; Bullmore, Ed/C-1706-2012	Sporns, Olaf/0000-0001-7265-4036; Honey, Christopher/0000-0002-0745-5089; Honey, Christopher/0000-0002-0745-5089; Bullmore, Ed/0000-0002-8955-8283	DFG [KO 1560/6-2]; J.S. McDonnell Foundation	DFG(German Research Foundation (DFG)); J.S. McDonnell Foundation	RK acknowledges support by the DFG KO 1560/6-2. OS, CH and RK were supported by the J.S. McDonnell Foundation. We thank Aviad Rubinstein for help in implementing graph analysis methods.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Artzy-Randrup Y, 2004, SCIENCE, V305; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; DACOSTA L, 2006, EUR PHYS J B, V48, P567; De Weerd P, 2003, EUR J NEUROSCI, V18, P1671, DOI 10.1046/j.1460-9568.2003.02862.x; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Friston KJ, 2002, ANNU REV NEUROSCI, V25, P221, DOI 10.1146/annurev.neuro.25.112701.142846; Fuster J. M., 2015, PREFRONTAL CORTEX, V5th; GLEICH D, 2006, MATLABBGL; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Hilgetag Claus C., 2002, P295; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Iturria-Medina Y, 2007, NEUROIMAGE, V36, P645, DOI 10.1016/j.neuroimage.2007.02.012; Kaiser M, 2004, BIOL CYBERN, V90, P311, DOI 10.1007/s00422-004-0479-1; Kaiser M, 2007, EUR J NEUROSCI, V25, P3185, DOI 10.1111/j.1460-9568.2007.05574.x; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Kasthuri N, 2007, NAT METHODS, V4, P307, DOI 10.1038/nmeth0407-307; Kotter R, 2005, PHILOS T R SOC B, V360, P751, DOI 10.1098/rstb.2005.1625; Kotter R, 2004, NEUROINFORMATICS, V2, P127; Kotter R, 2003, NEURAL NETWORKS, V16, P1261, DOI 10.1016/j.neunet.2003.06.002; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Masuda N, 2004, BIOL CYBERN, V90, P302, DOI 10.1007/s00422-004-0471-9; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; Quintana J, 1999, CEREB CORTEX, V9, P213, DOI 10.1093/cercor/9.3.213; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; Scannell JW, 1999, CEREB CORTEX, V9, P277, DOI 10.1093/cercor/9.3.277; SCHILLER PH, 1995, NATURE, V376, P342, DOI 10.1038/376342a0; SCHILLER PH, 1991, SCIENCE, V251, P1251, DOI 10.1126/science.2006413; Sommer MA, 2001, J NEUROPHYSIOL, V85, P1673, DOI 10.1152/jn.2001.85.4.1673; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O., 2002, NEUROSCIENCE DATABAS, P171; Sporns O, 2006, BIOSYSTEMS, V85, P55, DOI 10.1016/j.biosystems.2006.02.008; Stein BE., 1993, MERGING SENSES; Stephan KE, 2000, PHILOS T R SOC B, V355, P111, DOI 10.1098/rstb.2000.0552; Stephan KE, 2001, PHILOS T ROY SOC B, V356, P1159, DOI 10.1098/rstb.2001.0908; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Tononi G, 1998, TRENDS COGN SCI, V2, P474, DOI 10.1016/S1364-6613(98)01259-5; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Vezoli J, 2004, NEUROSCIENTIST, V10, P476, DOI 10.1177/1073858404268478; Wallace MT, 2004, P NATL ACAD SCI USA, V101, P2167, DOI 10.1073/pnas.0305697101; Wasserman S., 1994, SOCIAL NETWORK ANAL; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999	70	801	806	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1049	10.1371/journal.pone.0001049	http://dx.doi.org/10.1371/journal.pone.0001049			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940613	Green Published, gold, Green Submitted			2022-12-25	WOS:000207456100017
J	Ferreira, BI; Alonso, J; Carrillo, J; Acquadro, F; Largo, C; Suela, J; Teixeira, MR; Cerveira, N; Molares, A; Gomez-Lopez, G; Pestana, A; Sastre, A; Garcia-Miguel, P; Cigudosa, JC				Ferreira, B. I.; Alonso, J.; Carrillo, J.; Acquadro, F.; Largo, C.; Suela, J.; Teixeira, M. R.; Cerveira, N.; Molares, A.; Gomez-Lopez, G.; Pestana, A.; Sastre, A.; Garcia-Miguel, P.; Cigudosa, J. C.			Array CGH and gene-expression profiling reveals distinct genomic instability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewing's sarcoma	ONCOGENE			English	Article						Ewing's sarcoma; arrayCGH; expression profile; genomic instability	TUMORS; HYBRIDIZATION; TRANSLOCATION; PREDICTION; FUSION	Ewing's sarcoma (ES) is characterized by specific chromosome translocations, the most common being t(11; 22)(q24; q12). Additionally, other type of genetic abnormalities may occur and be relevant for explaining the variable tumour biology and clinical outcome. We have carried out a high-resolution array CGH and expression profiling on 25 ES tumour samples to characterize the DNA copy number aberrations (CNA) occurring in these tumours and determine their association with gene-expression profiles and clinical outcome. CNA were observed in 84% of the cases. We observed a median number of three aberrations per case. Besides numerical chromosome changes, smaller aberrations were found and defined at chromosomes 5p, 7q and 9p. All CNA were compiled to define the smallest overlapping regions of imbalance (SORI). A total of 35 SORI were delimited. Bioinformatics analyses were conducted to identify subgroups according to the pattern of genomic instability. Unsupervised and supervised clustering analysis (using SORI as variables) segregated the tumours in two distinct groups: one genomically stable (<= 3 CNA) and other genomically unstable (> 3 CNA). The genomic unstable group showed a statistically significant shorter overall survival and was more refractory to chemotherapy. Expression pro. le analysis revealed significant differences between both groups. Genes related with chromosome segregation, DNA repair pathways and cell-cycle control were upregulated in the genomically unstable group. This report elucidates, for the first time, data about genomic instability in ES, based on CNA and expression pro. ling, and shows that a genomically unstable group of Ewing's tumours is correlated with a significant poor prognosis.	[Ferreira, B. I.; Acquadro, F.; Largo, C.; Suela, J.; Cigudosa, J. C.] CNIO, Mol Cytogenet Grp, Madrid 28089, Spain; [Ferreira, B. I.; Acquadro, F.; Largo, C.; Suela, J.; Cigudosa, J. C.] CIBERER, Madrid, Spain; [Alonso, J.; Carrillo, J.; Pestana, A.] UAM, CSIC, Inst Invest Biomed A Sols, Dept Biol Mol & Celular Canc, Madrid, Spain; [Teixeira, M. R.; Cerveira, N.] Portuguese Oncol Inst & Biomed Sci Inst ICBAS, Dept Genet, Oporto, Portugal; [Molares, A.; Gomez-Lopez, G.] Hosp Rebullon, CHUVI, Fdn Biomed, Vigo, Pontevedra, Spain; [Gomez-Lopez, G.] CNIO, Unidad Bioinformat, Madrid, Spain; [Sastre, A.; Garcia-Miguel, P.] Hosp Infantil La Paz, Unidad Oncohematol Infantil, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Universidade do Porto; Complexo Hospitalario Universitario de Vigo; Centro Nacional de Investigaciones Oncologicas (CNIO); Hospital Universitario La Paz	Cigudosa, JC (corresponding author), CNIO, Mol Cytogenet Grp, 3 C Melchor Fernandez Almagro, Madrid 28089, Spain.	jalonso@iib.uam.es; jccigudosa@cnio.es	Molares-Vila, Alberto/AAA-3140-2021; García, Jaime Carrillo/AAC-5144-2020; Gomez-Lopez, Gonzalo/D-9123-2016; Teixeira, Manuel AC/AAZ-7251-2020; Cigudosa, Juan C/E-4105-2016; SUELA, JAVIER/K-3968-2016; Alonso, Javier/B-6012-2013; Teixeira, Manuel António Rodrigues/E-4885-2011	Gomez-Lopez, Gonzalo/0000-0002-4146-0551; Teixeira, Manuel AC/0000-0002-1959-0624; Alonso, Javier/0000-0002-6287-8391; Teixeira, Manuel António Rodrigues/0000-0002-4896-5982; ferreira, Bibiana/0000-0003-4772-9395; Cerveira, Nuno/0000-0001-5098-3840; Carrillo Garcia, Jaime/0000-0002-2861-3015				Armengol G, 1997, BRIT J CANCER, V75, P1403, DOI 10.1038/bjc.1997.242; AURIAS A, 1984, CANCER GENET CYTOGEN, V12, P21, DOI 10.1016/0165-4608(84)90003-7; Bandres E, 2005, J PEDIAT HEMATOL ONC, V27, P537, DOI 10.1097/01.mph.0000184576.38835.e2; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Brisset S, 2001, CANCER GENET CYTOGEN, V130, P57, DOI 10.1016/S0165-4608(01)00454-X; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Eilers PHC, 2005, BIOINFORMATICS, V21, P1146, DOI 10.1093/bioinformatics/bti148; Hattinger CM, 2002, BRIT J CANCER, V86, P1763, DOI 10.1038/sj.bjc.6600332; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kovar Heinrich, 1998, Current Opinion in Oncology, V10, P334, DOI 10.1097/00001622-199807000-00010; Mendiola M, 2006, INT J CANCER, V118, P1381, DOI 10.1002/ijc.21578; MUGNERET F, 1988, CANCER GENET CYTOGEN, V32, P239, DOI 10.1016/0165-4608(88)90286-5; Ohali A, 2004, ONCOGENE, V23, P8997, DOI 10.1038/sj.onc.1208060; Ozaki T, 2001, GENE CHROMOSOME CANC, V32, P164, DOI 10.1002/gcc.1178; Pinkel D, 2005, ANNU REV GENOM HUM G, V6, P331, DOI 10.1146/annurev.genom.6.080604.162140; Rouveirol C, 2006, BIOINFORMATICS, V22, P849, DOI 10.1093/bioinformatics/btl004; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thompson PM, 2001, CANCER RES, V61, P679; Ushigome U, 2002, PATHOLOGY GENETICS T, P298; Wu W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-309; Zielenska M, 2001, CANCER, V91, P2156, DOI 10.1002/1097-0142(20010601)91:11<2156::AID-CNCR1244>3.0.CO;2-I	21	45	61	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 27	2008	27	14					2084	2090		10.1038/sj.onc.1210845	http://dx.doi.org/10.1038/sj.onc.1210845			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	279MK	17952124				2022-12-25	WOS:000254359100013
J	Khan, EM; Lanir, R; Danielson, AR; Goldkorn, T				Khan, Elaine M.; Lanir, Roni; Danielson, Aaron R.; Goldkorn, Tzipora			Epidermal growth factor receptor exposed to cigarette smoke is aberrandy activated and undergoes perinuclear trafficking	FASEB JOURNAL			English	Article							ALPHA-CONVERTING ENZYME; LUNG EPITHELIAL-CELLS; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; TYROSINE KINASES; HUMAN CANCER; CBL; PATHWAY; POLYUBIQUITYLATION; INTERNALIZATION	Exposure to hydrogen peroxide (H2O2), one of the reactive oxidants in the gas phase of cigarette smoke (CS), induces aberrant phosphorylation of the epidermal growth factor receptor (EGFR), resulting in the lack of ubiquitination by c-Cbl, and impaired degradation. EGFR activation without the feedback regulation of normal degradation leads to uncontrolled cell growth and tumor promotion. Using immunoprecipitation, immunoblotting, and confocal microscopy, we now demonstrate that the pattern of EGFR activation by CS is similar to H2O2. We found that exposure of human airway epithelial cells to CS, as with exposure to H2O2, not only results in an increase in EGFR activation over time, but the EGFR activated by H2O2 or CS is neither ubiquitinated nor subsequently degraded due to its inability to bind the E3 ubiquitin ligase, c-Cbl, either directly or indirectly via the Grb2 adapter protein. Moreover, the stabilized H2O2- and CS-activated EGFR remains plasma membrane-bound, while a population of the receptor is trafficked to a perinuclear region. Concomitantly, CS exposure results in the activation of downstream Akt and ERKI/2 survival and proliferation pathways. Therefore, exposure to CS, like exposure to H2O2, results in prolonged signaling by the EGFR and may contribute to uncontrolled lung cell growth-Ehan, E. M., Lanir, R., Danielson, A. R., Goldkorn, T. Epidermal growth factor receptor exposed to cigarette smoke is aberrandy activated and undergoes perinuclear trafficking.	[Khan, Elaine M.; Lanir, Roni; Danielson, Aaron R.; Goldkorn, Tzipora] Univ Calif Davis, Dept Internal Med, Sch Med,Signal Transduct Lab, Genome & Biomed Sci Facil, Davis, CA 95616 USA	University of California System; University of California Davis	Goldkorn, T (corresponding author), Univ Calif Davis, Dept Internal Med, Sch Med,Signal Transduct Lab, Genome & Biomed Sci Facil, Rm 6321,451 E Hlth Sci Dr, Davis, CA 95616 USA.	ttgoldkorn@ucdavis.edu			NHLBI NIH HHS [T32 HL007013, T32 HL07013, R01 HL071871, R01 HL066189, HL-71871, HL-66189] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071871, R01HL066189, T32HL007013] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bao J, 2000, J BIOL CHEM, V275, P26178, DOI 10.1074/jbc.M002367200; Diamonti AJ, 2002, P NATL ACAD SCI USA, V99, P2866, DOI 10.1073/pnas.052709799; ECCLES SA, 1994, INVAS METAST, V14, P337; Franklin WA, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.31520; Henson ES, 2006, CELL SIGNAL, V18, P2089, DOI 10.1016/j.cellsig.2006.05.015; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Huang FT, 2005, MOL BIOL CELL, V16, P1268, DOI 10.1091/mbc.E04-09-0832; Huang RP, 2001, MOL CARCINOGEN, V30, P209, DOI 10.1002/mc.1030; Jiang XJ, 2003, TRAFFIC, V4, P529, DOI 10.1034/j.1600-0854.2003.t01-1-00109.x; Khan EM, 2006, J BIOL CHEM, V281, P14486, DOI 10.1074/jbc.M509332200; Lavrentiadou SN, 2001, AM J RESP CELL MOL, V25, P676, DOI 10.1165/ajrcmb.25.6.4321; Lemjabbar H, 2003, J BIOL CHEM, V278, P26202, DOI 10.1074/jbc.M207018200; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Mendez-Alvarez E, 1998, J APPL TOXICOL, V18, P443, DOI 10.1002/(SICI)1099-1263(199811/12)18:6<443::AID-JAT530>3.3.CO;2-G; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; NAKAYAMA T, 1984, GANN, V75, P95; Ravid T, 2004, J BIOL CHEM, V279, P37153, DOI 10.1074/jbc.M403210200; Ravid T, 2002, J BIOL CHEM, V277, P31214, DOI 10.1074/jbc.M204677200; Shao MXG, 2004, AM J PHYSIOL-LUNG C, V287, pL420, DOI 10.1152/ajplung.00019.2004; THURMAN RG, 1972, EUR J BIOCHEM, V25, P420, DOI 10.1111/j.1432-1033.1972.tb01711.x; Vicent S, 2004, BRIT J CANCER, V90, P1047, DOI 10.1038/sj.bjc.6601644; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Zhang Q, 2005, AM J RESP CELL MOL, V32, P72, DOI 10.1165/rcmb.2004-0198OC	24	74	74	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2008	22	3					910	917		10.1096/fj.06-7729com	http://dx.doi.org/10.1096/fj.06-7729com			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17971399	Green Accepted			2022-12-25	WOS:000254143700029
J	Krammer, C; Suhre, MH; Kremmer, E; Diemer, C; Hess, S; Schatzl, HM; Scheibel, T; Vorberg, I				Krammer, Carmen; Suhre, Michael H.; Kremmer, Elisabeth; Diemer, Claudia; Hess, Simone; Schaetzl, Hermann M.; Scheibel, Thomas; Vorberg, Ina			Prion protein/protein interactions: fusion with yeast Sup35p-NM modulates cytosolic PrP aggregation in mammalian cells	FASEB JOURNAL			English	Article						amyloid; protein misfolding; seeding; nucleation	SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; IN-VITRO; PROTEIN AGGREGATION; PSI+ PRION; N-TERMINUS; INHERITANCE; DETERMINANT; DISEASE; PROPAGATION	In mammalian prion diseases, an abnormally folded, aggregated form of the prion protein (PrPSc) appears to catalyze a conformational switch of its cellular isoform (PrPC) to an aggregated state. A similar prion-like phenomenon has been reported for the Saccharomyces cerevisiae translation termination factor Sup35p that can adopt a self-propagating conformation. We have compared aggregation propensities of chimeric proteins derived from the Sup35p prion domain NM and PrP in vitro and in the cytosol of mammalian cells. Sup35p-NM and PrP displayed strikingly different aggregation behaviors when expressed in mammalian cells, with NM remaining soluble and cytosolic PrP spontaneously aggregating due to the globular domain of PrP. When fused to PrP90-230, Sup35p-M exhibited an inhibitory effect for nucleation but increased aggregate growth, potentially by facilitating recruitment of newly synthesized chimeric proteins into the growing aggregates. This effect, however, could, to some extent, be counteracted by the prionforming region Sup35p-N, thereby increasing aggregate frequency. Interestingly, a lowered nucleation rate was also observed in the presence of the amino-terminal region of PrP, suggesting that Sup35p-M and PrP23-90 share some biological function in prion protein assembly. Our results provide new insights into prion protein aggregation behaviors, demonstrating the impact of dynamic interactions between prion domains and suggesting that aggregation of yeast and mammalian prion proteins is strongly influenced by yet unidentified cellular conditions or factors.	[Krammer, Carmen; Diemer, Claudia; Schaetzl, Hermann M.; Vorberg, Ina] Tech Univ Munich, Inst Virol, D-81675 Munich, Germany; [Suhre, Michael H.; Hess, Simone; Scheibel, Thomas] Tech Univ Munich, Dept Chem, D-8046 Garching, Germany; [Kremmer, Elisabeth] GSF Natl Res Ctr Environm & Hlth, Inst Mol Immunol, Munich, Germany	Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Vorberg, I (corresponding author), Tech Univ Munich, Inst Virol, Trogerstr 30, D-81675 Munich, Germany.	vorberg@lrz.tum.de	Suhre, Michael H./C-5145-2009; Nussbaum-Krammer, Carmen/AAY-3081-2020; Scheibel, Thomas/I-1170-2014; Schatzl, Hermann/G-4958-2011	Suhre, Michael H./0000-0002-2279-7765; Nussbaum-Krammer, Carmen/0000-0002-8689-1363; Scheibel, Thomas/0000-0002-0457-2423; Schatzl, Hermann/0000-0003-4972-8740				Aguzzi A, 2003, SCIENCE, V302, P814, DOI 10.1126/science.1087348; Bousset L, 2002, MICROBES INFECT, V4, P461, DOI 10.1016/S1286-4579(02)01561-7; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Chernoff Y, 2004, CURR OPIN CHEM BIOL, V8, P665, DOI 10.1016/j.cbpa.2004.09.002; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; Edskes HK, 1999, P NATL ACAD SCI USA, V96, P1498, DOI 10.1073/pnas.96.4.1498; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Grenier C, 2006, J NEUROCHEM, V97, P1456, DOI 10.1111/j.1471-4159.2006.03837.x; Heller U, 2003, J BIOL CHEM, V278, P36139, DOI 10.1074/jbc.M304002200; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; Kochneva-Pervukhova NV, 1998, CURR GENET, V34, P146, DOI 10.1007/s002940050379; Kochneva-Pervukhova NV, 1998, EMBO J, V17, P5805, DOI 10.1093/emboj/17.19.5805; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kristiansen M, 2005, J BIOL CHEM, V280, P38851, DOI 10.1074/jbc.M506600200; Krzewska J, 2006, EMBO J, V25, P822, DOI 10.1038/sj.emboj.7600985; Kushnirov VV, 1998, CELL, V94, P13, DOI 10.1016/S0092-8674(00)81216-7; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; Liebman SW, 2001, NATURE, V410, P161, DOI 10.1038/35065778; Liu JJ, 2002, P NATL ACAD SCI USA, V99, P16446, DOI 10.1073/pnas.252652099; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Mishra RS, 2003, J ALZHEIMERS DIS, V5, P15, DOI 10.3233/JAD-2003-5103; Nunziante M, 2005, J CELL SCI, V118, P4959, DOI 10.1242/jcs.02609; Nunziante M, 2003, J BIOL CHEM, V278, P3726, DOI 10.1074/jbc.M206313200; Orsi A, 2006, J BIOL CHEM, V281, P30431, DOI 10.1074/jbc.M605320200; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Proske D, 2002, CHEMBIOCHEM, V3, P717, DOI 10.1002/1439-7633(20020802)3:8<717::AID-CBIC717>3.0.CO;2-C; Prusiner SB, 1997, ANNU REV GENET, V31, P139, DOI 10.1146/annurev.genet.31.1.139; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Rajan RS, 2001, P NATL ACAD SCI USA, V98, P13060, DOI 10.1073/pnas.181479798; Rane NS, 2004, EMBO J, V23, P4550, DOI 10.1038/sj.emboj.7600462; Ross ED, 2005, NAT CELL BIOL, V7, P1039, DOI 10.1038/ncb1105-1039; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Scheibel T, 2004, P NATL ACAD SCI USA, V101, P2287, DOI 10.1073/pnas.0308754101; Scheibel T, 2001, CURR BIOL, V11, P366, DOI 10.1016/S0960-9822(01)00099-9; Scheibel T, 2001, NAT STRUCT BIOL, V8, P958, DOI 10.1038/nsb1101-958; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Sigurdson C, 2005, NEURODEGENER DIS, V2, P1, DOI 10.1159/000086425; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Soto C, 2006, TRENDS BIOCHEM SCI, V31, P150, DOI 10.1016/j.tibs.2006.01.002; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; VENDRELY C, 2006, PRIONS NEW RES, P251; Walker LC, 2006, TRENDS NEUROSCI, V29, P438, DOI 10.1016/j.tins.2006.06.010; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2004, ANNU REV GENET, V38, P681, DOI 10.1146/annurev.genet.38.072902.092200; Wigley WC, 1999, J CELL BIOL, V145, P481; Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zhou P, 2001, MOL MICROBIOL, V39, P37, DOI 10.1046/j.1365-2958.2001.02224.x	66	15	16	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2008	22	3					762	773		10.1096/fj.07-8733com	http://dx.doi.org/10.1096/fj.07-8733com			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17928365				2022-12-25	WOS:000254143700015
J	Hoffmann, D; Seebach, J; Cosma, A; Goebel, FD; Strimmer, K; Schatzl, HM; Erfle, V				Hoffmann, Dieter; Seebach, Judith; Cosma, Antonio; Goebel, Frank D.; Strimmer, Korbinian; Schatzl, Hermann M.; Erfle, Volker			Therapeutic vaccination reduces HIV sequence variability	FASEB JOURNAL			English	Article						Nef; genetic diversity; selection	CELL RESPONSES; T-CELLS; DENDRITIC CELLS; NEF SEQUENCES; VIRUS; EVOLUTION; SELECTION; AIDS; VARIANTS; VACCINES	With HIV persisting lifelong in infected persons, therapeutic vaccination is a novel alternative concept to control virus replication. Even though CD8 and CD4 cell responses to such immunizations have been demonstrated, their effects on virus replication are still unclear. In view of this fact, we studied the impact of a therapeutic vaccination with HIV nef delivered by a recombinant modified vaccinia Ankara vector on viral diversity. We investigated HIV sequences derived from chronically infected persons before and after therapeutic vaccination. Before immunization the mean +/- SE pairwise variability of patient-derived Nef protein sequences was 0.1527 +/- 0.0041. After vaccination the respective value was 0.1249 +/- 0.0042, resulting in a significant (P< 0.0001) difference between the two time points. The genes vif and 5' gag tested in parallel and nef sequences in control persons yielded a constant amino acid sequence variation. The data presented suggest that Nef immunization induced a selective pressure, limiting HIV sequence variability. To our knowledge this is the first report directly linking therapeutic HIV vaccination to decreasing diversity in patient-derived virus isolates.	[Hoffmann, Dieter; Seebach, Judith; Schatzl, Hermann M.] Tech Univ Munich, Inst Virol, Munich, Germany; [Cosma, Antonio; Erfle, Volker] Tech Univ Munich, GSF Natl Res Ctr Environm & Hlth, Clin Cooperat Grp Immune Monitoring, Munich, Germany; [Cosma, Antonio; Erfle, Volker] GSF Natl Res Ctr Environm & Hlth, Inst Mol Virol, Neuherberg, Germany; [Goebel, Frank D.] Univ Munich, Med Poliklin, D-8000 Munich, Germany; [Strimmer, Korbinian] Univ Leipzig, IMISE, Leipzig, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Leipzig University	Hoffmann, D (corresponding author), Tech Univ Munich, Inst Virol, Munich, Germany.	dieter.hoffmann@lrz.tum.de	Strimmer, Korbinian/C-1522-2009; Schatzl, Hermann/G-4958-2011	Strimmer, Korbinian/0000-0001-7917-2056; Schatzl, Hermann/0000-0003-4972-8740; Cosma, Antonio/0000-0002-3686-8034				Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Autran B, 2004, SCIENCE, V305, P205, DOI 10.1126/science.1100600; Ayyavoo V, 2000, AIDS, V14, P1, DOI 10.1097/00002030-200001070-00001; Barouch DH, 2001, IMMUNOL LETT, V79, P57, DOI 10.1016/S0165-2478(01)00266-8; Bazykin GA, 2006, P NATL ACAD SCI USA, V103, P19396, DOI 10.1073/pnas.0609484103; Betts MR, 2002, DNA CELL BIOL, V21, P665, DOI 10.1089/104454902760330200; Choi HJ, 2004, J BIOL CHEM, V279, P51688, DOI 10.1074/jbc.M410068200; Cornelissen M, 2007, AIDS, V21, P807, DOI 10.1097/QAD.0b013e3280f3c08a; Cosma A, 2003, VACCINE, V22, P21, DOI 10.1016/S0264-410X(03)00538-3; Couillin I, 2001, VIROLOGY, V279, P136, DOI 10.1006/viro.2000.0705; Deeks SG, 2006, BMJ-BRIT MED J, V332, P1489, DOI 10.1136/bmj.332.7556.1489; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Dorrell L, 2006, J VIROL, V80, P4705, DOI 10.1128/JVI.80.10.4705-4716.2006; Edwards CTT, 2006, GENETICS, V174, P1441, DOI 10.1534/genetics.105.052019; Erfle V, 2005, MICROBES INFECT, V7, P1400, DOI 10.1016/j.micinf.2005.07.015; Fletcher TM, 1997, EMBO J, V16, P5123, DOI 10.1093/emboj/16.16.5123; Ganeshan S, 1997, J VIROL, V71, P663, DOI 10.1128/JVI.71.1.663-677.1997; Gilliam BL, 2003, CURR TOP MED CHEM, V3, P1536, DOI 10.2174/1568026033451772; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gudmundsdotter L, 2006, SPRINGER SEMIN IMMUN, V28, P221, DOI 10.1007/s00281-006-0029-0; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Harrer E, 2005, ANTIVIR THER, V10, P285; Johnson WE, 2002, ANNU REV MED, V53, P499, DOI 10.1146/annurev.med.53.082901.104053; Joseph AM, 2005, CURR HIV RES, V3, P87, DOI 10.2174/1570162052773013; Kimata JT, 1999, NAT MED, V5, P535, DOI 10.1038/8414; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Kondo M, 2005, J INFECT DIS, V192, P56, DOI 10.1086/430739; KORBER B, 1992, AIDS RES HUM RETROV, V8, P1549, DOI 10.1089/aid.1992.8.1549; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lehmann MH, 2006, J CELL SCI, V119, P4520, DOI 10.1242/jcs.03231; Lehmann MH, 2006, EXP CELL RES, V312, P3659, DOI 10.1016/j.yexcr.2006.08.008; Lemey P, 2006, AIDS REV, V8, P125; Lichterfeld M, 2004, AIDS, V18, P1383, DOI 10.1097/01.aids.0000131329.51633.a3; McGrath KM, 2001, VIRUS RES, V76, P137, DOI 10.1016/S0168-1702(01)00271-4; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Mordelet E, 2004, FASEB J, V18, P1851, DOI 10.1096/fj.04-2308com; NEI M, 1986, MOL BIOL EVOL, V3, P418; Noe A, 2005, J ANTIMICROB CHEMOTH, V55, P410, DOI 10.1093/jac/dki038; O'Neill E, 2006, J VIROL, V80, P1311, DOI 10.1128/JVI.80.3.1311-1320.2006; Overbaugh J, 2001, SCIENCE, V292, P1106, DOI 10.1126/science.1059128; Priceputu E, 2007, J VIROL, V81, P4677, DOI 10.1128/JVI.02691-06; Quaranta MG, 2006, FASEB J, V20, P2198, DOI 10.1096/fj.06-6260rev; Quaranta MG, 2004, FASEB J, V18, P1459, DOI 10.1096/fj.04-1633fje; Quaranta MG, 2003, FASEB J, V17, P2025, DOI 10.1096/fj.03-0272com; Resch W, 2005, J VIROL, V79, P10638, DOI 10.1128/JVI.79.16.10638-10649.2005; Richman DD, 2004, J ANTIMICROB CHEMOTH, V53, P555, DOI 10.1093/jac/dkh157; Sagar M, 2003, J VIROL, V77, P12921, DOI 10.1128/JVI.77.23.12921-12926.2003; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; Singh MK, 2001, AIDS RES HUM RETROV, V17, P1265, DOI 10.1089/088922201750461320; Smith RA, 2004, J BIOL CHEM, V279, P26726, DOI 10.1074/jbc.M314038200; Stott EJ, 1996, J ANTIMICROB CHEMOTH, V37, P185, DOI 10.1093/jac/37.suppl_B.185; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Troyer RM, 2005, J VIROL, V79, P9006, DOI 10.1128/JVI.79.14.9006-9018.2005; Villefroy P, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-65; Visco-Comandini U, 2001, J BIOL REG HOMEOS AG, V15, P299; Yang ZH, 2000, GENETICS, V155, P431	60	7	8	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2008	22	2					437	444		10.1096/fj.06-7975com	http://dx.doi.org/10.1096/fj.06-7975com			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	257TY	17932027				2022-12-25	WOS:000252822600014
J	Clarke, RM; Lyons, A; O'Connell, F; Deighan, BF; Barry, CE; Anyakoha, NG; Nicolaou, A; Lynch, MA				Clarke, Rachael M.; Lyons, Anthony; O'Connell, Florence; Deighan, Brian F.; Barry, Claire E.; Anyakoha, Ngozi G.; Nicolaou, Anna; Lynch, Marina A.			A pivotal role for interleukin-4 in atorvastatin-associated neuroprotection in rat brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; COA REDUCTASE INHIBITOR; SMOOTH-MUSCLE-CELLS; NITRIC-OXIDE SYNTHASE; CD40 GENE-EXPRESSION; MICROGLIAL ACTIVATION; EICOSAPENTAENOIC ACID; INFLAMMATORY CHANGES; ALZHEIMERS-DISEASE; CONTROLLED TRIAL	Inflammatory changes, characterized by an increase in proinflammatory cytokine production and up-regulation of the corresponding signaling pathways, have been described in the brains of aged rats and rats treated with the potent immune modulatory molecule lipopolysaccharide ( LPS). These changes have been coupled with a deficit in long-term potentiation ( LTP) in hippocampus. The evidence suggests that anti-inflammatory agents, which attenuate the LPS-induced and age-associated increase in hippocampal interleukin-1 beta (IL-1 beta) concentration, lead to restoration of LTP. Here we report that atorvastatin, a member of the family of agents that act as inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase, exerts powerful anti-inflammatory effects in brain and that these effects are mediated by IL-4 and independent of its cholesterol-lowering actions. Treatment of rats with atorvastatin increased IL-4 concentration in hippocampal tissue prepared from LPS-treated and aged rats and abrogated the age-related and LPS-induced increases in pro-inflammatory cytokines, interferon-gamma ( IFN gamma) and IL-1 beta, and the accompanying deficit in LTP. The effect of atorvastatin on the LPS-induced increases in IFN gamma and IL-1 beta was absent in tissue prepared from IL-4(-/-) mice. The increase in IL-1 beta in LPS-treated and aged rats is associated with increased microglial activation, assessed by analysis of major histocompatibility complex II expression, and the evidence suggests that IFN gamma may trigger this activation. We propose that the primary effect of atorvastatin is to increase IL-4, which antagonizes the effects of IFN gamma, the associated increase in microglial activation, and the subsequent cascade of events.	[Anyakoha, Ngozi G.; Nicolaou, Anna] Univ Bradford, Sch Pharm, Bradford BD7 DP, W Yorkshire, England; [Clarke, Rachael M.; Lyons, Anthony; O'Connell, Florence; Deighan, Brian F.; Barry, Claire E.; Lynch, Marina A.] Trinity Coll Dublin, Inst Neurol, Dept Physiol, Dublin 2, Ireland	University of Bradford; Trinity College Dublin	Lynch, MA (corresponding author), Trinity Coll Dublin, Inst Neurol, Dept Physiol, Dublin 2, Ireland.	lynchma@tcd.ie	Nicolaou, Anna/D-4025-2018	Nicolaou, Anna/0000-0002-1314-413X; Lynch, Marina/0000-0002-4631-0499				ADOSRAKU RK, 1994, J LIPID RES, V35, P1925; Barry CE, 2005, J NEUROCHEM, V93, P221, DOI 10.1111/j.1471-4159.2004.03011.x; Bi XN, 2004, J BIOL CHEM, V279, P48238, DOI 10.1074/jbc.M405442200; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Bosel J, 2005, J NEUROCHEM, V92, P1386, DOI 10.1111/j.1471-4159.2004.02980.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caballero J, 2004, J CLIN PHARM THER, V29, P209, DOI 10.1111/j.1365-2710.2004.00560.x; Chauhan NB, 2004, J NEUROSCI RES, V78, P732, DOI 10.1002/jnr.20298; Clarke RM, 2007, NEUROPHARMACOLOGY, V52, P136, DOI 10.1016/j.neuropharm.2006.07.031; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Cordle A, 2005, J BIOL CHEM, V280, P34202, DOI 10.1074/jbc.M505268200; Crisby M, 2002, ALZ DIS ASSOC DIS, V16, P131, DOI 10.1097/00002093-200207000-00001; Delgado M, 2003, J BIOL CHEM, V278, P27620, DOI 10.1074/jbc.M303199200; Endres M, 2004, STROKE, V35, P2708, DOI 10.1161/01.STR.0000143319.73503.38; Endres M, 1998, P NATL ACAD SCI USA, V95, P8880, DOI 10.1073/pnas.95.15.8880; Greisenegger S, 2004, J NEUROL SCI, V221, P5, DOI 10.1016/j.jns.2004.01.015; Griffin R, 2006, J NEUROCHEM, V99, P1263, DOI 10.1111/j.1471-4159.2006.04165.x; Hattori Y, 2002, CARDIOVASC RES, V54, P649, DOI 10.1016/S0008-6363(02)00266-3; Huang KC, 2003, FEBS LETT, V555, P385, DOI 10.1016/S0014-5793(03)01297-3; Ito M, 2004, CIRCULATION, V110, P412, DOI 10.1161/01.CIR.0000136088.18960.E6; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kawashima S, 2003, STROKE, V34, P157, DOI 10.1161/01.STR.0000048213.18751.52; Kelly A, 2003, J BIOL CHEM, V278, P19453, DOI 10.1074/jbc.M301938200; King DS, 2003, PHARMACOTHERAPY, V23, P1663, DOI 10.1592/phco.23.15.1663.31953; Kobayashi M, 2006, INT J PHARMACEUT, V317, P19, DOI 10.1016/j.ijpharm.2006.02.043; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; Lindberg C, 2005, J NEUROSCI RES, V82, P10, DOI 10.1002/jnr.20615; Lonergan PE, 2004, J NEUROCHEM, V91, P20, DOI 10.1111/j.1471-4159.2004.02689.x; Lynch AM, 2007, NEUROBIOL AGING, V28, P845, DOI 10.1016/j.neurobiolaging.2006.04.006; LYNCH MA, 1985, NEUROSCI LETT, V62, P123, DOI 10.1016/0304-3940(85)90295-2; Maher FO, 2006, J NEUROCHEM, V96, P1560, DOI 10.1111/j.1471-4159.2006.03664.x; Maher FO, 2005, NEUROBIOL AGING, V26, P717, DOI 10.1016/j.neurobiolaging.2004.07.002; Marti-Fabregas J, 2004, STROKE, V35, P1117, DOI 10.1161/01.STR.0000125863.93921.3f; Martin DSD, 2002, J BIOL CHEM, V277, P34239, DOI 10.1074/jbc.M205289200; Matsumoto M, 2004, J IMMUNOL, V172, P7377, DOI 10.4049/jimmunol.172.12.7377; Menschikowski M, 2005, BBA-MOL CELL BIOL L, V1733, P157, DOI 10.1016/j.bbalip.2005.01.001; Milner R, 2003, J IMMUNOL, V170, P3850, DOI 10.4049/jimmunol.170.7.3850; Minogue AM, 2003, J BIOL CHEM, V278, P27971, DOI 10.1074/jbc.M302530200; Moore AH, 2002, ADV DRUG DELIVER REV, V54, P1627, DOI 10.1016/S0169-409X(02)00162-X; Moore ME, 2005, BIOCHEM SOC T, V33, P573, DOI 10.1042/BST0330573; Nguyen VT, 2000, J IMMUNOL, V165, P6235, DOI 10.4049/jimmunol.165.11.6235; Nguyen VT, 1998, EUR J IMMUNOL, V28, P2537, DOI 10.1002/(SICI)1521-4141(199808)28:08<2537::AID-IMMU2537>3.0.CO;2-1; Nolan Y, 2005, NEUROIMMUNOMODULAT, V12, P113, DOI 10.1159/000083583; Nolan Y, 2005, J BIOL CHEM, V280, P9354, DOI 10.1074/jbc.M412170200; Noula C, 2000, BBA-MOL CELL BIOL L, V1487, P15, DOI 10.1016/S1388-1981(00)00078-0; Ortego M, 2005, J CARDIOVASC PHARM, V45, P468, DOI 10.1097/01.fjc.0000159042.50488.e5; Senokuchi T, 2005, J BIOL CHEM, V280, P6627, DOI 10.1074/jbc.M412531200; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Sparks D L, 2002, J Nutr Health Aging, V6, P324; Stuve O, 2003, CELL MOL LIFE SCI, V60, P2483, DOI 10.1007/s00018-003-3146-0; Summers MJ, 2007, PHARMACOTHERAPY, V27, P183, DOI 10.1592/phco.27.2.183; Townsend KP, 2004, J NEUROSCI RES, V78, P167, DOI 10.1002/jnr.20234; Vaughan CJ, 2003, AM J CARDIOL, V91, p23B, DOI 10.1016/S0002-9149(02)03270-8; Vereker E, 2000, J NEUROSCI, V20, P6811, DOI 10.1523/JNEUROSCI.20-18-06811.2000; von Bardeleben R, 2003, BIOCHEM BIOPH RES CO, V307, P401, DOI 10.1016/S0006-291X(03)01205-1; Wagstaff LR, 2003, PHARMACOTHERAPY, V23, P871, DOI 10.1592/phco.23.7.871.32720; Wang HR, 2005, CLIN CHIM ACTA, V353, P53, DOI 10.1016/j.cccn.2004.10.007; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158	59	78	79	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1808	1817		10.1074/jbc.M707442200	http://dx.doi.org/10.1074/jbc.M707442200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	17981803	hybrid			2022-12-25	WOS:000252501000006
J	Eckstein, N; Servan, K; Girard, L; Cai, D; von Jonquieres, G; Jaehde, U; Kassack, MU; Gazdar, AF; Minna, JD; Royer, HD				Eckstein, Niels; Servan, Kati; Girard, Luc; Cai, Di; von Jonquieres, Georg; Jaehde, Ulrich; Kassack, Matthias U.; Gazdar, Adi F.; Minna, John D.; Royer, Hans-Dieter			Epidermal growth factor receptor pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR; EGF RECEPTOR; IN-VITRO; P53; PHOSPHORYLATION; EXPRESSION; AKT; PROLIFERATION; ACTIVATION; MOTILITY	The use of platinum complexes for the therapy of breast cancer is an emerging new treatment modality. To gain insight into the mechanisms underlying cisplatin resistance in breast cancer, we used estrogen receptor-positive MCF-7 cells as a model system. We generated cisplatin-resistant MCF-7 cells and determined the functional status of epidermal growth factor receptor ( EGFR), MAPK, and AKT signaling pathways by phosphoreceptor tyrosine kinase and phospho-MAPK arrays. The cisplatin-resistant MCF-7 cells are characterized by increased EGFR phosphorylation, high levels of AKT1 kinase activity, and ERK1 phosphorylation. In contrast, the JNK and p38 MAPK modules of the MAPK signaling pathway were inactive. These conditions were associated with inactivation of the p53 pathway and increased BCL-2 expression. We investigated the expression of genes encoding the ligands for the ERBB signaling cascade and found a selective up-regulation of amphiregulin expression, which occurred at later stages of cisplatin resistance development. Amphiregulin is a specific ligand of the EGFR (ERBB1) and a potent mitogen for epithelial cells. After exposure to cisplatin, the resistant MCF-7 cells secreted amphiregulin protein over extended periods of time, and knockdown of amphiregulin expression by specific short interfering RNA resulted in a nearly complete reversion of the resistant phenotype. To demonstrate the generality and importance of our findings, we examined amphiregulin expression and cisplatin resistance in a variety of human breast cancer cell lines and found a highly significant correlation. In contrast, amphiregulin levels did not significantly correlate with cisplatin resistance in a panel of lung cancer cell lines. We have thus identified a novel function of amphiregulin for cisplatin resistance in human breast cancer cells.	[Eckstein, Niels; Servan, Kati; von Jonquieres, Georg; Royer, Hans-Dieter] Stiftung Ctr Adv European Studies & Res, D-53175 Bonn, Germany; [Girard, Luc; Cai, Di; Gazdar, Adi F.; Minna, John D.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Jaehde, Ulrich] Univ Bonn, Dept Clin Pharm, D-53121 Bonn, Germany; [Kassack, Matthias U.] Univ Dusseldorf, Inst Pharmaceut & Med Chem, D-40225 Dusseldorf, Germany	Center of Advanced European Studies & Research (CAESAR); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Bonn; Heinrich Heine University Dusseldorf	Royer, HD (corresponding author), Stiftung Ctr Adv European Studies & Res, Ludwig Erhard Allee 2, D-53175 Bonn, Germany.	royer@caesar.de	Royer, Hans-dieter/AAH-6293-2019; von Jonquieres, Georg/W-1781-2019	von Jonquieres, Georg/0000-0002-7423-3355	NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA070907-10, P50 CA070907-110009, P50 CA070907-11, P50 CA070907, P50 CA070907-09, P50CA70907, P50 CA070907-109001] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beerli RR, 1996, J BIOL CHEM, V271, P6071, DOI 10.1074/jbc.271.11.6071; Benhar M, 2002, ONCOGENE, V21, P8723, DOI 10.1038/sj.onc.1205980; Bessard A, 2007, J CELL PHYSIOL, V212, P526, DOI 10.1002/jcp.21049; BROOKS SC, 1973, J BIOL CHEM, V248, P6251; Brown CL, 1998, J BIOL CHEM, V273, P17258, DOI 10.1074/jbc.273.27.17258; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Gazdar AF, 1998, INT J CANCER, V78, P766, DOI 10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Heron-Milhavet L, 2006, MOL CELL BIOL, V26, P8267, DOI 10.1128/MCB.00201-06; Hortobagyi GN, 1998, NEW ENGL J MED, V339, P974, DOI 10.1056/NEJM199810013391407; Hurley J, 2006, J CLIN ONCOL, V24, P1831, DOI 10.1200/JCO.2005.02.8886; Iyer R, 2003, LEUKEMIA RES, V27, P73, DOI 10.1016/S0145-2126(02)00064-4; JOHNSON GR, 1993, J BIOL CHEM, V268, P2924; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kiyatkin A, 2006, J BIOL CHEM, V281, P19925, DOI 10.1074/jbc.M600482200; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LEJEUNE S, 1993, CANCER RES, V53, P3597; Li XQ, 2005, BREAST CANCER RES, V7, pR589, DOI 10.1186/bcr1259; Liu LZ, 2007, CANCER RES, V67, P6325, DOI 10.1158/0008-5472.CAN-06-4261; Ma L, 2001, J PATHOL, V194, P413, DOI 10.1002/path.902; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Ott I, 2007, ANTI-CANCER AGENT ME, V7, P95, DOI 10.2174/187152007779314071; Panico L, 1996, INT J CANCER, V65, P51, DOI 10.1002/(SICI)1097-0215(19960103)65:1<51::AID-IJC9>3.0.CO;2-0; Pommier Y, 2004, ONCOGENE, V23, P2934, DOI 10.1038/sj.onc.1207515; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Robert N, 2006, J CLIN ONCOL, V24, P2786, DOI 10.1200/JCO.2005.04.1764; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SEIBERT K, 1983, CANCER RES, V43, P2223; SHOYAB M, 1988, P NATL ACAD SCI USA, V85, P6528, DOI 10.1073/pnas.85.17.6528; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Silvy M, 2001, BRIT J CANCER, V84, P936, DOI 10.1054/bjoc.2000.1678; TAKAHARA PM, 1995, NATURE, V377, P649, DOI 10.1038/377649a0; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Wang SL, 2006, CANCER RES, V66, P6982, DOI 10.1158/0008-5472.CAN-06-0511; Willmarth NE, 2006, J BIOL CHEM, V281, P37728, DOI 10.1074/jbc.M606532200; Winograd-Katz SE, 2006, ONCOGENE, V25, P7381, DOI 10.1038/sj.onc.1209737; Wong L, 1999, J BIOL CHEM, V274, P8900, DOI 10.1074/jbc.274.13.8900; Wu YL, 2001, ONCOGENE, V20, P240, DOI 10.1038/sj.onc.1204067; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yoeli-Lerner M, 2006, CELL CYCLE, V5, P603, DOI 10.4161/cc.5.6.2561; Zeng PY, 2005, CANCER BIOL THER, V4, P961, DOI 10.4161/cbt.4.9.1912; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	49	75	81	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					739	750		10.1074/jbc.M706287200	http://dx.doi.org/10.1074/jbc.M706287200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17942395	hybrid, Green Accepted			2022-12-25	WOS:000252128100012
J	Jurd, R; Thornton, C; Wang, J; Luong, K; Phamluong, K; Kharazia, V; Gibb, SL; Ron, D				Jurd, Rachel; Thornton, Claire; Wang, Jun; Luong, Ken; Phamluong, Khanhky; Kharazia, Viktor; Gibb, Stuart L.; Ron, Dorit			Mind bomb-2 is an E3 ligase that ubiquitinates the N-methyl-D-aspartate receptor NR2B subunit in a phosphorylation-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; NMDA-RECEPTOR; TYROSINE PHOSPHORYLATION; SCAFFOLDING PROTEIN; FYN-KINASE; DEGRADATION; ACTIVATION; TRAFFICKING; SENSITIVITY; PATHOPHYSIOLOGY	The N-methyl-D-aspartate receptor ( NMDAR) plays a critical role in synaptic plasticity. Post-translational modifications of NMDARs, such as phosphorylation, alter both the activity and trafficking properties of NMDARs. Ubiquitination is increasingly being recognized as another post-translational modification that can alter synaptic protein composition and function. We identified Mind bomb-2 as an E3 ubiquitin ligase that interacts with and ubiquitinates the NR2B subunit of the NMDAR in mammalian cells. The protein-protein interaction and the ubiquitination of the NR2B subunit were found to be enhanced in a Fyn phosphorylation-dependent manner. Immunocytochemical studies reveal that Mind bomb-2 is localized to postsynaptic sites and colocalizes with the NMDAR in apical dendrites of hippocampal neurons. Furthermore, we show that NMDAR activity is down-regulated by Mind bomb-2. These results identify a specific E3 ubiquitin ligase as a novel interactant with the NR2B subunit and suggest a possible mechanism for the regulation of NMDAR function involving both phosphorylation and ubiquitination.	[Jurd, Rachel; Thornton, Claire; Wang, Jun; Luong, Ken; Phamluong, Khanhky; Kharazia, Viktor; Gibb, Stuart L.; Ron, Dorit] Univ Calif San Francisco, Gallo Res Ctr, Emeryville, CA 94608 USA	University of California System; University of California San Francisco	Ron, D (corresponding author), Gallo Res Ctr, 5858 Horton St,Suite 200, Emeryville, CA 94608 USA.	dorit.ron@ucsf.edu	Wang, Jun/M-2337-2016; Thornton, Claire/AAF-7481-2019; Wang, Jun/N-8472-2015	Wang, Jun/0000-0002-0085-4722; Thornton, Claire/0000-0001-7676-3272; Wang, Jun/0000-0002-0085-4722; Kharazia, Viktor/0000-0003-0642-6080	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013438] Funding Source: NIH RePORTER; NIAAA NIH HHS [R01 AA013438-01A1, R01 AA 013438-01A1, R01 AA013438] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Ashique AM, 2006, BRAIN RES, V1069, P31, DOI 10.1016/j.brainres.2005.11.018; Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Bradley J, 2006, J NEUROSCI, V26, P1065, DOI 10.1523/JNEUROSCI.3347-05.2006; Buttner C, 2001, J BIOL CHEM, V276, P42978, DOI 10.1074/jbc.M102121200; Chen WB, 2004, DEV BIOL, V267, P361, DOI 10.1016/j.ydbio.2003.11.010; Choe EA, 2007, J NEUROSCI, V27, P9503, DOI 10.1523/JNEUROSCI.1408-07.2007; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Coyle JT, 2003, ANN NY ACAD SCI, V1003, P318, DOI 10.1196/annals.1300.020; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dunah AW, 2001, J NEUROSCI, V21, P5546, DOI 10.1523/JNEUROSCI.21-15-05546.2001; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fallon L, 2002, J BIOL CHEM, V277, P486, DOI 10.1074/jbc.M109806200; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Fuller KJ, 1998, BIOTECHNIQUES, V25, P85, DOI 10.2144/98251st04; Gurd JW, 1997, J NEUROCHEM, V69, P623; Gutala R, 2004, ALCOHOL CLIN EXP RES, V28, P1779, DOI 10.1097/01.ALC.0000148117.17707.B4; Hallett PJ, 2006, J NEUROSCI, V26, P4690, DOI 10.1523/JNEUROSCI.0792-06.2006; Harrison SC, 2003, CELL, V112, P737, DOI 10.1016/S0092-8674(03)00196-X; HEGDE AN, 1993, P NATL ACAD SCI USA, V90, P7436, DOI 10.1073/pnas.90.16.7436; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Kassenbrock CK, 2002, J BIOL CHEM, V277, P24967, DOI 10.1074/jbc.M201026200; Kato A, 2005, P NATL ACAD SCI USA, V102, P5600, DOI 10.1073/pnas.0501769102; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Kohr G, 1996, J PHYSIOL-LONDON, V492, P445; Koo BK, 2005, J BIOL CHEM, V280, P22335, DOI 10.1074/jbc.M501631200; Lai EC, 2002, CURR BIOL, V12, pR74, DOI 10.1016/S0960-9822(01)00679-0; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Miyakawa T, 1997, SCIENCE, V278, P698, DOI 10.1126/science.278.5338.698; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Nakazawa T, 2006, EMBO J, V25, P2867, DOI 10.1038/sj.emboj.7601156; Pace MC, 2006, J CELL PHYSIOL, V209, P8, DOI 10.1002/jcp.20693; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Planells-Cases R, 2006, CURR PHARM DESIGN, V12, P3583, DOI 10.2174/138161206778522092; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Ron D, 2004, NEUROSCIENTIST, V10, P325, DOI 10.1177/1073858404263516; Rosenblum K, 1996, P NATL ACAD SCI USA, V93, P10457, DOI 10.1073/pnas.93.19.10457; Rostas JAP, 1996, P NATL ACAD SCI USA, V93, P10452, DOI 10.1073/pnas.93.19.10452; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SUZUKI T, 1995, BIOCHEM BIOPH RES CO, V216, P582, DOI 10.1006/bbrc.1995.2662; Takagi N, 2003, J NEUROCHEM, V84, P67, DOI 10.1046/j.1471-4159.2003.01500.x; Thornton C, 2004, J BIOL CHEM, V279, P31357, DOI 10.1074/jbc.M402316200; Thornton C, 2003, J BIOL CHEM, V278, P23823, DOI 10.1074/jbc.M302389200; Wang J, 2007, J NEUROSCI, V27, P3593, DOI 10.1523/JNEUROSCI.4749-06.2007; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Wechsler A, 1998, EMBO J, V17, P3931, DOI 10.1093/emboj/17.14.3931; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Wu HY, 2007, J BIOL CHEM, V282, P20075, DOI 10.1074/jbc.M700624200; Yaka R, 2003, J NEUROSCI, V23, P3623; Yaka R, 2003, J BIOL CHEM, V278, P9630, DOI 10.1074/jbc.M209141200; Yaka R, 2002, P NATL ACAD SCI USA, V99, P5710, DOI 10.1073/pnas.062046299; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4	59	60	62	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					301	310		10.1074/jbc.M705580200	http://dx.doi.org/10.1074/jbc.M705580200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17962190	Green Accepted, hybrid			2022-12-25	WOS:000251940300034
J	Kervinen, J; Abad, M; Crysler, C; Kolpak, M; Mahan, AD; Masucci, JA; Bayoumy, S; Cummings, MD; Yao, X; Olson, M; de Garavilla, L; Kuo, L; Deckman, I; Spurlino, J				Kervinen, Jukka; Abad, Marta; Crysler, Carl; Kolpak, Michael; Mahan, Andrew D.; Masucci, John A.; Bayoumy, Shariff; Cummings, Maxwell D.; Yao, Xiang; Olson, Matthew; de Garavilla, Lawrence; Kuo, Lawrence; Deckman, Ingrid; Spurlino, John			Structural basis for elastolytic substrate specificity in rodent alpha-chymases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAST-CELL CHYMASE; ANGSTROM CRYSTAL-STRUCTURE; HAMSTER-CHEEK POUCH; SERINE PROTEASES; MAMMALIAN EVOLUTION; ACTIVE-SITE; CATHEPSIN-G; INHIBITOR; CLONING; INFLAMMATION	Divergence of substrate specificity within the context of a common structural framework represents an important mechanism by which new enzyme activity naturally evolves. We present enzymological and x-ray structural data for hamster chymase-2 (HAM2) that provides a detailed explanation for the unusual hydrolytic specificity of this rodent alpha-chymase. In enzymatic characterization, hamster chymase-1 (HAM1) showed typical chymase proteolytic activity. In contrast, HAM2 exhibited atypical substrate specificity, cleaving on the carboxyl side of the P1 substrate residues Ala and Val, characteristic of elastolytic rather than chymotryptic specificity. The 2.5-angstrom resolution crystal structure of HAM2 complexed to the peptidyl inhibitor MeOSuc-Ala-Ala-Pro-Ala-chloromethylketone revealed a narrow and shallow S1 substrate binding pocket that accommodated only a small hydrophobic residue ( e. g. Ala or Val). The different substrate specificities of HAM2 and HAM1 are explained by changes in four S1 substrate site residues ( positions 189, 190, 216, and 226). Of these, Asn(189), Val(190), and Val(216) form an easily identifiable triplet in all known rodent alpha-chymases that can be used to predict elastolytic specificity for novel chymase-like sequences. Phylogenetic comparison defines guinea pig and rabbit chymases as the closest orthologs to rodent alpha-chymases.	[Kervinen, Jukka; Abad, Marta; Crysler, Carl; Kolpak, Michael; Bayoumy, Shariff; Cummings, Maxwell D.; Olson, Matthew; Kuo, Lawrence; Deckman, Ingrid; Spurlino, John] Johnson & Johnson Pharmaceut Res & Dev, Exton, PA 19341 USA; [Mahan, Andrew D.; Masucci, John A.; de Garavilla, Lawrence] Res & Early Dev, Spring House, PA 19477 USA; [Yao, Xiang] W Coast Res & Early Dev, San Diego, CA 92121 USA	Johnson & Johnson; Johnson & Johnson USA	Kervinen, J (corresponding author), 665 Stockton Dr, Exton, PA 19341 USA.	jkervine@prdus.jnj.com; jspurli1@prdus.jnj.com						Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andoh A, 2006, ONCOL REP, V16, P103; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Blank U, 2007, IMMUNOL REV, V217, P79, DOI 10.1111/j.1600-065X.2007.00503.x; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Caughey GH, 2000, BBA-PROTEIN STRUCT M, V1480, P245, DOI 10.1016/S0167-4838(00)00076-5; Caughey GH, 2002, MOL IMMUNOL, V38, P1353, DOI 10.1016/S0161-5890(02)00087-1; Chandrasekharan UM, 1996, SCIENCE, V271, P502, DOI 10.1126/science.271.5248.502; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; de Garavilla L, 2005, J BIOL CHEM, V280, P18001, DOI 10.1074/jbc.M501302200; DErchia AM, 1996, NATURE, V381, P597, DOI 10.1038/381597a0; Gallwitz M, 2006, IMMUNOGENETICS, V58, P655, DOI 10.1007/s00251-006-0126-1; Gallwitz M, 2006, IMMUNOGENETICS, V58, P641, DOI 10.1007/s00251-006-0123-4; Greco MN, 2007, J MED CHEM, V50, P1727, DOI 10.1021/jm0700619; HEDSTROM L, 1992, SCIENCE, V255, P1249, DOI 10.1126/science.1546324; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hof P, 1996, EMBO J, V15, P5481, DOI 10.1002/j.1460-2075.1996.tb00933.x; IDE H, 1995, BIOCHEM J, V311, P675, DOI 10.1042/bj3110675; Itoh H, 1996, BIOCHEM J, V314, P923, DOI 10.1042/bj3140923; Karlson U, 2003, J BIOL CHEM, V278, P39625, DOI 10.1074/jbc.M301512200; Kovanen PT, 2007, IMMUNOL REV, V217, P105, DOI 10.1111/j.1600-065X.2007.00515.x; Krem MM, 2000, TRENDS CARDIOVAS MED, V10, P171, DOI 10.1016/S1050-1738(00)00068-2; Kunori Y, 2002, EUR J BIOCHEM, V269, P5921, DOI 10.1046/j.1432-1033.2002.03316.x; McAleese SM, 1998, BIOCHEM J, V333, P801, DOI 10.1042/bj3330801; MCNEIL HP, 1991, J BIOL CHEM, V266, P20316; Miyazaki M, 2006, PHARMACOL THERAPEUT, V112, P668, DOI 10.1016/j.pharmthera.2006.05.008; Muramatsu M, 2002, BRIT J PHARMACOL, V137, P554, DOI 10.1038/sj.bjp.0704893; Orito K, 2004, TOHOKU J EXP MED, V203, P287, DOI 10.1620/tjem.203.287; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pereira PJB, 1999, J MOL BIOL, V286, P163, DOI 10.1006/jmbi.1998.2462; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; POWERS JC, 1989, J CELL BIOCHEM, V39, P33, DOI 10.1002/jcb.240390105; RAWLINGS ND, 2004, HDB PROTEOLYTIC ENZY, P1417; Sakaguchi M, 2004, EUR J PHARMACOL, V493, P173, DOI 10.1016/j.ejphar.2004.04.024; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Shimizu M, 2006, J VET MED SCI, V68, P271, DOI 10.1292/jvms.68.271; Shiota N, 1997, J HYPERTENS, V15, P431, DOI 10.1097/00004872-199715040-00014; Shiota N, 1998, BIOCHEM J, V333, P417, DOI 10.1042/bj3330417; Sichler K, 2002, FEBS LETT, V530, P220, DOI 10.1016/S0014-5793(02)03495-6; Solivan S, 2002, FEBS LETT, V512, P133, DOI 10.1016/S0014-5793(02)02242-1; Takai S, 1996, LIFE SCI, V58, P591, DOI 10.1016/0024-3205(95)02328-3; Takao K, 2001, BBA-PROTEIN STRUCT M, V1545, P146, DOI 10.1016/S0167-4838(00)00272-7; Tchougounova E, 2003, J EXP MED, V198, P423, DOI 10.1084/jem.20030671; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WANG DC, 1985, J MOL BIOL, V185, P595, DOI 10.1016/0022-2836(85)90074-9; Wang ZM, 1998, BIOL CHEM, V379, P167, DOI 10.1515/bchm.1998.379.2.167; Wernersson S, 2006, DEV COMP IMMUNOL, V30, P901, DOI 10.1016/j.dci.2005.10.014; Wouters MA, 2003, MOL CELL, V12, P343, DOI 10.1016/S1097-2765(03)00308-3	51	17	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					427	436		10.1074/jbc.M707157200	http://dx.doi.org/10.1074/jbc.M707157200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17981788	hybrid			2022-12-25	WOS:000251940300047
J	Li, W; Wang, R; Li, M; Li, L; Wang, C; Welti, R; Wang, X				Li, Weiqi; Wang, Ruiping; Li, Maoyin; Li, Lixia; Wang, Chuanming; Welti, Ruth; Wang, Xuemin			Differential degradation of extraplastidic and plastidic lipids during freezing and post-freezing recovery in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE D-ALPHA; COLD-ACCLIMATION; SENESCENCE; TOLERANCE; PLANTS; GENES; DELTA; ACID	Changes in membrane lipid composition play important roles in plant adaptation to and survival after freezing. Plant response to cold and freezing involves three distinct phases: cold acclimation, freezing, and post-freezing recovery. Considerable progress has been made toward understanding lipid changes during cold acclimation and freezing, but little is known about lipid alteration during post-freezing recovery. We previously showed that phospholipase D (PLD) is involved in lipid hydrolysis and Arabidopsis thaliana freezing tolerance. This study was undertaken to determine how lipid species change during post-freezing recovery and to determine the effect of two PLDs, PLD alpha 1 and PLD delta, on lipid changes during post-freezing recovery. During post-freezing recovery, hydrolysis of plastidic lipids, monogalactosyldiacylglycerol and plastidic phosphatidylglycerol, is the most prominent change. In contrast, during freezing, hydrolysis of extraplastidic phospholipids, phosphatidylcholine and phosphatidylethanolamine, occurs. Suppression of PLD alpha 1 decreased phospholipid hydrolysis and phosphatidic acid production in both the freezing and post-freezing phases, whereas ablation of PLD delta increased lipid hydrolysis and phosphatidic acid production during post-freezing recovery. Thus, distinctly different changes in lipid hydrolysis occur in freezing and post-freezing recovery. The presence of PLD alpha 1 correlates with phospholipid hydrolysis in both freezing and post-freezing phases, whereas the presence of PLD delta correlates with reduced lipid hydrolysis during post-freezing recovery. These data suggest a negative role for PLD alpha 1 and a positive role for PLD delta in freezing tolerance.	[Li, Weiqi; Wang, Ruiping; Li, Lixia] Chinese Acad Sci, Kunming Inst Bot, Kunming 650204, Peoples R China; [Li, Maoyin; Wang, Xuemin] Univ Missouri, Donald Danforth Plant Sci Ctr, Dept Biol, St Louis, MO 63121 USA; [Wang, Chuanming] Honghe Univ, Dept Biol, Yunnan 661100, Peoples R China; [Welti, Ruth] Kansas State Univ, Kansas Lipidom Res Ctr, Div Biol, Manhattan, KS 66506 USA	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Donald Danforth Plant Science Center; University of Missouri System; University of Missouri Saint Louis; Honghe University; Kansas State University	Li, W (corresponding author), Chinese Acad Sci, Kunming Inst Bot, 132 Lanhei Rd, Kunming 650204, Peoples R China.	weiqili@mail.kib.ac.cn	Wang, Xuemin/M-2853-2013	Welti, Ruth/0000-0003-4373-2538; wang, xuemin/0000-0002-6251-6745; Li, Maoyin/0000-0002-9976-1349; Wang, chuanming/0000-0002-7942-0352	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR 016475] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abdrakhamanova A, 2003, PLANT CELL PHYSIOL, V44, P676, DOI 10.1093/pcp/pcg097; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; Dhonukshe P, 2003, PLANT CELL, V15, P2666, DOI 10.1105/tpc.014977; Fan L, 1997, PLANT CELL, V9, P2183, DOI 10.1105/tpc.9.12.2183; Gardiner JC, 2001, PLANT CELL, V13, P2143, DOI 10.1105/tpc.13.9.2143; Hsu FF, 2007, J AM SOC MASS SPECTR, V18, P783, DOI 10.1016/j.jasms.2006.12.012; LEVITT J, 1980, RESPONSES PLANTS ENV, V1, P254; Li WQ, 2004, NAT BIOTECHNOL, V22, P427, DOI 10.1038/nbt949; Marechal E, 1997, PHYSIOL PLANTARUM, V100, P65, DOI 10.1034/j.1399-3054.1997.1000106.x; Pappan K, 1998, ARCH BIOCHEM BIOPHYS, V353, P131, DOI 10.1006/abbi.1998.0640; Qin CB, 2002, PLANT PHYSIOL, V128, P1057, DOI 10.1104/pp.010928; Ryu SB, 1997, P NATL ACAD SCI USA, V94, P12717, DOI 10.1073/pnas.94.23.12717; SAKAI A, 1987, FROST SURVIVAL PLANT, P41; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; SOMERVILLE C, 1995, P NATL ACAD SCI USA, V92, P6215, DOI 10.1073/pnas.92.14.6215; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; UEMURA M, 1995, PLANT PHYSIOL, V109, P15, DOI 10.1104/pp.109.1.15; Wang XM, 2004, CURR OPIN PLANT BIOL, V7, P329, DOI 10.1016/j.pbi.2004.03.012; Wang XM, 2000, PROG LIPID RES, V39, P109, DOI 10.1016/S0163-7827(00)00002-3; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Xu CC, 2002, PLANT PHYSIOL, V129, P594, DOI 10.1104/pp.002725; Zhang WH, 2003, PLANT CELL, V15, P2285, DOI 10.1105/tpc.013961	24	113	133	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					461	468		10.1074/jbc.M706692200	http://dx.doi.org/10.1074/jbc.M706692200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17962199	Green Published, hybrid			2022-12-25	WOS:000251940300051
J	Liu, S; Wang, H; Currie, BM; Molinolo, A; Leung, HJ; Moayeri, M; Basile, JR; Alfano, RW; Gutkind, JS; Frankel, AE; Bugge, TH; Leppla, SH				Liu, Shihui; Wang, Hailun; Currie, Brooke M.; Molinolo, Alfredo; Leung, Howard J.; Moayeri, Mahtab; Basile, John R.; Alfano, Randall W.; Gutkind, J. Silvio; Frankel, Arthur E.; Bugge, Thomas H.; Leppla, Stephen H.			Matrix metalloproteinase-activated anthrax lethal toxin demonstrates high potency in targeting tumor vasculature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-KINASE; MELANOMA-CELLS; SUSCEPTIBILITY; ANGIOGENESIS; INACTIVATION; SENSITIVITY; DIPHTHAMIDE; MUTATIONS; MICE	Anthrax lethal toxin ( LT), a virulence factor secreted by Bacillus anthracis, is selectively toxic to human melanomas with the BRAF V600E activating mutation because of its proteolytic activities toward the mitogen-activated protein kinase kinases (MEKs). To develop LT variants with lower in vivo toxicity and high tumor specificity, and therefore greater potential for clinical use, we generated a mutated LT that requires activation by matrix metalloproteinases (MMPs). This engineered toxin was less toxic than wild-type LT to mice because of the limited expression of MMPs by normal cells. Moreover, the systemically administered toxin produced greater anti-tumor effects than wild-type LT toward human xenografted tumors. This was shown to result from its greater bioavailability, a consequence of the limited uptake and clearance of the modified toxin by normal cells. Furthermore, the MMP-activated LT had very potent anti-tumor activity not only to human melanomas containing the BRAF mutation but also to other tumor types, including lung and colon carcinomas regardless of their BRAF status. Tumor histology and in vivo angiogenesis assays showed that this antitumor activity is due largely to the indirect targeting of tumor vasculature and angiogenic processes. Thus, even tumors genetically deficient in anthrax toxin receptors were still susceptible to the toxin therapy in vivo. Moreover, the modified toxin also displayed lower immunogenicity compared with the wild-type toxin. All these properties suggest that this MMP-activated antitumor toxin has potential for use in cancer therapy.	[Currie, Brooke M.; Molinolo, Alfredo; Basile, John R.; Gutkind, J. Silvio; Bugge, Thomas H.] NIH, NIDCR, Oral & Pharyngeal Canc Branch, Bethesda, MD 20892 USA; [Liu, Shihui; Wang, Hailun; Leung, Howard J.; Moayeri, Mahtab; Leppla, Stephen H.] NIH, NIAID, Lab Bacterial Dis, Bethesda, MD 20892 USA; [Alfano, Randall W.; Frankel, Arthur E.] Scott & White Mem Hosp & Clin, Canc Res Inst, Temple, TX 76502 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Bugge, TH (corresponding author), NIH, NIDCR, Oral & Pharyngeal Canc Branch, Bldg 10, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov; sleppla@niaid.nih.gov	Gutkind, J. Silvio/A-1053-2009; Gutkind, J. Silvio/J-1201-2016	Gutkind, J. Silvio/0000-0002-5150-4482; Moayeri, Mahtab/0000-0002-4448-8883; Liu, Shihui/0000-0003-3444-1069	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000551, Z01DE000699] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AI000929-05] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abi-Habib RJ, 2006, CLIN CANCER RES, V12, P7437, DOI 10.1158/1078-0432.CCR-06-2019; Abi-Habib RJ, 2005, MOL CANCER THER, V4, P1303, DOI 10.1158/1535-7163.MCT-05-0145; Baldari CT, 2006, TRENDS IMMUNOL, V27, P434, DOI 10.1016/j.it.2006.07.002; Batty S, 2006, CELL MICROBIOL, V8, P130, DOI 10.1111/j.1462-5822.2005.00606.x; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; Guedez L, 2003, AM J PATHOL, V162, P1431, DOI 10.1016/S0002-9440(10)64276-9; Koo HM, 2002, P NATL ACAD SCI USA, V99, P3052, DOI 10.1073/pnas.052707699; LEPPLA SH, 2006, COMPREHENSIVE SOURCE, P323; Liu SH, 2000, CANCER RES, V60, P6061; Liu SH, 2005, NAT BIOTECHNOL, V23, P725, DOI 10.1038/nbt1091; Liu SH, 2004, MOL CELL BIOL, V24, P9487, DOI 10.1128/MCB.24.21.9487-9497.2004; Liu SH, 2003, MOL CELL, V12, P603, DOI 10.1016/j.molcel.2003.08.003; Liu SH, 2003, EXPERT OPIN BIOL TH, V3, P843, DOI 10.1517/14712598.3.5.843; Liu SH, 2003, J BIOL CHEM, V278, P5227, DOI 10.1074/jbc.M210321200; Liu SH, 2003, P NATL ACAD SCI USA, V100, P657, DOI 10.1073/pnas.0236849100; Liu SH, 2001, J BIOL CHEM, V276, P17976, DOI 10.1074/jbc.M011085200; Liu SH, 2007, CELL MICROBIOL, V9, P977, DOI 10.1111/j.1462-5822.2006.00845.x; Mizukami Y, 2005, NAT MED, V11, P992, DOI 10.1038/nm1294; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Moayeri M, 2007, INFECT IMMUN, V75, P5175, DOI 10.1128/IAI.00719-07; Mogridge J, 2002, P NATL ACAD SCI USA, V99, P7045, DOI 10.1073/pnas.052160199; Olsen E, 2001, J CLIN ONCOL, V19, P376, DOI 10.1200/JCO.2001.19.2.376; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Zeng QH, 2005, CANCER CELL, V8, P13, DOI 10.1016/j.ccr.2005.06.004	40	68	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					529	540		10.1074/jbc.M707419200	http://dx.doi.org/10.1074/jbc.M707419200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17974567	hybrid, Green Accepted			2022-12-25	WOS:000251940300058
J	Meske, V; Albert, F; Ohm, TG				Meske, Volker; Albert, Frank; Ohm, Thomas Georg			Coupling of mammalian target of rapamycin with phosphoinositide 3-kinase signaling pathway regulates protein phosphatase 2A- and glycogen synthase kinase-3 beta-dependent phosphorylation of Tau	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; PROTEIN PHOSPHATASE 2A; GLYCOGEN-SYNTHASE KINASE-3-BETA; GROWTH-FACTOR-I; ALZHEIMERS-DISEASE; DIABETES-MELLITUS; CELL-GROWTH; RAT-BRAIN; KINASE; INSULIN	Tau is an important microtubule-stabilizing protein in neurons. In its hyperphosphorylated form, Tau protein loses its ability to bind to microtubules and then accumulates and is part of pathological lesions characterizing tauopathies, e. g. Alzheimer disease. Glycogen synthase kinase-3 beta (GSK-3 beta), antagonized by protein phosphatase 2A (PP2A), regulates Tau phosphorylation at many sites. Diabetes mellitus is linked to an increased risk of developing Alzheimer disease. This could be partially caused by dysregulated GSK-3 beta. In a long term experiment (-16 h) using primary murine neuron cultures, we interfered in the insulin/phosphoinositide3-kinase (PI3K) (LY294002 treatment and insulin boost) and mammalian target of rapamycin (mTor) (AICAR and rapamycin treatment) signaling pathways and examined consequent changes in the activities of PP2A, GSK-3 beta, and Tau phosphorylation. We found that the coupling of PI3K with mTor signaling, in conjunction with a regulatory interaction between PP2A and SK-3 beta, changed activities of both enzymes always in the same direction. These balanced responses seem to ensure the steady Tau phosphorylation at GSK/PP2A-dependent sites observed over a long period of time (>= 6 h). This may help in preventing severe changes in Tau phosphorylation under conditions when neurons undergo transient fluctuations either in insulin or nutrient supply. On the other hand, the investigation of Tau protein at Ser-262 showed that interference in the insulin/PI3K and mTor signaling potentially influenced the Tau phosphorylation status at sites where only one of two enzymes (in this case PP2A) is involved in the regulation.	[Meske, Volker; Albert, Frank; Ohm, Thomas Georg] Inst Integrat Neuroanat, Ctr Anat, Dept Clin Cell & Neurobiol, D-10098 Berlin, Germany		Meske, V (corresponding author), Inst Integrat Neuroanat, Ctr Anat, Dept Clin Cell & Neurobiol, Charite Platz 1, D-10098 Berlin, Germany.	V.Meske@gmx.de						AGOSTINIS P, 1992, EUR J BIOCHEM, V205, P241, DOI 10.1111/j.1432-1033.1992.tb16774.x; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Berg CE, 2002, BIOCHEM BIOPH RES CO, V293, P1021, DOI 10.1016/S0006-291X(02)00333-9; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Bishop JD, 2006, J ENDOCRINOL, V190, P307, DOI 10.1677/joe.1.06368; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Carling D, 2004, CURR BIOL, V14, pR220, DOI 10.1016/j.cub.2004.02.048; CEGIELSKA A, 1994, MOL CELL BIOL, V14, P4616, DOI 10.1128/MCB.14.7.4616; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Clodfelder-Miller BJ, 2006, DIABETES, V55, P3320, DOI 10.2337/db06-0485; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; DREWES G, 1993, FEBS LETT, V336, P425, DOI 10.1016/0014-5793(93)80850-T; FLEMING LM, 1995, BIOCHEM J, V309, P41, DOI 10.1042/bj3090041; Freude S, 2005, DIABETES, V54, P3343, DOI 10.2337/diabetes.54.12.3343; GARVER TD, 1994, J NEUROCHEM, V63, P2279; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hartley D, 2002, J CELL BIOCHEM, V85, P304, DOI 10.1002/jcb.10135; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hong M, 1997, J BIOL CHEM, V272, P19547, DOI 10.1074/jbc.272.31.19547; IMAOKA T, 1983, J BIOL CHEM, V258, P1526; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; IQBAL K, 1994, FEBS LETT, V349, P104, DOI 10.1016/0014-5793(94)00650-4; ISHIGURO K, 1992, J BIOL CHEM, V267, P10897; Jamsa A, 2004, BIOCHEM BIOPH RES CO, V319, P993, DOI 10.1016/j.bbrc.2004.05.075; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; King TD, 2006, BIOCHEM PHARMACOL, V71, P1637, DOI 10.1016/j.bcp.2006.03.005; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Lee YI, 2005, J BIOL CHEM, V280, P22044, DOI 10.1074/jbc.M413987200; Leibson C L, 1997, Ann N Y Acad Sci, V826, P422, DOI 10.1111/j.1749-6632.1997.tb48496.x; Lesort M, 1999, J NEUROCHEM, V72, P576, DOI 10.1046/j.1471-4159.1999.0720576.x; Lesort M, 2000, NEUROSCIENCE, V99, P305, DOI 10.1016/S0306-4522(00)00200-1; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Lovestone S, 1999, BIOL PSYCHIAT, V45, P995, DOI 10.1016/S0006-3223(98)00183-8; MANDELKOW EM, 1992, FEBS LETT, V314, P315, DOI 10.1016/0014-5793(92)81496-9; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; MAYERJAEKEL RE, 1994, J CELL SCI, V107, P2609; MUMBY MC, 1987, J BIOL CHEM, V262, P6257; MunozMontano JR, 1997, FEBS LETT, V411, P183, DOI 10.1016/S0014-5793(97)00688-1; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Nanahoshi M, 1998, BIOCHEM BIOPH RES CO, V251, P520, DOI 10.1006/bbrc.1998.9493; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Ott A, 1996, DIABETOLOGIA, V39, P1392, DOI 10.1007/s001250050588; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Planel E, 2004, J NEUROSCI, V24, P2401, DOI 10.1523/JNEUROSCI.5561-03.2004; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; Sengupta A, 2006, NEUROCHEM RES, V31, P1473, DOI 10.1007/s11064-006-9205-9; Shi YJ, 2005, MOL CANCER THER, V4, P1533, DOI 10.1158/1535-7163.MCT-05-0068; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Tian Q, 2002, NEUROSIGNALS, V11, P262, DOI 10.1159/000067425; Tremblay F, 2005, ENDOCRINOLOGY, V146, P1328, DOI 10.1210/en.2004-0777; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; YOSHIDA H, 1993, J NEUROCHEM, V61, P1183, DOI 10.1111/j.1471-4159.1993.tb03642.x	60	76	80	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					100	109		10.1074/jbc.M704292200	http://dx.doi.org/10.1074/jbc.M704292200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17971449	hybrid			2022-12-25	WOS:000251940300012
J	Mohri-Shiomi, A; Garsin, DA				Mohri-Shiomi, Akiko; Garsin, Danielle A.			Insulin signaling and the heat shock response modulate protein homeostasis in the Caenorhabditis elegans intestine during infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-ELEGANS; MODEL HOST; LIFE-SPAN; PATHOGENESIS; AGGREGATION; DAF-16; INTERFERENCE; EXPRESSION; LONGEVITY; GENETICS	During infection, damage can occur to the host as an outcome of both pathogen virulence mechanisms and host defense strategies. Using aggregation of a model polyglutamine-containing protein as an indicator in Caenorhabditis elegans, we show that protein damage occurs specifically at the site of the host-pathogen interaction, the intestine, in response to various bacterial pathogens. We demonstrate that the insulin signaling pathway and the heat shock transcription factor (HSF-1) influence the amount of aggregation that occurs, in addition to heat shock proteins and oxidative stress enzymes. We also show that addition of the antioxidants epigallocatechin gallate and alpha-lipoic acid reduces polyglutamine aggregation. The influence of oxidative stress enzymes and exogenous antioxidants on protein aggregation suggests that reactive oxygen species produced by the host are a source of protein damage during infection. We propose a model in which heat shock proteins and oxidative stress enzymes regulated by insulin signaling and HSF-1 are required for tissue protection during infection, to minimize the effects of protein damage occurring as a result of host-pathogen interactions.	[Mohri-Shiomi, Akiko; Garsin, Danielle A.] Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Garsin, DA (corresponding author), 6431 Fannin St,MSB 1, Houston, TX 77030 USA.	Danielle.A.Garsin@uth.tmc.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076406] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI076406] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; BRENNER S, 1974, GENETICS, V77, P71; Brignull HR, 2007, ADV EXP MED BIOL, V594, P167; Brignull HR, 2006, METHOD ENZYMOL, V412, P256, DOI 10.1016/S0076-6879(06)12016-9; Brown MK, 2006, PHARMACOL BIOCHEM BE, V85, P620, DOI 10.1016/j.pbb.2006.10.017; Buchner J, 1996, FASEB J, V10, P10, DOI 10.1096/fasebj.10.1.8566529; Chavez V, 2007, GENETICS, V176, P1567, DOI 10.1534/genetics.107.072587; DUNNY GM, 1978, P NATL ACAD SCI USA, V75, P3479, DOI 10.1073/pnas.75.7.3479; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Garigan D, 2002, GENETICS, V161, P1101; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; HOPE IA, 1999, C ELEGANS PRACTICAL, P51; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Iandolo JJ, 2000, GRAM-POSITIVE PATHOGENS, P317; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kelly WG, 1997, GENETICS, V146, P227; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KRAMER JM, 1990, MOL CELL BIOL, V10, P2081, DOI 10.1128/MCB.10.5.2081; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nelson DW, 2003, GENE DEV, V17, P813, DOI 10.1101/gad.1090203; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Sakahira H, 2002, P NATL ACAD SCI USA, V99, P16412, DOI 10.1073/pnas.182426899; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; Wang JJ, 2002, DEVELOPMENT, V129, P4989; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	45	78	98	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					194	201		10.1074/jbc.M707956200	http://dx.doi.org/10.1074/jbc.M707956200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17951251	hybrid			2022-12-25	WOS:000251940300022
J	Yun, S; Hong, WP; Choi, JH; Yi, KS; Chae, SK; Ryu, SH; Suh, PG				Yun, Sanguk; Hong, Won-Pyo; Choi, Jang Hyun; Yi, Kye Sook; Chae, Suhn-Kee; Ryu, Sung Ho; Suh, Pann-Ghill			Phospholipase C-epsilon augments epidermal growth factor-dependent cell growth by inhibiting epidermal growth factor receptor down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN; RAS; AP-2; TRAFFICKING; ENDOCYTOSIS; EXPRESSION; EFFECTOR; ADAPTERS; SUBUNIT; DOMAINS	The down-regulation of the epidermal growth factor (EGF) receptor is critical for the termination of EGF-dependent signaling, and the dysregulation of this process can lead to oncogenesis. In the present study, we suggest a novel mechanism for the regulation of EGF receptor down-regulation by phospholipase C-epsilon. The overexpression of PLC-epsilon led to an increase in receptor recycling and decreased the down-regulation of the EGF receptor in COS-7 cells. Adaptor protein complex 2 (AP2) was identified as a novel binding protein that associates with the PLC-epsilon RA2 domain independently of Ras. The interaction of PLC-epsilon with AP2 was responsible for the suppression of EGF receptor down-regulation, since a perturbation in this interaction abolished this effect. Enhanced EGF receptor stability by PLC-epsilon led to the potentiation of EGF-dependent growth in COS-7 cells. Finally, the knockdown of PLC-epsilon in mouse embryo fibroblast cells elicited a severe defect in EGF-dependent growth. Our results indicated that PLC-epsilon could promote EGF-dependent cell growth by suppressing receptor down-regulation.	[Yun, Sanguk; Hong, Won-Pyo; Choi, Jang Hyun; Yi, Kye Sook; Ryu, Sung Ho; Suh, Pann-Ghill] Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Pohang 790784, South Korea; [Chae, Suhn-Kee] Paichai Univ, Ctr Biomed Res, Dept Biochem, Taejon 302735, South Korea	Pohang University of Science & Technology (POSTECH); Pai Chai University	Suh, PG (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Pohang 790784, South Korea.	pgs@postech.ac.kr	Suh, Pann-Ghill/F-3610-2010; Choi, Jang Hyun/B-3055-2012	Ryu, Sung Ho/0000-0003-0913-3048				Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; BECK KA, 1992, J CELL BIOL, V119, P787, DOI 10.1083/jcb.119.4.787; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Choi JH, 2004, J CELL SCI, V117, P3785, DOI 10.1242/jcs.01220; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Del Valle JM, 2003, J BIOL CHEM, V278, P17430, DOI 10.1074/jbc.M301569200; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; GALLUSSER A, 1993, EMBO J, V12, P5237, DOI 10.1002/j.1460-2075.1993.tb06219.x; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GOODMAN OB, 1995, J BIOL CHEM, V270, P23768, DOI 10.1074/jbc.270.40.23768; Huang FT, 2003, J BIOL CHEM, V278, P43411, DOI 10.1074/jbc.M306072200; Jin TG, 2001, J BIOL CHEM, V276, P30301, DOI 10.1074/jbc.M103530200; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kelley GG, 2006, J BIOL CHEM, V281, P2639, DOI 10.1074/jbc.M507681200; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; LEGENDREGUILLEM.V, 2002, J BIOL CHEM, V277, P28212; Li LM, 1996, CELL, V85, P319, DOI 10.1016/S0092-8674(00)81111-3; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; Matsuda M, 2001, J CELL BIOL, V153, P599, DOI 10.1083/jcb.153.3.599; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Palmieri D, 2006, BREAST CANCER RES TR, V100, P127, DOI 10.1007/s10549-006-9244-6; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P422, DOI 10.1016/S0968-0004(96)30038-8; Rao DS, 2003, CANCER CELL, V3, P471, DOI 10.1016/S1535-6108(03)00107-7; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; ROBINSON MS, 1994, CURR OPIN CELL BIOL, V6, P538, DOI 10.1016/0955-0674(94)90074-4; Shibatohge M, 1998, J BIOL CHEM, V273, P6218, DOI 10.1074/jbc.273.11.6218; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Song CH, 2002, ONCOGENE, V21, P8105, DOI 10.1038/sj.onc.1206003; Sorkina T, 1999, J CELL SCI, V112, P317; Sorli SC, 2005, ONCOGENE, V24, P90, DOI 10.1038/sj.onc.1208168; Tran DD, 2003, DEV CELL, V5, P245, DOI 10.1016/S1534-5807(03)00207-7	37	10	11	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					341	349		10.1074/jbc.M704180200	http://dx.doi.org/10.1074/jbc.M704180200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17956867	hybrid			2022-12-25	WOS:000251940300038
J	Butterworth, MB; Edinger, RS; Ovaa, H; Burg, D; Johnson, JP; Frizzell, RA				Butterworth, Michael B.; Edinger, Robert S.; Ovaa, Huib; Burg, Danny; Johnson, John P.; Frizzell, Raymond A.			The deubiquitinating enzyme UCH-L3 regulates the apical membrane recycling of the epithelial sodium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; CARBOXYL-TERMINAL HYDROLASE; UBIQUITIN-LIKE PROTEINS; SITE-DIRECTED PROBES; NA+ CHANNEL; CELL-SURFACE; SUBSTRATE-SPECIFICITY; PY MOTIF; ENAC; TRAFFICKING	The epithelial sodium channel ( ENaC) is ubiquitinated by the E3 ligase Nedd4-2 at the apical membranes of polarized cortical collecting duct (CCD) epithelial cells. This leads to ENaC endocytosis and possible degradation. Because ENaC is known to recycle at the apical membranes of CCD cells, deubiquitinating enzymes (DUBs) are likely involved in regulating ENaC surface density by facilitating ENaC recycling as opposed to degradation. Using a chemical probe approach to tag active DUBs, we identified ubiquitin C-terminal hydrolase (UCH) isoform L3 as the predominant DUB in endosomal compartments of CCD cells. Blocking UCH-L3 activity or reducing its expression by selective knockdown increased ENaC ubiquitination and resulted in its removal from the apical membranes of CCD cells. Functionally this caused a rapid reduction in transepithelial Na+ currents across the CCD epithelia. Surface biotinylation demonstrated the loss of ENaC from the apical surface when UCH-L3 was inhibited. Whole cell or apical surface immuno-precipitation demonstrated increased ENaC ubiquitination with UCH-L3 inhibition. This constitutes a novel function for UCH in epithelia and in the regulation of ion channels and demonstrates the dynamic regulation of apically located ENaC by recycling, which is facilitated by this DUB.	[Butterworth, Michael B.; Frizzell, Raymond A.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Edinger, Robert S.; Johnson, John P.] Univ Pittsburgh, Sch Med, Div Renal & Electrolyte, Pittsburgh, PA 15261 USA; [Ovaa, Huib; Burg, Danny] Netherlands Canc Inst, Div Cellular Biochem, NL-1066 CX Amsterdam, Netherlands	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Netherlands Cancer Institute	Butterworth, MB (corresponding author), Univ Pittsburgh, Dept Cell Biol & Physiol, 537S BST,3500 Terrace St, Pittsburgh, PA 15261 USA.	michael7@pitt.edu	; ovaa, huib/M-2334-2016	Butterworth, Michael/0000-0002-2173-8333; ovaa, huib/0000-0002-0068-054X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057718, R01DK047874, R01DK054814] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK57718, DK47874, DK54814] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abriel H, 2005, PHYSIOLOGY, V20, P398, DOI 10.1152/physiol.00033.2005; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Butterworth MB, 2005, AM J PHYSIOL-RENAL, V289, pF969, DOI 10.1152/ajprenal.00390.2003; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Debonneville C, 2004, MOL CELL BIOL, V24, P2397, DOI 10.1128/MCB.24.6.2397-2409.2004; Fakitsas P, 2007, J AM SOC NEPHROL, V18, P1084, DOI 10.1681/ASN.2006080902; Gormley K, 2003, BIOCHEM J, V371, P1, DOI 10.1042/BJ20021375; Goulet CC, 1998, J BIOL CHEM, V273, P30012, DOI 10.1074/jbc.273.45.30012; Hanwell D, 2002, J BIOL CHEM, V277, P9772, DOI 10.1074/jbc.M110904200; Hemelaar J, 2004, J PROTEOME RES, V3, P268, DOI 10.1021/pr0341080; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Kurihara LJ, 2000, MOL CELL BIOL, V20, P2498, DOI 10.1128/MCB.20.7.2498-2504.2000; Kwon J, 2004, BIOL REPROD, V71, P515, DOI 10.1095/biolreprod.104.027565; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Liu YC, 2003, CHEM BIOL, V10, P837, DOI 10.1016/j.chembiol.2003.08.010; LOWE J, 1990, J PATHOL, V161, P153, DOI 10.1002/path.1711610210; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; Metzler M, 2001, J BIOL CHEM, V276, P39271, DOI 10.1074/jbc.C100401200; Millard SM, 2006, J CELL BIOL, V173, P463, DOI 10.1083/jcb.200602082; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Ovaa H, 2005, METHOD ENZYMOL, V399, P468, DOI 10.1016/S0076-6879(05)99032-0; Ovaa H, 2004, P NATL ACAD SCI USA, V101, P2253, DOI 10.1073/pnas.0308411100; Ovaa H, 2003, ANGEW CHEM INT EDIT, V42, P3626, DOI 10.1002/anie.200351314; Ovaa H, 2007, NAT REV CANCER, V7, P613, DOI 10.1038/nrc2128; Snyder PM, 2001, J BIOL CHEM, V276, P28321, DOI 10.1074/jbc.M011487200; Soboleva TA, 2004, CURR PROTEIN PEPT SC, V5, P191, DOI 10.2174/1389203043379765; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Staub O, 2000, KIDNEY INT, V57, P809, DOI 10.1046/j.1523-1755.2000.00919.x; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; Wiemuth D, 2007, BIOCHEM J, V405, P147, DOI 10.1042/BJ20060747; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	38	81	87	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37885	37893		10.1074/jbc.M707989200	http://dx.doi.org/10.1074/jbc.M707989200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17967898	hybrid			2022-12-25	WOS:000251833600064
J	Garmier, M; Priault, P; Vidal, G; Driscoll, S; Djebbar, R; Boccara, M; Mathieu, C; Foyer, CH; De Paepe, R				Garmier, Marie; Priault, Pierrick; Vidal, Guillaume; Driscoll, Simon; Djebbar, Reda; Boccara, Martine; Mathieu, Chantal; Foyer, Christine H.; De Paepe, Rosine			Light and oxygen are not required for harpin-induced cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED HYPERSENSITIVE RESPONSE; PHOTOSYNTHETIC ELECTRON-TRANSPORT; CHLOROPLAST ENVELOPE MEMBRANES; SYSTEMIC ACQUIRED-RESISTANCE; ERWINIA-AMYLOVORA HARPIN; REACTIVE OXYGEN; HYDROGEN-PEROXIDE; ALTERNATIVE OXIDASE; PLANT-MITOCHONDRIA; DISEASE RESISTANCE	Nicotiana sylvestris leaves challenged by the bacterial elicitor harpin N-Ea were used as a model system in which to determine the respective roles of light, oxygen, photosynthesis, and respiration in the programmed cell death response in plants. The appearance of cell death markers, such as membrane damage, nuclear fragmentation, and induction of the stress-responsive element Tnt1, was observed in all conditions. However, the cell death process was delayed in the dark compared with the light, despite a similar accumulation of superoxide and hydrogen peroxide in the chloroplasts. In contrast, harpin- induced cell death was accelerated under very low oxygen (<0.1% O-2) compared with air. Oxygen deprivation impaired accumulation of chloroplastic reactive oxygen species (ROS) and the induction of cytosolic antioxidant genes in both the light and the dark. It also attenuates the collapse of photosynthetic capacity and the respiratory burst driven by mitochondrial alternative oxidase activity observed in air. Since alternative oxidase is known to limit overreduction of the respiratory chain, these results strongly suggest that mitochondrial ROS accumulate in leaves elicited under low oxygen. We conclude that the harpin- induced cell death does not require ROS accumulation in the apoplast or in the chloroplasts but that mitochondrial ROS could be important in the orchestration of the cell suicide program.	[Garmier, Marie; Vidal, Guillaume; Mathieu, Chantal; De Paepe, Rosine] Univ Paris 11, CNRS, Inst Plant Biotechnol, UMR 8618, F-91405 Orsay, France; [Priault, Pierrick] Univ Paris 11, CNRS, UMR 8079, F-91405 Orsay, France; [Driscoll, Simon; Foyer, Christine H.] Newcastle Univ, Sch Agr, Agr Bldg, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Djebbar, Reda] Univ Sci & Technol Houari Boumedienne, Fac Biol Sci, Lab Physiol Vegetale, Algiers 16111, Algeria	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; Newcastle University - UK; University Science & Technology Houari Boumediene	De Paepe, R (corresponding author), Univ Paris 11, CNRS, Inst Plant Biotechnol, UMR 8618, Batiment 630, F-91405 Orsay, France.	rosine.de-paepe@u-psud.fr	Foyer, Christine/K-2143-2012; Pierrick, PRIAULT/ABE-6051-2021; mathieu, chantal/ABD-5505-2021; Djebbar, Réda/P-7720-2016; Priault, Pierrick/AAI-7273-2020	Pierrick, PRIAULT/0000-0002-7386-4198; mathieu, chantal/0000-0002-4055-5233; Djebbar, Réda/0000-0003-3166-3299; Foyer, Christine/0000-0001-5989-6989				Adam AL, 1997, PLANT PHYSIOL, V115, P853, DOI 10.1104/pp.115.2.853; Allen JF, 2001, TRENDS PLANT SCI, V6, P317, DOI 10.1016/S1360-1385(01)02010-6; Ameisen JC, 2002, CELL DEATH DIFFER, V9, P367, DOI 10.1038/sj.cdd.4400950; Andi S, 2001, PLANT CELL PHYSIOL, V42, P446, DOI 10.1093/pcp/pce056; Baek D, 2004, PLANT MOL BIOL, V56, P15, DOI 10.1007/s11103-004-3096-4; Bailey-Serres J, 2005, ANN BOT-LONDON, V96, P507, DOI 10.1093/aob/mci206; BAKER CJ, 1993, PLANT PHYSIOL, V102, P1341, DOI 10.1104/pp.102.4.1341; Basset G, 2002, PLANT PHYSIOL, V128, P1149, DOI 10.1104/pp.010612; Bechtold U, 2005, PLANT CELL ENVIRON, V28, P1046, DOI 10.1111/j.1365-3040.2005.01340.x; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Blokhina OB, 2001, J EXP BOT, V52, P1179, DOI 10.1093/jexbot/52.359.1179; Boccara M, 2001, PLANT J, V28, P663, DOI 10.1046/j.1365-313x.2001.01186.x; Boccara M, 2007, PLANT J, V50, P338, DOI 10.1111/j.1365-313X.2007.03051.x; Bolwell GP, 2002, J EXP BOT, V53, P1367, DOI 10.1093/jexbot/53.372.1367; Bonfig KB, 2006, PLANTA, V225, P1, DOI 10.1007/s00425-006-0303-3; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chew O, 2003, J BIOL CHEM, V278, P46869, DOI 10.1074/jbc.M307525200; Clifton R, 2006, BBA-BIOENERGETICS, V1757, P730, DOI 10.1016/j.bbabio.2006.03.009; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Curtis MJ, 2002, PLANT J, V29, P295, DOI 10.1046/j.0960-7412.2001.01213.x; Dat JF, 2003, PLANT J, V33, P621, DOI 10.1046/j.1365-313X.2003.01655.x; Dayakar BV, 2003, PLANT MOL BIOL, V51, P913, DOI 10.1023/A:1023061303755; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Dietrich P, 2001, J EXP BOT, V52, P1959, DOI 10.1093/jexbot/52.363.1959; Dong HS, 1999, PLANT J, V20, P207, DOI 10.1046/j.1365-313x.1999.00595.x; Draper J, 1997, TRENDS PLANT SCI, V2, P162, DOI 10.1016/S1360-1385(97)01030-3; Drew MC, 1997, ANNU REV PLANT PHYS, V48, P223, DOI 10.1146/annurev.arplant.48.1.223; Dutilleul C, 2003, PLANT CELL, V15, P1212, DOI 10.1105/tpc.009464; Dutilleul C, 2003, PLANT PHYSIOL, V131, P264, DOI 10.1104/pp.011155; Ferro M, 2003, MOL CELL PROTEOMICS, V2, P325, DOI 10.1074/mcp.M300030-MCP200; Foyer CH, 2000, NEW PHYTOL, V146, P359, DOI 10.1046/j.1469-8137.2000.00667.x; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Foyer CH, 2003, PHYSIOL PLANTARUM, V119, P355, DOI 10.1034/j.1399-3054.2003.00223.x; Garmier M, 2002, PLANT PHYSIOL BIOCH, V40, P561, DOI 10.1016/S0981-9428(02)01399-2; GARMIER M, 2003, THESIS U PARIS SUD 1; Gaudriault S, 1998, FEBS LETT, V428, P224, DOI 10.1016/S0014-5793(98)00534-1; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Hail N, 2006, APOPTOSIS, V11, P889, DOI 10.1007/s10495-006-6712-8; HE SY, 1994, MOL PLANT MICROBE IN, V7, P289, DOI 10.1094/MPMI-7-0289; HE SY, 1993, CELL, V73, P1255, DOI 10.1016/0092-8674(93)90354-S; Huang HE, 2007, MOL PLANT PATHOL, V8, P129, DOI 10.1111/J.1364-3703.2006.00378.X; Ichinose Y, 2001, PLANT PHYSIOL BIOCH, V39, P771, DOI 10.1016/S0981-9428(01)01300-6; Igamberdiev AU, 1998, PHYSIOL PLANTARUM, V104, P431, DOI 10.1034/j.1399-3054.1998.1040319.x; JagerVottero P, 1997, P NATL ACAD SCI USA, V94, P1597, DOI 10.1073/pnas.94.4.1597; JAKOBEK JL, 1993, PLANT CELL, V5, P49, DOI 10.1105/tpc.5.1.49; KAISER WM, 1979, PLANTA, V145, P377, DOI 10.1007/BF00388364; Karpinski S, 1997, PLANT CELL, V9, P627, DOI 10.1105/tpc.9.4.627; Karpinski S, 2003, CURR OPIN PLANT BIOL, V6, P390, DOI 10.1016/S1369-5266(03)00061-X; Kemp PJ, 2006, EXP PHYSIOL, V91, P829, DOI 10.1113/expphysiol.2006.034587; Krause M, 2004, MOL PLANT MICROBE IN, V17, P131, DOI 10.1094/MPMI.2004.17.2.131; Lam E, 2001, NATURE, V411, P848, DOI 10.1038/35081184; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lawlor DW, 2002, ANN BOT-LONDON, V89, P871, DOI 10.1093/aob/mcf110; LI YM, 1993, BIOCHEM PHARMACOL, V46, P1435, DOI 10.1016/0006-2952(93)90109-A; Liu YD, 2007, PLANT J, V51, P941, DOI 10.1111/j.1365-313X.2007.03191.x; Lu ZG, 2005, P NATL ACAD SCI USA, V102, P2778, DOI 10.1073/pnas.0405374102; Matsumura H, 2003, P NATL ACAD SCI USA, V100, P15718, DOI 10.1073/pnas.2536670100; MILLAR AH, 1994, PLANT PHYSIOL BIOCH, V32, P847; Mishina TE, 2007, PLANT J, V50, P500, DOI 10.1111/j.1365-313X.2007.03067.x; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; Oh CS, 2005, FEMS MICROBIOL LETT, V253, P185, DOI 10.1016/j.femsle.2005.09.051; Pike SM, 1998, PHYSIOL MOL PLANT P, V53, P39, DOI 10.1006/pmpp.1998.0167; Pitzschke A, 2006, PLANT PHYSIOL, V141, P351, DOI 10.1104/pp.106.079160; POUTEAU S, 1994, PLANT J, V5, P535, DOI 10.1046/j.1365-313X.1994.5040535.x; Purvis AC, 1997, PHYSIOL PLANTARUM, V100, P165, DOI 10.1034/j.1399-3054.1997.1000119.x; RIBAS-CARBO M, 1995, PLANT PHYSIOL, V109, P829, DOI 10.1104/pp.109.3.829; RIBAS-CARBO M, 1994, BBA-BIOENERGETICS, V1188, P205, DOI 10.1016/0005-2728(94)90037-X; Sagi M, 2001, PLANT PHYSIOL, V126, P1281, DOI 10.1104/pp.126.3.1281; Samuel MA, 2005, PLANT J, V42, P406, DOI 10.1111/j.1365-313X.2005.02382.x; Scharte J, 2005, PLANT CELL ENVIRON, V28, P1421, DOI 10.1111/j.1365-3040.2005.01380.x; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Shulaev V, 2006, PLANT PHYSIOL, V141, P367, DOI 10.1104/pp.106.077925; Simons BH, 1999, PLANT PHYSIOL, V120, P529, DOI 10.1104/pp.120.2.529; Sweetlove LJ, 2004, ADV PHOTO RESPIRAT, V17, P307; TAKAHASHI T, 2005, BIOCHIM BIOPHYS ACTA, V1703, P352; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; VERNIQUET F, 1991, BIOCHEM J, V276, P643, DOI 10.1042/bj2760643; Vidal G, 2007, PLANT CELL, V19, P640, DOI 10.1105/tpc.106.044461; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; Xie ZX, 2000, MOL PLANT MICROBE IN, V13, P183, DOI 10.1094/MPMI.2000.13.2.183; Zhang LX, 2002, FEBS LETT, V512, P13, DOI 10.1016/S0014-5793(02)02218-4	85	26	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37556	37566		10.1074/jbc.M707226200	http://dx.doi.org/10.1074/jbc.M707226200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17951254	hybrid, Green Published			2022-12-25	WOS:000251833600031
J	Huecas, S; Schaffner-Barbero, C; Garcia, W; Yebenes, H; Palacios, JM; Diaz, JF; Menendez, M; Andreu, JM				Huecas, Sonia; Schaffner-Barbero, Claudia; Garcia, Wanius; Yebenes, Hugo; Palacios, Juan Manuel; Diaz, Jose Fernando; Menendez, Margarita; Andreu, Jose Manuel			The interactions of cell division protein FtsZ with guanine Nucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSEMBLY DYNAMICS; ESCHERICHIA-COLI; IN-VITRO; BACTERIAL CYTOKINESIS; CRYSTAL-STRUCTURE; TARGETING FTSZ; GTP HYDROLYSIS; SMALL-MOLECULE; TUBULIN; RING	Prokaryotic cell division protein FtsZ, an assembling GTPase, directs the formation of the septosome between daughter cells. FtsZ is an attractive target for the development of new antibiotics. Assembly dynamics of FtsZ is regulated by the binding, hydrolysis, and exchange of GTP. Wehave determined the energetics of nucleotide binding to model apoFtsZ from Methanococcus jannaschii and studied the kinetics of 2'/3 '-O-( N-methylanthraniloyl) ( mant)-nucleotide binding and dissociation from FtsZ polymers, employing calorimetric, fluorescence, and stopped-flow methods. FtsZ binds GTP and GDP with Kb values ranging from 20 to 300 mu M -1 under various conditions. GTP.Mg2+ and GDP . Mg2+ bind with slightly reduced affinity. Bound GTP and the coordinated Mg2+ ion play a minor structural role in FtsZ monomers, but Mg2+-assisted GTP hydrolysis triggers polymer disassembly. Mant-GTP binds and dissociates quickly from FtsZ monomers, with similar to 10-fold lower affinity than GTP. Mant-GTP displacement measured by fluorescence anisotropy provides a method to test the binding of any competing molecules to the FtsZ nucleotide site. Mant-GTP is very slowly hydrolyzed and remains exchangeable in FtsZ polymers, but it becomes kinetically stabilized, with a 30-fold slower k(+) and similar to 500-fold slower k -than in monomers. The mant-GTP dissociation rate from FtsZ polymers is comparable with the GTP hydrolysis turnover and with the reported subunit turnover in Escherichia coli FtsZ polymers. Although FtsZ polymers can exchange nucleotide, unlike its eukaryotic structural homologue tubulin, GDP dissociation may be slow enough for polymer disassembly to take place first, resulting in FtsZ polymers cycling with GTP hydrolysis similarly to microtubules.	[Huecas, Sonia; Schaffner-Barbero, Claudia; Garcia, Wanius; Yebenes, Hugo; Palacios, Juan Manuel; Diaz, Jose Fernando; Andreu, Jose Manuel] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain; [Menendez, Margarita] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Huecas, S (corresponding author), CSIC, Ctr Invest Biol, Ramiro Da Maeztu,9, E-28040 Madrid, Spain.	sonia@cib.csic.es; j.m.andreu@cib.csic.es	Menendez, Margarita/M-1795-2014; Huecas, Sonia/P-2542-2019; Huecas, Sonia/K-1754-2014; Silva, Wanius J. G./L-3948-2016; Díaz, J. Fernando/M-6853-2019; Díaz, J. Fernando/U-3532-2017	Menendez, Margarita/0000-0002-3267-4443; Huecas, Sonia/0000-0002-6419-441X; Huecas, Sonia/0000-0002-6419-441X; Díaz, J. Fernando/0000-0003-2743-3319; Díaz, J. Fernando/0000-0003-2743-3319; Yebenes, Hugo/0000-0002-0448-217X; Andreu, Jose M/0000-0001-8064-6933				Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; Andreu JM, 2002, J BIOL CHEM, V277, P43262, DOI 10.1074/jbc.M206723200; Andreu JM, 2001, BIOCHEMISTRY-US, V40, P11975, DOI 10.1021/bi010869+; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Beuria TK, 2005, BIOCHEMISTRY-US, V44, P16584, DOI 10.1021/bi050767+; Bevington P. R., 1969, DATA REDUCTION ERROR, P235; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buey RM, 2006, BIOCHEMISTRY-US, V45, P5933, DOI 10.1021/bi060334m; Burbank KS, 2006, CURR BIOL, V16, pR516, DOI 10.1016/j.cub.2006.06.044; Chen Y, 2007, J BIOL CHEM, V282, P27736, DOI 10.1074/jbc.M703788200; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Chung KM, 2007, J BIOL CHEM, V282, P14891, DOI 10.1074/jbc.M605177200; CORREIA JJ, 1987, J BIOL CHEM, V262, P17278; Diaz Jose Fernando, 2007, Methods Mol Med, V137, P245, DOI 10.1007/978-1-59745-442-1_17; Domadia P, 2007, BIOCHEM PHARMACOL, V74, P831, DOI 10.1016/j.bcp.2007.06.029; FRIGON RP, 1975, BIOCHEMISTRY-US, V14, P4567, DOI 10.1021/bi00692a002; Huang Q, 2006, J MED CHEM, V49, P463, DOI 10.1021/jm050920y; Huecas S, 2004, FEBS LETT, V569, P43, DOI 10.1016/j.febslet.2004.05.048; Huecas S, 2003, J BIOL CHEM, V278, P46146, DOI 10.1074/jbc.M307128200; HUECAS S, 2007, BIOPHYS J, DOI DOI 10.1529/BIOPHYSJ.107.107896; Ito H, 2006, MICROBIOL IMMUNOL, V50, P759, DOI 10.1111/j.1348-0421.2006.tb03851.x; Jaiswal R, 2007, BIOCHEMISTRY-US, V46, P4211, DOI 10.1021/bi602573e; Jameson DM, 1997, METHOD ENZYMOL, V278, P363; Kong CG, 2004, MOL CELL, V14, P233, DOI 10.1016/S1097-2765(04)00206-0; Lappchen T, 2005, BIOCHEMISTRY-US, V44, P7879, DOI 10.1021/bi047297o; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Margalit DN, 2004, P NATL ACAD SCI USA, V101, P11821, DOI 10.1073/pnas.0404439101; MEDRANO FJ, 1991, BIOCHEMISTRY-US, V30, P3770, DOI 10.1021/bi00229a026; Menendez M, 1998, J BIOL CHEM, V273, P167, DOI 10.1074/jbc.273.1.167; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Mingorance J, 2001, MOL MICROBIOL, V41, P83, DOI 10.1046/j.1365-2958.2001.02498.x; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Nogales E, 1999, CELL MOL LIFE SCI, V56, P133, DOI 10.1007/s000180050012; Ohashi Y, 1999, J BACTERIOL, V181, P1348, DOI 10.1128/JB.181.4.1348-1351.1999; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Oliva MA, 2003, J BIOL CHEM, V278, P33562, DOI 10.1074/jbc.M303798200; Oosawa F., 1975, THERMODYNAMICS POLYM; Paradis-Bleau C, 2007, BIOORGAN MED CHEM, V15, P1330, DOI 10.1016/j.bmc.2006.11.015; Pisareva VP, 2007, BIOCHEMISTRY-US, V46, P2622, DOI 10.1021/bi062134g; Possoz C, 2007, ANTIMICROB AGENTS CH, V51, P252, DOI 10.1128/AAC.00892-06; Reynolds RC, 2004, BIOORG MED CHEM LETT, V14, P3161, DOI 10.1016/j.bmcl.2004.04.012; Romberg L, 2004, BIOCHEMISTRY-US, V43, P282, DOI 10.1021/bi035465r; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Santra MK, 2004, J BIOL CHEM, V279, P25959, DOI 10.1074/jbc.M312473200; Schlieper D, 2005, P NATL ACAD SCI USA, V102, P9170, DOI 10.1073/pnas.0502859102; Simon I, 1996, J BIOL CHEM, V271, P20470, DOI 10.1074/jbc.271.34.20470; Sontag CA, 2005, J CELL BIOL, V169, P233, DOI 10.1083/jcb.200410027; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Stokes NR, 2005, J BIOL CHEM, V280, P39709, DOI 10.1074/jbc.M506741200; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Urgaonkar S, 2005, ORG LETT, V7, P5609, DOI 10.1021/ol052269z; Vicente M, 2006, MOL MICROBIOL, V61, P5, DOI 10.1111/j.1365-2958.2006.05233.x; Vollmer W, 2006, APPL MICROBIOL BIOT, V73, P37, DOI 10.1007/s00253-006-0586-0; Wang J, 2003, J BIOL CHEM, V278, P44424, DOI 10.1074/jbc.M307625200; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; Zhang BL, 2000, J BIOL CHEM, V275, P25299, DOI 10.1074/jbc.M001027200	60	56	65	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37515	37528		10.1074/jbc.M706399200	http://dx.doi.org/10.1074/jbc.M706399200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17977836	hybrid, Green Published			2022-12-25	WOS:000251833600027
J	Matsuda, Y; Koshiba, T; Osaki, T; Suyama, H; Arisaka, F; Toh, Y; Kawabata, SI				Matsuda, Yasuyuki; Koshiba, Takumi; Osaki, Tsukasa; Suyama, Haruka; Arisaka, Fumio; Toh, Yoshihiro; Kawabata, Shun-ichiro			An arthropod cuticular chitin-binding protein endows injured sites with transglutaminase-dependent mesh	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORNIFIED CELL-ENVELOPE; LIMULUS HEMOCYTE TRANSGLUTAMINASE; HORSESHOE-CRAB; CROSS-LINKING; CLOTTING PROTEIN; CLOTTABLE PROTEIN; MOLECULAR-BASIS; RECOGNITION; FIBRINOGEN; INVERTEBRATES	In mammals, the cornified cell envelope forms beneath the plasma membrane in epithelia and provides a vital physical barrier consisting of insoluble proteins cross-linked by transglutaminase (TGase). In the horseshoe crab Tachypleus tridentatus, TGase is stored in hemocytes and secreted in response to the simulation of bacterial lipopolysaccharides. Here we characterized a TGase substrate designated as caraxin that was identified in horseshoe crab cuticle. One of the homologs, caraxin-1, possessed a unique domain structure consisting of N- and C-terminal heptad repeats and a central domain with a tandem-repeated structure of a pentapeptide. Western blotting showed the specific localization of caraxin-1 in sub-cuticular epidermis. Moreover, we identified the pentapeptide motif to be a chitin-binding unit. Analytical ultracentrifugation revealed that caraxin-1 exists as an oligomer with 310-350 kDa, which is similar to 20-mer based on the molecular mass of the monomer. The oligomers were cross-linked by TGase to form an elaborate mesh with honeycomb structures, which was electron-microscopically found to be different from the clotting mesh triggered by lipopolysaccharide-induced hemocyte exocytosis. We determined several cross-linking sites in the N- and C-terminal domains of caraxin-1. The replacements of Leu to Pro at positions 36 and 118 in caraxin-1 reduced the alpha-helix content, which destroyed the TGase-dependent mesh, thus indicating the importance of the N- and C-terminal domains for the proper mesh formation. In arthropods, TGase-dependent protein cross-linking may be involved in the initial stage of host defense at the sub-cuticular epidermis, as in the case of mammalian skin.	[Matsuda, Yasuyuki; Koshiba, Takumi; Osaki, Tsukasa; Suyama, Haruka; Toh, Yoshihiro; Kawabata, Shun-ichiro] Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, Fukuoka 812, Japan; [Arisaka, Fumio] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biomol Engn, Midori Ku, Yokohama, Kanagawa 226, Japan	Kyushu University; Tokyo Institute of Technology	Kawabata, SI (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 812, Japan.	skawascb@mbox.nc.kyushu-u.ac.jp	Koshiba, Takumi/A-3996-2013	Koshiba, Takumi/0000-0001-8535-5043; Osaki, Tsukasa/0000-0002-9487-3253				Aeschlimann D, 2000, CONNECT TISSUE RES, V41, P1, DOI 10.3109/03008200009005638; Arakawa T, 2006, BIOPROCESS INT, V4, P42; Arakawa T., 2007, BIOPROCESS INT, V5, P36; Ariki S, 2004, P NATL ACAD SCI USA, V101, P953, DOI 10.1073/pnas.0306904101; ARMSTRONG PB, 1985, BLOOD CELLS MARINE I, P77; Bergner A, 1996, EMBO J, V15, P6789, DOI 10.1002/j.1460-2075.1996.tb01070.x; BURSEY CR, 1977, CAN J ZOOL, V55, P1158, DOI 10.1139/z77-150; Candi E, 1998, P NATL ACAD SCI USA, V95, P2067, DOI 10.1073/pnas.95.5.2067; DOOLITTLE RF, 1984, ANNU REV BIOCHEM, V53, P195, DOI 10.1146/annurev.bi.53.070184.001211; Elvin CM, 1996, J BIOL CHEM, V271, P8925, DOI 10.1074/jbc.271.15.8925; Folk J E, 1977, Adv Protein Chem, V31, P1, DOI 10.1016/S0065-3233(08)60217-X; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; Gokudan S, 1999, P NATL ACAD SCI USA, V96, P10086, DOI 10.1073/pnas.96.18.10086; Hamodrakas SJ, 2002, INSECT BIOCHEM MOLEC, V32, P1577, DOI 10.1016/S0965-1748(02)00079-6; ICHINOSE A, 1990, J BIOL CHEM, V265, P13411; Iijima M, 2005, FEBS J, V272, P4774, DOI 10.1111/j.1742-4658.2005.04891.x; Isakova V, 2003, BIOL BULL-US, V205, P203, DOI 10.2307/1543253; Iwanaga S, 1998, J BIOCHEM, V123, P1; Kajava AV, 2000, FEBS LETT, V473, P127, DOI 10.1016/S0014-5793(00)01502-7; Kalinin A, 2001, J CELL SCI, V114, P3069; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Kawabata S, 2002, BBA-GEN SUBJECTS, V1572, P414, DOI 10.1016/S0304-4165(02)00322-7; Kawasaki H, 2000, J BIOL CHEM, V275, P35297, DOI 10.1074/jbc.M006856200; KOPACEK P, 1993, EUR J BIOCHEM, V213, P591, DOI 10.1111/j.1432-1033.1993.tb17798.x; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Koshiba T, 2003, J BIOL CHEM, V278, P7573, DOI 10.1074/jbc.M211154200; Koshiba T, 2007, J BIOL CHEM, V282, P3962, DOI 10.1074/jbc.M609198200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lorand L, 2001, ANN NY ACAD SCI, V936, P291; Lorand L, 1980, Prog Hemost Thromb, V5, P245; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Osaki T, 2004, CELL MOL LIFE SCI, V61, P1257, DOI 10.1007/s00018-004-3396-5; Osaki T, 2002, J BIOL CHEM, V277, P40084, DOI 10.1074/jbc.M206773200; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; SATO T, 1994, BIOCHEM BIOPH RES CO, V204, P551, DOI 10.1006/bbrc.1994.2494; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Scherfer C, 2004, CURR BIOL, V14, P625, DOI 10.1016/j.cub.2004.03.030; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shen ZC, 1999, J MOL EVOL, V48, P341, DOI 10.1007/PL00006478; SHIGENAGA T, 1993, J BIOCHEM-TOKYO, V114, P307, DOI 10.1093/oxfordjournals.jbchem.a124173; SHINOHARA Y, 1995, J BIOCHEM-TOKYO, V117, P1076; Suetake T, 2000, J BIOL CHEM, V275, P17929, DOI 10.1074/jbc.C000184200; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; TOKUNAGA F, 1993, J BIOL CHEM, V268, P252; TOKUNAGA F, 1993, J BIOL CHEM, V268, P262; Willis JH, 1999, AM ZOOL, V39, P600; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606	47	19	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37316	37324		10.1074/jbc.M705731200	http://dx.doi.org/10.1074/jbc.M705731200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17967901	hybrid			2022-12-25	WOS:000251833600006
J	Winger, AM; Taylor, NL; Heazlewood, JL; Day, DA; Millar, AH				Winger, Alison M.; Taylor, Nicolas L.; Heazlewood, Joshua L.; Day, David A.; Millar, A. Harvey			The cytotoxic lipid peroxidation product 4-hydroxy-2-nonenal covalently modifies a selective range of proteins linked to respiratory function in plant mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; ALPHA-KETOGLUTARATE DEHYDROGENASE; TANDEM MASS-SPECTROMETRY; OXIDATIVE STRESS; 4-HYDROXY-TRANS-2-NONENAL HNE; ARABIDOPSIS-MITOCHONDRIA; POLYACRYLAMIDE GELS; ELECTRON-TRANSPORT; RAT-HEART; INHIBITION	Plants encounter a variety of environmental stresses that affect their cellular machinery and that they adapt to on a daily basis. Lipid peroxidation is one consequence, at the cellular level, of such stresses and yields cytotoxic lipid aldehydes, including 4-hydroxy-2-nonenal (HNE), that react with specific sites in proteins, leading to diverse changes in protein function and/or stability. We have assessed the sensitivity of plant mitochondrial proteins to HNE modification, using one-dimensional and two-dimensional denaturing PAGE and blue native-PAGE coupled to immunological detection and tandem mass spectrometry identification. A select range of proteins was modified by exogenous application of HNE to mitochondria isolated from Arabidopsis cell cultures. These included a number of proteins that directly interact with the ubiquinone pool, as well as a number of soluble matrix proteins. Mitochondria isolated from cell cultures following hydrogen peroxide, antimycin A, or menadione treatment had significantly reduced respiratory capacity and elevated levels of HNE adduction to specific subsets of proteins. Targets identified included the proteins affected by direct application of HNE but also some new proteins, including a number of matrix dehydrogenases, the inner membrane adenine nucleotide translocator, and the outer membrane voltage-dependent anion channel. Degradation products of some proteins were also found to be HNE adducted, suggesting a link between HNE adduction and protein turnover. Some of the major enzyme complexes that were HNE adducted did not show demonstrable changes in their maximal activity measured with artificial acceptors, but changes did occur in associations between respiratory chain complexes following stress treatments.	[Winger, Alison M.; Taylor, Nicolas L.; Heazlewood, Joshua L.; Millar, A. Harvey] Univ Western Australia, Australian Res Council Ctr Excellence Plant Energ, Nedlands, WA 6009, Australia; [Day, David A.] Univ Sydney, Sch Biol Sci, Australian Res Council Ctr, Sydney, NSW 2006, Australia	University of Western Australia; University of Sydney	Millar, AH (corresponding author), Univ Western Australia, Australian Res Council Ctr Excellence Plant Energ, 35 Stirling Highway, Nedlands, WA 6009, Australia.	hmillar@cyllene.uwa.edu.au	Day, David/F-6325-2011; Heazlewood, Joshua L/A-2554-2008; Taylor, Nicolas L/A-5731-2008; Millar, A. Harvey/A-5452-2008	Day, David/0000-0001-7967-2173; Heazlewood, Joshua L/0000-0002-2080-3826; Taylor, Nicolas L/0000-0003-2004-5217; Millar, A. Harvey/0000-0001-9679-1473				Aldini G, 2005, J MASS SPECTROM, V40, P946, DOI 10.1002/jms.872; Aldini G, 2006, J MASS SPECTROM, V41, P1149, DOI 10.1002/jms.1067; Balmer Y, 2004, P NATL ACAD SCI USA, V101, P2642, DOI 10.1073/pnas.0308583101; Baxter CJ, 2007, PLANT PHYSIOL, V143, P312, DOI 10.1104/pp.106.090431; Carbone DL, 2005, J PHARMACOL EXP THER, V315, P8, DOI 10.1124/jpet.105.088088; Carbone DL, 2005, CHEM RES TOXICOL, V18, P1324, DOI 10.1021/tx050078z; Carini M, 2004, MASS SPECTROM REV, V23, P281, DOI 10.1002/mas.10076; Chen JJ, 1998, BBA-GEN SUBJECTS, V1380, P336, DOI 10.1016/S0304-4165(98)00002-6; Chen JJ, 2001, J MOL CELL CARDIOL, V33, P1919, DOI 10.1006/jmcc.2001.1454; Chew O, 2003, J BIOL CHEM, V278, P46869, DOI 10.1074/jbc.M307525200; Choksi KB, 2004, BBA-MOL BASIS DIS, V1688, P95, DOI 10.1016/j.bbadis.2003.11.007; Clifton R, 2005, PLANT MOL BIOL, V58, P193, DOI 10.1007/s11103-005-5514-7; Clifton R, 2006, BBA-BIOENERGETICS, V1757, P730, DOI 10.1016/j.bbabio.2006.03.009; Deighton N, 1997, FREE RADICAL RES, V27, P255, DOI 10.3109/10715769709065764; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fenaille F, 2003, J AM SOC MASS SPECTR, V14, P215, DOI 10.1016/S1044-0305(02)00911-X; Finkemeier I, 2005, J BIOL CHEM, V280, P12168, DOI 10.1074/jbc.M413189200; FRIGUET B, 1994, ARCH BIOCHEM BIOPHYS, V311, P168, DOI 10.1006/abbi.1994.1222; Friguet B, 1997, FEBS LETT, V405, P21, DOI 10.1016/S0014-5793(97)00148-8; Giege P, 2003, PLANT CELL, V15, P2140, DOI 10.1105/tpc.012500; Hancock JT, 2005, PLANT PHYSIOL BIOCH, V43, P828, DOI 10.1016/j.plaphy.2005.07.012; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P15835, DOI 10.1021/bi981512h; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P552, DOI 10.1021/bi971958i; Ishizaki K, 2005, PLANT CELL, V17, P2587, DOI 10.1105/tpc.105.035162; Isom AL, 2004, J AM SOC MASS SPECTR, V15, P1136, DOI 10.1016/j.jasms.2004.03.013; Kristensen BK, 2004, PHYTOCHEMISTRY, V65, P1839, DOI 10.1016/j.phytochem.2004.04.007; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lashin OM, 2006, FREE RADICAL BIO MED, V40, P886, DOI 10.1016/j.freeradbiomed.2005.10.040; MARCILLAT O, 1988, BIOCHEM J, V254, P677, DOI 10.1042/bj2540677; MENZ RI, 1992, EUR J BIOCHEM, V208, P481, DOI 10.1111/j.1432-1033.1992.tb17211.x; Millar AH, 2001, METHOD CELL BIOL, V65, P53, DOI 10.1016/S0091-679X(01)65004-0; Millar AH, 2000, FEBS LETT, V481, P117, DOI 10.1016/S0014-5793(00)01976-1; Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946; Moller IM, 2006, FREE RADICAL BIO MED, V40, P430, DOI 10.1016/j.freeradbiomed.2005.08.036; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Moreau R, 2003, ANTIOXID REDOX SIGN, V5, P517, DOI 10.1089/152308603770310167; Musatov A, 2002, BIOCHEMISTRY-US, V41, P8212, DOI 10.1021/bi025896u; Perluigi M, 2005, FREE RADICAL BIO MED, V38, P960, DOI 10.1016/j.freeradbiomed.2004.12.021; Picklo MJ, 1999, J NEUROCHEM, V72, P1617, DOI 10.1046/j.1471-4159.1999.721617.x; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; RASMUSSON AG, 1991, PHYSIOL PLANTARUM, V83, P357, DOI 10.1111/j.1399-3054.1991.tb00106.x; Sabar M, 2005, PLANT J, V44, P893, DOI 10.1111/j.1365-313X.2005.02577.x; SAYRE LM, 1993, CHEM RES TOXICOL, V6, P19, DOI 10.1021/tx00031a002; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schneider C, 2001, J BIOL CHEM, V276, P20831, DOI 10.1074/jbc.M101821200; SINGER TP, 1973, PLANT PHYSIOL, V52, P616, DOI 10.1104/pp.52.6.616; Smith AMO, 2004, J BIOL CHEM, V279, P51944, DOI 10.1074/jbc.M408920200; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Taylor NL, 2005, MOL CELL PROTEOMICS, V4, P1122, DOI 10.1074/mcp.M400210-MCP200; Taylor NL, 2002, J BIOL CHEM, V277, P42663, DOI 10.1074/jbc.M204761200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vanlerberghe GC, 1997, ANNU REV PLANT PHYS, V48, P703, DOI 10.1146/annurev.arplant.48.1.703; Vieira HLA, 2001, ONCOGENE, V20, P4305, DOI 10.1038/sj.onc.1204575; Winger AM, 2005, BIOCHEM J, V387, P865, DOI 10.1042/BJ20042044; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131	55	67	69	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37436	37447		10.1074/jbc.M702385200	http://dx.doi.org/10.1074/jbc.M702385200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17947244	hybrid			2022-12-25	WOS:000251833600018
J	Zhang, J; Suzuki, K; Hitomi, T; Siragahan, RP				Zhang, Juan; Suzuki, Katsuhiro; Hitomi, Tomohiro; Siragahan, Reuben P.			TOM1L1 is a Lyn substrate involved in Fc epsilon RI signaling in mast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY IGE RECEPTOR; PROTEIN-TYROSINE KINASE; BASOPHILIC LEUKEMIA-CELLS; ANTIGEN RECEPTOR; ADAPTER PROTEIN; CROSS-LINKING; VHS DOMAIN; SYK; ACTIVATION; PHOSPHORYLATION	Protein- tyrosine kinase Lyn and Syk are critical for antigenreceptor-induced signal transduction in mast cells. To identify novel Lyn/Syk substrates, we screened an RBL-2H3 bacterial expression library for proteins that were tyrosine phosphorylated with baculoviral expressed Lyn or Syk. Five clones as potential Lyn substrates and eight clones as Syk substrates were identified including known substrates such as SLP-76, LAT, and alpha-tubulin. A potential substrate of Lyn identified was the molecule TOM1L1, which has several domains thought to be important for membrane trafficking and protein-protein interactions. Because the function of TOM1L1 is unclear, the rat TOM1L1 full-length cDNAwas isolated and used to express the protein in COS-1 and RBL-2H3 mast cells. In COS-1 cells, the co-transfection of TOM1L1 and Lyn, but not Syk, resulted in the tyrosine phosphorylation of TOM1L1. In RBL-2H3 mast cells, the overexpressed TOM1L1 was strongly tyrosine phosphorylated in non-stimulated cells, and this phosphorylation was enhanced by Fc epsilon RI aggregation. By subcellular fractionation, wild-type TOM1L1 was mainly in the cytoplasm with a small fraction constitutively associated with the membrane; this association was markedly reduced in deletion mutants lacking several of the protein interaction domains. The overexpression of TOM1L1 enhanced antigen-induced tumor necrosis factor (TNF) alpha generation and release. Both protein interaction domains (VHS and the coiled-coil domains) were required for the increased TNF alpha release, but not the increased TNF alpha generation. These results suggest that TOM1L1 is a novel protein involved in the Fc epsilon RI signal transduction for the generation of cytokines.	[Zhang, Juan; Suzuki, Katsuhiro; Hitomi, Tomohiro; Siragahan, Reuben P.] NIH, NIDCR, RAST Sect, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Siragahan, RP (corresponding author), NIH, NIDCR, RAST Sect, OIIB,Bldg 10,Rm 1N106, Bethesda, MD 20892 USA.	rs53x@nih.gov			NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [ZIADE000696, Z01DE000696] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BASCIANO LK, 1986, J BIOL CHEM, V261, P1823; Beitz LO, 1999, J BIOL CHEM, V274, P32662, DOI 10.1074/jbc.274.46.32662; BENHAMOU M, 1990, P NATL ACAD SCI USA, V87, P5327, DOI 10.1073/pnas.87.14.5327; BENHAMOU M, 1993, J BIOL CHEM, V268, P23318; Billin AN, 1999, J BIOL CHEM, V274, P36344, DOI 10.1074/jbc.274.51.36344; Deckert M, 1998, IMMUNITY, V9, P595, DOI 10.1016/S1074-7613(00)80657-3; Franco M, 2006, MOL CELL BIOL, V26, P1932, DOI 10.1128/MCB.26.5.1932-1947.2006; Goitsuka R, 2000, INT IMMUNOL, V12, P573, DOI 10.1093/intimm/12.4.573; HendricksTaylor LR, 1997, J BIOL CHEM, V272, P1363, DOI 10.1074/jbc.272.2.1363; Hitomi T, 1999, FEBS LETT, V445, P371, DOI 10.1016/S0014-5793(99)00153-2; JabrilCuenod B, 1996, J BIOL CHEM, V271, P16268, DOI 10.1074/jbc.271.27.16268; JOUVIN MHE, 1994, J BIOL CHEM, V269, P5918; Katoh Y, 2006, BIOCHEM BIOPH RES CO, V341, P143, DOI 10.1016/j.bbrc.2005.12.156; Katoh Y, 2004, J BIOL CHEM, V279, P24435, DOI 10.1074/jbc.M400059200; Kawakami Y, 2000, P NATL ACAD SCI USA, V97, P7423, DOI 10.1073/pnas.120175097; Kawakami Y, 2000, J IMMUNOL, V165, P1210, DOI 10.4049/jimmunol.165.3.1210; KIHARA H, 1994, J BIOL CHEM, V269, P22427; Larbolette O, 1999, MOL CELL BIOL, V19, P1539; Latour S, 1997, MOL CELL BIOL, V17, P4434, DOI 10.1128/MCB.17.8.4434; Li WJ, 2005, J BIOL CHEM, V280, P6036, DOI 10.1074/jbc.M406546200; Lock P, 1998, EMBO J, V17, P4346, DOI 10.1093/emboj/17.15.4346; Lohi O, 2002, FEBS LETT, V513, P19, DOI 10.1016/S0014-5793(01)03287-2; Lohi O, 1998, FEBS LETT, V440, P255, DOI 10.1016/S0014-5793(98)01401-X; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; MINOGUCHI K, 1994, J BIOL CHEM, V269, P16902; NISHIKATA H, 1992, J IMMUNOL, V149, P862; Okazaki H, 1997, J BIOL CHEM, V272, P32443, DOI 10.1074/jbc.272.51.32443; Peters JD, 1996, J BIOL CHEM, V271, P4755; PIROZZI G, 1995, J IMMUNOL, V155, P5811; Puertollano R, 2005, J BIOL CHEM, V280, P9258, DOI 10.1074/jbc.M412481200; Rawlings DJ, 1996, SCIENCE, V271, P822, DOI 10.1126/science.271.5250.822; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Seroussi E, 1999, GENOMICS, V57, P380, DOI 10.1006/geno.1998.5739; Seykora JT, 2002, J BIOL CHEM, V277, P2812, DOI 10.1074/jbc.M106813200; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Teramoto H, 1997, J BIOL CHEM, V272, P10751; Yamanashi Y, 1997, J EXP MED, V185, P1387, DOI 10.1084/jem.185.7.1387; Zhang J, 1996, J EXP MED, V184, P71, DOI 10.1084/jem.184.1.71; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	40	7	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37669	37677		10.1074/jbc.M705168200	http://dx.doi.org/10.1074/jbc.M705168200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17977829	hybrid			2022-12-25	WOS:000251833600043
J	Olsen, SK; Ota, N; Kishishita, S; Kukimoto-Niino, M; Murayama, K; Uchiyama, H; Toyama, M; Terada, T; Shirouzu, M; Kanagawa, O; Yokoyama, S				Olsen, Shaun K.; Ota, Naruhisa; Kishishita, Seiichiro; Kukimoto-Niino, Mutsuko; Murayama, Kazutaka; Uchiyama, Hidemi; Toyama, Mitsutoshi; Terada, Takaho; Shirouzu, Mikako; Kanagawa, Osami; Yokoyama, Shigeyuki			Crystal structure of the interleukin-15 center dot interleukin-15 receptor alpha complex - Insights into trans and cis presentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOKINE-RECEPTOR; GAMMA-CHAIN; HUMAN INTERLEUKIN-15; IL-2 RECEPTOR; BETA-CHAIN; LIGAND-BINDING; IN-VIVO; CELL; PROTEIN; IL-15R-ALPHA	Interleukin (IL)-15 is a pleiotropic cytokine that plays a pivotal role in both innate and adaptive immunity. IL-15 is unique among cytokines due to its participation in a trans signaling mechanism in which IL-15 receptor alpha(IL-15R alpha) from one subset of cells presents IL-15 to neighboring IL-2R beta/gamma(c)-expressing cells. Here we present the crystal structure of IL-15 in complex with the sushi domain of IL-15R alpha. The structure reveals that the alpha receptor-binding epitope of IL-15 adopts a unique conformation, which, together with amino acid substitutions, permits specific interactions with IL-15R alpha that account for the exceptionally high affinity of the IL-15 center dot IL-15R alpha complex. Interestingly, analysis of the topology of IL-15 and IL-15R alpha at the IL-15 center dot IL-15R alpha interface suggests that IL-15 should be capable of participating in a cis signaling mechanism similar to that of the related cytokine IL-2. Indeed, we present biochemical data demonstrating that IL-15 is capable of efficiently signaling in cis through IL-15R alpha and IL-2R beta/gamma(c) expressed on the surface of a single cell. Based on our data we propose that cis presentation of IL-15 may be important in certain biological contexts and that flexibility of IL-15R alpha permits IL-15 and its three receptor components to be assembled identically at the ligand-receptor interface whether IL-15 is presented in cis or trans. Finally, we have gained insights into IL-15 center dot IL-15R alpha center dot IL-2R beta center dot gamma(c) quaternary complex assembly through the use of molecular modeling.	[Olsen, Shaun K.; Kishishita, Seiichiro; Kukimoto-Niino, Mutsuko; Murayama, Kazutaka; Toyama, Mitsutoshi; Terada, Takaho; Shirouzu, Mikako; Yokoyama, Shigeyuki] RIKEN Yokohama Inst, RIKEN Gen Sci Ctr, Kanagawa 2300045, Japan; [Ota, Naruhisa; Uchiyama, Hidemi; Kanagawa, Osami] RIKEN Yokohama Inst, RIKEN Res Ctr Allergy & Immunol, Kanagawa 2300045, Japan; [Murayama, Kazutaka] Tohoku Univ, Biomed Engn Res Org, Sendai, Miyagi 9808575, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Dept Biophys & Biochem, Tokyo 1130033, Japan	RIKEN; RIKEN; Tohoku University; University of Tokyo	Yokoyama, S (corresponding author), RIKEN Yokohama Inst, RIKEN Gen Sci Ctr, 1-7-22 Suehiro Cho, Kanagawa 2300045, Japan.	yokoyama@biochem.s.u-tokyo.ac.jp	Shirouzu, Mikako/A-6521-2016; Toyama, Marcos H/P-4673-2017; Kishishita, Seiichiro/H-1836-2011; Kukimoto-Niino, Mutsuko/C-6704-2017; Yokoyama, Shigeyuki/N-6911-2015	Toyama, Marcos H/0000-0001-6836-3084; Kishishita, Seiichiro/0000-0001-7587-2581; Kukimoto-Niino, Mutsuko/0000-0002-4178-1611; Yokoyama, Shigeyuki/0000-0003-3133-7338; Olsen, Shaun/0000-0002-1265-7101				ANDERSON DM, 1995, J BIOL CHEM, V270, P29862; Aritomi M, 1999, NATURE, V401, P713, DOI 10.1038/44394; BAMFORD RN, 1994, P NATL ACAD SCI USA, V91, P4940, DOI 10.1073/pnas.91.11.4940; Bernard J, 2004, J BIOL CHEM, V279, P24313, DOI 10.1074/jbc.M312458200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Budagian V, 2004, J BIOL CHEM, V279, P40368, DOI 10.1074/jbc.M404125200; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Bulanova E, 2003, J IMMUNOL, V170, P5045, DOI 10.4049/jimmunol.170.10.5045; Bulanova E, 2007, J BIOL CHEM, V282, P13167, DOI 10.1074/jbc.M610036200; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; Chirifu M, 2007, NAT IMMUNOL, V8, P1001, DOI 10.1038/ni1492; deJong JLO, 1996, J IMMUNOL, V156, P1339; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DEXTER TM, 1980, J EXP MED, V152, P1036, DOI 10.1084/jem.152.4.1036; Dubois S, 1999, J BIOL CHEM, V274, P26978, DOI 10.1074/jbc.274.38.26978; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Eisenman J, 2002, CYTOKINE, V20, P121, DOI 10.1006/cyto.2002.1989; GIRI JG, 1995, EMBO J, V14, P3654, DOI 10.1002/j.1460-2075.1995.tb00035.x; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Hage T, 1999, CELL, V97, P271, DOI 10.1016/S0092-8674(00)80736-9; JOHNSTON JA, 1995, P NATL ACAD SCI USA, V92, P8705, DOI 10.1073/pnas.92.19.8705; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kigawa Takanori, 2002, Journal of Structural and Functional Genomics, V2, P29, DOI 10.1023/A:1013203532303; Kobayashi H, 2005, BLOOD, V105, P721, DOI 10.1182/blood-2003-12-4187; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leonard WJ, 1995, IMMUNOL REV, V148, P97, DOI 10.1111/j.1600-065X.1995.tb00095.x; Liparoto SF, 1999, J MOL RECOGNIT, V12, P316, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<316::AID-JMR468>3.0.CO;2-1; Lorenzen I, 2006, J BIOL CHEM, V281, P6642, DOI 10.1074/jbc.M513118200; Mortier E, 2006, J BIOL CHEM, V281, P1612, DOI 10.1074/jbc.M508624200; Myszka DG, 1996, PROTEIN SCI, V5, P2468, DOI 10.1002/pro.5560051209; Neely GG, 2001, J IMMUNOL, V167, P5011, DOI 10.4049/jimmunol.167.9.5011; NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T; Olosz F, 2000, J BIOL CHEM, V275, P30100, DOI 10.1074/jbc.M004976200; Olosz F, 2002, J BIOL CHEM, V277, P12047, DOI 10.1074/jbc.M110520200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PETIT DK, 1997, J BIOL CHEM, V272, P2312; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; QUERMENER A, 2006, PROTEINS, V65, P623; Rickert M, 2005, SCIENCE, V308, P1477, DOI 10.1126/science.1109745; ROZWARSKI DA, 1994, STRUCTURE, V2, P159, DOI 10.1016/S0969-2126(00)00018-6; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Ruchatz H, 1998, J IMMUNOL, V160, P5654; Sandau MM, 2004, J IMMUNOL, V173, P6537, DOI 10.4049/jimmunol.173.11.6537; Sato N, 2007, P NATL ACAD SCI USA, V104, P588, DOI 10.1073/pnas.0610115104; Schluns KS, 2005, INT J BIOCHEM CELL B, V37, P1567, DOI 10.1016/j.biocel.2005.02.017; Stauber DJ, 2006, P NATL ACAD SCI USA, V103, P2788, DOI 10.1073/pnas.0511161103; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Waldmann TA, 2001, IMMUNITY, V14, P105, DOI 10.1016/S1074-7613(01)00093-0; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Wei XQ, 2001, J IMMUNOL, V167, P277, DOI 10.4049/jimmunol.167.1.277; Yoon C, 2000, EMBO J, V19, P3530, DOI 10.1093/emboj/19.14.3530	56	68	76	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37191	37204		10.1074/jbc.M706150200	http://dx.doi.org/10.1074/jbc.M706150200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17947230	hybrid			2022-12-25	WOS:000251646000045
J	Shavinskaya, A; Boulant, S; Penin, F; McLauchlan, J; Bartenschlager, R				Shavinskaya, Anna; Boulant, Steeve; Penin, Francois; McLauchlan, John; Bartenschlager, Ralf			The lipid droplet binding domain of hepatitis C virus core protein is a major determinant for efficient virus assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL PEPTIDE PEPTIDASE; RNA REPLICATION; CELL-LINES; ASSOCIATION; EXPRESSION; PARTICLES; INFECTION; CLEAVAGE; INSIGHTS; CULTURE	Hepatitis C virus core protein forms the viral capsid and is targeted to lipid droplets (LDs) by its domain 2 (D2). By using a comparative analysis of two hepatitis C virus genomes (JFH1 and Jc1) differing in their level of virus production in cultured human hepatoma cells, we demonstrate that the core of the genotype 2a isolate J6 that is present in Jc1 mediates efficient assembly and release of infectious virions. Mapping studies identified a single amino acid residue in D2 as a major determinant for enhanced assembly and release of infectious Jc1 particles. Confocal microscopy analyses demonstrate that core protein in JFH1-replicating cells co-localizes perfectly with LDs and induces their accumulation in the perinuclear area, whereas no such accumulation of LDs and only a partial co-localization of core and LDs were found with the Jc1 genome. By using a fluorescence recovery after photobleaching assay, we found that green fluorescent protein-tagged D2 variants are mobile on LDs and that J6- and JFH1-D2 differ in their mobility. Taken together, our results demonstrate that the binding strength of the D2 domain of core for LDs is crucial for determining the efficiency of virus assembly.	[Shavinskaya, Anna; Bartenschlager, Ralf] Univ Heidelberg, Dept Mol Virol, D-69120 Heidelberg, Germany; [Boulant, Steeve; McLauchlan, John] Inst Virol, Med Res Council Virol Unit, Glasgow G11 5JR, Lanark, Scotland; [Penin, Francois] Univ Lyon, CNRS, UMR 5086, IFR 128,Inst Biol & Chim Prot, F-69397 Lyon, France	Ruprecht Karls University Heidelberg; University of Glasgow; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Bartenschlager, R (corresponding author), Univ Heidelberg, Dept Mol Virol, Neuenheimer Feld 345, D-69120 Heidelberg, Germany.	ralf_bartenschlager@med.uni-heidelberg.de	PENIN, Francois/A-7315-2008; Boulant, Steeve/W-3754-2019; Bartenschlager, Ralf/L-2582-2015	Boulant, Steeve/0000-0001-8614-4993; Bartenschlager, Ralf/0000-0001-5601-9307	MRC [MC_U130184143] Funding Source: UKRI; Medical Research Council [MC_UU_12014/1, MC_U130184143] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Appel N, 2006, J BIOL CHEM, V281, P9833, DOI 10.1074/jbc.R500026200; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Bartenschlager R, 2004, ADV VIRUS RES, V63, P71, DOI 10.1016/S0065-3527(04)63002-8; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Boulant S, 2005, J VIROL, V79, P11353, DOI 10.1128/JVI.79.17.11353-11365.2005; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200; Combet C, 2007, NUCLEIC ACIDS RES, V35, pD363, DOI 10.1093/nar/gkl970; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; Friebe P, 2005, J VIROL, V79, P380, DOI 10.1128/JVI.79.1.380-392.2005; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; Giannini C, 2003, CELL DEATH DIFFER, V10, pS27, DOI 10.1038/sj.cdd.4401121; Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Hussy P, 1996, VIROLOGY, V224, P93, DOI 10.1006/viro.1996.0510; Jolivet M, 1997, Patent application, Patent No. [1015481, EP 1015481]; JOLIVET M, 1998, Patent No. 9839360; KAUL A, 2007, J VIROL         0907; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; McHutchison John G, 2003, Clin Liver Dis, V7, P149, DOI 10.1016/S1089-3261(02)00077-6; McLauchlan J, 2000, J VIRAL HEPATITIS, V7, P2; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 1996, VIROLOGY, V222, P51, DOI 10.1006/viro.1996.0397; Moradpour D, 1996, J MED VIROL, V48, P234, DOI 10.1002/(SICI)1096-9071(199603)48:3<234::AID-JMV4>3.0.CO;2-9; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schaller T, 2007, J VIROL, V81, P4591, DOI 10.1128/JVI.02144-06; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; Targett-Adams P, 2003, J BIOL CHEM, V278, P15998, DOI 10.1074/jbc.M211289200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANREGENMORTEL MHV, 2000, VIRUS TAXONOMY 7 REP, P872; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; White SH, 1998, BBA-REV BIOMEMBRANES, V1376, P339, DOI 10.1016/S0304-4157(98)00021-5; Xu ZM, 2001, EMBO J, V20, P3840, DOI 10.1093/emboj/20.14.3840; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06	44	199	206	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37158	37169		10.1074/jbc.M707329200	http://dx.doi.org/10.1074/jbc.M707329200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17942391	hybrid			2022-12-25	WOS:000251646000042
J	Golubkov, VS; Chekanov, AV; Shiryaev, SA; Aleshin, AE; Ratnikov, BI; Gawlik, K; Radichev, I; Motamedchaboki, K; Smith, JW; Strongin, AY				Golubkov, Vladislav S.; Chekanov, Alexei V.; Shiryaev, Sergey A.; Aleshin, Alexander E.; Ratnikov, Boris I.; Gawlik, Katarzyna; Radichev, Ilian; Motamedchaboki, Khatereh; Smith, Jeffrey W.; Strongin, Alex Y.			Proteolysis of the membrane type-1 matrix metalloproteinase prodomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1-MATRIX METALLOPROTEINASE; INTRACELLULAR ACTIVATION; PERICELLULAR PROTEOLYSIS; CYSTEINE SWITCH; CELL-MIGRATION; IV COLLAGENASE; MT1-MMP; COMPLEX; FURIN; INVASION	Membrane type-1 matrix metalloproteinase (MT1-MMP) exerts its enhanced activity in multiple cancer types. Understanding the activation process of MT1-MMP is essential for designing novel and effective cancer therapies. Like all of the other MMPs, MT1-MMP is synthesized as a zymogen, the latency of which is maintained by its inhibitory prodomain. Proteolytic processing of the prodomain transforms the zymogen into a catalytically active enzyme. A sequential, two-step activation process is normally required for MMPs. Our in silico modeling suggests that the prodomain of MT1-MMP exhibits a conserved three helix-bundled structure and a " bait" loop region linking helixes 1 and 2. We hypothesized and then confirmed that in addition to furin cleavage there is also a cleavage at the bait region in the activation process of MT1-MMP. A two-step sequential activation of MT1-MMP is likely to include the MMP-dependent cleavage at either P(47)GD down arrow L-50 or P(58)QS down arrow L-61 or at both sites of the bait region. This event results in the activation intermediate. The activation process is then completed by a proprotein convertase cleaving the inhibitory prodomain at the (RRKR111)-R-108 down arrow Y-112 site, where Tyr(112) is the N-terminal residue of the mature MT1-MMP enzyme. Our findings suggest that the most efficient activation results from a two-step mechanism that eventually is required for the degradation of the inhibitory prodomain and the release of the activated, mature MT1-MMP enzyme. These findings shed more light on the functional role of the inhibitory prodomain and on the proteolytic control of MT1-MMP activation, a crucial process that may be differentially regulated in normal and cancer cells.	Burnham Inst Med Res, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Strongin, AY (corresponding author), 10901 N Torrey Pines Rd, La Jolla, CA USA.	strongin@burnham.org	Golubkov, Vladislav/L-6828-2017; Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	NATIONAL CANCER INSTITUTE [R01CA083017, R01CA077470] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER; NCI NIH HHS [CA83017, R01 CA083017, CA77470, R01 CA077470] Funding Source: Medline; NCRR NIH HHS [RR020843, U54 RR020843] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BECKER JW, 1995, PROTEIN SCI, V4, P1966, DOI 10.1002/pro.5560041002; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Deryugina EI, 1997, J CELL SCI, V110, P2473; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Fugere M, 2002, J BIOL CHEM, V277, P7648, DOI 10.1074/jbc.M107467200; Golubkov VS, 2005, J BIOL CHEM, V280, P25079, DOI 10.1074/jbc.M502779200; HANGLOW AC, 1993, AGENTS ACTIONS, V39, P148; Holmbeck K, 2004, J CELL PHYSIOL, V200, P11, DOI 10.1002/jcp.20065; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Itoh Y, 2006, IUBMB LIFE, V58, P589, DOI 10.1080/15216540600962818; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Kang TB, 2002, CANCER RES, V62, P675; Kotra LP, 2001, J AM CHEM SOC, V123, P3108, DOI 10.1021/ja001896a; Kridel SJ, 2002, J BIOL CHEM, V277, P23788, DOI 10.1074/jbc.M111574200; Maskos K, 2005, BIOCHIMIE, V87, P249, DOI 10.1016/j.biochi.2004.11.019; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Murphy G, 1999, APMIS, V107, P38, DOI 10.1111/j.1699-0463.1999.tb01524.x; Osenkowski P, 2004, J CELL PHYSIOL, V200, P2, DOI 10.1002/jcp.20064; PARK AJ, 1991, J BIOL CHEM, V266, P1584; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; Ratnikov B, 2000, ANAL BIOCHEM, V286, P149, DOI 10.1006/abio.2000.4798; Remacle AG, 2006, ONCOGENE, V25, P5648, DOI 10.1038/sj.onc.1209572; Rozanov DV, 2004, J BIOL CHEM, V279, P4260, DOI 10.1074/jbc.M311569200; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Seiki M, 2003, CANCER SCI, V94, P569, DOI 10.1111/j.1349-7006.2003.tb01484.x; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; STRONGIN AY, 1993, J BIOL CHEM, V268, P14033; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wewer UM, 2006, J BIOL CHEM, V281, P9418, DOI 10.1074/jbc.M513580200; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Yana I, 2002, CLIN EXP METASTAS, V19, P209, DOI 10.1023/A:1015527220537; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Zdobnov EM, 2002, BIOINFORMATICS, V18, P368, DOI 10.1093/bioinformatics/18.2.368; Zucker S, 2003, CURR TOP DEV BIOL, V54, P1, DOI 10.1016/S0070-2153(03)54004-2	42	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36283	36291		10.1074/jbc.M706290200	http://dx.doi.org/10.1074/jbc.M706290200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17938169	hybrid			2022-12-25	WOS:000251458300019
J	Hagihara, Y; Mine, S; Uegaki, K				Hagihara, Yoshihisa; Mine, Shouhei; Uegaki, Koichi			Stabilization of an immunoglobulin fold domain by an engineered disulfide bond at the buried hydrophobic region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBONIC-ANHYDRASE-II; AMINO-ACID PAIRS; ANTIBODY FRAGMENTS; CONFORMATIONAL STABILITY; GLOBULAR-PROTEINS; CRYSTAL-STRUCTURE; CHAIN; DISPLAY; THERMOSTABILITY; RESIDUES	We report for the first time the stabilization of an immunoglobulin fold domain by an engineered disulfide bond. In the llama single-domain antibody, which has human chorionic gonadotropin as its specific antigen, Ala(49) and Ile(70) are buried in the structure. A mutant with an artificial disulfide bond at this position showed a 10 degrees C higher midpoint temperature of thermal unfolding than that without the extra disulfide bond. The modified domains exhibited an antigen binding affinity comparable with that of the wild-type domain. Ala(49) and Ile(70) are conserved in camel and llama single-domain antibody frameworks. Therefore, domains against different antigens are expected to be stabilized by the engineered disulfide bond examined here. In addition to the effect of the loop constraints in the unfolded state, thermodynamic analysis indicated that internal interaction and hydration also control the stability of domains with disulfide bonds. The change in physical properties resulting from mutation often causes unpredictable and destabilizing effects on these interactions. The introduction of a hydrophobic cystine into the hydrophobic region maintains the hydrophobicity of the protein and is expected to minimize the unfavorable mutational effects.	Natl Inst Adv Ind Sci & Technol, Res Inst Cell Engn, Ikeda, Osaka 5638577, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Hagihara, Y (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Inst Cell Engn, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan.	hagihara-kappael@aist.go.jp	HAGIHARA, Yoshihisa/K-4996-2016	HAGIHARA, Yoshihisa/0000-0002-5980-1764	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR-01081] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BETZ SF, 1992, BIOCHEMISTRY-US, V31, P12337, DOI 10.1021/bi00164a007; Burton RE, 2000, PROTEIN SCI, V9, P776; Dani VS, 2003, PROTEIN ENG, V16, P187, DOI 10.1093/proeng/gzg024; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Desmyter A, 2001, J BIOL CHEM, V276, P26285, DOI 10.1074/jbc.M102107200; Doering DS, 1996, BIOCHEMISTRY-US, V35, P12677, DOI 10.1021/bi9615699; Dolk E, 2005, APPL ENVIRON MICROB, V71, P442, DOI 10.1128/AEM.71.1.442-450.2005; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; FAUCHERE JL, 1983, EUR J MED CHEM, V18, P369; GOTO Y, 1979, J BIOCHEM-TOKYO, V86, P1433, DOI 10.1093/oxfordjournals.jbchem.a132661; Hagihara Y, 2005, J BIOL CHEM, V280, P24752, DOI 10.1074/jbc.M503963200; Hagihara Y, 2002, J BIOL CHEM, V277, P51043, DOI 10.1074/jbc.M208893200; Hagihara Y, 2002, P NATL ACAD SCI USA, V99, P6619, DOI 10.1073/pnas.102172099; Hagihara Y, 1997, J BIOCHEM-TOKYO, V121, P128; Johnson CM, 1997, J MOL BIOL, V268, P198, DOI 10.1006/jmbi.1997.0928; Ko JH, 1996, BIOCHEM BIOPH RES CO, V221, P631, DOI 10.1006/bbrc.1996.0647; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Ladenson RC, 2006, ANAL CHEM, V78, P4501, DOI 10.1021/ac058044j; Lipovsek D, 2007, J MOL BIOL, V368, P1024, DOI 10.1016/j.jmb.2007.02.029; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; Martensson LG, 2002, BIOCHEMISTRY-US, V41, P15867, DOI 10.1021/bi020433+; MITCHINSON C, 1989, BIOCHEMISTRY-US, V28, P4807, DOI 10.1021/bi00437a043; Muyldermans S, 2001, J Biotechnol, V74, P277; Nagano N, 1999, FEBS LETT, V458, P69, DOI 10.1016/S0014-5793(99)01122-9; Ohhashi Y, 2002, J BIOCHEM, V131, P45, DOI 10.1093/oxfordjournals.jbchem.a003076; PACE CN, 1988, J BIOL CHEM, V263, P11820; Perez JMJ, 2001, BIOCHEMISTRY-US, V40, P74, DOI 10.1021/bi0009082; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POLAND DC, 1965, BIOPOLYMERS, V3, P379, DOI 10.1002/bip.1965.360030404; Reading NS, 2000, BIOTECHNOL PROGR, V16, P326, DOI 10.1021/bp0000151; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; Spinelli S, 1996, NAT STRUCT BIOL, V3, P752, DOI 10.1038/nsb0996-752; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; van der Linden RHJ, 1999, BBA-PROTEIN STRUCT M, V1431, P37, DOI 10.1016/S0167-4838(99)00030-8; WAKARCHUK WW, 1994, PROTEIN ENG, V7, P1379, DOI 10.1093/protein/7.11.1379; Zavodszky M, 2001, PROTEIN SCI, V10, P149, DOI 10.1110/ps.26801	38	78	82	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36489	36495		10.1074/jbc.M707078200	http://dx.doi.org/10.1074/jbc.M707078200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17932041	hybrid			2022-12-25	WOS:000251458300041
J	Hovhannisyan, RH; Carstens, RP				Hovhannisyan, Ruben H.; Carstens, Russ P.			Heterogeneous ribonucleoprotein M is a splicing regulatory protein that can enhance or silence splicing of alternatively spliced Exons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; TRACT-BINDING-PROTEIN; FACTOR RECEPTOR 2; HNRNP-M PROTEINS; IN-VIVO; IDENTIFICATION; SPECIFICITY; ACTIVATION; REPRESSION; EXPRESSION	Splicing of fibroblast growth factor receptor 2 (FGFR2) alternative exons IIIb and IIIc is regulated by the auxiliary RNA cis-element ISE/ISS-3 that promotes splicing of exons IIIb and silencing of exon IIIc. Using RNA affinity chromatography, we have identified heterogeneous nuclear ribonucleoprotein M (hnRNP M) as a splicing regulatory factor that binds to ISE/ISS-3 in a sequence-specific manner. Overexpression of hnRNP M promoted exon IIIc skipping in a cell line that normally includes it, and association of hnRNP M with ISE/ISS-3 was shown to contribute to this splicing regulatory function. Thus hnRNP M, along with other members of the hnRNP family of RNA-binding proteins, plays a combinatorial role in regulation of FGFR2 alternative splicing. We also determined that hnRNP M can affect the splicing of several other alternatively spliced exons. This activity of hnRNP M included the ability not only to induce exon skipping but also to promote exon inclusion. This is the first report demonstrating a role for this abundant hnRNP family member in alternative splicing in mammals and suggests that this protein may broadly contribute to the fidelity of splice site recognition and alternative splicing regulation.	Univ Penn, Sch Med, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Carstens, RP (corresponding author), Univ Penn, Sch Med, Dept Med, Renal Electrolyte & Hypertens Div, 480 Hill Pavil,380 S Univ Ave, Philadelphia, PA 19104 USA.	russcars@mail.med.upenn.edu			NCI NIH HHS [CA093769] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA093769] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baraniak AP, 2006, MOL CELL BIOL, V26, P1209, DOI 10.1128/MCB.26.4.1209-1222.2006; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blanchette M, 1999, EMBO J, V18, P1939, DOI 10.1093/emboj/18.7.1939; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Caputi M, 2004, J VIROL, V78, P6517, DOI 10.1128/JVI.78.12.6517-6526.2004; Carstens RP, 1998, MOL CELL BIOL, V18, P2205, DOI 10.1128/MCB.18.4.2205; Carstens RP, 2000, MOL CELL BIOL, V20, P7388, DOI 10.1128/MCB.20.19.7388-7400.2000; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Cooper TA, 1998, MOL CELL BIOL, V18, P4519, DOI 10.1128/MCB.18.8.4519; Cooper TA, 1999, METH MOL B, V118, P391; DATAR KV, 1993, NUCLEIC ACIDS RES, V21, P439, DOI 10.1093/nar/21.3.439; Del Gato-Konczak F, 2000, MOL CELL BIOL, V20, P6287, DOI 10.1128/MCB.20.17.6287-6299.2000; Del Gatto-Konczak F, 1999, MOL CELL BIOL, V19, P251; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Gattoni R, 1996, NUCLEIC ACIDS RES, V24, P2535, DOI 10.1093/nar/24.13.2535; Geng J, 2006, PROTEIN EXPRES PURIF, V48, P142, DOI 10.1016/j.pep.2006.01.021; Han J, 2005, NUCLEIC ACIDS RES, V33, P2769, DOI 10.1093/nar/gki561; Hase ME, 2006, J BIOL CHEM, V281, P39135, DOI 10.1074/jbc.M604235200; Hovhannisyan RH, 2006, NUCLEIC ACIDS RES, V34, P373, DOI 10.1093/nar/gkj407; Hovhannisyan RH, 2005, MOL CELL BIOL, V25, P250, DOI 10.1128/MCB.25.1.250-263.2005; Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677; Jin W, 1999, J BIOL CHEM, V274, P28035, DOI 10.1074/jbc.274.39.28035; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Jurica MS, 2002, METHODS, V28, P336, DOI 10.1016/S1046-2023(02)00240-2; Kafasla P, 2002, BIOCHEM J, V363, P793, DOI 10.1042/0264-6021:3630793; Kiesler E, 2005, J CELL BIOL, V168, P1013, DOI 10.1083/jcb.200407173; LADD AN, 2002, GENOME BIOL; Le Guienr C, 2001, J BIOL CHEM, V276, P40638, DOI 10.1074/jbc.M105642200; Le Guiner C, 2001, J BIOL CHEM, V276, P43677, DOI 10.1074/jbc.M107381200; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Muh SJ, 2002, J BIOL CHEM, V277, P50143, DOI 10.1074/jbc.M207409200; NASIM FH, 1990, GENE DEV, V4, P1172, DOI 10.1101/gad.4.7.1172; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Newman EA, 2006, RNA, V12, P1129, DOI 10.1261/rna.34906; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; PINOLROMA S, 1988, GENE DEV, V2, P215, DOI 10.1101/gad.2.2.215; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; SWANSON MS, 1988, EMBO J, V7, P3519, DOI 10.1002/j.1460-2075.1988.tb03228.x; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; Tsai A, 2006, NAT PROTOC, V1, P2820, DOI 10.1038/nprot.2006.371; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Walker J, 1998, METH MOL B, V77, P365; Yeh BK, 2003, P NATL ACAD SCI USA, V100, P2266, DOI 10.1073/pnas.0436500100; Zhang WQ, 2002, RNA, V8, P671, DOI 10.1017/S1355838202027036	46	57	62	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36265	36274		10.1074/jbc.M704188200	http://dx.doi.org/10.1074/jbc.M704188200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17959601	hybrid			2022-12-25	WOS:000251458300017
J	Kim, HJ; Li, Q; Tjon-Kon-Sang, S; So, I; Kiselyov, K; Muallem, S				Kim, Hyun Jin; Li, Qin; Tjon-Kon-Sang, Sandra; So, Insuk; Kiselyov, Kirill; Muallem, Shmuel			Gain-of-function mutation in TRPML3 causes the mouse varitint-waddler phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-HELIX; CHANNELS	TRPML3 is a member of the TRPML subfamily of the transient receptor potential cation channel superfamily. The TRPML3(A419P) mutation causes a severe form, whereas the TRPML3(I362T/A419P) mutation results in a mild form of the varitint-waddler phenotype. The channel properties of TRPML3 and how the mutations cause each phenotype are not known. In this study, we report the first channel properties of TRPML3 as a strongly inward rectifying cation channel with a novel regulation by extracytosolic Na+. Preincubating the extracytosolic face of TRPML3 in Na+ free medium is required for channel activation, but then the channel slowly inactivates. The A419P mutation locks the channel in an open unregulated state. Similar gain of function was observed with the A419G mutation, which, like A419P, is expected to destabilize the alpha-helical fifth transmembrane domain of TRPML3. The I362T mutation results in an inactive channel, but the channel properties of TRPML3(I362T/A419P) are similar to those of TRPML3(A419P). However, the surface expression and current density of TRPML3(I362T/A419P) are lower than those of TRPML3(A419P). The A419P mutation also affects channel glycosylation and causes massive cell death. These findings show that the varitint-waddler phenotype is due to a gain of function of TRPML3( A419P) that is reduced by the TRPML3(I362T/A419P) mutant, resulting in a milder phenotype.	Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; Seoul Natl Univ, Coll Med, Dept Physiol & Biophys, Seoul 110799, South Korea; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Seoul National University (SNU); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Muallem, S (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	Shmuel.Muallem@UTSouthwestern.edu	So, Insuk/J-2762-2012	Kiselyov, Kirill/0000-0001-6683-2895	NIDCR NIH HHS [DE12309] Funding Source: Medline; NIDDK NIH HHS [DK38938] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038938] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Atiba-Davies M, 2007, BBA-MOL BASIS DIS, V1772, P1028, DOI 10.1016/j.bbadis.2007.01.007; Aurora R, 1997, J BIOL CHEM, V272, P1413, DOI 10.1074/jbc.272.3.1413; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; Kiselyov K, 2007, J PHYSIOL-LONDON, V578, P641, DOI 10.1113/jphysiol.2006.119024; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; SAMATEY FA, 1995, P NATL ACAD SCI USA, V92, P4577, DOI 10.1073/pnas.92.10.4577; Song YM, 2006, EUR J CELL BIOL, V85, P1253, DOI 10.1016/j.ejcb.2006.08.004; Venkatachalam K, 2006, J BIOL CHEM, V281, P17517, DOI 10.1074/jbc.M600807200	9	89	90	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36138	36142		10.1074/jbc.C700190200	http://dx.doi.org/10.1074/jbc.C700190200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17962195	hybrid			2022-12-25	WOS:000251458300003
J	Zeng, XM; Kucharczyk, R; di Rago, JP; Tzagoloff, A				Zeng, Xiaomei; Kucharczyk, Roza; di Rago, Jean-Paul; Tzagoloff, Alexander			The leader peptide of yeast Atp6p is required for efficient interaction with the Atp9p ring of the mitochondrial ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MEMBRANE SYSTEM; F1F0-ATP SYNTHASE; GENE; SEQUENCE; SUBUNIT-6; COMPLEX; BIOGENESIS; MORPHOLOGY; MUTANTS	Atp6p (subunit 6) of the Saccharomyces cerevisiae mitochondrial ATPase is synthesized with an N-terminal 10-amino acid presequence that is cleaved during assembly of the complex. This study has examined the role of the Atp6p presequence in the function and assembly of the ATPase complex. Two mutants were constructed in which the codons for amino acids 2-9 or 2 -10 of the Atp6p precursor were deleted from the mitochondrial ATP6 gene. The concentration of Atp6p and ATPase complex was approximately 2 times less in the mutants. The lower concentration of ATPase complex in the leaderless mutants correlated with less Atp6p complexed with the Atp9p ring of the F-o sector and with accumulation of an Atp6p-Atp8p complex that aggregated into polymers destined for eventual proteolytic elimination. We propose that the presequence either targets Atp6p to the Atp9p or signals insertion of the Atp6p precursor into a microcompartment of the membrane for more efficient interaction with the Atp9p ring. Despite the ATPase deficiency, growth of the leaderless atp6 mutants on respiratory substrates and the efficiency of oxidative phosphorylation were similar to that of wild type, indicating that the mutations did not affect the proton permeability of mitochondria.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Univ Victor Segalen, Inst Biochim & Genet Cellulaires, F-33077 Bordeaux, France	Columbia University; UDICE-French Research Universities; Universite de Bordeaux	Tzagoloff, A (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	spud@cubpet2.bio.columbia.edu	Kucharczyk, Roza/H-8154-2012	Kucharczyk, Roza/0000-0002-8712-7535	NHLBI NIH HHS [R01 HL022174, HL2274] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL022174] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ackerman SH, 2005, PROG NUCLEIC ACID RE, V80, P95, DOI 10.1016/S0079-6603(05)80003-0; Bonnefoy N, 2001, METHOD CELL BIOL, V65, P381, DOI 10.1016/S0091-679X(01)65022-2; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X; FAYE G, 1974, J MOL BIOL, V88, P105, DOI 10.1016/0022-2836(74)90304-0; Fillingame RH, 2000, NAT STRUCT BIOL, V7, P1002, DOI 10.1038/80902; Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7; Guerin B, 1979, Methods Enzymol, V55, P149; HADIKUSUMO RG, 1988, BIOCHIM BIOPHYS ACTA, V933, P212, DOI 10.1016/0005-2728(88)90072-2; Hell K, 2000, J BIOL CHEM, V275, P4571, DOI 10.1074/jbc.275.7.4571; HENSGENS LAM, 1979, P NATL ACAD SCI USA, V76, P1663, DOI 10.1073/pnas.76.4.1663; King EJ, 1932, BIOCHEM J, V26, P292, DOI 10.1042/bj0260292; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACINO G, 1979, J BIOL CHEM, V254, P4617; MACINO G, 1980, CELL, V20, P507, DOI 10.1016/0092-8674(80)90637-6; MACREADIE IG, 1983, NUCLEIC ACIDS RES, V11, P4435, DOI 10.1093/nar/11.13.4435; MICHON T, 1988, EUR J BIOCHEM, V172, P621, DOI 10.1111/j.1432-1033.1988.tb13934.x; MUKHOPADHYAY A, 1994, FEBS LETT, V343, P160, DOI 10.1016/0014-5793(94)80310-2; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Osman C, 2007, MOL BIOL CELL, V18, P627, DOI 10.1091/mbc.E06-09-0839; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200; RIGOULET M, 1979, FEBS LETT, V102, P18, DOI 10.1016/0014-5793(79)80919-9; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Steele DF, 1996, P NATL ACAD SCI USA, V93, P5253, DOI 10.1073/pnas.93.11.5253; Stephens AN, 2003, J BIOL CHEM, V278, P17867, DOI 10.1074/jbc.M300967200; Torello AT, 1997, GENETICS, V145, P903; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8228; Velours J, 2000, J BIOENERG BIOMEMBR, V32, P383, DOI 10.1023/A:1005580020547; Zeng XM, 2007, MOL BIOL CELL, V18, P617, DOI 10.1091/mbc.E06-09-0801	33	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36167	36176		10.1074/jbc.M705436200	http://dx.doi.org/10.1074/jbc.M705436200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17940284	hybrid			2022-12-25	WOS:000251458300006
J	Techau, ME; Valdez-Taubas, J; Popoff, JF; Francis, R; Seaman, M; Blackwell, JM				Techau, Michala Eichner; Valdez-Taubas, Javier; Popoff, Jean-Francois; Francis, Richard; Seaman, Matthew; Blackwell, Jenefer M.			Evolution of differences in transport function in Slc11a family members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE PROTEIN-1 NRAMP1; MESSENGER-RNA STABILITY; UBIQUITIN LIGASE RSP5; NATURAL-RESISTANCE; FORMERLY NRAMP1; SUBCELLULAR-LOCALIZATION; MEMBRANE-PROTEINS; IRON TRANSPORT; SUPEROXIDE-DISMUTASE; GENOMIC ORGANIZATION	Slc11a1 ( formerly Nramp1) is a proton/divalent cation transporter that regulates cation homeostasis in macrophages. Slc11a2 mediates divalent cation uptake via the gut and delivery into cells. The mode of action of the two transporters remains controversial. Heterologous expression in frog oocytes shows Slc11a2 is a symporter, whereas Slc11a1 is an antiporter fluxing divalent cations against the proton gradient. This explains why Slc11a2, but not Slc11a1, can complement EGTA sensitivity in smf1 Delta/smf2 Delta/smf3 Delta yeast. However, some studies of transport in mammalian cells suggest Slc11a1 is a symporter. We now demonstrate that Slc11a1, but not Slc11a2, complements a divalent cation stress phenotype in bsd2 Delta/ rer1 Delta yeast. This is the first description of a yeast complementation assay for Slc11a1 function. Given the prior demonstration in frog oocytes that Slc11a1 acts as an antiporter, the most plausible interpretation of the data is that Slc11a1 is rescuing bsd2 Delta/ rer1 Delta yeast by exporting divalent cations. Chimaeras define the N terminus, and a segment of the protein core preceding transmembrane domain 9 through transmembrane domain 12, as important in rescuing the divalent cation stress phenotype. EGTA sensitivity and divalent cation stress phenotypes in yeast expressing Slc11a orthologues show that symport activity is ancestral. Molecular changes that mediate rescue of the divalent cation stress phenotype post- date frogs and co- evolved with Slc11a1 orthologues that regulate divalent cation homeostasis in macrophages and resistance to infection in chickens and mammals.	Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Inst Med Res, Cambridge CB2 2XY, England; MRC, Mol Biol Lab, Cambridge CB2 0QH, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; MRC Laboratory Molecular Biology	Blackwell, JM (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Inst Med Res, Hills Rd,Wellcome Trust MRC Bldg, Cambridge CB2 2XY, England.	jennie.blackwell@cimr.cam.ac.uk	Francis, Richard/K-2812-2019	Francis, Richard/0000-0003-1580-7934; Valdez Taubas, Javier/0000-0002-2806-9419	MRC [G117/452] Funding Source: UKRI; Medical Research Council [G117/452] Funding Source: Medline; Wellcome Trust [065642] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Agranoff D, 1999, J EXP MED, V190, P717, DOI 10.1084/jem.190.5.717; Atkinson PGP, 1998, FEBS LETT, V425, P239, DOI 10.1016/S0014-5793(98)00236-1; Atkinson PGP, 1999, IMMUNOLOGY, V96, P656; BARTON CH, 1994, J EXP MED, V179, P1683, DOI 10.1084/jem.179.5.1683; Blackwell JM, 2004, MOL B INT U, P53; BLACKWELL JM, 1995, MOL MED, V1, P194, DOI 10.1007/BF03401567; Blackwell JM, 2001, CELL MICROBIOL, V3, P773, DOI 10.1046/j.1462-5822.2001.00150.x; BLACKWELL JM, 2004, CELL MICROBIOL, P53; Brown DH, 1997, INFECT IMMUN, V65, P597, DOI 10.1128/IAI.65.2.597-603.1997; Canonne-Hergaux F, 2002, BLOOD, V100, P268, DOI 10.1182/blood.V100.1.268; Canonne-Hergaux F, 2001, BLOOD, V98, P3823, DOI 10.1182/blood.V98.13.3823; Canonne-Hergaux F, 1999, BLOOD, V93, P4406, DOI 10.1182/blood.V93.12.4406.412k21_4406_4417; CELLIER M, 1994, J EXP MED, V180, P1741, DOI 10.1084/jem.180.5.1741; Chung J, 2004, P NATL ACAD SCI USA, V101, P2700, DOI 10.1073/pnas.0306622101; Delaby C, 2005, BLOOD, V106, P3979, DOI 10.1182/blood-2005-06-2398; Delaby C, 2005, EXP CELL RES, V310, P43, DOI 10.1016/j.yexcr.2005.07.002; Dorschner MO, 1999, DNA CELL BIOL, V18, P573, DOI 10.1089/104454999315123; Ellis CD, 2004, J CELL BIOL, V166, P325, DOI 10.1083/jcb.200401157; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Forbes JR, 2003, BLOOD, V102, P1884, DOI 10.1182/blood-2003-02-0425; Garrick MD, 2006, BIOL RES, V39, P79, DOI 10.4067/S0716-97602006000100009; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goswami T, 2001, BIOCHEM J, V354, P511, DOI 10.1042/0264-6021:3540511; GRUENHEID S, 1995, GENOMICS, V25, P514, DOI 10.1016/0888-7543(95)80053-O; Gruenheid S, 1997, J EXP MED, V185, P717, DOI 10.1084/jem.185.4.717; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; HU J, 1995, MAMM GENOME, V6, P809, DOI 10.1007/BF00539010; Hu JX, 1997, GENOME RES, V7, P693, DOI 10.1101/gr.7.7.693; Hu JX, 1996, DNA CELL BIOL, V15, P113, DOI 10.1089/dna.1996.15.113; Jabado N, 2000, J EXP MED, V192, P1237, DOI 10.1084/jem.192.9.1237; Ke SH, 1997, NUCLEIC ACIDS RES, V25, P3371, DOI 10.1093/nar/25.16.3371; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; Knutson MD, 2003, BLOOD, V102, P4191, DOI 10.1182/blood-2003-04-1250; Kramer J, 2003, ANIM GENET, V34, P339, DOI 10.1046/j.1365-2052.2003.01027.x; Kuhn DE, 1999, J LEUKOCYTE BIOL, V66, P113, DOI 10.1002/jlb.66.1.113; Kuhn DE, 2001, J LEUKOCYTE BIOL, V69, P43; Lafuse WP, 2000, BIOCHEM J, V351, P687, DOI 10.1042/0264-6021:3510687; Lafuse WP, 2002, CELL IMMUNOL, V215, P195, DOI 10.1016/S0008-8749(02)00026-6; Lam-Yuk-Tseung S, 2005, BIOCHEMISTRY-US, V44, P12149, DOI 10.1021/bi050911r; Lam-Yuk-Tseung S, 2003, BLOOD, V101, P3699, DOI 10.1182/blood-2002-07-2108; Liu XF, 1999, J BIOL CHEM, V274, P4863, DOI 10.1074/jbc.274.8.4863; LIU XF, 1992, J BIOL CHEM, V267, P18298; LIU XF, 1994, MOL CELL BIOL, V14, P7037, DOI 10.1128/MCB.14.11.7037; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; Mercer JFB, 2001, TRENDS MOL MED, V7, P64, DOI 10.1016/S1471-4914(01)01920-7; Mete A, 2005, BLOOD CELL MOL DIS, V34, P151, DOI 10.1016/j.bcmd.2004.12.001; Miyabe S, 2000, BIOCHEM BIOPH RES CO, V276, P879, DOI 10.1006/bbrc.2000.3580; Mulero V, 2002, BIOCHEM J, V363, P89, DOI 10.1042/0264-6021:3630089; Olivier M, 1998, EUR J BIOCHEM, V251, P734, DOI 10.1046/j.1432-1327.1998.2510734.x; PENDLETON JW, 1993, P NATL ACAD SCI USA, V90, P6300, DOI 10.1073/pnas.90.13.6300; Pinner E, 1997, J BIOL CHEM, V272, P28933, DOI 10.1074/jbc.272.46.28933; Reddy JV, 2001, MOL BIOL CELL, V12, P3242, DOI 10.1091/mbc.12.10.3242; RODRIGUES V, 1995, EMBO J, V14, P3007, DOI 10.1002/j.1460-2075.1995.tb07303.x; Sato K, 2003, MOL BIOL CELL, V14, P3605, DOI 10.1091/mbc.E02-12-0777; Sato K, 2001, J CELL BIOL, V152, P935, DOI 10.1083/jcb.152.5.935; Searle S, 1998, J CELL SCI, V111, P2855; Sibthorpe D, 2004, DNA CELL BIOL, V23, P45, DOI 10.1089/104454904322745925; Stober CB, 2007, INFECT IMMUN, V75, P5059, DOI 10.1128/IAI.00153-07; Strausak D, 2001, BRAIN RES BULL, V55, P175, DOI 10.1016/S0361-9230(01)00454-3; Sullivan JA, 2007, MOL BIOL CELL, V18, P2429, DOI 10.1091/mbc.e07-01-0011; Tabuchi M, 1999, BIOCHEM J, V344, P211, DOI 10.1042/0264-6021:3440211; Tabuchi M, 2002, MOL BIOL CELL, V13, P4371, DOI 10.1091/mbc.E02-03-0165; Touret N, 2003, J BIOL CHEM, V278, P25548, DOI 10.1074/jbc.M212374200; VIDAL S, 1995, MAMM GENOME, V6, P224, DOI 10.1007/BF00352405; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; White JK, 2005, J LEUKOCYTE BIOL, V77, P311, DOI 10.1189/jlb.0904546; White JK, 2004, BIOCHEM J, V382, P811, DOI 10.1042/BJ20040808; Wyllie S, 2002, MICROBES INFECT, V4, P351, DOI 10.1016/S1286-4579(02)01548-4; Zwilling BS, 1999, INFECT IMMUN, V67, P1386, DOI 10.1128/IAI.67.3.1386-1392.1999	71	36	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35646	35656		10.1074/jbc.M707057200	http://dx.doi.org/10.1074/jbc.M707057200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17932044	hybrid			2022-12-25	WOS:000251458100025
J	Albright, RA; Joh, K; Morais-Cabral, JH				Albright, Ronald A.; Joh, Kyu; Morais-Cabral, Joao H.			Probing the structure of the dimeric KtrB membrane protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOL CROSS-LINKING; K+-UPTAKE SYSTEM; VIBRIO-ALGINOLYTICUS; ESCHERICHIA-COLI; POTASSIUM CHANNEL; LACTOSE PERMEASE; MOLECULAR RULERS; GLYCINE RESIDUES; TRANSPORTERS; SELECTIVITY	The KtrAB ion transporter is a complex of two proteins, KtrB and KtrA. The integral membrane protein KtrB is expected to adopt the structural architecture typified by the pore domain of potassium channels. Here we show that homo-dimerization of KtrB proteins is most likely a general property of this family of transporters. Using cysteine mutants and bifunctional cross-linkers we define regions of the Bacillus subtilis KtrB molecule that are close to the molecular 2-fold axis and to the dimer interface. Fitting of the cross-linking data to a potassium channel-like model suggests structural similarities between potassium channels and KtrB proteins in the extracellular half of the molecule and differences in the cytoplasmic regions.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Morais-Cabral, JH (corresponding author), Inst Biol Mol & Celular, R Campo Alegre 823, P-4150180 Oporto, Portugal.	jcabral@ibmc.up.pt	Morais-Cabral, Joao H/J-4914-2013	Morais-Cabral, Joao H/0000-0002-4461-9716	NIGMS NIH HHS [GM 068585] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068585] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028; Aller SG, 2004, J BIOL CHEM, V279, P53435, DOI 10.1074/jbc.M409421200; Amin DN, 2006, J BACTERIOL, V188, P894, DOI 10.1128/JB.188.3.894-901.2006; ARAKAWA T, 1992, ANAL BIOCHEM, V203, P53, DOI 10.1016/0003-2697(92)90042-6; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 1999, BIOPHYS J, V77, P775, DOI 10.1016/S0006-3495(99)76931-6; Ermolova N, 2003, P NATL ACAD SCI USA, V100, P10187, DOI 10.1073/pnas.1434239100; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Folta-Stogniew Ewa, 2006, V328, P97; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Guan L, 2002, P NATL ACAD SCI USA, V99, P3475, DOI 10.1073/pnas.052703699; HAYASHI Y, 1989, METHOD ENZYMOL, V172, P514; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kato Y, 2001, P NATL ACAD SCI USA, V98, P6488, DOI 10.1073/pnas.101556598; Kroning N, 2007, J BIOL CHEM, V282, P14018, DOI 10.1074/jbc.M609084200; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Maser P, 2002, P NATL ACAD SCI USA, V99, P6428, DOI 10.1073/pnas.082123799; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Nakamura T, 1998, J BACTERIOL, V180, P3491, DOI 10.1128/JB.180.13.3491-3494.1998; RUBIO F, 1995, SCIENCE, V270, P1660, DOI 10.1126/science.270.5242.1660; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Sorgen PL, 2002, P NATL ACAD SCI USA, V99, P14037, DOI 10.1073/pnas.182552199; Tholema N, 2005, J BIOL CHEM, V280, P41146, DOI 10.1074/jbc.M507647200; Tholema N, 1999, FEBS LETT, V450, P217, DOI 10.1016/S0014-5793(99)00504-9; Yernool D, 2003, BIOCHEMISTRY-US, V42, P12981, DOI 10.1021/bi030161q; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	27	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2007	282	48					35046	35055		10.1074/jbc.M704260200	http://dx.doi.org/10.1074/jbc.M704260200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	234IR	17932047	hybrid			2022-12-25	WOS:000251155200049
J	Lotscher, M; Recher, M; Lang, KS; Navarini, A; Hunziker, L; Santimaria, R; Glatzel, M; Schwarz, P; Boni, J; Zinkernagel, RM				Loetscher, Marius; Recher, Mike; Lang, Karl S.; Navarini, Alexander; Hunziker, Lukas; Santimaria, Roger; Glatzel, Markus; Schwarz, Petra; Boeni, Juerg; Zinkernagel, Rolf M.			Induced Prion Protein Controls Immune-Activated Retroviruses in the Mouse Spleen	PLOS ONE			English	Article								The prion protein (PrP) is crucially involved in transmissible spongiform encephalopathies (TSE), but neither its exact role in disease nor its physiological function are known. Here we show for mice, using histological, immunochemical and PCR-based methods, that stimulation of innate resistance was followed by appearance of numerous endogenous retroviruses and ensuing PrP up-regulation in germinal centers of the spleen. Subsequently, the activated retroviruses disappeared in a PrP-dependent manner. Our results reveal the regular involvement of endogenous retroviruses in murine immune responses and provide evidence for an essential function of PrP in the control of the retroviral activity. The interaction between PrP and ubiquitous endogenous retroviruses may allow new interpretations of TSE pathophysiology and explain the evolutionary conservation of PrP.	[Loetscher, Marius; Recher, Mike; Lang, Karl S.; Navarini, Alexander; Hunziker, Lukas; Santimaria, Roger; Zinkernagel, Rolf M.] Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland; [Glatzel, Markus; Schwarz, Petra] Univ Zurich, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Boeni, Juerg] Univ Zurich, Swiss Natl Ctr Retroviruses, CH-8091 Zurich, Switzerland	University of Zurich; University of Zurich; University of Zurich	Lotscher, M (corresponding author), CSL Behring AG, Bern, Switzerland.	marius.loetscher@cslbehring.com	Boeni, Juerg/B-8386-2015; Lang, Karl S/R-2505-2016; Glatzel, Markus/V-8844-2019; Navarini, Alexander/C-5504-2014; Glatzel, Markus/G-3356-2011	Glatzel, Markus/0000-0002-7720-8817; Navarini, Alexander/0000-0001-7059-632X; Glatzel, Markus/0000-0002-7720-8817; Lang, Karl/0000-0001-9783-7605; Recher, Mike/0000-0002-9121-6936; Hunziker, Lukas/0000-0003-0081-8518	Swiss National Science Foundation; Novartis Stiftung; EMDO Stiftung Zurich; Jubilaumsstiftung der Schweizerischen Mobiliar Genossenschaft	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Stiftung; EMDO Stiftung Zurich; Jubilaumsstiftung der Schweizerischen Mobiliar Genossenschaft	The work was supported in part by grants from the Swiss National Science Foundation, the Novartis Stiftung, the EMDO Stiftung Zurich, and the Jubilaumsstiftung der Schweizerischen Mobiliar Genossenschaft (all to ML).	Adler V, 2003, J MOL BIOL, V332, P47, DOI 10.1016/S0022-2836(03)00919-7; Baker CA, 2004, J NEUROVIROL, V10, P29, DOI 10.1080/13550280490261761; BENDHEIM PE, 1992, NEUROLOGY, V42, P149, DOI 10.1212/WNL.42.1.149; Boni J, 1996, J MED VIROL, V49, P23, DOI 10.1002/(SICI)1096-9071(199605)49:1&lt;23::AID-JMV4&gt;3.0.CO;2-M; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Chesebro B, 2003, BRIT MED BULL, V66, P1, DOI 10.1093/bmb/66.1.1; Corcoran LM, 1999, J IMMUNOL, V163, P5836; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; EVANS LH, 1990, J VIROL, V64, P6176, DOI 10.1128/JVI.64.12.6176-6183.1990; Gabus C, 2001, J BIOL CHEM, V276, P19301, DOI 10.1074/jbc.M009754200; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; Leblanc P, 2004, J MOL BIOL, V337, P1035, DOI 10.1016/j.jmb.2004.02.007; Leblanc P, 2006, EMBO J, V25, P2674, DOI 10.1038/sj.emboj.7601162; Lee KH, 2006, BIOCHEM BIOPH RES CO, V349, P122, DOI 10.1016/j.bbrc.2006.08.016; Lotscher M, 2003, J IMMUNOL, V170, P6040, DOI 10.4049/jimmunol.170.12.6040; Lower R, 1999, TRENDS MICROBIOL, V7, P350, DOI 10.1016/S0966-842X(99)01565-6; McVicar DW, 2002, J IMMUNOL, V169, P1721, DOI 10.4049/jimmunol.169.4.1721; Mironov A, 2003, J NEUROSCI, V23, P7183, DOI 10.1523/JNEUROSCI.23-18-07183.2003; MORONI C, 1977, NATURE, V269, P600, DOI 10.1038/269600a0; Nelson PN, 2003, J CLIN PATHOL-MOL PA, V56, P11, DOI 10.1136/mp.56.1.11; Nishida N, 2005, SCIENCE, V310, P493, DOI 10.1126/science.1118155; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Richt JA, 2007, NAT BIOTECHNOL, V25, P132, DOI 10.1038/nbt1271; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; SAKAGUCHI S, 1995, J VIROL, V69, P7586, DOI 10.1128/JVI.69.12.7586-7592.1995; Sayer NM, 2004, J BIOL CHEM, V279, P13102, DOI 10.1074/jbc.M310928200; Stengel A, 2006, BIOCHEM BIOPH RES CO, V343, P825, DOI 10.1016/j.bbrc.2006.03.021; TOKUYASU KT, 1980, HISTOCHEM J, V12, P381, DOI 10.1007/BF01011956; Weiss S, 1997, J VIROL, V71, P8790, DOI 10.1128/JVI.71.11.8790-8797.1997; WEISSMANN C, 1991, NATURE, V352, P679, DOI 10.1038/352679a0; WESTERGARD L, 2007, BIOCHIM BIOPHYS ACTA, V2, P2; White P, 2002, J IMMUNOL, V168, P869, DOI 10.4049/jimmunol.168.2.869; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831	36	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1158	10.1371/journal.pone.0001158	http://dx.doi.org/10.1371/journal.pone.0001158			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987132	Green Published, gold			2022-12-25	WOS:000207459000040
J	Sass, C; Little, DP; Stevenson, DW; Specht, CD				Sass, Chodon; Little, Damon P.; Stevenson, Dennis Wm.; Specht, Chelsea D.			DNA Barcoding in the Cycadales: Testing the Potential of Proposed Barcoding Markers for Species Identification of Cycads	PLOS ONE			English	Article							CHLOROPLAST GENOME; LAND PLANTS; NUCLEAR; GENE; ALIGNMENT; TAXONOMY; SEQUENCE; RATES; TERM; TALE	Barcodes are short segments of DNA that can be used to uniquely identify an unknown specimen to species, particularly when diagnostic morphological features are absent. These sequences could offer a new forensic tool in plant and animal conservation-especially for endangered species such as members of the Cycadales. Ideally, barcodes could be used to positively identify illegally obtained material even in cases where diagnostic features have been purposefully removed or to release confiscated organisms into the proper breeding population. In order to be useful, a DNA barcode sequence must not only easily PCR amplify with universal or near-universal reaction conditions and primers, but also contain enough variation to generate unique identifiers at either the species or population levels. Chloroplast regions suggested by the Plant Working Group of the Consortium for the Barcode of Life (CBoL), and two alternatives, the chloroplast psbA-trnH intergenic spacer and the nuclear ribosomal internal transcribed spacer (nrITS), were tested for their utility in generating unique identifiers for members of the Cycadales. Ease of amplification and sequence generation with universal primers and reaction conditions was determined for each of the seven proposed markers. While none of the proposed markers provided unique identifiers for all species tested, nrITS showed the most promise in terms of variability, although sequencing difficulties remain a drawback. We suggest a workflow for DNA barcoding, including database generation and management, which will ultimately be necessary if we are to succeed in establishing a universal DNA barcode for plants.	[Sass, Chodon; Specht, Chelsea D.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Little, Damon P.; Stevenson, Dennis Wm.] New York Bot Garden, Cullman Program Mol Systemat Studies, Bronx, NY 10458 USA	University of California System; University of California Berkeley; New York Botanical Garden	Specht, CD (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	cdspecht@nature.berkeley.edu	赵, 鹏/B-8401-2009	Specht, Chelsea/0000-0001-7746-512X	University of California; Berkeley College of Natural Resources; Committee on Research; Department of Plant and Microbial Biology	University of California(University of California System); Berkeley College of Natural Resources; Committee on Research; Department of Plant and Microbial Biology	Funding: Partial funds were provided by University of California, Berkeley College of Natural Resources, the Committee on Research, and the Department of Plant and Microbial Biology. The funders had no involvement in the design and conduct of the study, in the collection, analysis and interpretation of the data, or in the preparation, review or approval of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chaw SM, 2005, MOL PHYLOGENET EVOL, V37, P214, DOI 10.1016/j.ympev.2005.01.006; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; *CITES, 2007, CONV INT TRAD END SP; DasGupa B, 2005, BIOINFORMATICS, V21, P3424, DOI 10.1093/bioinformatics/bti547; Dasgupta Bhaskar, 2005, Int J Bioinform Res Appl, V1, P145, DOI 10.1504/IJBRA.2005.007574; DONALDSON JS, 2003, CYCADS STATUS SURVEY; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Driscoll HE, 2007, AM J BOT, V94, P1413, DOI 10.3732/ajb.94.8.1413; Ebach MC, 2005, BIOSCIENCE, V55, P822; Gompert Z, 2006, MOL ECOL, V15, P1759, DOI 10.1111/j.1365-294X.2006.02905.x; Gonzalez D, 2002, SYST BOT, V27, P654; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hermsen EJ, 2006, AM J BOT, V93, P724, DOI 10.3732/ajb.93.5.724; HILL K, 2004, WORLD LIST CYCADE; Hill KD, 2003, INT J PLANT SCI, V164, P933, DOI 10.1086/378538; Jakob SS, 2006, MOL BIOL EVOL, V23, P1602, DOI 10.1093/molbev/msl018; JONES DL, 1993, CYCADS WORLD; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; LIDHOLM J, 1991, NUCLEIC ACIDS RES, V19, P2881, DOI 10.1093/nar/19.11.2881; LIDHOLM J, 1991, MOL GEN GENET, V226, P345, DOI 10.1007/BF00260645; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Maggini F, 1998, PLANT SYST EVOL, V213, P199, DOI 10.1007/BF00985200; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; Presting GG, 2006, CAN J BOT, V84, P1434, DOI 10.1139/B06-117; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rubinoff D, 2006, CONSERV BIOL, V20, P1548, DOI 10.1111/j.1523-1739.2006.00542.x; Stoeckle M, 2003, BIOSCIENCE, V53, P796, DOI 10.1641/0006-3568(2003)053[0796:TDATBC]2.0.CO;2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Whitelock L. M., 2002, The cycads; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Wolf PG, 2003, DNA RES, V10, P59, DOI 10.1093/dnares/10.2.59	44	205	240	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1154	10.1371/journal.pone.0001154	http://dx.doi.org/10.1371/journal.pone.0001154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987130	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459000036
J	Branduardi, P; Fossati, T; Sauer, M; Pagani, R; Mattanovich, D; Porro, D				Branduardi, Paola; Fossati, Tiziana; Sauer, Michael; Pagani, Roberto; Mattanovich, Diethard; Porro, Danilo			Biosynthesis of Vitamin C by Yeast Leads to Increased Stress Resistance	PLOS ONE			English	Article								Background. In industrial large scale bio-reactions micro-organisms are generally exposed to a variety of environmental stresses, which might be detrimental for growth and productivity. Reactive oxygen species (ROS) play a key role among the common stress factors-directly-through incomplete reduction of O-2 during respiration, or indirectly-caused by other stressing factors. Vitamin C or L-ascorbic acid acts as a scavenger of ROS, thereby potentially protecting cells from harmful oxidative products. While most eukaryotes synthesize ascorbic acid, yeast cells produce erythro-ascorbic acid instead. The actual importance of this antioxidant substance for the yeast is still a subject of scientific debate. Methodology/Principal Findings. We set out to enable Saccharomyces cerevisiae cells to produce ascorbic acid intracellularly to protect the cells from detrimental effects of environmental stresses. We report for the first time the biosynthesis of L-ascorbic acid from D-glucose by metabolically engineered yeast cells. The amount of L-ascorbic acid produced leads to an improved robustness of the recombinant cells when they are subjected to stress conditions as often met during industrial fermentations. Not only resistance against oxidative agents as H2O2 is increased, but also the tolerance to low pH and weak organic acids at low pH is increased. Conclusions/Significance. This platform provides a new tool whose commercial applications may have a substantial impact on bio-industrial production of Vitamin C. Furthermore, we propose S. cerevisiae cells endogenously producing vitamin C as a cellular model to study the genesis/protection of ROS as well as genotoxicity.	[Branduardi, Paola; Fossati, Tiziana; Pagani, Roberto; Porro, Danilo] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy; [Sauer, Michael; Mattanovich, Diethard] Univ Appl Sci, Sch Bioengn, Vienna, Austria; [Sauer, Michael; Mattanovich, Diethard] Univ Nat Resources & Appl Life Sci, Inst Appl Microbiol, Vienna, Austria	University of Milano-Bicocca; University of Natural Resources & Life Sciences, Vienna	Porro, D (corresponding author), Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy.	danilo.porro@unimib.it	Sauer, Michael/A-4735-2009	Sauer, Michael/0000-0003-0510-2447; PORRO, DANILO/0000-0001-5723-3700; Mattanovich, Diethard/0000-0002-0907-4167	Tate and Lyle North America; University of Milano Bicocca	Tate and Lyle North America; University of Milano Bicocca	Funding: This work was partially supported by Tate and Lyle North America and the University of Milano Bicocca (Far 60%). No contribution was given.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bai ZH, 2003, CRIT REV BIOTECHNOL, V23, P267, DOI 10.1080/07388550390449294; Banhegyi G, 1997, FREE RADICAL BIO MED, V23, P793, DOI 10.1016/S0891-5849(97)00062-2; Brambilla L, 1999, FEMS MICROBIOL LETT, V171, P133, DOI 10.1111/j.1574-6968.1999.tb13423.x; Branduardi P, 2004, FEMS YEAST RES, V4, P493, DOI 10.1016/S1567-1356(03)00200-9; Bremus C, 2006, J BIOTECHNOL, V124, P196, DOI 10.1016/j.jbiotec.2006.01.010; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hancock RD, 2000, FEMS MICROBIOL LETT, V186, P245, DOI 10.1016/S0378-1097(00)00155-5; Hancock RD, 2002, TRENDS BIOTECHNOL, V20, P299, DOI 10.1016/S0167-7799(02)01991-1; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Huh WK, 1998, MOL MICROBIOL, V30, P895, DOI 10.1046/j.1365-2958.1998.01133.x; Huh WK, 2001, INFECT IMMUN, V69, P3939, DOI 10.1128/IAI.69.6.3939-3946.2001; KLIS FM, 1994, YEAST, V10, P851, DOI 10.1002/yea.320100702; KNEKT P, 1991, AM J EPIDEMIOL, V134, P471, DOI 10.1093/oxfordjournals.aje.a116118; LEVINE M, 1986, NEW ENGL J MED, V314, P892, DOI 10.1056/NEJM198604033141407; Linster CL, 2007, J BIOL CHEM, V282, P18879, DOI 10.1074/jbc.M702094200; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Mattanovich D, 2004, J BIOTECHNOL, V113, P121, DOI 10.1016/j.jbiotec.2004.04.035; MINET M, 1992, PLANT J, V2, P417; Naidu KA, 2003, NUTR J, V2, DOI 10.1186/1475-2891-2-7; O'Brien TJ, 2003, MUTAT RES-FUND MOL M, V533, P3, DOI 10.1016/j.mrfmmm.2003.09.006; PADH H, 1990, BIOCHEM CELL BIOL, V68, P1166, DOI 10.1139/o90-173; PADH H, 1991, NUTR REV, V49, P65, DOI 10.1111/j.1753-4887.1991.tb07407.x; Pastuszak I, 1998, J BIOL CHEM, V273, P30165, DOI 10.1074/jbc.273.46.30165; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Sambrook J., 2002, MOL CLONING LAB MANU; SASAKI DT, 1987, CYTOMETRY, V8, P413, DOI 10.1002/cyto.990080411; Sauer M, 2004, APPL ENVIRON MICROB, V70, P6086, DOI 10.1128/AEM.70.10.6086-6091.2004; Spickett CM, 2000, FREE RADICAL BIO MED, V28, P183, DOI 10.1016/S0891-5849(99)00214-2; SULLIVAN MX, 1955, ASS OFF AGR CHEM, V38, P514; Survase SA, 2006, FOOD TECHNOL BIOTECH, V44, P381; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; Trommer H, 2002, PHARM RES-DORDR, V19, P982, DOI 10.1023/A:1016414422106; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Xiao AF, 2006, APPL MICROBIOL BIOT, V72, P837, DOI 10.1007/s00253-006-0338-1	37	71	74	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1092	10.1371/journal.pone.0001092	http://dx.doi.org/10.1371/journal.pone.0001092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971855	Green Published, Green Submitted, gold			2022-12-25	WOS:000207458700009
J	Fouquet, A; Gilles, A; Vences, M; Marty, C; Blanc, M; Gemmell, NJ				Fouquet, Antoine; Gilles, Andre; Vences, Miguel; Marty, Christian; Blanc, Michel; Gemmell, Neil J.			Underestimation of Species Richness in Neotropical Frogs Revealed by mtDNA Analyses	PLOS ONE			English	Article							MOLECULAR PHYLOGENETICS; GENETIC-DIVERGENCE; AMPHIBIAN DECLINES; DNA; SPECIATION; BIOGEOGRAPHY; DIVERSITY; ANURA; PHYLOGEOGRAPHY; POPULATIONS	Background. Amphibians are rapidly vanishing. At the same time, it is most likely that the number of amphibian species is highly underestimated. Recent DNA barcoding work has attempted to define a threshold between intra- and inter-specific genetic distances to help identify candidate species. In groups with high extinction rates and poorly known species boundaries, like amphibians, such tools may provide a way to rapidly evaluate species richness. Methodology. Here we analyse published and new 16S rDNA sequences from 60 frog species of Amazonia-Guianas to obtain a minimum estimate of the number of undescribed species in this region. We combined isolation by distance, phylogenetic analyses, and comparison of molecular distances to evaluate threshold values for the identification of candidate species among these frogs. Principal Findings. In most cases, geographically distant populations belong to genetically highly distinct lineages that could be considered as candidate new species. This was not universal among the taxa studied and thus widespread species of Neotropical frogs really do exist, contrary to previous assumptions. Moreover, the many instances of paraphyly and the wide overlap between distributions of inter- and intra-specific distances reinforce the hypothesis that many cryptic species remain to be described. In our data set, pairwise genetic distances below 0.02 are strongly correlated with geographical distances. This correlation remains statistically significant until genetic distance is 0.05, with no such relation thereafter. This suggests that for higher distances allopatric and sympatric cryptic species prevail. Based on our analyses, we propose a more inclusive pairwise genetic distance of 0.03 between taxa to target lineages that could correspond to candidate species. Conclusions. Using this approach, we identify 129 candidate species, two-fold greater than the 60 species included in the current study. This leads to estimates of around 170 to 460 frog taxa unrecognized in Amazonia-Guianas. Significance. As a consequence the global amphibian decline detected especially in the Neotropics may be worse than realised.	[Fouquet, Antoine; Gemmell, Neil J.] Univ Canterbury, Sch Biol Sci, Mol Ecol Lab, Christchurch 1, New Zealand; [Fouquet, Antoine; Gilles, Andre] Univ Aix Marseille 1, Ctr St Charles, EA EGEE Evolut Genome Environm 3781, Marseille, France; [Vences, Miguel] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Div Evolutionary Biol, D-3300 Braunschweig, Germany; [Blanc, Michel] RN2 PK35, Roura, French Guiana	University of Canterbury; UDICE-French Research Universities; Aix-Marseille Universite; Braunschweig University of Technology	Fouquet, A (corresponding author), Univ Canterbury, Sch Biol Sci, Mol Ecol Lab, Christchurch 1, New Zealand.	afo23@student.canterbury.ac.nz	Vences, Miguel/E-5573-2010; 赵, 鹏/B-8401-2009; Gemmell, Neil J/C-6774-2009	Gemmell, Neil J/0000-0003-0671-3637; Fouquet, Antoine/0000-0003-4060-0281; Vences, Miguel/0000-0003-0747-0817	College of Science, University of Canterbury, New Zealand Postgraduate Study Abroad Award; ECOFOR	College of Science, University of Canterbury, New Zealand Postgraduate Study Abroad Award; ECOFOR	AF is supported by a Scholarship from the College of Science, University of Canterbury. Field work was also supported by University of Canterbury College of Science, New Zealand Postgraduate Study Abroad Award and the EGEE laboratory which was supported by an ECOFOR grant.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; BERVEN KA, 1990, EVOLUTION, V44, P2047, DOI 10.1111/j.1558-5646.1990.tb04310.x; BLAUSTEIN AR, 1994, CONSERV BIOL, V8, P60, DOI 10.1046/j.1523-1739.1994.08010060.x; Boistel Renaud, 2006, Acta Herpetologica, V1, P1; Bossuyt F, 2000, P NATL ACAD SCI USA, V97, P6585, DOI 10.1073/pnas.97.12.6585; BUSH MB, 1994, J BIOGEOGR, V21, P5, DOI 10.2307/2845600; Campbell JA, 2000, HERPETOL MONOGR, V14, P186, DOI 10.2307/1467048; Chek AA, 2003, EVOL ECOL RES, V5, P69; Chek AA, 2001, MOL PHYLOGENET EVOL, V18, P370, DOI 10.1006/mpev.2000.0889; CHERRY LM, 1977, AM ZOOL, V17, P910; CHERRY LM, 1978, SCIENCE, V200, P209, DOI 10.1126/science.635583; Collins AC, 2000, INT J PRIMATOL, V21, P421, DOI 10.1023/A:1005487802312; Collins JP, 2005, PHILOS T R SOC B, V360, P309, DOI 10.1098/rstb.2004.1588; Cortes-Ortiz L, 2003, MOL PHYLOGENET EVOL, V26, P64, DOI 10.1016/S1055-7903(02)00308-1; Crawford AJ, 2005, MOL PHYLOGENET EVOL, V35, P536, DOI 10.1016/j.ympev.2005.03.006; de Queiroz K, 1999, SPECIES, P49; DRAPER NR, 1990, APPL REGRESSION ANAL; Dubois A, 2005, ALYTES, V22, P19; Duellman W.E., 1982, P389; DUELLMAN WE, 2004, CUSCO AMAZONICO LIVE; Duellman WE, 1999, PATTERNS DISTRIBUTIO; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; Emerson S.B., 1986, FIELDIANA ZOOL, V43, P1; Evans BJ, 2004, MOL PHYLOGENET EVOL, V33, P197, DOI 10.1016/j.ympev.2004.04.018; Faivovich J, 2005, B AM MUS NAT HIST, P6, DOI 10.1206/0003-0090(2005)294[0001:SROTFF]2.0.CO;2; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fouquet A, 2007, MOL PHYLOGENET EVOL, V43, P567, DOI 10.1016/j.ympev.2006.12.006; FRAILEY C D, 1988, Acta Amazonica, V18, P119; Fromhage L, 2004, MOL PHYLOGENET EVOL, V31, P308, DOI 10.1016/j.ympev.2003.07.009; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Garda AA, 2007, MOL PHYLOGENET EVOL, V44, P104, DOI 10.1016/j.ympev.2006.11.028; Gascon C, 1998, BIOTROPICA, V30, P104, DOI 10.1111/j.1744-7429.1998.tb00373.x; Gemmell NJ, 1996, TRENDS GENET, V12, P338, DOI 10.1016/S0168-9525(96)80005-9; Glaw Frank, 1998, Herpetological Review, V29, P11; Grant T, 2006, B AM MUS NAT HIST, P6; Grau ET, 2005, MOL PHYLOGENET EVOL, V35, P637, DOI 10.1016/j.ympev.2004.12.004; HACKETT SJ, 1990, AUK, V107, P473; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Haffer J., 1990, P45; Haffer J, 1997, BIODIVERS CONSERV, V6, P451, DOI 10.1023/A:1018320925954; Hanken J, 1999, TRENDS ECOL EVOL, V14, P7, DOI 10.1016/S0169-5347(98)01534-1; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kohler J, 2005, BIOSCIENCE, V55, P693, DOI 10.1641/0006-3568(2005)055[0693:NAAGCA]2.0.CO;2; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Kusano T, 1999, HERPETOL J, V9, P9; LESCURE J, 2000, PATRIMOINES NATURELS, V45, P388; Lougheed SC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-23; Lymberakis P, 2007, MOL PHYLOGENET EVOL, V44, P115, DOI 10.1016/j.ympev.2007.03.009; LYNCH JD, 1979, ITS ORIGIN EVOLUTION, P189; Martin PR, 2004, EVOLUTION, V58, P938; Meegaskumbura M, 2002, SCIENCE, V298, P379, DOI 10.1126/science.298.5592.379; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Mulcahy DG, 2006, J BIOGEOGR, V33, P1889, DOI 10.1111/j.1365-2699.2006.01546.x; Noonan BP, 2005, MOL ECOL, V14, P3017, DOI 10.1111/j.1365-294X.2005.02624.x; Noonan BP, 2006, J BIOGEOGR, V33, P1007, DOI 10.1111/j.1365-2699.2006.01483.x; Nores M, 1999, J BIOGEOGR, V26, P475, DOI 10.1046/j.1365-2699.1999.t01-1-00311.x; Parra-Olea G, 2001, P NATL ACAD SCI USA, V98, P7888, DOI 10.1073/pnas.131203598; PECHMANN JHK, 1994, HERPETOLOGICA, V50, P65; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pounds JA, 2004, NATURE, V427, P107, DOI 10.1038/427107a; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; READING CJ, 1991, J ZOOL, V225, P201, DOI 10.1111/j.1469-7998.1991.tb03811.x; Roberts JL, 2006, MOL PHYLOGENET EVOL, V41, P149, DOI 10.1016/j.ympev.2006.05.005; Roy D, 2002, J BIOSCIENCES, V27, P187, DOI 10.1007/BF02704906; Salazar-Bravo J, 2001, MOL PHYLOGENET EVOL, V20, P173, DOI 10.1006/mpev.2001.0965; Salducci MD, 2005, CR BIOL, V328, P1009, DOI 10.1016/j.crvi.2005.07.005; SHUBIN NH, 1995, NATURE, V377, P49, DOI 10.1038/377049a0; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; SMITH MA, 2007, MOL ECOLOGY IN PRESS; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Suatoni E, 2006, MOL PHYLOGENET EVOL, V41, P86, DOI 10.1016/j.ympev.2006.04.025; SWOFFORD DL, 1997, TEST VERSION 4 0 0D6; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van de Peer Y, 1998, NUCLEIC ACIDS RES, V26, P179, DOI 10.1093/nar/26.1.179; Veith M, 2003, MOL PHYLOGENET EVOL, V26, P310, DOI 10.1016/S1055-7903(02)00324-X; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Vences M., 2006, HERPETOLOGICA BONNEN, P193; VENCES M, 2007, AMPHIBIAN BIOL, V7; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; WAKE DB, 1991, AM NAT, V138, P543, DOI 10.1086/285234; Wollenberg KC, 2006, COPEIA, P623, DOI 10.1643/0045-8511(2006)6[623:PVSROL]2.0.CO;2; Wynn A, 2001, TROP ZOOL, V14, P255, DOI 10.1080/03946975.2001.10531157; Young B.E., 2004, DISAPPEARING JEWELS	93	423	440	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1109	10.1371/journal.pone.0001109	http://dx.doi.org/10.1371/journal.pone.0001109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971872	gold, Green Published, Green Submitted			2022-12-25	WOS:000207458700026
J	Huang, YM; Genova, G; Roberts, M; Jackson, FR				Huang, Yanmei; Genova, Ginka; Roberts, Mary; Jackson, F. Rob			The LARK RNA-Binding Protein Selectively Regulates the Circadian Eclosion Rhythm by Controlling E74 Protein Expression	PLOS ONE			English	Article								Despite substantial progress in defining central components of the circadian pacemaker, the output pathways coupling the clock to rhythmic physiological events remain elusive. We previously showed that LARK is a Drosophila RNA-binding protein which functions downstream of the clock to mediate behavioral outputs. To better understand the roles of LARK in the circadian system, we sought to identify RNA molecules associated with it, in vivo, using a three-part strategy to (1) capture RNA ligands by immunoprecipitation, (2) visualize the captured RNAs using whole-genome microarrays, and (3) identify functionally relevant targets through genetic screens. We found that LARK is associated with a large number of RNAs, in vivo, consistent with its broad expression pattern. Overexpression of LARK increases protein abundance for certain targets without affecting RNA level, suggesting a translational regulatory role for the RNA-binding protein. Phenotypic screens of target-gene mutants have identified several with rhythm-specific circadian defects, indicative of effects on clock output pathways. In particular, a hypomorphic mutation in the E74 gene, E74(BG01805), was found to confer an early-eclosion phenotype reminiscent of that displayed by a mutant with decreased LARK gene dosage. Molecular analyses demonstrate that E74A protein shows diurnal changes in abundance, similar to LARK. In addition, the E74(BG01805) allele enhances the lethal phenotype associated with a lark null mutation, whereas overexpression of LARK suppresses the early eclosion phenotype of E74(BG01805), consistent with the idea that E74 is a target, in vivo. Our results suggest a model wherein LARK mediates the transfer of temporal information from the molecular oscillator to different output pathways by interacting with distinct RNA targets.	[Huang, Yanmei; Genova, Ginka; Roberts, Mary; Jackson, F. Rob] Tufts Univ, Sch Med, Dept Neurosci, Ctr Neurosci Res, Boston, MA 02111 USA	Tufts University	Jackson, FR (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Ctr Neurosci Res, Boston, MA 02111 USA.	rob.jackson@tufts.edu		Huang, Yanmei/0000-0003-0450-9173	Tufts University School of Medicine;  [NIH R01 HL59873];  [NIH P30 NS047243]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	Tufts University School of Medicine; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: This research was supported by NIH R01 HL59873, NIH P30 NS047243 and funds from Tufts University School of Medicine.	Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; ASHBURNER M, 1990, CELL, V61, P1, DOI 10.1016/0092-8674(90)90205-S; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Collins BH, 2004, P NATL ACAD SCI USA, V101, P1945, DOI 10.1073/pnas.0308240100; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Emery IF, 1997, P NATL ACAD SCI USA, V94, P4092, DOI 10.1073/pnas.94.8.4092; Enright AJ, 2004, GENOME BIOL, V5; Fang YS, 2007, GENE DEV, V21, P1506, DOI 10.1101/gad.1541607; FLETCHER JC, 1995, DEVELOPMENT, V121, P1455; Fletcher JC, 1997, P NATL ACAD SCI USA, V94, P4582, DOI 10.1073/pnas.94.9.4582; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gauthier SA, 2006, J EXP BIOL, V209, P1803, DOI 10.1242/jeb.02202; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Glaser FT, 2005, CURR BIOL, V15, P1352, DOI 10.1016/j.cub.2005.06.056; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Helfrich-Forster C, 2005, METHOD ENZYMOL, V393, P439, DOI 10.1016/S0076-6879(05)93021-8; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Jackson FR, 2005, METHOD ENZYMOL, V393, P663, DOI 10.1016/S0076-6879(05)93035-8; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Kar A, 2006, J BIOL CHEM, V281, P24479, DOI 10.1074/jbc.M603971200; Kojima S, 2007, P NATL ACAD SCI USA, V104, P1859, DOI 10.1073/pnas.0607567104; Kraves S, 2006, NAT NEUROSCI, V9, P212, DOI 10.1038/nn1633; Kuhlman SJ, 2006, J BIOL RHYTHM, V21, P470, DOI 10.1177/0748730406294316; Lai MC, 2003, EMBO J, V22, P1359, DOI 10.1093/emboj/cdg126; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; LEVINE JD, 1994, NEURON, V13, P967, DOI 10.1016/0896-6273(94)90262-3; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Lin JC, 2005, MOL CELL BIOL, V25, P10111, DOI 10.1128/MCB.25.22.10111-10121.2005; Lin JC, 2007, P NATL ACAD SCI USA, V104, P2235, DOI 10.1073/pnas.0611015104; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; LOROS JJ, 1989, SCIENCE, V243, P385, DOI 10.1126/science.2563175; Lukacsovich T, 2001, GENETICS, V157, P727; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; McNeil GP, 1998, NEURON, V20, P297, DOI 10.1016/S0896-6273(00)80457-2; Mehler MF, 2006, J PHYSIOL-LONDON, V575, P333, DOI 10.1113/jphysiol.2006.113191; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; MUNROE SD, 1995, ROLES E74 PROTEINS E; Myers EM, 2003, CURR BIOL, V13, P526, DOI 10.1016/S0960-9822(03)00167-2; Newby LM, 1996, J NEUROBIOL, V31, P117, DOI 10.1002/(SICI)1097-4695(199609)31:1<117::AID-NEU10>3.0.CO;2-I; NEWBY LM, 1993, GENETICS, V135, P1077; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Plante I, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/64347; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Schaffer R, 2001, PLANT CELL, V13, P113, DOI 10.1105/tpc.13.1.113; Schroeder AJ, 2003, J NEUROGENET, V17, P139; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; Silver R, 2005, METHOD ENZYMOL, V393, P451, DOI 10.1016/S0076-6879(05)93022-X; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Staiger D, 2003, PLANT J, V33, P361, DOI 10.1046/j.1365-313X.2003.01629.x; Staiger D, 2001, PHILOS T R SOC B, V356, P1755, DOI 10.1098/rstb.2001.0964; Steel CGH, 2006, COMP BIOCHEM PHYS A, V144, P351, DOI 10.1016/j.cbpa.2006.02.018; Suh J, 2007, NEURON, V55, P435, DOI 10.1016/j.neuron.2007.06.038; Taghert PH, 2006, J BIOL RHYTHM, V21, P445, DOI 10.1177/0748730406293910; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; THUMMEL CS, 1990, BIOESSAYS, V12, P561, DOI 10.1002/bies.950121202; THUMMEL CS, 1992, SCIENCE, V255, P39, DOI 10.1126/science.1553530; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Vitalini MW, 2006, J BIOL RHYTHM, V21, P432, DOI 10.1177/0748730406294396; Ying Shao-Yao, 2006, V342, P1, DOI 10.1385/1-59745-123-1:1; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135; Zhang XL, 2000, J NEUROBIOL, V45, P14, DOI 10.1002/1097-4695(200010)45:1<14::AID-NEU2>3.0.CO;2-X	68	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1107	10.1371/journal.pone.0001107	http://dx.doi.org/10.1371/journal.pone.0001107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971870	Green Published, Green Submitted, gold			2022-12-25	WOS:000207458700024
J	Sharot, T; Verfaellie, M; Yonelinas, AP				Sharot, Tali; Verfaellie, Mieke; Yonelinas, Andrew P.			How Emotion Strengthens the Recollective Experience: A Time-Dependent Hippocampal Process	PLOS ONE			English	Article								Emotion significantly strengthens the subjective recollective experience even when objective accuracy of the memory is not improved. Here, we examine if this modulation is related to the effect of emotion on hippocampal-dependent memory consolidation. Two critical predictions follow from this hypothesis. First, since consolidation is assumed to take time, the enhancement in the recollective experience for emotional compared to neutral memories should become more apparent following a delay. Second, if the emotion advantage is critically dependent on the hippocampus, then the effects should be reduced in amnesic patients with hippocampal damage. To test these predictions we examined the recollective experience for emotional and neutral photos at two retention intervals (Experiment 1), and in amnesics and controls (Experiment 2). Emotional memories were associated with an enhancement in the recollective experience that was greatest after a delay, whereas familiarity was not influenced by emotion. In amnesics with hippocampal damage the emotion effect on recollective experience was reduced. Surprisingly, however, these patients still showed a general memory advantage for emotional compared to neutral items, but this effect was manifest primarily as a facilitation of familiarity. The results support the consolidation hypothesis of recollective experience, but suggest that the effects of emotion on episodic memory are not exclusively hippocampally mediated. Rather, emotion may enhance recognition by facilitating familiarity when recollection is impaired due to hippocampal damage.	[Sharot, Tali] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England; [Verfaellie, Mieke] Boston Dept Vet Affairs, Memory Disorders Res Ctr, Boston, MA USA; [Verfaellie, Mieke] Boston Univ, Sch Med, Boston, MA 02118 USA; [Yonelinas, Andrew P.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA	University of London; University College London; Boston University; University of California System; University of California Davis	Sharot, T (corresponding author), UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England.	t.sharot@fil.ion.ucl.ac.uk		Yonelinas, Andrew/0000-0002-9580-4997; Verfaellie, Mieke/0000-0001-5535-4584	Margaret and Herman Sokol Postdcotoral Fellowship;  [MH059352];  [NH57681]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059352] Funding Source: NIH RePORTER	Margaret and Herman Sokol Postdcotoral Fellowship; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding: This study was supported by grant MH059352 to APY, NH57681 to MV, and the Margaret and Herman Sokol Postdcotoral Fellowship to TS.	Adolphs R, 2005, NAT NEUROSCI, V8, P512, DOI 10.1038/nn1413; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; [Anonymous], 1974, CONT DEV MATH PSYCHO; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0; Caine D, 2000, J INT NEUROPSYCH SOC, V6, P86, DOI 10.1017/S1355617700611116; Dolcos F, 2005, P NATL ACAD SCI USA, V102, P2626, DOI 10.1073/pnas.0409848102; Fenker DB, 2005, EUR J NEUROSCI, V21, P1993, DOI 10.1111/j.1460-9568.2005.04033.x; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; Hamann SB, 1997, NEUROPSYCHOLOGY, V11, P104; Hodges H, 1996, NEUROSCIENCE, V72, P959, DOI 10.1016/0306-4522(96)00004-8; KAN IP, NEUROPSYCHO IN PRESS; Kensinger EA, 2003, MEM COGNITION, V31, P1169, DOI 10.3758/BF03195800; Kensinger EA, 2004, COGN AFFECT BEHAV NE, V4, P1, DOI 10.3758/CABN.4.1.1; LaBar KS, 2005, BEHAV NEUROSCI, V119, P677, DOI 10.1037/0735-7044.119.3.677; Lang P. J., 1999, INT AFFECTIVE PICTUR; Macmillan N. A., 1991, DETECTION THEORY USE; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; McGaugh J.L., 1992, HDB EMOTION MEMORY R, P269; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Ochsner KN, 2000, J EXP PSYCHOL GEN, V129, P242, DOI 10.1037//0096-3445.129.2.242; Packard MG, 1998, NEUROBIOL LEARN MEM, V69, P163, DOI 10.1006/nlme.1997.3815; Paz R, 2006, NAT NEUROSCI, V9, P1321, DOI 10.1038/nn1771; RAJARAM S, 1993, MEM COGNITION, V21, P89, DOI 10.3758/BF03211168; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Richardson MP, 2004, NAT NEUROSCI, V7, P278, DOI 10.1038/nn1190; Seidman LJ, 2002, ARCH GEN PSYCHIAT, V59, P839, DOI 10.1001/archpsyc.59.9.839; Sharot T, 2004, NAT NEUROSCI, V7, P1376, DOI 10.1038/nn1353; SHAROT T, 2007, COGNITION IN PRESS; Sharot T, 2007, P NATL ACAD SCI USA, V104, P389, DOI 10.1073/pnas.0609230103; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stefanacci L, 1996, J COMP NEUROL, V375, P552; Talarico JM, 2003, PSYCHOL SCI, V14, P455, DOI 10.1111/1467-9280.02453; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Verfaellie M, 2000, NEUROPSYCHOLOGIA, V38, P484, DOI 10.1016/S0028-3932(99)00089-5; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961; YONELINAS AP, 1995, J MEM LANG, V34, P622, DOI 10.1006/jmla.1995.1028; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	40	60	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1068	10.1371/journal.pone.0001068	http://dx.doi.org/10.1371/journal.pone.0001068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971848	Green Published, Green Submitted, gold			2022-12-25	WOS:000207458700001
J	van Hooft, P; Greyling, BJ; Prins, HHT; Getz, WM; Jolles, AE; Bastos, ADS				van Hooft, Pim; Greyling, Barend J.; Prins, Herbert H. T.; Getz, Wayne M.; Jolles, Anna E.; Bastos, Armanda D. S.			Selection at the Y Chromosome of the African Buffalo Driven by Rainfall	PLOS ONE			English	Article								Selection coefficients at the mammalian Y chromosome typically do not deviate strongly from neutrality. Here we show that strong balancing selection, maintaining intermediate frequencies of DNA sequence variants, acts on the Y chromosome in two populations of African buffalo (Syncerus caffer). Significant correlations exist between sequence variant frequencies and annual rainfall in the years before conception, with five- to eightfold frequency changes over short time periods. Annual rainfall variation drives the balancing of sequence variant frequencies, probably by affecting parental condition. We conclude that sequence variants confer improved male reproductive success after either dry or wet years, making the population composition and dynamics very sensitive to climate change. The mammalian Y chromosome, interacting with ecological processes, may affect male reproductive success much more strongly than previously thought.	[van Hooft, Pim; Greyling, Barend J.; Getz, Wayne M.; Bastos, Armanda D. S.] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [van Hooft, Pim; Prins, Herbert H. T.] Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands; [Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Jolles, Anna E.] Oregon State Univ, Coll Vet Med, Corvallis, OR 97331 USA; [Jolles, Anna E.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA	University of Pretoria; Wageningen University & Research; University of California System; University of California Berkeley; Oregon State University; Oregon State University	van Hooft, P (corresponding author), Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, South Africa.	pim.vanhooft@wur.nl	Bastos, Armanda/B-6357-2009; Getz, Wayne/I-4521-2013	Bastos, Armanda/0000-0002-9223-4204; Jolles, Anna/0000-0003-3074-9912; Prins, Herbert/0000-0003-1131-5107; Getz, Wayne/0000-0001-8784-9354	US NIH/NSF Ecology of Infectious Disease Grant; University of Pretoria	US NIH/NSF Ecology of Infectious Disease Grant; University of Pretoria	Funding: This research was supported by an US NIH/NSF Ecology of Infectious Disease Grant awarded to WMG. Support for PVH was a post-doctoral bursary from the University of Pretoria.	Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; Bourgarel M, 2002, AFR J ECOL, V40, P186, DOI 10.1046/j.1365-2028.2002.00377.x; Caron A, 2003, ECOL APPL, V13, P1338, DOI 10.1890/02-5266; Carson HL, 2003, P NATL ACAD SCI USA, V100, P6584, DOI 10.1073/pnas.0732174100; Charbonnel N, 2005, HEREDITY, V95, P377, DOI 10.1038/sj.hdy.6800735; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P5677, DOI 10.1073/pnas.101456898; Cross PC, 2005, ANIM BEHAV, V69, P499, DOI 10.1016/j.anbehav.2004.08.006; Cummins J, 2001, REPROD FERT DEVELOP, V13, P533, DOI 10.1071/RD01064; El-Wishy AB, 2007, ANIM REPROD SCI, V97, P216, DOI 10.1016/j.anireprosci.2006.03.003; Georgiadis NJ, 2007, BIOL CONSERV, V137, P461, DOI 10.1016/j.biocon.2007.03.005; Govender N, 2006, J APPL ECOL, V43, P748, DOI 10.1111/j.1365-2664.2006.01184.x; Hellborg L, 2004, MOL BIOL EVOL, V21, P158, DOI 10.1093/molbev/msh008; Hoerling M, 2006, J CLIMATE, V19, P3989, DOI 10.1175/JCLI3842.1; James WH, 1998, J THEOR BIOL, V192, P113, DOI 10.1006/jtbi.1998.0649; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Jolles AE, 2005, ECOLOGY, V86, P2358, DOI 10.1890/05-0038; JOLLES AE, 2004, THESIS PRINCETON U P; Liu WS, 2003, CYTOGENET GENOME RES, V102, P53, DOI 10.1159/000075725; Liu WS, 2002, MAMM GENOME, V13, P320, DOI 10.1007/s00335-001-2133-8; MILLS MGL, 1995, WILDLIFE RES, V22, P75, DOI 10.1071/WR9950075; Ogutu JO, 2005, AFR J ECOL, V43, P332, DOI 10.1111/j.1365-2028.2005.00587.x; Owen-Smith N, 2005, J ANIM ECOL, V74, P774, DOI 10.1111/j.1365-2656.2005.00974.x; Prins HHT, 1996, ECOLOGY BEHAV AFRICA; Quintana-Murci L, 2001, FORENSIC SCI INT, V118, P169, DOI 10.1016/S0379-0738(01)00387-5; Rodwell TC, 2001, J MAMMAL, V82, P231, DOI 10.1644/1545-1542(2001)082&lt;0231:EOPEOB&gt;2.0.CO;2; Roldan ERS, 1999, TRENDS ECOL EVOL, V14, P58, DOI 10.1016/S0169-5347(98)01567-5; Simmons LW, 2006, P NATL ACAD SCI USA, V103, P16346, DOI 10.1073/pnas.0603474103; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Visscher DR, 2004, J ZOOL, V264, P111, DOI 10.1017/S0952836904005436; Whyte Ian, 2006, Gnusletter, V24, P14	32	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1086	10.1371/journal.pone.0001086	http://dx.doi.org/10.1371/journal.pone.0001086			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971851	gold, Green Published			2022-12-25	WOS:000207458700005
J	Wang, XG; Revskaya, E; Bryan, RA; Strickler, HD; Burk, RD; Casadevall, A; Dadachova, E				Wang, Xing Guo; Revskaya, Ekaterina; Bryan, Ruth A.; Strickler, Howard D.; Burk, Robert D.; Casadevall, Arturo; Dadachova, Ekaterina			Treating Cancer as an Infectious Disease-Viral Antigens as Novel Targets for Treatment and Potential Prevention of Tumors of Viral Etiology	PLOS ONE			English	Article								Background. Nearly 20% of human cancers worldwide have an infectious etiology with the most prominent examples being hepatitis B and C virus-associated hepatocellular carcinoma and human papilloma virus-associated cervical cancer. There is an urgent need to find new approaches to treatment and prevention of virus-associated cancers. Methodology/Principal Findings. Viral antigens have not been previously considered as targets for treatment or prevention of virus-associated cancers. We hypothesized that it was possible to treat experimental HPV16-associated cervical cancer ( CC) and Hepatitis B-associated hepatocellular carcinoma (HCC) by targeting viral antigens expressed on cancer cells with radiolabeled antibodies to viral antigens. Treatment of experimental CC and HCC tumors with 188 Re-labeled mAbs to E6 and HBx viral proteins, respectively, resulted in significant and dose-dependent retardation of tumor growth in comparison with untreated mice or mice treated with unlabeled antibodies. Conclusions/Significance. This strategy is fundamentally different from the prior uses of radioimmunotherapy in oncology, which targeted tumor-associated human antigens and promises increased specificity and minimal toxicity of treatment. It also raises an exciting possibility to prevent virus-associated cancers in chronically infected patients by eliminating cells infected with oncogenic viruses before they transform into cancer.	[Wang, Xing Guo; Revskaya, Ekaterina; Bryan, Ruth A.; Dadachova, Ekaterina] Albert Einstein Coll Med, Dept Nucl Med, Bronx, NY 10467 USA; [Strickler, Howard D.; Burk, Robert D.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Burk, Robert D.; Casadevall, Arturo; Dadachova, Ekaterina] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA; [Casadevall, Arturo] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Dadachova, E (corresponding author), Albert Einstein Coll Med, Dept Nucl Med, Bronx, NY 10467 USA.	edadacho@aecom.yu.edu	Dadachova, Ekaterina/I-7838-2013		NIH [AI60507, AI33774, AI33142, AI52733, HL59842, U54 AI157158, CA078527, AI-51519]; Albert Einstein College of Medicine Comprehensive Cancer Center; Center for AIDS Research at the Albert Einstein College of Medicine; NATIONAL CANCER INSTITUTE [R01CA078527, U01CA078527] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060507, R01AI033774, R37AI033142, R56AI060507, R01AI052733, R01AI033142, P30AI051519] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine Comprehensive Cancer Center; Center for AIDS Research at the Albert Einstein College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	E. Dadachova is supported by the NIH grant AI60507; A. Casadevall - by the NIH grants AI33774, AI33142, AI52733, HL59842, and U54 AI157158; R. D. Burk by the NIH grant CA078527. This work was supported in part by the Albert Einstein College of Medicine Comprehensive Cancer Center and the Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center funded by the National Institutes of Health (NIH AI-51519).	Arbach H, 2006, J VIROL, V80, P845, DOI 10.1128/JVI.80.2.845-853.2006; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; CASADEVALL A, 1992, J INFECT DIS, V165, P1086, DOI 10.1093/infdis/165.6.1086; Casadevall A, 2007, EXPERT OPIN BIOL TH, V7, P595, DOI 10.1517/14712598.7.5.595; Cesarman E, 2007, CURR TOP MICROBIOL, V312, P263; CHEN FM, 1989, CANCER RES, V49, P4578; Dadachova E, 2006, Q J NUCL MED MOL IM, V50, P193; Dadachova E, 2003, P NATL ACAD SCI USA, V100, P10942, DOI 10.1073/pnas.1731272100; Dadachova E, 2006, PLOS MED, V3, P2094, DOI 10.1371/journal.pmed.0030427; Dadachova E, 2007, CANCER BIOTHER RADIO, V22, P303, DOI 10.1089/cbr.2007.344; El-Aneed A, 2006, ANTICANCER RES, V26, P3293; Hwang GY, 2003, J CLIN MICROBIOL, V41, P5598, DOI 10.1128/JCM.41.12.5598-5603.2003; Jones EE, 2006, CURR MOL MED, V6, P795; Kaminski MS, 2005, NEW ENGL J MED, V352, P441, DOI 10.1056/NEJMoa041511; Kehmeier E, 2002, VIROLOGY, V299, P72, DOI 10.1006/viro.2002.1502; Lupberger J, 2007, WORLD J GASTROENTERO, V13, P74, DOI 10.3748/wjg.v13.i1.74; Milenic DE, 2004, NAT REV DRUG DISCOV, V3, P488, DOI 10.1038/nrd1413; Mortreux F, 2003, LEUKEMIA, V17, P26, DOI 10.1038/sj.leu.2402777; Oh KJ, 2004, J VIROL, V78, P5338, DOI 10.1128/JVI.78.10.5338-5346.2004; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Reifenberg K, 1999, J VIROL, V73, P10399, DOI 10.1128/JVI.73.12.10399-10405.1999; Schlecht NF, 2005, ONCOL REP, V14, P1239; Schweitzer AD, 2007, MELANOMA RES, V17, P291, DOI 10.1097/CMR.0b013e3282eeeae7; Sharkey RM, 2005, J NUCL MED, V46, p115S; Sharkey RM, 1997, INT J CANCER, V72, P477, DOI 10.1002/(SICI)1097-0215(19970729)72:3<477::AID-IJC16>3.0.CO;2-9; Yang JS, 2005, WORLD J GASTROENTERO, V11, P4098, DOI 10.3748/wjg.v11.i26.4098; Young LS, 2003, ONCOGENE, V22, P5108, DOI 10.1038/sj.onc.1206556	28	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1114	10.1371/journal.pone.0001114	http://dx.doi.org/10.1371/journal.pone.0001114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971877	Green Submitted, gold, Green Published			2022-12-25	WOS:000207458700031
J	Barbour, JD; Sauer, MM; Sharp, ER; Garrison, KE; Long, BR; Tomiyama, H; Bassichetto, KC; Oliveira, SM; Abbate, MC; Nixon, DF; Kallas, EG				Barbour, Jason D.; Sauer, Mariana M.; Sharp, Elizabeth R.; Garrison, Keith E.; Long, Brian R.; Tomiyama, Helena; Bassichetto, Katia C.; Oliveira, Solange M.; Abbate, Maria C.; Nixon, Douglas F.; Kallas, Esper G.			HIV-1/HSV-2 Co-Infected Adults in Early HIV-1 Infection Have Elevated CD4+T Cell Counts	PLOS ONE			English	Article								Introduction. HIV-1 is often acquired in the presence of pre-existing co-infections, such as Herpes Simplex Virus 2 (HSV-2). We examined the impact of HSV-2 status at the time of HIV-1 acquisition for its impact on subsequent clinical course, and total CD4+ T cell phenotypes. Methods. We assessed the relationship of HSV-1/HSV-2 co-infection status on CD4+ T cell counts and HIV-1 RNA levels over time prior in a cohort of 186 treatment naive adults identified during early HIV-1 infection. We assessed the activation and differentiation state of total CD4+ T cells at study entry by HSV-2 status. Results. Of 186 recently HIV-1 infected persons, 101 (54%) were sero-positive for HSV-2. There was no difference in initial CD8+ T cell count, or differences between the groups for age, gender, or race based on HSV-2 status. Persons with HIV-1/HSV-2 co-infection sustained higher CD4+ T cell counts over time (+69 cells/ul greater (SD = 33.7, p = 0.04) than those with HIV-1 infection alone (Figure 1), after adjustment for HIV-1 RNA levels (-57 cells per 1 log(10) higher HIV-1 RNA, p<0.0001). We did not observe a relationship between HSV-2 infection status with plasma HIV-1 RNA levels over time. HSV-2 acquistion after HIV-1 acquisition had no impact on CD4+ count or viral load. We did not detect differences in CD4+ T cell activation or differentiation state by HSV-2+ status. Discussion. We observed no effect of HSV-2 status on viral load. However, we did observe that treatment naive, recently HIV-1 infected adults co-infected with HSV-2+ at the time of HIV-1 acquisition had higher CD4+ T cell counts over time. If verified in other cohorts, this result poses a striking paradox, and its public health implications are not immediately clear.	[Sauer, Mariana M.; Tomiyama, Helena; Kallas, Esper G.] Univ Fed Sao Paulo, Div Infect Dis, Sao Paulo, Brazil; [Barbour, Jason D.] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA USA; [Sharp, Elizabeth R.; Garrison, Keith E.; Long, Brian R.; Nixon, Douglas F.] Univ Calif San Francisco, Dept Expt Med, San Francisco, CA USA; [Bassichetto, Katia C.; Oliveira, Solange M.; Abbate, Maria C.] Sao Paula City Hlth Syst, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kallas, EG (corresponding author), Univ Fed Sao Paulo, Div Infect Dis, Sao Paulo, Brazil.	kallas.dmed@epm.br	Nixon, Douglas/AAU-5734-2020; Kallas, Esper G/C-9539-2012	Nixon, Douglas/0000-0002-2801-1786; Kallas, Esper/0000-0003-2026-6925	Brazilian Program for STD and AIDS, Ministry of Health [914/BRA/3014 UNESCO/Kallas]; Sao Paulo City Health Department [2004-0.168.922-7/Kallas]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [04/15856-9/Kallas]; NIAID/NIH [AI066917/Barbour, AI064520/Nixon]; John E. Fogarty International Center [D43 TW00003]; AIDS Research Institute of the AIDS Biology Program at UCSF; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Brazilian Ministry of Education; FOGARTY INTERNATIONAL CENTER [D43TW000003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, K01AI066917, P01AI064520] Funding Source: NIH RePORTER	Brazilian Program for STD and AIDS, Ministry of Health; Sao Paulo City Health Department; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); John E. Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); AIDS Research Institute of the AIDS Biology Program at UCSF; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Ministry of Education; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported with funding from the Brazilian Program for STD and AIDS, Ministry of Health (914/BRA/3014 UNESCO/Kallas), the Sao Paulo City Health Department (2004-0.168.922-7/Kallas), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (04/15856-9/Kallas), the NIAID/NIH (AI066917/Barbour), (AI064520/Nixon) the John E. Fogarty International Center (D43 TW00003), The AIDS Research Institute of the AIDS Biology Program at UCSF. M. M. S. was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazilian Ministry of Education.	Barcy S, 2001, J IMMUNOL, V166, P6242, DOI 10.4049/jimmunol.166.10.6242; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Bosnjak L, 2005, J IMMUNOL, V174, P2220, DOI 10.4049/jimmunol.174.4.2220; Brown EL, 2006, AM J EPIDEMIOL, V164, P733, DOI 10.1093/aje/kwj270; Cachay ER, 2007, J INFECT DIS, V195, P1270, DOI 10.1086/513568; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Cunningham Anthony L, 2004, J HIV Ther, V9, P9; FILHO DJ, 2007, AIDS RES HU IN PRESS; Jones CA, 2003, J VIROL, V77, P11139, DOI 10.1128/JVI.77.20.11139-11149.2003; Kallas Esper Georges, 2004, Braz J Infect Dis, V8, P399, DOI 10.1590/S1413-86702004000600003; Mark KE, 2007, J INFECT DIS, V195, P1324, DOI 10.1086/513276; Mikloska Z, 2001, J VIROL, V75, P5958, DOI 10.1128/JVI.75.13.5958-5964.2001; Milligan GN, 1997, VIROLOGY, V229, P259, DOI 10.1006/viro.1997.8441; MILLIGAN GN, 1995, VIROLOGY, V212, P481, DOI 10.1006/viro.1995.1506; Milligan GN, 1998, J IMMUNOL, V160, P6093; Morrow RA, 2003, AM J CLIN PATHOL, V120, P839, DOI [10.1039/AKWHF62YYJ054HA6, 10.1309/AKWHF62YYJ054HA6]; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; REBBAPRAGADA A, 2006, AIDS 2006 16 INT AID; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; Schacker T, 2002, J INFECT DIS, V186, P1718, DOI 10.1086/345771; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915	22	19	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1080	10.1371/journal.pone.0001080	http://dx.doi.org/10.1371/journal.pone.0001080			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957262	Green Published, gold, Green Submitted			2022-12-25	WOS:000207458500025
J	Crossland, MD; Dakin, SC; Bex, PJ				Crossland, Michael D.; Dakin, Steven C.; Bex, Peter J.			Illusory Stimuli Can Be Used to Identify Retinal Blind Spots	PLOS ONE			English	Article								Background. Identification of visual field loss in people with retinal disease is not straightforward as people with eye disease are frequently unaware of substantial deficits in their visual field, as a consequence of perceptual completion ("filling-in'') of affected areas. Methodology. We attempted to induce a compelling visual illusion known as the induced twinkle after-effect (TwAE) in eight patients with retinal scotomas. Half of these patients experience filling-in of their scotomas such that they are unaware of the presence of their scotoma, and conventional campimetric techniques can not be used to identify their vision loss. The region of the TwAE was compared to microperimetry maps of the retinal lesion. Principal Findings. Six of our eight participants experienced the TwAE. This effect occurred in three of the four people who filled-in their scotoma. The boundary of the TwAE showed good agreement with the boundary of lesion, as determined by microperimetry. Conclusion. For the first time, we have determined vision loss by asking patients to report the presence of an illusory percept in blind areas, rather than the absence of a real stimulus. This illusory technique is quick, accurate and not subject to the effects of filling-in.	[Crossland, Michael D.; Dakin, Steven C.] Univ Coll London UCL, Inst Ophthalmol, London, England; [Bex, Peter J.] Harvard Univ, Schepens Eye Res Inst, Cambridge, MA 02138 USA	University of London; University College London; Harvard University; Schepens Eye Research Institute	Crossland, MD (corresponding author), Univ Coll London UCL, Inst Ophthalmol, London, England.	m.crossland@ucl.ac.uk	Crossland, Michael D/B-5600-2008; Dakin, Steven/B-7610-2008	Crossland, Michael D/0000-0001-6833-6043; Dakin, Steven/0000-0002-3548-9104	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; AMSLER M, 1947, OPHTHALMOLOGICA, V114, P248, DOI 10.1159/000300476; AULHORN E, 1989, P 8 INT PER SOC M OC; Baker CI, 2005, J NEUROSCI, V25, P614, DOI 10.1523/JNEUROSCI.3476-04.2005; Bellmann C, 2004, OPHTHALMOLOGY, V111, P2265, DOI 10.1016/j.ophtha.2004.06.019; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Chen CC, 2005, NEUROIMAGE, V24, P802, DOI 10.1016/j.neuroimage.2004.09.021; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; Crossland MD, 2005, OPHTHALMOLOGY, V112, P1579, DOI 10.1016/j.ophtha.2005.03.027; Crossland M, 2007, BRIT J OPHTHALMOL, V91, P391, DOI 10.1136/bjo.2006.095315; CULHAM LE, 1993, CLIN VISION SCI, V8, P551; DEWEERD P, 1995, NATURE, V377, P731, DOI 10.1038/377731a0; Evans J., 1996, HEALTH TRENDS, V28, P5; GERRITS HJM, 1969, VISION RES, V9, P439, DOI 10.1016/0042-6989(69)90092-3; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; HARDAGE L, 1995, VISION RES, V35, P757, DOI 10.1016/0042-6989(94)00167-K; Huk AC, 2002, J NEUROSCI, V22, P7195; Kolb M, 1995, Ger J Ophthalmol, V4, P228; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; Mendola JD, 2006, J COGNITIVE NEUROSCI, V18, P363, DOI 10.1162/089892906775990624; Morgan MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000256; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; RAMACHANDRAN VS, 1993, VISION RES, V33, P717, DOI 10.1016/0042-6989(93)90191-X; Reich LN, 2000, VISION RES, V40, P805, DOI 10.1016/S0042-6989(99)00215-1; Rubin GS, 1997, INVEST OPHTH VIS SCI, V38, P557; Schiefer U, 1998, VISION RES, V38, P1303, DOI 10.1016/S0042-6989(97)00254-X; SCHUCHARD RA, 1993, ARCH OPHTHALMOL-CHIC, V111, P776, DOI 10.1001/archopht.1993.01090060064024; SERGENT J, 1988, BRAIN, V111, P347, DOI 10.1093/brain/111.2.347; Sunness JS, 2004, OPHTHALMOLOGY, V111, P1595, DOI 10.1016/j.ophtha.2003.12.050; Timberlake GT, 2005, OPTOMETRY VISION SCI, V82, P177, DOI 10.1097/01.OPX.0000156311.49058.C8; TIMBERLAKE GT, 1986, INVEST OPHTH VIS SCI, V27, P1137; Tyler CW, 1998, PERCEPTION, V27, P203, DOI 10.1068/p270203; WEIL RS, 2007, P NATL ACAD SCI US; WHITE JM, 1990, INVEST OPHTH VIS SCI, V31, P1149; Whittaker S., 1986, DEV ORDER VISUAL SYS; Zaksas D, 2005, J NEUROPHYSIOL, V94, P4156, DOI 10.1152/jn.00505.2005	39	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1060	10.1371/journal.pone.0001060	http://dx.doi.org/10.1371/journal.pone.0001060			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957244	Green Published, gold, Green Submitted			2022-12-25	WOS:000207458500007
J	Norden, N; Chave, J; Belbenoit, P; Caubere, A; Chatelet, P; Forget, PM; Thebaud, C				Norden, Natalia; Chave, Jerome; Belbenoit, Pierre; Caubere, Adeline; Chatelet, Patrick; Forget, Pierre-Michel; Thebaud, Christophe			Mast Fruiting Is a Frequent Strategy in Woody Species of Eastern South America	PLOS ONE			English	Article							ANNUAL SEED PRODUCTION; RAIN-FOREST TREES; EL-NINO; PHENOLOGY; RECRUITMENT; DISPERSAL; PREDATION; PATTERNS; ECTOMYCORRHIZAL; CAESALPINIACEAE	Background. It is thought that mast seeding is a rare reproductive strategy in the tropics, since tropical climates are less variable, and fruit consumers tend to be more generalist in these regions. However, previous tests of this hypothesis were based on only few tropical datasets, and none from tropical South America. Moreover, reproductive strategies have been quantified based on the coefficient of variation of interannual seed production, an index that potentially confounds masting and high interannual variability in seed production. Methodology/Principal Findings. We developed a new approach to model the monthly variability in seed production for 28 tree species, and 20 liana species monitored during 5 years in a tropical forest of Central French Guiana. We found that 23% of the species showed a masting pattern, 54% an annual fruiting pattern, and 23% an irregular fruiting pattern. The majority of masting species were trees ( 8 out of 11), most of them animal-dispersed. The classification into reproductive strategies based on the coefficient of variation was inconsistent with our results in nearly half of the cases. Conclusions/Significance. Our study is the first to clearly evidence the frequency of the masting strategy in a tropical forest community of Eastern South America. The commonness of the masting strategy in tropical plants may promote species coexistence through storage dynamics.	[Norden, Natalia; Chave, Jerome; Thebaud, Christophe] Univ Toulouse 3, Lab Evolut & Diversite Biol, CNRS, UMR 5174, F-31062 Toulouse, France; [Belbenoit, Pierre; Caubere, Adeline; Forget, Pierre-Michel] CNRS MNHN, UMR 5176, Dept Ecol & Gest Biodiversite, Brunoy, France; [Chatelet, Patrick] CNRS Guyane, UPS 2561, Stn Etud Nouragues, Cayenne, French Guiana	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Museum National d'Histoire Naturelle (MNHN)	Chave, J (corresponding author), Univ Toulouse 3, Lab Evolut & Diversite Biol, CNRS, UMR 5174, F-31062 Toulouse, France.	chave@cict.fr	Thébaud, Christophe/N-3916-2016; Forget, Pierre-Michel/B-4355-2009	Thébaud, Christophe/0000-0002-8586-1234; Forget, Pierre-Michel/0000-0002-9252-974X	CNRS; MNHN (Plan pluriformation 'Ecologie Fonctionnelle et Developpement Durable'); Action Concertee Incitative Jeunes Chercheurs of the French research Ministry	CNRS(Centre National de la Recherche Scientifique (CNRS)); MNHN (Plan pluriformation 'Ecologie Fonctionnelle et Developpement Durable'); Action Concertee Incitative Jeunes Chercheurs of the French research Ministry	Financial support was provided by the CNRS, the MNHN (Plan pluriformation 'Ecologie Fonctionnelle et Developpement Durable') and through a grant Action Concertee Incitative Jeunes Chercheurs of the French research Ministry to JC.	ASHTON PS, 1988, AM NAT, V132, P44, DOI 10.1086/284837; AUGSPURGER CK, 1983, J ECOL, V71, P759, DOI 10.2307/2259591; Boggan J., 1997, CHECKLIST PLANTS GUI; BONGERS F, 2001, NOURAGUES DYNAMICS P; Brearley FQ, 2007, J ECOL, V95, P828, DOI 10.1111/j.1365-2745.2007.01258.x; Burgess P. F., 1972, Malayan Forester, V35, P103; Burnham K.P., 1998, MODEL SELECTION INFE, DOI [10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; CHAN TT, 1980, MALAYSIAN FORESTER, V43, P132; Chauvet S, 2004, J TROP ECOL, V20, P1, DOI 10.1017/S0266467404006121; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; Connell JH, 2000, ECOLOGY, V81, P568, DOI 10.1890/0012-9658(2000)081[0568:SDOTTY]2.0.CO;2; Croat T.B., 1978, FLORA BARRO COLORADO; Curran LM, 2000, ECOL MONOGR, V70, P129, DOI 10.1890/0012-9615(2000)070[0129:ETOTSS]2.0.CO;2; Curran LM, 2000, ECOL MONOGR, V70, P101, DOI 10.1890/0012-9615(2000)070[0101:VRTSVI]2.0.CO;2; Curran LM, 1999, SCIENCE, V286, P2184, DOI 10.1126/science.286.5447.2184; Dalling JW, 2002, J ECOL, V90, P714, DOI 10.1046/j.1365-2745.2002.00706.x; Feer F, 2002, BIOTROPICA, V34, P555, DOI 10.1111/j.1744-7429.2002.tb00574.x; Forget PM, 1999, J TROP ECOL, V15, P61, DOI 10.1017/S026646749900067X; FRANKIE GW, 1974, J ECOL, V62, P881, DOI 10.2307/2258961; GENTRY A H, 1974, Biotropica, V6, P64, DOI 10.2307/2989698; Hamann A, 2004, J ECOL, V92, P24, DOI 10.1111/j.1365-2745.2004.00845.x; Henkel TW, 2005, NEW PHYTOL, V167, P543, DOI 10.1111/j.1469-8137.2005.01431.x; Herrera CM, 1998, AM NAT, V152, P576, DOI 10.1086/286191; JANZEN D H, 1974, Biotropica, V6, P69, DOI 10.2307/2989823; Jones FA, 2005, AM NAT, V166, P543, DOI 10.1086/491661; KELLY D, 1994, TRENDS ECOL EVOL, V9, P465, DOI 10.1016/0169-5347(94)90310-7; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Koenig WD, 2000, AM NAT, V155, P59, DOI 10.1086/303302; Koenig WD, 2003, OIKOS, V102, P581, DOI 10.1034/j.1600-0706.2003.12272.x; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; MORI SA, 2002, GUIDE VASCULAR PLA 2; Newbery DM, 2006, NEW PHYTOL, V170, P561, DOI 10.1111/j.1469-8137.2006.01691.x; Newbery DM, 2005, NEW PHYTOL, V167, P324, DOI 10.1111/j.1469-8137.2005.01468.x; NEWSTROM LE, 1994, BIOTROPICA, V26, P141, DOI 10.2307/2388804; Norden N, 2007, J ECOL, V95, P507, DOI 10.1111/j.1365-2745.2007.01221.x; R Development Core Team, 2006, R LANG ENV STAT COMP; RATIARISON S, 2003, STRATEGIES FRUCTIFIC; Ropelewski CF, 1996, J CLIMATE, V9, P1043, DOI 10.1175/1520-0442(1996)009<1043:QSOPR>2.0.CO;2; SABATIER D, 1985, REV ECOL-TERRE VIE, V40, P289; Sakai S, 2002, BIOL J LINN SOC, V75, P233, DOI 10.1111/j.1095-8312.2002.tb01424.x; Sakai S, 2001, POPUL ECOL, V43, P77, DOI 10.1007/PL00012018; Sakai S, 2006, AM J BOT, V93, P1134, DOI 10.3732/ajb.93.8.1134; SARMIENTO G, 1983, ECOSYSTEMS WORLD B, V14, P219; Schauber EM, 2002, ECOLOGY, V83, P1214, DOI 10.1890/0012-9658(2002)083[1214:MBENZP]2.0.CO;2; SHIBATA M, 1995, ECOLOGY, V76, P1099, DOI 10.2307/1940918; Shibata M, 2002, ECOLOGY, V83, P1727, DOI 10.1890/0012-9658(2002)083[1727:SASPBP]2.0.CO;2; Sun IF, 2007, J ECOL, V95, P818, DOI 10.1111/j.1365-2745.2007.01235.x; TERSTEEGE H, 1991, VEGETATIO, V95, P177; VANROOSEMALEN MGM, 1985, FRUITS GUIANAN FLORA; Wright SJ, 2006, ECOL LETT, V9, P35, DOI 10.1111/j.1461-0248.2005.00851.x; Wright SJ, 2005, ECOLOGY, V86, P848, DOI 10.1890/03-0750	52	53	54	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1079	10.1371/journal.pone.0001079	http://dx.doi.org/10.1371/journal.pone.0001079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957261	Green Published, Green Submitted, gold			2022-12-25	WOS:000207458500024
J	Valente, D; Golani, I; Mitra, PP				Valente, Dan; Golani, Ilan; Mitra, Partha P.			Analysis of the Trajectory of Drosophila melanogaster in a Circular Open Field Arena	PLOS ONE			English	Article								Background. Obtaining a complete phenotypic characterization of a freely moving organism is a difficult task, yet such a description is desired in many neuroethological studies. Many metrics currently used in the literature to describe locomotor and exploratory behavior are typically based on average quantities or subjectively chosen spatial and temporal thresholds. All of these measures are relatively coarse-grained in the time domain. It is advantageous, however, to employ metrics based on the entire trajectory that an organism takes while exploring its environment. Methodology/Principal Findings. To characterize the locomotor behavior of Drosophila melanogaster, we used a video tracking system to record the trajectory of a single fly walking in a circular open field arena. The fly was tracked for two hours. Here, we present techniques with which to analyze the motion of the fly in this paradigm, and we discuss the methods of calculation. The measures we introduce are based on spatial and temporal probability distributions and utilize the entire time-series trajectory of the fly, thus emphasizing the dynamic nature of locomotor behavior. Marginal and joint probability distributions of speed, position, segment duration, path curvature, and reorientation angle are examined and related to the observed behavior. Conclusions/Significance. The measures discussed in this paper provide a detailed profile of the behavior of a single fly and highlight the interaction of the fly with the environment. Such measures may serve as useful tools in any behavioral study in which the movement of a fly is an important variable and can be incorporated easily into many setups, facilitating high-throughput phenotypic characterization.	[Valente, Dan; Mitra, Partha P.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Golani, Ilan] Tel Aviv Univ, Dept Zool, Fac Life Sci, IL-69978 Tel Aviv, Israel	Cold Spring Harbor Laboratory; Tel Aviv University	Valente, D (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	valente@cshl.edu		Mitra, Partha/0000-0001-8818-6804	Dart Neuroscience	Dart Neuroscience	This research was funded by an award from Dart Neuroscience, LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHER J, 1973, ANIM BEHAV, V21, P205, DOI 10.1016/S0003-3472(73)80065-X; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Clark DA, 2007, J NEUROPHYSIOL, V97, P1903, DOI 10.1152/jn.00892.2006; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; CRAWLEY JN, 2000, WHATS WRONG MY MOUSE, P329; Drai D, 2001, NEUROSCI BIOBEHAV R, V25, P409, DOI 10.1016/S0149-7634(01)00022-7; Drai D, 2000, J NEUROSCI METH, V96, P119, DOI 10.1016/S0165-0270(99)00194-6; Draper I, 2007, DEV NEUROBIOL, V67, P378, DOI 10.1002/dneu.20355; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; Hen I, 2004, J NEUROSCI METH, V133, P161, DOI 10.1016/j.jneumeth.2003.10.013; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Kafkafi N, 2005, P NATL ACAD SCI USA, V102, P4619, DOI 10.1073/pnas.0409554102; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lipkind D, 2004, J APPL PHYSIOL, V97, P347, DOI 10.1152/japplphysiol.00148.2004; Loader C., 1999, LOCAL REGRESSION LIK; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; MARGULIES C, 2005, CURR BIOL, V15, pR713; Martin JR, 1999, J COMP PHYSIOL A, V184, P73, DOI 10.1007/s003590050307; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; Martin JR, 2003, BEHAV PROCESS, V64, P145, DOI 10.1016/S0376-6357(03)00132-3; McClung C, 1998, CURR BIOL, V8, P109, DOI 10.1016/S0960-9822(98)70041-7; McGuire SE, 2005, PROG NEUROBIOL, V76, P328, DOI 10.1016/j.pneurobio.2005.09.003; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Rothenfluh A, 2002, CURR OPIN NEUROBIOL, V12, P639, DOI 10.1016/S0959-4388(02)00380-X; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; VALENTE D, 2007, IEEE MULTIM IN PRESS; Wolf FW, 2002, J NEUROSCI, V22, P11035	33	60	60	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1083	10.1371/journal.pone.0001083	http://dx.doi.org/10.1371/journal.pone.0001083			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957265	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000207458500028
J	Caceda, ER; Kochel, TJ				Caceda, Edna R.; Kochel, Tadeusz J.			Application of Modified Shell Vial Culture Procedure for Arbovirus Detection	PLOS ONE			English	Article								The isolation of arboviruses from patient's low titer sera can be difficult. Here we compared the detection efficiency of Dengue (DEN), Yellow Fever (YF), Saint Louis Encephalitis (SLE), West Nile (WN), Ilheus (ILH), Group C (GC), Oropouche (ORO), Mayaro (MAY) and Venezuela Encephalitis Equine (VEE) viruses using a Modified Shell Vial Culture (MSVC) protocol to a Standard Cell Culture (SCC) protocol. First the MSVC and SCC protocols were compared using five dilutions for each of the following stock viruses: DEN-1, DEN-2, DEN-3, DEN-4, YF, SLE, WN, ILH, GC, ORO, MAY and VEE. Next, patients' original sera from which viruses (DEN-1, DEN-2, DEN-3, YF, GC, ORO, MAY and VEE) had been previously isolated were compare by the two methods using five sera dilutions. In addition, seven sera that were positive for DEN-3 by RT-PCR and negative by SCC were processed by MSVC. The MSVC protocol was consistently 1-2 logs higher virus dilution more sensitive for virus detection than the SCC protocol for all stock Flaviviruses tested (DEN-1, DEN-2, DEN-3, DEN-4, YF, SLE, WN and ILH). MSVC was equal to or one log more sensitive for virus detection than SCC for the stock Bunyaviruses (GC and ORO). For the stock Alphavirus MAY, MSVC was equally or one log more sensitive for virus detection than SCC, while for VEE SCC was equally or one log more sensitive for virus detection than MSVC. MSVC was consistently one to two sera dilutions more sensitive than SCC for the detection of Flaviviruses from patients' sera. Both methods were approximately equally sensitive for the detection of Bunyaviruses from patients' sera and equal or one dilution less sensitive for the detection of Alphaviruses from patients' sera. Additionally, MSVC detected DEN virus in five of seven DEN-3 RT-PCR positive, SCC negative patients' sera.	[Caceda, Edna R.; Kochel, Tadeusz J.] Amer Embassy, Naval Med Res Ctr Detachment, Lima, Peru		Kochel, TJ (corresponding author), Amer Embassy, Naval Med Res Ctr Detachment, Lima, Peru.	Tad.Kochel@med.navy.mil			United States Department of Defense [847705.82000.25GB.B0016]	United States Department of Defense(United States Department of Defense)	This study was funded by the United States Department of Defense Global Emerging Infections Systems Research Program, WORK UNIT NUMBER: 847705.82000.25GB.B0016. The sponsor had no role in this study other than providing funding.	BULLER RS, 1995, CLIN DIAGN VIROL, V3, P317, DOI 10.1016/0928-0197(94)00048-Y; Crist GA, 2004, DIAGN MICR INFEC DIS, V49, P173, DOI 10.1016/j.diagmicrobio.2004.03.008; Engler HD, 1997, J CLIN MICROBIOL, V35, P2165, DOI 10.1128/JCM.35.8.2165-2167.1997; JOHNSTON SLG, 1990, J CLIN MICROBIOL, V28, P2394, DOI 10.1128/JCM.28.11.2394-2397.1990; LEE SHS, 1992, J VIROL METHODS, V39, P39, DOI 10.1016/0166-0934(92)90123-U; RANGAIAH JS, 2006, VIROL J, V3, P2; Roche RR, 2000, J CLIN MICROBIOL, V38, P3508, DOI 10.1128/JCM.38.9.3508-3510.2000; Steed L L, 1994, Clin Diagn Virol, V2, P181, DOI 10.1016/0928-0197(94)90021-3; Whistler T, 1997, CLIN DIAGN VIROL, V7, P193, DOI 10.1016/S0928-0197(97)00270-5	9	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1034	10.1371/journal.pone.0001034	http://dx.doi.org/10.1371/journal.pone.0001034			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940598	Green Published, gold, Green Submitted			2022-12-25	WOS:000207456100002
J	Walther, FJ; Waring, AJ; Hernandez-Juviel, JM; Gordon, LM; Schwan, AL; Jung, CL; Chang, YS; Wang, ZD; Notter, RH				Walther, Frans J.; Waring, Alan J.; Hernandez-Juviel, Jose M.; Gordon, Larry M.; Schwan, Adrian L.; Jung, Chun-Ling; Chang, Yusuo; Wang, Zhengdong; Notter, Robert H.			Dynamic Surface Activity of a Fully Synthetic Phospholipase-Resistant Lipid/Peptide Lung Surfactant	PLOS ONE			English	Article							PROTEINS SP-B; EUROPEAN CONSENSUS CONFERENCE; BRONCHOALVEOLAR LAVAGE FLUID; N-TERMINAL SEGMENT; PULMONARY SURFACTANT; DIFFERENTIAL SENSITIVITY; HYDROPHOBIC PROTEINS; EXOGENOUS SURFACTANT; MONOMOLECULAR LAYERS; SECONDARY STRUCTURE	Background. This study examines the surface activity and resistance to phospholipase degradation of a fully-synthetic lung surfactant containing a novel diether phosphonolipid (DEPN-8) plus a 34 amino acid peptide (Mini-B) related to native surfactant protein (SP)-B. Activity studies used adsorption, pulsating bubble, and captive bubble methods to assess a range of surface behaviors, supplemented by molecular studies using Fourier transform infrared (FTIR) spectroscopy, circular dichroism (CD), and plasmon resonance. Calf lung surfactant extract (CLSE) was used as a positive control. Results. DEPN-8+ 1.5% (by wt.) Mini-B was fully resistant to degradation by phospholipase A(2) (PLA(2)) in vitro, while CLSE was severely degraded by this enzyme. Mini-B interacted with DEPN-8 at the molecular level based on FTIR spectroscopy, and had significant plasmon resonance binding affinity for DEPN-8. DEPN-8+ 1.5% Mini-B had greatly increased adsorption compared to DEPN-8 alone, but did not fully equal the very high adsorption of CLSE. In pulsating bubble studies at a low phospholipid concentration of 0.5 mg/ml, DEPN-8+ 1.5% Mini-B and CLSE both reached minimum surface tensions,1 mN/m after 10 min of cycling. DEPN-8 (2.5 mg/ml)+ 1.5% Mini-B and CLSE (2.5 mg/ml) also reached minimum surface tensions,1 mN/m at 10 min of pulsation in the presence of serum albumin (3 mg/ml) on the pulsating bubble. In captive bubble studies, DEPN-8+ 1.5% Mini-B and CLSE both generated minimum surface tensions,1 mN/m on 10 successive cycles of compression/expansion at quasi-static and dynamic rates. Conclusions. These results show that DEPN-8 and 1.5% Mini-B form an interactive binary molecular mixture with very high surface activity and the ability to resist degradation by phospholipases in inflammatory lung injury. These characteristics are promising for the development of related fully-synthetic lipid/peptide exogenous surfactants for treating diseases of surfactant deficiency or dysfunction.	[Walther, Frans J.; Waring, Alan J.; Hernandez-Juviel, Jose M.; Gordon, Larry M.] Harbor Univ Calif Los Angeles UCLA, Los Angeles Biomed Res Inst, Med Ctr, Torrance, CA USA; [Walther, Frans J.] Leiden Univ, Dept Pediat, Med Ctr, Leiden, Netherlands; [Waring, Alan J.; Jung, Chun-Ling] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Schwan, Adrian L.] Univ Guelph, Dept Chem, Guelph, ON N1G 2W1, Canada; [Chang, Yusuo; Wang, Zhengdong; Notter, Robert H.] Univ Rochester, Dept Pediat, Rochester, NY USA; [Notter, Robert H.] Univ Rochester, Dept Environm Med, Rochester, NY USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California Los Angeles; University of Guelph; University of Rochester; University of Rochester	Walther, FJ (corresponding author), Harbor Univ Calif Los Angeles UCLA, Los Angeles Biomed Res Inst, Med Ctr, Torrance, CA USA.	fwalther@lumc.nl		Schwan, Adrian/0000-0003-3362-9633; Walther, Frans/0000-0003-1931-159X	National Institutes of Health [HL-56176, HL-55534]; Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center [800310-11-23, 512973-00-00]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056176, R01HL055534, R01HL092158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors gratefully acknowledge the financial support of the National Institutes of Health through grants HL-56176 and HL-55534 and the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center through grants 800310-11-23 and 512973-00-00. NIH and LA BioMed had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Ackerman SJ, 2003, CHEST, V123, p355S, DOI 10.1378/chest.123.3_suppl.355S; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Artigas A, 1998, INTENS CARE MED, V24, P378, DOI 10.1007/s001340050585; Attalah HL, 2003, EUR RESPIR J, V21, P1040, DOI 10.1183/09031936.03.00093002; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; CAILLON E, 1983, J BACTERIOL, V153, P1348, DOI 10.1128/JB.153.3.1348-1351.1983; *CAL APPL BIOS, 1990, INTR CLEAV TECHN, P10; CARPINO LA, 1995, J ORG CHEM, V60, P7718, DOI 10.1021/jo00129a005; Chang YS, 2005, CHEM PHYS LIPIDS, V137, P77, DOI 10.1016/j.chemphyslip.2005.07.002; Chang YS, 2004, BIOORG MED CHEM LETT, V14, P5983, DOI 10.1016/j.bmcl.2004.10.001; CHESS P, 2005, LUNG INJURY MECH PAT, P617; CURSTEDT T, 1987, EUR J BIOCHEM, V168, P255, DOI 10.1111/j.1432-1033.1987.tb13414.x; ENHORNING G, 1992, J APPL PHYSIOL, V73, P941, DOI 10.1152/jappl.1992.73.3.941; ENHORNING G, 1977, J APPL PHYSIOL, V43, P198, DOI 10.1152/jappl.1977.43.2.198; FIELDS C G, 1991, Peptide Research, V4, P95; Gordon LM, 2002, BBA-BIOMEMBRANES, V1559, P96, DOI 10.1016/S0005-2736(01)00443-6; Gordon LM, 2000, J PEPT RES, V55, P330, DOI 10.1034/j.1399-3011.2000.00693.x; Gordon LM, 1996, PROTEIN SCI, V5, P1662, DOI 10.1002/pro.5560050820; Goss CH, 2003, CRIT CARE MED, V31, P1607, DOI 10.1097/01.CCM.0000063475.65751.1D; Griese M, 1999, EUR RESPIR J, V13, P1455, DOI 10.1183/09031936.99.13614779; HALL SB, 1992, J APPL PHYSIOL, V72, P1708, DOI 10.1152/jappl.1992.72.5.1708; HALL SB, 1993, J APPL PHYSIOL, V75, P468, DOI 10.1152/jappl.1993.75.1.468; HALL SB, 1994, J LIPID RES, V35, P1386; HALL SB, 1992, AM REV RESPIR DIS, V145, P24, DOI 10.1164/ajrccm/145.1.24; Holm BA, 1999, PEDIATR RES, V46, P85, DOI 10.1203/00006450-199907000-00015; HOLM BA, 1991, J APPL PHYSIOL, V71, P317, DOI 10.1152/jappl.1991.71.1.317; HOLM BA, 1985, CHEM PHYS LIPIDS, V38, P287, DOI 10.1016/0009-3084(85)90022-2; Johansson J, 1998, BIOL NEONATE, V74, P9, DOI 10.1159/000047029; JOHNSON WC, 1990, PROTEIN-STRUCT FUNCT, V7, P214; KIM DK, 1995, AM J PHYSIOL-LUNG C, V269, pL109, DOI 10.1152/ajplung.1995.269.1.L109; Kostopanagiotou G, 2003, HEPATOLOGY, V37, P1130, DOI 10.1053/jhep.2003.50185; Lewis JF, 2003, CRIT CARE MED, V31, pS324, DOI 10.1097/01.CCM.0000057911.19145.9F; LIN WHC, 1989, SYNTHESIS PURIFICATI; MALCOLM JD, 1980, CAN J CHEM ENG, V58, P151, DOI 10.1002/cjce.5450580203; Nakos G, 2005, CRIT CARE MED, V33, P772, DOI 10.1097/01.CCM.0000158519.80090.74; Notter R. H., 2005, LUNG INJURY MECH PAT; NOTTER RH, 1982, PEDIATR RES, V16, P515, DOI 10.1203/00006450-198207000-00003; NOTTER RH, 1983, CHEM PHYS LIPIDS, V33, P67, DOI 10.1016/0009-3084(83)90009-9; Notter RH, 2002, CHEM PHYS LIPIDS, V114, P21, DOI 10.1016/S0009-3084(01)00197-9; Notter RH, 1997, REV CHEM ENG, V13, P1; NOTTER RH, 2000, LUNG SURFACTANTS BAS; Notter RH, 2007, BIOORG MED CHEM LETT, V17, P113, DOI 10.1016/j.bmcl.2006.09.083; OOSTERLAKENDIJKSTERHUIS MA, 1991, BIOCHEMISTRY-US, V30, P10965, DOI 10.1021/bi00109a022; OOSTERLAKENDIJKSTERHUIS MA, 1991, BIOCHEMISTRY-US, V30, P8276, DOI 10.1021/bi00247a024; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; REVAK SD, 1988, J CLIN INVEST, V81, P826, DOI 10.1172/JCI113391; Rubenfeld GD, 2003, CRIT CARE MED, V31, pS276, DOI 10.1097/01.CCM.0000057904.62683.2B; SARIN VK, 1990, P NATL ACAD SCI USA, V87, P2633, DOI 10.1073/pnas.87.7.2633; SCHOEL WM, 1994, BBA-GEN SUBJECTS, V1200, P281, DOI 10.1016/0304-4165(94)90169-4; SEEGER W, 1992, AM J PHYSIOL, V262, pL286, DOI 10.1152/ajplung.1992.262.3.L286; SEEGER W, 1993, EUR RESPIR J, V6, P971; Sreerama N, 1999, PROTEIN SCI, V8, P370; TOUCHSTONE JC, 1980, LIPIDS, V15, P61, DOI 10.1007/BF02534120; Touqui L, 1999, MOL MED TODAY, V5, P244, DOI 10.1016/S1357-4310(99)01470-7; TURCOTTE JG, 1991, BIOCHIM BIOPHYS ACTA, V1084, P1, DOI 10.1016/0005-2760(91)90048-M; TURCOTTE JG, 1977, BIOCHIM BIOPHYS ACTA, V488, P235, DOI 10.1016/0005-2760(77)90181-3; VADAS P, 1984, J LAB CLIN MED, V104, P873; Wang Z, 2003, AM J PHYSIOL-LUNG C, V285, pL550, DOI 10.1152/ajplung.00346.2002; WANG Z, 2005, LUNG INJURY MECH PAT, P297; WANG Z, 2007, AM J RESP C IN PRESS; Wang ZD, 1996, J LIPID RES, V37, P1749; Wang ZD, 1998, AM J RESP CRIT CARE, V158, P28, DOI 10.1164/ajrccm.158.1.9709041; WANG ZD, 1995, J LIPID RES, V36, P1283; Wang ZD, 1996, J LIPID RES, V37, P790; WARING A, 1989, Peptide Research, V2, P308; Waring AJ, 2005, J PEPT RES, V66, P364, DOI 10.1111/j.1399-3011.2005.00300.x; Waring AJ, 1996, PEPTIDE RES, V9, P28; Willson DF, 2005, JAMA-J AM MED ASSOC, V293, P470, DOI 10.1001/jama.293.4.470; YU SH, 1988, BIOCHIM BIOPHYS ACTA, V961, P337	70	22	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1039	10.1371/journal.pone.0001039	http://dx.doi.org/10.1371/journal.pone.0001039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940603	gold, Green Published, Green Submitted			2022-12-25	WOS:000207456100007
J	Colo, GP; Rubio, MF; Nojek, IM; Werbajh, SE; Echeverria, PC; Alvarado, CV; Nahmod, VE; Galigniana, MD; Costas, MA				Colo, G. P.; Rubio, M. F.; Nojek, I. M.; Werbajh, S. E.; Echeverria, P. C.; Alvarado, C. V.; Nahmod, V. E.; Galigniana, M. D.; Costas, M. A.			The p160 nuclear receptor co-activator RAC3 exerts an anti-apoptotic role through a cytoplasmatic action	ONCOGENE			English	Article						apoptosis; NF-kappa B; peroxides; nuclear receptor co-activators; MAP kinases	NF-KAPPA-B; TRANSCRIPTIONAL COACTIVATOR; EXPRESSION; AIB1; PROTEIN; BREAST; ACTIVATION; PATHWAY; GROWTH; STRESS	The p160 nuclear receptor co- activators represent a family of molecules, which are recruited by steroid nuclear receptors as well as other transcription factors that are overexpressed in several tumors. We investigated the role of one member of this family on the sensitivity of cells to apoptosis. We observed that overexpression of the RAC3 ( receptor- associated co- activator- 3) p160 co- activator inhibits hydrogen peroxide- induced cell death in human embryonic kidney 293 ( HEK293) cells. The mechanism involves the activation of anti- apoptotic pathways mediated through enhanced nuclear factor kappa B ( NF-kappa B) activity, inhibition of caspase- 9 activation, diminished apoptotic- inducing factor ( AIF) nuclear localization and a change in the activation pattern of several kinases, including an increase in both AKT and p38 kinase activities, and inhibition of ERK2. Moreover, RAC3 has been found associated with a protein complex containing AIF, Hsp90 and dynein, suggesting a role for the coactivator in the cytoplasmatic nuclear transport of these proteins associated with cytoskeleton. These results demonstrate that there are several molecular pathways that could be affected by their overexpression, including those not restricted to steroid regulation or the nuclear action of co- activators, which results in diminished sensitivity to apoptosis. Furthermore, this could represent one mechanism by which co- activators contribute to tumor development.	[Colo, G. P.; Rubio, M. F.; Nojek, I. M.; Werbajh, S. E.; Echeverria, P. C.; Alvarado, C. V.; Nahmod, V. E.; Costas, M. A.] Univ Buenos Aires, CONICET, Argentine Natl Res Council, Inst Invest Med Alfredo Lanari IDIM,Lab Biol Mol, Buenos Aires, DF, Argentina; [Galigniana, M. D.] Fdn Inst Leloir, Lab Receptores Nucl & Arquitectura Nucl, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Leloir Institute	Costas, MA (corresponding author), Univ Buenos Aires, CONICET, Argentine Natl Res Council, Inst Invest Med Alfredo Lanari IDIM,Lab Biol Mol, Combatientes Malvinas 3150,Cuerpo 2-Piso 1, Buenos Aires, DF, Argentina.	mcostas@lanari.fmed.uba.ar	Echeverria, Pablo Christian/A-9098-2010	Echeverria, Pablo Christian/0000-0003-1367-9692; Costas, Monica/0000-0002-4773-3389; GALIGNIANA, MARIO/0000-0002-9130-8574; Alvarado, Cecilia/0000-0003-3147-747X	FIC NIH HHS [R03TW007162-01A2] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R03TW007162] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Arnoult D, 2002, J CELL BIOL, V159, P923, DOI 10.1083/jcb.200207071; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Cavarretta ITR, 2002, MOL ENDOCRINOL, V16, P253, DOI 10.1210/me.16.2.253; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cobb MH, 1991, CURR OPIN CELL BIOL, V3, P1025, DOI 10.1016/0955-0674(91)90124-H; Costas MA, 2000, BBA-MOL CELL RES, V1499, P122, DOI 10.1016/S0167-4889(00)00113-0; Coste A, 2006, EMBO J, V25, P2453, DOI 10.1038/sj.emboj.7601106; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; Franco D, 2002, CELL DEATH DIFFER, V9, P1090, DOI 10.1038/sj.cdd.4401074; Galigniana MD, 2004, J BIOL CHEM, V279, P22483, DOI 10.1074/jbc.M402223200; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Glaeser M, 2001, HORM METAB RES, V33, P121, DOI 10.1055/s-2001-14938; Glass CK, 2000, GENE DEV, V14, P121; Gnanapragasam VJ, 2001, BRIT J CANCER, V85, P1928, DOI 10.1054/bjoc.2001.2179; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gurbuxani S, 2003, ONCOGENE, V22, P6669, DOI 10.1038/sj.onc.1206794; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Iwase H, 2003, BREAST CANCER RES TR, V80, P339, DOI 10.1023/A:1024916126532; Katoh I, 2004, J BIOL CHEM, V279, P15515, DOI 10.1074/jbc.M311819200; Kultz D, 1998, J EXP BIOL, V201, P3015; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; List HJ, 2001, BREAST CANCER RES TR, V68, P21, DOI 10.1023/A:1017910924390; Martelli AM, 2006, LEUKEMIA, V20, P911, DOI 10.1038/sj.leu.2404245; Na SY, 1998, J BIOL CHEM, V273, P10831, DOI 10.1074/jbc.273.18.10831; ONATE SA, 1995, SCIENCE, V270, P1354; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Park BG, 2005, TOXICOLOGY, V215, P115, DOI 10.1016/j.tox.2005.07.003; Peterson CL, 2000, J CELL BIOCHEM, V78, P179, DOI 10.1002/(SICI)1097-4644(20000801)78:2<179::AID-JCB1>3.0.CO;2-E; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Rubio MF, 2006, ONCOGENE, V25, P1367, DOI 10.1038/sj.onc.1209176; Sakakura C, 2000, INT J CANCER, V89, P217; Sheppard KA, 1998, J BIOL CHEM, V273, P29291, DOI 10.1074/jbc.273.45.29291; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang ZY, 2000, P NATL ACAD SCI USA, V97, P13549, DOI 10.1073/pnas.260463097; Werbajh S, 2000, FEBS LETT, V485, P195, DOI 10.1016/S0014-5793(00)02223-7; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Yan J, 2006, ACTA PHARMACOL SIN, V27, P387, DOI 10.1111/j.1745-7254.2006.00315.x; Zhang L, 2001, CELL DEATH DIFFER, V8, P528, DOI 10.1038/sj.cdd.4400838; Zhou G, 2003, MOL CELL BIOL, V23, P7742, DOI 10.1128/MCB.23.21.7742-7755.2003	50	45	46	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2008	27	17					2430	2444		10.1038/sj.onc.1210900	http://dx.doi.org/10.1038/sj.onc.1210900			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286KN	17968310				2022-12-25	WOS:000254844900008
J	Scian, MJ; Carchman, EH; Mohanraj, L; Stagliano, KER; Anderson, MAE; Deb, D; Crane, BM; Kiyono, T; Windle, B; Deb, SP; Deb, S				Scian, M. J.; Carchman, E. H.; Mohanraj, L.; Stagliano, K. E. R.; Anderson, M. A. E.; Deb, D.; Crane, B. M.; Kiyono, T.; Windle, B.; Deb, S. P.; Deb, S.			Wild-type p53 and p73 negatively regulate expression of proliferation related genes	ONCOGENE			English	Article						wild-type p53; transcriptional repression; cell cycle; DNA replication; microarray analysis	P53-MEDIATED TRANSCRIPTIONAL REPRESSION; CELL-CYCLE ARREST; TUMOR-SUPPRESSOR; DNA-DAMAGE; INDUCED APOPTOSIS; G(2)/M PROMOTERS; VIRAL PROMOTERS; PROTEIN; IDENTIFICATION; MODULATION	When normal cells come under stress, the wild-type (WT) p53 level increases resulting in the regulation of gene expression responsible for growth arrest or apoptosis. Here we show that elevated levels of WT p53 or its homologue, p73, inhibit expression of a number of cell cycle regulatory and growth promoting genes. Our analysis also identified a group of genes whose expression is differentially regulated by WT p53 and p73. We have infected p53-null H1299 human lung carcinoma cells with recombinant adenoviruses expressing WT p53, p73 or beta-galactosidase, and have undertaken microarray hybridization analyses to identify genes whose expression pro. le is altered by p53 or p73. Quantitative real-time PCR verified the repression of E2F5, centromere protein A and E, minichromosome maintenance proteins (MCM)-2, -3, -5, -6 and -7 and human CDC25B after p53 expression. 5-Fluorouracil treatment of col on carcinoma HCT116 cells expressing WT p53 results in a reduction of the cyclin B2 protein level suggesting that DNA damage may indeed cause repression of the se genes. Transient transcriptional assays verified that WT p53 repressed promoters of a number of these genes. Interestingly, a gain-of-function p53 mutant instead upregulated a number of the se promoters in transient transfection. Using promoter deletion mutants of MCM-7 we have found that WT p53-mediated repression needs a minimal promoter that contains a single E2F site and surrounding sequences. However, a single E2F site cannot be significantly repressed by WT p53. Many of the genes identified are also repressed by p21. Thus, our work shows that WT p53 and p73 repress a number of growth-related genes and that in many instances this repression may be through the induction of p21.	[Scian, M. J.; Carchman, E. H.; Mohanraj, L.; Stagliano, K. E. R.; Anderson, M. A. E.; Deb, D.; Crane, B. M.; Deb, S. P.; Deb, S.] Virginia Commonwealth Univ, Goodwin Res Lab, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Scian, M. J.; Carchman, E. H.; Mohanraj, L.; Stagliano, K. E. R.; Anderson, M. A. E.; Deb, D.; Crane, B. M.; Deb, S. P.; Deb, S.] Virginia Commonwealth Univ, Goodwin Res Lab, Massey Canc Ctr, Richmond, VA 23298 USA; [Kiyono, T.] Natl Canc Ctr, Res Inst, Div Virol, Tokyo 104, Japan; [Windle, B.] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; National Cancer Center - Japan; Virginia Commonwealth University	Deb, S (corresponding author), Virginia Commonwealth Univ, Goodwin Res Lab, Dept Biochem & Mol Biol, 401 Coll St, Richmond, VA 23298 USA.	sdeb@vcu.edu	Kiyono, Tohru/H-5834-2011	Anderson, Michelle/0000-0003-1510-2942	NATIONAL CANCER INSTITUTE [R01CA074172, F31CA097520, R01CA070712] Funding Source: NIH RePORTER; NCI NIH HHS [CA70712, CA74172, F31-CA97520] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aldaz CM, 2002, ONCOGENE, V21, P6366, DOI 10.1038/sj.onc.1205816; Altschmied J, 1997, BIOTECHNIQUES, V23, P436, DOI 10.2144/97233bm19; Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Basile V, 2006, J BIOL CHEM, V281, P2347, DOI 10.1074/jbc.M507712200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chae HD, 2005, EXP MOL MED, V37, P488, DOI 10.1038/emm.2005.60; Chao C, 2000, EMBO J, V19, P4967, DOI 10.1093/emboj/19.18.4967; Deb D, 2002, ONCOGENE, V21, P176, DOI 10.1038/sj/onc/1205035; Deb D, 2001, INT J ONCOL, V18, P401; DEB S, 1992, J VIROL, V66, P6164, DOI 10.1128/JVI.66.10.6164-6170.1992; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; Flatt PM, 2000, MOL CELL BIOL, V20, P4210, DOI 10.1128/MCB.20.12.4210-4223.2000; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Fontemaggi G, 2002, J BIOL CHEM, V277, P43359, DOI 10.1074/jbc.M205573200; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Ichimiya S, 2001, MED PEDIATR ONCOL, V36, P42, DOI 10.1002/1096-911X(20010101)36:1<42::AID-MPO1011>3.0.CO;2-K; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnsen JI, 2000, INT J CANCER, V88, P685, DOI 10.1002/1097-0215(20001201)88:5<685::AID-IJC1>3.0.CO;2-Z; Johnson TM, 2005, NAT GENET, V37, P145, DOI 10.1038/ng1498; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Kho PS, 2004, J BIOL CHEM, V279, P21183, DOI 10.1074/jbc.M311912200; Korner K, 2001, J BIOL CHEM, V276, P9662, DOI 10.1074/jbc.M008696200; Koumenis C, 2001, MOL CELL BIOL, V21, P1297, DOI 10.1128/MCB.21.4.1297-1310.2001; Kovalev S, 1998, CELL GROWTH DIFFER, V9, P897; Krause K, 2000, NUCLEIC ACIDS RES, V28, P4410, DOI 10.1093/nar/28.22.4410; Kubicka S, 1999, J BIOL CHEM, V274, P32137, DOI 10.1074/jbc.274.45.32137; Lee KC, 1999, MOL CELL BIOL, V19, P1279; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; Maeda Y, 2006, BIOCHEM J, V400, P303, DOI 10.1042/BJ20060614; Manni I, 2001, J BIOL CHEM, V276, P5570, DOI 10.1074/jbc.M006052200; Maxwell SA, 2000, P NATL ACAD SCI USA, V97, P13009, DOI 10.1073/pnas.230445997; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Moll UM, 2003, MOL CANCER RES, V1, P1001; Moskovits N, 2006, CANCER RES, V66, P10671, DOI 10.1158/0008-5472.CAN-06-2323; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Murphy M, 1996, GENE DEV, V10, P2971, DOI 10.1101/gad.10.23.2971; Prabhu NS, 1996, CLIN CANCER RES, V2, P1221; Prives C, 1999, J PATHOL, V187, P112; Scian MJ, 2005, MOL CELL BIOL, V25, P10097, DOI 10.1128/MCB.25.22.10097-10110.2005; Scian MJ, 2004, CANCER RES, V64, P7447, DOI 10.1158/0008-5472.CAN-04-1568; Scian MJ, 2004, ONCOGENE, V23, P4430, DOI 10.1038/sj.onc.1207553; Scoumanne A, 2006, CANCER RES, V66, P6271, DOI 10.1158/0008-5472.CAN-06-0121; Sengupta S, 2005, ONCOGENE, V24, P1738, DOI 10.1038/sj.onc.1208380; Senoo M, 2001, BIOCHEM BIOPH RES CO, V286, P628, DOI 10.1006/bbrc.2001.5429; Shats I, 2004, J BIOL CHEM, V279, P50976, DOI 10.1074/jbc.M402502200; Spurgers KB, 2006, J BIOL CHEM, V281, P25134, DOI 10.1074/jbc.M513901200; Stagliano Katherine E Roth, 2003, Methods Mol Biol, V234, P73; Stanelle J, 2003, CARDIOVASC RES, V59, P512, DOI 10.1016/S0008-6363(03)00392-4; SUBLER MA, 1992, J VIROL, V66, P4757, DOI 10.1128/JVI.66.8.4757-4762.1992; Sun YB, 2000, J BIOL CHEM, V275, P11327, DOI 10.1074/jbc.275.15.11327; Suzuki S, 1998, GENE, V216, P85, DOI 10.1016/S0378-1119(98)00323-0; Tannapfel A, 2000, DIGEST DIS SCI, V45, P317, DOI 10.1023/A:1005412626515; Taylor WR, 2001, J BIOL CHEM, V276, P1998, DOI 10.1074/jbc.M005101200; Thibault C, 2001, INT REV NEUROBIOL, V48, P219, DOI 10.1016/S0074-7742(01)48017-2; Urist M, 2002, CANCER CELL, V1, P311, DOI 10.1016/S1535-6108(02)00064-8; Valerie E, 1999, UROLOGY, V54, P1082, DOI 10.1016/S0090-4295(99)00311-8; Van Bodegom D, 2006, J BIOL CHEM, V281, P31234, DOI 10.1074/jbc.M606510200; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Woo RA, 2002, EMBO J, V21, P3000, DOI 10.1093/emboj/cdf307; Yang CR, 2000, FASEB J, V14, P379, DOI 10.1096/fasebj.14.2.379; Zhang LL, 2000, CANCER RES, V60, P3655; Zhao R, 2000, COLD SPRING HARB SYM, V65, P475, DOI 10.1101/sqb.2000.65.475	69	60	63	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2008	27	18					2583	2593		10.1038/sj.onc.1210898	http://dx.doi.org/10.1038/sj.onc.1210898			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	289LW	17982488				2022-12-25	WOS:000255057000008
J	Fuller, MD; Thompson, CH; Zhang, ZR; Freeman, CS; Schay, E; Szakacs, G; Bakos, E; Sarkadi, B; McMaster, D; French, RJ; Pohl, J; Kubanek, J; McCarty, NA				Fuller, Matthew D.; Thompson, Christopher H.; Zhang, Zhi-Ren; Freeman, Cody S.; Schay, Eszter; Szakacs, Gergely; Bakos, Eva; Sarkadi, Balazs; McMaster, Denis; French, Robert J.; Pohl, Jan; Kubanek, Julia; McCarty, Nael A.			State-dependent inhibition of cystic fibrosis transmembrane conductance regulator chloride channels by a novel peptide toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL FLUID SECRETION; HIGH-AFFINITY; ATP HYDROLYSIS; SCORPION-VENOM; CL-CHANNEL; ORGANIC-ANIONS; CFTR; CHLOROTOXIN; POTASSIUM; BINDING	Peptide toxins from animal venom have been used for many years for the identification and study of cation-permeable ion channels. However, no peptide toxins have been identified that interact with known anion-selective channels, including cystic fibrosis transmembrane conductance regulator (CFTR), the protein defective in cystic fibrosis and a member of the ABC transporter superfamily. Here, we describe the identification and initial characterization of a novel 3.7-kDa peptide toxin, GaTx1, which is a potent and reversible inhibitor of CFTR, acting from the cytoplasmic side of the membrane. Thus, GaTx1 is the first peptide toxin identified that inhibits a chloride channel of known molecular identity. GaTx1 exhibited high specificity, showing no effect on a panel of nine transport proteins, including Cl- and K+ channels, and ABC transporters. GaTx1-mediated inhibition of CFTR channel activity is strongly state-dependent; both potency and efficacy are reduced under conditions of elevated [ATP], suggesting that GaTx1 may function as a non-competitive inhibitor of ATP-dependent channel gating. This tool will allow the application of new quantitative approaches to study CFTR structure and function, particularly with respect to the conformational changes that underlie transitions between open and closed states.	[Fuller, Matthew D.; French, Robert J.] Emory Univ, Program Mol & Syst Pharmacol, Atlanta, GA 30322 USA; [Fuller, Matthew D.; Thompson, Christopher H.; Zhang, Zhi-Ren; Freeman, Cody S.; Kubanek, Julia; McCarty, Nael A.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Schay, Eszter; Szakacs, Gergely; Bakos, Eva] Hungarian Acad Sci, Inst Enzymol, H-1113 Budapest, Hungary; [Szakacs, Gergely; Sarkadi, Balazs] Hungarian Acad Sci, Natl Med Ctr, Inst Haematol & Immunol, H-1113 Budapest, Hungary; [French, Robert J.] Univ Calgary, Peptide Synth Core Facil, Calgary, AB T2N 4N1, Canada; [French, Robert J.] Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; [Pohl, Jan] Emory Univ, Microchem & Proteom Facil, Atlanta, GA 30322 USA; [Kubanek, Julia] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA	Emory University; University System of Georgia; Georgia Institute of Technology; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Hungarian Academy of Sciences; University of Calgary; University of Calgary; Emory University; University System of Georgia; Georgia Institute of Technology	McCarty, NA (corresponding author), Emory Univ, Program Mol & Syst Pharmacol, Atlanta, GA 30322 USA.	mccarty@gatech.edu	Sarkadi, Balazs/I-5024-2013; Szakacs, Gergely/A-2580-2009	Szakacs, Gergely/0000-0002-9311-7827; Kubanek, Julia/0000-0003-4482-1831				Ai-Awqati Q, 2002, J CLIN INVEST, V110, P1599, DOI 10.1172/JCI200217301; Al-Nakkash L, 1999, PFLUG ARCH EUR J PHY, V437, P553, DOI 10.1007/s004240050817; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; Bakos E, 1998, J BIOL CHEM, V273, P32167, DOI 10.1074/jbc.273.48.32167; Bakos E, 2000, MOL PHARMACOL, V57, P760, DOI 10.1124/mol.57.4.760; BAUKROWITZ T, 1994, NEURON, V12, P473, DOI 10.1016/0896-6273(94)90206-2; BECKER S, 1992, BIOCHEMISTRY-US, V31, P8229, DOI 10.1021/bi00150a016; BECQ F, 1994, P NATL ACAD SCI USA, V91, P9160, DOI 10.1073/pnas.91.19.9160; Berger W, 1997, INT J CANCER, V71, P108, DOI 10.1002/(SICI)1097-0215(19970328)71:1<108::AID-IJC18>3.0.CO;2-E; Bodo A, 2003, J BIOL CHEM, V278, P23529, DOI 10.1074/jbc.M303515200; CARSON MR, 1993, AM J PHYSIOL, V265, pL27, DOI 10.1152/ajplung.1993.265.1.L27; CASTLE NA, 1989, TRENDS NEUROSCI, V12, P59, DOI 10.1016/0166-2236(89)90137-9; Chang NS, 1998, BIOCHEMISTRY-US, V37, P4407, DOI 10.1021/bi9724927; Csanady L, 2000, J GEN PHYSIOL, V116, P477, DOI 10.1085/jgp.116.3.477; CUI G, 2006, PATCH CLAMP ANAL ADV, P353; Dalton S, 2003, GLIA, V42, P325, DOI 10.1002/glia.10212; Dassa E., 2003, ABC PROTEINS BACTERI, P3; DEBIN JA, 1993, AM J PHYSIOL, V264, pC361, DOI 10.1152/ajpcell.1993.264.2.C361; DEBIN JA, 1991, TOXICON, V29, P1403, DOI 10.1016/0041-0101(91)90128-E; Deshane J, 2003, J BIOL CHEM, V278, P4135, DOI 10.1074/jbc.M205662200; Devuyst O, 2002, AM J PHYSIOL-RENAL, V283, pF1176, DOI 10.1152/ajprenal.00184.2002; Esteve E, 2005, J BIOL CHEM, V280, P12833, DOI 10.1074/jbc.M412521200; French R J, 1999, Methods Enzymol, V294, P575; Froy O, 1999, J MOL EVOL, V48, P187, DOI 10.1007/PL00006457; Fuller MD, 2005, BIOPHYS J, V89, P3960, DOI 10.1529/biophysj.105.060731; Fuller MD, 2004, AM J PHYSIOL-CELL PH, V287, pC1328, DOI 10.1152/ajpcell.00162.2004; Gadsby David C., 1999, Physiological Reviews, V79, pS77; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; GADSBY DC, 1997, TRENDS BIOCHEM SCI, V19, P512; GOLDSTEIN SAN, 1992, BIOPHYS J, V62, P5, DOI 10.1016/S0006-3495(92)81760-5; Gross A, 1996, NEURON, V16, P399, DOI 10.1016/S0896-6273(00)80057-4; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Harrington MA, 1999, J BIOL CHEM, V274, P27536, DOI 10.1074/jbc.274.39.27536; Haug K, 2003, NAT GENET, V33, P527, DOI 10.1038/ng1121; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Hui KY, 2003, J GEN PHYSIOL, V122, P63, DOI 10.1085/jgp.200308842; HWANG TC, 1994, P NATL ACAD SCI USA, V91, P4698, DOI 10.1073/pnas.91.11.4698; Ikuma M, 2000, P NATL ACAD SCI USA, V97, P8675, DOI 10.1073/pnas.140220597; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; LEWIS RJ, 2003, NAT REV DRUG DISCOV, V2, P1; LIPPENS G, 1995, BIOCHEMISTRY-US, V34, P13, DOI 10.1021/bi00001a003; LOMIZE AL, 1991, BIOORG KHIM+, V17, P1613; Lyons SA, 2002, GLIA, V39, P162, DOI 10.1002/glia.10083; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; Maertens C, 2000, BRIT J PHARMACOL, V129, P791, DOI 10.1038/sj.bjp.0703102; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; PARK CS, 1991, P NATL ACAD SCI USA, V88, P2046, DOI 10.1073/pnas.88.6.2046; Possani LD, 2000, BIOCHIMIE, V82, P861, DOI 10.1016/S0300-9084(00)01167-6; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; RIORDAN JR, 1989, SCIENCE, V245, P1066; Routaboul C, 2007, J PHARMACOL EXP THER, V322, P1023, DOI 10.1124/jpet.107.123307; Schultz BD, 1999, PHYSL REV S, V79, P109; SMIT LS, 1993, P NATL ACAD SCI USA, V90, P9963, DOI 10.1073/pnas.90.21.9963; Sonawane ND, 2007, GASTROENTEROLOGY, V132, P1234, DOI 10.1053/j.gastro.2007.02.018; Soroceanu L, 1999, J NEUROSCI, V19, P5942, DOI 10.1523/JNEUROSCI.19-14-05942.1999; STAMPE P, 1994, BIOCHEMISTRY-US, V33, P443, DOI 10.1021/bi00168a008; Taddei A, 2004, FEBS LETT, V558, P52, DOI 10.1016/S0014-5793(04)00011-0; Thompson CH, 2005, J MEMBRANE BIOL, V208, P65, DOI 10.1007/s00232-005-0818-8; TRAVIS SM, 1993, J BIOL CHEM, V268, P15336; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang F, 1998, J GEN PHYSIOL, V111, P477, DOI 10.1085/jgp.111.3.477; Zhang ZR, 2004, J MEMBRANE BIOL, V201, P139, DOI 10.1007/s00232-004-0712-9; Zhang ZR, 2004, J MEMBRANE BIOL, V199, P15, DOI 10.1007/s00232-004-0672-0; Zhou Z, 2005, J PHYSIOL-LONDON, V569, P447, DOI 10.1113/jphysiol.2005.095083; Zou XQ, 2001, BIOCHEMISTRY-US, V40, P5579, DOI 10.1021/bi010133c	67	35	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37545	37555		10.1074/jbc.M708079200	http://dx.doi.org/10.1074/jbc.M708079200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17951250	hybrid			2022-12-25	WOS:000251833600030
J	Konrad, S; Engling, L; Schmidt, RE; Gessner, JE				Konrad, Stephanie; Engling, Linda; Schmidt, Reinhold E.; Gessner, J. Engelbert			Characterization of the murine IgG Fc receptor III and IIB gene promoters - A single two-nucleotide difference determines their inverse responsiveness to C5a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA RECEPTORS; ARTHUS REACTION; COMPLEMENT; AUTOIMMUNITY; NEUTROPHILS; TRANSCRIPTION; INHIBITION; ACTIVATION; STAT3	The two low affinity IgG Fc receptors (Fc gamma R), Fc gamma RIII and Fc gamma RIIB, are coexpressed on myeloid effector cells, and their genes, as reported here, are positively and negatively regulated by both C5a and interferon-gamma through different signaling mechanisms. Two 48- and 43- bp sequences (C5a- inductive region (CIR) and C5a-suppressive region (CSR)) in the Fc gamma RIII and Fc RIIB 5'- flanking regions that are necessary for C5a induction and suppression, respectively, are defined. Sequence analysis of the CIR and CSR, which localize apart from the interferon gamma- responsive regions in each gene, revealed the presence of a novel element that differs by two nucleotides between Fc gamma RIII and Fc gamma RIIB. Mutation analysis of the CIR and CSR showed that this small difference determines inverse responsiveness in an Fc gamma R gene context-dependent manner. Our study suggests that C5a uses similar DNA motifs (defined as GTGAXXTCCA) in both pathways of transcriptional induction and suppression of Fc gamma RIII and Fc gamma RIIB.	[Konrad, Stephanie; Engling, Linda; Schmidt, Reinhold E.; Gessner, J. Engelbert] Hannover Med Sch, Dept Clin Immunol & Rheumatol, D-30625 Hannover, Germany	Hannover Medical School	Gessner, JE (corresponding author), Hannover Med Sch, Dept Clin Immunol & Rheumatol, Carl-Neuberg-Str 1, D-30625 Hannover, Germany.	gessner.johannes@mh-hannover.de						Atkinson JP, 2006, J CLIN INVEST, V116, P304, DOI 10.1172/JCI27759; Baumann U, 2000, J IMMUNOL, V164, P1065, DOI 10.4049/jimmunol.164.2.1065; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; FEINMAN R, 1994, EMBO J, V13, P3852, DOI 10.1002/j.1460-2075.1994.tb06696.x; Fitch JCK, 1999, CIRCULATION, V100, P2499, DOI 10.1161/01.CIR.100.25.2499; Girardi G, 2003, J CLIN INVEST, V112, P1644, DOI 10.1172/JCI200318817; Godau J, 2004, J IMMUNOL, V173, P3437, DOI 10.4049/jimmunol.173.5.3437; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Kumar V, 2006, J CLIN INVEST, V116, P512, DOI 10.1172/JCI25536; Kuroki M, 1999, BIOCHEM J, V341, P691, DOI 10.1042/0264-6021:3410691; la Sala A, 2005, J IMMUNOL, V175, P2994, DOI 10.4049/jimmunol.175.5.2994; Lo RKH, 2003, J BIOL CHEM, V278, P52154, DOI 10.1074/jbc.M307299200; MONK PN, 2007, BR J PHARM; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Perianayagam MC, 2006, EUR J CLIN INVEST, V36, P353, DOI 10.1111/j.1365-2362.2006.01637.x; Radeke HH, 2002, J BIOL CHEM, V277, P27535, DOI 10.1074/jbc.M200419200; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Ravetch JV, 2002, J CLIN INVEST, V110, P1759, DOI 10.1172/JCI200217349; Schmidt RE, 2005, IMMUNOL LETT, V100, P56, DOI 10.1016/j.imlet.2005.06.022; Shushakova N, 2002, J CLIN INVEST, V110, P1823, DOI 10.1172/JCI200216577; Skokowa J, 2005, J IMMUNOL, V174, P3041, DOI 10.4049/jimmunol.174.5.3041; STEVENS JH, 1986, J CLIN INVEST, V77, P1812, DOI 10.1172/JCI112506; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Vakeva AP, 1998, CIRCULATION, V97, P2259, DOI 10.1161/01.CIR.97.22.2259; Volanakis J. E., 1998, HUMAN COMPLEMENT SYS; WEINSHANK RL, 1988, J EXP MED, V167, P1909, DOI 10.1084/jem.167.6.1909; Xiu Y, 2002, J IMMUNOL, V169, P4340, DOI 10.4049/jimmunol.169.8.4340	27	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37906	37912		10.1074/jbc.M707937200	http://dx.doi.org/10.1074/jbc.M707937200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17956862	hybrid			2022-12-25	WOS:000251833600066
J	Vavilin, D; Yao, D; Vermaas, W				Vavilin, Dmitrii; Yao, Danny; Vermaas, Wim			Small cab-like proteins retard degradation of photosystem II-associated chlorophyll in Synechocystis sp PCC 6803 - Kinetic analysis of pigment labeling with N-15 AND C-13	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-INDUCIBLE POLYPEPTIDES; DNA MICROARRAY ANALYSIS; A/B-BINDING-PROTEINS; SP STRAIN PCC-6803; GENE-EXPRESSION; OXYGENIC PHOTOSYNTHESIS; OSMOTIC-STRESS; PCC 6803; CYANOBACTERIA; PCC6803	Isotope ((NaNO3)-N-15, ((NH4)-N-15) SO4 or [C-13] glucose) labeling was used to analyze chlorophyll synthesis and degradation rates in a set of Synechocystis mutants that lacked single or multiple small Cab-like proteins (SCPs), as well as photosystem I or II. Whenall five small Cab-like proteins were inactivated in the wild-type background, chlorophyll stability was not affected unless the scpABCDE -strain was grown at a moderately high light intensity of 100 -300 mu mol photons m(-2) s(-1). However, the half-life time of chlorophyll was 5-fold shorter in the photosystem I-less/ scpABCDE -strain than in the photosystem I-less strain even when grown at low light intensity (similar to 3 mu mol photons m(-2) s(-1)) (32 +/- 5 and 161 +/- 25 h, respectively). In other photosystem I-less mutants that lacked one to four of the scp genes the chlorophyll lifetime was in between these two values, with the chlorophyll lifetime generally decreasing with an increasing number of inactivated scps. In contrast, the chlorophyll biosynthesis rate was only marginally affected by inactivation of scps except when all five scp genes were deleted. Small Cab-like protein deficiency did not significantly affect photoinhibition or turnover of photosystem II-associated beta-carotene. It is concluded that SCPs do not alter the stability of functional photosystem II complexes but retard the degradation of photosystem II-associated chlorophyll, consistent with the proposed involvement of SCPs in photosystem II re-assembly or/ and repair processes by temporarily binding chlorophyll while photosystem II protein components are being replaced.	[Vavilin, Dmitrii; Yao, Danny; Vermaas, Wim] Arizona State Univ, Sch Life Sci, Ctr Bioenergy & Photosynth, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Vavilin, D (corresponding author), Arizona State Univ, Sch Life Sci, Ctr Bioenergy & Photosynth, Box 874501, Tempe, AZ 85287 USA.	wim@asu.edu						Allakhverdiev SI, 2002, PLANT PHYSIOL, V130, P1443, DOI 10.1104/pp.011114; Baena-Gonzalez E, 2002, PHILOS T R SOC B, V357, P1451, DOI 10.1098/rstb.2002.1141; Bhaya D, 2002, FEMS MICROBIOL LETT, V215, P209, DOI 10.1111/j.1574-6968.2002.tb11393.x; Bricker TM, 1998, BBA-BIOENERGETICS, V1409, P50, DOI 10.1016/S0005-2728(98)00148-0; Bumba L, 2005, BBA-BIOENERGETICS, V1708, P1, DOI 10.1016/j.bbabio.2005.02.005; Clokie MRJ, 2006, ENVIRON MICROBIOL, V8, P2074, DOI 10.1111/j.1462-2920.2006.01171.x; Depka B, 1998, FEBS LETT, V424, P267, DOI 10.1016/S0014-5793(98)00188-4; Funk C, 1999, BIOCHEMISTRY-US, V38, P9397, DOI 10.1021/bi990545+; Grossman AR, 1995, ANNU REV GENET, V29, P231, DOI 10.1146/annurev.ge.29.120195.001311; Havaux M, 2003, BBA-BIOENERGETICS, V1557, P21, DOI 10.1016/S0005-2728(02)00391-2; He QF, 2001, J BIOL CHEM, V276, P306, DOI 10.1074/jbc.M008686200; Heddad M, 2002, COMP FUNCT GENOM, V3, P504, DOI 10.1002/cfg.221; Hihara Y, 2003, J BACTERIOL, V185, P1719, DOI 10.1128/JB.185.5.1719-1725.2003; Hihara Y, 2001, PLANT CELL, V13, P793, DOI 10.1105/tpc.13.4.793; Hu Q, 2000, APPL ENVIRON MICROB, V66, P133, DOI 10.1128/AEM.66.1.133-139.2000; JANSSON S, 1994, BBA-BIOENERGETICS, V1184, P1, DOI 10.1016/0005-2728(94)90148-1; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; Komenda J, 2000, PLANT MOL BIOL, V42, P635, DOI 10.1023/A:1006305308196; Li H, 2004, J BACTERIOL, V186, P3331, DOI 10.1128/JB.186.11.3331-3345.2004; Li ZL, 2000, BBA-BIOENERGETICS, V1460, P384, DOI 10.1016/S0005-2728(00)00207-3; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Mikami K, 2002, MOL MICROBIOL, V46, P905, DOI 10.1046/j.1365-2958.2002.03202.x; Nishiyama Y, 2005, PHOTOSYNTH RES, V84, P1, DOI 10.1007/s11120-004-6434-0; Ohta H, 2005, PHOTOSYNTH RES, V84, P225, DOI 10.1007/s11120-004-7761-x; Osanai T, 2006, DNA RES, V13, P185, DOI 10.1093/dnares/dsl010; Paithoonrangsarid K, 2004, J BIOL CHEM, V279, P53078, DOI 10.1074/jbc.M410162200; Promnares K, 2006, J BIOL CHEM, V281, P32705, DOI 10.1074/jbc.M606360200; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Shumskaya MA, 2005, J BIOL CHEM, V280, P21531, DOI 10.1074/jbc.m412174200; Sun J, 1998, METHOD ENZYMOL, V297, P124; Szabo I, 2005, EMBO REP, V6, P629, DOI 10.1038/sj.embor.7400460; TANG XS, 1994, BIOCHEMISTRY-US, V33, P4594, DOI 10.1021/bi00181a021; Tomo T, 2005, PHOTOSYNTH RES, V84, P77, DOI 10.1007/s11120-005-1302-0; Tu CJ, 2004, J BACTERIOL, V186, P3889, DOI 10.1128/JB.186.12.3889-3902.2004; Vavilin D, 2005, BBA-BIOENERGETICS, V1708, P91, DOI 10.1016/j.bbabio.2004.12.011; VAVILIN D, 2007, IN PRESS PHOTOSYNTHE; VAVILIN D, 2005, PHOTOSYNTHESIS FUNDA, V1, P896; Vavilin D, 2007, BBA-BIOENERGETICS, V1767, P920, DOI 10.1016/j.bbabio.2007.03.010; Xu H, 2004, J BIOL CHEM, V279, P27971, DOI 10.1074/jbc.M403307200; Xu H, 2002, PLANT MOL BIOL, V49, P149, DOI 10.1023/A:1014900806905; Yao D, 2007, J BIOL CHEM, V282, P267, DOI 10.1074/jbc.M605463200	43	51	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37660	37668		10.1074/jbc.M707133200	http://dx.doi.org/10.1074/jbc.M707133200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17971445	hybrid			2022-12-25	WOS:000251833600042
J	Teichert, RW; Jimenez, EC; Twede, V; Watkins, M; Hollmann, M; Bulaj, G; Olivera, BM				Teichert, Russell W.; Jimenez, Elsie C.; Twede, Vernon; Watkins, Maren; Hollmann, Michael; Bulaj, Grzegorz; Olivera, Baldomero M.			Novel conantokins from Conus parius venom are specific antagonists of N-methyl-D-aspartate receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CARBOXYGLUTAMATE; RAT MODEL; IN-VITRO; PEPTIDES; BINDING; CALCIUM	We report the discovery and characterization of three conantokin peptides from the venom of Conus parius. Each peptide (conantokin-Pr1, -Pr2, and -Pr3) contains 19 amino acids with three gamma-carboxyglutamate (Gla) residues, a post-translationally modified amino acid characteristic of conantokins. The new peptides contain several amino acid residues that differ from previous conantokin consensus sequences. Notably, the new conantokins lack Gla at the 3rd position from the N terminus, where the Gla residue is replaced by either aspartate or by another post-translationally modified residue, 4-trans-hydroxyproline. Conantokin-Pr3 is the first conantokin peptide to have three different post-translational modifications. Conantokins-Pr1 and -Pr2 adopt alpha-helical conformations in the presence of divalent cations ( Mg2+ and Ca2+) but are generally unstructured in the absence of divalent cations. Conantokin-Pr3 adopts an alpha-helical conformation even in the absence of divalent cations. Like other conantokins, the new peptides induced sleep in young mice and hyperactivity in older mice upon intracranial injection. Electrophysiological assays confirmed that conantokins-Pr1, -Pr2, and -Pr3 are N-methyl-D-aspartate ( NMDA) receptor antagonists, with highest potency for NR2B-containing NMDA receptors. Conantokin-Pr3 demonstrated similar to 10-fold selectivity for NR2B-containing NMDA receptors. However, conantokin-Pr2 showed minimal differences in potency between NR2B and NR2D. Conantokins-Pr1, -Pr2, and -Pr3 all demonstrated high specificity of block for NMDA receptors, when tested against various ligand-gated ion channels. Conus parius conantokins allow for a better definition of structural and functional features of conantokins as ligands targeting NMDA receptors.	[Teichert, Russell W.; Jimenez, Elsie C.; Twede, Vernon; Olivera, Baldomero M.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Watkins, Maren] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; [Bulaj, Grzegorz] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Jimenez, Elsie C.] Univ Philippines Baguio, Coll Sci, Dept Phys Sci, Baguio 2600, Philippines; [Hollmann, Michael] Ruhr Univ Bochum, Fac Chem & Biochem, Dept Biochem Receptor Biochem 1, D-44780 Bochum, Germany	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of the Philippines System; University of the Philippines Baguio; Ruhr University Bochum	Teichert, RW (corresponding author), 257 S 1400 E, Salt Lake City, UT 84112 USA.	russ_teichert@yahoo.com	Teichert, Russell W/H-2213-2013; Jimenez, Elsie/AAA-7347-2019	Teichert, Russell/0000-0002-9985-5214	NIGMS NIH HHS [GM48677] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blandl T, 1999, J PEPT RES, V53, P453, DOI 10.1034/j.1399-3011.1999.00042.x; Blandl T, 2001, J BIOL CHEM, V276, P7391, DOI 10.1074/jbc.M006648200; Bleakman D, 2006, SEMIN CELL DEV BIOL, V17, P592, DOI 10.1016/j.semcdb.2006.10.008; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Chen ZG, 1998, J BIOL CHEM, V273, P16248, DOI 10.1074/jbc.273.26.16248; CLARK C, 1981, TOXICON, V19, P691, DOI 10.1016/0041-0101(81)90106-9; CRUZ L J, 1976, Veliger, V18, P302; Donevan SD, 2000, MOL PHARMACOL, V58, P614, DOI 10.1124/mol.58.3.614; EDMAN P, 1967, EUR J BIOCHEM, V1, P80, DOI 10.1111/j.1432-1033.1967.tb00047.x; HAACK JA, 1990, J BIOL CHEM, V265, P6025; HAMMERLAND LG, 1992, EUR J PHARM-MOLEC PH, V226, P239, DOI 10.1016/0922-4106(92)90067-6; Heading Christine E, 2002, Curr Opin Investig Drugs, V3, P915; Jacobsen R, 1998, J PEPT RES, V51, P173; Jimenez EC, 2002, EPILEPSY RES, V51, P73, DOI 10.1016/S0920-1211(02)00101-8; Layer RT, 2004, CURR MED CHEM, V11, P3073, DOI 10.2174/0929867043363901; Malmberg AB, 2003, PAIN, V101, P109, DOI 10.1016/S0304-3959(02)00303-2; MCINTOSH JM, 1984, J BIOL CHEM, V259, P4343; MENA EE, 1990, NEUROSCI LETT, V118, P241, DOI 10.1016/0304-3940(90)90637-O; Olivera BM, 1999, CURR OPIN NEUROBIOL, V9, P772, DOI 10.1016/S0959-4388(99)00033-1; Prorok M, 1996, BIOCHEMISTRY-US, V35, P16528, DOI 10.1021/bi9621122; Prorok M, 2001, CURR DRUG TARGETS, V2, P313, DOI 10.2174/1389450013348542; Prorok M, 2007, CURR DRUG TARGETS, V8, P633, DOI 10.2174/138945007780618481; Wei JJ, 2006, NEUROSCI LETT, V405, P137, DOI 10.1016/j.neulet.2006.06.040; White H. S., 1997, Society for Neuroscience Abstracts, V23, P2164; White HS, 2000, J PHARMACOL EXP THER, V292, P425; Williams AJ, 2002, NEUROREPORT, V13, P821, DOI 10.1097/00001756-200205070-00017; Williams AJ, 2000, J PHARMACOL EXP THER, V294, P378	27	41	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36905	36913		10.1074/jbc.M706611200	http://dx.doi.org/10.1074/jbc.M706611200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17962189	hybrid			2022-12-25	WOS:000251646000016
J	Kipp, JJL; Kilen, SM; Woodruff, TK; Mayo, KE				Kipp, Jingjing L.; Kilen, Signe M.; Woodruff, Teresa K.; Mayo, Kelly E.			Activin regulates estrogen receptor gene expression in the mouse ovary	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBIN ALPHA-SUBUNIT; RAT GRANULOSA-CELLS; BREAST-CANCER CELLS; GROWTH-FACTOR-BETA; FOLLICLE-STIMULATING-HORMONE; TGF-BETA; TRANSCRIPTION FACTOR; MESSENGER-RNA; REPRODUCTIVE PHENOTYPES; SUPERFAMILY MEMBERS	Activin, a member of the transforming growth factor-beta superfamily, is an important modulator of follicle-stimulating hormone synthesis and secretion in the pituitary and plays autocrine/paracrine roles in the regulation of ovarian follicle development. From a microarray study on mouse ovarian granulosa cells, we discovered that the estrogen receptor beta(ER beta) is inducible by activin. We previously demonstrated that estrogen suppresses activin gene expression, suggesting a feedback relationship between these two follicle-regulating hormones. The purpose of this study was to investigate fully activin A regulation of ER expression. Real time reverse transcription-PCR assays on cultured granulosa cells showed that both ER alpha and ER alpha mRNAs were induced by activin A at 4, 12, and 24 h in a dose-responsive manner. Western blots confirmed an increase in their protein levels. Consistent with increased ER alpha and ER alpha expression, activin A stimulated estradiol-induced estrogen response element promoter activity. Activin A stimulation of ER expression was a direct effect at the level of gene transcription, as it was not abolished by cycloheximide but was abolished by actinomycin D, and in transfected granulosa cells activin A stimulated ER alpha promoter activity. To investigate the effect of activin in vivo and, thus, its biological significance, we examined ER expression in inhibin transgenic mice that have decreased activin expression and discovered that these mice had decreased ER alpha and ER alpha expression in the ovary. We also found that ER mRNA levels were decreased in Mullerian inhibiting substance promoter (MIS)-Smad2 dominant negative mice that have impaired activin signaling through Smad2, and small interfering RNAs targeting Smad2 or Smad3 suppressed ER alpha promoter activation, suggesting that Smad2 and Smad3 are involved in regulating ER levels. Therefore, this study reveals an important role for activin in inducing the expression of ERs in the mouse ovary and suggests important interplay between activin and estrogen signaling.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Northwestern Univ, Dept Obstet & Gynecol, Evanston, IL 60208 USA; Northwestern Univ, Ctr Reprod Sci, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Mayo, KE (corresponding author), 2205 Tech Dr,Hogan 4-112, Evanston, IL 60208 USA.	k-mayo@northwestern.edu		Woodruff, Teresa/0000-0002-1197-3399	NICHD NIH HHS [HD91291] Funding Source: Medline; NIDDK NIH HHS [T32 DK007169] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007169] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bernard DJ, 2001, MOL CELL ENDOCRINOL, V180, P55, DOI 10.1016/S0303-7207(01)00500-7; BOITANI C, 1995, ENDOCRINOLOGY, V136, P5438, DOI 10.1210/en.136.12.5438; Bristol-Gould SK, 2005, ENDOCRINOLOGY, V146, P5228, DOI 10.1210/en.2005-0697; Britt KL, 2004, BIOL REPROD, V71, P1712, DOI 10.1095/biolreprod.104.028175; Britt KL, 2002, J ENDOCRINOL, V175, P269, DOI 10.1677/joe.0.1750269; Britt KL, 2001, J STEROID BIOCHEM, V79, P181, DOI 10.1016/S0960-0760(01)00158-3; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burdette JE, 2005, CANCER RES, V65, P7968, DOI 10.1158/0008-5472.CAN-04-3553; Burkart AD, 2006, MOL ENDOCRINOL, V20, P584, DOI 10.1210/me.2005-0204; Burkart AD, 2005, ENDOCRINOLOGY, V146, P1909, DOI 10.1210/en.2004-0842; CARROLL RS, 1991, ENDOCRINOLOGY, V129, P3299, DOI 10.1210/endo-129-6-3299; CICATIELLO L, 1995, MOL ENDOCRINOL, V9, P1077, DOI 10.1210/me.9.8.1077; de Kretser DM, 2001, MOL CELL ENDOCRINOL, V180, P87, DOI 10.1016/S0303-7207(01)00502-0; deGraffenried LA, 2004, BREAST CANCER RES TR, V85, P111, DOI 10.1023/B:BREA.0000025398.93829.78; deGraffenried LA, 2002, J STEROID BIOCHEM, V82, P7, DOI 10.1016/S0960-0760(02)00151-6; DEKRETSER DM, 1989, BIOL REPROD, V40, P33, DOI 10.1095/biolreprod40.1.33; DePaolo LV, 1997, P SOC EXP BIOL MED, V214, P328; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Drummond AE, 2002, ENDOCRINOLOGY, V143, P1423, DOI 10.1210/en.143.4.1423; Dupont J, 2003, BIOL REPROD, V68, P1877, DOI 10.1095/biolreprod.102.012005; Dupont S, 2000, DEVELOPMENT, V127, P4277; DYKEMA JC, 1991, SERONO SYMP, P99; DYKEMA JC, 1994, ENDOCRINOLOGY, V135, P702, DOI 10.1210/en.135.2.702; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Findlay JK, 1999, TRENDS ENDOCRIN MET, V10, P183, DOI 10.1016/S1043-2760(98)00144-1; Findlay JK, 2002, MOL CELL ENDOCRINOL, V191, P35, DOI 10.1016/S0303-7207(02)00053-9; FINDLAY JK, 1993, BIOL REPROD, V48, P15, DOI 10.1095/biolreprod48.1.15; Findlay JK, 2001, MOL CELL ENDOCRINOL, V180, P139, DOI 10.1016/S0303-7207(01)00521-4; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Gehm BD, 1997, P NATL ACAD SCI USA, V94, P14138, DOI 10.1073/pnas.94.25.14138; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; GREENE GL, 1986, SCIENCE, V231, P1150, DOI 10.1126/science.3753802; Guo SQ, 2004, MOL CELL BIOL, V24, P8681, DOI 10.1128/MCB.24.19.8681-8690.2004; HASHIMOTO M, 1993, ENDOCRINOLOGY, V133, P1934, DOI 10.1210/en.133.5.1934; Igarashi M, 1988, Nihon Sanka Fujinka Gakkai Zasshi, V40, P973; Jaatinen R, 2002, J CLIN ENDOCR METAB, V87, P1254, DOI 10.1210/jc.87.3.1254; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Jefferson WN, 2000, BIOL REPROD, V62, P310, DOI 10.1095/biolreprod62.2.310; Kipp JL, 2007, ENDOCRINOLOGY, V148, P1968, DOI 10.1210/en.2006-1083; Knight PG, 2003, ANIM REPROD SCI, V78, P165, DOI 10.1016/S0378-4320(03)00089-7; Knight PG, 2001, REPRODUCTION, V121, P503, DOI 10.1530/reprod/121.4.503; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; KOIKE S, 1987, NUCLEIC ACIDS RES, V15, P2499, DOI 10.1093/nar/15.6.2499; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; KRUST A, 1986, EMBO J, V5, P891, DOI 10.1002/j.1460-2075.1986.tb04300.x; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; LAPOLT PS, 1989, MOL ENDOCRINOL, V3, P1666, DOI 10.1210/mend-3-10-1666; Lee SO, 2005, CANCER RES, V65, P3487, DOI 10.1158/0008-5472.CAN-04-3267; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; LORENZEN JR, 1981, AM J PHYSIOL, V240, pE209, DOI 10.1152/ajpendo.1981.240.2.E209; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; MacConell LA, 2002, ENDOCRINOLOGY, V143, P1066, DOI 10.1210/en.143.3.1066; Madureira PA, 2006, J BIOL CHEM, V281, P25167, DOI 10.1074/jbc.M603906200; Mather JP, 1997, P SOC EXP BIOL MED, V215, P209; Matsuda T, 2001, J BIOL CHEM, V276, P42908, DOI 10.1074/jbc.M105316200; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; McMullen ML, 2001, ENDOCRINOLOGY, V142, P5005, DOI 10.1210/en.142.11.5005; MEUNIER H, 1988, MOL ENDOCRINOL, V2, P1352, DOI 10.1210/mend-2-12-1352; MEUNIER H, 1988, P NATL ACAD SCI USA, V85, P247, DOI 10.1073/pnas.85.1.247; Monroe DG, 2000, MOL CELL BIOL, V20, P4626, DOI 10.1128/MCB.20.13.4626-4634.2000; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Moustakas A, 1998, P NATL ACAD SCI USA, V95, P6733, DOI 10.1073/pnas.95.12.6733; Mowa CN, 2000, J ENDOCRINOL, V167, P363, DOI 10.1677/joe.0.1670363; Mukherjee A, 1996, ENDOCRINOLOGY, V137, P3234, DOI 10.1210/en.137.8.3234; Palter SF, 2001, ENDOCR REV, V22, P389, DOI 10.1210/er.22.3.389; Pangas SA, 2002, J CLIN ENDOCR METAB, V87, P2644, DOI 10.1210/jc.87.6.2644; PARKSARGE OK, 1994, ENDOCRINOLOGY, V134, P709, DOI 10.1210/en.134.2.709; PEI L, 1991, MOL ENDOCRINOL, V5, P521, DOI 10.1210/mend-5-4-521; Peterson TJ, 2007, MOL CELL BIOL, V27, P5933, DOI 10.1128/MCB.00237-07; Petrel TA, 2003, J CELL BIOCHEM, V88, P181, DOI 10.1002/jcb.10353; Risbridger GP, 2001, ENDOCR REV, V22, P836, DOI 10.1210/er.22.6.836; SCHWARTZ NB, 1977, P NATL ACAD SCI USA, V74, P5721, DOI 10.1073/pnas.74.12.5721; SOKOL SY, 1992, DEV BIOL, V154, P348, DOI 10.1016/0012-1606(92)90073-P; Symonds D, 2003, ANAT REC PART A, V273A, P681, DOI 10.1002/ar.a.10090; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353; VALE WHA, 1990, GROWTH FACTORS THEIR, P211; van den Wijngaard A, 2000, MOL ENDOCRINOL, V14, P623, DOI 10.1210/me.14.5.623; WHITE R, 1987, MOL ENDOCRINOL, V1, P735, DOI 10.1210/mend-1-10-735; Woodruff TK, 2005, ENDOCRINOLOGY, V146, P3244, DOI 10.1210/en.2005-0630; WOODRUFF TK, 1990, ANNU REV PHYSIOL, V52, P807, DOI 10.1146/annurev.ph.52.030190.004111; WOODRUFF TK, 1988, SCIENCE, V239, P1296, DOI 10.1126/science.3125611; Yamamoto T, 2002, ENDOCRINOLOGY, V143, P2635, DOI 10.1210/en.143.7.2635; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854; YING SY, 1988, ENDOCR REV, V9, P267, DOI 10.1210/edrv-9-2-267; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	86	49	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36755	36765		10.1074/jbc.M705143200	http://dx.doi.org/10.1074/jbc.M705143200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17951260	hybrid, Green Submitted			2022-12-25	WOS:000251458300068
J	Wrobel, S				Wrobel, Sylvia			Science, serotonin, and sadness: the biology of antidepressants - A series for the public	FASEB JOURNAL			English	Editorial Material												sylviawrobel@comcast.net							0	6	6	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2007	21	13					3404	3417		10.1096/fj.07-1102ufm	http://dx.doi.org/10.1096/fj.07-1102ufm			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	225KW	17967927				2022-12-25	WOS:000250517800002
J	Laguri, C; Sadir, R; Rueda, P; Baleux, F; Gans, P; Arenzana-Seisdedos, F; Lortat-Jacob, H				Laguri, Cedric; Sadir, Rabia; Rueda, Patricia; Baleux, Francoise; Gans, Pierre; Arenzana-Seisdedos, Fernando; Lortat-Jacob, Hugues			The Novel CXCL12 gamma Isoform Encodes an Unstructured Cationic Domain Which Regulates Bioactivity and Interaction with Both Glycosaminoglycans and CXCR4	PLOS ONE			English	Article								Background. CXCL12 alpha, a chemokine that importantly promotes the oriented cell migration and tissue homing of many cell types, regulates key homeostatic functions and pathological processes through interactions with its cognate receptor (CXCR4) and heparan sulfate (HS). The alternative splicing of the cxcl12 gene generates a recently identified isoform, CXCL12 gamma, which structure/function relationships remain unexplored. The high occurrence of basic residues that characterize this isoform suggests however that it could feature specific regulation by HS. Methodology/Principal Findings. Using surface plasmon resonance and NMR spectroscopy, as well as chemically and recombinantly produced chemokines, we show here that CXCL12 gamma first 68 amino acids adopt a structure closely related to the well described a isoform, followed by an unfolded C-terminal extension of 30 amino acids. Remarkably, 60 % of these residues are either lysine or arginine, and most of them are clustered in typical HS binding sites. This provides the chemokine with the highest affinity for HP ever observed (Kd = 0.9 nM), and ensures a strong retention of the chemokine at the cell surface. This was due to the unique combination of two cooperative binding sites, one strictly required, found in the structured domain of the protein, the other one being the C-terminus which essentially functions by enhancing the half life of the complexes. Importantly, this peculiar C-terminus also regulates the balance between HS and CXCR4 binding, and consequently the biological activity of the chemokine. Conclusions/Significance. Together these data describe an unusual binding process that gives rise to an unprecedented high affinity between a chemokine and HS. This shows that the c isoform of CXCL12, which features unique structural and functional properties, is optimized to ensure its strong retention at the cell surface. Thus, depending on the chemokine isoform to which it binds, HS could differentially orchestrate the CXCL12 mediated directional cell kinesis.	[Laguri, Cedric; Sadir, Rabia; Gans, Pierre; Lortat-Jacob, Hugues] CNRS, UJF, CEA, UMR 5075,IBS, Grenoble, France; [Rueda, Patricia; Arenzana-Seisdedos, Fernando] Inst Pasteur, INSERM, Unite Pathogenie Virale Mol 819, F-75724 Paris, France; [Baleux, Francoise] Inst Pasteur, Unite Chim Organ, URA 2128, F-75724 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lortat-Jacob, H (corresponding author), CNRS, UJF, CEA, UMR 5075,IBS, Grenoble, France.	Hugues.Lortat-Jacob@ibs.fr	Arenzana-Seisdedos, Fernando/E-5835-2016	Rueda, Patricia/0000-0003-1553-0840; laguri, cedric/0000-0002-5429-6914	Agence Nationale de la Recherche (ANR); ANR; Junta de Andalucia (Spain)	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); ANR(French National Research Agency (ANR)); Junta de Andalucia (Spain)(Junta de Andalucia)	This work was supported by a grant from the Agence Nationale de la Recherche (ANR). CL is supported by a post doctoral fellowship from the ANR. PR is a fellowship recipient from the FPDI program supported by the Junta de Andalucia (Spain).	Agace WW, 2000, CURR BIOL, V10, P325, DOI 10.1016/S0960-9822(00)00380-8; Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Baryshnikova OK, 2006, PROTEIN SCI, V15, P2568, DOI 10.1110/ps.062255806; Bax A, 2003, PROTEIN SCI, V12, P1, DOI 10.1110/ps.0233303; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Campanella GSV, 2006, J IMMUNOL, V177, P6991, DOI 10.4049/jimmunol.177.10.6991; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Crane-Robinson C, 2006, TRENDS BIOCHEM SCI, V31, P547, DOI 10.1016/j.tibs.2006.08.006; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; DApuzzo M, 1997, EUR J IMMUNOL, V27, P1788, DOI 10.1002/eji.1830270729; Dealwis C, 1998, P NATL ACAD SCI USA, V95, P6941, DOI 10.1073/pnas.95.12.6941; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Gleichmann M, 2000, EUR J NEUROSCI, V12, P1857, DOI 10.1046/j.1460-9568.2000.00048.x; Gozansky EK, 2005, J MOL BIOL, V345, P651, DOI 10.1016/j.jmb.2004.11.003; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Lortat-Jacob H, 2002, P NATL ACAD SCI USA, V99, P1229, DOI 10.1073/pnas.032497699; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Ohnishi Y, 2000, J INTERF CYTOK RES, V20, P691, DOI 10.1089/10799900050116390; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Ottiger M, 1998, J MAGN RESON, V134, P365, DOI 10.1006/jmre.1998.1546; Pablos JL, 1999, AM J PATHOL, V155, P1577, DOI 10.1016/S0002-9440(10)65474-0; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Sadir R, 2004, J BIOL CHEM, V279, P43854, DOI 10.1074/jbc.M405392200; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Sweeney EA, 2002, BLOOD, V99, P44, DOI 10.1182/blood.V99.1.44; VanHaverbeke C, 2004, BIOCHEM J, V384, P93, DOI 10.1042/BJ20040757; Veldkamp CT, 2005, PROTEIN SCI, V14, P1071, DOI 10.1110/ps.041219505; Yu L, 2006, GENE, V374, P174, DOI 10.1016/j.gene.2006.02.001; Zhu Y, 2002, NAT NEUROSCI, V5, P719, DOI 10.1038/nn881	41	81	83	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1110	10.1371/journal.pone.0001110	http://dx.doi.org/10.1371/journal.pone.0001110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971873	gold, Green Published, Green Submitted			2022-12-25	WOS:000207458700027
J	van Vliet, MH; Klijn, CN; Wessels, LFA; Reinders, MJT				van Vliet, Martin H.; Klijn, Christiaan N.; Wessels, Lodewyk F. A.; Reinders, Marcel J. T.			Module-Based Outcome Prediction Using Breast Cancer Compendia	PLOS ONE			English	Article							GENE-EXPRESSION PATTERNS; MICROARRAY	Background. The availability of large collections of microarray datasets (compendia), or knowledge about grouping of genes into pathways (gene sets), is typically not exploited when training predictors of disease outcome. These can be useful since a compendium increases the number of samples, while gene sets reduce the size of the feature space. This should be favorable from a machine learning perspective and result in more robust predictors. Methodology. We extracted modules of regulated genes from gene sets, and compendia. Through supervised analysis, we constructed predictors which employ modules predictive of breast cancer outcome. To validate these predictors we applied them to independent data, from the same institution (intra-dataset), and other institutions (inter-dataset). Conclusions. We show that modules derived from single breast cancer datasets achieve better performance on the validation data compared to gene-based predictors. We also show that there is a trend in compendium specificity and predictive performance: modules derived from a single breast cancer dataset, and a breast cancer specific compendium perform better compared to those derived from a human cancer compendium. Additionally, the module-based predictor provides a much richer insight into the underlying biology. Frequently selected gene sets are associated with processes such as cell cycle, E2F regulation, DNA damage response, proteasome and glycolysis. We analyzed two modules related to cell cycle, and the OCT1 transcription factor, respectively. On an individual basis, these modules provide a significant separation in survival subgroups on the training and independent validation data.	[van Vliet, Martin H.; Klijn, Christiaan N.; Wessels, Lodewyk F. A.; Reinders, Marcel J. T.] Delft Univ Technol, Fac Elect Engn Math & Comp Sci, Informat & Commun Theory Grp, Delft, Netherlands; [van Vliet, Martin H.; Klijn, Christiaan N.; Wessels, Lodewyk F. A.] Netherlands Canc Inst, Bioinformat & Stat Grp, Dept Mol Biol, Amsterdam, Netherlands	Delft University of Technology; Netherlands Cancer Institute	van Vliet, MH (corresponding author), Delft Univ Technol, Fac Elect Engn Math & Comp Sci, Informat & Commun Theory Grp, Delft, Netherlands.	M.H.vanVliet@TUDelft.nl		Klijn, Christiaan/0000-0003-0878-4121	Netherlands Genomics Initiative (NGI)	Netherlands Genomics Initiative (NGI)	This work was part of the BioRange programme of the Netherlands Bioinformatics Centre (NBIC), which is supported by a BSIK grant through the Netherlands Genomics Initiative (NGI).	[Anonymous], MSIGDB; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Dorningos P., 1996, ICML; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jiang HY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-81; Jin TR, 1999, INT J CANCER, V81, P104, DOI 10.1002/(SICI)1097-0215(19990331)81:1<104::AID-IJC18>3.0.CO;2-Q; Kim RD, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r70; Malin S, 2005, NUCLEIC ACIDS RES, V33, P4618, DOI 10.1093/nar/gki744; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Shen RL, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-94; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; TANAY A, 2005, MOL SYSTEMS BIOL, V1; Teschendorff AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r101; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wessels LFA, 2005, BIOINFORMATICS, V21, P3755, DOI 10.1093/bioinformatics/bti429	23	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1047	10.1371/journal.pone.0001047	http://dx.doi.org/10.1371/journal.pone.0001047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940611	Green Published, gold, Green Submitted			2022-12-25	WOS:000207456100015
J	Zimmer, J; Bausinger, H; Andres, E; Donato, L; Hanau, D; Hentges, F; Moretta, A; de la Salle, H				Zimmer, Jacques; Bausinger, Huguette; Andres, Emmanuel; Donato, Lionel; Hanau, Daniel; Hentges, Francois; Moretta, Alessandro; de la Salle, Henri			Phenotypic Studies of Natural Killer Cell Subsets in Human Transporter Associated with Antigen Processing Deficiency	PLOS ONE			English	Article								Peripheral blood natural killer (NK) cells from patients with transporter associated with antigen processing (TAP) deficiency are hyporesponsive. The mechanism of this defect is unknown, but the phenotype of TAP-deficient NK cells is almost normal. However, we noticed a high percentage of CD56(bright) cells among total NK cells from two patients. We further investigated TAP-deficient NK cells in these patients and compared them to NK cells from two other TAP-deficient patients with no clinical symptoms and to individuals with chronic inflammatory diseases other than TAP deficiency (chronic lung diseases or vasculitis). Peripheral blood mononuclear cells isolated from venous blood were stained with fluorochrome-conjugated antibodies and the phenotype of NK cells was analyzed by flow cytometry. In addition, (51)Chromium release assays were performed to assess the cytotoxic activity of NK cells. In the symptomatic patients, CD56(bright) NK cells represented 28% and 45%, respectively, of all NK cells (higher than in healthy donors). The patients also displayed a higher percentage of CD56(dim) CD16(-) NK cells than controls. Interestingly, this unusual NK cell subtype distribution was not found in the two asymptomatic TAP-deficient cases, but was instead present in several of the other patients. Over-expression of the inhibitory receptor CD94/NKG2A by TAP-deficient NK cells was confirmed and extended to the inhibitory receptor ILT2 (CD85j). These inhibitory receptors were not involved in regulating the cytotoxicity of TAP-deficient NK cells. We conclude that expansion of the CD56(bright) NK cell subtype in peripheral blood is not a hallmark of TAP deficiency, but can be found in other diseases as well. This might reflect a reaction of the immune system to pathologic conditions. It could be interesting to investigate the relative distribution of NK cell subsets in various respiratory and autoimmune diseases.	[Zimmer, Jacques; Hentges, Francois] CRP Sante, Lab Immunogenet Allergol, Luxembourg, Luxembourg; [Bausinger, Huguette; Hanau, Daniel; de la Salle, Henri] INSERM, U725, Strasbourg, France; [Bausinger, Huguette; Hanau, Daniel; de la Salle, Henri] Univ Strasbourg 1, Strasbourg, France; [Bausinger, Huguette; Hanau, Daniel; de la Salle, Henri] Etab Francais Sang Alsace, Strasbourg, France; [Andres, Emmanuel] Hop Univ Strasbourg, Serv Med Interne, Clin Med B, Strasbourg, France; [Donato, Lionel] Hop Univ Strasbourg, Serv Pediat, Strasbourg, France; [Moretta, Alessandro] Univ Genoa, Dipartimento Med Sperimentale, Sez Istol, Genoa, Italy	Luxembourg Institute of Health; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Genoa	Zimmer, J (corresponding author), CRP Sante, Lab Immunogenet Allergol, Luxembourg, Luxembourg.	jacques.zimmer@crp-sante.lu	Andres, E/AAY-3767-2020; De La Salle, Henri/H-9353-2016; Andres, Emmanuel/AAX-1502-2020	De La Salle, Henri/0000-0001-5136-0776; Andres, Emmanuel/0000-0002-7914-7616; Zimmer, Jacques/0000-0002-7118-6944	"CRP-Sante'', Luxembourg; "Ministere de la Culture, de l'Enseignement Superieur et de la Recherche'' (Ministry of Culture, Higher Education and Research) of Luxembourg [BFR 96/003]	"CRP-Sante'', Luxembourg; "Ministere de la Culture, de l'Enseignement Superieur et de la Recherche'' (Ministry of Culture, Higher Education and Research) of Luxembourg	The "Laboratoire d'Immunogenetique-Allergologie'' is supported by an institutional grant from the "CRP-Sante'', Luxembourg. The work of Jacques Zimmer was partially financed by a grant (BFR 96/003) from the "Ministere de la Culture, de l'Enseignement Superieur et de la Recherche'' (Ministry of Culture, Higher Education and Research) of Luxembourg.	Andre P, 2000, P NATL ACAD SCI USA, V97, P3400, DOI 10.1073/pnas.040569797; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Cac NN, 2006, J ALLERGY CLIN IMMUN, V118, P526, DOI 10.1016/j.jaci.2006.04.023; Campbell JJ, 2001, J IMMUNOL, V166, P6477, DOI 10.4049/jimmunol.166.11.6477; Carson William, 1996, Methods (Orlando), V9, P327, DOI 10.1006/meth.1996.0038; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; de la Salle H, 1999, PRIMARY IMMUNODEFICIENCY DISEASES, P181; De la Salle H, 2002, CLIN EXP IMMUNOL, V128, P525, DOI 10.1046/j.1365-2249.2002.01862.x; de la Salle H, 1999, J CLIN INVEST, V103, pR9, DOI 10.1172/JCI5687; DELASALLE H, 1994, SCIENCE, V265, P237, DOI 10.1126/science.7517574; Dogu F, 2006, PARASITOL INT, V55, P219, DOI 10.1016/j.parint.2006.02.003; Donato L, 1997, REV FR ALLERGOL, V37, P127, DOI 10.1016/S0335-7457(97)80035-4; DONATO L, 1995, J PEDIATR-US, V127, P895, DOI 10.1016/S0022-3476(95)70024-2; Doucey MA, 2004, NAT IMMUNOL, V5, P328, DOI 10.1038/ni1043; Freud AG, 2006, IMMUNOL REV, V214, P56, DOI 10.1111/j.1600-065X.2006.00451.x; Furukawa H, 1999, J CLIN INVEST, V103, P755, DOI 10.1172/JCI5335; Gromme M, 2002, MOL IMMUNOL, V39, P181, DOI 10.1016/S0161-5890(02)00101-3; Jacobs R, 2001, EUR J IMMUNOL, V31, P3121, DOI 10.1002/1521-4141(2001010)31:10<3121::AID-IMMU3121>3.0.CO;2-4; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kubo T, 2006, SCAND J INFECT DIS, V38, P1122, DOI 10.1080/00365540600740520; Kumar V, 2005, NAT REV IMMUNOL, V5, P363, DOI 10.1038/nri1603; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; MAEDA H, 1985, IMMUNOGENETICS, V21, P549, DOI 10.1007/BF00395879; Markel G, 2004, BLOOD, V103, P1770, DOI 10.1182/blood-2003-06-2114; Matamoros N, 2001, CLIN EXP IMMUNOL, V125, P274, DOI 10.1046/j.1365-2249.2001.01595.x; Mavilio D, 2005, P NATL ACAD SCI USA, V102, P2886, DOI 10.1073/pnas.0409872102; NAGLER A, 1989, J IMMUNOL, V143, P3183; O'Connor GM, 2006, IMMUNOLOGY, V117, P1, DOI 10.1111/j.1365-2567.2005.02256.x; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Parissiadis A, 2005, BRIT J OPHTHALMOL, V89, P1661, DOI 10.1136/bjo.2005.078097; Plebani A, 1996, J AM ACAD DERMATOL, V35, P814, DOI 10.1016/S0190-9622(96)90091-2; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; ROBERTSON MJ, 1990, BLOOD, V76, P2421; Saraste M, 2007, NEUROL SCI, V28, P121, DOI 10.1007/s10072-007-0803-3; Shibata F, 2007, EUR J HAEMATOL, V79, P81, DOI 10.1111/j.1600-0609.2007.00874.x; Sivori S, 1996, EUR J IMMUNOL, V26, P2487, DOI 10.1002/eji.1830261032; Smyth MJ, 2002, NAT REV CANCER, V2, P850, DOI 10.1038/nrc928; Vitale M, 2002, BLOOD, V99, P1723, DOI 10.1182/blood.V99.5.1723; Wendt K, 2006, J LEUKOCYTE BIOL, V80, P1529, DOI 10.1189/jlb.0306191; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369; Zimmer J, 2005, QJM-INT J MED, V98, P719, DOI 10.1093/qjmed/hci112; Zimmer J, 1998, J EXP MED, V187, P117, DOI 10.1084/jem.187.1.117; Zimmer J, 1999, EUR J IMMUNOL, V29, P1286, DOI 10.1002/(SICI)1521-4141(199904)29:04<1286::AID-IMMU1286>3.0.CO;2-L	44	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1033	10.1371/journal.pone.0001033	http://dx.doi.org/10.1371/journal.pone.0001033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940597	Green Published, Green Submitted, gold			2022-12-25	WOS:000207456100001
J	Weiss, C; Faust, D; Schreck, I; Ruff, A; Farwerck, T; Melenberg, A; Schneider, S; Oesch-Bartlomowicz, B; Zatloukalova, J; Vondracek, J; Oesch, F; Dietrich, C				Weiss, C.; Faust, D.; Schreck, I.; Ruff, A.; Farwerck, T.; Melenberg, A.; Schneider, S.; Oesch-Bartlomowicz, B.; Zatloukalova, J.; Vondracek, J.; Oesch, F.; Dietrich, C.			TCDD deregulates contact inhibition in rat liver oval cells via Ah receptor, JunD and cyclin A	ONCOGENE			English	Article						aryl hydrocarbon receptor; contact inhibition; cell cycle control; JunD; cyclin A; liver oval cells	ARYL-HYDROCARBON RECEPTOR; C-JUN; EPITHELIAL-CELLS; DIOXIN RECEPTOR; TUMOR PROMOTION; GROWTH ARREST; PROLIFERATION; EXPRESSION; HEPATOCYTES; APOPTOSIS	The aryl hydrocarbon receptor (AhR) is a transcription factor involved in physiological processes, but also mediates most, if not all, toxic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Activation of the AhR by TCDD leads to its dimerization with aryl hydrocarbon nuclear translocator (ARNT) and transcriptional activation of several phase I and II metabolizing enzymes. However, this classical signalling pathway so far failed to explain the pleiotropic hazardous effects of TCDD, such as developmental toxicity and tumour promotion. Thus, there is an urgent need to de. ne genetic programmes orchestrated by AhR to unravel its role in physiology and toxicology. Here we show that TCDD treatment of rat liver oval cells leads to induction of the transcription factor JunD, resulting in transcriptional upregulation of the proto-oncogene cyclin A which finally triggers a release from contact inhibition. Ectopic expression of cyclin A in confluent cultures overcomes G(1) arrest, indicating that increased cyclin A levels are indeed sufficient to bypass contact inhibition. Functional interference with AhR-, but not with ARNT, abolished TCDD-induced increase in JunD and cyclin A and prevented loss of contact inhibition. In summary, we have discovered a novel AhR- dependent and probably ARNT-independent signalling pathway involving JunD and cyclin A, which mediates TCDD-induced deregulation of cell cycle control.	[Schreck, I.; Schneider, S.] Res Ctr Karlsruhe, Inst Genet & Toxicol, D-76344 Eggenstein Leopoldshafen, Germany; [Weiss, C.; Faust, D.; Ruff, A.; Farwerck, T.; Melenberg, A.; Oesch-Bartlomowicz, B.; Oesch, F.; Dietrich, C.] Johannes Gutenberg Univ Mainz, Inst Toxicol, D-55131 Mainz, Germany; [Zatloukalova, J.; Vondracek, J.] Acad Sci Czech Republ, Inst Biophys, CS-61265 Brno, Czech Republic	Helmholtz Association; Karlsruhe Institute of Technology; Johannes Gutenberg University of Mainz; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences	Dietrich, C (corresponding author), Johannes Gutenberg Univ Mainz, Inst Toxicol, Obere Zahlbacherstr 67, D-55131 Mainz, Germany.	carsten.weiss@itg.fzk.de; cdietric@uni-mainz.de	Vondracek, Jan/J-3037-2012; Weiss, Carsten/I-1811-2013; Prochazkova, Jirina/D-4403-2015; Oesch, Franz/AAA-8746-2020	Vondracek, Jan/0000-0003-4071-1969; Weiss, Carsten/0000-0002-5380-3208; Prochazkova, Jirina/0000-0003-2738-8546; 				ABERCROMBIE M, 1979, NATURE, V281, P259, DOI 10.1038/281259a0; Andersson P, 2002, P NATL ACAD SCI USA, V99, P9990, DOI 10.1073/pnas.152706299; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; [Anonymous], 1997, IARC Monogr Eval Carcinog Risks Hum, V69, P1; Bock KW, 2005, BIOCHEM PHARMACOL, V69, P1403, DOI 10.1016/j.bcp.2005.02.004; Casalino L, 2007, EMBO J, V26, P1878, DOI 10.1038/sj.emboj.7601617; Chang CY, 1998, MOL CELL BIOL, V18, P525, DOI 10.1128/MCB.18.1.525; Chramostova K, 2004, TOXICOL APPL PHARM, V196, P136, DOI 10.1016/j.taap.2003.12.008; Coleman WB, 1997, AM J PATHOL, V151, P353; DEGROOT RP, 1991, EMBO J, V10, P2523, DOI 10.1002/j.1460-2075.1991.tb07792.x; Dietrich C, 1997, ONCOGENE, V15, P2743, DOI 10.1038/sj.onc.1201439; Dietrich C, 2003, INT J CANCER, V103, P435, DOI 10.1002/ijc.10830; Dietrich C, 2002, TOXICOL APPL PHARM, V183, P117, DOI 10.1006/taap.2002.9475; Dietrich C, 1996, P NATL ACAD SCI USA, V93, P10815, DOI 10.1073/pnas.93.20.10815; Dumble ML, 2002, CARCINOGENESIS, V23, P435, DOI 10.1093/carcin/23.3.435; EAGLE H, 1967, NATURE, V213, P1102, DOI 10.1038/2131102a0; Faust D, 2005, ONCOGENE, V24, P7941, DOI 10.1038/sj.onc.1208948; FOX TR, 1993, CANCER RES, V53, P2265; Hailey JR, 2005, TOXICOL PATHOL, V33, P165, DOI 10.1080/01926230590888324; HEBERT CD, 1990, CARCINOGENESIS, V11, P1335, DOI 10.1093/carcin/11.8.1335; Heit I, 2001, ONCOGENE, V20, P5143, DOI 10.1038/sj.onc.1204657; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Hoffer A, 1996, TOXICOL APPL PHARM, V141, P238; Hushka DR, 1995, MUTAT RES-FUND MOL M, V333, P89, DOI 10.1016/0027-5107(95)00135-2; Kolluri SK, 1999, GENE DEV, V13, P1742, DOI 10.1101/gad.13.13.1742; Libbrecht L, 2000, J HEPATOL, V33, P76, DOI 10.1016/S0168-8278(00)80162-2; Ma Q, 1996, MOL CELL BIOL, V16, P8878; Marlowe JL, 2005, J CELL BIOCHEM, V96, P1174, DOI 10.1002/jcb.20656; MASON GGF, 1994, J BIOL CHEM, V269, P4438; Moennikes O, 2004, CANCER RES, V64, P4707, DOI 10.1158/0008-5472.CAN-03-0875; Munzel P, 1996, CARCINOGENESIS, V17, P197, DOI 10.1093/carcin/17.2.197; Musti AM, 1996, BIOL CHEM, V377, P619, DOI 10.1515/bchm3.1996.377.10.619; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; PITOT HC, 1980, CANCER RES, V40, P3616; PUGA A, 1992, DNA CELL BIOL, V11, P269, DOI 10.1089/dna.1992.11.269; Shafritz DA, 2002, J HEPATOL, V36, P552, DOI 10.1016/S0168-8278(02)00013-2; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shimizu M, 1998, EXP CELL RES, V239, P93, DOI 10.1006/excr.1997.3884; STEINBERG P, 1994, LAB INVEST, V71, P700; STINCHCOMBE S, 1995, CARCINOGENESIS, V16, P1271, DOI 10.1093/carcin/16.6.1271; TSAO MS, 1987, AM J PATHOL, V127, P168; TSAO MS, 1984, EXP CELL RES, V154, P38, DOI 10.1016/0014-4827(84)90666-9; Tuomisto J., 2005, TOXICOL APPL PHARM, V207, pS2; Vondracek J, 2005, TOXICOL SCI, V83, P53, DOI 10.1093/toxsci/kfi009; Weiss C, 2003, EMBO J, V22, P3686, DOI 10.1093/emboj/cdg364; Weiss C, 2005, ONCOGENE, V24, P4975, DOI 10.1038/sj.onc.1208679; Weiss C, 1996, EXP CELL RES, V226, P154, DOI 10.1006/excr.1996.0214; Weitzman JB, 2000, MOL CELL, V6, P1109, DOI 10.1016/S1097-2765(00)00109-X; Wieser RJ, 1999, ONCOGENE, V18, P277, DOI 10.1038/sj.onc.1202270; Worner W, 1996, CANCER RES, V56, P1272	50	72	77	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 3	2008	27	15					2198	2207		10.1038/sj.onc.1210859	http://dx.doi.org/10.1038/sj.onc.1210859			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	283FE	17952121				2022-12-25	WOS:000254621300010
J	Yin, X; DeWille, JW; Hai, T				Yin, X.; DeWille, J. W.; Hai, T.			A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development	ONCOGENE			English	Article						ATF3; transcriptional regulation; cancer cell dichotomy; cell motility; breast cancer; adaptive response	ACTIVATING TRANSCRIPTION FACTOR-3; RNA-POLYMERASE-II; BREAST-CANCER; BETA; CELLS; EXPRESSION; IDENTIFICATION; AMPLIFICATION; METASTASIS; SUPPRESSOR	Activating transcription factor 3 (ATF3) is a member of the ATF/cyclic AMP response element-binding family of transcription factors. We present evidence that ATF3 has a dichotomous role in cancer development. By both gain- and loss-of-function approaches, we found that ATF3 enhances apoptosis in the untransformed MCF10A mammary epithelial cells, but protects the aggressive MCF10CA1a cells and enhances its cell motility. Array analyses indicated that ATF3 upregulates the expression of several genes in the tumor necrosis factor pathway in the MCF10A cells but upregulates the expression of several genes implicated in tumor metastasis, including TWIST1, fibronectin (FN)-1, plasminogen activator inhibitor-1, urokinase-type plasminogen activator, caveolin-1 and Slug, in the MCF10CA1a cells. We present evidence that ATF3 binds to the endogenous promoters and regulates the transcription of the TWIST1, FN-1, Snail and Slug genes. Furthermore, conditioned medium experiments indicated that ATF3 has a paracrine/autocrine effect, consistent with its upregulation of genes encoding secreted factors. Finally, ATF3 gene copy number is > 2 in similar to 80% of the breast tumors examined (N = 48) and its protein level is elevated in similar to 50% of the tumors. These results provided a correlative argument that it is advantageous for the malignant cancer cells to express ATF3, consistent with its oncogenic roles suggested by the MCF10CA1a cell data.	[Yin, X.; Hai, T.] Ohio State Univ, Neurobiotechnol Ctr, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Yin, X.; DeWille, J. W.; Hai, T.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Yin, X.; Hai, T.] Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA; [DeWille, J. W.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Hai, T (corresponding author), Ohio State Univ, Neurobiotechnol Ctr, Dept Mol & Cellular Biochem, 174 Rightmire Hall,1060 Carmack Rd, Columbus, OH 43210 USA.	hai.2@osu.edu	Hai, Tsonwin/E-3185-2011; Hai, Tsonwin/H-4480-2011	Hai, Tsonwin/0000-0003-4510-0315; Hai, Tsonwin/0000-0003-4510-0315	NATIONAL CANCER INSTITUTE [R01CA118306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059605, R01DK064938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045758] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA118306] Funding Source: Medline; NIDDK NIH HHS [R01 DK059605, R01 DK064938] Funding Source: Medline; NINDS NIH HHS [P30-NS045758] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albertson DG, 2003, BREAST CANCER RES TR, V78, P289, DOI 10.1023/A:1023025506386; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Ameri K, 2007, ONCOGENE, V26, P284, DOI 10.1038/sj.onc.1209781; Baek SJ, 2004, CARCINOGENESIS, V25, P2425, DOI 10.1093/carcin/bgh255; Bandyopadhyay S, 2006, CANCER RES, V66, P11983, DOI 10.1158/0008-5472.CAN-06-0943; Bottone FG, 2003, J BIOL CHEM, V278, P25790, DOI 10.1074/jbc.M301002200; Bottone FG, 2005, MOL CANCER THER, V4, P693, DOI 10.1158/1535-7163.MCT-04-0337; Cheng CH, 2003, MOL CELL BIOL, V23, P1961, DOI 10.1128/MCB.23.6.1961-1967.2003; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Hai T, 1999, GENE EXPRESSION, V7, P321; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; HAI T, 2006, GENE EXPRESSION REGU, P322; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ishiguro T, 1996, CANCER RES, V56, P875; Ishiguro T, 2000, JPN J CANCER RES, V91, P833, DOI 10.1111/j.1349-7006.2000.tb01021.x; Ishiguro T, 2000, ONCOL RES, V12, P343, DOI 10.3727/096504001108747792; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Loeb LA, 2001, CANCER RES, V61, P3230; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Lu D, 2007, BIOCHEM J, V401, P559, DOI 10.1042/BJ20061081; Mallory JC, 2005, MOL PHARMACOL, V68, P1747, DOI 10.1124/mol.105.016519; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Pauletti G, 1996, ONCOGENE, V13, P63; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Rooney PH, 1999, BRIT J CANCER, V80, P862, DOI 10.1038/sj.bjc.6690433; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; SOULE HD, 1990, CANCER RES, V50, P6075; Syed V, 2005, ONCOGENE, V24, P1774, DOI 10.1038/sj.onc.1207991; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Yamaguchi K, 2006, CANCER RES, V66, P2376, DOI 10.1158/0008-5472.CAN-05-1987; Yan CH, 2005, MOL CANCER THER, V4, P233; Yu R, 1996, CANCER LETT, V107, P73, DOI 10.1016/0304-3835(96)04345-5	38	157	160	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 3	2008	27	15					2118	2127		10.1038/sj.onc.1210861	http://dx.doi.org/10.1038/sj.onc.1210861			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	283FE	17952119				2022-12-25	WOS:000254621300002
J	Zhu, JH; Chen, R; Yi, W; Cantin, GT; Fearns, C; Yang, Y; Yates, JR; Lee, JD				Zhu, J-H; Chen, R.; Yi, W.; Cantin, G. T.; Fearns, C.; Yang, Y.; Yates, J. R., III; Lee, J-D			Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling	ONCOGENE			English	Article						PTPN13; Her2; dephosphorylation; invasion and negative feedback	HUMAN-BREAST-CANCER; TUMOR-SUPPRESSOR; GROWTH; CELLS; NEU; METASTASIS; MUTATIONS; CARCINOMA; DISEASE; GENE	Deregulated Her2/ErbB2 receptor tyrosine kinase drives tumorigenesis and tumor progression in a variety of human tissues. Her2 transmits oncogenic signals through phosphorylation of its cytosolic domain. To study innate cellular mechanisms for containing Her2 oncogenic phosphorylation, a siRNA phosphatase library was screened for cellular phosphatase(s) that enhance phosphorylation in the signaling motif of Her2 after knockdown. We found that silencing protein tyrosine phosphatase PTPN13 significantly augmented growth factor-induced phosphorylation of the Her2 signaling domain and promoted the invasiveness of Her2-deregulated cancer cells. In addition, we discovered that growth factor-induced phosphorylation of PTPN13 was essential for the dephosphorylation of Her2 suggesting a negative feedback mechanism induced by growth factor to inhibit cellular Her2 activity through PTPN13. Importantly, we showed that PTPN13 mutations previously reported in human tumors significantly reduced the phosphatase activity of PTPN13, and consequently elevated the oncogenic potential of Her2 and the invasiveness of Her2-overexpressing human cancer cells. Taken together, these results suggest that cellular PTPN13 inhibits Her2 activity by dephosphorylating the signal domain of Her2 and plays a role in attenuating invasiveness and metastasis of Her2 overactive tumors.	[Zhu, J-H; Chen, R.; Yi, W.; Fearns, C.; Lee, J-D] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; [Cantin, G. T.; Yates, J. R., III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Yang, Y.] Johnson & Johnson Pharmaceut Res & Dev, San Diego, CA USA	Scripps Research Institute; Scripps Research Institute; Johnson & Johnson; Johnson & Johnson USA	Lee, JD (corresponding author), Scripps Res Inst, Dept Immunol, IMM-12,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jdlee@scripps.edu	Zhu, Jian-Hong/E-3927-2010	Zhu, Jian-Hong/0000-0001-9412-8264	NATIONAL CANCER INSTITUTE [R01CA079871, R01CA114059] Funding Source: NIH RePORTER; NCI NIH HHS [CA079871, CA114059] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Bentires-Alj M, 2007, CANCER RES, V67, P2420, DOI 10.1158/0008-5472.CAN-06-4610; Bompard G, 2002, J BIOL CHEM, V277, P47861, DOI 10.1074/jbc.M208950200; Cantin GT, 2006, J PROTEOME RES, V5, P127, DOI 10.1021/pr050270m; Engelman JA, 2006, CLIN CANCER RES, V12, p4372S, DOI 10.1158/1078-0432.CCR-06-0795; Erdmann KS, 2003, EUR J BIOCHEM, V270, P4789, DOI 10.1046/j.1432-1033.2003.03895.x; Gensler M, 2004, J BIOL CHEM, V279, P12110, DOI 10.1074/jbc.M309527200; Gil-Henn H, 2003, J BIOL CHEM, V278, P15579, DOI 10.1074/jbc.M210273200; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Hauck CR, 2002, EMBO J, V21, P6289, DOI 10.1093/emboj/cdf631; Hayes DF, 2002, SEMIN ONCOL, V29, P231, DOI 10.1053/sonc.2002.32899; Inazawa J, 1996, GENOMICS, V31, P240, DOI 10.1006/geno.1996.0039; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kim SW, 2004, CANCER RES, V64, P7732, DOI 10.1158/0008-5472.CAN-04-1323; Menard S, 2004, CELL MOL LIFE SCI, V61, P2965, DOI 10.1007/s00018-004-4277-7; Moody SE, 2002, CANCER CELL, V2, P451, DOI 10.1016/S1535-6108(02)00212-X; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Tartaglia M, 2005, EUR J MED GENET, V48, P81, DOI 10.1016/j.ejmg.2005.03.001; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Xu YR, 2005, J BIOL CHEM, V280, P42694, DOI 10.1074/jbc.M507722200; Yeh SH, 2006, CLIN CANCER RES, V12, P1097, DOI 10.1158/1078-0432.CCR-05-1383	27	55	55	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2008	27	18					2525	2531		10.1038/sj.onc.1210922	http://dx.doi.org/10.1038/sj.onc.1210922			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	289LW	17982484				2022-12-25	WOS:000255057000002
J	Reagan-Shaw, S; Nihal, M; Ahmad, N				Reagan-Shaw, Shannon; Nihal, Minakshi; Ahmad, Nihal			Dose translation from animal to human studies revisited	FASEB JOURNAL			English	Article						drug dose conversion; body surface area	BODY-SURFACE AREA; CHEMOTHERAPY; RESVERATROL; FORMULA; WEIGHT; ADULTS	As new drugs are developed, it is essential to appropriately translate the drug dosage from one animal species to another. A misunderstanding appears to exist regarding the appropriate method for allometric dose translations, especially when starting new animal or clinical studies. The need for education regarding appropriate translation is evident from the media response regarding some recent studies where authors have shown that resveratrol, a compound found in grapes and red wine, improves the health and life span of mice. Immediately after the online publication of these papers, the scientific community and popular press voiced concerns regarding the relevance of the dose of resveratrol used by the authors. The animal dose should not be extrapolated to a human equivalent dose (HED) by a simple conversion based on body weight, as was reported. For the more appropriate conversion of drug doses from animal studies to human studies, we suggest using the body surface area (BSA) normalization method. BSA correlates well across several mammalian species with several parameters of biology, including oxygen utilization, caloric expenditure, basal metabolism, blood volume, circulating plasma proteins, and renal function. We advocate the use of BSA as a factor when converting a dose for translation from animals to humans, especially for phase I and phase II clinical trials.	[Reagan-Shaw, Shannon; Nihal, Minakshi; Ahmad, Nihal] Univ Wisconsin, Dept Dermatol, Madison, WI 53706 USA; [Nihal, Minakshi; Ahmad, Nihal] Univ Wisconsin, Paul P Carbone Comprehens Canc Ctr, Madison, WI USA; [Ahmad, Nihal] Univ Wisconsin, Mol Environm Toxicol Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ahmad, N (corresponding author), Univ Wisconsin, Dept Dermatol, B-25 Med Sci Ctr,1300 Univ Ave, Madison, WI 53706 USA.	nahmad@wisc.edu	Ahmad, Nihal/AAR-4249-2021	Ahmad, Nihal/0000-0002-4239-9887				Baker SD, 2002, JNCI-J NATL CANCER I, V94, P1883, DOI 10.1093/jnci/94.24.1883; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; *CTR DRUG EV RES C, 2002, EST SAF START DOS CL; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; DuBois D, 1915, ARCH INTERN MED, V15, P868; DuBois E, 1936, BASAL METABOLISM HLT; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; Fremont L, 2000, LIFE SCI, V66, P663, DOI 10.1016/S0024-3205(99)00410-5; Gurney H, 2002, BRIT J CANCER, V86, P1297, DOI 10.1038/sj.bjc.6600139; Kaestner SA, 2007, CLIN ONCOL-UK, V19, P23, DOI 10.1016/j.clon.2006.10.010; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; PINKEL D, 1958, CANCER RES, V18, P853; Rubner M., 1883, Z BIOL, V19, P535; Sawyer M, 2001, INVEST NEW DRUG, V19, P171, DOI 10.1023/A:1010639201787; SCHEIN PS, 1970, CLIN PHARMACOL THER, V11, P3; Verbraecken J, 2006, METABOLISM, V55, P515, DOI 10.1016/j.metabol.2005.11.004; WADE N, 2006, NEW YORK TIMS   0927; Wang JF, 2004, EUR J APPL PHYSIOL, V92, P13, DOI 10.1007/s00421-004-1074-9; 2006, MSNBC           0927; 2007, MAYO CLIN HLTH LETT, V5, P4	20	4108	4435	32	378	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2008	22	3					659	661		10.1096/fj.07-9574LSF	http://dx.doi.org/10.1096/fj.07-9574LSF			3	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17942826				2022-12-25	WOS:000254143700004
J	Kennard, S; Liu, H; Lilly, B				Kennard, Simone; Liu, Hua; Lilly, Brenda			Transforming growth factor-beta(TGF-beta 1) down-regulates Notch3 in fibroblasts to promote smooth muscle gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; SERUM RESPONSE FACTOR; TGF-BETA; CELL DIFFERENTIATION; NEURAL CREST; ALPHA-ACTIN; SM22-ALPHA TRANSCRIPTION; DEPENDENT TRANSCRIPTION; VASCULAR DEVELOPMENT; 10T1/2 CELLS	Select signaling pathways have emerged as key players in regulating smooth muscle gene expression during myofibroblast and smooth muscle differentiation, an event that is important for wound healing and vascular remodeling. These include the transforming growth factor-beta (TGF-beta 1) signaling cascade, which has been assigned multiple roles in these cells, and the Notch pathway. Notch family members have been implicated in governing cell fate in a variety of cells; however, the mechanisms are not well understood. We sought to explore how these prominent signaling mediators regulate differentiation, and in particular, how they might converge to control the transcription of smooth muscle genes. Using TGF-beta 1 to induce the differentiation of 10T1/2 fibroblasts, we investigated the specific function of Notch3. Overexpression of activated Notch3 caused repression of TGF-beta 1-induced smooth muscle-specific genes, whereas knockdown of Notch3 by small interfering RNA did not convincingly alter their expression. Surprisingly, the addition of TGF-beta 1 caused a significant decrease in Notch3 RNA and protein and a reciprocal increase in Hes1 gene transcription. The repression of Notch3 was mediated by SMAD activity and p38 mitogen-activated protein ( MAP) kinase, whereas analysis of the Hes1 promoter revealed direct activation by Smad2 but not Smad3. Furthermore, the Hes1 repressor protein augmented Smad3 transactivation of the SM22 alpha promoter. These results offer a novel mechanism by which TGF-beta 1 promotes the expression of smooth muscle differentiation genes through the inhibition of Notch3 and activation of Hes1.	[Kennard, Simone; Liu, Hua; Lilly, Brenda] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; [Kennard, Simone; Liu, Hua; Lilly, Brenda] Med Coll Georgia, Dept Obstet & Gynecol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Lilly, B (corresponding author), Med Coll Georgia, Vasc Biol Ctr, 1459 Laney Walker Blvd, Augusta, GA 30912 USA.	blilly@mcg.edu	LILLY, BRENDA/N-6867-2015	LILLY, BRENDA/0000-0002-3125-7496; Kennard, Simone/0000-0002-7564-9192	NHLBI NIH HHS [HL 00086] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson LM, 2007, J CLIN INVEST, V117, P299, DOI 10.1172/JCI31288; Bertolino P, 2005, CHEST, V128, p585S, DOI 10.1378/chest.128.6_suppl.585S; Bianchi S, 2006, J CELL PHYSIOL, V207, P300, DOI 10.1002/jcp.20542; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Camoretti-Mercado B, 2006, J BIOL CHEM, V281, P20383, DOI 10.1074/jbc.M602748200; Campos AH, 2002, CIRC RES, V91, P999, DOI 10.1161/01.RES.0000044944.99984.25; Chen SY, 2006, J BIOL CHEM, V281, P1765, DOI 10.1074/jbc.M507771200; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; Chen SY, 2003, NUCLEIC ACIDS RES, V31, P1302, DOI 10.1093/nar/gkg224; de Jong DS, 2004, BIOCHEM BIOPH RES CO, V320, P100, DOI 10.1016/j.bbrc.2004.05.150; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Doi H, 2005, ARTERIOSCL THROM VAS, V25, P2328, DOI 10.1161/01.ATV.0000185829.47163.32; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Harlow E., 1999, USING ANTIBODIES LAB; Hautmann MB, 1997, J BIOL CHEM, V272, P10948; High FA, 2007, J CLIN INVEST, V117, P353, DOI 10.1172/JCI30070; Hinson JS, 2007, AM J PHYSIOL-HEART C, V292, pH1170, DOI 10.1152/ajpheart.00864.2006; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Kumar MS, 2003, ARTERIOSCL THROM VAS, V23, P737, DOI 10.1161/01.ATV.0000065197.07635.BA; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Li FM, 2007, J BIOL CHEM, V282, P10133, DOI 10.1074/jbc.C600225200; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; Lien SC, 2006, CELL SIGNAL, V18, P1270, DOI 10.1016/j.cellsig.2005.10.013; Lindner V, 2001, AM J PATHOL, V159, P875, DOI 10.1016/S0002-9440(10)61763-4; LOGAN C, 1993, DEVELOPMENT, V117, P905; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Morrow D, 2005, AM J PHYSIOL-CELL PH, V289, pC1188, DOI 10.1152/ajpcell.00198.2005; Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.81357.26; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Ono Y, 2007, J CELL PHYSIOL, V210, P358, DOI 10.1002/jcp.20838; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Park JT, 2006, CANCER RES, V66, P6312, DOI 10.1158/0008-5472.CAN-05-3610; Proweller A, 2005, J BIOL CHEM, V280, P8994, DOI 10.1074/jbc.M413316200; Qiu P, 2003, J MOL CELL CARDIOL, V35, P1407, DOI 10.1016/j.yjmcc.2003.09.002; Qiu P, 2002, CIRC RES, V90, P858, DOI 10.1161/01.RES.0000016504.08608.B9; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Qiu P, 2006, BIOCHEM BIOPH RES CO, V348, P351, DOI 10.1016/j.bbrc.2006.07.009; Singh NN, 2006, CYTOKINE GROWTH F R, V17, P487, DOI 10.1016/j.cytogfr.2006.09.002; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; SOIW RC, 2001, ANGIOGENESIS PROTOCO, P237; Subramanian SV, 2004, MOL BIOL CELL, V15, P4532, DOI 10.1091/mbc.E04-04-0348; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang WL, 2002, J BIOL CHEM, V277, P23165, DOI 10.1074/jbc.M201409200; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029; Yoshida T, 2004, ARTERIOSCL THROM VAS, V24, P1596, DOI 10.1161/01.ATV.0000137190.63214.c5; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; Zhou JL, 2004, J BIOL CHEM, V279, P15929, DOI 10.1074/jbc.M313822200	63	88	95	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1324	1333		10.1074/jbc.M706651200	http://dx.doi.org/10.1074/jbc.M706651200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17981798	hybrid			2022-12-25	WOS:000252282700015
J	Dreier, R; Gunther, BK; Mainz, T; Nemere, I; Bruckner, P				Dreier, Rita; Guenther, Birgit Kathrin; Mainz, Tom; Nemere, Ilka; Bruckner, Peter			Terminal differentiation of chick embryo chondrocytes requires shedding of a cell surface protein that binds 1,25-dihydroxyvitamin D3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCHONDRAL VASCULAR SYSTEM; COLLAGEN GENE-EXPRESSION; VITAMIN-D METABOLITES; ENDOCHONDRAL OSSIFICATION; GROWTH-PLATE; CARTILAGE DIFFERENTIATION; RESTING CHONDROCYTES; EXTRACELLULAR-MATRIX; MEMBRANE-RECEPTOR; BONE-DEVELOPMENT	Endochondral ossification comprises a cascade of cell differentiation culminating in chondrocyte hypertrophy and is negatively controlled by soluble environmental mediators at several checkpoints. Proteinases modulate this control by processing protein signals and/or their receptors. Here, we show that insulin-like growth factor I can trigger hypertrophic development by stimulating production and/or activation of proteinases in some populations of chick embryo chondrocytes. Cell surface targets of the enzymes include 1,25-dihydroxyvitamin D3 membrane-associated rapid response steroid receptor ( 1,25 D3 MARRS receptor), also known as ERp57/GRp58/ERp60. This protein is anchored to the outer surface of plasma membranes and inhibits late chondrocyte differentiation after binding of 1,25-dihydroxyvitamin D3. Upon treatment with insulin-like growth factor I, 1,25 D3 MARRS receptor is cleaved into two fragments of similar to 30 and 22 kDa. This process is abrogated along with hypertrophic development by E-64 or cystatin C, inhibitors of cysteine proteinases. Cell differentiation is enhanced by treatment with antibodies to 1,25 D3 MARRS receptor that either block binding of the inhibitory ligand 1,25-dihydroxyvitamin D3 or inactivate 1,25 D3 MARRS receptor left intact after treatment with proteinase inhibitors. Therefore, proteolytic shedding of 1,25 D3 MARRS receptor constitutes a molecular mechanism eliminating the 1,25-dihydroxyvitamin D3-induced barrier against late cartilage differentiation and is a potentially important step during endochondral ossification or cartilage degeneration in osteoarthritis.	[Dreier, Rita; Guenther, Birgit Kathrin; Mainz, Tom; Bruckner, Peter] Munster Univ Hosp, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; [Nemere, Ilka] Utah State Univ, Logan, UT 84322 USA	University of Munster; Utah System of Higher Education; Utah State University	Bruckner, P (corresponding author), Munster Univ Hosp, Inst Physiol Chem & Pathobiochem, Waldeyerstr 15, D-48149 Munster, Germany.	peter.bruckner@uni-muenster.de	Bruckner, Peter/F-4817-2019; Nemere, Ilka/A-7077-2008	Bruckner, Peter/0000-0002-5566-5611; 				Babarina AV, 2001, MATRIX BIOL, V20, P205, DOI 10.1016/S0945-053X(01)00132-9; BESSEY OA, 1946, J BIOL CHEM, V164, P321; Bittner K, 1998, EXP CELL RES, V238, P491, DOI 10.1006/excr.1997.3849; BOHME K, 1992, J CELL BIOL, V116, P1035, DOI 10.1083/jcb.116.4.1035; BOHME K, 1995, EXP CELL RES, V216, P191, DOI 10.1006/excr.1995.1024; Boyan BD, 2007, J STEROID BIOCHEM, V103, P467, DOI 10.1016/j.jsbmb.2006.11.003; BOYAN BD, 1990, CONNECT TISSUE RES, V24, P67, DOI 10.3109/03008209009152423; Boyan BD, 2003, CONNECT TISSUE RES, V44, P130, DOI 10.1080/03008200390152214; Boyan BD, 2003, J CELL BIOCHEM, V90, P1207, DOI 10.1002/jcb.10716; Boyan BD, 2002, CRIT REV ORAL BIOL M, V13, P143, DOI 10.1177/154411130201300205; BRUCKNER P, 1989, J CELL BIOL, V109, P2537, DOI 10.1083/jcb.109.5.2537; Cancedda R, 2000, INT J DEV BIOL, V44, P707; CANCEDDA R, 1995, INT REV CYTOL, V159, P265, DOI 10.1016/S0074-7696(08)62109-9; CAPASSO O, 1984, MOL CELL BIOL, V4, P1163, DOI 10.1128/MCB.4.6.1163; Erdmann S, 1996, J CELL BIOL, V135, P1179, DOI 10.1083/jcb.135.4.1179; Farjanel J, 2001, OSTEOARTHR CARTILAGE, V9, pS55, DOI 10.1053/joca.2001.0445; Felbor U, 2000, EMBO J, V19, P1187, DOI 10.1093/emboj/19.6.1187; GIBSON GJ, 1982, J CELL BIOL, V93, P767, DOI 10.1083/jcb.93.3.767; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; IYAMA K, 1991, ANAT RECORD, V229, P462, DOI 10.1002/ar.1092290405; Khanal RC, 2007, CURR MED CHEM, V14, P1087, DOI 10.2174/092986707780362871; Khanal RC, 2007, CRIT REV EUKAR GENE, V17, P31, DOI 10.1615/CritRevEukarGeneExpr.v17.i1.30; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; MULLERGLAUSER W, 1986, J CELL BIOL, V102, P1931, DOI 10.1083/jcb.102.5.1931; Nakase T, 2000, HISTOCHEM CELL BIOL, V114, P21; Nemere I, 2000, AM J PHYSIOL-ENDOC M, V278, pE1104, DOI 10.1152/ajpendo.2000.278.6.E1104; Nemere K, 2005, STEROIDS, V70, P455, DOI 10.1016/j.steroids.2005.02.005; Nemere K, 2004, J STEROID BIOCHEM, V89-90, P281, DOI 10.1016/j.jsbmb.2004.03.031; NORMAN AW, 1993, J NUTR, V123, P310, DOI 10.1093/jn/123.suppl_2.310; Ortega N, 2003, ANN NY ACAD SCI, V995, P109, DOI 10.1111/j.1749-6632.2003.tb03214.x; Potts W, 2004, INT J EXP PATHOL, V85, P85, DOI 10.1111/j.0959-9673.2004.00373.x; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; SCHMID TM, 1982, J BIOL CHEM, V257, P2444; Schwartz Z, 2002, ENDOCRINOLOGY, V143, P2775, DOI 10.1210/en.143.7.2775; SCHWARTZ Z, 1992, ENDOCRINOLOGY, V130, P2495, DOI 10.1210/en.130.5.2495; Soderstrom M, 1999, BBA-GENE STRUCT EXPR, V1446, P35, DOI 10.1016/S0167-4781(99)00068-8; Szuts V, 1998, MATRIX BIOL, V17, P435, DOI 10.1016/S0945-053X(98)90103-2; Teillaud C, 2005, J CELL BIOCHEM, V94, P139, DOI 10.1002/jcb.20275; TSCHAN T, 1990, J CELL BIOL, V111, P257, DOI 10.1083/jcb.111.1.257; VONDERMARK K, 1992, ARTHRITIS RHEUM-US, V35, P806, DOI 10.1002/art.1780350715; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Zijlstra A, 2004, J BIOL CHEM, V279, P27633, DOI 10.1074/jbc.M313617200	43	21	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1104	1112		10.1074/jbc.M703336200	http://dx.doi.org/10.1074/jbc.M703336200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17984094	hybrid			2022-12-25	WOS:000252128100050
J	Farley, SM; Purdy, DE; Ryabinina, OP; Schneider, P; Magun, BE; Iordanov, MS				Farley, Sherry M.; Purdy, David E.; Ryabinina, Olga P.; Schneider, Pascal; Magun, Bruce E.; Iordanov, Mihail S.			Fas ligand-induced proinflammatory transcriptional responses in reconstructed human epidermis - Recruitment of the epidermal growth factor receptor and activation of map kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KERATINOCYTE APOPTOSIS; CD95 LIGAND; INHIBITION; DEATH; CASPASES; FAMILY; PLAYS; CELLS; GAMMA; SKIN	Fas ligand ( FasL) exerts potent proapoptotic and proinflammatory actions on epidermal keratinocytes and has been implicated in the pathogenesis of eczema, toxic epidermal necrolysis, and drug-induced skin eruptions. We used reconstructed human epidermis to investigate the mechanisms of FasL-induced inflammatory responses and their relationships with FasL-triggered caspase activity. Caspase activity was a potent antagonist of the pro-inflammatory gene expression triggered by FasL prior to the onset of cell death. Furthermore, we found that FasL-stimulated autocrine production of epidermal growth factor receptor ( EGFR) ligands, and the subsequent activation of EGFR and ERK1 and ERK2 mitogen-activated protein kinases, were obligatory extracellular steps for the FasL-induced expression of a subset of inflammatory mediators, including CXCL8/interleukin (IL)-8, ICAM-1, IL-1 alpha, IL-1 beta, CCL20/MIP-3 alpha, and thymic stromal lymphopoietin. These results expand the known physiological role of EGFR and its ligands from promoting keratinocyte mitogenesis and survival to mediating FasL-induced epidermal inflammation.	[Farley, Sherry M.; Purdy, David E.; Ryabinina, Olga P.; Magun, Bruce E.; Iordanov, Mihail S.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA; [Schneider, Pascal] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	Oregon Health & Science University; University of Lausanne	Magun, BE (corresponding author), Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	magunb@ohsu.edu; iordanov@ohsu.edu		Schneider, Pascal/0000-0003-0677-9409	NATIONAL CANCER INSTITUTE [R01CA093718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI059335, R01AI059335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066439] Funding Source: NIH RePORTER; NCI NIH HHS [CA-93718] Funding Source: Medline; NIAID NIH HHS [AI059335] Funding Source: Medline; NIDDK NIH HHS [DK066439] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AIMOUSTAFA AE, 1999, CLIN CANC, V5, P681; Akdis M, 2003, FASEB J, V17, P1026, DOI 10.1096/fj.02-1070com; Baselga J, 2002, J CLIN ONCOL, V20, P4292, DOI 10.1200/JCO.2002.03.100; BELLGRAU D, 1995, NATURE, V377, P630, DOI 10.1038/377630a0; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Chatterjee M, 2004, BLOOD, V104, P3712, DOI 10.1182/blood-2004-04-1670; Choi HJ, 2006, BRIT J DERMATOL, V154, P419, DOI 10.1111/j.1365-2133.2005.07057.x; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Eidsmo L, 2005, AM J PATHOL, V166, P1099, DOI 10.1016/S0002-9440(10)62330-9; Farley SM, 2006, J INVEST DERMATOL, V126, P2438, DOI 10.1038/sj.jid.5700477; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Giustizieri ML, 2001, J ALLERGY CLIN IMMUN, V107, P871, DOI 10.1067/mai.2001.114707; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Iordanov MS, 2005, J INVEST DERMATOL, V125, P134, DOI 10.1111/j.0022-202X.2005.23804.x; Iordanov MS, 2002, MOL CELL BIOL, V22, P5380, DOI 10.1128/MCB.22.15.5380-5394.2002; KAWAMOTO T, 1992, IN VITRO CELL DEV-AN, V28A, P782; Klunker S, 2003, J IMMUNOL, V171, P1078, DOI 10.4049/jimmunol.171.2.1078; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kurth I, 2001, J EXP MED, V194, P855, DOI 10.1084/jem.194.6.855; Langley RGB, 1996, J AM ACAD DERMATOL, V35, P187, DOI 10.1016/S0190-9622(96)90320-5; Lloyd Alison C, 2006, J Biol, V5, P13, DOI 10.1186/jbiol46; Michel G, 1996, BIOCHEM PHARMACOL, V51, P1315, DOI 10.1016/0006-2952(96)00039-1; Newman JC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r81; OSHEROV N, 1994, EUR J BIOCHEM, V225, P1047, DOI 10.1111/j.1432-1033.1994.1047b.x; Pastore S, 1998, J ALLERGY CLIN IMMUN, V101, P538, DOI 10.1016/S0091-6749(98)70361-6; Poumay Y, 2004, ARCH DERMATOL RES, V296, P203, DOI 10.1007/s00403-004-0507-y; Raj D, 2006, J INVEST DERMATOL, V126, P243, DOI 10.1038/sj.jid.5700008; Ristow HJ, 1996, GROWTH REGULAT, V6, P96; Schaerli P, 2005, IMMUNITY, V23, P331, DOI 10.1016/j.immuni.2005.08.012; Schwarz T, 2000, J CLIN INVEST, V106, P9, DOI 10.1172/JCI10438; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Straus SE, 1999, ANN INTERN MED, V130, P591, DOI 10.7326/0003-4819-130-7-199904060-00020; Stuart PM, 1997, J CLIN INVEST, V99, P396, DOI 10.1172/JCI119173; Stur K, 2007, J INVEST DERMATOL, V127, P802, DOI 10.1038/sj.jid.5700648; Suda T, 1997, J EXP MED, V186, P2045, DOI 10.1084/jem.186.12.2045; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Trautmann A, 2000, J CLIN INVEST, V106, P25, DOI 10.1172/JCI9199; Trautmann A, 2001, J INVEST DERMATOL, V117, P927, DOI 10.1046/j.0022-202x.2001.01474.x; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Viard I, 1998, SCIENCE, V282, P490, DOI 10.1126/science.282.5388.490; Wu JG, 1996, J CLIN INVEST, V98, P1107, DOI 10.1172/JCI118892	43	31	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					919	928		10.1074/jbc.M705852200	http://dx.doi.org/10.1074/jbc.M705852200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17977827	Green Published, hybrid			2022-12-25	WOS:000252128100032
J	Nie, L; Wu, HQ; Sun, XH				Nie, Lei; Wu, Huaqing; Sun, Xiao-Hong			Ubiquitination and degradation of Tal1/SCL are induced by Notch signaling and depend on Skp2 and CHIP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL LEUKEMIA; PROTEIN; SCL; LIGASE; GENE; TRANSCRIPTION; EXPRESSION; HSC70; BOX; IDENTIFICATION	Notch signaling controls diverse eukaryotic differentiation processes in multiple cell types, thus demanding versatile tools with which Notch triggers downstream events. Ubiquitin-mediated proteolysis has previously been shown to be one such tool with which Notch regulates the turnover of the basic helix-loop-helix transcription factor, E47. Here, we show that Notch signaling also accelerated the degradation of Tal1/SCL ( T cell acute leukemia 1/stem cell leukemia) protein, a basic helix-loop-helix protein involved in the development of hematopoietic, vascular, and neuronal tissues. Notch-induced Tal1/SCL degradation was mediated by ubiquitination and proteasomes. The sequence responsible for Tal1 degradation was localized to a region in the C terminus of Tal1, which is evolutionarily conserved, thus suggesting a functional significance. Analogous to the situation for E47, Notch-induced Tal1/SCL degradation not only required Skp2, a substrate-binding subunit of SCF ubiquitin ligase complexes, but also relied on CHIP, a chaperone-binding protein with a ubiquitin ligase activity. In contrast to the fact that the N-terminal tetratricopeptide region (TPR) domain of CHIP is necessary and sufficient for E47 ubiquitination and degradation, CHIP promoted Tal1 degradation with both chaperone binding and ubiquitin ligase activities, which are mediated by its TPR domain and U box, respectively. Although the TPR domain was not involved in Tal1/SCL binding, it was required for enhancing its degradation. Likewise, the ubiquitin ligase activity of CHIP was dispensable for Tal1/SCL binding but essential for degradation. These findings provide both novel mechanistic insights into the operation of cullin-based ubiquitin ligase complexes and potential means by which Notch and Tal1/SCL regulate eukaryotic development.	[Nie, Lei; Wu, Huaqing; Sun, Xiao-Hong] Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation	Sun, XH (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	sunx@omrf.ouhsc.edu			NCI NIH HHS [CA77553, R01 CA077553] Funding Source: Medline; NIAID NIH HHS [R01 AI056129, AI056129] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA077553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056129] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allman D, 2002, CELL, V109, pS1, DOI 10.1016/S0092-8674(02)00689-X; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P10128, DOI 10.1073/pnas.86.24.10128; Bradley CK, 2006, EUR J NEUROSCI, V23, P1677, DOI 10.1111/j.1460-9568.2006.04712.x; BROWN L, 1990, EMBO J, V9, P3343, DOI 10.1002/j.1460-2075.1990.tb07535.x; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; CHEN Q, 1990, EMBO J, V9, P415, DOI 10.1002/j.1460-2075.1990.tb08126.x; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cornell RA, 2005, SEMIN CELL DEV BIOL, V16, P663, DOI 10.1016/j.semcdb.2005.06.009; Curtis DJ, 2004, BLOOD, V103, P3342, DOI 10.1182/blood-2003-09-3202; Elefanty AG, 1999, BLOOD, V94, P3754, DOI 10.1182/blood.V94.11.3754.423k05_3754_3763; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Harper JW, 2001, CURR BIOL, V11, pR431, DOI 10.1016/S0960-9822(01)00253-6; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Herberth B, 2005, INT J DEV NEUROSCI, V23, P449, DOI 10.1016/j.ijdevneu.2005.05.008; HSU HL, 1994, P NATL ACAD SCI USA, V91, P5947, DOI 10.1073/pnas.91.13.5947; Huang Z, 2004, MOL CELL BIOL, V24, P8951, DOI 10.1128/MCB.24.20.8951-8962.2004; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; King AM, 2007, J IMMUNOL, V178, P3521, DOI 10.4049/jimmunol.178.6.3521; Kunisato A, 2004, BLOOD, V103, P3336, DOI 10.1182/blood-2003-06-1935; Mahajan MA, 1996, ONCOGENE, V12, P2343; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Nie L, 2003, EMBO J, V22, P5780, DOI 10.1093/emboj/cdg567; Ohishi K, 2003, SEMIN CELL DEV BIOL, V14, P143, DOI 10.1016/S1084-9521(02)00183-0; Park ST, 1998, J BIOL CHEM, V273, P7030, DOI 10.1074/jbc.273.12.7030; Peng CY, 2007, NEURON, V53, P813, DOI 10.1016/j.neuron.2007.02.019; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Radtke F, 2005, BIOESSAYS, V27, P1117, DOI 10.1002/bies.20315; Reynaud D, 2005, BLOOD, V106, P2318, DOI 10.1182/blood-2005-02-0557; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393	44	25	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					684	692		10.1074/jbc.M704981200	http://dx.doi.org/10.1074/jbc.M704981200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17962192	hybrid			2022-12-25	WOS:000252128100005
J	Rennolds, J; Tower, C; Musgrove, L; Fan, L; Maloney, K; Clancy, JP; Kirk, KL; Sztul, E; Cormet-Boyaka, E				Rennolds, Jessica; Tower, Cristy; Musgrove, Lois; Fan, Lijuan; Maloney, Kevin; Clancy, John Paul; Kirk, Kevin L.; Sztul, Elizabeth; Cormet-Boyaka, Estelle			Cystic fibrosis transmembrane conductance regulator trafficking is mediated by the COPI coat in epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; EXCHANGE FACTOR; PLASMA-MEMBRANE; GOLGI; TRANSPORT; CFTR; ANTEROGRADE; DYNAMICS; PROTEIN; CARGO	Cystic fibrosis (CF) is caused by defects in the CF transmembrane conductance regulator (CFTR) that functions as a chloride channel in epithelial cells. The most common cause of CF is the abnormal trafficking of CFTR mutants. Therefore, understanding the cellular machineries that transit CFTR from the endoplasmic reticulum to the plasma membrane (PM) is important. The coat protein complex I (COPI) has been implicated in the anterograde and retrograde transport of proteins and lipids between the endoplasmic reticulum and the Golgi. Here, we investigated the role of COPI in CFTR trafficking. Blocking COPI recruitment to membranes by expressing an inactive form of the GBF1 guanine nucleotide exchange factor for ADP-ribosylation factor inhibits CFTR trafficking to the PM. Similarly, inhibiting COPI dissociation from membranes by expressing a constitutively active ADP-ribosylation factor 1 mutant arrests CFTR within disrupted Golgi elements. To definitively explore the relationship between COPI and CFTR in epithelial cells, we depleted beta-COP from the human colonic epithelial cell HT-29Cl.19A using small interfering RNA. beta-COP depletion did not affect CFTR synthesis but impaired its trafficking to the PM. The arrest occurred pre-Golgi as shown by reduced level of glycosylation. Importantly, decreased trafficking of CFTR had a functional consequence as cells depleted of beta-COP showed decreased cAMP-activated chloride currents. To explore the mechanism of COPI action in CFTR traffic we tested whether CFTR was COPI cargo. We discovered that the alpha-, beta-, and gamma-subunits of COPI co-immunoprecipitated with CFTR. Our results indicate that the COPI complex plays a critical role in CFTR trafficking to the PM.	[Cormet-Boyaka, Estelle] 201 Davis Heart & Lung Res Inst, Columbus, OH 43201 USA; [Rennolds, Jessica; Maloney, Kevin; Cormet-Boyaka, Estelle] Ohio State Univ, Div Pulm Crit Care & Sleep Med, Columbus, OH 43210 USA; [Tower, Cristy; Sztul, Elizabeth] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Musgrove, Lois; Kirk, Kevin L.] Univ Alabama Birmingham, Dept Phys & Biophys, Birmingham, AL 35294 USA; [Fan, Lijuan; Clancy, John Paul] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Cormet-Boyaka, E (corresponding author), 201 Davis Heart & Lung Res Inst, 473 W 12th Ave, Columbus, OH 43201 USA.	estelle.boyaka@osumc.edu	Cormet-Boyaka, Estelle/H-5624-2011	Tower-Gilchrist, Cristy/0000-0002-5236-5170				Aoe T, 1998, P NATL ACAD SCI USA, V95, P1624, DOI 10.1073/pnas.95.4.1624; Bannykh SI, 2000, TRAFFIC, V1, P852, DOI 10.1034/j.1600-0854.2000.011105.x; Chang XB, 1999, MOL CELL, V4, P137, DOI 10.1016/S1097-2765(00)80196-3; COBB RB, 2002, AM J PHYSIOL, V282, pL12; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; DASCHER C, 1994, J BIOL CHEM, V269, P1437; DENNING GM, 1992, J CLIN INVEST, V89, P339, DOI 10.1172/JCI115582; ELAZAR Z, 1994, J CELL BIOL, V124, P415, DOI 10.1083/jcb.124.4.415; Eugster A, 2004, MOL BIOL CELL, V15, P1011, DOI 10.1091/mbc.E03-10-0724; Faulstich D, 1996, J CELL BIOL, V135, P53, DOI 10.1083/jcb.135.1.53; Fu LW, 2003, J CELL BIOL, V160, P157, DOI 10.1083/jcb.200210086; Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730; Gilbert A, 1998, EXP CELL RES, V242, P144, DOI 10.1006/excr.1998.4101; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Heda GD, 2001, AM J PHYSIOL-CELL PH, V280, pC166, DOI 10.1152/ajpcell.2001.280.1.C166; Hermosilla R, 2004, TRAFFIC, V5, P993, DOI 10.1111/j.1600-0854.2004.00239.x; LESUFFLEUR T, 1991, INT J CANCER, V49, P731, DOI 10.1002/ijc.2910490517; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Lippincott-Schwartz Jennifer, 2006, Trends Cell Biol, V16, pe1, DOI 10.1016/j.tcb.2006.08.008; Liu W, 2005, J CELL BIOL, V168, P1053, DOI 10.1083/jcb.200410142; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Malsam J, 2005, SCIENCE, V307, P1095, DOI 10.1126/science.1108061; Moelleken J, 2007, P NATL ACAD SCI USA, V104, P4425, DOI 10.1073/pnas.0611360104; Nickel W, 1998, SEMIN CELL DEV BIOL, V9, P493, DOI 10.1006/scdb.1998.0256; Nickel W, 1998, J CELL SCI, V111, P3081; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Orci L, 2000, P NATL ACAD SCI USA, V97, P10400, DOI 10.1073/pnas.190292497; Paulsson KM, 2002, J BIOL CHEM, V277, P18266, DOI 10.1074/jbc.M201388200; Pepperkok R, 2000, J CELL SCI, V113, P135; Rechards M, 2003, TRAFFIC, V4, P553, DOI 10.1034/j.1600-0854.2003.t01-1-00114.x; Szul T, 2005, TRAFFIC, V6, P374, DOI 10.1111/j.1600-0854.2005.00282.x; Varga K, 2004, J BIOL CHEM, V279, P22578, DOI 10.1074/jbc.M401522200; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; WATERS M G, 1991, Current Opinion in Cell Biology, V3, P615, DOI 10.1016/0955-0674(91)90031-S; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200; Yu Y, 2007, BIOL CELL, V99, P433, DOI 10.1042/BC20060114	37	26	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					833	839		10.1074/jbc.M706504200	http://dx.doi.org/10.1074/jbc.M706504200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17932045	hybrid			2022-12-25	WOS:000252128100023
J	Ansari, S; Alahyan, M; Marston, SB; EL-Mezgueldi, M				Ansari, Saira; Alahyan, Mustapha; Marston, Steven B.; EL-Mezgueldi, Mohammed			Role of caldesmon in the Ca2+ regulation of smooth muscle thin filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-TROPOMYOSIN ACTIVATION; MYOSIN SUBFRAGMENT 1; ATPASE ACTIVITY; TROPONIN-TROPOMYOSIN; COOPERATIVE BINDING; ACTOMYOSIN ATPASE; SKELETAL-MUSCLE; MECHANICAL-PROPERTIES; HEAVY-MEROMYOSIN; ELEMENTARY STEPS	Smooth muscle thin filaments are made up of actin, tropomyosin, caldesmon, and a Ca2+-binding protein and their interaction with myosin is Ca2+-regulated. We suggested that Ca2+ regulation by caldesmon and Ca2+-calmodulin is achieved by controlling the state of thin filament through a cooperative-allosteric mechanism homologous to troponin-tropomyosin in striated muscles. In the present work, we have tested this hypothesis. We monitored directly the thin filament transition between the ON and OFF state using the excimer fluorescence of pyrene iodoacetamide (PIA)-labeled smooth muscle alpha alpha-tropomyosin homodimers. In steady state fluorescence measurements, myosin subfragment 1 (S1) cooperatively switches the thin filaments to the ON state, and this is exhibited as an increase in the excimer fluorescence. In contrast, caldesmon decreases the excimer fluorescence, indicating a switch of the thin filament to the OFF state. Addition of Ca2+-calmodulin increases the excimer fluorescence, indicating a switch of the thin filament to the ON state. The excimer fluorescence was also used to monitor the kinetics of the ON-OFF transition in a stopped-flow apparatus. When ATP induces S1 dissociation from actin-PIA-tropomyosin, the transition to the OFF state is delayed until all S1 molecules are dissociated actin. In contrast, caldesmon switches the thin filament to the OFF state in a cooperative way, and no lag is displayed in the time course of the caldesmon-induced fluorescence decrease. We have also studied caldesmon and Ca2+-calmodulin-caldesmon binding to actin-tropomyosin in the ON and OFF states. The results are used to discuss both caldesmon inhibition and Ca2+-calmodulin- caldesmon activation of actin-tropomyosin.	[EL-Mezgueldi, Mohammed] Univ Leicester, Dept Biochem, Henry Wellcome Bldg, Leicester LE1 9HN, Leics, England; [Ansari, Saira; Alahyan, Mustapha; Marston, Steven B.] Imperial Coll London, Natl Heart & Lung Inst, London SW3 6LY, England	University of Leicester; Imperial College London	EL-Mezgueldi, M (corresponding author), Univ Leicester, Dept Biochem, Henry Wellcome Bldg, Lancaster Rd, Leicester LE1 9HN, Leics, England.	mem16@le.ac.uk			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alahyan M, 2006, J BIOL CHEM, V281, P19433, DOI 10.1074/jbc.M507602200; Ansari S, 2003, J MUSCLE RES CELL M, V24, P513, DOI 10.1023/B:JURE.0000009812.74980.13; Borovikov YS, 2001, INT J BIOCHEM CELL B, V33, P1151, DOI 10.1016/S1357-2725(01)00091-7; Burton DJ, 1999, PFLUG ARCH EUR J PHY, V437, P267, DOI 10.1007/s004240050779; CHALOVICH JM, 1982, J BIOL CHEM, V257, P2432; CHALOVICH JM, 1988, CELL BIOPHYS, V12, P73, DOI 10.1007/BF02918351; Chalovich JM, 1998, ACTA PHYSIOL SCAND, V164, P427; CHALOVICH JM, 1990, ANN NY ACAD SCI, V599, P85; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; CHEN YD, 1992, BIOPHYS J, V63, P1063, DOI 10.1016/S0006-3495(92)81687-9; DABROWSKA R, 1985, BIOCHIM BIOPHYS ACTA, V842, P70, DOI 10.1016/0304-4165(85)90295-8; Earley JJ, 1998, CIRC RES, V83, P661, DOI 10.1161/01.RES.83.6.661; FRASER IDC, 1995, J BIOL CHEM, V270, P19688, DOI 10.1074/jbc.270.34.19688; Fraser IDC, 1997, BIOCHEMISTRY-US, V36, P5483, DOI 10.1021/bi962969z; FRASER IDC, 1995, THESIS LONDON U; Fredricksen S, 2003, BIOCHEMISTRY-US, V42, P6136, DOI 10.1021/bi0274017; Gao Y, 1999, BIOCHEMISTRY-US, V38, P15459, DOI 10.1021/bi991383k; GEEVES MA, 1987, BIOPHYS J, V52, P215, DOI 10.1016/S0006-3495(87)83208-3; GEEVES MA, 1994, BIOPHYS J, V67, P273, DOI 10.1016/S0006-3495(94)80478-3; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; GREENE LE, 1980, P NATL ACAD SCI-BIOL, V77, P2616, DOI 10.1073/pnas.77.5.2616; Heeley DH, 2002, P NATL ACAD SCI USA, V99, P16731, DOI 10.1073/pnas.252236399; HEMRIC ME, 1988, J BIOL CHEM, V263, P1878; HILL TL, 1980, P NATL ACAD SCI-BIOL, V77, P3186, DOI 10.1073/pnas.77.6.3186; Hodgkinson JL, 1997, BIOPHYS J, V72, P2398, DOI 10.1016/S0006-3495(97)78885-4; Horiuchi KY, 1995, BIOCHEMISTRY-US, V34, P16815, DOI 10.1021/bi00051a032; HORIUCHI KY, 1989, BIOCHEMISTRY-US, V28, P9111, DOI 10.1021/bi00449a023; Huber PAJ, 1998, BIOCHEMISTRY-US, V37, P2314, DOI 10.1021/bi971727b; Huber PAJ, 1996, BIOCHEM J, V316, P413, DOI 10.1042/bj3160413; ISHII Y, 1987, BIOCHEMISTRY-US, V26, P4922, DOI 10.1021/bi00390a005; Lehman W, 1997, J MOL BIOL, V274, P310, DOI 10.1006/jmbi.1997.1422; Lehrer SS, 1997, BIOCHEMISTRY-US, V36, P13449, DOI 10.1021/bi971568w; Lehrer SS, 1998, J MOL BIOL, V277, P1081, DOI 10.1006/jmbi.1998.1654; Malmquist U, 1996, PFLUG ARCH EUR J PHY, V432, P241, DOI 10.1007/s004240050130; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Marston S, 1998, ACTA PHYSIOL SCAND, V164, P401, DOI 10.1111/j.1365-201X.1998.tb10696.x; MARSTON S, 1990, BIOCHEM J, V272, P305, DOI 10.1042/bj2720305; MARSTON S, 2002, J MUSC RES CELL MOTI, V23, P38; MARSTON SB, 1984, J MUSCLE RES CELL M, V5, P559, DOI 10.1007/BF00713261; MARSTON SB, 1994, J BIOL CHEM, V269, P32104; MARSTON SB, 1992, J BIOL CHEM, V267, P16796; MARSTON SB, 1985, J MUSCLE RES CELL M, V6, P669, DOI 10.1007/BF00712237; MARSTON SB, 1986, BIOCHEM J, V237, P605, DOI 10.1042/bj2370605; MARSTON SB, 1993, J BIOL CHEM, V268, P12317; MARSTON SB, 1980, BIOCHEM J, V185, P355, DOI 10.1042/bj1850355; MARSTON SB, 1985, ADV PROTEIN PHOSPHAT, V2, P171; MCKILLOP DFA, 1991, BIOCHEM J, V279, P711, DOI 10.1042/bj2790711; Mirza M, 2007, J BIOL CHEM, V282, P13487, DOI 10.1074/jbc.M701071200; NGAI PK, 1984, J BIOL CHEM, V259, P3656; Notarianni G, 2000, J MUSCLE RES CELL M, V21, P537, DOI 10.1023/A:1026589704750; PRITCHARD K, 1989, BIOCHEM J, V257, P839, DOI 10.1042/bj2570839; REDWOOD CS, 1990, FEBS LETT, V270, P53, DOI 10.1016/0014-5793(90)81233-E; REDWOOD CS, 1993, J BIOL CHEM, V268, P10969; REDWOOD CS, 1992, IDENTIFICATION FUNCT; SANDERS C, 1986, J BIOL CHEM, V261, P2774; SMITH CWJ, 1987, J BIOL CHEM, V262, P116; SMITH CWJ, 1985, FEBS LETT, V184, P115, DOI 10.1016/0014-5793(85)80665-7; SOBUE K, 1982, BIOMED RES-TOKYO, V3, P188, DOI 10.2220/biomedres.3.188; Straub FB, 1942, STUD I MED CHEM U SZ, V2, P3; SWARTZ DR, 1992, J BIOL CHEM, V267, P20497; SZCZESNA D, 1994, BIOCHEMISTRY-US, V33, P6716, DOI 10.1021/bi00187a043; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; TRYBUS KM, 1980, P NATL ACAD SCI-BIOL, V77, P7209, DOI 10.1073/pnas.77.12.7209; VELAZ L, 1990, J BIOL CHEM, V265, P2929; VELAZ L, 1993, BIOPHYS J, V65, P892, DOI 10.1016/S0006-3495(93)81113-5; VELAZ L, 1989, J BIOL CHEM, V264, P9602; YAMASHIRO S, 1995, J BIOL CHEM, V270, P4023, DOI 10.1074/jbc.270.8.4023; Zhou X, 2000, BIOCHEMISTRY-US, V39, P1128, DOI 10.1021/bi992327m	68	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					47	56		10.1074/jbc.M706771200	http://dx.doi.org/10.1074/jbc.M706771200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17933868	hybrid			2022-12-25	WOS:000251940300007
J	Kario, E; Tirosh, B; Ploegh, HL; Navon, A				Kario, Edith; Tirosh, Boaz; Ploegh, Hidde L.; Navon, Ami			N-linked glycosylation does not impair proteasomal degradation but affects class I major histocompatibility complex presentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED-PROTEIN RESPONSE; MHC CLASS-I; ER-ASSOCIATED DEGRADATION; ENERGY-DEPENDENT PROTEASES; RECOGNIZES SUGAR CHAINS; E3 UBIQUITIN LIGASE; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; SACCHAROMYCES-CEREVISIAE; MISFOLDED GLYCOPROTEINS	The addition of N-linked glycans to nascent polypeptides occurs cotranslationally in the endoplasmic reticulum (ER). For many proteins the state of the glycans serves as an indicator, which allows the ER quality control system to monitor the conformation of polypeptides upon folding. Proteins that fail to fold in the ER are often dislocated to the cytoplasm, where they are subjected to proteasomal degradation. Although the addition of N-linked glycans occurs within the ER, non-lysosomal removal of the glycans occurs in the cytosol by the action of peptide N-glycanase (PNGase). In this study, we investigated the interplay between PNGase action and proteasomal degradation of ER misfolded proteins (i.e. whether PNGase acts prior to or following proteasomal degradation). Interestingly, we found that glycan removal from N-terminally extended peptides modulates the presentation of class I major histocompatibility complex-restricted epitopes. Our findings provide direct evidence that the proteasome is capable of degrading glycoproteins without prior removal of their glycans. This degradation is independent of either the identity of the glycosylated protein or the type and number of N-linked glycans it harbors. We also captured and characterized glycopeptides generated following proteasomal degradation of RNaseB. Although the carbohydrate moiety reduced the variability of the degradation products that include the glycosylated residue ( local effect), the overall global digestion pattern of RNaseB was unaffected. Together with earlier findings by others, our data support a model in which PNGase may act both upstream and downstream to proteasomal degradation and demonstrates its important role in class I major histocompatibility complex antigen presentation.	[Kario, Edith; Navon, Ami] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Tirosh, Boaz] Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel; [Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02124 USA	Weizmann Institute of Science; Hebrew University of Jerusalem; Massachusetts Institute of Technology (MIT); Whitehead Institute	Navon, A (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	ami.navon@weizmann.ac.il						Altrich-VanLith ML, 2006, J IMMUNOL, V177, P5440, DOI 10.4049/jimmunol.177.8.5440; Ben-Shahar S, 1999, J BIOL CHEM, V274, P21963, DOI 10.1074/jbc.274.31.21963; Biswas S, 2004, BIOCHEM BIOPH RES CO, V323, P149, DOI 10.1016/j.bbrc.2004.08.061; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; CHEN WS, 1994, J EXP MED, V180, P1471, DOI 10.1084/jem.180.4.1471; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; GOLDBERG AL, 1995, SCIENCE, V268, P522, DOI 10.1126/science.7725095; Gottesman S, 1997, CELL, V91, P435, DOI 10.1016/S0092-8674(00)80428-6; GOTTESMAN S, 1992, MICROBIOL REV, V56, P592, DOI 10.1128/MMBR.56.4.592-621.1992; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Hirsch C, 2004, EMBO REP, V5, P201, DOI 10.1038/sj.embor.7400066; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Hudrisier D, 1999, J BIOL CHEM, V274, P36274, DOI 10.1074/jbc.274.51.36274; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; JOAO HC, 1993, EUR J BIOCHEM, V218, P239, DOI 10.1111/j.1432-1033.1993.tb18370.x; Katiyar S, 2004, P NATL ACAD SCI USA, V101, P13774, DOI 10.1073/pnas.0405663101; Kisselev AF, 2002, J BIOL CHEM, V277, P22260, DOI 10.1074/jbc.M112360200; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lee BS, 2005, RAPID COMMUN MASS SP, V19, P1545, DOI 10.1002/rcm.1956; Lee JH, 2005, P NATL ACAD SCI USA, V102, P9144, DOI 10.1073/pnas.0502082102; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Misaghi S, 2004, CHEM BIOL, V11, P1677, DOI 10.1016/j.chembiol.2004.11.010; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Navon A, 2001, MOL CELL, V8, P1339, DOI 10.1016/S1097-2765(01)00407-5; Park H, 2001, P NATL ACAD SCI USA, V98, P11163, DOI 10.1073/pnas.201393498; Piwko W, 2006, NAT STRUCT MOL BIOL, V13, P691, DOI 10.1038/nsmb1122; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Rehm A, 2001, EMBO J, V20, P1573, DOI 10.1093/emboj/20.7.1573; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Romisch K, 1997, P NATL ACAD SCI USA, V94, P6730, DOI 10.1073/pnas.94.13.6730; Schott E, 2002, P NATL ACAD SCI USA, V99, P13735, DOI 10.1073/pnas.212515399; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Skipper JCA, 1996, J EXP MED, V183, P527, DOI 10.1084/jem.183.2.527; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Suzuki T, 2001, J BIOL CHEM, V276, P21601, DOI 10.1074/jbc.M100826200; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Tirosh B, 2005, J VIROL, V79, P2768, DOI 10.1128/JVI.79.5.2768-2779.2005; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Walz J, 1998, J STRUCT BIOL, V121, P19, DOI 10.1006/jsbi.1998.3958; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; Yoshida Y, 2003, J BIOL CHEM, V278, P43877, DOI 10.1074/jbc.M304157200; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800	64	39	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					244	254		10.1074/jbc.M706237200	http://dx.doi.org/10.1074/jbc.M706237200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17951257	hybrid			2022-12-25	WOS:000251940300028
J	Zhou, D; Shen, R; Ye, JJ; Li, Y; Tsark, W; Isbell, D; Tso, P; Chen, S				Zhou, Dujin; Shen, Ruoqing; Ye, Jing Jing; Li, Yuping; Tsark, Walter; Isbell, Donna; Tso, Patrick; Chen, Shiuan			Nuclear receptor coactivator PNRC2 regulates energy expenditure and adiposity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; PPAR-GAMMA; TRANSCRIPTIONAL REGULATION; ADIPOCYTE DIFFERENTIATION; GLUCOSE-HOMEOSTASIS; LIPOPROTEIN-LIPASE; LIPID HOMEOSTASIS; SKELETAL-MUSCLE; FAT-METABOLISM; BILE-ACID	PNRC2 was identified in our laboratory as a general cofactor for nuclear receptors. To better characterize the physiological function of PNRC2, we used gene-targeting technology to generate PNRC2-null mice ( PNRC2(-/-) mice). These PNRC2(-/-) mice are viable and fertile. PNRC2-null mice, especially male mice, are lean and are resistant to high fat diet-induced obesity but without the induction of insulin resistance. Male mice devoid of PNRC2 protein have a higher metabolic rate than wild-type mice. They consume more oxygen and produce more heat. Consistent with reduced adipose mass, the levels of leptin are lower in PNRC2(-/-) mice. This study provides evidence that PNRC2 plays one or more important roles in controlling the energy balance between energy storage and energy expenditure. PNRC2 may be a new target in the treatment of obesity and related metabolic diseases.	[Zhou, Dujin; Shen, Ruoqing; Ye, Jing Jing; Li, Yuping; Chen, Shiuan] Beckman Res Inst, Dept Surg Res, Duarte, CA 91010 USA; [Tsark, Walter] Beckman Res Inst, Transgen Mouse Facil, Duarte, CA 91010 USA; [Isbell, Donna] Beckman Res Inst, Anim Resources Ctr, Duarte, CA 91010 USA; [Tso, Patrick] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; University System of Ohio; University of Cincinnati	Chen, S (corresponding author), Beckman Res Inst, Dept Surg Res, Duarte, CA 91010 USA.	schen@coh.org	Li, Yuping/J-3138-2018		NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059630, R01DK060560] Funding Source: NIH RePORTER; NCI NIH HHS [CA 33572] Funding Source: Medline; NIDDK NIH HHS [DK 60560, DK 59630] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahima RS, 2005, TRENDS ENDOCRIN MET, V16, P307, DOI 10.1016/j.tem.2005.07.010; Albers M, 2005, MOL CELL PROTEOMICS, V4, P205, DOI 10.1074/mcp.M400169-MCP200; Berkenstam A, 2004, MECH AGEING DEV, V125, P707, DOI 10.1016/j.mad.2004.05.005; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chiang John Y L, 2005, Curr Opin Investig Drugs, V6, P994; Cooke PS, 2005, BIRTH DEFECTS RES A, V73, P472, DOI 10.1002/bdra.20142; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; D'Eon TM, 2005, J BIOL CHEM, V280, P35983, DOI 10.1074/jbc.M507339200; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Elmquist JK, 2005, J COMP NEUROL, V493, P63, DOI 10.1002/cne.20786; ENERBACK S, 1993, BIOCHIM BIOPHYS ACTA, V1169, P107, DOI 10.1016/0005-2760(93)90196-G; Farmer S R, 2004, Obes Rev, V5, P189, DOI 10.1111/j.1467-789X.2004.00157.x; Fayard E, 2004, TRENDS CELL BIOL, V14, P250, DOI 10.1016/j.tcb.2004.03.008; FOLCH J, 1951, J BIOL CHEM, V191, P833; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Handschin C, 2005, ARCH BIOCHEM BIOPHYS, V433, P387, DOI 10.1016/j.abb.2004.08.030; Havel PJ, 2002, CURR OPIN LIPIDOL, V13, P51, DOI 10.1097/00041433-200202000-00008; Hentschke M, 2003, BIOCHEM BIOPH RES CO, V312, P975, DOI 10.1016/j.bbrc.2003.11.025; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Ishibashi S, 1996, J BIOL CHEM, V271, P18017, DOI 10.1074/jbc.271.30.18017; Jakel H, 2006, DRUG NEWS PERSPECT, V19, P91, DOI 10.1358/dnp.2006.19.2.977445; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lau P, 2004, J BIOL CHEM, V279, P36828, DOI 10.1074/jbc.M404927200; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Makowski L, 2005, CURR OPIN LIPIDOL, V16, P543, DOI 10.1097/01.mol.0000180166.08196.07; Mayes J S, 2004, Obes Rev, V5, P197, DOI 10.1111/j.1467-789X.2004.00152.x; Moats Rex A, 2003, Mol Imaging, V2, P150, DOI 10.1162/153535003322556895; Moverare-Skrtic S, 2006, OBESITY, V14, P662, DOI 10.1038/oby.2006.75; Nedergaard J, 2005, BBA-MOL BASIS DIS, V1740, P293, DOI 10.1016/j.bbadis.2005.02.003; Palin SL, 2003, METABOLISM, V52, P383, DOI 10.1053/meta.2003.50088; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Ricquier D, 2005, P NUTR SOC, V64, P47, DOI 10.1079/PNS2004408; ROSEN, 1999, MOL CELL, V4, P611; Rosen ED, 2000, GENE DEV, V14, P1293; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Shulman GI, 2004, PHYSIOLOGY, V19, P183, DOI 10.1152/physiol.00007.2004; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Spiegelman BM, 2000, INT J OBESITY, V24, pS8, DOI 10.1038/sj.ijo.0801492; Staels B, 2001, J AM ACAD DERMATOL, V45, pS158, DOI 10.1067/mjd.2001.113718; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; Zhang M, 2001, J BIOL CHEM, V276, P41690, DOI 10.1074/jbc.M105117200; Zhou DJ, 2005, GENE, V361, P89, DOI 10.1016/j.gene.2005.07.012; Zhou DJ, 2001, NUCLEIC ACIDS RES, V29, P3939, DOI 10.1093/nar/29.19.3939; Zhou DJ, 2000, MOL ENDOCRINOL, V14, P986, DOI 10.1210/me.14.7.986	55	13	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					541	553		10.1074/jbc.M703234200	http://dx.doi.org/10.1074/jbc.M703234200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17971453	hybrid			2022-12-25	WOS:000251940300059
J	Perrin, MH; Grace, CRR; DiGruccio, MR; Fischer, WH; Maji, SK; Cantle, JP; Smith, S; Manning, G; Vale, WW; Riek, R				Perrin, Marilyn H.; Grace, Christy R. R.; DiGruccio, Michael R.; Fischer, Wolfgang H.; Maji, Samir K.; Cantle, Jeffrey P.; Smith, Sean; Manning, Gerard; Vale, Wylie W.; Riek, Roland			Distinct structural and functional roles of conserved residues in the first extracellular domain of receptors for corticotropin-releasing factor and related G-protein-coupled receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; 1ST EXTRACELLULAR DOMAIN; TYPE-2 RECEPTOR; CONSTITUTIVE ACTIVATION; CHIMERIC RECEPTORS; CRYSTAL-STRUCTURE; LIGAND-BINDING; MOLTEN GLOBULE; PEPTIDE LIGAND; ASPARTIC-ACID	The G-protein-coupled receptor B1 family includes corticotropin-releasing factor (CRF), growth hormone-releasing hormone, incretin, and pituitary adenylate cyclase-activating polypeptide receptors. The three-dimensional NMR structure of the first extracellular domain (ECD1) of CRF receptor 2 beta ( CRF-R2 beta), free and complexed with astressin, comprises a Sushi domain. This domain is stabilized in part by a salt bridge between Asp(65) and Arg(101). Analogous residues are conserved in other members of the B1 family. To address the importance of the salt bridge residues within this receptor family, we studied the effects of mutating the residues in full-length CRF-R2 beta and isolated ECD1. Mutation D65A or D65R/ R101D resulted in loss of the canonical disulfide arrangement, whereas R101A retained the Cys(4) -Cys(6) disulfide bond. The mutations resulted in misfolding within the ECD1 as determined by NMR and 1-anilino8-naphthalenesulfonate binding but did not prevent cell surface expression. The D65A mutation in CRF-R2 beta greatly reduced binding and activation, but the R101A substitution had only a small effect. Similar effects were seen on astressin binding to the ECD1. The different interactions of Asp65 and Arg101, deduced from the three-dimensional structure of the complex, are consistent with the differential effects seen in the mutants. The reduction in binding of Asp65 mutants is a consequence of a distinct Asp65 -Trp(71) interaction, which stabilizes the ligand-binding loop. Hence, loss of the salt bridge leads to disruption of the overall fold but does not abolish function. Because homologous mutations in other B1 receptors produce similar effects, these conserved residues may play similar roles in the entire receptor family.	[Perrin, Marilyn H.; DiGruccio, Michael R.; Fischer, Wolfgang H.; Cantle, Jeffrey P.; Smith, Sean; Vale, Wylie W.] Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; [Grace, Christy R. R.; Maji, Samir K.; Riek, Roland] Struct Biol Lab, La Jolla, CA 92037 USA; [Manning, Gerard] Razavi Newman Ctr Bioinformat, Salk Inst, La Jolla, CA 92037 USA; [Riek, Roland] ETH, Phys Chem Lab, Zurich, Switzerland	Salk Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Perrin, MH (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	perrin@salk.edu; riek@salk.edu	Manning, Gerard/C-8308-2009; Maji, Samir K. K./B-9640-2019	Maji, Samir K. K./0000-0002-9110-1565; DiGruccio, Michael/0000-0002-9375-2425; Riek, Roland/0000-0002-6333-066X; Manning, Gerard/0000-0002-5087-9151	NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK026741] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA014195] Funding Source: Medline; NHGRI NIH HHS [R01 HG004164, R01 HG004164-01] Funding Source: Medline; NIDDK NIH HHS [P01 DK26741] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CAO YJ, 1995, BIOCHEM BIOPH RES CO, V212, P673, DOI 10.1006/bbrc.1995.2021; CARRUTHERS CJL, 1994, J BIOL CHEM, V269, P29321; Chauhan M, 2005, BIOCHEMISTRY-US, V44, P782, DOI 10.1021/bi049153f; COUVINEAU A, 1995, BIOCHEM BIOPH RES CO, V206, P246, DOI 10.1006/bbrc.1995.1034; Couvineau A, 2006, ANN NY ACAD SCI, V1070, P205, DOI 10.1196/annals.1317.015; Dautzenberg FM, 1999, J NEUROCHEM, V73, P821, DOI 10.1046/j.1471-4159.1999.0730821.x; Dautzenberg FM, 2002, MOL PHARMACOL, V61, P1132, DOI 10.1124/mol.61.5.1132; de Maturana RL, 2003, J BIOL CHEM, V278, P10195, DOI 10.1074/jbc.M212147200; Di Paolo E, 1999, PEPTIDES, V20, P1187, DOI 10.1016/S0196-9781(99)00122-9; Gaudin P, 1998, J BIOL CHEM, V273, P4990, DOI 10.1074/jbc.273.9.4990; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Grauschopf U, 2000, BIOCHEMISTRY-US, V39, P8878, DOI 10.1021/bi0001426; Hoare SRJ, 2005, PEPTIDES, V26, P457, DOI 10.1016/j.peptides.2004.10.019; Hoare SRJ, 2004, BIOCHEMISTRY-US, V43, P3996, DOI 10.1021/bi036110a; HOLTMANN MH, 1995, J BIOL CHEM, V270, P14394, DOI 10.1074/jbc.270.24.14394; Ittner LM, 2004, BIOCHEM BIOPH RES CO, V319, P1203, DOI 10.1016/j.bbrc.2004.05.103; Kee F, 2005, GEN COMP ENDOCR, V140, P41, DOI 10.1016/j.ygcen.2004.09.010; LIN SC, 1993, NATURE, V364, P208, DOI 10.1038/364208a0; Negro A, 2006, P NATL ACAD SCI USA, V103, P15889, DOI 10.1073/pnas.0607499103; Nielsen SM, 2000, P NATL ACAD SCI USA, V97, P10277, DOI 10.1073/pnas.97.18.10277; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Perrin MH, 2003, J BIOL CHEM, V278, P15595, DOI 10.1074/jbc.M210476200; Perrin MH, 2001, J BIOL CHEM, V276, P31528, DOI 10.1074/jbc.M101838200; Perrin MH, 1998, ENDOCRINOLOGY, V139, P566, DOI 10.1210/en.139.2.566; Perrin MH, 1999, J PHARMACOL EXP THER, V288, P729; Redfield C, 2004, METHODS, V34, P121, DOI 10.1016/j.ymeth.2004.03.009; Schwarzenbacher R, 1999, EMBO J, V18, P6228, DOI 10.1093/emboj/18.22.6228; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; Vamvaca K, 2004, P NATL ACAD SCI USA, V101, P12860, DOI 10.1073/pnas.0404109101; Wilmen A, 1996, FEBS LETT, V398, P43, DOI 10.1016/S0014-5793(96)01214-8; [No title captured]	32	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37529	37536		10.1074/jbc.M703748200	http://dx.doi.org/10.1074/jbc.M703748200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17940290	hybrid			2022-12-25	WOS:000251833600028
J	Gupta, M; Copeland, PR				Gupta, Malavika; Copeland, Paul R.			Functional analysis of the interplay between translation termination, selenocysteine codon context, and selenocysteine insertion sequence-binding protein 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SELENOPROTEIN-P; OPEN READING FRAME; STOP CODON; MAMMALIAN SELENOCYSTEINE; UGA CODONS; EFFICIENCY; MACHINERY; MECHANISM; ELEMENT; GENE	A selenocysteine insertion sequence ( SECIS) element in the 3'-untranslated region and an in-frame UGA codon are the requisite cis-acting elements for the incorporation of selenocysteine into selenoproteins. Equally important are the trans-acting factors SBP2, Sec-tRNA([Ser] Sec), and eEFSec. Multiple in-frame UGAs and two SECIS elements make the mRNA encoding selenoprotein P ( Sel P) unique. To study the role of codon context in determining the efficiency of UGA readthrough at each of the 10 rat Sel P Sec codons, we individually cloned 27-nucleotide-long fragments representing each UGA codon context into a luciferase reporter construct harboring both Sel P SECIS elements. Significant differences, spanning an 8-fold range of UGA readthrough efficiency, were observed, but these differences were dramatically reduced in the presence of excess SBP2. Mutational analysis of the "fourth base" of contexts 1 and 5 revealed that only the latter followed the established rules for hierarchy of translation termination. In addition, mutations in either or both of the Sel P SECIS elements resulted in differential effects on UGA readthrough. Interestingly, even when both SECIS elements harbored a mutation of the core region required for Sec incorporation, context 5 retained a significantly higher level of readthrough than context 1. We also show that SBP2-dependent Sec incorporation is able to repress G418-induced UGA readthrough as well as eRF1-induced stimulation of termination. We conclude that a large codon context forms a cis-element that works together with Sec incorporation factors to determine readthrough efficiency.	[Gupta, Malavika; Copeland, Paul R.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Microbiol Mol Genet & Immunol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Copeland, PR (corresponding author), 675 Hoes Lane, Piscataway, NJ 08854 USA.	paul.copeland@umdnj.edu		Copeland, Paul/0000-0003-3343-0587	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068077] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM068077-01, R01 GM068077, GM068077] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berry MJ, 2005, NAT STRUCT MOL BIOL, V12, P389, DOI 10.1038/nsmb0505-389; Berry MJ, 2001, BIOFACTORS, V14, P17, DOI 10.1002/biof.5520140104; Caban K, 2006, CELL MOL LIFE SCI, V63, P73, DOI 10.1007/s00018-005-5402-y; Caban K, 2007, MOL CELL BIOL, V27, P6350, DOI 10.1128/MCB.00632-07; Chavatte L, 2005, NAT STRUCT MOL BIOL, V12, P408, DOI 10.1038/nsmb922; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; Copeland PR, 2003, GENE, V312, P17, DOI 10.1016/S0378-1119(03)00588-2; Cridge AG, 2006, NUCLEIC ACIDS RES, V34, P1959, DOI 10.1093/nar/gkl074; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Grundner-Culemann E, 1999, RNA, V5, P625, DOI 10.1017/S1355838299981542; Grundner-Culemann E, 2001, J MOL BIOL, V310, P699, DOI 10.1006/jmbi.2001.4809; Handy DE, 2006, J BIOL CHEM, V281, P3382, DOI 10.1074/jbc.M511295200; HILL KE, 1993, P NATL ACAD SCI USA, V90, P537, DOI 10.1073/pnas.90.2.537; HILL KE, 1991, J BIOL CHEM, V266, P10050; Howard MT, 2007, RNA, V13, P912, DOI 10.1261/rna.473907; Jacobs GH, 2006, NUCLEIC ACIDS RES, V34, pD37, DOI 10.1093/nar/gkj159; Kinzy SA, 2005, NUCLEIC ACIDS RES, V33, P5172, DOI 10.1093/nar/gki826; LEE BJ, 1990, MOL CELL BIOL, V10, P1940, DOI 10.1128/MCB.10.5.1940; Lesoon A, 1997, MOL CELL BIOL, V17, P1977, DOI 10.1128/MCB.17.4.1977; Ma SG, 2002, J BIOL CHEM, V277, P12749, DOI 10.1074/jbc.M111462200; Manuvakhova M, 2000, RNA, V6, P1044, DOI 10.1017/S1355838200000716; MCCAUGHAN KK, 1995, P NATL ACAD SCI USA, V92, P5431, DOI 10.1073/pnas.92.12.5431; Mehta A, 2004, J BIOL CHEM, V279, P37852, DOI 10.1074/jbc.M404639200; MOTTAGUITABAR S, 1994, EMBO J, V13, P249, DOI 10.1002/j.1460-2075.1994.tb06255.x; Namy O, 2001, EMBO REP, V2, P787, DOI 10.1093/embo-reports/kve176; Nasim MT, 2000, J BIOL CHEM, V275, P14846, DOI 10.1074/jbc.275.20.14846; POOLE ES, 1995, EMBO J, V14, P151, DOI 10.1002/j.1460-2075.1995.tb06985.x; Stoytcheva Z, 2006, MOL CELL BIOL, V26, P9177, DOI 10.1128/MCB.00856-06	29	21	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36797	36807		10.1074/jbc.M707061200	http://dx.doi.org/10.1074/jbc.M707061200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17954931	hybrid, Green Accepted			2022-12-25	WOS:000251646000004
J	Lecchi, S; Nelson, CJ; Allen, KE; Swaney, DL; Thompson, KL; Coon, JJ; Sussman, MR; Slayman, CW				Lecchi, Silvia; Nelson, Clark J.; Allen, Kenneth E.; Swaney, Danielle L.; Thompson, Katie L.; Coon, Joshua J.; Sussman, Michael R.; Slayman, Carolyn W.			Tandem phosphorylation of Ser-911 and Thr-912 at the C terminus of yeast plasma membrane H+-ATPase leads to glucose-dependent activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSFER DISSOCIATION; PROTEIN-SEQUENCE ANALYSIS; MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; REGULATORY DOMAIN; ION/ION REACTIONS; CALCIUM-PUMP; IDENTIFICATION; PHOSPHOLAMBAN; PEPTIDE	In recent years there has been growing interest in the post translational regulation of P-type ATPases by protein kinase mediated phosphorylation. Pma1 H+-ATPase, which is responsible for H+-dependent nutrient uptake in yeast ( Saccharomyces cerevisiae), is one such example, displaying a rapid 5-10-fold increase in activity when carbon-starved cells are exposed to glucose. Activation has been linked to Ser/Thr phosphorylation in the C-terminal tail of the ATPase, but the specific phosphorylation sites have not previously been mapped. The present study has used nanoflow high pressure liquid chromatography coupled with electrospray electron transfer dissociation tandem mass spectrometry to identify Ser-911 and Thr-912 as two major phosphorylation sites that are clearly related to glucose activation. In carbon-starved cells with low Pma1 activity, peptide 896-918, which was derived from the C terminus upon Lys-C proteolysis, was found to be singly phosphorylated at Thr-912, whereas in glucose-metabolizing cells with high ATPase activity, the same peptide was doubly phosphorylated at Ser-911 and Thr-912. Reciprocal N-14/N-15 metabolic labeling of cells was used to measure the relative phosphorylation levels at the two sites. The addition of glucose to carbon-starved cells led to a 3-fold reduction in the singly phosphorylated form and an 11-fold increase in the doubly phosphorylated form. These results point to a mechanism in which the stepwise phosphorylation of two tandemly positioned residues near the C terminus mediates glucose-dependent activation of the H+-ATPase.	Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	Yale University; Yale University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Slayman, CW (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06510 USA.	carolyn.slayman@yale.edu		Nelson, Clark/0000-0002-8796-8326	NHGRI NIH HHS [HG 002706] Funding Source: Medline; NIGMS NIH HHS [GM 80148, GM 15761] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015761, R37GM015761, R01GM080148] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Axelsen KB, 1999, BIOCHEMISTRY-US, V38, P7227, DOI 10.1021/bi982482l; CARAFOLI E, 1994, J NEUROBIOL, V25, P312, DOI 10.1002/neu.480250311; CHANG A, 1991, J CELL BIOL, V115, P289, DOI 10.1083/jcb.115.2.289; Chu GX, 2000, J BIOL CHEM, V275, P38938, DOI 10.1074/jbc.M004079200; Coon JJ, 2005, P NATL ACAD SCI USA, V102, P9463, DOI 10.1073/pnas.0503189102; Coon JJ, 2005, BIOTECHNIQUES, V38, P519, DOI 10.2144/05384TE01; Coon JJ, 2004, INT J MASS SPECTROM, V236, P33, DOI 10.1016/j.ijms.2004.05.005; ERASO P, 1994, J BIOL CHEM, V269, P10393; Fuglsang AT, 1999, J BIOL CHEM, V274, P36774, DOI 10.1074/jbc.274.51.36774; Goossens A, 2000, MOL CELL BIOL, V20, P7654, DOI 10.1128/MCB.20.20.7654-7661.2000; JIMENEZ CR, 1998, CURRENT PROTOCOLS PR, P41; Karim CB, 2006, J MOL BIOL, V358, P1032, DOI 10.1016/j.jmb.2006.02.051; Kuhlbrandt W, 2002, SCIENCE, V297, P1692, DOI 10.1126/science.1072574; Lecchi S, 2005, BIOCHEMISTRY-US, V44, P16624, DOI 10.1021/bi051555f; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo WS, 1998, J BIOL CHEM, V273, P4734, DOI 10.1074/jbc.273.8.4734; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; MANDALA SM, 1989, J BIOL CHEM, V264, P16276; Martin SE, 2000, ANAL CHEM, V72, P4266, DOI 10.1021/ac000497v; Mason AB, 1998, BBA-BIOMEMBRANES, V1372, P261, DOI 10.1016/S0005-2736(98)00065-0; McAlister GC, 2007, ANAL CHEM, V79, P3525, DOI 10.1021/ac070020k; Morsomme P, 2000, BBA-REV BIOMEMBRANES, V1469, P133, DOI 10.1016/S0304-4157(00)00015-0; Nelson CJ, 2007, PROTEOMICS, V7, P1279, DOI 10.1002/pmic.200600832; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; Pantano S, 2007, PROTEINS, V66, P930, DOI 10.1002/prot.21239; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PERLIN DS, 1989, J BIOL CHEM, V264, P21857; Portillo F, 2000, BBA-REV BIOMEMBRANES, V1469, P31, DOI 10.1016/S0304-4157(99)00011-8; PORTILLO F, 1991, FEBS LETT, V287, P71, DOI 10.1016/0014-5793(91)80018-X; PORTILLO F, 1989, FEBS LETT, V247, P381, DOI 10.1016/0014-5793(89)81375-4; SCHLESSER A, 1988, J BIOL CHEM, V263, P19480; SERRANO R, 1983, FEBS LETT, V156, P11, DOI 10.1016/0014-5793(83)80237-3; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Thiede B, 2000, RAPID COMMUN MASS SP, V14, P496, DOI 10.1002/(SICI)1097-0231(20000331)14:6<496::AID-RCM899>3.0.CO;2-1; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Traaseth NJ, 2006, J MOL BIOL, V358, P1041, DOI 10.1016/j.jmb.2006.02.047; van Hemert MJ, 2001, YEAST, V18, P889, DOI 10.1002/yea.739; Wang DG, 2003, PLANT PHYSIOL, V132, P2152, DOI 10.1104/pp.103.021485; Williams-Hart T, 2002, GENETICS, V160, P1423	42	88	89	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35471	35481		10.1074/jbc.M706094200	http://dx.doi.org/10.1074/jbc.M706094200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17932035	hybrid			2022-12-25	WOS:000251458100006
J	Lachaux, JP; Jerbi, K; Bertrand, O; Minotti, L; Hoffmann, D; Schoendorff, B; Kahane, P				Lachaux, Jean-Philippe; Jerbi, Karim; Bertrand, Olivier; Minotti, Lorella; Hoffmann, Dominique; Schoendorff, Benjamin; Kahane, Philippe			A Blueprint for Real-Time Functional Mapping via Human Intracranial Recordings	PLOS ONE			English	Article								Background. The surgical treatment of patients with intractable epilepsy is preceded by a pre-surgical evaluation period during which intracranial EEG recordings are performed to identify the epileptogenic network and provide a functional map of eloquent cerebral areas that need to be spared to minimize the risk of post-operative deficits. A growing body of research based on such invasive recordings indicates that cortical oscillations at various frequencies, especially in the gamma range (40 to 150 Hz), can provide efficient markers of task-related neural network activity. Principal Findings. Here we introduce a novel real-time investigation framework for mapping human brain functions based on online visualization of the spectral power of the ongoing intracranial activity. The results obtained with the first two implanted epilepsy patients who used the proposed online system illustrate its feasibility and utility both for clinical applications, as a complementary tool to electrical stimulation for presurgical mapping purposes, and for basic research, as an exploratory tool used to detect correlations between behavior and oscillatory power modulations. Furthermore, our findings suggest a putative role for high gamma oscillations in higher-order auditory processing involved in speech and music perception. Conclusion/Significance. The proposed real-time setup is a promising tool for presurgical mapping, the investigation of functional brain dynamics, and possibly for neurofeedback training and brain computer interfaces.	[Lachaux, Jean-Philippe; Jerbi, Karim; Bertrand, Olivier; Schoendorff, Benjamin] INSERM, U821, F-69500 Lyon, France; [Lachaux, Jean-Philippe; Jerbi, Karim; Bertrand, Olivier] Inst Federatif Neurosci, F-69000 Lyon, France; [Lachaux, Jean-Philippe; Jerbi, Karim; Bertrand, Olivier] Univ Lyon 1, F-69000 Lyon, France; [Jerbi, Karim] Coll France, CNRS, Lab Physiol Percept & Act, F-75231 Paris, France; [Minotti, Lorella; Kahane, Philippe] Grenoble Hosp, Dept Neurol, Grenoble, France; [Minotti, Lorella; Kahane, Philippe] Grenoble Hosp, INSERM, U704, Grenoble, France; [Hoffmann, Dominique] Grenoble Hosp, Dept Neurosurg, Grenoble, France; [Hoffmann, Dominique] Grenoble Hosp, INSERM, U318, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Lachaux, JP (corresponding author), INSERM, U821, F-69500 Lyon, France.	lachaux@lyon.inserm.fr	Lachaux, Jean-Philippe/K-1681-2017; Bertrand, Olivier/B-6165-2008; KAHANE, PHILIPPE/P-5669-2016	Bertrand, Olivier/0000-0003-0733-7979; 	Agence Nationale de la Recherche (ANR); Reseau National des Technologies Logicielles (RNTL); Neurobotics project (EU FET) [FP6-IST-001917]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Reseau National des Technologies Logicielles (RNTL); Neurobotics project (EU FET)	Funding: This work was supported by the Agence Nationale de la Recherche (ANR) and by the Reseau National des Technologies Logicielles (RNTL) via the Open-ViBE project, as well as the Neurobotics project (EU FET Neurobotics FP6-IST-001917).	Aoki F, 1999, CLIN NEUROPHYSIOL, V110, P524, DOI 10.1016/S1388-2457(98)00064-9; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Bartolomei F, 2004, NEUROLOGY, V63, P858, DOI 10.1212/01.WNL.0000137037.56916.3F; Belin P, 2002, COGNITIVE BRAIN RES, V13, P17, DOI 10.1016/S0926-6410(01)00084-2; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; BIDETCAULET A, 2003, NEUROIMAGE, V19, P1554; Birbaumer N, 2006, PROG BRAIN RES, V159, P369, DOI 10.1016/S0079-6123(06)59024-7; Boddaert N, 2004, NEUROIMAGE, V23, P364, DOI 10.1016/j.neuroimage.2004.06.016; Brovelli A, 2005, NEUROIMAGE, V28, P154, DOI 10.1016/j.neuroimage.2005.05.045; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; CHATRIAN GE, 1960, ELECTROEN CLIN NEURO, V12, P167, DOI 10.1016/0013-4694(60)90070-5; Crone NE, 2006, PROG BRAIN RES, V159, P275, DOI 10.1016/S0079-6123(06)59019-3; Crone NE, 2001, CLIN NEUROPHYSIOL, V112, P565, DOI 10.1016/S1388-2457(00)00545-9; Crone NE, 2001, NEUROLOGY, V57, P2045, DOI 10.1212/WNL.57.11.2045; Crone NE, 1998, BRAIN, V121, P2271, DOI 10.1093/brain/121.12.2271; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Edwards E, 2005, J NEUROPHYSIOL, V94, P4269, DOI 10.1152/jn.00324.2005; Fecteau S, 2004, NEUROIMAGE, V23, P840, DOI 10.1016/j.neuroimage.2004.09.019; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Graimann B, 2004, IEEE T BIO-MED ENG, V51, P954, DOI 10.1109/TBME.2004.826671; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Humphries C, 2005, HUM BRAIN MAPP, V26, P128, DOI 10.1002/hbm.20148; Jack A. I, 2004, TRUSTING SUBJECT USE; Kahane P, 2003, ANN NEUROL, V54, P615, DOI 10.1002/ana.10726; KAHANE P, 2004, HDB CLIN NEUROPHYSIO; Kahane P, 1993, NEUROPHYSIOL CLIN, V22, P305; Kahane P, 2006, EPILEPTIC DISORD, V8, pS16; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kim DS, 2004, NEUROIMAGE, V21, P876, DOI 10.1016/j.neuroimage.2003.10.018; Kubler A, 2005, NEUROLOGY, V64, P1775, DOI 10.1212/01.WNL.0000158616.43002.6D; Lachaux JP, 2005, NEUROIMAGE, V25, P491, DOI 10.1016/j.neuroimage.2004.11.052; Lachaux JP, 2003, J PHYSIOLOGY-PARIS, V97, P613, DOI 10.1016/j.jphysparis.2004.01.018; Lachaux JP, 2002, NEUROPHYSIOL CLIN, V32, P157, DOI 10.1016/S0987-7053(02)00301-5; Lachaux JP, 2000, EUR J NEUROSCI, V12, P2608, DOI 10.1046/j.1460-9568.2000.00163.x; LACHAUX JP, 2005, NEUROIMAGE IN PRESS; LACHAUX JP, 2007, HUM BRAIN MAPP; Le Van Quyen M, 2003, BIOL RES, V36, P67, DOI 10.4067/S0716-97602003000100006; LESSER R, 1994, J CLIN NEUROPHYSIOL, V11, P191, DOI 10.1097/00004691-199403000-00004; LESSER RP, 1987, J CLIN NEUROPHYSIOL, V4, P27, DOI 10.1097/00004691-198701000-00003; Lesser RP, 1998, EPILEPSIA, V39, pS69, DOI 10.1111/j.1528-1157.1998.tb05127.x; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Liegeois-Chauvel C, 2004, CEREB CORTEX, V14, P731, DOI 10.1093/cercor/bhh033; Lobel E, 2001, J NEUROSURG, V95, P804, DOI 10.3171/jns.2001.95.5.0804; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; LUDERS HO, 1995, ADV NEUROL, V67, P115; Lutz A, 2002, P NATL ACAD SCI USA, V99, P1586, DOI 10.1073/pnas.032658199; MAINY N, 2007, HUM BRAIN MAPP; Mainy N, 2007, HUM BRAIN MAPP, V28, P183, DOI 10.1002/hbm.20264; OJEMANN G, 1989, J NEUROSURG, V71, P316, DOI 10.3171/jns.1989.71.3.0316; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Penfield W, 1954, EPILEPSY FUNCTIONAL; Petitmengin C., 2006, PHENOMENOL COGN SCI, V5, P229, DOI [10.1007/sll097-006-9022-2, DOI 10.1007/S11097-006-9022-2, 10.1007/s11097-006-9022-2]; Petitot Jean, 1999, NATURALIZING PHENOME; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 2003, CLIN NEUROPHYSIOL, V114, P1226, DOI 10.1016/S1388-2457(03)00067-1; Pfurtscheller G., 2006, NEUROIMAGE; Pfurtscheller G, 2006, PROG BRAIN RES, V159, P433, DOI 10.1016/S0079-6123(06)59028-4; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Sinai A, 2005, BRAIN, V128, P1556, DOI 10.1093/brain/awh491; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Szurhaj W, 2005, EUR J NEUROSCI, V21, P1223, DOI 10.1111/j.1460-9568.2005.03966.x; Talairach J., 1988, COPLANAR STEREOTAXIC; Tallon-Baudry C, 2005, CEREB CORTEX, V15, P654, DOI 10.1093/cercor/bhh167; Tanji K, 2005, J NEUROSCI, V25, P3287, DOI 10.1523/JNEUROSCI.4948-04.2005; Thompson E, 2001, TRENDS COGN SCI, V5, P418, DOI 10.1016/S1364-6613(00)01750-2; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Varela Francisco, 1999, VIEW 1 PERSON METHOD; Varela Francisco J., 1996, J CONSCIOUSNESS STUD, V3, P330; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	77	61	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1094	10.1371/journal.pone.0001094	http://dx.doi.org/10.1371/journal.pone.0001094			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971857	gold, Green Published			2022-12-25	WOS:000207458700011
J	Leal, JFM; Fominaya, J; Cascon, A; Guijarro, MV; Blanco-Aparicio, C; Lleonart, M; Castro, ME; Cajal, SRY; Robledo, M; Beach, DH; Carnero, A				Leal, J. F. M.; Fominaya, J.; Cascon, A.; Guijarro, M. V.; Blanco-Aparicio, C.; Lleonart, M.; Castro, M. E.; Ramon y Cajal, S.; Robledo, M.; Beach, D. H.; Carnero, A.			Cellular senescence bypass screen identifies new putative tumor suppressor genes	ONCOGENE			English	Article						senescence; genetic screening; tumor suppressor; p53; BRF1; Csn2	COP9 SIGNALOSOME; CANCER-THERAPY; HUMAN-CELLS; P53; ACCUMULATION; DEGRADATION; P16(INK4A); DISRUPTION; HALLMARKS; ABSENCE	Senescence is a mechanism that limits cellular lifespan and constitutes a barrier against cellular immortalization. To identify new senescence regulatory genes that might play a role in tumorigenesis, we have designed and performed a large-scale antisense-based genetic screen in primary mouse embryo. broblasts (MEFs). Out of this screen, we have identified five different genes through which loss of function partially bypasses senescence. These genes belong to very different biochemical families: csn2 (component of the Cop9 signalosome), aldose reductase (a metabolic enzyme) and brf1 (subunit of the RNA polymerase II complex), S-adenosyl homocysteine hydrolase and Bub1. Inactivation, at least partial, of these genes confers resistance to both p53- and p16INK4a-induced proliferation arrest. Furthermore, such inactivation inhibits p53 but not E2F1 transcriptional activity and impairs DNA-damage-induced transcription of p21. Since the aim of the screen was to identify new regulators of tumorigenesis, we have tested their inactivation in human tumors. We have found, either by northern blot or quantitative reverse transcriptase-PCR analysis, that the expression of three genes, Csn2, Aldose reductase and Brf1, is lost at different ratios in tumors of different origins. These genes are located at common positions of loss of heterogeneity (15q21.2, 7q35 and 14q32.33); therefore, we have measured genomic losses of these specific genes in different tumors. We have found that Csn2 and Brf1 also show genomic losses of one allele in different tumors. Our data suggest that the three genes identified in the genome-wide loss-of-function genetic screen are putative tumor suppressors located at 15q21.2; 7q35 and 14q32.33.	[Leal, J. F. M.; Fominaya, J.; Guijarro, M. V.; Blanco-Aparicio, C.; Castro, M. E.; Carnero, A.] CNIO, Expt Therapeut Programme, Madrid 28029, Spain; [Cascon, A.; Robledo, M.] CNIO, Mol Pathol Programme, Madrid 28029, Spain; [Lleonart, M.; Ramon y Cajal, S.] Hosp Valle De Hebron, Dept Patol, Barcelona, Spain; [Beach, D. H.] Ctr Cutaneous Biol, Inst Cell & Mol Sci, London, England	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Hospital Universitari Vall d'Hebron; University of London; Queen Mary University London	Carnero, A (corresponding author), CNIO, Expt Therapeut Programme, C Melchor Fernandez Almagro 3, Madrid 28029, Spain.	acarnero@cnio.es	IBIS, CANCER/P-3323-2015; Leal, Juan F Martinez/N-6328-2013; LLeonart, Matilde E./Q-2662-2019; Ramon y Cajal, Santiago/H-4955-2016; Blanco-Aparicio, Carmen/I-3162-2015; Espinosas, Maribel/H-8083-2012; Robledo, Mercedes/O-2230-2013; Cascon, Alberto/G-3160-2014	Leal, Juan F Martinez/0000-0002-7538-0875; LLeonart, Matilde E./0000-0002-6196-7405; Ramon y Cajal, Santiago/0000-0002-3867-1390; Blanco-Aparicio, Carmen/0000-0002-3249-6595; Robledo, Mercedes/0000-0001-6256-5902; Cascon, Alberto/0000-0003-2119-891X; Carnero, Amancio/0000-0003-4357-3979	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Bech-Otschir D, 2002, J CELL SCI, V115, P467; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Carnero A, 2004, ONCOGENE, V23, P6006, DOI 10.1038/sj.onc.1207839; Carnero A, 2000, NUCLEIC ACIDS RES, V28, P2234, DOI 10.1093/nar/28.11.2234; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eichhorn K, 2001, J BIOL CHEM, V276, P21158, DOI 10.1074/jbc.M102295200; Greider Carol W., 2004, Cell, VS116, pS83, DOI 10.1016/S0092-8674(04)00053-4; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Larminie CGC, 1997, EMBO J, V16, P2061, DOI 10.1093/emboj/16.8.2061; Lefrancois-Martinez AM, 2004, J CLIN ENDOCR METAB, V89, P3010, DOI 10.1210/jc.2003-031830; Lleonart ME, 2006, ONCOL REP, V16, P603; Lykke-Andersen K, 2003, MOL CELL BIOL, V23, P6790, DOI 10.1128/MCB.23.19.6790-6797.2003; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Suzuki K, 2001, RADIAT RES, V155, P248, DOI 10.1667/0033-7587(2001)155[0248:RISLGA]2.0.CO;2; Wei N, 1998, CURR BIOL, V8, P919, DOI 10.1016/S0960-9822(07)00372-7; Yamasaki L, 1998, NAT GENET, V18, P360, DOI 10.1038/ng0498-360; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1; Yoneda-Kato N, 2005, EMBO J, V24, P1739, DOI 10.1038/sj.emboj.7600656	31	41	44	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR 27	2008	27	14					1961	1970		10.1038/sj.onc.1210846	http://dx.doi.org/10.1038/sj.onc.1210846			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	279MK	17968325				2022-12-25	WOS:000254359100001
J	Nakamura, Y; Ichinohe, M; Hirata, M; Matsuura, H; Fujiwara, T; Igarashi, T; Nakahara, M; Yamaguchi, H; Yasugi, S; Takenawa, T; Fukami, K				Nakamura, Yoshikazu; Ichinohe, Manabu; Hirata, Masayuki; Matsuura, Hirokazu; Fujiwara, Takashi; Igarashi, Takahiro; Nakahara, Masamichi; Yamaguchi, Hideki; Yasugi, Sadao; Takenawa, Tadaomi; Fukami, Kiyoko			Phospholipase C-delta 1 is an essential molecule downstream of Foxn1, the gene responsible for the nude mutation, in normal hair development	FASEB JOURNAL			English	Article						phosphoinositide; nude mice; hair follicle; hair keratin	C ISOZYMES; DIFFERENTIATION; FOLLICLE; EXPRESSION; MOUSE; PROTEIN; WHN; KERATINOCYTES; PHENOTYPE; HOXC13	Nude mice exhibit athymia and hairlessness by a loss-of-function mutation in the transcription factor Foxn1 gene. Although the immunological functions of Foxn1 have been studied intensively, there have been relatively few studies of its functions in skin. Foxn1 regulates expression of hair keratins, which is essential for normal hair structure; however, how Foxn1 regulates hair keratin expression and hair formation is largely unknown. In the present study, we found that mice lacking phospholipase C (PLC)-delta 1, a key molecule in the phosphoinositide signaling pathway, and nude mice show similar hair abnormalities, such as lack of cuticle and bending. We also found that expression of hair keratins was remarkably decreased in skin of PLC-delta 1 knockout mice. Furthermore, expression of PLC-delta 1 was induced in Foxn1-transfected U2OS cells. In addition, we showed that PLC-delta 1 expression was remarkably decreased in skin of nude mice. In skin and keratinocytes of nude mice as well as PLC-delta 1 KO mice, activation of PLC downstream effectors, such as PKC and nuclear factor of activated T cells, was impaired. These results indicate that PLC-delta 1 is an essential molecule downstream of Foxn1 in normal hair formation, and strongly suggest that hairlessness in nude mice is caused by insufficient expression of PLC-delta 1.	[Nakamura, Yoshikazu; Ichinohe, Manabu; Hirata, Masayuki; Matsuura, Hirokazu; Igarashi, Takahiro; Nakahara, Masamichi; Yamaguchi, Hideki; Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignal, Tokyo 1920392, Japan; [Fujiwara, Takashi] Ehime Univ, Integrated Ctr Sci, Dept Biol Resources, Toon City, Ehime, Japan; [Yasugi, Sadao] Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Tokyo 158, Japan; [Takenawa, Tadaomi] Kobe Univ, Grad Sch Med, Dept Lipid Biochem, Kobe, Hyogo 657, Japan	Tokyo University of Pharmacy & Life Sciences; Ehime University; Tokyo Metropolitan University; Kobe University	Fukami, K (corresponding author), Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignal, 1432-1 Horinouchi, Tokyo 1920392, Japan.	kfukami@ls.toyaku.ac.jp	Yamaguchi, Hideki/AAP-1767-2021	Yamaguchi, Hideki/0000-0003-2125-9655; Nakamura, Yoshikazu/0000-0001-8355-1091				Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; Brissette JL, 1996, GENE DEV, V10, P2212, DOI 10.1101/gad.10.17.2212; Bunce MW, 2006, BBA-MOL CELL BIOL L, V1761, P560, DOI 10.1016/j.bbalip.2006.03.002; DasGupta R, 1999, DEVELOPMENT, V126, P4557; FLANAGAN SP, 1966, GENET RES, V8, P295, DOI 10.1017/S0016672300010168; Frank J, 1999, NATURE, V398, P473, DOI 10.1038/18997; Fukami K, 2002, J BIOCHEM, V131, P293, DOI 10.1093/oxfordjournals.jbchem.a003102; Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11; Ishii Y, 1997, DEV GROWTH DIFFER, V39, P643; Janes SM, 2004, J CELL SCI, V117, P4157, DOI 10.1242/jcs.01302; Jave-Suarez LF, 2002, J BIOL CHEM, V277, P3718, DOI 10.1074/jbc.M101616200; Johns SA, 2005, DEV DYNAM, V232, P1062, DOI 10.1002/dvdy.20278; Kobielak K, 2003, J CELL BIOL, V163, P609, DOI 10.1083/jcb.200309042; Kulessa H, 2000, EMBO J, V19, P6664, DOI 10.1093/emboj/19.24.6664; LI J, 2007, DIFFERENTIATION; Meier N, 1999, MECH DEVELOP, V89, P215, DOI 10.1016/S0925-4773(99)00218-X; Nakamura Y, 2005, MOL CELL BIOL, V25, P10979, DOI 10.1128/MCB.25.24.10979-10988.2005; Nakamura Y, 2003, EMBO J, V22, P2981, DOI 10.1093/emboj/cdg302; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Nishida T, 2006, BIOCHEM BIOPH RES CO, V345, P1536, DOI 10.1016/j.bbrc.2006.05.065; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Okada M, 2005, FEBS LETT, V579, P4949, DOI 10.1016/j.febslet.2005.07.082; PANTELOURIS EM, 1968, NATURE, V217, P370, DOI 10.1038/217370a0; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Sayama K, 2002, J BIOL CHEM, V277, P40390, DOI 10.1074/jbc.M112423200; Schlake T, 1997, P NATL ACAD SCI USA, V94, P3842, DOI 10.1073/pnas.94.8.3842; Schlake T, 2000, DEV DYNAM, V217, P368, DOI 10.1002/(SICI)1097-0177(200004)217:4<368::AID-DVDY4>3.0.CO;2-Z; Yuhki M, 2004, DEVELOPMENT, V131, P1825, DOI 10.1242/dev.01079	30	43	45	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2008	22	3					841	849		10.1096/fj.07-9239com	http://dx.doi.org/10.1096/fj.07-9239com			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17938256				2022-12-25	WOS:000254143700022
J	Wang, H; Wen, S; Bunnett, NW; Leduc, R; Hollenberg, MD; MacNaughton, WK				Wang, Hongying; Wen, Shoubin; Bunnett, Nigel W.; Leduc, Richard; Hollenberg, Morley D.; MacNaughton, Wallace K.			Proteinase-activated receptor-2 induces cyclooxygenase-2 expression through beta-catenin and cyclic AMP-response element-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC-CANCER CELLS; COLON-CANCER; REGULATES EXPRESSION; COLORECTAL-CANCER; MOLECULAR-CLONING; COX-2 INHIBITORS; EPITHELIAL-CELLS; CARCINOMA CELLS; PROLIFERATION; PHOSPHORYLATION	Chronic inflammation of mucosae is associated with an increased cancer risk. Tumorigenesis in these tissues is associated with the activity of some proteinases, cyclooxygenase-2 (COX-2), and beta-catenin. Serine proteinases participate in both inflammation and tumorigenesis through the activation of proteinase-activated receptor-2 (PAR(2)), which up-regulates COX-2 by an unknown mechanism. We sought to determine whether beta-catenin participated in PAR2-induced COX-2 expression and through what cellular mechanism. In A549 epithelial cells, we showed that PAR2 activation increased COX-2 expression through the beta-catenin/T cell factor transcription pathway. This effect was dependent upon ERK1/2 MAPK, which inhibited the beta-catenin-regulating protein, glycogen synthase kinase-3 beta, and induced the activity of the cAMP-response element-binding protein ( CREB). Knockdown of CREB by small interfering RNA revealed that PAR(2)-induced beta-catenin transcriptional activity and COX-2 expression were CREB-dependent. A co-immunoprecipitation assay revealed a physical interaction between CREB and beta-catenin. Thus, PAR2 up-regulated COX-2 expression via an ERK1/2-mediated activation of the beta-catenin/Tcf-4 and CREB pathways. These findings reveal new cellular mechanisms by which serine proteinases may participate in tumor development and are particularly relevant to cancers associated with chronic mucosal inflammation, where serine proteinases are abundant and COX-2 overexpression is a common feature.	[Wang, Hongying; Wen, Shoubin; Hollenberg, Morley D.; MacNaughton, Wallace K.] Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; [MacNaughton, Wallace K.] Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; [Hollenberg, Morley D.] Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB T2N 4N1, Canada; [Bunnett, Nigel W.] Univ Calif San Francisco, Dept Surg & Physiol, San Francisco, CA 94143 USA; [Leduc, Richard] Univ Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada	University of Calgary; University of Calgary; University of Calgary; University of California System; University of California San Francisco; University of Sherbrooke	MacNaughton, WK (corresponding author), Univ Calgary, Dept Physiol & Biophys, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	wmacnaug@ucalgary.ca	Hollenberg, Morley/AFV-6966-2022	Bunnett, Nigel W./0000-0003-3367-0644; Wang, Hongying/0000-0001-8443-3839				Amir M, 2005, PHARMAZIE, V60, P563; APPLEBY SB, 1994, BIOCHEM J, V302, P723, DOI 10.1042/bj3020723; Araki Y, 2003, CANCER RES, V63, P728; Blanke C, 2004, CANCER INVEST, V22, P271, DOI 10.1081/CNV-120030216; Brown JR, 2005, J CLIN ONCOL, V23, P2840, DOI 10.1200/JCO.2005.09.051; Caruso R, 2006, AM J PATHOL, V169, P268, DOI 10.2353/ajpath.2006.050841; Chow LWC, 2005, BIOMED PHARMACOTHER, V59, pS281, DOI 10.1016/S0753-3322(05)80046-0; Cocks TM, 2000, TRENDS PHARMACOL SCI, V21, P103, DOI 10.1016/S0165-6147(99)01440-6; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Darmoul D, 2004, J BIOL CHEM, V279, P20927, DOI 10.1074/jbc.M401430200; Darmoul D, 2001, BRIT J CANCER, V85, P772, DOI 10.1054/bjoc.2001.1976; Dery O, 1998, AM J PHYSIOL-CELL PH, V274, pC1429, DOI 10.1152/ajpcell.1998.274.6.C1429; Desilets A, 2006, FEBS LETT, V580, P2227, DOI 10.1016/j.febslet.2006.03.030; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; GIARDIELLO FM, 1993, NEW ENGL J MED, V328, P1313, DOI 10.1056/NEJM199305063281805; Guger KA, 2000, DEV BIOL, V223, P441, DOI 10.1006/dbio.2000.9770; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hsi LC, 1999, CARCINOGENESIS, V20, P2045, DOI 10.1093/carcin/20.11.2045; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kawao N, 2005, J PHARMACOL EXP THER, V315, P576, DOI 10.1124/jpet.105.089490; Kim SJ, 2002, BIOCHEM BIOPH RES CO, V296, P221, DOI 10.1016/S0006-291X(02)00824-0; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Krysan Kostyantyn, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P209, DOI 10.2174/187152006776930882; Lee HK, 2006, NUCLEIC ACIDS RES, V34, P5705, DOI 10.1093/nar/gkl698; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Nath N, 2003, P NATL ACAD SCI USA, V100, P12584, DOI 10.1073/pnas.2134840100; Nelson RW, 1999, J CELL BIOL, V147, P367, DOI 10.1083/jcb.147.2.367; Nishibori M, 2005, J PHARMACOL SCI, V97, P25, DOI 10.1254/jphs.FMJ04005X5; NYSTEDT S, 1995, J BIOL CHEM, V270, P5950, DOI 10.1074/jbc.270.11.5950; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Oberst M, 2001, AM J PATHOL, V158, P1301, DOI 10.1016/S0002-9440(10)64081-3; Ohta T, 2003, INT J ONCOL, V23, P61; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Pradeep A, 2004, ONCOGENE, V23, P3689, DOI 10.1038/sj.onc.1207454; PRESCOTT SM, 2000, BIOCHIM BIOPHYS ACTA, V1470, P69, DOI [10.1016/s0304-419x(00)00006-8), DOI 10.1016/S0304-419X(00)00006-8]; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; Sendo T, 2003, CELL SIGNAL, V15, P773, DOI 10.1016/S0898-6568(03)00014-7; Sheehan KM, 1999, JAMA-J AM MED ASSOC, V282, P1254, DOI 10.1001/jama.282.13.1254; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Steinhoff M, 1999, EXP DERMATOL, V8, P282; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tang QB, 2001, ONCOGENE, V20, P5164, DOI 10.1038/sj.onc.1204667; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Wang HY, 2005, CANCER RES, V65, P8604, DOI 10.1158/0008-5472.CAN-05-1169; Xu LF, 2000, GENE DEV, V14, P585	49	41	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					809	815		10.1074/jbc.M703021200	http://dx.doi.org/10.1074/jbc.M703021200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17962194	hybrid			2022-12-25	WOS:000252128100020
J	Choi, H; Leto, TL; Hunyady, L; Catt, KJ; Bae, YS; Rhee, SG				Choi, Hyun; Leto, Thomas L.; Hunyady, Laszlo; Catt, Kevin J.; Bae, Yun Soo; Rhee, Sue Goo			Mechanism of angiotensin II-induced superoxide production in cells reconstituted with angiotensin type 1 receptor and the components of NADPH oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; NUCLEOTIDE EXCHANGE FACTOR; ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION PATHWAYS; INDUCED CARDIAC-HYPERTROPHY; PHOSPHOLIPASE-D ACTIVATION; COLON EPITHELIAL-CELLS; GROWTH-FACTOR RECEPTOR; SMALL GTPASE RAC; REACTIVE OXYGEN	The mechanism of angiotensin II (Ang II)-induced superoxide production was investigated with HEK293 or Chinese hamster ovary cells reconstituted with the angiotensin type 1 receptor (AT(1)R) and NADPH oxidase (either Nox1 or Nox2) along with a pair of adaptor subunits (either NOXO1 with NOXA1 or p47(phox) with p67(phox)). Ang II enhanced the activity of both Nox1 and Nox2 supported by either adaptor pair, with more effective activation of Nox1 in the presence of NOXO1 and NOXA1 and of Nox2 in the presence of p47(phox) and p67(phox). Expression of several AT(1)R mutants showed that interaction of the receptor with G proteins but not that with beta-arrestin or with other proteins (Jak2, phospholipase C-gamma 1, SH2 domain-containing phosphatase 2) that bind to the COOH-terminal region of AT(1)R, was necessary for Ang II-induced superoxide production. The effects of constitutively active alpha subunits of G proteins and of various pharmacological agents implicated signaling by a pathway comprising AT1R, G alpha(q/11), phospholipase C-beta, and protein kinase C as largely, but not exclusively, responsible for Ang II-induced activation of Nox1 and Nox2 in the reconstituted cells. A contribution of G alpha(12/13), phospholipase D, and phosphatidylinositol 3-kinase to Ang II-induced superoxide generation was also suggested, whereas Src and the epidermal growth factor receptor did not appear to participate in this effect of Ang II. In reconstituted cells stimulated with Ang II, Nox2 exhibited a more sensitive response than Nox1 to the perturbation of protein kinase C, phosphatidylinositol 3-kinase, or the small GTPase Rac1.	[Choi, Hyun; Bae, Yun Soo; Rhee, Sue Goo] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Leto, Thomas L.] NIH, NIAID, Host Def Lab, Bethesda, MD 20892 USA; [Hunyady, Laszlo] Semmelweis Univ, Dept Physiol, H-1088 Budapest, Hungary; [Catt, Kevin J.] NIH, NICHD, Endocrinol & Reprod Res Branch, Bethesda, MD 20892 USA	Ewha Womans University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Semmelweis University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Bae, YS (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, 1-1-1 Daehyundong,Seodamoongu, Seoul 120750, South Korea.	baeys@ewha.ac.kr; rheesg@ewha.ac.kr			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000184] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD000193, Z01HD000193, Z01HD000184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000614, Z01AI000614] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ali MS, 1997, J BIOL CHEM, V272, P23382, DOI 10.1074/jbc.272.37.23382; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bendall JK, 2002, CIRCULATION, V105, P293, DOI 10.1161/hc0302.103712; Bokoch GM, 2006, ANTIOXID REDOX SIGN, V8, P1533, DOI 10.1089/ars.2006.8.1533; Bokoch GM, 2003, TRENDS BIOCHEM SCI, V28, P502, DOI 10.1016/S0968-0004(03)00194-4; BONSER RW, 1991, BRIT J PHARMACOL, V103, P1237, DOI 10.1111/j.1476-5381.1991.tb12330.x; Booden MA, 2002, MOL CELL BIOL, V22, P4053, DOI 10.1128/MCB.22.12.4053-4061.2002; Brenner S, 2003, BLOOD, V102, P2789, DOI 10.1182/blood-2002-05-1482; Brown GE, 2003, MOL CELL, V11, P35, DOI 10.1016/S1097-2765(03)00005-4; Byrne JA, 2003, CIRC RES, V93, P802, DOI 10.1161/01.RES.0000099504.30207.F5; Cai H, 2003, TRENDS PHARMACOL SCI, V24, P471, DOI 10.1016/S0165-6147(03)00233-5; Cheng GJ, 2004, J BIOL CHEM, V279, P4737, DOI 10.1074/jbc.M305968200; Chikumi H, 2002, J BIOL CHEM, V277, P27130, DOI 10.1074/jbc.M204715200; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; de Gasparo M, 2000, PHARMACOL REV, V52, P415; DEMENDEZ I, 1995, BLOOD, V85, P1104, DOI 10.1182/blood.V85.4.1104.bloodjournal8541104; Diaz O, 2002, J BIOL CHEM, V277, P39368, DOI 10.1074/jbc.M202376200; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Exton JH, 1997, PHYSIOL REV, V77, P303, DOI 10.1152/physrev.1997.77.2.303; Fan GF, 2003, J BIOL CHEM, V278, P52432, DOI 10.1074/jbc.M310982200; Frank GD, 2003, ANTIOXID REDOX SIGN, V5, P771, DOI 10.1089/152308603770380070; Gaborik Z, 2001, MOL PHARMACOL, V59, P239, DOI 10.1124/mol.59.2.239; Gavazzi G, 2006, FEBS LETT, V580, P497, DOI 10.1016/j.febslet.2005.12.049; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; Geiszt M, 2003, J IMMUNOL, V171, P299, DOI 10.4049/jimmunol.171.1.299; Geiszt M, 2003, J BIOL CHEM, V278, P20006, DOI 10.1074/jbc.M301289200; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Gorin Y, 2003, AM J PHYSIOL-RENAL, V285, pF219, DOI 10.1152/ajprenal.00414.2002; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Hanna IR, 2002, ANTIOXID REDOX SIGN, V4, P899, DOI 10.1089/152308602762197443; Hattori Y, 2005, DIABETOLOGIA, V48, P1066, DOI 10.1007/s00125-005-1766-7; Hoyal CR, 2003, P NATL ACAD SCI USA, V100, P5130, DOI 10.1073/pnas.1031526100; HUNYADY L, 1994, J BIOL CHEM, V269, P31378; HUNYADY L, 1994, J BIOL CHEM, V269, P24798; Hunyady L, 1996, P NATL ACAD SCI USA, V93, P10040, DOI 10.1073/pnas.93.19.10040; Hunyady L, 2000, REGUL PEPTIDES, V91, P29, DOI 10.1016/S0167-0115(00)00137-3; Inanami O, 1998, J BIOL CHEM, V273, P9539, DOI 10.1074/jbc.273.16.9539; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Karlsson A, 2000, J LEUKOCYTE BIOL, V67, P396, DOI 10.1002/jlb.67.3.396; Kazama K, 2004, CIRC RES, V95, P1019, DOI 10.1161/01.RES.0000148637.85595.c5; Kim JH, 2005, MOL CELL BIOL, V25, P3194, DOI 10.1128/MCB.25.8.3194-3208.2005; Koga H, 1999, J BIOL CHEM, V274, P25051, DOI 10.1074/jbc.274.35.25051; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Landmesser U, 2002, HYPERTENSION, V40, P511, DOI 10.1161/01.HYP.0000032100.23772.98; Lassegue B, 2003, AM J PHYSIOL-REG I, V285, pR277, DOI 10.1152/ajpregu.00758.2002; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; Lavigne MC, 2001, CIRCULATION, V104, P79, DOI 10.1161/01.CIR.104.1.79; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Li JM, 2004, CIRCULATION, V109, P1307, DOI 10.1161/01.CIR.0000118463.23388.B9; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Matsuno K, 2005, CIRCULATION, V112, P2677, DOI 10.1161/CIRCULATIONAHA.105.573709; Miyano K, 2006, J BIOL CHEM, V281, P21857, DOI 10.1074/jbc.M513665200; Mollnau H, 2002, CIRC RES, V90, pE58, DOI 10.1161/01.RES.0000012569.55432.02; Morawietz H, 2001, BIOCHEM BIOPH RES CO, V285, P1130, DOI 10.1006/bbrc.2001.5312; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Price MO, 2002, J BIOL CHEM, V277, P19220, DOI 10.1074/jbc.M200061200; Price MO, 2002, BLOOD, V99, P2653, DOI 10.1182/blood.V99.8.2653; PURI PL, 1995, J BIOL CHEM, V270, P22129, DOI 10.1074/jbc.270.38.22129; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Saito Y, 2001, J MOL CELL CARDIOL, V33, P3, DOI 10.1006/jmcc.2000.1272; Sayeski PP, 1998, REGUL PEPTIDES, V78, P19, DOI 10.1016/S0167-0115(98)00137-2; Servitja JM, 2003, J BIOL CHEM, V278, P34339, DOI 10.1074/jbc.M302960200; Seshiah PN, 2002, CIRC RES, V91, P406, DOI 10.1161/01.RES.0000033523.08033.16; Seta K, 2002, J BIOL CHEM, V277, P9268, DOI 10.1074/jbc.M109221200; Shiose A, 2001, J BIOL CHEM, V276, P1417, DOI 10.1074/jbc.M007597200; Smith RD, 1998, MOL PHARMACOL, V54, P935, DOI 10.1124/mol.54.6.935; Spat A, 2004, PHYSIOL REV, V84, P489, DOI 10.1152/physrev.00030.2003; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; Thomas WG, 2003, TRENDS ENDOCRIN MET, V14, P130, DOI 10.1016/S1043-2760(03)00023-7; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Touyz RM, 2002, CIRC RES, V90, P1205, DOI 10.1161/01.RES.0000020404.01971.2F; Touyz RM, 2000, PHARMACOL REV, V52, P639; Touyz RM, 1999, HYPERTENSION, V34, P976, DOI 10.1161/01.HYP.34.4.976; Ueyama T, 2006, MOL CELL BIOL, V26, P2160, DOI 10.1128/MCB.26.6.2160-2174.2006; Ushio-Fukai M, 2001, ARTERIOSCL THROM VAS, V21, P489, DOI 10.1161/01.ATV.21.4.489; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; Venema RC, 1998, J BIOL CHEM, V273, P7703, DOI 10.1074/jbc.273.13.7703; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang HD, 2001, CIRC RES, V88, P947, DOI 10.1161/hh0901.089987; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wingler M, 2001, FREE RADICAL BIO MED, V31, P1456, DOI 10.1016/S0891-5849(01)00727-4; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003	93	50	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					255	267		10.1074/jbc.M708000200	http://dx.doi.org/10.1074/jbc.M708000200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17981802	hybrid			2022-12-25	WOS:000251940300029
J	Maillard, RA; Jordan, M; Beasley, DWC; Barrett, ADT; Lee, JC				Maillard, Rodrigo A.; Jordan, Matthew; Beasley, David W. C.; Barrett, Alan D. T.; Lee, J. Ching			Long range communication in the envelope protein domain III and its effect on the resistance of West Nile virus to antibody-mediated neutralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORNE ENCEPHALITIS-VIRUS; ACCESSIBLE SURFACE-AREAS; CIRCULAR-DICHROISM; ANTIGENIC DETERMINANTS; MONOCLONAL-ANTIBODY; BINDING SITE; FLUORESCENCE; GLYCOPROTEIN; CONFORMATION; TYROSINE	The envelope protein domain III (ED3) of West Nile virus is the major virus-specific neutralization domain and harbors most of the critical mutations that induce resistance against antibody-mediated neutralization. We investigated the molecular mechanisms of neutralization resistance by studying the biophysical perturbations of monoclonal antibody (mAb)-resistant mutations on ED3 wild type. Our results showed that although the solution structure between ED3 wild type and mutants was preserved, the mutations that confer the highest degree of resistance to mAbs showed low protein stability and high local dynamic motions. Interestingly, the latter was observed in regions outside the mutation sites, indicating long range communications within ED3. Thus, we hypothesized that the mechanisms involved in resistance to mAb neutralization may include, in addition to mutations in the epitope, long range effects among distant structural elements. This hypothesis is consistent with reported mutations in other flaviviruses whose surfaces are not exposed for the interaction with other macromolecules, yet they confer mAb neutralization resistance.	[Maillard, Rodrigo A.; Jordan, Matthew; Lee, J. Ching] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Beasley, David W. C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Barrett, Alan D. T.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Beasley, David W. C.; Barrett, Alan D. T.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA; [Beasley, David W. C.; Barrett, Alan D. T.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Lee, JC (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	jclee@utmb.edu	Lee, James C/A-7849-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077551] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 77551] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barrett ADT, 2001, ANN NY ACAD SCI, V951, P262; Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002; BERMAN HA, 1978, BIOCHEMISTRY-US, V17, P1704, DOI 10.1021/bi00602a019; Bhardwaj S, 2001, J VIROL, V75, P4002, DOI 10.1128/JVI.75.8.4002-4007.2001; BOLEN DW, 1988, BIOCHEMISTRY-US, V27, P8069, DOI 10.1021/bi00421a015; BRAHMS S, 1977, P NATL ACAD SCI USA, V74, P3208, DOI 10.1073/pnas.74.8.3208; BUCKLEY A, 1985, J GEN VIROL, V66, P2523, DOI 10.1099/0022-1317-66-12-2523; BUJALOWSKI W, 1994, J BIOL CHEM, V269, P31359; CECILIA D, 1991, VIROLOGY, V181, P70, DOI 10.1016/0042-6822(91)90471-M; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; CHANG CT, 1978, ANAL BIOCHEM, V91, P13, DOI 10.1016/0003-2697(78)90812-6; Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; DONOVAN JW, 1969, J BIOL CHEM, V244, P1961; EFTINK MR, 1977, BIOCHIM BIOPHYS ACTA, V491, P473, DOI 10.1016/0005-2795(77)90290-2; FIESER TM, 1987, P NATL ACAD SCI USA, V84, P8568, DOI 10.1073/pnas.84.23.8568; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; GILL JE, 1969, PHOTOCHEM PHOTOBIOL, V9, P313, DOI 10.1111/j.1751-1097.1969.tb07295.x; Holzmann H, 1997, J GEN VIROL, V78, P31, DOI 10.1099/0022-1317-78-1-31; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kaufmann B, 2006, P NATL ACAD SCI USA, V103, P12400, DOI 10.1073/pnas.0603488103; KAWAHARA K, 1966, J BIOL CHEM, V241, P3228; Lacowicz J.R., 1999, PRINCIPLES FLUORESCE; Li L, 2005, VIROLOGY, V335, P99, DOI 10.1016/j.virol.2005.02.011; Lin CW, 2003, J VIROL, V77, P2600, DOI 10.1128/JVI.77.4.2600-2606.2003; LONGWORTH JW, 1967, BIOCHIM BIOPHYS ACTA, V147, P526, DOI 10.1016/0005-2795(67)90012-8; MAKHATADZE GI, 1993, J MOL BIOL, V232, P639, DOI 10.1006/jmbi.1993.1416; Mandl CW, 2000, J VIROL, V74, P9601, DOI 10.1128/JVI.74.20.9601-9609.2000; McMinn PC, 1997, J GEN VIROL, V78, P2711, DOI 10.1099/0022-1317-78-11-2711; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; NOVOTNY J, 1986, P NATL ACAD SCI USA, V83, P226, DOI 10.1073/pnas.83.2.226; Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PARKER CA, 1960, ANALYST, V85, P587, DOI 10.1039/an9608500587; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; RAGONE R, 1984, BIOCHEMISTRY-US, V23, P1871, DOI 10.1021/bi00303a044; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SCHELLMAN JA, 1978, BIOPOLYMERS, V17, P1305, DOI 10.1002/bip.1978.360170515; Stern O, 1919, PHYS Z, V20, P183; TAINER JA, 1984, NATURE, V312, P127, DOI 10.1038/312127a0; Volk DE, 2004, J BIOL CHEM, V279, P38755, DOI 10.1074/jbc.M402385200; WESTHOF E, 1984, NATURE, V311, P123, DOI 10.1038/311123a0; WETLAUFER DB, 1958, J BIOL CHEM, V233, P1421; Yu S, 2004, BIOCHEMISTRY-US, V43, P9168, DOI 10.1021/bi049324g	47	14	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					613	622		10.1074/jbc.M706031200	http://dx.doi.org/10.1074/jbc.M706031200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17986445	hybrid			2022-12-25	WOS:000251940300066
J	Schevzov, G; Fath, T; Vrhovski, B; Vlahovich, N; Rajan, S; Hook, J; Joya, JE; Lemckert, F; Puttur, F; Lin, JJC; Hardeman, EC; Wieczorek, DF; O'Neill, GM; Gunning, PW				Schevzov, Galina; Fath, Thomas; Vrhovski, Bernadette; Vlahovich, Nicole; Rajan, Sudarsan; Hook, Jeff; Joya, Josephine E.; Lemckert, Frances; Puttur, Franz; Lin, Jim J. -C.; Hardeman, Edna C.; Wieczorek, David F.; O'Neill, Geraldine M.; Gunning, Peter W.			Divergent regulation of the sarcomere and the cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVELY SPLICED EXONS; ACTIN-BINDING PROTEINS; ALPHA-TROPOMYOSIN GENE; PRE-MESSENGER-RNA; NONMUSCLE TROPOMYOSIN; BETA-TROPOMYOSIN; SKELETAL-MUSCLE; SMOOTH-MUSCLE; F-ACTIN; CULTURING HIPPOCAMPAL	The existence of a feedback mechanism regulating the precise amounts of muscle structural proteins, such as actin and the actin-associated protein tropomyosin (Tm), in the sarcomeres of striated muscles is well established. However, the regulation of nonmuscle or cytoskeletal actin and Tms in nonmuscle cell structures has not been elucidated. Unlike the thin filaments of striated muscles, the actin cytoskeleton in nonmuscle cells is intrinsically dynamic. Given the differing requirements for the structural integrity of the actin thin filaments of the sarcomere compared with the requirement for dynamicity of the actin cytoskeleton in nonmuscle cells, we postulated that different regulatory mechanisms govern the expression of sarcomeric versus cytoskeletal Tms, as key regulators of the properties of the actin cytoskeleton. Comprehensive analyses of tissues from transgenic and knock-out mouse lines that overexpress the cytoskeletal Tms, Tm3 and Tm5NM1, and a comparison with sarcomeric Tms provide evidence for this. Moreover, we show that overexpression of a cytoskeletal Tm drives the amount of filamentous actin.	[Schevzov, Galina; Fath, Thomas; Vrhovski, Bernadette; Hook, Jeff; Lemckert, Frances; Puttur, Franz; O'Neill, Geraldine M.; Gunning, Peter W.] Childrens Hosp Westmead, Oncol Res Unit, Westmead, NSW 2145, Australia; [Schevzov, Galina; Fath, Thomas; O'Neill, Geraldine M.; Gunning, Peter W.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Hardeman, Edna C.] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia; [Vlahovich, Nicole; Joya, Josephine E.; Hardeman, Edna C.] Childrens Med Res Inst, Muscle Dev Unit, Westmead, NSW 2145, Australia; [Rajan, Sudarsan; Wieczorek, David F.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Lin, Jim J. -C.] Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA	University of Sydney; University of Sydney; University of Sydney; Children's Medical Research Institute - Australia; University System of Ohio; University of Cincinnati; University of Iowa	Gunning, PW (corresponding author), Childrens Hosp Westmead, Oncol Res Unit, Westmead, NSW 2145, Australia.	PeterG3@chw.edu.au	Hardeman, Edna C/F-8872-2012; Rajan, Sudarsan/A-6780-2008; O'Neill, Geraldine/F-3112-2014; Gunning, Peter W/E-9058-2010; Schevzov, Galina/G-5117-2013	Schevzov, Galina/0000-0002-0793-2279; Fath, Thomas/0000-0002-6877-7567; Gunning, Peter/0000-0003-0833-3128; Hardeman, Edna/0000-0003-1649-7712; O'Neill, Geraldine/0000-0001-9997-8794	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071952] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 71952] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Almenar-Queralt A, 1999, J BIOL CHEM, V274, P28466, DOI 10.1074/jbc.274.40.28466; Ayscough KR, 1998, CURR OPIN CELL BIOL, V10, P102, DOI 10.1016/S0955-0674(98)80092-6; BERNSTEIN BW, 1982, CELL MOTIL CYTOSKEL, V2, P1, DOI 10.1002/cm.970020102; Blanchard EM, 1997, CIRC RES, V81, P1005; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; BROSCHAT KO, 1986, J BIOL CHEM, V261, P3350; Bryce NS, 2003, MOL BIOL CELL, V14, P1002, DOI 10.1091/mbc.E02-04-0244; Cooley BC, 2001, ARCH BIOCHEM BIOPHYS, V390, P71, DOI 10.1006/abbi.2001.2347; Corbett MA, 2005, ANN NEUROL, V57, P42, DOI 10.1002/ana.20305; Crawford K, 2002, MOL CELL BIOL, V22, P5887, DOI 10.1128/MCB.22.16.5887-5896.2002; DesMarais V, 2002, J CELL SCI, V115, P4649, DOI 10.1242/jcs.00147; Dufour C, 1998, J BIOL CHEM, V273, P18547, DOI 10.1074/jbc.273.29.18547; Fewell JG, 1998, J CLIN INVEST, V101, P2630, DOI 10.1172/JCI2825; Giganti Adeline, 2003, Prog Cell Cycle Res, V5, P511; GIMONA M, 1994, CELL MOTIL CYTOSKEL, V27, P108, DOI 10.1002/cm.970270203; Gimona M, 1996, P NATL ACAD SCI USA, V93, P9618, DOI 10.1073/pnas.93.18.9618; Gulick J, 1997, CIRC RES, V80, P655, DOI 10.1161/01.RES.80.5.655; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; GUNNING PW, 2007, IN PRESS PHYSL REV; HAD L, 1994, J CELL SCI, V107, P2961; Hannan AJ, 1998, MOL CELL NEUROSCI, V11, P289, DOI 10.1006/mcne.1998.0693; HEALD RW, 1988, J BIOL CHEM, V263, P5254; Heimann K, 1999, J BIOL CHEM, V274, P10743, DOI 10.1074/jbc.274.16.10743; Hughes JAI, 2003, GLIA, V42, P25, DOI 10.1002/glia.10174; ISHIKAWA R, 1989, J BIOL CHEM, V264, P7490; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kee AJ, 2004, J CELL BIOL, V166, P685, DOI 10.1083/jcb.200406181; Kumar A, 2004, TRANSGENIC RES, V13, P531, DOI 10.1007/s11248-004-2823-6; Kumar A, 1997, P NATL ACAD SCI USA, V94, P4406, DOI 10.1073/pnas.94.9.4406; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEESMILLER JP, 1990, MOL CELL BIOL, V10, P1729, DOI 10.1128/MCB.10.4.1729; LESSARD JL, 1988, CELL MOTIL CYTOSKEL, V10, P349, DOI 10.1002/cm.970100302; LIN JJC, 1985, HYBRIDOMA, V4, P223, DOI 10.1089/hyb.1985.4.223; MATSUMURA F, 1985, J BIOL CHEM, V260, P3851; Meberg PJ, 2003, METHOD CELL BIOL, V71, P111, DOI 10.1016/S0091-679X(03)01007-0; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Moraczewska J, 1999, BIOCHEMISTRY-US, V38, P15885, DOI 10.1021/bi991816j; Muthuchamy M, 1999, CIRC RES, V85, P47; MUTHUCHAMY M, 1993, MOL CELL BIOL, V13, P3311, DOI 10.1128/MCB.13.6.3311; Muthuchamy M, 1995, J BIOL CHEM, V270, P30593, DOI 10.1074/jbc.270.51.30593; NOVY RE, 1993, BIOCHIM BIOPHYS ACTA, V1162, P255, DOI 10.1016/0167-4838(93)90289-4; NOVY RE, 1993, CELL MOTIL CYTOSKEL, V26, P248, DOI 10.1002/cm.970260308; Ono S, 2002, J CELL BIOL, V156, P1065, DOI 10.1083/jcb.200110013; Palermo J, 1996, CIRC RES, V78, P504, DOI 10.1161/01.RES.78.3.504; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Pelham RJ, 1996, J CELL SCI, V109, P981; Percival JM, 2004, MOL BIOL CELL, V15, P268, DOI 10.1091/mbc.e03-03-0176; Perry SV, 2001, J MUSCLE RES CELL M, V22, P5, DOI 10.1023/A:1010303732441; PITTENGER MF, 1995, J CELL SCI, V108, P3253; PITTENGER MF, 1992, J CELL BIOL, V118, P841, DOI 10.1083/jcb.118.4.841; Prabhakar R, 2001, J MOL CELL CARDIOL, V33, P1815, DOI 10.1006/jmcc.2001.1445; Qin H, 1997, J BIOCHEM BIOPH METH, V36, P63, DOI 10.1016/S0165-022X(97)00045-6; Rethinasamy P, 1998, CIRC RES, V82, P116; Schevzov G, 1997, MOL CELL NEUROSCI, V8, P439, DOI 10.1006/mcne.1997.0599; Schevzov G, 2005, MOL BIOL CELL, V16, P3425, DOI 10.1091/mbc.E04-10-0951; Schevzov G, 2005, J HISTOCHEM CYTOCHEM, V53, P557, DOI 10.1369/jhc.4A6505.2005; Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com; Stehn JR, 2006, CURR CANCER DRUG TAR, V6, P245, DOI 10.2174/156800906776842948; TemmGrove CJ, 1996, CELL MOTIL CYTOSKEL, V33, P223, DOI 10.1002/(SICI)1097-0169(1996)33:3<223::AID-CM6>3.0.CO;2-B; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VLAHOVICH N, 2007, IN PRESS CELL MOTIL, DOI DOI 10.1002/CM20245; Vrhovski B, 2003, J NEUROSCI RES, V72, P373, DOI 10.1002/jnr.10586; WANG YC, 1992, J BIOL CHEM, V267, P12004; WARREN KS, 1995, J CELL BIOL, V129, P697, DOI 10.1083/jcb.129.3.697; Warren RH, 1997, EXP CELL RES, V236, P294, DOI 10.1006/excr.1997.3728	65	32	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					275	283		10.1074/jbc.M704392200	http://dx.doi.org/10.1074/jbc.M704392200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17951248	hybrid			2022-12-25	WOS:000251940300031
J	Belak, ZR; Ovsenek, N				Belak, Zachery R.; Ovsenek, Nick			Assembly of the Yin Yang 1 transcription factor into messenger ribonucleoprotein particles requires direct RNA binding activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD-SHOCK DOMAIN; XENOPUS-OOCYTES; ZINC-FINGER; TRANSLATIONAL REPRESSION; GENE-EXPRESSION; FACTOR YY1; C-MYC; PROTEIN; LAEVIS; RECOGNITION	The early stages of vertebrate development depend heavily on control of maternally transcribed mRNAs that are stored for long periods in complexes termed messenger ribonucleoprotein particles (mRNPs) and utilized selectively following maturation and fertilization. The transcription factor Yin Yang 1 (YY1) is associated with cytoplasmic mRNPs in vertebrate oocytes; however, the mechanism by which any of the mRNP proteins associate with mRNA in the oocyte is unknown. Here we demonstrate the mechanism by which YY1 associates with mRNPs depends on its direct RNA binding activity. High affinity binding for U-rich single-stranded RNA and A: U RNA duplexes was observed in the nanomolar range, similar to the affinity for the cognate double-stranded DNA-binding element. Similar RNA binding affinity was observed with endogenous YY1 isolated from native mRNP complexes. In vivo expression experiments reveal epitope-tagged YY1 assembled into high molecular mass mRNPs, and assembly was blocked by microinjection of high affinity RNA substrate competitor. These findings present the first clues to how mRNPs assemble during early development.	[Belak, Zachery R.; Ovsenek, Nick] Univ Saskatchewan, Coll Med, Dept Anat & Cell Biol, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Ovsenek, N (corresponding author), Univ Saskatchewan, Coll Med, Dept Anat & Cell Biol, A308 Hlth Sci Bldg,107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	nick.ovsenek@usask.ca						Austen M, 1997, J BIOL CHEM, V272, P1709, DOI 10.1074/jbc.272.3.1709; BECKER KG, 1994, GENE, V150, P259, DOI 10.1016/0378-1119(94)90435-9; BOUVET P, 1994, CELL, V77, P931, DOI 10.1016/0092-8674(94)90141-4; BRADDOCK M, 1994, NUCLEIC ACIDS RES, V22, P5255, DOI 10.1093/nar/22.24.5255; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brzostowski J, 2000, EMBO J, V19, P3683, DOI 10.1093/emboj/19.14.3683; BUSHMEYER S, 1995, J BIOL CHEM, V270, P30213; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; Favot L, 2005, AM J PATHOL, V167, P1497, DOI 10.1016/S0002-9440(10)61236-9; Ficzycz A, 2002, J BIOL CHEM, V277, P8382, DOI 10.1074/jbc.M110304200; Ficzycz A, 2001, J BIOL CHEM, V276, P22819, DOI 10.1074/jbc.M011188200; Galvin KM, 1997, MOL CELL BIOL, V17, P3723, DOI 10.1128/MCB.17.7.3723; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Hiromura M, 2003, J BIOL CHEM, V278, P14046, DOI 10.1074/jbc.M300789200; Houbaviy HB, 1996, P NATL ACAD SCI USA, V93, P13577, DOI 10.1073/pnas.93.24.13577; Houbaviy HB, 2001, CHEM BIOL, V8, P179, DOI 10.1016/S1074-5521(00)90066-8; Krippner-Heidenreich A, 2005, MOL CELL BIOL, V25, P3704, DOI 10.1128/MCB.25.9.3704-3714.2005; Kwon HJ, 2003, BIOCHEM BIOPH RES CO, V306, P1008, DOI 10.1016/S0006-291X(03)01071-4; Ladomery M, 1997, NUCLEIC ACIDS RES, V25, P965, DOI 10.1093/nar/25.5.965; LEE TC, 1994, ONCOGENE, V9, P1047; Lieb B, 1998, EXP CELL RES, V245, P272, DOI 10.1006/excr.1998.4249; Lu D, 2003, NATURE, V426, P96, DOI 10.1038/nature02088; MARELLO K, 1992, NUCLEIC ACIDS RES, V20, P5593, DOI 10.1093/nar/20.21.5593; Matsumoto K, 1996, J BIOL CHEM, V271, P22706, DOI 10.1074/jbc.271.37.22706; Matsumoto K, 2000, NUCLEIC ACIDS RES, V28, P4689, DOI 10.1093/nar/28.23.4689; Minshall N, 2001, RNA, V7, P1728, DOI 10.1017/S135583820101158X; Minshall N, 2004, NUCLEIC ACIDS RES, V32, P1325, DOI 10.1093/nar/gkh303; Moller HM, 2005, J MOL BIOL, V351, P718, DOI 10.1016/j.jmb.2005.06.032; MOMOEDA M, 1995, PROTEIN EXPRES PURIF, V6, P169, DOI 10.1006/prep.1995.1021; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Morgan MJ, 2004, J BIOL CHEM, V279, P46826, DOI 10.1074/jbc.M406140200; OConnor MJ, 1996, J VIROL, V70, P6529, DOI 10.1128/JVI.70.10.6529-6539.1996; Palko L, 2004, J CELL SCI, V117, P465, DOI 10.1242/jcs.00870; Pestova TV, 2001, COLD SPRING HARB SYM, V66, P389, DOI 10.1101/sqb.2001.66.389; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Petkova V, 2001, J BIOL CHEM, V276, P7932, DOI 10.1074/jbc.M007411200; PISANESCHI G, 1994, BIOCHEM BIOPH RES CO, V205, P1236, DOI 10.1006/bbrc.1994.2797; Rincon-Arano H, 2005, J MOL BIOL, V349, P961, DOI 10.1016/j.jmb.2005.04.040; ROMANIUK PJ, 1985, NUCLEIC ACIDS RES, V13, P5369, DOI 10.1093/nar/13.14.5369; Satijn DPE, 2001, MOL CELL BIOL, V21, P1360, DOI 10.1128/MCB.21.4.1360-1369.2001; SETO E, 1993, NATURE, V365, P462, DOI 10.1038/365462a0; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; SHI Y, 1997, BIOCHIM BIOPHYS ACTA, V1332, P49; SHRIVASTAVA A, 1993, SCIENCE, V262, P1889, DOI 10.1126/science.8266081; Tanaka KJ, 2006, J BIOL CHEM, V281, P40096, DOI 10.1074/jbc.M609059200; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Wang CY, 2004, J BIOL CHEM, V279, P17750, DOI 10.1074/jbc.M310532200; Yang WH, 2006, RNA, V12, P547, DOI 10.1261/rna.2302706; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Yao YL, 2001, MOL CELL BIOL, V21, P5979, DOI 10.1128/MCB.21.17.5979-5991.2001; Yurkova MS, 1997, J BIOL CHEM, V272, P10870	54	18	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37913	37920		10.1074/jbc.M708057200	http://dx.doi.org/10.1074/jbc.M708057200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17974562	hybrid			2022-12-25	WOS:000251833600067
J	Clark, MB; Janicke, M; Gottesbuhren, U; Kleffmann, T; Legge, M; Poole, ES; Tate, WP				Clark, Michael B.; Jaenicke, Martina; Gottesbuehren, Undine; Kleffmann, Torsten; Legge, Michael; Poole, Elizabeth S.; Tate, Warren P.			Mammalian gene PEG10 expresses two reading frames by high efficiency-1 frameshifting in embryonic-associated tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LTR RETROTRANSPOSONS; ESCHERICHIA-COLI; MESSENGER-RNAS; PROTEINS; GAG; POL; IDENTIFICATION; ALIGNMENT; HIV-1; SEQUENCES	Paternally expressed gene 10 ( PEG10) is a mammalian gene that is essential for embryonic development in mice. The gene contains two overlapping open reading frames ( ORF1 and ORF2) and is derived from a retroelement that acquired a cellular function. It is not known if both reading frames are required for PEG10 function. Synthesis of ORF2 would be possible only if programmed-1 frameshifting occurred during ORF1 translation. In this study the frameshifting activity of PEG10 was analyzed in vivo, and a potential role for ORF2 was investigated. Phylogenetic analysis demonstrated that PEG10 is highly conserved in therian mammals, with all species retaining the elements necessary for frameshifting as well as functional motifs in each ORF. The frameshift site of PEG10 was highly active in cultured cells and produced the ORF1-2 protein. In mice, endogenous ORF1 and an ORF1-2 frameshift protein were detected in the developing placenta and amniotic membrane from 9.5 days post-coitus through to term with a very high frameshift efficiency (> 60%). Mutagenesis of the active site motif of a putative protease within ORF2 showed that this enzyme is active and participates in post-translational processing of PEG10 ORF1-2. Both PEG10 proteins were also detected in first trimester human placenta. By contrast, neither protein expression nor frameshifting was detected in adult mouse tissues. These studies imply that the ORF1-2 protein, synthesized utilizing the most efficient-1 frameshift mechanism yet documented in vivo, will have an essential function that is intrinsic to the importance of PEG10 in mammals.	[Clark, Michael B.; Jaenicke, Martina; Gottesbuehren, Undine; Kleffmann, Torsten; Legge, Michael; Poole, Elizabeth S.; Tate, Warren P.] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand	University of Otago	Tate, WP (corresponding author), Univ Otago, Dept Biochem, PO Box 56, Dunedin 9054, New Zealand.	warren.tate@stonebow.otago.ac.nz		Kleffmann, Torsten/0000-0001-9305-5980; Clark, Michael/0000-0002-2903-9537; Tate, Warren/0000-0002-6971-7734				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt J, 2005, GENE, V345, P101, DOI 10.1016/j.gene.2004.11.022; Brandt J, 2005, CYTOGENET GENOME RES, V110, P307, DOI 10.1159/000084963; Brierley I, 2006, VIRUS RES, V119, P29, DOI 10.1016/j.virusres.2005.10.008; Butler M, 2001, J MOL EVOL, V52, P260, DOI 10.1007/s002390010154; Campillos M, 2006, TRENDS GENET, V22, P585, DOI 10.1016/j.tig.2006.09.006; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cobucci-Ponzano B, 2006, NUCLEIC ACIDS RES, V34, P4258, DOI 10.1093/nar/gkl574; CRAIGEN WJ, 1985, P NATL ACAD SCI USA, V82, P3616, DOI 10.1073/pnas.82.11.3616; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Freyer C, 2002, J ANAT, V201, P101, DOI 10.1046/j.1469-7580.2002.00084.x; Gao X, 2003, RNA, V9, P1422, DOI 10.1261/rna.5105503; GESTELAND RF, 1992, SCIENCE, V257, P1640, DOI 10.1126/science.1529352; Hill M, 2005, CURR HIV RES, V3, P73, DOI 10.2174/1570162052772942; Hu CS, 2006, J IMMUNOL, V177, P6713, DOI 10.4049/jimmunol.177.10.6713; Ingr M, 2003, PROTEIN SCI, V12, P2173, DOI 10.1110/ps.03171903; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; Jacobs JL, 2007, NUCLEIC ACIDS RES, V35, P165, DOI 10.1093/nar/gkl1033; Kaufman M. H., 2001, ATLAS MOUSE DEV; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kikuno R, 1999, DNA Res, V6, P197, DOI 10.1093/dnares/6.3.197; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Li CM, 2006, CANCER RES, V66, P665, DOI 10.1158/0008-5472.CAN-05-1553; Lux A, 2005, J BIOL CHEM, V280, P8482, DOI 10.1074/jbc.M409197200; Manktelow E, 2005, NUCLEIC ACIDS RES, V33, P1553, DOI 10.1093/nar/gki299; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Namy O, 2004, MOL CELL, V13, P157, DOI 10.1016/S1097-2765(04)00031-0; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; O'Rahilly R., 1987, DEV STAGES HUMAN EMB; Okabe H, 2003, CANCER RES, V63, P3043; Ono R, 2006, NAT GENET, V38, P101, DOI 10.1038/ng1699; Ono R, 2003, GENOME RES, V13, P1696, DOI 10.1101/gr.906803; Ono R, 2001, GENOMICS, V73, P232, DOI 10.1006/geno.2001.6494; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Scarlett DJG, 2003, J BIOL CHEM, V278, P15095, DOI 10.1074/jbc.M211024200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shigemoto K, 2001, NUCLEIC ACIDS RES, V29, P4079, DOI 10.1093/nar/29.19.4079; Smallwood A, 2003, BIOL REPROD, V69, P286, DOI 10.1095/biolreprod.102.013078; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Suzuki S, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030055; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Volff JN, 2001, MOL BIOL EVOL, V18, P266, DOI 10.1093/oxfordjournals.molbev.a003801; Wills NM, 2006, J BIOL CHEM, V281, P7082, DOI 10.1074/jbc.M511629200; Zhang FW, 2007, J ANIM SCI, V85, P886, DOI 10.2527/jas.2006-278	48	63	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37359	37369		10.1074/jbc.M705676200	http://dx.doi.org/10.1074/jbc.M705676200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17942406	hybrid			2022-12-25	WOS:000251833600010
J	Smith, BC; Denu, JM				Smith, Brian C.; Denu, John M.			Acetyl-lysine analog peptides as mechanistic probes of protein deacetylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIR2 HISTONE/PROTEIN DEACETYLASES; HISTONE DEACETYLASE; ADP-RIBOSYLTRANSFERASE; NAD(+)-DEPENDENT DEACETYLASES; DEPENDENT DEACETYLASE; TRANSCRIPTION FACTORS; CALORIE RESTRICTION; CELL-SURVIVAL; NAD; FAMILY	Class III histone deacetylases (Sir2 or sirtuins) catalyze the NAD(+) -dependent conversion of acetyl-lysine residues to nicotinamide, 2 '-O-acetyl-ADP-ribose (OAADPr), and deacetylated lysine. Class I and II HDACs utilize a different deacetylation mechanism, utilizing an active site zinc to direct hydrolysis of acetyl-lysine residues to lysine and acetate. Here, using ten acetyl-lysine analog peptides, we have probed the substrate binding pockets of sirtuins and investigated the catalytic differences among sirtuins and class I and II deacetylases. For the sirtuin Hst2, acetyl-lysine analog peptide binding correlated with the hydrophobic substituent parameter pi with a slope of -0.35 from a plot of log K-d versus pi. Interestingly, propionyl-and butyryl-lysine peptides were found to bind tighter to Hst2 compared with acetyl-lysine peptide and showed measurable rates of catalysis with Hst2, Sirt1, Sirt2, and Sirt3, suggesting propionyl- and butyryl-lysine proteins may be sirtuin substrates in vivo. Unique among the acetyl-lysine analog peptides examined, homocitrulline peptide produced ADP-ribose instead of the corresponding OAADPr analog. The electron-withdrawing nature of each acetyl analog had a profound impact on the deacylation rate between deacetylase classes. The rate of catalysis with the acetyl-lysine analog peptides varied over five orders of magnitude with the class III deacetylase Hst2, revealing a linear free energy relationship with a slope of -1.57 when plotted versus the Taft constant, sigma*. HDAC8, a class I deacetylase, displayed the opposite trend with a slope of +0.79. These results are applicable toward the development of selective substrates and other mechanistic probes of protein deacetylases.	[Smith, Brian C.] Univ Wisconsin Madison, Dept Chem, Madison, WI 53706 USA; [Denu, John M.] Univ Wisconsin Madison, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Smith, BC (corresponding author), Univ Wisconsin Madison, Dept Chem, Madison, WI 53706 USA.		Smith, Brian C/D-9949-2013	Smith, Brian C/0000-0001-6330-2768	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065386, T32GM008349] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM065386, 5 T32 GM08349] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P623, DOI 10.1021/bi602513x; Blair DE, 2006, BIOCHEMISTRY-US, V45, P9416, DOI 10.1021/bi0606694; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Borra MT, 2004, METHOD ENZYMOL, V376, P171; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Borra MT, 2002, J BIOL CHEM, V277, P12632, DOI 10.1074/jbc.M111830200; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Cho CH, 1999, J PHYS CHEM B, V103, P1991, DOI 10.1021/jp9842953; CLELAND WW, 1975, BIOCHEMISTRY-US, V14, P3220, DOI 10.1021/bi00685a029; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Garcia-Salcedo JA, 2003, EMBO J, V22, P5851, DOI 10.1093/emboj/cdg553; GARRITY J, 2007, J BIOL CHEM; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hansch C, 1979, SUBSTITUENT CONSTANT; Holbert MA, 2005, CURR OPIN STRUC BIOL, V15, P673, DOI 10.1016/j.sbi.2005.10.006; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jackson AD, 2002, J BIOL CHEM, V277, P18535, DOI 10.1074/jbc.M200671200; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; JONES CS, 1980, J BIOL CHEM, V255, P1861; Khan AN, 2006, J BIOL CHEM, V281, P11702, DOI 10.1074/jbc.M511482200; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lee H, 2004, MOL CELL BIOL, V24, P765, DOI 10.1128/MCB.24.2.765-773.2004; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Macauley MS, 2005, J AM CHEM SOC, V127, P17202, DOI 10.1021/ja0567687; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; OPPENHEIMER NJ, 1978, FEBS LETT, V94, P368, DOI 10.1016/0014-5793(78)80979-X; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sauve AA, 2003, BIOCHEMISTRY-US, V42, P9249, DOI 10.1021/bi034959l; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Smith BC, 2006, BIOCHEMISTRY-US, V45, P272, DOI 10.1021/bi052014t; Smith BC, 2007, J AM CHEM SOC, V129, P5802, DOI 10.1021/ja070162w; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vocadlo DJ, 2005, BIOCHEMISTRY-US, V44, P12809, DOI 10.1021/bi051121k; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhao KH, 2004, P NATL ACAD SCI USA, V101, P8563, DOI 10.1073/pnas.0401057101	58	111	113	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37256	37265		10.1074/jbc.M707878200	http://dx.doi.org/10.1074/jbc.M707878200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17951578	hybrid			2022-12-25	WOS:000251646000051
J	Cao, DF; Lu, HL; Lewis, TL; Li, L				Cao, Dongfeng; Lu, Hailin; Lewis, Terry L.; Li, Ling			Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIABETES-MELLITUS; LEARNING-DEFICITS; US CHILDREN; HIGH-FAT; IN-VIVO; DIET; MICE; OBESITY; PRESENILINS; PROTEIN	Compelling evidence indicates that excess consumption of sugar-sweetened beverages plays an important role in the epidemic of obesity, a major risk factor for type 2 diabetes mellitus. Type 2 diabetes mellitus has been associated with a higher incidence of Alzheimer disease (AD). High fat diets promote AD-like pathology in mice. It is not known whether consumption of excess sugar as in calorically sweetened beverages with an otherwise normal diet affects the development of AD. In the present study, we provided 10% sucrose-sweetened water to a transgenic mouse model of AD with a normal rodent diet. Compared with the control mice with no sucrose added in the water, the sucrose group gained more body weight and developed glucose intolerance, hyperinsulinemia, and hypercholesterolemia. These metabolic changes were associated with the exacerbation of memory impairment and a 2 -3-fold increase in insoluble amyloid-beta protein levels and deposition in the brain. We further showed that the levels of expression and secretase-cleaved products of amyloid-beta precursor protein were not affected by sucrose intake. The steady-state levels of insulin-degrading enzyme did not change significantly, whereas there was a 2.5-fold increase in brain apoE levels. Therefore, we concluded that the up-regulation of apoE accelerated the aggregation of A beta, resulting in the exacerbation of cerebral amyloidosis in sucrose-treated mice. These data underscore the potential role of dietary sugar in the pathogenesis of AD and suggest that controlling the consumption of sugar-sweetened beverages may be an effective way to curtail the risk of developing AD.	Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Li, L (corresponding author), 1808 7th Ave S,BDB 658, Birmingham, AL 35294 USA.	lili@uab.edu		Li, Ling/0000-0002-9245-7387	NIA NIH HHS [AG025949] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R21AG025949] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AOYAMA Y, 1974, J NUTR, V104, P741, DOI 10.1093/jn/104.6.741; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Black RNA, 2006, DIABETES, V55, P3566, DOI 10.2337/db06-0220; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Cao DF, 2006, NEUROBIOL AGING, V27, P1632, DOI 10.1016/j.neurobiolaging.2005.09.011; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; FRAYN KN, 1995, AM J CLIN NUTR, V62, p250S, DOI 10.1093/ajcn/62.1.250S; Gonsolin D, 2007, MOL CELL BIOCHEM, V295, P217, DOI 10.1007/s11010-006-9291-7; Grundy SM, 1998, AM J CLIN NUTR, V67, p563S, DOI 10.1093/ajcn/67.3.563S; Haan MN, 2006, NAT CLIN PRACT NEURO, V2, P159, DOI 10.1038/ncpneuro0124; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Holtzman DM, 2000, ANN NEUROL, V47, P739, DOI 10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kiens B, 1996, AM J CLIN NUTR, V63, P47, DOI 10.1093/ajcn/63.1.47; Leibson CL, 1997, AM J EPIDEMIOL, V145, P301; Levin-Allerhand J A, 2002, J Nutr Health Aging, V6, P315; Li L, 2003, AM J PATHOL, V163, P2155, DOI 10.1016/S0002-9440(10)63572-9; Li L, 2006, ANN NEUROL, V60, P729, DOI 10.1002/ana.21053; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Marckmann P, 2000, METABOLISM, V49, P731, DOI 10.1053/meta.2000.6237; Mattson MP, 2003, ANN INTERN MED, V139, P441, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00012; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Pedersen WA, 2006, EXP NEUROL, V199, P265, DOI 10.1016/j.expneurol.2006.01.018; PFEUFFER M, 1992, J NUTR, V122, P1582, DOI 10.1093/jn/122.7.1582; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; REISER S, 1979, AM J CLIN NUTR, V32, P2206, DOI 10.1093/ajcn/32.11.2206; Ryu MH, 2003, J BIOCHEM MOL BIOL, V36, P312; Selkoe DJ, 2000, NEUROL CLIN, V18, P903, DOI 10.1016/S0733-8619(05)70232-2; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Shie FS, 2002, NEUROREPORT, V13, P455, DOI 10.1097/00001756-200203250-00019; Stolk RP, 1997, DIABETES CARE, V20, P792, DOI 10.2337/diacare.20.5.792; STROBL W, 1989, J BIOL CHEM, V264, P1190; Sumiyoshi M, 2006, J NUTR, V136, P582, DOI 10.1093/jn/136.3.582; WALLUM BJ, 1987, J CLIN ENDOCR METAB, V64, P190, DOI 10.1210/jcem-64-1-190; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5	41	263	266	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36275	36282		10.1074/jbc.M703561200	http://dx.doi.org/10.1074/jbc.M703561200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17942401	hybrid			2022-12-25	WOS:000251458300018
J	Edlich, F; Maestre-Martinez, M; Jarczowski, F; Weiwad, M; Moutty, MC; Malesevic, M; Jahreis, G; Fischer, G; Lucke, C				Edlich, Frank; Maestre-Martinez, Mitcheell; Jarczowski, Franziska; Weiwad, Matthias; Moutty, Marie-Christine; Malesevic, Miroslav; Jahreis, Gunther; Fischer, Gunter; Luecke, Christian			A novel calmodulin-Ca2+ target recognition activates the Bcl-2 regulator FKBP38	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; BINDING DOMAIN; INTACT-CELLS; CALCIUM; STIMULATION; SEQUENCE; BRAIN; NEUROMODULIN; COMPLEX; CYCLASE	The FK506-binding protein 38 (FKBP38) affects neuronal apoptosis control by suppressing the anti-apoptotic function of Bcl-2. The direct interaction between FKBP38 and Bcl-2, however, requires a prior activation of FKBP38 by the Ca2+ sensor calmodulin (CaM). Here we demonstrate for the first time that the formation of a complex between FKBP38 and CaM-Ca2+ involves two separate interaction sites, thus revealing a novel scenario of target protein regulation by CaM-Ca2+. The C-terminal FKBP38 residues Ser(290)-Asn(313) bind to the target protein-binding cleft of the Ca2+-coordinated C-terminal CaM domain, thereby enabling the N-terminal CaM domain to interact with the catalytic domain of FKBP38 in a Ca2+-independent manner. Only the latter interaction between the catalytic FKBP38 domain and the N-terminal CaM domain activates FKBP38 and, as a consequence, also regulates Bcl-2.	Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Germany	Max Planck Society	Fischer, G (corresponding author), Max Planck Res Unit Enzymol Prot Folding, Weinbergweg 22, D-06120 Halle, Germany.	fischer@enzyme-halle.mpg.de	Malesevic, Miroslav/D-8128-2012	Malesevic, Miroslav/0000-0002-1484-3709				Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; BAUDIER J, 1991, J BIOL CHEM, V266, P229; Black DJ, 2004, CELL CALCIUM, V35, P415, DOI 10.1016/j.ceca.2003.10.005; Brokx RD, 2001, J BIOL CHEM, V276, P14083, DOI 10.1074/jbc.M011026200; Bulgakov OV, 2004, DEVELOPMENT, V131, P2149, DOI 10.1242/dev.01122; CHAPMAN ER, 1991, J BIOL CHEM, V266, P207; CHAZIN WJ, 1995, NAT STRUCT BIOL, V2, P707, DOI 10.1038/nsb0995-707; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Edlich F, 2007, J BIOL CHEM, V282, P15341, DOI 10.1074/jbc.M611594200; Edlich F, 2006, J BIOL CHEM, V281, P14961, DOI 10.1074/jbc.M600452200; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; GREENLEE DV, 1982, BIOCHEMISTRY-US, V21, P2759, DOI 10.1021/bi00540a028; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Griffith LC, 2004, J NEUROSCI, V24, P8394, DOI 10.1523/JNEUROSCI.3604-04.2004; GUERINI D, 1984, J BIOL CHEM, V259, P5172; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Maestre-Martinez M, 2006, J BIOMOL NMR, V34, P197, DOI 10.1007/s10858-006-0018-6; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; POTTER JD, 1983, METHOD ENZYMOL, V102, P135; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Romoser VA, 1997, J BIOL CHEM, V272, P13270, DOI 10.1074/jbc.272.20.13270; Rosner M, 2003, ONCOGENE, V22, P4786, DOI 10.1038/sj.onc.1206776; Sinars CR, 2003, P NATL ACAD SCI USA, V100, P868, DOI 10.1073/pnas.0231020100; TESHIMA Y, 1978, J CYCLIC NUCL PROT, V4, P219; Tran QK, 2003, J BIOL CHEM, V278, P24247, DOI 10.1074/jbc.C300165200; Ulmer TS, 2003, J BIOL CHEM, V278, P29261, DOI 10.1074/jbc.M302837200; Wu BL, 2004, P NATL ACAD SCI USA, V101, P8348, DOI 10.1073/pnas.0305969101; YAMAKI T, 1980, BIOCHEM BIOPH RES CO, V94, P727, DOI 10.1016/0006-291X(80)91293-0; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758	36	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36496	36504		10.1074/jbc.M705061200	http://dx.doi.org/10.1074/jbc.M705061200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17942410	hybrid			2022-12-25	WOS:000251458300042
J	Gomez, MA; Li, S; Tremblay, ML; Olivier, M				Gomez, Maria Adelaida; Li, Samantha; Tremblay, Michel L.; Olivier, Martin			NRAMP-1 expression modulates protein-tyrosine phosphatase activity in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; NATURAL-RESISTANCE; INTRACELLULAR PARASITES; MURINE LEISHMANIASIS; REVERSIBLE OXIDATION; NEGATIVE REGULATOR; GENETIC-REGULATION; INNATE RESISTANCE; BALB/C MICE; IFN-GAMMA	NRAMP-1 (natural resistance-associated macrophage protein1) has been associated with innate resistance to unrelated intracellular pathogen infections, up-regulation of proinflammatory phagocyte functions, and susceptibility to autoimmune diseases. It is still unclear how the divalent cation transport function of NRAMP-1 accounts for the associated pleiotropic effects. In this study, we evaluated the impact of murine macrophage NRAMP-1 expression on the activity of protein-tyrosine phosphatases (PTPs) as an upstream event contributing to the NRAMP-1 regulation of signal transduction and control of effector macrophage functions. Functional expression of NRAMP-1 results in lower macrophage PTP activity and increased protein phosphorylation. Decreased PTP activity is not a result of changes in protein expression but rather a reversible regulatory mechanism involving the interaction with NRAMP-1 metal substrates. In the context of intracellular infections, NRAMP-1 expression prevents full macrophage PTP induction by Leishmania infection, correlating with higher nitric oxide production and lower parasite survival. We suggest that NRAMP-1 divalent cation transport leads to transient inhibition of PTPs via direct PTP-metal interaction and/or by reactive oxygen species-dependent PTP oxidation, consequently promoting positive signal transduction, as a backbone for the induction of proinflammatory phagocyte functions.	McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; McGill Univ, Dept Med, Montreal, PQ H3A 2B4, Canada; McGill Univ, Ctr Hlth, Ctr Study Host Resistance, Montreal, PQ H3G 1A4, Canada; McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Olivier, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Duff Med Bldg,Rm 610,3775 Univ St, Montreal, PQ H3A 2B4, Canada.	martin.olivier@mcgill.ca		Gomez, Maria Adelaida/0000-0001-8792-1563				Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Atkinson PGP, 1999, IMMUNOLOGY, V96, P656; BARRERA LF, 1994, IMMUNOLOGY, V82, P457; Barrera LF, 1997, MOL IMMUNOL, V34, P343, DOI 10.1016/S0161-5890(97)00018-7; BARTON CH, 1995, MOL MED, V1, P267, DOI 10.1007/BF03401551; Bisti S, 2000, EUR J IMMUNOL, V30, P3732, DOI 10.1002/1521-4141(200012)30:12&lt;3732::AID-IMMU3732&gt;3.0.CO;2-D; Bisti S, 2006, MICROBES INFECT, V8, P1473, DOI 10.1016/j.micinf.2006.01.004; Blackwell JM, 1999, IMMUNOL LETT, V65, P73, DOI 10.1016/S0165-2478(98)00127-8; Blackwell JM, 2004, MOL B INT U, P53; BLACKWELL JM, 1991, IMMUNOL LETT, V30, P241, DOI 10.1016/0165-2478(91)90032-6; Blanchette J, 1999, EUR J IMMUNOL, V29, P3737, DOI 10.1002/(SICI)1521-4141(199911)29:11&lt;3737::AID-IMMU3737&gt;3.0.CO;2-S; BLISKA JB, 1992, J EXP MED, V176, P1625, DOI 10.1084/jem.176.6.1625; BLISKA JB, 1993, TRENDS GENET, V9, P85, DOI 10.1016/0168-9525(93)90229-B; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown DH, 1997, INFECT IMMUN, V65, P597, DOI 10.1128/IAI.65.2.597-603.1997; BRUN R, 1979, ACTA TROP, V36, P289; BURRIDGE K, 1995, ANAL BIOCHEM, V232, P56, DOI 10.1006/abio.1995.9961; BUSCHMAN E, 1988, IMMUNOL LETT, V19, P199, DOI 10.1016/0165-2478(88)90143-5; Canonne-Hergaux F, 2002, BLOOD, V100, P268, DOI 10.1182/blood.V100.1.268; Cote JF, 2002, J BIOL CHEM, V277, P2973, DOI 10.1074/jbc.M106428200; CROCKER PR, 1984, INFECT IMMUN, V43, P1033, DOI 10.1128/IAI.43.3.1033-1040.1984; DECHASTELLIER C, 1993, INFECT IMMUN, V61, P3775, DOI 10.1128/IAI.61.9.3775-3784.1993; DENIS M, 1988, CLIN EXP IMMUNOL, V73, P370; DeVinney R, 2000, TRENDS MICROBIOL, V8, P29, DOI 10.1016/S0966-842X(99)01657-1; Forbes JR, 2003, BLOOD, V102, P1884, DOI 10.1182/blood-2003-02-0425; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Forget G, 2005, EUR J IMMUNOL, V35, P1906, DOI 10.1002/eji.200526037; Forget G, 2001, EUR J IMMUNOL, V31, P3185, DOI 10.1002/1521-4141(200111)31:11&lt;3185::AID-IMMU3185&gt;3.0.CO;2-J; Forget G, 2006, INFECT IMMUN, V74, P6272, DOI 10.1128/IAI.00853-05; Frehel C, 2002, CELL MICROBIOL, V4, P541, DOI 10.1046/j.1462-5822.2002.00213.x; Fritsche G, 2003, J IMMUNOL, V171, P1994, DOI 10.4049/jimmunol.171.4.1994; Furuya T, 1998, MOL BIOCHEM PARASIT, V92, P339, DOI 10.1016/S0166-6851(97)00246-6; Goswami T, 2001, BIOCHEM J, V354, P511, DOI 10.1042/0264-6021:3540511; Govoni G, 1999, INFECT IMMUN, V67, P2225, DOI 10.1128/IAI.67.5.2225-2232.1999; GROS P, 1981, J IMMUNOL, V127, P2417; Gruenheid S, 1997, J EXP MED, V185, P717, DOI 10.1084/jem.185.4.717; Haase H, 2005, J TRACE ELEM MED BIO, V19, P37, DOI 10.1016/j.jtemb.2005.02.004; Haase H, 2005, BIOMETALS, V18, P333, DOI 10.1007/s10534-005-3707-9; Haase H, 2003, EXP CELL RES, V291, P289, DOI 10.1016/S0014-4827(03)00406-3; Hackam DJ, 1998, J EXP MED, V188, P351, DOI 10.1084/jem.188.2.351; Heinonen KM, 2006, P NATL ACAD SCI USA, V103, P2776, DOI 10.1073/pnas.0508563103; Ibarra-Sanchez MD, 2001, ONCOGENE, V20, P4728, DOI 10.1038/sj.onc.1204648; Jabado N, 2000, J EXP MED, V192, P1237, DOI 10.1084/jem.192.9.1237; Jaramillo M, 2005, J IMMUNOL, V174, P475, DOI 10.4049/jimmunol.174.1.475; Kissler S, 2006, NAT GENET, V38, P479, DOI 10.1038/ng1766; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; Lafuse WP, 2000, BIOCHEM J, V351, P687, DOI 10.1042/0264-6021:3510687; Lafuse WP, 2002, CELL IMMUNOL, V215, P195, DOI 10.1016/S0008-8749(02)00026-6; Lahti A, 2000, J PHARMACOL EXP THER, V294, P1188; LISSNER CR, 1983, J IMMUNOL, V131, P3006; Markova B, 2005, METHODS, V35, P22, DOI 10.1016/j.ymeth.2004.07.004; Matte C, 2000, EUR J IMMUNOL, V30, P2555, DOI 10.1002/1521-4141(200009)30:9&lt;2555::AID-IMMU2555&gt;3.0.CO;2-X; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Olivier M, 1998, EUR J BIOCHEM, V251, P734, DOI 10.1046/j.1432-1327.1998.2510734.x; OLIVIER M, 1987, INFECT IMMUN, V55, P467, DOI 10.1128/IAI.55.2.467-471.1987; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Olivier M, 1998, J BIOL CHEM, V273, P13944, DOI 10.1074/jbc.273.22.13944; Picard V, 2000, J BIOL CHEM, V275, P35738, DOI 10.1074/jbc.M005387200; POSNER BI, 1994, J BIOL CHEM, V269, P4596; Richer E, 2004, MOL B INT U, P178; ROACH TIA, 1994, INFECT IMMUN, V62, P1176, DOI 10.1128/IAI.62.4.1176-1184.1994; ROACH TIA, 1991, INFECT IMMUN, V59, P3935, DOI 10.1128/IAI.59.11.3935-3944.1991; Rojas M, 1999, J IMMUNOL, V162, P6122; Roy G, 2000, MOL BIOCHEM PARASIT, V110, P195, DOI 10.1016/S0166-6851(00)00270-X; Saxena M, 2000, SEMIN IMMUNOL, V12, P387, DOI 10.1006/smim.2000.0219; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; Stoker AW, 2005, J ENDOCRINOL, V185, P19, DOI 10.1677/joe.1.06069; Suh SJ, 2006, ARCH BIOCHEM BIOPHYS, V447, P136, DOI 10.1016/j.abb.2006.01.016; Teixeira JE, 2002, INFECT IMMUN, V70, P1816, DOI 10.1128/IAI.70.4.1816-1823.2002; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; VIDAL S, 1995, J LEUKOCYTE BIOL, V58, P382, DOI 10.1002/jlb.58.4.382; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; Wojciechowski W, 1999, J IMMUNOL, V163, P2688; XIE QW, 1994, J BIOL CHEM, V269, P4705; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X; You M, 1999, MOL CELL BIOL, V19, P2416, DOI 10.1128/mcb.19.3.2416; Zwilling BS, 1999, INFECT IMMUN, V67, P1386, DOI 10.1128/IAI.67.3.1386-1392.1999	86	27	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36190	36198		10.1074/jbc.M703140200	http://dx.doi.org/10.1074/jbc.M703140200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17942403	hybrid			2022-12-25	WOS:000251458300008
J	List, K; Currie, B; Scharschmidt, TC; Szabo, R; Shireman, J; Molinolo, A; Cravatt, BF; Segre, J; Bugge, TH				List, Karin; Currie, Brooke; Scharschmidt, Tiffany C.; Szabo, Roman; Shireman, Jessica; Molinolo, Alfredo; Cravatt, Benjamin F.; Segre, Julia; Bugge, Thomas H.			Autosomal ichthyosis with hypotrichosis syndrome displays low matriptase proteolytic activity and is phenocopied in ST14 hypomorphic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE SERINE-PROTEASE; EPIDERMAL BARRIER FUNCTION; NETHERTON-SYNDROME; FILAGGRIN; SKIN; DIFFERENTIATION; CANCER; PROFILAGGRIN; DEGRADATION; INITIATION	Human autosomal recessive ichthyosis with hypotrichosis (ARIH) is an inherited disorder recently linked to homozygosity for a point mutation in the ST14 gene that causes a G827R mutation in the matriptase serine protease domain (G216 in chymotrypsin numbering). Here we show that human G827R matriptase has strongly reduced proteolytic activity toward small molecule substrates, as well as toward its candidate epidermal target, prostasin. To further investigate the possible contribution of low matriptase activity to ARIH, we generated an ST14 hypomorphic mouse strain that displays a 100-fold reduction in epidermal matriptase mRNA levels. Interestingly, unlike ST14 null mice, ST14 hypomorphic mice were viable and fertile but displayed a spectrum of abnormalities that strikingly resembled ARIH. Thus, ST14 hypomorphic mice developed hyperproliferative and retention ichthyosis with impaired desquamation, hypotrichosis with brittle, thin, uneven, and sparse hair, and tooth defects. Biochemical analysis of ST14 hypomorphic epidermis revealed reduced prostasin proteolytic activation and profilaggrin proteolytic processing, compatible with a primary role of matriptase in this process. This work strongly indicates that reduced activity of a matriptase-prostasin proteolytic cascade is the etiological origin of human ARIH and provides an important mouse model for the exploration of matriptase function in ARIH, as well as multiple other physiological and pathological processes.	NIDCR, Proteases & Tissue Remodeling Unit, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; NHGRI, NIH, Bethesda, MD 20892 USA; Howard Hughes Med Inst, Res Scholars Program, Chevy Chase, MD 20815 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Howard Hughes Medical Institute; Scripps Research Institute; Scripps Research Institute	Bugge, TH (corresponding author), NIDCR, Proteases & Tissue Remodeling Unit, Oral & Pharyngeal Canc Branch, NIH, 30 Convent Dr,Rm 211, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov		Scharschmidt, Tiffany/0000-0001-5517-089X	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000180, ZIAHG000180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000699] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; Basel-Vanagaite L, 2007, AM J HUM GENET, V80, P467, DOI 10.1086/512487; Bhatt AS, 2007, P NATL ACAD SCI USA, V104, P5771, DOI 10.1073/pnas.0606514104; Bugge TH, 2007, FRONT BIOSCI-LANDMRK, V12, P5060, DOI 10.2741/2448; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Chen LM, 2001, J BIOL CHEM, V276, P21434, DOI 10.1074/jbc.M011423200; CRAIK CS, 1985, SCIENCE, V228, P291, DOI 10.1126/science.3838593; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Dreher F, 1998, ACTA DERM-VENEREOL, V78, P186; Egelrud T, 2000, ACTA DERM-VENEREOL, P44; Friedrich R, 2002, J BIOL CHEM, V277, P2160, DOI 10.1074/jbc.M109830200; Hewett DR, 2005, HUM MOL GENET, V14, P335, DOI 10.1093/hmg/ddi030; Hobson JP, 2004, J BIOL CHEM, V279, P46981, DOI 10.1074/jbc.M403299200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jessani N, 2002, P NATL ACAD SCI USA, V99, P10335, DOI 10.1073/pnas.162187599; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kim MG, 1999, IMMUNOGENETICS, V49, P420, DOI 10.1007/s002510050515; KITAMOTO Y, 1994, P NATL ACAD SCI USA, V91, P7588, DOI 10.1073/pnas.91.16.7588; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; List K, 2006, AM J PATHOL, V168, P1513, DOI 10.2353/ajpath.2006.051071; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; List K, 2006, MOL MED, V12, P1, DOI 10.2119/2006-00022.List; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; MARCHETTI G, 1993, BRIT J HAEMATOL, V84, P285, DOI 10.1111/j.1365-2141.1993.tb03066.x; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nemes Z, 1999, EXP MOL MED, V31, P5, DOI 10.1038/emm.1999.2; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Parry GCN, 1998, J CLIN INVEST, V101, P560, DOI 10.1172/JCI814; Presland RB, 2000, J INVEST DERMATOL, V115, P1072, DOI 10.1046/j.1523-1747.2000.00178.x; Presland RB, 2000, CRIT REV ORAL BIOL M, V11, P383, DOI 10.1177/10454411000110040101; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P19; RESING KA, 1984, J CELL BIOL, V99, P1372, DOI 10.1083/jcb.99.4.1372; Rogers GE, 2004, INT J DEV BIOL, V48, P163, DOI 10.1387/ijdb.15272381; ROOP D, 1995, SCIENCE, V267, P474, DOI 10.1126/science.7529942; Satomi S, 2001, BIOCHEM BIOPH RES CO, V287, P995, DOI 10.1006/bbrc.2001.5686; Segre JA, 2006, J CLIN INVEST, V116, P1150, DOI 10.1172/JCI28521; Selwood T, 2002, BIOCHEMISTRY-US, V41, P3329, DOI 10.1021/bi015662v; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Uhland K, 2006, CELL MOL LIFE SCI, V63, P2968, DOI 10.1007/s00018-006-6298-x; Yang T, 2004, GENE DEV, V18, P2354, DOI 10.1101/gad.1232104; Zeeuwen PLJM, 2004, EUR J CELL BIOL, V83, P761, DOI 10.1078/0171-9335-00388	47	76	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36714	36723		10.1074/jbc.M705521200	http://dx.doi.org/10.1074/jbc.M705521200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17940283	hybrid			2022-12-25	WOS:000251458300064
J	di Magliano, MP; Biankin, AV; Heiser, PW; Cano, DA; Gutierrez, PJA; Deramaudt, T; Segara, D; Dawson, AC; Kench, JG; Henshall, SM; Sutherland, RL; Dlugosz, A; Rustgi, AK; Hebrok, M				di Magliano, Marina Pasca; Biankin, Andrew V.; Heiser, Patrick W.; Cano, David A.; Gutierrez, Pedro J. A.; Deramaudt, Therese; Segara, Davendra; Dawson, Amanda C.; Kench, James G.; Henshall, Susan M.; Sutherland, Robert L.; Dlugosz, Andrzej; Rustgi, Anil K.; Hebrok, Matthias			Common Activation of Canonical Wnt Signaling in Pancreatic Adenocarcinoma	PLOS ONE			English	Article								Pancreatic ductal adenocarcinoma (PDA) is an extremely aggressive malignancy, which carries a dismal prognosis. Activating mutations of the Kras gene are common to the vast majority of human PDA. In addition, recent studies have demonstrated that embryonic signaling pathway such as Hedgehog and Notch are inappropriately upregulated in this disease. The role of another embryonic signaling pathway, namely the canonical Wnt cascade, is still controversial. Here, we use gene array analysis as a platform to demonstrate general activation of the canonical arm of the Wnt pathway in human PDA. Furthermore, we provide evidence for Wnt activation in mouse models of pancreatic cancer. Our results also indicate that Wnt signaling might be activated downstream of Hedgehog signaling, which is an early event in PDA evolution. Wnt inhibition blocked proliferation and induced apoptosis of cultured adenocarcinoma cells, thereby providing evidence to support the development of novel therapeutical strategies for Wnt inhibition in pancreatic adenocarcinoma.	[di Magliano, Marina Pasca; Heiser, Patrick W.; Cano, David A.; Gutierrez, Pedro J. A.; Hebrok, Matthias] Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA; [Biankin, Andrew V.; Segara, Davendra; Dawson, Amanda C.; Kench, James G.; Henshall, Susan M.; Sutherland, Robert L.] St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia; [Biankin, Andrew V.] Bankstown Hosp, Dept Surg, Sydney, NSW, Australia; [Deramaudt, Therese; Rustgi, Anil K.] Univ Penn, Dept Genet, Div Gastroenterol, Philadelphia, PA 19104 USA; [Dlugosz, Andrzej] Univ Michigan, Dept Dermatol, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of California System; University of California San Francisco; Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of Pennsylvania; University of Michigan System; University of Michigan	Hebrok, M (corresponding author), Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA.	mhebrok@diabetes.ucsf.edu	Sutherland, Robert L/A-8378-2008; Cano, David A./B-8013-2015; Dawson, Amanda Caroline/ABC-2878-2021	Cano, David A./0000-0001-6264-3288; Dawson, Amanda Caroline/0000-0003-2447-3251; Biankin, Andrew/0000-0002-0362-5597; Pasca di Magliano, Marina/0000-0001-9632-9035; Heiser, Patrick/0000-0002-8831-4973; Kench, James Geoffrey/0000-0001-8687-4988	National Pancreas Foundation; Ministerio de Educacion, Cultura y Deporte, of the Spanish Government; Juvenile Diabetes Research Foundation; NIH [DK60694, CA112537- 01]; National Health and Medical Research Council of Australia; St. Vincent's Clinic Foundation; Cancer Institute NSW; Royal Australasian College of Surgeons; R.T. Hall Trust; UCSF Comprehensive Cancer Center; Lustgarten Foundation	National Pancreas Foundation; Ministerio de Educacion, Cultura y Deporte, of the Spanish Government(Spanish Government); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); St. Vincent's Clinic Foundation; Cancer Institute NSW; Royal Australasian College of Surgeons; R.T. Hall Trust; UCSF Comprehensive Cancer Center; Lustgarten Foundation	MP is supported by a grant from the National Pancreas Foundation. DAC was supported by a postdoctoral fellowship from the Ministerio de Educacion, Cultura y Deporte, of the Spanish Government and a postdoctoral fellowship from the Juvenile Diabetes Research Foundation. Research in AKR's laboratory is supported by grants from the National Pancreas Foundation and the NIH (DK60694). Research in AVB's laboratory is supported by the National Health and Medical Research Council of Australia, the St. Vincent's Clinic Foundation, the Cancer Institute NSW, the Royal Australasian College of Surgeons and the R.T. Hall Trust. AVB and SMH are supported by Cancer Institute NSW Fellowships. Research in MH's laboratory was supported by grants from the UCSF Comprehensive Cancer Center, a Lustgarten Foundation grant, and an NIH grant (CA112537- 01).	Abraham SC, 2002, AM J PATHOL, V160, P1361, DOI 10.1016/S0002-9440(10)62563-1; Al-Aynati MM, 2004, CLIN CANCER RES, V10, P1235, DOI 10.1158/1078-0432.CCR-03-0087; Anderson CB, 2002, P NATL ACAD SCI USA, V99, P8683, DOI 10.1073/pnas.122235399; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Biankin AV, 2003, PATHOLOGY, V35, P14, DOI 10.1080/003130202201472; Biankin AV, 2001, CANCER RES, V61, P8830; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Deramaudt TB, 2006, MOL CELL BIOL, V26, P4185, DOI 10.1128/MCB.01055-05; Dessimoz J, 2005, CURR BIOL, V15, P1677, DOI 10.1016/j.cub.2005.08.037; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hebrok M, 2003, MECH DEVELOP, V120, P45, DOI 10.1016/S0925-4773(02)00331-3; Hecht A, 2000, EMBO REP, V1, P24, DOI 10.1093/embo-reports/kvd012; Heiser PW, 2006, DEVELOPMENT, V133, P2023, DOI 10.1242/dev.02366; Heller RS, 2002, DEV DYNAM, V225, P260, DOI 10.1002/dvdy.10157; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Hruban RH, 2004, AM J SURG PATHOL, V28, P977, DOI 10.1097/01.pas.0000126675.59108.80; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Jaffee EM, 1998, CANCER J SCI AM, V4, P194; Kawahira H, 2005, DEV BIOL, V280, P111, DOI 10.1016/j.ydbio.2005.01.008; KLIMSTRA DS, 1994, AM J PATHOL, V145, P1547; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Lowy AM, 2003, ANN SURG ONCOL, V10, P284, DOI 10.1245/ASO.2003.05.003; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; MURTAUGH LC, 2005, BETA CATENIN ESSENTI; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; Papadopoulou S, 2005, DIABETES, V54, P2844, DOI 10.2337/diabetes.54.10.2844; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Qualtrough D, 2004, INT J CANCER, V110, P831, DOI 10.1002/ijc.20227; ROESSLER E, 2005, HUM MOL GENET; Rozenblum E, 1997, CANCER RES, V57, P1731; RULIFSON IC, 2007, P NATL ACAD IN PRESS; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Schreiber FS, 2004, GASTROENTEROLOGY, V127, P250, DOI 10.1053/j.gastro.2004.03.058; Tago K, 2000, GENE DEV, V14, P1741; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; van den Brink GR, 2004, NAT GENET, V36, P277, DOI 10.1038/ng1304; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Verma UN, 2003, CLIN CANCER RES, V9, P1291; Wells JM, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-4; Zeng G, 2006, NEOPLASIA, V8, P279, DOI 10.1593/neo.05607	52	166	171	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1155	10.1371/journal.pone.0001155	http://dx.doi.org/10.1371/journal.pone.0001155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17982507	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459000037
J	Yesson, C; Brewer, PW; Sutton, T; Caithness, N; Pahwa, JS; Burgess, M; Gray, WA; White, RJ; Jones, AC; Bisby, FA; Culham, A				Yesson, Chris; Brewer, Peter W.; Sutton, Tim; Caithness, Neil; Pahwa, Jaspreet S.; Burgess, Mikhaila; Gray, W. Alec; White, Richard J.; Jones, Andrew C.; Bisby, Frank A.; Culham, Alastair			How Global Is the Global Biodiversity Information Facility?	PLOS ONE			English	Article								There is a concerted global effort to digitize biodiversity occurrence data from herbarium and museum collections that together offer an unparalleled archive of life on Earth over the past few centuries. The Global Biodiversity Information Facility provides the largest single gateway to these data. Since 2004 it has provided a single point of access to specimen data from databases of biological surveys and collections. Biologists now have rapid access to more than 120 million observations, for use in many biological analyses. We investigate the quality and coverage of data digitally available, from the perspective of a biologist seeking distribution data for spatial analysis on a global scale. We present an example of automatic verification of geographic data using distributions from the International Legume Database and Information Service to test empirically, issues of geographic coverage and accuracy. There are over 1/2 million records covering 31% of all Legume species, and 84% of these records pass geographic validation. These data are not yet a global biodiversity resource for all species, or all countries. A user will encounter many biases and gaps in these data which should be understood before data are used or analyzed. The data are notably deficient in many of the world's biodiversity hotspots. The deficiencies in data coverage can be resolved by an increased application of resources to digitize and publish data throughout these most diverse regions. But in the push to provide ever more data online, we should not forget that consistent data quality is of paramount importance if the data are to be useful in capturing a meaningful picture of life on Earth.	[Yesson, Chris; Brewer, Peter W.; Sutton, Tim; Caithness, Neil; Bisby, Frank A.; Culham, Alastair] Univ Reading, Plant Sci Labs, Sch Biol Sci, Reading, Berks, England; [Pahwa, Jaspreet S.; Burgess, Mikhaila; Gray, W. Alec; White, Richard J.; Jones, Andrew C.] Cardiff Univ, Sch Comp Sci, Cardiff, S Glam, Wales	University of Reading; Cardiff University	Culham, A (corresponding author), Univ Reading, Plant Sci Labs, Sch Biol Sci, Reading, Berks, England.	a.culham@reading.ac.uk	Yesson, Chris/Q-1196-2017; Burgess, Mikhaila/AAZ-2064-2021; Culham, Alastair/AAP-8192-2021	Yesson, Chris/0000-0002-6731-4229; Burgess, Mikhaila/0000-0001-6367-4676; Culham, Alastair/0000-0002-7440-0133; Caithness, Neil/0000-0002-6234-4285	BBSRC [45/BEP17792]	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	BBSRC (grant 45/BEP17792 for BiodiversityWorld) employed some authors whilst writing manuscript. University of Reading studentship for CY.	Bisby FA, 2000, SCIENCE, V289, P2309, DOI 10.1126/science.289.5488.2309; Brummitt R.K., 2001, WORLD GEOGRAPHIC SCH, V2; Chapman A.D., 2006, GUIDE BEST PRACTICES; Chapman AD., 2005, PRINCIPLES METHODS D; Edwards JL, 2004, BIOSCIENCE, V54, P485; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Lane M. A., 2007, GBIF STRATEGIC OPERA; Lughadha EN, 2005, PHILOS T ROY SOC B, V360, P359, DOI 10.1098/rstb.2004.1596; Meier R, 2004, CONSERV BIOL, V18, P478, DOI 10.1111/j.1523-1739.2004.00233.x; Mittermeier R, 2005, HOTSPOTS REVISITED E; Pennisi E, 2000, SCIENCE, V289, P2306, DOI 10.1126/science.289.5488.2306; Ponder WF, 2001, CONSERV BIOL, V15, P648, DOI 10.1046/j.1523-1739.2001.015003648.x; Roskov Y., 2005, ILDIS WORLD DATABASE; Sanchez-Cordero V, 2000, P NATL ACAD SCI USA, V97, P7074, DOI 10.1073/pnas.97.13.7074; Shaffer HB, 1998, TRENDS ECOL EVOL, V13, P27, DOI 10.1016/S0169-5347(97)01177-4; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; Wheeler QD, 2004, BIOSCIENCE, V54, P717; Yesson C, 2006, SYST BIOL, V55, P785, DOI 10.1080/1063515060081570; Yesson C, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-72	19	217	229	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1124	10.1371/journal.pone.0001124	http://dx.doi.org/10.1371/journal.pone.0001124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987112	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000207459000008
J	Cheng, C; Fabrizio, P; Ge, HY; Wei, M; Longo, VD; Li, LM				Cheng, Chao; Fabrizio, Paola; Ge, Huanying; Wei, Min; Longo, Valter D.; Li, Lei M.			Significant and Systematic Expression Differentiation in Long-Lived Yeast Strains	PLOS ONE			English	Article								Background. Recent studies suggest that the regulation of longevity may be partially conserved in many eukaryotes ranging from yeast to mammals. The three yeast mutants sch9 Delta, ras2 Delta, tor1 Delta show extended chronological life span up to three folds. Our aim is to dissect the mechanisms that lead to the yeast life span extension. Methodology/Principal Findings. We obtain gene expression profiles of sch9 Delta, ras2 Delta, tor1 Delta as well as that for a wild type at day 2.5 in SDC medium using Affymetrix Yeast2.0 arrays. To accurately estimate the expression differentiation between the wild type and the long-lived mutants, we use sub-array normalization followed by a variant of the median-polishing summarization. The results are validated by the probe sets of S. pombe on the same chips. To translate the differentiation into changes of biological activities, we make statistical inference by integrating the expression profiles with biological gene subsets defined by Gene Ontology, KEGG pathways, and cellular localization of proteins. Other than subset-versus-other comparisons, we also make local comparisons between two directly-related gene subsets such as cytosolic and mitochondrial ribosomes. Our consensus is obtained by cross-examination of these inferences. The significant and systematic differentiation in the three long-lived strains includes: lower transcriptional activities; down-regulation of TCA cycle and oxidative phosphorylation versus up-regulation of the KEGG pathway Glycolysis/Gluconeogenesis; the overall reduction of mitochondrial activities. We also report some different expression patterns such as reduction of the activities relating to mitosis in ras2 Delta. Conclusions/Significance. The modification of energy pathways and modification of compartment activities such as down-regulation of mitochondrial ribosome proteins versus up-regulation of cytosolic ribosome proteins are directly associated with the life span extension in yeast. The results provide a new and systematic S. cerevisiae version of the free radical theory from the perspective of functional genomics.	[Cheng, Chao; Ge, Huanying; Li, Lei M.] Univ So Calif, Dept Biol Sci, Mol & Computat Biol Program, Los Angeles, CA 90089 USA; [Fabrizio, Paola; Wei, Min; Longo, Valter D.] Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA; [Li, Lei M.] Univ So Calif, Dept Math, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California	Li, LM (corresponding author), Univ So Calif, Dept Biol Sci, Mol & Computat Biol Program, Los Angeles, CA 90089 USA.	lilei@usc.edu	Li, Lei M/C-7196-2009; Wei, Min/GSI-8510-2022	Li, Lei M/0000-0002-6571-1079; fabrizio, paola/0000-0002-1144-7727; Wei, Min/0000-0002-2649-9271	NIH [R01 GM75308-01, P50 HG002790]; Center of Excellence in Genome Science at University of Southern California; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075308] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Excellence in Genome Science at University of Southern California; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This work is supported by the grant R01 GM75308-01 from NIH, and is partially supported by Center of Excellence in Genome Science at University of Southern California, the NIH P50 HG002790 grant.	Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cheng C, 2005, NUCLEIC ACIDS RES, V33, P5565, DOI 10.1093/nar/gki844; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jenkins NL, 2004, P ROY SOC B-BIOL SCI, V271, P2523, DOI 10.1098/rspb.2004.2897; Kaeberlein M, 2005, MECH AGEING DEV, V126, P491, DOI 10.1016/j.mad.2004.10.007; Kaeberlein M, 2005, MECH AGEING DEV, V126, P17, DOI 10.1016/j.mad.2004.09.013; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; KIRKWOOD TBL, 1988, CIBA F SYMP, V134, P193; Kirkwood TBL, 2002, MECH AGEING DEV, V123, P737, DOI 10.1016/S0047-6374(01)00419-5; KIRKWOOD TBL, 1992, AM J CLIN NUTR, V55, P1191; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; LI LM, 2007, DNA MICROARRAY NORMA; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Longo VD, 2005, NAT REV GENET, V6, DOI 10.1038/nrg1706; MORISHITA T, 1995, SCIENCE, V270, P1213, DOI 10.1126/science.270.5239.1213; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; OZCAN S, 1995, MOL CELL BIOL, V15, P1564; Partridge L, 2001, EXP GERONTOL, V36, P641, DOI 10.1016/S0531-5565(00)00232-1; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Rea S, 2003, DEV CELL, V5, P197, DOI 10.1016/S1534-5807(03)00242-9; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; Schadt EE, 2000, J CELL BIOCHEM, V80, P192; Schneper L, 2004, EUKARYOT CELL, V3, P108, DOI 10.1128/EC.3.1.108-120.2004; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tukey JW, 1977, EXPLORATORY DATA ANA	34	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1095	10.1371/journal.pone.0001095	http://dx.doi.org/10.1371/journal.pone.0001095			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971858	Green Submitted, gold, Green Published			2022-12-25	WOS:000207458700012
J	Suwanarusk, R; Russell, B; Chavchich, M; Chalfein, F; Kenangalem, E; Kosaisavee, V; Prasetyorini, B; Piera, KA; Barends, M; Brockman, A; Lek-Uthai, U; Anstey, NM; Tjitra, E; Nosten, F; Cheng, Q; Price, RN				Suwanarusk, Rossarin; Russell, Bruce; Chavchich, Marina; Chalfein, Ferryanto; Kenangalem, Enny; Kosaisavee, Varakorn; Prasetyorini, Budi; Piera, Kim A.; Barends, Marion; Brockman, Alan; Lek-Uthai, Usa; Anstey, Nicholas M.; Tjitra, Emiliana; Nosten, Francois; Cheng, Qin; Price, Ric N.			Chloroquine Resistant Plasmodium vivax: In Vitro Characterisation and Association with Molecular Polymorphisms	PLOS ONE			English	Article							WESTERN BORDER; SULFADOXINE-PYRIMETHAMINE; MALARIA; FALCIPARUM; SENSITIVITY; PAPUA; GENE; ANTIMALARIALS; ARTEMISININ; POPULATION	Background. Treatment failure of chloroquine for P. vivax infections has reached high levels in the eastern provinces of Indonesia, however, in vitro characterization of chloroquine resistance and its associated molecular profile have yet to be determined. Methods. Using a modified schizont maturation assay we investigated the in vitro chloroquine susceptibility profile and molecular polymorphisms of P. vivax isolates collected from Papua, Indonesia, where high levels of clinical chloroquine treatment failure have been reported, and from Thailand, where chloroquine treatment is generally effective. Results. The geometric mean chloroquine IC50 for P. vivax isolates from Papua (n = 145) was 312 nM [95% CI: 237-411 nM] compared to 46.8 nM [95% CI: 34.7-63.1 nM] from Thailand (n = 81); p<0.001. Correlating with the known clinical efficacy of the area, a cut off for chloroquine resistance was defined as 220nM, a level exceeded in 13.6% (11/81) of Thai isolates and 65% (94/145) of Papuan isolates; p<0.001. Several sequence polymorphisms in pvcrt-o and pvmdr1, and difference in pvmdr1 copy number were identified. A Y976F mutation in pvmdr1 was present in 96% (123/128) of Papuan isolates and 25% (17/69) of Thai isolates; p<0.001. Overall, the geometric mean chloroquine IC50 in isolates with the Y976F mutation was 283 nM [95% CI: 211379], compared to 44.5 nM [95% CI: 31.3-63.4] in isolates with the wild type; p<0.001. Pvmdr1 amplification occurred in 23% (15/66) of Thai isolates compared to none (0/104) of Indonesian isolates (p<0.001), but was not associated with increased chloroquine resistance after controlling for geographical location. Conclusions. In vitro susceptibility testing of P. vivax discriminates between populations with differing levels of clinical efficacy of chloroquine. The pvmdr1 polymorphism at Y976F may provide a useful tool to highlight areas of emerging chloroquine resistance, although further studies defining its clinical correlates are needed.	[Suwanarusk, Rossarin; Russell, Bruce; Piera, Kim A.; Brockman, Alan; Anstey, Nicholas M.; Price, Ric N.] Menzies Sch Hlth Res, Div Infect Dis, Int Hlth Program, Darwin, NT, Australia; [Suwanarusk, Rossarin; Russell, Bruce; Piera, Kim A.; Brockman, Alan; Anstey, Nicholas M.; Price, Ric N.] Charles Darwin Univ, Darwin, NT 0909, Australia; [Chavchich, Marina; Cheng, Qin] Australian Army Malaria Inst, Dept Drug Resistance & Diagnost, Brisbane, Qld, Australia; [Chalfein, Ferryanto; Kenangalem, Enny] Natl Inst Hlth Res & Dev, Timika, Indonesia; [Chalfein, Ferryanto; Kenangalem, Enny] Menzies Sch Hlth, Malaria Res Program, Timika, Indonesia; [Kenangalem, Enny] Dist Minist Hlth, Timika, Papua, Indonesia; [Kosaisavee, Varakorn; Lek-Uthai, Usa] Mahidol Univ, Fac Publ Hlth, Dept Parasitol, Bangkok 10700, Thailand; [Prasetyorini, Budi; Tjitra, Emiliana] Minist Hlth, Natl Inst Hlth Res & Dev, Jakarta, Indonesia; [Nosten, Francois] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Barends, Marion; Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot, Tak Province, Thailand; [Price, Ric N.] John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Vaccinol & Trop Med, Oxford OX3 9DU, England	Charles Darwin University; Menzies School of Health Research; Charles Darwin University; QIMR Berghofer Medical Research Institute; National Institute of Health Research & Development - Indonesia; Ministry of Health - Indonesia; Mahidol University; Ministry of Health - Indonesia; National Institute of Health Research & Development - Indonesia; Mahidol University; Mahidol University; University of Oxford	Price, RN (corresponding author), Menzies Sch Hlth Res, Div Infect Dis, Int Hlth Program, Darwin, NT, Australia.	rnp@menzies.edu.au	Russell, Bruce/A-9240-2011; Suwanarusk, Rossarin/E-2115-2013; Nosten, Francois/AAC-5509-2019; Cheng, Qin/AAO-2198-2020	Russell, Bruce/0000-0003-2333-4348; Suwanarusk, Rossarin/0000-0002-7310-245X; Nosten, Francois/0000-0002-7951-0745; Cheng, Qin/0000-0001-7776-4437; Price, Richard/0000-0003-2000-2874	The Wellcome Trust (UK); NHMRC (Australia)	The Wellcome Trust (UK)(Wellcome Trust); NHMRC (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	Funding: The Wellcome Trust (UK) and NHMRC (Australia)	Baird JK, 2004, ANTIMICROB AGENTS CH, V48, P4075, DOI 10.1128/AAC.48.11.4075-4083.2004; BAIRD JK, 1991, AM J TROP MED HYG, V44, P547, DOI 10.4269/ajtmh.1991.44.547; Baird JK, 1996, T ROY SOC TROP MED H, V90, P409, DOI 10.1016/S0035-9203(96)90526-X; Brega S, 2005, J INFECT DIS, V191, P272, DOI 10.1086/426830; Bruce MC, 1999, AM J TROP MED HYG, V61, P518, DOI 10.4269/ajtmh.1999.61.518; Chotivanich K, 2004, AM J TROP MED HYG, V70, P395, DOI 10.4269/ajtmh.2004.70.395; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Figtree M, 2000, MOL BIOCHEM PARASIT, V108, P53, DOI 10.1016/S0166-6851(00)00204-8; Fryauff DJ, 1998, AM J TROP MED HYG, V59, P513, DOI 10.4269/ajtmh.1998.59.513; GUTHMANN JP, 2007, TROP MED IN IN PRESS; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Kurcer MA, 2006, ANN TROP MED PARASIT, V100, P109, DOI 10.1179/136485906X86284; Looareesuwan S, 1999, ANN TROP MED PARASIT, V93, P225, DOI 10.1080/00034989958474; Luxemburger C, 1999, T ROY SOC TROP MED H, V93, P433, DOI 10.1016/S0035-9203(99)90149-9; MARLARTHAN, 1995, T ROY SOC TROP MED H, V89, P307, DOI 10.1016/0035-9203(95)90556-1; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; MURPHY GS, 1993, LANCET, V341, P96, DOI 10.1016/0140-6736(93)92568-E; Nomura T, 2001, J INFECT DIS, V183, P1653, DOI 10.1086/320707; Padley D, 2003, ANN TROP MED PARASIT, V97, P131, DOI 10.1179/000349803125002977; Phan GT, 2002, TROP MED INT HEALTH, V7, P858, DOI 10.1046/j.1365-3156.2002.00948.x; Phillips EJ, 1996, CLIN INFECT DIS, V23, P1171, DOI 10.1093/clinids/23.5.1171; Price RN, 1999, ANTIMICROB AGENTS CH, V43, P2943, DOI 10.1128/AAC.43.12.2943; PRICE RN, 2007, AM J TROP M IN PRESS; Ratcliff A, 2007, LANCET, V369, P757, DOI 10.1016/S0140-6736(07)60160-3; Ratcliff A, 2007, T ROY SOC TROP MED H, V101, P351, DOI 10.1016/j.trstmh.2006.06.008; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; RIECKMANN KH, 1989, LANCET, V2, P1183, DOI 10.1016/S0140-6736(89)91792-3; Russell BM, 2003, ANTIMICROB AGENTS CH, V47, P170, DOI 10.1128/AAC.47.1.170-173.2003; Sa JM, 2005, EXP PARASITOL, V109, P256, DOI 10.1016/j.exppara.2004.12.005; Sa JM, 2006, MOL BIOCHEM PARASIT, V150, P219, DOI 10.1016/j.molbiopara.2006.08.006; Soto J, 2001, AM J TROP MED HYG, V65, P90, DOI 10.4269/ajtmh.2001.65.90; Sumawinata IW, 2003, AM J TROP MED HYG, V68, P416, DOI 10.4269/ajtmh.2003.68.416; Tasanor O, 2002, ACTA TROP, V83, P49, DOI 10.1016/S0001-706X(02)00056-6; Tjitra E, 2002, ANTIMICROB AGENTS CH, V46, P3947, DOI 10.1128/AAC.46.12.3947-3953.2002	34	161	165	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1089	10.1371/journal.pone.0001089	http://dx.doi.org/10.1371/journal.pone.0001089			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971853	Green Published, gold			2022-12-25	WOS:000207458700007
J	Cowell, IG; Sunter, NJ; Singh, PB; Austin, CA; Durkacz, BW; Tilby, MJ				Cowell, Ian G.; Sunter, Nicola J.; Singh, Prim B.; Austin, Caroline A.; Durkacz, Barbara W.; Tilby, Michael J.			gamma H2AX Foci Form Preferentially in Euchromatin after Ionising-Radiation	PLOS ONE			English	Article								Background. The histone variant histone H2A. X comprises up to 25% of the H2A complement in mammalian cells. It is rapidly phosphorylated following exposure of cells to double-strand break (DSB) inducing agents such as ionising radiation. Within minutes of DSB generation, H2AX molecules are phosphorylated in large chromatin domains flanking DNA double-strand breaks (DSBs); these domains can be observed by immunofluorescence microscopy and are termed gamma H2AX foci. H2AX phosphorylation is believed to have a role mounting an efficient cellular response to DNA damage. Theoretical considerations suggest an essentially random chromosomal distribution of X-ray induced DSBs, and experimental evidence does not consistently indicate otherwise. However, we observed an apparently uneven distribution of gamma H2AX foci following X-irradiation with regions of the nucleus devoid of foci. Methodology/Principle Findings. Using immunofluorescence microscopy, we show that focal phosphorylation of histone H2AX occurs preferentially in euchromatic regions of the genome following X-irradiation. H2AX phosphorylation has also been demonstrated previously to occur at stalled replication forks induced by UV radiation or exposure to agents such as hydroxyurea. In this study, treatment of S-phase cells with hydroxyurea lead to efficient H2AX phosphorylation in both euchromatin and heterochromatin at times when these chromatin compartments were undergoing replication. This suggests a block to H2AX phosphorylation in heterochromatin that is at least partially relieved by ongoing DNA replication. Conclusions/Significance. We discus a number of possible mechanisms that could account for the observed pattern of H2AX phosphorylation. Since gamma H2AX is regarded as forming a platform for the recruitment or retention of other DNA repair and signaling molecules, these findings imply that the processing of DSBs in heterochromatin differs from that in euchromatic regions. The differential responses of heterochromatic and euchromatic compartments of the genome to DSBs will have implications for understanding the processes of DNA repair in relation to nuclear and chromatin organization.	[Cowell, Ian G.; Sunter, Nicola J.; Austin, Caroline A.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Singh, Prim B.] Forschungszentrum, Div Tumour Biol, Borstel, Germany; [Durkacz, Barbara W.; Tilby, Michael J.] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Cowell, IG (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	i.g.cowell@ncl.ac.uk	Singh, Prim/G-1088-2014	Singh, Prim/0000-0002-9571-0974; Austin, Caroline/0000-0002-1921-5947; Cowell, Ian/0000-0002-8606-0447	Breast Cancer Campaign [2002/343]; Leukaemia Research fund [0361]; Association for International Cancer Research [05-179]	Breast Cancer Campaign; Leukaemia Research fund; Association for International Cancer Research	This work was supported by the Breast Cancer Campaign (2002/343) and the Leukaemia Research fund (0361) and the Association for International Cancer Research (05-179).	Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bassing CH, 2004, CELL CYCLE, V3, P149; BRENNER DJ, 1992, INT J RADIAT BIOL, V61, P737, DOI 10.1080/09553009214551591; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Cowell IG, 2005, BIOCHEM PHARMACOL, V71, P13, DOI 10.1016/j.bcp.2005.09.029; Cowell IG, 2002, CHROMOSOMA, V111, P22, DOI 10.1007/s00412-002-0182-8; Dimitrova DS, 1999, MOL CELL, V4, P983, DOI 10.1016/S1097-2765(00)80227-0; Fernandez-Capetillo O, 2004, J EXP MED, V199, P1671, DOI 10.1084/jem.20032247; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; KARAGIANNIS TC, 2007, ONCOGENE; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kourmouli N, 2004, J CELL SCI, V117, P2491, DOI 10.1242/jcs.01238; Kourmouli N, 2000, EMBO J, V19, P6558, DOI 10.1093/emboj/19.23.6558; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Martinez-Lopez W, 2004, CYTOGENET GENOME RES, V104, P182, DOI 10.1159/000077486; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Puerto S, 2001, MUTAGENESIS, V16, P291, DOI 10.1093/mutage/16.4.291; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; SAUNDERS WS, 1993, J CELL SCI, V104, P573; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Singh PB, 2002, J STRUCT BIOL, V140, P10, DOI 10.1016/S1047-8477(02)00536-1; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; TENHAGEN KG, 1990, MOL CELL BIOL, V10, P6348, DOI 10.1128/MCB.10.12.6348; Wang HY, 2005, J CELL PHYSIOL, V202, P492, DOI 10.1002/jcp.20141; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Ward IM, 2004, J BIOL CHEM, V279, P9677, DOI 10.1074/jbc.C300554200; Ward J.F., 1985, RAD RES S, pS103; WARD JF, 1994, INT J RADIAT BIOL, V66, P427, DOI 10.1080/09553009414551401; WARTERS RL, 1992, RADIAT RES, V130, P309, DOI 10.2307/3578376; WREGGETT KA, 1994, CYTOGENET CELL GENET, V66, P99, DOI 10.1159/000133676; Wu R, 2005, MOL BIOL CELL, V16, P2872, DOI 10.1091/mbc.e04-11-0997	39	178	184	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1057	10.1371/journal.pone.0001057	http://dx.doi.org/10.1371/journal.pone.0001057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957241	Green Published, Green Submitted, gold			2022-12-25	WOS:000207458500004
J	Weiss, WR; Kumar, A; Jiang, G; Williams, J; Bostick, A; Conteh, S; Fryauff, D; Aguiar, J; Singh, M; O'Hagan, DT; Ulmer, JB; Richie, TL				Weiss, Walter R.; Kumar, Anita; Jiang, George; Williams, Jackie; Bostick, Anthony; Conteh, Solomon; Fryauff, David; Aguiar, Joao; Singh, Manmohan; O'Hagan, Derek T.; Ulmer, Jeffery B.; Richie, Thomas L.			Protection of Rhesus Monkeys by a DNA Prime/Poxvirus Boost Malaria Vaccine Depends on Optimal DNA Priming and Inclusion of Blood Stage Antigens	PLOS ONE			English	Article								Background. We have previously described a four antigen malaria vaccine consisting of DNA plasmids boosted by recombinant poxviruses which protects a high percentage of rhesus monkeys against Plasmodium knowlesi (Pk) malaria. This is a multi-stage vaccine that includes two pre-erythrocytic antigens, PkCSP and PkSSP2(TRAP), and two erythrocytic antigens, PkAMA-1 and PkMSP-1(42kD). The present study reports three further experiments where we investigate the effects of DNA dose, timing, and formulation. We also compare vaccines utilizing only the pre-erythrocytic antigens with the four antigen vaccine. Methodology. In three experiments, rhesus monkeys were immunized with malaria vaccines using DNA plasmid injections followed by boosting with poxvirus vaccine. A variety of parameters were tested, including formulation of DNA on poly-lactic co-glycolide (PLG) particles, varying the number of DNA injections and the amount of DNA, varying the interval between the last DNA injection to the poxvirus boost from 7 to 21 weeks, and using vaccines with from one to four malaria antigens. Monkeys were challenged with Pk sporozoites given iv 2 to 4 weeks after the poxvirus injection, and parasitemia was measured by daily Giemsa stained blood films. Immune responses in venous blood samples taken after each vaccine injection were measured by ELIspot production of interferon-gamma, and by ELISA. Conclusions. 1) the number of DNA injections, the formulation of the DNA plasmids, and the interval between the last DNA injection and the poxvirus injection are critical to vaccine efficacy. However, the total dose used for DNA priming is not as important; 2) the blood stage antigens PkAMA-1 and PkMSP-1 were able to protect against high parasitemias as part of a genetic vaccine where antigen folding is not well defined; 3) immunization with PkSSP2 DNA inhibited immune responses to PkCSP DNA even when vaccinations were given into separate legs; and 4) in a counter-intuitive result, higher interferon-gamma ELIspot responses to the PkCSP antigen correlated with earlier appearance of parasites in the blood, despite the fact that PkCSP vaccines had a protective effect.	[Weiss, Walter R.; Kumar, Anita; Jiang, George; Conteh, Solomon; Fryauff, David; Aguiar, Joao; Richie, Thomas L.] USN, Med Res Ctr, Silver Spring, MD USA; [Williams, Jackie; Bostick, Anthony] Walter Reed Army Inst Res, Silver Spring, MD USA; [Singh, Manmohan; O'Hagan, Derek T.; Ulmer, Jeffery B.] Chiron Corp, Emeryville, CA 94608 USA	United States Department of Defense; United States Navy; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Novartis	Weiss, WR (corresponding author), USN, Med Res Ctr, Silver Spring, MD USA.	weissw@nmrc.navy.mil	O'Hagan, Derek/AAV-1850-2021	Richie, Thomas/0000-0002-2946-5456	DOD funds allocated to the Naval Medical Research Center [6000.RAD1.F.A0309]	DOD funds allocated to the Naval Medical Research Center	This work was supported by DOD funds allocated to the Naval Medical Research Center (work unit number 6000.RAD1.F.A0309).	Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Anderson RJ, 2004, J IMMUNOL, V172, P3094, DOI 10.4049/jimmunol.172.5.3094; Bacon DJ, 2007, HUM VACCINES, V3, P48, DOI 10.4161/hv.3.2.3833; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Ballou W Ripley, 2005, Expert Opin Emerg Drugs, V10, P489, DOI 10.1517/14728214.10.3.489; Ballou WR, 2004, AM J TROP MED HYG, V71, P239; Bejon P, 2005, J INFECT DIS, V191, P619, DOI 10.1086/427243; Bejon P, 2006, INFECT IMMUN, V74, P6331, DOI 10.1128/IAI.00774-06; Blair PL, 2005, CURR TOP MICROBIOL, V295, P417; Carucci DJ, 2002, INT J PARASITOL, V32, P1539, DOI 10.1016/S0020-7519(02)00181-9; COLLINS CR, 2006, J BIOL CHEM; Dunachie SJ, 2006, INFECT IMMUN, V74, P5933, DOI 10.1128/IAI.00590-06; Enosse S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010005; Epstein JE, 2004, VACCINE, V22, P1592, DOI 10.1016/j.vaccine.2004.01.031; Epstein JE, 2002, HUM GENE THER, V13, P1551, DOI 10.1089/10430340260201644; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Fluck C, 2004, INFECT IMMUN, V72, P6300, DOI 10.1128/IAI.72.11.6300-6305.2004; Fluck C, 2007, INFECT GENET EVOL, V7, P44, DOI 10.1016/j.meegid.2006.03.006; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Genton B, 2000, VACCINE, V18, P2504, DOI 10.1016/S0264-410X(00)00036-0; Giersing B, 2005, INFECT IMMUN, V73, P3963, DOI 10.1128/IAI.73.7.3963-3970.2005; Gilbert SC, 2002, VACCINE, V20, P1039, DOI 10.1016/S0264-410X(01)00450-9; Heppner DG, 2005, VACCINE, V23, P2243, DOI 10.1016/j.vaccine.2005.01.042; Hill AVS, 2006, NAT REV IMMUNOL, V6, P21, DOI 10.1038/nri1746; HOFFMAN SL, 1994, VACCINE, V12, P1529, DOI 10.1016/0264-410X(94)90078-7; Imoukhuede EB, 2006, VACCINE, V24, P6526, DOI 10.1016/j.vaccine.2006.06.022; Krzych U, 2005, CURR TOP MICROBIOL, V297, P1; Kumar A, 2001, J IMMUNOL METHODS, V247, P49, DOI 10.1016/S0022-1759(00)00310-0; Le TP, 2000, VACCINE, V18, P1893, DOI 10.1016/S0264-410X(99)00407-7; LE TP, 1999, VACCINE IN PRESS; Mahanty S, 2003, J EXP BIOL, V206, P3781, DOI 10.1242/jeb.00646; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Moore AC, 2004, IMMUNOL REV, V199, P126, DOI 10.1111/j.0105-2896.2004.00138.x; O'Hagan D, 2001, J VIROL, V75, P9037, DOI 10.1128/JVI.75.19.9037-9043.2001; O'Hagan DT, 2006, METHODS, V40, P10, DOI 10.1016/j.ymeth.2006.05.017; Ockenhouse CF, 2006, VACCINE, V24, P3009, DOI 10.1016/j.vaccine.2005.11.028; Otten GR, 2005, J VIROL, V79, P8189, DOI 10.1128/JVI.79.13.8189-8200.2005; Rogers WO, 2002, INFECT IMMUN, V70, P4329, DOI 10.1128/IAI.70.8.4329-4335.2002; Rogers WO, 2001, INFECT IMMUN, V69, P5565, DOI 10.1128/IAI.69.9.5565-5572.2001; Sacci JB, 2005, MOL BIOCHEM PARASIT, V142, P177, DOI 10.1016/j.molbiopara.2005.03.018; SACCI JB, 2000, LASER CAPTURE MICROD; Saul A, 2005, VACCINE, V23, P3076, DOI 10.1016/j.vaccine.2004.09.040; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Sedegah M, 2004, GENES IMMUN, V5, P553, DOI 10.1038/sj.gene.6364125; Sedegah M, 2004, GENE THER, V11, P448, DOI 10.1038/sj.gt.3302139; Sedegah M, 2002, INFECT IMMUN, V70, P3493, DOI 10.1128/IAI.70.7.3493-3499.2002; Sedegah M, 1998, P NATL ACAD SCI USA, V95, P7648, DOI 10.1073/pnas.95.13.7648; Sedegah M, 2000, J IMMUNOL, V164, P5905, DOI 10.4049/jimmunol.164.11.5905; Shimp RL, 2006, PROTEIN EXPRES PURIF, V50, P58, DOI 10.1016/j.pep.2006.06.018; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Singh S, 2006, INFECT IMMUN, V74, P4573, DOI 10.1128/IAI.01679-05; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; Stowers AW, 2002, P NATL ACAD SCI USA, V99, P339, DOI 10.1073/pnas.012590199; Tsai CW, 2006, J BIOTECHNOL, V121, P458, DOI 10.1016/j.jbiotec.2005.08.025; Walsh DS, 2006, VACCINE, V24, P4167, DOI 10.1016/j.vaccine.2006.02.041; Walsh DS, 2004, AM J TROP MED HYG, V70, P499, DOI 10.4269/ajtmh.2004.70.499; Walther M, 2006, INFECT IMMUN, V74, P2706, DOI 10.1128/IAI.74.5.2706-2716.2006; Wang RB, 2004, J IMMUNOL, V172, P5561, DOI 10.4049/jimmunol.172.9.5561; Wang RB, 2005, INFECT IMMUN, V73, P2863, DOI 10.1128/IAI.73.5.2863-2872.2005; Wang RB, 2001, P NATL ACAD SCI USA, V98, P10817, DOI 10.1073/pnas.181123498; Webster DP, 2006, VACCINE, V24, P3026, DOI 10.1016/j.vaccine.2005.10.058; Webster DP, 2005, P NATL ACAD SCI USA, V102, P4836, DOI 10.1073/pnas.0406381102; Xie H, 2005, INFECT IMMUN, V73, P828, DOI 10.1128/IAI.73.2.828-833.2005; Zhang ZG, 2006, ACTA BIOCH BIOPH SIN, V38, P403, DOI 10.1111/j.1745-7270.2006.00178.x	66	30	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1063	10.1371/journal.pone.0001063	http://dx.doi.org/10.1371/journal.pone.0001063			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957247	gold, Green Published, Green Submitted			2022-12-25	WOS:000207458500010
J	Ozeri-Galai, E; Schwartz, M; Rahat, A; Kerem, B				Ozeri-Galai, E.; Schwartz, M.; Rahat, A.; Kerem, B.			Interplay between ATM and ATR in the regulation of common fragile site stability	ONCOGENE			English	Article						fragile sites; replication stress; ATM; ATR; double strand breaks; Chk1	DNA-DAMAGE RESPONSE; ONCOGENE-INDUCED SENESCENCE; IONIZING-RADIATION; PREFERENTIAL TARGETS; PHOSPHORYLATION; REPLICATION; ACTIVATION; CHECKPOINT; BREAKS; RECOMBINATION	Common fragile sites are specific genomic loci that form constrictions and gaps on metaphase chromosomes under conditions that slow, but do not arrest, DNA replication. These sites have been shown to have a role in various chromosomal rearrangements in tumors. Different DNA damage response proteins were shown to regulate fragile site stability, including ataxia-telangiectasia and Rad3-related (ATR) and its effector Chk1. Here, we investigated the role of ataxia-telangiectasia mutated (ATM), the main transducer of DNA double-strand break (DSB) signal, in this regulation. We demonstrate that replication stress conditions, which induce fragile site expression, lead to DNA fragmentation and recruitment of phosphorylated ATM to nuclear foci at DSBs. We further show that ATM plays a role in maintaining fragile site stability, which is revealed only in the absence of ATR. However, the activation of ATM under these replication stress conditions is ATR independent. Following conditions that induce fragile site expression both ATR and ATM phosphorylate Chk1, suggesting that both proteins regulate fragile site expression probably via their effect on Chk1 activation. Our findings provide new insights into the interplay between ATR and ATM pathways in response to partial replication inhibition and in the regulation of fragile site stability.	[Ozeri-Galai, E.; Schwartz, M.; Rahat, A.; Kerem, B.] Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Kerem, B (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel.	kerem@cc.huji.ac.il		Schwartz, Michal/0000-0001-5442-0201				Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Arlt MF, 2006, DNA REPAIR, V5, P1126, DOI 10.1016/j.dnarep.2006.05.010; Arlt MF, 2003, CYTOGENET GENOME RES, V100, P92, DOI 10.1159/000072843; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bester AC, 2006, GENE THER, V13, P1057, DOI 10.1038/sj.gt.3302752; Bolderson E, 2004, HUM MOL GENET, V13, P2937, DOI 10.1093/hmg/ddh316; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; CHENG CH, 1993, BIOCHEMISTRY-US, V32, P8568, DOI 10.1021/bi00084a025; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; Cuadrado M, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-7; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Durkin SG, 2006, ONCOGENE, V25, P4381, DOI 10.1038/sj.onc.1209466; Gatei M, 2001, J BIOL CHEM, V276, P17276, DOI 10.1074/jbc.M011681200; GLOVER TW, 1987, AM J HUM GENET, V41, P882; GLOVER TW, 1988, AM J HUM GENET, V43, P265; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; HECHT F, 1984, CLIN GENET, V26, P169; Hellman A, 2000, MOL CELL BIOL, V20, P4420, DOI 10.1128/MCB.20.12.4420-4427.2000; Ho GPH, 2006, MOL CELL BIOL, V26, P7005, DOI 10.1128/MCB.02018-05; IKEGAMI S, 1978, NATURE, V275, P458, DOI 10.1038/275458a0; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Le Beau MM, 1998, HUM MOL GENET, V7, P755, DOI 10.1093/hmg/7.4.755; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Richards RI, 2001, TRENDS GENET, V17, P339, DOI 10.1016/S0168-9525(01)02303-4; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schwartz M, 2006, CANCER LETT, V232, P13, DOI 10.1016/j.canlet.2005.07.039; Schwartz M, 2005, GENE DEV, V19, P2715, DOI 10.1101/gad.340905; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Thorland EC, 2003, ONCOGENE, V22, P1225, DOI 10.1038/sj.onc.1206170; Wang L, 1997, GENOMICS, V41, P485, DOI 10.1006/geno.1997.4690; Yoo HY, 2007, J BIOL CHEM, V282, P17501, DOI 10.1074/jbc.M701770200; YUNIS JJ, 1984, SCIENCE, V226, P1199, DOI 10.1126/science.6239375; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	46	47	47	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 3	2008	27	15					2109	2117		10.1038/sj.onc.1210849	http://dx.doi.org/10.1038/sj.onc.1210849			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	283FE	17934520				2022-12-25	WOS:000254621300001
J	Jung, H; Lee, KP; Park, SJ; Park, JH; Jang, YS; Choi, SY; Jung, JG; Jo, K; Park, DY; Yoon, JH; Park, JH; Lim, DS; Hong, GR; Choi, C; Park, YK; Lee, JW; Hong, HJ; Kim, S; Park, YW				Jung, H.; Lee, K. P.; Park, S. J.; Park, J. H.; Jang, Y-s; Choi, S-Y; Jung, J-G; Jo, K.; Park, D. Y.; Yoon, J. H.; Park, J-H; Lim, D-S; Hong, G-R; Choi, C.; Park, Y-K; Lee, J. W.; Hong, H. J.; Kim, S.; Park, Y. W.			TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition	ONCOGENE			English	Article						TMPRSS4; invasion; metastasis; E-cadherin; EMT; serine protease	TRANSMEMBRANE SERINE PROTEASES; SURFACE PROTEOLYTIC-ENZYMES; BREAST-CANCER CELLS; MATRIX METALLOPROTEINASES; PLASMINOGEN-ACTIVATOR; E-CADHERIN; MATRIPTASE; EXPRESSION; PROSTATE; PROTEIN	TMPRSS4 is a novel type II transmembrane serine protease found at the cell surface that is highly expressed in pancreatic, colon and gastric cancer tissues. However, the biological functions of TMPRSS4 in cancer are unknown. Here we show, using reverse transcription PCR, that TMPRSS4 is highly elevated in lung cancer tissues compared with normal tissues and is also broadly expressed in a variety of human cancer cell lines. Knockdown of TMPRSS4 by small interfering RNA treatment in lung and colon cancer cell lines was associated with reduction of cell invasion and cell-matrix adhesion as well as modulation of cell proliferation. Conversely, the invasiveness, motility and adhesiveness of SW480 colon carcinoma cells were significantly enhanced by TMPRSS4 overexpression. Furthermore, overexpression of TMPRSS4 induced loss of E-cadherin-mediated cell-cell adhesion, concomitant with the induction of SIP1/ZEB2, an E-cadherin transcriptional repressor, and led to epithelial mesenchymal transition events, including morphological changes, actin reorganization and upregulation of mesenchymal markers. TMPRSS4-overexpressing cells also displayed markedly increased metastasis to the liver in nude mice upon intrasplenic injection. Taken together, these studies suggest that TMPRSS4 controls the invasive and metastatic potential of human cancer cells by facilitating an epithelial-mesenchymal transition; TMPRSS4 may be a potential therapeutic target for cancer treatment.	[Jung, H.; Lee, K. P.; Park, S. J.; Park, J. H.; Jang, Y-s; Choi, S-Y; Jung, J-G; Jo, K.; Hong, H. J.; Kim, S.; Park, Y. W.] Korea Res Inst Biosci & Biotechnol, Therapeut Antibody Res Ctr, Taejon 305806, South Korea; [Lee, K. P.; Lim, D-S] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Park, D. Y.; Yoon, J. H.] Digital Genom Inc, Seoul, South Korea; [Park, J-H] Korea Canc Ctr Hosp, Dept Thorac Surg, Seoul, South Korea; [Hong, G-R; Park, Y-K] Chonnam Natl Univ, Sch Med, Dept Surg, Hwasun, South Korea; [Choi, C.] Chonnam Natl Univ, Sch Med, Dept Pathol, Hwasun, South Korea; [Lee, J. W.] Seoul Natl Univ, Coll Med, Inst Canc Res, Seoul, South Korea; [Lee, J. W.] Seoul Natl Univ, Coll Med, Dept Tumor Biol, Seoul, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST); National Cancer Center - Korea (NCC); Chonnam National University; Chonnam National University; Seoul National University (SNU); Seoul National University (SNU)	Kim, S (corresponding author), Korea Res Inst Biosci & Biotechnol, Therapeut Antibody Res Ctr, 52 Eoeun Dong, Taejon 305806, South Korea.	semikim@kribb.re.kr; ywpark@kribb.re.kr	Lim, Dae-Sik/C-1599-2011; Lee, Jung Weon/AAC-1146-2020; Lee, Jung Weon/F-9149-2012	Lim, Dae-Sik/0000-0003-2356-7555; Lee, Jung Weon/0000-0003-2722-8200; Lee, Kwang-Pyo/0000-0003-0067-6898; Kim, Semi/0000-0001-8043-1465				Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Aplin AE, 1998, PHARMACOL REV, V50, P197; Benaud CM, 2002, CLIN EXP METASTAS, V19, P639, DOI 10.1023/A:1020985632550; Berntzen G, 2005, J IMMUNOL METHODS, V298, P93, DOI 10.1016/j.jim.2005.01.002; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955-0674(02)00373-3; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; Del Rosso M, 2002, CLIN EXP METASTAS, V19, P193, DOI 10.1023/A:1015531321445; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Duffy MJ, 2002, BIOCHEM SOC T, V30, P207, DOI 10.1042/BST0300207; Duffy MJ, 1996, CLIN CANCER RES, V2, P613; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Feltes CM, 2002, CANCER RES, V62, P6688; Forbs D, 2005, INT J ONCOL, V27, P1061; Galkin AV, 2004, PROSTATE, V61, P228, DOI 10.1002/pros.20094; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Huang XK, 2005, CANCER RES, V65, P3470, DOI 10.1158/0008-5472.CAN-04-2807; Kebebew E, 2005, ANN SURG, V242, P353, DOI 10.1097/sla.0000179623.87329.6b; Kim S, 2002, J CLIN INVEST, V110, P933, DOI 10.1172/JCI200214268; Laferriere J, 2002, ANN NY ACAD SCI, V973, P562, DOI 10.1111/j.1749-6632.2002.tb04702.x; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; List K, 2006, MOL MED, V12, P1, DOI 10.2119/2006-00022.List; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; Maschler S, 2005, ONCOGENE, V24, P2032, DOI 10.1038/sj.onc.1208423; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Netzel-Arnett S, 2003, CANCER METAST REV, V22, P237, DOI 10.1023/A:1023003616848; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Srikantan V, 2002, CANCER RES, V62, P6812; Stetler-Stevenson WG, 2001, SEMIN CANCER BIOL, V11, P143, DOI 10.1006/scbi.2000.0365; Suzuki M, 2004, J BIOL CHEM, V279, P14899, DOI 10.1074/jbc.M313130200; Szabo R, 2003, THROMB HAEMOSTASIS, V90, P185, DOI 10.1160/TH03-02-0071; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; van Hengel J, 2007, BBA-MOL CELL RES, V1773, P78, DOI 10.1016/j.bbamcr.2006.08.033; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Wallrapp C, 2000, CANCER RES, V60, P2602; Xuan JA, 2006, CANCER RES, V66, P3611, DOI 10.1158/0008-5472.CAN-05-2983	44	119	132	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2008	27	18					2635	2647		10.1038/sj.onc.1210914	http://dx.doi.org/10.1038/sj.onc.1210914			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	289LW	17968309				2022-12-25	WOS:000255057000013
J	Stocklein, H; Smardova, J; Macak, J; Katzenberger, T; Holler, S; Wessendorf, S; Hutter, G; Dreyling, M; Haralambieva, E; Mader, U; Muller-Hermelink, HK; Rosenwald, A; Ott, G; Kalla, J				Stoecklein, H.; Smardova, J.; Macak, J.; Katzenberger, T.; Hoeller, S.; Wessendorf, S.; Hutter, G.; Dreyling, M.; Haralambieva, E.; Maeder, U.; Mueller-Hermelink, H. K.; Rosenwald, A.; Ott, G.; Kalla, J.			Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma	ONCOGENE			English	Article						diffuse large B-cell lymphoma; del(17p); TP53; HIC1	NON-HODGKINS-LYMPHOMA; COMPARATIVE GENOMIC HYBRIDIZATION; FUNCTIONAL ASSAY; BREAST-CANCER; P53 GENE; DNA HYPERMETHYLATION; DELETED REGION; MULTIPLE GENES; OVARIAN-CANCER; EXPRESSION	Deletions in the short arm of chromosome 17 (17p) involving the tumor suppressor TP53 occur in up to 20% of diffuse large B-cell lymphomas (DLBCLs). Although inactivation of both alleles of a tumor suppressor gene is usually required for tumor development, the overlap between TP53 deletions and mutations is poorly understood in DLBCLs, suggesting the possible existence of additional tumor suppressor genes in 17p. Using a bacterial artificial chromosome (BAC) and Phage 1 artificial chromosome (PAC) contig, we here de. ne a minimally deleted region in DLBCLs encompassing approximately 0.8MB telomeric to the TP53 locus. This genomic region harbors the tumor suppressor Hypermethylated in Cancer 1 (HIC1). Methylation-specific PCR demonstrated hypermethylation of HIC1 exon 1a in a substantial subset of DLBCLs, which is accompanied by simultaneous HIC1 deletion of the second allele in 90% of cases. In contrast, HIC1 inactivation by hypermethylation was rarely encountered in DLBCLs without concomitant loss of the second allele. DLBCL patients with complete inactivation of both HIC1 and TP53 may be characterized by an even inferior clinical course than patients with inactivation of TP53 alone, suggesting a functional cooperation between these two proteins. These findings strongly imply HIC1 as a novel tumor suppressor in a subset of DLBCLs.	[Ott, G.] Robert Bosch Krankenhaus, Dept Clin Pathol, D-70376 Stuttgart, Germany; [Stoecklein, H.; Katzenberger, T.; Hoeller, S.; Haralambieva, E.; Mueller-Hermelink, H. K.; Rosenwald, A.; Ott, G.; Kalla, J.] Univ Wurzburg, Inst Pathol, D-97070 Wurzburg, Germany; [Smardova, J.; Macak, J.] Masaryk Univ, Fac Med, Dept Pathol, Brno, Czech Republic; [Smardova, J.; Macak, J.] Fac Hosp Brno, Brno, Czech Republic; [Wessendorf, S.] Univ Ulm, Innere Med Klin 3, Ulm, Germany; [Hutter, G.; Dreyling, M.] Univ Munchen Grosshadern, Med Klin & Poliklin 2, Munich, Germany; [Maeder, U.] Univ Wurzburg, Interdisciplinary Canc Ctr, Wurzburg, Germany	Bosch; Robert Bosch Krankenhaus; University of Wurzburg; Masaryk University Brno; University Hospital Brno; Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; University of Wurzburg	Ott, G (corresponding author), Robert Bosch Krankenhaus, Dept Clin Pathol, Auerbachstr 110, D-70376 Stuttgart, Germany.	german.ott@rbk.de		Holler, Sylvia/0000-0001-9277-7076				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bea S, 2005, BLOOD, V106, P3183, DOI 10.1182/blood-2005-04-1399; Britschgi C, 2006, ONCOGENE, V25, P2030, DOI 10.1038/sj.onc.1209240; Chen CM, 2004, GENE DEV, V18, P320, DOI 10.1101/gad.1162204; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chen WY, 2003, NAT GENET, V33, P197, DOI 10.1038/ng1077; Chen WY, 2004, CANCER CELL, V6, P387, DOI 10.1016/j.ccr.2004.08.030; Deltour S, 1999, P NATL ACAD SCI USA, V96, P14831, DOI 10.1073/pnas.96.26.14831; Deltour S, 2002, MOL CELL BIOL, V22, P4890, DOI 10.1128/MCB.22.13.4890-4901.2002; Dong SM, 2001, CLIN CANCER RES, V7, P1982; Duddy PM, 2000, J MOL DIAGN, V2, P139, DOI 10.1016/S1525-1578(10)60629-0; FLAMAN JM, 1995, P NATL ACAD SCI USA, V92, P3963, DOI 10.1073/pnas.92.9.3963; Goff LK, 2000, BRIT J HAEMATOL, V111, P618, DOI 10.1046/j.1365-2141.2000.02352.x; Guerardel C, 2001, J BIOL CHEM, V276, P3078, DOI 10.1074/jbc.M008690200; Haralambieva E, 2002, J PATHOL, V198, P163, DOI 10.1002/path.1197; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hida Y, 2007, ARCH DERMATOL RES, V299, P103, DOI 10.1007/s00403-006-0725-6; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Ichikawa A, 1997, NEW ENGL J MED, V337, P529, DOI 10.1056/NEJM199708213370804; ISHIOKA C, 1993, NAT GENET, V5, P124, DOI 10.1038/ng1093-124; Issa JPJ, 1997, CANCER RES, V57, P1678; Jaffe ES, 2001, WHO CLASSIFICATION T; Kanai Y, 1999, HEPATOLOGY, V29, P703, DOI 10.1002/hep.510290338; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Koduru PRK, 1997, BLOOD, V90, P4078, DOI 10.1182/blood.V90.10.4078; Konishi H, 2003, ONCOGENE, V22, P1892, DOI 10.1038/sj.onc.1206304; LICHTER P, 1995, METHOD ENZYMOL, V254, P334; Lossos IS, 2005, J CLIN ONCOL, V23, P6351, DOI 10.1200/JCO.2005.05.012; Meinhold-Heerlein I, 2001, ONCOLOGY-BASEL, V60, P176, DOI 10.1159/000055316; Melki JR, 1999, CANCER RES, V59, P3730; Nenutil R, 2005, J PATHOL, V207, P251, DOI 10.1002/path.1838; Phillips NJ, 1996, CANCER RES, V56, P606; Pinte S, 2004, J BIOL CHEM, V279, P38313, DOI 10.1074/jbc.M401610200; Pinyol M, 2000, AM J PATHOL, V156, P1987, DOI 10.1016/S0002-9440(10)65071-7; Prowse AH, 2002, INT J CANCER, V99, P185, DOI 10.1002/ijc.10334; Rathi A, 2003, CLIN CANCER RES, V9, P3674; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Rosenwald A, 2003, CANCER CELL, V3, P185, DOI 10.1016/S1535-6108(03)00028-X; Rudiger T, 1998, AM J SURG PATHOL, V22, P1184, DOI 10.1097/00000478-199810000-00003; Sankar M, 1998, LEUKEMIA, V12, P510, DOI 10.1038/sj.leu.2400973; Savage KJ, 2003, BLOOD, V102, P3871, DOI 10.1182/blood-2003-06-1841; SAXENA A, 1992, CANCER RES, V52, P6716; Schlegelberger B, 1999, BLOOD, V94, P3114; Schultz DC, 1996, CANCER RES, V56, P1997; Seitz S, 2001, J PATHOL, V194, P318, DOI 10.1002/1096-9896(200107)194:3<318::AID-PATH881>3.0.CO;2-4; Shaffer LG., 2005, INT SYSTEM HUMAN CYT; Smardova J, 2001, TUMOR BIOL, V22, P59; Stokke T, 2001, BRIT J CANCER, V85, P1900, DOI 10.1054/bjoc.2001.2164; Stokke T, 2000, INT J CANCER, V89, P313, DOI 10.1002/1097-0215(20000720)89:4<313::AID-IJC1>3.0.CO;2-D; von Bergh A, 2000, GENE CHROMOSOME CANC, V28, P14, DOI 10.1002/(SICI)1098-2264(200005)28:1<14::AID-GCC2>3.3.CO;2-O; Waha A, 2004, INT J CANCER, V110, P542, DOI 10.1002/ijc.20165; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Waridel F, 1997, ONCOGENE, V14, P163, DOI 10.1038/sj.onc.1200812; Zettl A, 2000, AM J PATHOL, V157, P257, DOI 10.1016/S0002-9440(10)64536-1; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104	58	20	22	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2008	27	18					2613	2625		10.1038/sj.onc.1210901	http://dx.doi.org/10.1038/sj.onc.1210901			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	289LW	17982487				2022-12-25	WOS:000255057000011
J	Chang, YM; Stockinger, MP; Tashiro, H; Lin, CLG				Chang, Yueming; Stockinger, Michael P.; Tashiro, Hirofumi; Lin, Chien-Liang Glenn			A novel noncoding RNA rescues mutant SOD1-mediated cell death	FASEB JOURNAL			English	Article						ALS; neurodegeneration; rRNA	CU/ZN SUPEROXIDE-DISMUTASE; TRANSGENIC-MOUSE MODEL; MOTOR-NEURON DISEASE; ALZHEIMERS-DISEASE; EXTEND SURVIVAL; GENE; EXPRESSION; ALS; MICE; SUPEROXIDE-DISMUTASE-1	Transgenic mice expressing mutant Cu2+/Zn2+ superoxide dismutase SOD1 (G93A) develop similar clinical and pathological phenotypes to amyotrophic lateral sclerosis (ALS) patients. Here, we utilize representational difference analysis to identify the transcripts that are up-regulated in the presymptomatic stage of SOD1 (G93A) mice. Unexpectedly, three predominant clones were 18S or 28S ribosomal RNA (rRNA) segments. One of these clones corresponded to a capped and polyadenylated transcript containing a large portion of 18S rRNA, named MSUR1 (mutant SOD1-up-regulated RNA 1). In vitro expression experiments show that MSUR1 is able to rescue SOD1 (G93A)mediated cell death. Expression of MSUR1 significantly reduces SOD1 (G93A)-induced free radical levels and oxidative damage. Further, MSUR1 can reduce hydrogen peroxide-mediated cytotoxicity. MSUR1 does not encode a protein, suggesting its role as a functional noncoding RNA. It is widely expressed in various tissues. Searching the database of GenBank revealed that a large number of expressed sequence tag (EST) clones contain large portions of rRNA sequence, potentially indicating a heretofore overlooked class of mRNAs with functional significance.	[Chang, Yueming; Stockinger, Michael P.; Tashiro, Hirofumi; Lin, Chien-Liang Glenn] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Chang, Yueming; Lin, Chien-Liang Glenn] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Lin, CLG (corresponding author), Ohio State Univ, Dept Neurosci, 4198 Graves Hall,333 W 10th Ave, Columbus, OH 43210 USA.	lin.492@osu.edu	Lin, Chien-liang G/E-3513-2011		NIA NIH HHS [AG-17317] Funding Source: Medline; NIMH NIH HHS [MH-059805] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG017317] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Andrus PK, 1998, J NEUROCHEM, V71, P2041; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bruijn LI, 1996, NEUROPATH APPL NEURO, V22, P373, DOI 10.1111/j.1365-2990.1996.tb00907.x; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Butchbach MER, 2002, GENE, V292, P81, DOI 10.1016/S0378-1119(02)00669-8; Caricasole A, 2002, FASEB J, V16, P1331, DOI 10.1096/fj.02-0018fje; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Costa FF, 2007, GENE, V386, P1, DOI 10.1016/j.gene.2006.09.028; Costa FF, 2005, GENE, V357, P83, DOI 10.1016/j.gene.2005.06.019; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; DURHAM HD, 1993, NEUROTOXICOLOGY, V14, P387; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; Guo H, 2002, MOL CELL NEUROSCI, V21, P546, DOI 10.1006/mcne.2002.1198; GURNEY ME, 1994, NEW ENGL J MED, V331, P1721, DOI 10.1056/NEJM199412223312516; Hall ED, 1998, J NEUROSCI RES, V53, P66, DOI 10.1002/(SICI)1097-4547(19980701)53:1<66::AID-JNR7>3.3.CO;2-K; Halliwell B, 2000, IUBMB LIFE, V50, P251, DOI 10.1080/15216540051080930; Hashimoto Y, 2001, J NEUROSCI, V21, P9235, DOI 10.1523/JNEUROSCI.21-23-09235.2001; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Mauro VP, 1997, P NATL ACAD SCI USA, V94, P422, DOI 10.1073/pnas.94.2.422; Maximov V, 2002, MED HYPOTHESES, V59, P670, DOI 10.1016/S0306-9877(02)00223-2; Menzies FM, 2002, BRAIN, V125, P1522, DOI 10.1093/brain/awf167; MULDER DW, 1986, NEUROLOGY, V36, P511, DOI 10.1212/WNL.36.4.511; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Shamovsky I, 2006, NATURE, V440, P556, DOI 10.1038/nature04518; Sokolova T, 2001, NEUROSCI LETT, V297, P129, DOI 10.1016/S0304-3940(00)01689-X; Supattapone S, 2004, J MOL MED, V82, P348, DOI 10.1007/s00109-004-0534-3; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7	38	6	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2008	22	3					691	702		10.1096/fj.07-9532com	http://dx.doi.org/10.1096/fj.07-9532com			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17957031				2022-12-25	WOS:000254143700008
J	Kostiuk, MA; Corvi, MM; Keller, BO; Plummer, G; Prescher, JA; Hangauer, MJ; Bertozzi, CR; Rajaiah, G; Falck, JR; Berthiaume, LG				Kostiuk, Morris A.; Corvi, Maria M.; Keller, Bernd O.; Plummer, Greg; Prescher, Jennifer A.; Hangauer, Matthew J.; Bertozzi, Carolyn R.; Rajaiah, Gurram; Falck, John R.; Berthiaume, Luc G.			Identification of palmitoylated mitochondrial proteins using a bio-orthogonal azido-palmitate analogue	FASEB JOURNAL			English	Article						azido-fatty acid; carbamoyl phosphate synthetase 1; Staudinger ligation; 3-hydroxy-3-methylglutaryl CoA synthase	COENZYME-A DEHYDROGENASE; ACID BETA-OXIDATION; ELECTRON-TRANSFER FLAVOPROTEIN; ACYL-COA DEHYDROGENASES; RAT-LIVER MITOCHONDRIA; IRON-SULFUR FLAVOPROTEIN; SITE FATTY ACYLATION; GLUTAMATE-DEHYDROGENASE; CATALYTIC-PROPERTIES; IN-VITRO	Increased levels of circulating saturated free fatty acids, such as palmitate, have been implicated in the etiology of type II diabetes and cancer. In addition to being a constituent of glycerolipids and a source of energy, palmitate also covalently attaches to numerous cellular proteins via a process named palmitoylation. Recognized for its roles in membrane tethering, cellular signaling, and protein trafficking, palmitoylation is also emerging as a potential regulator of metabolism. Indeed, we showed previously that the acylation of two mitochondrial proteins at their active site cysteine residues result in their inhibition. Herein, we sought to identify other palmitoylated proteins in mitochondria using a nonradioactive bio-orthogonal azido-palmitate analog that can be selectively derivatized with various tagged triarylphosphines. Our results show that, like palmitate, incorporation of azido-palmitate occurred on mitochondrial proteins via thioester bonds at sites that could be competed out by palmitoyl-CoA. Using this method, we identified 21 putative palmitoylated proteins in the rat liver mitochondrial matrix, a compartment not recognized for its content in palmitoylated proteins, and confirmed the palmitoylation of newly identified mitochondrial 3-hydroxy 3-methylglutaryl-CoA synthase. We postulate that covalent modification and perhaps inhibition of various mitochondrial enzymes by palmitoyl-CoA could lead to the metabolic impairments found in obesity-related diseases.	[Kostiuk, Morris A.; Corvi, Maria M.; Plummer, Greg; Berthiaume, Luc G.] Univ Alberta, Fac Med & Dent, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada; [Keller, Bernd O.] Univ British Columbia, Child & Family Res Inst, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Prescher, Jennifer A.; Hangauer, Matthew J.; Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Chem & Mol Cell Biol, Berkeley, CA 94720 USA; [Prescher, Jennifer A.; Hangauer, Matthew J.; Bertozzi, Carolyn R.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Prescher, Jennifer A.; Hangauer, Matthew J.; Bertozzi, Carolyn R.] Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA USA; [Rajaiah, Gurram; Falck, John R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Alberta; Child & Family Research Institute; University of British Columbia; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Texas System; University of Texas Southwestern Medical Center Dallas	Berthiaume, LG (corresponding author), Univ Alberta, Fac Med & Dent, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada.	luc.berthiaume@ualberta.ca	Falck, John R/B-3030-2011	Falck, John R/0000-0002-9219-7845; Corvi, Maria/0000-0002-6192-5029; Berthiaume, Luc/0000-0003-0926-059X; Keller, Bernd/0000-0002-6154-5173	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058867, R37GM058867, R01GM031278] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM58867, R37 GM058867, R01 GM058867, R01 GM031278] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agnihotri G, 2003, BIOORGAN MED CHEM, V11, P9, DOI 10.1016/S0968-0896(02)00333-4; Bano MC, 1998, BIOCHEM J, V330, P723, DOI 10.1042/bj3300723; BECKMANN JD, 1985, BIOCHEMISTRY-US, V24, P3913, DOI 10.1021/bi00336a016; BECKMANN JD, 1985, BIOCHEMISTRY-US, V24, P3922, DOI 10.1021/bi00336a017; BERTHIAUME L, 1994, J BIOL CHEM, V269, P6498; BERTHIAUME L, 1995, METHOD ENZYMOL, V250, P454; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Bizzozero OA, 2001, BBA-PROTEIN STRUCT M, V1545, P278, DOI 10.1016/S0167-4838(00)00291-0; Corvi MM, 2001, J BIOL CHEM, V276, P45704, DOI 10.1074/jbc.M102766200; DEICHAITE I, 1988, MOL CELL BIOL, V8, P4295, DOI 10.1128/MCB.8.10.4295; DEICHAITE I, 1993, J BIOL CHEM, V268, P13738; DEVADAS B, 1992, J BIOL CHEM, V267, P7224; Duncan JA, 1996, J BIOL CHEM, V271, P23594, DOI 10.1074/jbc.271.38.23594; Eder M, 1997, EUR J BIOCHEM, V245, P600, DOI 10.1111/j.1432-1033.1997.00600.x; Faergeman NJ, 1997, BIOCHEM J, V323, P1; FAHIEN LA, 1983, ARCH BIOCHEM BIOPHYS, V220, P386, DOI 10.1016/0003-9861(83)90428-9; FAHIEN LA, 1979, ARCH BIOCHEM BIOPHYS, V192, P33, DOI 10.1016/0003-9861(79)90069-9; FAHIEN LA, 1989, J BIOL CHEM, V264, P12303; FRISELL WR, 1962, J BIOL CHEM, V237, P94; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; GILBERT HF, 1981, J BIOL CHEM, V256, P7371; HALL CL, 1980, J BIOL CHEM, V255, P3591; Hang HC, 2007, J AM CHEM SOC, V129, P2744, DOI 10.1021/ja0685001; He XY, 1996, BIOCHEMISTRY-US, V35, P9625, DOI 10.1021/bi960374y; Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569; IKEDA Y, 1985, J BIOL CHEM, V260, P1311; IKEDA Y, 1983, J BIOL CHEM, V258, P1077; IZAI K, 1992, J BIOL CHEM, V267, P1027; Kho Y, 2004, P NATL ACAD SCI USA, V101, P12479, DOI 10.1073/pnas.0403413101; KISPAL G, 1986, J BIOL CHEM, V261, P14209; Lam TKT, 2003, AM J PHYSIOL-ENDOC M, V284, pE863, DOI 10.1152/ajpendo.00033.2003; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Linder ME, 2003, BIOCHEMISTRY-US, V42, P4311, DOI 10.1021/bi034159a; LOWE DM, 1985, BIOCHEM J, V227, P591, DOI 10.1042/bj2270591; MAGEE AI, 1984, BIOCHIM BIOPHYS ACTA, V798, P156, DOI 10.1016/0304-4165(84)90298-8; Meertens LM, 1998, EMBO J, V17, P6972, DOI 10.1093/emboj/17.23.6972; Prescher JA, 2004, NATURE, V430, P873, DOI 10.1038/nature02791; REED WD, 1975, J BIOL CHEM, V250, P3117; Resh MD, 2006, METHODS, V40, P191, DOI 10.1016/j.ymeth.2006.04.013; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; ROSS NW, 1988, J NEUROSCI RES, V21, P35, DOI 10.1002/jnr.490210106; RUZICKA FJ, 1975, BIOCHEM BIOPH RES CO, V66, P622, DOI 10.1016/0006-291X(75)90555-0; RUZICKA FJ, 1977, J BIOL CHEM, V252, P8440; Saxon E, 2002, J AM CHEM SOC, V124, P14893, DOI 10.1021/ja027748x; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; SCHMIDT MFG, 1985, J GEN VIROL, V66, P2635, DOI 10.1099/0022-1317-66-12-2635; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; STUCKI JW, 1989, J BIOL CHEM, V264, P6376; SUMEGI B, 1984, J BIOL CHEM, V259, P8748; SUMEGI B, 1991, BIOCHIM BIOPHYS ACTA, V1081, P121, DOI 10.1016/0005-2760(91)90016-B; SUMEGI B, 1984, J BIOL CHEM, V259, P5040; Susin SA, 2000, METHOD ENZYMOL, V322, P205; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Utsumi T, 2003, FEBS LETT, V539, P37, DOI 10.1016/S0014-5793(03)00180-7; Veit M, 2000, BIOCHEM J, V345, P145, DOI 10.1042/0264-6021:3450145; Vilas GL, 2006, P NATL ACAD SCI USA, V103, P6542, DOI 10.1073/pnas.0600824103; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; WILCOX C, 1987, SCIENCE, V238, P1275, DOI 10.1126/science.3685978; WILLIAMSON G, 1984, BIOCHEM J, V218, P521, DOI 10.1042/bj2180521; Yang JY, 2005, BIOCHEMISTRY-US, V44, P11903, DOI 10.1021/bi0508082; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zhao LH, 2002, J BIOL CHEM, V277, P49352, DOI 10.1074/jbc.M209760200	66	101	104	1	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2008	22	3					721	732		10.1096/fj.07-9199com	http://dx.doi.org/10.1096/fj.07-9199com			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17971398	Green Accepted			2022-12-25	WOS:000254143700011
J	Padgett, CL; Lummis, SCR				Padgett, Claire L.; Lummis, Sarah C. R.			The F-loop of the GABA(A) receptor gamma(2) subunit contributes to benzodiazepine modulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GABA(A) RECEPTOR; STRUCTURAL DETERMINANTS; NICOTINIC RECEPTORS; AGONIST-BINDING; A RECEPTORS; CHANNEL; RESIDUES; SITE; MUTAGENESIS; SUBUNIT	GABA(A) receptors can be modulated by benzodiazepines, although these compounds do not directly activate or inhibit the receptors. The prototypic benzodiazepine, diazepam, potentiates responses to GABA in GABAA receptors that contain a gamma subunit. Here we have used mutagenesis, radioligand binding, voltage clamp electrophysiology, and homology modeling to probe the role of the F-loop residues Asp(192)-Arg(197) in the GABAA receptor gamma(2) subunit in diazepam potentiation of the GABA response. Substitution of all of these residues with Ala and/or a residue with similar chemical properties to the wild type residue decreased the level of diazepam potentiation, and one mutation (D192A) resulted in its complete ablation. None of the mutations changed the GABA EC50 or the [H-3] flumazenil binding affinity, suggesting they do not affect GABA or benzodiazepine binding characteristics; we therefore propose that they are involved in the diazepam-mediated conformational change that results in an increased response to GABA. Homology models of the receptor binding pocket in agonist-bound and unbound states suggest that the F-loop is flexible and has different orientations in the two states. Considering our data in relation to these models, we find that the F-loop residues could contribute to hydrogen bond networks and hydrophobic interactions with neighboring residues that change during receptor activation.	[Padgett, Claire L.; Lummis, Sarah C. R.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge	Lummis, SCR (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	sl120@cam.ac.uk			Wellcome Trust [051097] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Boileau AJ, 1999, J NEUROSCI, V19, P10213; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Buhr A, 1996, MOL PHARMACOL, V49, P1080; Campo-Soria C, 2006, BRIT J PHARMACOL, V148, P984, DOI 10.1038/sj.bjp.0706796; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; CZAJKOWSKI C, 1995, J BIOL CHEM, V270, P3160, DOI 10.1074/jbc.270.7.3160; Downing SS, 2005, BRIT J PHARMACOL, V145, P894, DOI 10.1038/sj.bjp.0706251; Jones-Davis DM, 2005, J NEUROSCI, V25, P8056, DOI 10.1523/JNEUROSCI.0348-05.2005; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; KAROBATH M, 1983, ADV BIOCHEM PSYCHOPH, V38, P37; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; KLEIN RL, 1994, J NEUROCHEM, V63, P2349; Kloda JH, 2007, MOL PHARMACOL, V71, P483, DOI 10.1124/mol.106.028662; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; LUMMIS SCR, 1993, EUR J PHARMACOL, V243, P7, DOI 10.1016/0014-2999(93)90160-J; Mercado J, 2006, J NEUROSCI, V26, P2031, DOI 10.1523/JNEUROSCI.4555-05.2006; Newell JG, 2003, J BIOL CHEM, V278, P13166, DOI 10.1074/jbc.M211905200; OSLEN RW, 1982, ANN REV PHARM TOXICO, V22, P245; Reeves DC, 2003, BIOPHYS J, V84, P2338, DOI 10.1016/S0006-3495(03)75039-5; Rusch D, 2005, ANESTHESIOLOGY, V102, P783; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sancar F, 2007, MOL PHARMACOL, V71, P38, DOI 10.1124/mol.106.029595; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Thompson AJ, 2006, J BIOL CHEM, V281, P16576, DOI 10.1074/jbc.M601265200; Turchin A, 1999, BIOTECHNIQUES, V26, P672, DOI 10.2144/99264st02; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031	30	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2702	2708		10.1074/jbc.M705699200	http://dx.doi.org/10.1074/jbc.M705699200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	17974564	hybrid			2022-12-25	WOS:000252622300027
J	Johnston, JW; Coussens, NP; Allen, S; Houtman, JCD; Turner, KH; Zaleski, A; Ramaswamy, S; Gibson, BW; Apicella, MA				Johnston, Jason W.; Coussens, Nathan P.; Allen, Simon; Houtman, Jon C. D.; Turner, Keith H.; Zaleski, Anthony; Ramaswamy, S.; Gibson, Bradford W.; Apicella, Michael A.			Characterization of the N-acetyl-5-neuraminic acid-binding site of the extracytoplasmic solute receptor (SiaP) of nontypeable Haemophilus influenzae strain 2019	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIALIC-ACID; STRUCTURAL-CHARACTERIZATION; SERUM RESISTANCE; LIPOPOLYSACCHARIDE; LIPOOLIGOSACCHARIDES; TRANSPORTER; IDENTIFICATION; SIALYLATION; ATCC-25586; COMPLEMENT	Nontypeable Haemophilus influenzae is an opportunistic human pathogen causing otitis media in children and chronic bronchitis and pneumonia in patients with chronic obstructive pulmonary disease. The outer membrane of nontypeable H. influenzae is dominated by lipooligosaccharides (LOS), many of which incorporate sialic acid as a terminal nonreducing sugar. Sialic acid has been demonstrated to be an important factor in the survival of the bacteria within the host environment. H. influenzae is incapable of synthesizing sialic acid and is dependent on scavenging free sialic acid from the host environment. To achieve this, H. influenzae utilizes a tripartite ATP-independent periplasmic transporter. In this study, we characterize the binding site of the extracytoplasmic solute receptor (SiaP) from nontypeable H. influenzae strain 2019. A crystal structure of N-acetyl-5-neuraminic acid (Neu5Ac)-bound SiaP was determined to 1.4 angstrom resolution. Thermodynamic characterization of Neu5Ac binding shows this interaction is enthalpically driven with a substantial unfavorable contribution from entropy. This is expected because the binding of SiaP to Neu5Ac is mediated by numerous hydrogen bonds and has several buried water molecules. Point mutations targeting specific amino acids were introduced in the putative binding site. Complementation with the mutated siaP constructs resulted either in full, partial, or no complementation, depending on the role of specific residues. Mass spectrometry analysis of the O-deacylated LOS of the R127K point mutation confirmed the observation of reduced incorporation of Neu5Ac into the LOS. The decreased ability of H. influenzae to import sialic acid had negative effects on resistance to complement-mediated killing and viability of biofilms in vitro, confirming the importance of sialic acid transport to the bacterium.	[Johnston, Jason W.; Houtman, Jon C. D.; Zaleski, Anthony; Apicella, Michael A.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Coussens, Nathan P.; Turner, Keith H.; Ramaswamy, S.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Allen, Simon; Gibson, Bradford W.] Buck Inst Age Res, Novato, CA 94945 USA	University of Iowa; University of Iowa; Buck Institute for Research on Aging	Apicella, MA (corresponding author), 51 Newton Rd, Iowa City, IA 52242 USA.	michael-apicella@uiowa.edu	Subramanian, Ramaswamy/Q-8671-2019; Turner, Keith/AAJ-6890-2021	Subramanian, Ramaswamy/0000-0002-6709-190X; Turner, Keith/0000-0002-3993-3831; Houtman, Jon/0000-0002-5307-9854	NIAID NIH HHS [AI07260-21, AI30040, AI024616] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024616, T32AI007260, R56AI024616, R37AI024616] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALEXEYEV MF, 1995, BIOTECHNIQUES, V18, P52; Allen S, 2005, INFECT IMMUN, V73, P5291, DOI 10.1128/IAI.73.9.5291-5300.2005; ANDREONI J, 1993, J INFECT DIS, V168, P227, DOI 10.1093/infdis/168.1.227; CAMPAGNARI AA, 1987, INFECT IMMUN, V55, P882, DOI 10.1128/IAI.55.4.882-887.1987; Dam J, 2005, BIOPHYS J, V89, P651, DOI 10.1529/biophysj.105.059584; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Figueira MA, 2007, INFECT IMMUN, V75, P325, DOI 10.1128/IAI.01054-06; Gibson BW, 1997, J AM SOC MASS SPECTR, V8, P645, DOI 10.1016/S1044-0305(97)00042-1; Greiner LL, 2004, INFECT IMMUN, V72, P4249, DOI 10.1128/IAI.72.7.4249-4260.2004; Hood DW, 1999, MOL MICROBIOL, V33, P679, DOI 10.1046/j.1365-2958.1999.01509.x; Hood DW, 2001, MOL MICROBIOL, V39, P341, DOI 10.1046/j.1365-2958.2001.02204.x; Johnston JW, 2007, MOL MICROBIOL, V66, P26, DOI 10.1111/j.1365-2958.2007.05890.x; Jones PA, 2002, J BIOL CHEM, V277, P14598, DOI 10.1074/jbc.M110986200; Kapatral V, 2003, GENOME RES, V13, P1180, DOI 10.1101/gr.566003; Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MANDRELL RE, 1992, INFECT IMMUN, V60, P1322, DOI 10.1128/IAI.60.4.1322-1328.1992; Mansson M, 2001, EUR J BIOCHEM, V268, P2148, DOI 10.1046/j.1432-1327.2001.02094.x; MARTINEZ J, 1995, J BACTERIOL, V177, P6005, DOI 10.1128/jb.177.20.6005-6010.1995; Masoud H, 1997, BIOCHEMISTRY-US, V36, P2091, DOI 10.1021/bi961989y; Mizan S, 2000, J BACTERIOL, V182, P6874, DOI 10.1128/JB.182.24.6874-6883.2000; Muller A, 2006, J BIOL CHEM, V281, P22212, DOI 10.1074/jbc.M603463200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; PHILLIPS NJ, 1992, BIOCHEMISTRY-US, V31, P4515, DOI 10.1021/bi00133a019; Post DMB, 2005, INFECT IMMUN, V73, P6727, DOI 10.1128/IAI.73.10.6727-6735.2005; Rao VK, 1999, FEMS MICROBIOL REV, V23, P99, DOI 10.1016/S0168-6445(98)00039-4; SCHWEDA EKH, 1993, CARBOHYD RES, V246, P319, DOI 10.1016/0008-6215(93)84043-6; Severi E, 2005, MOL MICROBIOL, V58, P1173, DOI 10.1111/j.1365-2958.2005.04901.x; Vimr E, 2000, MOL MICROBIOL, V36, P1113, DOI 10.1046/j.1365-2958.2000.01925.x; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V	32	58	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					855	865		10.1074/jbc.M706603200	http://dx.doi.org/10.1074/jbc.M706603200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17947229	hybrid			2022-12-25	WOS:000252128100026
J	Makabe, K; Nakanishi, T; Tsumoto, K; Tanaka, Y; Kondo, H; Umetsu, M; Sone, Y; Asano, R; Kumagai, I				Makabe, Koki; Nakanishi, Takeshi; Tsumoto, Kouhei; Tanaka, Yoshikazu; Kondo, Hidemasa; Umetsu, Mitsuo; Sone, Yukiko; Asano, Ryutaro; Kumagai, Izumi			Thermodynamic consequences of mutations in Vernier zone residues of a humanized anti-human epidermal growth factor receptor murine antibody-528	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENTARITY-DETERMINING REGIONS; RESHAPING HUMAN-ANTIBODIES; MOUSE MONOCLONAL-ANTIBODY; CANCER-IMMUNOTHERAPY; STRUCTURAL CONSEQUENCES; AFFINITY MATURATION; FRAMEWORK RESIDUES; LYSOZYME ANTIBODY; FAB FRAGMENTS; EGF-R	To investigate the role of Vernier zone residues, which are comprised in the framework regions and underlie the complementarity-determining regions (CDRs) of antibodies, in the specific, high affinity interactions of antibodies with their targets, we focused on the variable domain fragment of murine antihuman epidermal growth factor receptor antibody 528 (m528Fv). Grafting of the CDRs of m528Fv onto a selected framework region of human antibodies, referred to as humanization, reduced the antibody's affinity for its target by a factor of 1/40. The reduction in affinity was due to a substantial reduction in the negative enthalpy change associated with binding. Crystal structures of the ligand-free antibody fragments showed no noteworthy conformational changes due to humanization, and the loop structures of the CDRs of the humanized antibodies were identical to those of the parent antibodies. Several mutants of the CDR-grafted (humanized) variable domain fragment (h528Fv), in which some of the Vernier zone residues in the heavy chain were replaced with the parental murine residues, were constructed and prepared using a bacterial expression system. Thermodynamic analyses of the interactions between the mutants and the soluble extracellular domain of epidermal growth factor receptor showed that several single mutations and a double mutation increased the negative enthalpy and heat capacity changes. Combination of these mutations, however, led to somewhat reduced negative enthalpy and heat capacity changes. The affinity of each mutant for the target was within the range for the wild-type h528Fv, and this similarity was due to enthalpy-entropy compensation. These results suggest that Vernier zone residues make enthalpic contributions to antigen binding and that the regulation of conformational entropy changes upon humanization of murine antibodies must be carefully considered and optimized.	[Makabe, Koki; Nakanishi, Takeshi; Tsumoto, Kouhei; Tanaka, Yoshikazu; Umetsu, Mitsuo; Sone, Yukiko; Asano, Ryutaro; Kumagai, Izumi] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Kondo, Hidemasa] Natl Inst Adv Ind Sci & Technol, Res Inst Genome Based Biofactory, Toyohira Ku, Sapporo, Hokkaido 0628517, Japan	Tohoku University; National Institute of Advanced Industrial Science & Technology (AIST)	Kumagai, I (corresponding author), Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Aoba Ku, Aoba Yama 6-6-11-606, Sendai, Miyagi 9808579, Japan.	kmiz@kuma.che.tohoku.ac.jp	Asano, Ryutaro/G-7822-2016; Kondo, Hidemasa/M-7465-2018	Kondo, Hidemasa/0000-0003-2799-1775; Tanaka, Yoshikazu/0000-0002-7893-3236				AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Asano R, 2002, J BIOCHEM, V132, P903, DOI 10.1093/oxfordjournals.jbchem.a003303; Asano R, 2002, FEBS LETT, V528, P70, DOI 10.1016/S0014-5793(02)03254-4; Asano R, 2006, CLIN CANCER RES, V12, P4036, DOI 10.1158/1078-0432.CCR-06-0059; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baselga J, 2005, J CLIN ONCOL, V23, P2445, DOI 10.1200/JCO.2005.11.890; BHAT TN, 1990, NATURE, V347, P483, DOI 10.1038/347483a0; BRADEN BC, 1995, FASEB J, V9, P9, DOI 10.1096/fasebj.9.1.7821765; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Ciardiello F, 2001, CLIN CANCER RES, V7, P2958; Clark M, 2000, IMMUNOL TODAY, V21, P397, DOI 10.1016/S0167-5699(00)01680-7; CO MS, 1991, P NATL ACAD SCI USA, V88, P2869, DOI 10.1073/pnas.88.7.2869; CO MS, 1992, J IMMUNOL, V148, P1149; Cooper A, 1999, CURR OPIN CHEM BIOL, V3, P557, DOI 10.1016/S1367-5931(99)00008-3; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; DUNITZ JD, 1994, SCIENCE, V264, P670, DOI 10.1126/science.264.5159.670; Ewert S, 2004, METHODS, V34, P184, DOI 10.1016/j.ymeth.2004.04.007; FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M; Furukawa K, 1999, IMMUNITY, V11, P329, DOI 10.1016/S1074-7613(00)80108-9; Hayashi H, 2004, CANCER IMMUNOL IMMUN, V53, P497, DOI 10.1007/s00262-003-0465-9; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Holmes MA, 1997, J IMMUNOL, V158, P2192; Holmes MA, 2001, J IMMUNOL, V167, P296, DOI 10.4049/jimmunol.167.1.296; Jirholt P, 1998, GENE, V215, P471, DOI 10.1016/S0378-1119(98)00317-5; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Kabat EA, 1991, SEQUENCES PROTEINS I; Katayose Y, 1996, CANCER RES, V56, P4205; KAWAMOTO T, 1983, P NATL ACAD SCI-BIOL, V80, P1337, DOI 10.1073/pnas.80.5.1337; KETTLEBOROUGH CA, 1991, PROTEIN ENG, V4, P773, DOI 10.1093/protein/4.7.773; KIRKHAM PM, 1992, EMBO J, V11, P603, DOI 10.1002/j.1460-2075.1992.tb05092.x; KLIJN JGM, 1992, ENDOCR REV, V13, P3, DOI 10.1210/er.13.1.3; Kodama H, 2002, IMMUNOL LETT, V81, P99, DOI 10.1016/S0165-2478(01)00343-1; Kondo H, 1999, J BIOL CHEM, V274, P27623, DOI 10.1074/jbc.274.39.27623; Kumagai I, 2003, J BIOL CHEM, V278, P24929, DOI 10.1074/jbc.M301149200; Lachenmann MJ, 2004, PROTEIN SCI, V13, P3115, DOI 10.1110/ps.04866404; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LIVINGSTONE JR, 1991, BIOCHEMISTRY-US, V30, P4237, DOI 10.1021/bi00231a019; Lockhart C, 2005, SEMIN ONCOL, V32, P52, DOI 10.1053/j.seminoncol.2004.09.036; MARIUZZA RA, 1993, CURR OPIN IMMUNOL, V5, P50, DOI 10.1016/0952-7915(93)90080-C; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mendelsohn J, 2002, J CLIN ONCOL, V20, p1S, DOI 10.1200/JCO.2002.07.121; Morton CJ, 1996, PROTEIN SCI, V5, P2115, DOI 10.1002/pro.5560051018; Moyer JD, 1997, CANCER RES, V57, P4838; MURPHY KP, 1995, PROTEINS, V21, P83, DOI 10.1002/prot.340210202; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Nicaise M, 2004, PROTEIN SCI, V13, P1882, DOI 10.1110/ps.03540504; Nishibori N, 2006, MOL IMMUNOL, V43, P634, DOI 10.1016/j.molimm.2005.04.002; NONOMURA A, 1988, LIVER, V8, P157; OHTOMO T, 1995, MOL IMMUNOL, V32, P407, DOI 10.1016/0161-5890(95)00017-9; OOBATAKE M, 1993, PROG BIOPHYS MOL BIO, V59, P237, DOI 10.1016/0079-6107(93)90002-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padlan EA, 1996, ADV PROTEIN CHEM, V49, P57, DOI 10.1016/S0065-3233(08)60488-X; QUEEN C, 1989, P NATL ACAD SCI USA, V86, P10029, DOI 10.1073/pnas.86.24.10029; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; SATO K, 1994, MOL IMMUNOL, V31, P371; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SCHROEDER HW, 1990, INT IMMUNOL, V2, P41, DOI 10.1093/intimm/2.1.41; Shinoda M, 1998, CANCER RES, V58, P2838; SLIEKER LJ, 1985, J BIOL CHEM, V260, P687; Soderlind E, 2000, NAT BIOTECHNOL, V18, P852, DOI 10.1038/78458; SODERQUIST AM, 1984, J BIOL CHEM, V259, P2586; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Stern M, 2005, CRIT REV ONCOL HEMAT, V54, P11, DOI 10.1016/j.critrevonc.2004.10.011; Stockwin LH, 2003, BIOCHEM SOC T, V31, P433, DOI 10.1042/BST0310433; TAKAHASHI H, 1994, J MOL BIOL, V243, P494, DOI 10.1006/jmbi.1994.1675; Takemura S, 2002, CANCER IMMUNOL IMMUN, V51, P33, DOI 10.1007/s00262-001-0245-3; TORIGOE H, 1995, J BIOL CHEM, V270, P22218, DOI 10.1074/jbc.270.38.22218; TSUMOTO K, 1995, J BIOL CHEM, V270, P18551, DOI 10.1074/jbc.270.31.18551; Tsumoto K, 1998, J IMMUNOL METHODS, V219, P119, DOI 10.1016/S0022-1759(98)00127-6; VERHOEYEN M, 1988, SCIENCE, V239, P1534, DOI 10.1126/science.2451287; WEBER G, 1993, J PHYS CHEM-US, V97, P7108, DOI 10.1021/j100129a031; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; Wells A, 2000, ADV CANCER RES, V78, P31; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Xie HF, 2001, BIOCHEMISTRY-US, V40, P5700, DOI 10.1021/bi010034z; Yokota A, 2003, J BIOL CHEM, V278, P5410, DOI 10.1074/jbc.M210182200; Yoon SO, 2006, J BIOL CHEM, V281, P6985, DOI 10.1074/jbc.M511165200; Zolotnitsky G, 2004, P NATL ACAD SCI USA, V101, P11275, DOI 10.1073/pnas.0404311101	84	67	93	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1156	1166		10.1074/jbc.M706190200	http://dx.doi.org/10.1074/jbc.M706190200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17947238	hybrid			2022-12-25	WOS:000252128100056
J	Bloomer, WAC; VanDongen, HMA; VanDongen, AMJ				Bloomer, Wendy A. C.; VanDongen, Hendrika M. A.; VanDongen, Antonius M. J.			Arc/Arg3.1 translation is controlled by convergent N-methyl-D-aspartate and G(s)-coupled receptor signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; ARC MESSENGER-RNA; KINASE/EXTRACELLULAR REGULATED KINASE; CYTOSKELETON-ASSOCIATED PROTEIN; I ADENYLYL-CYCLASE; NMDA RECEPTOR; RESPONSE ELEMENT; EXPRESSION; ACTIVATION	Arc/Arg3.1 is an immediate early gene whose expression is necessary for the late-phase of long-term potentiation (LTP) and memory consolidation. Whereas pathways regulating Arc transcription have been extensively investigated, less is known about the role of post-transcriptional mechanisms in Arc expression. Fluorescence microscopy experiments in cultured hippocampal neurons revealed that Arc protein level was dramatically increased by activation of the cAMP-dependent protein kinase (PKA) pathway, which is implicated in long-term memory. A PKA-dependent increase in Arc protein level was observed after pharmacological or synaptic activation of N-methyl-D-aspartate (NMDA) receptors, which play a critical role in both LTP induction and learning. Arc protein was also up-regulated by activation of PKA through G(s)-coupled dopamine and beta-adrenergic receptors, which regulate the late-phase of LTP and memory. When agonists for the NMDA and G(s)-coupled receptors were co-applied, they had an additive effect on Arc protein expression. Interestingly, G(s)-coupled receptor stimulation was ineffective in the presence of an NMDA receptor antagonist, suggesting calcium influx through the NMDA receptor plays a gating role in this pathway. Stimulation of the cAMP/PKA pathway did not affect Arc mRNA level or protein stability, identifying translational efficacy as the main determinant of Arc protein expression level. It is concluded that efficient Arc translation requires NMDA receptor activity, whereas a further enhancement can be achieved with activation of G(s)-coupled receptors. These experiments have, therefore, revealed remarkable similarities in the signaling pathways that control Arc expression and those that regulate LTP, learning, and memory.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	VanDongen, AMJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, PO Box 3813, Durham, NC 27710 USA.	vando005@mc.duke.edu		VanDongen, Antonius/0000-0002-9923-3407				Ainger K, 1997, J CELL BIOL, V138, P1077, DOI 10.1083/jcb.138.5.1077; Bagni C, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0004.2000; Bailey CH, 2000, NAT REV NEUROSCI, V1, P11, DOI 10.1038/35036191; Bock J, 2005, NEUROSCIENCE, V133, P625, DOI 10.1016/j.neuroscience.2005.02.048; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Chotiner JK, 2003, NEUROSCIENCE, V116, P743, DOI 10.1016/S0306-4522(02)00797-2; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Corner MA, 2002, NEUROSCI BIOBEHAV R, V26, P127, DOI 10.1016/S0149-7634(01)00062-8; Dong E, 2003, P NATL ACAD SCI USA, V100, P5479, DOI 10.1073/pnas.1031602100; Fiorentini C, 2003, J BIOL CHEM, V278, P20196, DOI 10.1074/jbc.M213140200; FOSNAUGH JS, 1995, J NEUROCHEM, V64, P2377; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; HABETS AMMC, 1987, EXP BRAIN RES, V69, P43, DOI 10.1007/BF00247027; Kelly MP, 2002, NEUROSCIENCE, V110, P617, DOI 10.1016/S0306-4522(01)00605-4; Kobayashi H, 2005, EUR J NEUROSCI, V22, P2977, DOI 10.1111/j.1460-9568.2005.04508.x; Kosturko LD, 2006, MOL BIOL CELL, V17, P3521, DOI 10.1091/mbc.E05-10-0946; Kremerskothen J, 2002, NEUROSCI LETT, V321, P153, DOI 10.1016/S0304-3940(01)02532-0; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Li L, 2005, MOL CELL BIOL, V25, P10286, DOI 10.1128/MCB.25.23.10286-10300.2005; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Lin H, 2004, BIOCHEM BIOPH RES CO, V316, P501, DOI 10.1016/j.bbrc.2004.02.086; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; McIntyre CK, 2005, P NATL ACAD SCI USA, V102, P10718, DOI 10.1073/pnas.0504436102; Montag-Sallaz M, 1999, J NEUROBIOL, V38, P234, DOI 10.1002/(SICI)1097-4695(19990205)38:2<234::AID-NEU6>3.0.CO;2-G; Pei L, 2004, J NEUROSCI, V24, P1149, DOI 10.1523/JNEUROSCI.3922-03.2004; Pei Q, 2000, NEUROPHARMACOLOGY, V39, P463, DOI 10.1016/S0028-3908(99)00148-3; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Rodriguez JJ, 2005, EUR J NEUROSCI, V21, P2384, DOI 10.1111/j.1460-9568.2005.04068.x; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Schiltz CA, 2005, EUR J NEUROSCI, V21, P1703, DOI 10.1111/j.1460-9568.2005.04001.x; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shan JG, 2000, J BIOL CHEM, V275, P38286, DOI 10.1074/jbc.M007642200; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Sutton MA, 2005, J NEUROBIOL, V64, P116, DOI 10.1002/neu.20152; Teber I, 2004, MOL BRAIN RES, V121, P131, DOI 10.1016/j.molbrainres.2003.11.017; Thomas GM, 2005, P NATL ACAD SCI USA, V102, P15006, DOI 10.1073/pnas.0507476102; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Ven TJV, 2005, J NEUROSCI, V25, P9488, DOI 10.1523/JNEIROSCI.2450-05.2005; Waltereit R, 2001, J NEUROSCI, V21, P5484, DOI 10.1523/JNEUROSCI.21-15-05484.2001; Wang C, 2005, INT J GREEN ENERGY, V2, P91, DOI 10.1081/GE-200051313; Wang HB, 2002, J NEUROCHEM, V83, P946, DOI 10.1046/j.1471-4159.2002.01206.x; WAYMAN GA, 1994, J BIOL CHEM, V269, P25400; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; Young JZ, 2006, EUR J NEUROSCI, V23, P1784, DOI 10.1111/j.1460-9568.2006.04707.x; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5	57	55	64	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					582	592		10.1074/jbc.M702451200	http://dx.doi.org/10.1074/jbc.M702451200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17981809	Green Published, hybrid			2022-12-25	WOS:000251940300063
J	Siafakas, AR; Sorrell, TC; Wright, LC; Wilson, C; Larsen, M; Boadle, R; Williamson, PR; Djordjevic, JT				Siafakas, A. Rosemary; Sorrell, Tania C.; Wright, Lesley C.; Wilson, Christabel; Larsen, Michelle; Boadle, Ross; Williamson, Peter R.; Djordjevic, Julianne T.			Cell wall-linked cryptococcal phospholipase B1 is a source of secreted enzyme and a determinant of cell wall integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ALPHA-AGGLUTININ; VIRULENCE FACTOR; CANDIDA-ALBICANS; NEOFORMANS; PROTEIN; YEAST; IDENTIFICATION; MANNOPROTEINS; LYSOPHOSPHOLIPASE	Phospholipase B (plb1) is secreted by pathogenic fungi and is a proven virulence determinant in Cryptococcus neoformans. Cell-associated plb1 is presumptively involved in fungal membrane biogenesis and remodelling. We have also identified it in cryptococcal cell walls. Motif scanning programs predict that Plb1 is attached to cryptococcal membranes via a glycosylphosphatidylinositol (GPI) anchor, which could regulate Plb1 export and secretion. A functional GPI anchor was identified in cellassociated Plb1 by (G) PI-specific phospholipase C (PLC)-induced release of Plb1 from strain H99 membrane rafts and inhibition of GPI anchor synthesis by YW3548, which prevented Plb1 secretion and transport to membranes and cell walls. Plb1 containing beta-1,6-linked glucan was released from H99 (wildtype strain) cell walls by beta-1,3 glucanase, consistent with covalent attachment of Plb1 via beta-1,6-linked glucans to beta-1,3-linked glucan in the central scaffold of the wall. Naturally secreted Plb1 also contained beta-1,6-linked glucan, confirming that it originated from the cell wall. Plb1 maintains cell wall integrity because a H99 deletion mutant, Delta PLB1, exhibited a morphological defect and was more susceptible than H99 to cell wall disruption by SDS and Congo red. Growth of Delta PLB1 was unaffected by caffeine, excluding an effect of Plb1 on cell wall biogenesis-related signaling pathways. Environmental (heat) stress caused Plb1 accumulation in cell walls, with loss from membranes and reduced secretion, further supporting the importance of Plb1 in cell wall integrity. This is the first demonstration that Plb1 contributes to fungal survival by maintaining cell wall integrity and that the cell wall is a source of secreted enzyme.	[Siafakas, A. Rosemary; Sorrell, Tania C.; Wright, Lesley C.; Wilson, Christabel; Larsen, Michelle; Djordjevic, Julianne T.] Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol, Westmead Millennium Inst, Sydney, NSW 2145, Australia; [Boadle, Ross] Westmead Hosp, Westmead Millennium Inst, ICPMR, Electron Microscope Lab, Sydney, NSW 2145, Australia; [Williamson, Peter R.] Univ Illinois, Coll Med, Dept Med, Infect Dis Sect, Chicago, IL 60612 USA	University of Sydney; Westmead Institute for Medical Research; University of Sydney; Westmead Institute for Medical Research; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Djordjevic, JT (corresponding author), Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol, Westmead Millennium Inst, Level 3 ICPMR Bldg, Sydney, NSW 2145, Australia.	julie_djordjevic@wmi.usyd.edu.au	Sorrell, Tania/AAZ-5286-2020	Espedido, Aritee Rosemary/0000-0002-8059-1757; Sorrell, Tania/0000-0001-9460-0960; Djordjevic, Julianne/0000-0003-4207-4115				Banks IR, 2005, EUKARYOT CELL, V4, P1902, DOI 10.1128/EC.4.11.1902-1912.2005; Bates S, 2006, J BIOL CHEM, V281, P90, DOI 10.1074/jbc.M510360200; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Brul S, 1997, ANTON LEEUW INT J G, V72, P229, DOI 10.1023/A:1000429208049; Chen SCA, 1997, J INFECT DIS, V175, P414, DOI 10.1093/infdis/175.2.414; Chen SCA, 1997, INFECT IMMUN, V65, P405, DOI 10.1128/IAI.65.2.405-411.1997; Chen SCA, 2000, BIOCHEM J, V347, P431, DOI 10.1042/0264-6021:3470431; Cox GM, 2001, MOL MICROBIOL, V39, P166, DOI 10.1046/j.1365-2958.2001.02236.x; DENOBEL JG, 1990, YEAST, V6, P491, DOI 10.1002/yea.320060606; Djordjevic JT, 2005, BIOCHEM J, V389, P803, DOI 10.1042/BJ20050063; Eigenheer RA, 2007, FEMS YEAST RES, V7, P499, DOI 10.1111/j.1567-1364.2006.00198.x; Fujii T, 1999, BBA-GEN SUBJECTS, V1427, P133, DOI 10.1016/S0304-4165(99)00012-4; Hamilton AJ, 1997, INFECT IMMUN, V65, P488, DOI 10.1128/IAI.65.2.488-494.1997; Heung LJ, 2005, J BIOL CHEM, V280, P28547, DOI 10.1074/jbc.M503404200; Himmelreich U, 2003, MICROBES INFECT, V5, P285, DOI 10.1016/S1286-4579(03)00028-5; Kapteyn JC, 1996, GLYCOBIOLOGY, V6, P337, DOI 10.1093/glycob/6.3.337; Kollar R, 1997, J BIOL CHEM, V272, P17762, DOI 10.1074/jbc.272.28.17762; Kraus PR, 2003, MOL MICROBIOL, V48, P1377, DOI 10.1046/j.1365-2958.2003.03508.x; Kuranda K, 2006, MOL MICROBIOL, V61, P1147, DOI 10.1111/j.1365-2958.2006.05300.x; LEE KS, 1994, J BIOL CHEM, V269, P19725; Levitz SM, 2006, FEMS YEAST RES, V6, P513, DOI 10.1111/j.1567-1364.2006.00071.x; Lipke PN, 1998, J BACTERIOL, V180, P3735, DOI 10.1128/JB.180.15.3735-3740.1998; LU CF, 1995, J CELL BIOL, V128, P333, DOI 10.1083/jcb.128.3.333; LU CF, 1994, MOL CELL BIOL, V14, P4825, DOI 10.1128/MCB.14.7.4825; Macekova D, 2006, J BASIC MICROB, V46, P470, DOI 10.1002/jobm.200610143; Martinez-Lopez R, 2004, MICROBIOL-SGM, V150, P3341, DOI 10.1099/mic.0.27320-0; Muller G, 1996, MOL CELL BIOL, V16, P442; Muller G, 2000, BIOCHEMISTRY-US, V39, P1475, DOI 10.1021/bi9920432; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Reese AJ, 2003, MOL MICROBIOL, V50, P1401, DOI 10.1046/j.1365-2958.2003.03780.x; Rodrigues ML, 2007, EUKARYOT CELL, V6, P48, DOI 10.1128/EC.00318-06; Santangelo R, 2004, INFECT IMMUN, V72, P2229, DOI 10.1128/IAI.72.4.2229-2239.2004; Santangelo RT, 1999, J MED MICROBIOL, V48, P731, DOI 10.1099/00222615-48-8-731; Siafakas AR, 2006, EUKARYOT CELL, V5, P488, DOI 10.1128/EC.5.3.488-498.2006; Sutterlin C, 1997, EMBO J, V16, P6374, DOI 10.1093/emboj/16.21.6374; Sutterlin C, 1997, J CELL SCI, V110, P2703; WOJCIECHOWICZ D, 1993, MOL CELL BIOL, V13, P2554, DOI 10.1128/MCB.13.4.2554; Zhu XD, 2001, INFECT IMMUN, V69, P5589, DOI 10.1128/IAI.69.9.5589-5596.2001	38	62	64	5	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37508	37514		10.1074/jbc.M707913200	http://dx.doi.org/10.1074/jbc.M707913200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17947228	hybrid			2022-12-25	WOS:000251833600026
J	Knutson, CG; Wang, H; Rizzo, CJ; Marnett, LJ				Knutson, Charles G.; Wang, Hao; Rizzo, Carmelo J.; Marnett, Lawrence J.			Metabolism and elimination of the endogenous DNA adduct, 3-(2-deoxy-beta-D-erythropentofuranosyl)-pyrimido[1,2-alpha]purine-10(3H)-one, in the rat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; IN-VIVO; MALONDIALDEHYDE; DEOXYGUANOSINE; URINE; ACIDS; CARCINOGENESIS; PEROXIDATION; INFLAMMATION; NUCLEOSIDES	Endogenously occurring damage to DNA is a contributing factor to the onset of several genetic diseases, including cancer. Monitoring urinary levels of DNA adducts is one approach to assess genomic exposure to endogenous damage. However, metabolism and alternative routes of elimination have not been considered as factors that may limit the detection of DNA adducts in urine. We recently demonstrated that the peroxidation-derived deoxyguanosine adduct, 3-(2-deoxy-beta-D-erythropentofuranosyl)-pyrimido[1,2-alpha] purine-10(3H)one (M(1)dG), is subject to enzymatic oxidation in vivo resulting in the formation of a major metabolite, 6-oxo-M(1)dG. Based on the administration of [C-14] M1dG (22 mu Ci/kg) to Sprague-Dawley rats (n = 4), we now report that 6-oxo-M1dG is the principal metabolite of M(1)dG in vivo representing 45% of the total administered dose. When [C-14] 6-oxo-M(1)dG was administered to Sprague-Dawley rats, 6-oxo-M(1)dG was recovered unchanged (> 97% stability). These studies also revealed that M(1)dG and 6- oxo-M(1)dG are subject to biliary elimination. Additionally, both M(1)dG and 6- oxo-M(1)dG exhibited a long residence time following administration (> 48 h), and the major species observed in urine at late collections was 6-oxo-M(1)dG.	Vanderbilt Univ, Sch Med,AB Hancock Jr Mem Lab Canc Res, Dept Biochem,Vanderbilt Ingram Canc Ctr, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Chem,Vanderbilt Ingram Canc Ctr, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol,Vanderbilt Ingram Canc Ctr, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med,AB Hancock Jr Mem Lab Canc Res, Dept Biochem,Vanderbilt Ingram Canc Ctr, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol, 850 A Robinson Res Bldg, Nashville, TN 37232 USA.	larry.marnett@vanderbilt.edu		Rizzo, Carmelo/0000-0001-9005-611X	NCI NIH HHS [CA87819] Funding Source: Medline; NIEHS NIH HHS [T32 ES007028] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA087819, R37CA087819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BASU AK, 1988, CHEM RES TOXICOL, V1, P53, DOI 10.1021/tx00001a010; BASU AK, 1983, CARCINOGENESIS, V4, P331, DOI 10.1093/carcin/4.3.331; CHAUDHARY AK, 1994, SCIENCE, V265, P1580, DOI 10.1126/science.8079172; Dedon PC, 1998, P NATL ACAD SCI USA, V95, P11113, DOI 10.1073/pnas.95.19.11113; Dedon PC, 2004, ARCH BIOCHEM BIOPHYS, V423, P12, DOI 10.1016/j.abb.2003.12.017; DICZFALUSY U, 1977, FEBS LETT, V84, P271, DOI 10.1016/0014-5793(77)80704-7; Fink SP, 1997, P NATL ACAD SCI USA, V94, P8652, DOI 10.1073/pnas.94.16.8652; HAMBERG M, 1967, J BIOL CHEM, V242, P5344; Hamilton SR, 2001, J BIOL CHEM, V276, P27981, DOI 10.1074/jbc.M100518200; Hoberg AM, 2004, J MASS SPECTROM, V39, P38, DOI 10.1002/jms.547; Jeong YC, 2005, FREE RADICAL BIO MED, V39, P1021, DOI 10.1016/j.freeradbiomed.2005.05.018; Johnson KA, 1997, J BIOL CHEM, V272, P11434; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Knutson CG, 2007, CHEM RES TOXICOL, V20, P550, DOI 10.1021/tx600334x; MEYER C, 1993, SYNLETT, P386; Niedernhofer LJ, 2003, J BIOL CHEM, V278, P31426, DOI 10.1074/jbc.M212549200; Ohshima H, 2003, ARCH BIOCHEM BIOPHYS, V417, P3, DOI 10.1016/S0003-9861(03)00283-2; Otteneder M, 2003, ANAL BIOCHEM, V315, P147, DOI 10.1016/S0003-2697(02)00697-8; Otteneder MB, 2006, P NATL ACAD SCI USA, V103, P6665, DOI 10.1073/pnas.0602017103; SETO H, 1983, B CHEM SOC JPN, V56, P1799, DOI 10.1246/bcsj.56.1799; Sundaram M, 2001, J BIOL CHEM, V276, P45270, DOI 10.1074/jbc.M107169200; SZEKELY J, 2007, IN PRESS NUCLEOSIDES, V26; VanderVeen LA, 2003, P NATL ACAD SCI USA, V100, P14247, DOI 10.1073/pnas.2332176100; Wada S, 2000, J PHARMACOL EXP THER, V294, P844; Wang MY, 1997, CHEM RES TOXICOL, V10, P772, DOI 10.1021/tx960193x; World Health Organization, 2001, IPCS ENV HLTH CRIT 2; Zhou XF, 2005, J BIOL CHEM, V280, P25377, DOI 10.1074/jbc.M503079200	28	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36257	36264		10.1074/jbc.M706814200	http://dx.doi.org/10.1074/jbc.M706814200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17951255	hybrid			2022-12-25	WOS:000251458300016
J	Lamour, V; Detry, C; Sanchez, C; Henrotin, Y; Castronovo, V; Bellahcene, A				Lamour, Virginie; Detry, Cedric; Sanchez, Christelle; Henrotin, Yves; Castronovo, Vincent; Bellahcene, Akeila			Runx2-and histone deacetylase 3-mediated repression is relieved in differentiating human osteoblast cells to allow high bone sialoprotein expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MINERALIZED TISSUE FORMATION; MESSENGER-RNA EXPRESSION; TRANSCRIPTION FACTOR; OSTEOSARCOMA CELL; CANCER-CELLS; HUMAN BREAST; OSTEOCALCIN PROMOTER; MATRIX PROTEIN; MARROW CELLS; LINE SAOS-2	Bone sialoprotein (BSP) is a bone matrix glycoprotein whose expression coincides with terminal osteoblastic differentiation and the onset of mineralization. In this study we show that BSP expression is considerably increased in confluent Saos-2 human osteosarcoma cells and in differentiating normal human osteoblasts, concomitantly with the decrease of Runx2, a key transcription factor controlling bone formation. Therefore, we investigated the role of Runx2 in the regulation of BSP expression in Saos-2 cells. Using a mobility shift assay, we demonstrated that Runx2 binds to the BSP promoter only in preconfluent cells. Histone deacetylase 3 (HDAC3) has been recently shown to act as a Runx2 co-repressor. Chromatin immunoprecipitation assays demonstrated that both Runx2 and HDAC3 are detectable at the BSP promoter in preconfluent Saos-2 cells but not when they are confluent and overexpress BSP. Consistently, nuclear Runx2 protein level is down-regulated, whereas Saos-2 cells became increasingly confluent. Finally, the suppression of HDAC3, Runx2, or both by RNA interference induced the expression of BSP at both mRNA and protein levels in Saos-2 cells. Our data demonstrate that Runx2 and HDAC3 repress BSP gene expression and that this repression is suspended upon osteoblastic cell differentiation. Both the nuclear disappearance of Runx2 and the non-recruitment of HDAC3 represent new means to relieve Runx2-mediated suppression of BSP expression, thus allowing the acquisition of a fully differentiated and mineralization-competent phenotype by osteoblast cells.	Univ Liege, Metastasis Res Lab, Ctr Expt Canc Res, B-4000 Liege, Belgium; Univ Liege, Bone & Cartilage Metab Res Unit, B-4000 Liege, Belgium	University of Liege; University of Liege	Bellahcene, A (corresponding author), Univ Liege, Metastasis Res Lab, Ctr Expt Canc Res, Bat B23, B-4000 Liege, Belgium.	a.bellahcene@ulg.ac.be		Henrotin, Yves/0000-0003-1073-449X; sanchez, christelle/0000-0002-1005-8172				Bae SC, 2006, GENE, V366, P58, DOI 10.1016/j.gene.2005.10.017; Banerjee C, 2001, ENDOCRINOLOGY, V142, P4026, DOI 10.1210/en.142.9.4026; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; Barnes GL, 2003, CANCER RES, V63, P2631; Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10622; Bellahcene A, 2007, BREAST CANCER RES TR, V101, P135, DOI 10.1007/s10549-006-9279-8; BELLAHCENE A, 1994, CANCER RES, V54, P2823; Benson MD, 1999, J BONE MINER RES, V14, P396, DOI 10.1359/jbmr.1999.14.3.396; BIANCO P, 1991, CALCIFIED TISSUE INT, V49, P421, DOI 10.1007/BF02555854; Brenner O, 2004, P NATL ACAD SCI USA, V101, P16016, DOI 10.1073/pnas.0407180101; Chaplet ML, 2004, BIOCHEM J, V384, P591, DOI 10.1042/BJ20040380; Chen J, 2003, CONNECT TISSUE RES, V44, P279, DOI 10.1080/03008200390181771; CHEN JK, 1992, J BONE MINER RES, V7, P987; CHEN JK, 1991, MATRIX, V11, P133, DOI 10.1016/S0934-8832(11)80217-9; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Drissi H, 1999, CANCER RES, V59, P3705; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; FISHER LW, 1990, J BIOL CHEM, V265, P2347; FLORES ME, 1992, EXP CELL RES, V201, P526, DOI 10.1016/0014-4827(92)90305-R; Floyd ZE, 2001, J BIOL CHEM, V276, P22468, DOI 10.1074/jbc.M009388200; Fujita T, 2001, BIOCHEM BIOPH RES CO, V280, P348, DOI 10.1006/bbrc.2000.4108; Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hassig CA, 1997, CURR OPIN CHEM BIOL, V1, P300, DOI 10.1016/S1367-5931(97)80066-X; Hoshi K, 1999, BONE, V25, P639, DOI 10.1016/S8756-3282(99)00223-9; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175; IBARAKI K, 1992, J BONE MINER RES, V7, P743; IKEDA K, 1990, BIOCHEM BIOPH RES CO, V168, P889, DOI 10.1016/0006-291X(90)91112-6; Javed A, 2001, MOL CELL BIOL, V21, P2891, DOI 10.1128/MCB.21.8.2891-2905.2001; Javed A, 2000, J CELL SCI, V113, P2221; Jimenez MJG, 1999, MOL CELL BIOL, V19, P4431; KASUGAI S, 1991, J CELL PHYSIOL, V147, P111, DOI 10.1002/jcp.1041470115; Kim RH, 1996, BIOCHEM J, V318, P219, DOI 10.1042/bj3180219; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Lee HW, 2006, MOL ENDOCRINOL, V20, P2432, DOI 10.1210/me.2006-0061; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Lian JB, 2003, J CELL PHYSIOL, V196, P301, DOI 10.1002/jcp.10316; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; MCQUILLAN DJ, 1995, BONE, V16, P415; MURRAY E, 1987, J BONE MINER RES, V2, P231; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; OLDBERG A, 1988, J BIOL CHEM, V263, P19433; OLDBERG A, 1989, J CELL BIOL, V109, P3183, DOI 10.1083/jcb.109.6.3183; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Porte D, 1999, ONCOGENE, V18, P667, DOI 10.1038/sj.onc.1202333; Pratap J, 2005, MOL CELL BIOL, V25, P8581, DOI 10.1128/MCB.25.19.8581-8591.2005; Prince M, 2001, J CELL BIOCHEM, V80, P424, DOI 10.1002/1097-4644(20010301)80:3<424::AID-JCB160>3.0.CO;2-6; Roca H, 2005, J BIOL CHEM, V280, P30845, DOI 10.1074/jbc.M503942200; RODAN SB, 1987, CANCER RES, V47, P4961; ROSS FP, 1993, J BIOL CHEM, V268, P9901; Sanchez C, 2005, OSTEOARTHR CARTILAGE, V13, P988, DOI 10.1016/j.joca.2005.07.012; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; Schroeder TM, 2005, J BONE MINER RES, V20, P2254, DOI 10.1359/JBMR.050813; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Shen J, 2003, MOL ENDOCRINOL, V17, P743, DOI 10.1210/me.2002-0122; Shen R, 2006, J BIOL CHEM, V281, P16347, DOI 10.1074/jbc.M603439200; Shirangi TR, 2002, FASEB J, V16, P420, DOI 10.1096/fj.01-0617fje; Shui CX, 2003, J BONE MINER RES, V18, P213, DOI 10.1359/jbmr.2003.18.2.213; Song A, 1998, MOL CELL BIOL, V18, P4994, DOI 10.1128/MCB.18.9.4994; Sudhakar S, 2001, BIOCHEM BIOPH RES CO, V286, P74, DOI 10.1006/bbrc.2001.5363; VILLARREAL XC, 1989, BIOCHEMISTRY-US, V28, P6483, DOI 10.1021/bi00441a049; Waltregny D, 2000, J BONE MINER RES, V15, P834, DOI 10.1359/jbmr.2000.15.5.834; Yang J, 2001, CANCER RES, V61, P5652; YAO KL, 1994, J BONE MINER RES, V9, P231; Yeung F, 2002, J BIOL CHEM, V277, P2468, DOI 10.1074/jbc.M105947200; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zhang JH, 2003, INT J ONCOL, V23, P1043	73	55	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36240	36249		10.1074/jbc.M705833200	http://dx.doi.org/10.1074/jbc.M705833200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17956871	hybrid			2022-12-25	WOS:000251458300014
J	Moffatt, P; Thomas, G; Sellin, K; Bessette, MC; Lafreniere, F; Akhouayri, O; St-Arnaud, R; Lanctot, C				Moffatt, Pierre; Thomas, Gethin; Sellin, Karine; Bessette, Marie-Claude; Lafreniere, Francois; Akhouayri, Omar; St-Arnaud, Rene; Lanctot, Christian			Osteocrin is a specific ligand of the natriuretic peptide clearance receptor that modulates bone growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-RECEPTOR; CHONDROCYTE PROLIFERATION; SKELETAL OVERGROWTH; MESSENGER-RNA; EXPRESSION; OSTEOBLAST; ANP; DIFFERENTIATION; STIMULATION; MUSCLIN	Osteocrin (Ostn) is a recently discovered secreted protein produced by cells of the osteoblast lineage that shows a well conserved homology with members of the natriuretic peptide (NP) family. We hypothesized that Ostn could interact with the NP receptors, thereby modulating NP actions on the skeleton. Ostn binds specifically and saturably to the NP peptide receptor-C (NPR-C) receptor with a K-d of similar to 5 nM with no binding to the GC-A or GC-B receptors. Deletion of several of the residues deemed important for NP binding to NPR-C led to abolition of Ostn binding, confirming the presence of a "natriuretic motif." Functionally, Ostn was able to augment C-type natriuretic peptide-stimulated cGMP production in both pre-chondrocytic (ATDC5) and osteoblastic (UMR106) cells, suggesting increased NP levels due to attenuation of NPR-C associated NP clearance. Ostn-transgenic mice displayed elongated bones and a marked kyphosis associated with elevated bone cGMP levels, suggesting that elevated natriuretic peptide activity contributed to the increased bone length possibly through an increase in growth plate chondrocyte proliferation. Thus, we have demonstrated that Ostn is a naturally occurring ligand of the NPR-C clearance receptor and may act to locally modulate the actions of the natriuretic system in bone by blocking the clearance action of NPR-C, thus locally elevating levels of C-type natriuretic peptide.	Shriners Hosp Children, Montreal, PQ H3G 1A6, Canada; McGill Univ, Dept Human Genet, Montreal, PQ H3A 2T5, Canada; Enobia Pharma, Montreal, PQ H1W 4A4, Canada; Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld, Australia; Phenogene Therapeut, Montreal, PQ H3A 1L2, Canada	McGill University; McGill University; University of Queensland	Moffatt, P (corresponding author), Shriners Hosp Children, 1529 Cedar Ave, Montreal, PQ H3G 1A6, Canada.	pmoffatt@shriners.mcgill.ca	Thomas, Gethin P/A-3624-2011	Lanctot, Christian/0000-0003-3211-3061; Thomas, Gethin/0000-0001-9081-3686; Moffatt, Pierre/0000-0002-5793-1944	CIHR [68826-1] Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR))		ANANDSRIVASTAVA MB, 1990, J BIOL CHEM, V265, P8566; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Banzet S, 2007, BIOCHEM BIOPH RES CO, V353, P713, DOI 10.1016/j.bbrc.2006.12.074; Bartels CF, 2004, AM J HUM GENET, V75, P27, DOI 10.1086/422013; Bord S, 2005, J HISTOCHEM CYTOCHEM, V53, P1181, DOI 10.1369/jhc.4C6561.2005; BOURQUE WT, 1993, J HISTOCHEM CYTOCHEM, V41, P1429, DOI 10.1177/41.9.7689084; Chauhan SD, 2003, P NATL ACAD SCI USA, V100, P1426, DOI 10.1073/pnas.0336365100; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Chusho H, 2000, ENDOCRINOLOGY, V141, P3807, DOI 10.1210/en.141.10.3807; Chusho H, 2001, P NATL ACAD SCI USA, V98, P4016, DOI 10.1073/pnas.071389098; Dacic S, 2001, J BONE MINER RES, V16, P1228, DOI 10.1359/jbmr.2001.16.7.1228; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Flanagan JG, 2000, METHOD ENZYMOL, V327, P198, DOI 10.1016/S0076-6879(00)27277-7; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; FLETCHER AE, 1986, FEBS LETT, V208, P263, DOI 10.1016/0014-5793(86)81029-8; Fujishige K, 1999, BBA-MOL CELL RES, V1452, P219, DOI 10.1016/S0167-4889(99)00141-X; Hagiwara H, 1996, J BIOCHEM-TOKYO, V119, P264; HAGIWARA H, 1994, J BIOL CHEM, V269, P10729; Hagiwara H, 1996, AM J PHYSIOL-CELL PH, V270, pC1311, DOI 10.1152/ajpcell.1996.270.5.C1311; He XL, 2001, SCIENCE, V293, P1657, DOI 10.1126/science.1062246; HIRATA Y, 1985, BIOCHEM BIOPH RES CO, V128, P538, DOI 10.1016/0006-291X(85)90080-4; Hirose S, 2001, CAN J PHYSIOL PHARM, V79, P665, DOI 10.1139/cjpp-79-8-665; Hogan B, 1994, MANIPULATING MOUSE E; Inoue A, 1996, BIOCHEM BIOPH RES CO, V221, P703, DOI 10.1006/bbrc.1996.0660; Jaubert J, 1999, P NATL ACAD SCI USA, V96, P10278, DOI 10.1073/pnas.96.18.10278; JOHN SWM, 1995, SCIENCE, V267, P679, DOI 10.1126/science.7839143; Kaneki H, 2001, J BONE MINER RES, V16, pS498; KISHIMOTO I, 1994, J BIOL CHEM, V269, P28300; KOYAMA S, 1994, INT J PEPT PROT RES, V43, P332; Krejci P, 2005, J CELL SCI, V118, P5089, DOI 10.1242/jcs.02618; Levin ER, 1998, NEW ENGL J MED, V339, P321; LEVIN ER, 1993, AM J PHYSIOL, V264, pE483, DOI 10.1152/ajpendo.1993.264.4.E483; MAACK T, 1987, SCIENCE, V238, P675, DOI 10.1126/science.2823385; Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403; Matsuo H, 2001, CAN J PHYSIOL PHARM, V79, P736; MISONO KS, 1984, BIOCHEM BIOPH RES CO, V119, P524, DOI 10.1016/S0006-291X(84)80279-X; Miyazawa T, 2002, ENDOCRINOLOGY, V143, P3604, DOI 10.1210/en.2002-220307; MOSS ML, 1965, ACTA ANAT, V60, P262; Nashida T, 1996, BIOCHEM MOL BIOL INT, V40, P1243; Nishimoto SK, 2003, J BIOL CHEM, V278, P11843, DOI 10.1074/jbc.M211449200; Nishizawa H, 2004, J BIOL CHEM, V279, P19391, DOI 10.1074/jbc.C400066200; OLINS GM, 1988, J BIOL CHEM, V263, P10989; Pagano M, 2001, J BIOL CHEM, V276, P22064, DOI 10.1074/jbc.M101587200; PAVLIN D, 1992, J CELL BIOL, V116, P227, DOI 10.1083/jcb.116.1.227; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Rose RA, 2004, AM J PHYSIOL-HEART C, V286, pH1970, DOI 10.1152/ajpheart.00893.2003; Rouger K, 2002, AM J PHYSIOL-CELL PH, V283, pC773, DOI 10.1152/ajpcell.00112.2002; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SMYTH EM, 1994, LIFE SCI, V54, P1, DOI 10.1016/0024-3205(94)00571-0; Staiger H, 2006, HORM METAB RES, V38, P614, DOI 10.1055/s-2006-951310; Suda M, 2002, J BONE MINER METAB, V20, P136, DOI 10.1007/s007740200019; Suda M, 1996, BIOCHEM BIOPH RES CO, V223, P1, DOI 10.1006/bbrc.1996.0836; Suda M, 1998, P NATL ACAD SCI USA, V95, P2337, DOI 10.1073/pnas.95.5.2337; SUGA SI, 1992, ENDOCRINOLOGY, V130, P229, DOI 10.1210/en.130.1.229; Tamura N, 2000, P NATL ACAD SCI USA, V97, P4239, DOI 10.1073/pnas.070371497; Thomas G, 2003, J BIOL CHEM, V278, P50563, DOI 10.1074/jbc.M307310200; Tsuji T, 2005, J BIOL CHEM, V280, P14288, DOI 10.1074/jbc.C500024200; Veale CA, 2000, BIOORG MED CHEM LETT, V10, P1949, DOI 10.1016/S0960-894X(00)00387-5; Yamashita Y, 2000, J BIOCHEM-TOKYO, V127, P177, DOI 10.1093/oxfordjournals.jbchem.a022591; Yanaka N, 1998, AM J PHYSIOL-ENDOC M, V275, pE965, DOI 10.1152/ajpendo.1998.275.6.E965; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971; Yasoda A, 1998, J BIOL CHEM, V273, P11695, DOI 10.1074/jbc.273.19.11695	62	60	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36454	36462		10.1074/jbc.M708596200	http://dx.doi.org/10.1074/jbc.M708596200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17951249	hybrid			2022-12-25	WOS:000251458300037
J	Loza, MJ; McCall, CE; Li, LW; Isaacs, WB; Xu, JF; Chang, BL				Loza, Matthew J.; McCall, Charles E.; Li, Liwu; Isaacs, William B.; Xu, Jianfeng; Chang, Bao-Li			Assembly of Inflammation-Related Genes for Pathway-Focused Genetic Analysis	PLOS ONE			English	Article								Recent identifications of associations between novel variants in inflammation-related genes and several common diseases emphasize the need for systematic evaluations of these genes in disease susceptibility. Considering that many genes are involved in the complex inflammation responses and many genetic variants in these genes have the potential to alter the functions and expression of these genes, we assembled a list of key inflammation-related genes to facilitate the identification of genetic associations of diseases with an inflammation-related etiology. We first reviewed various phases of inflammation responses, including the development of immune cells, sensing of danger, influx of cells to sites of insult, activation and functional responses of immune and non-immune cells, and resolution of the immune response. Assisted by the Ingenuity Pathway Analysis, we then identified 17 functional sub-pathways that are involved in one or multiple phases. This organization would greatly increase the chance of detecting gene-gene interactions by hierarchical clustering of genes with their functional closeness in a pathway. Finally, as an example application, we have developed tagging single nucleotide polymorphism (tSNP) arrays for populations of European and African descent to capture all the common variants of these key inflammation-related genes. Assays of these tSNPs have been designed and assembled into two Affymetrix ParAllele customized chips, one each for European (12,011 SNPs) and African (21,542 SNPs) populations. These tSNPs have greater coverage for these nflammation-related genes compared to the existing genome-wide arrays, particularly in the African population. These tSNP arrays can facilitate systematic evaluation of inflammation pathways in disease susceptibility. For additional applications, other genotyping platforms could also be employed. For existing genome-wide association data, this list of key inflammation-related genes and associated subpathways can facilitate comprehensive inflammation pathway-focused association analyses.	[Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Dept Epidemiol & Prevent, Winston Salem, NC 27109 USA; [Loza, Matthew J.] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Ctr Human Genom, Winston Salem, NC 27103 USA; [Li, Liwu] Virginia Polytech Inst & State Univ, Dept Biol, Blacksburg, VA 24061 USA; [Isaacs, William B.] Johns Hopkins Univ, Dept Urol, Inst Med, Baltimore, MD USA; [Isaacs, William B.] Johns Hopkins Univ, Inst Med, Dept Oncol, Baltimore, MD USA; [Chang, Bao-Li] Wake Forest Univ, Bowman Gray Sch Med, Dept Pediat Med, Ctr Human Genom, Winston Salem, NC USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Virginia Polytechnic Institute & State University; Johns Hopkins University; Johns Hopkins University; Wake Forest University; Wake Forest Baptist Medical Center	Xu, JF (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Dept Epidemiol & Prevent, Winston Salem, NC 27109 USA.	jxu@wfubmc.edu; bchang@wfubmc.edu		Li, Liwu/0000-0001-8870-5299; Loza, Matthew/0000-0002-8609-118X	National Heart, Lung, and Blood Institute-Women's Health Initiative [HHSN268200764321C]; National Cancer Institute [CA119069, CA105055]; NATIONAL CANCER INSTITUTE [R01CA105055, R01CA119069] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute-Women's Health Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study is supported by National Heart, Lung, and Blood Institute-Women's Health Initiative HHSN268200764321C, National Cancer Institute CA119069 and CA105055.	Aganna E, 2002, ARTHRITIS RHEUM-US, V46, P2445, DOI 10.1002/art.10509; Aoki Takeshi, 2006, J Hum Genet, V51, P677, DOI 10.1007/s10038-006-0007-3; Calder PC, 2006, PROSTAG LEUKOTR ESS, V75, P197, DOI 10.1016/j.plefa.2006.05.012; Conley YP, 2006, HUM MOL GENET, V15, P3206, DOI 10.1093/hmg/ddl396; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cox DG, 2004, BRIT J CANCER, V91, P339, DOI 10.1038/sj.bjc.6601906; De Bakker Paul I W, 2006, Pac Symp Biocomput, P478, DOI 10.1142/9789812701626_0044; DINU V, 2007, GENET EPIDEMIOL; Dode C, 2002, AM J HUM GENET, V70, P1498, DOI 10.1086/340786; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Ernst PB, 2000, ANNU REV MICROBIOL, V54, P615, DOI 10.1146/annurev.micro.54.1.615; Forrester JS, 2005, MED HYPOTHESES, V65, P227, DOI 10.1016/j.mehy.2005.03.010; GAUDET MM, 2007, HUM GENET; Goronzy JJ, 2005, IMMUNOL REV, V204, P55, DOI 10.1111/j.0105-2896.2005.00245.x; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Han JH, 2005, NAT IMMUNOL, V6, P1198, DOI 10.1038/ni1274; Hedelin M, 2007, INT J CANCER, V120, P398, DOI 10.1002/ijc.22319; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Howson JMM, 2007, DIABETOLOGIA, V50, P741, DOI 10.1007/s00125-007-0603-6; James SP, 2005, J ALLERGY CLIN IMMUN, V115, P25, DOI 10.1016/j.jaci.2004.11.011; Johansson A, 2007, HUM GENET, V122, P141, DOI 10.1007/s00439-007-0379-2; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Koh WP, 2004, BRIT J CANCER, V90, P1760, DOI 10.1038/sj.bjc.6601797; Kuper H, 2000, J INTERN MED, V248, P171, DOI 10.1046/j.1365-2796.2000.00742.x; Lawrence T, 2007, INT J EXP PATHOL, V88, P85, DOI 10.1111/j.1365-2613.2006.00507.x; Lee YH, 2007, RHEUMATOLOGY, V46, P49, DOI 10.1093/rheumatology/kel170; Lee YH, 2006, EUR J HUM GENET, V14, P364, DOI 10.1038/sj.ejhg.5201566; Lin HJ, 2002, CANCER EPIDEM BIOMAR, V11, P1305; LOZA MJ, 2007, J ALLERGY C IN PRESS; Montpetit A, 2006, PLOS GENET, V2, P282, DOI 10.1371/journal.pgen.0020027; Mueller JC, 2005, AM J HUM GENET, V76, P387, DOI 10.1086/427925; Neuman MG, 2007, TRANSL RES, V149, P173, DOI 10.1016/j.trsl.2006.11.009; Oostenbrug LE, 2006, DIGEST LIVER DIS, V38, P834, DOI 10.1016/j.dld.2006.06.042; Payne F, 2007, J LEUKOCYTE BIOL, V81, P581, DOI 10.1189/jlb.0906577; Pharoah P, 2006, JNCI-J NATL CANCER I, V98, P1382, DOI 10.1093/jnci/djj374; Rahman P, 2006, ANN RHEUM DIS, V65, P919, DOI 10.1136/ard.2005.039164; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Shacter E, 2002, ONCOLOGY-NY, V16, P217; Shahedi K, 2006, INT J CANCER, V119, P668, DOI 10.1002/ijc.21864; Siezen CLE, 2006, INT J CANCER, V119, P297, DOI 10.1002/ijc.21858; Siezen CLE, 2005, CARCINOGENESIS, V26, P449, DOI 10.1093/carcin/bgh336; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Tenesa A, 2006, EUR J HUM GENET, V14, P357, DOI 10.1038/sj.ejhg.5201554; Touitou I, 2001, EUR J HUM GENET, V9, P473, DOI 10.1038/sj.ejhg.5200658; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Ulrich CM, 2006, NAT REV CANCER, V6, P130, DOI 10.1038/nrc1801; Willer CJ, 2006, GENET EPIDEMIOL, V30, P180, DOI 10.1002/gepi.20131; Willerson JT, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000129535.04194.38; XU Z, 2007, EUR J HUM GENET; Zheng SL, 2006, PROSTATE, V66, P1556, DOI 10.1002/pros.20496	52	79	80	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1035	10.1371/journal.pone.0001035	http://dx.doi.org/10.1371/journal.pone.0001035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940599	Green Published, Green Submitted, gold			2022-12-25	WOS:000207456100003
J	Summermatter, S; Mainieri, D; Russell, AP; Seydoux, J; Montani, JP; Buchala, A; Solinas, G; Dulloo, AG				Summermatter, S.; Mainieri, D.; Russell, A. P.; Seydoux, J.; Montani, J. P.; Buchala, A.; Solinas, G.; Dulloo, A. G.			Thrifty metabolism that favors fat storage after caloric restriction: a role for skeletal muscle phosphatidylinositol-3-kinase activity and AMP-activated protein kinase	FASEB JOURNAL			English	Article						thermogenesis; weight cycling; catch-up growth; obesity; diabetes	STEAROYL-COA DESATURASE-1; CATCH-UP FAT; DE-NOVO LIPOGENESIS; DIRECTLY STIMULATES THERMOGENESIS; LIPID OXIDATION; WEIGHT-LOSS; UNCOUPLING PROTEIN-3; ENERGY-METABOLISM; ADIPOSE-TISSUE; BODY-WEIGHT	Energy conservation directed at accelerating body fat recovery (or catch-up fat) contributes to obesity relapse after slimming and to excess fat gain during catch-up growth after malnutrition. To investigate the mechanisms underlying such thrifty metabolism for catch-up fat, we tested whether during refeeding after caloric restriction rats exhibiting catch-up fat driven by suppressed thermogenesis have diminished skeletal muscle phosphatidylinositol-3-kinase (PI3K) activity or AMP-activated protein kinase (AMPK) signaling-two pathways required for hormone-induced thermogenesis in ex vivo muscle preparations. The results show that during isocaloric refeeding with a low-fat diet, at time points when body fat, circulating free fatty acids, and intramyocellular lipids in refed animals do not exceed those of controls, muscle insulin receptor substrate 1-associated PI3K activity (basal and in vivo insulin-stimulated) is lower than that in controls. Isocaloric refeeding with a high-fat diet, which exacerbates the suppression of thermogenesis, results in further reductions in muscle PI3K activity and in impaired AMPK phosphorylation (basal and in vivo leptin-stimulated). It is proposed that reduced skeletal muscle PI3K/AMPK signaling and suppressed thermogenesis are interdependent. Defective PI3K or AMPK signaling will reduce the rate of substrate cycling between de novo lipogenesis and lipid oxidation, leading to suppressed thermogenesis, which accelerates body fat recovery and furthermore sensitizes skeletal muscle to dietary fat-induced impairments in PI3K/AMPK signaling.	[Summermatter, S.; Mainieri, D.; Montani, J. P.; Solinas, G.; Dulloo, A. G.] Univ Fribourg, Dept Med, Div Physiol, CH-1700 Fribourg, Switzerland; [Buchala, A.] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; [Russell, A. P.] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr, Melbourne, Vic, Australia; [Seydoux, J.] Univ Geneva, Fac Med, Dept Basic Neurosci, Geneva, Switzerland	University of Fribourg; University of Fribourg; Deakin University; University of Geneva	Dulloo, AG (corresponding author), Univ Fribourg, Dept Med, Div Physiol, Rue Musee 5, CH-1700 Fribourg, Switzerland.	abdul.dulloo@unifr.ch	Buchala, Antony/A-2656-2012; Solinas, Giovanni/P-6596-2017; Solinas, Giovanni/R-4777-2019	Solinas, Giovanni/0000-0002-0140-2621; Solinas, Giovanni/0000-0002-0140-2621; Russell, Aaron/0000-0002-7323-9501; Summermatter, Serge/0000-0003-4870-0148; DULLOO, Abdul/0000-0003-3877-6149; MAINIERI, DAVIDE/0000-0003-0797-5794				Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; ARIANO MA, 1973, J HISTOCHEM CYTOCHEM, V21, P51, DOI 10.1177/21.1.51; Barnes BR, 2002, DIABETES, V51, P2703, DOI 10.2337/diabetes.51.9.2703; Boss O, 1998, J BIOL CHEM, V273, P5, DOI 10.1074/jbc.273.1.5; BOYLE PC, 1978, PHYSIOL BEHAV, V21, P261, DOI 10.1016/0031-9384(78)90050-1; Cadenas S, 1999, FEBS LETT, V462, P257, DOI 10.1016/S0014-5793(99)01540-9; Cannon B, 2006, BBA-BIOENERGETICS, V1757, P449, DOI 10.1016/j.bbabio.2006.05.016; Cettour-Rose P, 2005, DIABETES, V54, P751, DOI 10.2337/diabetes.54.3.751; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Crescenzo R, 2003, FEBS LETT, V544, P138, DOI 10.1016/S0014-5793(03)00491-5; Crescenzo R, 2003, DIABETES, V52, P1090, DOI 10.2337/diabetes.52.5.1090; Crescenzo R, 2006, DIABETES, V55, P2286, DOI 10.2337/db06-0312; Dobrzyn A, 2005, AM J PHYSIOL-ENDOC M, V288, pE599, DOI 10.1152/ajpendo.00439.2004; Dulloo AG, 1998, AM J CLIN NUTR, V68, P599, DOI 10.1093/ajcn/68.3.599; Dulloo AG, 2004, PHYSIOL BEHAV, V83, P587, DOI 10.1016/j.physbeh.2004.07.028; Dulloo AG, 2004, INT J OBESITY, V28, pS29, DOI 10.1038/sj.ijo.0802861; DULLOO AG, 1990, AM J CLIN NUTR, V52, P415, DOI 10.1093/ajcn/52.3.415; Dulloo AG, 2001, INT J OBESITY, V25, pS22, DOI 10.1038/sj.ijo.0801907; Dulloo AG, 2002, INT J OBESITY, V26, pS46, DOI 10.1038/sj.ijo.0802127; Dulloo AG, 2002, FEBS LETT, V515, P109, DOI 10.1016/S0014-5793(02)02449-3; DULLOO AG, 1995, AM J PHYSIOL-REG I, V269, pR365, DOI 10.1152/ajpregu.1995.269.2.R365; ENTENMAN C, 1957, METHOD ENZYMOL, V3, P299, DOI 10.1016/S0076-6879(57)03395-9; Evans SA, 2005, AM J PHYSIOL-REG I, V288, pR1468, DOI 10.1152/ajpregu.00602.2004; Harper ME, 2001, BIOCHEM SOC T, V29, P768, DOI 10.1042/bst0290768; HARRIS RBS, 1984, J NUTR, V114, P1143, DOI 10.1093/jn/114.6.1143; HILL JO, 1984, AM J PHYSIOL, V247, pR318, DOI 10.1152/ajpregu.1984.247.2.R318; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Hutchinson DS, 2006, DIABETES, V55, P682, DOI 10.2337/diabetes.55.03.06.db05-0901; Keys A, 1950, BIOL HUMAN STARVATIO; Kim YB, 2000, ENDOCRINOLOGY, V141, P2328, DOI 10.1210/en.141.7.2328; Liu Y, 2006, BIOCHEM BIOPH RES CO, V339, P701, DOI 10.1016/j.bbrc.2005.11.068; MacLean PS, 2004, AM J PHYSIOL-REG I, V287, pR1306, DOI 10.1152/ajpregu.00463.2004; Mainieri D, 2006, FASEB J, V20, P1751, DOI 10.1096/fj.06-5934fje; MILLER DS, 1959, BRIT J NUTR, V13, P501, DOI 10.1079/BJN19590064; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Park SH, 2002, J APPL PHYSIOL, V93, P2081, DOI 10.1152/japplphysiol.00504.2002; Pirola L, 2001, J BIOL CHEM, V276, P21544, DOI 10.1074/jbc.M011330200; Rahman SM, 2003, P NATL ACAD SCI USA, V100, P11110, DOI 10.1073/pnas.1934571100; Russell AP, 2003, FEBS LETT, V551, P104, DOI 10.1016/S0014-5793(03)00875-5; Samec S, 1998, FASEB J, V12, P715, DOI 10.1096/fasebj.12.9.715; Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004; Solinas G, 2006, ENDOCRINOLOGY, V147, P31, DOI 10.1210/en.2005-1033; Solinas G, 2004, FEBS LETT, V577, P539, DOI 10.1016/j.febslet.2004.10.066; Sriwijitkamol A, 2006, AM J PHYSIOL-ENDOC M, V290, pE925, DOI 10.1152/ajpendo.00429.2005; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang D, 1998, J BIOL CHEM, V273, P25420, DOI 10.1074/jbc.273.39.25420; Weyer C, 2000, AM J CLIN NUTR, V72, P946; Yang YA, 2003, EXP CELL RES, V282, P132, DOI 10.1016/S0014-4827(02)00023-X	49	41	41	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2008	22	3					774	785		10.1096/fj.07-8972com	http://dx.doi.org/10.1096/fj.07-8972com			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17928359	Green Submitted			2022-12-25	WOS:000254143700016
J	Yona, S; Lin, HH; Dri, P; Davies, JQ; Hayhoe, RPG; Lewis, SM; Heinsbroek, SEM; Brown, KA; Perretti, M; Hamann, J; Treacher, DF; Gordon, S; Stacey, M				Yona, Simon; Lin, Hsi-Hsien; Dri, Pietro; Davies, John Q.; Hayhoe, Richard P. G.; Lewis, Sion M.; Heinsbroek, Sigrid E. M.; Brown, K. Alun; Perretti, Mauro; Hamann, Joerg; Treacher, David F.; Gordon, Siamon; Stacey, Martin			Ligation of the adhesion-GPCR EMR2 regulates human neutrophil function	FASEB JOURNAL			English	Article						inflammation; migration; sepsis	ACTIVATION ANTIGEN CD97; EGF-TM7 RECEPTOR CD97; LIGAND CD55; CHONDROITIN SULFATE; MYELOID CELLS-1; CELLULAR LIGAND; FAMILY; EXPRESSION; MOLECULE; MEMBER	At present, similar to 150 different members of the adhesion-G protein-coupled receptor (GPCR) family have been identified in metazoans. Surprisingly, very little is known about their function, although they all possess large extracellular domains coupled to a seven-transmembrane domain, suggesting a potential role in cell adhesion and signaling. Here, we demonstrate how the human-restricted adhesion-GPCR, EMR2 (epidermal growth factor-like module-containing mucin-like hormone receptor), regulates neutrophil responses by potentiating the effects of a number of proinflammatory mediators and show that the transmembrane region is critical for adhesion-GPCR function. Using an anti-EMR2 antibody, ligation of EMR2 increases neutrophil adhesion and migration, and augments superoxide production and proteolytic enzyme degranulation. On neutrophil activation, EMR2 is rapidly translocated to membrane ruffles and the leading edge of the cell. Further supporting the role in neutrophil, activation, EMR2 expression on circulating neutrophils is significantly increased in patients with systemic inflammation. These data illustrate a definitive function for a human adhesion-GPCR within the innate immune system and suggest an important role in potentiating the inflammatory response. Ligation of the adhesion-GPCR EMR2 regulates human neutrophil function.	[Yona, Simon; Davies, John Q.; Heinsbroek, Sigrid E. M.; Gordon, Siamon; Stacey, Martin] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Lin, Hsi-Hsien] Chang Gung Univ, Dept Microbiol & Immunol, Tao Yuan, Taiwan; [Dri, Pietro] Univ Trieste, Dept Physiol & Pathol, Trieste, Italy; [Hayhoe, Richard P. G.; Perretti, Mauro] Univ London, William Harvey Res Inst, London, England; [Lewis, Sion M.; Brown, K. Alun; Treacher, David F.] Kings Coll London, St Thomas Hosp, London WC2R 2LS, England; [Hamann, Joerg] Univ Amsterdam, Dept Expt Immunol, Amsterdam, Holland, Netherlands	University of Oxford; Chang Gung University; University of Trieste; University of London; Queen Mary University London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Amsterdam	Gordon, S (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	siamon.gordon@path.ox.ac.uk; martin.stacey@path.ox.ac.uk	LIN, Hsi-Hsien/N-1488-2015; lewis, Sion/C-2258-2009; Yona, Simon/ABE-6572-2020	Hamann, Jorg/0000-0002-9448-1727; Yona, Simon/0000-0002-3984-2008; Hayhoe, Richard/0000-0002-7335-2715	Medical Research Council [G0500623] Funding Source: Medline; MRC [G0500623] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alonso-Lebrero JL, 2000, BLOOD, V95, P2413, DOI 10.1182/blood.V95.7.2413.007k17_2413_2419; BAUD V, 1995, GENOMICS, V26, P334, DOI 10.1016/0888-7543(95)80218-B; Bjarnadottir TK, 2004, GENOMICS, V84, P23, DOI 10.1016/j.ygeno.2003.12.004; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown KA, 2006, LANCET, V368, P157, DOI 10.1016/S0140-6736(06)69005-3; Brzostowski JA, 2001, TRENDS BIOCHEM SCI, V26, P291, DOI 10.1016/S0968-0004(01)01804-7; Chang GW, 2007, BIOCHEM BIOPH RES CO, V353, P133, DOI 10.1016/j.bbrc.2006.11.148; Chiang N, 2003, BRIT J PHARMACOL, V139, P89, DOI 10.1038/sj.bjp.0705220; DEWALD B, 1988, J BIOL CHEM, V263, P16179; Fagerholm SC, 2006, BLOOD, V108, P3379, DOI 10.1182/blood-2006-03-013557; Galle J, 2006, AM J PATHOL, V169, P1802, DOI 10.2353/ajpath.2006.060006; Hafezi-Moghadam A, 2001, J EXP MED, V193, P863, DOI 10.1084/jem.193.7.863; Hamann J, 1999, ARTHRITIS RHEUM-US, V42, P650, DOI 10.1002/1529-0131(199904)42:4<650::AID-ANR7>3.0.CO;2-S; HAMANN J, 1995, J IMMUNOL, V155, P1942; Hamann J, 1996, J EXP MED, V184, P1185, DOI 10.1084/jem.184.3.1185; Hayhoe RPG, 2006, BLOOD, V107, P2123, DOI 10.1182/blood-2005-08-3099; Heyworth PG, 2003, CURR OPIN IMMUNOL, V15, P578, DOI 10.1016/S0952-7915(03)00109-2; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Kop EN, 2005, ARTHRITIS RHEUM-US, V52, P442, DOI 10.1002/art.20788; Krasnoperov VG, 1997, NEURON, V18, P925, DOI 10.1016/S0896-6273(00)80332-3; Kwakkenbos MJ, 2005, J LEUKOCYTE BIOL, V77, P112, DOI 10.1189/jlb.0704402; Kwakkenbos MJ, 2004, IMMUNOGENETICS, V55, P655, DOI 10.1007/s00251-003-0625-2; Kwakkenbos MJ, 2002, J LEUKOCYTE BIOL, V71, P854; Lattin J, 2007, J LEUKOCYTE BIOL, V82, P16, DOI 10.1189/jlb.0107051; Leemans JC, 2004, J IMMUNOL, V172, P1125, DOI 10.4049/jimmunol.172.2.1125; Lin HH, 2004, J BIOL CHEM, V279, P31823, DOI 10.1074/jbc.M402974200; Lin HH, 1997, GENOMICS, V41, P301, DOI 10.1006/geno.1997.4674; Lin HH, 2005, J EXP MED, V201, P1615, DOI 10.1084/jem.20042307; Lin HH, 2000, GENOMICS, V67, P188, DOI 10.1006/geno.2000.6238; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Luttrell LM, 2002, J CELL SCI, V115, P455; MCPHAIL LC, 1984, J BIOL CHEM, V259, P5768; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nechiporuk T, 2001, J BIOL CHEM, V276, P4150, DOI 10.1074/jbc.M004814200; Netea MG, 2006, J LEUKOCYTE BIOL, V80, P1454, DOI 10.1189/jlb.1205758; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; Perretti M, 1996, NAT MED, V2, P1259, DOI 10.1038/nm1196-1259; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Qureshi SS, 2001, CLIN EXP IMMUNOL, V125, P258, DOI 10.1046/j.1365-2249.2001.01596.x; Radsak MP, 2004, J IMMUNOL, V172, P4956, DOI 10.4049/jimmunol.172.8.4956; Schioth HB, 2005, GEN COMP ENDOCR, V142, P94, DOI 10.1016/j.ygcen.2004.12.018; Schoenberg MH, 1998, LANGENBECK ARCH SURG, V383, P44, DOI 10.1007/s004230050090; Stacey M, 2003, BLOOD, V102, P2916, DOI 10.1182/blood-2002-11-3540; Stacey M, 2002, J BIOL CHEM, V277, P29283, DOI 10.1074/jbc.M204306200; Stacey M, 2001, J BIOL CHEM, V276, P18863, DOI 10.1074/jbc.M101147200; Stacey M, 2000, TRENDS BIOCHEM SCI, V25, P284, DOI 10.1016/S0968-0004(00)01583-8; VANGELDER BF, 1962, BIOCHIM BIOPHYS ACTA, V58, P593, DOI 10.1016/0006-3002(62)90073-2; Visser L, 2002, J NEUROIMMUNOL, V132, P156, DOI 10.1016/S0165-5728(02)00306-5; WADDELL TK, 1994, J BIOL CHEM, V269, P18485; Wang T, 2005, BLOOD, V105, P2836, DOI 10.1182/blood-2004-07-2878; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Whittaker CA, 2006, DEV BIOL, V300, P252, DOI 10.1016/j.ydbio.2006.07.044	58	72	74	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2008	22	3					741	751		10.1096/fj.07-9435com	http://dx.doi.org/10.1096/fj.07-9435com			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17928360				2022-12-25	WOS:000254143700013
J	John, SA; Clements, JL; Russell, LM; Garrett-Sinha, LA				John, Shinu A.; Clements, James L.; Russell, Lisa M.; Garrett-Sinha, Lee Ann			Ets-1 regulates plasma cell differentiation by interfering with the activity of the transcription factor Blimp-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL; EXPRESSION; GENE; ACTIVATION; REPRESSION; DNA; PROTEINS; GATA-1; PAX-5; PU.1	Development of immunoglobulin-secreting plasma cells from B cells is a tightly regulated process controlled by the action of a number of transcription factors. In particular, the transcription factor Blimp-1 is a key positive regulator of plasmacytic differentiation via its ability to suppress expression of genes involved in the mature B cell program. The transcription factor Ets-1 is a negative regulator of plasmacytic differentiation, as indicated by the development of increased numbers of IgM-secreting plasma cells in Ets-1 knock-out mice. We have previously shown that Ets-1-deficient B cells undergo enhanced differentiation into IgM-secreting plasma cells in response to Toll-like receptor 9 (TLR9) signaling. We now explore the mechanism by which Ets-1 limits differentiation downstream of TLR9. Our results indicate that Ets-1 physically interacts with Blimp-1, which leads to a block in Blimp-1 DNA binding activity and a reduction in the ability of Blimp-1 to repress target genes without interfering with Blimp-1 protein levels. In addition, we show that Ets-1 induces the expression of several target genes that are repressed by Blimp-1, including Pax-5. These results reveal a previously unknown mechanism for the control of Blimp-1 activity by Ets-1 and suggest that expression of Ets-1 must be down-regulated before plasmacytic differentiation can occur.	[John, Shinu A.; Russell, Lisa M.; Garrett-Sinha, Lee Ann] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA; [Clements, James L.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute	Garrett-Sinha, LA (corresponding author), 140 Farber Hall,3435 Main St, Buffalo, NY 14214 USA.	leesinha@buffalo.edu	Garrett-Sinha, Lee Ann/K-5911-2019	Garrett-Sinha, Lee Ann/0000-0001-7806-4352				Barton K, 1998, IMMUNITY, V9, P555, DOI 10.1016/S1074-7613(00)80638-X; BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; Calame K, 2006, IMMUNOL REV, V211, P269, DOI 10.1111/j.0105-2896.2006.00377.x; Choi YS, 2006, BIOCHEM J, V398, P497, DOI 10.1042/BJ20060375; Clements JL, 2006, J IMMUNOL, V177, P905, DOI 10.4049/jimmunol.177.2.905; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Grund EM, 2005, J IMMUNOL METHODS, V296, P31, DOI 10.1016/j.jim.2004.10.008; Kim Y, 2007, J CELL PHYSIOL, V211, P253, DOI 10.1002/jcp.20933; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Maier H, 2003, NUCLEIC ACIDS RES, V31, P5483, DOI 10.1093/nar/gkg785; Maier H, 2003, MOL CELL BIOL, V23, P1946, DOI 10.1128/MCB.23.6.1946-1960.2003; Messika EJ, 1998, J EXP MED, V188, P515, DOI 10.1084/jem.188.3.515; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Nera KP, 2006, SCAND J IMMUNOL, V64, P190, DOI 10.1111/j.1365-3083.2006.01809.x; Nera KP, 2006, IMMUNITY, V24, P283, DOI 10.1016/j.immuni.2006.02.003; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; O'Riordan M, 2000, IMMUNOL REV, V175, P94, DOI 10.1034/j.1600-065X.2000.017503.x; Ochiai K, 2006, J BIOL CHEM, V281, P38226, DOI 10.1074/jbc.M607592200; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Piskurich JF, 1998, J IMMUNOL, V160, P233; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; ROUSSEL MF, 1994, ONCOGENE, V9, P405; Ruprecht CR, 2006, EUR J IMMUNOL, V36, P810, DOI 10.1002/eji.200535744; Schliephake DE, 1996, EUR J IMMUNOL, V26, P268, DOI 10.1002/eji.1830260142; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2005, J EXP MED, V202, P1471, DOI 10.1084/jem.20051611; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Starck J, 2003, MOL CELL BIOL, V23, P1390, DOI 10.1128/MCB.23.4.1390-1402.2003; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Usui T, 1997, J IMMUNOL, V158, P3197; Wang D, 2005, INT IMMUNOL, V17, P1179, DOI 10.1093/intimm/dxh295; Zhang P, 2000, BLOOD, V96, P2641; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	42	64	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					951	962		10.1074/jbc.M705262200	http://dx.doi.org/10.1074/jbc.M705262200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17977828	hybrid			2022-12-25	WOS:000252128100035
J	Grzela, R; Szolajska, E; Ebel, C; Madern, D; Favier, A; Wojtal, I; Zagorski, W; Chroboczek, J				Grzela, Renata; Szolajska, Ewa; Ebel, Christine; Madern, Dominique; Favier, Adrien; Wojtal, Izabela; Zagorski, Wlodzimierz; Chroboczek, Jadwiga			Virulence factor of potato virus Y, genome-attached terminal protein VPg, is a highly disordered protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; TOBACCO ETCH POTYVIRUS; INITIATION-FACTOR EIF4E; TURNIP-MOSAIC-VIRUS; FACTOR ISO 4E; LINKED PROTEIN; FELINE CALICIVIRUS; UNFOLDED PROTEINS; COAT PROTEIN; TRANSLATION	Potato virus Y (PVY) is a common potyvirus of agricultural importance, belonging to the picornavirus superfamily of RNA plus-stranded viruses. A covalently linked virus-encoded protein VPg required for virus infectivity is situated at the 5' end of potyvirus RNA. VPg seems to be involved in multiple interactions, both with other viral products and host proteins. VPgs of potyviruses have no known homologs, and there is no atomic structure available. To understand the molecular basis of VPg multifunctionality, we have analyzed structural features of VPg from PVY using structure prediction programs, functional assays, and biochemical and biophysical analyses. Structure predictions suggest that VPg exists in a natively unfolded conformation. In contrast with ordered proteins, PVY VPg is not denatured by elevated temperatures, has sedimentation values incompatible with a compact globular form, and shows a CD spectrum of a highly disordered protein, and HET-HETSOFAST NMR analysis suggests the presence of large unstructured regions. Although VPg has a propensity to form dimers, no functional differences were seen between the monomer and dimer. These data strongly suggest that the VPg of PVY should be classified among intrinsically disordered proteins. Intrinsic disorder lies at the basis of VPg multifunctionality, which is necessary for virus survival in the host.	[Grzela, Renata; Ebel, Christine; Madern, Dominique; Favier, Adrien; Chroboczek, Jadwiga] CNRS, CEA, Inst Biol Struct, F-38027 Grenoble, France; [Grzela, Renata; Szolajska, Ewa; Wojtal, Izabela; Zagorski, Wlodzimierz] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Chroboczek, J (corresponding author), Univ Grenoble 1, CNRS, CEA, Inst Biol Struct, 41 Rue Jules Horowitz, F-38027 Grenoble, France.	wisia@ibs.fr	Chroboczek, Jadwiga/M-6554-2014	Grzela, Renata/0000-0002-1971-6012; Szolajska, Ewa/0000-0002-7400-4333; Ebel, Christine/0000-0002-6912-500X				Beauchemin C, 2007, J VIROL, V81, P775, DOI 10.1128/JVI.01277-06; Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102; Borgstrom B, 2001, MOL PLANT MICROBE IN, V14, P707, DOI 10.1094/MPMI.2001.14.6.707; Bourhis JM, 2004, VIRUS RES, V99, P157, DOI 10.1016/j.virusres.2003.11.007; Bourhis JM, 2005, PROTEIN SCI, V14, P1975, DOI 10.1110/ps.051411805; CARRINGTON JC, 1991, PLANT CELL, V3, P953, DOI 10.1105/tpc.3.9.953; Chen JW, 2006, J PROTEOME RES, V5, P888, DOI 10.1021/pr060049p; DELPHIN C, 1994, EUR J BIOCHEM, V223, P683, DOI 10.1111/j.1432-1033.1994.tb19041.x; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; DUNKER AK, 1998, PAC S BIOCOMP, V3, P473; Dunoyer P, 2004, J VIROL, V78, P2301, DOI 10.1128/JVI.78.5.2301-2309.2004; Duprat A, 2002, PLANT J, V32, P927, DOI 10.1046/j.1365-313X.2002.01481.x; EBEL C, 2007, PROTEIN STRUCTURES M; Fellers J, 1998, J GEN VIROL, V79, P2043, DOI 10.1099/0022-1317-79-8-2043; Graumann J, 2001, STRUCTURE, V9, P377, DOI 10.1016/S0969-2126(01)00599-8; Grzela R, 2006, BIOCHIMIE, V88, P887, DOI 10.1016/j.biochi.2006.02.012; Gunasekaran K, 2003, TRENDS BIOCHEM SCI, V28, P81, DOI 10.1016/S0968-0004(03)00003-3; Herbert TP, 1997, J GEN VIROL, V78, P1033, DOI 10.1099/0022-1317-78-5-1033; HONG YL, 1995, VIROLOGY, V214, P159, DOI 10.1006/viro.1995.9944; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Ivanov KI, 2001, J BIOL CHEM, V276, P13530, DOI 10.1074/jbc.M009551200; Kang BC, 2005, PLANT J, V42, P392, DOI 10.1111/j.1365-313X.2005.02381.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lellis AD, 2002, CURR BIOL, V12, P1046, DOI 10.1016/S0960-9822(02)00898-9; Leonard S, 2000, J VIROL, V74, P7730, DOI 10.1128/JVI.74.17.7730-7737.2000; Leonard S, 2004, J GEN VIROL, V85, P1055, DOI 10.1099/vir.0.19706-0; Liang Y, 2006, MOL CELLS, V22, P13; LUCIANO CS, 1991, J GEN VIROL, V72, P205, DOI 10.1099/0022-1317-72-1-205; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Mitra T, 2004, J VIROL, V78, P4931, DOI 10.1128/JVI.78.9.4931-4935.2004; Murphy JF, 1996, VIROLOGY, V220, P535, DOI 10.1006/viro.1996.0344; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Puustinen P, 2004, J BIOL CHEM, V279, P38103, DOI 10.1074/jbc.M402910200; Puustinen P, 2002, J VIROL, V76, P12703, DOI 10.1128/JVI.76.24.12703-12711.2002; RESTREPO MA, 1990, PLANT CELL, V2, P987, DOI 10.1105/tpc.2.10.987; RESTREPOHARTWIG MA, 1994, J VIROL, V68, P2388, DOI 10.1128/JVI.68.4.2388-2397.1994; Romero P, 1998, Pac Symp Biocomput, P437; Ruffel S, 2002, PLANT J, V32, P1067, DOI 10.1046/j.1365-313X.2002.01499.x; Sanchez-Puig N, 2005, PROTEIN SCI, V14, P1410, DOI 10.1110/ps.051368005; Satheshkumar PS, 2005, J BIOL CHEM, V280, P30291, DOI 10.1074/jbc.M504122200; Schaad MC, 1996, J VIROL, V70, P7039, DOI 10.1128/JVI.70.10.7039-7048.1996; Schaad MC, 1997, J VIROL, V71, P8624, DOI 10.1128/JVI.71.11.8624-8631.1997; Schanda P, 2006, MAGN RESON CHEM, V44, pS177, DOI 10.1002/mrc.1825; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Spudich GM, 1996, P NATL ACAD SCI USA, V93, P7512, DOI 10.1073/pnas.93.15.7512; Sreerama N, 2003, PROTEIN SCI, V12, P384, DOI 10.1110/ps.0235003; THOMAS PD, 1993, PROTEIN SCI, V2, P2050, DOI 10.1002/pro.5560021206; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; VANDEVEN FJM, 1990, EUR J BIOCHEM, V190, P583, DOI 10.1111/j.1432-1033.1990.tb15613.x; Wittmann S, 1997, VIROLOGY, V234, P84, DOI 10.1006/viro.1997.8634; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yambao MLM, 2003, J GEN VIROL, V84, P2861, DOI 10.1099/vir.0.19312-0	58	53	56	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					213	221		10.1074/jbc.M705666200	http://dx.doi.org/10.1074/jbc.M705666200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17971447	hybrid			2022-12-25	WOS:000251940300024
J	Muretta, JM; Romenskaia, I; Mastick, CC				Muretta, Joseph M.; Romenskaia, Irina; Mastick, Cynthia Corley			Insulin releases Glut4 from static storage compartments into cycling endosomes and increases the rate constant for Glut4 exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3T3-L1 ADIPOCYTES; GLUCOSE-TRANSPORTER; RESPONSIVE AMINOPEPTIDASE; SUBCELLULAR TRAFFICKING; REGULATED TRANSPORT; ADIPOSE-CELLS; LOCALIZATION; RETENTION; MECHANISM; MEMBRANE	In adipocytes, insulin triggers the redistribution of Glut4 from intracellular compartments to the plasma membrane. Two models have been proposed to explain the effect of insulin on Glut4 localization. In the first, termed dynamic exchange, Glut4 continually cycles between the plasma membrane and intracellular compartments in basal cells, and the major effect of insulin is through changes in the exocytic and endocytic rate constants, k(ex) and k(en). In the second model, termed static retention, Glut4 is packaged in specialized storage vesicles (GSVs) in basal cells and does not traffic through the plasma membrane or endosomes. Insulin triggers GSV exocytosis, increasing the amount of Glut4 in the actively cycling pool. Using a flow cytometry-based assay, we found that Glut4 is regulated by both static and dynamic retention mechanisms. In basal cells, 75-80% of the Glut4 is packaged in noncycling GSVs. Insulin increased the amount of Glut4 in the actively cycling pool 4-5-fold. Insulin also increased kex in the cycling pool 3-fold. After insulin withdrawal, Glut4 is rapidly cleared from the plasma membrane (t(1/2) of 20 min) by rapid adjustments in kex and ken and recycled into static compartments. Complete recovery of the static pool required more than 3 h, however. We conclude that in fully differentiated confluent adipocytes, both the dynamic and static retention mechanisms are important for the regulation of plasma membrane Glut4 content. However, cell culture conditions affect Glut4 trafficking. For example, replating after differentiation inhibited the static retention of Glut4, which may explain differences in previous reports.	[Muretta, Joseph M.; Romenskaia, Irina; Mastick, Cynthia Corley] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Mastick, CC (corresponding author), Univ Nevada, Dept Biochem & Mol Biol, Mailstop 330, Reno, NV 89557 USA.	cmastick@unr.edu	Mastick, Cynthia/G-9841-2017	Mastick, Cynthia/0000-0003-4769-5412	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056197] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 56197] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; CAIN CC, 1991, J BIOL CHEM, V266, P11746; CAIN CC, 1988, J CELL BIOL, V106, P269, DOI 10.1083/jcb.106.2.269; CAIN CC, 1989, P NATL ACAD SCI USA, V86, P544, DOI 10.1073/pnas.86.2.544; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; Carvalho E, 2004, J BIOL CHEM, V279, P21598, DOI 10.1074/jbc.M312269200; Coster ACF, 2004, TRAFFIC, V5, P763, DOI 10.1111/j.1600-0854.2004.00218.x; Dawson K, 2001, BIOCHEM BIOPH RES CO, V287, P445, DOI 10.1006/bbrc.2001.5620; Foster LJ, 2000, AM J PHYSIOL-CELL PH, V279, pC877, DOI 10.1152/ajpcell.2000.279.4.C877; FROST SC, 1985, J BIOL CHEM, V260, P2646; Furusawa Chikara, 2005, Biophysics (Nagoya-shi), V1, P25, DOI 10.2142/biophysics.1.25; GIBBS EM, 1986, J BIOL CHEM, V261, P6597; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; HOLMAN GD, 1994, J BIOL CHEM, V269, P17516; JHUN BH, 1992, J BIOL CHEM, V267, P17710; Karylowski O, 2004, MOL BIOL CELL, V15, P870, DOI 10.1091/mbc.E03-07-0517; Martin OJ, 2006, J BIOL CHEM, V281, P484, DOI 10.1074/jbc.M505944200; Muretta JM, 2007, J CELL SCI, V120, P1168, DOI 10.1242/jcs.03413; SATOH S, 1993, J BIOL CHEM, V268, P17820; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Waters SB, 1997, J BIOL CHEM, V272, P23323, DOI 10.1074/jbc.272.37.23323; Zeigerer A, 2002, MOL BIOL CELL, V13, P2421, DOI 10.1091/mbc.E02-02-0071; Zeigerer A, 2004, MOL BIOL CELL, V15, P4406, DOI 10.1091/mbc.e04-04-0333	23	61	61	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					311	323		10.1074/jbc.M705756200	http://dx.doi.org/10.1074/jbc.M705756200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17967900	hybrid			2022-12-25	WOS:000251940300035
J	Geurtsen, J; Angevaare, E; Janssen, M; Hamstra, HJ; ten Hove, J; de Haan, A; Kuipers, B; Tommassen, J; van der Ley, P				Geurtsen, Jeroen; Angevaare, Eline; Janssen, Marlieke; Hamstra, Hendrik-Jan; ten Hove, Jan; de Haan, Alex; Kuipers, Betsy; Tommassen, Jan; van der Ley, Peter			A novel secondary acyl chain in the lipopolysaccharide of Bordetella pertussis required for efficient infection of human macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-A BIOSYNTHESIS; ESCHERICHIA-COLI ENCODES; INTRACELLULAR SURVIVAL; MULTICOPY SUPPRESSOR; MSBB GENE; HTRB GENE; SALMONELLA; EXPRESSION; SEQUENCE; MUTATION	Lipopolysaccharide is one of the major constituents of the Gram-negative bacterial outer membrane and is a potent stimulator of the host innate immune response. The biosynthesis of the lipid A moiety of lipopolysaccharide is a complex process in which multiple gene products are involved. Two late lipid A acyl transferases, LpxL and LpxM, were first identified in Escherichia coli and shown to be responsible for the addition of secondary acyl chains to the 2' and 3' positions of lipid A, respectively. Here, we describe the identification of two lpxL homologues in the genome of Bordetella pertussis. We show that one of them, LpxL2, is responsible for the addition of the secondary myristate group that is normally present at the 2' position of B. pertussis lipid A, whereas the other one, LpxL1, mediates the addition of a previously unrecognized secondary 2-hydroxy laurate at the 2 position. Increased expression of lpxL1 results in the appearance of a hexa-acylated lipopolysaccharide form with strongly increased endotoxic activity. In addition, we show that an lpxL1-deficient mutant of B. pertussis displays a defect in the infection of human macrophages.	[Geurtsen, Jeroen; Angevaare, Eline; Hamstra, Hendrik-Jan; ten Hove, Jan; de Haan, Alex; Kuipers, Betsy; van der Ley, Peter] Nehterlands Vaccine Inst, NL-3720 AL Bilthoven, Netherlands; [Geurtsen, Jeroen; Janssen, Marlieke; Tommassen, Jan] Univ Utrecht, Dept Mol Microbiol, NL-3584 CH Utrecht, Netherlands	Utrecht University	van der Ley, P (corresponding author), Nehterlands Vaccine Inst, PO Box 457, NL-3720 AL Bilthoven, Netherlands.	peter.van.der.ley@nvi-vaccin.nl	Tommassen, Jan/I-1690-2016	Tommassen, Jan/0000-0001-7633-4945				ALEXEYEV MF, 1995, GENE, V160, P63, DOI 10.1016/0378-1119(95)00108-I; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Babinski KJ, 2002, J BIOL CHEM, V277, P25937, DOI 10.1074/jbc.M204067200; CAROFF M, 1994, J BACTERIOL, V176, P5156, DOI 10.1128/jb.176.16.5156-5159.1994; CHEERS C, 1969, IMMUNOLOGY, V17, P875; CLEMENTZ T, 1991, J BIOL CHEM, V266, P9687; Clementz T, 1996, J BIOL CHEM, V271, P12095, DOI 10.1074/jbc.271.20.12095; Clementz T, 1997, J BIOL CHEM, V272, P10353; Cognet I, 2003, J IMMUNOL METHODS, V272, P199, DOI 10.1016/S0022-1759(02)00506-9; COLEMAN J, 1988, J BACTERIOL, V170, P1268, DOI 10.1128/jb.170.3.1268-1274.1988; CROWELL DN, 1987, J BACTERIOL, V169, P5727, DOI 10.1128/jb.169.12.5727-5734.1987; FRIEDMAN RL, 1992, INFECT IMMUN, V60, P4578, DOI 10.1128/IAI.60.11.4578-4585.1992; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Garrett TA, 1997, J BIOL CHEM, V272, P21855, DOI 10.1074/jbc.272.35.21855; Geurtsen J, 2006, INFECT IMMUN, V74, P5574, DOI 10.1128/IAI.00834-06; Gibbons HS, 2000, J BIOL CHEM, V275, P32940, DOI 10.1074/jbc.M005779200; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Isobe T, 1999, J BACTERIOL, V181, P2648, DOI 10.1128/JB.181.8.2648-2651.1999; KAROW M, 1992, J BACTERIOL, V174, P702, DOI 10.1128/jb.174.3.702-710.1992; KAROW M, 1991, J BACTERIOL, V173, P741, DOI 10.1128/jb.173.2.741-750.1991; KASUGA T, 1953, KITASATO ARCH EXP ME, V27, P21; KELLY TM, 1993, J BIOL CHEM, V268, P19866; KOLASKAR AS, 1985, NUCLEIC ACIDS RES, V13, P185, DOI 10.1093/nar/13.1.185; LEE NG, 1995, J BIOL CHEM, V270, P27151, DOI 10.1074/jbc.270.45.27151; Low KB, 1999, NAT BIOTECHNOL, V17, P37, DOI 10.1038/5205; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Post DMB, 2002, INFECT IMMUN, V70, P909, DOI 10.1128/IAI.70.2.909-920.2002; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rebeil R, 2006, J BACTERIOL, V188, P1381, DOI 10.1128/JB.188.4.1381-1388.2006; Rutten L, 2006, P NATL ACAD SCI USA, V103, P7071, DOI 10.1073/pnas.0509392103; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; Sunshine MG, 1997, J BACTERIOL, V179, P5521, DOI 10.1128/jb.179.17.5521-5533.1997; Sweet CR, 2002, J BIOL CHEM, V277, P18281, DOI 10.1074/jbc.M201057200; TAKADA H, 1989, CRIT REV MICROBIOL, V16, P477, DOI 10.3109/10408418909104475; Thalen M, 1999, J BIOTECHNOL, V75, P147, DOI 10.1016/S0168-1656(99)00155-8; TOMMASSEN J, 1983, EMBO J, V2, P1275, DOI 10.1002/j.1460-2075.1983.tb01581.x; van der Ley P, 2001, INFECT IMMUN, V69, P5981, DOI 10.1128/IAI.69.10.5981-5990.2001; WELCH DF, 1991, CLIN MICROBIOL REV, V4, P422, DOI 10.1128/CMR.4.4.422-438.1991; WESTPHAL O, 1965, METHODS CARBOHYDR RE, V5, P91; Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519; WINKLER KC, 1948, ARCH BIOCHEM, V18, P97; Young K, 1995, J BIOL CHEM, V270, P30384, DOI 10.1074/jbc.270.51.30384; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324	45	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37875	37884		10.1074/jbc.M706391200	http://dx.doi.org/10.1074/jbc.M706391200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17967899	hybrid, Green Published			2022-12-25	WOS:000251833600063
J	Shutes, A; Onesto, C; Picard, V; Leblond, B; Schweighoffer, F; Der, CJ				Shutes, Adam; Onesto, Cercina; Picard, Virginie; Leblond, Bertrand; Schweighoffer, Fabien; Der, Channing J.			Specificity and mechanism of action of EHT 1864, a novel small molecule inhibitor of rac family small GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-GTPASES; NUCLEOTIDE EXCHANGE; SPLICE VARIANT; BREAST-CANCER; PROTEIN; BINDING; ACTIVATION; EXPRESSION; TRANSFORMATION; COMPLEX	There is now considerable experimental evidence that aberrant activation of Rho family small GTPases promotes the uncontrolled proliferation, invasion, and metastatic properties of human cancer cells. Therefore, there is considerable interest in the development of small molecule inhibitors of Rho GTPase function. However, to date, most efforts have focused on inhibitors that indirectly block Rho GTPase function, by targeting either enzymes involved in post-translational processing or downstream protein kinase effectors. We recently determined that the EHT 1864 small molecule can inhibit Rac function in vivo. In this study, we evaluated the biological and biochemical specificities and biochemical mechanism of action of EHT 1864. We determined that EHT 1864 specifically inhibited Rac1-dependent platelet-derived growth factor-induced lamellipodia formation. Furthermore, our biochemical analyses with recombinant Rac proteins found that EHT 1864 possesses high affinity binding to Rac1, as well as the related Rac1b, Rac2, and Rac3 isoforms, and this association promoted the loss of bound nucleotide, inhibiting both guanine nucleotide association and Tiam1 Rac guanine nucleotide exchange factor-stimulated exchange factor activity in vitro. EHT 1864 therefore places Rac in an inert and inactive state, preventing its engagement with downstream effectors. Finally, we evaluated the ability of EHT 1864 to block Rac-dependent growth transformation, and we determined that EHT 1864 potently blocked transformation caused by constitutively activated Rac1, as well as Rac-dependent transformation caused by Tiam1 or Ras. Taken together, our results suggest that EHT 1864 selectively inhibits Rac downstream signaling and transformation by a novel mechanism involving guanine nucleotide displacement.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; ExonHit Therapeut, F-75013 Paris, France	University of North Carolina; University of North Carolina Chapel Hill	Der, CJ (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, 450 West Dr,CB 7295, Chapel Hill, NC 27599 USA.	cjder@med.unc.edu	Leblond, Bertrand/A-3076-2015	Leblond, Bertrand/0000-0003-2585-9834; Der, Channing/0000-0002-7751-2747	NCI NIH HHS [CA67771, CA92240, CA063071] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA063071, U19CA067771, R01CA092240] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDO S, 1992, J BIOL CHEM, V267, P25709; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Basso AD, 2006, J LIPID RES, V47, P15, DOI 10.1194/jlr.R500012-JLR200; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Boettner B, 2002, GENE, V286, P155, DOI 10.1016/S0378-1119(02)00426-2; Chan AY, 2005, ONCOGENE, V24, P7821, DOI 10.1038/sj.onc.1208909; CHEN SY, 1994, ONCOGENE, V9, P2691; CHUANG TH, 1993, J BIOL CHEM, V268, P775; DeNicola G, 2005, CANCER BIOL THER, V4, P509, DOI 10.4161/cbt.4.5.1781; Deroanne C, 2003, J CELL SCI, V116, P1367, DOI 10.1242/jcs.00308; Desire L, 2005, J BIOL CHEM, V280, P37516, DOI 10.1074/jbc.M507913200; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Ferraro D, 2006, ONCOGENE, V25, P3689, DOI 10.1038/sj.onc.1209409; Fiegen D, 2004, J BIOL CHEM, V279, P4743, DOI 10.1074/jbc.M310281200; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Goodison S, 2005, CANCER RES, V65, P6042, DOI 10.1158/0008-5472.CAN-04-3043; Haeusler LC, 2006, METHOD ENZYMOL, V406, P1, DOI 10.1016/S0076-6879(06)06001-0; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; HART M, 1995, METHOD ENZYMOL, V255, P129; HIRAOKA K, 1992, BIOCHEM BIOPH RES CO, V182, P921, DOI 10.1016/0006-291X(92)91820-G; Hwang SL, 2005, J CLIN NEUROSCI, V12, P571, DOI 10.1016/j.jocn.2004.08.013; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jordan P, 1999, ONCOGENE, V18, P6835, DOI 10.1038/sj.onc.1203233; Joyce PL, 2003, CANCER RES, V63, P7959; Karnoub AE, 2001, NAT STRUCT BIOL, V8, P1037, DOI 10.1038/nsb719; KHOSRAVIFAR R, 1995, MOL CELL BIOL, V15, P6443; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; Kleer CG, 2005, BREAST CANCER RES TR, V93, P101, DOI 10.1007/s10549-005-4170-6; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MANNE V, 1984, P NATL ACAD SCI-BIOL, V81, P6953, DOI 10.1073/pnas.81.22.6953; Matos P, 2003, J BIOL CHEM, V278, P50442, DOI 10.1074/jbc.M308215200; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; ONOZAWA T, 1995, YEAST, V11, P801, DOI 10.1002/yea.320110902; Phillips RA, 2003, BIOCHEMISTRY-US, V42, P3956, DOI 10.1021/bi027316z; Reid TS, 2004, J MOL BIOL, V343, P417, DOI 10.1016/j.jmb.2004.08.056; Renshaw MW, 1996, CURR BIOL, V6, P76, DOI 10.1016/S0960-9822(02)00424-4; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; SASAKI T, 1993, J BIOL CHEM, V268, P23959; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Sebti SM, 2000, ONCOGENE, V19, P6584, DOI 10.1038/sj.onc.1204146; Shutes A, 2002, BIOCHEMISTRY-US, V41, P3828, DOI 10.1021/bi0119464; Singh A, 2004, ONCOGENE, V23, P9369, DOI 10.1038/sj.onc.1208182; Thapar R, 2002, BIOCHEMISTRY-US, V41, P3875, DOI 10.1021/bi0120087; vanLeeuwen FN, 1995, ONCOGENE, V11, P2215; Wennerberg K, 2002, J BIOL CHEM, V277, P47810, DOI 10.1074/jbc.M203816200; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Westwick JK, 1997, MOL CELL BIOL, V17, P1324, DOI 10.1128/MCB.17.3.1324; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; YAMASHITA T, 1988, J BIOL CHEM, V263, P17181; Zohn IE, 1998, MOL CELL BIOL, V18, P1225, DOI 10.1128/MCB.18.3.1225	60	224	235	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35666	35678		10.1074/jbc.M703571200	http://dx.doi.org/10.1074/jbc.M703571200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17932039	hybrid, Green Published			2022-12-25	WOS:000251458100027
J	Cox, HS; Kalon, S; Allamuratova, S; Sizaire, V; Tigay, ZN; Rusch-Gerdes, S; Karimovich, HA; Kebede, Y; Mills, C				Cox, Helen S.; Kalon, Stobdan; Allamuratova, Sholpan; Sizaire, Vinciane; Tigay, Zinaida N.; Ruesch-Gerdes, Sabine; Karimovich, Hamraev A.; Kebede, Yared; Mills, Clair			Multidrug-Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB among Treatment Failures	PLOS ONE			English	Article								Background. A pilot programme to treat multidrug-resistant TB (MDR-TB) was implemented in Karakalpakstan, Uzbekistan in 2003. This region has particularly high levels of MDR-TB, with 13% and 40% among new and previously treated cases, respectively. Methodology. This study describes the treatment process and outcomes for the first cohort of patients enrolled in the programme, between October 2003 and January 2005. Confirmed MDR-TB cases were treated with an individualised, second-line drug regimen based on drug susceptibility test results, while suspected MDR-TB cases were treated with a standardised regimen pending susceptibility results. Principal Findings. Of 108 MDR-TB patients, 87 were started on treatment during the study period. Of these, 33 (38%) were infected with strains resistant to at least one second-line drug at baseline, but none had initial ofloxacin resistance. Treatment was successful for 54 (62%) patients, with 13 (15%) dying during treatment, 12 (14%) defaulting and 8 (8%) failing treatment. Poor clinical condition and baseline second-line resistance contributed to treatment failure or death. Treatment regimens were changed in 71 (82%) patients due to severe adverse events or drug resistance. Adverse events were most commonly attributed to cycloserine, ethionamide and p-aminosalicylic acid. Extensively drug resistant TB (XDR-TB) was found among 4 of the 6 patients who failed treatment and were still alive in November 2006. Conclusions. While acceptable treatment success was achieved, the complexity of treatment and the development of XDR-TB among treatment failures are important issues to be addressed when considering scaling up MDR-TB treatment.	[Cox, Helen S.] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia; [Kebede, Yared; Mills, Clair] Med Sans Frontieres, Amsterdam, Netherlands; [Sizaire, Vinciane] Med Sans Frontieres, London, England; [Kalon, Stobdan; Allamuratova, Sholpan] Med Sans Frontieres, Tashkent, Uzbekistan; [Tigay, Zinaida N.; Karimovich, Hamraev A.] Minist Hlth, Karakalpakstan, Uzbekistan; [Ruesch-Gerdes, Sabine] Natl Reference Ctr Mycobacteria, Forchungszentrum Borstel, Borstel, Germany	Burnet Institute; Doctors Without Borders; Doctors Without Borders	Cox, HS (corresponding author), Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia.	hcox@burnet.edu.au		Cox, Helen/0000-0002-6538-7192	Medecins Sans Frontieres, Holland; Ministry of Health in Karakalpakstan; National Reference Center for Mycobacteria in Germany	Medecins Sans Frontieres, Holland; Ministry of Health in Karakalpakstan; National Reference Center for Mycobacteria in Germany	The MDR-TB program is funded primarily by Medecins Sans Frontieres, Holland, with contributions in kind from the Ministry of Health in Karakalpakstan and the National Reference Center for Mycobacteria in Germany. All the authors are connected to these three organisations, with the exception of the principal author who is currently employed elsewhere.	[Anonymous], 2006, M WHO GLOB TASK FORC; Ataniyazova O., 2001, Acta Paediatrica, V90, P589, DOI 10.1080/080352501750197791; Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Blower SM, 2004, NAT MED, V10, P1111, DOI 10.1038/nm1102; Cox HS, 2004, EMERG INFECT DIS, V10, P865, DOI 10.3201/eid1005.030718; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gupta R, 2002, TROP MED INT HEALTH, V7, P970, DOI 10.1046/j.1365-3156.2002.00960.x; Kent PT, 1985, GUIDE LEVEL 3 LAB; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Nathanson E, 2006, EMERG INFECT DIS, V12, P1389, DOI 10.3201/eid1209.051618; Olle-Goig JE, 2005, INT J TUBERC LUNG D, V9, P765; Organization WH, 1997, WHOTB97229; Small I, 2001, LANCET, V358, P1649; World Health Organization, 2003, TREATM TUB GUID NAT	14	79	83	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1126	10.1371/journal.pone.0001126	http://dx.doi.org/10.1371/journal.pone.0001126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987113	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459000010
J	Ding, K; McDonough, SJ; Kullo, IJ				Ding, Keyue; McDonough, Samantha J.; Kullo, Iftikhar J.			Evidence for Positive Selection in the C-terminal Domain of the Cholesterol Metabolism Gene PCSK9 Based on Phylogenetic Analysis in 14 Primate Species	PLOS ONE			English	Article								Background. Cholesterol homeostasis is maintained through finely tuned mechanisms regulating intestinal absorption, hepatic biosynthesis and secretion as well as plasma clearance. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a secreted enzyme of the serine protease family that reduces cellular uptake of plasma low-density lipoprotein (LDL) cholesterol by promoting LDL receptor (LDL-R) degradation. Species-specific positive selection has been noted in the LDLR promoter, leading to differential expression of LDLR among primates. Whether PCSK9 experienced significant selective pressure to maintain a functional relationship with its target protein, LDL-R, is unknown. Methodology/Principal Findings. We compiled the sequences of the coding regions of PCSK9 from 14 primate species in the clade of Hominoids, Old World monkeys and New World monkeys. To detect selective pressure at the protein level, the ratios of nonsynonymous/synonymous substitution rate (d(N)/d(S)) under different evolutionary models were calculated across the phylogeny of PCSK9. Maximum likelihood analyses of d(N)/d(S) ratios for the aligned coding region sequences among 14 primate species indicated that PCSK9 was subject to a strong functional constraint (i.e., purifying selection). However, positive selection was noted in the functional carboxyl-terminal (C-terminal) domain in many branches across the phylogeny, especially in the lineage leading to the orangutan. Furthermore, at least five positively selected amino acids were detected in this lineage using the branch-site model A. In a sliding-window analysis, several d(N)/d(S) peaks in the C-terminal domain in both the human and the orangutan branches were noted. Conclusions. These results suggest that among primates, differential selective pressure has shaped evolutionary patterns in the functional domains of PCSK9, an important regulator of cholesterol homeostasis.	[Ding, Keyue; McDonough, Samantha J.; Kullo, Iftikhar J.] Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic	Kullo, IJ (corresponding author), Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Rochester, MN 55905 USA.	kullo.iftikhar@mayo.edu		Ding, Keyue/0000-0002-3496-6415	Mayo Foundation; NIH [HL75794]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075794] Funding Source: NIH RePORTER	Mayo Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This work was supported by funds from the Mayo Foundation and NIH grant HL75794.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Attie AD, 2005, CELL METAB, V1, P290, DOI 10.1016/j.cmet.2005.04.006; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Berge KE, 2006, ARTERIOSCL THROM VAS, V26, P1094, DOI 10.1161/01.ATV.0000204337.81286.1c; Bingham B, 2006, CYTOM PART A, V69A, P1123, DOI 10.1002/cyto.a.20346; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Choi SS, 2003, GENOME RES, V13, P2252, DOI 10.1101/gr.1431603; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Crissey SD, 1999, ZOO BIOL, V18, P551, DOI 10.1002/(SICI)1098-2361(1999)18:6&lt;551::AID-ZOO9&gt;3.0.CO;2-S; Ding K, 2006, GENET EPIDEMIOL, V30, P557, DOI 10.1002/gepi.20169; Elagoz A, 2002, J BIOL CHEM, V277, P11265, DOI 10.1074/jbc.M109011200; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Espenshade PJ, 1999, J BIOL CHEM, V274, P22795, DOI 10.1074/jbc.274.32.22795; Fleagle JG, 1999, P NATL ACAD SCI USA, V96, P1157, DOI 10.1073/pnas.96.3.1157; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Hahn MW, 2004, GENETICS, V167, P867, DOI 10.1534/genetics.103.025726; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Huttley GA, 2000, NAT GENET, V25, P410, DOI 10.1038/78092; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kullo IJ, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-48; Lalanne F, 2005, J LIPID RES, V46, P1312, DOI 10.1194/jlr.M400396-JLR200; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; Lynn DJ, 2005, GENETICS, V170, P1189, DOI 10.1534/genetics.104.039040; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; MBIKAY M, 2007, MED HYPOTHESES; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Messler W, 1997, NATURE, V385, P151, DOI 10.1038/385151a0; Nakajima T, 2004, AM J HUM GENET, V74, P898, DOI 10.1086/420793; Naoumova RP, 2005, ARTERIOSCL THROM VAS, V25, P2654, DOI 10.1161/01.ATV.0000190668.94752.ab; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Naureckiene S, 2003, ARCH BIOCHEM BIOPHYS, V420, P55, DOI 10.1016/j.abb.2003.09.011; Nei M., 2000, MOL EVOLUTION PHYLOG; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nielsen R, 1998, GENETICS, V148, P929; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Perry GH, 2007, MOL BIOL EVOL, V24, P853, DOI 10.1093/molbev/msm002; Poirier S, 2006, J NEUROCHEM, V98, P838, DOI 10.1111/j.1471-4159.2006.03928.x; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Rockman MV, 2004, CURR BIOL, V14, P1531, DOI 10.1016/j.cub.2004.08.051; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Schaner P, 2001, NAT GENET, V27, P318, DOI 10.1038/85893; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 2006, BIOL CHEM, V387, P871, DOI 10.1515/BC.2006.110; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Shioji K, 2004, J HUM GENET, V49, P109, DOI 10.1007/s10038-003-0114-3; Sun XM, 2005, HUM MOL GENET, V14, P1161, DOI 10.1093/hmg/ddi128; Tall AR, 2006, NEW ENGL J MED, V354, P1310, DOI 10.1056/NEJMe068026; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Thompson EE, 2004, AM J HUM GENET, V75, P1059, DOI 10.1086/426406; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; YANG ZH, 1994, MOL BIOL EVOL, V11, P316; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Young JH, 2005, PLOS GENET, V1, P730, DOI 10.1371/journal.pgen.0010082; Yue P, 2006, HUM MUTAT, V27, P460, DOI 10.1002/humu.20316; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	73	20	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1098	10.1371/journal.pone.0001098	http://dx.doi.org/10.1371/journal.pone.0001098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971861	Green Published, Green Submitted, gold			2022-12-25	WOS:000207458700015
J	Jalili, M; Lavoie, S; Deppen, P; Meuli, R; Do, KQ; Cuenod, M; Hasler, M; De Feo, O; Knyazeva, MG				Jalili, Mahdi; Lavoie, Suzie; Deppen, Patricia; Meuli, Reto; Do, Kim Q.; Cuenod, Michel; Hasler, Martin; De Feo, Oscar; Knyazeva, Maria G.			Dysconnection Topography in Schizophrenia Revealed with State-Space Analysis of EEG	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; HUMAN CEREBRAL-CORTEX; MAGNETIC-RESONANCE; TEMPORAL-LOBE; NEGATIVE SYMPTOMS; PLANUM TEMPORALE; BRAIN-DAMAGE; AUDITORY HALLUCINATIONS; PSYCHIATRIC-DISORDERS; ONSET SCHIZOPHRENIA	Background. The dysconnection hypothesis has been proposed to account for pathophysiological mechanisms underlying schizophrenia. Widespread structural changes suggesting abnormal connectivity in schizophrenia have been imaged. A functional counterpart of the structural maps would be the EEG synchronization maps. However, due to the limits of currently used bivariate methods, functional correlates of dysconnection are limited to the isolated measurements of synchronization between preselected pairs of EEG signals. Methods/Results. To reveal a whole-head synchronization topography in schizophrenia, we applied a new method of multivariate synchronization analysis called S-estimator to the resting dense-array ( 128 channels) EEG obtained from 14 patients and 14 controls. This method determines synchronization from the embedding dimension in a state-space domain based on the theoretical consequence of the cooperative behavior of simultaneous time series-the shrinking of the state-space embedding dimension. The S-estimator imaging revealed a specific synchronization landscape in schizophrenia patients. Its main features included bilaterally increased synchronization over temporal brain regions and decreased synchronization over the postcentral/parietal region neighboring the midline. The synchronization topography was stable over the course of several months and correlated with the severity of schizophrenia symptoms. In particular, direct correlations linked positive, negative, and general psychopathological symptoms to the hyper-synchronized temporal clusters over both hemispheres. Along with these correlations, general psychopathological symptoms inversely correlated within the hypo-synchronized postcentral midline region. While being similar to the structural maps of cortical changes in schizophrenia, the S-maps go beyond the topography limits, demonstrating a novel aspect of the abnormalities of functional cooperation: namely, regionally reduced or enhanced connectivity. Conclusion/Significance. The new method of multivariate synchronization significantly boosts the potential of EEG as an imaging technique compatible with other imaging modalities. Its application to schizophrenia research shows that schizophrenia can be explained within the concept of neural dysconnection across and within large-scale brain networks.	[Meuli, Reto; Knyazeva, Maria G.] CHU Vaudois, Dept Radiol, Lausanne, Switzerland; [Lavoie, Suzie; Deppen, Patricia; Meuli, Reto; Do, Kim Q.; Cuenod, Michel; Knyazeva, Maria G.] Univ Lausanne, Lausanne, Switzerland; [Jalili, Mahdi; Hasler, Martin] Ecole Polytech Fed Lausanne, IC Sch Comp & Commun Sci, Lab Nonlinear Syst ICLANOS, CH-1015 Lausanne, Switzerland; [Lavoie, Suzie; Deppen, Patricia; Do, Kim Q.; Cuenod, Michel] CHU Vaudois, Ctr Psychiat Neurosci, Dept Psychiat, Lausanne, Switzerland; [De Feo, Oscar] Natl Univ Ireland Univ Coll Cork, Cork, Ireland; [Knyazeva, Maria G.] CHU Vaudois, Dept Neurol, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University College Cork; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Knyazeva, MG (corresponding author), CHU Vaudois, Dept Radiol, Lausanne, Switzerland.	Maria.Knyazeva@chuv.ch	Do, Kim Q./G-6694-2016	Do, Kim Q./0000-0003-1968-1646	Interdisciplinary FBM-UNIL	Interdisciplinary FBM-UNIL	This work was supported by the Interdisciplinary FBM-UNIL grant to MG Knyazeva.	Allefeld C, 2004, INT J BIFURCAT CHAOS, V14, P417, DOI 10.1142/S0218127404009521; Anderson JE, 2002, SCHIZOPHR RES, V58, P123, DOI 10.1016/S0920-9964(01)00372-3; Andreasen NC, 1995, EUR NEUROPSYCHOPHARM, V5, P37, DOI 10.1016/0924-977X(95)00028-N; BARTA PE, 1990, AM J PSYCHIAT, V147, P1457; Bartzokis G, 2005, AM J PSYCHIAT, V162, P1229, DOI 10.1176/appi.ajp.162.6.1229-a; Beasley CL, 2005, SCHIZOPHR RES, V73, P69, DOI 10.1016/j.schres.2004.08.011; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop C.M., 2006, PATTERN RECOGNITION; Bleuler E., 1911, DEMENTIA PRAECOX GRO; Boccaletti S, 2002, PHYS REP, V366, P1, DOI 10.1016/S0370-1573(02)00137-0; BROOMHEAD DS, 1986, PHYSICA D, V20, P217, DOI 10.1016/0167-2789(86)90031-X; Carmeli C, 2005, NEUROIMAGE, V25, P339, DOI 10.1016/j.neuroimage.2004.11.049; CARMELI C, 2006, ASSESSING COOEPRATIV; CARMELI C, 2006, ASSESSING DEPENDENCE; Celka P, 2006, PHYSIOL MEAS, V27, P737, DOI 10.1088/0967-3334/27/8/008; Cotter D, 2002, CEREB CORTEX, V12, P386, DOI 10.1093/cercor/12.4.386; CUTTING J, 1992, BRIT J PSYCHIAT, V160, P583, DOI 10.1192/bjp.160.5.583; DeLisi LE, 1998, PSYCHIAT RES-NEUROIM, V84, P75, DOI 10.1016/S0925-4927(98)00047-X; DeLisi Lynn E, 2006, Dialogues Clin Neurosci, V8, P71; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; FLAUM M, 1995, AM J PSYCHIAT, V152, P704; FLORHENRY P, 1984, BIOL PSYCHOL, V19, P257, DOI 10.1016/0301-0511(84)90042-5; Ford JM, 2002, BIOL PSYCHIAT, V51, P485, DOI 10.1016/S0006-3223(01)01335-X; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; Gallagher S, 2004, PSYCHOPATHOLOGY, V37, P8, DOI 10.1159/000077014; Gaser C, 1999, NEUROIMAGE, V10, P107, DOI 10.1006/nimg.1999.0458; Gibbons J.D., 2003, NONPARAMETRIC STAT I; Giuliani NR, 2005, SCHIZOPHR RES, V74, P135, DOI 10.1016/j.schres.2004.08.019; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goldstein JM, 1999, ARCH GEN PSYCHIAT, V56, P537, DOI 10.1001/archpsyc.56.6.537; Greenstein D, 2006, J CHILD PSYCHOL PSYC, V47, P1003, DOI 10.1111/j.1469-7610.2006.01658.x; Guevara R, 2005, NEUROINFORMATICS, V3, P301, DOI 10.1385/NI:3:4:301; Gur RE, 2000, ARCH GEN PSYCHIAT, V57, P769, DOI 10.1001/archpsyc.57.8.769; HAGLUND MM, 1992, NATURE, V358, P668, DOI 10.1038/358668a0; Heilman KM, 1998, J CLIN NEUROPHYSIOL, V15, P409, DOI 10.1097/00004691-199809000-00005; Higashima M, 2006, CLIN EEG NEUROSCI, V37, P10, DOI 10.1177/155005940603700104; Hoffman R E, 1991, J Neuropsychiatry Clin Neurosci, V3, P169; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Honey GD, 2002, SCHIZOPHR RES, V53, P45, DOI 10.1016/S0920-9964(01)00154-2; Hubl D, 2004, ARCH GEN PSYCHIAT, V61, P658, DOI 10.1001/archpsyc.61.7.658; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Innocenti GM, 2003, MOL PSYCHIATR, V8, P261, DOI 10.1038/sj.mp.4001205; Kantz H., 2004, NONLINEAR TIME SERIE; Kasai K, 2003, ARCH GEN PSYCHIAT, V60, P766, DOI 10.1001/archpsyc.60.8.766; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Klemm E, 1996, PSYCHIAT RES-NEUROIM, V68, P1, DOI 10.1016/S0925-4927(96)02837-5; Knyazeva MG, 2006, NEUROIMAGE, V29, P593, DOI 10.1016/j.neuroimage.2005.07.045; Knyazeva MG, 1999, J NEUROPHYSIOL, V82, P3095, DOI 10.1152/jn.1999.82.6.3095; Koeda T, 1995, ELECTROEN CLIN NEURO, V95, P397, DOI 10.1016/0013-4694(95)00171-9; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Kucharska-Pietura K, 2006, PROG BRAIN RES, V156, P467, DOI 10.1016/S0079-6123(06)56026-1; KYLE NL, 1988, PSYCHIAT CLIN N AM, V11, P367; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Mann K, 1997, BIOL PSYCHIAT, V42, P655, DOI 10.1016/S0006-3223(96)00497-0; McCarley RW, 1999, BIOL PSYCHIAT, V45, P1099, DOI 10.1016/S0006-3223(99)00018-9; Merrin EL, 1996, SCHIZOPHR RES, V19, P151, DOI 10.1016/0920-9964(96)88522-7; MERRIN EL, 1989, BIOL PSYCHIAT, V25, P60, DOI 10.1016/0006-3223(89)90147-9; Mitchell RLC, 2005, BRAIN, V128, P963, DOI 10.1093/brain/awh466; NAGASE Y, 1992, BIOL PSYCHIAT, V32, P1028, DOI 10.1016/0006-3223(92)90064-7; Nestor PG, 2007, SCHIZOPHR RES, V91, P103, DOI 10.1016/j.schres.2006.11.025; Norman RMG, 1997, BRIT J PSYCHIAT, V170, P411, DOI 10.1192/bjp.170.5.411; Nunez PL, 2001, HUM BRAIN MAPP, V13, P125, DOI 10.1002/hbm.1030; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; OSHIMA K, 2006, STATE CHANGE DETECTI; PAKKENBERG B, 1987, BRIT J PSYCHIAT, V151, P744, DOI 10.1192/bjp.151.6.744; Pell MD, 2006, PROG BRAIN RES, V156, P303, DOI 10.1016/S0079-6123(06)56017-0; Pikovsky A., 2003, SYNCHRONIZATION UNIV; Pinkofsky HB, 1997, CLIN ELECTROENCEPHAL, V28, P155, DOI 10.1177/155005949702800307; Potkin SG, 2002, AM J PSYCHIAT, V159, P227, DOI 10.1176/appi.ajp.159.2.227; Quiroga RQ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041903; Rapoport JL, 1999, ARCH GEN PSYCHIAT, V56, P649, DOI 10.1001/archpsyc.56.7.649; ROBERTS GW, 1990, BIOL PSYCHIAT, V28, P127, DOI 10.1016/0006-3223(90)90630-K; Ross ED, 2001, J NEUROL NEUROSUR PS, V70, P597, DOI 10.1136/jnnp.70.5.597; SCOTT TF, 1993, J NEUROPSYCH CLIN N, V5, P287; Selemon LD, 1999, BIOL PSYCHIAT, V45, P17, DOI 10.1016/S0006-3223(98)00281-9; SELEMON LD, 1995, ARCH GEN PSYCHIAT, V52, P805; SHAW JC, 1983, PSYCHOL MED, V13, P299, DOI 10.1017/S0033291700050911; SHENTON ME, 1992, NEW ENGL J MED, V327, P604, DOI 10.1056/NEJM199208273270905; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Spencer KM, 2003, J NEUROSCI, V23, P7407; Srinivasan R, 2006, PROG BRAIN RES, V159, P29, DOI 10.1016/S0079-6123(06)59003-X; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Strang G., 2003, INTRO LINEAR ALGEBRA, DOI 10.4324/9780203788219; Suzuki M, 2002, SCHIZOPHR RES, V55, P41, DOI 10.1016/S0920-9964(01)00224-9; Takahashi T, 2007, PSYCHIAT RES-NEUROIM, V154, P209, DOI 10.1016/j.pscychresns.2006.10.001; Tauscher J, 1998, BIOL PSYCHIAT, V44, P438, DOI 10.1016/S0006-3223(97)00428-9; Thompson PM, 2001, P NATL ACAD SCI USA, V98, P11650, DOI 10.1073/pnas.201243998; Uhlhaas PJ, 2006, J NEUROSCI, V26, P8168, DOI 10.1523/JNEUROSCI.2002-06.2006; Uranova NA, 2007, INT J NEUROPSYCHOPH, V10, P537, DOI 10.1017/S1461145707007626; Vidal CN, 2006, ARCH GEN PSYCHIAT, V63, P25, DOI 10.1001/archpsyc.63.1.25; Wada Y, 1998, CLIN ELECTROENCEPHAL, V29, P170, DOI 10.1177/155005949802900408; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wiesenfeldt M, 2001, INT J BIFURCAT CHAOS, V11, P2217, DOI 10.1142/S0218127401003231; Winterer G, 2001, SCHIZOPHR RES, V49, P129, DOI 10.1016/S0920-9964(00)00128-6; Woods BT, 1998, AM J PSYCHIAT, V155, P1661, DOI 10.1176/ajp.155.12.1661; Yeragani VK, 2006, PSYCHIAT RES, V141, P53, DOI 10.1016/j.psychres.2005.07.016; Zhou SY, 2007, SCHIZOPHR RES, V89, P35, DOI 10.1016/j.schres.2006.08.032	101	54	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1059	10.1371/journal.pone.0001059	http://dx.doi.org/10.1371/journal.pone.0001059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957243	Green Published, gold			2022-12-25	WOS:000207458500006
J	Lee, T; Langford, KJ; Askham, JM; Bruning-Richardson, A; Morrison, EE				Lee, T.; Langford, K. J.; Askham, J. M.; Bruning-Richardson, A.; Morrison, E. E.			MCAK associates with EB1	ONCOGENE			English	Article						EB1; MCAK; APC; microtubule	APC TUMOR-SUPPRESSOR; MICROTUBULE PLUS-END; MAMMALIAN-CELLS; PROTEIN; P150(GLUED); KINESIN; DEPOLYMERIZATION; POLYMERIZATION; DOMAINS	The microtubule ( MT)- associated protein EB1 localizes to and promotes growth at MT plus ends. The MT depolymerizing kinesin MCAK has also been reported to track growing MT plus ends. Here, we confirm that human MCAK colocalizes with EB1 at growing MT ends when expressed as a GFP fusion protein in transfected cells. We show that MCAK associates with the C- terminus of EB1 and EB3 but much less efficiently with RP1. EB1 associates with the N- terminal localization and regulatory domain in MCAK but not with the motor domain of the protein. The interaction is competitive with the binding of other EB1 ligands and does not require MTs. Knockdown of EB1 expression using siRNA impaired the ability of GFP- MCAK to localize to MT tips in transfected cells. We propose that MCAK is targeted to growing MT ends by EB1, that MCAK is held in an inactive conformation when associated with EB1 and that this could provide the basis for a mechanism that facilitates rapid switching between phases of MT growth and depolymerization.	[Lee, T.; Langford, K. J.; Askham, J. M.; Bruning-Richardson, A.; Morrison, E. E.] Univ Leeds, St James Univ Hosp, Leeds Inst Mol Med, Div Canc Med Res,CRUK Clin Ctr Leeds, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital; University of Leeds	Morrison, EE (corresponding author), Univ Leeds, St James Univ Hosp, Leeds Inst Mol Med, Div Canc Med Res,CRUK Clin Ctr Leeds, Beckett St, Leeds LS9 7TF, W Yorkshire, England.	e.e.morrison@leeds.ac.uk		Bruning-Richardson, Anke/0000-0002-9862-9805	Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Askham JM, 2000, ONCOGENE, V19, P1950, DOI 10.1038/sj.onc.1203498; Askham JM, 2002, MOL BIOL CELL, V13, P3627, DOI 10.1091/mbc.E02-01-0061; Banks JD, 2004, CURR BIOL, V14, P2033, DOI 10.1016/j.cub.2004.10.049; Bu W, 2003, J BIOL CHEM, V278, P49721, DOI 10.1074/jbc.M306194200; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Draviam VM, 2006, EMBO J, V25, P2814, DOI 10.1038/sj.emboj.7601168; Ems-McClung SC, 2007, MOL BIOL CELL, V18, P282, DOI 10.1091/mbc.E06-08-0724; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Kinoshita K, 2006, J MUSCLE RES CELL M, V27, P107, DOI 10.1007/s10974-005-9045-2; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057; Langford KJ, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-3; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Maney T, 2001, J BIOL CHEM, V276, P34753, DOI 10.1074/jbc.M106626200; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Moore AT, 2005, J CELL BIOL, V169, P391, DOI 10.1083/jcb.200411089; Moores CA, 2006, J CELL SCI, V119, P3905, DOI 10.1242/jcs.03224; Morrison EE, 2007, CELL MOL LIFE SCI, V64, P307, DOI 10.1007/s00018-007-6360-3; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Ohi R, 2007, CURR BIOL, V17, P953, DOI 10.1016/j.cub.2007.04.057; Riess NP, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-17; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Watson P, 2006, J CELL SCI, V119, P2758, DOI 10.1242/jcs.02999	25	49	50	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2008	27	17					2494	2500		10.1038/sj.onc.1210867	http://dx.doi.org/10.1038/sj.onc.1210867			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286KN	17968321				2022-12-25	WOS:000254844900014
J	Harada, T; Chelala, C; Bhakta, V; Chaplin, T; Caulee, K; Baril, P; Young, BD; Lemoine, NR				Harada, T.; Chelala, C.; Bhakta, V.; Chaplin, T.; Caulee, K.; Baril, P.; Young, B. D.; Lemoine, N. R.			Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays	ONCOGENE			English	Article						pancreatic cancer; tissue microdissection; SNP array; genetic alterations; SKAP2/SCAP2	UNIPARENTAL DISOMY; TISSUE MICRODISSECTION; HOMOZYGOUS DELETIONS; GENETIC ALTERATIONS; HETEROZYGOSITY; ADENOCARCINOMA; HYBRIDIZATION; ABERRATIONS	To identify genomic abnormalities characteristic of pancreatic ductal adenocarcinoma (PDAC) in vivo, a panel of 27 microdissected PDAC specimens were analysed using high-density microarrays representing similar to 116000 single nucleotide polymorphism (SNP) loci. We detected frequent gains of 1q, 2, 3, 5, 7p, 8q, 11, 14q and 17q (>= 78% of cases), and losses of 1p, 3p, 6, 9p, 13q, 14q, 17p and 18q (>= 44%). Although the results were comparable with those from array CGH, regions of those genetic changes were defined more accurately by SNP arrays. Integrating the Ensembl public data, we have generated 'gene' copy number indices that facilitate the search for novel candidates involved in pancreatic carcinogenesis. Copy numbers in a subset of the genes were validated using quantitative real-time PCR. The SKAP2/SCAP2 gene (7p15.2), which belongs to the src family kinases, was most frequently (63%) amplified in our sample set and its recurrent overexpression (67%) was confirmed by reverse transcription-PCR. Furthermore, fluorescence in situ hybridization and in situ RNA hybridization analyses for this gene have demonstrated a significant correlation between DNA copy number and mRNA expression level in an independent sample set (P < 0.001). These findings indicate that the dysregulation of SKAP2/SCAP2, which is mostly caused by its increased gene copy number, is likely to be associated with the development of PDA C.	[Harada, T.; Chelala, C.; Bhakta, V.; Caulee, K.; Baril, P.; Lemoine, N. R.] Univ London, Ctr Mol Oncol, Inst Canc, Barts & London Sch Med & Dent,Canc Res UK, London EC1M 6BQ, England; [Chaplin, T.; Young, B. D.] Univ London, Ctr Med Oncol, Inst Canc, Barts & London Sch Med & Dent,Canc Res UK, London EC1M 6BQ, England	Cancer Research UK; University of London; Queen Mary University London; Cancer Research UK; University of London; Queen Mary University London	Lemoine, NR (corresponding author), Univ London, Ctr Mol Oncol, Inst Canc, Barts & London Sch Med & Dent,Canc Res UK, Charterhouse Sq, London EC1M 6BQ, England.	nick.lemoine@cancer.org.uk		chelala, claude/0000-0002-2488-0669; BARIL, Patrick/0000-0001-8290-9899	Cancer Research UK [A6253, A6789, A6438] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Andersen CL, 2007, CARCINOGENESIS, V28, P38, DOI 10.1093/carcin/bgl086; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Bignell GR, 2004, GENOME RES, V14, P287, DOI 10.1101/gr.2012304; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Calhoun ES, 2006, CANCER RES, V66, P7920, DOI 10.1158/0008-5472.CAN-06-0721; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Fitzgibbon J, 2005, CANCER RES, V65, P9152, DOI 10.1158/0008-5472.CAN-05-2017; Fujita M, 2007, J BIOL CHEM, V282, P5736, DOI 10.1074/jbc.M606175200; GRIFFIN CA, 1995, CANCER RES, V55, P2394; Harada T, 2007, BRIT J CANCER, V96, P373, DOI 10.1038/sj.bjc.6603563; Harada T, 2002, CANCER RES, V62, P835; Harada T, 2002, ONCOLOGY-BASEL, V62, P251, DOI 10.1159/000059573; Huang Jing, 2004, Human Genomics, V1, P287; Iacobuzio-Donahue CA, 2004, CANCER RES, V64, P871, DOI 10.1158/0008-5472.CAN-03-2756; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Janne PA, 2004, ONCOGENE, V23, P2716, DOI 10.1038/sj.onc.1207329; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Karhu R, 2006, GENE CHROMOSOME CANC, V45, P721, DOI 10.1002/gcc.20337; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Lindblad-Toh K, 2000, NAT BIOTECHNOL, V18, P1001, DOI 10.1038/79269; Lips EH, 2007, J PATHOL, V212, P269, DOI 10.1002/path.2180; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Midorikawa Y, 2006, ONCOGENE, V25, P5581, DOI 10.1038/sj.onc.1209537; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Raghavan M, 2005, CANCER RES, V65, P375; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Ried T, 1999, GENE CHROMOSOME CANC, V25, P195, DOI 10.1002/(SICI)1098-2264(199907)25:3<195::AID-GCC1>3.0.CO;2-8; Saramaki OR, 2006, INT J CANCER, V119, P1322, DOI 10.1002/ijc.21976; TAKAHASHI T, 2003, J BIOL, P42225; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	32	101	106	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2008	27	13					1951	1960		10.1038/sj.onc.1210832	http://dx.doi.org/10.1038/sj.onc.1210832			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	276NZ	17952125	Green Accepted			2022-12-25	WOS:000254150600015
J	Olesen, LE; Ford, MGJ; Schmid, EM; Vallis, Y; Babu, MM; Li, PH; Mills, IG; Mcmahon, HT; Praefcke, GJK				Olesen, Lene E.; Ford, Marijn G. J.; Schmid, Eva M.; Vallis, Yvonne; Babu, M. Madan; Li, Peter H.; Mills, Ian G.; Mcmahon, Harvey T.; Praefcke, Gerrit J. K.			Solitary and repetitive binding motifs for the AP2 complex alpha-appendage in amphiphysin and other accessory proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-COATED PITS; SYNAPTIC VESICLE ENDOCYTOSIS; FUNCTIONAL DISSECTION; DOMAIN; AP-2; INTERACTS; MEMBRANE; DYNAMIN; MODEL; IDENTIFICATION	Adaptor protein (AP) complexes bind to transmembrane proteins destined for internalization and to membrane lipids, so linking cargo to the accessory internalization machinery. This machinery interacts with the appendage domains of APs, which have platform and beta-sandwich subdomains, forming the binding surfaces for interacting proteins. Proteins that interact with the subdomains do so via short motifs, usually found in regions of low structural complexity of the interacting proteins. So far, up to four motifs have been identified that bind to and partially compete for at least two sites on each of the appendage domains of the AP2 complex. Motifs in individual accessory proteins, their sequential arrangement into motif domains, and partial competition for binding sites on the appendage domains coordinate the formation of endocytic complexes in a temporal and spatial manner. In this work, we examine the dominant interaction sequence in amphiphysin, a synapse-enriched accessory protein, which generates membrane curvature and recruits the scission protein dynamin to the necks of coated pits, for the platform subdomain of the alpha-appendage. The motif domain of amphiphysin1 contains one copy of each of a DX(F/W) and FXDXF motif. We find that the FXDXF motif is the main determinant for the high affinity interaction with the alpha-adaptin appendage. We describe the optimal sequence of the FXDXF motif using thermodynamic and structural data and show how sequence variation controls the affinities of these motifs for the alpha-appendage.	[Olesen, Lene E.; Ford, Marijn G. J.; Schmid, Eva M.; Vallis, Yvonne; Babu, M. Madan; Li, Peter H.; Mills, Ian G.; Mcmahon, Harvey T.] MRC, Mol Biol Lab, Div Neurobiol, Cambridge CB2 2QH, England; [Praefcke, Gerrit J. K.] Ctr Mol Med Cologne, Inst Genet, D-50674 Cologne, Germany	MRC Laboratory Molecular Biology; University of Cologne	Mcmahon, HT (corresponding author), MRC, Mol Biol Lab, Div Neurobiol, Hills Rd, Cambridge CB2 2QH, England.	hmm@mrc-lmb.cam.ac.uk; gpraefck@uni-koeln.de	Mohan, Babu P./I-7362-2019; Mills, Ian/AAK-9292-2020	Mills, Ian/0000-0001-5347-5083; Praefcke, Gerrit/0000-0001-8818-1499	MRC [MC_U105178795, MC_U105185859] Funding Source: UKRI; Medical Research Council [MC_U105185859, MC_U105178795] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AHLE S, 1986, EMBO J, V5, P3143, DOI 10.1002/j.1460-2075.1986.tb04621.x; Allaire PD, 2006, J NEUROSCI, V26, P13202, DOI 10.1523/JNEUROSCI.4608-06.2006; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brett TJ, 2002, STRUCTURE, V10, P797, DOI 10.1016/S0969-2126(02)00784-0; Burman JL, 2005, FEBS LETT, V579, P2177, DOI 10.1016/j.febslet.2005.03.008; Collins BM, 2003, NAT STRUCT BIOL, V10, P607, DOI 10.1038/nsb955; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; de Beer T, 1998, SCIENCE, V281, P1357, DOI 10.1126/science.281.5381.1357; Dell'Angelica EC, 2001, TRENDS CELL BIOL, V11, P315, DOI 10.1016/S0962-8924(01)02043-8; Edeling MA, 2006, DEV CELL, V10, P329, DOI 10.1016/j.devcel.2006.01.016; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Haffner C, 2000, CURR BIOL, V10, P471, DOI 10.1016/S0960-9822(00)00446-2; Hinrichsen L, 2006, P NATL ACAD SCI USA, V103, P8715, DOI 10.1073/pnas.0600312103; Iovine MK, 1995, J CELL BIOL, V131, P1699, DOI 10.1083/jcb.131.6.1699; Jha A, 2004, J BIOL CHEM, V279, P2281, DOI 10.1074/jbc.M305644200; Jockusch WJ, 2005, NEURON, V46, P869, DOI 10.1016/j.neuron.2005.05.004; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kalthoff C, 2002, J BIOL CHEM, V277, P8209, DOI 10.1074/jbc.M111587200; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; LESLIE AGW, 1992, JOINT CCP4 ESF EACMB, V26; Lui WWY, 2003, MOL BIOL CELL, V14, P2385, DOI 10.1091/mbc.e02-11-0735; Lundmark R, 2002, BIOCHEM J, V362, P597, DOI 10.1042/0264-6021:3620597; Mattera R, 2004, J BIOL CHEM, V279, P8018, DOI 10.1074/jbc.M311873200; McMahon HT, 1997, FEBS LETT, V413, P319, DOI 10.1016/S0014-5793(97)00928-9; Meyerholz A, 2005, TRAFFIC, V6, P1225, DOI 10.1111/j.1600-0854.2005.00355.x; Miele AE, 2004, NAT STRUCT MOL BIOL, V11, P242, DOI 10.1038/nsmb736; Miller GJ, 2003, NAT STRUCT BIOL, V10, P599, DOI 10.1038/nsb953; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Mishra SK, 2005, J BIOL CHEM, V280, P19270, DOI 10.1074/jbc.M501029200; Mishra SK, 2004, J BIOL CHEM, V279, P46191, DOI 10.1074/jbc.M408095200; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; PEARSE BMF, 1984, EMBO J, V3, P1951, DOI 10.1002/j.1460-2075.1984.tb02075.x; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Ritter B, 2003, EMBO REP, V4, P1089, DOI 10.1038/sj.embor.7400004; Ritter B, 2007, EMBO J, V26, P4066, DOI 10.1038/sj.emboj.7601836; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Slepnev VI, 2000, J BIOL CHEM, V275, P17583, DOI 10.1074/jbc.M910430199; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; Tebar F, 1996, J BIOL CHEM, V271, P28727, DOI 10.1074/jbc.271.46.28727; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Walther K, 2004, P NATL ACAD SCI USA, V101, P964, DOI 10.1073/pnas.0307862100; Wasiak S, 2003, FEBS LETT, V555, P437, DOI 10.1016/S0014-5793(03)01299-7; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Wigge P, 1997, CURR BIOL, V7, P554, DOI 10.1016/S0960-9822(06)00254-5; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	61	21	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5099	5109		10.1074/jbc.M708621200	http://dx.doi.org/10.1074/jbc.M708621200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	17986441	hybrid, Green Published			2022-12-25	WOS:000253426500067
J	Gast, D; Riedle, S; Issa, Y; Pfeifer, M; Beckhove, P; Sanderson, MP; Arlt, M; Moldenhauer, G; Fogel, M; Kruger, A; Altevogt, P				Gast, D.; Riedle, S.; Issa, Y.; Pfeifer, M.; Beckhove, P.; Sanderson, M. P.; Arlt, M.; Moldenhauer, G.; Fogel, M.; Krueger, A.; Altevogt, P.			The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies	ONCOGENE			English	Article						cell migration; tumor growth; signaling; therapeutic antibodies	CELL-ADHESION MOLECULE; ACTIVATED PROTEIN-KINASES; MELANOMA PROGRESSION; MALIGNANT-MELANOMA; OVARIAN CARCINOMAS; NEURITE OUTGROWTH; L1 CD171; MIGRATION; METASTASIS; BINDING	L1 cell adhesion molecule (L1-CAM) is a transmembrane cell adhesion molecule involved in cell migration and axon guidance in the developing nervous system. L1 is also overexpressed in ovarian and endometrial carcinomas and is associated with a bad prognosis. In carcinoma cell lines, L1 overexpression augments cell motility, tumor growth in mice and induces expression of Erk-dependent genes. Here, we show that a mutation in the cytoplasmic portion of L1 (T1247A, S1248A) abrogates Erk activation, blocks cell migration on extracellular matrix proteins and did not augment tumor growth in non-obese diabetic/severe combined immuno-deficient mice. In cells expressing mutant L1, the induction of Erk-dependent genes such as beta 3-integrin, cathepsin-B and several transcription factors is eliminated and the invasive phenotype is abrogated. L1 antibodies showed similar effects. They prevented Erk activation and interfered with the Erk-dependent gene expression pattern. These findings provide a rationale for the mode of action of L1 antibodies and suggest that interference with L1 function could become a valuable target for therapy.	[Gast, D.; Riedle, S.; Issa, Y.; Pfeifer, M.; Beckhove, P.; Sanderson, M. P.; Moldenhauer, G.; Altevogt, P.] German Canc Res Ctr, Tumor Immunol Programme, D-69120 Heidelberg, Germany; [Arlt, M.; Krueger, A.] Tech Univ Munich, Inst Expt Oncol & Therapy, Munich, Germany; [Fogel, M.] Kaplan Med Ctr, Dept Pathol, Rehovot, Israel	Helmholtz Association; German Cancer Research Center (DKFZ); Technical University of Munich; Hebrew University of Jerusalem; Kaplan Medical Center	Altevogt, P (corresponding author), German Canc Res Ctr, Tumor Immunol Programme, D010,Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	P.Altevogt@dkfz.de	Sanderson, Michael/I-1674-2017	Sanderson, Michael/0000-0001-5362-486X				Allory Y, 2005, CLIN CANCER RES, V11, P1190; Arlt MJE, 2006, CANCER RES, V66, P936, DOI 10.1158/0008-5472.CAN-05-1818; Bar-Eli M, 2001, PIGM CELL RES, V14, P78, DOI 10.1034/j.1600-0749.2001.140202.x; Brunner G, 1998, EXP CELL RES, V239, P301, DOI 10.1006/excr.1997.3877; Cheng L, 2005, J NEUROCHEM, V94, P1102, DOI 10.1111/j.1471-4159.2005.03254.x; Cheng L, 2005, J NEUROSCI, V25, P395, DOI 10.1523/JNEUROSCI.4097-04.2005; Colucci-D'Amato L, 2003, BIOESSAYS, V25, P1085, DOI 10.1002/bies.10355; Fogel M, 2003, LANCET, V362, P869, DOI 10.1016/S0140-6736(03)14342-5; Fogel M, 2003, CANCER LETT, V189, P237, DOI 10.1016/S0304-3835(02)00513-X; Gast D, 2005, INT J CANCER, V115, P658, DOI 10.1002/ijc.20869; Gavert N, 2005, J CELL BIOL, V168, P633, DOI 10.1083/jcb.200408051; Gutwein P, 2000, J BIOL CHEM, V275, P15490, DOI 10.1074/jbc.275.20.15490; Gutwein P, 2002, FASEB J, V16, P292, DOI 10.1096/fj.02-0430fje; Huszar M, 2006, HUM PATHOL, V37, P1000, DOI 10.1016/j.humpath.2006.03.014; IGNELZI MA, 1994, NEURON, V12, P873, DOI 10.1016/0896-6273(94)90339-5; Knogler K, 2007, CLIN CANCER RES, V13, P603, DOI 10.1158/1078-0432.CCR-06-1486; Lotan R, 1996, FASEB J, V10, P1031, DOI 10.1096/fasebj.10.9.8801164; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Meier F, 2006, INT J CANCER, V119, P549, DOI 10.1002/ijc.21880; MOLDENHAUER G, 1987, BRIT J CANCER, V56, P714, DOI 10.1038/bjc.1987.276; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; Primiano T, 2003, CANCER CELL, V4, P41, DOI 10.1016/S1535-6108(03)00169-7; Schaefer AW, 1999, J BIOL CHEM, V274, P37965, DOI 10.1074/jbc.274.53.37965; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schmid RS, 2000, J NEUROSCI, V20, P4177; Senner V, 2002, GLIA, V38, P146, DOI 10.1002/glia.10058; Shtutman M, 2006, CANCER RES, V66, P11370, DOI 10.1158/0008-5472.CAN-06-2106; Silletti S, 2004, J BIOL CHEM, V279, P28880, DOI 10.1074/jbc.M404075200; Tang NF, 2006, J NEUROCHEM, V96, P1480, DOI 10.1111/j.1471-4159.2006.03649.x; Thelen K, 2002, J NEUROSCI, V22, P4918, DOI 10.1523/JNEUROSCI.22-12-04918.2002; Thies A, 2002, EUR J CANCER, V38, P1708, DOI 10.1016/S0959-8049(02)00105-3	31	69	71	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 21	2008	27	9					1281	1289		10.1038/sj.onc.1210747	http://dx.doi.org/10.1038/sj.onc.1210747			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	266BT	17952127				2022-12-25	WOS:000253407000010
J	Bedoukian, MA; Whitesell, JD; Peterson, EJ; Clay, CM; Partin, KM				Bedoukian, Matthew A.; Whitesell, Jennifer D.; Peterson, Erik J.; Clay, Colin M.; Partin, Kathryn M.			The stargazin C terminus encodes an intrinsic and transferable membrane sorting signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPA RECEPTOR TRAFFICKING; 2 DISTINCT MECHANISMS; EXPRESSION; DESENSITIZATION; IDENTIFICATION; DEACTIVATION; MODULATION; PLASTICITY; TRANSPORT; DOMAINS	Activity-dependent plasticity of alpha-amino-3-hydroxy-5methylisoxazole-4-propionic acid receptors is regulated by their auxiliary subunit, stargazin. Association with stargazin enhances alpha-amino-3-hydroxy-5-methylisoxazole-4- propionic acid receptor surface expression and modifies the receptor's biophysical properties. Fusing the cytoplasmic C terminus of stargazin to the C- terminal domains of either GluR1 or the gonadotropin- releasing hormone receptor permits efficient trafficking from the endoplasmic reticulum and sorting to the basolateral membrane without altering other properties of either receptor.	[Bedoukian, Matthew A.; Whitesell, Jennifer D.; Peterson, Erik J.; Clay, Colin M.; Partin, Kathryn M.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	Colorado State University	Partin, KM (corresponding author), Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.	kathy.partin@research.colostate.edu	Partin, Kathryn/A-8706-2015; Partin, Kathryn/AAI-5412-2021	Partin, Kathryn/0000-0003-3801-3299; Partin, Kathryn/0000-0003-3801-3299; Whitesell, Jennifer/0000-0002-2961-5207	NIMH NIH HHS [R01 MH064700] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064700] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bedoukian MA, 2006, J BIOL CHEM, V281, P23908, DOI 10.1074/jbc.M600679200; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Deng F, 2006, J NEUROSCI, V26, P7875, DOI 10.1523/JNEUROSCI.1851-06.2006; Hall RA, 1997, J NEUROCHEM, V68, P625; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Horvat RD, 2001, MOL ENDOCRINOL, V15, P695, DOI 10.1210/me.15.5.695; Knollman PE, 2005, J BIOL CHEM, V280, P24506, DOI 10.1074/jbc.M501978200; Leever JD, 2003, MOL PHARMACOL, V64, P5, DOI 10.1124/mol.64.1.5; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Navratil AM, 2003, J BIOL CHEM, V278, P31593, DOI 10.1074/jbc.M304273200; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Scannevin RH, 1996, J CELL BIOL, V135, P1619, DOI 10.1083/jcb.135.6.1619; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tucker TA, 2003, AM J PHYSIOL-CELL PH, V284, pC791, DOI 10.1152/ajpcell.00435.2002; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Vandenberghe W, 2005, J NEUROSCI, V25, P1095, DOI 10.1523/JNEUROSCI.3568-04.2005; Vandenberghe W, 2005, P NATL ACAD SCI USA, V102, P485, DOI 10.1073/pnas.0408269102; Ziff EB, 2007, NEURON, V53, P627, DOI 10.1016/j.neuron.2007.02.006	22	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1597	1600		10.1074/jbc.M708141200	http://dx.doi.org/10.1074/jbc.M708141200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17986442	hybrid			2022-12-25	WOS:000252282700045
J	Abramovitz, L; Shapira, T; Ben-Dror, I; Dror, V; Granot, L; Rousso, T; Landoy, E; Blau, L; Thiel, G; Vardimon, L				Abramovitz, Lilach; Shapira, Tamar; Ben-Dror, Iris; Dror, Vardit; Granot, Limor; Rousso, Tal; Landoy, Elad; Blau, Lior; Thiel, Gerald; Vardimon, Lily			Dual role of NRSF/REST in activation and repression of the glucocorticoid response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRICTIVE SILENCER FACTOR; TRANSCRIPTION FACTOR REST; HISTONE DEACETYLASE INHIBITION; NEURONAL GENES; TARGET GENES; BIOLOGICAL-ACTIVITY; PROMOTER ACTIVITY; EXPRESSION; COMPLEX; ELEMENT	Restriction of glutamine synthetase to the nervous system is mainly achieved through the mutual function of the glucocorticoid receptor and the neural restrictive silencing factor, NRSF/REST. Glucocorticoids induce glutamine synthetase expression in neural tissues while NRSF/REST represses the hormonal response in non-neural cells. NRSF/REST is a modular protein that contains two independent repression domains, at the N and C termini of the molecule, and is dominantly expressed in nonneural cells. Neural tissues express however splice variants, REST4/5, which contain the repression domain at the N, but not at the C terminus of the molecule. Here we show that full-length NRSF/REST or its C-terminal domain can inhibit almost completely the induction of gene transcription by glucocorticoids. By contrast, the N-terminal domain not only fails to repress the hormonal response but rather stimulates it markedly. The inductive activity of the N-terminal domain is mediated by hBrm, which is recruited to the promoter only in the concomitant presence of GR. Importantly, a similar inductive activity is also exerted by the splice variant REST4. These findings raise the possibility that NRSF/REST exhibits a dual role in regulation of glutamine synthetase. It represses gene induction in nonneural cells and enhances the hormonal response, via its splice variant, in the nervous system.	[Abramovitz, Lilach; Shapira, Tamar; Ben-Dror, Iris; Dror, Vardit; Granot, Limor; Rousso, Tal; Landoy, Elad; Blau, Lior; Vardimon, Lily] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel; [Thiel, Gerald] Univ Saarland, Med Ctr, Dept Med Biochem & Mol Biol, D-66421 Homburg, Germany	Tel Aviv University; Saarland University	Vardimon, L (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel.	vardi@post.tau.ac.il		Abramovitz, Lilach/0000-0001-9961-9986				Armisen R, 2002, J NEUROSCI, V22, P8347; Avisar N, 1999, J BIOL CHEM, V274, P11399, DOI 10.1074/jbc.274.16.11399; Bai G, 2003, J NEUROCHEM, V86, P992, DOI 10.1046/j.1471-4159.2003.01922.x; Balasubramanian B, 1999, MOL CELL BIOL, V19, P2977; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Battaglioli E, 2002, J BIOL CHEM, V277, P41038, DOI 10.1074/jbc.M205691200; BENDROR I, 1993, P NATL ACAD SCI USA, V90, P1117, DOI 10.1073/pnas.90.3.1117; Bessis A, 1997, P NATL ACAD SCI USA, V94, P5906, DOI 10.1073/pnas.94.11.5906; Brene S, 2000, EUR J NEUROSCI, V12, P1525, DOI 10.1046/j.1460-9568.2000.00040.x; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Ferguson M, 2003, NUCLEIC ACIDS RES, V31, P3123, DOI 10.1093/nar/gkg403; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Hebbar PB, 2003, MOL CELL BIOL, V23, P887, DOI 10.1128/MCB.23.3.887-898.2003; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Kallunki P, 1998, P NATL ACAD SCI USA, V95, P3233, DOI 10.1073/pnas.95.6.3233; Krumm A, 1998, P NATL ACAD SCI USA, V95, P13501, DOI 10.1073/pnas.95.23.13501; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Laribee RN, 2001, J IMMUNOL, V167, P5160, DOI 10.4049/jimmunol.167.9.5160; Lee JH, 2000, J MOL NEUROSCI, V15, P205, DOI 10.1385/JMN:15:3:205; LEE JS, 1995, GENE DEV, V9, P1188, DOI 10.1101/gad.9.10.1188; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Lietz M, 2001, EUR J NEUROSCI, V14, P1303, DOI 10.1046/j.0953-816x.2001.01762.x; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Magin A, 2002, NEUROCHEM INT, V40, P195, DOI 10.1016/S0197-0186(01)00091-2; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Naruse Y, 1999, P NATL ACAD SCI USA, V96, P13691, DOI 10.1073/pnas.96.24.13691; Ooi L, 2006, J BIOL CHEM, V281, P38974, DOI 10.1074/jbc.M605370200; Palm K, 1998, J NEUROSCI, V18, P1280; Paz I, 1999, GENE, V236, P33, DOI 10.1016/S0378-1119(99)00264-4; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Roopra A, 2000, MOL CELL BIOL, V20, P2147, DOI 10.1128/MCB.20.6.2147-2157.2000; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; SADOWSKI I, 1992, GENE, V118, P137, DOI 10.1016/0378-1119(92)90261-M; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Shimojo M, 1999, MOL CELL BIOL, V19, P6788; Shimojo M, 2001, J BIOL CHEM, V276, P13121, DOI 10.1074/jbc.M011193200; Tabuchi A, 2002, BIOCHEM BIOPH RES CO, V290, P415, DOI 10.1006/bbrc.2001.6194; TapiaRamirez J, 1997, P NATL ACAD SCI USA, V94, P1177, DOI 10.1073/pnas.94.4.1177; Thiel G, 1998, J BIOL CHEM, V273, P26891, DOI 10.1074/jbc.273.41.26891; Vardimon L, 1999, J NEUROBIOL, V40, P513, DOI 10.1002/(SICI)1097-4695(19990915)40:4<513::AID-NEU8>3.0.CO;2-D; Wang XQ, 2002, BIOCHEM BIOPH RES CO, V294, P660, DOI 10.1016/S0006-291X(02)00523-5; Watanabe H, 2006, ONCOGENE, V25, P470, DOI 10.1038/sj.onc.1209068; Yoo JY, 2001, BIOCHEM BIOPH RES CO, V283, P928, DOI 10.1006/bbrc.2001.4857; YOSHINAGA SK, 1992, SCIENCE, V258, P1598, DOI 10.1126/science.1360703; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454	56	31	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					110	119		10.1074/jbc.M707366200	http://dx.doi.org/10.1074/jbc.M707366200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17984088	hybrid			2022-12-25	WOS:000251940300013
J	Hakuno, F; Kurihara, S; Watson, RT; Pessin, JE; Takahashi, SI				Hakuno, Fumihiko; Kurihara, Shigekazu; Watson, Robert T.; Pessin, Jeffrey E.; Takahashi, Shin-Ichiro			53BP2S, interacting with insulin receptor substrates, modulates insulin signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; PHOSPHATIDYLINOSITOL 3-KINASE ACTIVATION; DEOXYRIBONUCLEIC-ACID SYNTHESIS; STIMULATED GLUT4 TRANSLOCATION; NECROSIS-FACTOR-ALPHA; TYROSINE KINASE; PHOSPHOINOSITIDE 3-KINASE; SERINE PHOSPHORYLATION; TUMOR-SUPPRESSOR; GLUCOSE-UPTAKE	It is well known that insulin receptor substrates (IRS) act as a mediator for signal transduction of insulin, insulin-like growth factors, and several cytokines. To identify proteins that interact with IRS and modulate IRS-mediated signals, we performed yeast two-hybrid screening with IRS-1 as bait. Out of 109 cDNA-positive clones identified from a human placental cDNA library, two clones encoded 53BP2, p53-binding protein 2 (53BP2S), a short form splicing variant of the apoptosis-stimulating protein of p53 that possesses Src homology region 3 domain, and ankyrin repeats domain, and had been reported to interact with p53, Bcl-2, and NF-kappa B. Interaction of 53BP2S with IRS-1 was confirmed by glutathione S-transferase pull-down and co-immunoprecipitation assays in COS-7 cells and 3T3-L1 adipocytes. The Src homology region 3 domain and ankyrin repeats domain of 53BP2S were responsible for its interaction with IRS-1, whereas the phosphotyrosine binding domain and a central domain ( amino acid residues 750 - 861) of IRS-1 were required for its interaction with 53BP2S. In CHO-C400 cells, expression of 53BP2S reduced insulin-stimulated IRS-1 tyrosine phosphorylation with a concomitant enhancement of IRS-2 tyrosine phosphorylation. In addition, the amount of the phosphatidylinositol 3-kinase regulatory p85 subunit associated with tyrosine-phosphorylated proteins, and activation of Akt was enhanced by 53BP2S expression. Although 53BP2S also enhanced Akt activation in 3T3-L1 adipocytes, insulin-induced glucose transporter 4 translocation was markedly inhibited in accordance with reduction of insulin-induced AS160 phosphorylation. Together these data demonstrate that 53BP2S interacts and modulates the insulin signals mediated by IRSs.	[Hakuno, Fumihiko; Kurihara, Shigekazu; Takahashi, Shin-Ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Hakuno, Fumihiko; Kurihara, Shigekazu; Takahashi, Shin-Ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Watson, Robert T.; Pessin, Jeffrey E.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	University of Tokyo; University of Tokyo; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Takahashi, SI (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Anim Sci, Lab Cell Regulat,Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	atkshin@mail.ecc.u-tokyo.ac.jp		Takahashi, Shin-Ichiro/0000-0002-2323-2010; Hakuno, Fumihiko/0000-0002-4447-6225				Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Ariga M, 2000, BIOCHEM J, V348, P409, DOI 10.1042/0264-6021:3480409; BACKER JM, 1992, J BIOL CHEM, V267, P1367; Bae SS, 2003, J BIOL CHEM, V278, P49530, DOI 10.1074/jbc.M306782200; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Clark SF, 1998, J CELL BIOL, V140, P1211, DOI 10.1083/jcb.140.5.1211; CLARKE JF, 1994, BIOCHEM J, V300, P631, DOI 10.1042/bj3000631; Elmendorf JS, 1998, J BIOL CHEM, V273, P13289, DOI 10.1074/jbc.273.21.13289; Gao ZG, 2003, J BIOL CHEM, V278, P24944, DOI 10.1074/jbc.M300423200; GRONBORG M, 1993, J BIOL CHEM, V268, P23435; Gual P, 2003, DIABETOLOGIA, V46, P1532, DOI 10.1007/s00125-003-1223-4; Helps NR, 1995, FEBS LETT, V377, P295, DOI 10.1016/0014-5793(95)01347-4; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Jiang T, 1998, J BIOL CHEM, V273, P11017, DOI 10.1074/jbc.273.18.11017; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; JULLIEN D, 1993, J BIOL CHEM, V268, P15246; Kabuta T, 2002, J BIOL CHEM, V277, P6846, DOI 10.1074/jbc.M107058200; Kanzaki M, 2002, J BIOL CHEM, V277, P25867, DOI 10.1074/jbc.C200292200; KOTANI K, 1995, BIOCHEM BIOPH RES CO, V209, P343, DOI 10.1006/bbrc.1995.1509; Le Marchand-Brustel Y, 2003, BIOCHEM SOC T, V31, P1152; Martin SS, 1996, J BIOL CHEM, V271, P17605, DOI 10.1074/jbc.271.30.17605; Mauvais-Jarvis F, 2002, J CLIN INVEST, V109, P141, DOI 10.1172/JCI200213305; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; MYERS MG, 1994, MOL CELL BIOL, V14, P3577, DOI 10.1128/MCB.14.6.3577; Nakaga H, 2000, CANCER RES, V60, P101; Naumovski L, 1996, MOL CELL BIOL, V16, P3884; Nedachi T, 2000, ENDOCRINOLOGY, V141, P2429, DOI 10.1210/en.141.7.2429; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Ogihara T, 1997, J BIOL CHEM, V272, P25267, DOI 10.1074/jbc.272.40.25267; OKADA T, 1994, J BIOL CHEM, V269, P3568; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Sharma PM, 1998, J BIOL CHEM, V273, P18528, DOI 10.1074/jbc.273.29.18528; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835; TAKAHASHI S, 1990, ENDOCRINOLOGY, V126, P736, DOI 10.1210/endo-126-2-736; TAKAHASHI SI, 1991, J BIOL CHEM, V266, P7834; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; TANTI JF, 1994, J BIOL CHEM, V269, P6051; Ueno H, 2000, MOL BIOL CELL, V11, P735, DOI 10.1091/mbc.11.2.735; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yang JP, 1999, ONCOGENE, V18, P5177, DOI 10.1038/sj.onc.1202904	56	23	25	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37747	37758		10.1074/jbc.M702472200	http://dx.doi.org/10.1074/jbc.M702472200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17965023	hybrid			2022-12-25	WOS:000251833600051
J	Huzil, JT; Pannu, R; Ptak, C; Garen, G; Ellison, MJ				Huzil, J. Torin; Pannu, Rajeet; Ptak, Christopher; Garen, Grace; Ellison, Michael J.			Direct catalysis of lysine 48-linked polyubiquitin chains by the ubiquitin-activating enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MULTIUBIQUITIN CHAIN; LIGASE COMPLEX; PROTEIN LIGASE; DEGRADATION; PATHWAY; CONJUGATION; SYSTEM; TAIL; E2	Within the ubiquitin degradation pathway, the canonical signal is a lysine 48-linked polyubiquitin chain that is assembled upon an internal lysine residue of a substrate protein. Once constructed, this ubiquitin chain becomes the principle signal for recognition and target degradation by the 26S proteasome. The mechanism by which polyubiquitin chains are assembled on a substrate protein, however, has yet to be clearly defined. In an in vitro model system, purified E2-ubiquitin thiolester was unable to catalyze the formation of polyubiquitin chains in the absence of the ubiquitin-activating enzyme E1. Mutagenesis of key residues within the E1 active site revealed that its conserved catalytic cysteine residue is essential for the formation of these chains. Moreover, inactivation of the E2 active site had no effect on the ability of E1 to catalyze ubiquitin chain formation. These findings strongly suggest E1 is responsible for not only the activation of ubiquitin but also for the direct catalytic extension of a lysine 48-linked polyubiquitin chain.	[Huzil, J. Torin; Pannu, Rajeet; Ptak, Christopher; Garen, Grace; Ellison, Michael J.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Ellison, Michael J.] Univ Alberta, Inst Biomol Design, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta	Ellison, MJ (corresponding author), Univ Alberta, 3-67 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	michael.ellison@ualberta.ca						ARNASON T, 1994, MOL CELL BIOL, V14, P7876, DOI 10.1128/MCB.14.12.7876; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; GREGORI L, 1990, J BIOL CHEM, V265, P8354; HAAS A, 1990, J BIOL CHEM, V265, P21664; HAAS AL, 1988, J BIOL CHEM, V263, P13258; Haldeman MT, 1997, BIOCHEMISTRY-US, V36, P10526, DOI 10.1021/bi970750u; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; HATFIELD PM, 1990, J BIOL CHEM, V265, P15813; HATFIELD PM, 1992, J BIOL CHEM, V267, P14799; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P1619, DOI 10.1073/pnas.81.6.1619; Hodgins R, 1996, J BIOL CHEM, V271, P28766, DOI 10.1074/jbc.271.46.28766; HODGINS RRW, 1992, J BIOL CHEM, V267, P8807; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Huang DT, 2004, NAT STRUCT MOL BIOL, V11, P927, DOI 10.1038/nsmb826; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; KLEMPERER NS, 1989, BIOCHEMISTRY-US, V28, P6035, DOI 10.1021/bi00440a047; Leimkuhler S, 2001, J BIOL CHEM, V276, P22024, DOI 10.1074/jbc.M102072200; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Mastrandrea LD, 1998, BIOCHEMISTRY-US, V37, P9784, DOI 10.1021/bi9800911; Mastrandrea LD, 1999, J BIOL CHEM, V274, P27299, DOI 10.1074/jbc.274.38.27299; MCGRATH JP, 1991, EMBO J, V10, P227, DOI 10.1002/j.1460-2075.1991.tb07940.x; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; PICKART CM, 1988, J BIOL CHEM, V263, P15076; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; PTAK C, 1994, J BIOL CHEM, V269, P26539; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; SEUFERT W, 1992, EMBO J, V11, P3077, DOI 10.1002/j.1460-2075.1992.tb05379.x; Staszczak M, 2007, INT J BIOCHEM CELL B, V39, P319, DOI 10.1016/j.biocel.2006.08.013; SUNG P, 1991, EMBO J, V10, P2187, DOI 10.1002/j.1460-2075.1991.tb07754.x; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; VAN NS, 1991, P NATL ACAD SCI USA, V88, P10297; VanDemark AP, 2003, NAT STRUCT BIOL, V10, P244, DOI 10.1038/nsb0403-244; VANNOCKER S, 1993, J BIOL CHEM, V268, P24766; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; WALKER JE, 1982, BIOCHEM SOC T, V10, P203, DOI 10.1042/bst0100203; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	45	9	10	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37454	37460		10.1074/jbc.M705242200	http://dx.doi.org/10.1074/jbc.M705242200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17951259	hybrid			2022-12-25	WOS:000251833600020
J	Xu, H; Shi, Y; Wang, JL; Jones, D; Weilrauch, D; Ying, R; Wakim, B; Pritchard, KA				Xu, Hao; Shi, Yang; Wang, Jingli; Jones, Deron; Weilrauch, Dorothee; Ying, Rong; Wakim, Basam; Pritchard, Kirkwood A., Jr.			A heat shock protein 90 binding domain in endothelial nitric-oxide synthase influences enzyme function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAT FUSION PROTEINS; SUPEROXIDE ANION; TRANSDUCTION; PHOSPHORYLATION; ACTIVATION; GENERATION; BALANCE; HSP90; L-4F	Previous reports suggest heat shock protein 90 (hsp90) associates with endothelial nitric-oxide synthase (eNOS) to increase nitric oxide (center dot NO) generation. Ansamycin inhibition of chaperone-dependent activity increases eNOS generation of superoxide anion (O-2 radical anion) upon enzyme activation. In the present study we identify where hsp90 binds to eNOS using overlapping decoy peptides based on the amino acid (aa) sequence of eNOS (291-420). B1, B2, and B3 peptides inhibited hsp90 association with eNOS in cell lysates from proliferating bovine aortic endothelial cells. B2 (aa 301-320), common to both B1 and B3, decreased stimulated center dot NO production and hsp90 association in bovine aortic endothelial cells. The B2/ B3 peptide was redesigned to TSB2 that includes a TAT protein transduction domain and shortened to 14 aa. TSB2 impaired vasodilation of isolated facialis arteries in vitro and in vivo and increased eNOS-dependent O-2 radical anion radical anion generation in native endothelial cells on mouse aortas, whereas a control peptide, TSB(Ctr), which has the four glutamic acids in TSB2 substituted with alanine, showed no such effects. Site-directed mutagenesis of eNOS at 310, 314, 318, and 323 Glu to Ala yields an eNOS mutant that exhibited reduced hsp90 association and generated O-2 radical anion rather than center dot NO upon activation. Together, these data demonstrate that hsp90 associates with eNOS at aa 310 -323. Moreover, a decoy peptide based on this sequence is sufficient to displace hsp90 from eNOS and uncouple eNOS activity from center dot NO generation. Thus, Glu-310, Glu-314, Glu-318, and Glu-323 in eNOS, although each does not do much by itself, synergistically they increase " cooperativity" in the association step that is critical for maintaining hsp90-eNOS interactions and promoting coupled eNOS activity. Such chaperone-dependent signaling may play an important role in modulating the balance of center dot NOandO(2) radical anion generation from eNOS and, therefore, vascular function.	[Xu, Hao; Shi, Yang; Wang, Jingli; Jones, Deron; Ying, Rong; Pritchard, Kirkwood A., Jr.] Med Coll Wisconsin, Childrens Res Inst, Dept Surg, Div Pediat Surg, Milwaukee, WI 53226 USA; [Weilrauch, Dorothee] Med Coll Wisconsin, Childrens Res Inst, Dept Anesthesiol, Milwaukee, WI 53226 USA; [Wakim, Basam] Med Coll Wisconsin, Cardiovasc Res Ctr, Childrens Res Inst, Dept Biochem, Milwaukee, WI USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Shi, Y (corresponding author), Med Coll Wisconsin, Childrens Res Inst, Dept Surg, Div Pediat Surg, Milwaukee, WI 53226 USA.	yangshi@mcw.edu; kpritch@mcw.edu			NHLBI NIH HHS [HL71214, HL48251, HL080468] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080468, R01HL071214, R01HL048251] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Dolgilevich S, 2002, BIOCHEM BIOPH RES CO, V299, P505, DOI 10.1016/S0006-291X(02)02664-5; Drouin A, 2007, CARDIOVASC RES, V73, P73, DOI 10.1016/j.cardiores.2006.10.005; DUNHAM AJ, 1995, ANAL CHEM, V67, P220, DOI 10.1021/ac00097a033; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Fulton D, 2004, J BIOL CHEM, V279, P30349, DOI 10.1074/jbc.M402155200; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Guo XQ, 2004, EXP EYE RES, V78, P997, DOI 10.1016/j.exer.2003.12.010; Gustafsson AB, 2002, CIRCULATION, V106, P735, DOI 10.1161/01.CIR.0000023943.50821.F7; Jagnandan D, 2005, AM J PHYSIOL-CELL PH, V289, pC1024, DOI 10.1152/ajpcell.00162.2005; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Oak JH, 2007, DIABETES, V56, P118, DOI 10.2337/db06-0288; Osuka K, 2004, STROKE, V35, P2582, DOI 10.1161/01.STR.0000143454.14159.28; Ou J, 2003, FREE RADICAL BIO MED, V34, P269, DOI 10.1016/S0891-5849(02)01299-6; Ou JS, 2004, AM J PHYSIOL-HEART C, V286, pH561, DOI 10.1152/ajpheart.00736.2003; Ou JS, 2003, CIRCULATION, V107, P2337, DOI 10.1161/01.CIR.0000070589.61860.A9; Ou ZJ, 2003, CIRCULATION, V107, P1520, DOI 10.1161/01.CIR.0000061949.17174.B6; Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200; PRITCHARD KA, 1995, CIRC RES, V77, P510, DOI 10.1161/01.RES.77.3.510; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Sakai H, 2006, INVEST OPHTH VIS SCI, V47, P4427, DOI 10.1167/iovs.06-0047; Salerno JC, 1997, J BIOL CHEM, V272, P29769, DOI 10.1074/jbc.272.47.29769; Stepp DW, 2002, AM J PHYSIOL-HEART C, V283, pH750, DOI 10.1152/ajpheart.00029.2002; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4	25	54	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37567	37574		10.1074/jbc.M706464200	http://dx.doi.org/10.1074/jbc.M706464200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17971446	hybrid			2022-12-25	WOS:000251833600032
J	Hou, T; Ray, S; Brasier, AR				Hou, Tieying; Ray, Sutapa; Brasier, Allan R.			The functional role of an interleukin 6-inducible CDK9 center dot STAT3 complex in human gamma-fibrinogen gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; PERIPHERAL-BLOOD LYMPHOCYTES; PROMONOCYTIC CELL-LINES; CDK9 PHOSPHORYLATES P53; TAT-ASSOCIATED KINASE; ACUTE-PHASE RESPONSE; FACTOR P-TEFB; HIV-1 TAT; TRANSCRIPTION ELONGATION; IN-VITRO	The signal transducer and activator of transcription 3 (STAT3) is an IL-6-inducible transcription factor that mediates the hepatic acute phase response (APR). Using gamma-fibrinogen (FBG) as a model of the APR, we investigated the requirement of an IL-6-inducible complex of STAT3 with cyclin-dependent kinase 9 (CDK9) on gamma-FBG expression in HepG2 hepatocarcinoma cells. IL-6 induces rapid nuclear translocation of Tyrphosphorylated STAT3 that forms a nuclear complex with CDK9 in nondenaturing co-immunoprecipitation and confocal colocalization assays. To further understand this interaction, we found that CDK9-STAT3 binding is mediated via both STAT NH2-terminal modulatory and COOH-terminal transactivation domains. Both IL-6-inducible gamma-FBG reporter gene and endogenous mRNA expression are significantly decreased after CDK9 inhibition using the potent CDK inhibitor, flavopiridol ( FP), or specific CDK9 siRNA. Moreover, chromatin immunoprecipitation (ChIP) experiments revealed an IL-6-inducible STAT3 and CDK9 binding to the proximal gamma-FBG promoter as well as increased loading of RNA Pol II and phospho-Ser(2) CTD Pol II on the TATA box and coding regions. Finally, FP specifically and efficiently inhibits association of phospho-Ser(2) CTD RNA Pol II on the gamma-FBG promoter, indicating that CDK9 kinase activity mediates IL-6-inducible CTD phosphorylation. Our data indicate that IL-6 induces a STAT3 center dot CDK9 complex mediated by bivalent STAT3 domains and CDK9 kinase activity is necessary for licensing Pol II to enter a transcriptional elongation mode. Therefore, disruption of IL-6 signaling by CDK9 inhibitors could be a potential therapeutic strategy for inflammatory disease.	[Hou, Tieying] Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Ray, Sutapa; Brasier, Allan R.] Univ Texas Galveston, Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Brasier, Allan R.] Univ Texas Galveston, Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Brasier, AR (corresponding author), Univ Texas Galveston, Med Branch, Div Endocrinol, MRB 8-138,301 Univ Blvd, Galveston, TX 77555 USA.	arbrasie@utmb.edu	Ray, Sutapa/D-3272-2012	Brasier, Allan/0000-0002-5012-4090; Ray, Sutapa/0000-0003-4234-2124	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL070925] Funding Source: Medline; NIEHS NIH HHS [P30 ES06676] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Bieniasz PD, 1998, EMBO J, V17, P7056, DOI 10.1093/emboj/17.23.7056; BRASIER AR, 1989, BIOTECHNIQUES, V7, P1116; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Claudio PP, 2006, J CELL PHYSIOL, V208, P602, DOI 10.1002/jcp.20698; Duan HO, 2006, J BIOL CHEM, V281, P12451, DOI 10.1074/jbc.M600294200; Duan HO, 2003, J BIOL CHEM, V278, P41270, DOI 10.1074/jbc.M304210200; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; FU J, 2007, MOL CELL BIOL, V27, P4661; Garriga J, 1998, ONCOGENE, V17, P3093, DOI 10.1038/sj.onc.1202548; Garriga J, 2004, GENE, V337, P15, DOI 10.1016/j.gene.2004.05.007; Ghose R, 2001, J VIROL, V75, P11336, DOI 10.1128/JVI.75.23.11336-11343.2001; Giraud S, 2004, ONCOGENE, V23, P7391, DOI 10.1038/sj.onc.1207972; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; GRANA X, 1994, P NATL ACAD SCI USA, V91, P3834, DOI 10.1073/pnas.91.9.3834; Haga S, 2003, J CLIN INVEST, V112, P989, DOI 10.1172/JCI200317970; Hagihara K, 2005, GENES CELLS, V10, P1051, DOI 10.1111/j.1365-2443.2005.00900.x; HAWIGER J, 1995, SEMIN HEMATOL, V32, P99; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Herrmann CH, 1998, J VIROL, V72, P9881, DOI 10.1128/JVI.72.12.9881-9888.1998; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Iankova I, 2006, MOL ENDOCRINOL, V20, P1494, DOI 10.1210/me.2005-0222; JIANG SL, 1992, FOLIA HISTOCHEM CYTO, V30, P133; Kanazawa S, 2000, IMMUNITY, V12, P61, DOI 10.1016/S1074-7613(00)80159-4; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; Lee DK, 2001, J BIOL CHEM, V276, P9978, DOI 10.1074/jbc.M002285200; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; MADORE SJ, 1993, J VIROL, V67, P3703, DOI 10.1128/JVI.67.7.3703-3711.1993; Marshall RM, 2005, J IMMUNOL, V175, P6402, DOI 10.4049/jimmunol.175.10.6402; MIZUGUCHI J, 1995, J BIOL CHEM, V270, P28350; Murphy TL, 2000, MOL CELL BIOL, V20, P7121, DOI 10.1128/MCB.20.19.7121-7131.2000; Ni ZY, 2007, J IMMUNOL, V178, P345, DOI 10.4049/jimmunol.178.1.345; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Ping YH, 2001, J BIOL CHEM, V276, P12951, DOI 10.1074/jbc.M006130200; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Radhakrishnan SK, 2006, CELL CYCLE, V5, P519, DOI 10.4161/cc.5.5.2514; RAMJI DP, 1993, NUCLEIC ACIDS RES, V21, P289, DOI 10.1093/nar/21.2.289; Rana TM, 1999, ARCH BIOCHEM BIOPHYS, V365, P175, DOI 10.1006/abbi.1999.1206; Ray A, 2000, J IMMUNOL, V165, P3411, DOI 10.4049/jimmunol.165.6.3411; Ray S, 2005, GASTROENTEROLOGY, V129, P1616, DOI 10.1053/j.gastro.2005.07.055; Ray S, 2002, MOL ENDOCRINOL, V16, P824, DOI 10.1210/me.16.4.824; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Rooney MM, 1996, J BIOL CHEM, V271, P8553, DOI 10.1074/jbc.271.15.8553; Sahni A, 2000, BLOOD, V96, P3772, DOI 10.1182/blood.V96.12.3772.h8003772_3772_3778; Sahni A, 2004, BLOOD, V104, P409, DOI 10.1182/blood-2004-01-0126; Sahni A, 2003, J THROMB HAEMOST, V1, P1304, DOI 10.1046/j.1538-7836.2003.00250.x; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sherman CT, 2001, MOL ENDOCRINOL, V15, P441, DOI 10.1210/me.15.3.441; Shore SM, 2003, GENE, V307, P175, DOI 10.1016/S0378-1119(03)00466-9; Song A, 1998, MOL CELL BIOL, V18, P4994, DOI 10.1128/MCB.18.9.4994; Strehlow I, 1998, J BIOL CHEM, V273, P28049, DOI 10.1074/jbc.273.43.28049; Ugarova TP, 2003, BIOCHEMISTRY-US, V42, P9365, DOI 10.1021/bi034057k; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wimmer J, 1999, VIROLOGY, V255, P182, DOI 10.1006/viro.1998.9589; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yang XZ, 1997, P NATL ACAD SCI USA, V94, P12331, DOI 10.1073/pnas.94.23.12331; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	65	61	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37091	37102		10.1074/jbc.M706458200	http://dx.doi.org/10.1074/jbc.M706458200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17956865	hybrid			2022-12-25	WOS:000251646000036
J	Gotzek, D; Shoemaker, DD; Ross, KG				Gotzek, Dietrich; Shoemaker, D. DeWayne; Ross, Kenneth G.			Molecular Variation at a Candidate Gene Implicated in the Regulation of Fire Ant Social Behavior	PLOS ONE			English	Article							AMINO-ACID SITES; SOLENOPSIS-INVICTA HYMENOPTERA; DETECTING POSITIVE SELECTION; EPISODIC ADAPTIVE EVOLUTION; CODON-SUBSTITUTION MODELS; INTEGRATED SOFTWARE; POPULATION-GENETICS; ORGANIZATION; DNA; POLYMORPHISM	The fire ant Solenopsis invicta and its close relatives display an important social polymorphism involving differences in colony queen number. Colonies are headed by either a single reproductive queen (monogyne form) or multiple queens (polygyne form). This variation in social organization is associated with variation at the gene Gp-9, with monogyne colonies harboring only B-like allelic variants and polygyne colonies always containing b-like variants as well. We describe naturally occurring variation at Gp-9 in fire ants based on 185 full-length sequences, 136 of which were obtained from S. invicta collected over much of its native range. While there is little overall differentiation between most of the numerous alleles observed, a surprising amount is found in the coding regions of the gene, with such substitutions usually causing amino acid replacements. This elevated coding-region variation may result from a lack of negative selection acting to constrain amino acid replacements over much of the protein, different mutation rates or biases in coding and non-coding sequences, negative selection acting with greater strength on non-coding than coding regions, and/or positive selection acting on the protein. Formal selection analyses provide evidence that the latter force played an important role in the basal b-like lineages coincident with the emergence of polygyny. While our data set reveals considerable paraphyly and polyphyly of S. invicta sequences with respect to those of other fire ant species, the b-like alleles of the socially polymorphic species are monophyletic. An expanded analysis of colonies containing alleles of this clade confirmed the invariant link between their presence and expression of polygyny. Finally, our discovery of several unique alleles bearing various combinations of b-like and B-like codons allows us to conclude that no single b-like residue is completely predictive of polygyne behavior and, thus, potentially causally involved in its expression. Rather, all three typical b-like residues appear to be necessary.	[Ross, Kenneth G.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [Gotzek, Dietrich] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Shoemaker, D. DeWayne] ARS, USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL USA	University System of Georgia; University of Georgia; University of Lausanne; United States Department of Agriculture (USDA)	Ross, KG (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.	kenross@uga.edu		Shoemaker, DeWayne/0000-0003-3659-8393	Georgia Agricultural Experiment Stations (University of Georgia); United States Department of Agriculture	Georgia Agricultural Experiment Stations (University of Georgia); United States Department of Agriculture(United States Department of Agriculture (USDA))	Partial funding for this research came from the Georgia Agricultural Experiment Stations (University of Georgia) and grants from the United States Department of Agriculture to DDS and KGR.	Ahrens ME, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-35; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Bofkin L, 2007, MOL BIOL EVOL, V24, P513, DOI 10.1093/molbev/msl178; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Chen YP, 2003, SOUTHWEST ENTOMOL, V28, P27; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Eyre-Walker A, 2006, TRENDS ECOL EVOL, V21, P569, DOI 10.1016/j.tree.2006.06.015; FILIPSKI J, 1988, J THEOR BIOL, V134, P159, DOI 10.1016/S0022-5193(88)80199-1; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Gillespie J. H., 1991, CAUSES MOL EVOLUTION; Golding GB, 1998, MOL BIOL EVOL, V15, P355, DOI 10.1093/oxfordjournals.molbev.a025932; GOTZEK D, 2007, J INS BEHAV IN PRESS; Gotzek D, 2007, Q REV BIOL, V82, P201, DOI 10.1086/519965; Haddrill PR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r67; Hallar BL, 2007, GENETICA, V131, P69, DOI 10.1007/s10709-006-9114-5; HEDRICK PW, 2004, GENETICS POPULATION; Ho JWK, 2006, BIOINFORMATICS, V22, P2162, DOI 10.1093/bioinformatics/btl283; Huelsenbeck JP, 2004, J MOL EVOL, V58, P661, DOI 10.1007/s00239-004-2588-9; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Imyanitov EN, 2002, BIOTECHNIQUES, V33, P484, DOI 10.2144/02333bm04_11841a; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; Keller L, 2002, CURR BIOL, V12, pR180, DOI 10.1016/S0960-9822(02)00737-6; Ko WY, 2006, GENETICS, V174, P349, DOI 10.1534/genetics.105.054346; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Krieger MJB, 2005, MOL BIOL EVOL, V22, P2090, DOI 10.1093/molbev/msi203; Krieger MJB, 2005, BIOESSAYS, V27, P91, DOI 10.1002/bies.20129; Krieger MJB, 1997, MOL ECOL, V6, P997, DOI 10.1046/j.1365-294X.1997.00264.x; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LARGET B, 2005, STAT METHODS MOL EVO; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Maddison D. R., 2000, MACCLADE 4 ANAL PHYL; MADDISON WP, 2006, MESQUITE MODULAR SYS; MEILLOUR PNL, 2003, INSECT PHEROMONE BIO, P509; Mescher MC, 2003, ANN ENTOMOL SOC AM, V96, P810, DOI 10.1603/0013-8746(2003)096[0810:DOTTSF]2.0.CO;2; Messler W, 1997, NATURE, V385, P151, DOI 10.1038/385151a0; Milne I, 2004, BIOINFORMATICS, V20, P1806, DOI 10.1093/bioinformatics/bth155; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Nachman MW, 2005, GENETICA, V123, P125, DOI 10.1007/s10709-004-2723-y; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nei M., 2000, MOL EVOLUTION PHYLOG; Nielsen R, 1998, GENETICS, V148, P929; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Parry-Smith DJ, 1998, GENE, V221, pGC57, DOI 10.1016/S0378-1119(97)00650-1; Phillips PC, 2005, GENETICA, V123, P15, DOI 10.1007/s10709-004-2704-1; Pitts JP, 2005, ZOOL SCR, V34, P493, DOI 10.1111/j.1463-6409.2005.00203.x; PITTS JP, 2007, ZOOTAXA IN PRESS; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ronquist F., 2005, MRBAYES 3 1 MANUAL; Rooney AP, 1999, MOL BIOL EVOL, V16, P706, DOI 10.1093/oxfordjournals.molbev.a026153; Rosenberg NA, 2003, EVOLUTION, V57, P1465, DOI 10.1554/03-012; Ross KG, 2007, BIOL J LINN SOC, V92, P541, DOI 10.1111/j.1095-8312.2007.00853.x; Ross KG, 2005, MOL ECOL, V14, P3419, DOI 10.1111/j.1365-294X.2005.02661.x; Ross KG, 1997, GENETICS, V147, P643; ROSS KG, 1995, ANNU REV ECOL SYST, V26, P631, DOI 10.1146/annurev.es.26.110195.003215; Ross KG, 1997, GENETICS, V145, P961; Ross KG, 1998, P NATL ACAD SCI USA, V95, P14232, DOI 10.1073/pnas.95.24.14232; Ross KG, 2003, GENETICS, V165, P1853; Ross KG, 2002, BEHAV ECOL SOCIOBIOL, V51, P287, DOI [10.1007/s00265-001-0431-5, 10.1007/S00265-001-0431-5]; ROSS KG, 1993, GENETICS, V135, P843; Rousset F, 1997, GENETICS, V145, P1219; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scheffler K, 2005, MOL BIOL EVOL, V22, P2531, DOI 10.1093/molbev/msi250; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shoemaker DD, 2006, ANN ENTOMOL SOC AM, V99, P1213, DOI 10.1603/0013-8746(2006)99[1213:PGOTIF]2.0.CO;2; Shoemaker DD, 2006, MOL PHYLOGENET EVOL, V38, P200, DOI 10.1016/j.ympev.2005.07.014; SIKES DS, 2001, SOFTWARE MANUAL PAUP; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Tschinkel WR., 2006, FIRE ANTS; Vasemagi A, 2005, MOL ECOL, V14, P3623, DOI 10.1111/j.1365-294X.2005.02690.x; VOGT RG, 2005, ENDOCRINOLOGY, V3, P753; Wagner GP, 2004, MOL BIOL EVOL, V21, P2116, DOI 10.1093/molbev/msh221; Wheat CW, 2006, MOL BIOL EVOL, V23, P499, DOI 10.1093/molbev/msj062; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang JZ, 1997, MOL BIOL EVOL, V14, P1335, DOI 10.1093/oxfordjournals.molbev.a025743	92	22	32	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1088	10.1371/journal.pone.0001088	http://dx.doi.org/10.1371/journal.pone.0001088			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987107	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459000001
J	Kalis, M; Leveen, P; Lyssenko, V; Almgren, P; Groop, L; Cilio, CM				Kalis, Martins; Leveen, Per; Lyssenko, Valeriya; Almgren, Peter; Groop, Leif; Cilio, Corrado M.			Variants in the FFAR1 Gene Are Associated with Beta Cell Function	PLOS ONE			English	Article								Background. The FFAR1 receptor is expressed mainly in pancreatic beta cells and is activated by medium to long chain free fatty acids (FFAs), as well as by thiazolidinediones, resulting in elevated Ca2+ concentrations and promotion of insulin secretion. These properties suggest that FFAR1 could be a mediator of lipotoxicity and a potential candidate gene for Type 2 diabetes (T2D). We therefore investigated whether variations at the FFAR1 locus are associated with T2D and beta cell function. Methodology/Principal Findings. We re-sequenced the FFAR1 region in 96 subjects (48 healthy and 48 T2D individuals) and found 13 single nucleotide polymorphisms (SNPs) 8 of which were not previously described. Two SNPs located in the upstream region of the FFAR1 gene (rs1978013 and rs1978014) were chosen and genotyped in 1929 patients with T2D and 1405 healthy control subjects. We observed an association of rs1978013 and rs1978014 with insulinogenic index in males (p = 0.024) and females (p = 0.032), respectively. After Bonferroni corrections, no association with T2D was found in the case-control material, however a haplotype consisting of the T-G alleles conferred protection against T2D (p = 0.0010). Conclusions/Significance. Variation in the FFAR1 gene may contribute to impaired beta cell function in T2D.	[Kalis, Martins; Leveen, Per; Cilio, Corrado M.] Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Cellular Autoimmun Unit, Malmo, Sweden; [Lyssenko, Valeriya; Almgren, Peter; Groop, Leif] Lund Univ, Malmo Univ Hosp, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital	Cilio, CM (corresponding author), Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Cellular Autoimmun Unit, Malmo, Sweden.	corrado.cilio@med.lu.se			UMAS Foundations; Diabetes Program at Lund University; Albert Pahlssons Foundation; Swedish Research Council; Sigrid Juselius Foundation; Folkhalsan Research Foundation; Swedish Diabetes Research Foundation; Juvenile Diabetes Research Foundation [11-2004-38]	UMAS Foundations; Diabetes Program at Lund University; Albert Pahlssons Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Folkhalsan Research Foundation; Swedish Diabetes Research Foundation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This study was supported by UMAS Foundations, Diabetes Program at Lund University, Albert Pahlssons Foundation, Swedish Research Council, Sigrid Juselius Foundation, Folkhalsan Research Foundation and Swedish Diabetes Research Foundation. CMC is supported by Juvenile Diabetes Research Foundation (Grant 11-2004-38).	Ahren B, 2005, CURR MOL MED, V5, P275, DOI 10.2174/1566524053766004; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; An P, 2005, DIABETES, V54, P909, DOI 10.2337/diabetes.54.3.909; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chu WS, 2007, DIABETES, V56, P856, DOI 10.2337/db06-1305; *DAL LAB WHIT I, 2007, HAPL; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Del Prato S, 2004, HORM METAB RES, V36, P775, DOI 10.1055/s-2004-826163; Elbein SC, 2002, DIABETES, V51, P528, DOI 10.2337/diabetes.51.2.528; ESKIN E, 2006, HAP HAPLOTYPE ANAL S; *GEN, 2007, MATINSPECTOR; Gierl MS, 2006, GENE DEV, V20, P2465, DOI 10.1101/gad.381806; Groop L, 2000, INT J CLIN PRACT, P3; Groop L, 1996, DIABETES, V45, P1585, DOI 10.2337/diabetes.45.11.1585; Guo YF, 2006, J CLIN ENDOCR METAB, V91, P4001, DOI 10.1210/jc.2006-0549; Halperin E, 2004, BIOINFORMATICS, V20, P1842, DOI 10.1093/bioinformatics/bth149; Hamid YH, 2005, DIABETIC MED, V22, P74, DOI 10.1111/j.1464-5491.2005.01505.x; HAWKINS RK, 1985, EXP EYE RES, V41, P701, DOI 10.1016/0014-4835(85)90179-4; Hevener A, 2002, DIABETES, V51, P1907, DOI 10.2337/diabetes.51.6.1907; Ho E, 1999, P SOC EXP BIOL MED, V222, P205, DOI 10.1046/j.1525-1373.1999.d01-137.x; Itoh Y, 2005, HEPATOL RES, V33, P171, DOI 10.1016/j.hepres.2005.09.028; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; JACHEZ B, 1988, IMMUNOLOGY, V64, P31; Kotarsky K, 2003, BIOCHEM BIOPH RES CO, V301, P406, DOI 10.1016/S0006-291X(02)03064-4; LankatButtgereit B, 1997, PEPTIDES, V18, P617, DOI 10.1016/S0196-9781(97)00001-6; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; LeRoith D, 2002, AM J MED, V113, p3S; Malhotra A, 2007, DIABETES, V56, P890, DOI 10.2337/db06-1057; Manco M, 2004, DIABETES OBES METAB, V6, P402, DOI 10.1111/j.1462-8902.2004.00356.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mori Y, 2002, DIABETES, V51, P1247, DOI 10.2337/diabetes.51.4.1247; Ogawa T, 2005, METABOLISM, V54, P296, DOI 10.1016/j.metabol.2004.09.008; Panhuysen CIM, 2003, DIABETOLOGIA, V46, P579, DOI 10.1007/s00125-003-1066-z; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; PURCELL S, 2003, GENETIC POWER CALCUL; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Sawzdargo M, 1997, BIOCHEM BIOPH RES CO, V239, P543, DOI 10.1006/bbrc.1997.7513; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Steppel Jeanne H, 2004, Curr Diab Rep, V4, P169, DOI 10.1007/s11892-004-0019-3; Svoboda M, 1999, MOL GENET METAB, V68, P258, DOI 10.1006/mgme.1999.2913; TOMITA T, 2006, DIABETOLOGIA; van Tilburg JHO, 2003, J CLIN ENDOCR METAB, V88, P2223, DOI 10.1210/jc.2002-021252	45	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1090	10.1371/journal.pone.0001090	http://dx.doi.org/10.1371/journal.pone.0001090			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987108	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459000002
J	Herron-Olson, L; Fitzgerald, JR; Musser, JM; Kapur, V				Herron-Olson, Lisa; Fitzgerald, J. Ross; Musser, James M.; Kapur, Vivek			Molecular Correlates of Host Specialization in Staphylococcus aureus	PLOS ONE			English	Article								Background. The majority of Staphylococcus aureus isolates that are recovered from either serious infections in humans or from mastitis in cattle represent genetically distinct sets of clonal groups. Moreover, population genetic analyses have provided strong evidence of host specialization among S. aureus clonal groups associated with human and ruminant infection. However, the molecular basis of host specialization in S. aureus is not understood. Methodology/Principal Findings. We sequenced the genome of strain ET3-1, a representative isolate of a common bovine mastitis-causing S. aureus clone. Strain ET3-1 encodes several genomic elements that have not been previously identified in S. aureus, including homologs of virulence factors from other Gram-positive pathogens. Relative to the other sequenced S. aureus associated with human infection, allelic variation in ET3-1 was high among virulence and surface-associated genes involved in host colonization, toxin production, iron metabolism, antibiotic resistance, and gene regulation. Interestingly, a number of well-characterized S. aureus virulence factors, including protein A and clumping factor A, exist as pseudogenes in ET3-1. Whole-genome DNA microarray hybridization revealed considerable similarity in the gene content of highly successful S. aureus clones associated with bovine mastitis, but not among those clones that are only infrequently recovered from bovine hosts. Conclusions/Significance. Whole genome sequencing and comparative genomic analyses revealed a set of molecular genetic features that distinguish clones of highly successful bovine-associated S. aureus optimized for mastitis pathogenesis in cattle from those that infect human hosts or are only infrequently recovered from bovine sources. Further, the results suggest that modern bovine specialist clones diverged from a common ancestor resembling human-associated S. aureus clones through a combination of foreign DNA acquisition and gene decay.	[Herron-Olson, Lisa; Kapur, Vivek] Univ Minnesota, Dept Microbiol Vet Pathobiol, St Paul, MN 55108 USA; [Herron-Olson, Lisa; Kapur, Vivek] Univ Minnesota, Biomed Genom Ctr, St Paul, MN 55108 USA; [Fitzgerald, J. Ross] Univ Edinburgh, Lab Bacterial Evolut & Pathogenesis, Edinburgh, Midlothian, Scotland; [Musser, James M.] Methodist Hosp, Ctr Mol & Translat Human Infect Dis Res, Res Inst, Houston, TX 77030 USA; [Musser, James M.] Methodist Hosp, Dept Pathol, Houston, TX 77030 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Edinburgh; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston	Kapur, V (corresponding author), Univ Minnesota, Dept Microbiol Vet Pathobiol, St Paul, MN 55108 USA.	vkapur@umn.edu	Kapur, Vivek/F-7610-2013	Kapur, Vivek/0000-0002-9648-0138	USDA-NRI Sustaining Animal Health; Well-Being Program; NIH NIGMS Biological Process Technology Institute [GM08347]; University of Minnesota Martha Kunze Graduate Fellowship	USDA-NRI Sustaining Animal Health; Well-Being Program; NIH NIGMS Biological Process Technology Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Minnesota Martha Kunze Graduate Fellowship	This research was funded by a competitive award from the USDA-NRI Sustaining Animal Health and Well-Being Program (to VK). LHO was supported by NIH NIGMS Biological Process Technology Institute fellowship GM08347 and University of Minnesota Martha Kunze Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson KL, 2006, AM J VET RES, V67, P1185, DOI 10.2460/ajvr.67.7.1185; Arvidson S, 2001, INT J MED MICROBIOL, V291, P159, DOI 10.1078/1438-4221-00112; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Barrio MB, 2006, MICROBES INFECT, V8, P2068, DOI 10.1016/j.micinf.2006.03.004; Bayles KW, 1998, INFECT IMMUN, V66, P336, DOI 10.1128/IAI.66.1.336-342.1998; Bayliss CD, 2001, J CLIN INVEST, V107, P657, DOI 10.1172/JCI12557; Beres SB, 2004, P NATL ACAD SCI USA, V101, P11833, DOI 10.1073/pnas.0404163101; Berriman Matt, 2003, Briefings in Bioinformatics, V4, P124, DOI 10.1093/bib/4.2.124; Bitter W, 1998, NATURE, V391, P499, DOI 10.1038/35166; Boyer E, 2002, INFECT IMMUN, V70, P6032, DOI 10.1128/IAI.70.11.6032-6042.2002; Brouillette E, 2003, MICROB PATHOGENESIS, V35, P159, DOI 10.1016/S0882-4010(03)00112-8; CIFRIAN E, 1994, J DAIRY SCI, V77, P970, DOI 10.3168/jds.S0022-0302(94)77033-8; Clarke SR, 2002, INFECT IMMUN, V70, P6680, DOI 10.1128/IAI.70.12.6680-6687.2002; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cucarella C, 2004, INFECT IMMUN, V72, P2177, DOI 10.1128/IAI.72.4.2177-2185.2004; Dego OK, 2002, VET QUART, V24, P181, DOI 10.1080/01652176.2002.9695135; Eiglmeier K, 2001, LEPROSY REV, V72, P387; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Erskine RJ, 2002, J DAIRY SCI, V85, P1111, DOI 10.3168/jds.S0022-0302(02)74172-6; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fitzgerald JR, 1997, EPIDEMIOL INFECT, V119, P261, DOI 10.1017/S0950268897007802; Fitzgerald JR, 2001, P NATL ACAD SCI USA, V98, P8821, DOI 10.1073/pnas.161098098; Fitzgerald JR, 2001, J BACTERIOL, V183, P63, DOI 10.1128/JB.183.1.63-70.2001; Fueyo JM, 2005, J CLIN MICROBIOL, V43, P1278, DOI 10.1128/JCM.43.3.1278-1284.2005; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gilot P, 2004, J CLIN MICROBIOL, V42, P1265, DOI 10.1128/JCM.42.3.1265-1269.2004; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gresham HD, 2000, J IMMUNOL, V164, P3713, DOI 10.4049/jimmunol.164.7.3713; Haveri M, 2005, J CLIN MICROBIOL, V43, P959, DOI 10.1128/JCM.43.2.959-961.2005; Herron LL, 2002, INFECT IMMUN, V70, P3978, DOI 10.1128/IAI.70.7.3978-3981.2002; Herron-Olson L, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng107; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Iandolo JJ, 2002, GENE, V289, P109, DOI 10.1016/S0378-1119(02)00481-X; Jarraud S, 2000, J BACTERIOL, V182, P6517, DOI 10.1128/JB.182.22.6517-6522.2000; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Josefsson E, 1998, MICROBIOL-UK, V144, P3387, DOI 10.1099/00221287-144-12-3387; KAPUR V, 1995, J CLIN MICROBIOL, V33, P376, DOI 10.1128/JCM.33.2.376-380.1995; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Leitner G, 2003, FEMS IMMUNOL MED MIC, V35, P99, DOI 10.1016/S0928-8244(02)00458-3; LINDSAY JA, 1994, INFECT IMMUN, V62, P2309, DOI 10.1128/IAI.62.6.2309-2314.1994; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Lowy FD, 2000, TRENDS MICROBIOL, V8, P341, DOI 10.1016/S0966-842X(00)01803-5; Luong TT, 2002, J BACTERIOL, V184, P3623, DOI 10.1128/JB.184.13.3623-3629.2002; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; MCCARTHY JEG, 1990, TRENDS GENET, V6, P78, DOI 10.1016/0168-9525(90)90098-Q; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Musser J. M., 1990, MOL BIOL STAPHYLOCOC, P59; MUSSER JM, 1990, P NATL ACAD SCI USA, V87, P225, DOI 10.1073/pnas.87.1.225; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nizet V, 2000, INFECT IMMUN, V68, P4245, DOI 10.1128/IAI.68.7.4245-4254.2000; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; O'Brien DP, 2006, J BIOL CHEM, V281, P13317, DOI 10.1074/jbc.M601805200; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Rainard P, 2003, CLIN DIAGN LAB IMMUN, V10, P272, DOI 10.1128/CDLI.10.2.272-277.2003; RECSEI P, 1986, MOL GEN GENET, V202, P58, DOI 10.1007/BF00330517; Reinoso E, 2004, MICROBIOL RES, V159, P245, DOI 10.1016/j.micres.2004.04.002; REINOSO E, 2006, MICROBIOL RES; Retzer MD, 1996, J BIOL CHEM, V271, P1166, DOI 10.1074/jbc.271.2.1166; Schuberth HJ, 2001, VET MICROBIOL, V82, P187, DOI 10.1016/S0378-1135(01)00386-8; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Swofford DL, 2001, SYST BIOL, V50, P525, DOI 10.1080/106351501750435086; Takeuchi S, 2001, VET MICROBIOL, V79, P267, DOI 10.1016/S0378-1135(00)00354-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tikofsky LL, 2003, MICROB DRUG RESIST, V9, pS39; TRIVIER D, 1995, FEMS MICROBIOL LETT, V127, P195; Trivier D, 1996, FEMS MICROBIOL LETT, V141, P117, DOI 10.1111/j.1574-6968.1996.tb08373.x; Vasudevan P, 2003, VET MICROBIOL, V92, P179, DOI 10.1016/S0378-1135(02)00360-7; Wells SJ, 1998, J DAIRY SCI, V81, P3029, DOI 10.3168/jds.S0022-0302(98)75867-9; Wilson DJ, 1999, J DAIRY SCI, V82, P1664, DOI 10.3168/jds.S0022-0302(99)75395-6; Witney AA, 2005, APPL ENVIRON MICROB, V71, P7504, DOI 10.1128/AEM.71.11.7504-7514.2005; Wright JS, 2005, J BACTERIOL, V187, P5585, DOI 10.1128/JB.187.16.5585-5594.2005; Yamada T, 2005, VET MICROBIOL, V110, P97, DOI 10.1016/j.vetmic.2005.07.006; Zadoks R, 2000, J CLIN MICROBIOL, V38, P1931, DOI 10.1128/JCM.38.5.1931-1939.2000; Zou D, 2000, BIOSCI BIOTECH BIOCH, V64, P2631, DOI 10.1271/bbb.64.2631	76	184	831	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1120	10.1371/journal.pone.0001120	http://dx.doi.org/10.1371/journal.pone.0001120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971880	Green Published, gold, Green Submitted			2022-12-25	WOS:000207458700034
J	Slot, JC; Hibbett, DS				Slot, Jason C.; Hibbett, David S.			Horizontal Transfer of a Nitrate Assimilation Gene Cluster and Ecological Transitions in Fungi: A Phylogenetic Study	PLOS ONE			English	Article							NITRITE REDUCTASE; SUPERNUMERARY CHROMOSOME; HYPOCREA-JECORINA; SELFISH OPERONS; EVOLUTION; TRICHODERMA; EXPRESSION; INFERENCE; NITROGEN; MRBAYES	High affinity nitrate assimilation genes in fungi occur in a cluster (fHANT-AC) that can be coordinately regulated. The clustered genes include nrt2, which codes for a high affinity nitrate transporter; euknr, which codes for nitrate reductase; and NAD(P)H-nir, which codes for nitrite reductase. Homologs of genes in the fHANT-AC occur in other eukaryotes and prokaryotes, but they have only been found clustered in the oomycete Phytophthora (heterokonts). We performed independent and concatenated phylogenetic analyses of homologs of all three genes in the fHANT-AC. Phylogenetic analyses limited to fungal sequences suggest that the fHANT-AC has been transferred horizontally from a basidiomycete (mushrooms and smuts) to an ancestor of the ascomycetous mold Trichoderma reesei. Phylogenetic analyses of sequences from diverse eukaryotes and eubacteria, and cluster structure, are consistent with a hypothesis that the fHANT-AC was assembled in a lineage leading to the oomycetes and was subsequently transferred to the Dikarya (Ascomycota+Basidiomycota), which is a derived fungal clade that includes the vast majority of terrestrial fungi. We propose that the acquisition of high affinity nitrate assimilation contributed to the success of Dikarya on land by allowing exploitation of nitrate in aerobic soils, and the subsequent transfer of a complete assimilation cluster improved the fitness of T. reesei in a new niche. Horizontal transmission of this cluster of functionally integrated genes supports the "selfish operon" hypothesis for maintenance of gene clusters.	[Slot, Jason C.; Hibbett, David S.] Clark Univ, Dept Biol, Worcester, MA 01610 USA	Clark University	Slot, JC (corresponding author), Clark Univ, Dept Biol, Worcester, MA 01610 USA.	jslot@clarku.edu	Slot, Jason/L-5500-2018; Slot, Jason/E-4802-2011		National Science Foundation Doctoral Dissertation Improvement [DEB0608017]	National Science Foundation Doctoral Dissertation Improvement(National Science Foundation (NSF))	Funding: This work was made possible by a National Science Foundation Doctoral Dissertation Improvement grant (DEB0608017, to DSH and JCS). The National Science Foundation played no role in the production of data or of the manuscript and this manuscript does not imply its approval of the research or publication of the results.	Abe Y, 2002, MOL GENET GENOMICS, V267, P636, DOI 10.1007/s00438-002-0697-y; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bailly J, 2007, NEW PHYTOL, V175, P155, DOI 10.1111/j.1469-8137.2007.02066.x; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Brito N, 1996, BIOCHEM J, V317, P89, DOI 10.1042/bj3170089; CARBONE I, 2007, MOL ECOL; Celar F, 2003, BIOL CONTROL, V28, P19, DOI 10.1016/S1049-9644(03)00049-5; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Fleetwood DJ, 2007, APPL ENVIRON MICROB, V73, P2571, DOI 10.1128/AEM.00257-07; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; Han YN, 2001, PLANT J, V25, P305, DOI 10.1046/j.1365-313x.2001.00969.x; He CZ, 1998, GENETICS, V150, P1459; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Howlett BJ, 2007, CURR BIOL, V17, pR87, DOI 10.1016/j.cub.2006.11.047; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jargeat P, 2003, CURR GENET, V43, P199, DOI 10.1007/s00294-003-0387-2; Jayaraj J., 1998, Journal of Mycology and Plant Pathology, V28, P23; JOHNSTONE IL, 1990, GENE, V90, P181, DOI 10.1016/0378-1119(90)90178-T; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kavanaugh LA, 2006, MOL BIOL EVOL, V23, P1879, DOI 10.1093/molbev/msl070; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Laich F, 2002, APPL ENVIRON MICROB, V68, P1211, DOI 10.1128/AEM.68.3.1211-1219.2002; Lawrence J, 1999, CURR OPIN GENET DEV, V9, P642, DOI 10.1016/S0959-437X(99)00025-8; Lawrence JG, 1997, TRENDS MICROBIOL, V5, P355, DOI 10.1016/S0966-842X(97)01110-4; LEYVAL C, 1991, NEW PHYTOL, V119, P93, DOI 10.1111/j.1469-8137.1991.tb01011.x; Lieckfeldt E, 2000, MYCOLOGIA, V92, P374, DOI 10.2307/3761493; LUQUE I, 1993, PLANT MOL BIOL, V21, P1201, DOI 10.1007/BF00023618; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17, DOI 10.1128/.61.1.17-32.1997; Muro-Pastor MI, 1999, EMBO J, V18, P1584, DOI 10.1093/emboj/18.6.1584; OSTRIKOVA NA, 1983, APPL BIOCHEM MICROB, V19, P392; Price MN, 2005, GENOME RES, V15, P809, DOI 10.1101/gr.3368805; PUNT PJ, 1995, MOL CELL BIOL, V15, P5688; QUESADA A, 1993, MOL GEN GENET, V240, P387, DOI 10.1007/BF00280390; Randall TA, 2005, MOL PLANT MICROBE IN, V18, P229, DOI 10.1094/MPMI-18-0229; Richards TA, 2006, CURR BIOL, V16, P1857, DOI 10.1016/j.cub.2006.07.052; Rocha-Ramirez V, 2002, EUKARYOT CELL, V1, P594, DOI 10.1128/EC.1.4.594-605.2002; Rosewich UL, 2000, ANNU REV PHYTOPATHOL, V38, P325, DOI 10.1146/annurev.phyto.38.1.325; Saikia R., 2001, Environment and Ecology, V19, P849; Samuels GJ, 2006, PHYTOPATHOLOGY, V96, P195, DOI 10.1094/PHYTO-96-0195; Sarrocco S, 2006, MYCOL RES, V110, P179, DOI 10.1016/j.mycres.2005.08.005; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Seiboth B, 2005, APPL ENVIRON MICROB, V71, P851, DOI 10.1128/AEM.71.2.851-857.2005; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SLOT JC, 2007, MOL BIOL EVOL; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stemmler SJ, 2003, EUR J SOIL SCI, V54, P725, DOI 10.1046/j.1351-0754.2003.0571.x; Stolz JF, 2002, CHEMBIOCHEM, V3, P198, DOI 10.1002/1439-7633(20020301)3:2/3<198::AID-CBIC198>3.0.CO;2-C; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsuda A, 2003, SCIENCE, V300, P958, DOI 10.1126/science.1082000; Wakelin SA, 1999, NEW ZEAL J AGR RES, V42, P337, DOI 10.1080/00288233.1999.9513383; Walton JD, 2000, FUNGAL GENET BIOL, V30, P167, DOI 10.1006/fgbi.2000.1224; Wong S, 2005, NAT GENET, V37, P777, DOI 10.1038/ng1584; Zhang S, 2004, APPL ENVIRON MICROB, V70, P6875, DOI 10.1128/AEM.70.11.6875-6883.2004	56	101	108	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1097	10.1371/journal.pone.0001097	http://dx.doi.org/10.1371/journal.pone.0001097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971860	Green Submitted, Green Published, gold			2022-12-25	WOS:000207458700014
J	Yoo, MH; Xu, XM; Carlson, BA; Patterson, AD; Gladyshev, VN; Hatfield, DL				Yoo, Min-Hyuk; Xu, Xue-Ming; Carlson, Bradley A.; Patterson, Andrew D.; Gladyshev, Vadim N.; Hatfield, Dolph L.			Targeting Thioredoxin Reductase 1 Reduction in Cancer Cells Inhibits Self-Sufficient Growth and DNA Replication	PLOS ONE			English	Article								Thioredoxin reductase 1 (TR1) is a major redox regulator in mammalian cells. As an important antioxidant selenoprotein, TR1 is thought to participate in cancer prevention, but is also known to be over-expressed in many cancer cells. Numerous cancer drugs inhibit TR1, and this protein has been proposed as a target for cancer therapy. We previously reported that reduction of TR1 levels in cancer cells reversed many malignant characteristics suggesting that deficiency in TR1 function is antitumorigenic. The molecular basis for TR1's role in cancer development, however, is not understood. Herein, we found that, among selenoproteins, TR1 is uniquely overexpressed in cancer cells and its knockdown in a mouse cancer cell line driven by oncogenic k-ras resulted in morphological changes characteristic of parental (normal) cells, without significant effect on cell growth under normal growth conditions. When grown in serum-deficient medium, TR1 deficient cancer cells lose self-sufficiency of growth, manifest a defective progression in their S phase and a decreased expression of DNA polymerase a, an enzyme important in DNA replication. These observations provide evidence that TR1 is critical for self-sufficiency in growth signals of malignant cells, that TR1 acts largely as a pro-cancer protein and it is indeed a primary target in cancer therapy.	[Yoo, Min-Hyuk; Xu, Xue-Ming; Carlson, Bradley A.; Patterson, Andrew D.; Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Nebraska System; University of Nebraska Lincoln	Hatfield, DL (corresponding author), NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	hatfield@mail.nih.gov	Patterson, Andrew/ABF-1575-2020; Gladyshev, Vadim N/A-9894-2013; Patterson, Andrew/G-3852-2012; Gladyshev, Vadim N/J-6187-2013	Patterson, Andrew/0000-0003-2073-0070; Patterson, Andrew/0000-0003-2073-0070; Gladyshev, Vadim/0000-0002-0372-7016	National Institutes of Health [CA080946, GM065204]; National Cancer Institute; Center for Cancer Research; PRAT Fellowship; NIGMS; NATIONAL CANCER INSTITUTE [R01CA080946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM065204, R01GM065204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PRAT Fellowship; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research, and by NIH grants CA080946 and GM065204 to VNG. ADP was sponsored by the PRAT Fellowship, NIGMS, NIH.	Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Biaglow JE, 2005, CANCER BIOL THER, V4, P6; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Diwadkar-Navsariwala V, 2006, P NATL ACAD SCI USA, V103, P8179, DOI 10.1073/pnas.0508218103; Fujino G, 2006, SEMIN CANCER BIOL, V16, P427, DOI 10.1016/j.semcancer.2006.09.003; Gladyshev VN, 1999, P NATL ACAD SCI USA, V96, P835, DOI 10.1073/pnas.96.3.835; Gladyshev VN, 1998, J BIOL CHEM, V273, P8910, DOI 10.1074/jbc.273.15.8910; Gromer S, 2005, CELL MOL LIFE SCI, V62, P2414, DOI 10.1007/s00018-005-5143-y; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hatfield D.L., 2002, SELENIUM ITS MOL BIO, V36, P235, DOI 10.1080/10715760290006394; HOLMGREN A, 2006, SELENIUM ITS MOL BIO, P183; Irons R, 2006, J NUTR, V136, P1311, DOI 10.1093/jn/136.5.1311; Koc A, 2006, J BIOL CHEM, V281, P15058, DOI 10.1074/jbc.M601968200; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lu J, 2007, P NATL ACAD SCI USA, V104, P12288, DOI 10.1073/pnas.0701549104; Moos PJ, 2003, J BIOL CHEM, V278, P745, DOI 10.1074/jbc.M211134200; MULLER EGD, 1994, J BIOL CHEM, V269, P24466; Nguyen P, 2006, CANCER LETT, V236, P164, DOI 10.1016/j.canlet.2005.04.028; NODA M, 1983, P NATL ACAD SCI-BIOL, V80, P5602, DOI 10.1073/pnas.80.18.5602; NODA M, 1992, BIOCHEM J, V283, P347; Novoselov SV, 2005, ONCOGENE, V24, P8003, DOI 10.1038/sj.onc.1208940; Pavlov YI, 2006, INT REV CYTOL, V255, P41, DOI 10.1016/S0074-7696(06)55002-8; Rundlof AK, 2004, ANTIOXID REDOX SIGN, V6, P41, DOI 10.1089/152308604771978336; Urig S, 2006, SEMIN CANCER BIOL, V16, P452, DOI 10.1016/j.semcancer.2006.09.004; Yoo MH, 2006, J BIOL CHEM, V281, P13005, DOI 10.1074/jbc.C600012200	26	102	104	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1112	10.1371/journal.pone.0001112	http://dx.doi.org/10.1371/journal.pone.0001112			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971875	gold, Green Submitted, Green Published			2022-12-25	WOS:000207458700029
J	Akashi, H; Goel, P; John, A				Akashi, Hiroshi; Goel, Piyush; John, Anoop			Ancestral Inference and the Study of Codon Bias Evolution: Implications for Molecular Evolutionary Analyses of the Drosophila melanogaster Subgroup	PLOS ONE			English	Article								Reliable inference of ancestral sequences can be critical to identifying both patterns and causes of molecular evolution. Robustness of ancestral inference is often assumed among closely related species, but tests of this assumption have been limited. Here, we examine the performance of inference methods for data simulated under scenarios of codon bias evolution within the Drosophila melanogaster subgroup. Genome sequence data for multiple, closely related species within this subgroup make it an important system for studying molecular evolutionary genetics. The effects of asymmetric and lineage-specific substitution rates (i.e., varying levels of codon usage bias and departures from equilibrium) on the reliability of ancestral codon usage was investigated. Maximum parsimony inference, which has been widely employed in analyses of Drosophila codon bias evolution, was compared to an approach that attempts to account for uncertainty in ancestral inference by weighting ancestral reconstructions by their posterior probabilities. The latter approach employs maximum likelihood estimation of rate and base composition parameters. For equilibrium and most non-equilibrium scenarios that were investigated, the probabilistic method appears to generate reliable ancestral codon bias inferences for molecular evolutionary studies within the D. melanogaster subgroup. These reconstructions are more reliable than parsimony inference, especially when codon usage is strongly skewed. However, inference biases are considerable for both methods under particular departures from stationarity (i.e., when adaptive evolution is prevalent). Reliability of inference can be sensitive to branch lengths, asymmetry in substitution rates, and the locations and nature of lineage-specific processes within a gene tree. Inference reliability, even among closely related species, can be strongly affected by ( potentially unknown) patterns of molecular evolution in lineages ancestral to those of interest.	[Akashi, Hiroshi; Goel, Piyush; John, Anoop] Penn State Univ, Inst Mol Evolutionary Genet, Dept Biol, State Coll, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Akashi, H (corresponding author), Penn State Univ, Inst Mol Evolutionary Genet, Dept Biol, State Coll, PA USA.	akashi@psu.edu			US National Science Foundation	US National Science Foundation(National Science Foundation (NSF))	This research is supported by a grant from the US National Science Foundation.	Akashi H, 2006, GENETICS, V172, P1711, DOI 10.1534/genetics.105.049676; Akashi H, 1997, GENETICS, V146, P295; AKASHI H, 1994, GENETICS, V136, P927; AKASHI H, 1995, GENETICS, V139, P1067; Akashi H, 1999, GENETICS, V151, P221; Akashi H, 2001, CURR OPIN GENET DEV, V11, P660, DOI 10.1016/S0959-437X(00)00250-1; Akashi H, 1996, GENETICS, V144, P1297; Alvarez-Valin F, 2004, MOL PHYLOGENET EVOL, V31, P788, DOI 10.1016/j.ympev.2004.01.016; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Arndt PF, 2007, GENE, V390, P75, DOI 10.1016/j.gene.2006.11.022; Arndt PF, 2003, MOL BIOL EVOL, V20, P1887, DOI 10.1093/molbev/msg204; Bachtrog D, 2003, GENETICS, V165, P1221; Bartolome C, 2005, GENETICS, V169, P1495, DOI 10.1534/genetics.104.033068; Baudry E, 2003, GENETICS, V165, P1619; Begun DJ, 2002, GENETICS, V162, P1725; Begun DJ, 2001, MOL BIOL EVOL, V18, P1343, DOI 10.1093/oxfordjournals.molbev.a003918; Belle EMS, 2004, J MOL EVOL, V58, P653, DOI 10.1007/s00239-004-2587-x; Blanchette M, 2004, GENOME RES, V14, P2412, DOI 10.1101/gr.2800104; Bustamante CD, 2002, NATURE, V416, P531, DOI 10.1038/416531a; Bustamante CD, 2001, GENETICS, V159, P1779; COLLINS TM, 1994, SYST BIOL, V43, P482, DOI 10.2307/2413547; Comeron JM, 2005, MOL BIOL EVOL, V22, P2519, DOI 10.1093/molbev/msi246; Comeron JM, 2002, GENETICS, V161, P389; DuMont VB, 2004, GENETICS, V167, P171, DOI 10.1534/genetics.167.1.171; Duret L, 2000, TRENDS GENET, V16, P287, DOI 10.1016/S0168-9525(00)02041-2; Duret L, 2002, GENETICS, V162, P1837; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Eanes WF, 1996, GENETICS, V144, P1027; Eyre-Walker A, 1998, J MOL EVOL, V47, P686, DOI 10.1007/PL00006427; Fay JC, 2000, GENETICS, V155, P1405; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; Galtier N, 1998, MOL BIOL EVOL, V15, P871, DOI 10.1093/oxfordjournals.molbev.a025991; Galtier N, 2000, J MOL EVOL, V50, P224, DOI 10.1007/s002399910025; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hernandez RD, 2007, MOL BIOL EVOL, V24, P1792, DOI 10.1093/molbev/msm108; Huelsenbeck JP, 2001, SYST BIOL, V50, P351, DOI 10.1080/106351501300317978; Iida K, 2000, GENE, V261, P93, DOI 10.1016/S0378-1119(00)00482-0; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Jukes T. H, 1969, MAMMALIAN PROTEIN ME, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404; Kanaya S, 2001, J MOL EVOL, V53, P290, DOI 10.1007/s002390010219; Kanaya S, 1999, GENE, V238, P143, DOI 10.1016/S0378-1119(99)00225-5; Kliman RM, 1999, J MOL EVOL, V49, P343, DOI 10.1007/PL00006557; Kliman RM, 1998, J MOL EVOL, V46, P534, DOI 10.1007/PL00006334; Ko WY, 2006, GENETICS, V174, P349, DOI 10.1534/genetics.105.054346; Ko WY, 2003, J MOL EVOL, V57, P562, DOI 10.1007/s00239-003-2510-x; Krishnan NM, 2004, MOL BIOL EVOL, V21, P1871, DOI 10.1093/molbev/msh198; KURLAND CG, 1992, ANNU REV GENET, V26, P29, DOI 10.1146/annurev.ge.26.120192.000333; Li Wen-Hsiung, 1997; Llopart A, 1999, GENETICS, V152, P269; Llopart A, 2000, GENETICS, V155, P1245; LONG MY, 1993, SCIENCE, V260, P91, DOI 10.1126/science.7682012; MASIDE X, 2007, GENETICS; Maside XL, 2004, CURR BIOL, V14, P150, DOI 10.1016/j.cub.2003.12.055; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McVean GAT, 1999, J MOL EVOL, V49, P63, DOI 10.1007/PL00006535; McVean GAT, 1999, GENET RES, V74, P145, DOI 10.1017/S0016672399003912; Messler W, 1997, NATURE, V385, P151, DOI 10.1038/385151a0; Moriyama EN, 1998, NUCLEIC ACIDS RES, V26, P3188, DOI 10.1093/nar/26.13.3188; Moriyama EN, 1997, J MOL EVOL, V45, P514, DOI 10.1007/PL00006256; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nielsen R, 2002, SYST BIOL, V51, P729, DOI 10.1080/10635150290102393; Nielsen R, 2007, MOL BIOL EVOL, V24, P228, DOI 10.1093/molbev/msl146; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Perez JA, 2003, MOL BIOL EVOL, V20, P1867, DOI 10.1093/molbev/msg199; PERNA NT, 1995, MOL BIOL EVOL, V12, P359; Pollard DA, 2006, PLOS GENET, V2, P1634, DOI 10.1371/journal.pgen.0020173; Power IL, 2003, AGROFOREST SYST, V57, P225, DOI 10.1023/A:1024838311287; Presgraves DC, 2005, CURR BIOL, V15, P1651, DOI 10.1016/j.cub.2005.07.065; Qin H, 2004, GENETICS, V168, P2245, DOI 10.1534/genetics.104.030866; Ree RH, 1998, SYST BIOL, V47, P582, DOI 10.1080/106351598260590; Rodriguez-Trelles F, 2000, J MOL EVOL, V50, P1; Rodriguez-Trelles F, 1999, GENETICS, V153, P339; Rodriguez-Trelles F, 2000, MOL BIOL EVOL, V17, P1710, DOI 10.1093/oxfordjournals.molbev.a026269; SAWYER SA, 1987, P NATL ACAD SCI USA, V84, P6225, DOI 10.1073/pnas.84.17.6225; SHARP PM, 1995, PHILOS T R SOC B, V349, P241, DOI 10.1098/rstb.1995.0108; SHIELDS DC, 1988, MOL BIOL EVOL, V5, P704; Smith NGC, 2002, J MOL EVOL, V55, P197, DOI 10.1007/s00239-002-2316-2; Snedecor G.W., 1989, AMES IOWA STATE U PR; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Takano-Shimizu T, 2001, MOL BIOL EVOL, V18, P606, DOI 10.1093/oxfordjournals.molbev.a003841; Takano-Shimizu T, 1999, GENETICS, V153, P1285; Templeton AR, 1996, GENETICS, V144, P1263; Webster MT, 2003, MOL BIOL EVOL, V20, P278, DOI 10.1093/molbev/msg037; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102; WONG A, 2006, MOL PHYLOGENET EVOL; Wright SI, 2004, MOL BIOL EVOL, V21, P1719, DOI 10.1093/molbev/msh191; YANG ZH, 1995, GENETICS, V141, P1641; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; YANG ZH, 1995, MOL BIOL EVOL, V12, P451; Zhang JZ, 1997, J MOL EVOL, V44, pS139, DOI 10.1007/PL00000067; Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852; Zhang Z, 2002, GENETICS, V161, P1187	93	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1065	10.1371/journal.pone.0001065	http://dx.doi.org/10.1371/journal.pone.0001065			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957249	Green Submitted, gold, Green Published			2022-12-25	WOS:000207458500012
J	Conboy, CM; Spyrou, C; Thorne, NP; Wade, EJ; Barbosa-Morais, NL; Wilson, MD; Bhattacharjee, A; Young, RA; Tavare, S; Lees, JA; Odom, DT				Conboy, Caitlin M.; Spyrou, Christiana; Thorne, Natalie P.; Wade, Elizabeth J.; Barbosa-Morais, Nuno L.; Wilson, Michael D.; Bhattacharjee, Arindam; Young, Richard A.; Tavare, Simon; Lees, Jacqueline A.; Odom, Duncan T.			Cell Cycle Genes Are the Evolutionarily Conserved Targets of the E2F4 Transcription Factor	PLOS ONE			English	Article							PROTEIN COMPLEX; IN-VIVO; ELEGANS; BINDING; IDENTIFICATION; SPECIFICITY; ANTAGONISM; EXPRESSION; DISTINCT; MODEL	Maintaining quiescent cells in G0 phase is achieved in part through the multiprotein subunit complex known as DREAM, and in human cell lines the transcription factor E2F4 directs this complex to its cell cycle targets. We found that E2F4 binds a highly overlapping set of human genes among three diverse primary tissues and an asynchronous cell line, which suggests that tissue-specific binding partners and chromatin structure have minimal influence on E2F4 targeting. To investigate the conservation of these transcription factor binding events, we identified the mouse genes bound by E2f4 in seven primary mouse tissues and a cell line. E2f4 bound a set of mouse genes that was common among mouse tissues, but largely distinct from the genes bound in human. The evolutionarily conserved set of E2F4 bound genes is highly enriched for functionally relevant regulatory interactions important for maintaining cellular quiescence. In contrast, we found minimal mRNA expression perturbations in this core set of E2f4 bound genes in the liver, kidney, and testes of E2f4 null mice. Thus, the regulatory mechanisms maintaining quiescence are robust even to complete loss of conserved transcription factor binding events.	[Conboy, Caitlin M.; Spyrou, Christiana; Thorne, Natalie P.; Barbosa-Morais, Nuno L.; Wilson, Michael D.; Tavare, Simon; Odom, Duncan T.] Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge, England; [Spyrou, Christiana] Univ Cambridge, Stat Lab, Dept Pure Math & Math Stat, Cambridge CB2 1SB, England; [Thorne, Natalie P.; Tavare, Simon] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 9EW, England; [Wade, Elizabeth J.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; [Bhattacharjee, Arindam] Agilent Technol, Andover, MA USA; [Young, Richard A.; Lees, Jacqueline A.] MIT, Dept Biol, Cambridge, MA USA; [Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; University of Connecticut; Agilent Technologies; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Odom, DT (corresponding author), Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge, England.	duncan.odom@cancer.org.uk	Wilson, Michael D/K-6294-2014; Young, Richard A/F-6495-2012; Barbosa-Morais, Nuno L/I-2743-2013	Wilson, Michael D/0000-0002-4015-3066; Young, Richard A/0000-0001-8855-8647; Barbosa-Morais, Nuno L/0000-0002-1215-0538; Odom, Duncan/0000-0001-6201-5599; Conboy, Caitlin/0000-0001-8280-056X	NIH [N01DK92310, NCRR ICR U4Z RR16606, U19DK6125, U42RR16597]; EPSRC; CRUK; JDRF [6-2006-1099]; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR016597, U42RR016606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [N01DK092310] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); CRUK(Cancer Research UK); JDRF(Juvenile Diabetes Research Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from NIH (DTO, JL, EF, RAY), EPSRC ( CS) and CRUK (DTO, ST, NPT, NBM). Tissue distribution programs were generously supported by the JDRF (6-2006-1099) and NIH (N01DK92310; NCRR ICR U4Z RR16606; U19DK6125; U42RR16597).	Beall EL, 2002, NATURE, V420, P833, DOI 10.1038/nature01228; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bolstad BM CF, 2005, QUALITY ASSESSMENT A; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Cam H, 2003, CANCER CELL, V3, P311, DOI 10.1016/S1535-6108(03)00080-1; Ceol CJ, 2006, GENETICS, V173, P709, DOI 10.1534/genetics.106.056465; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Dudoit S, 2002, GENOME BIOL, V3; Fay DS, 2000, GENESIS, V26, P279, DOI 10.1002/(SICI)1526-968X(200004)26:4<279::AID-GENE100>3.0.CO;2-C; Frolov MV, 2001, GENE DEV, V15, P2146, DOI 10.1101/gad.903901; Gaubatz S, 2000, MOL CELL, V6, P729, DOI 10.1016/S1097-2765(00)00071-X; Giangrande PH, 2004, GENE DEV, V18, P2941, DOI 10.1101/gad.1239304; Giangrande PH, 2004, EMBO J, V23, P1336, DOI 10.1038/sj.emboj.7600134; Harrison MM, 2006, P NATL ACAD SCI USA, V103, P16782, DOI 10.1073/pnas.0608461103; Huber PJ, 1981, ROBUST STAT; Humbert PO, 2000, MOL CELL, V6, P281, DOI 10.1016/S1097-2765(00)00029-0; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Khaitovich P, 2005, GENETICS, V170, P929, DOI 10.1534/genetics.104.037135; Kinross KM, 2006, BLOOD, V108, P886, DOI 10.1182/blood-2005-09-008656; Kong LJ, 2007, ONCOGENE, V26, P321, DOI 10.1038/sj.onc.1209817; Korenjak M, 2006, CURR MOL MED, V6, P705; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Lonnstedt I, 2002, STAT SINICA, V12, P31; MacIsaac KD, 2006, BIOINFORMATICS, V22, P423, DOI 10.1093/bioinformatics/bti815; Moberg K, 1996, MOL CELL BIOL, V16, P1436; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Odom DT, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100059; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; *R COR DEV TEAM, 2005, R LANG ENV STAT COMP; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Rempel RE, 2000, MOL CELL, V6, P293, DOI 10.1016/S1097-2765(00)00030-7; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stevens C, 2003, ARCH BIOCHEM BIOPHYS, V412, P157, DOI 10.1016/S0003-9861(03)00054-7; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi Y, 2000, GENE DEV, V14, P804; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; [No title captured]	43	45	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1061	10.1371/journal.pone.0001061	http://dx.doi.org/10.1371/journal.pone.0001061			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957245	Green Published, Green Submitted, gold			2022-12-25	WOS:000207458500008
J	Huang, CC; Wang, JM; Kikkawa, U; Mukai, H; Shen, MR; Morita, I; Chen, BK; Chang, WC				Huang, C-C; Wang, J-M; Kikkawa, U.; Mukai, H.; Shen, M-R; Morita, I.; Chen, B-K; Chang, W-C			Calcineurin-mediated dephosphorylation of c-Jun Ser-243 is required for c-Jun protein stability and cell transformation	ONCOGENE			English	Article						calcineurin; c-jun; dephosphorylation; cell transformation	AP-1 ACTIVITY; DNA-BINDING; KINASE; PHOSPHORYLATION; TUMORIGENESIS; COOPERATION; EXPRESSION; REGULATOR	The proto-oncogene c-Jun plays an important role in regulating tumor progression. We previously reported that the serine/ threonine phosphatase calcineurin ( CaN, also called PP2B) dephosphorylates the C- terminus ( Ser- 243) of c- Jun, resulting in the increase in c- Jun and Sp1 interaction, and subsequent c- Jun- induced gene expression. Here, we demonstrate the interaction of c- Jun and CaN in the nucleus of living cells by fluorescence resonance energy transfer assay and that this interaction is mediated through the calmodulin- binding domain of CaN. Furthermore, c- Jun protein stability was altered by CaN- mediated dephosphorylation at the Ser- 243 site of c-Jun. The half-life of the c-Jun mutant, c-Jun-S243A was longer than that of the wild-type c- Jun. Moreover, silencing of endogenous CaN expression led to increased c- Jun ubiquitination and decreased stability. In 46% of clinical cervical tissue samples obtained from patients with cervical cancer, enhanced c- Jun and CaN expression, as well as decreased phospho-Ser-243 expression levels were detected. Our results suggest that CaN stabilizes c- Jun by dephosphorylating c-Jun at Ser-243 to enhance its tumorigenic ability.	[Wang, J-M; Chen, B-K] Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Biosignal Transduct, Tainan 701, Taiwan; [Huang, C-C; Wang, J-M; Shen, M-R; Chen, B-K; Chang, W-C] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan; [Wang, J-M; Shen, M-R; Chen, B-K; Chang, W-C] Natl Cheng Kung Univ, Ctr Gene Regulat & Signal Transduct, Tainan 701, Taiwan; [Kikkawa, U.; Mukai, H.] Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 657, Japan; [Morita, I.] Tokyo Med & Dent Univ, Grad Sch, Dept Cellular Physiol Chem, Bunkyo Ku, Tokyo, Japan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Kobe University; Tokyo Medical & Dental University (TMDU)	Chen, BK (corresponding author), Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Biosignal Transduct, Tainan 701, Taiwan.	bkchen58@mail.ncku.edu.tw; wcchang@mail.ncku.edu.tw	wang, ju-ming/A-1875-2011	Mukai, Hideyuki/0000-0002-0167-8695				Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; BOS TJ, 1990, GENE DEV, V4, P1677, DOI 10.1101/gad.4.10.1677; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; Chen BK, 2007, MOL BIOL CELL, V18, P1118, DOI 10.1091/mbc.E06-09-0797; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; GOTO S, 1987, CANCER-AM CANCER SOC, V60, P2948, DOI 10.1002/1097-0142(19871215)60:12<2948::AID-CNCR2820601217>3.0.CO;2-N; Hou Q, 2004, FEBS LETT, V577, P294, DOI 10.1016/j.febslet.2004.10.002; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; Lakshmikuttyamma A, 2005, J CELL BIOCHEM, V95, P731, DOI 10.1002/jcb.20437; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nomura T, 2002, UROL RES, V30, P102, DOI 10.1007/s00240-002-0239-4; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; SCHUTTE J, 1989, P NATL ACAD SCI USA, V86, P2257, DOI 10.1073/pnas.86.7.2257; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; WONG WY, 1992, ONCOGENE, V7, P2077	22	27	29	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2008	27	17					2422	2429		10.1038/sj.onc.1210888	http://dx.doi.org/10.1038/sj.onc.1210888			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286KN	17952113				2022-12-25	WOS:000254844900007
J	Atamna, H; Nguyen, A; Schultz, C; Boyle, K; Newberry, J; Kato, H; Ames, BN				Atamna, Hani; Nguyen, Andy; Schultz, Carla; Boyle, Kathleen; Newberry, Justin; Kato, Hiroyuki; Ames, Bruce N.			Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways	FASEB JOURNAL			English	Article						aging; complex TV; heme; cytochrome c	T-BUTYL HYDROXYLAMINE; IFOSFAMIDE-INDUCED ENCEPHALOPATHY; NO-SYNTHASE INHIBITOR; CYTOCHROME-C; IN-VITRO; MEMORY RETENTION; NITRIC-OXIDE; REDUCTION; RATS; SUPEROXIDE	Methylene blue (MB) has been used clinically for about a century to treat numerous ailments. We show that MB and other diaminophenothiazines extend the life span of human IMR90 fibroblasts in tissue culture by >20 population doubling (PDLs). MB delays senescence at nM levels in IMR90 by enhancing mitochondrial function. MB increases mitochondrial complex IV by 30%, enhances cellular oxygen consumption by 37-70%, increases heme synthesis, and reverses premature senescence caused by H2O2 or cadmium. MB also induces phase-2 antioxidant enzymes in hepG2 cells. Flavin-dependent enzymes are known to use NAD(P)H to reduce MB to leucomethylene blue (MBH2), whereas cytochrome c reoxidizes MBH2 to MB. Experiments on lysates from rat liver mitochondria suggest the ratio MB/cytochrome c is important for the protective actions of MB. We propose that the cellular senescence delay caused by MB is due to cycling between MB and MBH2 in mitochondria, which may partly explain the increase in specific mitochondrial activities. Cycling of MB between oxidized and reduced forms may block oxidant production by mitochondria. Mitochondrial dysfunction and oxidative stress are thought to be key aberrations that lead to cellular senescence and aging. MB may be useful to delay mitochondrial dysfunction with aging and the decrease in complex IV in Alzheimer disease.	[Atamna, Hani] Childrens Hosp Oakland, Res Inst, Nutr Metab Ctr, Oakland, CA 94609 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Atamna, H (corresponding author), Childrens Hosp Oakland, Res Inst, Nutr Metab Ctr, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	hatamna@chori.org						Atamna H, 2006, P NATL ACAD SCI USA, V103, P3381, DOI 10.1073/pnas.0600134103; Atamna H, 2000, J BIOL CHEM, V275, P6741, DOI 10.1074/jbc.275.10.6741; Atamna H, 2001, FASEB J, V15, P2196, DOI 10.1096/fj.01-0134com; Atamna H, 1996, BIOCHEM PHARMACOL, V51, P693, DOI 10.1016/S0006-2952(95)02258-9; BONGARD RD, 1995, AM J PHYSIOL-LUNG C, V269, pL78, DOI 10.1152/ajplung.1995.269.1.L78; Boon EM, 2003, BIOCONJUGATE CHEM, V14, P1140, DOI 10.1021/bc034139l; BRISTOL DW, 2006, TOXICOLOGY CARCINOGE; Callaway NL, 2004, PHARMACOL BIOCHEM BE, V77, P175, DOI 10.1016/j.pbb.2003.10.007; Callaway NL, 2002, NEUROSCI LETT, V332, P83, DOI 10.1016/S0304-3940(02)00827-3; Carr HS, 2003, ACCOUNTS CHEM RES, V36, P309, DOI 10.1021/ar0200807; Chandler JE, 2000, THERIOGENOLOGY, V54, P261, DOI 10.1016/S0093-691X(00)00346-0; Clifton Jack 2nd, 2003, Am J Ther, V10, P289; de-Oliveira RW, 1999, BRAZ J MED BIOL RES, V32, P1529, DOI 10.1590/S0100-879X1999001200012; DEGUCHI T, 1978, BIOCHIM BIOPHYS ACTA, V544, P8, DOI 10.1016/0304-4165(78)90204-0; Demirbilek S, 2006, EUR SURG RES, V38, P35, DOI 10.1159/000091525; Dierks EA, 1998, ARCH BIOCHEM BIOPHYS, V351, P1, DOI 10.1006/abbi.1997.0408; Dorta DJ, 2003, J INORG BIOCHEM, V97, P251, DOI 10.1016/S0162-0134(03)00314-3; Fujisawa H, 1999, J GERONTOL A-BIOL, V54, pB276, DOI 10.1093/gerona/54.7.B276; Furian AF, 2007, NEUROCHEM INT, V50, P164, DOI 10.1016/j.neuint.2006.07.012; Gabrielli D, 2004, PHOTOCHEM PHOTOBIOL, V79, P227, DOI 10.1562/BE-03-27.1; Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013; GRUETTER CA, 1981, J PHARMACOL EXP THER, V219, P181; Haluzik M, 1999, ENDOCR RES, V25, P163, DOI 10.1080/07435809909066138; Haluzik M, 1998, PHYSIOL RES, V47, P337; HAYFLICK L, 1992, EXP GERONTOL, V27, P363, DOI 10.1016/0531-5565(92)90066-9; Hintze KJ, 2003, J NUTR, V133, P2721, DOI 10.1093/jn/133.9.2721; Hipkiss AR, 2001, MECH AGEING DEV, V122, P169, DOI 10.1016/S0047-6374(00)00231-1; HRUSHESKY WJM, 1985, LANCET, V1, P565; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; KAMAT PV, 1987, J PHYS CHEM-US, V91, P396, DOI 10.1021/j100286a029; KELNER MJ, 1985, J BIOL CHEM, V260, P5168; KELNER MJ, 1988, ARCH BIOCHEM BIOPHYS, V262, P422, DOI 10.1016/0003-9861(88)90393-1; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Kwok Edmund S H, 2006, J Intensive Care Med, V21, P359, DOI 10.1177/0885066606290671; LAGERCRANTZ C, 1991, FREE RADICAL RES COM, V14, P395, DOI 10.3109/10715769109093428; Lamond Scott, 2003, Reprod Biomed Online, V7, P407; Lee JH, 2004, CARCINOGENESIS, V25, P1435, DOI 10.1093/carcin/bgh139; MARTINEZ JL, 1978, PHYSIOL PSYCHOL, V6, P387; MAYER B, 1993, BIOCHEM PHARMACOL, V45, P367, DOI 10.1016/0006-2952(93)90072-5; MCCORD JM, 1970, J BIOL CHEM, V245, P1374; MCFARLAND GA, 1994, EXP CELL RES, V212, P167, DOI 10.1006/excr.1994.1132; Mellish KJ, 2002, PHOTOCHEM PHOTOBIOL, V75, P392, DOI 10.1562/0031-8655(2002)075<0392:IVPAOA>2.0.CO;2; Merker MP, 1997, AM J PHYSIOL-LUNG C, V272, pL673, DOI 10.1152/ajplung.1997.272.4.L673; Patel PN, 2006, ANN PHARMACOTHER, V40, P299, DOI 10.1345/aph.1G114; Pelgrims J, 2000, BRIT J CANCER, V82, P291, DOI 10.1054/bjoc.1999.0917; Rezzani R, 2001, NEPHRON, V89, P329, DOI 10.1159/000046094; Rice Lesley, 1998, Biochemical Society Transactions, V26, pS319; Riedel W, 2003, MOL CELL BIOCHEM, V247, P83, DOI 10.1023/A:1024142400835; SALARIS SC, 1991, BIOCHEM PHARMACOL, V42, P499, DOI 10.1016/0006-2952(91)90311-R; SILLS MR, 1994, ARCH PEDIAT ADOL MED, V148, P306, DOI 10.1001/archpedi.1994.02170030076017; Sweet G, 2007, J AM COLL SURGEONS, V204, P454, DOI 10.1016/j.jamcollsurg.2006.12.030; TEICHER BA, 1990, RADIAT RES, V121, P187, DOI 10.2307/3577503; Visarius TM, 1999, J PHARMACOL EXP THER, V289, P820; Wagner G, 2006, CURR DRUG TARGETS, V7, P1531; Wagner SJ, 1998, PHOTOCHEM PHOTOBIOL, V67, P343, DOI 10.1562/0031-8655(1998)067<0343:FAVPBA>2.3.CO;2; WAGNER SJ, 1995, TRANSFUSION, V35, P407, DOI 10.1046/j.1537-2995.1995.35595259151.x; Wariishi H, 2000, J BIOL CHEM, V275, P32919, DOI 10.1074/jbc.M004223200; Zhao YG, 2003, J BIOL CHEM, V278, P2356, DOI 10.1074/jbc.M209681200	58	211	226	0	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2008	22	3					703	712		10.1096/fj.07-9610com	http://dx.doi.org/10.1096/fj.07-9610com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17928358				2022-12-25	WOS:000254143700009
J	Kim, YJ; Hwang, SY; Hwang, JS; Lee, JW; Oh, ES; Han, IO				Kim, Yoon-Jung; Hwang, So-Young; Hwang, Ji-Sun; Lee, Jung-Weon; Oh, Eok-Soo; Han, Inn-Oc			C6 glioma cell insoluble matrix components enhance interferon-gamma-stimulated inducible nitric-oxide synthase/nitric oxide production in BV2 microglial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; INTEGRIN; ACTIVATION; ADHESION; LIPOPOLYSACCHARIDE; ASTROCYTES; EXPRESSION; MIGRATION; CYTOKINES; BRAIN	Microglia are the primary central nervous system immune effector cells. Microglial activation is linked to interactions with extracellular cytokines and the extracellular matrix (ECM). Astrocytomas are characterized by their diffuse nature, which is regulated by insoluble ECM components produced by the tumor cells that are largely absent from normal central nervous system tissue. The present study examined the influence of astrocytoma (C6 rat glioma) insoluble matrix components on interferon-gamma (IFN-gamma)- mediated inducible nitric-oxide synthase (iNOS) induction in microglial cells. We found that IFN-gamma-stimulated iNOS induction and nitric oxide release was greater in microglia cultured on C6 glioma cell-derived matrices compared with microglia cultured on primary rat astrocyte-derived matrices. Culture of microglia on C6 glioma cell-derived matrices also led to activation of STAT1, augmentation of IFN-gamma-induced STAT-3 activation, and an increase in IFN-gamma-activated site (GAS)- luciferase reporter activity. In addition, culture of microglia on C6 glioma cell-derived matrices activated NF-kappa B DNA binding activity and transcriptional activity. The results suggest that insoluble matrix components derived from malignant glioma cells can regulate microglia activation. These factors may include ECM components, such as fibronectin, collagen, laminin, vitronectin, and other nondiffusible compounds, and laminin seems to a critical regulator of this process. Microglia activation and subsequent brain inflammation may influence tumor growth, treatment, and metastasis. Better understanding of the regulation of microglial activation by astrocytoma-derived insoluble matrix components may be important in the development of immune-based treatment strategies against malignant brain tumors.	[Kim, Yoon-Jung; Hwang, So-Young; Hwang, Ji-Sun; Han, Inn-Oc] Inha Univ, Dept Physiol & Biophys, Coll Med, Inchon 402751, South Korea; [Lee, Jung-Weon] Seoul Natl Univ, Coll Med, Inst Canc Res, Dept Tumor Biol, Seoul 110799, South Korea; [Oh, Eok-Soo] Ewha Womans Univ, Dept Life Sci, Div Mol Life Sci, Seoul 120750, South Korea; [Oh, Eok-Soo] Ewha Womans Univ, Ctr Cell Signaling Res, Seoul 120750, South Korea	Inha University; Seoul National University (SNU); Ewha Womans University; Ewha Womans University	Han, IO (corresponding author), Inha Univ, Dept Physiol & Biophys, Coll Med, 253 Yonghyun Dong, Inchon 402751, South Korea.	iohan@inha.ac.kr	Lee, Jung Weon/AAC-1146-2020; Lee, Jung Weon/F-9149-2012	Lee, Jung Weon/0000-0003-2722-8200; 				Aloisi F, 1999, ADV EXP MED BIOL, V468, P123; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; DIAMOND MS, 1994, CURR BIOL, V4, P506, DOI 10.1016/S0960-9822(00)00111-1; DUSTIN ML, 1991, ANNU REV IMMUNOL, V9, P27, DOI 10.1146/annurev.iy.09.040191.000331; EGAN RA, 1991, BRAIN RES, V568, P330, DOI 10.1016/0006-8993(91)91421-V; Feuerstein GZ, 1998, NEUROIMMUNOMODULAT, V5, P143, DOI 10.1159/000026331; FRISEN J, 1995, NEUROSCIENCE, V65, P293, DOI 10.1016/0306-4522(94)00467-J; Gladson CL, 1999, J NEUROPATH EXP NEUR, V58, P1029, DOI 10.1097/00005072-199910000-00001; Guan JL, 1997, MATRIX BIOL, V16, P195, DOI 10.1016/S0945-053X(97)90008-1; Han IO, 2003, J NEUROSCI RES, V73, P659, DOI 10.1002/jnr.10706; HUTTENLOCHER A, 1995, CURR OPIN CELL BIOL, V7, P697, DOI 10.1016/0955-0674(95)80112-X; Hwang SY, 2004, BIOCHEM BIOPH RES CO, V318, P691, DOI 10.1016/j.bbrc.2004.04.082; Jack C, 2005, J NEUROSCI RES, V81, P363, DOI 10.1002/jnr.20482; Kim HS, 2004, J NEUROIMMUNOL, V151, P85, DOI 10.1016/j.jneuroim.2004.02.006; Kim WK, 2004, J IMMUNOL, V172, P7015, DOI 10.4049/jimmunol.172.11.7015; Kloss CUA, 2001, EXP NEUROL, V168, P32, DOI 10.1006/exnr.2000.7575; Labeur MS, 1999, J IMMUNOL, V162, P168; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LAYWELL ED, 1991, ANN NY ACAD SCI, V633, P122; Mettouchi A, 2001, MOL CELL, V8, P115, DOI 10.1016/S1097-2765(01)00285-4; Milner R, 2003, J IMMUNOL, V170, P3850, DOI 10.4049/jimmunol.170.7.3850; Milner R, 2002, J NEUROSCI, V22, P1562, DOI 10.1523/JNEUROSCI.22-05-01562.2002; MORRIS CS, 1991, J NEUROL SCI, V101, P47, DOI 10.1016/0022-510X(91)90017-2; Nakagawa T, 1996, J NEURO-ONCOL, V28, P13, DOI 10.1007/BF00300442; Niquet J, 1996, GLIA, V16, P359, DOI 10.1002/(SICI)1098-1136(199604)16:4<359::AID-GLIA8>3.0.CO;2-V; Raines EW, 2000, INT J EXP PATHOL, V81, P173, DOI 10.1046/j.1365-2613.2000.00155.x; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Roggendorf W, 1996, ACTA NEUROPATHOL, V92, P288, DOI 10.1007/s004010050520; Rosales AA, 1997, BRAIN RES, V748, P195, DOI 10.1016/S0006-8993(96)01301-7; Sola C, 2002, EUR J NEUROSCI, V16, P1275, DOI 10.1046/j.1460-9568.2002.02199.x; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; Werb Z, 1998, ANN NY ACAD SCI, V857, P110, DOI 10.1111/j.1749-6632.1998.tb10111.x	32	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2526	2533		10.1074/jbc.M610219200	http://dx.doi.org/10.1074/jbc.M610219200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	17981810	hybrid			2022-12-25	WOS:000252622300009
J	Sherwood, TW; Askwith, CC				Sherwood, Thomas W.; Askwith, Candice C.			Endogenous arginine-phenylalanine-amide-related peptides alter steady-state desensitization of ASIC1a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; TARANTULA TOXIN PSALMOTOXIN-1; PROTON-GATED CHANNELS; DORSAL-HORN NEURONS; INTRACELLULAR PH; SENSORY NEURONS; RFAMIDE NEUROPEPTIDES; EXTRACELLULAR DOMAIN; CEREBRAL-ISCHEMIA; SODIUM-CHANNEL	The acid-sensing ion channels ( ASICs) are proton-gated, voltage-insensitive cation channels expressed throughout the nervous system. ASIC1a plays a role in learning, pain, and fear-related behaviors. In addition, activation of ASIC1a during prolonged acidosis following cerebral ischemia induces neuronal death. ASICs undergo steady-state desensitization, a characteristic that limits ASIC1a activity and may play a prominent role in the prevention of ASIC1a-evoked neuronal death. In this study, we found exogenous and endogenous arginine-phenylalanineamide ( RF-amide)-related peptides decreased the pH sensitivity of ASIC1a steady-state desensitization. During conditions that normally induced steady-state desensitization, these peptides profoundly enhanced ASIC1a activity. We also determined that human ASIC1a required more acidic pH to undergo steady-state desensitization compared with mouse ASIC1a. Surprisingly, steady-state desensitization of human ASIC1a was also affected by a greater number of peptides compared with mouse ASIC1a. Mutation of five amino acids in a region of the extracellular domain changed the characteristics of human ASIC1a to those of mouse ASIC1a, suggesting that this region plays a pivotal role in neuropeptide and pH sensitivity of steady-state desensitization. Overall, these experiments lend vital insight into steady-state desensitization of ASIC1a and expand our understanding of the structural determinants of RF-amide-related peptide modulation. Furthermore, our finding that endogenous peptides shift steady-state desensitization suggests that RF-amides could impact the role of ASIC1a in both pain and neuronal damage following stroke and ischemia.	[Sherwood, Thomas W.; Askwith, Candice C.] Ohio State Univ, Dept Neurosci, Coll Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Askwith, CC (corresponding author), Ohio State Univ, Dept Neurosci, Coll Med, 4197 Graves Hall,333 W 10th Ave, Columbus, OH 43210 USA.	askwith.1@osu.edu						Adams CM, 1998, J BIOL CHEM, V273, P30204, DOI 10.1074/jbc.273.46.30204; ALLEN GV, 1995, NEUROSCIENCE, V68, P1037, DOI 10.1016/0306-4522(95)00198-R; Allen NJ, 2002, J PHYSIOL-LONDON, V543, P521, DOI 10.1113/jphysiol.2002.020297; ANDREWS BT, 1988, J PHARMACOL EXP THER, V247, P1248; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Babinski K, 2000, J BIOL CHEM, V275, P28519, DOI 10.1074/jbc.M004114200; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Catarsi S, 2001, NEUROPHARMACOLOGY, V41, P592, DOI 10.1016/S0028-3908(01)00107-1; Chartrel N, 2006, PEPTIDES, V27, P1110, DOI 10.1016/j.peptides.2005.06.035; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; Chen XM, 2006, NEUROPHARMACOLOGY, V50, P964, DOI 10.1016/j.neuropharm.2006.01.007; CHEUNG RTF, 1995, J COMP NEUROL, V360, P101, DOI 10.1002/cne.903600108; CHEUNG RTF, 1995, J COMP NEUROL, V362, P535, DOI 10.1002/cne.903620408; Cho JH, 2007, AM J PHYSIOL-CELL PH, V292, pC2161, DOI 10.1152/ajpcell.00598.2006; Chu XP, 2006, J NEUROSCI, V26, P5329, DOI 10.1523/JNEUROSCI.0938-06.2006; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200; Cottrell GA, 2001, FEBS LETT, V489, P71, DOI 10.1016/S0014-5793(01)02081-6; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Deval E, 2003, NEUROPHARMACOLOGY, V44, P662, DOI 10.1016/S0028-3908(03)00047-9; Duan B, 2007, J NEUROSCI, V27, P11139, DOI 10.1523/JNEUROSCI.3364-07.2007; Fukusumi S, 2006, PEPTIDES, V27, P1073, DOI 10.1016/j.peptides.2005.06.031; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; Hey JG, 2007, STROKE, V38, P670, DOI 10.1161/01.STR.0000251443.68897.99; Huang BS, 2002, HYPERTENSION, V39, P557, DOI 10.1161/hy02t2.103004; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jiang Y, 2003, J BIOL CHEM, V278, P27652, DOI 10.1074/jbc.M302945200; Kagansky N, 2001, ARCH NEUROL-CHICAGO, V58, P1209, DOI 10.1001/archneur.58.8.1209; KRAIG RP, 1983, J NEUROPHYSIOL, V49, P831, DOI 10.1152/jn.1983.49.3.831; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Lingueglia E, 2006, PEPTIDES, V27, P1138, DOI 10.1016/j.peptides.2005.06.037; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; Mercado F, 2006, J NEUROPHYSIOL, V96, P1615, DOI 10.1152/jn.00378.2006; Nishimura M, 2000, HYPERTENSION, V35, P443, DOI 10.1161/01.HYP.35.1.443; Ostrovskaya O, 2004, J NEUROCHEM, V91, P252, DOI 10.1111/j.1471-4159.2004.02688.x; Panula P, 1999, BRAIN RES, V848, P191, DOI 10.1016/S0006-8993(99)02044-2; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Pignataro G, 2007, BRAIN, V130, P151, DOI 10.1093/brain/awl325; Poirot O, 2004, J BIOL CHEM, V279, P38448, DOI 10.1074/jbc.M407381200; RAFFA RB, 1988, PEPTIDES, V9, P915, DOI 10.1016/0196-9781(88)90141-6; Salinas M, 2006, J PHYSIOL-LONDON, V570, P339, DOI 10.1113/jphysiol.2005.095810; Siesjo BK, 1996, ACT NEUR S, V66, P8; SIESJO BK, 1988, NEUROCHEM PATHOL, V9, P31; SMITH ML, 1986, J CEREBR BLOOD F MET, V6, P574, DOI 10.1038/jcbfm.1986.104; Tsutsui K, 2006, PEPTIDES, V27, P1121, DOI 10.1016/j.peptides.2005.06.036; VONHANWEHR R, 1986, J NEUROCHEM, V46, P331; Waldmann R, 2001, ADV EXP MED BIOL, V502, P293; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang WZ, 2006, J BIOL CHEM, V281, P29369, DOI 10.1074/jbc.M605122200; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Wu LJ, 2004, J BIOL CHEM, V279, P43716, DOI 10.1074/jbc.M403557200; Xie JH, 2003, J NEUROPHYSIOL, V89, P2459, DOI 10.1152/jn.00707.2002; Xie JH, 2002, J NEUROPHYSIOL, V87, P2835, DOI 10.1152/jn.2002.87.6.2835; Xiong ZG, 2006, J MEMBRANE BIOL, V209, P59, DOI 10.1007/s00232-005-0840-x; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; YANG HY, 2007, IN PRESS NEUROPEPTID; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Yoshida H, 2003, BBA-MOL CELL RES, V1593, P151, DOI 10.1016/S0167-4889(02)00389-0	66	59	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1818	1830		10.1074/jbc.M705118200	http://dx.doi.org/10.1074/jbc.M705118200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	17984098	hybrid			2022-12-25	WOS:000252501000007
J	Chandramouli, S; Yu, CY; Yusoff, P; Lao, DH; Leong, HF; Mizuno, K; Guy, GR				Chandramouli, Sumana; Yu, Chye Yun; Yusoff, Permeen; Lao, Dieu-Hung; Leong, Hwei Fen; Mizuno, Kensaku; Guy, Graeme R.			Tesk1 interacts with spry2 to abrogate its inhibition of ERK phosphorylation downstream of receptor tyrosine kinase signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; SPROUTY PROTEINS; COFILIN PHOSPHORYLATION; ACTIN REORGANIZATION; TRANSLOCATION DOMAIN; LIM KINASE; GROWTH; ACTIVATION; RAS; ANTAGONIST	The Sprouty ( Spry) proteins function as inhibitors of the Ras-ERK pathway downstream of various receptor tyrosine kinases. In this study, we have identified Tesk1 ( testicular protein kinase 1) as a novel regulator of Spry2 function. Endogenous Tesk1 and Spry2 exist in a complex in cell lines and mouse tissues. Tesk1 coexpression relocalizes Spry2 to vesicles including endosomes, inhibiting its translocation to membrane ruffles upon growth factor stimulation. Independent of its kinase activity, Tesk1 binding leads to a loss of Spry2 function as an inhibitor of ERK phosphorylation and reverses inhibition of basic fibroblast growth factor (bFGF)- and nerve growth factor-induced neurite outgrowth in PC12 cells by Spry2. Furthermore, depletion of endogenous Tesk1 in PC12 cells leads to a reduction in neurite outgrowth induced by bFGF. Tesk1 nullifies the inhibitory effect of Spry2 by abrogating its interaction with the adaptor protein Grb2 and interfering with its serine dephosphorylation upon bFGF and FGF receptor 1 stimulation by impeding its binding to the catalytic subunit of protein phosphatase 2A. A construct of Tesk1 that binds to Spry2 but does not localize to the vesicles does not interfere with its function, highlighting the importance of subcellular localization of Tesk1 in this context. Conversely, Tesk1 does not affect interaction of Spry2 with the E3 ubiquitin ligase, c-Cbl, and consequently, does not affect its inhibition of Cbl-mediated ubiquitination of the epidermal growth factor receptor. By selectively modulating the downstream effects of Spry2, Tesk1 may thus serve as a molecular determinant of the signaling outcome.	[Chandramouli, Sumana; Yu, Chye Yun; Yusoff, Permeen; Lao, Dieu-Hung; Leong, Hwei Fen; Guy, Graeme R.] Inst Mol & Cell Biol, Singapore 138673, Singapore; [Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Tohoku University	Guy, GR (corresponding author), Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	mcbgg@imcb.a-star.edu.sg	Mizuno, Kensaku/G-8631-2015	Chandramouli, Sumana/0000-0001-6994-506X				Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Christofori G, 2003, NAT CELL BIOL, V5, P377, DOI 10.1038/ncb0503-377; DaSilva J, 2006, MOL CELL BIOL, V26, P1898, DOI 10.1128/MCB.26.5.1898-1907.2006; Edwin F, 2006, J BIOL CHEM, V281, P4816, DOI 10.1074/jbc.M508300200; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; Endo M, 2003, J NEUROSCI, V23, P2527; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Guy GR, 2003, J CELL SCI, V116, P3061, DOI 10.1242/jcs.00652; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Haglund K, 2005, EMBO REP, V6, P635, DOI 10.1038/sj.embor.7400453; Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Kim HJ, 2007, CURR BIOL, V17, P455, DOI 10.1016/j.cub.2007.01.059; Kramer S, 1999, DEVELOPMENT, V126, P2515; LaLonde DP, 2005, J BIOL CHEM, V280, P21680, DOI 10.1074/jbc.m500752200; Lao DH, 2007, J BIOL CHEM, V282, P9117, DOI 10.1074/jbc.M607563200; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; Leeksma OC, 2002, EUR J BIOCHEM, V269, P2546, DOI 10.1046/j.1432-1033.2002.02921.x; Lim J, 2000, J BIOL CHEM, V275, P32837, DOI 10.1074/jbc.M002156200; Lim J, 2002, MOL CELL BIOL, V22, P7953, DOI 10.1128/MCB.22.22.7953-7966.2002; Lo TL, 2006, CANCER LETT, V242, P141, DOI 10.1016/j.canlet.2005.12.032; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Mason JM, 2004, MOL BIOL CELL, V15, P2176, DOI 10.1091/mbc.E03-07-0503; Minowada G, 1999, DEVELOPMENT, V126, P4465; Nonami A, 2005, GENES CELLS, V10, P887, DOI 10.1111/j.1365-2443.2005.00886.x; Rodriguez-Viciana P, 2006, P NATL ACAD SCI USA, V103, P19290, DOI 10.1073/pnas.0609343103; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Shaw AT, 2007, GENE DEV, V21, P694, DOI 10.1101/gad.1526207; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; Toshima J, 1998, BIOCHEM BIOPH RES CO, V249, P107, DOI 10.1006/bbrc.1998.9099; Toshima J, 2001, J BIOL CHEM, V276, P31449, DOI 10.1074/jbc.M102988200; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Toshima J, 1999, J BIOL CHEM, V274, P12171, DOI 10.1074/jbc.274.17.12171; Tsumura Y, 2005, BIOCHEM J, V387, P627, DOI 10.1042/BJ20041181; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; Yigzaw Y, 2003, J BIOL CHEM, V278, P284, DOI 10.1074/jbc.M210359200; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200	44	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1679	1691		10.1074/jbc.M705457200	http://dx.doi.org/10.1074/jbc.M705457200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17974561	hybrid			2022-12-25	WOS:000252282700055
J	Kudryashov, DS; Cordero, CL; Reisler, E; Satchell, KJF				Kudryashov, Dmitri S.; Cordero, Christina L.; Reisler, Emil; Satchell, Karla J. Fullner			Characterization of the enzymatic activity of the actin cross-linking domain from the Vibrio cholerae MARTX(Vc) toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-AFFINITY SITES; RTX TOXIN; ATP HYDROLYSIS; F-ACTIN; DIVALENT-CATION; YEAST COFILIN; BINDING; POLYMERIZATION; FILAMENTS; ADF/COFILIN	Vibrio cholerae is a Gram-negative bacterial pathogen that exports enterotoxins, which alter host cells through a number of mechanisms resulting in diarrheal disease. Among the secreted toxins is the multifunctional, autoprocessing RTX toxin (MARTX(Vc)), which disrupts actin cytoskeleton by covalently cross-linking actin monomers into oligomers. The region of the toxin responsible for cross-linking activity is the actin cross-linking domain (ACD). In this study, we demonstrate unambiguously that ACD utilizes G-and not F-actin as a substrate for the cross-linking reaction and hydrolyzes one molecule of ATP per cross-linking event. Furthermore, major actin-binding proteins that regulate actin cytoskeleton in vivo do not block the cross-linking reaction in vitro. Cofilin inhibits the cross-linking of G- and F-actin, at a high mole ratio to actin but accelerates F-actin cross-linking at low mole ratios. DNase I completely blocks the cross-linking of actin, likely due to steric hindrance with one of the cross-linking sites on actin. In the context of the holotoxin, the inhibition of Rho by the Rho-inactivating domain of MARTX(Vc) (Sheahan, K. L., and Satchell, K. J. F. (2007) Cell. Microbiol. 9, 1324-1335) would accelerate F-actin depolymerization and provide G- actin, alone or in complex with actin-binding proteins, for cross-linking by ACD, ultimately leading to the observed rapid cell rounding.	[Cordero, Christina L.; Satchell, Karla J. Fullner] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA; [Kudryashov, Dmitri S.; Reisler, Emil] Univ Calif Los Angeles, Inst Mol Biol, Dept Chem & Biochem, Los Angeles, CA 90095 USA	Northwestern University; Feinberg School of Medicine; University of California System; University of California Los Angeles	Satchell, KJF (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, 303 E Chicago Ave,Tarry 3-713, Chicago, IL 60611 USA.	k-satchell@northwestern.edu	Kudryashov, Dmitri/P-9004-2014; Satchell, Karla/GSN-3100-2022	Kudryashov, Dmitri/0000-0003-1782-3305	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051490, F31AI052490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077190] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI051490-05, F31 AI 52490, AI 051490, R01 AI051490, F31 AI052490] Funding Source: Medline; NIGMS NIH HHS [R01 GM077190, GM 077190] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; Bobkov AA, 2002, J MOL BIOL, V323, P739, DOI 10.1016/S0022-2836(02)01008-2; CARLIER MF, 1987, J BIOL CHEM, V262, P3052; CARLIER MF, 1987, BIOCHEM BIOPH RES CO, V143, P1069, DOI 10.1016/0006-291X(87)90361-5; CARLIER MF, 1986, J BIOL CHEM, V261, P778; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chen H, 2004, BIOCHEMISTRY-US, V43, P7127, DOI 10.1021/bi049797n; Cordero CL, 2007, J CLIN MICROBIOL, V45, P2289, DOI 10.1128/JCM.00349-07; Cordero CL, 2006, J BIOL CHEM, V281, P32366, DOI 10.1074/jbc.M605275200; Du JY, 1998, BIOCHEMISTRY-US, V37, P13276, DOI 10.1021/bi981117r; Fullner KJ, 2000, EMBO J, V19, P5315, DOI 10.1093/emboj/19.20.5315; GERSHMAN LC, 1986, BIOCHEM BIOPH RES CO, V135, P607, DOI 10.1016/0006-291X(86)90036-7; Goldsmith SC, 2001, J BIOMOL STRUCT DYN, V19, P405, DOI 10.1080/07391102.2001.10506750; Goode BL, 1998, J CELL BIOL, V142, P723, DOI 10.1083/jcb.142.3.723; Hatanaka H, 1996, CELL, V85, P1047, DOI 10.1016/S0092-8674(00)81305-7; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; KAISER DA, 1989, CELL MOTIL CYTOSKEL, V14, P251, DOI 10.1002/cm.970140211; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kim E, 1998, BIOCHEMISTRY-US, V37, P17793, DOI 10.1021/bi9812874; KINOSIAN HJ, 1993, J BIOL CHEM, V268, P8683; Klenchin VA, 2003, NAT STRUCT BIOL, V10, P1058, DOI 10.1038/nsb1006; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; Kudryashov DS, 2003, BIOPHYS J, V85, P2466, DOI 10.1016/S0006-3495(03)74669-4; Kudryashov DS, 2006, J MOL BIOL, V358, P785, DOI 10.1016/j.jmb.2006.02.029; KUROKAWA H, 1990, BIOCHEM BIOPH RES CO, V168, P451, DOI 10.1016/0006-291X(90)92342-W; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Olivier V, 2007, INFECT IMMUN, V75, P5043, DOI 10.1128/IAI.00508-07; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Paavilainen VO, 2007, P NATL ACAD SCI USA, V104, P3113, DOI 10.1073/pnas.0608725104; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; POLLARD TD, 1992, J BIOL CHEM, V267, P20339; ROUAYRENC JF, 1981, EUR J BIOCHEM, V116, P73, DOI 10.1111/j.1432-1033.1981.tb05302.x; Saito S, 1996, CLIN EXP PHARMACOL P, V23, P743, DOI 10.1111/j.1440-1681.1996.tb01770.x; Satchell KJF, 2007, INFECT IMMUN, V75, P5079, DOI 10.1128/IAI.00525-07; Schuler H, 2001, BBA-PROTEIN STRUCT M, V1549, P137, DOI 10.1016/S0167-4838(01)00255-2; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700; Sheahan KL, 2007, CELL MICROBIOL, V9, P1324, DOI 10.1111/j.1462-5822.2006.00876.x; Sheahan KL, 2004, P NATL ACAD SCI USA, V101, P9798, DOI 10.1073/pnas.0401104101; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Steele-Mortimer O, 2000, TRAFFIC, V1, P107, DOI 10.1034/j.1600-0854.2000.010203.x; TELLAM R, 1985, BIOCHEMISTRY-US, V24, P4455, DOI 10.1021/bi00337a029; Van Troys M, 1997, J BIOL CHEM, V272, P32750, DOI 10.1074/jbc.272.52.32750; Wriggers W, 1998, J MOL BIOL, V282, P921, DOI 10.1006/jmbi.1998.2048; ZIMMERLE CT, 1987, BIOCHEMISTRY-US, V26, P6545, DOI 10.1021/bi00394a039	47	34	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					445	452		10.1074/jbc.M703910200	http://dx.doi.org/10.1074/jbc.M703910200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17951576	Green Accepted, hybrid			2022-12-25	WOS:000251940300049
J	Liu, C; Zhang, Y; Cao, D; He, Y; Kuang, T; Yang, C				Liu, Cheng; Zhang, Yajie; Cao, Derong; He, Yikun; Kuang, Tingyun; Yang, Chunhong			Structural and functional analysis of the antiparallel strands in the lumenal loop of the major light-harvesting chlorophyll a/b complex of photosystem II (LHCIIb) by site-directed mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FEMTOSECOND TRANSIENT ABSORPTION; NEOXANTHIN-BINDING-SITE; HIGHER-PLANTS; ENERGY-TRANSFER; IN-VITRO; ESCHERICHIA-COLI; AMINO-ACIDS; FLUORESCENCE; PROTEIN; XANTHOPHYLLS	The light-harvesting chlorophyll a/b-binding protein of photosystem II ( LHCIIb) fulfills multiple functions, such as light harvesting and energy dissipation under different illuminations. The crystal structure of LHCIIb at the near atomic resolution reveals an antiparallel strands structure in the lumenal loop between the transmembrane helices B/C. To study the structural and functional significances of this structure, three amino acids (Val-119, His-120, and Ser-123) in this region have been exchanged to Phe, Leu, and Gly, respectively, and the influence of the mutagenesis on the structure and function of LHCIIb has been investigated. The results are as follows. 1) Circular dichroism spectra of the mutations reveals that the antiparallel strands in the lumenal region are very important for adjusting pigment conformation in the neoxanthin domain of LHCIIb. Although the mutagenesis causes only a slight loss of the Neo binding in the complexes (V119F, 0.09; S123G, 0.19; and H120L, 0.27), it imparts remarkable changes to the pigment conformation. 2) Substituting Ser-123 with Gly results in a higher susceptibility to photodamage, an increased tendency to aggregate, and enhanced fluorescence quenching induced by the medium acidification. These results demonstrate that this antiparallel strands domain plays an important role in regulating the pigment conformation and in adjusting the aggregation and the fluorescence yield of LHCIIb.	[Liu, Cheng; Zhang, Yajie; Kuang, Tingyun; Yang, Chunhong] Chinese Acad Sci, Inst Bot, Key Lab Photosynthesis & Environm Mol Physiol, Beijing 100093, Peoples R China; [Cao, Derong] S China Univ Technol, Coll Chem, Guangzhou 510640, Peoples R China; [He, Yikun; Kuang, Tingyun] Capital Normal Univ, Coll Life Sci, Beijing 100037, Peoples R China; [Yang, Chunhong] Johannes Gutenberg Univ Mainz, Inst Allgemeine Bot, D-55099 Mainz, Germany; [Liu, Cheng; Zhang, Yajie] Grad Univ, Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; South China University of Technology; Capital Normal University; Johannes Gutenberg University of Mainz; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, C (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Photosynthesis & Environm Mol Physiol, 20 Nanxincun, Beijing 100093, Peoples R China.	yangch@ibcas.ac.cn						ALLEN JF, 1995, PHYSIOL PLANTARUM, V93, P196, DOI 10.1034/j.1399-3054.1995.930128.x; CASHMORE AR, 1984, P NATL ACAD SCI-BIOL, V81, P2960, DOI 10.1073/pnas.81.10.2960; Cogdell RJ, 2006, TRENDS PLANT SCI, V11, P59, DOI 10.1016/j.tplants.2005.12.002; Connelly JP, 1997, BIOCHEMISTRY-US, V36, P281, DOI 10.1021/bi962467l; Croce R, 1999, FEBS LETT, V456, P1, DOI 10.1016/S0014-5793(99)00907-2; Croce R, 1999, J BIOL CHEM, V274, P29613, DOI 10.1074/jbc.274.42.29613; Croce R, 2003, BIOPHYS J, V84, P2517, DOI 10.1016/S0006-3495(03)75057-7; CROFTS AR, 1994, FEBS LETT, V352, P265, DOI 10.1016/0014-5793(94)00976-7; Formaggio E, 2001, J MOL BIOL, V314, P1157, DOI 10.1006/jmbi.2000.5179; Gilmore AM, 1998, BIOCHEMISTRY-US, V37, P13582, DOI 10.1021/bi981384x; Goss R, 2005, BIOCHEMISTRY-US, V44, P4028, DOI 10.1021/bi047464k; Gradinaru CC, 2003, J PHYS CHEM B, V107, P3938, DOI 10.1021/jp026278q; Grudzinski W, 2001, BBA-BIOENERGETICS, V1503, P291, DOI 10.1016/S0005-2728(00)00206-1; Gruszecki WI, 2006, BBA-BIOENERGETICS, V1757, P1504, DOI 10.1016/j.bbabio.2006.08.002; Hobe S, 2003, J BIOL CHEM, V278, P5912, DOI 10.1074/jbc.M211145200; HOBE S, 1994, EMBO J, V13, P3423, DOI 10.1002/j.1460-2075.1994.tb06647.x; Hobe S, 2006, J BIOL CHEM, V281, P25156, DOI 10.1074/jbc.M604828200; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holt NE, 2003, CHEM PHYS LETT, V379, P305, DOI 10.1016/j.cplett.2003.08.039; Horton P, 2000, PHILOS T R SOC B, V355, P1361, DOI 10.1098/rstb.2000.0698; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; Horton P, 2005, J EXP BOT, V56, P365, DOI 10.1093/jxb/eri023; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Kirchhoff H, 2003, BBA-BIOENERGETICS, V1606, P105, DOI 10.1016/S0005-2728(03)00105-1; Kleima FJ, 1999, BIOCHEMISTRY-US, V38, P6587, DOI 10.1021/bi982823v; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; MARTINSON TA, 1995, ANAL BIOCHEM, V228, P123, DOI 10.1006/abio.1995.1323; Mick V, 2004, BIOCHEMISTRY-US, V43, P5467, DOI 10.1021/bi036198s; Niedzwiedzki D, 2005, J PHOTOCH PHOTOBIO B, V78, P109, DOI 10.1016/j.jphotobiol.2004.09.012; Palacios MA, 2004, BBA-BIOENERGETICS, V1656, P177, DOI 10.1016/j.bbabio.2004.04.002; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; PAULSEN H, 1990, PLANTA, V181, P204, DOI 10.1007/BF02411539; Pesaresi P, 1997, FEBS LETT, V402, P151, DOI 10.1016/S0014-5793(96)01518-9; Peterman EJG, 1997, BIOCHEMISTRY-US, V36, P12208, DOI 10.1021/bi9711689; Remelli R, 1999, J BIOL CHEM, V274, P33510, DOI 10.1074/jbc.274.47.33510; Rogl H, 1998, FEBS LETT, V432, P21, DOI 10.1016/S0014-5793(98)00825-4; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Ruban AV, 2002, J BIOL CHEM, V277, P42937, DOI 10.1074/jbc.M207823200; RUBAN AV, 1994, BBA-BIOENERGETICS, V1186, P123, DOI 10.1016/0005-2728(94)90143-0; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P39, DOI 10.1016/0167-4838(92)90496-Z; Ruban AV, 2001, J BIOL CHEM, V276, P24862, DOI 10.1074/jbc.M103263200; Snyder AM, 2004, J BIOL CHEM, V279, P5162, DOI 10.1074/jbc.M309676200; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Vasilev S, 1997, BIOCHEMISTRY-US, V36, P7503, DOI 10.1021/bi9625253; Walters RG, 1996, P NATL ACAD SCI USA, V93, P14204, DOI 10.1073/pnas.93.24.14204; Wentworth M, 2004, BIOCHEMISTRY-US, V43, P501, DOI 10.1021/bi034975i; Wentworth M, 2000, FEBS LETT, V471, P71, DOI 10.1016/S0014-5793(00)01369-7; Wentworth M, 2003, J BIOL CHEM, V278, P21845, DOI 10.1074/jbc.M302586200; Yang CH, 1999, BIOCHEMISTRY-US, V38, P16205, DOI 10.1021/bi990738x	51	29	39	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					487	495		10.1074/jbc.M705736200	http://dx.doi.org/10.1074/jbc.M705736200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17959607	hybrid			2022-12-25	WOS:000251940300054
J	Snowden, T; Shim, KS; Schmutte, C; Acharya, S; Fishel, R				Snowden, Timothy; Shim, Kang-Sup; Schmutte, Christoph; Acharya, Samir; Fishel, Richard			hMSH4-hMSH5 adenosine nucleotide processing and interactions with homologous recombination machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA MISMATCH REPAIR; RAD51 NUCLEOPROTEIN FILAMENT; MUTS HOMOLOG; CROSSING-OVER; MEIOTIC RECOMBINATION; RECIPROCAL RECOMBINATION; SACCHAROMYCES-CEREVISIAE; CHROMOSOMAL LOCALIZATION; HOLLIDAY JUNCTION; MAMMALIAN MEIOSIS	We have previously demonstrated that the human heterodimeric meiosis-specific MutS homologs, hMSH4-hMSH5, bind uniquely to a Holliday Junction and its developmental progenitor (Snowden, T., Acharya, S., Butz, C., Berardini, M., and Fishel, R. (2004) Mol. Cell 15, 437-451). ATP binding by hMSH4-hMSH5 resulted in the formation of a sliding clamp that dissociated from the Holliday Junction crossover region embracing two duplex DNA arms. The loading of multiple hMSH4-hMSH5 sliding clamps was anticipated to stabilize the interaction between parental chromosomes during meiosis double-stranded break repair. Here we have identified the interaction region between the individual subunits of hMSH4-hMSH5 that are likely involved in clamp formation and show that each subunit of the heterodimer binds ATP. We have determined that ADP-->ATP exchange is uniquely provoked by Holliday Junction recognition. Moreover, the hydrolysis of ATP by hMSH4-hMSH5 appears to occur after the complex transits the open ends of model Holliday Junction oligonucleotides. Finally, we have identified several components of the double-stranded break repair machinery that strongly interact with hMSH4-hMSH5. These results further underline the function(s) and interactors of hMSH4-hMSH5 that ensure accurate chromosomal repair and segregation during meiosis.	[Snowden, Timothy] Kimmel Canc Ctr, Genet & Mol Biol Program, Philadelphia, PA 19107 USA; [Shim, Kang-Sup; Schmutte, Christoph; Acharya, Samir; Fishel, Richard] Ohio State Univ, Sch Med & Publ Hlth, Columbus, OH 43210 USA	Jefferson University; University System of Ohio; Ohio State University	Fishel, R (corresponding author), Wiseman 485N,400 W 12th Ave, Columbus, OH 43210 USA.	rfishel@osu.edu			NATIONAL CANCER INSTITUTE [R01CA067007, T32CA009662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080176, R01GM062556] Funding Source: NIH RePORTER; NCI NIH HHS [CA 67007, R01 CA067007-14, R01 CA067007, T32 CA009662, T32 CA 09662] Funding Source: Medline; NIGMS NIH HHS [GM 62556, R01 GM080176-16, R01 GM062556-05, R01 GM062556-08, R01 GM080176, R01 GM080176-17, R01 GM062556] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Allers T, 2001, MOL CELL, V8, P225, DOI 10.1016/S1097-2765(01)00280-5; Blackwell LJ, 1998, J BIOL CHEM, V273, P32049, DOI 10.1074/jbc.273.48.32049; Bocher T, 1999, CANCER RES, V59, P816; BOCKER T, 1999, BIOCHIM BIOPHYS ACTA, V31, P1; de Vries SS, 1999, GENE DEV, V13, P523, DOI 10.1101/gad.13.5.523; DUCKETT DR, 1988, CELL, V55, P79, DOI 10.1016/0092-8674(88)90011-6; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Eisen JA, 1998, NUCLEIC ACIDS RES, V26, P4291, DOI 10.1093/nar/26.18.4291; Fishel R, 1999, NAT MED, V5, P1239, DOI 10.1038/15191; Fishel R, 1998, GENE DEV, V12, P2096, DOI 10.1101/gad.12.14.2096; Fishel R, 1997, CURR OPIN GENET DEV, V7, P105, DOI 10.1016/S0959-437X(97)80117-7; Franklin FCH, 2006, BIOCHEM SOC T, V34, P542, DOI 10.1042/BST0340542; Gradia S, 2000, J BIOL CHEM, V275, P3922, DOI 10.1074/jbc.275.6.3922; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Guerrette S, 1999, J BIOL CHEM, V274, P6336, DOI 10.1074/jbc.274.10.6336; Guerrette S, 1998, MOL CELL BIOL, V18, P6616, DOI 10.1128/MCB.18.11.6616; HABER LT, 1991, EMBO J, V10, P2707, DOI 10.1002/j.1460-2075.1991.tb07815.x; Hassold T, 2000, HUM MOL GENET, V9, P2409, DOI 10.1093/hmg/9.16.2409; Her C, 1998, GENOMICS, V52, P50, DOI 10.1006/geno.1998.5374; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Higgins JD, 2004, GENE DEV, V18, P2557, DOI 10.1101/gad.317504; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Kelly KO, 2000, GENETICS, V156, P617; Kleckner N, 1996, P NATL ACAD SCI USA, V93, P8167, DOI 10.1073/pnas.93.16.8167; Kneitz B, 2000, GENE DEV, V14, P1085; Kolas NK, 2004, CYTOGENET GENOME RES, V107, P216, DOI 10.1159/000080600; Kolas NK, 2005, J CELL BIOL, V171, P447, DOI 10.1083/jcb.200506170; Kuznetsov S, 2007, J CELL BIOL, V176, P581, DOI 10.1083/jcb.200608130; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lamers MH, 2003, EMBO J, V22, P746, DOI 10.1093/emboj/cdg064; Lenzi ML, 2005, AM J HUM GENET, V76, P112, DOI 10.1086/427268; Lipkin SM, 2002, NAT GENET, V31, P385, DOI 10.1038/ng931; Liu YL, 2007, J BIOL CHEM, V282, P1973, DOI 10.1074/jbc.M609066200; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; Mazin AV, 2000, MOL CELL, V6, P583, DOI 10.1016/S1097-2765(00)00057-5; Mazin AV, 2003, J BIOL CHEM, V278, P14029, DOI 10.1074/jbc.M212779200; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; Moens PB, 2002, J CELL SCI, V115, P1611; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; Neyton S, 2004, MOL HUM REPROD, V10, P917, DOI 10.1093/molehr/gah123; Novak JE, 2001, GENETICS, V158, P1013; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Schmutte C, 2001, J BIOL CHEM, V276, P33011, DOI 10.1074/jbc.M102670200; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Sturtevant A. H., 1915, Zs indukt Abstamm Berlin, V13, DOI 10.1007/BF01792906; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wilson T, 1999, J BIOL CHEM, V274, P21659, DOI 10.1074/jbc.274.31.21659; Zalevsky J, 1999, GENETICS, V153, P1271	56	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					145	154		10.1074/jbc.M704060200	http://dx.doi.org/10.1074/jbc.M704060200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17977839	Green Accepted, hybrid			2022-12-25	WOS:000251940300017
J	Lagna, G; Ku, MM; Nguyen, PH; Neuman, NA; Davis, BN; Hata, A				Lagna, Giorgio; Ku, Manching M.; Nguyen, Peter H.; Neuman, Nicole A.; Davis, Brandi N.; Hata, Akiko			Control of phenotypic plasticity of smooth muscle cells by bone morphogenetic protein signaling through the myocardin-related transcription factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; PRIMARY PULMONARY-HYPERTENSION; SERUM RESPONSE FACTOR; BMPR-II; SM22-ALPHA TRANSCRIPTION; ARTERIAL-HYPERTENSION; DEPENDENT ACTIVATION; GENE-EXPRESSION; RECEPTOR; SMAD	Vascular smooth muscle cells (VSMCs), unlike other muscle cells, do not terminally differentiate. In response to injury, VSMCs change phenotype, proliferate, and migrate as part of the repair process. Dysregulation of this plasticity program contributes to the pathogenesis of several vascular disorders, such as atherosclerosis, restenosis, and hypertension. The discovery of mutations in the gene encoding BMPRII, the type II subunit of the receptor for bone morphogenetic proteins (BMPs), in patients with pulmonary arterial hypertension (PAH) provided an indication that BMP signaling may affect the homeostasis of VSMCs and their phenotype modulation. Here we report that BMP signaling potently induces SMC-specific genes in pluripotent cells and prevents dedifferentiation of arterial SMCs. The BMP-induced phenotype switch requires intact RhoA/ROCK signaling but is not blocked by inhibitors of the TGF beta and PI3K/ Akt pathways. Furthermore, nuclear localization and recruitment of the myocardin-related transcription factors (MRTF-A and MRTF-B) to a smooth muscle alpha-actin promoter is observed in response to BMP treatment. Thus, BMP signaling modulates VSMC phenotype via cross-talk with the RhoA/MRTFs pathway, and may contribute to the development of the pathological characteristics observed in patients with PAH and other obliterative vascular diseases.	[Lagna, Giorgio; Ku, Manching M.; Nguyen, Peter H.; Neuman, Nicole A.; Davis, Brandi N.; Hata, Akiko] Tufts Univ New England Med Ctr, MCRI, Boston, MA 02111 USA; [Ku, Manching M.; Neuman, Nicole A.; Davis, Brandi N.; Hata, Akiko] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Lagna, G (corresponding author), Tufts Univ New England Med Ctr, MCRI, 750 Washington St,Box 8486, Boston, MA 02111 USA.	glagna@tufts-nemc.org	Davis-Dusenbery, Brandi/N-2798-2013	Davis-Dusenbery, Brandi/0000-0001-7811-8613	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL086572] Funding Source: NIH RePORTER; NHLBI NIH HHS [R21 HL086572] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abdalla SA, 2004, EUR RESPIR J, V23, P373, DOI 10.1183/09031936.04.00085504; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Beppu H, 2004, AM J PHYSIOL-LUNG C, V287, pL1241, DOI 10.1152/ajplung.00239.2004; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Callis TE, 2005, CIRC RES, V97, P992, DOI 10.1161/01.RES.0000190670.92879.7d; CHAMLEYCAMPBELL J, 1979, PHYSIOL REV, V59, P1, DOI 10.1152/physrev.1979.59.1.1; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Dorai H, 2000, J CELL PHYSIOL, V184, P37, DOI 10.1002/(SICI)1097-4652(200007)184:1<37::AID-JCP4>3.0.CO;2-M; Du Lingling, 2003, New England Journal of Medicine, V348, P500, DOI 10.1056/NEJMoa021650; Elliott CG, 2006, CIRCULATION, V113, P2509, DOI 10.1161/CIRCULATIONAHA.105.601930; Foletta VC, 2003, J CELL BIOL, V162, P1089, DOI 10.1083/jcb.200212060; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Grainger DJ, 2004, ARTERIOSCL THROM VAS, V24, P399, DOI 10.1161/01.ATV.0000114567.76772.33; Guo JH, 2004, TOXICOL APPL PHARM, V194, P79, DOI 10.1016/j.taap.2003.09.002; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Hautmann MB, 1997, J BIOL CHEM, V272, P10948; Hayashi K, 1999, J CELL BIOL, V145, P727, DOI 10.1083/jcb.145.4.727; Hayashi K, 2006, MOL CELL BIOL, V26, P9456, DOI 10.1128/MCB.00759-06; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hinson JS, 2007, AM J PHYSIOL-HEART C, V292, pH1170, DOI 10.1152/ajpheart.00864.2006; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Iyemere VP, 2006, J INTERN MED, V260, P192, DOI 10.1111/j.1365-2796.2006.01692.x; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; King KE, 2003, J BIOL CHEM, V278, P11661, DOI 10.1074/jbc.M211337200; Ku MC, 2006, J BIOL CHEM, V281, P5277, DOI 10.1074/jbc.M510004200; Lagna G, 2006, AM J PHYSIOL-LUNG C, V291, pL1059, DOI 10.1152/ajplung.00180.2006; Lee-Hoeflich ST, 2004, EMBO J, V23, P4792, DOI 10.1038/sj.emboj.7600418; Li L, 1997, DEV BIOL, V187, P311, DOI 10.1006/dbio.1997.8621; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Long L, 2006, CIRC RES, V98, P818, DOI 10.1161/01.RES.0000215809.47923.fd; Machado RD, 2003, HUM MOL GENET, V12, P3277, DOI 10.1093/hmg/ddg365; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Mack CP, 1999, CIRC RES, V84, P852; Madsen CS, 1998, CIRC RES, V82, P908; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miano JM, 2000, J BIOL CHEM, V275, P9814, DOI 10.1074/jbc.275.13.9814; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Misiakos EP, 2001, EUR SURG RES, V33, P264, DOI 10.1159/000049716; Morrell NW, 2001, CIRCULATION, V104, P790, DOI 10.1161/hc3201.094152; Morty RE, 2007, ARTERIOSCL THROM VAS, V27, P1072, DOI 10.1161/ATVBAHA.107.141200; Moser M, 2005, THROMB HAEMOSTASIS, V94, P713, DOI 10.1160/TH05-05-0312; Nagaoka T, 2006, J APPL PHYSIOL, V100, P996, DOI 10.1152/japplphysiol.01028.2005; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; NAKAOKAA T, 2004, J CLIN INVEST, V43, pS33; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; Newman JH, 2004, J AM COLL CARDIOL, V43, p33S, DOI 10.1016/j.jacc.2004.02.028; Nishihara A, 2002, MOL BIOL CELL, V13, P3055, DOI 10.1091/mbc.E02-02-0063; Nishimura T, 2003, CIRCULATION, V108, P1640, DOI 10.1161/01.CIR.0000087592.47401.37; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Proweller A, 2005, J BIOL CHEM, V280, P8994, DOI 10.1074/jbc.M413316200; Puri A, 2007, NAT CLIN PRACT CARD, V4, P319, DOI 10.1038/ncpcardio0890; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Rolfe BE, 2005, ATHEROSCLEROSIS, V183, P1, DOI 10.1016/j.atherosclerosis.2005.04.023; RUBIN LJ, 1997, PRIMARY PULMONARY HY; Runo JR, 2003, LANCET, V361, P1533, DOI 10.1016/S0140-6736(03)13167-4; Takahashi H, 2006, AM J PHYSIOL-LUNG C, V290, pL450, DOI 10.1152/ajplung.00206.2005; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; van den Driesche S, 2003, CARDIOVASC RES, V58, P20, DOI 10.1016/S0008-6363(02)00852-0; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Willette RN, 1999, J VASC RES, V36, P120, DOI 10.1159/000025634; Ying Y, 2000, BIOL REPROD, V63, P1781, DOI 10.1095/biolreprod63.6.1781; Zhang S, 2003, AM J PHYSIOL-LUNG C, V285, pL740, DOI 10.1152/ajplung.00284.2002	75	131	139	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37244	37255		10.1074/jbc.M708137200	http://dx.doi.org/10.1074/jbc.M708137200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17947237	hybrid, Green Accepted			2022-12-25	WOS:000251646000050
J	Bodai, L; Pardi, N; Ujfaludi, Z; Bereczki, O; Komonyi, O; Balint, E; Boros, IM				Bodai, Laszlo; Pardi, Norbert; Ujfaludi, Zsuzsanna; Bereczki, Orsolya; Komonyi, Orban; Balint, Eva; Boros, Imre M.			Daxx-like protein of Drosophila interacts with Dmp53 and affects longevity and Ark mRNA level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53 ACTIVITY; DNA-DAMAGE; LIFE-SPAN; APOPTOSIS; MELANOGASTER; EXPRESSION; HOMOLOG; DEATH; CELL; PML	Daxx-like protein (DLP), the Drosophila homolog of Daxx, binds Drosophila melanogaster p53 (Dmp53) through its C-terminal region. We generated DLP mutants and found that although DLP expression is developmentally regulated, it is not essential for the execution of the developmental program. The effects DLP mutations show in the loss of heterozygosity assay and on phenotypes resulting from Dmp53 overexpression indicate a genetic interaction between DLP and Dmp53. In contrast to Dmp53 mutants, however, loss of DLP does not result in radiosensitivity indicating that it does not play an essential role in the activation of Dmp53-dependent response after ionizing radiation, and DLP is also not required for the irradiation-induced activation of reaper. In contrast, DLP is involved in the transcriptional regulation of Ark, because Ark mRNA level is decreased in DLP mutants and increased upon ectopic overexpression of DLP. Interestingly, DLP mutants have reduced longevity and reduced female fertility. Altogether, our data suggest complex functions for DLP, which include an anti-apoptotic effect exerted through repression of some Dmp53 functions, and activation of some proapoptotic genes.	Univ Szeged, Dept Biochem & Mol Biol, Chromatin Res Grp USZ HAS, H-6726 Szeged, Hungary; Biol Res Ctr, Inst Biochem, H-6726 Szeged, Hungary	Szeged University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Boros, IM (corresponding author), Univ Szeged, Dept Biochem & Mol Biol, Kozep Fasor 52, H-6726 Szeged, Hungary.	borosi@bio.u-szeged.hu	Ujfaludi, Zsuzsanna/AAC-7657-2020; Balint, Eva/B-8695-2008; Bodai, Laszlo/A-9764-2012	Balint, Eva/0000-0002-1258-6892; Bodai, Laszlo/0000-0001-8411-626X; Ujfaludi Dr., Zsuzsanna/0000-0003-4738-0963; Boros, Imre/0000-0001-8504-9687				ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Bauer JH, 2005, CURR BIOL, V15, P2063, DOI 10.1016/j.cub.2005.10.051; Boehrer S, 2004, HEMATOL J, V5, P513, DOI 10.1038/sj.thj.6200547; BREEDEN L, 1985, COLD SPRING HARB SYM, V50, P643, DOI 10.1101/SQB.1985.050.01.078; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Coates PJ, 2005, J PATHOL, V205, P221, DOI 10.1002/path.1701; Emelyanov AV, 2002, J BIOL CHEM, V277, P11156, DOI 10.1074/jbc.M111763200; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; Gostissa M, 2004, J BIOL CHEM, V279, P48013, DOI 10.1074/jbc.M310801200; Hainaut P, 1998, NUCLEIC ACIDS RES, V26, P205, DOI 10.1093/nar/26.1.205; Jin SK, 2000, P NATL ACAD SCI USA, V97, P7301, DOI 10.1073/pnas.97.13.7301; Kim EJ, 2003, NUCLEIC ACIDS RES, V31, P5356, DOI 10.1093/nar/gkg741; Lee JH, 2003, FEBS LETT, V550, P5, DOI 10.1016/S0014-5793(03)00771-3; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Ohiro Y, 2003, MOL CELL BIOL, V23, P322, DOI 10.1128/MCB.23.1.322-334.2003; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Peters M, 2002, P NATL ACAD SCI USA, V99, P11305, DOI 10.1073/pnas.172382899; Price DM, 2002, GENETICS, V161, P721; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Salomoni P, 2006, TRENDS CELL BIOL, V16, P97, DOI 10.1016/j.tcb.2005.12.002; Schuler M, 2005, TRENDS GENET, V21, P182, DOI 10.1016/j.tig.2005.01.001; Sogame N, 2003, P NATL ACAD SCI USA, V100, P4696, DOI 10.1073/pnas.0736384100; STAPLETON M, 2002, GENOME BIOL, V0003; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zhao LY, 2004, J BIOL CHEM, V279, P50566, DOI 10.1074/jbc.M406743200; Zhao LY, 2003, J VIROL, V77, P11809, DOI 10.1128/JVI.77.21.11809-11821.2003	33	11	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36386	36393		10.1074/jbc.M705547200	http://dx.doi.org/10.1074/jbc.M705547200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17933869	hybrid			2022-12-25	WOS:000251458300030
J	Li, D; Fournel-Gigleux, S; Barre, L; Mulliert, G; Netter, P; Magdalou, J; Ouzzine, M				Li, Dong; Fournel-Gigleux, Sylvie; Barre, Lydia; Mulliert, Guillermo; Netter, Patrick; Magdalou, Jacques; Ouzzine, Mohamed			Identification of aspartic acid and histidine residues mediating the reaction mechanism and the substrate specificity of the human UDP-glucuronosyltransferases 1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL MODIFICATION; CRYSTAL-STRUCTURES; EXPRESSION; SEQUENCE; PROTEIN; GLYCOSYLTRANSFERASES; GLUCOSYLTRANSFERASE; GLUCURONIDATION; REVEALS; RAT	The human UDP-glucuronosyltransferase UGT1A6 is the primary phenol-metabolizing UDP-glucuronosyltransferase isoform. It catalyzes the nucleophilic attack of phenolic xenobiotics on UDP-glucuronic acid, leading to the formation of water-soluble glucuronides. The catalytic mechanism proposed for this reaction is an acid-base mechanism that involves an aspartic/glutamic acid and/or histidine residue. Here, we investigated the role of 14 highly conserved aspartic/glutamic acid residues over the entire sequence of human UGT1A6 by site-directed mutagenesis. We showed that except for aspartic residues Asp-150 and Asp-488, the substitution of carboxylic residues by alanine led to active mutants but with decreased enzyme activity and lower affinity for acceptor and/or donor substrate. Further analysis including mutation of the corresponding residue in other UGT1A isoforms suggests that Asp-150 plays a major catalytic role. In this report we also identified a single active site residue important for glucuronidation of phenols and carboxylic acid substrates by UGT1A enzyme family. Replacing Pro-40 of UGT1A4 by histidine expanded the glucuronidation activity of the enzyme to phenolic and carboxylic compounds, therefore, leading to UGT1A3-type isoform in terms of substrate specificity. Conversely, when His-40 residue of UGT1A3 was replaced with proline, the substrate specificity shifted toward that of UGT1A4 with loss of glucuronidation of phenolic substrates. Furthermore, mutation of His-39 residue of UGT1A1 (His-40 in UGT1A4) to proline led to loss of glucuronidation of phenols but not of estrogens. This study provides a step forward to better understand the glucuronidation mechanism and substrate recognition, which is invaluable for a better prediction of drug metabolism and toxicity in human.	Univ Nancy 1, CNRS, UMR 7561, Fac Med, F-54505 Vandoeuvre Les Nancy, France; Univ Nancy 1, CNRS, UMR 7036, Fac Sci, F-54505 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Lorraine	Ouzzine, M (corresponding author), Univ Nancy 1, CNRS, UMR 7561, Fac Med, BP 184, F-54505 Vandoeuvre Les Nancy, France.	ouzzine@medecine.uhp-nancy.fr	Ouzzine, Mohamed/G-4368-2013	OUZZINE, Mohamed/0000-0003-0058-4950				BANSAL SK, 1980, ANAL BIOCHEM, V109, P321, DOI 10.1016/0003-2697(80)90655-7; BATTAGLIA E, 1994, ARCH BIOCHEM BIOPHYS, V309, P266, DOI 10.1006/abbi.1994.1112; BATTAGLIA E, 1994, FEBS LETT, V346, P146, DOI 10.1016/0014-5793(94)00453-6; BOCK KW, 1991, CRIT REV BIOCHEM MOL, V26, P129, DOI 10.3109/10409239109081125; BOCK KW, 1993, BIOCHEM PHARMACOL, V45, P1809, DOI 10.1016/0006-2952(93)90437-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; CLARKE DJ, 1994, HDB EXPT PHARM, V112, P3; Funhoff EG, 2005, FEBS J, V272, P2968, DOI 10.1111/j.1742-4658.2005.04686.x; Green MD, 1998, DRUG METAB DISPOS, V26, P507; Ha S., 2001, Current Drug Targets - Infectious Disorders, V1, P201, DOI 10.2174/1568005014606116; Harley CA, 1996, J BIOL CHEM, V271, P24625, DOI 10.1074/jbc.271.40.24625; Herber R, 1995, DRUG METAB DISPOS, V23, P1305; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; Iwano H, 1997, BIOCHEM J, V325, P587, DOI 10.1042/bj3250587; Kapitonov D, 1999, GLYCOBIOLOGY, V9, P961, DOI 10.1093/glycob/9.10.961; Kiang TKL, 2005, PHARMACOL THERAPEUT, V106, P97, DOI 10.1016/j.pharmthera.2004.10.013; King CD, 1999, ARCH BIOCHEM BIOPHYS, V365, P156, DOI 10.1006/abbi.1999.1155; Krishnaswamy S, 2004, DRUG METAB DISPOS, V32, P862, DOI 10.1124/dmd.32.8.862; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lariviere L, 2003, J MOL BIOL, V330, P1077, DOI 10.1016/S0022-2836(03)00635-1; Li Q, 1997, J BIOL CHEM, V272, P3272, DOI 10.1074/jbc.272.6.3272; LILIENBLUM W, 1982, BIOCHEM PHARMACOL, V31, P907, DOI 10.1016/0006-2952(82)90319-7; Mackenzie PI, 1997, PHARMACOGENETICS, V7, P255, DOI 10.1097/00008571-199708000-00001; Miley MJ, 2007, J MOL BIOL, V369, P498, DOI 10.1016/j.jmb.2007.03.066; Mulichak AM, 2003, P NATL ACAD SCI USA, V100, P9238, DOI 10.1073/pnas.1233577100; Mulichak AM, 2001, STRUCTURE, V9, P547, DOI 10.1016/S0969-2126(01)00616-5; Offen W, 2006, EMBO J, V25, P1396, DOI 10.1038/sj.emboj.7600970; Ouzzine M, 2000, MOL PHARMACOL, V58, P1609, DOI 10.1124/mol.58.6.1609; Ouzzine M, 2006, FEBS LETT, V580, P1953, DOI 10.1016/j.febslet.2006.02.058; Ouzzine M, 1999, J BIOL CHEM, V274, P31401, DOI 10.1074/jbc.274.44.31401; OUZZINE M, 1994, ARCH BIOCHEM BIOPHYS, V310, P196, DOI 10.1006/abbi.1994.1157; Radominska-Pandya A, 1999, DRUG METAB REV, V31, P817, DOI 10.1081/DMR-100101944; SEGEL IH, 1975, ENZYME KINETICS, P18; Shao H, 2005, PLANT CELL, V17, P3141, DOI 10.1105/tpc.105.035055; TEPHLY TR, 1990, TRENDS PHARMACOL SCI, V11, P276, DOI 10.1016/0165-6147(90)90008-V; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; von Heijne G, 1994, Subcell Biochem, V22, P1; Watts KT, 2006, CHEM BIOL, V13, P1317, DOI 10.1016/j.chembiol.2006.10.008	42	25	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36514	36524		10.1074/jbc.M703107200	http://dx.doi.org/10.1074/jbc.M703107200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17956868	hybrid			2022-12-25	WOS:000251458300044
J	Ren, Y; Chen, ZM; Chen, LW; Woods, NT; Reuther, GW; Cheng, JQ; Wang, HG; Wu, J				Ren, Yuan; Chen, Zhengming; Chen, Liwei; Woods, Nicholas T.; Reuther, Gary W.; Cheng, Jin Q.; Wang, Hong-Gang; Wu, Jie			Shp2(E76K) mutant confers cytokine-independent survival of TF-1 myeloid cells by up-regulating Bcl-X-L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUVENILE MYELOMONOCYTIC LEUKEMIA; SIGNALING PATHWAY; CANCER-CELLS; KINASE ACTIVATION; SHP-2 PHOSPHATASE; ORGANIC-COMPOUND; PTPN11 MUTATIONS; DOWN-REGULATION; PROTEIN; APOPTOSIS	Shp2 has been known to mediate growth factor-stimulated cell proliferation, but its role in cell survival is less clear. Gain-of-function Shp2 mutants such as Shp2(E76K) are associated with myeloid leukemias. We found that Shp2(E76K) could transform cytokine-dependent human TF-1 myeloid cells into cytokine independence and further characterized the Shp2(E76K)-induced cell survival mechanism in this study. Expression of Shp2(E76K) suppressed the cytokine withdrawal-induced intrinsic/mitochondrial apoptosis pathway, which is controlled by the Bcl-2 family proteins. Analysis of Bcl-2 family proteins showed that Bcl-XL and Mcl-1 were up-regulated in Shp2(E76K)-transformed TF-1 (TF-1/Shp2(E76K)) cells. Knockdown of Bcl-X-L but not Mcl-1 with short hairpin RNAs prevented Shp2(E76K)-induced cytokine-independent survival. Roscovitine, which down-regulated Mcl-1, also did not prevent cytokine-independent survival of TF-1/Shp2(E76K) cells, whereas the Bcl-X-L inhibitor HA14-1 did. Ras and mitogen-activated protein kinases Erk1 and Erk2 (Erk1/2) were constitutively activated in TF-1/Shp2(E76K) cells, whereas little active Akt was detected under cytokine-free conditions. Shp2(E76K)-induced Bcl-X-L expression was suppressed by Mek inhibitors and by a dominant-negative Mek1 mutant but not by the phosphoinositide 3-phosphate inhibitor LY294002 and the Akt inhibitor API-2. Inhibition of Erk1/2 blocked cytokine-independent survival of TF-1/Shp2(E76K) cells, whereas inhibition of Akt had a minimal effect on cytokine-independent survival of TF-1/Shp2(E76K) cells. These results show that Shp2(E76K) can evoke constitutive Erk1/2 activation in TF-1 cells. Furthermore, Shp2(E76K) induces cytokine-independent survival of TF-1 cells by a novel mechanism involving up-regulation of Bcl-X-L through the Erk1/2 pathway.	Univ S Florida, Mol Oncol Program, Tampa, FL 33612 USA; Univ S Florida, H Lee Moffitt Canc Ctr, Res Inst, Drug Discovery Program, Tampa, FL 33612 USA; Univ S Florida, Dept Interdisciplinary Oncol, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Wu, J (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Res Inst, Mol Oncol Program, 12902 Magnolia Dr, Tampa, FL 33612 USA.	jerry.wu@moffitt.org	Wang, Hong-Gang/A-3018-2015; Reuther, Gary/AFR-2892-2022; Wu, Jie/R-2404-2019	Wang, Hong-Gang/0000-0003-0551-0571; Wu, Jie/0000-0002-2864-1606; Woods, Nicholas/0000-0002-4962-9083	NCI NIH HHS [R01 CA077467, P01 CA118210, R01CA077467, R01 CA077467-09, P01CA118210] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA077467, P01CA118210] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; An J, 2007, ONCOGENE, V26, P652, DOI 10.1038/sj.onc.1209830; Arico M, 1997, BLOOD, V90, P479, DOI 10.1182/blood.V90.2.479.479_479_488; Bai JR, 2005, CANCER RES, V65, P2344, DOI 10.1158/0008-5472.CAN-04-3502; Bennett AM, 1996, MOL CELL BIOL, V16, P1189; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; CATLING AD, 1995, MOL CELL BIOL, V15, P5214; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Chan RJ, 2005, BLOOD, V105, P3737, DOI 10.1182/blood-2004-10-4002; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Cunnick JM, 2000, J BIOL CHEM, V275, P13842, DOI 10.1074/jbc.275.18.13842; Cunnick JM, 2002, J BIOL CHEM, V277, P9498, DOI 10.1074/jbc.M110547200; Cunnick JM, 2001, J BIOL CHEM, V276, P24380, DOI 10.1074/jbc.M010275200; Deb TB, 1998, J BIOL CHEM, V273, P16643, DOI 10.1074/jbc.273.27.16643; Dorsey JF, 2002, BLOOD, V99, P1388, DOI 10.1182/blood.V99.4.1388; Doshi JM, 2006, J MED CHEM, V49, P7731, DOI 10.1021/jm060968r; Emanuel PD, 1996, MOL MED TODAY, V2, P468, DOI 10.1016/1357-4310(96)10044-7; Gelb BD, 2006, HUM MOL GENET, V15, pR220, DOI 10.1093/hmg/ddl197; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Kratz CP, 2005, BLOOD, V106, P2183, DOI 10.1182/blood-2005-02-0531; Lauchle JO, 2006, PEDIATR BLOOD CANCER, V46, P579, DOI 10.1002/pbc.20644; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; Manero F, 2006, CANCER RES, V66, P2757, DOI 10.1158/0008-5472.CAN-05-2097; Mohi MG, 2007, CURR OPIN GENET DEV, V17, P23, DOI 10.1016/j.gde.2006.12.011; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Pei XY, 2004, MOL CANCER THER, V3, P1513; Ren Y, 2004, J BIOL CHEM, V279, P8497, DOI 10.1074/jbc.M312575200; RIVARD N, 1995, J BIOL CHEM, V270, P11017, DOI 10.1074/jbc.270.18.11017; Schubbert S, 2005, BLOOD, V106, P311, DOI 10.1182/blood-2004-11-4207; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; XIAO S, 1994, J BIOL CHEM, V269, P21244; Xie HM, 2005, J IMMUNOL, V175, P7981, DOI 10.4049/jimmunol.175.12.7981; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Yang WT, 2006, DEV CELL, V10, P317, DOI 10.1016/j.devcel.2006.01.002; Yu M, 2006, J BIOL CHEM, V281, P28615, DOI 10.1074/jbc.M603742200; Yu WM, 2006, J BIOL CHEM, V281, P5426, DOI 10.1074/jbc.M507622200	46	12	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36463	36473		10.1074/jbc.M705789200	http://dx.doi.org/10.1074/jbc.M705789200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17942397	hybrid, Green Accepted			2022-12-25	WOS:000251458300038
J	Felberbaum-Corti, M; Morel, E; Cavalli, V; Vilbois, F; Gruenberg, J				Felberbaum-Corti, Michela; Morel, Etienne; Cavalli, Valeria; Vilbois, Francis; Gruenberg, Jean			The Redox Sensor TXNL1 Plays a Regulatory Role in Fluid Phase Endocytosis	PLOS ONE			English	Article								Background. Small GTPases of the Rab family can cycle between a GTP- and a GDP-bound state and also between membrane and cytosol. The latter cycle is mediated by the Guanine Nucleotide Dissociation Inhibitor GDI, which can selectively extract GDP-bound Rab proteins from donor membranes, and then reload them on target membranes. In previous studies, we found that capture of the small GTPase Rab5, a key regulator of endocytic membrane traffic, by GDI is stimulated by oxidative stress via p38MAPK, resulting in increased fluid phase endocytosis. Methodology/Principal Findings. When purifying the GDI stimulating activity we found that that it copurified with a high MW protein complex, which included p38MAPK. Here we report the identification and characterization of another component of this complex as the thioredoxin-like protein TXNL1. Our observations indicate that TXNL1 play a selective role in the regulation of fluid phase endocytosis, by controlling GDI capacity to capture Rab5. Conclusions/Significance. Oxidants, which are known to cause cellular damage, can also trigger signaling pathways, in particular via members of the thioredoxin family. We propose that TXNL1 acts as an effector of oxidants or a redox sensor by converting redox changes into changes of GDI capacity to capture Rab5, which in turn modulates fluid phase endocytosis.	[Felberbaum-Corti, Michela; Morel, Etienne; Cavalli, Valeria; Gruenberg, Jean] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Vilbois, Francis] Serono Pharmaceut Res Inst, Geneva, Switzerland	University of Geneva	Gruenberg, J (corresponding author), Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland.	jean.gruenberg@biochem.unige.ch	MOREL, Etienne L/F-4765-2010; MOREL, Etienne/N-2194-2014	MOREL, Etienne L/0000-0001-7340-1313; MOREL, Etienne/0000-0002-4763-4954	Swiss National Science Foundation; Swiss Telethon Foundation; Fondation pour la Recherche Medicale (FRM); Roche Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Telethon Foundation; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Roche Research Foundation	Support was from the Swiss National Science Foundation and the Swiss Telethon Foundation (to JG) and Fondation pour la Recherche Medicale (FRM) and Roche Research Foundation (to EM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKI S, 1990, J BIOL CHEM, V265, P13007; Barlowe C, 1997, J CELL BIOL, V139, P1097, DOI 10.1083/jcb.139.5.1097; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Casagrande S, 2002, P NATL ACAD SCI USA, V99, P9745, DOI 10.1073/pnas.152168599; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Chinni SR, 1998, EXP CELL RES, V242, P373, DOI 10.1006/excr.1998.4105; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Felberbaum-Corti M, 2005, METHOD ENZYMOL, V403, P367, DOI 10.1016/S0076-6879(05)03032-6; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Gonzalez-Gaitan Marcos, 2003, Cell, V115, P513, DOI 10.1016/S0092-8674(03)00932-2; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Haendeler J, 2002, NAT CELL BIOL, V4, P743, DOI 10.1038/ncb851; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Huang Qizhi, 2004, Cell and Tissue Banking, V5, P3, DOI 10.1023/B:CATB.0000022234.02322.13; Jimenez A, 2006, FEBS LETT, V580, P960, DOI 10.1016/j.febslet.2006.01.025; Jin J, 2002, EUR J BIOCHEM, V269, P2060, DOI 10.1046/j.1432-1033.2002.02844.x; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; Lee KK, 1998, J BIOL CHEM, V273, P19160, DOI 10.1074/jbc.273.30.19160; Mace T, 2005, EMBO J, V24, P3235, DOI 10.1038/sj.emboj.7600799; Miranda-Vizuete A, 1998, BIOCHEM BIOPH RES CO, V243, P284, DOI 10.1006/bbrc.1997.8003; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Powis G, 2001, ANNU REV PHARMACOL, V41, P261, DOI 10.1146/annurev.pharmtox.41.1.261; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.pbio.0020261; Slusarewicz P, 1997, P NATL ACAD SCI USA, V94, P5582, DOI 10.1073/pnas.94.11.5582; STEELEMORTIMER O, 1993, FEBS LETT, V329, P313, DOI 10.1016/0014-5793(93)80244-O; Vergarajauregui S, 2006, TRAFFIC, V7, P686, DOI 10.1111/j.1600-0854.2006.00420.x; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2; Wickner W, 2000, ANNU REV BIOCHEM, V69, P247, DOI 10.1146/annurev.biochem.69.1.247; Winyard PG, 2005, TRENDS BIOCHEM SCI, V30, P453, DOI 10.1016/j.tibs.2005.06.001; Witte S, 2000, J BIOL CHEM, V275, P1902, DOI 10.1074/jbc.275.3.1902; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Xu ZY, 1996, J CELL BIOL, V132, P787, DOI 10.1083/jcb.132.5.787; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	41	24	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1144	10.1371/journal.pone.0001144	http://dx.doi.org/10.1371/journal.pone.0001144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987124	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459000027
J	Buytaert, E; Matroule, JY; Durinck, S; Close, P; Kocanova, S; Vandenheede, JR; Witte, PA; Piette, J; Agostinis, P				Buytaert, E.; Matroule, J. Y.; Durinck, S.; Close, P.; Kocanova, S.; Vandenheede, J. R.; de Witte, P. A.; Piette, J.; Agostinis, P.			Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells	ONCOGENE			English	Article						photodynamic therapy; microarrays; p38(MAPK)	ACTIVATED PROTEIN-KINASE; PHOTODYNAMIC THERAPY; P38 MAPK; SIGNALING PATHWAYS; UP-REGULATION; ER STRESS; EXPRESSION; GENE; TRANSCRIPTION; INHIBITION	Photodynamic therapy (PDT) is an anticancer approach utilizing a light-absorbing molecule and visible light irradiation to generate, in the presence of O-2, cytotoxic reactive oxygen species, which cause tumor ablation. Given that the photosensitizer hypericin is under consideration for PDT treatment of bladder cancer we used oligonucleotide microarrays in the T24 bladder cancer cell line to identify differentially expressed genes with therapeutic potential. This study reveals that the expression of several genes involved in various metabolic processes, stress-induced cell death, autophagy, proliferation, inflammation and carcinogenesis is strongly affected by PDT and pinpoints the coordinated induction of a cluster of genes involved in the unfolded protein response pathway after endoplasmic reticulum stress and in antioxidant response. Analysis of PDT-treated cells after p38(MAPK) inhibition or silencing unraveled that the induction of an important subset of differentially expressed genes regulating growth and invasion, as well as adaptive mechanisms against oxidative stress, is governed by this stress-activated kinase. Moreover, p38(MAPK) inhibition blocked autonomous regrowth and migration of cancer cells escaping PDT-induced cell death. This analysis identifies new molecular effectors of the cancer cell response to PDT opening attractive avenues to improve the therapeutic efficacy of hypericin-based PDT of bladder cancer.	[Buytaert, E.; Kocanova, S.; Vandenheede, J. R.; Agostinis, P.] Catholic Univ Louvain, Fac Med, Dept Mol & Cell Biol, Brabant, Belgium; [Matroule, J. Y.; Close, P.; Piette, J.] Univ Liege, Lab Virol & Immunol, Liege, Belgium; [Durinck, S.] Catholic Univ Louvain, Dept Elect Engn, ESAT SCD, Brabant, Belgium; [de Witte, P. A.] Catholic Univ Louvain, Fac Pharm, Lab Pharmaceut Biol & Phytopharmacol, Brabant, Belgium	Universite Catholique Louvain; University of Liege; Universite Catholique Louvain; Universite Catholique Louvain	Agostinis, P (corresponding author), KULeuven, Dept Mol & Cell Biol, Herestr 49,Campus Gasthuisberg, B-3000 Louvain, Brabant, Belgium.	patrizia.agostinis@med.kuleuven.be	Agostinis, Patrizia/AAO-2468-2020; Agostinis, Patrizia/ABI-1177-2020	Agostinis, Patrizia/0000-0003-1314-2115; de Witte, Peter/0000-0002-9989-9567; CLOSE, PIERRE/0000-0002-8844-9616				Agostinis P, 2004, PHOTOCH PHOTOBIO SCI, V3, P721, DOI 10.1039/b315237e; Assefa Z, 1999, J BIOL CHEM, V274, P8788, DOI 10.1074/jbc.274.13.8788; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birney E, 2006, NUCLEIC ACIDS RES, V34, pD556, DOI 10.1093/nar/gkj133; Bostrom PJ, 2000, INT J CANCER, V88, P417, DOI 10.1002/1097-0215(20001101)88:3<417::AID-IJC14>3.3.CO;2-7; Buytaert E, 2006, FASEB J, V20, P756, DOI 10.1096/fj.05-4305fje; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Caristi S, 2005, J BIOL CHEM, V280, P14433, DOI 10.1074/jbc.M410725200; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; D'Hallewin MA, 2002, BJU INT, V89, P760, DOI 10.1046/j.1464-410X.2002.02690.x; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Elenitoba-Johnson KSJ, 2003, P NATL ACAD SCI USA, V100, P7259, DOI 10.1073/pnas.1137463100; Espel E, 2005, SEMIN CELL DEV BIOL, V16, P59, DOI 10.1016/j.semcdb.2004.11.008; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hashimoto S, 2000, CLIN EXP ALLERGY, V30, P48; Hendrickx N, 2003, J BIOL CHEM, V278, P52231, DOI 10.1074/jbc.M307591200; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hori O, 2006, MOL CELL BIOL, V26, P4257, DOI 10.1128/MCB.02055-05; Huang XK, 2005, CANCER RES, V65, P3470, DOI 10.1158/0008-5472.CAN-04-2807; Imasato A, 2002, J BIOL CHEM, V277, P47444, DOI 10.1074/jbc.M208140200; Itoh K, 1999, FREE RADICAL RES, V31, P319, DOI 10.1080/10715769900300881; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Johansson N, 2000, J CELL SCI, V113, P227; Kamuhabwa A, 2004, PHOTOCH PHOTOBIO SCI, V3, P772, DOI 10.1039/b315586b; Kocanova S, 2007, APOPTOSIS, V12, P731, DOI 10.1007/s10495-006-0016-x; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; LIN Z, 2004, MOL CELL PROTEOMICS, V820; Liu RY, 2000, J BIOL CHEM, V275, P21086, DOI 10.1074/jbc.M001281200; Lou H, 2006, MOL PHARMACOL, V69, P1662, DOI 10.1124/mol.105.019794; Ma YJ, 2004, J BIOL CHEM, V279, P13792, DOI 10.1074/jbc.M313724200; Makowski M, 2003, CLIN CANCER RES, V9, P5417; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Oh-Hashi K, 2001, FREE RADICAL BIO MED, V30, P213, DOI 10.1016/S0891-5849(00)00461-5; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Park JI, 2003, ONCOGENE, V22, P4314, DOI 10.1038/sj.onc.1206478; Reunanen N, 2002, J BIOL CHEM, V277, P32360, DOI 10.1074/jbc.M204296200; Sanchez-Carbayo M, 2002, CANCER RES, V62, P6973; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Sengupta N, 2004, J R SOC PROMO HEALTH, V124, P228, DOI 10.1177/146642400412400520; Suarez-Cuervo C, 2004, CLIN EXP METASTAS, V21, P525, DOI 10.1007/s10585-004-3503-x; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tsai PW, 2003, J BIOL CHEM, V278, P5750, DOI 10.1074/jbc.M204863200; Van de Putte M, 2005, BRIT J CANCER, V92, P1406, DOI 10.1038/sj.bjc.6602512; Verwanger T, 2002, INT J ONCOL, V21, P1353; Volanti C, 2004, ONCOGENE, V23, P8649, DOI 10.1038/sj.onc.1207871; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wild PJ, 2005, MOL CANCER THER, V4, P516, DOI 10.1158/1535-7163.MCT-04-0141; Wong S, 2004, LASER SURG MED, V35, P336, DOI 10.1002/lsm.20110; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257	55	75	76	0	15	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2008	27	13					1916	1929		10.1038/sj.onc.1210825	http://dx.doi.org/10.1038/sj.onc.1210825			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	276NZ	17952126	Green Published			2022-12-25	WOS:000254150600011
J	Gunawardena, SR; Ruis, BL; Meyer, JA; Kapoor, M; Conklin, KF				Gunawardena, Shanaka R.; Ruis, Brian L.; Meyer, Julia A.; Kapoor, Meenal; Conklin, Kathleen F.			NOM1 targets protein phosphatase I to the nucleolus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA TUMOR-SUPPRESSOR; MYOSIN PHOSPHATASE; CATALYTIC SUBUNIT; BINDING; TYPE-1; DEPHOSPHORYLATES; PHOSPHORYLATION; INTERPHASE; PP1-GAMMA; ISOFORM	Protein phosphatase I (PP1) is an essential eukaryotic serine/threonine phosphatase required for many cellular processes, including cell division, signaling, and metabolism. In mammalian cells there are three major isoforms of the PP1 catalytic subunit (PP1 alpha, PP1 beta, and PP1 gamma) that are over 90% identical. Despite this high degree of identity, the PP1 catalytic subunits show distinct localization patterns in interphase cells; PP1 alpha is primarily nuclear and largely excluded from nucleoli, whereas PP1 gamma and to a lesser extent PP1 beta concentrate in the nucleoli. The subcellular localization and the substrate specificity of PP1 catalytic subunits are determined by their interaction with targeting subunits, most of which bind PP1 through a so-called "RVXF" sequence. Although PP1 targeting subunits have been identified that direct PP1 to a number of subcellular locations and/or substrates, no targeting subunit has been identified that localizes PP1 to the nucleolus. Identification of nucleolar PP1 targeting subunit(s) is important because all three PP1 isoforms are included in the nucleolar proteome, enzymatically active PP1 is present in nucleoli, and PP1 gamma is highly concentrated in nucleoli of interphase cells. In this study, we identify NOM1 ( nucleolar protein with MIF4G domain 1) as a PP1-interacting protein and further identify the NOM1 RVXF motif required for its binding to PP1. We also define the NOM1 nucleolar localization sequence. Finally, we demonstrate that NOM1 can target PP1 to the nucleolus and show that a specific NOM1 RVXF motif and the NOM1 nucleolar localization sequence are required for this targeting activity. We therefore conclude that NOM1 is a PP1 nucleolar targeting subunit, the first identified in eukaryotic cells.	[Gunawardena, Shanaka R.; Ruis, Brian L.; Meyer, Julia A.; Kapoor, Meenal; Conklin, Kathleen F.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Conklin, Kathleen F.] Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; [Conklin, Kathleen F.] Univ Minnesota, Ctr Canc, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Conklin, KF (corresponding author), 321 Church St SE,6-160 Jackson, Minneapolis, MN 55455 USA.	conkl001@umn.edu	Meyer, Julia/ABD-4452-2021					ALBERTS AS, 1993, P NATL ACAD SCI USA, V90, P388, DOI 10.1073/pnas.90.2.388; Allen PB, 1998, J BIOL CHEM, V273, P4089, DOI 10.1074/jbc.273.7.4089; Andreassen PR, 1998, J CELL BIOL, V141, P1207, DOI 10.1083/jcb.141.5.1207; Angus SP, 2003, MOL CELL BIOL, V23, P8172, DOI 10.1128/MCB.23.22.8172-8188.2003; Berndt N, 1997, CURR BIOL, V7, P375, DOI 10.1016/S0960-9822(06)00185-0; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Cohen PTW, 2002, J CELL SCI, V115, P241; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Huang HS, 2005, ARCH BIOCHEM BIOPHYS, V443, P33, DOI 10.1016/j.abb.2005.08.021; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Jiao W, 2006, J BIOL CHEM, V281, P38098, DOI 10.1074/jbc.M605271200; KIM DW, 1990, GENE, V91, P217, DOI 10.1016/0378-1119(90)90091-5; Kotani H, 1998, BIOCHEM BIOPH RES CO, V249, P292, DOI 10.1006/bbrc.1998.9126; Lesage B, 2004, J BIOL CHEM, V279, P55978, DOI 10.1074/jbc.M411911200; Meiselbach H, 2006, CHEM BIOL, V13, P49, DOI 10.1016/j.chembiol.2005.10.009; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Negi SS, 2006, J CELL SCI, V119, P3676, DOI 10.1242/jcs.03090; Nelson DA, 1997, J BIOL CHEM, V272, P4528, DOI 10.1074/jbc.272.7.4528; Okada T, 2004, INT J ONCOL, V25, P1383; Parra M, 2007, GENE DEV, V21, P638, DOI 10.1101/gad.1513107; Rubin E, 2001, ONCOGENE, V20, P3776, DOI 10.1038/sj.onc.1204518; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Simmons HM, 2005, GENE, V347, P137, DOI 10.1016/j.gene.2004.12.027; Simmons HM, 2002, LEUKEMIA, V16, P2408, DOI 10.1038/sj.leu.2402773; Takemura M, 2002, EXP CELL RES, V276, P233, DOI 10.1006/excr.2002.5523; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Trinkle-Mulcahy L, 2001, J CELL SCI, V114, P4219; Trinkle-Mulcahy L, 2003, MOL BIOL CELL, V14, P107, DOI 10.1091/mbc.E02-07-0376; Trinkle-Mulcahy Laura, 2007, V365, P133; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Vietri M, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-3; Wakula P, 2003, J BIOL CHEM, V278, P18817, DOI 10.1074/jbc.M300175200; Wu XL, 2001, BIOCHEMISTRY-US, V40, P7410, DOI 10.1021/bi002796k	36	15	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					398	404		10.1074/jbc.M706708200	http://dx.doi.org/10.1074/jbc.M706708200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17965019	hybrid			2022-12-25	WOS:000251940300044
J	Shen, X; Koga, T; Park, BC; SundarRaj, N; Yue, BYJT				Shen, Xiang; Koga, Takahisa; Park, Bum-Chan; SundarRaj, Nirmala; Yue, Beatrice Y. J. T.			Rho GTPase and cAMP/protein kinase A signaling mediates myocilin-induced alterations in cultured human trabecular meshwork cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; LYSOPHOSPHATIDIC ACID; PROTEIN-KINASE; GLAUCOMA GENE; OUTFLOW FACILITY; BINDING PROTEIN; ACTIN; ADHESION; PHOSPHORYLATION; EXPRESSION	Myocilin is a gene linked to the most common form of glaucoma, a major blinding disease. The trabecular meshwork (TM), a specialized eye tissue, is believed to be involved, at least in part, in the development of glaucoma. The myocilin expression is known to be up-regulated by glucocorticoids in TM cells, and an altered myocilin level may be the culprit in conditions such as corticosteroid glaucoma. Wild type myocilin, when transfected into cultured human TM cells, induced a dramatic loss of actin stress fibers and focal adhesions. Myocilin transfectants displayed a heightened sensitivity to trypsin. Adhesion to fibronectin, collagens, and vitronectin was compromised. The fibronectin deposition and the levels of fibronectin protein and mRNA were also reduced in myocilin transfectants. The fibronectin deposition could be restored by treatment with lysophosphatidic acid, a Rho stimulator. Assays further revealed that upon myocilin overexpression, the activity of RhoA was diminished, whereas the cAMP level and the protein kinase A (PKA) activity were augmented. Myocilin protein did not affect actin polymerization. The collapse of actin stress fibers and increased trypsin sensitivity from myocilin transfection could be reverted by co-expression of constitutively active RhoA or by treatment with PKA inhibitor H-89. The PKA activity, however, was not modified by co-expression of either constitutively active or dominant negative RhoA. These results demonstrate that myocilin has a deadhesive activity and triggers signaling events. cAMP/PKA activation and the downstream Rho inhibition are possible mechanisms by which myocilin in overabundance may lead to TM cell or tissue damage.	[Shen, Xiang; Koga, Takahisa; Park, Bum-Chan; Yue, Beatrice Y. J. T.] Univ Illinois, Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA; [SundarRaj, Nirmala] Univ Pittsburgh, Dept Ophthalmol, Pittsburgh, PA 15213 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yue, BYJT (corresponding author), Univ Illinois, Coll Med, Dept Ophthalmol & Visual Sci, 1855 W Taylor St, Chicago, IL 60612 USA.	beatyue@uic.edu			NEI NIH HHS [P30 EY001792, R01 EY005628, EY 01792, P30 EY001792-309005, EY 05628, R01 EY003263, R01 EY003890, EY 03890, EY 03263, R01 EY005628-22] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY003890, R01EY005628, P30EY001792, R01EY003263] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALEXANDER JP, 1991, INVEST OPHTH VIS SCI, V32, P172; ANDO H, 1993, INVEST OPHTH VIS SCI, V34, P3541; BILL A, 1975, INVEST OPHTH VISUAL, V14, P1; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Caballero M, 2000, BBA-MOL BASIS DIS, V1502, P447, DOI 10.1016/S0925-4439(00)00068-5; CALTHORPE CM, 1990, EXP EYE RES, V51, P39, DOI 10.1016/0014-4835(90)90168-T; CHANG IL, 1991, CURR EYE RES, V10, P1101, DOI 10.3109/02713689109024127; Clark A F, 1995, J Glaucoma, V4, P354; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; Dormond O, 2002, J BIOL CHEM, V277, P45838, DOI 10.1074/jbc.M209213200; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; Gong G, 2004, HUM MOL GENET, V13, pR91, DOI 10.1093/hmg/ddh074; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; Hardy KM, 2005, J BIOL CHEM, V280, P28917, DOI 10.1074/jbc.M504803200; Honjo M, 2001, INVEST OPHTH VIS SCI, V42, P137; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Jacobson N, 2001, HUM MOL GENET, V10, P117, DOI 10.1093/hmg/10.2.117; Kato M, 1999, J HEPATOL, V31, P91, DOI 10.1016/S0168-8278(99)80168-8; Kreisberg JI, 1997, AM J PHYSIOL-RENAL, V273, pF283, DOI 10.1152/ajprenal.1997.273.2.F283; LAMPUGNANI MG, 1990, LAB INVEST, V63, P521; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lee CW, 2003, BIOCHEM BIOPH RES CO, V305, P455, DOI 10.1016/S0006-291X(03)00790-3; Lin YL, 2007, J CELL BIOL, V177, P829, DOI 10.1083/jcb.200608121; Liu XY, 2005, MOL VIS, V11, P1112; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; Midwood KS, 2002, MOL BIOL CELL, V13, P3601, DOI 10.1091/mbc.E02-05-0292; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; Park BC, 2007, GENES CELLS, V12, P969, DOI 10.1111/j.1365-2443.2007.01102.x; Park BC, 2006, AM J PATHOL, V169, P1976, DOI 10.2353/ajpath.2006.060400; Park BC, 2006, MOL VIS, V12, P832; Pereira M, 2002, J CELL SCI, V115, P609; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RHO PV, 2001, INVEST OPHTH VIS SCI, V42, P1029; Sakai H, 2006, INVEST OPHTH VIS SCI, V47, P4427, DOI 10.1167/iovs.06-0047; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; SMIRNOV VN, 1989, J MOL CELL CARDIOL, V21, P3, DOI 10.1016/0022-2828(89)90832-8; Srinivas SP, 2006, INVEST OPHTH VIS SCI, V47, P4011, DOI 10.1167/iovs.05-1127; Stamer WD, 1998, INVEST OPHTH VIS SCI, V39, P1804; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Stumpff F, 2000, OPHTHALMOLOGICA, V214, P33, DOI 10.1159/000027471; Tamm ER, 2002, PROG RETIN EYE RES, V21, P395, DOI 10.1016/S1350-9462(02)00010-1; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; TAYLOR SS, 1989, J BIOL CHEM, V264, P8443; TIAN B, 2006, CURR OPIN OPHTHALMOL, V17, P168; Tian BH, 2000, INVEST OPHTH VIS SCI, V41, P619; Ueda J, 2000, J HISTOCHEM CYTOCHEM, V48, P1321, DOI 10.1177/002215540004801003; van Leeuwen FN, 2003, BIOCHEM SOC T, V31, P1209; Vittitow JL, 2002, MOL VIS, V8, P32; Vouret-Craviari V, 2002, J CELL SCI, V115, P2475; Weiner JA, 2001, J NEUROSCI, V21, P7069, DOI 10.1523/JNEUROSCI.21-18-07069.2001; Wentz-Hunter K, 2004, EXP CELL RES, V297, P39, DOI 10.1016/j.yexcr.2004.02.024; Wentz-Hunter K, 2003, MOL VIS, V9, P308; YUE BYJT, 1990, EXP CELL RES, V187, P65, DOI 10.1016/0014-4827(90)90117-S; Yue BYJT, 1996, SURV OPHTHALMOL, V40, P379; Zhou LL, 1996, INVEST OPHTH VIS SCI, V37, P104; ZHOU LL, 1995, INVEST OPHTH VIS SCI, V36, P787; Zhou LL, 2000, EXP EYE RES, V70, P457, DOI 10.1006/exer.1999.0806	60	47	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					603	612		10.1074/jbc.M708250200	http://dx.doi.org/10.1074/jbc.M708250200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17984096	Green Accepted, hybrid			2022-12-25	WOS:000251940300065
J	Demirel, O; Waibler, Z; Kalinke, U; Grunebach, F; Appel, S; Brossart, P; Hasilik, A; Tampe, R; Abele, R				Demirel, Oezlem; Waibler, Zoe; Kalinke, Ulrich; Gruenebach, Frank; Appel, Silke; Brossart, Peter; Hasilik, Andrej; Tampe, Robert; Abele, Rupert			Identification of a lysosomal peptide transport system induced during dendritic cell development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN-PROCESSING TAP; NECROSIS-FACTOR-ALPHA; RESTRICTED T-CELLS; CLASS-I MOLECULES; CROSS-PRESENTATION; ENDOPLASMIC-RETICULUM; TUMOR-ANTIGEN; INFLAMMATORY CYTOKINES; CYTOPLASMIC ANTIGENS; STIMULATORY CAPACITY	The delivery of protein fragments to major histocompatibility complex (MHC)-loading compartments of professional antigen-presenting cells is essential in the adaptive immune response against pathogens. Apart from the crucial role of the transporter associated with antigen processing (TAP) for peptide loading of MHC class I molecules in the endoplasmic reticulum, TAP-independent translocation pathways have been proposed but not identified so far. Based on its overlapping substrate specificity with TAP, we herein investigated the ABC transporter ABCB9, also named TAP-like (TAPL). Remarkably, TAPL expression is strongly induced during differentiation of monocytes to dendritic cells and to macrophages. TAPL does not, however, restore MHC class I surface expression in TAP-deficient cells, demonstrating that TAPL alone or in combination with single TAP subunits does not form a functional transport complex required for peptide loading of MHC I in the endoplasmic reticulum. In fact, by using quantitative immunofluorescence and subcellular fractionation, TAPL was detected in the lysosomal compartment co-localizing with the lysosome-associated membrane protein LAMP-2. By in vitro assays, we demonstrate a TAPL-specific translocation of peptides into isolated lysosomes, which strictly requires ATP hydrolysis. These results suggest a mechanism by which antigenic peptides have access to the lysosomal compartment in professional antigen-presenting cells.	[Gruenebach, Frank; Appel, Silke; Brossart, Peter] Univ Tubingen, Dept Hematol Oncol & Immunol, D-72076 Tubingen, Germany; [Demirel, Oezlem; Tampe, Robert; Abele, Rupert] Univ Frankfurt, Bioctr, Inst Biochem, D-60438 Frankfurt, Germany; [Waibler, Zoe; Kalinke, Ulrich] Paul Ehrlich Inst, Div Immunol, D-63225 Langen, Germany; [Hasilik, Andrej] Univ Marburg, Inst Physiol Chem, D-35032 Marburg, Germany	Eberhard Karls University of Tubingen; Goethe University Frankfurt; Paul Ehrlich Institute; Philipps University Marburg	Appel, S (corresponding author), Univ Tubingen, Dept Hematol Oncol & Immunol, Otfried-Muller-Str 10, D-72076 Tubingen, Germany.	tampe@em.uni-frankfurt.de; abele@em.uni-frankfurt.de	Tampé, Robert/H-2953-2015	Tampé, Robert/0000-0002-0403-2160; Appel, Silke/0000-0002-2199-2315; Kalinke, Ulrich/0000-0003-0503-9564				Abele R, 2004, PHYSIOLOGY, V19, P216, DOI 10.1152/physiol.00002.2004; Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; ANDERSON K, 1991, J EXP MED, V174, P489, DOI 10.1084/jem.174.2.489; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; BACHMANN MF, 1995, EUR J IMMUNOL, V25, P1739, DOI 10.1002/eji.1830250637; BACIK I, 1994, J IMMUNOL, V152, P381; BAHRAM S, 1991, P NATL ACAD SCI USA, V88, P10094, DOI 10.1073/pnas.88.22.10094; Brossart P, 2001, CANCER RES, V61, P6846; Brossart P, 2000, CANCER RES, V60, P4485; Buelens C, 1997, EUR J IMMUNOL, V27, P756, DOI 10.1002/eji.1830270326; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; COSTES S, 2002, P MICROSC MICROANAL, V8, P1040; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Dani A, 2004, J CELL SCI, V117, P4219, DOI 10.1242/jcs.01288; Day PM, 1997, P NATL ACAD SCI USA, V94, P8064, DOI 10.1073/pnas.94.15.8064; de la Salle H, 1999, J CLIN INVEST, V103, pR9, DOI 10.1172/JCI5687; DELASALLE H, 1994, SCIENCE, V265, P237, DOI 10.1126/science.7517574; Dissanayake SK, 2005, J IMMUNOL, V174, P1811, DOI 10.4049/jimmunol.174.4.1811; Efron PA, 2005, J ENDOTOXIN RES, V11, P145, DOI 10.1179/096805105X46583; Gorbulev S, 2001, P NATL ACAD SCI USA, V98, P3732, DOI 10.1073/pnas.061467898; Granucci F, 2001, EUR J IMMUNOL, V31, P2539, DOI 10.1002/1521-4141(200109)31:9<2539::AID-IMMU2539>3.0.CO;2-9; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Heintke S, 2003, FEBS LETT, V533, P42, DOI 10.1016/S0014-5793(02)03746-8; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; JACOBSON S, 1989, J VIROL, V63, P1756, DOI 10.1128/JVI.63.4.1756-1762.1989; JARAQUEMADA D, 1990, J EXP MED, V172, P947, DOI 10.1084/jem.172.3.947; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; KLEIJMEER MJ, 1992, NATURE, V357, P342, DOI 10.1038/357342a0; Kobayashi A, 2004, BIOL PHARM BULL, V27, P1916, DOI 10.1248/bpb.27.1916; Kobayashi A, 2003, BIOCHEM BIOPH RES CO, V309, P815, DOI 10.1016/j.bbrc.2003.08.081; Kobayashi A, 2000, J BIOCHEM, V128, P711, DOI 10.1093/oxfordjournals.jbchem.a022805; Koch J, 2004, J BIOL CHEM, V279, P10142, DOI 10.1074/jbc.M312816200; Koopmann JO, 1996, EUR J IMMUNOL, V26, P1720, DOI 10.1002/eji.1830260809; Lacaille VG, 1998, J BIOL CHEM, V273, P17386, DOI 10.1074/jbc.273.28.17386; Lackman RL, 2006, J IMMUNOL, V177, P4833, DOI 10.4049/jimmunol.177.7.4833; Lapointe R, 2000, EUR J IMMUNOL, V30, P3291, DOI 10.1002/1521-4141(200011)30:11<3291::AID-IMMU3291>3.0.CO;2-2; Leveson-Gower DB, 2004, BIOCHEMISTRY-US, V43, P14257, DOI 10.1021/bi0491245; Lich JD, 2000, J EXP MED, V191, P1513, DOI 10.1084/jem.191.9.1513; Lizee G, 2003, NAT IMMUNOL, V4, P1065, DOI 10.1038/ni989; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; MALNATI MS, 1992, NATURE, V357, P702, DOI 10.1038/357702a0; Mellman I, 2005, ADV EXP MED BIOL, V560, P63; Mizumoto N, 2005, J INVEST DERMATOL, V124, P718, DOI 10.1111/j.0022-202X.2005.23616.x; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Norbury CC, 2001, J IMMUNOL, V166, P4355, DOI 10.4049/jimmunol.166.7.4355; Pieters J, 1997, CURR OPIN IMMUNOL, V9, P89, DOI 10.1016/S0952-7915(97)80164-1; RADONS J, 1992, EUR J CELL BIOL, V57, P184; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; Sharma S, 2000, J BACTERIOL, V182, P6570, DOI 10.1128/JB.182.23.6570-6576.2000; Shen LJ, 2006, CURR OPIN IMMUNOL, V18, P85, DOI 10.1016/j.coi.2005.11.003; Uinuk-ool TS, 2003, IMMUNOGENETICS, V55, P38, DOI 10.1007/s00251-003-0548-y; Wang RF, 1999, SCIENCE, V284, P1351, DOI 10.1126/science.284.5418.1351; Wilson NS, 2004, BLOOD, V103, P2187, DOI 10.1182/blood-2003-08-2729; Wirths S, 2002, CANCER RES, V62, P5065; Wolters JC, 2005, J BIOL CHEM, V280, P23631, DOI 10.1074/jbc.M503231200; Yamaguchi Y, 1999, FEBS LETT, V457, P231, DOI 10.1016/S0014-5793(99)01042-X; Zhang F, 2000, J BIOL CHEM, V275, P23287, DOI 10.1074/jbc.M001819200; Zhou DL, 2005, IMMUNITY, V22, P571, DOI 10.1016/j.immuni.2005.03.009	60	35	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37836	37843		10.1074/jbc.M708139200	http://dx.doi.org/10.1074/jbc.M708139200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17977821	hybrid			2022-12-25	WOS:000251833600059
J	Hanada, T; Noda, NN; Satomi, Y; Ichimura, Y; Fujioka, Y; Takao, T; Inagaki, F; Ohsumi, Y				Hanada, Takao; Noda, Nobuo N.; Satomi, Yoshinori; Ichimura, Yoshinobu; Fujioka, Yuko; Takao, Toshifumi; Inagaki, Fuyuhiko; Ohsumi, Yoshinori			The Atg12-Atg5 conjugate has a novel E3-like activity for protein lipidation in autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; YEAST; MEMBRANE; ATG8; SYSTEM; ENZYME; DISSECTION; MECHANISMS; PATHWAY; COMPLEX	Autophagy is a bulk degradation process in eukaryotic cells; autophagosomes enclose cytoplasmic components for degradation in the lysosome/vacuole. Autophagosome formation requires two ubiquitin-like conjugation systems, the Atg12 and Atg8 systems, which are tightly associated with expansion of autophagosomal membrane. Previous studies have suggested that there is a hierarchy between these systems; the Atg12 system is located upstream of the Atg8 system in the context of Atg protein organization. However, the concrete molecular relationship is unclear. Here, we show using an in vitro Atg8 conjugation system that the Atg12-Atg5 conjugate, but not unconjugated Atg12 or Atg5, strongly enhances the formation of the other conjugate, Atg8-PE. The Atg12-Atg5 conjugate promotes the transfer of Atg8 from Atg3 to the substrate, phosphatidylethanolamine ( PE), by stimulating the activity of Atg3. We also show that the Atg12-Atg5 conjugate interacts with both Atg3 and PE-containing liposomes. These results indicate that the Atg12-Atg5 conjugate is a ubiquitin-protein ligase (E3)-like enzyme for Atg8-PE conjugation reaction, distinctively promoting protein-lipid conjugation.	[Hanada, Takao; Ichimura, Yoshinobu; Ohsumi, Yoshinori] Natl Inst Basic Biol, Div Mol & Cell Biol, Okazaki, Aichi 444, Japan; [Noda, Nobuo N.; Fujioka, Yuko; Inagaki, Fuyuhiko] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biol Struct, Kita Ku, Sapporo, Hokkaido 001, Japan; [Satomi, Yoshinori; Takao, Toshifumi] Osaka Univ, Inst Protein Res, Suita, Osaka 5650871, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Hokkaido University; Osaka University	Ohsumi, Y (corresponding author), Natl Inst Basic Biol, Div Mol & Cell Biol, Okazaki, Aichi 444, Japan.	yohsumi@nibb.ac.jp	Ohsumi, Yoshinori/C-6449-2009; Noda, Nobuo/P-1397-2015	Ohsumi, Yoshinori/0000-0003-2384-2166; Hanada, Takao/0000-0003-2732-4008; Noda, Nobuo/0000-0002-6940-8069; Fujioka, Yuko/0000-0002-6905-0669; Satomi, Yoshinori/0000-0002-8991-1040				Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Hanada T, 2005, AUTOPHAGY, V1, P110, DOI 10.4161/auto.1.2.1858; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Noda T, 2002, TRENDS CELL BIOL, V12, P231, DOI 10.1016/S0962-8924(02)02278-X; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Shintani T, 1999, EMBO J, V18, P5234, DOI 10.1093/emboj/18.19.5234; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Suzuki NN, 2005, AUTOPHAGY, V1, P119, DOI 10.4161/auto.1.2.1859; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Yamada Y, 2007, J BIOL CHEM, V282, P8036, DOI 10.1074/jbc.M611473200; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	28	773	800	5	88	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37298	37302		10.1074/jbc.C700195200	http://dx.doi.org/10.1074/jbc.C700195200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17986448	hybrid			2022-12-25	WOS:000251833600003
J	Lin, FT; Lai, YJ; Makarova, N; Tigyi, G; Lin, WC				Lin, Fang-Tsyr; Lai, Yun-Ju; Makarova, Natalia; Tigyi, Gabor; Lin, Weei-Chin			The lysophosphatidic acid 2 receptor mediates down-regulation of Siva-1 to promote cell survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; NF-KAPPA-B; INDUCED APOPTOSIS; SIGNALING PATHWAYS; BETA-ARRESTIN; KINASE 2; UBIQUITINATION; DEATH; GENE; DEGRADATION	Lysophosphatidic acid (LPA) promotes cell survival through the activation of G protein-coupled LPA receptors. However, whether different LPA receptors activate distinct anti-apoptotic signaling pathways is not yet clear. Here we report a novel mechanism by which the LPA(2) receptor targets the proapoptotic Siva-1 protein for LPA-dependent degradation, thereby attenuating Siva-1 function in DNA damage response. The carboxylterminal tail of the LPA2 receptor, but not LPA(1) or LPA(3) receptor, specifically associates with the carboxyl cysteine-rich domain of Siva-1. Prolonged LPA stimulation promotes the association of Siva-1 with the LPA(2) receptor and targets both proteins for ubiquitination and degradation. As a result, adriamycin-induced Siva-1 protein stabilization is attenuated by LPA in an LPA(2)-dependent manner, and the function of Siva-1 in promoting DNA damage-induced apoptosis is inhibited by LPA pretreatment. Consistent with this result, inhibition of the LPA2 receptor expression increases Siva-1 protein levels and augments adriamycin-induced caspase-3 cleavage and apoptosis. Together, these findings reveal a critical and specific role for the LPA(2) receptor through which LPA directly inactivates a critical component of the death machinery to promote cell survival.	[Lin, Fang-Tsyr; Lai, Yun-Ju; Lin, Weei-Chin] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; [Lin, Weei-Chin] Univ Alabama, Dept Med, Div Hematol & Oncol, Birmingham, AL 35294 USA; [Makarova, Natalia; Tigyi, Gabor] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Tennessee System; University of Tennessee Health Science Center	Lin, FT (corresponding author), Univ Alabama, Dept Cell Biol, MCLM 360A,1918 Univ Blvd, Birmingham, AL 35294 USA.	flin@uab.edu			NATIONAL CANCER INSTITUTE [R01CA092160, R01CA100848, R01CA100857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080405] Funding Source: NIH RePORTER; NCI NIH HHS [CA100848, R01 CA092160-09, R01 CA100848, R01 CA092160, R01 CA100857] Funding Source: Medline; NIAID NIH HHS [R01 AI080405, R01 AI080405-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		An SZ, 1997, FEBS LETT, V417, P279, DOI 10.1016/S0014-5793(97)01301-X; Baker DL, 2001, ANAL BIOCHEM, V292, P287, DOI 10.1006/abio.2001.5063; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Cao C, 2001, J BIOL CHEM, V276, P11465, DOI 10.1074/jbc.C100050200; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Cook LB, 2003, MOL ENDOCRINOL, V17, P1777, DOI 10.1210/me.2003-0073; Daoud SS, 2003, CANCER RES, V63, P2782; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Deng W, 2007, GASTROENTEROLOGY, V132, P1834, DOI 10.1053/j.gastro.2007.03.038; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Dupre DJ, 2003, J BIOL CHEM, V278, P48228, DOI 10.1074/jbc.M304082200; Fang XJ, 2000, BIOCHEM J, V352, P135, DOI 10.1042/0264-6021:3520135; Fortin A, 2004, J BIOL CHEM, V279, P28706, DOI 10.1074/jbc.M400376200; Fukushima N, 1998, P NATL ACAD SCI USA, V95, P6151, DOI 10.1073/pnas.95.11.6151; Gudi R, 2006, ONCOGENE, V25, P3458, DOI 10.1038/sj.onc.1209381; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Hu XJ, 2005, J BIOL CHEM, V280, P9498, DOI 10.1074/jbc.M410455200; Jacobs SBR, 2007, CELL DEATH DIFFER, V14, P1374, DOI 10.1038/sj.cdd.4402128; Kang YC, 2004, CELL DEATH DIFFER, V11, P1287, DOI 10.1038/sj.cdd.4401489; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; Liu K, 2006, EMBO J, V25, P4795, DOI 10.1038/sj.emboj.7601355; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; MARTIN SJ, 1990, J IMMUNOL, V145, P1859; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Nocentini G, 1997, P NATL ACAD SCI USA, V94, P6216, DOI 10.1073/pnas.94.12.6216; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Penela P, 1998, J BIOL CHEM, V273, P35238, DOI 10.1074/jbc.273.52.35238; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Prasad KVS, 1997, P NATL ACAD SCI USA, V94, P6346, DOI 10.1073/pnas.94.12.6346; Py B, 2004, J IMMUNOL, V172, P4008, DOI 10.4049/jimmunol.172.7.4008; Qin LF, 2002, LIFE SCI, V70, P1677, DOI 10.1016/S0024-3205(01)01554-5; Radeff-Huang J, 2004, J CELL BIOCHEM, V92, P949, DOI 10.1002/jcb.20094; Raj GV, 2004, PROSTATE, V61, P105, DOI 10.1002/pros.20083; Salcedo A, 2006, EMBO J, V25, P4752, DOI 10.1038/sj.emboj.7601351; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Spinicelli S, 2002, CELL DEATH DIFFER, V9, P1382, DOI 10.1038/sj.cdd.4401140; Virag T, 2003, MOL PHARMACOL, V63, P1032, DOI 10.1124/mol.63.5.1032; Wang B, 2004, J BIOL CHEM, V279, P54140, DOI 10.1074/jbc.M410493200; Wojcikiewicz RJH, 2004, TRENDS PHARMACOL SCI, V25, P35, DOI 10.1016/j.tips.2003.11.008; Xiao H, 2000, EMBO J, V19, P956, DOI 10.1093/emboj/19.5.956; Xu J, 2004, J BIOL CHEM, V279, P10459, DOI 10.1074/jbc.M311891200; Xu Y, 1998, JAMA-J AM MED ASSOC, V280, P719, DOI 10.1001/jama.280.8.719; Xue L, 2002, P NATL ACAD SCI USA, V99, P6925, DOI 10.1073/pnas.102182299; Ye XQ, 2002, BBA-MOL CELL BIOL L, V1585, P108, DOI 10.1016/S1388-1981(02)00330-X; Yoon Y, 1999, ONCOGENE, V18, P7174, DOI 10.1038/sj.onc.1203144	49	55	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37759	37769		10.1074/jbc.M705025200	http://dx.doi.org/10.1074/jbc.M705025200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17965021	Green Accepted, hybrid			2022-12-25	WOS:000251833600052
J	Fuenzalida, K; Quintanilla, R; Ramos, P; Piderit, D; Fuentealba, RA; Martinez, G; Inestrosa, NC; Bronfman, M				Fuenzalida, Karen; Quintanilla, Rodrigo; Ramos, Patricio; Piderit, Daniela; Fuentealba, Rodrigo A.; Martinez, Gabriela; Inestrosa, Nibaldo C.; Bronfman, Miguel			Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; PPAR-GAMMA; CELL-DEATH; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; SIGNALING PATHWAY; SURVIVAL; AGONISTS; TROGLITAZONE; LIGAND	Peroxisome proliferator-activated receptor gamma(PPAR gamma) has been proposed as a therapeutic target for neurodegenerative diseases because of its anti-inflammatory action in glial cells. However, PPAR gamma agonists prevent beta-amyloid (A beta)-induced neurodegeneration in hippocampal neurons, and PPAR gamma is activated by the nerve growth factor (NGF) survival pathway, suggesting a neuroprotective anti-inflammatory independent action. Here we show that the PPAR gamma agonist rosiglitazone (RGZ) protects hippocampal and dorsal root ganglion neurons against A beta-induced mitochondrial damage and NGF deprivation-induced apoptosis, respectively, and promotes PC12 cell survival. In neurons and in PC12 cells RGZ protective effects are associated with increased expression of the Bcl-2 anti-apoptotic protein. NGF-differentiated PC12 neuronal cells constitutively overexpressing PPAR gamma are resistant to A beta-induced apoptosis and morphological changes and show functionally intact mitochondria and no increase in reactive oxygen species when challenged with up to 50 mu M H2O2. Conversely, cells expressing a dominant negative mutant of PPAR gamma show increased A beta-induced apoptosis and disruption of neuronal-like morphology and are highly sensitive to oxidative stress-induced impairment of mitochondrial function. Cells overexpressing PPAR gamma present a 4-to 5-fold increase in Bcl-2 protein content, whereas in dominant negative PPAR gamma-expressing cells, Bcl-2 is barely detected. Bcl-2 knockdown by small interfering RNA in cells overexpressing PPAR gamma results in increased sensitivity to A beta and oxidative stress, further suggesting that Bcl-2 up-regulation mediates PPAR gamma protective effects. PPAR gamma prosurvival action is independent of the signal-regulated MAPK or the Akt prosurvival pathways. Altogether, these data suggest that PPAR gamma supports survival in neurons in part through a mechanism involving increased expression of Bcl-2.	[Fuenzalida, Karen; Quintanilla, Rodrigo; Ramos, Patricio; Piderit, Daniela; Fuentealba, Rodrigo A.; Martinez, Gabriela; Inestrosa, Nibaldo C.; Bronfman, Miguel] Pontificia Univ Catolica Chile, Dept Cellular & Mol Biol, Joaquin V Luco & Millennium Inst Fundamental & Ap, Fac Ciencias Biol,Ctr Regulac Celular & Patol, Santiago 340, Chile	Pontificia Universidad Catolica de Chile	Bronfman, M (corresponding author), Pontificia Univ Catolica Chile, Dept Cellular & Mol Biol, Joaquin V Luco & Millennium Inst Fundamental & Ap, Fac Ciencias Biol,Ctr Regulac Celular & Patol, 114-D, Santiago 340, Chile.	mbronfman@bio.puc.cl	QUINTANILLA, RODRIGO/ABG-8829-2021; martinez, gabriela/GWV-0033-2022; Martinez, Gabriela/E-2964-2017; Ramos, Patricio/ABE-5961-2021; Ramos, Patricio/B-6665-2017; Martínez, Gabriela/GWR-1584-2022	Ramos, Patricio/0000-0001-8341-314X; Fuentealba, Rodrigo/0000-0001-8724-091X; Fuenzalida, Karen/0000-0001-8829-7336				Abramov AY, 2003, J NEUROSCI, V23, P5088; Akaike M, 2004, MOL CELL BIOL, V24, P8691, DOI 10.1128/MCB.24.19.8691-8704.2004; Aoun P, 2003, EUR J PHARMACOL, V472, P65, DOI 10.1016/S0014-2999(03)01867-3; Baek SJ, 2003, J BIOL CHEM, V278, P5845, DOI 10.1074/jbc.M208394200; Bernardo A, 2006, CURR PHARM DESIGN, V12, P93, DOI 10.2174/138161206780574579; Bishop-Bailey D, 1999, J BIOL CHEM, V274, P17042, DOI 10.1074/jbc.274.24.17042; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Butts BD, 2004, INT J ONCOL, V24, P1305; Chen F, 2003, J CELL BIOCHEM, V90, P732, DOI 10.1002/jcb.10668; Chintharlapalli S, 2005, MOL PHARMACOL, V68, P1782, DOI 10.1124/mol.105.017046; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Davies GF, 2001, BIOCHEM PHARMACOL, V62, P1071, DOI 10.1016/S0006-2952(01)00764-X; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; EICHLER ME, 1989, BRAIN RES, V482, P340, DOI 10.1016/0006-8993(89)91197-9; Feinstein Douglas L, 2003, Diabetes Technol Ther, V5, P67, DOI 10.1089/152091503763816481; Feng LF, 2006, J DRUG TARGET, V14, P21, DOI 10.1080/10611860500527947; Fuenzalida KM, 2005, J BIOL CHEM, V280, P9604, DOI 10.1074/jbc.M409447200; Futami Takashi, 2002, Nucleic Acids Res Suppl, P251; Gardner OS, 2003, J BIOL CHEM, V278, P46261, DOI 10.1074/jbc.M307827200; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Harris SG, 2001, EUR J IMMUNOL, V31, P1098, DOI 10.1002/1521-4141(200104)31:4<1098::AID-IMMU1098>3.0.CO;2-I; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; Holle L, 2004, INT J ONCOL, V24, P615; Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032; Jang JH, 2004, BIOCHEM BIOPH RES CO, V320, P880, DOI 10.1016/j.bbrc.2004.06.035; Jung TW, 2006, BIOCHEM BIOPH RES CO, V340, P221, DOI 10.1016/j.bbrc.2005.11.177; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kiaei M, 2005, EXP NEUROL, V191, P331, DOI 10.1016/j.expneurol.2004.10.007; Landreth GE, 2001, NEUROBIOL AGING, V22, P937, DOI 10.1016/S0197-4580(01)00296-2; Lawlor MA, 2001, J CELL SCI, V114, P2903; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; Leisewitz AV, 2003, J NEUROCHEM, V85, P135, DOI 10.1046/j.1471-4159.2003.01641.x; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Liu YZ, 1999, NUCLEIC ACIDS RES, V27, P2086, DOI 10.1093/nar/27.10.2086; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Michaelidis TM, 1996, NEURON, V17, P75, DOI 10.1016/S0896-6273(00)80282-2; Miranda S, 1999, BIOCHEM BIOPH RES CO, V258, P44, DOI 10.1006/bbrc.1999.0580; Moore KJ, 2001, NAT MED, V7, P41, DOI 10.1038/83328; Nemenoff RA, 2005, EUR J CANCER, V41, P2561, DOI 10.1016/j.ejca.2005.08.015; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Padilla J, 2000, J IMMUNOL, V165, P6941, DOI 10.4049/jimmunol.165.12.6941; Ptasinska A, 2007, FASEB J, V21, P950, DOI 10.1096/fj.06-6822com; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Roth AD, 2003, J NEUROSCI RES, V72, P425, DOI 10.1002/jnr.10596; Russell JW, 1998, J NEUROBIOL, V36, P455, DOI 10.1002/(SICI)1097-4695(19980915)36:4<455::AID-NEU1>3.0.CO;2-V; Saille C, 1999, NEUROSCIENCE, V92, P1455, DOI 10.1016/S0306-4522(99)00089-5; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Soane L, 2005, J BIOENERG BIOMEMBR, V37, P179, DOI 10.1007/s10863-005-6590-8; Strum JC, 2007, J ALZHEIMERS DIS, V11, P45; Teng KK, 2004, CELL MOL LIFE SCI, V61, P35, DOI 10.1007/s00018-003-3099-3; Uryu S, 2002, BRAIN RES, V924, P229, DOI 10.1016/S0006-8993(01)03242-5; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Vogelbaum MA, 1998, J NEUROSCI, V18, P8928; Wacheck V, 2003, OLIGONUCLEOTIDES, V13, P393, DOI 10.1089/154545703322617078; Walsh GS, 2004, J NEUROSCI, V24, P9638, DOI 10.1523/JNEUROSCI.1299-04.2004; Wang MH, 1999, DIABETES, V48, P254, DOI 10.2337/diabetes.48.2.254; Wang YL, 2002, J BIOL CHEM, V277, P31781, DOI 10.1074/jbc.M204279200; Ward MW, 2000, J NEUROSCI, V20, P7208; Watson GS, 2006, J NEUROL SCI, V245, P21, DOI 10.1016/j.jns.2005.08.017; Watson GS, 2003, CNS DRUGS, V17, P27, DOI 10.2165/00023210-200317010-00003; Winn RA, 2006, J BIOL CHEM, V281, P26943, DOI 10.1074/jbc.M604145200; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhao XR, 2006, BRAIN RES, V1073, P460, DOI 10.1016/j.brainres.2005.12.061; Zhao Y, 2005, J NEUROCHEM, V94, P1395, DOI 10.1111/j.1471-4159.2005.03275.x; Zhao Y, 2006, FASEB J, V20, P1162, DOI 10.1096/fj.05-5007com	74	219	236	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37006	37015		10.1074/jbc.M700447200	http://dx.doi.org/10.1074/jbc.M700447200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17965419	hybrid			2022-12-25	WOS:000251646000027
J	Monde, K; Maeda, Y; Tanaka, Y; Harada, S; Yusa, K				Monde, Kazuaki; Maeda, Yosuke; Tanaka, Yuetsu; Harada, Shinji; Yusa, Keisuke			Gp120 V3-dependent impairment of R5 HIV-1 infectivity due to virion-incorporated CCR5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4 DOWN-REGULATION; CELL-SURFACE CCR5; ENVELOPE GLYCOPROTEIN; DILEUCINE MOTIF; VIRAL INFECTIVITY; TYPE-1 ENVELOPE; TROPIC HIV-1; BINDING-SITE; NEF PROTEIN	Entry of R5 human immunodeficiency virus type 1 (HIV-1) into target cells requires sequential interactions of the envelope glycoprotein gp120 with the receptor CD4 and the coreceptor CCR5. We investigated replication of 45 R5 viral clones derived from the HIV-1(JR-FLan) library carrying 0 - 10 random amino acid substitutions in the gp120 V3 loop. It was found that 6.7% (3/45) of the viruses revealed >= 10-fold replication suppression in PM1/CCR5 cells expressing high levels of CCR5 compared with PM1 cells expressing low levels of CCR5. In HIV-1(V3L#08), suppression of replication was not associated with entry events and viral production but with a marked decrease in infectivity of nascent progeny virus. HIV-1(V3L#08), generated from infected PM1/CCR5 cells, was 98% immunoprecipitated by anti-CCR5 monoclonal antibody T21/8, whereas the other infectious viruses were only partially precipitated, suggesting that incorporation of larger amounts of CCR5 into the virions caused impairment of viral infectivity in HIV-1(V3L#08). The results demonstrate the implications of an alternative influence of CCR5 on HIV-1 replication.	[Monde, Kazuaki; Maeda, Yosuke; Harada, Shinji; Yusa, Keisuke] Kumamoto Univ, Grad Sch Med Sci, Dept Med Virol, Kumamoto 8608556, Japan; [Tanaka, Yuetsu] Univ Ryukyus, Fac Med, Dept Immunol & Infect Dis, Okinawa Asia Res Ctr Med Sci, Okinawa 9030215, Japan	Kumamoto University; University of the Ryukyus	Yusa, K (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Med Virol, Honjo 1-1-1, Kumamoto 8608556, Japan.	yusak@kumamoto-u.ac.jp	Monde, Kazuaki/I-6493-2019	Monde, Kazuaki/0000-0002-8314-5306				AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Bresnahan PA, 1998, CURR BIOL, V8, P1235, DOI 10.1016/S0960-9822(07)00517-9; Cantin R, 1997, J VIROL, V71, P1922, DOI 10.1128/JVI.71.3.1922-1930.1997; Cantin R, 1997, BLOOD, V90, P1091, DOI 10.1182/blood.V90.3.1091.1091_1091_1100; Craig HM, 1998, P NATL ACAD SCI USA, V95, P11229, DOI 10.1073/pnas.95.19.11229; DELWART EL, 1989, J VIROL, V63, P273, DOI 10.1128/JVI.63.1.273-280.1989; Doms RW, 1997, VIROLOGY, V235, P179, DOI 10.1006/viro.1997.8703; Dragic T, 1998, J VIROL, V72, P279, DOI 10.1128/JVI.72.1.279-285.1998; Esser MT, 2001, J VIROL, V75, P6173, DOI 10.1128/JVI.75.13.6173-6182.2001; Farzan M, 1998, J VIROL, V72, P1160, DOI 10.1128/JVI.72.2.1160-1164.1998; GELEZIUNAS R, 1994, FASEB J, V8, P593, DOI 10.1096/fasebj.8.9.8005387; Greenberg M, 1998, CURR BIOL, V8, P1239, DOI 10.1016/S0960-9822(07)00518-0; Hachiya A, 2001, ANTIMICROB AGENTS CH, V45, P495, DOI 10.1128/AAC.45.2.495-501.2001; HOXIE JA, 1987, HUM IMMUNOL, V18, P39, DOI 10.1016/0198-8859(87)90111-X; Inudoh M, 1998, MICROBIOL IMMUNOL, V42, P875, DOI 10.1111/j.1348-0421.1998.tb02364.x; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lallos LB, 1999, AIDS RES HUM RETROV, V15, P895, DOI 10.1089/088922299310601; Lama J, 1999, CURR BIOL, V9, P622, DOI 10.1016/S0960-9822(99)80284-X; Lee B, 1999, J BIOL CHEM, V274, P9617, DOI 10.1074/jbc.274.14.9617; Levesque K, 2003, J BIOL CHEM, V278, P28346, DOI 10.1074/jbc.M300327200; Lin YL, 2002, P NATL ACAD SCI USA, V99, P15590, DOI 10.1073/pnas.242134499; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; Maeda Y, 2000, J VIROL, V74, P1787, DOI 10.1128/JVI.74.4.1787-1793.2000; Mangasarian A, 1997, IMMUNITY, V6, P67, DOI 10.1016/S1074-7613(00)80243-5; Mariani R, 2000, J VIROL, V74, P3859, DOI 10.1128/JVI.74.8.3859-3870.2000; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Moore JP, 1997, CURR OPIN IMMUNOL, V9, P551, DOI 10.1016/S0952-7915(97)80110-0; Moore JP, 1997, SCIENCE, V276, P51, DOI 10.1126/science.276.5309.51; O'Connor KH, 2005, J IMMUNOL METHODS, V299, P21, DOI 10.1016/j.jim.2004.11.025; Ott DE, 2002, REV MED VIROL, V12, P359, DOI 10.1002/rmv.367; Ott DE, 1997, REV MED VIROL, V7, P167, DOI 10.1002/(SICI)1099-1654(199709)7:3&lt;167::AID-RMV199&gt;3.0.CO;2-K; PALESE P, 1974, VIROLOGY, V61, P397, DOI 10.1016/0042-6822(74)90276-1; Peters PJ, 2004, J VIROL, V78, P6915, DOI 10.1128/JVI.78.13.6915-6926.2004; Piguet V, 1998, EMBO J, V17, P2472, DOI 10.1093/emboj/17.9.2472; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Reeves JD, 2004, J VIROL, V78, P5476, DOI 10.1128/JVI.78.10.5476-5485.2004; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Reyues J, 2003, JAIDS-J ACQ IMM DEF, V34, P114, DOI 10.1097/00126334-200309010-00018; Rizzuto C, 2000, AIDS RES HUM RETROV, V16, P741, DOI 10.1089/088922200308747; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; STECK FT, 1966, VIROLOGY, V29, P628, DOI 10.1016/0042-6822(66)90287-X; Suphaphiphat P, 2003, J VIROL, V77, P3832, DOI 10.1128/JVI.77.6.3832-3837.2003; Tremblay MJ, 1998, IMMUNOL TODAY, V19, P346, DOI 10.1016/S0167-5699(98)01286-9; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Walter BL, 2005, J VIROL, V79, P4828, DOI 10.1128/JVI.79.8.4828-4837.2005; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yusa K, 2005, J BIOL CHEM, V280, P30083, DOI 10.1074/jbc.M414360200; Zhang WT, 1999, BIOCHEMISTRY-US, V38, P9405, DOI 10.1021/bi990654o	54	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36923	36932		10.1074/jbc.M705298200	http://dx.doi.org/10.1074/jbc.M705298200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17971448	hybrid			2022-12-25	WOS:000251646000018
J	Mukhopadhyay, A; Yang, CS; Wei, BX; Weiner, H				Mukhopadhyay, Abhijit; Yang, Chun-Song; Wei, Baoxian; Weiner, Henry			Precursor protein is readily degraded in mitochondrial matrix space if the leader is not processed by mitochondrial processing peptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDEHYDE DEHYDROGENASE; SIGNAL PEPTIDE; SACCHAROMYCES-CEREVISIAE; ASPARTATE-AMINOTRANSFERASE; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; YEAST FUMARASE; IN-VIVO; IMPORT	It is not known why leader peptides are removed by the mitochondrial processing peptidase after import into the matrix space. The leaders of yeast aldehyde dehydrogenase ( pALDH) and malate dehydrogenase were mutated so that they would not be processed after import. The recombinant nonprocessed precursor of yeast pALDH possessed a similar specific activity as the corresponding mature form but was much less stable. The nonprocessed pALDH was transformed into a yeast strain missing ALDHs. The transformed yeast grew slowly on ethanol as the sole carbon source showing that the nonprocessed precursor was functional in vivo. Western blot analysis showed that the amount of precursor was 15-20% of that found in cells transformed with the native enzyme. Pulse-chase experiments revealed that the turnover rate for the nonprocessed precursor was greater than that of the mature protein indicating that the nonprocessed precursor could have been degraded. By using carbonyl cyanide m-chlorophenylhydrazone, we showed that the nonprocessed precursor was degraded in the matrix space. The nonprocessed precursor forms of precursor yeast malate dehydrogenase and rat liver pALDH also were degraded in the matrix space of HeLa cell mitochondria faster than their corresponding mature forms. In the presence of o-phenanthroline, an inhibitor of mitochondrial processing peptidase, the wild type precursor was readily degraded in the matrix space. Collectively, this study showed that the precursor form is less stable in the matrix space than is the mature form and provides an explanation for why the leader peptide is removed from the precursors.	[Mukhopadhyay, Abhijit; Yang, Chun-Song; Wei, Baoxian; Weiner, Henry] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Weiner, H (corresponding author), Purdue Univ, Dept Biochem, 175S Univ St, W Lafayette, IN 47907 USA.	mukhopad@purdue.edu; Hweiner@purdue.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010795, R01AA005812, R37AA005812] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA05812, AA10795] Funding Source: Medline; NIGMS NIH HHS [GM53169] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berezov A, 2005, PROTEIN J, V24, P465, DOI 10.1007/s10930-005-7642-y; Braun HP, 1997, INT J BIOCHEM CELL B, V29, P1043, DOI 10.1016/S1357-2725(97)00032-0; DIEDERICHS K, 1991, J MOL BIOL, V217, P541, DOI 10.1016/0022-2836(91)90756-V; FUJIKI M, 1993, J BIOL CHEM, V268, P1914; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Glaser E, 2006, BIOL CHEM, V387, P1441, DOI 10.1515/BC.2006.180; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Gliubich F, 1998, ACTA CRYSTALLOGR D, V54, P481, DOI 10.1107/S090744499701216X; Hammen PK, 1996, J BIOL CHEM, V271, P21041, DOI 10.1074/jbc.271.35.21041; HAMMEN PK, 1994, BIOCHEMISTRY-US, V33, P8610, DOI 10.1021/bi00194a028; HARTL FU, 1987, CELL, V51, P1027, DOI 10.1016/0092-8674(87)90589-7; Ito A, 1999, BIOCHEM BIOPH RES CO, V265, P611, DOI 10.1006/bbrc.1999.1703; JARVIS JA, 1995, J BIOL CHEM, V270, P1323, DOI 10.1074/jbc.270.3.1323; JENG JJ, 1991, ARCH BIOCHEM BIOPHYS, V289, P214, DOI 10.1016/0003-9861(91)90464-T; KARSLAKE C, 1990, BIOCHEMISTRY-US, V29, P9872, DOI 10.1021/bi00494a017; Kaser M, 2000, SEMIN CELL DEV BIOL, V11, P181, DOI 10.1006/scdb.2000.0166; Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452; MacKenzie JA, 2007, BBA-MOL BASIS DIS, V1772, P509, DOI 10.1016/j.bbadis.2006.12.002; MCPHALEN CA, 1992, J MOL BIOL, V227, P197, DOI 10.1016/0022-2836(92)90691-C; Mukhopadhyay A, 2005, CELL MOL LIFE SCI, V62, P1890, DOI 10.1007/s00018-005-5178-0; Mukhopadhyay A, 2004, BIOCHEM J, V382, P385, DOI 10.1042/BJ20040065; Mukhopadhyay A, 2003, J BIOL CHEM, V278, P13712, DOI 10.1074/jbc.M212743200; Mukhopadhyay A, 2002, PROTEIN SCI, V11, P1026, DOI 10.1110/ps.3760102; Nett JH, 1997, J BIOL CHEM, V272, P2212; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ni L, 1999, PROTEIN SCI, V8, P2784; PAK YK, 1990, J BIOL CHEM, V265, P14298; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Roberts DL, 1996, P NATL ACAD SCI USA, V93, P14355, DOI 10.1073/pnas.93.25.14355; Sass E, 2001, J BIOL CHEM, V276, P46111, DOI 10.1074/jbc.M106061200; SCHMID D, 1992, EUR J BIOCHEM, V208, P699, DOI 10.1111/j.1432-1033.1992.tb17237.x; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; SZTUL ES, 1987, J CELL BIOL, V105, P2631, DOI 10.1083/jcb.105.6.2631; Taylor AB, 2001, STRUCTURE, V9, P615, DOI 10.1016/S0969-2126(01)00621-9; THORNTON K, 1993, J BIOL CHEM, V268, P19906; Trevino RJ, 1999, J BIOL CHEM, V274, P13938, DOI 10.1074/jbc.274.20.13938; VERNER K, 1993, TRENDS BIOCHEM SCI, V18, P366, DOI 10.1016/0968-0004(93)90090-A; WALTNER M, 1995, J BIOL CHEM, V270, P26311, DOI 10.1074/jbc.270.44.26311; Wang LY, 2000, BIOCHEM J, V351, P469, DOI 10.1042/0264-6021:3510469; Wang XP, 1998, J BACTERIOL, V180, P822, DOI 10.1128/JB.180.4.822-830.1998; Weaver T, 1998, J MOL BIOL, V280, P431, DOI 10.1006/jmbi.1998.1862; YAFFE MP, 1985, EMBO J, V4, P2069, DOI 10.1002/j.1460-2075.1985.tb03893.x	42	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37266	37275		10.1074/jbc.M706594200	http://dx.doi.org/10.1074/jbc.M706594200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17959599	hybrid			2022-12-25	WOS:000251646000052
J	Guo, D; Sarkar, J; Suino-Powell, K; Xu, Y; Matsumoto, K; Jia, YZ; Yu, S; Khare, S; Haldar, K; Rao, MS; Foreman, JE; Monga, SPS; Peters, JM; Xu, HE; Reddy, JK				Guo, Dongsheng; Sarkar, Joy; Suino-Powell, Kelly; Xu, Yong; Matsumoto, Kojiro; Jia, Yuzhi; Yu, Songtao; Khare, Sonal; Haldar, Kasturi; Rao, M. Sambasiva; Foreman, Jennifer E.; Monga, Satdarshan P. S.; Peters, Jeffrey M.; Xu, H. Eric; Reddy, Janardan K.			Induction of nuclear translocation of constitutive androstane receptor by peroxisome proliferator-activated receptor alpha synthetic ligands in mouse liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COA HYDRATASE/3-HYDROXYACYL-COA DEHYDROGENASE; UNION-OF-PHARMACOLOGY; BETA-OXIDATION; PPAR-ALPHA; TRANSCRIPTIONAL REGULATION; STRUCTURAL DETERMINANTS; (PPAR)-BINDING PROTEIN; TARGETED DISRUPTION; GENE-EXPRESSION; X-RECEPTOR	Peroxisome proliferators activate nuclear receptor peroxisome proliferator-activated receptor alpha ( PPAR alpha) and enhance the transcription of several genes in liver. We report here that synthetic PPAR alpha ligands Wy-14,643, ciprofibrate, clofibrate, and others induce the nuclear translocation of constitutive androstane receptor (CAR) in mouse liver cells in vivo. Adeno-viral-enhanced green fluorescent protein-CAR expression demonstrated that PPAR alpha synthetic ligands drive CAR into the hepatocyte nucleus in a PPAR alpha- and PPAR beta-independent manner. This translocation is dependent on the transcription coactivator PPAR-binding protein but independent of coactivators PRIP and SRC-1. PPAR alpha ligand-induced nuclear translocation of CAR is not associated with induction of Cyp2b10 mRNA in mouse liver. PPAR alpha ligands interfered with coactivator recruitment to the CAR ligand binding domain and reduced the constitutive transactivation of CAR. Both Wy-14,643 and ciprofibrate occupied the ligand binding pocket of CAR and adapted a binding mode similar to that of the CAR inverse agonist androstenol. These observations, therefore, provide information for the first time to indicate that PPAR alpha ligands not only serve as PPAR alpha agonists but possibly act as CAR antagonists.	Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA; Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA	Northwestern University; Feinberg School of Medicine; Van Andel Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Reddy, JK (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pathol, 303 E Chicago Ave, Chicago, IL 60611 USA.	jkreddy@northwestern.edu	Xu, H. Eric/ABD-7487-2021; Haldar, Kasturi/C-6685-2014; Peters, Jeffrey/D-8847-2011; guo, Dongsheng/A-2196-2010	Monga, Satdarshan/0000-0002-8437-3378; Peters, Jeffrey/0000-0003-2782-2998; Xu, H. Eric/0000-0002-6829-8144; Khare, Sonal/0000-0002-4044-3581; Foreman, Jennifer/0000-0001-8480-1734	NATIONAL CANCER INSTITUTE [R01CA104578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023750, R37GM023750] Funding Source: NIH RePORTER; NCI NIH HHS [CA104578] Funding Source: Medline; NIGMS NIH HHS [GM23750] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Chang TKH, 2006, DRUG METAB REV, V38, P51, DOI 10.1080/03602530600569828; CHU RY, 1995, P NATL ACAD SCI USA, V92, P11593, DOI 10.1073/pnas.92.25.11593; Columbano A, 2001, HEPATOLOGY, V34, P262, DOI 10.1053/jhep.2001.26172; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Fan CY, 1996, J BIOL CHEM, V271, P24698, DOI 10.1074/jbc.271.40.24698; Fan CY, 1998, J BIOL CHEM, V273, P15639, DOI 10.1074/jbc.273.25.15639; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Forman BM, 1998, NATURE, V395, P612, DOI 10.1038/26996; Guo DS, 2006, BIOCHEM BIOPH RES CO, V347, P485, DOI 10.1016/j.bbrc.2006.06.129; Halgren TA, 1999, J COMPUT CHEM, V20, P730, DOI 10.1002/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO;2-T; Hermanson O, 2002, TRENDS ENDOCRIN MET, V13, P55, DOI 10.1016/S1043-2760(01)00527-6; Honkakoski P, 1998, J BIOCHEM MOL TOXIC, V12, P3; Hosseinpour F, 2006, MOL PHARMACOL, V69, P1095, DOI 10.1124/mol.105.019505; Huang WD, 2005, MOL ENDOCRINOL, V19, P1646, DOI 10.1210/me.2004-0520; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Jia YZ, 2005, P NATL ACAD SCI USA, V102, P12531, DOI 10.1073/pnas.0506000102; Jia YZ, 2004, J BIOL CHEM, V279, P24427, DOI 10.1074/jbc.M402391200; Kanno Y, 2007, BBA-MOL CELL RES, V1773, P934, DOI 10.1016/j.bbamcr.2007.03.020; Kassam A, 2000, J BIOL CHEM, V275, P4345, DOI 10.1074/jbc.275.6.4345; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Kobayashi K, 2003, MOL PHARMACOL, V64, P1069, DOI 10.1124/mol.64.5.1069; Koike C, 2005, FEBS LETT, V579, P6733, DOI 10.1016/j.febslet.2005.10.070; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; MANAUTOU JE, 1994, TOXICOL APPL PHARM, V129, P252, DOI 10.1006/taap.1994.1250; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Michalik L, 2007, CELL, V129, P649, DOI 10.1016/j.cell.2007.05.001; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Min GS, 2002, J BIOL CHEM, V277, P26356, DOI 10.1074/jbc.M200051200; Moore DD, 2006, PHARMACOL REV, V58, P742, DOI 10.1124/pr.58.4.6; Peters JM, 2005, J MOL MED-JMM, V83, P774, DOI 10.1007/s00109-005-0678-9; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Qi C, 1999, P NATL ACAD SCI USA, V96, P1585, DOI 10.1073/pnas.96.4.1585; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Reddy JK, 2006, AD DEV BIOL, V16, P389, DOI 10.1016/S1574-3349(06)16012-3; REDDY JK, 1975, SCIENCE, V190, P787, DOI 10.1126/science.1198095; Reddy JK, 2004, AM J PATHOL, V164, P2305, DOI 10.1016/S0002-9440(10)63787-X; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; REDDY JK, 1980, NATURE, V283, P397, DOI 10.1038/283397a0; REDDY JK, 1986, P NATL ACAD SCI USA, V83, P1747, DOI 10.1073/pnas.83.6.1747; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Sarkar J, 2007, GENE EXPRESSION, V13, P255; Shan L, 2004, MOL CELL, V16, P907, DOI 10.1016/S1097-2765(04)00728-2; Simonsson USH, 2006, EUR J CLIN INVEST, V36, P647, DOI 10.1111/j.1365-2362.2006.01700.x; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Suino K, 2004, MOL CELL, V16, P893, DOI 10.1016/j.molcel.2004.11.036; Swales K, 2004, MOL ENDOCRINOL, V18, P1589, DOI 10.1210/me.2003-0397; Thomas J, 2003, J BIOL CHEM, V278, P2403, DOI 10.1074/jbc.M209629200; Timsit YE, 2007, STEROIDS, V72, P231, DOI 10.1016/j.steroids.2006.12.006; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tzameli I, 2000, MOL CELL BIOL, V20, P2951, DOI 10.1128/MCB.20.9.2951-2958.2000; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; WRIGHT E, 2005, BIOCHEMISTRY-US, V46, P862; Xia J, 2005, J BIOL CHEM, V280, P7285, DOI 10.1074/jbc.M409696200; XIA J, 2007, IN PRESS ARCH BIOCH; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Yamada H, 2000, BIOCHEM BIOPH RES CO, V277, P66, DOI 10.1006/bbrc.2000.3620; Yu ST, 2007, BBA-MOL CELL BIOL L, V1771, P936, DOI 10.1016/j.bbalip.2007.01.008; Zhang J, 2002, SCIENCE, V298, P422, DOI 10.1126/science.1073502; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500	66	31	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36766	36776		10.1074/jbc.M707183200	http://dx.doi.org/10.1074/jbc.M707183200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17962186	hybrid			2022-12-25	WOS:000251458300069
J	Tozawa, Y; Nozawa, A; Kanno, T; Narisawa, T; Masuda, S; Kasai, K; Nanamiya, H				Tozawa, Yuzuru; Nozawa, Akira; Kanno, Takuya; Narisawa, Takakuni; Masuda, Shinji; Kasai, Koji; Nanamiya, Hideaki			Calcium-activated (p)ppGpp synthetase in chloroplasts of land plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPOT-DEPENDENT ACCUMULATION; PROTEIN-SYNTHESIS SYSTEM; STRUCTURAL BASIS; BACTERIAL; IDENTIFICATION; BINDING; PPGPP; RELA; ARABIDOPSIS; CALMODULIN	The genetic system of chloroplasts, including the machinery for transcription, translation, and DNA replication, exhibits substantial similarity to that of eubacteria. Chloroplasts are also thought to possess a system for generating guanosine 5 '-triphosphate ((p) ppGpp), which triggers the stringent response in eubacteria, with genes encoding chloroplastic (p) ppGpp synthetase having been identified. We now describe the identification and characterization of genes (OsCRSH1, OsCRSH2, and OsCRSH3) for a novel type of ( p) ppGpp synthetase in rice. The proteins encoded by these genes contain a putative chloroplast transit peptide at the NH2 terminus, a central RelA-SpoT-like domain, and two EF-hand motifs at the COOH terminus. The recombinant OsCRSH1 protein was imported into chloroplasts in vitro, and genetic complementation analysis revealed that expression of OsCRSH1 suppressed the phenotype of an Escherichia coli mutant deficient in the RelA and SpoT enzymes. Biochemical analysis showed that the OsCRSH proteins possess (p)ppGpp synthetase activity that is dependent both on Ca2+ and on the EF-hand motifs. A data base search identified a CRSH homolog in the dicotyledon Arabidopsis thaliana, indicating that such genes are conserved among both monocotyledonous and dicotyledonous land plants. CRSH proteins thus likely function as Ca2+-activated (p)ppGpp synthetases in plant chloroplasts, implicating both Ca2+ and (p)ppGpp signaling in regulation of the genetic system of these organelles.	Ehime Univ, Grad Sch Sci & Engn, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime 8908577, Japan; Ehime Univ, Grad Sch Sci & Engn, Dept Appl Chem, Matsuyama, Ehime 8908577, Japan; Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Sci, Yokohama, Kanagawa 2268501, Japan; Univ Tokyo, Biotechnol Res Ctr, Tokyo 1138657, Japan	Ehime University; Ehime University; Tokyo Institute of Technology; University of Tokyo	Tozawa, Y (corresponding author), Ehime Univ, Grad Sch Sci & Engn, Cell Free Sci & Technol Res Ctr, 3 Bunkyo Cho, Matsuyama, Ehime 8908577, Japan.	tozaway@ccr.ehime-u.ac.jp	Tozawa, Yuzuru/G-2657-2013; Tozawa, Yuzuru/AAM-9620-2020; Masuda, Shinji/A-2703-2014	Tozawa, Yuzuru/0000-0002-3885-1105; Masuda, Shinji/0000-0002-5349-4927; Nozawa, Akira/0000-0003-4886-0213				Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Battesti A, 2006, MOL MICROBIOL, V62, P1048, DOI 10.1111/j.1365-2958.2006.05442.x; Braeken K, 2006, TRENDS MICROBIOL, V14, P45, DOI 10.1016/j.tim.2005.11.006; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Day IS, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0056; Ettinger WF, 1999, PLANT PHYSIOL, V119, P1379, DOI 10.1104/pp.119.4.1379; GHANOTAKIS DF, 1984, FEBS LETT, V167, P127, DOI 10.1016/0014-5793(84)80846-7; Givens RM, 2004, J BIOL CHEM, V279, P7495, DOI 10.1074/jbc.M311573200; GOGFREY HP, 2002, TRENDS MICROBIOL, V10, P349; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Hou ZL, 1999, J BIOL CHEM, V274, P17505, DOI 10.1074/jbc.274.25.17505; HUANG LQ, 1993, P NATL ACAD SCI USA, V90, P10066, DOI 10.1073/pnas.90.21.10066; JARRETT HW, 1982, J BIOL CHEM, V257, P13795; JOHNSON CH, 1995, SCIENCE, V269, P1863, DOI 10.1126/science.7569925; Kanno T, 2005, PLANT PHYSIOL, V138, P2260, DOI 10.1104/pp.105.062885; Kanno T, 2007, PROTEIN EXPRES PURIF, V52, P59, DOI 10.1016/j.pep.2006.09.007; Kasai K, 2005, PLANTA, V222, P438, DOI 10.1007/s00425-005-1559-8; Kasai K, 2004, NUCLEIC ACIDS RES, V32, P5732, DOI 10.1093/nar/gkh916; Kasai K, 2002, NUCLEIC ACIDS RES, V30, P4985, DOI 10.1093/nar/gkf628; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; MANIATIS T, 1982, MOL CLONING LAB MAN; McCormack E, 2005, TRENDS PLANT SCI, V10, P383, DOI 10.1016/j.tplants.2005.07.001; Milon P, 2006, P NATL ACAD SCI USA, V103, P13962, DOI 10.1073/pnas.0606384103; Mittenhuber G, 2001, J MOL MICROB BIOTECH, V3, P585; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Reddy ASN, 2001, PLANT SCI, V160, P381, DOI 10.1016/S0168-9452(00)00386-1; Sai JQ, 2002, PLANT CELL, V14, P1279, DOI 10.1105/tpc.000653; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; SEYFZADEH M, 1993, P NATL ACAD SCI USA, V90, P11004, DOI 10.1073/pnas.90.23.11004; Takahashi K, 2004, P NATL ACAD SCI USA, V101, P4320, DOI 10.1073/pnas.0308555101; Tozawa Y, 1998, NUCLEIC ACIDS RES, V26, P415, DOI 10.1093/nar/26.2.415; Turner WL, 2004, PLANT PHYSIOL, V135, P1243, DOI 10.1104/pp.104.040428; van der Biezen EA, 2000, P NATL ACAD SCI USA, V97, P3747, DOI 10.1073/pnas.060392397; Vinella D, 2005, MOL MICROBIOL, V56, P958, DOI 10.1111/j.1365-2958.2005.04601.x; Wang JD, 2007, CELL, V128, P865, DOI 10.1016/j.cell.2006.12.043; Wendrich TM, 2002, MOL CELL, V10, P779, DOI 10.1016/S1097-2765(02)00656-1; WOLOSIUK RA, 1993, FASEB J, V7, P622, DOI 10.1096/fasebj.7.8.8500687; XIAO H, 1991, J BIOL CHEM, V266, P5980	40	54	60	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35536	35545		10.1074/jbc.M703820200	http://dx.doi.org/10.1074/jbc.M703820200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17938177	hybrid			2022-12-25	WOS:000251458100013
J	von Degenfeld, G; Wehrman, TS; Hammer, MM; Blau, HM				von Degenfeld, Georges; Wehrman, Tom S.; Hammer, Mark M.; Blau, Helen M.			A universal technology for monitoring G-protein-coupled receptor activation in vitro and noninvasively in live animals	FASEB JOURNAL			English	Article						luminescent in vivo imaging; in vivo pharmacology; GPCRs	BETA-GALACTOSIDASE; DRUG; TRAFFICKING; ARRESTINS; SYSTEM; ASSAYS	G-protein coupled receptors ( GPCRs) are a versatile and ubiquitous family of membrane receptors that transmit extracellular signals to mammalian cells and constitute the most important class of drug targets. Yet, sensitive and specific methods are lacking that would allow quantitative comparisons of pharmacologic properties of these receptors in physiological or pathological settings in live animals. We sought to overcome these limitations by employing low affinity, reversible beta-galactosidase complementation to quantify GPCR activation via interaction with beta-arrestin. A panel of cell lines was engineered expressing different GPCRs together with the reporter system. In vitro evaluation revealed highly sensitive, dynamic, and specific assessment of GPCR agonists and antagonists. Following implantation of the cells into mice, it was possible for the first time to monitor pharmacological GPCR activation and inhibition in their physiological context by noninvasive bioluminescence imaging in living animals. This technology has unique advantages that enable novel applications in the functional investigation of GPCR modulation in live animals in biological research and drug discovery.	Baxter Lab, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Baxter Lab Genet Pharmacol, Stanford, CA 94305 USA	Stanford University	Blau, HM (corresponding author), Bayer HealthCare, Cardiovasc Res, Wuppertal, Germany.	hblau@stanford.edu	Hammer, Mark/AAR-9625-2020	Hammer, Mark/0000-0002-1700-7984	NIA NIH HHS [AG020961, AG024987, T32 AG0259, AG009521] Funding Source: Medline; NIBIB NIH HHS [EB005011] Funding Source: Medline; NICHD NIH HHS [HD018179] Funding Source: Medline; NIGMS NIH HHS [T32 GM08412] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG009521, T32AG000259, R01AG024987, R01AG020961, R01AG009521] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Eglen RM, 2005, COMB CHEM HIGH T SCR, V8, P311, DOI 10.2174/1386207054020813; GEIGER R, 1992, BIOL CHEM H-S, V373, P1187, DOI 10.1515/bchm3.1992.373.2.1187; HAMMER MM, 2007, FASEB J, V21, DOI DOI 10.1096/FJ.07.8777COM; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lipworth BJ, 1997, BRIT J CLIN PHARMACO, V43, P9, DOI 10.1111/j.1365-2125.1997.tb00025.x; Lundstrom K, 2006, CURR PROTEIN PEPT SC, V7, P465, DOI 10.2174/138920306778559403; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Newman SP, 1999, PHARM SCI TECHNOL TO, V2, P181, DOI 10.1016/S1461-5347(99)00152-2; Oakley RH, 2002, ASSAY DRUG DEV TECHN, V1, P21, DOI 10.1089/154065802761001275; Sadikot Ruxana T, 2005, Proc Am Thorac Soc, V2, P537, DOI 10.1513/pats.200507-067DS; Schlyer S, 2006, DRUG DISCOV TODAY, V11, P481, DOI 10.1016/j.drudis.2006.04.008; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Thomsen W, 2005, CURR OPIN BIOTECH, V16, P655, DOI 10.1016/j.copbio.2005.10.008; Wakefield ID, 2002, FUND CLIN PHARMACOL, V16, P209, DOI 10.1046/j.1472-8206.2002.00099.x; Weber MA, 2005, AM J HYPERTENS, V18, p169S, DOI 10.1016/j.amjhyper.2005.09.009; Wehrman TS, 2006, P NATL ACAD SCI USA, V103, P19063, DOI 10.1073/pnas.0605218103; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Wehrman TS, 2006, NAT METHODS, V3, P295, DOI 10.1038/NMETH868; Wehrman TS, 2005, NAT METHODS, V2, P521, DOI 10.1038/NMETH771; Yan YX, 2002, J BIOMOL SCREEN, V7, P451, DOI 10.1177/108705702237677	25	25	25	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2007	21	14					3819	3826		10.1096/fj.07-9597com	http://dx.doi.org/10.1096/fj.07-9597com			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	236DP	17942828				2022-12-25	WOS:000251283500006
J	Schymeinsky, J; Then, C; Sindrilaru, A; Gerstl, R; Jakus, Z; Tybulewicz, VLJ; Scharffetter-Kochanek, K; Walzog, B				Schymeinsky, Juergen; Then, Cornelia; Sindrilaru, Anca; Gerstl, Ronald; Jakus, Zoltan; Tybulewicz, Victor L. J.; Scharffetter-Kochanek, Karin; Walzog, Barbara			Syk-Mediated Translocation of PI3K delta to the Leading Edge Controls Lamellipodium Formation and Migration of Leukocytes	PLOS ONE			English	Article							PHOSPHOTYROSINE-BINDING DOMAIN; PROTEIN-TYROSINE KINASE; PHOSPHOINOSITIDE 3-KINASE; HUMAN NEUTROPHILS; PHOSPHATIDYLINOSITOL 3-KINASE; PROTOONCOGENE PRODUCT; PHOSPHOLIPASE-C; CELL ACTIVATION; LINKER REGION; T-CELLS	The non-receptor tyrosine kinase Syk is mainly expressed in the hematopoietic system and plays an essential role in beta(2) integrin-mediated leukocyte activation. To elucidate the signaling pathway downstream of Syk during beta(2) integrin (CD11/CD18)-mediated migration and extravasation of polymorphonuclear neutrophils (PMN), we generated neutrophil-like differentiated HL-60 (dHL-60) cells expressing a fluorescently tagged Syk mutant lacking the tyrosine residue at the position 323 (Syk-Tyr(323)) that is known to be required for the binding of the regulatory subunit p85 of the phosphatidylinositol 3-kinase (PI3K) class I-A. Syk-Tyr(323) was found to be critical for the enrichment of the catalytic subunit p110 delta of PI3K class I-A as well as for the generation of PI3K products at the leading edge of the majority of polarized cells. In accordance, the translocation of PI3K p110 delta to the leading edge was diminished in Syk deficient murine PMN. Moreover, the expression of EGFP-Syk Y323F interfered with proper cell polarization and it impaired efficient migration of dHL-60 cells. In agreement with a major role of beta(2) integrins in the recruitment of phagocytic cells to sites of lesion, mice with a Syk-deficient hematopoietic system demonstrated impaired PMN infiltration into the wounded tissue that was associated with prolonged cutaneous wound healing. These data imply a novel role of Syk via PI3K p110 delta signaling for beta(2) integrin-mediated migration which is a prerequisite for efficient PMN recruitment in vivo.	[Schymeinsky, Juergen; Then, Cornelia; Gerstl, Ronald; Walzog, Barbara] Univ Munich, Dept Physiol, D-8000 Munich, Germany; [Sindrilaru, Anca; Scharffetter-Kochanek, Karin] Univ Ulm, Dept Dermatol & Allerg Dis, Ulm, Germany; [Jakus, Zoltan] Semmelweis Univ, Sch Med, Dept Physiol, Budapest, Hungary; [Tybulewicz, Victor L. J.] Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England	University of Munich; Ulm University; Semmelweis University; MRC National Institute for Medical Research	Walzog, B (corresponding author), Univ Munich, Dept Physiol, Pettenkoferstr 12, D-8000 Munich, Germany.	walzog@lrz.uni-muenchen.de	Sindrilaru, Anca/G-1203-2014; Jakus, Zoltán/O-1762-2015	Jakus, Zoltán/0000-0002-6304-2369; Tybulewicz, Victor/0000-0003-2439-0798; Scharffetter-Kochanek, Karin/0000-0002-9655-685X	Deutsche Forschungsgemeinschaft [Wa 1048/2-3, SFB 497-C7]; Medical Research Council [MC_U117527252] Funding Source: researchfish; MRC [MC_U117527252] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work has been funded by grants of the Deutsche Forschungsgemeinschaft; Wa 1048/2-3 (to B. Walzog) and SFB 497-C7 (to K. ScharffetterKochanek).	Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Abtahian F, 2006, MOL CELL BIOL, V26, P6936, DOI 10.1128/MCB.01040-06; ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175; Axelsson L, 2000, EXP CELL RES, V256, P257, DOI 10.1006/excr.2000.4816; Beitz LO, 1999, J BIOL CHEM, V274, P32662, DOI 10.1074/jbc.274.46.32662; Berton G, 2005, TRENDS IMMUNOL, V26, P208, DOI 10.1016/j.it.2005.02.002; Boulven I, 2006, J IMMUNOL, V176, P7621, DOI 10.4049/jimmunol.176.12.7621; Caveggion E, 2003, J CELL PHYSIOL, V195, P276, DOI 10.1002/jcp.10236; Chavakis E, 2005, J EXP MED, V201, P63, DOI 10.1084/jem.20041402; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Groesch TD, 2006, J MOL BIOL, V356, P1222, DOI 10.1016/j.jmb.2005.11.095; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Hannigan M, 2002, P NATL ACAD SCI USA, V99, P3603, DOI 10.1073/pnas.052010699; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hong JJ, 2002, J BIOL CHEM, V277, P31703, DOI 10.1074/jbc.M201362200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jones NP, 2005, J CELL SCI, V118, P2695, DOI 10.1242/jcs.02374; Kunisaki Y, 2006, J CELL BIOL, V174, P647, DOI 10.1083/jcb.200602142; Lee KS, 2006, FASEB J, V20, P455, DOI 10.1096/fj.05-5045com; Liu LX, 2007, BLOOD, V110, P1191, DOI 10.1182/blood-2006-11-060103; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Moon KD, 2005, J BIOL CHEM, V280, P1543, DOI 10.1074/jbc.M407805200; Mouneimne G, 2004, J CELL BIOL, V166, P697, DOI 10.1083/jcb.200405156; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Peters T, 2005, EMBO J, V24, P3400, DOI 10.1038/sj.emboj.7600809; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Popa-Nita O, 2007, J LEUKOCYTE BIOL, V82, P763, DOI 10.1189/jlb.0307174; Puri KD, 2004, BLOOD, V103, P3448, DOI 10.1182/blood-2003-05-1667; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Sada K, 2000, J IMMUNOL, V164, P338, DOI 10.4049/jimmunol.164.1.338; Sada K, 2001, J BIOCHEM-TOKYO, V130, P177, DOI 10.1093/oxfordjournals.jbchem.a002970; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Schruefer R, 2006, J VASC RES, V43, P1, DOI 10.1159/000088975; Schymeinsky J, 2007, THROMB HAEMOSTASIS, V98, P262, DOI 10.1160/TH07-02-0156; Schymeinsky J, 2006, BLOOD, V108, P3919, DOI 10.1182/blood-2005-12-030387; Sebzda E, 2006, DEV CELL, V11, P349, DOI 10.1016/j.devcel.2006.07.007; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Theilgaard-Monch K, 2004, J IMMUNOL, V172, P7684, DOI 10.4049/jimmunol.172.12.7684; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Van Keymeulen A, 2006, J CELL BIOL, V174, P437, DOI 10.1083/jcb.200604113; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; von Willebrand M, 1998, CELL SIGNAL, V10, P407, DOI 10.1016/S0898-6568(97)00139-3; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Willeke T, 2000, J LEUKOCYTE BIOL, V68, P284; Yankee TM, 1999, J IMMUNOL, V163, P5827	56	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1132	10.1371/journal.pone.0001132	http://dx.doi.org/10.1371/journal.pone.0001132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987119	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459000016
J	Cartwright, P; Halgedahl, SL; Hendricks, JR; Jarrard, RD; Marques, AC; Collins, AG; Lieberman, BS				Cartwright, Paulyn; Halgedahl, Susan L.; Hendricks, Jonathan R.; Jarrard, Richard D.; Marques, Antonio C.; Collins, Allen G.; Lieberman, Bruce S.			Exceptionally Preserved Jellyfishes from the Middle Cambrian	PLOS ONE			English	Article								Cnidarians represent an early diverging animal group and thus insight into their origin and diversification is key to understanding metazoan evolution. Further, cnidarian jellyfish comprise an important component of modern marine planktonic ecosystems. Here we report on exceptionally preserved cnidarian jellyfish fossils from the Middle Cambrian (similar to 505 million years old) Marjum Formation of Utah. These are the first described Cambrian jellyfish fossils to display exquisite preservation of soft part anatomy including detailed features of structures interpreted as trailing tentacles and subumbrellar and exumbrellar surfaces. If the interpretation of these preserved characters is correct, their presence is diagnostic of modern jellyfish taxa. These new discoveries may provide insight into the scope of cnidarian diversity shortly after the Cambrian radiation, and would reinforce the notion that important taxonomic components of the modern planktonic realm were in place by the Cambrian period.	[Hendricks, Jonathan R.; Lieberman, Bruce S.] Univ Kansas, Dept Geol, Nat Hist Museum, Lawrence, KS 66045 USA; [Hendricks, Jonathan R.; Lieberman, Bruce S.] Univ Kansas, Div Invertebrate Paleontol, Nat Hist Museum, Lawrence, KS 66045 USA; [Cartwright, Paulyn] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Halgedahl, Susan L.; Jarrard, Richard D.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; [Marques, Antonio C.] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil; [Collins, Allen G.] Fisheries Serv, Natl Systemat Lab, NOAA, Natl Museum Nat Hist,Smithsonian Inst, Washington, DC USA	University of Kansas; University of Kansas; University of Kansas; Utah System of Higher Education; University of Utah; Universidade de Sao Paulo; National Oceanic Atmospheric Admin (NOAA) - USA; Smithsonian Institution; Smithsonian National Museum of Natural History	Lieberman, BS (corresponding author), Univ Kansas, Dept Geol, Nat Hist Museum, Lawrence, KS 66045 USA.	blieber@ku.edu	Marques, Antonio Carlos/E-8049-2011; Collins, Allen G/A-7944-2008	Marques, Antonio Carlos/0000-0002-2884-0541; Collins, Allen G/0000-0002-3664-9691; Cartwright, Paulyn/0000-0002-8174-6933	NSF [AToL EF-0531779, EAR-0518976]; FAPESP; CNPq	NSF(National Science Foundation (NSF)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding: This work was supported by grants from NSF AToL EF-0531779 (to PC and AGC), NSF EAR-0518976 (to BSL) and FAPESP and CNPq (Brazil, to ACM).	ALLISON PA, 1993, GEOLOGY, V21, P527, DOI 10.1130/0091-7613(1993)021<0527:EFRDOS>2.3.CO;2; ALLISON PA, 1995, GEOLOGY, V23, P1079, DOI 10.1130/0091-7613(1995)023<1079:ISBAPO>2.3.CO;2; BRIGGS DEG, 1984, U KANSAS PALEONTOLOG, V111, P1; Butterfield NJ, 1997, PALEOBIOLOGY, V23, P247, DOI 10.1017/S009483730001681X; CAMPBELL RD, 1987, CELL TISSUE RES, V249, P647; Conway Morris S., 1986, PALEONTOLOGICAL CONT, V117, P1; CONWAY MS, 1993, PALAEONTOLOGY, V36, P593; Fedonkin M.A., 1992, P389; Finnerty JR, 2004, SCIENCE, V304, P1335, DOI 10.1126/science.1091946; Gaines RR, 2005, PALAEOGEOGR PALAEOCL, V220, P193, DOI 10.1016/j.palaeo.2004.07.034; Garm A, 2006, CELL TISSUE RES, V325, P333, DOI 10.1007/s00441-005-0134-8; Gehling JG, 2000, PALAEONTOLOGY, V43, P427, DOI 10.1111/j.0031-0239.2000.00134.x; Gershwin Lisa-Ann, 2005, Beagle, V21, P27; Glaessner M. F., 1966, Palaeontology, V9, P599; Hagadorn JW, 2002, GEOLOGY, V30, P147, DOI 10.1130/0091-7613(2002)030<0147:SOALCS>2.0.CO;2; Hou X. -G., 2004, CAMBRIAN FOSSILS CHE; Hou XG, 2005, LETHAIA, V38, P193, DOI 10.1080/00241160510013295; Hughes NC, 2000, J PALEONTOL, V74, P828, DOI 10.1666/0022-3360(2000)074<0828:LCCFWA>2.0.CO;2; JOHNSON R G, 1968, Fieldiana Geology, V12, P109; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Lewis C, 2005, MAR BIOL, V147, P477, DOI 10.1007/s00227-005-1602-0; Marques AC, 2004, INVERTEBR BIOL, V123, P23; Morris SC, 1996, PHILOS T ROY SOC B, V351, P279, DOI 10.1098/rstb.1996.0024; Narbonne GM, 2005, ANNU REV EARTH PL SC, V33, P421, DOI 10.1146/annurev.earth.33.092203.122519; NARBONNE GM, 1991, J PALEONTOL, V65, P186, DOI 10.1017/S0022336000020412; Nielsen C, 1996, BIOL J LINN SOC, V57, P385; NORRIS RD, 1989, LETHAIA, V22, P381, DOI 10.1111/j.1502-3931.1989.tb01439.x; OSSIAN CR, 1973, J PALEONTOL, V47, P990; PEARSE JS, 1978, SCIENCE, V199, P458, DOI 10.1126/science.22934; PLUMMER P S, 1980, Transactions of the Royal Society of South Australia, V104, P13; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Robison R.A., 1991, P77; ROSS MI, 2000, PALEOGIS ARCVIEW 3 5; Russell F. S., 1970, MEDUSAE BRIT ISLES, V2; STANLEY GD, 1986, PROBLEMATIC FOSSIL T, P68; Van Iten H, 2006, J SYST PALAEONTOL, V4, P109, DOI 10.1017/S1477201905001793; WADE M, 1971, Proceedings of the Royal Society of Victoria, V84, P183; Waggoner Benjamin M., 1995, Palaeontologische Zeitschrift, V69, P7; Walcott Charles Doolittle, 1911, Smithsonian Institution Miscellaneous Collection, V57; WILLOUGHBY RH, 1979, J PALEONTOL, V53, P494; Yanagihara AA, 2002, CELL TISSUE RES, V308, P307, DOI 10.1007/s00441-002-0545-8	41	98	101	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1121	10.1371/journal.pone.0001121	http://dx.doi.org/10.1371/journal.pone.0001121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V11YE	17971881	Green Published, gold			2022-12-25	WOS:000207566100001
J	Morel, E; Gruenberg, J				Morel, Etienne; Gruenberg, Jean			The p11/S100A10 Light Chain of Annexin A2 Is Dispensable for Annexin A2 Association to Endosomes and Functions in Endosomal Transport	PLOS ONE			English	Article								Background. Annexin A2 is a peripheral membrane protein that belongs to the annexin family of Ca2+ and phospholipid-binding proteins. This protein, which plays a role in membrane organization and dynamics in particular along the endocytic pathway, exists as a heterotetrameric complex, consisting of two annexin A2 molecules bound via their N-termini to a dimer of p11/S100A10 light chains. The light chain, and thus presumably formation of the heterotetramer, was reported to control annexin A2 association to the plasma membrane and to cortical actin, as well as the distribution of recycling endosomes. However, the specific role of the light chain and the functions of monomeric versus heterotetrameric annexin A2 have remained elusive in the endocytic pathway. Methodology/Principal Findings. Here, we have investigated whether p11 plays a role in the endosomal functions of annexin A2. Using morphological and biochemical approaches, we found that p11, unlike annexin A2, was not present on early endosomes. Neither was the heterotetramer detected on purified early endosomes, while it was clearly present in total cell lysates. Moreover, knockdown of p11 with siRNAs did not affect annexin A2 targeting to early endosomes, and, conversely, binding of annexin A2 to purified endosomes or liposomes occurred without p11 in vitro. Finally, while we could confirm that annexin A2 knockdown inhibits transport beyond early endosomes, p11 knockdown had no such effects on early-to-late endosome transport. Conclusions/Significance. Our data show that the binding of annexin A2 to endosomal membranes and its role in endosomal trafficking are independent of the p11/S100A10 light chain. We thus conclude that annexin A2 functions are fully supported by the monomeric form of the protein, at least the endocytic pathway leading to lysosomes.	[Morel, Etienne; Gruenberg, Jean] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland	University of Geneva	Gruenberg, J (corresponding author), Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland.	jean.gruenberg@biochem.unige.ch	MOREL, Etienne L/F-4765-2010; MOREL, Etienne/N-2194-2014	MOREL, Etienne L/0000-0001-7340-1313; MOREL, Etienne/0000-0002-4763-4954	Swiss National Science Foundation; Swiss Telethon Foundation; Fondation pour la Recherche Medicale (FRM); Roche Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Telethon Foundation; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Roche Research Foundation	Support was from the Swiss National Science Foundation and the Swiss Telethon Foundation (to JG), the Fondation pour la Recherche Medicale (FRM) and the Roche Research Foundation (to EM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; BECKER T, 1990, EMBO J, V9, P4207, DOI 10.1002/j.1460-2075.1990.tb07868.x; BECKER T, 1992, EUR J BIOCHEM, V207, P541, DOI 10.1111/j.1432-1033.1992.tb17080.x; Benaud C, 2004, J CELL BIOL, V164, P133, DOI 10.1083/jcb.200307098; BORTHWICK LA, 2007, MOL BIOL CELL; CREUTZ CE, 1992, SCIENCE, V258, P924, DOI 10.1126/science.1439804; EMANS N, 1993, J CELL BIOL, V120, P1357, DOI 10.1083/jcb.120.6.1357; FUTTER CE, 2007, TRAFFIC; GERKE V, 1984, EMBO J, V3, P227, DOI 10.1002/j.1460-2075.1984.tb01789.x; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; GLENNEY JR, 1985, FEBS LETT, V192, P79, DOI 10.1016/0014-5793(85)80047-8; GOULD KL, 1986, MOL CELL BIOL, V6, P2738, DOI 10.1128/MCB.6.7.2738; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Harder T, 1997, MOL BIOL CELL, V8, P533, DOI 10.1091/mbc.8.3.533; HARDER T, 1993, J CELL BIOL, V123, P1119, DOI 10.1083/jcb.123.5.1119; Hayes MJ, 2004, J BIOL CHEM, V279, P14157, DOI 10.1074/jbc.M313025200; Huber LA, 2000, TRAFFIC, V1, P494, DOI 10.1034/j.1600-0854.2000.010607.x; JOHNSSON N, 1988, FEBS LETT, V236, P201, DOI 10.1016/0014-5793(88)80314-4; JOHNSSON N, 1988, EMBO J, V7, P2435, DOI 10.1002/j.1460-2075.1988.tb03089.x; Jost M, 1997, J CELL SCI, V110, P221; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Merrifield CJ, 2001, CURR BIOL, V11, P1136, DOI 10.1016/S0960-9822(01)00321-9; OSBORN M, 1988, EXP CELL RES, V175, P81, DOI 10.1016/0014-4827(88)90257-1; Petiot A, 2003, J CELL BIOL, V162, P971, DOI 10.1083/jcb.200303018; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Rescher U, 2000, J CELL SCI, V113, P3931; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; RESCHER U, 2007, S100A10 P11 FAMILY F; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Seemann J, 1997, FEBS LETT, V413, P185, DOI 10.1016/S0014-5793(97)00911-3; THIEL C, 1992, J CELL SCI, V103, P733; THIEL C, 1991, FEBS LETT, V285, P59, DOI 10.1016/0014-5793(91)80724-H; Zobiack N, 2003, MOL BIOL CELL, V14, P4896, DOI 10.1091/mbc.E03-06-0387	36	50	52	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1118	10.1371/journal.pone.0001118	http://dx.doi.org/10.1371/journal.pone.0001118			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971878	Green Submitted, Green Published, gold			2022-12-25	WOS:000207458700032
J	Fall, S; Mercier, A; Bertolla, F; Calteau, A; Gueguen, L; Perriere, G; Vogel, TM; Simonet, P				Fall, Saliou; Mercier, Anne; Bertolla, Franck; Calteau, Alexandra; Gueguen, Laurent; Perriere, Guy; Vogel, Timothy M.; Simonet, Pascal			Horizontal Gene Transfer Regulation in Bacteria as a "Spandrel'' of DNA Repair Mechanisms	PLOS ONE			English	Article								Horizontal gene transfer (HGT) is recognized as the major force for bacterial genome evolution. Yet, numerous questions remain about the transferred genes, their function, quantity and frequency. The extent to which genetic transformation by exogenous DNA has occurred over evolutionary time was initially addressed by an in silico approach using the complete genome sequence of the Ralstonia solanacearum GMI1000 strain. Methods based on phylogenetic reconstruction of prokaryote homologous genes families detected 151 genes (13.3%) of foreign origin in the R. solanacearum genome and tentatively identified their bacterial origin. These putative transfers were analyzed in comparison to experimental transformation tests involving 18 different genomic DNA positions in the genome as sites for homologous or homeologous recombination. Significant transformation frequency differences were observed among these positions tested regardless of the overall genomic divergence of the R. solanacearum strains tested as recipients. The genomic positions containing the putative exogenous DNA were not systematically transformed at the highest frequencies. The two genomic "hot spots'', which contain recA and mutS genes, exhibited transformation frequencies from 2 to more than 4 orders of magnitude higher than positions associated with other genes depending on the recipient strain. These results support the notion that the bacterial cell is equipped with active mechanisms to modulate acquisition of new DNA in different genomic positions. Bio-informatics study correlated recombination "hot-spots'' to the presence of Chi-like signature sequences with which recombination might be preferentially initiated. The fundamental role of HGT is certainly not limited to the critical impact that the very rare foreign genes acquired mainly by chance can have on the bacterial adaptation potential. The frequency to which HGT with homologous and homeologous DNA happens in the environment might have led the bacteria to hijack DNA repair mechanisms in order to generate genetic diversity without losing too much genomic stability.	[Fall, Saliou; Vogel, Timothy M.; Simonet, Pascal] Univ Lyon, Environm Microbial Genom Grp, Lab AMPERE UMR CNRS 5005, Ecole Cent Lyon, Ecully, France; [Mercier, Anne; Bertolla, Franck] Univ Lyon 1, UMR CNRS 5557, F-69622 Villeurbanne, France; [Calteau, Alexandra; Gueguen, Laurent; Perriere, Guy] Univ Lyon 1, Lab Biometrie & Biol Evolut, UMR CNRS 5558, F-69622 Villeurbanne, France	Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Simonet, P (corresponding author), Univ Lyon, Environm Microbial Genom Grp, Lab AMPERE UMR CNRS 5005, Ecole Cent Lyon, Ecully, France.	pascal.simonet@ec-lyon.fr		CALTEAU, Alexandra/0000-0002-5871-9347; Vogel, Timothy/0000-0002-9542-3246	EU project TRANSBAC [QLK3-CT2001-02242]; ANR project PLOBEN [ANR-05-POGM-004-01]	EU project TRANSBAC; ANR project PLOBEN(French National Research Agency (ANR))	This work was funded in part by the EU project TRANSBAC (QLK3-CT2001-02242, 5th RTD Program) and in part by the ANR project PLOBEN (ANR-05-POGM-004-01).	BAKKALI M, 2007, PLOS ONE E, V741, P1; Bertolla F, 1997, APPL ENVIRON MICROB, V63, P4965, DOI 10.1128/AEM.63.12.4965-4968.1997; Bertolla F, 1999, MOL PLANT MICROBE IN, V12, P467, DOI 10.1094/MPMI.1999.12.5.467; BOUCHER C, 1986, MOL GEN GENET, V205, P270, DOI 10.1007/BF00430438; BRAU B, 1984, MOL GEN GENET, V193, P179, DOI 10.1007/BF00327434; Brown EW, 2001, J BACTERIOL, V183, P1631, DOI 10.1128/JB.183.5.1631-1644.2001; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Charif D., 2007, STRUCTURAL APPROACHE, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Daubin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r57; Daubin V, 2003, MOL BIOL EVOL, V20, P471, DOI 10.1093/molbev/msg022; Delmas S, 2005, DNA REPAIR, V4, P221, DOI 10.1016/j.dnarep.2004.09.008; Denamur E, 2000, CELL, V103, P711, DOI 10.1016/S0092-8674(00)00175-6; DIXON DA, 1995, J BIOL CHEM, V270, P16360, DOI 10.1074/jbc.270.27.16360; Doolittle WF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-116; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; El Karoui M, 1999, RES MICROBIOL, V150, P579, DOI 10.1016/S0923-2508(99)00132-1; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Gonin M, 2000, J BACTERIOL, V182, P337, DOI 10.1128/JB.182.2.337-347.2000; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Guidot A, 2007, J BACTERIOL, V189, P377, DOI 10.1128/JB.00999-06; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAYWARD AC, 1994, DIS ITS CAUSATIVE AG, P9; HENNECKE F, 1991, NATURE, V353, P776, DOI 10.1038/353776a0; HUMBERT O, 1995, P NATL ACAD SCI USA, V92, P9052, DOI 10.1073/pnas.92.20.9052; Kay E, 2002, MICROBIAL ECOL, V43, P291, DOI 10.1007/s00248-002-2007-y; Kobayashi I, 2001, NUCLEIC ACIDS RES, V29, P3742, DOI 10.1093/nar/29.18.3742; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Lawrence JG, 2002, TRENDS MICROBIOL, V10, P1, DOI 10.1016/S0966-842X(01)02282-X; Li XZ, 1998, J BACTERIOL, V180, P2987, DOI 10.1128/JB.180.11.2987-2991.1998; Lieb M, 1996, MOL MICROBIOL, V20, P467, DOI 10.1046/j.1365-2958.1996.5291066.x; Matic I, 1996, TRENDS MICROBIOL, V4, P69, DOI 10.1016/0966-842X(96)81514-9; Metzgar D, 2000, CELL, V101, P581, DOI 10.1016/S0092-8674(00)80869-7; Nakamura Y, 2004, NAT GENET, V36, P760, DOI 10.1038/ng1381; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; PAGET E, 1994, FEMS MICROBIOL ECOL, V15, P109, DOI 10.1111/j.1574-6941.1994.tb00235.x; PALLERONI NJ, 1971, J BACTERIOL, V107, P690, DOI 10.1128/JB.107.3.690-696.1971; Ragan MA, 2001, CURR OPIN GENET DEV, V11, P620, DOI 10.1016/S0959-437X(00)00244-6; Rocha EPC, 2002, TRENDS GENET, V18, P291, DOI 10.1016/S0168-9525(02)02690-2; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Taha MK, 1996, MOL MICROBIOL, V19, P1073, DOI 10.1046/j.1365-2958.1996.448979.x; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; WATSON GS, 1961, BIOMETRIKA, V48, P109, DOI 10.2307/2333135; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851	49	48	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1055	10.1371/journal.pone.0001055	http://dx.doi.org/10.1371/journal.pone.0001055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957239	Green Published, Green Submitted, gold			2022-12-25	WOS:000207458500002
J	Sarndahl, E; Bergstrom, I; Brodin, VP; Nijm, J; Setterud, HL; Jonasson, L				Sarndahl, Eva; Bergstrom, Ida; Brodin, Veronika Patcha; Nijm, Johnny; Setterud, Helen Lundqvist; Jonasson, Lena			Neutrophil Activation Status in Stable Coronary Artery Disease	PLOS ONE			English	Article								Background. During the last years, neutrophils have emerged as important players in atherogenesis. They are highly activated in peripheral blood of patients with unstable angina. Moreover, a primed state of circulating neutrophils has been proposed in patients with stable angina. Our aim was to investigate the neutrophil activation status in patients with stable coronary artery disease ( CAD) at conventional drug treatment. Methodology and Principal Findings. Thirty patients with stable CAD and 30 healthy controls were included using a paired design. The neutrophil expression of CD18 and high-affinity state of CD11b was analysed by flow cytometry before and after stimulation with chemoattractants. Also, the production of reactive oxygen species (ROS) was determined by chemiluminescence. During basal conditions, the neutrophil expression of CD18 or high-affinity state of CD11b did not differ between patients and controls. Chemoattractants (Interleukin-8 and Leukotriene B(4)) did not increase either the expression or the amount of high-affinity CD11b/CD18-integrins in CAD patients compared to controls, and had no effect on the production of ROS. On the other hand, the ROS production in response to C3bi-opsonised yeast particles and the neutrophils' inherent capacity to produce ROS were both significantly decreased in patients. Conclusion/Significance. We could not find any evidence that neutrophils in patients with stable CAD were primed, i.e. more prone to activation, compared to cells from healthy controls. According to our data, the circulating neutrophils in CAD patients rather showed an impaired activation status. It remains to be elucidated whether the neutrophil dysfunction in CAD is mainly a marker of chronic disease, an atherogenic factor or a consequence of the drug treatment.	[Sarndahl, Eva; Bergstrom, Ida; Setterud, Helen Lundqvist] Linkoping Univ, Fac Hlth Sci, Div Med Microbiol, Dept Clin & Expt Med, Linkoping, Sweden; [Brodin, Veronika Patcha] Linkoping Univ, Fac Hlth Sci, Div Cell Biol, Dept Clin & Expt Med, Linkoping, Sweden; [Nijm, Johnny; Jonasson, Lena] Linkoping Univ, Fac Hlth Sci, Div Cardiol, Dept Med & Hlth, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University	Sarndahl, E (corresponding author), Univ Orebro, Dept Clin Med, Orebro, Sweden.	eva.sarndahl@ikm.oru.se			Medical Research Council of Southeast Sweden; County Council of ystergotland; Foundation of "Gamla Tjanarinnor''; Biomedical Research School; Cardiovascular Inflammation Research Centre (CIRC) at the Faculty of Health Sciences at Linkoping University; Swedish Heart & Lung Foundation	Medical Research Council of Southeast Sweden(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); County Council of ystergotland; Foundation of "Gamla Tjanarinnor''; Biomedical Research School; Cardiovascular Inflammation Research Centre (CIRC) at the Faculty of Health Sciences at Linkoping University; Swedish Heart & Lung Foundation(Swedish Heart-Lung Foundation)	This work was supported by grants from the Medical Research Council of Southeast Sweden, the County Council of ystergotland, the Foundation of "Gamla Tjanarinnor'', the Biomedical Research School and the Cardiovascular Inflammation Research Centre (CIRC) at the Faculty of Health Sciences at Linkoping University. Veronika Patcha Brodin was supported by a fellowship from the Swedish Heart & Lung Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 1999, J BIOL CHEM, V274, P6027, DOI 10.1074/jbc.274.10.6027; BELLER DI, 1982, J EXP MED, V156, P1000, DOI 10.1084/jem.156.4.1000; Boekholdt SM, 2004, ARTERIOSCL THROM VAS, V24, P1503, DOI 10.1161/01.ATV.0000134294.54422.2e; Buffon A, 2002, NEW ENGL J MED, V347, P5, DOI 10.1056/NEJMoa012295; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Cougoule C, 2004, SEMIN CELL DEV BIOL, V15, P679, DOI 10.1016/j.semcdb.2004.09.001; DIAMOND MS, 1993, J CELL BIOL, V120, P545, DOI 10.1083/jcb.120.2.545; DIAMOND MS, 1993, J CELL BIOL, V120, P1031, DOI 10.1083/jcb.120.4.1031; Egger G, 2001, INFLAMMATION, V25, P129, DOI 10.1023/A:1007174723608; Fiorucci S, 2003, BRIT J PHARMACOL, V139, P1351, DOI 10.1038/sj.bjp.0705356; Gahmberg CG, 2002, VOX SANG, V83, P355, DOI 10.1111/j.1423-0410.2002.tb05333.x; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Guasti L, 2006, J HYPERTENS, V24, P2423, DOI 10.1097/01.hjh.0000251903.62804.77; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; HED J, 1982, IMMUNOLOGY, V45, P727; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; Lindmark E, 2001, THROMB RES, V103, P249, DOI 10.1016/S0049-3848(01)00313-9; Lundqvist H, 1995, INFLAMM RES, V44, P510, DOI 10.1007/BF01757354; Madjid M, 2004, J AM COLL CARDIOL, V44, P1945, DOI 10.1016/j.jacc.2004.07.056; MEHTA J, 1989, CIRCULATION, V79, P549, DOI 10.1161/01.CIR.79.3.549; Naruko T, 2002, CIRCULATION, V106, P2894, DOI 10.1161/01.CIR.0000042674.89762.20; Nijm J, 2005, AM J CARDIOL, V95, P452, DOI 10.1016/j.amjcard.2004.10.009; Ott I, 1996, CIRCULATION, V94, P1239, DOI 10.1161/01.CIR.94.6.1239; Papayianni A, 1996, J IMMUNOL, V156, P2264; Patcha V, 2004, EXP CELL RES, V300, P308, DOI 10.1016/j.yexcr.2004.07.015; Patel PB, 2004, AM J CARDIOL, V93, P410, DOI 10.1016/j.amjcard.2003.10.033; Paulsson J, 2007, ATHEROSCLEROSIS, V192, P328, DOI 10.1016/j.atherosclerosis.2006.08.003; Prasad K, 2006, CARDIOVASC DRUG REV, V24, P33, DOI 10.1111/j.1527-3466.2006.00033.x; Price DT, 1999, AM J MED, V107, P85, DOI 10.1016/S0002-9343(99)00153-9; Rothenbacher D, 2006, ARTERIOSCL THROM VAS, V26, P194, DOI 10.1161/01.ATV.0000191633.52585.14; Sarndahl E, 1996, J BIOL CHEM, V271, P15267; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Wilsson A, 1996, J LEUKOCYTE BIOL, V59, P902, DOI 10.1002/jlb.59.6.902; Yang YY, 2004, ATHEROSCLEROSIS, V174, P207, DOI 10.1016/j.atherosclerosis.2004.01.024	35	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1056	10.1371/journal.pone.0001056	http://dx.doi.org/10.1371/journal.pone.0001056			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957240	Green Published, gold			2022-12-25	WOS:000207458500003
J	Twellmeyer, J; Wende, A; Wolfertz, J; Pfeiffer, F; Panhuysen, M; Zaigler, A; Soppa, J; Welzl, G; Oesterhelt, D				Twellmeyer, Jens; Wende, Andy; Wolfertz, Jan; Pfeiffer, Friedhelm; Panhuysen, Markus; Zaigler, Alexander; Soppa, Joerg; Welzl, Gerhard; Oesterhelt, Dieter			Microarray Analysis in the Archaeon Halobacterium salinarum Strain R1	PLOS ONE			English	Article							MEMBRANE PROTEOME; PURPLE MEMBRANE; DNA-MICROARRAY; GENE; HALOBIUM; TRANSDUCER; CHEMOTAXIS; EXPRESSION; DESIGN; GROWTH	Background. Phototrophy of the extremely halophilic archaeon Halobacterium salinarum was explored for decades. The research was mainly focused on the expression of bacteriorhodopsin and its functional properties. In contrast, less is known about genome wide transcriptional changes and their impact on the physiological adaptation to phototrophy. The tool of choice to record transcriptional profiles is the DNA microarray technique. However, the technique is still rarely used for transcriptome analysis in archaea. Methodology/Principal Findings. We developed a whole-genome DNA microarray based on our sequence data of the Hbt. salinarum strain R1 genome. The potential of our tool is exemplified by the comparison of cells growing under aerobic and phototrophic conditions, respectively. We processed the raw fluorescence data by several stringent filtering steps and a subsequent MAANOVA analysis. The study revealed a lot of transcriptional differences between the two cell states. We found that the transcriptional changes were relatively weak, though significant. Finally, the DNA microarray data were independently verified by a real-time PCR analysis. Conclusion/Significance. This is the first DNA microarray analysis of Hbt. salinarum cells that were actually grown under phototrophic conditions. By comparing the transcriptomics data with current knowledge we could show that our DNA microarray tool is well applicable for transcriptome analysis in the extremely halophilic archaeon Hbt. salinarum. The reliability of our tool is based on both the high-quality array of DNA probes and the stringent data handling including MAANOVA analysis. Among the regulated genes more than 50% had unknown functions. This underlines the fact that haloarchaeal phototrophy is still far away from being completely understood. Hence, the data recorded in this study will be subject to future systems biology analysis.	[Twellmeyer, Jens; Wende, Andy; Wolfertz, Jan; Pfeiffer, Friedhelm; Oesterhelt, Dieter] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Panhuysen, Markus] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Zaigler, Alexander; Soppa, Joerg] Goethe Univ Frankfurt, Inst Mol Biosci, Frankfurt, Germany; [Welzl, Gerhard] GSF Forschungszentrum Umwelt & Gesundheit, Natl Res Ctr Environm & Hlth, Inst Biomath & Biometry, Neuherberg, Germany	Max Planck Society; Max Planck Society; Goethe University Frankfurt; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Oesterhelt, D (corresponding author), Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.	oesterhe@biochem.mpg.de	Pfeiffer, Friedhelm/K-1757-2019	Pfeiffer, Friedhelm/0000-0003-4691-3246; Soppa, Jorg/0000-0002-6132-5840	Deutsche Forschungsgesellschaft (DFG) [OE 52/18-1]	Deutsche Forschungsgesellschaft (DFG)(German Research Foundation (DFG))	The work was supported by the Deutsche Forschungsgesellschaft (DFG) by the funds OE 52/18-1. The DFG was not involved in the design or conduct of the study nor in any other part of the work.	AREGGER M, 2003, THESIS LUDWIGMAXIMIL; Baliga NS, 2002, P NATL ACAD SCI USA, V99, P14913, DOI 10.1073/pnas.192558999; Baliga NS, 2001, P NATL ACAD SCI USA, V98, P2521, DOI 10.1073/pnas.051632498; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bisle B, 2006, MOL CELL PROTEOMICS, V5, P1543, DOI 10.1074/mcp.M600106-MCP200; Brooun A, 1998, J BACTERIOL, V180, P1642, DOI 10.1128/JB.180.7.1642-1646.1998; DASSARMA S, 1988, P NATL ACAD SCI USA, V85, P6861, DOI 10.1073/pnas.85.18.6861; Dharmadi Y, 2004, BIOTECHNOL PROGR, V20, P1309, DOI 10.1021/bp0400240; Diehl F, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e38; Freeman WM, 1999, BIOTECHNIQUES, V26, P112, DOI 10.2144/99261rv01; GROPP F, 1994, P NATL ACAD SCI USA, V91, P5475, DOI 10.1073/pnas.91.12.5475; Klein C, 2005, PROTEOMICS, V5, P180, DOI 10.1002/pmic.200400943; Kokoeva MV, 2000, MOL MICROBIOL, V35, P647, DOI 10.1046/j.1365-2958.2000.01735.x; Lee MLT, 2000, P NATL ACAD SCI USA, V97, P9834, DOI 10.1073/pnas.97.18.9834; Mary-Huard T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-63; Muller JA, 2005, J BACTERIOL, V187, P1659, DOI 10.1128/JB.187.5.1659-1667.2005; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; OESTERHELT D, 1982, METHOD ENZYMOL, V88, P417; OESTERHELT D, 1983, ANN INST PASTEUR MIC, VB134, P137, DOI 10.1016/S0769-2609(83)80101-X; Peck RF, 2001, J BIOL CHEM, V276, P5739, DOI 10.1074/jbc.M009492200; Raddatz G, 2001, BIOINFORMATICS, V17, P98, DOI 10.1093/bioinformatics/17.1.98; Rousseeuw P. J., 1987, ROBUST REGRESSION OU; RUDOLPH J, 1995, EMBO J, V14, P667, DOI 10.1002/j.1460-2075.1995.tb07045.x; Ruepp A, 1996, J BACTERIOL, V178, P4942, DOI 10.1128/jb.178.16.4942-4947.1996; SHAND RF, 1991, J BACTERIOL, V173, P4692, DOI 10.1128/jb.173.15.4692-4699.1991; STOECKENIUS W, 1968, J CELL BIOL, V38, P337, DOI 10.1083/jcb.38.2.337; SUMPER M, 1976, FEBS LETT, V69, P149, DOI 10.1016/0014-5793(76)80673-4; SUMPER M, 1976, ANGEW CHEM INT EDIT, V15, P187, DOI 10.1002/anie.197601871; Tebbe A, 2005, PROTEOMICS, V5, P168, DOI 10.1002/pmic.200400910; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Whitehead K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100091; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863; YAO VJ, 1992, P NATL ACAD SCI USA, V89, P11915, DOI 10.1073/pnas.89.24.11915; Zaigler A, 2003, MOL MICROBIOL, V48, P1089, DOI 10.1046/j.1365-2958.2003.03497.x	35	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1064	10.1371/journal.pone.0001064	http://dx.doi.org/10.1371/journal.pone.0001064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957248	Green Submitted, Green Published, gold			2022-12-25	WOS:000207458500011
J	Zhao, JS; Punj, V; Matta, H; Mazzacurati, L; Schamus, S; Yang, YQ; Yang, TB; Hong, Y; Chaudhary, PM				Zhao, Jinshun; Punj, Vasu; Matta, Hittu; Mazzacurati, Lucia; Schamus, Sandra; Yang, Yanqiang; Yang, Tianbing; Hong, Yan; Chaudhary, Preet M.			K13 Blocks KSHV Lytic Replication and Deregulates vIL6 and hIL6 Expression: A Model of Lytic Replication Induced Clonal Selection in Viral Oncogenesis	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; NF-KAPPA-B; PRIMARY-EFFUSION LYMPHOMA; KAPOSIS-SARCOMA; DNA-SEQUENCES; GROWTH-FACTOR; HUMAN INTERLEUKIN-6; ENDOTHELIAL-CELLS; SIGNAL TRANSDUCER; INDUCED APOPTOSIS	Background. Accumulating evidence suggests that dysregulated expression of lytic genes plays an important role in KSHV ( Kaposi's sarcoma associated herpesvirus) tumorigenesis. However, the molecular events leading to the dysregulation of KSHV lytic gene expression program are incompletely understood. Methodology/Principal Findings. We have studied the effect of KSHV-encoded latent protein vFLIP K13, a potent activator of the NF-kappa B pathway, on lytic reactivation of the virus. We demonstrate that K13 antagonizes RTA, the KSHV lytic-regulator, and effectively blocks the expression of lytic proteins, production of infectious virions and death of the infected cells. Induction of lytic replication selects for clones with increased K13 expression and NF-kappa B activity, while siRNA-mediated silencing of K13 induces the expression of lytic genes. However, the suppressive effect of K13 on RTA-induced lytic genes is not uniform and it fails to block RTA-induced viral IL6 secretion and cooperates with RTA to enhance cellular IL-6 production, thereby dysregulating the lytic gene expression program. Conclusions/Significance. Our results support a model in which ongoing KSHV lytic replication selects for clones with progressively higher levels of K13 expression and NF-kappa B activity, which in turn drive KSHV tumorigenesis by not only directly stimulating cellular survival and proliferation, but also indirectly by dysregulating the viral lytic gene program and allowing non-lytic production of growth-promoting viral and cellular genes. Lytic Replication-Induced Clonal Selection (LyRICS) may represent a general mechanism in viral oncogenesis.	[Zhao, Jinshun; Punj, Vasu; Matta, Hittu; Mazzacurati, Lucia; Schamus, Sandra; Yang, Yanqiang; Hong, Yan; Chaudhary, Preet M.] Univ Pittsburgh, Dept Med, Div Hematol Oncol, Hillman Canc Ctr, Pittsburgh, PA 15260 USA; [Yang, Tianbing] Univ Pittsburgh, Spang Translat Res Core Facil, Hillman Canc Ctr, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chaudhary, PM (corresponding author), Univ Pittsburgh, Dept Med, Div Hematol Oncol, Hillman Canc Ctr, Pittsburgh, PA 15260 USA.	chaudharypm@upmc.edu	Chaudhary, Preet/E-1970-2018	mazzacurati, lucia/0000-0002-8336-8032	National Institutes of Health [CA85177, CA124621]; Leukemia & Lymphoma Society; Mario Lemieux Foundation; NATIONAL CANCER INSTITUTE [R01CA085177, R01CA124621] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Mario Lemieux Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health (CA85177 and CA124621), the Leukemia & Lymphoma Society, and the Mario Lemieux Foundation.	An JB, 2003, ONCOGENE, V22, P3371, DOI 10.1038/sj.onc.1206407; Andreoni M, 2001, J INFECTION, V43, P195, DOI 10.1053/jinf.2001.0899; Aoki Y, 1999, BLOOD, V93, P4034, DOI 10.1182/blood.V93.12.4034.412k38_4034_4043; Aoki Y, 2000, J HEMATOTH STEM CELL, V9, P137, DOI 10.1089/152581600319351; Babcock GJ, 1999, J EXP MED, V190, P567, DOI 10.1084/jem.190.4.567; Brousset P, 2001, HUM PATHOL, V32, P95, DOI 10.1053/hupa.2001.21131; Brown HJ, 2003, J VIROL, V77, P8532, DOI 10.1128/JVI.77.15.8532-8540.2003; BURGER R, 1994, ANN HEMATOL, V69, P25, DOI 10.1007/BF01757344; Cannon JS, 1999, J INFECT DIS, V180, P824, DOI 10.1086/314956; Cannon M, 2006, BLOOD, V107, P277, DOI 10.1182/blood-2005-06-2350; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Chang PJ, 2002, J VIROL, V76, P3168, DOI 10.1128/JVI.76.7.3168-3178.2002; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chatterjee M, 2002, SCIENCE, V298, P1432, DOI 10.1126/science.1074883; Chaudhary PM, 1999, ONCOGENE, V18, P5738, DOI 10.1038/sj.onc.1202976; Chugh P, 2005, P NATL ACAD SCI USA, V102, P12885, DOI 10.1073/pnas.0408577102; COHEN T, 1996, INTERLEUKIN 6 INDUCE, P736; Deng HY, 2000, J GEN VIROL, V81, P3043, DOI 10.1099/0022-1317-81-12-3043; Deng HY, 2002, BLOOD, V100, P1919, DOI 10.1182/blood-2002-01-0015; Deng HY, 2002, J VIROL, V76, P8252, DOI 10.1128/JVI.76.16.8252-8264.2002; ENSOLI B, 1995, P ASSOC AM PHYSICIAN, V107, P8; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Field N, 2003, J CELL SCI, V116, P3721, DOI 10.1242/jcs.00691; Foussat A, 1999, EUR CYTOKINE NETW, V10, P501; Ganem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133; Godfrey A, 2005, BLOOD, V105, P2510, DOI 10.1182/blood-2004-08-3052; Grisotto MG, 2006, J CLIN INVEST, V116, P1264, DOI 10.1172/JCI26666; Grossmann C, 2006, J VIROL, V80, P7179, DOI 10.1128/JVI.01603-05; Grundhoff A, 2004, J CLIN INVEST, V113, P124, DOI 10.1172/JCI200417803; Grundhoff A, 2001, J VIROL, V75, P1857, DOI 10.1128/JVI.75.4.1857-1863.2001; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Hayward GS, 2003, CANCER CELL, V3, P1, DOI 10.1016/S1535-6108(03)00002-3; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Inoue N, 2003, J VIROL, V77, P8147, DOI 10.1128/JVI.77.14.8147-8152.2003; Jenkins FJ, 2002, J INFECT DIS, V185, P1238, DOI 10.1086/340237; Jenner RG, 2001, J VIROL, V75, P891, DOI 10.1128/JVI.75.2.891-902.2001; Jones KD, 1999, BLOOD, V94, P2871; KAAYA EE, 1992, EUR J CANCER, V28A, P1890, DOI 10.1016/0959-8049(92)90030-6; Krishnan HH, 2004, J VIROL, V78, P3601, DOI 10.1128/JVI.78.7.3601-3620.2004; LAM KMC, 1991, LANCET, V337, P876, DOI 10.1016/0140-6736(91)90203-2; Lan K, 2004, J VIROL, V78, P6585, DOI 10.1128/JVI.78.12.6585-6594.2004; Lee BS, 2002, J VIROL, V76, P12185, DOI 10.1128/JVI.76.23.12185-12199.2002; Li H, 2002, J VIROL, V76, P5627, DOI 10.1128/JVI.76.11.5627-5636.2002; Liu CQ, 2001, J VIROL, V75, P10933, DOI 10.1128/JVI.75.22.10933-10940.2001; Liu L, 2002, J BIOL CHEM, V277, P13745, DOI 10.1074/jbc.M110480200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lukac DM, 2001, J VIROL, V75, P6786, DOI 10.1128/JVI.75.15.6786-6799.2001; Matta H, 2007, ONCOGENE, V26, P1656, DOI 10.1038/sj.onc.1209931; MILES SA, 1990, P NATL ACAD SCI USA, V87, P4068, DOI 10.1073/pnas.87.11.4068; Molden J, 1997, J BIOL CHEM, V272, P19625, DOI 10.1074/jbc.272.31.19625; Montaner S, 2003, CANCER CELL, V3, P23, DOI 10.1016/S1535-6108(02)00237-4; Moore PS, 1996, SCIENCE, V274, P1739, DOI 10.1126/science.274.5293.1739; Nakamura H, 2003, J VIROL, V77, P4205, DOI 10.1128/JVI.77.7.4205-4220.2003; Nicholas J, 1997, NAT MED, V3, P287, DOI 10.1038/nm0397-287; Nicholas J, 2007, FRONT BIOSCI-LANDMRK, V12, P265, DOI 10.2741/2063; Parravicini C, 2000, AM J PATHOL, V156, P743, DOI 10.1016/S0002-9440(10)64940-1; Paulose-Murphy M, 2001, J VIROL, V75, P4843, DOI 10.1128/JVI.75.10.4843-4853.2001; Picard D, 2000, METHOD ENZYMOL, V327, P385, DOI 10.1016/S0076-6879(00)27291-1; Qunibi W, 1998, TRANSPLANTATION, V65, P583, DOI 10.1097/00007890-199802270-00024; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; Sarid R, 1998, J VIROL, V72, P1005, DOI 10.1128/JVI.72.2.1005-1012.1998; Schulz TF, 2006, J PATHOL, V208, P187, DOI 10.1002/path.1904; Sirianni MC, 2002, EUR J IMMUNOL, V32, P2711, DOI 10.1002/1521-4141(2002010)32:10<2711::AID-IMMU2711>3.0.CO;2-3; Sodhi A, 2004, FASEB J, V18, P422, DOI 10.1096/fj.03-1035hyp; Song MJ, 2003, J VIROL, V77, P9451, DOI 10.1128/JVI.77.17.9451-9462.2003; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Staskus KA, 1999, J VIROL, V73, P4181, DOI 10.1128/JVI.73.5.4181-4187.1999; Sturzl M, 1999, J NATL CANCER I, V91, P1725, DOI 10.1093/jnci/91.20.1725; Sun Q, 2006, ONCOGENE, V25, P2717, DOI 10.1038/sj.onc.1209298; Sun Q, 2003, BLOOD, V101, P1956, DOI 10.1182/blood-2002-07-2072; Sun QM, 2003, J BIOL CHEM, V278, P52437, DOI 10.1074/jbc.M304199200; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; WABINGA HR, 1993, INT J CANCER, V54, P26, DOI 10.1002/ijc.2910540106	75	40	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1067	10.1371/journal.pone.0001067	http://dx.doi.org/10.1371/journal.pone.0001067			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957251	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000207458500014
J	Leder, A; McMenamin, J; Zhou, F; Moran, JL; Beier, D; Leder, P				Leder, A.; McMenamin, J.; Zhou, F.; Moran, J. L.; Beier, D. R.; Leder, P.			Genome-wide SNP analysis of Tg.AC transgenic mice reveals an oncogenic collaboration between v-Ha-ras and Ink4a, which is absent in p53 deficiency	ONCOGENE			English	Article						Tg.AC; SNP screen; ras; ink4a (cdkn2a); ink4b (cdkn2b); p53	TUMOR-SUPPRESSOR LOCUS; CELLULAR SENESCENCE; MOUSE; P16(INK4A); PATHWAYS; P16; RETINOBLASTOMA; INHIBITION; P15(INK4B); MUTATIONS	Oncogenesis is a progressive process often involving collaboration between various oncogenes and tumor suppressors. To identify those genes that collaborate with oncogenic ras, we took advantage of the Tg. AC transgenic mouse, a line that harbors the v- Ha- ras transgene and spontaneously develops an array of malignant tumors. By crossing Tg. AC mice on an inbred FVB background to other inbred strains, F1 mice were created that could be analysed using genome wide, single nucleotide polymorphism ( SNP) screens. Loss of heterozygosity ( LOH) in tumors and tumor cell lines marked a somatic event, possibly the inactivation of tumor suppressor gene( s). LOH could also represent DNA damage, a sign of genomic instability in the pretransformed cell. Nonetheless, the screens showed no evidence of such generalized genomic instability. Instead, they revealed a single region of LOH on chromosome 4 that occurred via somatic recombination/ gene conversion, generating a region of isoparental disomy. This LOH provided a clue that linked v- Ha- ras to the inactivation of the Ink4a locus in 25 of 32 tumor cell lines. This collaboration is seen regardless of tumor type or genetic background. In contrast, tumors that develop in bitransgenic mice bearing both the v- Ha- ras gene and a heterozygous mutant p53 allele tend to retain the Ink4a locus and instead lose the p53 wild- type allele. This suggests that different strategies can be selected to collaborate with v- Ha- ras in tumorigenesis.	[Leder, A.; McMenamin, J.; Zhou, F.; Leder, P.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Moran, J. L.; Beier, D. R.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Leder, P (corresponding author), Harvard Univ, Sch Med, Dept Genet, NRB 356B,77 Ave Louis Pasteur, Boston, MA 02115 USA.	leder@genetics.med.harvard.edu		Moran, Jennifer/0000-0002-5664-4716				Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Berger JH, 2007, CURR MOL MED, V7, P63, DOI 10.2174/156652407779940477; Campbell PM, 2004, SEMIN CANCER BIOL, V14, P105, DOI 10.1016/j.semcancer.2003.09.015; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; CARDIFF RD, 1993, AM J PATHOL, V142, P1199; Chin L, 1997, GENE DEV, V11, P2822, DOI 10.1101/gad.11.21.2822; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DRYJA TP, 1984, NEW ENGL J MED, V310, P550, DOI 10.1056/NEJM198403013100902; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Guan RJ, 1999, GASTROENTEROLOGY, V116, P1063, DOI 10.1016/S0016-5085(99)70009-0; Humble MC, 2005, ONCOGENE, V24, P8217, DOI 10.1038/sj.onc.1209000; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kelly-Spratt KS, 2004, PLOS BIOL, V2, P1138, DOI 10.1371/journal.pbio.0020242; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Leder A, 1997, BLOOD, V90, P1275, DOI 10.1182/blood.V90.3.1275.1275_1275_1282; LEDER A, 1990, P NATL ACAD SCI USA, V87, P9178, DOI 10.1073/pnas.87.23.9178; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; LINARDOPOULOS S, 1995, CANCER RES, V55, P5168; LUKAS J, 1995, NATURE, V375, P503, DOI 10.1038/375503a0; Moran JL, 2006, GENOME RES, V16, P436, DOI 10.1101/gr.4563306; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; Tannapfel A, 2000, GUT, V47, P721, DOI 10.1136/gut.47.5.721; Uhrbom L, 2002, CANCER RES, V62, P5551	32	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2008	27	17					2456	2465		10.1038/sj.onc.1210866	http://dx.doi.org/10.1038/sj.onc.1210866			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286KN	17952114				2022-12-25	WOS:000254844900010
J	Savio, MG; Rotondo, G; Maglie, S; Rossetti, G; Bender, JR; Pardi, R				Savio, M. G.; Rotondo, G.; Maglie, S.; Rossetti, G.; Bender, J. R.; Pardi, R.			COP1D, an alternatively spliced constitutive photomorphogenic-1 (COP1) product, stabilizes UV stress-induced c-Jun through inhibition of full-length COP1	ONCOGENE			English	Article						AP-1; transcription; ubiquitin ligase; alternative splicing; genotoxic stress	UBIQUITIN LIGASE COP1; TRANSCRIPTION FACTORS; NEGATIVE REGULATOR; P53; PROTEIN; KINASES; CELLS; TRANSACTIVATION; DEGRADATION; EXPRESSION	COP1 is an evolutionarily conserved RING-finger ubiquitin ligase acting within a Cullin- RING ligase ( CRL) complex that promotes polyubiquitination of c- Jun and p53. Stability of the above substrates is affected by post-translational changes priming the proteins for polyubiquitination and proteasome- dependent degradation. However, degradation of both substrates is controlled indirectly by signaling pathways affecting the E3 ligases involved in their polyubiquitination. Here, we report the identification of COP1D, a ubiquitously expressed splice variant of COP1 lacking a portion of a coiled- coil region involved in intermolecular associations. While being unable to associate with other components of the CRL complex, COP1D exerts a dominant- negative function over the full- length protein, due to its ability to heterodimerize with COP1 and sequester it from the enzymatically active complex. Ectopic expression of COP1D antagonizes the function of COP1, while its selective downregulation by RNA interference promotes more efficient degradation of c- Jun and p53 by the full- length protein. The COP1/ COP1D mRNA ratio is modulated by UV stress and a decreased COP1/ COP1D ratio correlates with elevated c- Jun, but not p53 protein levels in invasive ductal breast cancer. Thus, dynamic changes of the COP1/ COP1D ratio provide an additional level of regulation of the half-life of the substrates of this E3 ligase under homeostatic or pathological conditions.	[Savio, M. G.; Rotondo, G.; Maglie, S.; Rossetti, G.; Pardi, R.] Univ Vita Salute San Raffaele, Sch Med, DIBIT Sci Inst San Raffaele, Unit Leukocyte Biol, I-20132 Milan, Italy; [Bender, J. R.] Yale Univ, Sch Med, Sect Cardiovasc Med, Raymond & Beverly Sackler Fdn Cardiovasc Lab, New Haven, CT USA	Vita-Salute San Raffaele University; Yale University	Pardi, R (corresponding author), Univ Vita Salute San Raffaele, Sch Med, DIBIT Sci Inst San Raffaele, Unit Leukocyte Biol, I-20132 Milan, Italy.	pardi.ruggero@hsr.it	rossetti, grazisa/C-3722-2015	rossetti, grazisa/0000-0001-6361-311X; Rotondo, Giuseppe/0000-0001-7811-1753	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043331] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL43331] Funding Source: Medline	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bianchi E, 2003, J BIOL CHEM, V278, P19682, DOI 10.1074/jbc.M212681200; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Dornan D, 2004, CANCER RES, V64, P7226, DOI 10.1158/0008-5472.CAN-04-2601; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Dornan D, 2006, SCIENCE, V313, P1122, DOI 10.1126/science.1127335; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Fuchs SY, 1997, J BIOL CHEM, V272, P32163, DOI 10.1074/jbc.272.51.32163; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Koivusalo R, 2006, CANCER RES, V66, P11817, DOI 10.1158/0008-5472.CAN-06-2185; Krummel KA, 2005, P NATL ACAD SCI USA, V102, P10188, DOI 10.1073/pnas.0503068102; Langer S, 2006, EUR J GYNAECOL ONCOL, V27, P345; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; MATLASHEWSKI G, 1986, EUR J BIOCHEM, V154, P665, DOI 10.1111/j.1432-1033.1986.tb09449.x; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Reed SE, 2004, CANCER RES, V64, P795, DOI 10.1158/0008-5472.CAN-03-3417; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Subramanian C, 2004, P NATL ACAD SCI USA, V101, P6798, DOI 10.1073/pnas.0307964101; Torii KU, 1998, EMBO J, V17, P5577, DOI 10.1093/emboj/17.19.5577; Tsuge T, 2001, MOL GENET GENOMICS, V265, P43, DOI 10.1007/s004380000396; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Yanagawa Y, 2004, GENE DEV, V18, P2172, DOI 10.1101/gad.1229504; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007; Yi CL, 2005, CANCER RES, V65, P5835, DOI 10.1158/0008-5472.CAN-05-0423	28	23	24	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2008	27	17					2401	2411		10.1038/sj.onc.1210892	http://dx.doi.org/10.1038/sj.onc.1210892			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286KN	17968316				2022-12-25	WOS:000254844900005
J	Tommiska, J; Bartkova, J; Heinonen, M; Hautala, L; Kilpivaara, O; Eerola, H; Aittomaki, K; Hofstetter, B; Lukas, J; von Smitten, K; Blomqvist, C; Ristimaki, A; Heikkila, P; Bartek, J; Nevanlinna, H				Tommiska, J.; Bartkova, J.; Heinonen, M.; Hautala, L.; Kilpivaara, O.; Eerola, H.; Aittomaki, K.; Hofstetter, B.; Lukas, J.; von Smitten, K.; Blomqvist, C.; Ristimaki, A.; Heikkila, P.; Bartek, J.; Nevanlinna, H.			The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer	ONCOGENE			English	Article						DNA damage response; triple-negative breast cancer; BRCA1/BRCA2 familial cancer; ATM defects; genetic instability	ONCOGENE-INDUCED SENESCENCE; DOUBLE-STRAND BREAKS; BRCA2 MUTATIONS; POLY(ADP-RIBOSE) POLYMERASE; HISTOPATHOLOGICAL FEATURES; ATAXIA-TELANGIECTASIA; ANTICANCER BARRIER; PROTEIN EXPRESSION; FAMILIES; TUMORS	The ataxia- telangiectasia- mutated ( ATM) kinase is a key transducer of DNA damage signals within the genome maintenance machinery and a tumour suppressor whose germline mutations predispose to familial breast cancer. ATM signalling is constitutively activated in early stages of diverse types of human malignancies and cell culture models in response to oncogene- induced DNA damage providing a barrier against tumour progression. As BRCA1 and BRCA2 are also components of the genome maintenance network and their mutations predispose to breast cancer, we have examined the ATM expression in human breast carcinomas of BRCA1/ 2 mutation carriers, sporadic cases and familial non- BRCA1/ 2 patients. Our results show that ATM protein expression is aberrantly reduced more frequently among BRCA1 ( 33%; P 0.0003) and BRCA2 ( 30%; P 0.0009) tumours than in non- BRCA1/ 2 tumours ( 10.7%). Furthermore, the non-BRCA1/ 2 tumours with reduced ATM expression were more often estrogen receptor ( ER) negative ( P 0.0002), progesterone receptor ( PR) negative ( P 0.004) and were of higher grade ( P 0.0004). In our series of 1013 non-BRCA1/ 2 cases, ATM was more commonly deficient ( 20%; P 0.0006) and p53 was overabundant ( 47%; P<0.0000000001) among the difficult- to- treat ER/ PR/ ERBB2- triple- negative subset of tumours compared with cases that expressed at least one of these receptors ( 10 and 16% of aberrant ATM and p53, respectively). We propose a model of conditional haploinsufficiency' for BRCA1/ 2 under conditions of enhanced DNA damage in precancerous lesions resulting in more robust activation and hence increased selection for inactivation or loss of ATM in tumours of BRCA1/ 2 mutation carriers, with implications for genomic instability and curability of diverse subsets of human breast cancer.	[Tommiska, J.; Hautala, L.; Kilpivaara, O.; Eerola, H.; Nevanlinna, H.] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00029 Helsinki, Finland; [Bartkova, J.; Hofstetter, B.; Lukas, J.; Bartek, J.] Danish Canc Soc, Inst Canc Biol, Copenhagen, Denmark; [Bartkova, J.; Hofstetter, B.; Lukas, J.; Bartek, J.] Danish Canc Soc, Ctr Genotox Stress Res, Copenhagen, Denmark; [Heinonen, M.; Ristimaki, A.; Heikkila, P.] HUSLAB, Dept Pathol, Helsinki, Finland; [Heinonen, M.; Ristimaki, A.; Heikkila, P.] Univ Helsinki, Cent Hosp, Haartman Inst, FIN-00029 Helsinki, Finland; [Heinonen, M.; Ristimaki, A.] Univ Helsinki, Genome Scale Biol Program, Helsinki, Finland; [Eerola, H.; Blomqvist, C.] Univ Helsinki, Cent Hosp, Dept Oncol, FIN-00029 Helsinki, Finland; [Aittomaki, K.] Univ Helsinki, Cent Hosp, Dept Clin Genet, FIN-00029 Helsinki, Finland; [von Smitten, K.] Univ Helsinki, Cent Hosp, Dept Surg, FIN-00029 Helsinki, Finland; [Blomqvist, C.] Univ Uppsala Hosp, Dept Oncol, S-75185 Uppsala, Sweden	University of Helsinki; Helsinki University Central Hospital; Danish Cancer Society; Danish Cancer Society; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Uppsala University; Uppsala University Hospital	Nevanlinna, H (corresponding author), Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, POB 700, FIN-00029 Helsinki, Finland.	jb@cancer.dk; heli.nevanlinna@hus.fi	Bartek, Jiri/G-5870-2014	Hautala, Laura/0000-0002-5501-2792; Nevanlinna, Heli/0000-0002-0916-2976; Blomqvist, Carl/0000-0003-3041-1938; Tommiska, Johanna/0000-0001-7958-8262; Lukas, Jiri/0000-0001-9087-506X				Angele S, 2003, HISTOPATHOLOGY, V43, P347, DOI 10.1046/j.1365-2559.2003.01713.x; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bartek J, 2007, CELL CYCLE, V6, P2344, DOI 10.4161/cc.6.19.4754; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bartkova J, 2005, CELL CYCLE, V4, P838, DOI 10.4161/cc.4.6.1742; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Eerola H, 2005, BREAST CANCER RES, V7, pR465, DOI 10.1186/bcr1025; Eerola H, 2005, BREAST CANCER RES, V7, pR93, DOI 10.1186/bcr953; Eerola H, 2000, EUR J CANCER, V36, P1143, DOI 10.1016/S0959-8049(00)00093-9; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Honrado E, 2005, MODERN PATHOL, V18, P1305, DOI 10.1038/modpathol.3800453; IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kilpivaara O, 2005, INT J CANCER, V113, P575, DOI 10.1002/ijc.20638; Lassus H, 2004, GYNECOL ONCOL, V92, P31, DOI 10.1016/j.ygyno.2003.10.010; Lukas C, 2001, CANCER RES, V61, P4990; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Palacios J, 2003, CLIN CANCER RES, V9, P3606; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prokopcova J, 2007, BREAST CANCER RES TR, V104, P121, DOI 10.1007/s10549-006-9406-6; Pylkas K, 2007, CARCINOGENESIS, V28, P1040, DOI 10.1093/carcin/bgl237; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Syrjakoski K, 2000, J NATL CANCER I, V92, P1529, DOI 10.1093/jnci/92.18.1529; Tanner M, 2000, AM J PATHOL, V157, P1467, DOI 10.1016/S0002-9440(10)64785-2; Tommiska J, 2005, CLIN CANCER RES, V11, P5098, DOI 10.1158/1078-0432.CCR-05-0173; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Vahteristo P, 2002, AM J HUM GENET, V71, P432, DOI 10.1086/341943; Vahteristo P, 2001, BRIT J CANCER, V84, P704, DOI 10.1054/bjoc.2000.1626; Vehmanen P, 1997, HUM MOL GENET, V6, P2309, DOI 10.1093/hmg/6.13.2309; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	41	86	90	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2008	27	17					2501	2506		10.1038/sj.onc.1210885	http://dx.doi.org/10.1038/sj.onc.1210885			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286KN	17982490				2022-12-25	WOS:000254844900015
J	Uttamsingh, S; Bao, X; Nguyen, KT; Bhanot, M; Gong, J; Chan, JK; Liu, F; Chu, TT; Wang, LH				Uttamsingh, S.; Bao, X.; Nguyen, K. T.; Bhanot, M.; Gong, J.; Chan, JL-K; Liu, F.; Chu, T. T.; Wang, L-H			Synergistic effect between EGF and TGF-beta 1 in inducing oncogenic properties of intestinal epithelial cells	ONCOGENE			English	Article						EGF; TGF-beta 1; EMT; invasion; colony formation	GROWTH-FACTOR-BETA; ANCHORAGE-INDEPENDENT GROWTH; TRANSCRIPTION FACTOR SNAIL; E-CADHERIN; TGF-BETA; PHOSPHATIDYLINOSITOL 3-KINASE; MESENCHYMAL TRANSITIONS; GENE-EXPRESSION; CANCER-CELLS; TRANSFORMATION	Transforming growth factor (TGF)-beta 1 has a biphasic effect on rat intestinal epithelial (RIE) cells. By itself, TGF-beta 1 functions as a tumor suppressor by inhibiting the growth, migration and invasion of RIE cells. We show in this study that in conjunction with epidermal-growth factor (EGF), TGF-beta 1 helped to augment migration, invasion and anchorage-independent growth (AIG) compared to that by EGF alone. EGF plus TGF-beta 1 induced a dramatic morphological change characteristic of epithelial-mesenchymal transition (EMT). The mechanism for this enhanced effect of TGF-beta 1 and EGF on oncogenic properties was explored by analysis of EGF- and TGF-beta 1-mediated signaling pathways and complementary DNA arrays. TGF-beta 1 augmented EGF-mediated signaling of mitogen-activated protein kinase (MAPK) and AKT by enhancing and prolonging the activation of the former and prolonging the activation of the latter. Inhibition of MAPK, but not phosphoinositide-3 kinase (PI3K), abolished TGF-beta 1 plus EGF-induced EMT and down-regulation of E-cadherin at mRNA and protein levels. By contrast, cell migration and invasion were sensitive to inhibition of either MAPK or PI3 kinase. TGF-beta 1 plus EGF-induced AIG was significantly more resistant to inhibition of PI3K and MAPK compared to that induced by EGF alone. EGF and TGF-beta 1 synergistically induced the expression of a series of proteases including matrix metalloproteinase (MMP) 1 (collagenase), MMP3, MMP9, MMP10, MMP14 and cathepsin. Among them, the expression of MMP1, MMP3, MMP9 and MMP10 was MAPK dependent. Inhibition of the MMPs or cathepsin significantly blocked EGF plus TGF-beta 1-induced invasion, but had no effect on colony formation. Phospholipase C (PLC) and Cox2 induced by EGF plus TGF-beta 1 also played a significant role in invasion, whereas PLC was also important for colony formation. Our study reveals specific signaling functions and induction of genes differentially required for enhanced effect of EGF- and TGF-beta 1-induced oncogenic properties, and helps to explain the tumor-promoting effect of TGF-beta 1 in human cancer with elevated expression or activation of TGF-beta 1 and receptor protein tyrosine kinases.	[Uttamsingh, S.; Bao, X.; Nguyen, K. T.; Bhanot, M.; Gong, J.; Chan, JL-K; Wang, L-H] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Liu, F.] Rutgers State Univ, Ernest Mario Sch Pharm, Ctr Adv Biotechnol & Med, Piscataway, NJ USA; [Liu, F.] Rutgers State Univ, Ernest Mario Sch Pharm, Susan Lehman Cullman Lab Canc Res, Piscataway, NJ USA; [Chu, T. T.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Icahn School of Medicine at Mount Sinai	Wang, LH (corresponding author), Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA.	lu-hai.wang@mssm.edu	Wang, Lu-Hai/E-3986-2010; Gong, Jianli/G-1212-2011		NATIONAL CANCER INSTITUTE [R01CA055054, R01CA029339] Funding Source: NIH RePORTER; NCI NIH HHS [CA29339, CA55054] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ASSOIAN RK, 1989, ANAL BIOCHEM, V177, P95, DOI 10.1016/0003-2697(89)90020-1; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bracke ME, 1996, CURR TOP MICROBIOL, V213, P123; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; DELARCO JE, 1978, J CELL PHYSIOL, V94, P335, DOI 10.1002/jcp.1040940311; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF1202, DOI 10.1152/ajprenal.00406.2005; GLICK AB, 1994, GENE DEV, V8, P2429, DOI 10.1101/gad.8.20.2429; Gold LI, 1999, CRIT REV ONCOGENESIS, V10, P303; Itoh Y, 2002, ESSAYS BIOCHEM, V38, P21, DOI 10.1042/bse0380021; JONG SMJ, 1987, ONCOGENE RES, V1, P7; Kizaka-Kondoh S, 2000, FEBS LETT, V466, P160, DOI 10.1016/S0014-5793(99)01784-6; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Nguyen KT, 2000, ONCOGENE, V19, P5385, DOI 10.1038/sj.onc.1203911; Sachdev P, 2002, J BIOL CHEM, V277, P17638, DOI 10.1074/jbc.M111575200; Saha Debabrata, 1999, Neoplasia (New York), V1, P508; Seton-Rogers SE, 2004, P NATL ACAD SCI USA, V101, P1257, DOI 10.1073/pnas.0308090100; Siegel PM, 2003, P NATL ACAD SCI USA, V100, P8430, DOI 10.1073/pnas.0932636100; Stolz DB, 1997, J CELL PHYSIOL, V170, P57; Tang BW, 1998, NAT MED, V4, P802, DOI 10.1038/nm0798-802; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Uttamsingh S, 2003, J BIOL CHEM, V278, P18798, DOI 10.1074/jbc.M211522200; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wang LH, 2004, MT SINAI J MED, V71, P361; WELCH DR, 1990, P NATL ACAD SCI USA, V87, P7678, DOI 10.1073/pnas.87.19.7678; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948	28	122	125	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2008	27	18					2626	2634		10.1038/sj.onc.1210915	http://dx.doi.org/10.1038/sj.onc.1210915			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	289LW	17982486				2022-12-25	WOS:000255057000012
J	Teghanemt, A; Re, F; Prohinar, P; Widstrom, R; Gioannini, TL; Weiss, JP				Teghanemt, Athmane; Re, Fabio; Prohinar, Polonca; Widstrom, Richard; Gioannini, Theresa L.; Weiss, Jerrold P.			Novel roles in human MD-2 of phenylalanines 121 and 126 and tyrosine 131 in activation of toll-like receptor 4 by endotoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-4; LIPOPOLYSACCHARIDE-BINDING; CELL ACTIVATION; LIPID-IVA; NEISSERIA-MENINGITIDIS; MONOMERIC ENDOTOXIN; SIGNAL-TRANSDUCTION; TLR4-MD-2 COMPLEX; PROTEIN COMPLEXES; TLR4	Potent mammalian cell activation by Gram-negative bacterial endotoxin requires sequential protein-endotoxin and protein-protein interactions involving lipopolysaccharide-binding protein, CD14, MD-2, and Toll-like receptor 4 (TLR4). TLR4 activation requires simultaneous binding of MD-2 to endotoxin ( E) and the ectodomain of TLR4. We now describe mutants of recombinant human MD-2 that bind TLR4 and react with E center dot CD14 but do not support cellular responsiveness to endotoxin. The mutants F121A/K122A MD-2 and Y131A/K132A MD-2 react with E center dot CD14 only when co-expressed with TLR4. Single mutants K122A and K132A each react with E center dot CD14 +/- TLR4 and promote TLR4-dependent cell activation by endotoxin suggesting that Phe(121) and Tyr(131) are needed for TLR4-independent transfer of endotoxin from CD14 to MD-2 and also needed for TLR4 activation by bound E center dot MD-2. The mutant F126A MD-2 reacts as well as wild-type MD-2 with E center dot CD14 +/- TLR4. E center dot MD-2(F126A) binds TLR4 with high affinity (K-d similar to 200 pM) but does not activate TLR4 and instead acts as a potent TLR4 antagonist, inhibiting activation of HEK/TLR4 cells by wildtype E center dot MD-2. These findings reveal roles of Phe121 and Tyr131 in TLR4-independent interactions of human MD-2 with E center dot CD14 and, together with Phe(126), in activation of TLR4 by bound E center dot MD-2. These findings strongly suggest that the structural properties of E center dot MD-2, not E alone, determine agonist or antagonist effects on TLR4.	[Teghanemt, Athmane; Prohinar, Polonca; Widstrom, Richard; Gioannini, Theresa L.; Weiss, Jerrold P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Teghanemt, Athmane; Prohinar, Polonca; Widstrom, Richard; Gioannini, Theresa L.; Weiss, Jerrold P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Inflammat Program, Iowa City, IA 52242 USA; [Weiss, Jerrold P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA; [Gioannini, Theresa L.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA; [Gioannini, Theresa L.] Vet Adm Med Ctr, Iowa City, IA 52246 USA; [Re, Fabio] Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN 38163 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Tennessee System; University of Tennessee Health Science Center	Weiss, JP (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, 2501 Crosspk Rd, Coralville, IA 52241 USA.	jerrold-weiss@uiowa.edu		Weiss, Jerrold/0000-0003-1476-4485	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI054665, R01AI059372] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI 54665, AI 59372] Funding Source: Medline; PHS HHS [P01 44642] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Akashi S, 2001, INT IMMUNOL, V13, P1595, DOI 10.1093/intimm/13.12.1595; Beutler B, 2003, ANNU REV PHARMACOL, V43, P609, DOI 10.1146/annurev.pharmtox.43.100901.135729; Gangloff M, 2004, TRENDS BIOCHEM SCI, V29, P294, DOI 10.1016/j.tibs.2004.04.008; Giardina PC, 2001, J BIOL CHEM, V276, P5883, DOI 10.1074/jbc.M009273200; Gioannini TL, 2007, IMMUNOL RES, V39, P249, DOI 10.1007/s12026-007-0069-0; Gioannini TL, 2007, J BIOL CHEM, V282, P7877, DOI 10.1074/jbc.M605031200; Gioannini TL, 2005, J ENDOTOXIN RES, V11, P117, DOI 10.1179/096805105X35198; Gioannini TL, 2003, J ENDOTOXIN RES, V9, P401, DOI 10.1179/096805103225002773; Gioannini TL, 2002, J BIOL CHEM, V277, P47818, DOI 10.1074/jbc.M206404200; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hyakushima N, 2004, J IMMUNOL, V173, P6949, DOI 10.4049/jimmunol.173.11.6949; Jia HP, 2004, AM J PHYSIOL-LUNG C, V287, pL428, DOI 10.1152/ajplung.00377.2003; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kawasaki K, 2003, J IMMUNOL, V170, P413, DOI 10.4049/jimmunol.170.1.413; Kawasaki K, 2001, J ENDOTOXIN RES, V7, P232, DOI 10.1177/09680519010070030701; Kennedy MN, 2004, J BIOL CHEM, V279, P34698, DOI 10.1074/jbc.M405444200; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kitchens RL, 2001, J CLIN INVEST, V108, P485, DOI 10.1172/JCI200113139; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Miyake K, 2003, INT IMMUNOPHARMACOL, V3, P119, DOI 10.1016/S1567-5769(02)00258-8; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Mullen GED, 2003, P NATL ACAD SCI USA, V100, P3919, DOI 10.1073/pnas.0630495100; Muroi M, 2006, J BIOL CHEM, V281, P5484, DOI 10.1074/jbc.M509193200; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Post DMB, 2005, J BIOL CHEM, V280, P38383, DOI 10.1074/jbc.M508063200; Prohinar P, 2007, J BIOL CHEM, V282, P1010, DOI 10.1074/jbc.M609400200; Re F, 2003, J IMMUNOL, V171, P5272, DOI 10.4049/jimmunol.171.10.5272; Re F, 2002, J BIOL CHEM, V277, P23427, DOI 10.1074/jbc.M202554200; Saitoh S, 2004, J ENDOTOXIN RES, V10, P257, DOI 10.1179/096805104225005904; Saitoh S, 2004, INT IMMUNOL, V16, P961, DOI 10.1093/intimm/dxh097; Teghanemt A, 2005, J IMMUNOL, V175, P4669, DOI 10.4049/jimmunol.175.7.4669; Tsuneyoshi N, 2005, J IMMUNOL, V174, P340, DOI 10.4049/jimmunol.174.1.340; Ulevitch RJ, 1999, CURR OPIN IMMUNOL, V11, P19, DOI 10.1016/S0952-7915(99)80004-1; Viriyakosol S, 2006, J BIOL CHEM, V281, P11955, DOI 10.1074/jbc.M511627200; Viriyakosol S, 2000, J ENDOTOXIN RES, V6, P489, DOI 10.1179/096805100101532379; Visintin A, 2005, J IMMUNOL, V175, P6465, DOI 10.4049/jimmunol.175.10.6465; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; Yang H, 2000, J BIOL CHEM, V275, P20861, DOI 10.1074/jbc.M002896200	40	38	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1257	1266		10.1074/jbc.M705994200	http://dx.doi.org/10.1074/jbc.M705994200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17977838	hybrid			2022-12-25	WOS:000252282700008
J	Kuraoka, I; Ito, S; Wada, T; Hayashida, M; Lee, L; Saijo, M; Nakatsu, Y; Matsumoto, M; Matsunaga, T; Handa, H; Qin, J; Nakatani, Y; Tanaka, K				Kuraoka, Isao; Ito, Shinsuke; Wada, Tadashi; Hayashida, Mika; Lee, Lily; Saijo, Masafumi; Nakatsu, Yoshimichi; Matsumoto, Megumi; Matsunaga, Tsukasa; Handa, Hiroshi; Qin, Jun; Nakatani, Yoshihiro; Tanaka, Kiyoji			Isolation of XAB2 complex involved in pre-mRNA splicing, transcription, and transcription-coupled repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; CYCLOBUTANE PYRIMIDINE DIMER; DNA-REPAIR; COCKAYNE-SYNDROME; POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; XERODERMA-PIGMENTOSUM; NUCLEAR-MATRIX; CANCER-CELLS	Nucleotide excision repair is a versatile repair pathway that counteracts the deleterious effects of various DNA lesions. In nucleotide excision repair, there is a transcription-coupled repair (TCR) pathway that focuses on DNA damage that blocks RNA polymerase IIo in transcription elongation. XAB2 (XPA-binding protein 2), containing tetratricopeptide repeats, has been isolated by virtue of its ability to interact with xeroderma pigmentosum group A protein (XPA). Moreover, XAB2 has been shown to interact with Cockayne syndrome group A and B proteins (CSA and CSB) and RNA polymerase II, as well as XPA, and is involved in TCR and transcription. Here we purified XAB2 as a multimeric protein complex consisting of hAquarius, XAB2, hPRP19, CCDC16, hISY1, and PPIE, which are involved in pre-mRNA splicing. Knockdown of XAB2 with small interfering RNA in HeLa cells resulted in a hypersensitivity to killing by UV light and a decreased recovery of RNA synthesis after UV irradiation and regular RNA synthesis. Enhanced interaction of XAB2 with RNA polymerase IIo or XPA was observed in cells treated with DNA-damaging agents, indicating DNA damage-responsive activity of the XAB2 complex. These results indicated that the XAB2 complex is a multifunctional factor involved in pre-mRNA splicing, transcription, and TCR.	[Kuraoka, Isao; Ito, Shinsuke; Hayashida, Mika; Lee, Lily; Saijo, Masafumi; Nakatsu, Yoshimichi; Tanaka, Kiyoji] Osaka Univ, Grad Sch Frontier Biosci, Labs Organismal Biosyst, Suita, Osaka 5650871, Japan; [Kuraoka, Isao; Saijo, Masafumi; Tanaka, Kiyoji] Japan Sci & Technol Agcy, Solut Oriented Res Sci & Technol, Suita, Osaka 5650871, Japan; [Matsumoto, Megumi; Matsunaga, Tsukasa] Kanazawa Univ, Grad Sch Nat Sci & Technol, Lab Human Mol Genet, Kakuma, Kanazawa 9201192, Japan; [Wada, Tadashi; Handa, Hiroshi] Tokyo Inst Technol, Fac Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan; [Wada, Tadashi; Handa, Hiroshi] Tokyo Inst Technol, Frontier Collaborat Res Ctr, Yokohama, Kanagawa 2268501, Japan; [Qin, Jun] Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; [Nakatani, Yoshihiro] Dana Farber Canc Inst, Boston, MA 02115 USA; [Nakatani, Yoshihiro] Harvard Univ, Sch Med, Boston, MA 02115 USA	Osaka University; Japan Science & Technology Agency (JST); Kanazawa University; Tokyo Institute of Technology; Tokyo Institute of Technology; Baylor College of Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Kuraoka, I (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Labs Organismal Biosyst, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	ikuraoka@nk-cc.go.jp; ktanaka@fbs.osaka-u.ac.jp		Nakatsu, Yoshimichi/0000-0001-7408-7071; Kuraoka, Isao/0000-0001-6391-3411				Araujo SJ, 2000, GENE DEV, V14, P349; Bedford MT, 1998, P NATL ACAD SCI USA, V95, P10602, DOI 10.1073/pnas.95.18.10602; Ben-Yehuda S, 2000, GENETICS, V156, P1503; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Brendel M, 2003, MUTAT RES-REV MUTAT, V544, P179, DOI 10.1016/j.mrrev.2003.06.018; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Dahan O, 2002, NUCLEIC ACIDS RES, V30, P4361, DOI 10.1093/nar/gkf563; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Dix I, 1999, RNA, V5, P360, DOI 10.1017/S1355838299981396; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P8502, DOI 10.1073/pnas.91.18.8502; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Goldstrohm AC, 2001, MOL CELL BIOL, V21, P7617, DOI 10.1128/MCB.21.22.7617-7628.2001; Grey M, 1996, NUCLEIC ACIDS RES, V24, P4009, DOI 10.1093/nar/24.20.4009; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; GUZDER SN, 1995, J BIOL CHEM, V270, P12973, DOI 10.1074/jbc.270.22.12973; Hasegawa J, 2003, J BIOCHEM, V133, P133, DOI 10.1093/jb/mvg013; Hirose T, 2006, MOL CELL, V23, P673, DOI 10.1016/j.molcel.2006.07.011; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Inukai N, 2004, J BIOL CHEM, V279, P8190, DOI 10.1074/jbc.M311412200; Ito S, 2007, MOL CELL, V26, P231, DOI 10.1016/j.molcel.2007.03.013; Kamiuchi S, 2002, P NATL ACAD SCI USA, V99, P201, DOI 10.1073/pnas.012473199; Kim JO, 1998, ONCOGENE, V17, P1019, DOI 10.1038/sj.onc.1202006; Kwei JSM, 2004, BIOCHEM BIOPH RES CO, V320, P1133, DOI 10.1016/j.bbrc.2004.06.066; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Mahajan KN, 2003, P NATL ACAD SCI USA, V100, P10746, DOI 10.1073/pnas.1631060100; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Matsushima Y, 1997, BIOSCI BIOTECH BIOCH, V61, P905, DOI 10.1271/bbb.61.905; Mercatante DR, 2002, BBA-MOL BASIS DIS, V1587, P126, DOI 10.1016/S0925-4439(02)00075-3; Mercatante DR, 2001, J BIOL CHEM, V276, P16411, DOI 10.1074/jbc.M009256200; Mi HF, 1996, FEBS LETT, V398, P201, DOI 10.1016/S0014-5793(96)01248-3; NAGAI A, 1995, BIOCHEM BIOPH RES CO, V211, P960, DOI 10.1006/bbrc.1995.1905; Nagai K, 2004, BIOCHEM BIOPH RES CO, V316, P512, DOI 10.1016/j.bbrc.2004.02.077; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Nakatsu Y, 2000, J BIOL CHEM, V275, P34931, DOI 10.1074/jbc.M004936200; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; Ohnuma-Ishikawa K, 2007, CANCER RES, V67, P1019, DOI 10.1158/0008-5472.CAN-06-1638; Prakash S, 2000, MUTAT RES-FUND MOL M, V451, P13, DOI 10.1016/S0027-5107(00)00037-3; Reed R, 2003, CURR OPIN CELL BIOL, V15, P326, DOI 10.1016/S0955-0674(03)00048-6; Saijo M, 2007, MOL CELL BIOL, V27, P2538, DOI 10.1128/MCB.01288-06; Sam M, 1998, DEV DYNAM, V212, P304, DOI 10.1002/(SICI)1097-0177(199806)212:2<304::AID-AJA15>3.0.CO;2-3; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Stein P, 2003, RNA, V9, P187, DOI 10.1261/rna.2860603; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Villa T, 2005, GENE DEV, V19, P1894, DOI 10.1101/gad.1336305; Wang Y, 2000, GENE DEV, V14, P927; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Yonemasu R, 2005, DNA REPAIR, V4, P479, DOI 10.1016/j.dnarep.2004.12.004; Zorio DAR, 2004, EXP CELL RES, V296, P91, DOI 10.1016/j.yexcr.2004.03.019	54	75	82	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					940	950		10.1074/jbc.M706647200	http://dx.doi.org/10.1074/jbc.M706647200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17981804	hybrid			2022-12-25	WOS:000252128100034
J	Petrovic, V; Costa, RH; Lau, LF; Raychaudhuri, P; Tyner, AL				Petrovic, Vladimir; Costa, Robert H.; Lau, Lester F.; Raychaudhuri, Pradip; Tyner, Angela L.			FoxM1 regulates growth factor-induced expression of kinase-interacting stathmin (KIS) to promote cell cycle progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD BOX M1; TRANSCRIPTION FACTOR; HEPATOCELLULAR-CARCINOMA; UBIQUITIN LIGASE; INHIBITOR P27; LIVER-REGENERATION; TUMOR-SUPPRESSOR; P27(KIP1); PROTEIN; GENES	The Forkhead box M1 ( FoxM1) transcription factor is essential for cell cycle progression and mitosis. FoxM1 regulates expression of Skp2 and Cks1, subunits of the SCF ubiquitin ligase complex, which ubiquitinates p27(Kip1) and targets it for degradation. Kinase-interacting stathmin (KIS) is a growth factor-dependent nuclear kinase that regulates cell cycle progression by phosphorylating p27(Kip1) to promote its nuclear export. Here we present an additional mechanism of FoxM1-mediated regulation of p27(Kip1) and provide evidence that FoxM1 regulates growth factor-induced expression of KIS. In cells harboring FoxM1 deletion or expressing FoxM1-short interfering RNA, the expression of KIS is impaired, leading to an accumulation of p27(Kip1) in the nucleus. Furthermore, we show that KIS is a direct transcriptional target of FoxM1. Thus FoxM1 promotes cell cycle progression by down-regulating p27(Kip1) through multiple mechanisms.	[Petrovic, Vladimir; Costa, Robert H.; Lau, Lester F.; Raychaudhuri, Pradip; Tyner, Angela L.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, MC 669, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tyner, AL (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet, MC 669, 900 S Ashland Ave, Chicago, IL 60607 USA.	atyner@uic.edu		Lau, Lester/0000-0002-4364-2914; Tyner, Angela/0000-0001-7448-8625	NATIONAL CANCER INSTITUTE [R01CA124488, R01CA046565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK044525, R01DK044525, R01DK068503, R01DK054687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021842] Funding Source: NIH RePORTER; NCI NIH HHS [CA 46565, CA 124488] Funding Source: Medline; NIA NIH HHS [R01 AG021842-05, R01 AG021842, AG 21842] Funding Source: Medline; NIDDK NIH HHS [R01 DK044525-14, R01 DK044525, DK 44525, DK 054687, R01 DK054687, R01 DK054687-09, DK 068503] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adam Taghreed, 2003, Cost Eff Resour Alloc, V1, P3, DOI 10.1186/1478-7547-1-3; Alessandrini A, 1997, LEUKEMIA, V11, P342, DOI 10.1038/sj.leu.2400581; Armengol C, 2003, J HEPATOL, V38, P591, DOI 10.1016/S0168-8278(03)00025-4; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Costa RH, 2005, CURR OPIN GENET DEV, V15, P42, DOI 10.1016/j.gde.2004.12.007; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527; Heselmeyer K, 1997, GENE CHROMOSOME CANC, V19, P233, DOI 10.1002/(SICI)1098-2264(199708)19:4<233::AID-GCC5>3.0.CO;2-Y; HOGAN B, 1994, MANIPULATING MOUSE E, P260; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kalinina OA, 2003, ONCOGENE, V22, P6266, DOI 10.1038/sj.onc.1206640; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Korver W, 1997, GENOMICS, V46, P435, DOI 10.1006/geno.1997.5065; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Kotoshiba S, 2005, J BIOL CHEM, V280, P17694, DOI 10.1074/jbc.M500866200; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Maucuer A, 1997, J BIOL CHEM, V272, P23151, DOI 10.1074/jbc.272.37.23151; MAUCUER A, 1995, P NATL ACAD SCI USA, V92, P3100, DOI 10.1073/pnas.92.8.3100; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Rausa FM, 2000, MOL CELL BIOL, V20, P8264, DOI 10.1128/MCB.20.21.8264-8282.2000; Rodriguez S, 2005, CANCER GENET CYTOGEN, V157, P140, DOI 10.1016/j.cancergencyto.2004.08.017; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shiyanov P, 1997, MOL BIOL CELL, V8, P1815, DOI 10.1091/mbc.8.9.1815; Singh B, 2001, CANCER RES, V61, P4506; Spirin KS, 1996, CANCER RES, V56, P2400; Tannapfel A, 2000, INT J CANCER, V89, P350, DOI 10.1002/1097-0215(20000720)89:4<350::AID-IJC6>3.0.CO;2-3; Teh MT, 2002, CANCER RES, V62, P4773; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; van den Boom J, 2003, AM J PATHOL, V163, P1033, DOI 10.1016/S0002-9440(10)63463-3; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; Wang XH, 2002, J BIOL CHEM, V277, P44310, DOI 10.1074/jbc.M207510200; Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; Ye HG, 1999, MOL CELL BIOL, V19, P8570; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Zettl A, 2004, AM J PATHOL, V164, P1837, DOI 10.1016/S0002-9440(10)63742-X; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	44	49	52	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					453	460		10.1074/jbc.M705792200	http://dx.doi.org/10.1074/jbc.M705792200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17984092	hybrid			2022-12-25	WOS:000251940300050
J	Sakamoto, Y; Ogita, H; Komura, H; Takai, Y				Sakamoto, Yasuhisa; Ogita, Hisakazu; Komura, Hitomi; Takai, Yoshimi			Involvement of nectin in inactivation of integrin alpha(v)beta(3) after the establishment of cell-cell adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL PHOSPHATE KINASE; HOMOPHILIC BINDING-SITE; INTEGRIN ACTIVATION; PTP-MU; TYROSINE PHOSPHORYLATION; ADHERENS JUNCTIONS; FOCAL ADHESIONS; RPTP-MU; IN-VIVO; C-SRC	Integrin plays an essential role in the formation of cell-matrix junctions and is also involved in the fundamental cellular functions. In the process of the formation of cell-cell junctions, an immunoglobulin-like cell-cell adhesion molecule nectin initially trans-interacts together and promotes the formation of adherens junctions (AJs) cooperatively with another cell-cell adhesion molecule cadherin. The activation of integrin alpha(v)beta(3) is critically necessary for this nectin-induced formation of AJs. However, after the establishment of AJs, integrin alpha(v)beta(3) becomes inactive and retains the association with nectin at AJs. The molecular mechanism of this dynamic regulation of integrin alpha(v)beta(3) during the formation of AJs remains unclear. We found here that the expression of phosphatidylinositol-phosphate kinase type I gamma 90 (PIPKI gamma 90), which is involved in the regulation of integrin activation, in Madin-Darby canine kidney cells, preferentially reversed the inactivation of integrin alpha(v)beta(3) at cell-cell adhesion sites and partially disrupted E-cadherin-based AJs. The activation of PIPKI gamma is correlated with its phosphorylation state. The tyrosine phosphatase protein-tyrosine phosphatase mu (PTP mu) effectively dephosphorylated PIPKI gamma and thus canceled the PIPKI gamma-dependent activation of integrin alpha(v)beta(3) by blocking the interaction of integrin alpha(v)beta(3) with talin. Moreover, PTP mu associated with nectin, and its phosphatase activity was enhanced by the trans-interaction of nectin, leading to the decrease in PIPKI gamma 90 phosphorylation. Therefore, the trans-interaction of nectin essentially functions in the inactivation of integrin at AJs through the PTP mu-induced inactivation of PIPKI gamma.	Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Kobe, Hyogo 6500017, Japan; [Sakamoto, Yasuhisa; Ogita, Hisakazu; Komura, Hitomi; Takai, Yoshimi] Osaka Univ, Grad Sch Med, Fac Med, Dept Mol Biol & Biochem, Suita, Osaka 5650871, Japan	Kobe University; Osaka University	Takai, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Kobe, Hyogo 6500017, Japan.	ytakai@med.kobe-u.ac.jp	Ogita, Hisakazu/AAE-4416-2020	Sakamoto, Yasuhisa/0000-0003-1833-6197; Ogita, Hisakazu/0000-0001-6750-1668				ABERCROMBIE M, 1953, EXP CELL RES, V5, P111, DOI 10.1016/0014-4827(53)90098-6; Brady-Kalnay SM, 1998, J CELL BIOL, V141, P287, DOI 10.1083/jcb.141.1.287; BRADYKALNAY SM, 1994, J BIOL CHEM, V269, P28472; BRADYKALNAY SM, 1995, J CELL BIOL, V130, P977, DOI 10.1083/jcb.130.4.977; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Carragher NO, 1999, J CELL BIOL, V147, P619, DOI 10.1083/jcb.147.3.619; Cismasiu VB, 2004, J BIOL CHEM, V279, P26922, DOI 10.1074/jbc.M313115200; Daniel JM, 1997, BIOESSAYS, V19, P883, DOI 10.1002/bies.950191008; Del Vecchio RL, 2005, J BIOL CHEM, V280, P1603, DOI 10.1074/jbc.M410181200; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Feiken E, 2000, J BIOL CHEM, V275, P15350, DOI 10.1074/jbc.275.20.15350; FISHER HW, 1967, SCIENCE, V155, P581, DOI 10.1126/science.155.3762.581; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Fujito T, 2005, J CELL BIOL, V171, P165, DOI 10.1083/jcb.200501090; Fukuhara T, 2004, J CELL BIOL, V166, P393, DOI 10.1083/jcb.200401093; Fukuyama T, 2005, J BIOL CHEM, V280, P815, DOI 10.1074/jbc.M411099200; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Honda T, 2003, GENES CELLS, V8, P51, DOI 10.1046/j.1365-2443.2003.00616.x; Ikeda W, 2004, J BIOL CHEM, V279, P18015, DOI 10.1074/jbc.M312969200; Ikeda W, 2003, J BIOL CHEM, V278, P28167, DOI 10.1074/jbc.M303586200; Katsumi A, 2005, J BIOL CHEM, V280, P16546, DOI 10.1074/jbc.C400455200; Kawakatsu T, 2005, J BIOL CHEM, V280, P4940, DOI 10.1074/jbc.M408710200; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Kiosses WB, 2001, NAT CELL BIOL, V3, P316, DOI 10.1038/35060120; Kodama A, 1999, ONCOGENE, V18, P3996, DOI 10.1038/sj.onc.1202773; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; Minami Y, 2007, J BIOL CHEM, V282, P18481, DOI 10.1074/jbc.M611330200; Ogita H, 2006, IUBMB LIFE, V58, P334, DOI 10.1080/15216540600719622; Ozaki M, 2007, GENES CELLS, V12, P651, DOI 10.1111/j.1365-2443.2007.01083.x; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Sakamoto Y, 2006, J BIOL CHEM, V281, P19631, DOI 10.1074/jbc.M600301200; Sakisaka T, 1999, ONCOGENE, V18, P1609, DOI 10.1038/sj.onc.1202451; Sui XF, 2005, AM J PATHOL, V166, P1247, DOI 10.1016/S0002-9440(10)62343-7; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Yamamoto Y, 2002, ONCOGENE, V21, P2545, DOI 10.1038/sj.onc.1205335; Zondag GCM, 2000, J BIOL CHEM, V275, P11264, DOI 10.1074/jbc.275.15.11264	44	26	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					496	505		10.1074/jbc.M704195200	http://dx.doi.org/10.1074/jbc.M704195200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17965016	hybrid			2022-12-25	WOS:000251940300055
J	Van Itallie, CM; Betts, L; Smedley, JG; McClane, BA; Anderson, JM				Van Itallie, Christina M.; Betts, Laurie; Smedley, James G., III; McClane, Bruce A.; Anderson, James M.			Structure of the claudin-binding domain of Clostridium perfringens enterotoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL FRAGMENT; CRYSTAL-STRUCTURE; PROTEIN; TOXIN; CANCER; RECEPTORS; COMPLEX	Clostridium perfringens enterotoxin is a common cause of food-borne and antibiotic-associated diarrhea. The toxin's receptors on intestinal epithelial cells include claudin-3 and -4, members of a large family of tight junction proteins. Toxin-induced cytolytic pore formation requires residues in the NH2-terminal half, whereas residues near the COOH terminus are required for binding to claudins. The claudin-binding COOH-terminal domain is not toxic and is currently under investigation as a potential drug absorption enhancer. Because claudin-4 is overexpressed on some human cancers, the toxin is also being investigated for targeting chemotherapy. Our aim was to solve the structure of the claudin-binding domain to advance its therapeutic applications. The structure of a 14-kDa fragment containing residues 194 to the native COOH terminus at position 319 was solved by x-ray diffraction to a resolution of 1.75 angstrom. The structure is a nine-strand beta sandwich with previously unappreciated similarity to the receptor-binding domains of several other toxins of spore-forming bacteria, including the collagen-binding domain of ColG from Clostridium histolyticum and the large Cry family of toxins ( including Cry4Ba) of Bacillus thuringiensis. Correlations with previous studies suggest that the claudin-4 binding site is on a large surface loop between strands beta 8 and beta 9 or includes these strands. The sequence that was crystallized (residues 194-319) binds to purified human claudin-4 with a 1: 1 stoichiometry and affinity in the submicromolar range similar to that observed for binding of native toxin to cells. Our results provide a structural framework to advance therapeutic applications of the toxin and suggest a common ancestor for several receptor-binding domains of bacterial toxins.	[Van Itallie, Christina M.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA; [Betts, Laurie] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Anderson, James M.] Univ N Carolina, Sch Med, Dept Cell Mol Physiol, Chapel Hill, NC 27599 USA; [Smedley, James G., III; McClane, Bruce A.] Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Anderson, JM (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.	jandersn@med.unc.edu		Anderson, James/0000-0003-2765-7996	NIAID NIH HHS [R37 AI019844, R37 AI 19844] Funding Source: Medline; NIDDK NIH HHS [R01 DK 45134, P30 DK 034987] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI019844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045134, P30DK034987] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boonserm P, 2005, J MOL BIOL, V348, P363, DOI 10.1016/j.jmb.2005.02.013; Burton SL, 1999, J MOL BIOL, V287, P1011, DOI 10.1006/jmbi.1999.2649; Chakrabarti G, 2005, CELL MICROBIOL, V7, P129, DOI 10.1111/j.1462-5822.2004.00442.x; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352; Ebihara C, 2006, J PHARMACOL EXP THER, V316, P255, DOI 10.1124/jpet.105.093351; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujita K, 2000, FEBS LETT, V476, P258, DOI 10.1016/S0014-5793(00)01744-0; Gardberg A, 2003, STRUCTURE, V11, P1265, DOI 10.1016/j.str.2003.09.003; GUERRA C, 2003, MATH METHODS PROTEIN, P109; HANNA PC, 1991, J BIOL CHEM, V266, P11037; Harada M, 2007, BIOCHEM PHARMACOL, V73, P206, DOI 10.1016/j.bcp.2006.10.002; Katahira J, 1997, J BIOL CHEM, V272, P26652, DOI 10.1074/jbc.272.42.26652; KNOWLES BH, 1994, ADV INSECT PHYSIOL, V24, P275, DOI 10.1016/S0065-2806(08)60085-5; KOKAIKUN JF, 1997, CLIN INFECT DIS   S2, V25, P165; Kominsky SL, 2007, CANCER RES, V67, P7977, DOI 10.1158/0008-5472.CAN-07-1314; Kondoh M, 2005, MOL PHARMACOL, V67, P749, DOI 10.1124/mol.104.008375; MCPHERSON A, 1987, J BIOL CHEM, V262, P1791; Michl P, 2001, GASTROENTEROLOGY, V121, P678, DOI 10.1053/gast.2001.27124; Mitic LL, 2003, PROTEIN SCI, V12, P218, DOI 10.1110/ps.0233903; Miyakawa MEF, 2005, INFECT IMMUN, V73, P8407, DOI 10.1128/IAI.73.12.8407-8410.2005; Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Robertson SL, 2007, CELL MICROBIOL, V9, P2734, DOI 10.1111/j.1462-5822.2007.00994.x; Santin AD, 2005, CANCER RES, V65, P4334, DOI 10.1158/0008-5472.CAN-04-3472; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Singh U, 2000, J BIOL CHEM, V275, P18407, DOI 10.1074/jbc.M001530200; Smedley JG, 2005, REV PHYSIOL BIOCH P, V152, P183, DOI 10.1007/s10254-004-0036-2; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Stocker A, 2000, ANTIOXID REDOX SIGN, V2, P397, DOI 10.1089/15230860050192170; Takahashi A, 2005, J CONTROL RELEASE, V108, P56, DOI 10.1016/j.jconrel.2005.07.008; Wendt KS, 2001, NAT STRUCT BIOL, V8, P784, DOI 10.1038/nsb0901-784; Wilson JJ, 2003, EMBO J, V22, P1743, DOI 10.1093/emboj/cdg172	35	88	90	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					268	274		10.1074/jbc.M708066200	http://dx.doi.org/10.1074/jbc.M708066200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17977833	hybrid, Green Published			2022-12-25	WOS:000251940300030
J	Di Padova, M; Caretti, G; Zhao, P; Hoffman, EP; Sartorelli, V				Di Padova, Monica; Caretti, Giuseppina; Zhao, Po; Hoffman, Eric P.; Sartorelli, Vittorio			MyoD acetylation influences temporal patterns of skeletal muscle gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCYTE ENHANCER FACTOR-2; MYOGENIC DIFFERENTIATION; TRANSCRIPTIONAL ACTIVATION; REGULATORY FACTORS; DISTINCT ROLES; DNA-BINDING; IN-VITRO; CHROMATIN; PROTEINS; COMPLEX	MyoD is sufficient to initiate the skeletal muscle gene expression program. Transcription of certain MyoD target genes occurs in the early phases, whereas that of others is induced only at later stages, although MyoD is present throughout the differentiation process. MyoD acetylation regulates transcriptional competency, yet whether this post-translational modification is equally relevant for activation of all the MyoD targets is unknown. Moreover, the molecular mechanisms through which acetylation ensures that MyoD achieves its optimal activity remain unexplored. To address these two outstanding issues, we have coupled genome- wide expression profiling and chromatin immunoprecipitation in a model system in which MyoD or its nonacetylatable version was inducibly activated in mouse embryonic fibroblasts derived from MyoD(-/-) /Myf5 (-/-) mice. Our results reveal that MyoD acetylation influences transcription of selected genes expressed at defined stages of the muscle program by regulating chromatin access of MyoD, histone acetylation, and RNA polymerase II recruitment.	[Di Padova, Monica; Caretti, Giuseppina; Sartorelli, Vittorio] NIH, NIAMS, Lab Muscle Stem Cells & Gene Regulat, Bethesda, MD 20892 USA; [Zhao, Po; Hoffman, Eric P.] Childrens Natl Med Ctr, Res Ctr Genet Med, Washington, DC 20010 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Children's National Health System	Sartorelli, V (corresponding author), NIH, NIAMS, Lab Muscle Stem Cells & Gene Regulat, 50 S Dr,Rm 1351, Bethesda, MD 20892 USA.	sartorev@mail.nih.gov		Hoffman, Eric/0000-0001-6470-5139; DI PADOVA, Monica/0000-0003-3808-7159; Sartorelli, Vittorio/0000-0002-9284-3675	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041126, Z01AR041126] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Caretti G, 2006, DEV CELL, V11, P547, DOI 10.1016/j.devcel.2006.08.003; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; Delgado I, 2003, GENOMICS, V82, P109, DOI 10.1016/S0888-7543(03)00104-6; Dilworth FJ, 2004, P NATL ACAD SCI USA, V101, P11593, DOI 10.1073/pnas.0404192101; Duquet A, 2006, EMBO REP, V7, P1140, DOI 10.1038/sj.embor.7400820; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Hardin PE, 2006, CELL, V125, P424, DOI 10.1016/j.cell.2006.04.010; HOLLENBERG SM, 1993, P NATL ACAD SCI USA, V90, P8028, DOI 10.1073/pnas.90.17.8028; Iezzi S, 2004, DEV CELL, V6, P673, DOI 10.1016/S1534-5807(04)00107-8; Ishibashi J, 2005, J CELL BIOL, V171, P471, DOI 10.1083/jcb.200502101; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; LYONS GE, 1991, DEVELOPMENT, V113, P1017; Ma KW, 2005, MOL CELL BIOL, V25, P3575, DOI 10.1128/MCB.25.9.3575-3582.2005; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Penn BH, 2004, GENE DEV, V18, P2348, DOI 10.1101/gad.1234304; Polesskaya A, 2000, J BIOL CHEM, V275, P34359, DOI 10.1074/jbc.M003815200; Polesskaya A, 2001, MOL CELL BIOL, V21, P5312, DOI 10.1128/MCB.21.16.5312-5320.2001; Polesskaya A, 2001, EMBO J, V20, P6816, DOI 10.1093/emboj/20.23.6816; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Puri PL, 2001, MOL CELL, V8, P885, DOI 10.1016/S1097-2765(01)00373-2; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; RUDNICKI MA, 1995, BIOESSAYS, V17, P203, DOI 10.1002/bies.950170306; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Sartorelli V, 2001, FRONT BIOSCI-LANDMRK, V6, pD1024, DOI 10.2741/Sartorel; SASSOON D, 1989, NATURE, V341, P303, DOI 10.1038/341303a0; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Solanes G, 2003, MOL ENDOCRINOL, V17, P1944, DOI 10.1210/me.2002-0395; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Wyzykowski JC, 2002, MOL CELL BIOL, V22, P6199, DOI 10.1128/MCB.22.17.6199-6208.2002; Yoshida N, 1998, J CELL SCI, V111, P769; Zhao P, 2002, J BIOL CHEM, V277, P30091, DOI 10.1074/jbc.M202668200; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005	44	37	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37650	37659		10.1074/jbc.M707309200	http://dx.doi.org/10.1074/jbc.M707309200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17965412	hybrid			2022-12-25	WOS:000251833600041
J	Xu, Y; Zhang, J; Chen, XB				Xu, Yang; Zhang, Jin; Chen, Xinbin			The activity of p53 is differentially regulated by Brm-and Brg1-containing SWI/SNF chromatin remodeling complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REGULATION; DNA-DAMAGE; CELL-LINES; IN-VIVO; RECRUITMENT; ACTIVATION; PROMOTER; BINDING; FAMILY; GENE	Brahma (Brm) and Brahma-related gene-1 (Brg1) ATPases share similarities in structure and function, but their presence in human SWI/SNF chromatin remodeling complexes is mutually exclusive. Although Brm and Brg1 can compensate for each other, it is possible that Brm and Brg1 have their unique properties to differentially regulate gene expression in vivo. To explore this, we examined the requirement of Brm and Brg1 for p53-dependent transcription, especially p53-mediated induction of p21 and MDM2, using cell lines in which Brm or Brg1 could be inducibly knocked down. We found that Brg1, but not Brm, is required for p21 induction in MCF7 cells. However, in Brg1-deficient H1299 cells, Brm is also required for p21 induction. Likewise, Brm is necessary for induction of p21 in MCF7 cells in which Brg1 is stably knocked down. In contrast, Brg1 has little, if any, effect on p53-mediated induction of MDM2 in cells that have Brm and vice versa. In addition, we demonstrated that the impaired induction of p21 upon Brg1 knockdown is at least in part due to decreased p53 binding to the p21 promoter. Taken together, we provided evidence that Brg1 is preferentially recruited by p53 for inducing a subset of target genes through chromatin remodeling. Thus, we hypothesize that the potential tumor suppressor function for Brg1 is mediated in part through the p53 pathway.	[Xu, Yang; Zhang, Jin; Chen, Xinbin] Univ Calif Davis, Ctr Comparat Oncol, Davis, CA 95616 USA; [Xu, Yang] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Hematol, Hangzhou 310009, Peoples R China	University of California System; University of California Davis; Zhejiang University	Chen, XB (corresponding author), Univ Calif Davis, Ctr Comparat Oncol, 2128 Tupper Hall, Davis, CA 95616 USA.	xbchen@ucdavis.edu			NCI NIH HHS [CA076069, CA102188, CA081237] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA076069, R01CA076069, R01CA102188, R01CA081237] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Coisy-Quivy M, 2006, CANCER RES, V66, P5069, DOI 10.1158/0008-5472.CAN-05-0596; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Harms KL, 2005, MOL CELL BIOL, V25, P2014, DOI 10.1128/MCB.25.5.2014-2030.2005; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Liu G, 2006, MOL CELL BIOL, V26, P1398, DOI 10.1128/MCB.26.4.1398-1413.2006; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; Liu K, 2004, GENE DEV, V18, P673, DOI 10.1101/gad.1180204; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Mellor J, 2005, MOL CELL, V19, P147, DOI 10.1016/j.molcel.2005.06.023; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Nozell S, 2002, ONCOGENE, V21, P1285, DOI 10.1038/sj.onc.1205191; Reisman DN, 2005, APPL IMMUNOHISTO M M, V13, P66, DOI 10.1097/00129039-200503000-00011; Reisman DN, 2003, CANCER RES, V63, P560; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Simone C, 2006, J CELL PHYSIOL, V207, P309, DOI 10.1002/jcp.20514; Strobeck MW, 2002, J BIOL CHEM, V277, P4782, DOI 10.1074/jbc.M109532200; Strobeck MW, 2001, J BIOL CHEM, V276, P9273, DOI 10.1074/jbc.M009747200; Szak ST, 2001, MOL CELL BIOL, V21, P3375, DOI 10.1128/MCB.21.10.3375-3386.2001; Vassilev LT, 2004, CELL CYCLE, V3, P419; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wang F, 2004, J BIOL CHEM, V279, P46733, DOI 10.1074/jbc.M409002200; Wang S, 2004, EMBO J, V23, P2293, DOI 10.1038/sj.emboj.7600231; Wong AKC, 2000, CANCER RES, V60, P6171; Zhu JH, 1998, J BIOL CHEM, V273, P13030, DOI 10.1074/jbc.273.21.13030	36	46	46	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37429	37435		10.1074/jbc.M706039200	http://dx.doi.org/10.1074/jbc.M706039200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17938176	hybrid			2022-12-25	WOS:000251833600017
J	Bhowmik, S; Horsman, GP; Bolin, JT; Eltis, LD				Bhowmik, Shiva; Horsman, Geoff P.; Bolin, Jeffrey T.; Eltis, Lindsay D.			The molecular basis for inhibition of BphD, a C-C bond hydrolase involved in polychlorinated biphenyls degradation - Large 3-substituents prevent tautomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-HYDROXY-6-KETO-NONA-2,4-DIENE-1,9-DIOIC ACID 5,6-HYDROLASE; MICROBIAL-DEGRADATION; CATALYTIC MECHANISM; CHLORINE SUBSTITUTION; SERINE HYDROLASE; KINETIC-ANALYSIS; X-RAY; ENZYMES; CRYSTALLOGRAPHY; IDENTIFICATION	The microbial degradation of polychlorinated biphenyls (PCBs) by the biphenyl catabolic (Bph) pathway is limited in part by the pathway's fourth enzyme, BphD. BphD catalyzes an unusual carbon-carbon bond hydrolysis of 2-hydroxy-6-oxo-6phenylhexa-2,4-dienoic acid (HOPDA), in which the substrate is subject to histidine-mediated enol-keto tautomerization prior to hydrolysis. Chlorinated HOPDAs such as 3-Cl HOPDA inhibit BphD. Here we report that BphD preferentially hydrolyzed a series of 3-substituted HOPDAs in the order H > F > Cl > Me, suggesting that catalysis is affected by steric, not electronic, determinants. Transient state kinetic studies performed using wild-type BphD and the hydrolysis-defective S112A variant indicated that large 3-substituents inhibited His-265-catalyzed tautomerization by 5 orders of magnitude. Structural analyses of S112A center dot 3-Cl HOPDA and S112A center dot 3,10-diF HOPDA complexes revealed a non-productive binding mode in which the plane defined by the carbon atoms of the dienoate moiety of HOPDA is nearly orthogonal to that of the proposed keto tautomer observed in the S112A center dot HOPDA complex. Moreover, in the 3-Cl HOPDA complex, the 2-hydroxo group is moved by 3.6 A from its position near the catalytic His-265 to hydrogen bond with Arg-190 and access of His-265 is blocked by the 3- Cl substituent. Nonproductive binding may be stabilized by interactions involving the 3-substituent with non-polar side chains. Solvent molecules have poor access to C6 in the S112A center dot 3- Cl HOPDA structure, more consistent with hydrolysis occurring via an acyl-enzyme than a gem-diol intermediate. These results provide insight into engineering BphD for PCB degradation.	Purdue Univ, Ctr Canc, Markey Ctr Struct Biol, Dept Biol Sci, W Lafayette, IN 47907 USA; Univ British Columbia, Inst Life Sci, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of British Columbia; University of British Columbia	Eltis, LD (corresponding author), Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	leltis@interchange.ubc.ca	Eltis, Lindsay D/J-8272-2015; Horsman, Geoff/AAQ-2349-2020	Eltis, Lindsay D/0000-0002-6774-8158; Horsman, Geoff/0000-0002-2023-2349				ALLEN FH, 1987, J CHEM SOC PERK T 2, pS1, DOI 10.1039/p298700000s1; Allred A.L, 1958, J INORG NUCL CHEM, V5, P215; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Camps P, 1999, J MED CHEM, V42, P3227, DOI 10.1021/jm980620z; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; Dai SD, 2002, NAT STRUCT BIOL, V9, P934, DOI 10.1038/nsb866; Dvir H, 2002, BIOCHEMISTRY-US, V41, P2970, DOI 10.1021/bi011652i; Fleming SM, 2000, BIOCHEMISTRY-US, V39, P1522, DOI 10.1021/bi9923095; Fortin PD, 2006, J BACTERIOL, V188, P4424, DOI 10.1128/JB.01849-05; FURUKAWA K, 1978, APPL ENVIRON MICROB, V35, P223, DOI 10.1128/AEM.35.2.223-227.1978; FURUKAWA K, 1979, APPL ENVIRON MICROB, V38, P301, DOI 10.1128/AEM.38.2.301-310.1979; Henderson IMJ, 1997, BIOCHEMISTRY-US, V36, P12252, DOI 10.1021/bi971116j; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Horsman GP, 2007, J BIOL CHEM, V282, P19894, DOI 10.1074/jbc.M702237200; Horsman GP, 2006, BIOCHEMISTRY-US, V45, P11071, DOI 10.1021/bi0611098; Jacobson JL, 1996, NEW ENGL J MED, V335, P783, DOI 10.1056/NEJM199609123351104; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Knerr S, 2006, CRIT REV TOXICOL, V36, P663, DOI 10.1080/10408440600845304; Lam WWY, 1997, BIOCHEMISTRY-US, V36, P12242, DOI 10.1021/bi971115r; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li C, 2005, J MOL BIOL, V346, P241, DOI 10.1016/j.jmb.2004.11.032; Li JJ, 2007, ORG BIOMOL CHEM, V5, P507, DOI 10.1039/b615605c; Li JJ, 2006, BIOCHEMISTRY-US, V45, P12461, DOI 10.1021/bi0612519; LIU H, 1992, J CHEM EDUC, V69, P783; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nerdinger S, 1999, CHEM COMMUN, P2259, DOI 10.1039/a907279i; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pieper DH, 2005, APPL MICROBIOL BIOT, V67, P170, DOI 10.1007/s00253-004-1810-4; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Seah SYK, 2007, J BACTERIOL, V189, P4038, DOI 10.1128/JB.01950-06; Seah SYK, 1998, J BIOL CHEM, V273, P22943, DOI 10.1074/jbc.273.36.22943; Seah SYK, 2001, J BACTERIOL, V183, P1511, DOI 10.1128/JB.183.5.1511-1516.2001; Seah SYK, 2000, J BIOL CHEM, V275, P15701, DOI 10.1074/jbc.275.21.15701; SEEGER M, 1995, APPL ENVIRON MICROB, V61, P2654, DOI 10.1128/AEM.61.7.2654-2658.1995; SETO M, 1995, APPL ENVIRON MICROB, V61, P3353, DOI 10.1128/AEM.61.9.3353-3358.1995; Speare DM, 2004, ORG BIOMOL CHEM, V2, P2942, DOI 10.1039/b410322j; Speare DM, 2002, CHEM COMMUN, P2304, DOI 10.1039/b208168g; Toft G, 2004, REPROD TOXICOL, V19, P5, DOI 10.1016/j.reprotox.2004.05.006; Vaillancourt FH, 2002, J BIOL CHEM, V277, P2019, DOI 10.1074/jbc.M106890200; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Zhao YH, 2003, J ORG CHEM, V68, P7368, DOI 10.1021/jo034808o	46	18	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36377	36385		10.1074/jbc.M707035200	http://dx.doi.org/10.1074/jbc.M707035200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17932031	hybrid			2022-12-25	WOS:000251458300029
J	Okada, M; Jang, SW; Ye, KQ				Okada, Masashi; Jang, Sung-Wuk; Ye, Keqiang			Ebp1 association with nucleophosmin/B23 is essential for regulating cell proliferation and suppressing apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERBB-3 BINDING-PROTEIN; NUCLEAR MATRIX PROTEIN; RIBONUCLEOPROTEIN COMPLEXES; CENTROSOME DUPLICATION; MEDIATED TRANSCRIPTION; RIBOSOME BIOGENESIS; TUMOR-SUPPRESSOR; 3T3 FIBROBLASTS; GROWTH-FACTOR; EXPRESSION	Ebp1 and NPM/B23 are essential for cell proliferation and survival. Ebp1 possesses p42 and p48 isoforms. Whereas p42 exclusively resides in the cytoplasm, p48 localizes in both the cytoplasm and the nucleolus. Here, we show that Ebp1 forms a complex with B23, and this complex plays a critical role in cell proliferation and survival. p42 specifically associates with B23 upon epidermal growth factor stimulation, while p48 constantly binds B23. Moreover, Ser(360) phosphorylation in p42, but not p48, is critical for the interaction. p48 constitutively binds B23 in the nucleolus, for which B23 Lys(263) sumoylation is indispensable. By contrast, p42 selectively binds unsumoylated B23 mutants. Interestingly, B23 K263R, an unsumoylated mutant, triggers p42 nuclear translocation and interacts with it in the nucleus even in the absence of epidermal growth factor. In contrast, the nucleolar residency of p48 is abolished in B23 K263R cells. During the cell cycle, p42 selectively colocalizes with B23 in the mitotic cells, correlating with its phosphorylation status in mitosis. Knocking down of B23 or Ebp1 substantially decreases ribosome biogenesis and cell survival. Thus, B23 distinctively binds Ebp1 isoforms and regulates cell proliferation and survival through p42 and p48, respectively.	Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University	Ye, KQ (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	kye@emory.edu	Okada, Masashi/AAC-2171-2021		NINDS NIH HHS [R01,NS045627] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045627] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn JY, 2006, EMBO J, V25, P2083, DOI 10.1038/sj.emboj.7601111; Ahn JY, 2005, MOL CELL, V18, P435, DOI 10.1016/j.molcel.2005.04.010; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; FEUERSTEIN N, 1988, J CELL BIOL, V107, P1629, DOI 10.1083/jcb.107.5.1629; FEUERSTEIN N, 1987, J BIOL CHEM, V262, P11389; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; HADJIOLOVA KV, 1994, MOL CELL BIOL, V14, P4044, DOI 10.1128/MCB.14.6.4044; HERRERA JE, 1995, NUCLEIC ACIDS RES, V23, P3974, DOI 10.1093/nar/23.19.3974; Higuchi Y, 1998, BIOCHEM BIOPH RES CO, V248, P597, DOI 10.1006/bbrc.1998.8978; Huang N, 2005, J BIOL CHEM, V280, P5496, DOI 10.1074/jbc.M407856200; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Jiang PS, 2000, CANCER LETT, V153, P151, DOI 10.1016/S0304-3835(00)00362-1; Kondo T, 1997, ONCOGENE, V15, P1275, DOI 10.1038/sj.onc.1201286; Kowalinski E, 2007, ACTA CRYSTALLOGR F, V63, P768, DOI 10.1107/S1744309107038985; Kurki S, 2004, CELL CYCLE, V3, P976; Lessor TJ, 2000, J CELL PHYSIOL, V183, P321, DOI 10.1002/(SICI)1097-4652(200006)183:3<321::AID-JCP4>3.0.CO;2-O; Liu X, 2007, P NATL ACAD SCI USA, V104, P9679, DOI 10.1073/pnas.0701806104; Liu ZX, 2006, P NATL ACAD SCI USA, V103, P10917, DOI 10.1073/pnas.0602923103; Monie TP, 2007, EMBO J, V26, P3936, DOI 10.1038/sj.emboj.7601817; Nozawa Y, 1996, J PATHOL, V178, P48; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Ou K, 2006, J PROTEOME RES, V5, P2194, DOI 10.1021/pr060115n; Pinol-Roma S, 1999, MOL BIOL CELL, V10, P77, DOI 10.1091/mbc.10.1.77; RADOMSKI N, 1995, EXP CELL RES, V220, P434, DOI 10.1006/excr.1995.1335; Savkur RS, 1998, NUCLEIC ACIDS RES, V26, P4508, DOI 10.1093/nar/26.19.4508; SCHMIDTZACHMANN MS, 1988, CHROMOSOMA, V96, P417, DOI 10.1007/BF00303035; SCHMIDTZACHMANN MS, 1987, EMBO J, V6, P1881, DOI 10.1002/j.1460-2075.1987.tb02447.x; Squatrito M, 2006, BIOCHEM BIOPH RES CO, V344, P859, DOI 10.1016/j.bbrc.2006.03.205; Squatrito M, 2004, ONCOGENE, V23, P4454, DOI 10.1038/sj.onc.1207579; Tago K, 2005, P NATL ACAD SCI USA, V102, P7689, DOI 10.1073/pnas.0502978102; Takemura M, 2002, EXP CELL RES, V276, P233, DOI 10.1006/excr.2002.5523; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Wu MH, 2002, CARCINOGENESIS, V23, P93, DOI 10.1093/carcin/23.1.93; Wu MH, 2002, J BIOL CHEM, V277, P48234, DOI 10.1074/jbc.M206550200; Xia XM, 2001, J CELL PHYSIOL, V187, P209, DOI 10.1002/jcp.1075; Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601; Ye KQ, 1999, J NEUROSCI, V19, P10747, DOI 10.1523/JNEUROSCI.19-24-10747.1999; Yoo JY, 2000, BRIT J CANCER, V82, P683; Zhang YX, 2005, NUCLEIC ACIDS RES, V33, P6024, DOI 10.1093/nar/gki903; Zhang YX, 2005, P NATL ACAD SCI USA, V102, P9890, DOI 10.1073/pnas.0503829102; Zhang YX, 2004, J BIOL CHEM, V279, P26126, DOI 10.1074/jbc.M314305200; Zhang YX, 2003, NUCLEIC ACIDS RES, V31, P2168, DOI 10.1093/nar/gkg318; Zhang YX, 2002, ONCOGENE, V21, P5609, DOI 10.1038/sj.onc.1205638; Zirwes RF, 1997, MOL BIOL CELL, V8, P231, DOI 10.1091/mbc.8.2.231	45	45	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36744	36754		10.1074/jbc.M706169200	http://dx.doi.org/10.1074/jbc.M706169200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17951246	hybrid			2022-12-25	WOS:000251458300067
J	Pontes, O; Lawrence, RJ; Silva, M; Preuss, S; Costa-Nunes, P; Earley, K; Neves, N; Viegas, W; Pikaard, CS				Pontes, Olga; Lawrence, Richard J.; Silva, Manuela; Preuss, Sasha; Costa-Nunes, Pedro; Earley, Keith; Neves, Nuno; Viegas, Wanda; Pikaard, Craig S.			Postembryonic Establishment of Megabase-Scale Gene Silencing in Nucleolar Dominance	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; EPIGENETIC ON/OFF SWITCH; RIBOSOMAL-RNA GENES; DNA METHYLATION; RDNA CHROMATIN; DOSAGE CONTROL; ARABIDOPSIS; PLANTS; HETEROCHROMATIN; EXPRESSION	Nucleolar dominance is an epigenetic phenomenon in plant and animal genetic hybrids that describes the expression of 45S ribosomal RNA genes (rRNA genes) inherited from only one progenitor due to the silencing of the other progenitor's rRNA genes. rRNA genes are tandemly arrayed at nucleolus organizer regions (NORs) that span millions of basepairs, thus gene silencing in nucleolar dominance occurs on a scale second only to X-chromosome inactivation in female mammals. In Arabidopsis suecica, the allotetraploid hybrid of A. thaliana and A. arenosa, the A. thaliana-derived rRNA genes are subjected to nucleolar dominance and are silenced via repressive chromatin modifications. However, the developmental stage at which nucleolar dominance is established in A. suecica is currently unknown. We show that nucleolar dominance is not apparent in seedling cotyledons formed during embryogenesis but becomes progressively established during early postembryonic development in tissues derived from both the shoot and root apical meristems. The progressive silencing of A. thaliana rRNA genes correlates with the transition of A. thaliana NORs from a decondensed euchromatic state associated with histone H3 that is trimethylated on lysine 4 (H3K4me3) to a highly condensed heterochromatic state in which the NORs are associated with H3K9me2 and 5-methylcytosine-enriched chromocenters. In RNAi-lines in which the histone deacetylases HDA6 and HDT1 are knocked down, the developmentally regulated condensation and inactivation of A. thaliana NORs is disrupted. Collectively, these data demonstrate that HDA6 and HDT1 function in the postembryonic establishment of nucleolar dominance, a process which recurs in each generation.	[Pontes, Olga; Silva, Manuela; Costa-Nunes, Pedro; Neves, Nuno; Viegas, Wanda] Univ Tecn Lisboa, Inst Super Agron, Ctr Bot Aplicada & Agr, P-1100 Lisbon, Portugal; [Pontes, Olga; Lawrence, Richard J.; Preuss, Sasha; Costa-Nunes, Pedro; Earley, Keith; Pikaard, Craig S.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Neves, Nuno] Univ Nova Lisboa, Fac Ciencias & Tecnol, Secc Autonoma Biotecnol, Caparica, Portugal	Universidade de Lisboa; Washington University (WUSTL); Universidade Nova de Lisboa	Viegas, W (corresponding author), Univ Tecn Lisboa, Inst Super Agron, Ctr Bot Aplicada & Agr, P-1100 Lisbon, Portugal.	wandaviegas@isa.utl.pt; pikaard@biology.wustl.edu	Silva, Manuela/GSN-4031-2022; Pontes, Olga MF/F-9768-2011; Silva, Manuela/ABF-7085-2020; Pikaard, Craig S/K-8772-2012	Pontes, Olga MF/0000-0003-3316-1145; Silva, Manuela/0000-0003-4677-870X; Pikaard, Craig S/0000-0001-8204-7459; Viegas, Wanda/0000-0003-4660-1226	National Institutes of Health [2RO1-GM60380]; National Science Foundation [9975930]; Fundacao de Ciencia e Tecnologia (Portugal) [SFRH/BPD/17508/2004, SFRH/BPD/20320/2004, POCI/BIA-BDE/57575/2004]; Fundacao para a Ciencia e Tecnologia [POCI/BIA-BCM/59389/2004]; Fundo Comunitario Europeu FEDER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060380] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Fundacao de Ciencia e Tecnologia (Portugal); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundo Comunitario Europeu FEDER(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the Pikaard lab was supported by National Institutes of Health grant 2RO1-GM60380. RNAi vector development was supported by the National Science Foundation under grant number 9975930. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Institutes of Health or National Science Foundation. O.P. and M. S were supported by fellowships SFRH/BPD/17508/2004 and SFRH/BPD/20320/2004 and M. S. was additionally supported under project POCI/BIA-BDE/57575/2004 from the Fundacao de Ciencia e Tecnologia (Portugal). Research in the Viegas lab was supported by the Fundacao para a Ciencia e Tecnologia (project POCI/BIA-BCM/59389/2004 to N.N.) and Fundo Comunitario Europeu FEDER.	Bender J, 2004, ANNU REV PLANT BIOL, V55, P41, DOI 10.1146/annurev.arplant.55.031903.141641; CASTILHO A, 1995, CHROMOSOME RES, V3, P169, DOI 10.1007/BF00710710; Chen ZJ, 1997, P NATL ACAD SCI USA, V94, P3442, DOI 10.1073/pnas.94.7.3442; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; Chen ZJ, 1998, P NATL ACAD SCI USA, V95, P14891, DOI 10.1073/pnas.95.25.14891; Earley K, 2006, GENE DEV, V20, P1283, DOI 10.1101/gad.1417706; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fransz P, 2003, CHROMOSOME RES, V11, P227, DOI 10.1023/A:1022835825899; Fransz PF, 2002, CURR OPIN PLANT BIOL, V5, P560, DOI 10.1016/S1369-5266(02)00298-4; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Grummt I, 2003, NAT REV MOL CELL BIO, V4, P641, DOI 10.1038/nrm1171; GUERCHE P, 1990, PLANT CELL, V2, P469, DOI 10.1105/tpc.2.5.469; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; LAWSON EJR, 1995, TRENDS GENET, V11, P263, DOI 10.1016/S0168-9525(00)89072-1; Lewis MS, 2001, P NATL ACAD SCI USA, V98, P14536, DOI 10.1073/pnas.251424098; Masui Y, 1998, BIOL CELL, V90, P537, DOI 10.1016/S0248-4900(99)80011-2; Mathieu O, 2003, PLANT CELL, V15, P2929, DOI 10.1105/tpc.017467; McStay B, 2006, GENE DEV, V20, P1207, DOI 10.1101/gad.1436906; NAVASHIN M., 1934, CYTOLOGIA, V5, P169, DOI 10.1508/cytologia.5.169; NEVES N, 1995, THEOR APPL GENET, V91, P529, DOI 10.1007/BF00222984; Neves N, 2005, ANNU PLANT REV, V19, P201, DOI 10.1002/9780470988626.ch7; Pikaard CS, 2000, TRENDS GENET, V16, P495, DOI 10.1016/S0168-9525(00)02113-2; Pontes O, 2004, P NATL ACAD SCI USA, V101, P18240, DOI 10.1073/pnas.0407258102; Pontes O, 2003, P NATL ACAD SCI USA, V100, P11418, DOI 10.1073/pnas.1932522100; PREUSS S, 2007, BIOCH BIOPHYS ACTA; Preuss S, 2007, BBA-GENE STRUCT EXPR, V1769, P383, DOI 10.1016/j.bbaexp.2007.02.005; REEDER RH, 1985, J CELL BIOL, V101, P2013, DOI 10.1083/jcb.101.5.2013; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945; SILVA M, 1995, CHROMOSOME RES, V3, P492, DOI 10.1007/BF00713964; Spring H, 1996, INT J DEV BIOL, V40, P263; WALLACE H, 1971, HEREDITY, V27, P1, DOI 10.1038/hdy.1971.66; WOLFFE AP, 1994, J CELL SCI, V107, P2055	33	52	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1157	10.1371/journal.pone.0001157	http://dx.doi.org/10.1371/journal.pone.0001157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987131	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459000039
J	Fabene, PF; Merigo, F; Galie, M; Benati, D; Bernardi, P; Farace, P; Nicolato, E; Marzola, P; Sbarbati, A				Fabene, Paolo Francesco; Merigo, Flavia; Galie, Mirco; Benati, Donatella; Bernardi, Paolo; Farace, Paolo; Nicolato, Elena; Marzola, Pasquina; Sbarbati, Andrea			Pilocarpine-Induced Status Epilepticus in Rats Involves Ischemic and Excitotoxic Mechanisms	PLOS ONE			English	Article								The neuron loss characteristic of hippocampal sclerosis in temporal lobe epilepsy patients is thought to be the result of excitotoxic, rather than ischemic, injury. In this study, we assessed changes in vascular structure, gene expression, and the time course of neuronal degeneration in the cerebral cortex during the acute period after onset of pilocarpine-induced status epilepticus (SE). Immediately after 2 hr SE, the subgranular layers of somatosensory cortex exhibited a reduced vascular perfusion indicative of ischemia, whereas the immediately adjacent supragranular layers exhibited increased perfusion. Subgranular layers exhibited necrotic pathology, whereas the supergranular layers were characterized by a delayed (24 h after SE) degeneration apparently via programmed cell death. These results indicate that both excitotoxic and ischemic injuries occur during pilocarpine-induced SE. Both of these degenerative pathways, as well as the widespread and severe brain damage observed, should be considered when animal model-based data are compared to human pathology.	[Fabene, Paolo Francesco; Merigo, Flavia; Galie, Mirco; Benati, Donatella; Bernardi, Paolo; Farace, Paolo; Nicolato, Elena; Sbarbati, Andrea] Univ Verona, Dept Morphol & Biomed Sci, Sect Anat & Histol, I-37100 Verona, Italy; [Marzola, Pasquina] Univ Verona, Ctr Expt Magnet Resonance Imaging, I-37100 Verona, Italy	University of Verona; University of Verona	Fabene, PF (corresponding author), Univ Verona, Dept Morphol & Biomed Sci, Sect Anat & Histol, I-37100 Verona, Italy.	paolo@anatomy.univr.it	Farace, Paolo/AAK-4072-2020	Farace, Paolo/0000-0002-6051-2345; GALIE', Mirco/0000-0002-6441-8313; Fabene, Paolo/0000-0002-9644-4399; MARZOLA, Pasquina/0000-0001-6936-8901	MIUR; EC [LSHM-CT-2006-037315]	MIUR(Ministry of Education, Universities and Research (MIUR)); EC(European CommissionEuropean Commission Joint Research Centre)	Funding: This study was supported by grants of MIUR (MIUR 60% and FIRB) and by the EC grant LSHM-CT-2006-037315.	Anguelova E, 2000, NEUROSCI LETT, V280, P99, DOI 10.1016/S0304-3940(00)00762-X; Barber AJ, 1997, DEV DYNAM, V208, P62, DOI 10.1002/(SICI)1097-0177(199701)208:1<62::AID-AJA6>3.0.CO;2-#; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dousset V, 1999, AM J NEURORADIOL, V20, P223; Fabene PF, 2006, NEUROBIOL DIS, V21, P80, DOI 10.1016/j.nbd.2005.06.013; Fabene PF, 2004, CURR DRUG TARGETS, V5, P629, DOI 10.2174/1389450043345218; Fabene PF, 2003, NEUROIMAGE, V18, P375, DOI 10.1016/S1053-8119(02)00025-3; GALLYAS F, 1990, ACTA NEUROPATHOL, V79, P620, DOI 10.1007/BF00294239; Gillardon F, 1996, BRAIN RES, V739, P244, DOI 10.1016/S0006-8993(96)00829-3; Hirase H, 2004, NEUROSCIENCE, V128, P209, DOI 10.1016/j.neuroscience.2004.07.002; KANE DJ, 1995, J NEUROSCI RES, V40, P269, DOI 10.1002/jnr.490400216; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Leroy C, 2003, EXP NEUROL, V182, P361, DOI 10.1016/S0014-4886(03)00122-5; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; MCINTYRE DC, 1982, BRAIN RES, V250, P53, DOI 10.1016/0006-8993(82)90952-0; MELDRUM B.S., 1992, GREENFIELDS NEUROPAT, P1246; MELDRUM BS, 1976, BRAIN, V99, P523, DOI 10.1093/brain/99.3.523; MELDRUM BS, 1973, ARCH NEUROL-CHICAGO, V28, P10, DOI 10.1001/archneur.1973.00490190028002; Mergenthaler P, 2004, METAB BRAIN DIS, V19, P151, DOI 10.1023/B:MEBR.0000043966.46964.e6; NADLER JV, 1978, J NEUROCHEM, V31, P147, DOI 10.1111/j.1471-4159.1978.tb12442.x; Nersesyan H, 2004, J CEREBR BLOOD F MET, V24, P1057, DOI 10.1097/01.WCB.0000131669.02027.3E; OLTVAI ZN, 1993, CELL, V74, P619; Plumier JCL, 1996, NEUROSCIENCE, V75, P849, DOI 10.1016/0306-4522(96)00317-X; Poirier JL, 2000, NEUROSCIENCE, V97, P59, DOI 10.1016/S0306-4522(00)00026-9; Quach N, 2005, BRAIN RES, V1042, P236, DOI 10.1016/j.brainres.2005.02.053; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; SATOH JI, 1995, J NEUROSCI RES, V41, P805, DOI 10.1002/jnr.490410611; Sbarbati A, 1996, ACTA NEUROPATHOL, V92, P56, DOI 10.1007/s004010050489; SCHWOB JE, 1980, NEUROSCIENCE, V5, P991, DOI 10.1016/0306-4522(80)90181-5; Sloviter RS, 2005, CR BIOL, V328, P143, DOI 10.1016/j.crvi.2004.10.010; SLOVITER RS, 1981, NEUROPHARMACOLOGY, V20, P1003, DOI 10.1016/0028-3908(81)90088-5; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Valentim LM, 2001, NEUROSCIENCE, V107, P43, DOI 10.1016/S0306-4522(01)00325-6; VANDENPOL AN, 1990, J COMP NEUROL, V296, P654, DOI 10.1002/cne.902960410; Villoslada P, 2004, PROG BRAIN RES, V146, P403; Yamada K, 2002, STROKE, V33, P87, DOI 10.1161/hs0102.101893; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0	37	56	58	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1105	10.1371/journal.pone.0001105	http://dx.doi.org/10.1371/journal.pone.0001105			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971868	Green Published, gold, Green Submitted			2022-12-25	WOS:000207458700022
J	Cornelisse, LN; van Elburg, RAJ; Meredith, RM; Yuste, R; Mansvelder, HD				Cornelisse, L. Niels; van Elburg, Ronald A. J.; Meredith, Rhiannon M.; Yuste, Rafael; Mansvelder, Huibert D.			High Speed Two-Photon Imaging of Calcium Dynamics in Dendritic Spines: Consequences for Spine Calcium Kinetics and Buffer Capacity	PLOS ONE			English	Article								Rapid calcium concentration changes in postsynaptic structures are crucial for synaptic plasticity. Thus far, the determinants of postsynaptic calcium dynamics have been studied predominantly based on the decay kinetics of calcium transients. Calcium rise times in spines in response to single action potentials (AP) are almost never measured due to technical limitations, but they could be crucial for synaptic plasticity. With high-speed, precisely-targeted, two-photon point imaging we measured both calcium rise and decay kinetics in spines and secondary dendrites in neocortical pyramidal neurons. We found that both rise and decay kinetics of changes in calcium-indicator fluorescence are about twice as fast in spines. During AP trains, spine calcium changes follow each AP, but not in dendrites. Apart from the higher surface-to-volume ratio (SVR), we observed that neocortical dendritic spines have a markedly smaller endogenous buffer capacity with respect to their parental dendrites. Calcium influx time course and calcium extrusion rate were both in the same range for spines and dendrites when fitted with a dynamic multi-compartment model that included calcium binding kinetics and diffusion. In a subsequent analysis we used this model to investigate which parameters are critical determinants in spine calcium dynamics. The model confirmed the experimental findings: a higher SVR is not sufficient by itself to explain the faster rise time kinetics in spines, but only when paired with a lower buffer capacity in spines. Simulations at zero calcium-dye conditions show that calmodulin is more efficiently activated in spines, which indicates that spine morphology and buffering conditions in neocortical spines favor synaptic plasticity.	[Cornelisse, L. Niels; van Elburg, Ronald A. J.; Meredith, Rhiannon M.; Mansvelder, Huibert D.] Vrije Univ Amsterdam, Dept Expt Neurophysiol, CNCR, Amsterdam, Netherlands; [Cornelisse, L. Niels] Vrije Univ Amsterdam, Dept Funct Genom, CNCR, Amsterdam, Netherlands; [Yuste, Rafael] Columbia Univ, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10032 USA	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Columbia University; Howard Hughes Medical Institute	Cornelisse, LN (corresponding author), Vrije Univ Amsterdam, Dept Expt Neurophysiol, CNCR, Amsterdam, Netherlands.	niels.cornelisse@cncr.vu.nl; huib.mansvelder@cncr.vu.nl	Meredith, Rhiannon/A-4657-2010; van Elburg, Ronald/A-5463-2010; Mansvelder, Huibert/N-6138-2018	van Elburg, Ronald/0000-0001-9508-1461; Mansvelder, Huibert/0000-0003-1365-5340; Meredith, Rhiannon/0000-0003-0228-4169; Cornelisse, Lennart Niels/0000-0001-9425-2935	National Eye Institute; New York STAR Center for High Resolution Imaging of Functional Neural Circuits and HHMI; Netherlands Royal Academy of Sciences; Netherlands Organization for Scientific Research (NWO) [911-03-014]; Medical Research Council (ZonMW) [917-76-360, 912-04-022]; Center for Medical Systems Biology	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); New York STAR Center for High Resolution Imaging of Functional Neural Circuits and HHMI; Netherlands Royal Academy of Sciences; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Medical Research Council (ZonMW)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Netherlands Organization for Health Research and Development); Center for Medical Systems Biology	RY is supported by grants from the National Eye Institute, the New York STAR Center for High Resolution Imaging of Functional Neural Circuits and HHMI. HDM is supported by grants from the Netherlands Royal Academy of Sciences and the Netherlands Organization for Scientific Research (NWO, 911-03-014), and the Medical Research Council (ZonMW, 917-76-360, 912-04-022). LNC was supported by the Center for Medical Systems Biology.	ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Antic SD, 2003, J PHYSIOL-LONDON, V550, P35, DOI 10.1113/jphysiol.2002.033746; Blatow M, 2003, NEURON, V38, P79, DOI 10.1016/S0896-6273(03)00196-X; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Franks KM, 2002, BIOESSAYS, V24, P1130, DOI 10.1002/bies.10193; Goldberg JH, 2003, NEURON, V40, P807, DOI 10.1016/S0896-6273(03)00714-1; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Holmes WR, 2000, J COMPUT NEUROSCI, V8, P65, DOI 10.1023/A:1008969032563; Holthoff K, 2002, NEURON, V33, P425, DOI 10.1016/S0896-6273(02)00576-7; KAKIUCHI S, 1982, J BIOCHEM-TOKYO, V92, P1041, DOI 10.1093/oxfordjournals.jbchem.a134019; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kits KS, 1999, BIOPHYS J, V76, P1693, DOI 10.1016/S0006-3495(99)77328-5; Klingauf J, 1997, BIOPHYS J, V72, P674, DOI 10.1016/S0006-3495(97)78704-6; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; Lee SH, 2000, J PHYSIOL-LONDON, V525, P419, DOI 10.1111/j.1469-7793.2000.t01-2-00419.x; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LLINAS R, 1982, P NATL ACAD SCI-BIOL, V79, P2415, DOI 10.1073/pnas.79.7.2415; Majewska A, 2000, PFLUG ARCH EUR J PHY, V441, P398, DOI 10.1007/s004240000435; Majewska A, 2000, J NEUROSCI, V20, P1722; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; Markram H, 1998, J COMPUT NEUROSCI, V5, P331, DOI 10.1023/A:1008891229546; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matveev V, 2002, BIOPHYS J, V83, P1368, DOI 10.1016/S0006-3495(02)73907-6; Nagerl UV, 2000, BIOPHYS J, V79, P3009, DOI 10.1016/S0006-3495(00)76537-4; Naraghi M, 1997, CELL CALCIUM, V22, P255, DOI 10.1016/S0143-4160(97)90064-6; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Nikolenko V, 2003, METHODS, V30, P3, DOI 10.1016/S1046-2023(03)00003-3; NOWYCKY MC, 1993, BIOPHYS J, V64, P77, DOI 10.1016/S0006-3495(93)81342-0; Nuriya M, 2006, P NATL ACAD SCI USA, V103, P786, DOI 10.1073/pnas.0510092103; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Sabatini BL, 2001, CURR OPIN NEUROBIOL, V11, P349, DOI 10.1016/S0959-4388(00)00218-X; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; Sabatini BL, 1998, BIOPHYS J, V74, P1549, DOI 10.1016/S0006-3495(98)77867-1; Saggau P, 2006, CURR OPIN NEUROBIOL, V16, P543, DOI 10.1016/j.conb.2006.08.011; Schmidt H, 2003, J PHYSIOL-LONDON, V551, P13, DOI 10.1113/jphysiol.2002.035824; Schmidt H, 2003, BIOPHYS J, V84, P2599, DOI 10.1016/S0006-3495(03)75065-6; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Tank DW, 1995, J NEUROSCI, V15, P7940; TIMMERMAN MP, 1986, FEBS LETT, V209, P1, DOI 10.1016/0014-5793(86)81073-0; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; WAGNER J, 1994, BIOPHYS J, V67, P447, DOI 10.1016/S0006-3495(94)80500-4; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 1999, J NEUROSCI, V19, P1976; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	50	41	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1073	10.1371/journal.pone.0001073	http://dx.doi.org/10.1371/journal.pone.0001073			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957255	Green Published, gold, Green Submitted			2022-12-25	WOS:000207458500018
J	von der Haar, T				von der Haar, Tobias			Optimized Protein Extraction for Quantitative Proteomics of Yeasts	PLOS ONE			English	Article								Background. The absolute quantification of intracellular protein levels is technically demanding, but has recently become more prominent because novel approaches like systems biology and metabolic control analysis require knowledge of these parameters. Current protocols for the extraction of proteins from yeast cells are likely to introduce artifacts into quantification procedures because of incomplete or selective extraction. Principal Findings. We have developed a novel procedure for protein extraction from S. cerevisiae based on chemical lysis and simultaneous solubilization in SDS and urea, which can extract the great majority of proteins to apparent completeness. The procedure can be used for different Saccharomycetes yeast species and varying growth conditions, is suitable for high-throughput extraction in a 96-well format, and the resulting extracts can easily be post-processed for use in non-SDS compatible procedures like 2D gel electrophoresis. Conclusions. An improved method for quantitative protein extraction has been developed that removes some of the sources of artefacts in quantitative proteomics experiments, while at the same time allowing novel types of applications.	Univ Kent, Prot Sci Grp, Dept Biosci, Canterbury, Kent, England	University of Kent	von der Haar, T (corresponding author), Univ Kent, Prot Sci Grp, Dept Biosci, Canterbury, Kent, England.	T.von-der-Haar@kent.ac.uk		von der Haar, Tobias/0000-0002-6031-9254	Wellcome Trust (UK) Research Career Development Fellowship [075438/Z/04/Z]	Wellcome Trust (UK) Research Career Development Fellowship(Wellcome Trust)	This work was funded by a Wellcome Trust (UK) Research Career Development Fellowship (Ref. 075438/Z/04/Z). The funders had no role in the design or conduct of this study, nor in the preparation of the manuscript.	Brachmann CB, 1998, YEAST, V14, P115; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; ELBARADI TTAL, 1984, EUR J BIOCHEM, V144, P393, DOI 10.1111/j.1432-1033.1984.tb08477.x; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Remacha M, 1995, BIOCHEM CELL BIOL, V73, P959, DOI 10.1139/o95-103; STARK GR, 1960, J BIOL CHEM, V235, P3177; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tuite MF, 2006, METHODS, V39, P9, DOI 10.1016/j.ymeth.2006.04.001; von der Haar T, 2007, TRENDS MICROBIOL, V15, P78, DOI 10.1016/j.tim.2006.12.002; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6	17	111	113	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1078	10.1371/journal.pone.0001078	http://dx.doi.org/10.1371/journal.pone.0001078			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957260	Green Accepted, Green Published, gold			2022-12-25	WOS:000207458500023
J	Mohler, PJ; Healy, JA; Xue, H; Puca, AA; Kline, CF; Allingham, RR; Kranias, EG; Rockman, HA; Bennett, V				Mohler, Peter J.; Healy, Jane A.; Xue, Hui; Puca, Annibale A.; Kline, Crystal F.; Allingham, R. Rand; Kranias, Evangelia G.; Rockman, Howard A.; Bennett, Vann			Ankyrin-B Syndrome: Enhanced Cardiac Function Balanced by Risk of Cardiac Death and Premature Senescence	PLOS ONE			English	Article							MEMBRANE ATTACHMENT SITE; LONG-QT SYNDROME; LATERAL MEMBRANE; RECEPTOR; ATPASE; EXPRESSION; SPECTRIN; MICE; CELL; PURIFICATION	Here we report the unexpected finding that specific human ANK2 variants represent a new example of balanced human variants. The prevalence of certain ANK2 (encodes ankyrin-B) variants range from 2 percent of European individuals to 8 percent in individuals from West Africa. Ankyrin-B variants associated with severe human arrhythmia phenotypes (eg E1425G, V1516D, R1788W) were rare in the general population. Variants associated with less severe clinical and in vitro phenotypes were unexpectedly common. Studies with the ankyrin-B+/- mouse reveal both benefits of enhanced cardiac contractility, as well as costs in earlier senescence and reduced lifespan. Together these findings suggest a constellation of traits that we term "ankyrin-B syndrome'', which may contribute to both aging-related disorders and enhanced cardiac function.	[Mohler, Peter J.; Kline, Crystal F.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Mohler, Peter J.; Kline, Crystal F.] Univ Iowa, Dept Mol Physiol & Biophys, Carver Coll Med, Iowa City, IA 52242 USA; [Rockman, Howard A.; Bennett, Vann] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Healy, Jane A.; Bennett, Vann] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Xue, Hui; Rockman, Howard A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Allingham, R. Rand] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [Puca, Annibale A.] Policlin MultiMed, IRCCS, Milan, Italy; [Kranias, Evangelia G.] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA; [Healy, Jane A.; Xue, Hui; Bennett, Vann] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	University of Iowa; University of Iowa; Duke University; Duke University; Duke University; Duke University; University System of Ohio; University of Cincinnati; Duke University; Howard Hughes Medical Institute	Mohler, PJ (corresponding author), Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA.	peter-mohler@uiowa.edu; v.bennett@cellbio.duke.edu	Puca, Annibale Alessandro/K-2099-2018		NIH [HL084583, HL083422, HL-26057, HL-64018, HL-77101, HL056687]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083422, P50HL077101, R01HL056687, R01HL026057, R37HL026057, R01HL084583, R01HL064018] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We acknowledge financial support from the NIH (HL084583 and HL083422 to PJM; HL-26057, HL-64018 and HL-77101 to EGK, HL056687 to HR). PJM is also supported by the Pew Charitable Trusts. VB acknowledges support from the Muscular Dystrophy Association.	AGRE P, 1982, NEW ENGL J MED, V306, P1155, DOI 10.1056/NEJM198205133061906; AGRE P, 1985, NATURE, V314, P380, DOI 10.1038/314380a0; Barki-Harrington L, 2003, CIRCULATION, V108, P1611, DOI 10.1161/01.CIR.0000092166.30360.78; BENNETT V, 1979, J BIOL CHEM, V254, P2533; BENNETT V, 1978, J BIOL CHEM, V253, P2292; BENNETT V, 1979, NATURE, V281, P597, DOI 10.1038/281597a0; Bhasin N, 2007, AM J PHYSIOL-HEART C, V293, pH109, DOI 10.1152/ajpheart.00059.2007; Cho MC, 1999, J BIOL CHEM, V274, P22251, DOI 10.1074/jbc.274.32.22251; Eber SW, 1996, NAT GENET, V13, P214, DOI 10.1038/ng0696-214; Esposito G, 2000, AM J PHYSIOL-HEART C, V279, pH3101, DOI 10.1152/ajpheart.2000.279.6.H3101; Glitsch HG, 2001, PHYSIOL REV, V81, P1791, DOI 10.1152/physrev.2001.81.4.1791; Hauptman PJ, 1999, CIRCULATION, V99, P1265, DOI 10.1161/01.CIR.99.9.1265; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; Mohler PJ, 2007, CIRCULATION, V115, P432, DOI 10.1161/CIRCULATIONAHA.106.656512; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P9137, DOI 10.1073/pnas.0402546101; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Mohler PJ, 2002, J BIOL CHEM, V277, P10599, DOI 10.1074/jbc.M110958200; Muller-Ehmsen J, 2001, AM J PHYSIOL-CELL PH, V281, pC1355, DOI 10.1152/ajpcell.2001.281.4.C1355; Nicholls DG, 2002, INT J BIOCHEM CELL B, V34, P1372, DOI 10.1016/S1357-2725(02)00077-8; Perrino C, 2006, J CLIN INVEST, V116, P1547, DOI 10.1172/JCI25397; Priori SG, 1999, CIRCULATION, V99, P529, DOI 10.1161/01.CIR.99.4.529; Rockman HA, 1998, P NATL ACAD SCI USA, V95, P7000, DOI 10.1073/pnas.95.12.7000; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Roden DM, 2004, TRENDS CARDIOVAS MED, V14, P112, DOI 10.1016/j.tcm.2004.01.001; Scotland P, 1998, J CELL BIOL, V143, P1305, DOI 10.1083/jcb.143.5.1305; Sherman J, 2005, HEART RHYTHM, V2, P1218, DOI 10.1016/j.hrthm.2005.07.026; Tuvia S, 1999, J CELL BIOL, V147, P995, DOI 10.1083/jcb.147.5.995; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Wang JN, 2001, AM J PHYSIOL-CELL PH, V281, pC1336, DOI 10.1152/ajpcell.2001.281.4.C1336; Wolska BM, 1996, AM J PHYSIOL-CELL PH, V271, pC391, DOI 10.1152/ajpcell.1996.271.1.C391; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	36	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1051	10.1371/journal.pone.0001051	http://dx.doi.org/10.1371/journal.pone.0001051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940615	Green Published, gold, Green Submitted			2022-12-25	WOS:000207456100019
J	Semple, MG; Dankert, HM; Ebrahimi, B; Correia, JB; Booth, JA; Stewart, JP; Smyth, RL; Hart, CA				Semple, Malcolm G.; Dankert, Hinke M.; Ebrahimi, Bahram; Correia, Jailson B.; Booth, J. Angela; Stewart, James P.; Smyth, Rosalind L.; Hart, C. Anthony			Severe Respiratory Syncytial Virus Bronchiolitis in Infants Is Associated with Reduced Airway Interferon Gamma and Substance P	PLOS ONE			English	Article								Background. Severe human respiratory syncytial virus (hRSV) bronchiolitis in previously well infants may be due to differences in the innate immune response to hRSV infection. Aim: to determine if factors mediating proposed mechanisms for severe bronchiolitis differ with severity of disease. Methodology/Principle Findings. 197 infants admitted to hospital with hRSV bronchiolitis were recruited and grouped according to no oxygen requirement (n = 27), oxygen dependence (n = 114) or mechanical ventilation (n = 56). We collected clinical data, nasopharyngeal aspirate (NPA) and if ventilated bronchoalveolar lavage (BAL). Interferon-gamma (IFN-gamma), substance P (SP), interleukin 9 (IL-9), urea and hRSV load, were measured in cell free supernatant from NPA and BAL. Multivariate analysis compared independent effects of clinical, virological and immunological variables upon disease severity. IFN-gamma and SP concentrations were lower in NPA from infants who required oxygen or mechanical ventilation. Viral load and IL-9 concentrations were high but did not vary with severity of disease. Independent predictors of severe disease (in diminishing size of effect) were low weight on admission, low gestation at birth, low NPA IFN-gamma and NPA SP. Nasal airway sampling appears to be a useful surrogate for distal airway sampling since concentrations of IFN-gamma, SP, IL-9 and viral load in NPA correlate with the same in BAL. Conclusions. Our data support two proposed mechanisms for severe hRSV disease; reduced local IFN-gamma response and SP mediated inflammation. We found large amounts of hRSV and IL-9 in airways secretions from the upper and lower respiratory tract but could not associate these with disease severity.	[Semple, Malcolm G.; Dankert, Hinke M.; Booth, J. Angela; Smyth, Rosalind L.] Univ Liverpool, Div Child Hlth, Sch Reprod & Dev Med, Liverpool L69 3BX, Merseyside, England; [Semple, Malcolm G.; Ebrahimi, Bahram; Correia, Jailson B.; Stewart, James P.; Hart, C. Anthony] Univ Liverpool, Div Med Microbiol & Genito Urinary Med, Sch Infect & Host Def, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Semple, MG (corresponding author), Univ Liverpool, Div Child Hlth, Sch Reprod & Dev Med, Liverpool L69 3BX, Merseyside, England.	m.g.semple@liver-pool.ac.uk	Semple, Malcolm Gracie/A-8790-2008; Correia, Jailson B./J-4331-2015; Stewart, James/A-6034-2012	Semple, Malcolm Gracie/0000-0001-9700-0418; Stewart, James/0000-0002-8928-2037; de Barros Correia, Jailson/0000-0002-0927-2219; Ebrahimi, Bahram/0000-0002-8758-4592	National Clinician Scientist; Royal Liverpool Children's Hospital; American Thoracic Society	National Clinician Scientist; Royal Liverpool Children's Hospital; American Thoracic Society	This study was funded by a National Clinician Scientist Award to Dr MG Semple by the Department of Health, HMG United Kingdom. This study was supported by an equipment grant from the Royal Liverpool Children's Hospital (Alder Hey) Endowment Fund. Oral presentation of this data at The 2006 American Thoracic Society International Conference San Diego USA was supported by an International Trainee Travel Award to MGS from the American Thoracic Society. None of the sponsors had any role in the study design, execution or writing of this paper.	Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Bont L, 2000, Paediatr Respir Rev, V1, P221, DOI 10.1053/prrv.2000.0052; Bont L, 2001, J INFECT DIS, V184, P355, DOI 10.1086/322035; BRAUNSTEIN G, 1991, AM REV RESPIR DIS, V144, P630, DOI 10.1164/ajrccm/144.3_Pt_1.630; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; de Blic J, 2000, EUR RESPIR J, V15, P217; DeVincenzo JP, 2005, J INFECT DIS, V191, P1861, DOI 10.1086/430008; Dong Q, 1999, EUR J IMMUNOL, V29, P2130, DOI 10.1002/(SICI)1521-4141(199907)29:07<2130::AID-IMMU2130>3.0.CO;2-S; EVERARD ML, 1994, ARCH DIS CHILD, V71, P428, DOI 10.1136/adc.71.5.428; EXCLER JL, 2005, STATE ART NEW VACCIN, P14; Friedrich L, 2006, AM J RESP CRIT CARE, V173, P442, DOI 10.1164/rccm.200503-444OC; Greensill J, 2003, EMERG INFECT DIS, V9, P372, DOI 10.3201/eid0903.020289; HALL CB, 1975, J INFECT DIS, V132, P151, DOI 10.1093/infdis/132.2.151; Heaney LG, 1996, CLIN EXP ALLERGY, V26, P799, DOI 10.1046/j.1365-2222.1996.d01-385.x; Hjalmarson O, 2002, AM J RESP CRIT CARE, V165, P83, DOI 10.1164/ajrccm.165.1.2107093; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; HOSMER DW, 1978, COMPUT PROG BIOMED, V8, P121, DOI 10.1016/0010-468X(78)90047-8; Jartti T, 2004, EMERG INFECT DIS, V10, P1095, DOI 10.3201/eid1006.030629; Johnson JE, 2007, MODERN PATHOL, V20, P108, DOI 10.1038/modpathol.3800725; Kaltreider HB, 1997, AM J RESP CELL MOL, V16, P133, DOI 10.1165/ajrcmb.16.2.9032120; King KA, 2001, AM J RESP CELL MOL, V24, P101, DOI 10.1165/ajrcmb.24.2.4264; Leader S, 2002, PEDIATR INFECT DIS J, V21, P629, DOI 10.1097/00006454-200207000-00005; Legg JP, 2003, AM J RESP CRIT CARE, V168, P633, DOI 10.1164/rccm.200210-1148OC; Lo MS, 2005, J VIROL, V79, P9315, DOI 10.1128/JVI.79.14.9315-9319.2005; LOCKITCH G, 1988, CLIN CHEM, V34, P1622; McNamara PS, 2004, LANCET, V363, P1031, DOI 10.1016/S0140-6736(04)15838-8; McNamara PS, 2004, EUR RESPIR J, V23, P106, DOI 10.1183/09031936.03.00048103; McNamara PS, 2003, ARCH DIS CHILD, V88, P922, DOI 10.1136/adc.88.10.922; Mills PC, 2006, J FELINE MED SURG, V8, P105, DOI 10.1016/j.jfms.2005.11.001; Mills PC, 2005, NEW ZEAL VET J, V53, P423, DOI 10.1080/00480169.2005.36587; Nicolaides NC, 1997, P NATL ACAD SCI USA, V94, P13175, DOI 10.1073/pnas.94.24.13175; Perkins SM, 2005, J CLIN MICROBIOL, V43, P2356, DOI 10.1128/JCM.43.5.2356-2362.2005; Piedimonte G, 1999, AM J PHYSIOL-LUNG C, V277, pL831, DOI 10.1152/ajplung.1999.277.4.L831; Pierson RN, 2000, ANN NY ACAD SCI, V904, P1; Ratjen F, 1996, PEDIATR PULM, V21, P184, DOI 10.1002/(SICI)1099-0496(199603)21:3<184::AID-PPUL6>3.0.CO;2-Q; Reader JR, 2003, AM J RESP CELL MOL, V28, P664, DOI 10.1165/rcmb.2002-0207OC; RENNARD SI, 1986, J APPL PHYSIOL, V60, P532, DOI 10.1152/jappl.1986.60.2.532; Sabogal C, 2005, PEDIATR RES, V57, P819, DOI 10.1203/01.PDR.0000157679.67227.11; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; Smyth RL, 2002, PEDIATR PULM, V33, P339, DOI 10.1002/ppul.10080; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; TALKE H, 1965, KLIN WOCHENSCHR, V43, P174, DOI 10.1007/BF01484513; Temann UA, 1998, J EXP MED, V188, P1307, DOI 10.1084/jem.188.7.1307; Tortorolo L, 2005, AM J RESP CRIT CARE, V172, P233, DOI 10.1164/rccm.200412-1693OC; Tripp RA, 2003, J VIROL, V77, P6580, DOI 10.1128/JVI.77.11.6580-6584.2003; Wright PF, 2002, J INFECT DIS, V185, P1011, DOI 10.1086/339822; WRIGHT PF, 2000, WHOVB0008; YOUNG HA, 1995, J LEUKOCYTE BIOL, V58, P373, DOI 10.1002/jlb.58.4.373	48	45	49	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1038	10.1371/journal.pone.0001038	http://dx.doi.org/10.1371/journal.pone.0001038			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940602	Green Published, Green Submitted, gold			2022-12-25	WOS:000207456100006
J	Moulin, S; Llanos, S; Kim, SH; Peters, G				Moulin, S.; Llanos, S.; Kim, S-H; Peters, G.			Binding to nucleophosmin determines the localization of human and chicken ARF but not its impact on p53	ONCOGENE			English	Article						ARF; nucleophosmin; nucleolus; p53; MDM2; chicken embryo fibroblasts	TUMOR-SUPPRESSOR PROTEIN; CELL-CYCLE ARREST; NUCLEOLAR LOCALIZATION; STABILIZES P53; NUCLEAR EXPORT; MDM2; P14(ARF); LOCUS; DEGRADATION; P19(ARF)	The ARF tumour suppressor gene encodes a small highly basic protein whose known functions are largely determined by the amino acids encoded within the first exon. In mammals, the protein incorporates additional residues specified by an alternative reading frame in the second exon of INK4a, but this arrangement does not apply to the chicken homologue. In exploring the intracellular localization of chicken p7(ARF), we found that while the FLAG- and HA- tagged versions localize in the nucleolus, in line with mammalian ARF, the GFP- tagged version is excluded from the nucleolus. Here we show that irrespective of the source or composition of the ARF fusion proteins, versions that accumulate in the nucleolus share the ability to bind to nucleophosmin ( NPM). Depletion of NPM with siRNA results in the re- location and destabilization of nucleolar forms of ARF but has little effect on the location or stability of a nucleoplasmic form of ARF. Importantly, knockdown of endogenous NPM does not impair the ability of ARF to bind to MDM2 and stabilize p53. These findings support the view that nucleolar localization determines the stability of ARF but not its primary function.	[Moulin, S.; Llanos, S.; Kim, S-H; Peters, G.] London Res Inst, Canc Res UK, Mol Oncol Lab, London WC2A 3PX, England	Cancer Research UK	Peters, G (corresponding author), London Res Inst, Canc Res UK, Mol Oncol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	gordon.peters@cancer.org.uk	Kim, Soo Hyun/ABG-8773-2020; , Susana/AAA-9282-2019	Kim, Soo Hyun/0000-0002-9394-1437; Llanos, Susana/0000-0002-8555-9326				Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Brady SN, 2004, MOL CELL BIOL, V24, P9327, DOI 10.1128/MCB.24.21.9327-9338.2004; Clark PA, 2002, ONCOGENE, V21, P4498, DOI 10.1038/sj.onc.1205558; Colombo E, 2006, CANCER RES, V66, P3044, DOI 10.1158/0008-5472.CAN-05-2378; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; den Besten W, 2005, CELL CYCLE, V4, P1593; Enomoto T, 2006, J BIOL CHEM, V281, P18463, DOI 10.1074/jbc.M602788200; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Kim SH, 2003, P NATL ACAD SCI USA, V100, P211, DOI 10.1073/pnas.0135557100; Kim SH, 2006, J CELL SCI, V119, P2435, DOI 10.1242/jcs.02989; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Llanos S, 2001, NAT CELL BIOL, V3, P445, DOI 10.1038/35074506; Lohrum MAE, 2000, CURR BIOL, V10, P539, DOI 10.1016/S0960-9822(00)00472-3; QUELLE DE, 1995, CELL, V83, P993; Quelle DE, 1997, P NATL ACAD SCI USA, V94, P669, DOI 10.1073/pnas.94.2.669; Rizos H, 2000, ONCOGENE, V19, P2978, DOI 10.1038/sj.onc.1203629; Rodway H, 2004, ONCOGENE, V23, P6186, DOI 10.1038/sj.onc.1207854; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Weber JD, 2000, MOL CELL BIOL, V20, P2517, DOI 10.1128/MCB.20.7.2517-2528.2000; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhang YP, 1999, MOL CELL, V3, P579, DOI 10.1016/S1097-2765(00)80351-2	31	15	15	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2008	27	17					2382	2389		10.1038/sj.onc.1210887	http://dx.doi.org/10.1038/sj.onc.1210887			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286KN	17968318				2022-12-25	WOS:000254844900003
J	Yu, PJ; Ferrari, G; Pirelli, L; Galloway, AC; Mignatti, P; Pintucci, G				Yu, P-J; Ferrari, G.; Pirelli, L.; Galloway, A. C.; Mignatti, P.; Pintucci, G.			Thrombin cleaves the high molecular weight forms of basic fibroblast growth factor (FGF-2): a novel mechanism for the control of FGF-2 and thrombin activity	ONCOGENE			English	Article						endothelial cells; inflammation; migration; proliferation; proteolysis; serine proteinases	ACTIVATED RECEPTORS; ENDOTHELIAL-CELLS; EXPRESSION; MIGRATION; TRANSLATION; METHYLATION; TRANSACTIVATION; ANGIOGENESIS; DIVERSITY; ISOFORMS	The fgf-2 gene encodes low molecular weight (LMW, 18 kDa) and high molecular weight (HMW, 22-24 kDa) forms that originate from alternative translation of a single mRNA and exhibit diverse biological functions. HMW fibroblast growth factor-2 (FGF-2) inhibits cell migration and induces cell transformation or growth arrest in a cell type-and dose-dependent fashion. Conversely, LMW FGF-2 upregulates both cell proliferation and migration in most cell types. Although transcriptional and translational regulation of HMW and LMW FGF-2 has been extensively investigated, little is known about post-translational control of their relative expression. Here we report that thrombin, a key coagulation factor and inflammatory mediator, cleaves HMW FGF-2 into an LMW FGF-2-like form that stimulates endothelial cell migration and proliferation. The effect of thrombin on these cell functions requires HMW FGF-2 cleavage. This post-translational control mechanism adds a novel level of complexity to the regulation of FGF-2, and links the activities of thrombin and FGF-2 in patho-physiological processes in which both molecules are expressed.	[Yu, P-J; Ferrari, G.; Pirelli, L.; Galloway, A. C.; Mignatti, P.; Pintucci, G.] NYU, Sch Med, Seymour Cohn Cardiovasc Res Lab, Dept Cardiothorac Surg, New York, NY 10016 USA; [Mignatti, P.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University	Pintucci, G (corresponding author), NYU, Sch Med, Seymour Cohn Cardiovasc Res Lab, Dept Cardiothorac Surg, 530 1st Ave,NB-15W16, New York, NY 10016 USA.	pintug01@med.nyu.edu	Ferrari, Giovanni/A-3390-2009	Mignatti, Paolo/0000-0002-8157-457X; Galoway, Aubrey/0000-0001-5461-3820; Ferrari, Giovanni/0000-0002-8863-2496	NHLBI NIH HHS [5R01 HL70203-01, R01 HL070203] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070203] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arai T, 2005, J BIOL CHEM, V280, P5145, DOI 10.1074/jbc.M409234200; Balcaitis S, 2003, NEUROREPORT, V14, P2373, DOI 10.1097/00001756-200312190-00017; BIKFALVI A, 1995, J CELL BIOL, V129, P233, DOI 10.1083/jcb.129.1.233; BURGESS WH, 1991, CELL REGUL, V2, P87, DOI 10.1091/mbc.2.2.87; Claus P, 2004, NEUROSCI LETT, V360, P117, DOI 10.1016/j.neulet.2004.01.046; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Counter CM, 1998, ONCOGENE, V16, P1217, DOI 10.1038/sj.onc.1201882; Cucina A, 2002, CELL BIOCHEM FUNCT, V20, P39, DOI 10.1002/cbf.938; DANIEL TO, 1986, J BIOL CHEM, V261, P9579; Ding L, 2002, J BIOL CHEM, V277, P31056, DOI 10.1074/jbc.M203658200; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Ferrari G, 2006, P NATL ACAD SCI USA, V103, P17260, DOI 10.1073/pnas.0605556103; FLORKIEWICZ RZ, 1989, P NATL ACAD SCI USA, V86, P3978, DOI 10.1073/pnas.86.11.3978; HERBERT JM, 1994, BIOCHEM J, V303, P227, DOI 10.1042/bj3030227; Ishibashi T, 2003, ARTERIOSCL THROM VAS, V23, P681, DOI 10.1161/01.ATV.0000065194.00822.C7; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Klein S, 2000, J BIOL CHEM, V275, P3150, DOI 10.1074/jbc.275.5.3150; Klein S, 1996, J BIOL CHEM, V271, P22583, DOI 10.1074/jbc.271.37.22583; LOBB RR, 1988, BIOCHEMISTRY-US, V27, P2572, DOI 10.1021/bi00407a045; Malecki J, 2004, MOL BIOL CELL, V15, P801, DOI 10.1091/mbc.E03-08-0589; Mann KG, 2003, CHEST, V124, p1S, DOI 10.1378/chest.124.3_suppl.1S; MIGNATTI P, 1991, P NATL ACAD SCI USA, V88, P11007, DOI 10.1073/pnas.88.24.11007; O'Brien PJ, 2000, J BIOL CHEM, V275, P13502, DOI 10.1074/jbc.275.18.13502; Ornitz DM, 2001, GENOME BIOL, V2; Papadimitriou E, 1997, AM J PHYSIOL-CELL PH, V272, pC1112, DOI 10.1152/ajpcell.1997.272.4.C1112; Pintucci G, 1996, MOL BIOL CELL, V7, P1249, DOI 10.1091/mbc.7.8.1249; Pintucci G, 2002, FASEB J, V16, P598, DOI 10.1096/fj.01-0815fje; Piotrowicz RS, 1997, J BIOL CHEM, V272, P7042, DOI 10.1074/jbc.272.11.7042; PRATS H, 1989, P NATL ACAD SCI USA, V86, P1836, DOI 10.1073/pnas.86.6.1836; Quarto N, 2005, GENE, V356, P49, DOI 10.1016/j.gene.2005.05.014; Rauch BH, 2005, J BIOL CHEM, V280, P17507, DOI 10.1074/jbc.M410848200; Rauch BH, 2004, CIRC RES, V94, P340, DOI 10.1161/01.RES.0000111805.09592.D8; Rickles FR, 2003, CHEST, V124, p58S, DOI 10.1378/chest.124.3_suppl.58S; Sharony R, 2006, AM J PHYSIOL-HEART C, V290, pH1651, DOI 10.1152/ajpheart.00530.2005; Sorensen V, 2006, BIOESSAYS, V28, P504, DOI 10.1002/bies.20405; Taverna S, 2003, J BIOL CHEM, V278, P51911, DOI 10.1074/jbc.M304192200; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Tsopanoglou NE, 1999, J BIOL CHEM, V274, P23969, DOI 10.1074/jbc.274.34.23969; VAGNER S, 1995, MOL CELL BIOL, V15, P35, DOI 10.1128/MCB.15.1.35; Yu PJ, 2007, J CELL BIOCHEM, V100, P1100, DOI 10.1002/jcb.21116	40	15	15	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2008	27	18					2594	2601		10.1038/sj.onc.1210899	http://dx.doi.org/10.1038/sj.onc.1210899			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	289LW	17968311	Green Accepted			2022-12-25	WOS:000255057000009
J	Selman, C; Lingard, S; Choudhury, AI; Batterham, RL; Claret, M; Clements, M; Ramadani, F; Okkenhaug, K; Schuster, E; Blanc, E; Piper, MD; Al-Qassab, H; Speakman, JR; Carmignac, D; Robinson, ICA; Thornton, JM; Gems, D; Partridge, L; Withers, DJ				Selman, Colin; Lingard, Steven; Choudhury, Agharul I.; Batterham, Rachel L.; Claret, Marc; Clements, Melanie; Ramadani, Faruk; Okkenhaug, Klaus; Schuster, Eugene; Blanc, Eric; Piper, Matthew D.; Al-Qassab, Hind; Speakman, John R.; Carmignac, Danielle; Robinson, Iain C. A.; Thornton, Janet M.; Gems, David; Partridge, Linda; Withers, Dominic J.			Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice	FASEB JOURNAL			English	Article						aging; longevity; insulin signaling	INSULIN-RECEPTOR GENE; CALORIC RESTRICTION; DWARF MICE; BODY-WEIGHT; EXPRESSION; IGF-1; LONGEVITY; INSIGHTS; MUTATION; DISRUPTION	Recent evidence suggests that alterations in insulin/insulin-like growth factor 1 (IGF1) signaling (IIS) can increase mammalian life span. For example, in several mouse mutants, impairment of the growth hormone (GH)/IGF1 axis increases life span and also insulin sensitivity. However, the intracellular signaling route to altered mammalian aging remains unclear. We therefore measured the life span of mice lacking either insulin receptor substrate (IRS) 1 or 2, the major intracellular effectors of the IIS receptors. Our provisional results indicate that female Irs1(-/-) mice are long-lived. Furthermore, they displayed resistance to a range of age-sensitive markers of aging including skin, bone, immune, and motor dysfunction. These improvements in health were seen despite mild, lifelong insulin resistance. Thus, enhanced insulin sensitivity is not a prerequisite for IIS mutant longevity. Irs1(-/-) female mice also displayed normal anterior pituitary function, distinguishing them from long-lived somatotrophic axis mutants. In contrast, Irs2(-/-) mice were short-lived, whereas Irs1(+/-) and Irs2(+/-) mice of both sexes showed normal life spans. Our results therefore suggest that IRS1 signaling is an evolutionarily conserved pathway regulating mammalian life span and may be a point of intervention for therapies with the potential to delay age-related processes.	[Selman, Colin; Lingard, Steven; Choudhury, Agharul I.; Batterham, Rachel L.; Claret, Marc; Clements, Melanie; Al-Qassab, Hind; Withers, Dominic J.] UCL, Rayne Inst, Ctr Diabet & Endocrinol, Dept Med, London, England; [Piper, Matthew D.; Gems, David; Partridge, Linda] UCL, Dept Biol, Ctr Res Ageing, London, England; [Ramadani, Faruk; Okkenhaug, Klaus] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England; [Schuster, Eugene; Blanc, Eric; Thornton, Janet M.] European Bioinformat Inst, Cambridge, England; [Speakman, John R.] Univ Aberdeen, Sch Biol Sci, ACERO, Aberdeen, Scotland; [Carmignac, Danielle; Robinson, Iain C. A.] Med Res Council Natl Inst Med Res, Div Mol Neuroendocrinol, London, England	University of London; King's College London; University College London; University of London; University College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; European Molecular Biology Laboratory (EMBL); University of Aberdeen; MRC National Institute for Medical Research	Withers, DJ (corresponding author), UCL, Rayne Inst, Ctr Diabet & Endocrinol, Dept Med, Univ St, London, England.	d.withers@ucl.ac.uk	Partridge, Linda/A-5501-2010; Speakman, John R./A-9494-2008; Blanc, Eric/C-5424-2009; Okkenhaug, Klaus/H-3154-2019; Okkenhaug, Klaus/D-5149-2012; Piper, Matthew/C-1714-2008; Withers, Dominic J/D-7671-2014; Partridge, Linda/E-7342-2015; Ramadani, Faruk/HHM-9664-2022	Speakman, John R./0000-0002-2457-1823; Okkenhaug, Klaus/0000-0002-9432-4051; Okkenhaug, Klaus/0000-0002-9432-4051; Piper, Matthew/0000-0003-3245-7219; Withers, Dominic J/0000-0002-8009-7521; Ramadani, Faruk/0000-0001-8228-4868; Thornton, Janet/0000-0003-0824-4096; Batterham, Rachel/0000-0002-5477-8585; Partridge, Linda/0000-0001-9615-0094; Selman, Colin/0000-0002-8727-0593; Gems, David/0000-0002-6653-4676; Claret, Marc/0000-0001-7766-9296; Schuster, Eugene/0000-0001-5076-2810	Biotechnology and Biological Sciences Research Council [BBS/E/B/0000M979, JF19128] Funding Source: Medline; Medical Research Council [MC_U117531708, G108/551, G0600866, G9900989, MC_U120097114] Funding Source: Medline; Wellcome Trust [066750] Funding Source: Medline; MRC [G0600866, MC_U117531708, G9900989, G108/551] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Akbar AN, 2004, NAT REV IMMUNOL, V4, P737, DOI 10.1038/nri1440; Amador-Noguez D, 2004, AGING CELL, V3, P423, DOI 10.1111/j.1474-9728.2004.00125.x; Apweiler R, 2000, BIOINFORMATICS, V16, P1145, DOI 10.1093/bioinformatics/16.12.1145; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayyadevara S, 2005, AGING CELL, V4, P299, DOI 10.1111/j.1474-9726.2005.00172.x; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Barger JL, 2003, EXP GERONTOL, V38, P1343, DOI 10.1016/j.exger.2003.10.017; Bartke A, 2006, TRENDS ENDOCRIN MET, V17, P33, DOI 10.1016/j.tem.2006.01.002; Batterham RL, 2006, CELL METAB, V4, P223, DOI 10.1016/j.cmet.2006.08.001; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Breslin T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-193; Breyer F, 2006, HEALTH POLICY, V75, P178, DOI 10.1016/j.healthpol.2005.03.011; Brown-Borg HM, 2000, EXP GERONTOL, V35, P199, DOI 10.1016/S0531-5565(00)00079-6; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598; CARMIGNAC DF, 1990, J ENDOCRINOL, V127, P69, DOI 10.1677/joe.0.1270069; Choudhury AI, 2005, J CLIN INVEST, V115, P940; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Gazdag AC, 1999, DIABETES, V48, P1930, DOI 10.2337/diabetes.48.10.1930; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Halloran BP, 2002, J BONE MINER RES, V17, P1044, DOI 10.1359/jbmr.2002.17.6.1044; HARRISON DE, 1984, P NATL ACAD SCI-BIOL, V81, P1835, DOI 10.1073/pnas.81.6.1835; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hubbard T, 2005, NUCLEIC ACIDS RES, V33, pD447, DOI 10.1093/nar/gki138; Joshi RL, 1996, EMBO J, V15, P1542, DOI 10.1002/j.1460-2075.1996.tb00498.x; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KROOK A, 1993, LANCET, V342, P277, DOI 10.1016/0140-6736(93)91820-C; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Miller RA, 1997, FASEB J, V11, P775, DOI 10.1096/fasebj.11.10.9271362; Miller RA, 2001, J GERONTOL A-BIOL, V56, pB180, DOI 10.1093/gerona/56.4.B180; Ogata N, 2000, J CLIN INVEST, V105, P935, DOI 10.1172/JCI9017; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Piper M. D. W., 2005, DRUG DISCOV TODAY DI, V2, P249; Rincon M, 2004, MECH AGEING DEV, V125, P397, DOI 10.1016/j.mad.2004.03.006; Selman C, 2006, PHYSIOL GENOMICS, V27, P187, DOI 10.1152/physiolgenomics.00084.2006; Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Turturro A, 2002, J GERONTOL A-BIOL, V57, pB379, DOI 10.1093/gerona/57.11.B379; van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002; Vergara M, 2004, J GERONTOL A-BIOL, V59, P1244, DOI 10.1093/gerona/59.12.1244; Weindruch R., 1988, RETARDATION AGING DI; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116	60	381	392	0	39	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2008	22	3					807	818		10.1096/fj.07-9261com	http://dx.doi.org/10.1096/fj.07-9261com			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17928362				2022-12-25	WOS:000254143700019
J	Domaoal, RA; McMahon, M; Thio, CL; Bailey, CM; Tirado-Rives, J; Obikhod, A; Detorio, M; Rapp, KL; Siliciano, RF; Schinazi, RF; Anderson, KS				Domaoal, Robert A.; McMahon, Moira; Thio, Chloe L.; Bailey, Christopher M.; Tirado-Rives, Julian; Obikhod, Aleksander; Detorio, Mervi; Rapp, Kimberly L.; Siliciano, Robert F.; Schinazi, Raymond F.; Anderson, Karen S.			Pre-steady-state kinetic studies establish entecavir 5 '-triphosphate as a substrate for HIV-1 reverse transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-B-VIRUS; DRUG-RESISTANCE; DNA-POLYMERASES; INHIBITION; MECHANISM; TYPE-1; REPLICATION; NUCLEOTIDE; 4'-AZIDOTHYMIDINE	The novel 2 '-deoxyguanosine analog Entecavir (ETV) is a potent inhibitor of hepatitis B virus (HBV) replication and is recommended for treatment in human immunodeficiency virus type 1 (HIV-1) and HBV-co-infected patients because it had been reported that ETV is HBV-specific. Recent clinical observations, however, have suggested that ETV may indeed demonstrate anti-HIV-1 activity. To investigate this question at a molecular level, kinetic studies were used to examine the interaction of 5'-triphosphate form of ETV with wild type (WT) HIV-1 reverse transcriptase (RT) and the nucleoside reverse transcriptase inhibitor-resistant mutation M184V. Using single turnover kinetic assays, we found that HIV-1 WT RT and M184V RT could use the activated ETV triphosphate metabolite as a substrate for incorporation. The mutant displayed a slower incorporation rate, a lower binding affinity, and a lower incorporation efficiency with the 5'-triphosphate form of ETV compared with WTRT, suggesting a kinetic basis for resistance. Our results are supported by cell-based assays in primary human lymphocytes that show inhibition of WT HIV-1 replication by ETV and decreased susceptibility of the HIV-1 containing the M184V mutation. This study has important therapeutic implications as it establishes ETV as an inhibitor for HIV-1 RT and illustrates the mechanism of resistance by the M184V mutant.	[Domaoal, Robert A.; Bailey, Christopher M.; Anderson, Karen S.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [McMahon, Moira; Thio, Chloe L.; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Med, Baltimore, MD 21205 USA; [Obikhod, Aleksander; Detorio, Mervi; Rapp, Kimberly L.; Schinazi, Raymond F.] Emory Univ, Sch Med, Vet Affairs Med Ctr, Decatur, GA 30033 USA; [Tirado-Rives, Julian] Yale Univ, Dept Chem, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Johns Hopkins University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Yale University	Anderson, KS (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	karen.anderson@yale.edu	Tirado-Rives, Julian/A-4992-2012	Tirado-Rives, Julian/0000-0001-7330-189X; Bailey, Chris/0000-0002-5962-9511; McMahon, Moira/0000-0001-9810-8623	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051178, R37AI041980, R37AI051178, R01AI044616, R01AI043222, P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049551] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [5R37-AI-041980, R37 AI051178, R37 AI041980, R01 AI043222, R01 AI051178, 5P30-AI-50409, AI-51178, P30 AI050409, R01 AI044616, AI-44616, AI-43222] Funding Source: Medline; NIGMS NIH HHS [GM-49551, R01 GM049551] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benson Constance A., 2004, Morbidity and Mortality Weekly Report, V53, P1; Boyer PL, 2005, J MOL BIOL, V345, P441, DOI 10.1016/j.jmb.2004.10.021; CHEN MS, 1992, J BIOL CHEM, V267, P257; CHEN MS, 1993, BIOCHEMISTRY-US, V32, P6002, DOI 10.1021/bi00074a011; Frisch M.J., 2016, GAUSSIAN 16 REVISION; GANEM D, 1994, INFECT AGENT DIS, V3, P85; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Innaimo SF, 1997, ANTIMICROB AGENTS CH, V41, P1444, DOI 10.1128/AAC.41.7.1444; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kerr SG, 1997, BIOCHEMISTRY-US, V36, P14064, DOI 10.1021/bi9713862; Langley DR, 2007, J VIROL, V81, P3992, DOI 10.1128/JVI.02395-06; Locarnini SA, 1996, ANTIVIR CHEM CHEMOTH, V7, P53, DOI 10.1177/095632029600700201; McMahon MA, 2007, NEW ENGL J MED, V356, P2614, DOI 10.1056/NEJMoa067710; Murakami E, 2005, ANTIVIR RES, V67, P10, DOI 10.1016/j.antiviral.2004.12.004; Nakata H, 2007, ANTIMICROB AGENTS CH, V51, P2701, DOI 10.1128/AAC.00277-07; Ono SK, 2001, J CLIN INVEST, V107, P449, DOI 10.1172/JCI11100; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ray AS, 2002, BIOCHEMISTRY-US, V41, P5150, DOI 10.1021/bi0121858; Rivkin A, 2007, DRUG TODAY, V43, P201, DOI 10.1358/dot.2007.43.4.1037479; SCHINAZI RF, 1990, ANTIMICROB AGENTS CH, V34, P1061, DOI 10.1128/AAC.34.6.1061; SCHINAZI RF, 1992, ANTIMICROB AGENTS CH, V36, P2423, DOI 10.1128/AAC.36.11.2423; SEEGER C, 1991, CURR TOP MICROBIOL, V168, P41; Seifer M, 1998, ANTIMICROB AGENTS CH, V42, P3200, DOI 10.1128/AAC.42.12.3200; Skoog D.A., 1992, PRINCIPLES INSTRUMEN; Soriano V, 2004, J VIRAL HEPATITIS, V11, P2, DOI 10.1046/j.1365-2893.2003.00491.x; 2006, VERSION 7 5; 2006, VERSION 4 0	27	32	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5452	5459		10.1074/jbc.M707834200	http://dx.doi.org/10.1074/jbc.M707834200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	17962184	hybrid, Green Accepted			2022-12-25	WOS:000253426700025
J	Venteclef, N; Haroniti, A; Tousaint, JJ; Talianidis, I; Delerive, P				Venteclef, Nicolas; Haroniti, Anna; Tousaint, Jean-Jacques; Talianidis, Iannis; Delerive, Philippe			Regulation of anti-atherogenic apolipoprotein m gene expression by the orphan nuclear receptor LRH-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-ACID BIOSYNTHESIS; STEROIDOGENIC FACTOR-I; ACUTE-PHASE RESPONSE; LIVER-X RECEPTOR; FEEDBACK-REGULATION; HOMOLOG-1 CONTROLS; TRANSCRIPTION; METABOLISM; SHP; INDUCTION	The orphan nuclear receptor liver receptor homolog-1 (LRH-1, NR5A2) has been reported to play a crucial role in early development, in the control of the hepatic inflammatory response, in intestinal cell crypt renewal as well as in bile acid biosynthesis and reverse cholesterol transport (RCT). Here, we report the identification of apolipoprotein M(APOM) as a novel target gene for LRH-1. Using gene-silencing experiments, adenovirus-mediated overexpression, transient transfection, and chromatin immunoprecipitation (ChIP) assays, it is shown that LRH-1 directly regulates human and mouse APOM transcription by binding to an LRH-1 response element located in the proximal APOM promoter region. In addition, we demonstrate that bile acids suppress APOM expression in a SHP-dependent manner in vitro and in vivo by inhibiting LRH-1 transcriptional activity on the APOM promoter as demonstrated by in vivo ChIP assay. Taken together, our results demonstrate that LRH-1 is a novel regulator of APOM transcription and further extend the role of this orphan nuclear receptor in lipoprotein metabolism and cholesterol homeostasis.	[Venteclef, Nicolas; Tousaint, Jean-Jacques; Delerive, Philippe] GlaxoSmithKline R&D, CVU CEDD, F-91951 Les Ulis, France; [Haroniti, Anna; Talianidis, Iannis] Biomed Sci Res Ctr Alexander Fleming, GR-16672 Athens, Greece	GlaxoSmithKline; Alexander Fleming Biomedical Sciences Research Center	Delerive, P (corresponding author), GlaxoSmithKline R&D, CVU CEDD, 25 Ave Quebec, F-91951 Les Ulis, France.	delerive@hotmail.com	Talianidis, Iannis/F-7556-2016; Venteclef, Nicolas/K-8484-2017	Talianidis, Iannis/0000-0002-1209-3609; Venteclef, Nicolas/0000-0002-6313-1214				BARD JM, 1990, METABOLISM, V39, P269, DOI 10.1016/0026-0495(90)90046-F; Botrugno OA, 2004, MOL CELL, V15, P499, DOI 10.1016/j.molcel.2004.07.009; Boulias K, 2005, EMBO J, V24, P2624, DOI 10.1038/sj.emboj.7600728; CASTILLOOLIVARE.A, 2000, J BIOL CHEM, V275, P17793; CASTILLOOLIVARE.A, 2004, J BIOL CHEM, V279, P16813; Chalkiadaki A, 2005, MOL CELL BIOL, V25, P5095, DOI 10.1128/MCB.25.12.5095-5105.2005; Chen F, 2003, J BIOL CHEM, V278, P19909, DOI 10.1074/jbc.M207903200; Christoffersen C, 2006, J LIPID RES, V47, P1833, DOI 10.1194/jlr.M600055-JLR200; Claudel T, 2002, J CLIN INVEST, V109, P961; Clyne CD, 2002, J BIOL CHEM, V277, P20591, DOI 10.1074/jbc.M201117200; Dahlback B, 2006, CURR OPIN LIPIDOL, V17, P291, DOI 10.1097/01.mol.0000226122.10005.88; Delerive P, 2004, MOL ENDOCRINOL, V18, P2378, DOI 10.1210/me.2004-0132; Fayard E, 2003, J BIOL CHEM, V278, P35725, DOI 10.1074/jbc.M302370200; Fayard E, 2004, TRENDS CELL BIOL, V14, P250, DOI 10.1016/j.tcb.2004.03.008; Freeman LA, 2004, J LIPID RES, V45, P1197, DOI 10.1194/jlr.C400002-JLR200; Galarneau L, 1996, MOL CELL BIOL, V16, P3853; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Huang JS, 2007, HEPATOLOGY, V46, P147, DOI 10.1002/hep.21632; Insull W, 2006, SOUTH MED J, V99, P257, DOI 10.1097/01.smj.0000208120.73327.db; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Ktistaki E, 1997, SCIENCE, V277, P109, DOI 10.1126/science.277.5322.109; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; Lee YK, 2006, J BIOL CHEM, V281, P7850, DOI 10.1074/jbc.M509115200; Lee YK, 1999, J BIOL CHEM, V274, P20869, DOI 10.1074/jbc.274.30.20869; Li Y, 2005, MOL CELL, V17, P491, DOI 10.1016/j.molcel.2005.02.002; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Luo Y, 2001, J BIOL CHEM, V276, P24767, DOI 10.1074/jbc.M100912200; Malerod L, 2005, BIOCHEM BIOPH RES CO, V336, P1096, DOI 10.1016/j.bbrc.2005.08.237; Matsukuma KE, 2007, J BIOL CHEM, V282, P20164, DOI 10.1074/jbc.M702895200; Melter M, 2000, AM J GASTROENTEROL, V95, P3522; Mueller M, 2006, J EXP MED, V203, P2057, DOI 10.1084/jem.20060357; Nitta M, 1999, P NATL ACAD SCI USA, V96, P6660, DOI 10.1073/pnas.96.12.6660; Ortlund EA, 2005, NAT STRUCT MOL BIOL, V12, P357, DOI 10.1038/nsmb910; Pare JF, 2004, J BIOL CHEM, V279, P21206, DOI 10.1074/jbc.M401523200; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Richter S, 2003, DIABETES, V52, P2989, DOI 10.2337/diabetes.52.12.2989; Schoonjans K, 2002, EMBO REP, V3, P1181, DOI 10.1093/embo-reports/kvf238; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Srivastava RAK, 2000, EUR J BIOCHEM, V267, P4272, DOI 10.1046/j.1432-1327.2000.01473.x; Suzuki T, 2002, ENDOCR RES, V28, P537, DOI 10.1081/ERC-120016835; Tallet F, 1996, CLIN CHIM ACTA, V244, P1, DOI 10.1016/0009-8981(95)06161-4; Venteclef N, 2007, J BIOL CHEM, V282, P4393, DOI 10.1074/jbc.M608993200; Venteclef N, 2006, MOL CELL BIOL, V26, P6799, DOI 10.1128/MCB.00579-06; Wang W, 2005, P NATL ACAD SCI USA, V102, P7505, DOI 10.1073/pnas.0409482102; Wolfrum C, 2005, NAT MED, V11, P418, DOI 10.1038/nm1211; Xu N, 2004, BIOCHEM BIOPH RES CO, V321, P916, DOI 10.1016/j.bbrc.2004.06.180; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286	51	50	60	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3694	3701		10.1074/jbc.M706382200	http://dx.doi.org/10.1074/jbc.M706382200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	17977826	hybrid			2022-12-25	WOS:000253083500002
J	Shankaran, SS; Capell, A; Hruscha, AT; Fellerer, K; Neumann, M; Schmid, B; Haass, C				Shankaran, Sunita S.; Capell, Anja; Hruscha, Alexander T.; Fellerer, Katrin; Neumann, Manuela; Schmid, Bettina; Haass, Christian			Missense mutations in the progranulin gene linked to frontotemporal lobar degeneration with ubiquitin-immunoreactive inclusions reduce progranulin production and secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; GRANULIN-EPITHELIN PRECURSOR; GROWTH-FACTOR PCDGF; CELL-LINE; POSITIVE INCLUSIONS; DEMENTIA; TDP-43; ZEBRAFISH; PROTEIN; TAU	Loss of function mutations in progranulin cause tau-negative frontotemporal lobar degeneration with ubiquitin-positive inclusions. A major protein component of these inclusions is TDP-43, which becomes hyperphosphorylated, ubiquitinated, and cleaved to generate C-terminal fragments, which apparently translocate from nuclei to the cytoplasm. Most progranulin mutations are nonsense mutations resulting in nonsense-mediated mRNA decay and consequently reduced progranulin protein levels. However, some missense mutations are described that occur within the signal sequence and mature progranulin. We now demonstrate that a progranulin mutation located within the signal sequence (PGRN A9D) results in cytoplasmic missorting with extremely low expression. In contrast, two other progranulin mutations (PGRN P248L and R432C) are expressed as immature proteins but are inefficiently transported through and partially degraded within the secretory pathway, resulting in a significantly reduced secretion. Thus apparently all progranulin mutations cause reduced protein expression or secretion, although by different cellular mechanisms. To investigate a putative relationship between reduced expression of progranulin and TDP-43 relocalization and deposition, we down-regulated progranulin in human cell lines and in zebrafish. Upon reduction of progranulin, neither a major redistribution of TDP-43 nor proteolytic processing to disease-characterizing C-terminal fragments could be observed.	[Shankaran, Sunita S.; Capell, Anja; Hruscha, Alexander T.; Fellerer, Katrin; Schmid, Bettina; Haass, Christian] Univ Munich, Dept Biochem, Adolf Butenandt Inst, Lab Neurodegenerat Dis Res, D-80336 Munich, Germany; [Shankaran, Sunita S.; Capell, Anja; Hruscha, Alexander T.; Fellerer, Katrin; Schmid, Bettina; Haass, Christian] Univ Munich, Munich Ctr Integrated Prot Sci, D-80336 Munich, Germany; [Neumann, Manuela] Univ Munich, Ctr Neuropathol & Pr Res, D-80336 Munich, Germany	University of Munich; University of Munich; University of Munich	Haass, C (corresponding author), Univ Munich, Dept Biochem, Adolf Butenandt Inst, Lab Neurodegenerat Dis Res, Schillerstr 44, D-80336 Munich, Germany.	chaass@med.uni-muenchen.de	Neumann, Manuela/F-6558-2011	Neumann, Manuela/0000-0002-6232-4057				Ahmed Z, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-7; Ayala YM, 2006, FEBS LETT, V580, P1339, DOI 10.1016/j.febslet.2006.01.052; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Benussi L, 2008, NEUROBIOL AGING, V29, P427, DOI 10.1016/j.neurobiolaging.2006.10.028; Boeve BF, 2006, BRAIN, V129, P3103, DOI 10.1093/brain/awl268; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Cadieux B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-156; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Capell A, 2000, NAT CELL BIOL, V2, P205, DOI 10.1038/35008626; Chiba S, 2007, J REPROD DEVELOP, V53, P297, DOI 10.1262/jrd.18108; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Davidson Y, 2007, ACTA NEUROPATHOL, V113, P521, DOI 10.1007/s00401-006-0189-y; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; He ZH, 2002, CANCER RES, V62, P5590; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Josephs KA, 2007, J NEUROPATH EXP NEUR, V66, P142, DOI 10.1097/nen.0b013e31803020cf; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lu RQ, 2000, P NATL ACAD SCI USA, V97, P3993, DOI 10.1073/pnas.97.8.3993; Mackenzie IRA, 2006, BRAIN, V129, P3081, DOI 10.1093/brain/awl271; Masellis M, 2006, BRAIN, V129, P3115, DOI 10.1093/brain/awl276; Mukherjee O, 2006, ANN NEUROL, V60, P314, DOI 10.1002/ana.20963; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Neary D, 2000, ANN NY ACAD SCI, V920, P46; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P152, DOI 10.1097/nen.0b013e31803020b9; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P177, DOI 10.1097/01.jnen.0000248554.45456.58; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pizarro GO, 2007, INT J CANCER, V120, P2339, DOI 10.1002/ijc.22559; Rademakers R, 2002, MOL PSYCHIATR, V7, P1064, DOI 10.1038/sj.mp.4001198; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; Schymick JC, 2007, J NEUROL NEUROSUR PS, V78, P754, DOI 10.1136/jnnp.2006.109553; Seelaar H, 2007, BRAIN, V130, P1375, DOI 10.1093/brain/awm024; van der Zee J, 2007, HUM MUTAT, V28, P416, DOI 10.1002/humu.9484; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Zanocco-Marani T, 1999, CANCER RES, V59, P5331; Zhang HD, 1998, P NATL ACAD SCI USA, V95, P14202, DOI 10.1073/pnas.95.24.14202; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; ZHOU J, 1993, J BIOL CHEM, V268, P10863; Zuccato E, 2004, J BIOL CHEM, V279, P16980, DOI 10.1074/jbc.M313439200	43	139	143	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1744	1753		10.1074/jbc.M705115200	http://dx.doi.org/10.1074/jbc.M705115200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17984093	hybrid			2022-12-25	WOS:000252282700061
J	Strop, P; Kaiser, SE; Vrljic, M; Brunger, AT				Strop, Pavel; Kaiser, Stephen E.; Vrljic, Marija; Brunger, Axel T.			The structure of the yeast plasma membrane SNARE complex reveals destabilizing water-filled cavities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; SYNAPTOTAGMIN; FUSION; CRYSTALLOGRAPHY; MECHANISMS; SOFTWARE	SNARE proteins form a complex that leads to membrane fusion between vesicles, organelles, and plasma membrane in all eukaryotic cells. We report the 1.7 angstrom resolution structure of the SNARE complex that mediates exocytosis at the plasma membrane in the yeast Saccharomyces cerevisiae. Similar to its neuronal and endosomal homologues, the S. cerevisiae SNARE complex forms a parallel four-helix bundle in the center of which is an ionic layer. The S. cerevisiae SNARE complex exhibits increased helix bending near the ionic layer, contains water-filled cavities in the complex core, and exhibits reduced thermal stability relative to mammalian SNARE complexes. Mutagenesis experiments suggest that the water-filled cavities contribute to the lower stability of the S. cerevisiae complex.	Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Struct Biol & Photon Sci, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University	Brunger, AT (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	brunger@stanford.edu		Brunger, Axel/0000-0001-5121-2036				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; Antonin W, 2000, EMBO J, V19, P6453, DOI 10.1093/emboj/19.23.6453; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst JA, 2003, J BIOL CHEM, V278, P8630, DOI 10.1074/jbc.M211889200; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Gerber SH, 2002, DIABETES, V51, pS3, DOI 10.2337/diabetes.51.2007.S3; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Lagow RD, 2007, PLOS BIOL, V5, P800, DOI 10.1371/journal.pbio.0050072; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Mayer A, 2002, ANNU REV CELL DEV BI, V18, P289, DOI 10.1146/annurev.cellbio.18.032202.114809; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Rice LM, 1997, FEBS LETT, V415, P49, DOI 10.1016/S0014-5793(97)01091-0; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Zwilling D, 2007, EMBO J, V26, P9, DOI 10.1038/sj.emboj.7601467	27	36	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1113	1119		10.1074/jbc.M707912200	http://dx.doi.org/10.1074/jbc.M707912200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17956869	hybrid			2022-12-25	WOS:000252128100051
J	Tew, GW; Lorimer, EL; Berg, TJ; Zhi, HY; Li, RS; Williams, CL				Tew, Gaik Wei; Lorimer, Ellen L.; Berg, Tracy J.; Zhi, Huiying; Li, Rongshan; Williams, Carol L.			SmgGDS regulates cell proliferation, migration, and NF-kappa B transcriptional activity in non-small cell lung carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP/GTP EXCHANGE PROTEIN; RHO-FAMILY; SUPEROXIDE DISMUTASES; NUCLEAR-LOCALIZATION; POLYBASIC REGION; BINDING PROTEIN; CANCER-CELLS; RAP1 GTPASE; STEM-CELLS; EXPRESSION	Non-small cell lung carcinoma (NSCLC) is promoted by the increased activities of several small GTPases, including K-Ras4B, Rap1A, Rap1B, RhoC, and Rac1. SmgGDS is an unusual guanine nucleotide exchange factor that activates many of these small GTPases, and thus may promote NSCLC development or progression. We report here that SmgGDS protein levels are elevated in NSCLC tumors, compared with normal lung tissue from the same patients or from individuals without cancer. To characterize SmgGDS functions in NSCLC, we tested the effects of silencing SmgGDS expression by transfecting cultured NSCLC cells with SmgGDS small interfering RNA (siRNA). Cells with silenced SmgGDS expression form fewer colonies in soft agar, do not proliferate in culture due to an arrest in G(1) phase, and exhibit disrupted myosin organization and reduced cell migration. The transcriptional activity of NF-kappa B in NSCLC cells is diminished by transfecting the cells with SmgGDS siRNA, and enhanced by transfecting the cells with a cDNA encoding SmgGDS. Because RhoA is a major substrate for SmgGDS, we investigated whether diminished RhoA expression mimics the effects of diminished SmgGDS expression. Silencing RhoA expression with RhoA siRNA disrupts myosin organization, but only moderately decreases cell proliferation and does not inhibit migration. Our finding that the aggressive NSCLC phenotype is more effectively suppressed by silencing SmgGDS than by silencing RhoA is consistent with the ability of SmgGDS to regulate multiple small GTPases in addition to RhoA. These results demonstrate that SmgGDS promotes the malignant NSCLC phenotype and is an intriguing therapeutic target in NSCLC.	[Tew, Gaik Wei; Lorimer, Ellen L.; Berg, Tracy J.; Williams, Carol L.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Ctr Cardiovasc, Milwaukee, WI 53226 USA; [Zhi, Huiying; Li, Rongshan] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Williams, CL (corresponding author), 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	Williams@mcw.edu			NIGMS NIH HHS [GM069700, R01 GM069700] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069700] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Aznar S, 2001, CANCER LETT, V165, P1, DOI 10.1016/S0304-3835(01)00412-8; Babbar N, 2006, CANCER RES, V66, P11125, DOI 10.1158/0008-5472.CAN-06-3174; Berman KS, 2002, CLIN CANCER RES, V8, P354; Berns A, 2005, CELL, V121, P811, DOI 10.1016/j.cell.2005.06.004; Bolick DT, 2005, ARTERIOSCL THROM VAS, V25, P2301, DOI 10.1161/01.ATV.0000186181.19909.a6; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Campbell KJ, 2004, CELL CYCLE, V3, P869; Castanotto D, 2007, NUCLEIC ACIDS RES, V35, P5154, DOI 10.1093/nar/gkm543; Castranova V, 2004, FREE RADICAL BIO MED, V37, P916, DOI 10.1016/j.freeradbiomed.2004.05.032; CHUANG TH, 1994, BIOCHEM J, V303, P761, DOI 10.1042/bj3030761; Denlinger Chadrick E, 2004, Semin Thorac Cardiovasc Surg, V16, P28, DOI 10.1053/j.semtcvs.2003.12.004; Frost JA, 2000, J BIOL CHEM, V275, P19693, DOI 10.1074/jbc.M909860199; FUJIOKA H, 1992, J BIOL CHEM, V267, P926; Fujita H, 2005, J BIOL CHEM, V280, P5022, DOI 10.1074/jbc.M409701200; Grimes KR, 2006, ONCOL REP, V16, P771; HATA Y, 1991, J BIOL CHEM, V266, P6571; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; Hirata T, 2004, J HUM GENET, V49, P290, DOI 10.1007/s10038-004-0148-1; Ho WC, 2005, CANCER RES, V65, P4273, DOI 10.1158/0008-5472.CAN-04-3494; Hogan C, 2004, MOL CELL BIOL, V24, P6690, DOI 10.1128/mcb.24.15.6690-6700.2004; Hutchinson JP, 2000, BIOCHEMISTRY-US, V39, P11348, DOI 10.1021/bi0007573; Ikoma T, 2004, CLIN CANCER RES, V10, P1192, DOI 10.1158/1078-0432.CCR-03-0275; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Johnson BE, 2004, CLIN CANCER RES, V10, p4254S, DOI 10.1158/1078-0432.CCR-040016; Jones DR, 2000, ANN THORAC SURG, V70, P930, DOI 10.1016/S0003-4975(00)01635-0; Joyce D, 2001, CYTOKINE GROWTH F R, V12, P73, DOI 10.1016/S1359-6101(00)00018-6; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim CFB, 2005, COLD SH Q B, V70, P241, DOI 10.1101/sqb.2005.70.037; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kinnula VL, 2003, AM J RESP CRIT CARE, V167, P1600, DOI 10.1164/rccm.200212-1479SO; Kinnula VL, 2004, FREE RADICAL BIO MED, V36, P718, DOI 10.1016/j.freeradbiomed.2003.12.010; Lang WH, 2004, CELL SIGNAL, V16, P457, DOI 10.1016/j.cellsig.2003.09.002; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Li RS, 2005, APPL IMMUNOHISTO M M, V13, P85, DOI 10.1097/00129039-200503000-00014; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Maehara K, 2000, J CELL BIOCHEM, V77, P474, DOI 10.1002/(SICI)1097-4644(20000601)77:3<474::AID-JCB12>3.0.CO;2-H; Maeno K, 2006, ONCOGENE, V25, P271, DOI 10.1038/sj.onc.1209018; Mascaux C, 2005, BRIT J CANCER, V92, P131, DOI 10.1038/sj.bjc.6602258; Mazieres J, 2004, CLIN CANCER RES, V10, P2742, DOI 10.1158/1078-0432.CCR-03-0149; Mijatovic T, 2006, MOL CANCER THER, V5, P391, DOI 10.1158/1535-7163.MCT-05-0367; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; Park GY, 2006, CURR DRUG TARGETS, V7, P661, DOI 10.2174/138945006777435317; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Pourazar J, 2005, AM J PHYSIOL-LUNG C, V289, pL724, DOI 10.1152/ajplung.00055.2005; Qanungo S, 2004, J BIOL CHEM, V279, P50455, DOI 10.1074/jbc.M406749200; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Schrump DS, 2005, SEMIN ONCOL, V32, P488, DOI 10.1053/j.seminoncol.2005.07.007; Shafer SH, 2003, INT J ONCOL, V23, P389; Shikada Y, 2003, CLIN CANCER RES, V9, P5282; Shumilla JA, 1999, J BIOL CHEM, V274, P36207, DOI 10.1074/jbc.274.51.36207; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Strassheim D, 1999, J BIOL CHEM, V274, P18675, DOI 10.1074/jbc.274.26.18675; Strassheim D, 2000, CANCER RES, V60, P2730; Sun WY, 2004, CANCER LETT, V212, P83, DOI 10.1016/j.canlet.2004.03.023; Tichelaar JW, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-155; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Varker KA, 2002, BIOCHEM PHARMACOL, V63, P597, DOI 10.1016/S0006-2952(01)00901-7; Vermeulen L, 2006, CANC TREAT, V130, P89; Wang SW, 2003, ONCOGENE, V22, P6204, DOI 10.1038/sj.onc.1206653; Wang X, 2006, CANCER RES, V66, P1089, DOI 10.1158/0008-5472.CAN-05-2698; Wei CY, 2006, MOL PHARMACOL, V69, P960, DOI 10.1124/mol.105.017368; Weidauer E, 2004, TOXICOL LETT, V151, P69, DOI 10.1016/j.toxlet.2004.02.014; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Wittchen ES, 2005, CURR OPIN HEMATOL, V12, P14, DOI 10.1097/01.moh.0000147892.83713.a7; YAKU H, 1994, BIOCHEM BIOPH RES CO, V198, P811, DOI 10.1006/bbrc.1994.1116; Yao PL, 2005, AM J RESP CELL MOL, V32, P540, DOI 10.1165/rcmb.2004-0223OC; YOSHIDA Y, 1992, MOL CELL BIOL, V12, P3407, DOI 10.1128/MCB.12.8.3407; Zhang ZF, 2006, ANN THORAC SURG, V82, P243, DOI 10.1016/j.athoracsur.2006.01.049	77	53	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					963	976		10.1074/jbc.M707526200	http://dx.doi.org/10.1074/jbc.M707526200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17951244	hybrid			2022-12-25	WOS:000252128100036
J	Bansode, RR; Huang, W; Roy, SK; Mehta, M; Mehta, KD				Bansode, Rishipal R.; Huang, Wei; Roy, Sanjit K.; Mehta, Madhu; Mehta, Kamal D.			Protein kinase C beta deficiency increases fatty acid oxidation and reduces fat storage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; RECEPTOR TRANSCRIPTION; OBESITY RESISTANCE; INSULIN-RESISTANCE; GLUCOSE-TRANSPORT; MICE; CELLS; GENE; PHOSPHORYLATION; DYSFUNCTION	Metabolic syndrome is common in the general population, but there is little information available on the underlying signaling mechanisms regulating triglyceride (TG) content in the body. In the current study, we have uncovered a role for protein kinase C beta (PKC beta) in TG homeostasis by studying the consequences of a targeted disruption of this kinase. PKC beta(-/-) mutant mice were considerably leaner and the size of white fat depots was markedly decreased compared with wild-type littermates. TG content in the liver and skeletal muscle of PKC beta(-/-) mice was also significantly low. Interestingly, mutant animals were hyperphagic and exhibited higher food intake and reduced feed efficiency versus wild type. The protection from obesity involves elevated oxygen consumption/ energy expenditure and increased fatty acid oxidation in adipose tissue with concurrent increased mitochondria genesis, up-regulation of PGC-1 alpha and UCP-2, and down-regulation of perilipin. The ability of PKC beta deficiency to promote fat burning in adipocytes may suggest novel therapeutic strategies for obesity and obesity-related disorders.	[Bansode, Rishipal R.; Huang, Wei; Roy, Sanjit K.; Mehta, Kamal D.] Ohio State Univ, Coll Med, Dorothy M Davis Heart & Lung Res Inst, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Mehta, Madhu] Ohio State Univ, Coll Med, Dorothy M Davis Heart & Lung Res Inst, Dept Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Mehta, KD (corresponding author), Ohio State Univ, Coll Med, Dorothy M Davis Heart & Lung Res Inst, Dept Mol & Cellular Biochem, 464 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	Mehta.80@osu.edu	Bansode, Rishipal/E-9293-2010; Huang, Wei/E-3270-2011	Bansode, Rishipal/0000-0001-7826-2711; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079091] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL079091, HL 079091] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Benton CR, 2006, J APPL PHYSIOL, V100, P377, DOI 10.1152/japplphysiol.00781.2005; Cline GW, 2001, J BIOL CHEM, V276, P20240, DOI 10.1074/jbc.M102540200; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; Farese RV, 2002, AM J PHYSIOL-ENDOC M, V283, pE1, DOI 10.1152/ajpendo.00045.2002; Gaidhu MP, 2006, J BIOL CHEM, V281, P25956, DOI 10.1074/jbc.M602992200; GAO Z, 2006, AM J PHYSIOL-ENDOC M, V292, pE84; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Ginsberg HN, 2006, OBESITY, V14, p41S, DOI 10.1038/oby.2006.281; Huang W, 2005, J CELL PHYSIOL, V205, P37, DOI 10.1002/jcp.20372; Huang W, 2004, J LIPID RES, V45, P1519, DOI 10.1194/jlr.M400088-JLR200; Ishii H, 1996, SCIENCE, V272, P728, DOI 10.1126/science.272.5262.728; Itani SI, 2000, DIABETES, V49, P1353, DOI 10.2337/diabetes.49.8.1353; Kapoor GS, 2003, J LIPID RES, V44, P584, DOI 10.1194/jlr.M200302-JLR200; Lee Y, 2002, P NATL ACAD SCI USA, V99, P11848, DOI 10.1073/pnas.182420899; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Letiges M, 2002, MOL ENDOCRINOL, V16, P847, DOI 10.1210/me.16.4.847; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Matsumoto M, 2003, J CLIN INVEST, V112, P935, DOI 10.1172/JCI200318816; Mehta KD, 2002, MOL CELL BIOL, V22, P3783, DOI 10.1128/MCB.22.11.3783-3793.2002; Meier M, 2000, VASC MED, V5, P173, DOI 10.1177/1358836X0000500307; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Oberkofler H, 2006, ENDOCRINOLOGY, V147, P966, DOI 10.1210/en.2005-0817; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Reitman ML, 2002, ANNU REV NUTR, V22, P459, DOI 10.1146/annurev.nutr.22.010402.102849; Schmitz-Peiffer C, 2002, ANN NY ACAD SCI, V967, P146; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Standaert ML, 1999, ENDOCRINOLOGY, V140, P4470, DOI 10.1210/en.140.10.4470; Surwit RS, 1998, P NATL ACAD SCI USA, V95, P4061, DOI 10.1073/pnas.95.7.4061; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xia Z, 2002, J BIOL CHEM, V277, P45874, DOI 10.1074/jbc.M207281200	35	44	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					231	236		10.1074/jbc.M707268200	http://dx.doi.org/10.1074/jbc.M707268200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17962198	hybrid			2022-12-25	WOS:000251940300026
J	Bao, Y; Lopez, JA; James, DE; Hunziker, W				Bao, Yiqun; Lopez, Jamie A.; James, David E.; Hunziker, Walter			Snapin interacts with the exo70 subunit of the exocyst and modulates GLUT4 trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-INDUCED TRANSLOCATION; VESICULAR TRANSPORT; SACCHAROMYCES-CEREVISIAE; 3T3-L1 ADIPOCYTES; MEMBRANE-PROTEIN; SEC6/8 COMPLEX; GOLGI-COMPLEX; EXOCYTOSIS; CELLS; YEAST	The exocyst is a multisubunit complex that has been implicated in the transport of vesicles from the Golgi complex to the plasma membrane, possibly acting as a vesicle tether and contributing to the specificity of membrane fusion. Here we characterize a novel interaction between the Exo70 subunit of the exocyst and Snapin, a ubiquitous protein known to associate with at least two t-SNAREs, SNAP23 and SNAP25. The interaction between Exo70 and Snapin is mediated via an N-terminal coil-coil domain in Exo70 and a C-terminal helical region in Snapin. Exo70 competes with SNAP23 for Snapin binding, suggesting that Snapin does not provide a direct link between the exocyst and the SNARE complex but, rather, mediates cross-talk between the two complexes by sequential interactions. The insulin-regulated trafficking of GLUT4 to the plasma membrane serves to facilitate glucose uptake in adipocytes, and both SNAP23 and the exocyst have been implicated in this process. In this study, depletion of Snapin in adipocytes using RNA interference inhibits insulin-stimulated glucose uptake. Thus, Snapin interacts with the exocyst and plays a modulatory role in GLUT4 vesicle trafficking.	[Bao, Yiqun; Hunziker, Walter] Inst Cell & Mol Biol, Epithelial Cell Biol Lab, Singapore 138673, Singapore; [Lopez, Jamie A.; James, David E.] Garvan Inst Med Res, Diabetes Obes Res Program, Sydney, NSW 2010, Australia	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Garvan Institute of Medical Research	Hunziker, W (corresponding author), Inst Cell & Mol Biol, Epithelial Cell Biol Lab, 61 Biopolis Dr, Singapore 138673, Singapore.	hunziker@imcb.a-star.edu.sg	Hunziker, Walter/B-3140-2010; Hunziker, Walter/GSM-8190-2022	Hunziker, Walter/0000-0002-5265-4933; Lopez Bernal, Jamie/0000-0002-1301-5653; James, David/0000-0001-5946-5257				AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; Buxton P, 2003, BIOCHEM J, V375, P433, DOI 10.1042/BJ20030427; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; Conibear E, 2003, MOL BIOL CELL, V14, P1610, DOI 10.1091/mbc.E02-10-0654; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Guo W, 1999, J BIOL CHEM, V274, P23558, DOI 10.1074/jbc.274.33.23558; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Hamburger ZA, 2006, J MOL BIOL, V356, P9, DOI 10.1016/j.jmb.2005.09.099; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Kawanishi M, 2000, J BIOL CHEM, V275, P8240, DOI 10.1074/jbc.275.11.8240; Li MJ, 2005, METHOD ENZYMOL, V392, P218, DOI 10.1016/S0076-6879(04)92013-7; Malide D, 2000, J CELL SCI, V113, P4203; Matern HT, 2001, P NATL ACAD SCI USA, V98, P9648, DOI 10.1073/pnas.171317898; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Novick P, 2006, BIOCHEM SOC T, V34, P683, DOI 10.1042/BST0340683; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Rea S, 1998, J BIOL CHEM, V273, P18784, DOI 10.1074/jbc.273.30.18784; SHIM J, 1991, J CELL BIOL, V113, P55, DOI 10.1083/jcb.113.1.55; Sivaram MVS, 2005, BIOCHEMISTRY-US, V44, P6302, DOI 10.1021/bi048008z; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Tian JH, 2005, J NEUROSCI, V25, P10546, DOI 10.1523/JNEUROSCI.3275-05.2005; Tsuboi T, 2005, J BIOL CHEM, V280, P25565, DOI 10.1074/jbc.M501674200; Vega IE, 2001, J NEUROSCI, V21, P3839, DOI 10.1523/JNEUROSCI.21-11-03839.2001; Vites O, 2004, J BIOL CHEM, V279, P26251, DOI 10.1074/jbc.M404079200; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wiederkehr A, 2004, J CELL BIOL, V167, P875, DOI 10.1083/jcb.200408001; Zuo XF, 2006, NAT CELL BIOL, V8, P1383, DOI 10.1038/ncb1505	33	40	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					324	331		10.1074/jbc.M706873200	http://dx.doi.org/10.1074/jbc.M706873200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17947242	hybrid			2022-12-25	WOS:000251940300036
J	Nagaraj, VA; Arumugam, R; Gopalakrishnan, B; Jyothsna, YS; Rangarajan, PN; Padmanaban, G				Nagaraj, Viswanathan Arun; Arumugam, Rajavel; Gopalakrishnan, Bulusu; Jyothsna, Yeleswarapu Sri; Rangarajan, Pundi N.; Padmanaban, Govindarajan			Unique properties of Plasmodium falciparum porphobilinogen deaminase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UROPORPHYRINOGEN-III SYNTHASE; AMINOLEVULINIC-ACID DEHYDRATASE; HUMAN MALARIAL PARASITE; HYDROXYMETHYLBILANE SYNTHASE; HUMAN-ERYTHROCYTES; HEME-BIOSYNTHESIS; RECOMBINANT STRAIN; CATALYTIC SITE; METABOLIC MAPS; PURIFICATION	The hybrid pathway for heme biosynthesis in the malarial parasite proposes the involvement of parasite genome-coded enzymes of the pathway localized in different compartments such as apicoplast, mitochondria, and cytosol. However, knowledge on the functionality and localization of many of these enzymes is not available. In this study, we demonstrate that porphobilinogen deaminase encoded by the Plasmodium falciparum genome (PfPBGD) has several unique biochemical properties. Studies carried out with PfPBGD partially purified from parasite membrane fraction, as well as recombinant PfPBGD lacking N-terminal 64 amino acids expressed and purified from Escherichia coli cells ( Delta PfPBGD), indicate that both the proteins are catalytically active. Surprisingly, PfPBGD catalyzes the conversion of porphobilinogen to uroporphyrinogen III (UROGEN III), indicating that it also possesses uroporphyrinogen III synthase (UROS) activity, catalyzing the next step. This obviates the necessity to have a separate gene for UROS that has not been so far annotated in the parasite genome. Interestingly, Delta PfPBGD gives rise to UROGEN III even after heat treatment, although UROS from other sources is known to be heat-sensitive. Based on the analysis of active site residues, a Delta PfPBGDL116K mutant enzyme was created and the specific activity of this recombinant mutant enzyme is 5-fold higher than Delta PfPBGD. More interestingly, Delta PfPBGDL116K catalyzes the formation of uroporphyrinogen I ( UROGEN I) in addition to UROGEN III, indicating that with increased PBGD activity the UROS activity of PBGD may perhaps become rate-limiting, thus leading to non-enzymatic cyclization of preuroporphyrinogen to UROGEN I. PfPBGD is localized to the apicoplast and is catalytically very inefficient compared with the host red cell enzyme.	[Nagaraj, Viswanathan Arun; Arumugam, Rajavel; Rangarajan, Pundi N.; Padmanaban, Govindarajan] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Gopalakrishnan, Bulusu; Jyothsna, Yeleswarapu Sri] Innovat Labs Hyderabad, Div Life Sci, Tata Consult Serv, Hyderabad 500081, Andhra Pradesh, India	Indian Institute of Science (IISC) - Bangalore	Padmanaban, G (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	geepee@biochem.iisc.ernet.in	Rangarajan, Pundi/A-7365-2009; Bulusu, Gopalakrishnan/R-3053-2019; Rajavelu, Arumugam/B-7832-2013	Rangarajan, Pundi/0000-0002-6536-9891; Rajavelu, Arumugam/0000-0001-6666-8925; Bulusu, Gopalakrishnan/0000-0002-4958-7573				ALWAN AF, 1989, BIOCHEM J, V264, P397, DOI 10.1042/bj2640397; AMILLET JM, 1995, YEAST, V11, P419, DOI 10.1002/yea.320110504; Beale SI, 1999, PHOTOSYNTH RES, V60, P43, DOI 10.1023/A:1006297731456; Bonday ZQ, 1997, J BIOL CHEM, V272, P21839, DOI 10.1074/jbc.272.35.21839; Bonday ZQ, 2000, NAT MED, V6, P898, DOI 10.1038/78659; CHARTRAND P, 1979, J GEN MICROBIOL, V110, P61, DOI 10.1099/00221287-110-1-61; Dhanasekaran S, 2004, J BIOL CHEM, V279, P6934, DOI 10.1074/jbc.M311409200; Erlandsen EJ, 2000, SCAND J CLIN LAB INV, V60, P627; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; FITCH CD, 1982, ANTIMICROB AGENTS CH, V21, P819, DOI 10.1128/AAC.21.5.819; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Guegan R, 2003, MOL MICROBIOL, V49, P745, DOI 10.1046/j.1365-2958.2003.03589.x; JORDAN PM, 1987, FEBS LETT, V225, P87, DOI 10.1016/0014-5793(87)81136-5; JORDAN PM, 1979, J CHEM SOC CHEM COMM, P204, DOI 10.1039/c39790000204; JORDAN PM, 1988, BIOCHEM J, V254, P427, DOI 10.1042/bj2540427; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LANDER M, 1991, BIOCHEM J, V275, P447, DOI 10.1042/bj2750447; LANNFELT L, 1989, SCAND J CLIN LAB INV, V49, P677, DOI 10.3109/00365518909091544; LIM CK, 1983, BIOCHEM J, V211, P435, DOI 10.1042/bj2110435; LOUIE GV, 1992, NATURE, V359, P33, DOI 10.1038/359033a0; Mathews MAA, 2001, EMBO J, V20, P5832, DOI 10.1093/emboj/20.21.5832; MILLER AD, 1989, BIOCHEM J, V262, P119, DOI 10.1042/bj2620119; Padmanaban G, 2007, TRENDS BIOCHEM SCI, V32, P443, DOI 10.1016/j.tibs.2007.09.005; Padmanaban G, 2007, CURR SCI INDIA, V92, P1545; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Sato S, 2004, PROTIST, V155, P117, DOI 10.1078/1434461000169; Sato S, 2002, CURR GENET, V40, P391, DOI 10.1007/s00294-002-0273-3; Sharma A, 2005, INDIAN J BIOCHEM BIO, V42, P145; SMYTHE E, 1988, BIOCHEM J, V251, P237, DOI 10.1042/bj2510237; SUROLIA N, 1992, BIOCHEM BIOPH RES CO, V187, P744, DOI 10.1016/0006-291X(92)91258-R; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TSAI SF, 1988, P NATL ACAD SCI USA, V85, P7049, DOI 10.1073/pnas.85.19.7049; van Dooren GG, 2006, FEMS MICROBIOL REV, V30, P596, DOI 10.1111/j.1574-6976.2006.00027.x; Varadharajan S, 2004, BIOCHEM J, V384, P429, DOI 10.1042/BJ20040952; Varadharajan S, 2002, BIOCHEM J, V367, P321, DOI 10.1042/BJ20020834; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Wilson RJM, 2005, BIOL REV, V80, P129, DOI 10.1017/S1464793104006591	38	36	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					437	444		10.1074/jbc.M706861200	http://dx.doi.org/10.1074/jbc.M706861200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17962188	hybrid			2022-12-25	WOS:000251940300048
J	Paukert, M; Chen, XM; Polleichtner, G; Schindelin, H; Grunder, S				Paukert, Martin; Chen, Xuanmao; Polleichtner, Georg; Schindelin, Hermann; Gruender, Stefan			Candidate amino acids involved in H+ gating of acid-sensing ion channel 1a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; NA+ CHANNEL; EXTRACELLULAR DOMAIN; IDENTIFICATION; ION-CHANNEL-1; EXPRESSION; SUBUNIT; FAMILY; DESENSITIZATION; PERMEATION	Acid-sensing ion channels are ligand-gated cation channels, gated by extracellular H+. H+ is the simplest ligand possible, and whereas for larger ligands that gate ion channels complex binding sites in the three-dimensional structure of the proteins have to be assumed, H+ could in principle gate a channel by titration of a single amino acid. Experimental evidence suggests a more complex situation, however. For example, it has been shown that extracellular Ca2+ ions compete with H+; probably Ca2+ ions bound to the extracellular loop of ASICs stabilize the closed state of the channel and have to be displaced before the channel can open. In such a scheme, amino acids contributing to Ca2+ binding would also be candidates contributing to H+ gating. In this study we systematically screened more than 40 conserved, charged amino acids in the extracellular region of ASIC1a for a possible contribution to H+ gating. We identified four amino acids where substitution strongly affects H+ gating: Glu(63), His(72)/His(73), and Asp(78). These amino acids are highly conserved among H+-sensitive ASICs and are candidates for the "H+ sensor" of ASICs.	Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21205 USA; [Chen, Xuanmao; Polleichtner, Georg; Gruender, Stefan] Univ Wurzburg, Dept Physiol 2, D-97070 Wurzburg, Germany; [Paukert, Martin; Chen, Xuanmao; Gruender, Stefan] Univ Tubingen, Dept Physiol 2, D-72076 Tubingen, Germany; [Schindelin, Hermann] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Inst Biol Struct, D-97078 Wurzburg, Germany	Johns Hopkins University; University of Wurzburg; Eberhard Karls University of Tubingen; University of Wurzburg	Paukert, M (corresponding author), Johns Hopkins Univ, Dept Neurosci, 725 N Wolfe St,WBSB 1001, Baltimore, MD 21205 USA.	mpauker1@jhmi.edu; stefan.gruender@uni-wuerzburg.de	Schindelin, Hermann/Q-2697-2019; Gründer, Stefan/I-2495-2019; chen, xuanmao/I-7576-2013	Gründer, Stefan/0000-0002-7635-9883; Chen, Xuanmao/0000-0002-0057-8510				Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Benson CJ, 1999, CIRC RES, V84, P921; Chen XM, 2007, J BIOL CHEM, V282, P30406, DOI 10.1074/jbc.M702229200; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200; Coscoy S, 1999, J BIOL CHEM, V274, P10129, DOI 10.1074/jbc.274.15.10129; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Firsov D, 1999, J BIOL CHEM, V274, P2743, DOI 10.1074/jbc.274.5.2743; Grunder S, 2000, NEUROREPORT, V11, P1607; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 1999, J GEN PHYSIOL, V114, P13, DOI 10.1085/jgp.114.1.13; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Paukert M, 2004, J BIOL CHEM, V279, P18783, DOI 10.1074/jbc.M401477200; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Sakai H, 1999, J PHYSIOL-LONDON, V519, P323, DOI 10.1111/j.1469-7793.1999.0323m.x; Saugstad JA, 2004, J BIOL CHEM, V279, P55514, DOI 10.1074/jbc.M411849200; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; Sheng SH, 2000, J BIOL CHEM, V275, P8572, DOI 10.1074/jbc.275.12.8572; Smith ESJ, 2007, NEUROSCI LETT, V426, P12, DOI 10.1016/j.neulet.2007.07.047; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Zhang P, 2006, J GEN PHYSIOL, V127, P109, DOI 10.1085/jgp.200509396	30	87	89	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					572	581		10.1074/jbc.M706811200	http://dx.doi.org/10.1074/jbc.M706811200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17981796	hybrid, Green Published			2022-12-25	WOS:000251940300062
J	Zhang, YQ; Rao, R				Zhang, Yong-Qiang; Rao, Rajini			Global disruption of cell cycle progression and nutrient response by the antifungal agent amiodarone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; NITROGEN; GLUCOSE; CALCINEURIN; METABOLISM; PATHWAYS; CALCIUM; STRESS	The antiarrhythmic drug amiodarone has fungicidal activity against a broad range of fungi. In Saccharomyces cerevisiae, it elicits an immediate influx of Ca2+ followed by mitochondrial fragmentation and eventual cell death. To dissect the mechanism of its toxicity, we assessed the transcriptional response of S. cerevisiae to amiodarone by DNA microarray. Consistent with the drug-induced calcium burst, more than half of the differentially transcribed genes were induced by high levels of CaCl2. Amiodarone also caused rapid nuclear accumulation of the calcineurin-regulated Crz1. The majority of genes induced by amiodarone within 10 min were involved in utilization of alternative carbon and nitrogen sources and in mobilizing energy reserves. The similarity to nutrient starvation responses seen in stationary phase cells, rapamycin treatment, and late stages of shift to diauxic conditions and nitrogen depletion suggests that amiodarone may interfere with nutrient sensing and regulatory networks. Transcription of a set of nutrient-responsive genes was affected by amiodarone but not CaCl2, indicating that activation of the starvation response was independent of Ca2+. Genes down-regulated by amiodarone were involved in all stages of cell cycle control. A moderate dose of amiodarone temporarily delayed cell cycle progression at G(1), S, and G(2)/M phases, with the Swe1-mediated delay in G(2)/Mphase being most prominent in a calcineurin-dependent manner. Overall, the transcriptional responses to amiodarone revealed by this study were found to be distinct from other classes of antifungals, including the azole drugs, pointing toward a novel target pathway in combating fungal pathogenesis.	[Zhang, Yong-Qiang; Rao, Rajini] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University	Rao, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	rrao@jhmi.edu			NIAID NIH HHS [R01 AI065983] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065983] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal AK, 2003, J BIOL CHEM, V278, P34998, DOI 10.1074/jbc.M306291200; Alexander MR, 2001, MOL BIOL CELL, V12, P53, DOI 10.1091/mbc.12.1.53; ANTUNESMADEIRA MD, 1995, INT J CARDIOL, V48, P211; Begley TJ, 2002, MOL CANCER RES, V1, P103; Benaim G, 2006, J MED CHEM, V49, P892, DOI 10.1021/jm050691f; Birrell GW, 2002, P NATL ACAD SCI USA, V99, P8778, DOI 10.1073/pnas.132275199; Boer VM, 2003, J BIOL CHEM, V278, P3265, DOI 10.1074/jbc.M209759200; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Brauer MJ, 2005, MOL BIOL CELL, V16, P2503, DOI 10.1091/mbc.E04-11-0968; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; Courchesne WE, 2003, MOL MICROBIOL, V47, P223, DOI 10.1046/j.1365-2958.2003.03291.x; Courchesne WE, 2002, J PHARMACOL EXP THER, V300, P195, DOI 10.1124/jpet.300.1.195; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Haugen AC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r95; Kafadar KA, 2004, EUKARYOT CELL, V3, P1147, DOI 10.1128/EC.3.5.1147-1153.2004; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17, DOI 10.1128/.61.1.17-32.1997; Millard PJ, 1997, APPL ENVIRON MICROB, V63, P2897, DOI 10.1128/AEM.63.7.2897-2905.1997; Mizunuma M, 1998, NATURE, V392, P303, DOI 10.1038/32695; Onyewu C, 2007, ANTIMICROB AGENTS CH, V51, P3743, DOI 10.1128/AAC.00492-07; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; Rosa SMLJ, 2000, BBA-MOL CELL BIOL L, V1487, P286, DOI 10.1016/S1388-1981(00)00122-0; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Sen Gupta S, 2003, J BIOL CHEM, V278, P28831, DOI 10.1074/jbc.M303300200; Steinbach WJ, 2007, NAT REV MICROBIOL, V5, P418, DOI 10.1038/nrmicro1680; Wu J, 2004, P NATL ACAD SCI USA, V101, P3148, DOI 10.1073/pnas.0308321100; Yadav J, 2007, MOL BIOL CELL, V18, P1480, DOI 10.1091/mbc.E06-11-1049; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200	36	28	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37844	37853		10.1074/jbc.M707593200	http://dx.doi.org/10.1074/jbc.M707593200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17974566	hybrid			2022-12-25	WOS:000251833600060
J	Teghanemt, A; Prohinar, P; Gioannini, TL; Weiss, JP				Teghanemt, Athmane; Prohinar, Polonca; Gioannini, Theresa L.; Weiss, Jerrold P.			Transfer of monomeric endotoxin from MD-2 to CD14	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; GRAM-NEGATIVE BACTERIA; NEISSERIA-MENINGITIDIS; CELL ACTIVATION; ENDOTHELIAL-CELLS; RECEPTOR; LBP; LPS; RECOGNITION; EXPRESSION	Potent Toll-like receptor 4 (TLR4)-dependent cell activation by endotoxin depends on sequential transfer of monomers of endotoxin from an aggregated form to CD14 via the lipopolysaccharide-binding protein and then to MD-2. We now show that monomeric endotoxin can be transferred in reverse from MD-2 to CD14 but not to lipopolysaccharide-binding protein. Reverse transfer requires a similar to 1000-fold molar excess of CD14 to endotoxin-MD-2. Transfer of endotoxin from MD-2 to extracellular soluble CD14 reduces activation of cells expressing TLR4 without MD-2. However, transfer of endotoxin from MD-2 to membrane CD14 (mCD14) makes cells expressing MD-2 center dot TLR4 sensitive to activation by the endotoxin-MD-2 complex. An endotoxin-mutant (F126A) MD-2 complex that does not activate cells expressing TLR4 alone potently activates cells expressing mCD14, MD-2, and TLR4 by transferring endotoxin to mCD14, which then transfers endotoxin to endogenous wildtype MD-2 center dot TLR4. These findings describe a novel pathway of endotoxin transfer that provides an additional layer of regulation of cell activation by endotoxin.	Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Inflammat Program, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA; Vet Affairs Med Ctr, Iowa City, IA 52246 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Weiss, JP (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA.	jerrold-weiss@uiowa.edu		Weiss, Jerrold/0000-0003-1476-4485	NIAID NIH HHS [AI59372] Funding Source: Medline; PHS HHS [P0144642] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059372] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Dunzendorfer S, 2004, FASEB J, V18, P1117, DOI 10.1096/fj.03-1263fje; Gangloff M, 2004, TRENDS BIOCHEM SCI, V29, P294, DOI 10.1016/j.tibs.2004.04.008; Giardina PC, 2001, J BIOL CHEM, V276, P5883, DOI 10.1074/jbc.M009273200; Gioannini TL, 2007, IMMUNOL RES, V39, P249, DOI 10.1007/s12026-007-0069-0; Gioannini TL, 2007, J BIOL CHEM, V282, P7877, DOI 10.1074/jbc.M605031200; Gioannini TL, 2005, J ENDOTOXIN RES, V11, P117, DOI 10.1179/096805105X35198; Gioannini TL, 2003, J ENDOTOXIN RES, V9, P401, DOI 10.1179/096805103225002773; Gioannini TL, 2002, J BIOL CHEM, V277, P47818, DOI 10.1074/jbc.M206404200; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Hamann L, 2002, BIOCHEM BIOPH RES CO, V295, P553, DOI 10.1016/S0006-291X(02)00710-6; Heumann D, 2003, J ENDOTOXIN RES, V9, P381, DOI 10.1179/0963805103225003312; Iovine N, 2002, J BIOL CHEM, V277, P7970, DOI 10.1074/jbc.M109622200; Jersmann HPA, 2001, INFECT IMMUN, V69, P479, DOI 10.1128/IAI.69.1.479-485.2001; Jia HP, 2004, AM J PHYSIOL-LUNG C, V287, pL428, DOI 10.1152/ajplung.00377.2003; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Kitchens RL, 2005, J ENDOTOXIN RES, V11, P225, DOI 10.1179/096805105X46565; Kitchens RL, 2003, J ENDOTOXIN RES, V9, P113, DOI 10.1179/096805103125001504; Kobayashi Y, 2000, J PATHOL, V192, P263; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Miyake K, 2003, INT IMMUNOPHARMACOL, V3, P119, DOI 10.1016/S1567-5769(02)00258-8; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Post DMB, 2006, J ENDOTOXIN RES, V12, P93, DOI 10.1177/09680519060120020501; Post DMB, 2005, J BIOL CHEM, V280, P38383, DOI 10.1074/jbc.M508063200; Post DMB, 2003, INFECT IMMUN, V71, P647, DOI 10.1128/IAI.71.2.647-655.2003; Prohinar P, 2007, J BIOL CHEM, V282, P1010, DOI 10.1074/jbc.M609400200; Pugin J, 2004, BLOOD, V104, P4071, DOI 10.1182/blood-2003-04-1290; Re F, 2003, J IMMUNOL, V171, P5272, DOI 10.4049/jimmunol.171.10.5272; Teghanemt A, 2005, J IMMUNOL, V175, P4669, DOI 10.4049/jimmunol.175.7.4669; TEGHANEMT A, 2007, J BIOL CHEM     1030; Ulevitch RJ, 1999, CURR OPIN IMMUNOL, V11, P19, DOI 10.1016/S0952-7915(99)80004-1; Weiss J, 2003, BIOCHEM SOC T, V31, P785, DOI 10.1042/BST0310785; Yang H, 2000, J BIOL CHEM, V275, P20861, DOI 10.1074/jbc.M002896200; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554; Zweigner J, 2006, MICROBES INFECT, V8, P946, DOI 10.1016/j.micinf.2005.10.006	37	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36250	36256		10.1074/jbc.M705995200	http://dx.doi.org/10.1074/jbc.M705995200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17934216	hybrid			2022-12-25	WOS:000251458300015
J	Lu, BB; Xu, CC; Awai, K; Jones, AD; Benning, C				Lu, Binbin; Xu, Changcheng; Awai, Koichiro; Jones, A. Daniel; Benning, Christoph			A small ATPase protein of Arabidopsis, TGD3, involved in chloroplast lipid import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENVELOPE MEMBRANE; TRAFFICKING; MUTANT; GALACTOLIPIDS; BIOSYNTHESIS; ACCUMULATION; TRANSPORTERS; METABOLISM; DEFICIENT; PHOSPHATE	Polar lipid trafficking is essential in eukaryotic cells as membranes of lipid assembly are often distinct from final destination membranes. A striking example is the biogenesis of the photosynthetic membranes (thylakoids) in plastids of plants. Lipid biosynthetic enzymes at the endoplasmic reticulum and the inner and outer plastid envelope membranes are involved. This compartmentalization requires extensive lipid trafficking. Mutants of Arabidopsis are available that are disrupted in the incorporation of endoplasmic reticulum-derived lipid precursors into thylakoid lipids. Two proteins affected in two of these mutants, trigalactosyldiacylglycerol 1 (TGD1) and TGD2, encode the permease and substrate binding component, respectively, of a proposed lipid translocator at the inner chloroplast envelope membrane. Here we describe a third protein of Arabidopsis, TGD3, a small ATPase proposed to be part of this translocator. As in the tgd1 and tgd2 mutants, triacylglycerols and trigalactolipids accumulate in a tgd3 mutant carrying a T-DNA insertion just 5' of the TGD3 coding region. The TGD3 protein shows basal ATPase activity and is localized inside the chloroplast beyond the inner chloroplast envelope membrane. Proteins orthologous to TGD1, -2, and -3 are predicted to be present in Gram - bacteria, and the respective genes are organized in operons suggesting a common biochemical role for the gene products. Based on the current analysis, it is hypothesized that TGD3 is the missing ATPase component of a lipid transporter involving TGD1 and TGD2 required for the biosynthesis of ER-derived thylakoid lipids in Arabidopsis.	Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Benning, C (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, Biochem 215, E Lansing, MI 48824 USA.	benning@msu.edu	Jones, Arthur D/C-2670-2013; Awai, Koichiro/B-5119-2010; Benning, Christoph/Y-2528-2019	Awai, Koichiro/0000-0002-1731-7499; Benning, Christoph/0000-0001-8585-3667; Jones, A. Daniel/0000-0002-7408-6690				Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambudkar SV, 2006, FEBS LETT, V580, P1049, DOI 10.1016/j.febslet.2005.12.051; Awai K, 2006, P NATL ACAD SCI USA, V103, P10817, DOI 10.1073/pnas.0602754103; Benning C, 2006, CURR OPIN PLANT BIOL, V9, P241, DOI 10.1016/j.pbi.2006.03.012; Benning C, 2005, J BIOL CHEM, V280, P2397, DOI 10.1074/jbc.R400032200; BENNING C, 1995, ARCH BIOCHEM BIOPHYS, V317, P103, DOI 10.1006/abbi.1995.1141; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; CLINE K, 1984, PLANT PHYSIOL, V75, P675, DOI 10.1104/pp.75.3.675; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Doerrler WT, 2006, MOL MICROBIOL, V60, P542, DOI 10.1111/j.1365-2958.2006.05130.x; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Doerrler WT, 2001, J BIOL CHEM, V276, P11461, DOI 10.1074/jbc.C100091200; Dormann P, 1999, SCIENCE, V284, P2181, DOI 10.1126/science.284.5423.2181; DORMANN P, 1995, PLANT CELL, V7, P1801, DOI 10.1105/tpc.7.11.1801; Dormann P, 2002, TRENDS PLANT SCI, V7, P112, DOI 10.1016/S1360-1385(01)02216-6; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Froehlich JE, 2001, J BIOL CHEM, V276, P31806, DOI 10.1074/jbc.M104652200; HEINZ E, 1983, PLANT PHYSIOL, V72, P273, DOI 10.1104/pp.72.2.273; Houjou T, 2005, RAPID COMMUN MASS SP, V19, P654, DOI 10.1002/rcm.1836; Jackson DT, 1998, J BIOL CHEM, V273, P16583, DOI 10.1074/jbc.273.26.16583; Jarvis P, 2000, P NATL ACAD SCI USA, V97, P8175, DOI 10.1073/pnas.100132197; Miquel M, 1998, PLANT PHYSIOL, V117, P923, DOI 10.1104/pp.117.3.923; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9; Rossak M, 1997, ARCH BIOCHEM BIOPHYS, V340, P219, DOI 10.1006/abbi.1997.9931; ROUGHAN PG, 1982, ANNU REV PLANT PHYS, V33, P97, DOI 10.1146/annurev.pp.33.060182.000525; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; SIEBERTZ HP, 1977, Z NATURFORSCH C, V32, P193; Tefsen B, 2005, J BIOL CHEM, V280, P35961, DOI 10.1074/jbc.M509026200; Xu CC, 2005, PLANT CELL, V17, P3094, DOI 10.1105/tpc.105.035592; Xu CC, 2003, EMBO J, V22, P2370, DOI 10.1093/emboj/cdg234; Zhao Q, 2004, J BIOL CHEM, V279, P48505, DOI 10.1074/jbc.M408343200	35	95	103	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35945	35953		10.1074/jbc.M704063200	http://dx.doi.org/10.1074/jbc.M704063200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17938172	hybrid			2022-12-25	WOS:000251458100055
J	Behonick, DJ; Xing, ZQ; Lieu, S; Buckley, JM; Lotz, JC; Marcucio, RS; Werb, Z; Miclau, T; Colnot, C				Behonick, Danielle J.; Xing, Zhiqing; Lieu, Shirley; Buckley, Jenni M.; Lotz, Jeffrey C.; Marcucio, Ralph S.; Werb, Zena; Miclau, Theodore; Colnot, Celine			Role of Matrix Metalloproteinase 13 in Both Endochondral and Intramembranous Ossification during Skeletal Regeneration	PLOS ONE			English	Article								Extracellular matrix (ECM) remodeling is important during bone development and repair. Because matrix metalloproteinase 13 (MMP13, collagenase-3) plays a role in long bone development, we have examined its role during adult skeletal repair. In this study we find that MMP13 is expressed by hypertrophic chondrocytes and osteoblasts in the fracture callus. We demonstrate that MMP13 is required for proper resorption of hypertrophic cartilage and for normal bone remodeling during non-stabilized fracture healing, which occurs via endochondral ossification. However, no difference in callus strength was detected in the absence of MMP13. Transplant of wild- type bone marrow, which reconstitutes cells only of the hematopoietic lineage, did not rescue the endochondral repair defect, indicating that impaired healing in Mmp13(-/-) mice is intrinsic to cartilage and bone. Mmp13(-/-) mice also exhibited altered bone remodeling during healing of stabilized fractures and cortical defects via intramembranous ossification. This indicates that the bone phenotype occurs independently from the cartilage phenotype. Taken together, our findings demonstrate that MMP13 is involved in normal remodeling of bone and cartilage during adult skeletal repair, and that MMP13 may act directly in the initial stages of ECM degradation in these tissues prior to invasion of blood vessels and osteoclasts.	[Xing, Zhiqing; Lieu, Shirley; Marcucio, Ralph S.; Miclau, Theodore; Colnot, Celine] Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco Gen Hosp, Cellular & Mol Biol Lab, San Francisco, CA 94143 USA; [Behonick, Danielle J.; Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Behonick, Danielle J.; Werb, Zena] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Buckley, Jenni M.; Lotz, Jeffrey C.] Univ Calif San Francisco, Dept Orthopaed Surg, Orthopaed Bioengn Lab, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Colnot, C (corresponding author), Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco Gen Hosp, Cellular & Mol Biol Lab, San Francisco, CA 94143 USA.	colnotc@orthosurg.ucsf.edu	Colnot, Celine/D-4997-2017	Colnot, Celine/0000-0001-8423-8718; Marcucio, Ralph/0000-0002-0537-818X; Behonick, Dani/0000-0003-1149-0597	National Institutes of Health [AG023218, AR046238, AR053645, DE016701]; Musculoskeletal Transplant Foundation; UCSF Research Evaluation and Allocation Committee; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046238, R01AR053645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE016701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023218] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Musculoskeletal Transplant Foundation; UCSF Research Evaluation and Allocation Committee; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by grants from the National Institutes of Health (AG023218 and AR046238 to ZW, AR053645 to TM, RM and CC, DE016701 to CC), the Musculoskeletal Transplant Foundation and the UCSF Research Evaluation and Allocation Committee (CC).	ALBRECHT U, 1997, VISUALIZATION GENE E; BLAVIER L, 1995, J CELL SCI, V108, P3649; Buckley JM, 2007, BONE, V40, P767, DOI 10.1016/j.bone.2006.10.025; Colnot C, 2006, BIOCHEM BIOPH RES CO, V350, P557, DOI 10.1016/j.bbrc.2006.09.079; Colnot C, 2005, CLIN ORTHOP RELAT R, P69, DOI 10.1097/01.blo.0000167251.26164.37; Colnot C, 2003, DEVELOPMENT, V130, P4123, DOI 10.1242/dev.00559; Colnot CI, 2001, MECH DEVELOP, V100, P245, DOI 10.1016/S0925-4773(00)00532-3; CRAWFORD NR, 1995, SPINE, V20, P2097, DOI 10.1097/00007632-199510000-00005; DOEGE KJ, 1999, GUIDEBOOK EXTRACELLU, P359; Egeblad M, 2007, DEV DYNAM, V236, P1683, DOI 10.1002/dvdy.21159; Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288; Ferguson C, 1999, MECH DEVELOP, V87, P57, DOI 10.1016/S0925-4773(99)00142-2; Gerber HP, 2000, TRENDS CARDIOVAS MED, V10, P223, DOI 10.1016/S1050-1738(00)00074-8; GOLDRING MB, 1990, CLIN ORTHOP RELAT R, P245; Henle P, 2005, BONE, V37, P791, DOI 10.1016/j.bone.2005.06.015; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Karsdal MA, 2001, J BIOL CHEM, V276, P39350, DOI 10.1074/jbc.M008738200; Kasper G, 2007, STEM CELLS, V25, P1985, DOI 10.1634/stemcells.2006-0676; Kusano K, 1998, ENDOCRINOLOGY, V139, P1338, DOI 10.1210/en.139.3.1338; Lee ER, 1999, DEV DYNAM, V215, P190, DOI 10.1002/(SICI)1097-0177(199907)215:3<190::AID-AJA2>3.0.CO;2-B; Lehmann W, 2005, BONE, V36, P300, DOI 10.1016/j.bone.2004.10.010; Lu CY, 2004, HISTOCHEM CELL BIOL, V121, P493, DOI 10.1007/s00418-004-0653-5; Lu CY, 2005, J ORTHOP RES, V23, P1300, DOI 10.1016/j.orthres.2005.04.003; Martignetti JA, 2001, NAT GENET, V28, P261, DOI 10.1038/90100; Ortega N, 2005, MOL BIOL CELL, V16, P3028, DOI 10.1091/mbc.E04-12-1119; Ortega N, 2004, TRENDS CELL BIOL, V14, P86, DOI 10.1016/j.tcb.2003.12.003; Parikka V, 2005, MATRIX BIOL, V24, P438, DOI 10.1016/j.matbio.2005.06.009; Roberts W E, 1988, J Dent Educ, V52, P804; Sato T, 1998, J BONE MINER RES, V13, P59, DOI 10.1359/jbmr.1998.13.1.59; SCOTT DK, 1992, MOL ENDOCRINOL, V6, P2153, DOI 10.1210/me.6.12.2153; Selvamurugan N, 2006, J CELL BIOCHEM, V99, P545, DOI 10.1002/jcb.20878; SINGER H, 1995, J CLIN INVEST, V95, P2178; STEELE DG, 1988, BONE BIOL ANATOMY BI, P10; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Thompson Z, 2002, J ORTHOPAED RES, V20, P1091, DOI 10.1016/S0736-0266(02)00017-7; Uusitalo M, 2000, ACTA OPHTHALMOL SCAN, V78, P536, DOI 10.1034/j.1600-0420.2000.078005536.x; Varghese S, 1996, ENDOCRINOLOGY, V137, P431, DOI 10.1210/en.137.2.431; VARGHESE S, 1995, ENDOCRINOLOGY, V136, P2156, DOI 10.1210/en.136.5.2156; Varghese S, 2000, ENDOCRINOLOGY, V141, P2185, DOI 10.1210/en.141.6.2185; Vortkamp A, 1998, MECH DEVELOP, V71, P65, DOI 10.1016/S0925-4773(97)00203-7; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Weizmann S, 2005, MATRIX BIOL, V24, P520, DOI 10.1016/j.matbio.2005.07.003; Yamagiwa H, 1999, BONE, V25, P197, DOI 10.1016/S8756-3282(99)00157-X	46	115	118	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1150	10.1371/journal.pone.0001150	http://dx.doi.org/10.1371/journal.pone.0001150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987127	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459000033
J	Sheu, ML; Liu, SH; Lan, KH				Sheu, Meei Ling; Liu, Shing Hwa; Lan, Keng Hsin			Honokiol Induces Calpain-Mediated Glucose-Regulated Protein-94 Cleavage and Apoptosis in Human Gastric Cancer Cells and Reduces Tumor Growth	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; WEIGHT NATURAL-PRODUCT; DRUG-RESISTANCE; DEATH PROGRAM; IN-VITRO; CASPASE; GRP94; EXPRESSION; INDUCTION; MAGNOLOL	Background. Honokiol, a small molecular weight natural product, has been shown to possess potent anti-neoplastic and anti-angiogenic properties. Its molecular mechanisms and the ability of anti-gastric cancer remain unknown. It has been shown that the anti-apoptotic function of the glucose-regulated proteins (GRPs) predicts that their induction in neoplastic cells can lead to cancer progression and drug resistance. We explored the effects of honokiol on the regulation of GRPs and apoptosis in human gastric cancer cells and tumor growth. Methodology and Principal Findings. Treatment of various human gastric cancer cells with honokiol led to the induction of GRP94 cleavage, but did not affect GRP78. Silencing of GRP94 by small interfering RNA (siRNA) could induce cell apoptosis. Treatment of cells with honokiol or chemotherapeutics agent etoposide enhanced the increase in apoptosis and GRP94 degradation. The calpain activity and calpain-II (m-calpain) protein (but not calpain-I (mu-calpain)) level could also be increased by honokiol. Honokiol-induced GRP94 down-regulation and apoptosis in gastric cancer cells could be reversed by siRNA targeting calpain-II and calpain inhibitors. Furthermore, the results of immunofluorescence staining and immunoprecipitation revealed a specific interaction of GRP94 with calpain-II in cells following honokiol treatment. We next observed that tumor GRP94 over-expression and tumor growth in BALB/c nude mice, which were inoculated with human gastric cancer cells MKN45, are markedly decreased by honokiol treatment. Conclusions and Significance. These results provide the first evidence that honokiol-induced calpain-II-mediated GRP94 cleavage causes human gastric cancer cell apoptosis. We further suggest that honokiol may be a possible therapeutic agent to improve clinical outcome of gastric cancer.	[Sheu, Meei Ling] Natl Chung Hsing Univ, Inst Med Technol, Taichung 40227, Taiwan; [Sheu, Meei Ling] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan; [Liu, Shing Hwa] Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei 10764, Taiwan; [Liu, Shing Hwa] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Lan, Keng Hsin] Natl Yang Ming Univ, Dept Med, Div Gastroenterol, Taipei 112, Taiwan	National Chung Hsing University; Taichung Veterans General Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University	Sheu, ML (corresponding author), Natl Chung Hsing Univ, Inst Med Technol, Taichung 40227, Taiwan.	mlsheu@nchu.edu.tw; shliu@ha.mc.ntu.edu.tw	Sheu, Meei-Ling/AAT-3401-2020	Sheu, Meei-Ling/0000-0002-0431-1282; LIU, SHING-HWA/0000-0002-9976-1197	National Science Council of Taiwan [NSC95-2320-B040-005]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	Funding: This work was supported by research grants from National Science Council of Taiwan (NSC95-2320-B040-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XH, 2003, J BIOL CHEM, V278, P35501, DOI 10.1074/jbc.M302967200; Battle TE, 2005, BLOOD, V106, P690, DOI 10.1182/blood-2004-11-4273; Beliakoff J, 2004, ANTI-CANCER DRUG, V15, P651, DOI 10.1097/01.cad.0000136876.11928.be; Benetti R, 2001, EMBO J, V20, P2702, DOI 10.1093/emboj/20.11.2702; Blomgren K, 2001, J BIOL CHEM, V276, P10191, DOI 10.1074/jbc.M007807200; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.3.CO;2-B; Chavany C, 1996, J BIOL CHEM, V271, P4974; Chen XX, 2002, CARCINOGENESIS, V23, P123, DOI 10.1093/carcin/23.1.123; Chiang CK, 2006, KIDNEY INT, V70, P682, DOI 10.1038/sj.ki.5001617; Fettucciari K, 2006, J IMMUNOL, V176, P7542, DOI 10.4049/jimmunol.176.12.7542; Fu Y, 2006, CANCER BIOL THER, V5, P741, DOI 10.4161/cbt.5.7.2970; Gazit G, 1999, BREAST CANCER RES TR, V54, P135, DOI 10.1023/A:1006102411439; HUGHES CS, 1989, CANCER RES, V49, P4452; Ishitsuka K, 2005, BLOOD, V106, P1794, DOI 10.1182/blood-2005-01-0346; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kato M, 2000, J BIOCHEM, V127, P297, DOI 10.1093/oxfordjournals.jbchem.a022607; KOONG AC, 1994, INT J RADIAT ONCOL, V28, P661, DOI 10.1016/0360-3016(94)90191-0; Kubota H, 2005, INT J RADIAT BIOL, V81, P701, DOI 10.1080/09553000500434727; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lin WC, 2000, ONCOGENE, V19, P5680, DOI 10.1038/sj.onc.1203924; Liou KT, 2003, BRAIN RES, V992, P159, DOI 10.1016/j.brainres.2003.08.026; LITTLE E, 1995, J BIOL CHEM, V270, P9526, DOI 10.1074/jbc.270.16.9526; Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1; Liu SL, 2005, CANCER RES, V65, P9126, DOI 10.1158/0008-5472.CAN-05-0945; LO YC, 1994, BIOCHEM PHARMACOL, V47, P549, DOI 10.1016/0006-2952(94)90187-2; MENORET A, 1994, INT J CANCER, V56, P400, DOI 10.1002/ijc.2910560319; Neumar RW, 2003, J BIOL CHEM, V278, P14162, DOI 10.1074/jbc.M212255200; Ohtsu A, 2006, J CLIN ONCOL, V24, P2188, DOI 10.1200/JCO.2006.05.9758; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Park J, 2004, EUR J PHARMACOL, V496, P189, DOI 10.1016/j.ejphar.2004.05.047; Pezzuto JM, 1997, BIOCHEM PHARMACOL, V53, P121, DOI 10.1016/S0006-2952(96)00654-5; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Rao RV, 2001, J BIOL CHEM, V276, P33869, DOI 10.1074/jbc.M102225200; Reddy RK, 1999, J BIOL CHEM, V274, P28476, DOI 10.1074/jbc.274.40.28476; SAREEN D, 2007, MOL PHARM IN PRESS; SHEN J, 1987, P NATL ACAD SCI USA, V84, P3278, DOI 10.1073/pnas.84.10.3278; Sheu ML, 2005, ARTERIOSCL THROM VAS, V25, P539, DOI 10.1161/01.ATV.0000155462.24263.e4; Tan YF, 2006, J BIOL CHEM, V281, P16016, DOI 10.1074/jbc.M601299200; Tomida A, 1996, INT J CANCER, V68, P391, DOI 10.1002/(SICI)1097-0215(19961104)68:3<391::AID-IJC19>3.0.CO;2-B; Utz PJ, 2000, CELL DEATH DIFFER, V7, P589, DOI 10.1038/sj.cdd.4400696; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Witkowski JM, 2002, BLOOD, V100, P1802, DOI 10.1182/blood-2001-11-0073; Yie Q, 2002, HEPATOLOGY, V36, P592, DOI 10.1053/jhep.2002.35441; Zhai H, 2003, EUR J PHARMACOL, V474, P199, DOI 10.1016/S0014-2999(03)02075-2	44	63	65	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1096	10.1371/journal.pone.0001096	http://dx.doi.org/10.1371/journal.pone.0001096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971859	gold, Green Published, Green Submitted			2022-12-25	WOS:000207458700013
J	Ziv, E; Nemenman, I; Wiggins, CH				Ziv, Etay; Nemenman, Ilya; Wiggins, Chris H.			Optimal Signal Processing in Small Stochastic Biochemical Networks	PLOS ONE			English	Article							MAP KINASE; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; NOISE; INFORMATION; SPECIFICITY; FLUCTUATIONS; DIFFERENTIATION; TRANSDUCTION; PROBABILITY	We quantify the influence of the topology of a transcriptional regulatory network on its ability to process environmental signals. By posing the problem in terms of information theory, we do this without specifying the function performed by the network. Specifically, we study the maximum mutual information between the input ( chemical) signal and the output ( genetic) response attainable by the network in the context of an analytic model of particle number fluctuations. We perform this analysis for all biochemical circuits, including various feedback loops, that can be built out of 3 chemical species, each under the control of one regulator. We find that a generic network, constrained to low molecule numbers and reasonable response times, can transduce more information than a simple binary switch and, in fact, manages to achieve close to the optimal information transmission fidelity. These high-information solutions are robust to tenfold changes in most of the networks' biochemical parameters; moreover they are easier to achieve in networks containing cycles with an odd number of negative regulators ( overall negative feedback) due to their decreased molecular noise ( a result which we derive analytically). Finally, we demonstrate that a single circuit can support multiple high-information solutions. These findings suggest a potential resolution of the "cross-talk'' phenomenon as well as the previously unexplained observation that transcription factors that undergo proteolysis are more likely to be auto-repressive.	[Ziv, Etay] Columbia Univ, Coll Phys & Surg, New York, NY 10027 USA; [Ziv, Etay] Columbia Univ, Dept Biomed Engn, New York, NY USA; [Wiggins, Chris H.] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY USA; [Wiggins, Chris H.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY USA; [Nemenman, Ilya] Los Alamos Natl Lab, Comp Computat & Stat Sci Div, Los Alamos, NM USA; [Nemenman, Ilya] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA	Columbia University; Columbia University; Columbia University; Columbia University; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Ziv, E (corresponding author), Columbia Univ, Coll Phys & Surg, New York, NY 10027 USA.	ez87@columbia.edu		Nemenman, Ilya/0000-0003-3024-4244	NSF [ECS-0425850]; DOE [DE-AC52-06NA25396]; NIH [1U54CA121852]; Krell Institute's DOE CSGF; DOD NDSEGF; NIH-MSTP; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Krell Institute's DOE CSGF(United States Department of Energy (DOE)); DOD NDSEGF; NIH-MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by NSF Grant No. ECS-0425850 to CW and IN. IN was further supported by DOE under Contract No. DE-AC52-06NA25396. CW was further funded by NIH Grant No. 1U54CA121852. EZ was funded by the Krell Institute's DOE CSGF grant, DOD NDSEGF grant, and the NIH-MSTP grant.	ALBERT R, 2004, COMPLEX NETWORKS; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; BALL K, 2005, ARXIVMATHPR0508015; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; Bialek W, 2005, P NATL ACAD SCI USA, V102, P10040, DOI 10.1073/pnas.0504321102; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; Bundschuh R, 2003, BIOPHYS J, V84, P1606, DOI 10.1016/S0006-3495(03)74970-4; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Davidson EH, 2006, REG GEN GEN REG; Detwiler PB, 2000, BIOPHYS J, V79, P2801, DOI 10.1016/S0006-3495(00)76519-2; El-Samad H, 2006, BIOPHYS J, V90, P3749, DOI 10.1529/biophysj.105.060491; Elf J, 2003, GENOME RES, V13, P2475, DOI 10.1101/gr.1196503; Elf J, 2003, BIOPHYS J, V84, P154, DOI 10.1016/S0006-3495(03)74839-5; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fodde R, 2002, SCIENCE, V298, P761, DOI 10.1126/science.1077707; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; GARCIA JA, 2006, SCI STKE, V337, P25; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Ghosh B, 2006, PHYS BIOL, V3, P29, DOI 10.1088/1478-3975/3/1/003; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GLEISS PM, 2000, ARXIVCONDMAT0009124; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Hohenstein P, 2004, PLOS BIOL, V2, P165, DOI 10.1371/journal.pbio.0020040; HUANG CYF, 2004, J CELL BIOL, V164, P354; Hume DA, 2000, BLOOD, V96, P2323, DOI 10.1182/blood.V96.7.2323.h8002323_2323_2328; Ingram PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-108; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Levin MD, 2003, FEBS LETT, V550, P135, DOI 10.1016/S0014-5793(03)00857-3; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; LIU EW, 2005, J CHEM PHYS, V123, DOI DOI 10.1063/1.2109987; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; MARKEVICH NI, 1996, P NATL ACAD SCI USA, V93, P10078; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Min W, 2006, J PHYS CHEM B, V110, P20093, DOI 10.1021/jp065187g; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rao CV, 2003, J CHEM PHYS, V118, P4999, DOI 10.1063/1.1545446; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; ROSS IL, 1994, IMMUNOL CELL BIOL, V72, P177, DOI 10.1038/icb.1994.26; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Salgado H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-5; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; SCHLESSINGER J, 1994, COLD SPRING HARB SYM, V59, P173, DOI 10.1101/SQB.1994.059.01.021; Schneidman E, 1998, NEURAL COMPUT, V10, P1679, DOI 10.1162/089976698300017089; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Shannon CE., 1949, MATH THEORY COMMUNIC; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sinitsyn NA, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/58001; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; TKACIK G, 2000, ARXIV07050313QBIOMN; TREVES A, 1995, NEURAL COMPUT, V7, P399, DOI 10.1162/neco.1995.7.2.399; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Vilar JMG, 2002, P NATL ACAD SCI USA, V99, P5988, DOI 10.1073/pnas.092133899; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Voigt CA, 2005, GENETICS, V169, P1187, DOI 10.1534/genetics.104.031955; Wagner A, 2005, P NATL ACAD SCI USA, V102, P11775, DOI 10.1073/pnas.0501094102; Wall ME, 2005, J MOL BIOL, V349, P501, DOI 10.1016/j.jmb.2005.04.022; WALTERS MC, 1995, P NATL ACAD SCI USA, V92, P7125, DOI 10.1073/pnas.92.15.7125; Wigler M, 2002, SCIENCE, V296, P1407, DOI 10.1126/science.1072445; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269	81	90	90	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1077	10.1371/journal.pone.0001077	http://dx.doi.org/10.1371/journal.pone.0001077			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957259	Green Submitted, Green Published, gold			2022-12-25	WOS:000207458500022
J	Ma, ZY; Janmey, PA; Finkel, TH				Ma, Zhengyu; Janmey, Paul A.; Finkel, Terri H.			The receptor deformation model of TCR triggering	FASEB JOURNAL			English	Article						T cell receptor; signaling; TCR signal initiation; cytoskeleton; mechanical force	T-CELL-ACTIVATION; ANTIGEN PRESENTATION; DENDRITIC CELLS; MULTIVALENT ENGAGEMENT; IMMUNOLOGICAL SYNAPSE; CONFORMATIONAL-CHANGE; SIGNAL-TRANSDUCTION; LYMPH-NODES; MHC LIGANDS; PEPTIDE	Through T cell receptors (TCRs), T cells can detect and respond to very small numbers of foreign peptides among a huge number of self-peptides presented by major histocompatibility complexes (pMHCs) on the surface of antigen-presenting cells (APCs). How T cells achieve such remarkable sensitivity and specificity through pMHC-TCR binding is an intensively pursued issue in immunology today; the key question is how pMHC-TCR binding initiates, or triggers, a signal from TCRs. Multiple competing models have been proposed, none of which fully explains the sensitivity and specificity of TCR triggering. What has been omitted from existing theories is that the pMHC-TCR interaction at the T cell/APC interface must be under constant mechanical stress, due to the dynamic nature of cell-cell interaction. Taking this condition into consideration, we propose the receptor deformation model of TCR triggering. In this model, TCR signaling is initiated by conformational changes of the TCR/CD3 complex, induced by a pulling force originating from the cytoskeleton and transmitted through pMHC-TCR binding interactions with enough strength to resist rupture. By introducing mechanical force into a model of T cell signal initiation, the receptor deformation model provides potential mechanistic solutions to the sensitivity and specificity of TCR triggering.	[Ma, Zhengyu; Finkel, Terri H.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Janmey, Paul A.] Univ Penn, Sch Med, Inst Med & Engn, Dept Bioengn, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Ma, ZY (corresponding author), 1104G Abramson Res Bldg,3516 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	maz@email.chop.edu; finkelt@email.chop.edu			NIAID NIH HHS [R21 AI078387, R21 AI078387-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078387] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Barisas BG, 1999, MOL IMMUNOL, V36, P701, DOI 10.1016/S0161-5890(99)00091-7; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Brossard C, 2005, EUR J IMMUNOL, V35, P1741, DOI 10.1002/eji.200425857; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Casares S, 1999, J EXP MED, V190, P543, DOI 10.1084/jem.190.4.543; Cebecauer M, 2005, J IMMUNOL, V174, P6809, DOI 10.4049/jimmunol.174.11.6809; Cemerski S, 2006, CURR OPIN IMMUNOL, V18, P298, DOI 10.1016/j.coi.2006.03.011; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; DONNADIEU E, 1994, CURR BIOL, V4, P584, DOI 10.1016/S0960-9822(00)00130-5; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Dustin ML, 2001, ANNU REV CELL DEV BI, V17, P133, DOI 10.1146/annurev.cellbio.17.1.133; Gil D, 2005, J EXP MED, V201, P517, DOI 10.1084/jem.20042036; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; GRAY LS, 1988, J IMMUNOL, V141, P2424; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; INABA K, 1986, J EXP MED, V163, P247, DOI 10.1084/jem.163.2.247; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Krogsgaard M, 2005, NAT IMMUNOL, V6, P239, DOI 10.1038/ni1173; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; La Gruta NL, 2004, J IMMUNOL, V172, P3662, DOI 10.4049/jimmunol.172.6.3662; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Levin SE, 2005, J EXP MED, V201, P489, DOI 10.1084/jem.20050179; LOCKSLEY RM, 1993, SCIENCE, V261, P1448, DOI 10.1126/science.8367726; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Munnelly HM, 2000, INT IMMUNOL, V12, P1319, DOI 10.1093/intimm/12.9.1319; OIWA K, 1990, P NATL ACAD SCI USA, V87, P7893, DOI 10.1073/pnas.87.20.7893; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; SCHILHAM MW, 1993, EUR J IMMUNOL, V23, P1299, DOI 10.1002/eji.1830230617; Schwesinger F, 2000, P NATL ACAD SCI USA, V97, P9972, DOI 10.1073/pnas.97.18.9972; Sporri R, 2002, EUR J IMMUNOL, V32, P3161, DOI 10.1002/1521-4141(200211)32:11<3161::AID-IMMU3161>3.0.CO;2-6; Stones JD, 2006, J IMMUNOL, V176, P1498, DOI 10.4049/jimmunol.176.3.1498; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Tskvitaria-Fuller I, 2003, J IMMUNOL, V171, P2287, DOI 10.4049/jimmunol.171.5.2287; Underhill DM, 1999, J EXP MED, V190, P1909, DOI 10.1084/jem.190.12.1909; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Wiedemann A, 2005, IMMUNOL LETT, V98, P57, DOI 10.1016/j.imlet.2004.10.014; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	51	60	60	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2008	22	4					1002	1008		10.1096/fj.07-9331hyp	http://dx.doi.org/10.1096/fj.07-9331hyp			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	282PZ	17984179	Green Accepted			2022-12-25	WOS:000254581000006
J	Intemann, KK; de Melo-Martin, I				Intemann, Kristen K.; de Melo-Martin, Inmaculada			Regulating scientific research: should scientists be left alone?	FASEB JOURNAL			English	Article						stem cell research; regulations; scientific autonomy; ethical values	EMBRYONIC STEM-CELLS; SCIENCE; BIOETHICS; POLITICS; LINES	In our current political climate, decisions about whether to fund research on new stem cell fines or do chimera experiments seem to arbitrarily depend on the religious and economic interests of the administration. Not unreasonably, many scientists believe that science should be left to its own devices in determining research priorities and conducting research. When nonscientific considerations constrain research, it is claimed that values are inappropriately dictating scientific decisions. This assumes, however, that all ethical and social values are irrelevant to such decisions. Using the case of embryonic stem cell research to illustrate the debate, we argue here that this position is untenable for several reasons. First, the aims of science, particularly in the case of the biomedical sciences, cannot be completely extricated from ethical and social aims. Hence, value judgments will be necessary to assess research priorities and methodologies. Second, maintaining this position is inconsistent with actual scientific practices. Scientists already recognize that there are some ethical values that appropriately constrain research, such as in human subject experimentation. Therefore, the problem cannot be that ethical values are brought to bear on science per se but that those values are highly questionable or are imposed by those who often lack the scientific expertise necessary to understand how ethical concerns may relate to the research. Finally, we argue that to the extent value judgments must be made, consensus about such values should be reached by a diverse group of stakeholders, including scientists, community members, policymakers, and ethicists.	[de Melo-Martin, Inmaculada] Weill Cornell Med Coll, Dept Publ Hlth, Div Med Eth, New York, NY 10021 USA; [Intemann, Kristen K.] Montana State Univ, Dept Hist & Philosophy, Bozeman, MT 59717 USA	Cornell University; Montana State University System; Montana State University Bozeman	Intemann, KK (corresponding author), Weill Cornell Med Coll, Dept Publ Hlth, Div Med Eth, 411 E 69th St, New York, NY 10021 USA.	imd2001@med.cornell.edu	de Melo-Martin, Inmaculada/AEE-1312-2022	de Melo-Martin, Inmaculada/0000-0001-8656-8497				Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; Baltimore D, 2004, SCIENCE, V305, P1873, DOI 10.1126/science.305.5692.1873; Blackburn E, 2004, NEW ENGL J MED, V350, P1379, DOI 10.1056/NEJMp048072; Brown P, 2006, INT J HEALTH SERV, V36, P417, DOI 10.2190/0WMQ-VEYT-E11H-UY47; Brumfiel G, 2004, NATURE, V427, P663, DOI [10.1038/427663a, 10.1038/427663b]; Caplan A. L., 1992, MED WENT MAD; Daley GQ, 2003, NEW ENGL J MED, V349, P211, DOI 10.1056/NEJMp030088; Haack S., 1998, MANIFESTO PASSIONATE; Habermas J., 1996, FACTS NORMS CONTRIBU; Jain T, 2005, FERTIL STERIL, V84, P221, DOI 10.1016/j.fertnstert.2005.01.118; Jones JH, 1981, BAD BLOOD TUSKEGEE S; Joravsky D., 1970, LYSENKO AFFAIR; Kincaid H., 2007, VALUE FREE SCI; Kitcher Philip, 2001, SCI TRUTH DEMOCRACY; Lacey H., 1999, IS SCI VALUE FREE VA; McKee M, 2003, EUR J PUBLIC HEALTH, V13, P289, DOI 10.1093/eurpub/13.4.289; MEDVEDEV Z, 1969, RISE FALL LYSENKO; Raikwar SP, 2006, PHYSIOLOGY, V21, P19, DOI 10.1152/physiol.00034.2005; Rawls J., 1971, THEORY JUSTICE; Roll-Hansen N, 2005, ENDEAVOUR, V29, P143, DOI 10.1016/j.endeavour.2005.10.003; Scott CT, 2006, NAT BIOTECHNOL, V24, P487, DOI 10.1038/nbt0506-487; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0; Turner L, 2004, NAT BIOTECHNOL, V22, P509, DOI 10.1038/nbt0504-509; Watson JD, 1997, J MOL MED-JMM, V75, P624, DOI 10.1007/s001099770001; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Wolpert L, 1999, NATURE, V398, P281, DOI 10.1038/18543	26	8	8	1	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2008	22	3					654	658		10.1096/fj.07-9077LSF	http://dx.doi.org/10.1096/fj.07-9077LSF			5	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17928363				2022-12-25	WOS:000254143700003
J	Sakashita, T; Hamada, N; Ikeda, DD; Yanase, S; Suzuki, M; Ishii, N; Kobayashi, Y				Sakashita, Tetsuya; Hamada, Nobuyuki; Ikeda, Daisuke D.; Yanase, Sumino; Suzuki, Michiyo; Ishii, Naoaki; Kobayashi, Yasuhiko			Modulatory effect of ionizing radiation on food-NaCl associative learning: the role of gamma subunit of G protein in Caenorhabditis elegans	FASEB JOURNAL			English	Article						learning behavior; irradiation; nematode; GPC-1	C-ELEGANS; PLASTICITY; NEUROGENESIS; CHEMOTAXIS; IRRADIATION; ADAPTATION; NEURONS; PATHWAY	Ionizing radiation (IR) is known to impair learning by suppressing adult neurogenesis in the hippocampus. However, in a mature nervous system, IR-induced functional alterations that are independent of neurogenesis remain largely unknown. In the present study, we analyzed the effects of IR on a food-NaCl associative learning paradigm of adult Caenorhabditis elegans that does not undergo neurogenesis. We observed that a decrease in chemotaxis toward NaCl occurs only after combined starvation and exposure to NaCl. Exposure to IR induced an additional decrease in chemotaxis immediately after an acute dose in the transition stage of the food-NaCl associative learning. Strikingly, chronic irradiation induced negative chemotaxis in the exposed animals, i.e., the primary avoidance response. IR-induced additional decreases in chemotaxis after acute and chronic irradiation were significantly suppressed in the gpc-1 mutant, which was defective in GPC-1 (one of the two gamma subunits of the heterotrimeric G-protein). Chemotaxis to cAMP, but not to lysine and benzaldehyde, was influenced by IR during the food-NaCl associative learning. Our novel findings suggest that IR behaves as a modulator in the food-NaCl associative learning via C elegans GPC-1 and a specific neuronal network and may shed light on the modulatory effect of IR on learning.	[Sakashita, Tetsuya; Hamada, Nobuyuki; Suzuki, Michiyo; Kobayashi, Yasuhiko] Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Microbeam Radiat Biol Grp, Takasaki, Gunma 3701292, Japan; [Hamada, Nobuyuki; Kobayashi, Yasuhiko] Gunma Univ, Grad Sch Med, Dept Quantum Biol, Maebashi, Gunma 371, Japan; [Ikeda, Daisuke D.] Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Tokyo 113, Japan; [Ikeda, Daisuke D.] Univ Tokyo, Grad Sch Sci, Grad Program Biophys & Biochem, Tokyo 113, Japan; [Yanase, Sumino] Daito Bunka Univ, Sch Sports & Hlth Sci, Higashi Matsuyama, Saitama, Japan; [Ishii, Naoaki] Tokai Univ, Sch Med, Dept Mol & Life Sci, Isehara, Kanagawa 25911, Japan	Japan Atomic Energy Agency; Gunma University; University of Tokyo; University of Tokyo; Tokai University	Sakashita, T (corresponding author), Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Microbeam Radiat Biol Grp, 1233 Watanuki Machi, Takasaki, Gunma 3701292, Japan.	sakashita.tetsuya@jaea.go.jp		Hamada, Nobuyuki/0000-0003-2518-6131				BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BRENNER S, 1974, GENETICS, V77, P71; CASARETT AP, 1973, RADIAT RES, V53, P455, DOI 10.2307/3573778; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Czurko A, 1997, P NATL ACAD SCI USA, V94, P2766, DOI 10.1073/pnas.94.6.2766; Fan Y, 2007, EUR J NEUROSCI, V25, P38, DOI 10.1111/j.1460-9568.2006.05269.x; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hobert O, 2003, J NEUROBIOL, V54, P203, DOI 10.1002/neu.10168; Hukema RK, 2006, EMBO J, V25, P312, DOI 10.1038/sj.emboj.7600940; ISHII N, 1990, INT J RADIAT BIOL, V58, P827, DOI 10.1080/09553009014552201; Jansen G, 2002, EMBO J, V21, P986, DOI 10.1093/emboj/21.5.986; KOJIMA T, 1989, APPL RADIAT ISOTOPES, V40, P851, DOI 10.1016/0883-2889(89)90006-3; Matsumoto H, 2007, J RADIAT RES, V48, P97, DOI 10.1269/jrr.06090; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Mohri A, 2005, GENETICS, V169, P1437, DOI 10.1534/genetics.104.036111; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Narici L, 2004, ADV SPACE RES-SERIES, V33, P1352, DOI 10.1016/j.asr.2003.09.052; Nuttley WM, 2002, P NATL ACAD SCI USA, V99, P12449, DOI 10.1073/pnas.192101699; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; RABIN BM, 1989, RADIAT RES, V119, P113, DOI 10.2307/3577371; Saeki S, 2001, J EXP BIOL, V204, P1757; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Scotto-Lomassese S, 2003, J NEUROSCI, V23, P9289; SPARROW AH, 1967, RADIAT RES, V32, P915, DOI 10.2307/3572296; Spitz DR, 2004, CANCER METAST REV, V23, P311, DOI 10.1023/B:CANC.0000031769.14728.bc; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Wong CS, 2004, MOL INTERV, V4, P273, DOI 10.1124/mi.4.5.7	28	10	13	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2008	22	3					713	720		10.1096/fj.07-9259com	http://dx.doi.org/10.1096/fj.07-9259com			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17947388				2022-12-25	WOS:000254143700010
J	Marri, L; Trost, P; Trivelli, X; Gonnelli, L; Pupillo, P; Sparla, F				Marri, Lucia; Trost, Paolo; Trivelli, Xavier; Gonnelli, Leonardo; Pupillo, Paolo; Sparla, Francesca			Spontaneous assembly of photosynthetic supramolecular complexes as mediated by the intrinsically unstructured protein CP12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; CALVIN CYCLE ACTIVITY; C-TERMINAL EXTENSION; SPINACH-CHLOROPLASTS; LIGHT REGULATION; B-SUBUNIT; PHOSPHORIBULOKINASE; ARABIDOPSIS; DISORDER; ISOFORM	CP12 is a protein of 8.7 kDa that contributes to Calvin cycle regulation by acting as a scaffold element in the formation of a supramolecular complex with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and phosphoribulokinase (PRK) in photosynthetic organisms. NMR studies of recombinant CP12 (isoform 2) of Arabidopsis thaliana show that CP12-2 is poorly structured. CP12-2 is monomeric in solution and contains four cysteines, which can form two intramolecular disulfides with midpoint redox potentials of -326 and -352 mV, respectively, at pH 7.9. Site-specific mutants indicate that the C-terminal disulfide is involved in the interaction between CP12-2 and GAPDH (isoform A(4)), whereas the N-terminal disulfide is involved in the interaction between this binary complex and PRK. In the presence of NAD, oxidized CP12-2 interacts with A(4)-GAPDH(K-D (=) 0.18 mu M) to form a binary complex of 170 kDa with (A(4)-GAPDH)-(CP12-2)(2) stoichiometry, as determined by isothermal titration calorimetry and multiangle light scattering analysis. PRK is a dimer and by interacting with this binary complex (K-D = 0.17 mu M) leads to a 498-kDa ternary complex constituted by two binary complexes and two PRK dimers, i.e. ((A(4)-GAPDH)-(CP12-2)(2)-(PRK))(2). Thermodynamic parameters indicate that assembly of both binary and ternary complexes is exoergonic although penalized by a decrease in entropy that suggests an induced folding of CP12-2 upon binding to partner proteins. The redox dependence of events leading to supramolecular complexes is consistent with a role of CP12 in coordinating the reversible inactivation of chloroplast enzymes A(4)-GAPDH and PRK during darkness in photosynthetic tissues.	[Marri, Lucia; Trost, Paolo; Pupillo, Paolo; Sparla, Francesca] Univ Bologna, Dept Expt Evolut Biol, Lab Mol Plant Physiol, I-40126 Bologna, Italy; [Trivelli, Xavier] Univ Lille, UMR 8576, CNRS, IFR 147 Sci & Technol, F-59655 Villeneuve Dascq, France; [Gonnelli, Leonardo] Univ Florence, Magnet Resonance Ctr, I-50019 Florence, Italy	University of Bologna; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; University of Florence	Trost, P (corresponding author), Univ Bologna, Dept Expt Evolut Biol, Lab Mol Plant Physiol, I-40126 Bologna, Italy.	trost@alma.unibo.it	Trost, Paolo/F-2425-2011	Trivelli, Xavier/0000-0001-6775-9650; Trost, Paolo/0000-0002-6347-8701; Sparla, Francesca/0000-0002-2103-4870				Baalmann E, 1996, PLANT MOL BIOL, V32, P505, DOI 10.1007/BF00019102; BAALMANN E, 1994, BOT ACTA, V107, P313, DOI 10.1111/j.1438-8677.1994.tb00801.x; Baalmann E, 1995, ARCH BIOCHEM BIOPHYS, V324, P201, DOI 10.1006/abbi.1995.0031; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; CERFF R, 1979, J BIOL CHEM, V254, P6094; Collin V, 2003, J BIOL CHEM, V278, P23747, DOI 10.1074/jbc.M302077200; Conway ME, 2004, BIOCHEMISTRY-US, V43, P7356, DOI 10.1021/bi0498050; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Fermani S, 2007, P NATL ACAD SCI USA, V104, P11109, DOI 10.1073/pnas.0611636104; Fermani S, 2001, J MOL BIOL, V314, P527, DOI 10.1006/jmbi.2001.5172; Figge RM, 1999, MOL BIOL EVOL, V16, P429, DOI 10.1093/oxfordjournals.molbev.a026125; Gardebien F, 2006, J MOL GRAPH MODEL, V25, P186, DOI 10.1016/j.jmgm.2005.12.003; Graciet E, 2004, J EXP BOT, V55, P1245, DOI 10.1093/jxb/erh107; Graciet E, 2003, BIOCHEMISTRY-US, V42, P8163, DOI 10.1021/bi034474x; Graciet E, 2003, EUR J BIOCHEM, V270, P129, DOI 10.1046/j.1432-1033.2003.03372.x; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Lebreton S, 2003, J BIOL CHEM, V278, P12078, DOI 10.1074/jbc.M213096200; Lebreton S, 2006, FEBS J, V273, P3358, DOI 10.1111/j.1742-4658.2006.05342.x; Li AD, 1997, PLANT PHYSIOL, V115, P1201, DOI 10.1104/pp.115.3.1201; Marri L, 2005, J EXP BOT, V56, P73, DOI 10.1093/jxb/eri020; Marri L, 2005, PLANT PHYSIOL, V139, P1433, DOI 10.1104/pp.105.068445; Michels J, 2002, PROTEIN SCI, V11, P1565, DOI 10.1110/ps.2760102; Petersen J, 2006, MOL BIOL EVOL, V23, P1109, DOI 10.1093/molbev/msj123; Pohlmeyer K, 1996, PLANT MOL BIOL, V32, P969, DOI 10.1007/BF00020493; PORTER MA, 1990, PLANTA, V181, P349, DOI 10.1007/BF00195887; PORTER MA, 1988, J BIOL CHEM, V263, P123; PUPILLO P, 1975, EUR J BIOCHEM, V51, P475, DOI 10.1111/j.1432-1033.1975.tb03947.x; Qi JF, 2001, J BIOL CHEM, V276, P35247, DOI 10.1074/jbc.M103855200; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Raines CA, 2006, J EXP BOT, V57, P1857, DOI 10.1093/jxb/erl011; Scagliarini S, 1998, J EXP BOT, V49, P1307, DOI 10.1093/jexbot/49.325.1307; Scheibe R, 2002, EUR J BIOCHEM, V269, P5617, DOI 10.1046/j.1432-1033.2002.03269.x; Sparla F, 2002, J BIOL CHEM, V277, P44946, DOI 10.1074/jbc.M206873200; Tamoi M, 2005, PLANT J, V42, P504, DOI 10.1111/j.1365-313X.2005.02391.x; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Trost P, 2006, PHOTOSYNTH RES, V89, P263, DOI 10.1007/s11120-006-9099-z; TROST P, 1993, PLANTA, V190, P320, DOI 10.1007/BF00196960; Wedel N, 1997, P NATL ACAD SCI USA, V94, P10479, DOI 10.1073/pnas.94.19.10479; Wedel N, 1998, P NATL ACAD SCI USA, V95, P9699, DOI 10.1073/pnas.95.16.9699; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WOLOSIUK RA, 1993, FASEB J, V7, P622, DOI 10.1096/fasebj.7.8.8500687; Yao J, 1997, FEBS LETT, V419, P285, DOI 10.1016/S0014-5793(97)01474-9; Zaffagnini M, 2007, FEBS J, V274, P212, DOI 10.1111/j.1742-4658.2006.05577.x	45	59	61	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1831	1838		10.1074/jbc.M705650200	http://dx.doi.org/10.1074/jbc.M705650200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	17947231	hybrid			2022-12-25	WOS:000252501000008
J	Cooper, SE; Murawsky, CM; Lowe, N; Travers, AA				Cooper, Sarah E.; Murawsky, Christopher M.; Lowe, Nicholas; Travers, Andrew A.			Two modes of degradation of the tramtrack transcription factors by Siah homologues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL FATE; DROSOPHILA EYE; UBIQUITIN LIGASE; FINGER PROTEIN; R7 CELL; GENE; STABILITY; REPRESSOR; PHYLLOPOD; ACTS	The Siah proteins, mammalian homologues of the Drosophila Sina protein, function as ubiquitin-protein isopeptide ligase enzymes to target a wide range of cellular proteins for degradation. We report here a novel Drosophila protein that is homologous to Sina, named Sina-Homologue (SinaH). We show that it can direct the degradation of the transcriptional repressor Tramtrack (Ttk) using two different mechanisms. One is similar to Sina and requires the adaptor Phyllopod, and the other is a novel mechanism of recognition. This novel mode of targeting for degradation is specific for the 69-kDa Ttk isoform, Ttk69. Ttk69 contains a region that is required for binding of SinaH and for SinaH-directed degradation. This region contains an AXVXP motif, which is the consensus sequence found in Siah substrate proteins. These results suggest that degradation directed by SinaH differs from that directed by Sina and is more similar to that found in vertebrates. We speculate that SinaH may be involved in regulating the levels of developmentally important transcription factors.	[Cooper, Sarah E.; Murawsky, Christopher M.; Lowe, Nicholas; Travers, Andrew A.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Cooper, SE (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	scooper@mrc-lmb.cam.ac.uk		Murawsky, Christopher/0000-0002-9698-052X	Medical Research Council [U.1051.01.011(78785), MC_U105184288] Funding Source: Medline; MRC [MC_U105184288] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Badenhorst P, 2002, MECH DEVELOP, V117, P87, DOI 10.1016/S0925-4773(02)00183-1; Badenhorst P, 2001, DEVELOPMENT, V128, P4093; Baonza A, 2002, NAT CELL BIOL, V4, P976, DOI 10.1038/ncb887; Boehm J, 2001, EMBO J, V20, P4153, DOI 10.1093/emboj/20.15.4153; Boulton SJ, 2000, EMBO J, V19, P5376, DOI 10.1093/emboj/19.20.5376; CARTHEW RW, 1990, CELL, V63, P561, DOI 10.1016/0092-8674(90)90452-K; CHANG HC, 1995, CELL, V80, P463, DOI 10.1016/0092-8674(95)90497-2; Cooper SE, 2007, MECH DEVELOP, V124, P584, DOI 10.1016/j.mod.2007.04.007; Dallman JE, 2004, J NEUROSCI, V24, P7186, DOI 10.1523/JNEUROSCI.0238-04.2004; Dong XZ, 1999, GENE DEV, V13, P954, DOI 10.1101/gad.13.8.954; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Giesen K, 1997, DEVELOPMENT, V124, P2307; GUO M, 1995, NEURON, V14, P913, DOI 10.1016/0896-6273(95)90330-5; HARRISON SD, 1990, EMBO J, V9, P207, DOI 10.1002/j.1460-2075.1990.tb08097.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; House CM, 2003, P NATL ACAD SCI USA, V100, P3101, DOI 10.1073/pnas.0534783100; Hu G, 1997, GENOMICS, V46, P103, DOI 10.1006/geno.1997.4997; Kauffmann RC, 1996, GENE DEV, V10, P2167, DOI 10.1101/gad.10.17.2167; Li SH, 2002, MOL CELL BIOL, V22, P6854, DOI 10.1128/MCB.22.19.6854-6865.2002; Li SH, 1997, CELL, V90, P469, DOI 10.1016/S0092-8674(00)80507-3; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; Murawsky CM, 2001, EMBO REP, V2, P1089, DOI 10.1093/embo-reports/kve252; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Pi HW, 2001, DEVELOPMENT, V128, P2699; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; READ D, 1992, EMBO J, V11, P1035, DOI 10.1002/j.1460-2075.1992.tb05142.x; Santelli E, 2005, J BIOL CHEM, V280, P34278, DOI 10.1074/jbc.M506707200; Sourisseau T, 2001, J CELL SCI, V114, P1409; Tang AH, 1997, CELL, V90, P459, DOI 10.1016/S0092-8674(00)80506-1; Tiedt R, 2001, EMBO J, V20, P4143, DOI 10.1093/emboj/20.15.4143; Wen Y, 2000, GENETICS, V156, P195; XIONG WC, 1993, GENE DEV, V7, P1085, DOI 10.1101/gad.7.6.1085; Zhang X, 1998, MOL ENDOCRINOL, V12, P513, DOI 10.1210/me.12.4.513	34	5	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1076	1083		10.1074/jbc.M707765200	http://dx.doi.org/10.1074/jbc.M707765200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17962185	hybrid, Green Accepted			2022-12-25	WOS:000252128100047
J	Ploskon, E; Arthur, CJ; Evans, SE; Williams, C; Crosby, J; Simpson, TJ; Crump, MP				Ploskon, Eliza; Arthur, Christopher J.; Evans, Simon E.; Williams, Christopher; Crosby, John; Simpson, Thomas J.; Crump, Matthew P.			A mammalian type I fatty acid synthase acyl carrier protein domain does not sequester acyl chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; BACKBONE DYNAMICS; SURFACE-TOPOGRAPHY; NMR-SPECTROSCOPY; EXCHANGE-RATES; COMPUTED ATLAS; EGLIN-C; IDENTIFICATION; RESTRAINTS; ASSIGNMENT	The synthases that produce fatty acids in mammals (FASs) are arranged as large multidomain polypeptides. The growing fatty acid chain is bound covalently during chain elongation and reduction to the acyl carrier protein (ACP) domain that is then able to access each catalytic site. In this work we report the high-resolution nuclear magnetic resonance (NMR) solution structure of the isolated rat fatty acid synthase apoACP domain. The final ensemble of NMR structures and backbone N-15 relaxation studies show that apoACP adopts a single, well defined fold. On conversion to the holo form, several small chemical shift changes are observed on the ACP for residues surrounding the phosphopantetheine attachment site ( as monitored by backbone H-1-N-15 correlation experiments). However, there are negligible chemical shift changes when the holo form is modified to either the hexanoyl or palmitoyl forms. For further NMR analysis, a C-13,N-15-labeled hexanoyl-ACP sample was prepared and full chemical shift assignments completed. Analysis of two-dimensional F-2-filtered and three-dimensional C-13-edited nuclear Overhauser effect spectroscopy experiments revealed no detectable NOEs to the acyl chain. These experiments demonstrate that unlike other FAS ACPs studied, this Type I ACP does not sequester a covalently linked acyl moiety, although transient interactions cannot be ruled out. This is an important mechanistic difference between the ACPs from Type I and Type II FASs and may be significant for the modulation and regulation of these important mega-synthases.	Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England	University of Bristol	Crump, MP (corresponding author), Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England.	matt.crump@bristol.ac.uk	Simpson, Thomas J/P-5058-2015; Arthur, Christopher J/F-9710-2011; Wiliams, Christopher/P-4904-2015	Wiliams, Christopher/0000-0001-5806-9842; Arthur, Christopher/0000-0001-7577-8472; Crump, Matthew/0000-0002-7868-5818	Biotechnology and Biological Sciences Research Council [BB/F014570/1, B20055] Funding Source: Medline; Wellcome Trust Funding Source: Medline; BBSRC [BB/F014570/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ANDREC M, 1995, PROTEIN SCI, V4, P983; Arthur C, 2002, CHEMBIOCHEM, V3, P253, DOI 10.1002/1439-7633(20020301)3:2/3<253::AID-CBIC253>3.0.CO;2-7; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Bonvin AMJJ, 2001, J BIOMOL NMR, V21, P221, DOI 10.1023/A:1012935005256; Breeze AL, 2000, PROG NUCL MAG RES SP, V36, P323, DOI 10.1016/S0079-6565(00)00020-0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CONSTANTINIDES PP, 1986, ARCH BIOCHEM BIOPHYS, V250, P267, DOI 10.1016/0003-9861(86)90726-5; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Crump MP, 1997, BIOCHEMISTRY-US, V36, P6000, DOI 10.1021/bi970006+; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Findlow SC, 2003, BIOCHEMISTRY-US, V42, P8423, DOI 10.1021/bi0342259; Fogh Rasmus, 2002, Nature Structural Biology, V9, P416, DOI 10.1038/nsb0602-416; Habeck Michael, 2004, Methods Mol Biol, V278, P379; HOLAK TA, 1986, BIOCHEMISTRY-US, V25, P5766, DOI 10.1021/bi00367a063; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; ISHIMA R, 1995, BIOCHEMISTRY-US, V34, P3162, DOI 10.1021/bi00010a005; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kay LE, 1995, PROG BIOPHYS MOL BIO, V63, P277, DOI 10.1016/0079-6107(95)00007-0; Keating MM, 2002, BBA-PROTEINS PROTEOM, V1601, P208, DOI 10.1016/S1570-9639(02)00470-3; KIM Y, 1989, BIOCHEMISTRY-US, V28, P8792, DOI 10.1021/bi00448a017; Kim Y, 2006, BIOCHEM BIOPH RES CO, V341, P776, DOI 10.1016/j.bbrc.2006.01.025; KIM YM, 1990, PROTEINS, V8, P377, DOI 10.1002/prot.340080411; Koglin A, 2006, SCIENCE, V312, P273, DOI 10.1126/science.1122928; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; Kuhajda FP, 2005, TRENDS PHARMACOL SCI, V26, P541, DOI 10.1016/j.tips.2005.09.002; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; Li Q, 2003, BIOCHEMISTRY-US, V42, P4648, DOI 10.1021/bi0274120; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Lomakin IB, 2007, CELL, V129, P319, DOI 10.1016/j.cell.2007.03.013; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; MAYO KH, 1985, BIOCHEMISTRY-US, V24, P7834, DOI 10.1021/bi00347a049; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Pellecchia M, 1999, NAT STRUCT BIOL, V6, P336; Peng JW, 1995, BIOCHEMISTRY-US, V34, P16733, DOI 10.1021/bi00051a023; PENG JW, 1992, BIOCHEMISTRY-US, V31, P8571, DOI 10.1021/bi00151a027; PENG JW, 1992, J MAGN RESON, V98, P308, DOI 10.1016/0022-2364(92)90135-T; Peterson RD, 2004, J BIOMOL NMR, V28, P59, DOI 10.1023/B:JNMR.0000012861.95939.05; Qiu XY, 2004, ACTA CRYSTALLOGR D, V60, P1545, DOI 10.1107/S0907444904015422; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Reed MAC, 2003, ORG BIOMOL CHEM, V1, P463, DOI 10.1039/b208941f; ROCK CO, 1979, J BIOL CHEM, V254, P7123; Roujeinikova A, 2002, STRUCTURE, V10, P825, DOI 10.1016/S0969-2126(02)00775-X; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; Sharma AK, 2006, BIOCHEMISTRY-US, V45, P6904, DOI 10.1021/bi060368u; Tropf S, 1998, CHEM BIOL, V5, P135, DOI 10.1016/S1074-5521(98)90058-8; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Winston RL, 1998, ANAL BIOCHEM, V262, P83, DOI 10.1006/abio.1998.2754; Wong HC, 2002, J BIOL CHEM, V277, P15874, DOI 10.1074/jbc.M112300200; Xu GY, 2001, STRUCTURE, V9, P277, DOI 10.1016/S0969-2126(01)00586-X; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413; Zhang YM, 2001, J BIOL CHEM, V276, P8231, DOI 10.1074/jbc.M008042200; Zhang YQ, 2003, J BIOL CHEM, V278, P10417, DOI 10.1074/jbc.M211044200; Zornetzer GA, 2006, BIOCHEMISTRY-US, V45, P5217, DOI 10.1021/bi052062d	57	59	59	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					518	528		10.1074/jbc.M703454200	http://dx.doi.org/10.1074/jbc.M703454200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17971456	hybrid			2022-12-25	WOS:000251940300057
J	Yeh, LK; Liu, CY; Chien, CL; Converse, RL; Kao, WWY; Chen, MS; Hu, FR; Hsieh, FJ; Wang, IJ				Yeh, Lung-Kun; Liu, Chia-Yang; Chien, Chung-Liang; Converse, Richard L.; Kao, Winston W. -Y.; Chen, Muh-Shy; Hu, Fung-Rong; Hsieh, Fon-Jou; Wang, I-Jong			Molecular analysis and characterization of zebrafish keratocan (zKera) gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KERATAN SULFATE PROTEOGLYCAN; LEUCINE-RICH PROTEOGLYCANS; PROTEIN; PERSPECTIVES; EVOLUTION; SEQUENCE; CLONING; EYE	Corneal small leucine-rich proteoglycans play a pivotal role in maintaining corneal transparency and function. In this study, we isolated and characterized the zebrafish ( Danio rerio) keratocan (zKera) gene. The human keratocan sequence was used to search zebrafish homologues. The zKera full-length genomic DNA and cDNA were generated via PCR of zebrafish genomic DNA and reverse transcription-PCR of total zebrafish eye RNA, respectively. The zKera spanning 3.5 kilobase pairs consists of two exons and one intron and a TATA-less promoter. The zKera encodes 341 amino acids with 59% identity to its human counterpart and 57% identity to that of mouse keratocan. Like mouse and chick keratocan, zKera mRNA is selectively expressed in the adult cornea; however, during embryonic development, zKera mRNA is expressed in both the brain and the cornea. Interestingly, it is expressed mainly in corneal epithelium but also in the stroma. A pseudogene was proved by introducing a zKera promoter-driven enhanced green fluorescence protein reporter gene into fertilized zebrafish eggs. Using morpholino-antisense against zKera to knock down zKera resulted in a lethal phenotype due to massive caspase-dependent apoptosis, which was noted by a significant increase of active caspase-3 and caspase-8 in the developing forebrain area, including the eyes. This is different from mouse, for which keratocan-deficient mice are viable. Taken together, our data indicate that mammalian keratocan is conserved in zebrafish in terms of gene structure, expression pattern, and promoter function.	[Chen, Muh-Shy; Hu, Fung-Rong; Wang, I-Jong] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei 100, Taiwan; [Yeh, Lung-Kun; Chien, Chung-Liang] Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, Taipei 100, Taiwan; [Yeh, Lung-Kun] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Ophthalmol, Tao Yuan 333, Taiwan; [Liu, Chia-Yang; Converse, Richard L.; Kao, Winston W. -Y.] Univ Cincinnati, Coll Med, Dept Ophthalmol, Cincinnati, OH 45267 USA; [Kao, Winston W. -Y.] Univ Cincinnati, Coll Med, Dept Cell Biol Neurosci & Anat, Cincinnati, OH 45267 USA	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Wang, IJ (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, 7 Chug-Shan S Rd, Taipei 100, Taiwan.	ijong@ha.mc.ntu.edu.tw		Liu, Chia-yang/0000-0002-8398-5516; CHIEN, CHUNG-LIANG/0000-0001-9806-486X; HU, FUNG-RONG/0000-0002-2102-5317; Wang, I-Jong/0000-0002-3045-0614	NEI NIH HHS [R01 EY 12486, EY 11845] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011845, R01EY012486] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANTONSSON P, 1991, J BIOL CHEM, V266, P16859; Braat AK, 2001, GENESIS, V30, P183, DOI 10.1002/gene.1060; BRITTEN RJ, 1971, Q REV BIOL, V46, P111, DOI 10.1086/406830; Chang HY, 2000, SCIENCE, V290, P1978, DOI 10.1126/science.290.5498.1978; Chen T T, 1996, Biotechnol Annu Rev, V2, P205, DOI 10.1016/S1387-2656(08)70011-5; Conrad AH, 2003, MATRIX BIOL, V22, P323, DOI 10.1016/S0945-053X(03)00039-8; Corpuz LM, 1996, J BIOL CHEM, V271, P9759, DOI 10.1074/jbc.271.16.9759; ERNST B, 2000, CARBOHYDRATES CHEM B, P717; FUNDERBURGH JL, 1993, J BIOL CHEM, V268, P11874; Funderburgh JL, 1997, J BIOL CHEM, V272, P28089, DOI 10.1074/jbc.272.44.28089; FUNDERBURGH JL, 1995, INVEST OPHTH VIS SCI, V36, P2296; Hackett P.B, 2000, RECENT ADV MARINE BI, V4, P77; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Karlen S, 2001, GENESIS, V30, P126, DOI 10.1002/gene.1046; Kennedy BN, 2001, J BIOL CHEM, V276, P14037, DOI 10.1074/jbc.M010490200; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Lele Z, 2001, GENESIS, V30, P190, DOI 10.1002/gene.1063; LIU CY, 1994, J BIOL CHEM, V269, P24627; Liu CY, 2003, J BIOL CHEM, V278, P21672, DOI 10.1074/jbc.M301169200; Liu CY, 1998, J BIOL CHEM, V273, P22584, DOI 10.1074/jbc.273.35.22584; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Negron JF, 2004, DEV DYNAM, V231, P161, DOI 10.1002/dvdy.20124; Pellegata NS, 2000, NAT GENET, V25, P91, DOI 10.1038/75664; Piatigorsky J, 2003, INTEGR COMP BIOL, V43, P492, DOI 10.1093/icb/43.4.492; PIATIGORSKY J, 1988, PROG RETIN EYE RES, V17, P145; Soules KA, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-12; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Udvadia AJ, 2003, DEV BIOL, V256, P1, DOI 10.1016/S0012-1606(02)00083-0; Vorbach C, 2002, GENE DEV, V16, P3223, DOI 10.1101/gad.1032702; WEINHEIM W, 2001, EXP EYE RES, V73, P411; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041; WILSON AC, 1987, TRENDS GENET, V3, P241, DOI 10.1016/0168-9525(87)90257-5; Xu YS, 2000, J BIOL CHEM, V275, P24645, DOI 10.1074/jbc.M001159200; ZUCKERKANDL E, 1994, J MOL EVOL, V39, P661, DOI 10.1007/BF00160412	37	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					506	517		10.1074/jbc.M707656200	http://dx.doi.org/10.1074/jbc.M707656200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17965408	hybrid			2022-12-25	WOS:000251940300056
J	Takaki, E; Fujimoto, M; Nakahari, T; Yonemura, S; Miyata, Y; Hayashida, N; Yamamoto, K; Vallee, RB; Mikuriya, T; Sugahara, K; Yamashita, H; Inouye, S; Nakai, A				Takaki, Eiichi; Fujimoto, Mitsuaki; Nakahari, Takashi; Yonemura, Shigenobu; Miyata, Yoshihiko; Hayashida, Naoki; Yamamoto, Kaoru; Vallee, Richard B.; Mikuriya, Tsuyoshi; Sugahara, Kazuma; Yamashita, Hiroshi; Inouye, Sachiye; Nakai, Akira			Heat shock transcription factor 1 is required for maintenance of ciliary beating in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONES; MALE-INFERTILITY; LENS DEVELOPMENT; SITUS-INVERSUS; BETA-TUBULIN; RAT TRACHEAL; MOUSE; HSF1; GENE; HYDROCEPHALUS	Heat shock transcription factors (HSFs) maintain protein homeostasis through regulating expression of heat shock proteins, especially in stressed conditions. In addition, HSFs are involved in cellular differentiation and development by regulating development-related genes, as well as heat shock genes. Here, we showed chronic sinusitis and mild hydrocephalus in postnatal HSF1-null mice, which are associated with impaired mucociliary clearance and cerebrospinal flow, respectively. Analysis of ciliary beating revealed that the amplitude of the beating was significantly reduced, and ciliary beat frequencies were lower in the respiratory epithelium, ependymal cells, oviduct, and trachea of HSF1-null mice than those of wild-type mice. Cilia possess a common axonema structure composed of microtubules of alpha- and beta-tubulin. We found a marked reduction in alpha- and ciliary beta(iv)-tubulin in the HSF1-null cilia, which is developmentally associated with reduced Hsp90 expression in HSF1-null mice. Treatment of the respiratory epithelium with geldanamycin resulted in rapid reduction of ciliary beating in a dose-dependent manner. Furthermore, Hsp90 was physically associated with ciliary beta(iv)-tubulin, and Hsp90 stabilizes tubulin polymerization in vitro. These results indicate that HSF1 is required to maintain ciliary beating in postnatal mice, probably by regulating constitutive expression of Hsp90 that is important for tubulin polymerization.	[Takaki, Eiichi; Fujimoto, Mitsuaki; Hayashida, Naoki; Yamamoto, Kaoru; Inouye, Sachiye; Nakai, Akira] Yamaguchi Univ, Sch Med, Dept Biochem, Ube, Yamaguchi 7558505, Japan; [Yamashita, Hiroshi] Yamaguchi Univ, Sch Med, Dept Otolaryngol, Ube, Yamaguchi 7558505, Japan; [Nakahari, Takashi] Osaka Med Coll, Dept Physiol, Osaka 5698686, Japan; [Yonemura, Shigenobu] RIKEN Ctr Dev Biol, Lab Cellular Morphogenesis, Kobe, Hyogo 6500047, Japan; [Miyata, Yoshihiko] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Kyoto 6068502, Japan; [Vallee, Richard B.] Columbia Univ, Dept Pathol, Coll Phys & Surg, New York, NY 10032 USA	Yamaguchi University; Yamaguchi University; Osaka Medical College; RIKEN; Kyoto University; Columbia University	Nakai, A (corresponding author), Yamaguchi Univ, Sch Med, Dept Biochem, Ube, Yamaguchi 7558505, Japan.	anakai@yamaguchi-u.ac.jp	Hayashida, Naoki/HGA-3453-2022; Miyata, Y/X-7111-2019	Mikuriya, Takefumi/0000-0001-7389-5421; Hayashida, Naoki/0000-0002-8785-8012				AFZELIUS BA, 1994, METABOLIC MOL BASES, P3943; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; BLOCH MA, 1995, J CELL SCI, V108, P3541; Bu L, 2002, NAT GENET, V31, P276, DOI 10.1038/ng921; Casano C, 2003, J HISTOCHEM CYTOCHEM, V51, P1581, DOI 10.1177/002215540305101202; Chang YH, 2006, GENE DEV, V20, P836, DOI 10.1101/gad.366906; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; Dale EC, 1997, CELL STRESS CHAPERON, V2, P87, DOI 10.1379/1466-1268(1997)002<0087:MKHSPG>2.3.CO;2; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Foster WM, 2001, J APPL PHYSIOL, V90, P1111, DOI 10.1152/jappl.2001.90.3.1111; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Hayashi T, 2005, EXP PHYSIOL, V90, P535, DOI 10.1113/expphysiol.2004.028746; Hayashida N, 2006, EMBO J, V25, P4773, DOI 10.1038/sj.emboj.7601370; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Ibanez-Tallon I, 2003, HUM MOL GENET, V12, pR27, DOI 10.1093/hmg/ddg061; Ibanez-Tallon I, 2002, HUM MOL GENET, V11, P715, DOI 10.1093/hmg/11.6.715; Inouye S, 2004, J BIOL CHEM, V279, P38701, DOI 10.1074/jbc.M405986200; Inouye S, 2003, MOL CELL BIOL, V23, P5882, DOI 10.1128/MCB.23.16.5882-5895.2003; Izu H, 2004, BIOL REPROD, V70, P18, DOI 10.1095/biolreprod.103.020065; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; Jensen-Smith HC, 2003, CELL MOTIL CYTOSKEL, V55, P213, DOI 10.1002/cm.10122; Kallio M, 2002, EMBO J, V21, P2591, DOI 10.1093/emboj/21.11.2591; Kawakami M, 2004, EXP PHYSIOL, V89, P739, DOI 10.1113/expphysiol.2004.028670; Kobayashi Y, 2002, MOL CELL BIOL, V22, P2769, DOI 10.1128/MCB.22.8.2769-2776.2002; Liang P, 1997, J CELL SCI, V110, P1431; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Mikami A, 2002, J CELL SCI, V115, P4801, DOI 10.1242/jcs.00168; Min JN, 2004, GENESIS, V40, P205, DOI 10.1002/gene.20087; MIYATA Y, 1995, BIOCHEMISTRY-US, V34, P8123, DOI 10.1021/bi00025a019; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Nakai A, 1999, CELL STRESS CHAPERON, V4, P86, DOI 10.1379/1466-1268(1999)004<0086:NAITVH>2.3.CO;2; Nakai A, 2000, EMBO J, V19, P1545, DOI 10.1093/emboj/19.7.1545; Nakai A, 2001, EMBO J, V20, P2885, DOI 10.1093/emboj/20.11.2885; Neesen J, 2001, HUM MOL GENET, V10, P1117, DOI 10.1093/hmg/10.11.1117; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; RENTHAL R, 1993, CELL MOTIL CYTOSKEL, V25, P19, DOI 10.1002/cm.970250104; Sakamoto M, 2006, CIRC RES, V99, P1411, DOI 10.1161/01.RES.0000252345.80198.97; Santos SD, 2004, NEUROSCIENCE, V126, P657, DOI 10.1016/j.neuroscience.2004.03.023; Sapiro R, 2002, MOL CELL BIOL, V22, P6298, DOI 10.1128/MCB.22.17.6298-6305.2002; Satouh Y, 2005, MOL BIOL CELL, V16, P626, DOI 10.1091/mbc.e04-09-0784; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Stephens RE, 1999, CELL MOTIL CYTOSKEL, V44, P274, DOI 10.1002/(SICI)1097-0169(199912)44:4<274::AID-CM5>3.0.CO;2-O; STURGESS JM, 1980, NEW ENGL J MED, V303, P318, DOI 10.1056/NEJM198008073030606; Takaki E, 2006, J BIOL CHEM, V281, P4931, DOI 10.1074/jbc.M506911200; Tanabe M, 1998, EMBO J, V17, P1750, DOI 10.1093/emboj/17.6.1750; Tanabe M, 1999, J BIOL CHEM, V274, P27845, DOI 10.1074/jbc.274.39.27845; Tanaka KI, 2007, MOL PHARMACOL, V71, P985, DOI 10.1124/mol.106.033282; Vent J, 2005, J CELL SCI, V118, P4333, DOI 10.1242/jcs.02550; Wang GH, 2004, GENESIS, V38, P66, DOI 10.1002/gene.20005; Williams NE, 1997, J CELL SCI, V110, P1665; Wirth D, 2003, TOXICOL APPL PHARM, V192, P12, DOI 10.1016/S0041-008X(03)00256-4; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Yan LJ, 2002, EMBO J, V21, P5164, DOI 10.1093/emboj/cdf528; Yang C, 2005, MOL BIOL CELL, V16, P637, DOI 10.1091/mbc.E04-09-0787; Yue L, 1999, GENETICS, V151, P1065; Zheng H, 2004, J IMMUNOL, V173, P5929, DOI 10.4049/jimmunol.173.10.5929; Zou YZ, 2003, CIRCULATION, V108, P3024, DOI 10.1161/01.CIR.0000101923.54751.77	60	48	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37285	37292		10.1074/jbc.M704562200	http://dx.doi.org/10.1074/jbc.M704562200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17965413	hybrid			2022-12-25	WOS:000251646000054
J	Deng, YZ; Chen, PP; Wang, Y; Yin, D; Koeffler, HP; Li, BJ; Tong, XJ; Xie, D				Deng, Yue-Zhen; Chen, Ping-Ping; Wang, Yan; Yin, Dong; Koeffler, H. Phillip; Li, Baojie; Tong, Xiang-Jun; Xie, Dong			Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR GENE-EXPRESSION; PROGNOSTIC MARKER; FACTOR CTGF; CANCER; PROGRESSION; ACTIVATION; BINDING; KINASE; CYR61; WNT	Connective tissue growth factor (CTGF or CCN2), a member of the CCN family, is involved in diverse biological processes such as cell adhesion, proliferation, and angiogenesis. In this study, we show that overexpression of CTGF occurred in a significant proportion of esophageal squamous cell carcinoma (ESCC) samples that were of a high tumor grade and metastatic. Forced expression of CTGF in Eca109 ESCC cells accelerated their growth in culture and significantly increased tumor formation in nude mice, whereas RNA interference-mediated knockdown of CTGF in ESCC cells significantly inhibited cell growth and colony formation, as well as tumorigenicity in vivo. Moreover, overexpression of CTGF in ESCC cells resulted in the accumulation and nuclear translocation of beta-catenin, leading to activation of beta-catenin-T-cell factor (TCF)/Lef signaling. Up-regulation of c-Myc and cyclin D1, two target genes of beta-catenin-TCF/Lef signaling, was also observed in the CTGF-overexpressing cells. These effects of CTGF in ESCC cells were abolished by transfection with either dominant negative beta-catenin or dominant negative TCF4. Furthermore, we identified a beta-cateninTCF/Lef-binding site (TBE) in the promoter region of CTGF and found that CTGF is a transcriptional target of beta-cateninTCF/Lef signaling. Taken together, these results revealed that the interaction of CTGF and beta-catenin-TCF/Lef forms a positive feedback loop, which could contribute to the tumorigenicity of ESCC.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Mol Oncol Lab, Shanghai 200031, Peoples R China; Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; Zhengzhou Univ, Coll Publ Hlth, Zhengzhou 450052, Peoples R China; Univ Calif Los Angeles, Sch Med, Div Hematol Oncol, Los Angeles, CA 90048 USA; Inst Mol & Cell Biol, Singapore 138673, Singapore; Beijing Univ, Coll Life Sci, Beijing 100083, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Zhengzhou University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Peking University	Xie, D (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Mol Oncol Lab, 294 Tai-Yuan Rd, Shanghai 200031, Peoples R China.	dxie@sibs.ac.cn	Wang, Yan/G-1213-2012	Xie, Dong/0000-0002-1150-8657				BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Chang CC, 2004, JNCI-J NATL CANCER I, V96, P364, DOI 10.1093/jnci/djh059; Chapman ML, 1997, BIOPHYS J, V72, P708, DOI 10.1016/S0006-3495(97)78707-1; Clement G, 2006, ONCOGENE, V25, P3084, DOI 10.1038/sj.onc.1209338; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dornhofer N, 2006, CANCER RES, V66, P5816, DOI 10.1158/0008-5472.CAN-06-0081; Goss KJH, 1998, INT J CANCER, V78, P629; Grabowski P, 2003, BRIT J CANCER, V88, P115, DOI 10.1038/sj.bjc.6600696; Hishikawa K, 1999, J BIOL CHEM, V274, P37461, DOI 10.1074/jbc.274.52.37461; IGARASHI A, 1995, J INVEST DERMATOL, V105, P280, DOI 10.1111/1523-1747.ep12318465; Igarashi A, 1996, J INVEST DERMATOL, V106, P729, DOI 10.1111/1523-1747.ep12345771; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Ito Y, 1998, KIDNEY INT, V53, P853, DOI 10.1046/j.1523-1755.1998.00820.x; KATO J, 1993, GENE DEV, V7, P331; Kihara C, 2000, JPN J CANCER RES, V91, P190, DOI 10.1111/j.1349-7006.2000.tb00931.x; Kothapalli D, 1998, FASEB J, V12, P1151, DOI 10.1096/fasebj.12.12.1151; Leu SJ, 2003, J BIOL CHEM, V278, P33801, DOI 10.1074/jbc.M305862200; Levy L, 2002, J BIOL CHEM, V277, P42386, DOI 10.1074/jbc.M207418200; Li GM, 2006, J GENE MED, V8, P889, DOI 10.1002/jgm.894; Lin BR, 2005, GASTROENTEROLOGY, V128, P9, DOI 10.1053/j.gastro.2004.10.007; Lu SH, 2000, MUTAT RES-REV MUTAT, V462, P343, DOI 10.1016/S1383-5742(00)00023-5; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; McCabe ML, 2005, INT IMMUNOPHARMACOL, V5, P1113, DOI 10.1016/j.intimp.2004.11.017; Morales CP, 2002, LANCET, V360, P1587, DOI 10.1016/S0140-6736(02)11569-8; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MUNOZ N, 1993, ENDOSCOPY, V25, P609, DOI 10.1055/s-2007-1010415; Oemar BS, 1997, CIRCULATION, V95, P831; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Polakis P, 2000, GENE DEV, V14, P1837; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Rimerman RA, 2000, J BIOL CHEM, V275, P14736, DOI 10.1074/jbc.M910241199; Shakunaga T, 2000, CANCER, V89, P1466, DOI 10.1002/1097-0142(20001001)89:7<1466::AID-CNCR8>3.0.CO;2-G; Stoner GD, 2001, CARCINOGENESIS, V22, P1737, DOI 10.1093/carcin/22.11.1737; Suzuma K, 2000, J BIOL CHEM, V275, P40725, DOI 10.1074/jbc.M006509200; Tamatani T, 1998, BIOCHEM BIOPH RES CO, V251, P748, DOI 10.1006/bbrc.1998.9543; Wang LD, 2003, WORLD J GASTROENTERO, V9, P1156, DOI 10.3748/wjg.v9.i6.1156; Xie D, 2004, CANCER RES, V64, P1987, DOI 10.1158/0008-5472.CAN-03-0666; Xie D, 2004, CLIN CANCER RES, V10, P2072, DOI 10.1158/1078-0432.CCR-0659-03; Xie D, 2001, CANCER RES, V61, P8917; Xing EP, 1999, CARCINOGENESIS, V20, P77, DOI 10.1093/carcin/20.1.77; Xing EP, 1999, CLIN CANCER RES, V5, P1231; Xu LF, 2000, GENE DEV, V14, P585; Yang F, 2005, CANCER RES, V65, P8887, DOI 10.1158/0008-5472.CAN-05-1702	46	108	119	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36571	36581		10.1074/jbc.M704141200	http://dx.doi.org/10.1074/jbc.M704141200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17951630	hybrid			2022-12-25	WOS:000251458300050
J	Mellgren, RL; Huang, XH				Mellgren, Ronald L.; Huang, Xinhua			Fetuin A stabilizes m-calpain and facilitates plasma membrane repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBOTIC THROMBOCYTOPENIC PURPURA; CALCIUM-DEPENDENT PROTEASE; GIRDLE MUSCULAR-DYSTROPHY; MEDIATES PROGRESSION; CRYSTAL-STRUCTURE; LIVER-INJURY; C2 DOMAINS; SERUM; CELLS; VESICLES	Yeast two-hybrid experiments identified alpha(2)-Heremans-Schmid glycoprotein (human fetuin A) as a binding partner for calpain domain III (DIII). The tandem DIIIs of calpain-10 interacted under the most selective culture conditions, but DIIIs of m-calpain, calpain-3, and calpain-5 also interacted under less stringent selection. DIIIs of mu-calpain, calpain-6, and the tandem DIII-like domains of the Dictyostelium Cpl protein did not interact with alpha(2)-Heremans-Schmid glycoprotein in the yeast two-hybrid system. Bovine fetuin A stabilized proteolytic activity of purified m-calpain incubated in the presence of mM calcium chloride and prevented calcium-dependent m-calpain aggregation. Consistent with the yeast two-hybrid studies, fetuin A neither stabilized mu-calpain nor prevented its aggregation. Confocal immunofluorescence microscopy of scratch-damaged L6 myotubes demonstrated accumulation of m-calpain at the wound site in association with the membrane repair protein, dysferlin. m-Calpain also co-localized with fluorescein-labeled fetuin A at the wound site. The effect of fetuin A on calpain-mediated plasma membrane resealing was investigated using fibroblasts from Capns1(-/-) and Capns1(+/+) mouse embryos. Capns1 encodes the small noncatalytic subunit that is required for the proteolytic function of m- and mu-calpains. Thus, Capns1(-/-) fibroblasts do not express these calpains in active form. Fetuin A increased resealing of scrape-damaged wild-type fibroblasts but not Capns1(-/-) fibroblasts. These studies identify fetuin A as a potential extracellular regulator of m-calpain at nascent sites of plasma membrane wounding.	Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA	University System of Ohio; University of Toledo	Mellgren, RL (corresponding author), Univ Toledo, Coll Med, Dept Physiol & Pharmacol, 3000 Arlington Ave, Toledo, OH 43614 USA.	ronald.mellgren@utoledo.edu						Ardoin SP, 2007, SCAND J IMMUNOL, V66, P159, DOI 10.1111/j.1365-3083.2007.01984.x; Bai JH, 2004, TRENDS BIOCHEM SCI, V29, P143, DOI 10.1016/j.tibs.2004.01.008; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; BRADFORD HN, 1993, J BIOL CHEM, V268, P26546; BROWN WM, 1992, BIOESSAYS, V14, P749, DOI 10.1002/bies.950141105; Cartellieri S, 2002, BIOTECHNOL APPL BIOC, V35, P83, DOI 10.1042/BA20010067; COOLICAN SA, 1986, J BIOL CHEM, V261, P4170; CRESSIE NAC, 1981, BIOMETRICS, V37, P235, DOI 10.2307/2530414; Dourdin N, 1999, EXP CELL RES, V246, P433, DOI 10.1006/excr.1998.4325; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Frangie C, 2006, J BIOL CHEM, V281, P26624, DOI 10.1074/jbc.M603007200; Furlan M, 2001, BEST PRACT RES CL HA, V14, P437, DOI 10.1053/beha.2001.0142; Galvez AS, 2007, CIRC RES, V100, P1071, DOI 10.1161/01.RES.0000261938.28365.11; Ginestra A, 1998, ANTICANCER RES, V18, P3433; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Godell CM, 1997, P NATL ACAD SCI USA, V94, P4751, DOI 10.1073/pnas.94.9.4751; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; HARLOW E, 1999, USING ANTIBODIES LAB, P85; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Huang XH, 2003, BIOCHEMISTRY-US, V42, P1789, DOI 10.1021/bi026461+; Jia ZC, 2001, BIOPHYS J, V80, P2590, DOI 10.1016/S0006-3495(01)76229-7; Kazi JA, 1998, J BIOCHEM-TOKYO, V124, P179, DOI 10.1093/oxfordjournals.jbchem.a022077; Klinge L, 2007, FASEB J, V21, P1768, DOI 10.1096/fj.06-7659com; LEE TL, 1993, J CELL SCI, V105, P167; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Limaye PB, 2003, TOXICOL APPL PHARM, V191, P211, DOI 10.1016/S0041-008X(03)00250-3; Liu XL, 2004, ANNU REV PHARMACOL, V44, P349, DOI 10.1146/annurev.pharmtox.44.101802.121804; MAKI M, 1987, FEBS LETT, V223, P174, DOI 10.1016/0014-5793(87)80531-8; Mathews ST, 1997, LIFE SCI, V61, P1583, DOI 10.1016/S0024-3205(97)00737-6; Matsumura Y, 2001, J MOL CELL CARDIOL, V33, P1133, DOI 10.1006/jmcc.2001.1373; Mehendale HM, 2005, TRENDS PHARMACOL SCI, V26, P232, DOI 10.1016/j.tips.2005.03.008; MELLGREN RL, 1982, J BIOL CHEM, V257, P7203; MELLGREN RL, 1989, RBC-CELL BIOL REV, V20, P139; MELLGREN RL, 1987, FASEB J, V1, P110, DOI 10.1096/fasebj.1.2.2886390; MELLGREN RL, 1991, J BIOL CHEM, V266, P13920; MELLGREN RL, 1986, ARCH BIOCHEM BIOPHYS, V246, P233, DOI 10.1016/0003-9861(86)90468-6; Mellgren RL, 2007, J BIOL CHEM, V282, P2567, DOI 10.1074/jbc.M604560200; Moldoveanu T, 2003, NAT STRUCT BIOL, V10, P371, DOI 10.1038/nsb917; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nalefski EA, 2001, BIOCHEMISTRY-US, V40, P3089, DOI 10.1021/bi001968a; Niapour M, 2007, CYTOM PART A, V71A, P475, DOI 10.1002/cyto.a.20399; Ono Y, 1999, CALPAIN PHARM TOXICO, P1; Osawa M, 2005, HUM GENET, V116, P146, DOI 10.1007/s00439-004-1222-7; Pal GP, 2003, STRUCTURE, V11, P1521, DOI 10.1016/j.str.2003.11.007; Pal GP, 2001, J BIOL CHEM, V276, P47233, DOI 10.1074/jbc.M105149200; Patchell BJ, 2006, CLIN EXP ALLERGY, V36, P585, DOI 10.1111/j.1365-2222.2006.02394.x; Pavord S, 1997, BRIT J HAEMATOL, V97, P762, DOI 10.1046/j.1365-2141.1997.1282947.x; Ray S, 2003, BBA-PROTEINS PROTEOM, V1652, P91, DOI 10.1016/j.bbapap.2003.08.004; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; SANDBERG H, 1985, THROMB RES, V39, P63, DOI 10.1016/0049-3848(85)90122-7; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; Schote U, 1998, BBA-BIOMEMBRANES, V1415, P135, DOI 10.1016/S0005-2736(98)00188-6; Taverna S, 2003, J BIOL CHEM, V278, P51911, DOI 10.1074/jbc.M304192200; Townsend DeWayne, 2007, Expert Rev Cardiovasc Ther, V5, P99, DOI 10.1586/14779072.5.1.99; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Xiao Z, 2007, J CELL PHYSIOL, V210, P325, DOI 10.1002/jcp.20826; XIE XY, 1991, J NEUROSCI, V11, P3257; YAMAMOTO S, 1992, ARTHRITIS RHEUM-US, V35, P1309, DOI 10.1002/art.1780351111	59	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35868	35877		10.1074/jbc.M706929200	http://dx.doi.org/10.1074/jbc.M706929200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17942392	hybrid			2022-12-25	WOS:000251458100048
J	Miraucourt, LS; Dallel, R; Voisin, DL				Miraucourt, Lois S.; Dallel, Radhouane; Voisin, Daniel L.			Glycine Inhibitory Dysfunction Turns Touch into Pain through PKCgamma Interneurons	PLOS ONE			English	Article							PROTEIN-KINASE-C; SUPERFICIAL DORSAL-HORN; TRIGEMINAL NUCLEUS ORALIS; SUBSTANTIA-GELATINOSA NEURONS; SPINAL-CORD; NEUROPATHIC PAIN; NMDA RECEPTOR; SOMATOSENSORY THALAMUS; CENTRAL SENSITIZATION; CONVERGENT NEURONS	Dynamic mechanical allodynia is a widespread and intractable symptom of neuropathic pain for which there is a lack of effective therapy. During tactile allodynia, activation of the sensory fibers which normally detect touch elicits pain. Here we provide a new behavioral investigation into the dynamic component of tactile allodynia that developed in rats after segmental removal of glycine inhibition. Using in vivo electrophysiological recordings, we show that in this condition innocuous mechanical stimuli could activate superficial dorsal horn nociceptive specific neurons. These neurons do not normally respond to touch. We anatomically show that the activation was mediated through a local circuit involving neurons expressing the gamma isoform of protein kinase C (PKC gamma). Selective inhibition of PKC gamma as well as selective blockade of glutamate NMDA receptors in the superficial dorsal horn prevented both activation of the circuit and allodynia. Thus, our data demonstrates that a normally inactive circuit in the dorsal horn can be recruited to convert touch into pain. It also provides evidence that glycine inhibitory dysfunction gates tactile input to nociceptive specific neurons through PKC gamma-dependent activation of a local, excitatory, NMDA receptor-dependent, circuit. As a consequence of these findings, we suggest that pharmacological inhibition of PKC gamma might provide a new tool for alleviating allodynia in the clinical setting.	[Miraucourt, Lois S.; Dallel, Radhouane; Voisin, Daniel L.] INSERM, E216, F-63000 Clermont Ferrand, France; [Miraucourt, Lois S.; Dallel, Radhouane; Voisin, Daniel L.] CHU Clermont Ferrand, F-63000 Clermont Ferrand, France; [Miraucourt, Lois S.; Dallel, Radhouane; Voisin, Daniel L.] Univ Auvergne Clermont1, F-63000 Clermont Ferrand, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Clermont Ferrand	Dallel, R (corresponding author), INSERM, E216, F-63000 Clermont Ferrand, France.	radhouane.dallel@u-clermont1.fr; daniel.voisin@bordeaux.inserm.fr	Dallel, Radhouane/W-4599-2017	Dallel, Radhouane/0000-0001-7494-116X	INSERM; MENESR; Universite d'Auvergne-Clermont1 (France)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); MENESR; Universite d'Auvergne-Clermont1 (France)	This work was supported by funding from INSERM, MENESR, and Universite d'Auvergne-Clermont1 (France).	Ahmadi S, 2002, NAT NEUROSCI, V5, P34, DOI 10.1038/nn778; AZERAD J, 1982, BRAIN RES, V246, P7, DOI 10.1016/0006-8993(82)90137-8; Baron R, 2006, NAT CLIN PRACT NEURO, V2, P95, DOI 10.1038/ncpneuro0113; Bester H, 2000, J COMP NEUROL, V428, P45, DOI 10.1002/1096-9861(20001204)428:1<45::AID-CNE5>3.0.CO;2-A; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; CAMPBELL JN, 1988, PAIN, V32, P89, DOI 10.1016/0304-3959(88)90027-9; CASTROLOPES JM, 1993, BRAIN RES, V620, P287, DOI 10.1016/0006-8993(93)90167-L; Catheline G, 1999, PAIN, V80, P347, DOI 10.1016/S0304-3959(98)00234-6; Chen L, 2001, CHEM BIOL, V8, P1123, DOI 10.1016/S1074-5521(01)00076-X; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Dahlhaus A, 2005, J PHYSIOL-LONDON, V566, P355, DOI 10.1113/jphysiol.2005.088567; Dallel R, 1996, EUR J PHARMACOL, V314, P19, DOI 10.1016/S0014-2999(96)00480-3; Dallel R, 1998, J NEUROSCI, V18, P3529; Dallel R, 2004, J COMP NEUROL, V470, P181, DOI 10.1002/cne.11043; DALLEL R, 1990, BRAIN RES, V521, P95, DOI 10.1016/0006-8993(90)91529-P; Dallel R, 1999, EUR J NEUROSCI, V11, P31, DOI 10.1046/j.1460-9568.1999.00404.x; DAVIES J, 1981, NEUROSCI LETT, V21, P77, DOI 10.1016/0304-3940(81)90061-6; De Chazeron I, 2004, NEUROSCIENCE, V127, P921, DOI 10.1016/j.neuroscience.2004.06.005; Dorn GW, 2002, ANNU REV PHYSIOL, V64, P407, DOI 10.1146/annurev.physiol.64.081501.155903; DUBNER R, 1983, ANNU REV NEUROSCI, V6, P381, DOI 10.1146/annurev.ne.06.030183.002121; FEIL K, 1995, J COMP NEUROL, V353, P506, DOI 10.1002/cne.903530404; FROMM GH, 1993, APS J, V2, P1; Gauriau C, 2002, EXP PHYSIOL, V87, P251, DOI 10.1113/eph8702357; Guy N, 2005, EUR J NEUROSCI, V21, P741, DOI 10.1111/j.1460-9568.2005.03918.x; Harris JA, 1998, BRAIN RES BULL, V45, P1, DOI 10.1016/S0361-9230(97)00277-3; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; HU JW, 1992, PAIN, V48, P53, DOI 10.1016/0304-3959(92)90131-T; Hu JW, 1999, ARCH ORAL BIOL, V44, P287, DOI 10.1016/S0003-9969(98)00111-3; Hughes DI, 2003, J NEUROSCI, V23, P9491; Ikeda H, 2006, SCIENCE, V312, P1659, DOI 10.1126/science.1127233; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Jensen TS, 2003, PAIN, V102, P1, DOI 10.1016/S0304-3959(03)00006-X; KOLTZENBURG M, 1994, BRAIN, V117, P579, DOI 10.1093/brain/117.3.579; KUMAZAWA T, 1978, J COMP NEUROL, V177, P417, DOI 10.1002/cne.901770305; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Li HF, 2005, BRIT J PHARMACOL, V144, P301, DOI 10.1038/sj.bjp.0706033; LIGHT AR, 1979, J COMP NEUROL, V186, P133, DOI 10.1002/cne.901860203; Liu Q, 2007, NAT NEUROSCI, V10, P946, DOI 10.1038/nn1937; Lu Y, 2005, J NEUROSCI, V25, P3900, DOI 10.1523/JNEUROSCI.0102-05.2005; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Ma WY, 2001, PAIN, V93, P295, DOI 10.1016/S0304-3959(01)00335-9; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; MAO JR, 1995, NEUROSCI LETT, V198, P75, DOI 10.1016/0304-3940(95)11975-3; Martin WJ, 2001, J NEUROSCI, V21, P5321, DOI 10.1523/JNEUROSCI.21-14-05321.2001; Meyer RA, 2006, WALL MELZACKS TXB PA, V5, P3; MITCHELL K, 1993, J NEUROSCI, V13, P2371, DOI 10.1523/JNEUROSCI.13-06-02371.1993; Mochly-Rosen D, 1998, FASEB J, V12, P35; Moore KA, 2002, J NEUROSCI, V22, P6724, DOI 10.1523/jneurosci.22-15-06724.2002; Narikawa K, 2000, J NEUROPHYSIOL, V84, P2171, DOI 10.1152/jn.2000.84.4.2171; OCHOA JL, 1993, ANN NEUROL, V33, P465, DOI 10.1002/ana.410330509; Onaka M, 1996, ANESTHESIOLOGY, V84, P1215, DOI 10.1097/00000542-199605000-00024; Park SJ, 2001, J NEUROPHYSIOL, V85, P1836, DOI 10.1152/jn.2001.85.5.1836; PAXINOS G, 1997, RAT BRAIN STEREOTAXI, P266; PERPER JA, 1985, J FORENSIC SCI, V30, P1248; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; Polgar E, 1999, BRAIN RES, V833, P71, DOI 10.1016/S0006-8993(99)01500-0; RABOISSON P, 1995, J NEUROPHYSIOL, V73, P496, DOI 10.1152/jn.1995.73.2.496; Sakai N, 2004, GENES CELLS, V9, P945, DOI 10.1111/j.1365-2443.2004.00779.x; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; Seagrove LC, 2004, PAIN, V108, P76, DOI 10.1016/j.pain.2003.12.004; Sessle BJ, 2000, CRIT REV ORAL BIOL M, V11, P57, DOI 10.1177/10454411000110010401; SHERMAN SE, 1994, PAIN, V56, P17, DOI 10.1016/0304-3959(94)90146-5; Shumilla JA, 2005, J PAIN, V6, P535, DOI 10.1016/j.jpain.2005.03.005; Simpson RK, 1998, NEUROL RES, V20, P161; Sorkin LS, 1996, PAIN, V68, P283, DOI 10.1016/S0304-3959(96)03130-2; South SM, 2003, J NEUROSCI, V23, P5031; SUGIURA Y, 1986, SCIENCE, V234, P358, DOI 10.1126/science.3764416; Sweitzer SM, 2004, PAIN, V110, P281, DOI 10.1016/j.pain.2004.04.004; Sweitzer SM, 2004, J PHARMACOL EXP THER, V309, P616, DOI 10.1124/jpet.103.060350; Todd A. J., 2006, WALL MELZACKS TXB PA, P73; Torsney C, 2006, J NEUROSCI, V26, P1833, DOI 10.1523/JNEUROSCI.4584-05.2006; Vanegas H, 2004, BRAIN RES REV, V46, P295, DOI 10.1016/j.brainresrev.2004.07.004; Voisin DL, 2005, J PHYSIOL-LONDON, V566, P929, DOI 10.1113/jphysiol.2005.086520; VOS BP, 1994, J NEUROSCI, V14, P2708; Weng HR, 2002, EXP NEUROL, V175, P209, DOI 10.1006/exnr.2002.7886; Wiesenfeld-Hallin Z, 1997, BEHAV BRAIN SCI, V20, P420, DOI 10.1017/S0140525X97261480; WILLIS WD, 1993, APS J, V2, P23; Woda A, 2004, EUR J NEUROSCI, V19, P2009, DOI 10.1111/j.0953-816X.2004.03328.x; Woda A, 2001, NEUROSCIENCE, V107, P317, DOI 10.1016/S0306-4522(01)00359-1; Woolf CJ, 1998, PAIN, V77, P227, DOI 10.1016/S0304-3959(98)00099-2; WOOLF CJ, 1987, J COMP NEUROL, V261, P105, DOI 10.1002/cne.902610109; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; WOOLF CJ, 2006, WALL MELZACKS TXB PA, P91; YAKSH TL, 1989, PAIN, V37, P111, DOI 10.1016/0304-3959(89)90160-7; Yamamura H, 1999, J NEUROPHYSIOL, V81, P479, DOI 10.1152/jn.1999.81.2.479; ZAKRZEWSKA JM, 2006, CLIN EVID, V15, P1827; Zheng X, 1999, P NATL ACAD SCI USA, V96, P15262, DOI 10.1073/pnas.96.26.15262; Zou XJ, 2004, BRAIN RES, V1020, P95, DOI 10.1016/j.brainres.2004.06.017	89	134	135	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1116	10.1371/journal.pone.0001116	http://dx.doi.org/10.1371/journal.pone.0001116			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987109	Green Submitted, gold, Green Published			2022-12-25	WOS:000207459000004
J	Peckham, SH; Diaz, DM; Walli, A; Ruiz, G; Crowder, LB; Nichols, WJ				Peckham, S. Hoyt; Maldonado Diaz, David; Walli, Andreas; Ruiz, Georgita; Crowder, Larry B.; Nichols, Wallace J.			Small-Scale Fisheries Bycatch Jeopardizes Endangered Pacific Loggerhead Turtles	PLOS ONE			English	Article							SEA-TURTLES; CARETTA-CARETTA; MIGRATION; STRANDINGS; INCENTIVES; MORTALITY; IMPACTS; HABITAT	Background. Although bycatch of industrial-scale fisheries can cause declines in migratory megafauna including seabirds, marine mammals, and sea turtles, the impacts of small-scale fisheries have been largely overlooked. Small-scale fisheries occur in coastal waters worldwide, employing over 99% of the world's 51 million fishers. New telemetry data reveal that migratory megafauna frequent coastal habitats well within the range of small-scale fisheries, potentially producing high bycatch. These fisheries occur primarily in developing nations, and their documentation and management are limited or non-existent, precluding evaluation of their impacts on non-target megafauna. Principal Findings/Methodology. 30 North Pacific loggerhead turtles that we satellite-tracked from 1996-2005 ranged oceanwide, but juveniles spent 70% of their time at a high use area coincident with small-scale fisheries in Baja California Sur, Mexico (BCS). We assessed loggerhead bycatch mortality in this area by partnering with local fishers to 1) observe two small-scale fleets that operated closest to the high use area and 2) through shoreline surveys for discarded carcasses. Minimum annual bycatch mortality in just these two fleets at the high use area exceeded 1000 loggerheads year(-1), rivaling that of oceanwide industrial-scale fisheries, and threatening the persistence of this critically endangered population. As a result of fisher participation in this study and a bycatch awareness campaign, a consortium of local fishers and other citizens are working to eliminate their bycatch and to establish a national loggerhead refuge. Conclusions/Significance.. Because of the overlap of ubiquitous small-scale fisheries with newly documented high-use areas in coastal waters worldwide, our case study suggests that small-scale fisheries may be among the greatest current threats to non-target megafauna. Future research is urgently needed to quantify small-scale fisheries bycatch worldwide. Localizing coastal high use areas and mitigating bycatch in partnership with small-scale fishers may provide a crucial solution toward ensuring the persistence of vulnerable megafauna.	[Peckham, S. Hoyt] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Peckham, S. Hoyt; Maldonado Diaz, David] Grp Tortuguero AC, La Paz, Baja Calif Sur, Mexico; [Walli, Andreas] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Crowder, Larry B.] Duke Univ, Ctr Marine Conservat, Nicholas Sch Environm & Earth Sci, Beaufort, NC USA; [Nichols, Wallace J.] Calif Acad Sci, San Francisco, CA 94118 USA; [Nichols, Wallace J.] Ocean Conservancy, Davenport, CA USA	University of California System; University of California Santa Cruz; Stanford University; Duke University; California Academy of Sciences	Peckham, SH (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	hoyt@biology.ucsc.edu			David and Lucile Packard Foundation; USFWS; NMFS-SWFSC; Western Pacific Fisheries Management Council; Project GLOBAL; Gordon and Betty Moore Foundation; PADI Foundation; TE Foundation; Wallace Research Foundation; School for Field Studies; Earthwatch Institute; ONR/National Oceanographic Partnership Program; Ocean Conservancy; ProPeninsula; Fulbright and Marshall Fellowships; CILS-NSF; UCMEXUS	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); USFWS(US Fish & Wildlife Service); NMFS-SWFSC; Western Pacific Fisheries Management Council; Project GLOBAL; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); PADI Foundation; TE Foundation; Wallace Research Foundation; School for Field Studies; Earthwatch Institute; ONR/National Oceanographic Partnership Program(Office of Naval Research); Ocean Conservancy; ProPeninsula; Fulbright and Marshall Fellowships; CILS-NSF; UCMEXUS	This work was supported by the David and Lucile Packard Foundation, USFWS, NMFS-SWFSC, Western Pacific Fisheries Management Council, Project GLOBAL, Gordon and Betty Moore Foundation, PADI Foundation, T&E Foundation, Wallace Research Foundation, School for Field Studies, Earthwatch Institute, ONR/National Oceanographic Partnership Program, Ocean Conservancy and ProPeninsula. WJN was supported by Fulbright and Marshall Fellowships. SHP was supported with CILS-NSF, Project Global and UCMEXUS graduate fellowships and awards.	Berkes F., 2001, MANAGING SMALL SCALE; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; BOWEN BW, 1995, P NATL ACAD SCI USA, V92, P3731, DOI 10.1073/pnas.92.9.3731; CROUSE DT, 1987, ECOLOGY, V68, P1412, DOI 10.2307/1939225; CROWDER LB, 1994, ECOL APPL, V4, P437, DOI 10.2307/1941948; DELGADO SG, 2004, MARITIME STUDIES, V4, P89; Epperly SP, 1996, B MAR SCI, V59, P289; Hart KM, 2006, BIOL CONSERV, V129, P283, DOI 10.1016/j.biocon.2005.10.047; Heppell Selina S., 2005, P211; Hilborn R, 2005, PHILOS T R SOC B, V360, P47, DOI 10.1098/rstb.2004.1569; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 2007, ECOL RES, V22, P16, DOI 10.1007/s11284-006-0075-z; Jacobson S.K., 1999, COMMUNICATION SKILLS; James MC, 2005, ECOL LETT, V8, P195, DOI 10.1111/j.1461-0248.2004.00710.x; KAMEZAKI N., 2003, LOGGERHEAD SEA TURTL, P210; Koch V, 2006, BIOL CONSERV, V128, P327, DOI 10.1016/j.biocon.2005.09.038; Lewison RL, 2007, CONSERV BIOL, V21, P79, DOI 10.1111/j.1523-1739.2006.00592.x; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Lewison RL, 2004, ECOL LETT, V7, P221, DOI 10.1111/j.1461-0248.2004.00573.x; MACKENZIEMOHR J, 1999, FOSTERING SUSTAINABL; MANGEL M, 1993, ECOL APPL, V3, P221, DOI 10.2307/1941825; McClanahan TR, 2006, CURR BIOL, V16, P1408, DOI 10.1016/j.cub.2006.05.062; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Nichols WJ, 2000, B MAR SCI, V67, P937; NICHOLS WJ, 2004, CONSERVATION PRACTIC, V5, P30; NICHOLS WJ, 2003, BIOL CONSERVATION SE, P1; Panayotou T, 1982, MANAGEMENT CONCEPTS; Pauly D., 2006, MAR STUD MAST, V4, P7, DOI DOI 10.1126/SCIENCE.279.5352.860.PMID:9452385; PECKHAM SH, BY CATCH RE IN PRESS; Polovina J, 2006, DEEP-SEA RES PT II, V53, P326, DOI 10.1016/j.dsr2.2006.01.006; Polovina JJ, 2004, FISH OCEANOGR, V13, P36, DOI 10.1046/j.1365-2419.2003.00270.x; Read AJ, 2006, CONSERV BIOL, V20, P163, DOI 10.1111/j.1523-1739.2006.00338.x; Sala E, 2004, FISHERIES, V29, P19, DOI 10.1577/1548-8446(2004)29[19:FDCFWI]2.0.CO;2; SERVICE NMF, 2004, ENDANGERED SPECIES A; SILVERMAN BW, 1986, DENSITY ANAL STAT DE; Spotila JR, 2000, NATURE, V405, P529, DOI 10.1038/35014729; Tasker ML, 2000, ICES J MAR SCI, V57, P531, DOI 10.1006/jmsc.2000.0714; WETHERALL JA, 1993, INPFC S BIOL DISTR S, P519; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	40	160	184	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1041	10.1371/journal.pone.0001041	http://dx.doi.org/10.1371/journal.pone.0001041			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940605	Green Published, gold			2022-12-25	WOS:000207456100009
J	Endo, Y; Sakai, R; Ouchi, M; Onimatsu, H; Hioki, M; Kagawa, S; Uno, F; Watanabe, Y; Urata, Y; Tanaka, N; Fujiwara, T				Endo, Y.; Sakai, R.; Ouchi, M.; Onimatsu, H.; Hioki, M.; Kagawa, S.; Uno, F.; Watanabe, Y.; Urata, Y.; Tanaka, N.; Fujiwara, T.			Virus-mediated oncolysis induces danger signal and stimulates cytotoxic T-lymphocyte activity via proteasome activator upregulation	ONCOGENE			English	Article						adenovirus; telomerase; dendritic cell; uric acid; danger signal	DENDRITIC CELLS; URIC-ACID; CANCER; PA28	Dendritic cells ( DCs) are the most potent antigen-presenting cells and acquire cellular antigens and danger signals from dying cells to initiate antitumor immune responses via direct cell- to- cell interaction and cytokine production. The optimal forms of tumor cell death for priming DCs for the release of danger signals are not fully understood. OBP- 301 ( Telomelysin) is a telomerase-specific replication- competent adenovirus that induces selective E1 expression and exclusively kills human cancer cells. Here, we show that OBP- 301 replication produced the endogenous danger signaling molecule, uric acid, in infected human tumor cells, which in turn stimulated DCs to produce interferon-gamma ( IFN-gamma) and interleukin 12 ( IL- 12). Subsequently, IFN-gamma release upregulated the endogenous expression of the proteasome activator PA28 in tumor cells and resulted in the induction of cytotoxic T- lymphocytes. Our data suggest that virus- mediated oncolysis might be the effective stimulus for immature DCs to induce specific activity against human cancer cells.	[Endo, Y.; Sakai, R.; Hioki, M.; Kagawa, S.; Uno, F.; Fujiwara, T.] Okayama Univ Hosp, Ctr Gene & Cell Therapy, Okayama 7008558, Japan; [Endo, Y.; Sakai, R.; Hioki, M.; Kagawa, S.; Uno, F.; Tanaka, N.; Fujiwara, T.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg, Div Surg Oncol, Okayama, Japan; [Ouchi, M.; Onimatsu, H.; Watanabe, Y.; Urata, Y.] Oncolys BioPharma Inc, Tokyo, Japan	Okayama University; Okayama University; Oncolys BioPharma	Fujiwara, T (corresponding author), Okayama Univ Hosp, Ctr Gene & Cell Therapy, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	toshi_f@md.okayama-u.ac.jp	Kagawa, Shunsuke/B-2189-2011	Kagawa, Shunsuke/0000-0002-3610-8211				Aliberti J, 2003, J IMMUNOL, V170, P5349, DOI 10.4049/jimmunol.170.11.5349; Bartholomae WC, 2004, J IMMUNOL, V173, P1012, DOI 10.4049/jimmunol.173.2.1012; Glantzounis GK, 2005, CURR PHARM DESIGN, V11, P4145, DOI 10.2174/138161205774913255; Ho LJ, 2001, J IMMUNOL, V166, P1499, DOI 10.4049/jimmunol.166.3.1499; Hu DE, 2004, CANCER RES, V64, P5059, DOI 10.1158/0008-5472.CAN-04-1586; Kawashima T, 2004, CLIN CANCER RES, V10, P285, DOI 10.1158/1078-0432.CCR-1075-3; Lenaerts L, 2006, ANTIVIR RES, V71, P172, DOI 10.1016/j.antiviral.2006.04.007; LINDENMANN J, 1967, J EXP MED, V126, P93, DOI 10.1084/jem.126.1.93; Manjili MH, 2005, IMMUNOBIOLOGY, V210, P295, DOI 10.1016/j.imbio.2005.04.002; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Sijts A, 2002, MOL IMMUNOL, V39, P165, DOI 10.1016/S0161-5890(02)00099-8; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Sun Y, 2002, CANCER RES, V62, P2875; Taki M, 2005, ONCOGENE, V24, P3130, DOI 10.1038/sj.onc.1208460; Umeoka T, 2004, CANCER RES, V64, P6259, DOI 10.1158/0008-5472.CAN-04-1335; Watanabe T, 2006, EXP CELL RES, V312, P256, DOI 10.1016/j.yexcr.2005.10.026	16	72	77	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2008	27	17					2375	2381		10.1038/sj.onc.1210884	http://dx.doi.org/10.1038/sj.onc.1210884			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286KN	17982491	Green Submitted			2022-12-25	WOS:000254844900002
J	Fazel, SS; Chen, L; Angoulvant, D; Li, SH; Weisel, RD; Keating, A; Li, RK				Fazel, Shafie S.; Chen, Liwen; Angoulvant, Denis; Li, Shu-Hong; Weisel, Richard D.; Keating, Armand; Li, Ren-Ke			Activation of c-kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury	FASEB JOURNAL			English	Article						myocardial infarction; heart failure; stem cells; cell signaling	ACUTE MYOCARDIAL-INFARCTION; COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM-CELLS; THERAPEUTIC ANGIOGENESIS; INFLAMMATORY RESPONSE; ENDOTHELIAL-CELLS; TISSUE INHIBITORS; CLINICAL-TRIAL; HEART-FAILURE; EXPRESSION	Cardiovascular disease is the number-one cause of mortality in the developed world. The aim of this study is to define the mechanisms by which bone marrow progenitor cells are mobilized in response to cardiac ischemic injury. We used a closed-chest model of murine cardiac infarction/reperfusion, which segregated the surgical thoracotomy from the induction of cardiac infarction, so that we could study isolated fluctuations in cytokines without the confounding impact of surgery. We show here that bone marrow activation of the c-kit tyrosine kinase receptor in response to released soluble KitL is necessary for bone marrow progenitor cell mobilization after ischemic cardiac injury. We also show that release of KitL and c-kit activation require the activity of matrix metalloproteinase-9 within the bone marrow compartment. Finally, we demonstrate that mice with c-kit dysfunction develop cardiac failure after myocardial infarction and that bone marrow transplantation rescues the failing cardiac phenotype. In light of the ongoing trials of progenitor cell therapy for heart disease, our study outlines the endogenous repair mechanisms that are invoked after cardiac injury. Amplification of this pathway may aid in restoration of cardiac function after myocardial infaretion.-Fazel, S. S., Chen, L., Angoulvant, D., Li, S. H., Weisel, R. D., Keating, A., Li, R. K. Activation of c-kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury.	[Fazel, Shafie S.; Chen, Liwen; Angoulvant, Denis; Li, Shu-Hong; Weisel, Richard D.; Li, Ren-Ke] Univ Toronto, Toronto Gen Hosp, MaRS Ctr,Dept Surg, Res Inst,Div Cardiac Surg, Toronto, ON M5G 1L7, Canada; [Keating, Armand] Univ Toronto, Univ Hlth Network, Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Li, RK (corresponding author), Univ Toronto, Toronto Gen Hosp, MaRS Ctr,Dept Surg, Res Inst,Div Cardiac Surg, Toronto Med Discovery Tower,Rm 3-702,101 Coll St, Toronto, ON M5G 1L7, Canada.	renkeli@uhnres.utoronto.ca	angoulvant, denis/A-6239-2009; Angoulvant, Denis/Q-9743-2019	Angoulvant, Denis/0000-0003-0788-8092; Li, Ren-Ke/0000-0002-2584-060X				Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Ayach BB, 2006, P NATL ACAD SCI USA, V103, P2304, DOI 10.1073/pnas.0510997103; Badorff C, 2003, CIRCULATION, V107, P1024, DOI 10.1161/01.CIR.0000051460.85800.BB; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; Broudy VC, 1996, BLOOD, V88, P75; Bubnic SJ, 2002, BONE MARROW TRANSPL, V30, P867, DOI 10.1038/sj.bmt.1703761; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; Dewald O, 2004, AM J PATHOL, V164, P665, DOI 10.1016/S0002-9440(10)63154-9; Dewald O, 2003, P NATL ACAD SCI USA, V100, P2700, DOI 10.1073/pnas.0438035100; Fazel S, 2005, ANN THORAC SURG, V79, pS2238, DOI 10.1016/j.athoracsur.2005.02.085; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Frangogiannis NG, 1998, CIRCULATION, V98, P687, DOI 10.1161/01.CIR.98.7.687; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Heissig B, 2005, J EXP MED, V202, P739, DOI 10.1084/jem.20050959; Heissig B, 2003, THROMB HAEMOSTASIS, V90, P570, DOI 10.1160/TH03-03-0188; Irwin MW, 1999, CIRCULATION, V99, P1492, DOI 10.1161/01.CIR.99.11.1492; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Kajstura J, 2005, CIRC RES, V96, P127, DOI 10.1161/01.RES.0000151843.79801.60; Kang HJ, 2004, LANCET, V363, P751, DOI 10.1016/S0140-6736(04)15689-4; Kuhlmann MT, 2006, J EXP MED, V203, P87, DOI 10.1084/jem.20051151; Lehrke S, 2006, CIRC RES, V99, P553, DOI 10.1161/01.RES.0000238375.88582.d8; Li TS, 2005, CARDIOVASC RES, V65, P64, DOI 10.1016/j.cardiores.2004.08.019; Li TS, 2003, AM J PHYSIOL-HEART C, V285, pH931, DOI 10.1152/ajpheart.01146.2002; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Lyman SD, 1998, BLOOD, V91, P1101, DOI 10.1182/blood.V91.4.1101; Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999; Massa M, 2005, BLOOD, V105, P199, DOI 10.1182/blood-2004-05-1831; Matsui J, 2004, J BIOL CHEM, V279, P18600, DOI 10.1074/jbc.M311643200; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; Miyamoto T, 1997, ATHEROSCLEROSIS, V129, P207, DOI 10.1016/S0021-9150(96)06043-1; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pollick C, 1995, J Am Soc Echocardiogr, V8, P602, DOI 10.1016/S0894-7317(05)80373-6; Rafii S, 2002, SEMIN CELL DEV BIOL, V13, P61, DOI 10.1006/scdb.2001.0285; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Rouet-Benzineb P, 1999, EUR J HEART FAIL, V1, P337, DOI 10.1016/S1388-9842(99)00048-3; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Sheng T, 2005, CIRCULATION, V111, P2438, DOI 10.1161/01.CIR.0000167553.49133.81; Smith MA, 2001, BLOOD REV, V15, P191, DOI 10.1054/blre.2001.0167; Spinale FG, 1998, CIRC RES, V82, P482, DOI 10.1161/01.RES.82.4.482; Starckx S, 2002, LEUKEMIA LYMPHOMA, V43, P233, DOI 10.1080/10428190290005982; Virag JI, 2003, AM J PATHOL, V163, P2433, DOI 10.1016/S0002-9440(10)63598-5; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Yang EV, 2006, CANCER RES, V66, P10357, DOI 10.1158/0008-5472.CAN-06-2496; Zhang H, 2005, AM J PHYSIOL-HEART C, V289, pH2089, DOI 10.1152/ajpheart.00019.2005; Ziegelhoeffer T, 2004, CIRC RES, V94, P230, DOI 10.1161/01.RES.0000110419.50982.1C	60	54	58	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2008	22	3					930	940		10.1096/fj.07-8636com	http://dx.doi.org/10.1096/fj.07-8636com			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17967925				2022-12-25	WOS:000254143700031
J	Wang, YQ; Zhu, M; Ayalew, M; Ruff, JA				Wang, Yuqi; Zhu, Ming; Ayalew, Mihretu; Ruff, Jack A.			Down-regulation of Pkc1-mediated signaling by the deubiquitinating enzyme Ubp3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MAP KINASE; G-PROTEIN; HISTONE H2B; UBIQUITINATION; YEAST; DEGRADATION; ACTIVATION; SPECIFICITY; PROTEASOME	Regulated ubiquitination and degradation of signaling proteins have emerged as key mechanisms for modulating the strength and duration of signaling pathways. The reversible nature of the ubiquitination process as well as the large number and diversity of the deubiquitinating enzymes raise the possibility that signaling pathways might be modulated by specific deubiquitinating enzyme(s). Here we provide evidence that in the yeast Saccharomyces cerevisiae, the Pkc1-mediated signaling pathway that controls the cell wall integrity is negatively regulated by the deubiquitinating enzyme Ubp3. Disruption of the UBP3 gene leads to an enhanced activation of the cell wall integrity pathway MAPK Slt2 when cells are challenged with a variety of pathway activation agents such as pheromone and Congo red. The ubp3 deletion mutants accumulate high levels of Pkc1, suggesting potential regulation of Pkc1 by Ubp3. Consistent with this, Pkc1 and Ubp3 interact in vivo, and the stability of Pkc1 is markedly increased in the ubp3 deletion mutants. Moreover, disruption of the PKC1 gene, but not the genes that encode components downstream of Pkc1, completely suppresses other phenotypes displayed by the ubp3 deletion mutants such as hyperactivation of the pheromone-responsive MAPK Fus3 (Wang, Y., and Dohlman, H. G. ( 2002) J. Biol. Chem. 277, 15766-15772). These findings demonstrate that Ubp3 can regulate Pkc1 by facilitating its destruction and provide the initial evidence that Pkc1 plays a positive role in modulating the parallel pheromone-signaling pathway.	[Wang, Yuqi; Zhu, Ming; Ayalew, Mihretu; Ruff, Jack A.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA	Saint Louis University	Wang, YQ (corresponding author), St Louis Univ, Dept Biol, 128 Macelwane Hall,3507 Laclede Ave, St Louis, MO 63103 USA.	ywang8@slu.edu						Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Buehrer BM, 1997, MOL CELL BIOL, V17, P6517, DOI 10.1128/MCB.17.11.6517; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Dohlman HG, 2002, ANNU REV PHYSIOL, V64, P129, DOI 10.1146/annurev.physiol.64.081701.133448; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; ERREDE B, 1995, MOL REPROD DEV, V42, P477, DOI 10.1002/mrd.1080420416; Esch RK, 2002, P NATL ACAD SCI USA, V99, P9160, DOI 10.1073/pnas.142034399; Flandez M, 2004, J BIOL CHEM, V279, P11027, DOI 10.1074/jbc.M306412200; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Lee HW, 1996, J BIOL CHEM, V271, P20973, DOI 10.1074/jbc.271.35.20973; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; RONCERO C, 1985, J BACTERIOL, V163, P1180, DOI 10.1128/JB.163.3.1180-1185.1985; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wang YQ, 2004, SCIENCE, V306, P1508, DOI 10.1126/science.1104568; Wang YQ, 2003, J BIOL CHEM, V278, P22284, DOI 10.1074/jbc.M301272200; Wang YQ, 2002, J BIOL CHEM, V277, P15766, DOI 10.1074/jbc.M111733200; Wang YQ, 2006, CIRC RES, V99, P1305, DOI 10.1161/01.RES.0000251641.57410.81; WATANABE M, 1994, J BIOL CHEM, V269, P16829; Zarzov P, 1996, EMBO J, V15, P83, DOI 10.1002/j.1460-2075.1996.tb00336.x	30	15	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1954	1961		10.1074/jbc.M705682200	http://dx.doi.org/10.1074/jbc.M705682200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	17986446	hybrid			2022-12-25	WOS:000252501000022
J	Fujiwara, K; Daido, S; Yamamoto, A; Kobayashi, R; Yokoyama, T; Aoki, H; Iwado, E; Shinojima, N; Kondo, Y; Kondo, S				Fujiwara, Keishi; Daido, Shigeru; Yamamoto, Akitsugu; Kobayashi, Ryuji; Yokoyama, Tomohisa; Aoki, Hiroshi; Iwado, Eiji; Shinojima, Naoki; Kondo, Yasuko; Kondo, Seiji			Pivotal role of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) in apoptosis and autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; MALIGNANT GLIOMA-CELLS; HUMAN COLON-CANCER; CARCINOMA CELLS; P21 WAF1/CIP1; CERAMIDE; P53; BCL-2; MACROAUTOPHAGY; CAMPTOTHECIN	Programmed cell death (PCD) is involved in a variety of biologic events. Based on the morphologic appearance of the cells, there are two types of PCD as follows: apoptotic(type I) and autophagic(type II). However, the molecular machinery that determines the type of PCD is poorly defined. The purpose of this study was to show whether the presence of the cyclin-dependent kinase (CDK) inhibitor p21(WAF1/CIP1), a modulator of apoptosis, determines which type of PCD the cell undergoes. Treatment with C-2-ceramide was associated with both the cleavage of caspase-3 and poly(ADP- ribose) polymerase and the degradation of autophagy-related Beclin 1 and Atg5 proteins, without a change in the cyclin-CDK activity, which culminated in apoptosis in p21(+/+) mouse embryonic fibroblasts (MEFs). On the other hand, C-2-ceramide did not cleave caspase-3 or poly(ADP- ribose) polymerase and kept Beclin 1 and Atg5 proteins stable in p21(+/+) MEFs, events that this time culminated in autophagy. When expression of the p21 protein was inhibited by small interfering RNA or when the overexpression of Beclin 1 or Atg5 was induced, autophagy rather than apoptosis was initiated in the p21(+/+) MEFs treated with C-2-ceramide. In contrast, the exogenous expression of p21 or the silencing of Beclin 1 and Atg5 with small interfering RNA increased the number of apoptotic cells and decreased the number of autophagic cells among C-2-ceramide-treated p21(+/+) MEFs. gamma-Irradiation, which endogenously generates ceramide, induced a similar tendency in these MEFs. These results suggest that p21 plays an essential role in determining the type of cell death, positively for apoptosis and negatively for autophagy.	[Fujiwara, Keishi; Daido, Shigeru; Yokoyama, Tomohisa; Aoki, Hiroshi; Iwado, Eiji; Shinojima, Naoki; Kondo, Yasuko; Kondo, Seiji] Univ Texas, MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Yamamoto, Akitsugu] Nagahama Inst Biosci & Technol, Dept Cell Biol & Biosci, Shiga 5260829, Japan; [Kobayashi, Ryuji] Univ Texas, MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; [Kondo, Seiji] Univ Texas, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Kondo, Seiji] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; Baylor College of Medicine	Kondo, S (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Neurosurg, 1515 Holcombe Blvd,Unit BSRB 1004, Houston, TX 77030 USA.	seikondo@mdanderson.org	Shinojima, Naoki/GSI-6790-2022; Shinojima, Naoki/AAW-3038-2021	Shinojima, Naoki/0000-0003-3352-7936	NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NCI NIH HHS [CA 16672] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bursch W, 2000, ANN NY ACAD SCI, V926, P1, DOI 10.1111/j.1749-6632.2000.tb05594.x; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Chopin V, 2004, EXP CELL RES, V298, P560, DOI 10.1016/j.yexcr.2004.04.038; CIFONE MG, 1994, J EXP MED, V180, P1547, DOI 10.1084/jem.180.4.1547; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Daido S, 2005, CANCER RES, V65, P4368, DOI 10.1158/0008-5472.CAN-04-4202; Detjen KM, 2003, EXP CELL RES, V282, P78, DOI 10.1016/S0014-4827(02)00011-3; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gartel AL, 2002, MOL CANCER THER, V1, P639; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Han ZY, 2002, J BIOL CHEM, V277, P17154, DOI 10.1074/jbc.M112401200; HARPER JW, 1993, CELL, V75, P805; Ito H, 2005, HUM GENE THER, V16, P685, DOI 10.1089/hum.2005.16.685; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang KH, 1999, EXP CELL RES, V253, P403, DOI 10.1006/excr.1999.4644; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kondo S, 1996, ONCOGENE, V13, P1279; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lockshin RA, 2002, CURR OPIN CELL BIOL, V14, P727, DOI 10.1016/S0955-0674(02)00383-6; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mahyar-Roemer M, 2001, ONCOGENE, V20, P3387, DOI 10.1038/sj.onc.1204440; Mengubas K, 1999, ONCOGENE, V18, P2499, DOI 10.1038/sj.onc.1202622; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Noda T, 2002, TRENDS CELL BIOL, V12, P231, DOI 10.1016/S0962-8924(02)02278-X; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Qiao L, 2002, HEPATOLOGY, V36, P39, DOI 10.1053/jhep.2002.33899; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Scovassi AI, 2004, BIOCHEM PHARMACOL, V68, P1041, DOI 10.1016/j.bcp.2004.04.023; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Shibata MA, 2001, CANCER GENE THER, V8, P23, DOI 10.1038/sj.cgt.7700275; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Tian H, 2000, CANCER RES, V60, P679; Tsao YP, 1999, J VIROL, V73, P4983, DOI 10.1128/JVI.73.6.4983-4990.1999; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Weiss RH, 2003, CANCER CELL, V4, P425, DOI 10.1016/S1535-6108(03)00308-8; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Xu Y, 2006, J BIOL CHEM, V281, P19179, DOI 10.1074/jbc.M513377200; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhang YK, 1999, INT J CANCER, V83, P790, DOI 10.1002/(SICI)1097-0215(19991210)83:6<790::AID-IJC15>3.0.CO;2-6	55	90	97	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					388	397		10.1074/jbc.M611043200	http://dx.doi.org/10.1074/jbc.M611043200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17959603	hybrid			2022-12-25	WOS:000251940300043
J	Baggaley, E; McLarnon, S; Demeter, I; Varga, G; Bruce, JIE				Baggaley, Erin; McLarnon, Stuart; Demeter, Irma; Varga, Gabor; Bruce, Jason I. E.			Differential regulation of the apical plasma membrane Ca2+-ATPase by protein kinase a in parotid acinar cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; CALCIUM-PUMP; SALIVARY-GLANDS; CA2+ PUMP; ENDOPLASMIC-RETICULUM; SIGNALING DYNAMICS; PANCREATIC ACINAR; CYTOSOLIC CA2+; ISOFORMS 2B; RAT	Cross-talk between intracellular calcium ([Ca2+](i)) signaling and cAMP defines the specificity of stimulus-response coupling in a variety of cells. Previous studies showed that protein kinase A (PKA) potentiates and phosphorylates the plasma membrane Ca2+-ATPase (PMCA) in a Ca2+-dependent manner in parotid acinar cells (Bruce, J. I. E., Yule, D. I., and Shuttleworth, T. J. (2002) J. Biol. Chem. 277, 48172 -48181). The aim of this study was to further investigate the spatial regulation of [Ca2+](i) clearance in parotid acinar cells. Par-C10 cells were used to functionally isolate the apical and basolateral PMCA activity by applying La3+ to the opposite side to inhibit the PMCA. Activation of PKA (using forskolin) differentially potentiated apical [Ca2+](i) clearance in mouse parotid acinar cells and apical PMCA activity in Par-C10 cells. Immunofluorescence of parotid tissue slices revealed that PMCA1 was distributed throughout the plasma membrane, PMCA2 was localized to the basolateral membrane, and PMCA4 was localized to the apical membrane of parotid acinar cells. However, in situ phosphorylation assays demonstrated that PMCA1 was the only isoform phosphorylated by PKA following stimulation. Similarly, immunofluorescence of acutely isolated parotid acinar cells showed that the regulatory subunit of PKA (RII beta) translocated to the apical region following stimulation. These data suggest that PKA-mediated phosphorylation of PMCA1 differentially regulates [Ca2+](i) clearance in the apical region of parotid acinar cells because of a dynamic translocation of PKA. Such tight spatial regulation of Ca2+ efflux is likely important for the fine-tuning of Ca2+-dependent effectors close to the apical membrane important for the regulation of fluid secretion and exocytosis.	[Baggaley, Erin; McLarnon, Stuart; Bruce, Jason I. E.] Univ Manchester, Fac Life Sci, Manchester M13 9NT, Lancs, England; [Demeter, Irma; Varga, Gabor] Semmelweis Univ, Dept Oral Biol, H-1089 Budapest, Hungary	University of Manchester; Semmelweis University	Bruce, JIE (corresponding author), Univ Manchester, Fac Life Sci, 2nd Floor Core Technol Facil,46 Grafton St, Manchester M13 9NT, Lancs, England.	jason.bruce@manchester.ac.uk	Varga, Gábor/O-8858-2017	Varga, Gabor/0000-0002-5506-8198	Biotechnology and Biological Sciences Research Council [BB/C514607/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Ankorina-Stark I, 2002, J MEMBRANE BIOL, V186, P43, DOI 10.1007/s00232-001-0134-x; Bautista DM, 2002, J PHYSIOL-LONDON, V541, P877, DOI 10.1113/jphysiol.2001.016154; Belan PV, 1996, J BIOL CHEM, V271, P7615, DOI 10.1074/jbc.271.13.7615; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Bretscher A, 1997, J CELL SCI, V110, P3011; Bruce JIE, 2004, J BIOL CHEM, V279, P12909, DOI 10.1074/jbc.M309070200; Bruce JIE, 2002, J BIOL CHEM, V277, P48172, DOI 10.1074/jbc.M208393200; Bruce JIE, 2002, J BIOL CHEM, V277, P1340, DOI 10.1074/jbc.M106609200; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; CARAFOLI E, 1991, PHYSIOL REV, V71, P129, DOI 10.1152/physrev.1991.71.1.129; Caride AJ, 2001, J BIOL CHEM, V276, P39797, DOI 10.1074/jbc.M104380200; Castle AM, 2002, J CELL SCI, V115, P2963; Collins TJ, 2001, J BIOL CHEM, V276, P26411, DOI 10.1074/jbc.M101101200; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; DeMarco SJ, 2002, J BIOL CHEM, V277, P10506, DOI 10.1074/jbc.M111616200; DeMarco SJ, 2001, J BIOL CHEM, V276, P21594, DOI 10.1074/jbc.M101448200; Giovannucci DR, 2002, J PHYSIOL-LONDON, V540, P469, DOI 10.1113/jphysiol.2001.013453; GREEB J, 1989, J BIOL CHEM, V264, P18569; Gromadzinska E, 2001, BBA-PROTEIN STRUCT M, V1549, P19, DOI 10.1016/S0167-4838(01)00244-8; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guerini D, 2003, J BIOL CHEM, V278, P38141, DOI 10.1074/jbc.M302400200; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Henn V, 2004, J BIOL CHEM, V279, P26654, DOI 10.1074/jbc.M312835200; HERSCHER CJ, 1994, J BIOL CHEM, V269, P10400; Hillman DE, 1996, NEUROSCIENCE, V72, P315, DOI 10.1016/0306-4522(95)00518-8; Ishikawa Y, 2006, J PHARMACOL SCI, V100, P495, DOI 10.1254/jphs.CRJ06007X; JAMES PH, 1989, BIOCHEMISTRY-US, V28, P4253, DOI 10.1021/bi00436a020; KASAI H, 1993, CELL, V74, P669, DOI 10.1016/0092-8674(93)90514-Q; Kurihara K, 2003, BIOCHEM PHARMACOL, V66, P239, DOI 10.1016/S0006-2952(03)00259-4; LARSSON O, 1989, ACTA PHYSIOL SCAND, V137, P231, DOI 10.1111/j.1748-1716.1989.tb08743.x; Lee MG, 1997, J BIOL CHEM, V272, P15771, DOI 10.1074/jbc.272.25.15771; MASON MJ, 1991, J BIOL CHEM, V266, P20856; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; Monteith GR, 1998, J PHARMACOL TOXICOL, V40, P183, DOI 10.1016/S1056-8719(99)00004-0; Penniston JT, 1998, J MEMBRANE BIOL, V165, P101, DOI 10.1007/s002329900424; Perez-Cornejo P, 2004, BIOCHEM BIOPH RES CO, V316, P612, DOI 10.1016/j.bbrc.2004.02.097; Reuter H, 2005, CARDIOVASC RES, V67, P198, DOI 10.1016/j.cardiores.2005.04.031; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; Schuh K, 2003, J BIOL CHEM, V278, P9778, DOI 10.1074/jbc.M212507200; Schuh K, 2001, J CELL BIOL, V155, P201, DOI 10.1083/jcb.200104131; Segawa A, 1998, CELL TISSUE RES, V291, P325, DOI 10.1007/s004410051002; Shmigol A, 1998, PFLUG ARCH EUR J PHY, V437, P158, DOI 10.1007/s004240050761; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Takemura H, 1999, BIOCHEM BIOPH RES CO, V259, P656, DOI 10.1006/bbrc.1999.0818; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Tojyo Y, 1997, CELL CALCIUM, V22, P455, DOI 10.1016/S0143-4160(97)90073-7; Trotter KW, 1999, J CELL BIOL, V147, P1481, DOI 10.1083/jcb.147.7.1481; Turner JT, 1998, AM J PHYSIOL-CELL PH, V275, pC367, DOI 10.1152/ajpcell.1998.275.2.C367; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497; Yule DI, 2001, J GEN PHYSIOL, V117, P431, DOI 10.1085/jgp.117.5.431; Zabe M, 2001, J BIOL CHEM, V276, P14704, DOI 10.1074/jbc.M009850200; Zeng WZ, 1997, AM J PHYSIOL-CELL PH, V273, pC442, DOI 10.1152/ajpcell.1997.273.2.C442; Zhang XJ, 1999, BIOCHEM J, V340, P519, DOI 10.1042/0264-6021:3400519	57	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37678	37693		10.1074/jbc.M703416200	http://dx.doi.org/10.1074/jbc.M703416200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17938178	hybrid			2022-12-25	WOS:000251833600044
J	Jha, SK; Udgaonkar, JB				Jha, Santosh Kumar; Udgaonkar, Jayant B.			Exploring the cooperativity of the fast folding reaction of a small protein using pulsed thiol labeling and mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDE-CHAIN PACKING; HYDROGEN-EXCHANGE; TRANSITION-STATES; COLD DENATURATION; HYDROPHOBIC CORE; BARSTAR; INTERMEDIATE; KINETICS; PATHWAYS; DYNAMICS	It has been difficult to obtain directly residue-specific information on side chain packing during a fast (ms) protein folding reaction. Such information is necessary to determine the extent to which structural changes in different parts of the protein molecule are coupled together in defining the cooperativity of the overall folding transition. In this study, structural changes occurring during the major fast folding reaction of the small protein barstar have been characterized at the level of individual residue side chains. A pulsed cysteine labeling methodology has been employed in conjunction with mass spectrometry. This provides, with ms temporal resolution, direct information on structure formation at 10 different locations in barstar during its folding. Cysteine residues located on the surface of native barstar, at four different positions, remain fully solvent-accessible throughout the folding process, indicating the absence of any ephemeral nonnative structure in which these four cysteine residues get transiently buried. For buried cysteine residues, the rates of the change in cysteine-thiol accessibility to rapid chemical labeling by the thiol reagent methyl methanethiosulfonate appear to be dependent upon the location of the cysteine residue in the protein and are different from the rate measured by the change in tryptophan fluorescence. But the rates vary over only a 3-fold range. Nevertheless, a comparison of the kinetics of the change in accessibility of the cysteine 3 thiol with those of the change in the fluorescence of tryptophan 53, as well as of their denaturant dependences, indicates that the major folding reaction comprises more than one step.	[Jha, Santosh Kumar; Udgaonkar, Jayant B.] Tata Inst Fundamental Res, Natl Ctr & Biol Sci, Bangalore 560065, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Udgaonkar, JB (corresponding author), Tata Inst Fundamental Res, Natl Ctr & Biol Sci, Bangalore 560065, Karnataka, India.	jayant@ncbs.res.in						AGASHE VR, 1995, BIOCHEMISTRY-US, V34, P3286, DOI 10.1021/bi00010a019; AGASHE VR, 1995, NATURE, V377, P754, DOI 10.1038/377754a0; Ahmed Z, 2005, J AM CHEM SOC, V127, P10943, DOI 10.1021/ja050664e; Anil B, 2006, BIOCHEMISTRY-US, V45, P10110, DOI 10.1021/bi060636o; BALDWIN RL, 1995, J BIOMOL NMR, V5, P103; BALLERY N, 1993, BIOCHEMISTRY-US, V32, P708, DOI 10.1021/bi00053a040; Bhuyan AK, 1999, BIOCHEMISTRY-US, V38, P9158, DOI 10.1021/bi990285w; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; BOWIE JU, 1989, BIOCHEMISTRY-US, V28, P7139, DOI 10.1021/bi00444a001; Chan HS, 2004, METHOD ENZYMOL, V380, P350; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cho JH, 2006, J MOL BIOL, V359, P1437, DOI 10.1016/j.jmb.2006.04.038; Cho JH, 2004, J MOL BIOL, V338, P827, DOI 10.1016/j.jmb.2004.02.073; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DILL KA, 1993, P NATL ACAD SCI USA, V90, P1942, DOI 10.1073/pnas.90.5.1942; Eaton WA, 1999, P NATL ACAD SCI USA, V96, P5897, DOI 10.1073/pnas.96.11.5897; ENGLANDER SW, 1992, ANNU REV BIOPH BIOM, V21, P243, DOI 10.1146/annurev.biophys.21.1.243; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; FINKELSTEIN AV, 2002, PROTEIN PHYS, P205; Frieden C, 2003, BIOCHEMISTRY-US, V42, P12439, DOI 10.1021/bi030192l; Goldenberg DP, 1999, NAT STRUCT BIOL, V6, P987, DOI 10.1038/14866; Ha JH, 1998, NAT STRUCT BIOL, V5, P730, DOI 10.1038/1436; Holtzer ME, 1997, BIOPHYS J, V73, P1031, DOI 10.1016/S0006-3495(97)78136-0; Huang F, 2007, P NATL ACAD SCI USA, V104, P123, DOI 10.1073/pnas.0609717104; JACOBS MD, 1994, P NATL ACAD SCI USA, V91, P449, DOI 10.1073/pnas.91.2.449; Juneja J, 2003, CURR SCI INDIA, V84, P157; Juneja J, 2002, BIOCHEMISTRY-US, V41, P2641, DOI 10.1021/bi011480p; KHURANA R, 1995, PROTEIN SCI, V4, P1133, DOI 10.1002/pro.5560040612; Klimov DK, 1998, FOLD DES, V3, P127, DOI 10.1016/S1359-0278(98)00018-2; Krishna MMG, 2007, PROTEIN SCI, V16, P449, DOI 10.1110/ps.062655907; Kussell E, 2003, PROTEINS, V52, P303, DOI 10.1002/prot.10426; Lakshmikanth GS, 2001, NAT STRUCT BIOL, V8, P799, DOI 10.1038/nsb0901-799; Levitt M, 1997, ANNU REV BIOCHEM, V66, P549, DOI 10.1146/annurev.biochem.66.1.549; Li H, 2007, BIOCHEMISTRY-US, V46, P4337, DOI 10.1021/bi6026083; LIM WA, 1989, NATURE, V339, P31, DOI 10.1038/339031a0; Ma HR, 2005, P NATL ACAD SCI USA, V102, P2283, DOI 10.1073/pnas.0409270102; Nolting B, 1997, P NATL ACAD SCI USA, V94, P826, DOI 10.1073/pnas.94.3.826; Nolting B, 1997, BIOCHEMISTRY-US, V36, P9899, DOI 10.1021/bi962879u; Northey JGB, 2002, NAT STRUCT BIOL, V9, P126, DOI 10.1038/nsb748; Osvath S, 2003, J MOL BIOL, V333, P187, DOI 10.1016/j.jmb.2003.08.011; Pradeep L, 2004, BIOCHEMISTRY-US, V43, P11393, DOI 10.1021/bi049320b; Pradeep L, 2004, J BIOL CHEM, V279, P40303, DOI 10.1074/jbc.M406323200; Pradeep L, 2002, J MOL BIOL, V324, P331, DOI 10.1016/S0022-2836(02)01068-9; RADFORD SE, 1992, NATURE, V358, P302, DOI 10.1038/358302a0; Ramachandran S, 2000, J MOL BIOL, V297, P733, DOI 10.1006/jmbi.2000.3605; Rami BR, 2003, BIOCHEMISTRY-US, V42, P7986, DOI 10.1021/bi030006b; Rami BR, 2001, BIOCHEMISTRY-US, V40, P15267, DOI 10.1021/bi011701r; Reich L, 2006, PROTEINS, V63, P1052, DOI 10.1002/prot.20966; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; RODER H, 1988, NATURE, V335, P700, DOI 10.1038/335700a0; Roy M, 2003, J MOL BIOL, V328, P693, DOI 10.1016/S0022-2836(03)00340-1; Sabelko J, 1999, P NATL ACAD SCI USA, V96, P6031, DOI 10.1073/pnas.96.11.6031; Sadqi M, 2006, NATURE, V442, P317, DOI 10.1038/nature04859; Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5; Schanda P, 2007, P NATL ACAD SCI USA, V104, P11257, DOI 10.1073/pnas.0702069104; SCHREIBER G, 1993, BIOCHEMISTRY-US, V32, P11195, DOI 10.1021/bi00092a032; SHASTRY MCR, 1995, J MOL BIOL, V247, P1013, DOI 10.1006/jmbi.1994.0196; SHASTRY MCR, 1994, PROTEIN SCI, V3, P1409, DOI 10.1002/pro.5560030907; Shortle D, 2002, ADV PROTEIN CHEM, V62, P1; Silverman JA, 2002, J BIOL CHEM, V277, P30968, DOI 10.1074/jbc.M203172200; Sinha KK, 2007, J MOL BIOL, V370, P385, DOI 10.1016/j.jmb.2007.04.061; Sinha KK, 2005, J MOL BIOL, V353, P704, DOI 10.1016/j.jmb.2005.08.056; Song JX, 1999, NAT STRUCT BIOL, V6, P129, DOI 10.1038/5815; Sridevi K, 2004, J MOL BIOL, V337, P699, DOI 10.1016/j.jmb.2003.12.083; Sridevi K, 2002, BIOCHEMISTRY-US, V41, P1568, DOI 10.1021/bi011494v; Sridevi K, 2000, J MOL BIOL, V302, P479, DOI 10.1006/jmbi.2000.4060; SRIDEVI K, 2003, THESIS, P62; Swaminathan R, 1996, BIOCHEMISTRY-US, V35, P9150, DOI 10.1021/bi9603478; UDGAONKAR JB, 1990, P NATL ACAD SCI USA, V87, P8197, DOI 10.1073/pnas.87.21.8197; Wani AH, 2006, BIOCHEMISTRY-US, V45, P11226, DOI 10.1021/bi060647h; Weikl TR, 2007, J MOL BIOL, V365, P1578, DOI 10.1016/j.jmb.2006.10.082; Wong KB, 1996, J MOL BIOL, V259, P805, DOI 10.1006/jmbi.1996.0359; Zaidi FN, 1997, NAT STRUCT BIOL, V4, P1016, DOI 10.1038/nsb1297-1016	74	42	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37479	37491		10.1074/jbc.M706714200	http://dx.doi.org/10.1074/jbc.M706714200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17959598	hybrid			2022-12-25	WOS:000251833600023
J	Katsuyama, Y; Matsuzawa, M; Funa, N; Horinouchi, S				Katsuyama, Yohei; Matsuzawa, Miku; Funa, Nobutaka; Horinouchi, Sueharu			In vitro synthesis of curcuminoids by type III polyketide synthase from Oryza sativa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BENZALACETONE SYNTHASE; CHALCONE SYNTHASE; BIOSYNTHESIS; PHENYLPHENALENONES	Curcuminoids, major components of the spice turmeric, are used as a traditional Asian medicine and a food additive. Curcumin, a representative curcuminoid, has received a great deal of attention because of its anti-inflammatory, anticarcinogenic, and antitumor activities. Here we report a novel type III polyketide synthase named curcuminoid synthase from Oryza sativa, which synthesizes bisdemethoxycurcumin via a unique mechanism from two 4-coumaroyl-CoAs and one malonyl-CoA. The reaction begins with the thioesterification of the thiol moiety of Cys-174 by a starter molecule, 4-coumaroyl-CoA. Decarboxylative condensation of the first extender substrate, malonyl-CoA, onto the thioester of 4-coumarate results in the formation of a diketide-CoA intermediate. Subsequent hydrolysis of the intermediate yields a beta-keto acid, which in turn acts as the second extender substrate. The beta-keto acid is then joined to the Cys-174-bound 4-coumarate by decarboxylative condensation to form bisdemethoxycurcumin. This reaction violates the traditional head-to-tail model of polyketide assembly; the growing diketide intermediate is hydrolyzed to a beta-keto acid that subsequently serves as the second extender to form curcuminoids. Curcuminoid synthase appears to be capable of the synthesis of not only diarylheptanoids but also gingerol analogues, because it synthesized cinnamoyl(hexanoyl) methane, a putative intermediate of gingerol, from cinnamoyl-CoA and 3-oxo-octanoic acid.	[Katsuyama, Yohei; Matsuzawa, Miku; Funa, Nobutaka; Horinouchi, Sueharu] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Horinouchi, S (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan.	asuhori@mail.ecc.u-tokyo.ac.jp						Abe I, 2001, EUR J BIOCHEM, V268, P3354, DOI 10.1046/j.1432-1327.2001.02255.x; Abe I, 2003, J BIOL CHEM, V278, P25218, DOI 10.1074/jbc.M303276200; Austin MB, 2004, CHEM BIOL, V11, P1179, DOI 10.1016/j.chembiol.2004.05.024; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Blecher M, 1981, Methods Enzymol, V72, P404; Brand S, 2006, PLANTA, V224, P413, DOI 10.1007/s00425-006-0228-x; DENNIFF P, 1980, J CHEM SOC PERK T 1, P2637, DOI 10.1039/p19800002637; Duvoix A, 2005, CANCER LETT, V223, P181, DOI 10.1016/j.canlet.2004.09.041; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; GILBERT IH, 1995, BIOORG MED CHEM LETT, V5, P1587, DOI 10.1016/0960-894X(95)00276-Y; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; HIRAI N, 1994, PHYTOCHEMISTRY, V37, P383, DOI 10.1016/0031-9422(94)85064-X; HOLSCHER D, 1995, NAT PROD LETT, V7, P177, DOI 10.1080/10575639508043208; HOLSCHER D, 1995, J CHEM SOC CHEM COMM, P525, DOI 10.1039/c39950000525; Katsuyama Y, 2007, CHEM BIOL, V14, P613, DOI 10.1016/j.chembiol.2007.05.004; Kress WJ, 2001, SYST BIOL, V50, P926, DOI 10.1080/106351501753462885; Kuchitsu K, 1997, PLANT CELL PHYSIOL, V38, P1012, DOI 10.1093/oxfordjournals.pcp.a029265; Lokot IP, 1999, TETRAHEDRON, V55, P4783, DOI 10.1016/S0040-4020(99)00150-7; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; MATSUMURA S, 1985, B CHEM SOC JPN, V3, P310; Ramirez-Ahumada MD, 2006, PHYTOCHEMISTRY, V67, P2017, DOI 10.1016/j.phytochem.2006.06.028; Ricke DO, 2006, CURR OPIN CHEM BIOL, V10, P303, DOI 10.1016/j.cbpa.2006.06.024; ROUGHLEY PJ, 1973, J CHEM SOC PERK T 1, P2379, DOI 10.1039/p19730002379; Schroder J, 1997, TRENDS PLANT SCI, V2, P373, DOI 10.1016/S1360-1385(97)01104-7; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009	25	73	79	4	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37702	37709		10.1074/jbc.M707569200	http://dx.doi.org/10.1074/jbc.M707569200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17932040	hybrid			2022-12-25	WOS:000251833600046
J	Alvarez-Rodiguez, R; Barzi, M; Berenguer, J; Pons, S				Alvarez-Rodiguez, Ruben; Barzi, Mercedes; Berenguer, Jordi; Pons, Sebastian			Bone morphogenetic protein 2 opposes Shh-mediated proliferation in cerebellar granule cells through a TIEG-1-based regulation of Nmyc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-MYC ONCOGENE; C-MYC; HEDGEHOG; GENE; EXPRESSION; AMPLIFICATION; GROWTH; TIEG; PROGRESSION; MUTATIONS	Nmyc is a potent regulator of cell cycle in cerebellar granular neuron precursors (CGNPs) and has been proposed to be the main effector of Shh ( Sonic hedgehog) proliferative activity. Nmyc ectopic expression is sufficient to promote cell autonomous proliferation and can lead to tumorigenesis. Bone morphogenetic protein 2 (BMP2) antagonizes Shh proliferative effect by promoting cell cycle exit and differentiation in CGNPs. Here we report that BMP2 opposes Shh mitogenic activity by blocking Nmyc expression. We have identified TIEG-1 (KLF10) as the intermediary factor that blocks Nmyc expression through the occupancy of the Sp1 sites present in its promoter. We also demonstrate that TIEG-1 ectopic expression in CGNPs induces cell cycle arrest that can lead to apoptosis but fails to promote differentiation. Moreover, TIEG-1 synergizes with BMP2 activity to terminally differentiate CGNPs and independent differentiator signals such as dibutyryl cAMP and prevents apoptosis in TIEG-1 arrested cells. All together, these data strongly suggest that the BMP2 pathway triggers cell cycle exit and differentiation as two separated but coordinated processes, where TIEG-1 acts as a mediator of the cell cycle arrest.	[Alvarez-Rodiguez, Ruben; Barzi, Mercedes; Berenguer, Jordi; Pons, Sebastian] Biomed Res Inst, CSIC, Dept Cell Death & Proliferat, IDIBAPS, Barcelona 08036, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Pons, S (corresponding author), Biomed Res Inst, CSIC, Dept Cell Death & Proliferat, IDIBAPS, Rosello 161,6th Fl, Barcelona 08036, Spain.	spfnqi@iibb.csic.es	Pons, Sebastian/K-7794-2014; Berenguer, Jordi/AAK-5540-2020	Pons, Sebastian/0000-0003-1027-0621; Berenguer de Felipe, Jordi/0000-0003-4007-1631				Aldosari N, 2002, ARCH PATHOL LAB MED, V126, P540; Altman J, 1997, DEV CEREBELLAR SYSTE; Bonvini P, 1998, ONCOGENE, V16, P1131, DOI 10.1038/sj.onc.1201625; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cook T, 1999, J BIOL CHEM, V274, P29500, DOI 10.1074/jbc.274.41.29500; Cook T, 1998, J BIOL CHEM, V273, P25929, DOI 10.1074/jbc.273.40.25929; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Ellenrieder V, 2002, EMBO J, V21, P2451, DOI 10.1093/emboj/21.10.2451; Epstein DJ, 1996, DEVELOPMENT, V122, P2885; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; GARSON JA, 1985, LANCET, V2, P718; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Hefferan TE, 2000, J BIOL CHEM, V275, P20255, DOI 10.1074/jbc.C000135200; Hefferan TE, 2000, J CELL BIOCHEM, V78, P380, DOI 10.1002/1097-4644(20000901)78:3<380::AID-JCB4>3.0.CO;2-L; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HIRNING U, 1991, MECH DEVELOP, V33, P119, DOI 10.1016/0925-4773(91)90078-K; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Hynes M, 2000, NAT NEUROSCI, V3, P41, DOI 10.1038/71114; Johnsen SA, 2004, SIGNAL TRANSDUCT, V4, P29; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Kramps C, 2004, J BIOL CHEM, V279, P5110, DOI 10.1074/jbc.M304758200; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; LITTLE MH, 1992, P NATL ACAD SCI USA, V89, P4791, DOI 10.1073/pnas.89.11.4791; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Malynn BA, 2000, GENE DEV, V14, P1390; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, GENE DEV, V14, P627; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; MUGRAUER G, 1988, J CELL BIOL, V107, P1325, DOI 10.1083/jcb.107.4.1325; Nicot A, 2002, J NEUROSCI, V22, P9244; Noti JD, 2004, J BIOL CHEM, V279, P26948, DOI 10.1074/jbc.M310634200; Noveen A, 1996, BIOCHEM BIOPH RES CO, V219, P180, DOI 10.1006/bbrc.1996.0202; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Pons S, 2001, DEVELOPMENT, V128, P1481; Rios I, 2004, DEVELOPMENT, V131, P3159, DOI 10.1242/dev.01188; SCHWAB M, 1984, P NATL ACAD SCI-BIOL, V81, P4940, DOI 10.1073/pnas.81.15.4940; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Strieder V, 2003, J BIOL CHEM, V278, P2983, DOI 10.1074/jbc.M207596200; Tachibana I, 1997, J CLIN INVEST, V99, P2365, DOI 10.1172/JCI119418; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Tuthill MC, 2003, MOL GENET METAB, V80, P272, DOI 10.1016/S1096-7192(03)00133-1; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; WONG AJ, 1986, SCIENCE, V233, P461, DOI 10.1126/science.3014659; Xie JW, 1997, CANCER RES, V57, P2369; Yagi K, 2002, J BIOL CHEM, V277, P854, DOI 10.1074/jbc.M104170200	54	52	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37170	37180		10.1074/jbc.M705414200	http://dx.doi.org/10.1074/jbc.M705414200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17951258	hybrid			2022-12-25	WOS:000251646000043
J	Chen, JX; Chloupkova, M; Gao, JW; Chapman-Arvedson, TL; Enns, CA				Chen, Juxing; Chloupkova, Maja; Gao, Junwei; Chapman-Arvedson, Tara L.; Enns, Caroline A.			HFE modulates transferrin receptor 2 levels in hepatoma cells via interactions that differ from transferrin receptor 1-HFE interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY HEMOCHROMATOSIS PROTEIN; NEONATAL FC-RECEPTOR; CRYSTAL-STRUCTURE; IRON-METABOLISM; MESSENGER-RNAS; BINDING; GENE; EXPRESSION; PHENOTYPE; COMPLEX	Mutations in the transmembrane glycoproteins transferrin receptor 2 (TfR2) and HFE are associated with hereditary hemochromatosis. Interactions between HFE and transferrin receptor 1 (TfR1) have been mapped to the alpha 1- and alpha 2-helices in HFE and to the helical domain of TfR1. Recently, TfR2 was also reported to interact with HFE in transfected mammalian cells. To test whether similar HFE residues are important for both TfR1 and TfR2 binding, a mutant form of HFE (W81AHFE) that has a similar to 5,000-fold lower affinity for TfR1 than HFE was employed. As expected, W81AHFE does not interact with TfR1. However, we found that the same mutation in HFE does not affect the TfR2/HFE interaction. This finding indicates that the TfR2/HFE and TfR1/HFE interactions are distinct. We further observed that, unlike TfR1/HFE, Tf does not compete with HFE for binding to TfR2 and that binding is independent of pH ( pH 6 - 7.5). TfR2-TfR1 and HFE-HLA-B7 chimeras were generated to map the domains of the TfR2/HFE interaction. TfR1 and HLA-B7 were chosen because of their similar overall structures with TfR2 and HFE, respectively. We mapped the interacting domains to the putative stalk and protease-like domains of TfR2 located between residues 104 and 250 and to the alpha 3 domain of HFE, both of which differ from the TfR1/HFE interacting domains. Furthermore, we found that HFE increases TfR2 levels in hepatic cells independent of holo-Tf.	[Chen, Juxing; Chloupkova, Maja; Gao, Junwei; Enns, Caroline A.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA; [Chapman-Arvedson, Tara L.] Amgen Inc, Thousand Oaks, CA 91320 USA	Oregon Health & Science University; Amgen	Enns, CA (corresponding author), 3181 SW Sam Jackson Pk Rd,L215, Portland, OR 97239 USA.	ennsca@ohsu.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072166] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK072166] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Bennett MJ, 2000, NATURE, V403, P46, DOI 10.1038/47417; Bomford A, 2002, LANCET, V360, P1673, DOI 10.1016/S0140-6736(02)11607-2; Bothwell TH, 1998, SEMIN HEMATOL, V35, P55; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Carlson H, 2005, BLOOD, V105, P2564, DOI 10.1182/blood-2004-03-1204; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Chen JX, 2007, J BIOL CHEM, V282, P6201, DOI 10.1074/jbc.M610127200; Corsi B, 1999, FEBS LETT, V460, P149, DOI 10.1016/S0014-5793(99)01330-7; Cullen LM, 1999, ANNU REV MED, V50, P87; Davies PS, 2003, BIOCHEM J, V373, P145, DOI 10.1042/BJ20030202; Dupic F, 2002, GASTROENTEROLOGY, V122, P745, DOI 10.1053/gast.2002.31877; ENNS CA, 1981, J BIOL CHEM, V256, P2620; Enns CA, 2001, TRAFFIC, V2, P167, DOI 10.1034/j.1600-0854.2001.020303.x; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Feder JN, 1997, J BIOL CHEM, V272, P14025, DOI 10.1074/jbc.272.22.14025; Fleming RE, 2000, P NATL ACAD SCI USA, V97, P2214, DOI 10.1073/pnas.040548097; Fleming RE, 2001, P NATL ACAD SCI USA, V98, P2707, DOI 10.1073/pnas.051630898; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Goswami T, 2006, J BIOL CHEM, V281, P28494, DOI 10.1074/jbc.C600197200; Gross CN, 1998, J BIOL CHEM, V273, P22068, DOI 10.1074/jbc.273.34.22068; Johnson MB, 2007, MOL BIOL CELL, V18, P743, DOI 10.1091/mbc.E06-09-0798; Johnson MB, 2004, BLOOD, V104, P4287, DOI 10.1182/blood-2004-06-2477; Kawabata H, 2000, J BIOL CHEM, V275, P16618, DOI 10.1074/jbc.M908846199; Kawabata H, 2004, BRIT J HAEMATOL, V127, P464, DOI 10.1111/j.1365-2141.2004.05224.x; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; Lebron JA, 1999, J MOL BIOL, V294, P239, DOI 10.1006/jmbi.1999.3252; Lebron JA, 1999, J MOL BIOL, V289, P1109, DOI 10.1006/jmbi.1999.2842; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Levy JE, 2000, J CLIN INVEST, V105, P1209, DOI 10.1172/JCI9635; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.iy.13.040195.003103; Nicolas G, 2004, BLOOD, V103, P2841, DOI 10.1182/blood-2003-09-3358; Riedel HD, 1999, BLOOD, V94, P3915, DOI 10.1182/blood.V94.11.3915.423k27_3915_3921; Robb A, 2004, BLOOD, V104, P4294, DOI 10.1182/blood-2004-06-2481; Roetto A, 2002, BLOOD CELL MOL DIS, V29, P465, DOI 10.1006/bcmd.2002.0585; TSUNOO H, 1983, ARCH BIOCHEM BIOPHYS, V225, P42, DOI 10.1016/0003-9861(83)90005-X; Vaughn DE, 1997, J MOL BIOL, V274, P597, DOI 10.1006/jmbi.1997.1388; VERLAND S, 1989, J IMMUNOL, V143, P945; Vogt TM, 2003, BLOOD, V101, P2008, DOI 10.1182/blood-2002-09-2742; Waheed A, 1999, P NATL ACAD SCI USA, V96, P1579, DOI 10.1073/pnas.96.4.1579; Warren RA, 1997, J BIOL CHEM, V272, P2116; West AP, 2001, J MOL BIOL, V313, P385, DOI 10.1006/jmbi.2001.5048; West AP, 2000, J BIOL CHEM, V275, P38135, DOI 10.1074/jbc.C000664200; Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378; Zhang AS, 2003, P NATL ACAD SCI USA, V100, P9500, DOI 10.1073/pnas.1233675100	49	68	70	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36862	36870		10.1074/jbc.M706720200	http://dx.doi.org/10.1074/jbc.M706720200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17956864	hybrid			2022-12-25	WOS:000251646000011
J	Kadyrov, FA; Holmes, SF; Arana, ME; Lukianova, OA; O'Donnell, M; Kunkel, TA; Modrich, P				Kadyrov, Farid A.; Holmes, Shannon F.; Arana, Mercedes E.; Lukianova, Olga A.; O'Donnell, Mike; Kunkel, Thomas A.; Modrich, Paul			Saccharomyces cerevisiae MutL alpha is a mismatch repair endonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; MUTATOR PHENOTYPES; ATP BINDING; DNA-BINDING; YEAST; REPLICATION; SYSTEM; EXCISION; CLAMP; GENE	MutL homologs are crucial for mismatch repair and genetic stability, but their function is not well understood. Human MutL alpha (MLH1-PMS2 heterodimer) harbors a latent endonuclease that is dependent on the integrity of a PMS2 DQHA(X)(2)E(X)(4)E motif (Kadyrov, F. A., Dzantiev, L., Constantin, N., and Modrich, P. (2006) Cell 126, 297-308). This sequence element is conserved in many MutL homologs, including the PMS1 subunit of Saccharomyces cerevisiae MutL alpha, but is absent in MutL proteins from bacteria like Escherichia coli that rely on d(GATC) methylation for strand directionality. We show that yeast MutL alpha is a strand-directed endonuclease that incises DNA in a reaction that depends on a mismatch, yMutS alpha, yRFC, yPCNA, ATP, and a pre-existing strand break, whereas E. coli MutL is not. Amino acid substitution within the PMS1 DQHA(X)(2)E(X)(4)E motif abolishes yMutL alpha endonuclease activity in vitro and confers strong genetic instability in vivo, but does not affect yMutL alpha ATPase activity or the ability of the protein to support assembly of the yMutL alpha center dot yMutS alpha center dot heteroduplex ternary complex. The loaded form of yPCNA may play an important effector role in directing yMutL alpha incision to the discontinuous strand of a nicked heteroduplex.	[Kadyrov, Farid A.; Lukianova, Olga A.; Modrich, Paul] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Modrich, Paul] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Holmes, Shannon F.; Arana, Mercedes E.; Kunkel, Thomas A.] Natl Inst Hlth, Struct Biol Lab, Res Triangle Pk, NC 27709 USA; [Holmes, Shannon F.; Arana, Mercedes E.; Kunkel, Thomas A.] Natl Inst Hlth, Genet Mol Lab, NIEHS, Res Triangle Pk, NC 27709 USA; [O'Donnell, Mike] Rockefeller Univ, Lab DNA Replicat, New York, NY 10021 USA; [O'Donnell, Mike] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Duke University; Duke University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Modrich, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	modrich@biochem.duke.edu	Kunkel, Thomas A./D-5088-2019	Kunkel, Thomas A./0000-0002-9900-1788; O'Donnell, Michael/0000-0001-9002-4214; Modrich, Paul/0000-0001-8708-9885	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045190, R37GM038839, R01GM038839] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; Intramural NIH HHS [Z01 ES065089-11] Funding Source: Medline; NIGMS NIH HHS [GM 38839, R01 GM045190-17, R01 GM045190, R01 GM038839, R37 GM038839, GM45190] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AU KG, 1992, J BIOL CHEM, V267, P12142; AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; Blackwell LJ, 2001, J BIOL CHEM, V276, P33233, DOI 10.1074/jbc.M105076200; Blackwell LJ, 2001, J BIOL CHEM, V276, P34339, DOI 10.1074/jbc.M104256200; Burdett V, 2001, P NATL ACAD SCI USA, V98, P6765, DOI 10.1073/pnas.121183298; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; COOPER DL, 1993, J BIOL CHEM, V268, P11823; Deschenes SM, 2007, CANCER LETT, V249, P148, DOI 10.1016/j.canlet.2006.08.008; Drotschmann K, 1999, P NATL ACAD SCI USA, V96, P2970, DOI 10.1073/pnas.96.6.2970; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; ERDENIZ N, 2007, DNA REPAIR AMST, P1463; FANG WH, 1993, J BIOL CHEM, V268, P11838; Finkelstein J, 2003, ANAL BIOCHEM, V319, P78, DOI 10.1016/S0003-2697(03)00273-2; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Goldstein AL, 1999, YEAST, V15, P507, DOI 10.1002/(SICI)1097-0061(199904)15:6<507::AID-YEA369>3.0.CO;2-P; Hall MC, 2001, PROTEIN EXPRES PURIF, V21, P333, DOI 10.1006/prep.2000.1379; Hall MC, 2002, J BIOL CHEM, V277, P3673, DOI 10.1074/jbc.M106120200; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; LANGLEROUAULT F, 1987, EMBO J, V6, P1121, DOI 10.1002/j.1460-2075.1987.tb04867.x; Lee SD, 2006, J MOL BIOL, V355, P175, DOI 10.1016/j.jmb.2005.10.059; Miyaki M, 1997, ONCOGENE, V15, P2877, DOI 10.1038/sj.onc.1201668; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Nielsen FC, 2004, ONCOGENE, V23, P1457, DOI 10.1038/sj.onc.1207265; ONRUST R, 1995, J BIOL CHEM, V270, P13366, DOI 10.1074/jbc.270.22.13366; Reardon JT, 2003, GENE DEV, V17, P2539, DOI 10.1101/gad.1131003; RUNYON GT, 1993, BIOCHEMISTRY-US, V32, P602, DOI 10.1021/bi00053a028; Shcherbakova PV, 1999, MOL CELL BIOL, V19, P3177; Spampinato C, 2000, J BIOL CHEM, V275, P9863, DOI 10.1074/jbc.275.13.9863; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; SU SS, 1988, J BIOL CHEM, V263, P6829; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Viswanathan M, 2001, J BIOL CHEM, V276, P31053, DOI 10.1074/jbc.M105481200; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	42	173	176	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37181	37190		10.1074/jbc.M707617200	http://dx.doi.org/10.1074/jbc.M707617200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17951253	hybrid, Green Accepted			2022-12-25	WOS:000251646000044
J	Riekhof, WR; Wu, J; Gijon, MA; Zarini, S; Murphy, RC; Voelker, DR				Riekhof, Wayne R.; Wu, James; Gijon, Miguel A.; Zarini, Simona; Murphy, Robert C.; Voelker, Dennis R.			Lysophosphatidylcholine metabolism in Saccharomyces cerevisiae - The role of P-type ATPases in transport and a broad specificity acyltransferase in acylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNSATURATED FATTY-ACIDS; YEAST PLASMA-MEMBRANE; ARACHIDONIC-ACID; HUMAN NEUTROPHIL; GENE; PHOSPHATIDYLETHANOLAMINE; IDENTIFICATION; BIOSYNTHESIS; RESPIRATION; ENCODES	We recently described a new route for the synthesis of phosphatidylethanolamine (PtdEtn) from exogenous lyso-PtdEtn, which we have termed the exogenous lysolipid metabolism ( ELM) pathway. The ELM pathway for lyso-PtdEtn requires the action of plasma membrane P-type ATPases Dnf1p and Dnf2p and their requisite beta-subunit, Lem3p, for the active uptake of lyso-PtdEtn. In addition, the acyl-CoA-dependent acyltransferase, Ale1p, mediates the acylation of the imported lysolipid to form PtdEtn. We now report that these components of the lyso-PtdEtn ELM pathway are also active with lyso-1-acyl-2-hydroxyl-sn-glycero-3-phosphocholine (PtdCho) as a substrate. Lyso-PtdCho supports the growth of a choline auxotrophic pem1 Delta pem2 Delta strain. Uptake of radiolabeled lyso- PtdCho was impaired by the dnf2 Delta and lem3 Delta mutations. Introduction of a lem3 Delta mutation into a pem1 Delta pem2 Delta background impaired the ability of the resulting strain to grow with lyso- PtdCho as the sole precursor of PtdCho. After import of lyso- PtdCho, the recently characterized lyso- PtdEtn acyltransferase, Ale1p, functioned as the sole lyso- PtdCho acyltransferase in yeast. A pem1 Delta pem2 Delta ale1 Delta strain grew with lyso- PtdCho as a substrate but showed a profound reduction in PtdCho content when lysoPtdCho was the only precursor of PtdCho. Ale1p acylates lyso- PtdCho with a preference for monounsaturated acyl-CoA species, and the specific LPCAT activity of Ale1p in yeast membranes is >50-fold higher than the basal rate of de novo aminoglycerophospholipid biosynthesis from phosphatidylserine synthase activity. In addition to lyso- PtdCho, lyso- PtdEtn, and lyso- phosphatidic acid, Ale1p was also active with lysophosphatidylserine, lysophosphatidylglycerol, and lysophosphatidylinositol as substrates. These results establish a new pathway for the net synthesis of PtdCho in yeast and provide new tools for the study of PtdCho synthesis, transport, and remodeling.	[Riekhof, Wayne R.; Wu, James; Voelker, Dennis R.] Natl Jewish Med & Res Ctr, Dept Med, Cell Biol Program, Denver, CO 80206 USA; [Gijon, Miguel A.; Zarini, Simona; Murphy, Robert C.] Univ Colorado, Dept Pharmacol, Aurora, CO 80045 USA; [Gijon, Miguel A.; Zarini, Simona; Murphy, Robert C.] Hlth Sci Ctr, Aurora, CO 80045 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Voelker, DR (corresponding author), Natl Jewish Med & Res Ctr, Dept Med, Cell Biol Program, 1400 Jackson St, Denver, CO 80206 USA.	voelkerd@njc.org	Murphy, Robert/AAO-5349-2020	Murphy, Robert/0000-0002-9430-6515; Zarini, Simona/0000-0002-7460-3299	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL025785, R37HL025785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032453, R01GM081461, F32GM076798, R37GM032453] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL25785] Funding Source: Medline; NIGMS NIH HHS [5R37 GM32453, R01 GM081461, GM076798, R01 GM032453] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Athenstaedt K, 1997, J BACTERIOL, V179, P7611, DOI 10.1128/jb.179.24.7611-7616.1997; Benghezal M, 2007, J BIOL CHEM, V282, P30845, DOI 10.1074/jbc.M702719200; BENNING C, 1995, ARCH BIOCHEM BIOPHYS, V317, P103, DOI 10.1006/abbi.1995.1141; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CHILTON FH, 1986, J BIOL CHEM, V261, P7771; CHILTON FH, 1987, BIOCHIM BIOPHYS ACTA, V917, P48, DOI 10.1016/0005-2760(87)90282-7; FERNANDEZMURRAY JP, 2006, BIOCHIM BIOPHYS ACTA, V1771, P331; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Hanson PK, 2003, J BIOL CHEM, V278, P36041, DOI 10.1074/jbc.M305263200; Iwamoto K, 2004, GENES CELLS, V9, P891, DOI 10.1111/j.1365-2443.2004.00782.x; Jain S, 2007, J BIOL CHEM, V282, P30562, DOI 10.1074/jbc.M706326200; Merkel O, 2005, BIOCHEM J, V387, P489, DOI 10.1042/BJ20041272; NAGIEC MM, 1993, J BIOL CHEM, V268, P22156; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sohlenkamp C, 2000, J BIOL CHEM, V275, P18919, DOI 10.1074/jbc.M000844200; STEIN O., 1965, LIFE SCI, V4, P203, DOI 10.1016/0024-3205(65)90120-7; STEIN Y, 1966, BIOCHIM BIOPHYS ACTA, V116, P95, DOI 10.1016/0005-2760(66)90095-6; Tamaki H, 2007, J BIOL CHEM, V282, P34288, DOI 10.1074/jbc.M704509200; TROTTER PJ, 1995, J BIOL CHEM, V270, P6071, DOI 10.1074/jbc.270.11.6071; WALENGA RW, 1975, J BIOL CHEM, V250, P9121; WALENGA RW, 1975, J BIOL CHEM, V250, P9130; Zarini S, 2006, J BIOL CHEM, V281, P10134, DOI 10.1074/jbc.M510783200	26	90	95	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36853	36861		10.1074/jbc.M706718200	http://dx.doi.org/10.1074/jbc.M706718200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17951629	hybrid			2022-12-25	WOS:000251646000010
J	Craven, RJ; Mallory, JC; Hand, RA				Craven, Rolf J.; Mallory, Julia C.; Hand, Randal A.			Regulation of iron homeostasis mediated by the heme-binding protein Dap1 (damage resistance protein 1) via the p450 protein Erg11/Cyp51	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER ZONE ANTIGEN; SACCHAROMYCES-CEREVISIAE; PROGESTERONE-RECEPTOR; YEAST; GENE; IDENTIFICATION; BIOSYNTHESIS; TRANSPORT; ENDOCYTOSIS; EXPRESSION	Fungal infections arise frequently in immunocompromised patients, and sterol synthesis is a primary pathway targeted by antifungal drugs. In particular, the P450 protein Erg11/Cyp51 catalyzes a critical step in ergosterol synthesis, and the azole class of antifungal drugs inhibits Erg11. Dap1 is a heme-binding protein related to cytochrome b(5) that activates Erg11, so that cells lacking Dap1 accumulate the Erg11 substrate and are hypersensitive to Erg11 inhibitors. Heme binding by Dap1 is crucial for its function, and point mutants in its heme-binding domain render Dap1 inactive for sterol biosynthesis and DNA damage resistance. Like Dap1, the human homologue, PGRMC1/Hpr6, also regulates sterol synthesis and DNA damage resistance. In the present study, we demonstrate that the Dap1 heme-1 domain is required for growth under conditions of low iron availability. Loss of Dap1 is suppressed by elevated levels of Erg11 but not by increased heme biosynthesis. Dap1 localizes to punctate cytoplasmic structures that co-fractionate with endosomes, and Dap1 contributes to the integrity of the vacuole. The results suggest that Saccharomyces cerevisiae Dap1 stimulates a P450-catalyzed step in sterol synthesis via a distinct localization from its homologues in Schizosaccharomyces pombe and mammals and that this function regulates iron metabolism.	Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA; Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of Kentucky; University of North Carolina; University of North Carolina Chapel Hill	Craven, RJ (corresponding author), Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA.	rolf.craven@uky.edu			NCRR NIH HHS [P20 RR 15592] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015592] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ARTHINGTON BA, 1991, GENE, V102, P39, DOI 10.1016/0378-1119(91)90535-J; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; BAYNES RD, 1990, ANNU REV NUTR, V10, P133, DOI [10.1146/annurev.nutr.10.1.133, 10.1146/annurev.nu.10.070190.001025]; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Chen OS, 2000, J BIOL CHEM, V275, P7626, DOI 10.1074/jbc.275.11.7626; Craven RJ, 2002, GENETICS, V161, P493; Craven RJ, 2001, GENETICS, V158, P145; Crisp RJ, 2003, J BIOL CHEM, V278, P45499, DOI 10.1074/jbc.M307229200; Crudden G, 2006, J PHARMACOL EXP THER, V316, P448, DOI 10.1124/jpet.105.094631; Crudden G, 2005, TUMOR BIOL, V26, P142, DOI 10.1159/000086485; DANCIS A, 1990, MOL CELL BIOL, V10, P2294, DOI 10.1128/MCB.10.5.2294; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Falkenstein E, 1996, BIOCHEM BIOPH RES CO, V229, P86, DOI 10.1006/bbrc.1996.1761; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; GABER RF, 1989, MOL CELL BIOL, V9, P3447, DOI 10.1128/MCB.9.8.3447; Gaspar ML, 2007, BBA-MOL CELL BIOL L, V1771, P241, DOI 10.1016/j.bbalip.2006.06.011; Gerdes D, 1998, BIOL CHEM, V379, P907; Ghosh K, 2005, BIOCHEMISTRY-US, V44, P16729, DOI 10.1021/bi0511585; GUARENTE L, 1984, CELL, V36, P503, DOI 10.1016/0092-8674(84)90243-5; Hand RA, 2003, EUKARYOT CELL, V2, P306, DOI 10.1128/EC.2.2.306-317.2003; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hughes AL, 2007, CELL METAB, V5, P143, DOI 10.1016/j.cmet.2006.12.009; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; Krebs CJ, 2000, P NATL ACAD SCI USA, V97, P12816, DOI 10.1073/pnas.97.23.12816; Labombarda F, 2003, J NEUROCHEM, V87, P902, DOI 10.1046/j.1471-4159.2003.02055.x; Lepesheva GI, 2007, BBA-GEN SUBJECTS, V1770, P467, DOI 10.1016/j.bbagen.2006.07.018; Li LT, 1996, J BIOL CHEM, V271, P16927, DOI 10.1074/jbc.271.28.16927; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Li LT, 2001, J BIOL CHEM, V276, P5036, DOI 10.1074/jbc.M008969200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Mallory JC, 2005, MOL CELL BIOL, V25, P1669, DOI 10.1128/MCB.25.5.1669-1679.2005; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Mifsud W, 2002, GENOME BIOL, V3; Min L, 2004, MOL CELL ENDOCRINOL, V215, P143, DOI 10.1016/j.mce.2003.11.025; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; Nolte I, 2000, BBA-PROTEIN STRUCT M, V1543, P123, DOI 10.1016/S0167-4838(00)00188-6; Prasad T, 2006, ANTIMICROB AGENTS CH, V50, P3597, DOI 10.1128/AAC.00653-06; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Rahier A, 2000, BIOCHEM SOC T, V28, P799, DOI 10.1042/BST0280799; Raza FS, 2001, EUR J BIOCHEM, V268, P2141, DOI 10.1046/j.1432-1327.2001.02096.x; REDDY VVR, 1977, J BIOL CHEM, V252, P2797; Roy CN, 2001, HUM MOL GENET, V10, P2181, DOI 10.1093/hmg/10.20.2181; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; Selmin O, 1996, CARCINOGENESIS, V17, P2609, DOI 10.1093/carcin/17.12.2609; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; Souza CM, 2007, BBA-MOL CELL BIOL L, V1771, P442, DOI 10.1016/j.bbalip.2006.08.006; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Van Ho A, 2002, ANNU REV MICROBIOL, V56, P237, DOI 10.1146/annurev.micro.56.012302.160847; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; WEINSTEIN JD, 1986, ARCH BIOCHEM BIOPHYS, V245, P44, DOI 10.1016/0003-9861(86)90188-8; WICHMANN H, 1992, CELL, V71, P1131, DOI 10.1016/S0092-8674(05)80062-5; Wiwatwattana N, 2007, NUCLEIC ACIDS RES, V35, pD810, DOI 10.1093/nar/gkl1000; Zhang L, 1999, CELL MOL LIFE SCI, V56, P415, DOI 10.1007/s000180050442; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1993, J BACTERIOL, V175, P2853, DOI 10.1128/JB.175.10.2853-2858.1993; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	64	46	49	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36543	36551		10.1074/jbc.M706770200	http://dx.doi.org/10.1074/jbc.M706770200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17954932	Green Published, hybrid			2022-12-25	WOS:000251458300047
J	Scott, KC; White, CV; Willard, HF				Scott, Kristin C.; White, Caroline V.; Willard, Huntington F.			An RNA Polymerase III-Dependent Heterochromatin Barrier at Fission Yeast Centromere 1	PLOS ONE			English	Article								Heterochromatin formation involves the nucleation and spreading of structural and epigenetic features along the chromatin fiber. Chromatin barriers and associated proteins counteract the spreading of heterochromatin, thereby restricting it to specific regions of the genome. We have performed gene expression studies and chromatin immunoprecipitation on strains in which native centromere sequences have been mutated to study the mechanism by which a tRNA(Alanine) gene barrier (cen1 tDNA(Ala)) blocks the spread of pericentromeric heterochromatin at the centromere of chromosome 1 (cen1) in the fission yeast, Schizosaccharomyces pombe. Within the centromere, barrier activity is a general property of tDNAs and, unlike previously characterized barriers, requires the association of both transcription factor IIIC and RNA Polymerase III. Although the cen1 tDNA Ala gene is actively transcribed, barrier activity is independent of transcriptional orientation. These findings provide experimental evidence for the involvement of a fully assembled RNA polymerase III transcription complex in defining independent structural and functional domains at a eukaryotic centromere.	[Scott, Kristin C.; White, Caroline V.; Willard, Huntington F.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA	Duke University	Scott, KC (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA.	kristin.scott@duke.edu			March of Dimes Birth Defects Foundation; Program in Genome Biology of the Duke Institute for Genome Sciences and Policy	March of Dimes Birth Defects Foundation(March of Dimes); Program in Genome Biology of the Duke Institute for Genome Sciences and Policy	Funding: This work was supported by a grant from the March of Dimes Birth Defects Foundation and funds from the Program in Genome Biology of the Duke Institute for Genome Sciences and Policy.	Avramova Z, 1999, TRENDS GENET, V15, P138, DOI 10.1016/S0168-9525(99)01712-6; Bolton EC, 2003, GENOME RES, V13, P254, DOI 10.1101/gr.612203; Braglia P, 2007, MOL CELL BIOL, V27, P1545, DOI 10.1128/MCB.00773-06; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Chedin S, 1998, COLD SPRING HARB SYM, V63, P381, DOI 10.1101/sqb.1998.63.381; Chedin S, 1998, GENE DEV, V12, P3857, DOI 10.1101/gad.12.24.3857; Chiu YH, 2003, GENETICS, V165, P115; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Conesa C, 2005, MOL CELL BIOL, V25, P8631, DOI 10.1128/MCB.25.19.8631-8642.2005; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Donze D, 2002, BIOESSAYS, V24, P344, DOI 10.1002/bies.10072; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; Ekwall K, 1996, J CELL SCI, V109, P2637; Fourel G, 2001, EMBO REP, V2, P124, DOI 10.1093/embo-reports/kve024; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; GERLACH VL, 1995, MOL CELL BIOL, V15, P1455; GORDON M, 2007, MOL CELL BIOL; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hamada M, 2001, MOL CELL BIOL, V21, P6870, DOI 10.1128/MCB.21.20.6870-6881.2001; Huang Y, 2001, NUCLEIC ACIDS RES, V29, P2675, DOI 10.1093/nar/29.13.2675; Huisinga KL, 2006, CHROMOSOMA, V115, P110, DOI 10.1007/s00412-006-0052-x; HULL MW, 1994, MOL CELL BIOL, V14, P1266, DOI 10.1128/MCB.14.2.1266; Jia ST, 2004, CELL, V119, P469, DOI 10.1016/j.cell.2004.10.020; Kassavetis GA, 1998, P NATL ACAD SCI USA, V95, P9196, DOI 10.1073/pnas.95.16.9196; Kimura A, 2004, GENES CELLS, V9, P499, DOI 10.1111/j.1356-9597.2004.00740.x; KINSEY PT, 1991, NUCLEIC ACIDS RES, V19, P1317, DOI 10.1093/nar/19.6.1317; Lan F, 2007, MOL CELL, V26, P89, DOI 10.1016/j.molcel.2007.02.023; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MORSE RH, 1992, MOL CELL BIOL, V12, P4015, DOI 10.1128/MCB.12.9.4015; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma KI, 2006, CELL, V125, P859, DOI 10.1016/j.cell.2006.04.028; Oki M, 2005, MOL CELL, V19, P707, DOI 10.1016/j.molcel.2005.07.022; Oki M, 2004, MOL CELL BIOL, V24, P1956, DOI 10.1128/MCB.24.5.1956-1967.2004; Pidoux A, 2004, METHODS, V33, P252, DOI 10.1016/j.ymeth.2003.11.021; Pidoux AL, 2004, CHROMOSOME RES, V12, P521, DOI 10.1023/B:CHRO.0000036586.81775.8b; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Scott KC, 2006, CURR BIOL, V16, P119, DOI 10.1016/j.cub.2005.11.065; Simms TA, 2004, NUCLEIC ACIDS RES, V32, P5206, DOI 10.1093/nar/gkh858; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; Sun FL, 1999, CELL, V99, P459, DOI 10.1016/S0092-8674(00)81534-2; TAKAHASHI K, 1991, J MOL BIOL, V218, P13, DOI 10.1016/0022-2836(91)90867-6; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; Valenzuela L, 2006, ANNU REV GENET, V40, P107, DOI 10.1146/annurev.genet.39.073003.113546; Wang L, 2005, J BIOL CHEM, V280, P8637, DOI 10.1074/jbc.C500017200; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005; WITTIG S, 1982, NATURE, V297, P31, DOI 10.1038/297031a0	52	52	53	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1099	10.1371/journal.pone.0001099	http://dx.doi.org/10.1371/journal.pone.0001099			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971862	Green Published, Green Submitted, gold			2022-12-25	WOS:000207458700016
J	Beach, S; Tang, H; Park, S; Dhillon, AS; Keller, ET; Kolch, W; Yeung, KC				Beach, S.; Tang, H.; Park, S.; Dhillon, A. S.; Keller, E. T.; Kolch, W.; Yeung, K. C.			Snail is a repressor of RK1P transcription in metastatic prostate cancer cells	ONCOGENE			English	Article						regulation of RKIP expression; EMT; prostate cancer metastasis	KINASE INHIBITOR PROTEIN; EPITHELIAL-MESENCHYMAL TRANSITIONS; E-CADHERIN; UP-REGULATION; EXPRESSION; HYPERMETHYLATION	Diminished expression of the metastasis suppressor protein RKIP was previously reported in a number of cancers. The underlying mechanism remains unknown. Here, we show that the expression of RKIP negatively correlates with that of Snail zinc-transcriptional repressor, a key modulator of normal and neoplastic epithelial-mesenchymal transition (EMT) program. With a combination of loss-of-function and gain-of-function approaches, we showed that Snail repressed the expression of RKIP in metastatic prostate cancer cell lines. The effect of Snail on RKIP was on the level of transcriptional initiation and mediated by a proximal E-box on the RKIP promoter. Our results therefore suggest that RKIP is a novel component of the Snail transcriptional regulatory network important for the progression and metastasis of cancer.	[Beach, S.; Tang, H.; Park, S.; Yeung, K. C.] Univ Toledo, Coll Med, Dept Biochem & Canc Biol, Toledo, OH 43614 USA; [Keller, E. T.] Univ Michigan Hlth Syst, Ctr Comprehens Canc, Ann Arbor, MI USA; [Keller, E. T.; Kolch, W.] Univ Michigan Hlth Syst, Dept Urol, Ann Arbor, MI USA; [Dhillon, A. S.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Kolch, W.] Univ Glasgow, Sir Henry Wellcome Funct Genom Facil, Glasgow G12 8QQ, Lanark, Scotland	University System of Ohio; University of Toledo; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Beatson Institute; University of Glasgow	Yeung, KC (corresponding author), Univ Toledo, Coll Med, Dept Biochem & Canc Biol, Hlth Sci Campus,BHSB Room 469,3035 Arlington Ave, Toledo, OH 43614 USA.	kam.yeung@utoledo.edu	Keller, Evan T/M-1446-2016; Admin, SBI/HGB-2738-2022; Kolch, Walter/ABF-2102-2021	Keller, Evan T/0000-0002-7592-7535; Kolch, Walter/0000-0001-5777-5016; Dhillon, Amardeep/0000-0002-6065-663X	NATIONAL CANCER INSTITUTE [R01CA098513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064767] Funding Source: NIH RePORTER; Cancer Research UK Funding Source: Medline; NCI NIH HHS [R01 CA098513-05, R01 CA098513] Funding Source: Medline; NIGMS NIH HHS [R01 GM064767, R01 GM64767] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Research UK(Cancer Research UK); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Al-Mulla F, 2006, J CLIN ONCOL, V24, P5672, DOI 10.1200/JCO.2006.07.5499; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chatterjee D, 2004, J BIOL CHEM, V279, P17515, DOI 10.1074/jbc.M313816200; De Craene B, 2005, CELL SIGNAL, V17, P535, DOI 10.1016/j.cellsig.2004.10.011; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Fu Z, 2003, J NATL CANCER I, V95, P878, DOI 10.1093/jnci/95.12.878; Fu Z, 2006, PROSTATE, V66, P248, DOI 10.1002/pros.20319; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Hagan S, 2005, CLIN CANCER RES, V11, P7392, DOI 10.1158/1078-0432.CCR-05-0283; Herman JG, 2000, CURR TOP MICROBIOL, V249, P35; Jiao W, 2002, BRIT J CANCER, V86, P98, DOI 10.1038/sj.bjc.6600017; Jorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Knight S.W., 2001, SCIENCE, V2, P2; Lee HC, 2006, GASTROENTEROLOGY, V131, P1208, DOI 10.1053/j.gastro.2006.07.012; Nakayama H, 1998, DEV BIOL, V199, P150, DOI 10.1006/dbio.1998.8914; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Park S, 2005, ONCOGENE, V24, P3535, DOI 10.1038/sj.onc.1208435; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Poser I, 2001, J BIOL CHEM, V276, P24661, DOI 10.1074/jbc.M011224200; Schuierer MM, 2006, ONCOL REP, V16, P451; Schuierer MM, 2004, CANCER RES, V64, P5186, DOI 10.1158/0008-5472.CAN-03-3861; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Yokoyama K, 2001, ORAL ONCOL, V37, P65, DOI 10.1016/S1368-8375(00)00059-2; Zhang LZ, 2004, SURGERY, V136, P708, DOI 10.1016/j.surg.2003.12.013; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	31	136	148	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 3	2008	27	15					2243	2248		10.1038/sj.onc.1210860	http://dx.doi.org/10.1038/sj.onc.1210860			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	283FE	17952120	Green Accepted			2022-12-25	WOS:000254621300015
J	Morozov, VM; Massoll, NA; Vladimirova, OV; Maul, GG; Ishov, AM				Morozov, V. M.; Massoll, N. A.; Vladimirova, O. V.; Maul, G. G.; Ishov, A. M.			Regulation of c-met expression by transcription repressor Daxx	ONCOGENE			English	Article						Daxx; c-met; transcription; DNA methylation; histone acetylation; metastatic breast cancer	HEPATOCYTE GROWTH-FACTOR; FACTOR RECEPTOR; HGF RECEPTOR; FUNCTIONAL INTERACTIONS; EPITHELIAL-CELLS; SYNDROME PROTEIN; PROTOONCOGENE; INHIBITION; ACTIVATION; CANCER	The protooncogene c-met encodes the tyrosine kinase receptor for the hepatocyte growth factor/scatter factor (HGF/SF). While overexpression of c-met is documented in many types of tumors, the mechanism of c-met regulation remains elusive. Here, we demonstrate Daxx as a repressor of c-met transcription. The expression of c-met is elevated in Daxx knockout mouse cells and is reversed by Daxx reconstitution. C-met promoter analysis of Daxx(-/-) cells reveled changes in chromatin acetylation, but not in DNA methylation. Daxx binds to the mouse c-met promoter and Daxx-binding region is sufficient for transcription repression, while HDAC2 is associated with c-met promoter mostly in Daxx(+/+) cells, pointing to Daxx-dependent HDAC2 recruitment as a potential mechanism of c-met repression. HGF-induced cell mobility and invasion confirmed augmented activity of c-Met/HGF pathway in Daxx(-/-) cells. Finally, inverse correlation between Daxx and c-Met in cancer cell lines and in metastatic breast cancer specimens suggests potential function of Daxx as a c-met repressor during cancer progression.	[Morozov, V. M.; Ishov, A. M.] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Morozov, V. M.; Ishov, A. M.] Univ Florida, Shands Canc Ctr, Gainesville, FL 32610 USA; [Massoll, N. A.] Univ Florida, Dept Pathol, Gainesville, FL 32610 USA; [Massoll, N. A.] Univ Florida, Lab Med, Gainesville, FL 32610 USA; [Vladimirova, O. V.; Maul, G. G.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; The Wistar Institute	Ishov, AM (corresponding author), Univ Florida, Dept Anat & Cell Biol, 1376 Mowry Rd,Room 358, Gainesville, FL 32610 USA.	ishov@ufl.edu	Ishov, Alexander/E-4912-2010	Morozov, Viacheslav/0000-0002-4901-7722				Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Boon EMJ, 2002, CANCER RES, V62, P5126; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; Gambarotta G, 1996, ONCOGENE, V13, P1911; Gibbons RJ, 2000, NAT GENET, V24, P368, DOI 10.1038/74191; Hollenbach AD, 1999, EMBO J, V18, P3702, DOI 10.1093/emboj/18.13.3702; Hollenbach AD, 2002, J CELL SCI, V115, P3319; Ishov AM, 2004, J CELL SCI, V117, P3807, DOI 10.1242/jcs.01230; Kim EJ, 2003, NUCLEIC ACIDS RES, V31, P5356, DOI 10.1093/nar/gkg741; Leroy C, 2006, ANN NY ACAD SCI, V1090, P188, DOI 10.1196/annals.1378.021; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Li RZ, 2000, ONCOGENE, V19, P745, DOI 10.1038/sj.onc.1203385; Maulik G, 2002, CYTOKINE GROWTH F R, V13, P41, DOI 10.1016/S1359-6101(01)00029-6; Michaelson JS, 2003, J CELL SCI, V116, P345, DOI 10.1242/jcs.00234; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Morotti A, 2002, ONCOGENE, V21, P4885, DOI 10.1038/sj.onc.1205622; Muromoto R, 2004, J IMMUNOL, V172, P2985, DOI 10.4049/jimmunol.172.5.2985; Ohiro Y, 2003, MOL CELL BIOL, V23, P322, DOI 10.1128/MCB.23.1.322-334.2003; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Radaeva S, 2002, GASTROENTEROLOGY, V122, P1020, DOI 10.1053/gast.2002.32388; RONG S, 1994, P NATL ACAD SCI USA, V91, P4731, DOI 10.1073/pnas.91.11.4731; Salomoni P, 2006, TRENDS CELL BIOL, V16, P97, DOI 10.1016/j.tcb.2005.12.002; Seol DW, 1999, J BIOL CHEM, V274, P3565, DOI 10.1074/jbc.274.6.3565; Seol DW, 2000, ONCOGENE, V19, P1132, DOI 10.1038/sj.onc.1203404; Seol DW, 1998, BBA-GENE STRUCT EXPR, V1395, P252, DOI 10.1016/S0167-4781(97)00202-9; Shimoda K, 2002, J IMMUNOL, V169, P4707, DOI 10.4049/jimmunol.169.9.4707; Takayama H, 1997, P NATL ACAD SCI USA, V94, P701, DOI 10.1073/pnas.94.2.701; Tang J, 2004, J BIOL CHEM, V279, P20369, DOI 10.1074/jbc.M401321200; Tzeng SL, 2006, J BIOL CHEM, V281, P15405, DOI 10.1074/jbc.M601807200; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Zhang XH, 2005, AM J PHYSIOL-RENAL, V288, pF16, DOI 10.1152/ajprenal.00318.2003; Zhang XH, 2003, AM J PHYSIOL-RENAL, V284, pF1216, DOI 10.1152/ajprenal.00426.2002; Zhao LY, 2003, J VIROL, V77, P11809, DOI 10.1128/JVI.77.21.11809-11821.2003	35	33	34	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR 3	2008	27	15					2177	2186		10.1038/sj.onc.1210865	http://dx.doi.org/10.1038/sj.onc.1210865			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	283FE	17952115				2022-12-25	WOS:000254621300008
J	Yamaguchi, Y; Passeron, T; Hoashi, T; Watabe, H; Rouzaud, F; Yasumoto, K; Hara, T; Tohyama, C; Katayama, I; Miki, T; Hearing, VJ				Yamaguchi, Yuji; Passeron, Thierry; Hoashi, Toshihiko; Watabe, Hidenori; Rouzaud, Franocois; Yasumoto, Ken-ichi; Hara, Takahiko; Tohyama, Chiharu; Katayama, Ichiro; Miki, Toru; Hearing, Vincent J.			Dickkopf 1 (DKK1) regulates skin pigmentation and thickness by affecting Wnt/beta-catenin signaling in keratinocytes	FASEB JOURNAL			English	Article						keratin 9; epithelial cell transforming sequence 2; protease-activated receptor 2; glucose synthase kinase; melanocyte	PROTEINASE-ACTIVATED RECEPTOR-2; MESENCHYMAL-EPITHELIAL INTERACTIONS; EXPOSING BONE-MARROW; ADULT STEM-CELLS; PALMOPLANTAR FIBROBLASTS; GENE-EXPRESSION; WNT; DIFFERENTIATION; PATHWAY; PHOSPHORYLATION	The epidermis (containing primarily keratinocytes and melanocytes) overlies the dermis (containing primarily fibroblasts) of human skin. We previously reported that dickkopf 1 (DKK1) secreted by fibroblasts in the dermis elicits the hypopigmented phenotype of palmoplantar skin due to suppression of melanocyte function and growth via the regulation of two important signaling factors, microphthalmia-associated transcription factor (MITF) and beta-catenin. We now report that treatment of keratinocytes with DKK1 increases their proliferation and decreases their uptake of melanin and that treatment of reconstructed skin with DKK1 induces a thicker and less pigmented epidermis. DNA microarray analysis revealed many genes regulated by DKK1, and several with critical expression patterns were validated by reverse transcriptase-polymerase chain reaction and Western blotting. DKK1 induced the expression of keratin 9 and a-Kelch-like ECT2 interacting protein (alpha KLEIP) but down-regulated the expression of beta-catenin, glycogen synthase kinase 3(3, protein kinase C, and proteinase-activated receptor-2 (PAR-2), which is consistent with the expression patterns of those proteins in human palmoplantar skin. Treatment of reconstructed skin with DKK1 reproduced the expression patterns of those key proteins observed in palmoplantar skin. These findings further elucidate why human skin is thicker and paler on the palms and soles than on the trunk through topographical and site-specific differences in the secretion of DKK1 by dermal fibroblasts that affects the overlying epidermis.	[Yamaguchi, Yuji] Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Yamaguchi, Yuji; Passeron, Thierry; Hoashi, Toshihiko; Watabe, Hidenori; Rouzaud, Franocois; Yasumoto, Ken-ichi; Hara, Takahiko; Miki, Toru; Hearing, Vincent J.] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Yamaguchi, Yuji; Tohyama, Chiharu; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Dept Dermatol, Osaka, Japan	Nagoya City University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Osaka University	Yamaguchi, Y (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	jaijin@med.nagoya-cu.ac	Yamaguchi, Yuji/B-9312-2008; Yamaguchi, Yuji/X-6681-2019; Tohyama, Chiharu/AAI-5598-2020	Tohyama, Chiharu/0000-0003-1061-6872; Yasumoto, Ken-ichi/0000-0002-8090-1161; Passeron, Thierry/0000-0002-0797-6570; Yamaguchi, Yuji/0000-0003-4338-2662	Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC010785, ZIABC010785, ZIABC010786, Z01BC010786] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Babiarz-Magee L, 2004, PIGM CELL RES, V17, P241, DOI 10.1111/j.1600-0749.2004.00133.x; Brandner JM, 2004, J INVEST DERMATOL, V122, P1310, DOI 10.1111/j.0022-202X.2004.22529.x; Carroll K, 2004, NAT REV MOL CELL BIO, V5, P55, DOI 10.1038/nrm1278; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; Di WL, 2005, J CELL SCI, V118, P1505, DOI 10.1242/jcs.01733; Fang XJ, 2002, MOL CELL BIOL, V22, P2099, DOI 10.1128/MCB.22.7.2099-2110.2002; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200; Gregory CA, 2005, J BIOL CHEM, V280, P2309, DOI 10.1074/jbc.M406275200; Hachem JP, 2006, J INVEST DERMATOL, V126, P2074, DOI 10.1038/sj.jid.5700351; Hara T, 2004, MOL BIOL CELL, V15, P1172, DOI 10.1091/mbc.E03-07-0531; Hoashi T, 2005, J BIOL CHEM, V280, P14006, DOI 10.1074/jbc.M413692200; Hofbauer KH, 2003, EUR J BIOCHEM, V270, P4515, DOI 10.1046/j.1432-1033.2003.03846.x; Ikeda A, 2002, J CELL SCI, V115, P9; Ikeda A, 2001, HUM MOL GENET, V10, P1325, DOI 10.1093/hmg/10.12.1325; Jarzab B, 2005, CANCER RES, V65, P1587, DOI 10.1158/0008-5472.CAN-04-3078; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; KNAPP AC, 1986, J CELL BIOL, V103, P657, DOI 10.1083/jcb.103.2.657; Kobayashi S, 1996, FEBS LETT, V386, P149, DOI 10.1016/0014-5793(96)00393-6; Kushimoto T, 2001, P NATL ACAD SCI USA, V98, P10698, DOI 10.1073/pnas.191184798; Li W, 2004, J INVEST DERMATOL, V123, P622, DOI 10.1111/j.0022-202X.2004.23416.x; Mackay A, 2003, ONCOGENE, V22, P2680, DOI 10.1038/sj.onc.1206349; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; MIKI T, 1993, NATURE, V362, P462, DOI 10.1038/362462a0; Papp H, 2003, EXP DERMATOL, V12, P811, DOI 10.1111/j.0906-6705.2003.00097.x; Pullar CE, 2006, FASEB J, V20, P76, DOI 10.1096/fj.05-4188com; Saito H, 2003, PIGM CELL RES, V16, P261, DOI 10.1034/j.1600-0749.2003.00039.x; Scott G, 2003, J INVEST DERMATOL, V121, P529, DOI 10.1046/j.1523-1747.2003.12427.x; Scott G, 2001, J INVEST DERMATOL, V117, P1412, DOI 10.1046/j.0022-202x.2001.01575.x; Seeliger S, 2003, FASEB J, V17, P1871, DOI 10.1096/fj.02-1112com; Seiberg M, 2000, EXP CELL RES, V254, P25, DOI 10.1006/excr.1999.4692; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; Steinhoff M, 1999, EXP DERMATOL, V8, P282; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Yamaguchi Y, 2001, J DERMATOL, V28, P521, DOI 10.1111/j.1346-8138.2001.tb00025.x; Yamaguchi Y, 2005, BRIT J DERMATOL, V152, P664, DOI 10.1111/j.1365-2133.2005.06401.x; Yamaguchi Y, 2004, J CELL BIOL, V165, P275, DOI 10.1083/jcb.200311122; Yamaguchi Y, 2004, BRIT J DERMATOL, V151, P1019, DOI 10.1111/j.1365-2133.2004.06170.x; Yamaguchi Y, 2001, ARCH DERMATOL, V137, P621; Yamaguchi Y, 2005, J DERMATOL SCI, V40, P1, DOI 10.1016/j.jdermsci.2005.04.006; Yamaguchi Y, 1999, J INVEST DERMATOL, V112, P483, DOI 10.1046/j.1523-1747.1999.00544.x; Yamaguchi Y, 2007, J INVEST DERMATOL, V127, P1217, DOI 10.1038/sj.jid.5700629; Yamaguchi Y, 2006, FASEB J, V20, P1486, DOI 10.1096/fj.06-5725fje; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049	53	100	109	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2008	22	4					1009	1020		10.1096/fj.07-9475com	http://dx.doi.org/10.1096/fj.07-9475com			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	282PZ	17984176				2022-12-25	WOS:000254581000007
J	Araki, W; Takahashi-Sasaki, N; Chui, DH; Saito, S; Takeda, K; Shirotani, K; Takahashi, K; Murayama, KS; Kametani, F; Shiraishi, H; Komano, H; Tabira, T				Araki, Wataru; Takahashi-Sasaki, Noriko; Chui, De-Hua; Saito, Shinya; Takeda, Kazuya; Shirotani, Keiro; Takahashi, Keikichi; Murayama, Kiyoko S.; Kametani, Fuyuki; Shiraishi, Hirohisa; Komano, Hiroto; Tabira, Takeshi			A family of membrane proteins associated with presenilin expression and gamma-secretase function	FASEB JOURNAL			English	Article						Alzheimer's disease; beta-amyloid; nicastrin	AMYLOID-BETA-PEPTIDE; ALZHEIMERS-DISEASE; DIFFERENTIAL DISPLAY; PROTEOLYTIC RELEASE; TALKING POINT; MESSENGER-RNA; MUTATIONS; NICASTRIN; COMPLEX; TRAFFICKING	Presenilin 1 (PS1) forms the gamma-secretase complex with at least three components: nicastrin, APH-1, and PEN-2. This complex mediates intramembrane cleavage of amyloid precursor protein (APP) to generate beta-amyloid protein (A beta) as well as other type 1 transmembrane proteins. Although PS1 mutations linked to familial Alzheimer's disease influence these cleavages, their biological consequences have not been fully understood. In this study, we used mRNA differential display analysis to identify a gene, denoted adoplin-1/ORMDL-1, which displays significantly reduced expression in association with PS1 mutations. Adoplin-1 and two highly homologous genes (adoplin-2, -3) constitute a gene family that encodes transmembrane proteins. The mRNA and protein levels of adoplins (particularly adoplin-1, -2) were markedly elevated in PS-deficient fibroblasts, compared to wild-type cells. Moreover, knockdown of the three adoplins by RNA interference affected maturation of nicastrin and its association with PS1. Adoplin knockdown additionally resulted in elevated levels of APP C-terminal fragments and decreased A beta production, suggestive of reduced gamma-secretase activity. Our data collectively indicate that adoplins are unique molecules with PS-related expression and functions that may play important role(s) in the maturation and activity of the gamma-secretase complex.	[Araki, Wataru; Saito, Shinya; Murayama, Kiyoko S.] NCNP, Natl Inst Neurosci, Dept Demyelinating Dis & Aging, Tokyo 1878502, Japan; [Takahashi-Sasaki, Noriko] Tokyo Univ Agr & Technol, Katayanagi Adv Res Labs, Tokyo, Japan; [Chui, De-Hua] Peking Univ, Neurosci Res Inst, Beijing 100871, Peoples R China; [Takeda, Kazuya; Takahashi, Keikichi; Tabira, Takeshi] NCGG, Natl Inst Longev Sci, Aichi, Japan; [Shirotani, Keiro] Hokkaido Univ, Grad Sch Med Sci, Dept Biochem, Sapporo, Hokkaido, Japan; [Kametani, Fuyuki] Tokyo Metropolitan Org Med Res, Tokyo Inst Psychiat, Tokyo, Japan; [Shiraishi, Hirohisa; Komano, Hiroto] Iwate Med Univ, Fac Pharmaceut Sci, Iwate, Japan	National Center for Neurology & Psychiatry - Japan; Tokyo University of Agriculture & Technology; Peking University; Hokkaido University; Tokyo Institute of Psychiatry; Tokyo Metropolitan Institute of Medical Science; Iwate Medical University	Araki, W (corresponding author), NCNP, Natl Inst Neurosci, Dept Demyelinating Dis & Aging, Tokyo 1878502, Japan.	araki@ncnp.go.jp	Araki, Wataru/G-7913-2014; Kametani, Fuyuki/G-4752-2011	Araki, Wataru/0000-0001-8467-6937; Kametani, Fuyuki/0000-0001-9125-7001				Araki W, 2001, J NEUROCHEM, V79, P1161, DOI 10.1046/j.1471-4159.2001.00638.x; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Chen FS, 2002, J BIOL CHEM, V277, P36521, DOI 10.1074/jbc.M205093200; Chui DH, 2001, J ALZHEIMERS DIS, V3, P231; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; HJELMQVIST L, 2002, GENOME BIOL, V3; KAMETANI F, 1993, BIOCHEM BIOPH RES CO, V191, P392, DOI 10.1006/bbrc.1993.1230; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee RKK, 1997, P NATL ACAD SCI USA, V94, P5422, DOI 10.1073/pnas.94.10.5422; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Luo WJ, 2003, J BIOL CHEM, V278, P7850, DOI 10.1074/jbc.C200648200; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Mirnics K, 2005, J NEUROSCI, V25, P1571, DOI 10.1523/JNEUROSCI.4145-04.2005; Saito S, 2005, BIOCHEM BIOPH RES CO, V327, P18, DOI 10.1016/j.bbrc.2004.11.130; Saito S, 2005, BIOCHEM BIOPH RES CO, V330, P1068, DOI 10.1016/j.bbrc.2005.03.096; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Selkoe DJ, 2002, J CLIN INVEST, V110, P1375, DOI 10.1172/JCI200216783; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shirotani K, 1999, NEUROSCI LETT, V262, P37, DOI 10.1016/S0304-3940(99)00037-3; Shirotani K, 2000, J BIOL CHEM, V275, P3681, DOI 10.1074/jbc.275.5.3681; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Takeda K, 2004, EUR J NEUROSCI, V19, P258, DOI 10.1111/j.0953-816X.2003.03135.x; WANG XK, 1995, BIOTECHNIQUES, V18, P448; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Xia XF, 2001, P NATL ACAD SCI USA, V98, P10863, DOI 10.1073/pnas.191284198; Yang DS, 2002, J BIOL CHEM, V277, P28135, DOI 10.1074/jbc.M110871200; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhang YW, 2005, J BIOL CHEM, V280, P17020, DOI 10.1074/jbc.M409467200; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102	40	9	16	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2008	22	3					819	827		10.1096/fj.07-9072com	http://dx.doi.org/10.1096/fj.07-9072com			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17928364				2022-12-25	WOS:000254143700020
J	Huang, JH; Gabrielsen, JS; Cooksey, RC; Luo, B; Boros, LG; Jones, DL; Jouihan, HA; Soesanto, Y; Knecht, L; Hazel, MW; Kushner, JP; McClain, DA				Huang, Jingyu; Gabrielsen, J. Scott; Cooksey, Robert C.; Luo, Bai; Boros, Laszlo G.; Jones, Deborah L.; Jouihan, Hani A.; Soesanto, Yudi; Knecht, Lauren; Hazel, Mark W.; Kushner, James P.; McClain, Donald A.			Increased glucose disposal and AMP-dependent kinase signaling in a mouse model of hemochromatosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; INSULIN SECRETORY CAPACITY; HEREDITARY HEMOCHROMATOSIS; OXIDATIVE STRESS; SERUM FERRITIN; IRON; RESISTANCE; ADIPOCYTES; SENSITIVITY; DYSFUNCTION	Hereditary hemochromatosis is an inherited disorder of increased iron absorption that can result in cirrhosis, diabetes, and other morbidities. We have investigated the mechanisms underlying supranormal glucose tolerance despite decreased insulin secretion in a mouse model of hemochromatosis with deletion of the hemochromatosis gene (Hfe(-/-)). Hfe(-/-) mice on 129Sv or C57BL/6J backgrounds have decreased glucose excursions after challenge compared with controls. In the C57BL/6J/Hfe(-/-), for example, incremental area under the glucose curve is reduced 52% (p < 0.001) despite decreased serum insulin, and homeostasis model assessment insulin resistance is decreased 50% (p < 0.05). When studied by the euglycemic clamp technique 129Sv/Hfe(-/-) mice exhibit a 20% increase in glucose disposal (p < 0.05) at submaximal insulin but no increase at maximal insulin compared with wild types. [1,2-C-13]D-glucose clearance from plasma is significantly increased in Hfe(-/-) mice (19%, p < 0.05), and lactate derived from glycolysis is elevated 5.1-fold in Hfe(-/-) mice (p < 0.0001). Basal but not insulin-stimulated glucose uptake is elevated in isolated soleus muscle from Hfe(-/-) mice (p < 0.03). Compared with controls Hfe(-/-) mice exhibit no differences in serum lipid, insulin, glucagon, or thyroid hormone levels; adiponectin levels are elevated 41% (p < 0.05), and the adiponectin message in adipocytes is increased 83% (p = 0.04). Insulin action measured by phosphorylation of Akt is not enhanced in muscle, but phosphorylation of AMP-dependent kinase is increased. We conclude that supranormal glucose tolerance in iron overload is characterized by increased glucose disposal that does not result from increased insulin action. Instead, the Hfe(-/-) mice demonstrate increased adiponectin levels and activation of AMP-dependent kinase.	[Huang, Jingyu; Gabrielsen, J. Scott; Cooksey, Robert C.; Luo, Bai; Jones, Deborah L.; Jouihan, Hani A.; McClain, Donald A.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA; [Huang, Jingyu; Gabrielsen, J. Scott; Cooksey, Robert C.; Luo, Bai; Jones, Deborah L.; Jouihan, Hani A.; Soesanto, Yudi; Knecht, Lauren; Hazel, Mark W.; Kushner, James P.; McClain, Donald A.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84132 USA; [Cooksey, Robert C.; McClain, Donald A.] VA Affairs Med Ctr, Res Serv, Salt Lake City, UT 84132 USA; [Boros, Laszlo G.] SIDMAP, Los Angeles, CA 90064 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	McClain, DA (corresponding author), Univ Utah, Sch Med, Div Endocrinol, 30 N 2030 E, Salt Lake City, UT 84132 USA.	donald.mcclain@hsc.utah.edu		McClain, Don/0000-0002-3310-2359	NCATS NIH HHS [UL1 TR001420] Funding Source: Medline; NIDDK NIH HHS [DK59512, R01 DK081842] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081842, R56DK059512, R01DK059512] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abraham D, 2006, DIABETOLOGIA, V49, P2546, DOI 10.1007/s00125-006-0445-7; Bahceci M, 2007, J ENDOCRINOL INVEST, V30, P210, DOI 10.1007/BF03347427; BARON AD, 1988, AM J PHYSIOL, V255, P769; BOTHWELL TH, 1995, METABOLIC MOL BASES, P2237; Cooksey RC, 2004, ENDOCRINOLOGY, V145, P5305, DOI 10.1210/en.2004-0392; Cooksey RC, 2002, ANN NY ACAD SCI, V967, P102; CUSHMAN SW, 1978, J LIPID RES, V19, P269; Edwards C, 1999, WINTROBES CLIN HEMAT, P1056; Feder JN, 1997, J BIOL CHEM, V272, P14025, DOI 10.1074/jbc.272.22.14025; Fujii N, 2006, AM J PHYSIOL-ENDOC M, V291, pE867, DOI 10.1152/ajpendo.00207.2006; Gillum RF, 2001, INT J OBESITY, V25, P639, DOI 10.1038/sj.ijo.0801561; Haurie V, 2003, J BIOL CHEM, V278, P45391, DOI 10.1074/jbc.M307447200; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hue L, 2002, J MOL CELL CARDIOL, V34, P1091, DOI 10.1006/jmcc.2002.2063; Iwasaki T, 2005, DIABETES CARE, V28, P2486, DOI 10.2337/diacare.28.10.2486; Jehn M, 2004, DIABETES CARE, V27, P2422, DOI 10.2337/diacare.27.10.2422; Kamigaki M, 2006, BIOCHEM BIOPH RES CO, V339, P624, DOI 10.1016/j.bbrc.2005.11.059; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; LEE WNP, 1995, ANAL BIOCHEM, V226, P100, DOI 10.1006/abio.1995.1197; Levy JE, 1999, BLOOD, V94, P9, DOI 10.1182/blood.V94.1.9.413a43_9_11; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McClain DA, 2006, DIABETOLOGIA, V49, P1661, DOI 10.1007/s00125-006-0200-0; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Nemeth E, 2005, BLOOD, V105, P1803, DOI 10.1182/blood-2004-08-3042; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Qi L, 2007, DIABETES CARE, V30, P101, DOI 10.2337/dc06-1686; Rebouche CJ, 2004, J BIOCHEM BIOPH METH, V58, P239, DOI 10.1016/j.jbbm.2003.11.003; Rumberger JM, 2004, DIABETES, V53, P2535, DOI 10.2337/diabetes.53.10.2535; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Subauste AR, 2007, AM J PHYSIOL-ENDOC M, V293, pE159, DOI 10.1152/ajpendo.00629.2006; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	36	30	30	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37501	37507		10.1074/jbc.M703625200	http://dx.doi.org/10.1074/jbc.M703625200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17971451	hybrid			2022-12-25	WOS:000251833600025
J	Ropolo, A; Grasso, D; Pardo, R; Sacchetti, ML; Archange, C; Lo Re, A; Seux, M; Nowak, J; Gonzalez, CD; Iovanna, JL; Vaccaro, MI				Ropolo, Alejandro; Grasso, Daniel; Pardo, Romina; Sacchetti, Maria L.; Archange, Cendrine; Lo Re, Andrea; Seux, Mylene; Nowak, Jonathan; Gonzalez, Claudio D.; Iovanna, Juan L.; Vaccaro, Maria I.			The pancreatitis-induced vacuole membrane protein 1 triggers autophagy in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; DEATH; YEAST; ATG9; EXPRESSION; MARKER; VMP1; RAT; LC3; AUTOPHAGOCYTOSIS	Autophagy is a degradation process of cytoplasmic cellular constituents, which serves as a survival mechanism in starving cells, and it is characterized by sequestration of bulk cytoplasm and organelles in double-membrane vesicles called autophagosomes. Autophagy has been linked to a variety of pathological processes such as neurodegenerative diseases and tumorigenesis, which highlights its biological and medical importance. We have previously characterized the vacuole membrane protein 1 (VMP1) gene, which is highly activated in acute pancreatitis, a disease associated with morphological changes resembling autophagy. Here we show that VMP1 expression triggers autophagy in mammalian cells. VMP1 expression induces the formation of ultrastructural features of autophagy and recruitment of the microtubule-associated protein 1 light-chain 3 (LC3), which is inhibited after treatment with the autophagy inhibitor 3-methiladenine. VMP1 is induced by starvation and rapamycin treatments. Its expression is necessary for autophagy, because VMP1 small interfering RNA inhibits autophagosome formation under both autophagic stimuli. VMP1 is a transmembrane protein that co-localizes with LC3, a marker of the autophagosomes. It interacts with Beclin 1, a mammalian autophagy initiator, through the VMP1-Atg domain, which is essential for autophagosome formation. VMP1 endogenous expression co-localizes with LC3 in pancreas tissue undergoing pancreatitis-induced autophagy. Finally, VMP1 stable expression targeted to pancreas acinar cell in transgenic mice induces autophagosome formation. Our results identify VMP1 as a novel autophagy-related membrane protein involved in the initial steps of the mammalian cell autophagic process.	[Archange, Cendrine; Seux, Mylene; Nowak, Jonathan; Iovanna, Juan L.] INSERM, Unit 624, F-13288 Marseille, France; [Ropolo, Alejandro; Grasso, Daniel; Pardo, Romina; Sacchetti, Maria L.; Vaccaro, Maria I.] Univ Buenos Aires, Sch Med, Dept Physiol, Buenos Aires, DF, Argentina; [Gonzalez, Claudio D.] CEMIC Univ Hosp, Buenos Aires, DF, Argentina	Institut National de la Sante et de la Recherche Medicale (Inserm); University of Buenos Aires; Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); University of Buenos Aires	Iovanna, JL (corresponding author), INSERM, Unit 624, 163 Ave Luminy,Case 915, F-13288 Marseille, France.	iovanna@marseille.inserm.fr; mvaccaro@fmed.uba.ar	Iovanna, Juan/M-9805-2017; Vaccaro, Maria I./L-8348-2017	Iovanna, Juan/0000-0003-1822-2237; Vaccaro, Maria/0000-0002-2456-747X; Gonzalez, Claudio/0000-0002-3772-8850; GRASSO, DANIEL/0000-0002-8932-716X				ADLER G, 1985, DIGESTION, V32, P10, DOI 10.1159/000199210; AHO HJ, 1980, SCAND J GASTROENTERO, V15, P417, DOI 10.3109/00365528009181494; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Dusetti NJ, 2002, BIOCHEM BIOPH RES CO, V290, P641, DOI 10.1006/bbrc.2001.6244; Fernandez-Zapico ME, 2003, EMBO J, V22, P4748, DOI 10.1093/emboj/cdg470; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; HELIN H, 1980, VIRCHOWS ARCH A, V387, P259, DOI 10.1007/BF00454829; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Jiang PH, 2004, PANCREAS, V29, P225, DOI 10.1097/00006676-200410000-00008; Juhasz G, 2006, PLOS BIOL, V4, P161, DOI 10.1371/journal.pbio.0040036; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DJ, 2004, NATURE, V431, P31, DOI 10.1038/431031a; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Komatsu M, 2007, CELL DEATH DIFFER, V14, P887, DOI 10.1038/sj.cdd.4402120; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Legakis JE, 2007, AUTOPHAGY, V3, P422, DOI 10.4161/auto.4129; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mari M, 2007, AUTOPHAGY, V3, P145, DOI 10.4161/auto.3608; MITCHENER JS, 1976, AM J PATHOL, V83, P485; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Reggiori F, 2005, AUTOPHAGY, V1, P101, DOI 10.4161/auto.1.2.1840; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Vaccaro MI, 2003, PANCREATOLOGY, V3, P69, DOI 10.1159/000069150; Wagner S, 2006, TRENDS BIOTECHNOL, V24, P364, DOI 10.1016/j.tibtech.2006.06.008; WATANABE O, 1984, AM J PHYSIOL, V246, P457; WEBBER JL, 2007, AUTOHAGY, V3, P145; WILLEMER S, 1989, VIRCHOWS ARCH A, V415, P115, DOI 10.1007/BF00784348; Yen WL, 2007, MOL BIOL CELL, V18, P581, DOI 10.1091/mbc.E06-07-0612; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172	49	148	161	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37124	37133		10.1074/jbc.M706956200	http://dx.doi.org/10.1074/jbc.M706956200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17940279	hybrid			2022-12-25	WOS:000251646000039
J	Zhao, DH; Curatti, L; Rubio, LM				Zhao, Dehua; Curatti, Leonardo; Rubio, Luis M.			Evidence for nifU and nifS participation in the biosynthesis of the iron-molybdenum cofactor of nitrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO SYNTHESIS; AZOTOBACTER-VINELANDII; FEMO-COFACTOR; CRYSTALLOGRAPHIC STRUCTURE; KLEBSIELLA-PNEUMONIAE; FIXATION GENES; MOFE-PROTEIN; CLUSTER; SULFUR; MATURATION	The nifU and nifS genes encode the components of a cellular machinery dedicated to the assembly of [2Fe-2S] and [4Fe-4S] clusters required for growth under nitrogen-fixing conditions. The NifU and NifS proteins are involved in the production of active forms of the nitrogenase component proteins, NifH and NifDK. Although NifH contains a [4Fe-4S] cluster, the NifDK component carries two complex metalloclusters, the iron-molybdenum cofactor (FeMo-co) and the [8Fe-7S] P-cluster. FeMo-co, located at the active site of NifDK, is composed of 7 iron, 9 sulfur, 1 molybdenum, 1 homocitrate, and 1 unidentified light atom. To investigate whether NifUS are required for FeMo-co biosynthesis and to understand at what level(s) they might participate in this process, we analyzed the effect of nifU and nifS mutations on the formation of active NifB protein and on the accumulation of NifB-co, an isolatable intermediate of the FeMo-co biosynthetic pathway synthesized by the product of the nifB gene. The nifU and nifS genes were required to accumulate NifB-co in a nifN mutant background. This result clearly demonstrates the participation of NifUS in NifB-co synthesis and suggests a specific role of NifUS as the major provider of [Fe-S] clusters that serve as metabolic substrates for the biosynthesis of FeMo-co. Surprisingly, although nifB expression was attenuated in nifUS mutants, the assembly of the [Fe-S] clusters of NifB was compensated by other non-nif machinery for the assembly of [Fe-S] clusters, indicating that NifUS are not essential to synthesize active NifB.	[Zhao, Dehua; Curatti, Leonardo; Rubio, Luis M.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Rubio, LM (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, 111 Koshland Hall, Berkeley, CA 94720 USA.	lrubio@nature.berkeley.edu	Rubio, Luis M./B-5827-2009	Rubio, Luis M./0000-0003-1596-2475	PHS HHS [35332] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALLEN RM, 1995, J BIOL CHEM, V270, P26890, DOI 10.1074/jbc.270.45.26890; BRANDNER JP, 1989, J BACTERIOL, V171, P360, DOI 10.1128/jb.171.1.360-368.1989; BULEN WA, 1966, P NATL ACAD SCI USA, V56, P979, DOI 10.1073/pnas.56.3.979; CHAN MK, 1993, SCIENCE, V260, P792, DOI 10.1126/science.8484118; Christiansen J, 1998, BIOCHEMISTRY-US, V37, P12611, DOI 10.1021/bi981165b; Curatti L, 2006, P NATL ACAD SCI USA, V103, P5297, DOI 10.1073/pnas.0601115103; Curatti L, 2005, P NATL ACAD SCI USA, V102, P6291, DOI 10.1073/pnas.0501216102; Curatti L, 2007, P NATL ACAD SCI USA, V104, P17626, DOI 10.1073/pnas.0703050104; Dos Santos PC, 2007, J BACTERIOL, V189, P2854, DOI 10.1128/JB.01734-06; Dos Santos PC, 2004, CHEM REV, V104, P1159, DOI 10.1021/cr020608l; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; Hernandez JA, 2007, MOL MICROBIOL, V63, P177, DOI 10.1111/j.1365-2958.2006.05514.x; JACOBSON MR, 1989, MOL GEN GENET, V219, P49, DOI 10.1007/BF00261156; Johnson DC, 2005, BIOCHEM SOC T, V33, P90, DOI 10.1042/BST0330090; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; KIM JS, 1992, NATURE, V360, P553, DOI 10.1038/360553a0; KUO CF, 1988, ANAL BIOCHEM, V170, P183, DOI 10.1016/0003-2697(88)90106-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ludden PW, 2004, CATALYSTS FOR NITROGEN FIXATION: NITROGENASES, RELEVANT CHEMICAL MODELS AND COMMERCIAL PROCESSES, P219; MACNEIL T, 1978, J BACTERIOL, V136, P253, DOI 10.1128/JB.136.1.253-266.1978; NAGATANI HH, 1974, J BACTERIOL, V120, P697, DOI 10.1128/JB.120.2.697-701.1974; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Rangaraj P, 1997, P NATL ACAD SCI USA, V94, P11250, DOI 10.1073/pnas.94.21.11250; Rangaraj P, 2001, J BIOL CHEM, V276, P15968, DOI 10.1074/jbc.M100907200; ROBERTS GP, 1978, J BACTERIOL, V136, P267, DOI 10.1128/JB.136.1.267-279.1978; Rubio LM, 2002, J BIOL CHEM, V277, P14299, DOI 10.1074/jbc.M107289200; Rubio LM, 2005, J BACTERIOL, V187, P405, DOI 10.1128/JB.187.2.405-414.2005; Sambrook J, 2001, MOL CLONING LAB MANU; SHAH VK, 1972, BIOCHIM BIOPHYS ACTA, V256, P498, DOI 10.1016/0005-2728(72)90078-3; SHAH VK, 1994, J BIOL CHEM, V269, P1154; SHAH VK, 1973, BIOCHIM BIOPHYS ACTA, V305, P445, DOI 10.1016/0005-2728(73)90190-4; SHAH VK, 1977, P NATL ACAD SCI USA, V74, P3249, DOI 10.1073/pnas.74.8.3249; SHOKOLENKO IN, 1995, BIOTECHNIQUES, V18, P596; Smith AD, 2005, BIOCHEMISTRY-US, V44, P12955, DOI 10.1021/bi051257i; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STEWART WDP, 1967, P NATL ACAD SCI USA, V58, P2071, DOI 10.1073/pnas.58.5.2071; Walker KA, 2004, J BACTERIOL, V186, P4056, DOI 10.1128/JB.186.13.4056-4066.2004; Yang TC, 2005, J AM CHEM SOC, V127, P12804, DOI 10.1021/ja0552489; Yuvaniyama P, 2000, P NATL ACAD SCI USA, V97, P599, DOI 10.1073/pnas.97.2.599; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; ZHENG LM, 1994, J BIOL CHEM, V269, P18723; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031	44	40	42	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37016	37025		10.1074/jbc.M708097200	http://dx.doi.org/10.1074/jbc.M708097200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17959596	hybrid			2022-12-25	WOS:000251646000028
J	Irimia, A; Eoff, RL; Pallan, PS; Guengerich, FP; Egli, M				Irimia, Adriana; Eoff, Robert L.; Pallan, Pradeep S.; Guengerich, F. Peter; Egli, Martin			Structure and activity of Y-class DNA polymerase DPO4 from Sulfolobus solfataricus with templates containing the hydrophobic thymine analog 2,4-difluorotoluene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPHOSPHATE INCORPORATION; SUBANGSTROM INCREMENTS; CRYSTAL-STRUCTURES; DIFFRACTION DATA; SITE TIGHTNESS; STEADY-STATE; DUPLEX DNA; FIDELITY; REPLICATION; BYPASS	The 2,4-difluorotoluene (DFT) analog of thymine has been used extensively to probe the relative importance of shape an dhydrogen bonding for correct nucleotide insertion by DNA polymerases. As far as high fidelity (A-class) polymerases are concerned, shape is considered by some as key to incorporation of A(T) opposite T(A) and G(C) opposite C(G). We have carried out a detailed kinetic analysis of invitro primer extension opposite DFT-containingtemplates by the trans-lesion (Y-class) DNA polymerase Dpo4 from Sulfolobus solfataricus. Although full-length product formation was observed, steady-state kinetic data show that dATP insertion opposite DFT is greatly inhibited relative to insertion opposite T (similar to 5,000-fold). No products were observed in the pre-steady-state. Furthermore, it is noteworthy that Dpo4 strongly prefers dATP opposite DFT over dGTP (similar to 200-fold) and that the polymerase is able to extend an A: DFT but not a G: DFT pair. We present crystal structures of Dpo4 in complex with DNA duplexes containing the DFT analog, the first for any DNA polymerase. In the structures, template-DFT is either positioned opposite primer-A or -G at the -1 site or is unopposed by a primer base and followed by adGTP:A mismatch pair at the active site, representative of a -1 frameshift. The three structures provide insight into the discrimination by Dpo4 between dATP and dGTP opposite DFT and its inability to extend beyond aG: DFT pair. Although hydrogen bonding is clearly important for error-free replication by this Y-class DNA polymerase, our work demonstrates that Dpo4 also relies on shape and electrostatics to distinguish between correct and incorrect incoming nucleotide.	Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University	Egli, M (corresponding author), Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Dept Biochem, 607 Light Hall, Nashville, TN 37232 USA.	martin.egli@vanderbilt.edu			NCI NIH HHS [F32 CA119776] Funding Source: Medline; NIEHS NIH HHS [P30 ES000267, P01 ES05355, R01 ES010375] Funding Source: Medline; NIGMS NIH HHS [GM055237] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA119776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010375, P30ES000267, P01ES005355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055237] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Brieba LG, 2004, EMBO J, V23, P3452, DOI 10.1038/sj.emboj.7600354; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAMBILLAU C, 1997, TURBO FRODO; Christian NP, 2001, J AM SOC MASS SPECTR, V12, P744, DOI 10.1016/S1044-0305(01)00228-8; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Einolf HJ, 1998, BIOCHEMISTRY-US, V37, P13300, DOI 10.1021/bi981346d; Eoff RL, 2007, J BIOL CHEM, V282, P19831, DOI 10.1074/jbc.M702290200; Eoff RL, 2007, J BIOL CHEM, V282, P13573, DOI 10.1074/jbc.M700656200; Eoff RL, 2007, J BIOL CHEM, V282, P1456, DOI 10.1074/jbc.M609661200; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2116, DOI 10.1021/bi035746z; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Guckian KM, 1998, NAT STRUCT BIOL, V5, P954, DOI 10.1038/2930; Guckian KM, 1996, J AM CHEM SOC, V118, P8182, DOI 10.1021/ja961733f; Guengerich FP, 2006, CHEM REV, V106, P420, DOI 10.1021/cr0404693; Irimia A, 2006, BIOCHEMISTRY-US, V45, P5949, DOI 10.1021/bi052511+; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim TW, 2006, J BIOL CHEM, V281, P2289, DOI 10.1074/jbc.M510744200; Kim TW, 2005, P NATL ACAD SCI USA, V102, P15803, DOI 10.1073/pnas.0505113102; Kool ET, 2006, CHEM COMMUN, P3665, DOI 10.1039/b605414e; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; LI F, 2007, IN PRESS NUCL ACIDS, V35; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Ling H, 2004, P NATL ACAD SCI USA, V101, P2265, DOI 10.1073/pnas.0308332100; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mizukami S, 2006, BIOCHEMISTRY-US, V45, P2772, DOI 10.1021/bi051961z; Morales JC, 1998, NAT STRUCT BIOL, V5, P950, DOI 10.1038/2925; Moran S, 1997, P NATL ACAD SCI USA, V94, P10506, DOI 10.1073/pnas.94.20.10506; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potapova O, 2006, BIOCHEMISTRY-US, V45, P890, DOI 10.1021/bi051792i; Trincao J, 2004, NAT STRUCT MOL BIOL, V11, P457, DOI 10.1038/nsmb755; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; Warren JJ, 2006, P NATL ACAD SCI USA, V103, P19701, DOI 10.1073/pnas.0609580103; Washington MT, 2003, MOL CELL BIOL, V23, P5107, DOI 10.1128/MCB.23.14.5107-5112.2003; Wolfle WT, 2005, MOL CELL BIOL, V25, P7137, DOI 10.1128/MCB.25.16.7137-7143.2005; Xia J, 2006, ACS CHEM BIOL, V1, P176, DOI 10.1021/cb600063p; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200	43	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36421	36433		10.1074/jbc.M707267200	http://dx.doi.org/10.1074/jbc.M707267200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17951245	hybrid			2022-12-25	WOS:000251458300034
J	Li, X; Lee, YK; Jeng, JC; Yen, Y; Schultz, DC; Shih, HM; Ann, DK				Li, Xu; Lee, Yung-Kang; Jeng, Jen-Chong; Yen, Yun; Schultz, David C.; Shih, Hsiu-Ming; Ann, David K.			Role for KAP1 serine 824 phosphorylation and sumoylation/desumoylation switch in regulating KAP1-mediated transcriptional repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; DNA-DAMAGE; DEPENDENT TRANSCRIPTION; SUMO MODIFICATION; MDM2 INTERACTION; G(2) CHECKPOINT; C-JUN; P53; CANCER; CELLS	As a multifunctional protein, KRAB domain-associated protein 1 (KAP1) is reportedly subjected to multiple protein post-translational modifications, including phosphorylation and sumoylation. However, gaps exist in our knowledge of how KAP1 phosphorylation cross-talks with KAP1 sumoylation and what the biological consequence is. Here, we show that doxorubicin (Dox) treatment induces KAP1 phosphorylation at Ser-824 via an ataxia telangiectasia mutated (ATM)-dependent manner, correlating with the transcriptional de-repression of p21(WAF1/CIP1) and Gadd45 alpha. A S824A substitution of KAP1, which ablates the ATM-induced phosphorylation, results in an increase of KAP1 sumoylation and repression of p21 transcription in Dox-treated cells. By contrast, a S824D mutation of KAP1, which mimics constitutive phosphorylation of KAP1, leads to a decrease of KAP1 sumoylation and stimulation of p21 transcription before the exposure of Dox. We further provide evidence that SENP1 deSUMOylase is involved in activating basal, but not Dox-induced, KAP1 Ser-824 phosphorylation, rendering a stimulation of p21 and Gadd45 alpha transcription. Moreover, KAP1 and differential sumoylation of KAP1 were also demonstrated to fine-tune the transcription of three additional KAP1-targeted genes, including Bax, Puma, and Noxa. Taken together, our results suggest a novel role for ATM that selectively stimulates KAP1 Ser-824 phosphorylation to repress its sumoylation, leading to the de-repression of expression of a subset of genes involved in promoting cell cycle control and apoptosis in response to genotoxic stresses.	City Hope Natl Med Ctr, Dep Clin & Mol Pharmacol, Duarte, CA 91010 USA; Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90033 USA; Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	City of Hope; University of Southern California; Academia Sinica - Taiwan; The Wistar Institute	Ann, DK (corresponding author), City Hope Natl Med Ctr, Dep Clin & Mol Pharmacol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	dann@coh.org	Yen, Yun/H-9591-2016; Shih, Hsiu-Ming/S-7023-2018; Li, Xu/A-7108-2013		NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE010742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014183] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE 10742, DE 14183] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Bossis G, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-13; Broude EV, 2007, ONCOGENE, V26, P6954, DOI 10.1038/sj.onc.1210516; Cheng JK, 2005, J BIOL CHEM, V280, P14492, DOI 10.1074/jbc.M412185200; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Lechner MS, 2000, MOL CELL BIOL, V20, P6449, DOI 10.1128/MCB.20.17.6449-6465.2000; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lin JY, 2004, FEBS LETT, V573, P15, DOI 10.1016/j.febslet.2004.07.059; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Nefkens I, 2003, J CELL SCI, V116, P513, DOI 10.1242/jcs.00253; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Okamoto K, 2006, BIOCHEM BIOPH RES CO, V351, P216, DOI 10.1016/j.bbrc.2006.10.022; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Passalaris TM, 1999, MOL CELL BIOL, V19, P5872, DOI 10.1128/mcb.19.9.5872; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; Wang QZ, 1996, J NATL CANCER I, V88, P956, DOI 10.1093/jnci/88.14.956; White DE, 2006, CANCER RES, V66, P11594, DOI 10.1158/0008-5472.CAN-06-4138; Yun JH, 2003, MOL CELL BIOL, V23, P7305, DOI 10.1128/MCB.23.20.7305-7314.2003; Zhao LY, 2003, J VIROL, V77, P11809, DOI 10.1128/JVI.77.21.11809-11821.2003; Zheng L, 2000, MOL CELL, V6, P757, DOI 10.1016/S1097-2765(00)00075-7; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	45	128	132	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36177	36189		10.1074/jbc.M706912200	http://dx.doi.org/10.1074/jbc.M706912200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17942393	hybrid			2022-12-25	WOS:000251458300007
J	Mirsaliotis, A; Nurkiyanova, K; Lamb, D; Kuo, CWS; Brighty, DW				Mirsaliotis, Antonis; Nurkiyanova, Kulpash; Lamb, Daniel; Kuo, Chien-Wen S.; Brighty, David W.			Resistance to neutralization by antibodies targeting the coiled coil of fusion-active envelope is a common feature of retroviruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; HEPARAN-SULFATE PROTEOGLYCANS; MALTOSE-BINDING PROTEIN; CELL-CELL FUSION; CONFORMATIONAL EPITOPES; SURFACE GLYCOPROTEIN; MEMBRANE-FUSION; HIV-1 GP41; HTLV-I	The human T-cell leukemia virus transmembrane glycoprotein (TM) is a typical class 1 membrane fusion protein and a subunit of the viral envelope glycoprotein complex. Following activation, the TM undergoes conformational transitions from a native nonfusogenic state to a fusion-active pre-hairpin intermediate that subsequently resolves to a compact trimer-of-hairpins or six-helix bundle. Disruption of these structural transitions inhibits membrane fusion and viral entry and validates TM as an anti-viral and vaccine target. To investigate the immunological properties of fusion-active TM, we have generated a panel of monoclonal antibodies that recognize the coiled-coil domain of the pre-hairpin intermediate. Antibody reactivity is highly sensitive to the conformation of the coiled coil as binding is dramatically reduced or lost on denatured antigen. Moreover, a unique group of antibodies are 100-1000-fold more reactive with the coiled coil than the trimer-of-hairpins form of TM. The antibodies recognize virally expressed envelope, and significantly, some selectively bind to envelope only under conditions that promote membrane fusion. Most importantly, many of the antibodies potently block six-helix bundle formation in vitro. Nevertheless, viral envelope was remarkably resistant to neutralization by antibodies directed to the coiled coil. The data imply that the coiled coil of viral envelope is poorly exposed to antibody during membrane fusion. We suggest that resistance to neutralization by antibodies directed to fusion-associated structures is a common property of retroviral TM and perhaps of other viral class I fusion proteins. These observations have significant implications for vaccine design.	Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland	University of Dundee	Brighty, DW (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland.	brighty@cancer.org.uk						AstierGin T, 1997, J INFECT DIS, V175, P716, DOI 10.1093/infdis/175.3.716; Brighty DW, 2001, J VIROL, V75, P10472, DOI 10.1128/JVI.75.21.10472-10478.2001; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Center RJ, 1998, PROTEIN SCI, V7, P1612, DOI 10.1002/pro.5560070715; De Rosny E, 2001, J VIROL, V75, P8859, DOI 10.1128/JVI.75.18.8859-8863.2001; DOKHELAR MC, 1989, J ACQ IMMUN DEF SYND, V2, P431; Eckert DM, 1999, CELL, V99, P103, DOI 10.1016/S0092-8674(00)80066-5; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; FREY S, 1995, J VIROL, V69, P1462, DOI 10.1128/JVI.69.3.1462-1472.1995; Golding H, 2002, J VIROL, V76, P6780, DOI 10.1128/JVI.76.13.6780-6790.2002; Gorny MK, 2000, J VIROL, V74, P6186, DOI 10.1128/JVI.74.13.6186-6192.2000; Grange MP, 1997, DNA CELL BIOL, V16, P1439, DOI 10.1089/dna.1997.16.1439; Hadlock KG, 1997, J VIROL, V71, P5828, DOI 10.1128/JVI.71.8.5828-5840.1997; Hadlock KG, 2002, AIDS RES HUM RETROV, V18, P57, DOI 10.1089/088922202753394727; Hadlock KG, 1999, J VIROL, V73, P1205, DOI 10.1128/JVI.73.2.1205-1212.1999; Hunter E., 1997, P71; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Jassal SR, 2001, J VIROL, V75, P8317, DOI 10.1128/JVI.75.17.8317-8328.2001; Jassal SR, 2001, VIRUS RES, V78, P17, DOI 10.1016/S0168-1702(01)00279-9; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Jones KS, 2005, J VIROL, V79, P12692, DOI 10.1128/JVI.79.20.12692-12702.2005; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Kobe B, 1999, P NATL ACAD SCI USA, V96, P4319, DOI 10.1073/pnas.96.8.4319; Manel N, 2003, CELL, V115, P449, DOI 10.1016/S0092-8674(03)00881-X; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Miller MD, 2005, P NATL ACAD SCI USA, V102, P14759, DOI 10.1073/pnas.0506927102; Mirsaliotis A, 2007, J VIROL, V81, P6019, DOI 10.1128/JVI.02544-06; Mirsaliotis A, 2007, J GEN VIROL, V88, P660, DOI 10.1099/vir.0.82390-0; MOORE JP, 1993, J VIROL, V67, P863, DOI 10.1128/JVI.67.2.863-875.1993; Pinon JD, 2003, J VIROL, V77, P9922, DOI 10.1128/JVI.77.18.9922-9930.2003; Pinon JD, 2003, J VIROL, V77, P3281, DOI 10.1128/JVI.77.5.3281-3290.2003; Sagara Y, 1996, J VIROL, V70, P1564, DOI 10.1128/JVI.70.3.1564-1569.1996; SATTENTAU QJ, 1995, VIROLOGY, V206, P713, DOI 10.1016/S0042-6822(95)80094-8; SATTENTAU QJ, 1993, J VIROL, V67, P7383, DOI 10.1128/JVI.67.12.7383-7393.1993; SATTENTAU QJ, 1995, J EXP MED, V182, P185, DOI 10.1084/jem.182.1.185; Sodroski JG, 1999, CELL, V99, P243, DOI 10.1016/S0092-8674(00)81655-4; Sundaram R, 2004, J BIOL CHEM, V279, P24141, DOI 10.1074/jbc.M313210200; THIRIART C, 1989, J IMMUNOL, V143, P1832; Weissenhorn W, 1999, MOL MEMBR BIOL, V16, P3, DOI 10.1080/096876899294706; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051; WILD C, 1995, AIDS RES HUM RETROV, V11, P323, DOI 10.1089/aid.1995.11.323; Zwick MB, 2004, NAT MED, V10, P133, DOI 10.1038/nm0204-133; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	44	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36724	36735		10.1074/jbc.M706827200	http://dx.doi.org/10.1074/jbc.M706827200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17940280	hybrid			2022-12-25	WOS:000251458300065
J	Neimanis, S; Albig, W; Doenecke, D; Kahle, J				Neimanis, Sonja; Albig, Werner; Doenecke, Detlef; Kahle, Joerg			Sequence elements in both subunits of the DNA fragmentation factor are essential for its nuclear transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE-ACTIVATED DNASE; MAMMALIAN IMPORTIN-ALPHA; AMINO-ACID MOTIF; LARGE-T-ANTIGEN; LOCALIZATION SIGNAL; PROTEIN IMPORT; KARYOPHERIN-ALPHA; CRYSTALLOGRAPHIC ANALYSIS; MULTIPLE PATHWAYS; CRYSTAL-STRUCTURE	DNA cleavage is a biochemical hallmark of apoptosis. In humans, apoptotic DNA cleavage is executed by DNA fragmentation factor (DFF) 40. In proliferating cells DFF40 is expressed in the presence of its chaperone and inhibitor DFF45, which results in the formation of the DFF complex. Here, we present a systematic analysis of the nuclear import of the DFF complex. Our in vitro experiments demonstrate that the importin alpha/beta-heterodimer mediates the translocation of the DFF complex from the cytoplasm to the nucleus. Both DFF subunits interact directly with the importin alpha/beta-heterodimer. However, importin alpha/beta binds more tightly to the DFF complex compared with the individual subunits. Additionally, the isolated C-terminal regions of both DFF subunits together bind importin alpha/beta more strongly than the individual C termini. Our results from in vivo studies reveal that the C-terminal regions of both DFF subunits harbor nuclear localization signals. Furthermore, nuclear import of the DFF complex requires the C-terminal regions of both subunits. In more detail, one basic cluster in the C-terminal region of each subunit, DFF40 (RLKRK) and DFF45 (KRAR), is essential for nuclear accumulation of the DFF complex. Based on these findings two alternative models for the interaction of importin alpha/beta with the DFF complex are presented.	Univ Gottingen, Mol Biol Abt, Inst Biochem & Mol Zellbiol, D-37073 Gottingen, Germany	University of Gottingen	Doenecke, D (corresponding author), Univ Gottingen, Mol Biol Abt, Inst Biochem & Mol Zellbiol, Humboldtallee 23, D-37073 Gottingen, Germany.	ddoenec@gwdg.de						ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Conti Elena, 2002, Results Probl Cell Differ, V35, P93; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; DINGWALL C, 1988, J CELL BIOL, V107, P841, DOI 10.1083/jcb.107.3.841; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fanara P, 2000, J BIOL CHEM, V275, P21218, DOI 10.1074/jbc.M002217200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Goebel W, 2007, BIOL CHEM, V388, P197, DOI 10.1515/BC.2007.022; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Inohara N, 1999, J BIOL CHEM, V274, P270, DOI 10.1074/jbc.274.1.270; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kohler M, 1997, FEBS LETT, V417, P104, DOI 10.1016/S0014-5793(97)01265-9; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Lechardeur D, 2005, J BIOL CHEM, V280, P40216, DOI 10.1074/jbc.M502220200; Lechardeur D, 2000, J CELL BIOL, V150, P321, DOI 10.1083/jcb.150.2.321; Leung SW, 2003, J BIOL CHEM, V278, P41947, DOI 10.1074/jbc.M307162200; Liku ME, 2005, MOL BIOL CELL, V16, P5026, DOI 10.1091/mbc.E05-05-0412; Liu XS, 1999, J BIOL CHEM, V274, P13836, DOI 10.1074/jbc.274.20.13836; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Madrid AS, 2006, CHROMOSOMA, V115, P98, DOI 10.1007/s00412-005-0043-3; Mingot JM, 2001, EMBO J, V20, P3685, DOI 10.1093/emboj/20.14.3685; Miyamoto Y, 1997, J BIOL CHEM, V272, P26375, DOI 10.1074/jbc.272.42.26375; Muhlhausser P, 2001, EMBO REP, V2, P690, DOI 10.1093/embo-reports/kve168; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Otomo T, 2000, NAT STRUCT BIOL, V7, P658, DOI 10.1038/77957; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Romanelli MG, 2002, EUR J BIOCHEM, V269, P2727, DOI 10.1046/j.1432-1033.2002.02942.x; Sakahira H, 2000, J BIOL CHEM, V275, P8091, DOI 10.1074/jbc.275.11.8091; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Samejima K, 2000, EXP CELL RES, V255, P314, DOI 10.1006/excr.2000.4801; Strom AC, 2001, GENOME BIOL, V2; Weis K, 1996, EMBO J, V15, P1818, DOI 10.1002/j.1460-2075.1996.tb00531.x; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YONEDA Y, 1987, EXP CELL RES, V173, P586, DOI 10.1016/0014-4827(87)90297-7; Zhou P, 2001, P NATL ACAD SCI USA, V98, P6051, DOI 10.1073/pnas.111145098	55	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35821	35830		10.1074/jbc.M703110200	http://dx.doi.org/10.1074/jbc.M703110200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17938174	hybrid			2022-12-25	WOS:000251458100044
J	Llagostera, E; Catalucci, D; Marti, L; Liesa, M; Camps, M; Ciaraldi, TP; Kondo, R; Reddy, S; Dillmann, WH; Palacin, M; Zorzano, A; Ruiz-Lozano, P; Gomis, R; Kaliman, P				Llagostera, Esther; Catalucci, Daniele; Marti, Luc; Liesa, Marc; Camps, Marta; Ciaraldi, Theodore P.; Kondo, Richard; Reddy, Sita; Dillmann, Wolfgang H.; Palacin, Manuel; Zorzano, Antonio; Ruiz-Lozano, Pilar; Gomis, Ramon; Kaliman, Perla			Role of Myotonic Dystrophy Protein Kinase (DMPK) in Glucose Homeostasis and Muscle Insulin Action	PLOS ONE			English	Article								Myotonic dystrophy 1 (DM1) is caused by a CTG expansion in the 3'-unstranslated region of the DMPK gene, which encodes a serine/threonine protein kinase. One of the common clinical features of DM1 patients is insulin resistance, which has been associated with a pathogenic effect of the repeat expansions. Here we show that DMPK itself is a positive modulator of insulin action. DMPK-deficient (dmpk(-/-)) mice exhibit impaired insulin signaling in muscle tissues but not in adipocytes and liver, tissues in which DMPK is not expressed. Dmpk(-/-) mice display metabolic derangements such as abnormal glucose tolerance, reduced glucose uptake and impaired insulin-dependent GLUT4 trafficking in muscle. Using DMPK mutants, we show that DMPK is required for a correct intracellular trafficking of insulin and IGF-1 receptors, providing a mechanism to explain the molecular and metabolic phenotype of dmpk(-/-) mice. Taken together, these findings indicate that reduced DMPK expression may directly influence the onset of insulin-resistance in DM1 patients and point to dmpk as a new candidate gene for susceptibility to type 2-diabetes.	[Gomis, Ramon; Kaliman, Perla] Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Endocrinol & Diabet Unit, Barcelona, Spain; [Ruiz-Lozano, Pilar] Burnham Inst Med Res, La Jolla, CA USA; [Reddy, Sita] Univ So Calif, Inst Med Genet, Los Angeles, CA USA; [Llagostera, Esther; Camps, Marta; Palacin, Manuel; Zorzano, Antonio] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Spain; [Catalucci, Daniele; Ciaraldi, Theodore P.; Kondo, Richard; Dillmann, Wolfgang H.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Catalucci, Daniele] Ist Ric & Cura Cancro IRCC Multimed, Milan, Italy; [Marti, Luc; Liesa, Marc; Palacin, Manuel; Zorzano, Antonio] Inst Res Biomed, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Sanford Burnham Prebys Medical Discovery Institute; University of Southern California; University of Barcelona; University of California System; University of California San Diego; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Kaliman, P (corresponding author), Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Endocrinol & Diabet Unit, Barcelona, Spain.	pkaliman@clinic.ub.es	Camps, Marta/F-6557-2016; Liesa, Marc/K-8590-2019; Catalucci, Daniele/B-6745-2015; Catalucci, Daniele/AAA-6056-2022; Zorzano, Antonio/R-5479-2018	Camps, Marta/0000-0001-5392-1792; Liesa, Marc/0000-0002-5909-8570; Catalucci, Daniele/0000-0001-7041-6114; Catalucci, Daniele/0000-0001-7041-6114; Palacin, Manuel/0000-0002-8670-293X	Ministerio de Ciencia y Tecnologia, Spain [SAF2004-01281]; National Institutes of Health [HL065484]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL065484, R01HL065484] Funding Source: NIH RePORTER	Ministerio de Ciencia y Tecnologia, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by SAF2004-01281 from the Ministerio de Ciencia y Tecnologia, Spain and the "Ramon y Cajal Research Program'' (to PK), and National Institutes of Health Grant HL065484 (to PR-L).	ACCILI D, 1989, EMBO J, V8, P2509, DOI 10.1002/j.1460-2075.1989.tb08388.x; An P, 2005, DIABETES, V54, P909, DOI 10.2337/diabetes.54.3.909; Berul CI, 1999, J CLIN INVEST, V103, pR1, DOI 10.1172/JCI5346; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Buckley DA, 2002, J CLIN PATHOL-MOL PA, V55, P46, DOI 10.1136/mp.55.1.46; Bush EW, 2000, BIOCHEMISTRY-US, V39, P8480, DOI 10.1021/bi992142f; Ciaraldi TP, 2001, J CLIN ENDOCR METAB, V86, P5838, DOI 10.1210/jc.86.12.5838; Dansithong W, 2005, J BIOL CHEM, V280, P5773, DOI 10.1074/jbc.M410781200; Egea G, 2006, CURR OPIN CELL BIOL, V18, P168, DOI 10.1016/j.ceb.2006.02.007; Fecchi K, 2006, FASEB J, V20, P705, DOI 10.1096/fj.05-4661fje; Fernandez AM, 2001, GENE DEV, V15, P1926, DOI 10.1101/gad.908001; Foti M, 2007, P NATL ACAD SCI USA, V104, P1242, DOI 10.1073/pnas.0610523104; Fuller W, 2001, ANAL BIOCHEM, V293, P216, DOI 10.1006/abio.2001.5127; Furukawa N, 2005, CELL METAB, V2, P119, DOI 10.1016/j.cmet.2005.06.011; Harper P.S., 1989, MYOTONIC DYSTROPHY; Issad T, 2005, BIOCHIMIE, V87, P111, DOI 10.1016/j.biochi.2004.12.008; Jansen G, 1996, NAT GENET, V13, P316, DOI 10.1038/ng0796-316; Jin S, 2000, CELL MOTIL CYTOSKEL, V45, P133, DOI 10.1002/(SICI)1097-0169(200002)45:2<133::AID-CM5>3.0.CO;2-S; Kaliman P, 2005, J BIOL CHEM, V280, P8016, DOI 10.1074/jbc.M412845200; KNUTSON VP, 1991, FASEB J, V5, P2130, DOI 10.1096/fasebj.5.8.2022311; Kondo RP, 2006, J PHYSIOL-LONDON, V571, P131, DOI 10.1113/jphysiol.2005.101428; KRENTZ AJ, 1992, DIABETOLOGIA, V35, P1170, DOI 10.1007/BF00401372; Lam LT, 2000, HUM MOL GENET, V9, P2167, DOI 10.1093/hmg/9.14.2167; Leung T, 1996, MOL CELL BIOL, V16, P5313; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Morin N, 2002, J PHARMACOL EXP THER, V303, P1238, DOI 10.1124/jpet.102.040592; MOXLEY RT, 1978, J CLIN INVEST, V62, P857, DOI 10.1172/JCI109198; MOXLEY RT, 1984, ANN NEUROL, V15, P157, DOI 10.1002/ana.410150208; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; Reddy S, 1996, NAT GENET, V13, P325, DOI 10.1038/ng0796-325; Ridley AJ, 2001, TRAFFIC, V2, P303, DOI 10.1034/j.1600-0854.2001.002005303.x; Salvatori S, 2005, NEUROL SCI, V26, P235, DOI 10.1007/s10072-005-0466-x; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Shimizu M, 2000, FEBS LETT, V475, P273, DOI 10.1016/S0014-5793(00)01692-6; van Tilburg JHO, 2003, J CLIN ENDOCR METAB, V88, P2223, DOI 10.1210/jc.2002-021252; VIALETTES B, 1986, HORM METAB RES, V18, P395, DOI 10.1055/s-2007-1012325; Woodman SE, 2004, NEUROLOGY, V62, P538, DOI 10.1212/WNL.62.4.538; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	40	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1134	10.1371/journal.pone.0001134	http://dx.doi.org/10.1371/journal.pone.0001134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987120	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459000018
J	Volkmann, N; Lui, HJ; Hazelwood, L; Trybus, KM; Lowey, S; Hanein, D				Volkmann, Niels; Lui, HongJun; Hazelwood, Larnele; Trybus, Kathleen M.; Lowey, Susan; Hanein, Dorit			The R403Q Myosin Mutation Implicated in Familial Hypertrophic Cardiomyopathy Causes Disorder at the Actomyosin Interface	PLOS ONE			English	Article							BETA-CARDIAC MYOSIN; SMOOTH-MUSCLE MYOSIN; ESSENTIAL LIGHT-CHAIN; HEAVY-CHAIN; 3-DIMENSIONAL STRUCTURE; MOTOR DOMAIN; HETEROLOGOUS EXPRESSION; ELECTRON CRYOMICROSCOPY; CRYSTAL-STRUCTURE; GENE MUTATION	Background. Mutations in virtually all of the proteins comprising the cardiac muscle sarcomere have been implicated in causing Familial Hypertrophic Cardiomyopathy (FHC). Mutations in the beta-myosin heavy chain (MHC) remain among the most common causes of FHC, with the widely studied R403Q mutation resulting in an especially severe clinical prognosis. In vitro functional studies of cardiac myosin containing the R403Q mutation have revealed significant changes in enzymatic and mechanical properties compared to wild-type myosin. It has been proposed that these molecular changes must trigger events that ultimately lead to the clinical phenotype. Principal Findings. Here we examine the structural consequences of the R403Q mutation in a recombinant smooth muscle myosin subfragment (S1), whose kinetic features have much in common with slow beta-MHC. We obtained three-dimensional reconstructions of wild-type and R403Q smooth muscle S1 bound to actin filaments in the presence (ADP) and absence (apo) of nucleotide by electron cryomicroscopy and image analysis. We observed that the mutant S1 was attached to actin at highly variable angles compared to wild-type reconstructions, suggesting a severe disruption of the actin-myosin interaction at the interface. Significance. These results provide structural evidence that disarray at the molecular level may be linked to the histopathological myocyte disarray characteristic of the diseased state.	[Trybus, Kathleen M.; Lowey, Susan] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Volkmann, Niels; Lui, HongJun; Hazelwood, Larnele; Hanein, Dorit] Burnham Inst Med Res, La Jolla, CA USA	University of Vermont; Sanford Burnham Prebys Medical Discovery Institute	Lowey, S (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA.	Susan.Lowey@uvm.edu; dorit@burnham.org			NIH [AR47199, GM076503, HL059408, AR47906]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR047906, R01AR047199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076503] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants AR47199 for electron microscopy and image analysis to DH, GM076503 for software development to NV, HL059408 to KMT, and AR47906 to SL.	Bonne G, 1998, CIRC RES, V83, P580, DOI 10.1161/01.RES.83.6.580; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; Cuda G, 1997, J MUSCLE RES CELL M, V18, P275, DOI 10.1023/A:1018613907574; DEROSIER DJ, 1970, J MOL BIOL, V52, P355, DOI 10.1016/0022-2836(70)90036-7; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; FERRANS VJ, 1972, CIRCULATION, V45, P769, DOI 10.1161/01.CIR.45.4.769; Fujita H, 1997, J CLIN INVEST, V99, P1010, DOI 10.1172/JCI119228; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Hanein D, 1999, ULTRAMICROSCOPY, V76, P233, DOI 10.1016/S0304-3991(98)00086-2; Hanein D, 1997, J CELL BIOL, V139, P387, DOI 10.1083/jcb.139.2.387; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Iorga B, 2007, J BIOL CHEM, V282, P3559, DOI 10.1074/jbc.M608191200; Jontes JD, 1998, J CELL BIOL, V141, P155, DOI 10.1083/jcb.141.1.155; Kim SJ, 1999, AM J PHYSIOL-HEART C, V276, pH1780, DOI 10.1152/ajpheart.1999.276.5.H1780; Kollmar M, 2002, EMBO J, V21, P2517, DOI 10.1093/emboj/21.11.2517; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maass AH, 2000, CURR OPIN CARDIOL, V15, P189, DOI 10.1097/00001573-200005000-00012; MARGOSSIAN SS, 1985, J BIOL CHEM, V260, P3747; Marian AJ, 1999, J CLIN INVEST, V104, P1683, DOI 10.1172/JCI7956; Miller G, 2003, J PHYSIOL-LONDON, V548, P167, DOI 10.1113/jphysiol.2002.031922; Owen CH, 1996, J STRUCT BIOL, V116, P167, DOI 10.1006/jsbi.1996.0027; Palmiter KA, 2000, J MUSCLE RES CELL M, V21, P609, DOI 10.1023/A:1005678905119; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Rost LE, 1998, ULTRAMICROSCOPY, V72, P187, DOI 10.1016/S0304-3991(98)00017-5; Sata M, 1996, J CLIN INVEST, V98, P2866, DOI 10.1172/JCI119115; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; SWEENEY HL, 1994, J BIOL CHEM, V269, P1603; Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5; TRACHTENBERG S, 1987, J MOL BIOL, V195, P581, DOI 10.1016/0022-2836(87)90184-7; TRYBUS KM, 1994, J BIOL CHEM, V269, P20819; Tyska MJ, 2000, CIRC RES, V86, P737, DOI 10.1161/01.RES.86.7.737; VANBUREN P, 1995, CIRC RES, V77, P439, DOI 10.1161/01.RES.77.2.439; Volkmann N, 2005, MOL CELL, V19, P595, DOI 10.1016/j.molcel.2005.07.015; Volkmann N, 2003, P NATL ACAD SCI USA, V100, P3227, DOI 10.1073/pnas.0536510100; Volkmann N, 2000, NAT STRUCT BIOL, V7, P1147; Volkmann N, 1999, J STRUCT BIOL, V125, P176, DOI 10.1006/jsbi.1998.4074; Volkmann N, 2002, J STRUCT BIOL, V138, P123, DOI 10.1016/S1047-8477(02)00009-6; Wang Q, 2003, J CELL SCI, V116, P4227, DOI 10.1242/jcs.00709; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0; Yamashita H, 2000, J BIOL CHEM, V275, P28045	46	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1123	10.1371/journal.pone.0001123	http://dx.doi.org/10.1371/journal.pone.0001123			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987111	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459000007
J	Begliomini, C; Caria, A; Grodd, W; Castiello, U				Begliomini, Chiara; Caria, Andrea; Grodd, Wolfgang; Castiello, Umberto			Comparing Natural and Constrained Movements: New Insights into the Visuomotor Control of Grasping	PLOS ONE			English	Article								Background. Neurophysiological studies showed that in macaques, grasp-related sensorimotor transformations are accomplished in a circuit connecting the anterior intraparietal sulcus (area AIP) with premotor area F5. Single unit recordings of macaque indicate that activity of neurons in this circuit is not simply linked to any particular object. Instead, responses correspond to the final hand configuration used to grasp the object. Although a human homologue of such a circuit has been identified, its role in planning and controlling different grasp configurations has not been decisively shown. We used functional magnetic resonance imaging to explicitly test whether activity within this network varies depending on the congruency between the adopted grasp and the grasp called by the stimulus. Methodology/Principal Findings. Subjects were requested to reach towards and grasp a small or a large stimulus naturally (i.e., precision grip, involving the opposition of index finger and thumb, for a small size stimulus and a whole hand grasp for a larger stimulus) or with an constrained grasp (i.e., a precision grip for a large stimulus and a whole hand grasp for a small stimulus). The human anterior intraparietal sulcus (hAIPS) was more active for precise grasping than for whole hand grasp independently of stimulus size. Conversely, both the dorsal premotor cortex (dPMC) and the primary motor cortex (M1) were modulated by the relationship between the type of grasp that was adopted and the size of the stimulus. Conclusions/Significance. The demonstration that activity within the hAIPS is modulated according to different types of grasp, together with the evidence in humans that the dorsal premotor cortex is involved in grasp planning and execution offers a substantial contribution to the current debate about the neural substrates of visuomotor grasp in humans.	[Castiello, Umberto] Univ Padua, Dept Gen Psychol, Padua, Italy; [Begliomini, Chiara] Univ Trento, Ctr Mind & Brain Sci, Rovereto, Italy; [Caria, Andrea] Univ Tubingen, Inst Med Psychol, Tubingen, Germany; [Grodd, Wolfgang] Univ Tubingen Hosp, Dept Neuroradiol, CNS, Sect Expt MRI, Tubingen, Germany; [Castiello, Umberto] Univ London, Dept Psychol, Egham, Surrey, England	University of Padua; University of Trento; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of London; Royal Holloway University London	Castiello, U (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	umberto.castiello@unipd.it	BEGLIOMINI, CHIARA/D-1516-2014	BEGLIOMINI, CHIARA/0000-0001-7433-0414; Caria, Andrea/0000-0003-2017-7084; Castiello, Umberto/0000-0003-0629-1286	Ministero dell'Universita e della Ricerca (MUR)	Ministero dell'Universita e della Ricerca (MUR)(Ministry of Education, Universities and Research (MIUR))	Funding: This work was supported by a grant from the Ministero dell'Universita e della Ricerca (MUR) to Prof. Umberto Castiello.	Begliomini C, 2007, EUR J NEUROSCI, V25, P1245, DOI 10.1111/j.1460-9568.2007.05365.x; Binkofski F, 1998, NEUROLOGY, V50, P1253, DOI 10.1212/WNL.50.5.1253; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; CAMINITI R, 1991, J NEUROSCI, V11, P1182; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Castiello U, 1996, NEUROREPORT, V7, P825, DOI 10.1097/00001756-199602290-00034; CASTIELLO U, 1993, EXP BRAIN RES, V94, P163; Cavina-Pratesi C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000424; Culham J.C., 2004, ATTENTION PERFORM, P417; Culham JC, 2003, EXP BRAIN RES, V153, P180, DOI 10.1007/s00221-003-1591-5; Culham JC, 2006, NEUROPSYCHOLOGIA, V44, P2668, DOI 10.1016/j.neuropsychologia.2005.11.003; Davare M, 2006, J NEUROSCI, V26, P2260, DOI 10.1523/JNEUROSCI.3386-05.2006; DUVERNOY P, 1991, HUMAN BRAIN STRUCTUR; Ehrsson HH, 2000, EUR J NEUROSCI, V12, P3385, DOI 10.1046/j.1460-9568.2000.00209.x; Ehrsson HH, 2001, J NEUROPHYSIOL, V85, P2613, DOI 10.1152/jn.2001.85.6.2613; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Frey SH, 2005, COGNITIVE BRAIN RES, V23, P397, DOI 10.1016/j.cogbrainres.2004.11.010; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; FU QG, 1993, J NEUROPHYSIOL, V70, P2097, DOI 10.1152/jn.1993.70.5.2097; GALLESE V, 1994, NEUROREPORT, V5, P1525, DOI 10.1097/00001756-199407000-00029; GENTILUCCI M, 1991, NEUROPSYCHOLOGIA, V29, P361, DOI 10.1016/0028-3932(91)90025-4; Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0; Glaser DE, 2001, NEUROIMAGE, V13, pS127; Gomez JE, 2000, EUR J NEUROSCI, V12, P3748, DOI 10.1046/j.1460-9568.2000.00232.x; Grefkes C, 2001, NEUROIMAGE, V14, P617, DOI 10.1006/nimg.2001.0858; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; Hagberg GE, 2001, NEUROIMAGE, V14, P1193, DOI 10.1006/nimg.2001.0880; Hazeltine E, 2003, NEUROPSYCHOLOGIA, V41, P1208, DOI 10.1016/S0028-3932(03)00040-X; HEPPREYMOND MC, 1998, COMP PRIMATE BIOL; Johnson-Frey SH, 2005, CEREB CORTEX, V15, P681, DOI 10.1093/cercor/bhh169; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; Kuhtz-Buschbeck JP, 2001, EUR J NEUROSCI, V14, P382, DOI 10.1046/j.0953-816x.2001.01639.x; LEMON RN, 1981, J PHYSIOL-LONDON, V311, P521, DOI 10.1113/jphysiol.1981.sp013602; LEMON RN, 1993, EXP PHYSIOL, V78, P263, DOI 10.1113/expphysiol.1993.sp003686; LEMON RN, 1976, PROC R SOC SER B-BIO, V194, P341, DOI 10.1098/rspb.1976.0083; LEMON RN, 1986, J PHYSL, V38, P497; Manthey S, 2003, COGNITIVE BRAIN RES, V15, P296, DOI 10.1016/S0926-6410(02)00201-X; Mason CR, 2002, ARCH ITAL BIOL, V140, P229; Morrow MM, 2003, J NEUROPHYSIOL, V89, P2279, DOI 10.1152/jn.00632.2002; MUIR RB, 1983, BRAIN RES, V261, P312, DOI 10.1016/0006-8993(83)90635-2; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; Napier J. R., 1993, HANDS; NAPIER JR, 1956, J BONE JOINT SURG BR, V38, P902, DOI 10.1302/0301-620X.38B4.902; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Raos V, 2006, J NEUROPHYSIOL, V95, P709, DOI 10.1152/jn.00463.2005; Raos V, 2004, J NEUROPHYSIOL, V92, P1990, DOI 10.1152/jn.00154.2004; Raos V, 2003, J NEUROPHYSIOL, V89, P1503, DOI 10.1152/jn.00661.2002; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; SAKATA H, 1992, CONTROL ARM MOVEMENT, P185; TAIRA M, 1990, EXP BRAIN RES, V83, P29; Talairach J., 1988, COPLANAR STEREOTAXIC; TALLIS R, 2004, HAND PHILOS ENQUIRY; Umilta MA, 2007, J NEUROPHYSIOL, V98, P488, DOI 10.1152/jn.01094.2006; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25	56	46	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1108	10.1371/journal.pone.0001108	http://dx.doi.org/10.1371/journal.pone.0001108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971871	gold, Green Published, Green Submitted			2022-12-25	WOS:000207458700025
J	Peirce, JL; Broman, KW; Lu, L; Williams, RW				Peirce, Jeremy L.; Broman, Karl W.; Lu, Lu; Williams, Robert W.			A Simple Method for Combining Genetic Mapping Data from Multiple Crosses and Experimental Designs	PLOS ONE			English	Article								Background. Over the past decade many linkage studies have defined chromosomal intervals containing polymorphisms that modulate a variety of traits. Many phenotypes are now associated with enough mapping data that meta-analysis could help refine locations of known QTLs and detect many novel QTLs. Methodology/Principal Findings. We describe a simple approach to combining QTL mapping results for multiple studies and demonstrate its utility using two hippocampus weight loci. Using data taken from two populations, a recombinant inbred strain set and an advanced intercross population we demonstrate considerable improvements in significance and resolution for both loci. 1-LOD support intervals were improved 51% for Hipp1a and 37% for Hipp9a. We first generate locus-wise permuted P-values for association with the phenotype from multiple maps, which can be done using a permutation method appropriate to each population. These results are then assigned to defined physical positions by interpolation between markers with known physical and genetic positions. We then use Fisher's combination test to combine position-by-position probabilities among experiments. Finally, we calculate genome-wide combined P-values by generating locus-specific P-values for each permuted map for each experiment. These permuted maps are then sampled with replacement and combined. The distribution of best locus-specific P-values for each combined map is the null distribution of genome-wide adjusted P-values. Conclusions/Significance. Our approach is applicable to a wide variety of segregating and non-segregating mapping populations, facilitates rapid refinement of physical QTL position, is complementary to other QTL fine mapping methods, and provides an appropriate genome-wide criterion of significance for combined mapping results.	[Peirce, Jeremy L.; Lu, Lu; Williams, Robert W.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Ctr Neurosci, Memphis, TN USA; [Peirce, Jeremy L.; Lu, Lu; Williams, Robert W.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Ctr Genom & Bioinformat, Memphis, TN USA; [Broman, Karl W.] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Johns Hopkins University	Peirce, JL (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Ctr Neurosci, Memphis, TN USA.	jpeirce@utmem.edu	Williams, Robert W./H-8789-2016	Williams, Robert W./0000-0001-8924-4447; Broman, Karl/0000-0002-4914-6671	NIMH [P20-MH62009]; NIDA; NSF; NIAAA [U01AA13499, U24AA135B, U01AA01442501]; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH062009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA013499] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NSF(National Science Foundation (NSF)); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Our thanks for financial support from (1) P20-MH62009 from NIMH, NIDA, and NSF. (2) INIA grants U01AA13499 and U24AA135B from NIAAA, and INIA grant U01AA01442501 from NIAAA. The funding agencies had no role in design, conduct, analysis, and interpretation of data or preparation of the manuscript.	Belknap JK, 2001, MAMM GENOME, V12, P893, DOI 10.1007/s00335-001-2074-2; Bolivar VJ, 2001, GENOME RES, V11, P1549, DOI 10.1101/gr.194001; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chesler EJ, 2004, NAT NEUROSCI, V7, P485, DOI 10.1038/nn0504-485; CHURCHILL GA, 1994, GENETICS, V138, P963; DARVASI A, 1995, GENETICS, V141, P1199; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Haldane JBS, 1931, GENETICS, V16, P0357; Hitzemann R, 2003, MAMM GENOME, V14, P733, DOI 10.1007/s00335-003-2277-9; Hitzemann R, 2002, GENES BRAIN BEHAV, V1, P214, DOI 10.1034/j.1601-183X.2002.10403.x; Iakoubova OA, 2001, GENOMICS, V74, P89, DOI 10.1006/geno.2000.6497; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1989, GENETICS, V121, P185; Li RH, 2005, GENETICS, V169, P1699, DOI 10.1534/genetics.104.033993; Lu L, 2001, J NEUROSCI, V21, P3503, DOI 10.1523/JNEUROSCI.21-10-03503.2001; Lyon ML, 1989, GENETIC VARIANTS STR, P773; Park YG, 2003, GENOME RES, V13, P118, DOI 10.1101/gr.786403; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; PEIRCE JL, GENOME RESHUFF UNPUB; Province MA, 2001, AM J HUM GENET, V69, P660, DOI 10.1086/323316; Sen S, 2001, GENETICS, V159, P371; Taylor BA, 1999, MAMM GENOME, V10, P335, DOI 10.1007/s003359900998; Walling GA, 2000, GENETICS, V155, P1369; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299; Williams RW, 1998, J NEUROSCI, V18, P138; ZOU F, 2005, GENETICS	28	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1036	10.1371/journal.pone.0001036	http://dx.doi.org/10.1371/journal.pone.0001036			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940600	gold, Green Submitted, Green Published			2022-12-25	WOS:000207456100004
J	Huet, E; Vallee, B; Szul, D; Verrecchia, F; Mourah, S; Jester, JV; Hoang-Xuan, T; Menashi, S; Gabison, EE				Huet, Eric; Vallee, Benoit; Szul, Dominika; Verrecchia, Franck; Mourah, Samia; Jester, James V.; Hoang-Xuan, Thanh; Menashi, Suzanne; Gabison, Eric E.			Extracellular matrix metalloprteinase inducer/CD147 promotes myofibroblast differentiation by inducing alpha-smooth muscle actin expression and collagen gel contraction: implications in tissue remodeling	FASEB JOURNAL			English	Article						epithelial-stromal interactions; wound healing; MMPs; TGh beta	GROWTH-FACTOR-BETA; TUMOR-STROMAL INTERACTIONS; BREAST-CANCER CELLS; METALLOPROTEINASE INDUCER; GENE-EXPRESSION; TGF-BETA; DERMAL FIBROBLASTS; EMMPRIN; INDUCTION; BASIGIN	Extracellular matrix metalloproteinase inducer (EMMPRIN) is a cell surface glycoprotein enriched on tumor cells and normal epithelia. It is mainly known for its ability to induce matrix metalloproteinase production in fibroblasts following epithelial-stromal interaction. We sought to examine whether EMMPRIN has a broader role promoting fibroblast-to-myofibroblast differentiation. Because alpha-smooth muscle actin (alpha SMA) is considered a marker of this differentiation process, we analyzed the effect of EMMPRIN on its expression in corneal and skin fibroblasts by Western blots, immunocytochemistry, and a functional assay of collagen lattice contraction. Increasing EMMPRIN expression by cDNA transfection or by treatment with exogenously added recombinant EMMPRIN resulted in an up-regulation of alpha SMA expression. EMMPRIN also increased the contractile properties of the treated fibroblasts as demonstrated by the immunohistochemical appearance of stress fibers and by the accelerated contraction of fibroblast-embedded collagen lattices. Blocking EMMPRIN expression by small interfering RNA inhibited alpha SMA and collagen gel contraction induced not only by EMMPRIN but also by transforming growth factor-beta, a major mediator of myofibroblast differentiation that also regulated EMMPRIN expression. These findings, combined with the fact that EMMPRIN and aSMA colocalized to the same cells in the stroma of pathological corneas, expand on the mechanism by which EMMPRIN remodels extracellular matrix during wound healing and cancer.	[Huet, Eric; Vallee, Benoit; Szul, Dominika; Menashi, Suzanne; Gabison, Eric E.] Univ Paris 12, CNRS, CRRET Lab, UMR 7149, F-94010 Creteil, France; [Verrecchia, Franck] Hop St Louis, INSERM, U697, Paris, France; [Mourah, Samia] Hop St Louis, INSERM, Pharmacol Lab, U716, Paris, France; [Jester, James V.] Univ Calif Irvine, Dept Ophthalmol, Irvine, CA USA; [Hoang-Xuan, Thanh; Gabison, Eric E.] Rothschild & Bichat Hosp, AP HP, Fdn Ophtalmol A, Dept Ophthalmol, Paris, France	Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California Irvine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP	Menashi, S (corresponding author), Univ Paris 12, CNRS, CRRET Lab, UMR 7149, Av Gen Gaulle, F-94010 Creteil, France.	menashi@univ-paris12.fr	HUET, Eric/R-3178-2018; Verrecchia, Franck/G-5535-2018	HUET, Eric/0000-0002-5541-5954; Verrecchia, Franck/0000-0003-4920-2554; Jester, James/0000-0002-9246-0981				Berton A., 2000, Molecular Cell Biology Research Communications, V3, P173, DOI 10.1006/mcbr.2000.0210; Betsuyaku T, 2003, AM J RESP CELL MOL, V28, P600, DOI 10.1165/rcmb.2002-0059OC; Bisson C, 2003, INT J CANCER, V105, P7, DOI 10.1002/ijc.11012; Chen X, 2001, HISTOCHEM CELL BIOL, V115, P465; Curtin KD, 2005, J CELL SCI, V118, P2649, DOI 10.1242/jcs.02408; DeCastro R, 1996, J INVEST DERMATOL, V106, P1260, DOI 10.1111/1523-1747.ep12348959; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Fini ME, 2005, CORNEA, V24, pS2, DOI 10.1097/01.ico.0000178743.06340.2c; Gabison EE, 2005, AM J PATHOL, V166, P209, DOI 10.1016/S0002-9440(10)62245-6; Gabison EE, 2003, OPHTHALMOLOGY, V110, P1626, DOI 10.1016/S0161-6420(03)00486-X; Gabison EE, 2005, BIOCHIMIE, V87, P361, DOI 10.1016/j.biochi.2004.09.023; Guo HM, 1997, J BIOL CHEM, V272, P24; Hinz B, 2006, EUR J CELL BIOL, V85, P175, DOI 10.1016/j.ejcb.2005.09.004; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Jester JV, 1996, CORNEA, V15, P505; Jester JV, 2003, INVEST OPHTH VIS SCI, V44, P1850, DOI 10.1167/iovs.02-0973; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Karsdal MA, 2002, J BIOL CHEM, V277, P44061, DOI 10.1074/jbc.M207205200; KATAOKA H, 1993, CANCER RES, V53, P3154; Konttinen YT, 2000, ARTHRITIS RHEUM, V43, P275, DOI 10.1002/1529-0131(200002)43:2<275::AID-ANR6>3.0.CO;2-#; Langholz O, 1995, J CELL BIOL, V131, P1903, DOI 10.1083/jcb.131.6.1903; Lin HC, 2001, INVEST OPHTH VIS SCI, V42, P2517; Marieb EA, 2004, CANCER RES, V64, P1229, DOI 10.1158/0008-5472.CAN-03-2832; Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219; Mauviel A, 1996, J BIOL CHEM, V271, P10917, DOI 10.1074/jbc.271.18.10917; Menashi S, 2003, CANCER RES, V63, P7575; Mio T, 1996, IN VITRO CELL DEV-AN, V32, P427; Nakamura T, 1997, CANCER RES, V57, P3305; Nielsen BS, 2001, CANCER RES, V61, P7091; Norgauer J, 2002, BRIT J DERMATOL, V147, P1180, DOI 10.1046/j.1365-2133.2002.05025.x; Petridou S, 2000, INVEST OPHTH VIS SCI, V41, P89; Philipp K, 2005, INT J MOL MED, V15, P299; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Shackel NA, 2002, AM J PATHOL, V160, P641, DOI 10.1016/S0002-9440(10)64884-5; Sidhu SS, 2004, ONCOGENE, V23, P956, DOI 10.1038/sj.onc.1207070; Stuelten CH, 2005, J CELL SCI, V118, P2143, DOI 10.1242/jcs.02334; Sun JX, 2001, CANCER RES, V61, P2276; Tang Y, 2005, CANCER RES, V65, P3193, DOI 10.1158/0008-5472.CAN-04-3605; Tang Y, 2004, MOL CANCER RES, V2, P73; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Toole BP, 2003, CURR TOP DEV BIOL, V54, P371, DOI 10.1016/S0070-2153(03)54015-7; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Verrecchia Franck, 2002, Curr Rheumatol Rep, V4, P143, DOI 10.1007/s11926-002-0010-4; Yan L, 2005, THROMB HAEMOSTASIS, V93, P199, DOI 10.1160/TH04-08-0536; Yu Q, 2000, GENE DEV, V14, P163; Yuan WH, 2001, J BIOL CHEM, V276, P38502, DOI 10.1074/jbc.M107081200; Yurchenko V, 2006, IMMUNOLOGY, V117, P301, DOI 10.1111/j.1365-2567.2005.02316.x; Zucker S, 2001, AM J PATHOL, V158, P1921, DOI 10.1016/S0002-9440(10)64660-3	50	73	78	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2008	22	4					1144	1154		10.1096/fj.07-8748com	http://dx.doi.org/10.1096/fj.07-8748com			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	282PZ	17965264				2022-12-25	WOS:000254581000020
J	Ichimura, K; Vogazianou, AP; Liu, L; Pearson, DM; Backlund, LM; Plant, K; Baird, K; Langford, CF; Gregory, SG; Collins, VP				Ichimura, K.; Vogazianou, A. P.; Liu, L.; Pearson, D. M.; Backlund, L. M.; Plant, K.; Baird, K.; Langford, C. F.; Gregory, S. G.; Collins, V. P.			1p36 is a preferential target of chromosome 1 deletions in astrocytic tumours and homozygously deleted in a subset of glioblastomas	ONCOGENE			English	Article						microarray; array-CGH; methylation; astrocytoma; oligodendroglioma	COMPARATIVE GENOMIC HYBRIDIZATION; PHASE-III TRIAL; OLIGODENDROGLIAL TUMORS; ANAPLASTIC OLIGODENDROGLIOMA; EUROPEAN ORGANIZATION; GENETIC-ANALYSIS; HUMAN GLIOMAS; ARRAY-CGH; P73 GENE; 19Q LOSS	Astrocytic, oligodendroglial and mixed gliomas are the commonest gliomas in adults. They have distinct phenotypes and clinical courses, but as they exist as a continuous histological spectrum, differentiating them can be difficult. Co-deletions of total 1p and 19q are found in the majority of oligodendrogliomas and considered as a diagnostic marker and a prognostic indicator. The 1p status of astrocytomas has not yet been thoroughly examined. Using a chromosome 1 tile path array, we investigated 108 adult astrocytic tumours for copy number alterations. Total 1p deletions were rare (2%), however partial deletions involving 1p36 were frequently identified in anaplastic astrocytomas (22%) and glioblastomas (34%). Multivariate analysis showed that patients with total 1p deletions had significantly longer survival (P=0.005). In nine glioblastomas homozygous deletions at 1p36 were identified. No somatic mutations were found among the five genes located in the homozygously deleted region. However, the CpG island of TNFRSF9 was hypermethylated in 19% of astrocytic tumours and 87% of glioma cell lines. TNFRSF9 expression was upregulated after demethylation of glioma cell lines. Akt3 amplifications were found in four glioblastomas. Our results indicate that 1p deletions are common anaplastic astrocytomas and glioblastomas but are distinct from the 1p abnormalities in oligodendrogliomas.	[Ichimura, K.; Vogazianou, A. P.; Liu, L.; Pearson, D. M.; Plant, K.; Baird, K.; Collins, V. P.] Univ Cambridge, Dept Pathol, Div Mol Histopathol, Addenbrookes Hosp, Cambridge CB2 0QQ, England; [Backlund, L. M.] Karolinska Univ Hosp, Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Langford, C. F.; Gregory, S. G.] Wellcome Trust Sanger Inst, Cambridge, England; [Langford, C. F.; Gregory, S. G.] Duke Univ, Med Ctr, Duke Ctr Human Genet, Durham, NC USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Karolinska Institutet; Karolinska University Hospital; Wellcome Trust Sanger Institute; Duke University	Ichimura, K (corresponding author), Univ Cambridge, Dept Pathol, Div Mol Histopathol, Addenbrookes Hosp, Level 3,Lab Block,Box 231, Cambridge CB2 0QQ, England.	ki212@cam.ac.uk		Backlund, Magnus/0000-0003-0397-6538; Gregory, Simon/0000-0002-7805-1743	Cancer Research UK [A6618] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Alonso ME, 2001, INT J ONCOL, V19, P609; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Barbashina V, 2005, CLIN CANCER RES, V11, P1119; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; BIGNER SH, 1988, CANCER RES, V48, P405; Buckley PG, 2005, CANCER RES, V65, P2653, DOI 10.1158/0008-5472.CAN-04-3651; Cairncross G, 2006, J CLIN ONCOL, V24, P2707, DOI 10.1200/JCO.2005.04.3414; Dong Z, 2004, BRIT J CANCER, V91, P1105, DOI 10.1038/sj.bjc.6602093; Felsberg J, 2004, BRAIN PATHOL, V14, P121, DOI 10.1111/j.1750-3639.2004.tb00044.x; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Gregory SG, 2006, NATURE, V441, P315, DOI 10.1038/nature04727; Griffin CA, 2006, J NEUROPATH EXP NEUR, V65, P988, DOI 10.1097/01.jnen.0000235122.98052.8f; Harden SV, 2003, J UROLOGY, V169, P1138, DOI 10.1097/01.ju.0000049627.90307.4d; Hashimoto K, 2004, MODERN PATHOL, V17, P617, DOI 10.1038/modpathol.3800107; Hashimoto N, 2003, CANCER-AM CANCER SOC, V97, P2254, DOI 10.1002/cncr.11322; He J, 2001, J NEUROPATH EXP NEUR, V60, P863, DOI 10.1093/jnen/60.9.863; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Homma T, 2006, J NEUROPATH EXP NEUR, V65, P846, DOI 10.1097/01.jnen.0000235118.75182.94; Ichimura K, 2006, ONCOGENE, V25, P1261, DOI 10.1038/sj.onc.1209156; Ichimura K, 2000, CANCER RES, V60, P417; Ichimura K, 2004, J NEURO-ONCOL, V70, P137, DOI 10.1007/s11060-004-2747-2; Ichimura K, 1998, GENE CHROMOSOME CANC, V22, P9, DOI 10.1002/(SICI)1098-2264(199805)22:1<9::AID-GCC2>3.0.CO;2-1; Idbaih A, 2005, ANN NEUROL, V58, P483, DOI 10.1002/ana.20607; Ino Y, 2000, J NEUROSURG, V92, P983, DOI 10.3171/jns.2000.92.6.0983; Iuchi T, 2002, GENE CHROMOSOME CANC, V35, P170, DOI 10.1002/gcc.10080; Jenkins RB, 2006, CANCER RES, V66, P9852, DOI 10.1158/0008-5472.CAN-06-1796; Kleihues P, 2000, PATHOLOGY GENETICS T; Knobbe CB, 2003, BRAIN PATHOL, V13, P507; Koschny R, 2002, CANCER GENET CYTOGEN, V135, P147, DOI 10.1016/S0165-4608(01)00650-1; Kros JM, 2007, J NEUROPATH EXP NEUR, V66, P545, DOI 10.1097/01.jnen.0000263869.84188.72; Liu L, 2005, J MOL MED, V83, P917, DOI 10.1007/s00109-005-0700-2; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Mueller W, 2002, AM J PATHOL, V161, P313, DOI 10.1016/S0002-9440(10)64183-1; Nigro JM, 2001, AM J PATHOL, V158, P1253, DOI 10.1016/S0002-9440(10)64076-X; Reifenberger G, 2003, J NEUROPATH EXP NEUR, V62, P111, DOI 10.1093/jnen/62.2.111; Schmidt EE, 1999, J NEUROPATH EXP NEUR, V58, P1170, DOI 10.1097/00005072-199911000-00007; Schmidt MC, 2002, J NEUROPATH EXP NEUR, V61, P321, DOI 10.1093/jnen/61.4.321; Smith JS, 2000, J CLIN ONCOL, V18, P636, DOI 10.1200/JCO.2000.18.3.636; Smith JS, 1999, ONCOGENE, V18, P4144, DOI 10.1038/sj.onc.1202759; Thomas D, 2001, J CLIN ONCOL, V19, P509, DOI 10.1200/JCO.2001.19.2.509; Ueki K, 2002, CLIN CANCER RES, V8, P196; van den Bent MJ, 2006, J CLIN ONCOL, V24, P2715, DOI 10.1200/JCO.2005.04.6078; von Deimling A, 2000, J NEUROPATH EXP NEUR, V59, P544, DOI 10.1093/jnen/59.6.544; Waerner T, 2001, CELL GROWTH DIFFER, V12, P201; Watanabe T, 2002, ACTA NEUROPATHOL, V104, P357, DOI 10.1007/s00401-002-0549-1; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Yanagisawa H, 2000, HUM MOL GENET, V9, P1433, DOI 10.1093/hmg/9.9.1433	47	66	69	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 27	2008	27	14					2097	2108		10.1038/sj.onc.1210848	http://dx.doi.org/10.1038/sj.onc.1210848			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	279MK	17934521	Green Accepted			2022-12-25	WOS:000254359100015
J	Tsutsui, S; Vergote, D; Shariat, N; Warren, K; Ferguson, SSG; Power, C				Tsutsui, Shigeki; Vergote, David; Shariat, Neda; Warren, Kenneth; Ferguson, Stephen S. G.; Power, Christopher			Glucocorticoids regulate innate immunity in a model of multiple sclerosis: reciprocal interactions between the A1 adenosine receptor and beta-arrestin-1 in monocytoid cells	FASEB JOURNAL			English	Article						central nervous system; cytokines; experimental autoimmune encephalomyelitis; G protein-coupled receptor	PROTEIN-COUPLED RECEPTORS; BLOOD MONONUCLEAR-CELLS; MICROGLIAL CELLS; UP-REGULATION; INTRACEREBRAL HEMORRHAGE; GENE-EXPRESSION; NERVOUS-SYSTEM; BETA-ARRESTIN; ACTIVATION; BRAIN	Desensitization of seven transmembrane receptors (7TMRs), which are modulated by the beta-arrestins, leads to altered G protein activation. The A1 adenosine receptor (A1AR) is an antiinflammatory 7TMR exhibiting reduced expression and activity in both multiple sclerosis (MS) and the murine MS model, experimental autoimmune encephalomyelitis (EAE) in monocytoid cells. Herein, we report that beta-arrestin-1 expression was increased in brains of MS patients relative to non-MS brains, whereas A1AR expression was concomitantly reduced. This inverse relationship between beta-arrestin-1 and A1AR was confirmed in cultured monocytoid cells as beta-arrestin-1 overexpression resulted in a down-regulation of A1AR together with the internalization of the surface receptor. Moreover, a physical interaction between beta-arrestin-1 and A1AR was demonstrated in monocytoid cells. Proinflammatory cytokines regulated the A1AR/beta-arrestin-1 interactions, while A1AR activation also modulated proinflammatory cytokines expression. During EAE, beta-arrestin-1 and A1AR expression in the spinal cord displayed a similar pattern compared to that observed in MS brains. EAE-induced neuroinflammation and neurobehavioral deficits were suppressed by glucocorticoid treatments, accompanied by concurrent reduced beta-arrestin-1 and enhanced A1AR expression. Thus, the interplay between beta-arrestin-1 and A1AR in the central nervous system during neuroinflammation represents a reciprocal regulatory mechanism through which neuroprotective therapeutic strategies for neuroinflammatory diseases might be further developed.	[Vergote, David; Warren, Kenneth; Power, Christopher] Univ Alberta, Dept Med, Heritage Med Res Ctr, Edmonton, AB T6G 2S2, Canada; [Tsutsui, Shigeki; Vergote, David; Shariat, Neda; Power, Christopher] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Ferguson, Stephen S. G.] Univ Western Ontario, Dept Physiol & Pharmacol, Cell Biol Res Grp, Robarts Res Inst, London, ON, Canada	University of Alberta; University of Calgary; Western University (University of Western Ontario)	Power, C (corresponding author), Univ Alberta, Dept Med, Heritage Med Res Ctr, Rm 611, Edmonton, AB T6G 2S2, Canada.	chris.power@ualberta.ca	Power, Christopher/C-7181-2013	Power, Christopher/0000-0002-5131-9711; Vergote, David/0000-0002-1298-3783				Bar-Or A, 1999, J NEUROIMMUNOL, V100, P252, DOI 10.1016/S0165-5728(99)00193-9; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Boven LA, 2003, J IMMUNOL, V170, P2638, DOI 10.4049/jimmunol.170.5.2638; Brundula V, 2002, BRAIN, V125, P1297, DOI 10.1093/brain/awf133; Brusaferri F, 2000, J NEUROL, V247, P435, DOI 10.1007/s004150070172; Burgoon MP, 2004, FRONT BIOSCI-LANDMRK, V9, P786, DOI 10.2741/1278; Cato ACB, 1996, BIOESSAYS, V18, P371, DOI 10.1002/bies.950180507; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Forooghian F, 2007, J CLIN IMMUNOL, V27, P388, DOI 10.1007/s10875-007-9091-1; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; GARLOW SJ, 1995, MOL BRAIN RES, V31, P201, DOI 10.1016/0169-328X(95)00043-R; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Gelati M, 2002, ARCH NEUROL-CHICAGO, V59, P774, DOI 10.1001/archneur.59.5.774; GERWINS P, 1991, MOL PHARMACOL, V40, P149; Giorelli M, 2002, CELL SIGNAL, V14, P673, DOI 10.1016/S0898-6568(02)00011-6; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Hasko G, 1996, J IMMUNOL, V157, P4634; HAUSDORFF WP, 1991, P NATL ACAD SCI USA, V88, P2979, DOI 10.1073/pnas.88.8.2979; Johnston JB, 2001, ANN NEUROL, V49, P650, DOI 10.1002/ana.1007; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Jones G, 2006, NEUROBIOL DIS, V21, P1, DOI 10.1016/j.nbd.2005.07.018; Kohno H, 2007, EXP EYE RES, V84, P569, DOI 10.1016/j.exer.2006.11.011; Lassmann H, 2001, CURR OPIN NEUROL, V14, P253, DOI 10.1097/00019052-200106000-00001; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Leussink VI, 2001, ARCH NEUROL-CHICAGO, V58, P91, DOI 10.1001/archneur.58.1.91; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Liu JL, 1998, NAT MED, V4, P78, DOI 10.1038/nm0198-078; Mayne M, 2001, STROKE, V32, P240, DOI 10.1161/01.STR.32.1.240; Mayne M, 1999, ANN NEUROL, V45, P633, DOI 10.1002/1531-8249(199905)45:5<633::AID-ANA12>3.0.CO;2-X; McEwan IJ, 1997, BIOESSAYS, V19, P153, DOI 10.1002/bies.950190210; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Morrow SA, 2004, NEUROLOGY, V63, P1079, DOI 10.1212/01.WNL.0000138572.82125.F5; Navikas V, 1996, J NEUROSCI RES, V45, P322, DOI 10.1002/(SICI)1097-4547(19960815)45:4<322::AID-JNR1>3.0.CO;2-B; Nguyen MD, 2002, NAT REV NEUROSCI, V3, P216, DOI 10.1038/nrn752; Nie ZZ, 1997, MOL PHARMACOL, V52, P456, DOI 10.1124/mol.52.3.456; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; OHGURO H, 1993, P NATL ACAD SCI USA, V90, P3241, DOI 10.1073/pnas.90.8.3241; PARRUTI G, 1993, J BIOL CHEM, V268, P9753; Pender MP, 2002, INTERN MED J, V32, P554, DOI 10.1046/j.1445-5994.2002.00269.x; Pitzalis C, 2002, ANN NY ACAD SCI, V966, P108, DOI 10.1111/j.1749-6632.2002.tb04208.x; PLESS IB, 1993, PEDIATRICS, V91, P1131; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Ren HZ, 1999, MOL PHARMACOL, V55, P309, DOI 10.1124/mol.55.2.309; Rivkees SA, 1999, J BIOL CHEM, V274, P14204, DOI 10.1074/jbc.274.20.14204; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Sorensen TL, 1999, J CLIN INVEST, V103, P807, DOI 10.1172/JCI5150; Svenningsson P, 1997, J PHARMACOL EXP THER, V280, P1094; TEURICH S, 1995, CHEM SENSES, V20, P251, DOI 10.1093/chemse/20.2.251; Tsutsui S, 2005, ANN NEUROL, V57, P883, DOI 10.1002/ana.20502; Tsutsui S, 2004, J NEUROSCI, V24, P1521, DOI 10.1523/JNEUROSCI.4271-03.2004; ULVESTAD E, 1994, J NEUROPATH EXP NEUR, V53, P492, DOI 10.1097/00005072-199409000-00008; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Vecil GG, 2000, J NEUROSCI RES, V61, P212, DOI 10.1002/1097-4547(20000715)61:2<212::AID-JNR12>3.0.CO;2-9; Vroon A, 2003, J NEUROIMMUNOL, V137, P79, DOI 10.1016/S0165-5728(03)00050-X; Wandinger KP, 1998, ACTA NEUROL SCAND, V97, P359, DOI 10.1111/j.1600-0404.1998.tb05966.x; Wang JH, 2001, J BIOL CHEM, V276, P49236, DOI 10.1074/jbc.M108523200; Wardas J, 2002, POL J PHARMACOL, V54, P313; Wise A, 2004, ANNU REV PHARMACOL, V44, P43, DOI 10.1146/annurev.pharmtox.44.101802.121419; Yong VW, 2004, FRONT BIOSCI, V9, P864, DOI 10.2741/1276; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571	65	37	40	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2008	22	3					786	796		10.1096/fj.07-9002com	http://dx.doi.org/10.1096/fj.07-9002com			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17965263				2022-12-25	WOS:000254143700017
J	Osusky, M; Teschke, L; Wang, XY; Wong, K; Buckley, JT				Osusky, Milan; Teschke, Lisa; Wang, Xiaoying; Wong, Kevin; Buckley, J. Thomas			A chimera of interleukin 2 and a binding variant of aerolysin is selectively toxic to cells displaying the interleukin 2 receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL-FORMING TOXIN; SEPTICUM ALPHA-TOXIN; AEROMONAS-SALMONICIDA; RECEPTOR-BINDING; MEMBRANE-CHANNEL; BETA-SUBUNIT; PROTEIN; PROAEROLYSIN; EXPRESSION; DOMAIN	Aerolysin is a bacterial toxin that binds to glycosylphosphatidylinositol-anchored proteins (GPI-AP) on mammalian cells and oligomerizes, inserting into the target membranes and forming channels that cause cell death. We have made a variant of aerolysin, R336A, that has greatly reduced the ability to bind to GPI-AP, and as a result it is only very weakly active. Fusion of interleukin 2 (IL2) to the N terminus of R336A-aerolysin results in a hybrid that has little or no activity against cells that do not have an IL2 receptor because it cannot bind to the GPI-AP on the cells. Strikingly, the presence of the IL2 moiety allows this hybrid to bind to cells displaying high affinity IL2 receptors. Once bound, the hybrid molecules form insertion-competent oligomers. Cell death occurs at picomolar concentrations of the hybrid, whereas the same cells are insensitive to much higher concentrations of R336A-aerolysin lacking the IL2 domain. The targeted channel-forming hybrid protein may have important advantages as a therapeutic agent.	[Osusky, Milan; Teschke, Lisa; Wang, Xiaoying; Wong, Kevin; Buckley, J. Thomas] Protox Therapeut Inc, Vancouver, BC V6C 3E8, Canada		Buckley, JT (corresponding author), Protox Therapeut Inc, 1210-885 W Georgia St, Vancouver, BC V6C 3E8, Canada.	tbuckley@protoxtherapeutics.com						Abrami L, 1998, J BIOL CHEM, V273, P32656, DOI 10.1074/jbc.273.49.32656; BUCKLEY JT, 1990, BIOCHEM CELL BIOL, V68, P221, DOI 10.1139/o90-029; BUCKLEY JT, 1999, COMPREHENSIVE SOURCE, P362; Cabiaux V, 1997, BIOCHEMISTRY-US, V36, P15224, DOI 10.1021/bi971216p; Cowell S, 1997, MOL MICROBIOL, V25, P343, DOI 10.1046/j.1365-2958.1997.4691828.x; Diep DB, 1998, J BIOL CHEM, V273, P2355, DOI 10.1074/jbc.273.4.2355; Diep DB, 1998, MOL MICROBIOL, V30, P341, DOI 10.1046/j.1365-2958.1998.01068.x; DUPREZ V, 1985, P NATL ACAD SCI USA, V82, P6932, DOI 10.1073/pnas.82.20.6932; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; HARAYAMA S, 1980, MOL GEN GENET, V180, P47, DOI 10.1007/BF00267351; HOWARD SP, 1985, J BACTERIOL, V161, P1118, DOI 10.1128/JB.161.3.1118-1124.1985; HOWARD SP, 1985, J BACTERIOL, V163, P336, DOI 10.1128/JB.163.1.336-340.1985; HULI J, 1987, J EXP MED, V165, P157, DOI 10.1084/jem.165.1.157; Li Z, 2005, CELL MOL IMMUNOL, V2, P106; LORBERBOUMGALSKI H, 1990, J BIOL CHEM, V265, P16311; MacKenzie CR, 1999, J BIOL CHEM, V274, P22604, DOI 10.1074/jbc.274.32.22604; Melton JA, 2004, J BIOL CHEM, V279, P14315, DOI 10.1074/jbc.M313758200; Miller J. H., 1972, EXPT MOL GENETICS, P431; MINAMI Y, 1993, ANNU REV IMMUNOL, V11, P245, DOI 10.1146/annurev.immunol.11.1.245; Nelson KL, 1997, J BIOL CHEM, V272, P12170, DOI 10.1074/jbc.272.18.12170; PARKER MW, 1994, NATURE, V367, P292, DOI 10.1038/367292a0; ROSOLEN A, 1989, BLOOD, V73, P1968; Rossjohn J, 1998, J STRUCT BIOL, V121, P92, DOI 10.1006/jsbi.1997.3947; Rossjohn J, 1998, BIOCHEMISTRY-US, V37, P741, DOI 10.1021/bi9721039; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sellman BR, 1997, MOL MICROBIOL, V25, P429, DOI 10.1046/j.1365-2958.1997.4541820.x; Steinberger I, 1997, SCAND J IMMUNOL, V46, P129, DOI 10.1046/j.1365-3083.1997.d01-101.x; UCHIYAMA T, 1981, J IMMUNOL, V126, P1393; VANDERGOOT FG, 1993, BIOCHEMISTRY-US, V32, P2636, DOI 10.1021/bi00061a023; WILLIAMS DP, 1987, PROTEIN ENG, V1, P493, DOI 10.1093/protein/1.6.493; Williams SA, 2007, JNCI-J NATL CANCER I, V99, P376, DOI 10.1093/jnci/djk065; WONG KR, 1989, J BACTERIOL, V171, P2523, DOI 10.1128/jb.171.5.2523-2527.1989; Wong L, 2005, SEMIN ONCOL, V32, P591, DOI 10.1053/j.seminoncol.2005.08.002	33	4	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1572	1579		10.1074/jbc.M706424200	http://dx.doi.org/10.1074/jbc.M706424200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17981806	hybrid			2022-12-25	WOS:000252282700042
J	Buxade, M; Morrice, N; Krebs, DL; Proud, CG				Buxade, Maria; Morrice, Nick; Krebs, Danielle L.; Proud, Christopher G.			The PSF.p54(nrb) complex is a novel Mnk substrate that binds the mRNA for tumor necrosis factor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; INITIATION-FACTOR 4E; PHOSPHORYLATION; PSF; TRANSLATION; IDENTIFICATION; ELEMENTS; CLONING	To identify new potential substrates for the MAP kinase signal-integrating kinases (Mnks), we employed a proteomic approach. The Mnks are targeted to the translational machinery through their interaction with the cap-binding initiation factor complex. Wetested whether proteins retained on cap resin were substrates for the Mnks in vitro, and identified one such protein as PSF (the PTB (polypyrimidine tract-binding protein)-associated splicing factor). Mnks phosphorylate PSF at two sites in vitro, and our data show that PSF is an Mnk substrate in vivo. We also demonstrate that PSF, together with its partner, p54(nrb), binds RNAs that contain AU-rich elements (AREs), such as those for proinflammatory cytokines (e. g. tumor necrosis factor alpha (TNF alpha)). Indeed, PSF associates specifically with the TNF alpha mRNA in living cells. PSF is phosphorylated at two sites by the Mnks. Our data show that Mnk-mediated phosphorylation increases the binding of PSF to the TNF alpha mRNA in living cells. These findings identify a novel Mnk substrate. They also suggest that the Mnk-catalyzed phosphorylation of PSF may regulate the fate of specific mRNAs by modulating their binding to PSF.p54nrb.	[Buxade, Maria; Proud, Christopher G.] Univ Dundee, Coll Life Sci, Div Mol Physiol, Dundee DD1 5EH, Scotland; [Morrice, Nick] Univ Dundee, Coll Life Sci, Med Res Council Protein Phosphorylat Unit, Dundee DD1 5EH, Scotland; [Buxade, Maria; Krebs, Danielle L.; Proud, Christopher G.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of Dundee; University of Dundee; University of British Columbia	Proud, CG (corresponding author), Univ Dundee, Coll Life Sci, Div Mol Physiol, Dundee DD1 5EH, Scotland.	cgpr@interchange.ubc.ca	Buxade, Maria/F-7870-2014	Buxade, Maria/0000-0002-3020-8393; Proud, Christopher/0000-0003-0704-6442; Krebs, Danielle/0000-0002-6522-7308				Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Herbert TP, 2000, J BIOL CHEM, V275, P11249, DOI 10.1074/jbc.275.15.11249; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; Karin Michael, 2005, Proc Am Thorac Soc, V2, P386, DOI 10.1513/pats.200504-034SR; Knauf U, 2001, MOL CELL BIOL, V21, P5500, DOI 10.1128/MCB.21.16.5500-5511.2001; Knebel A, 2001, EMBO J, V20, P4360, DOI 10.1093/emboj/20.16.4360; MADER S, 1995, MOL CELL BIOL, V15, P4990; Mathur M, 2001, MOL CELL BIOL, V21, P2298, DOI 10.1128/MCB.21.7.2298-2311.2001; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; O'Loghlen A, 2004, EXP CELL RES, V299, P343, DOI 10.1016/j.yexcr.2004.06.006; PATTON JG, 1993, GENE DEV, V7, P393, DOI 10.1101/gad.7.3.393; Proteau A, 2005, J MOL BIOL, V346, P1163, DOI 10.1016/j.jmb.2004.12.034; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Raught B, 2000, COLD SPRING HARBOR M, V39, P245; Rom E, 1998, J BIOL CHEM, V273, P13104, DOI 10.1074/jbc.273.21.13104; Rousseau S, 2002, EMBO J, V21, P6505, DOI 10.1093/emboj/cdf639; Sachs A, 2000, COLD SPRING HARBOR M, V39, P447; Scheper GC, 2003, MOL CELL BIOL, V23, P5692, DOI 10.1128/MCB.23.16.5692-5705.2003; Scheper GC, 2001, MOL CELL BIOL, V21, P743, DOI 10.1128/MCB.21.3.743-754.2001; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Shav-Tal Y, 2001, MOL BIOL CELL, V12, P2328, DOI 10.1091/mbc.12.8.2328; STERN BD, 1993, PROTEIN EXPRES PURIF, V4, P320, DOI 10.1006/prep.1993.1041; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Urban RJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE423, DOI 10.1152/ajpendo.00057.2002; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Wang XM, 1998, J BIOL CHEM, V273, P9373, DOI 10.1074/jbc.273.16.9373; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Williamson BL, 2006, MOL CELL PROTEOMICS, V5, P337, DOI 10.1074/mcp.M500210-MCP200; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952; Zolotukhin AS, 2003, MOL CELL BIOL, V23, P6618, DOI 10.1128/MCB.23.18.6618-6630.2003	36	59	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					57	65		10.1074/jbc.M705286200	http://dx.doi.org/10.1074/jbc.M705286200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17965020	Green Accepted, hybrid			2022-12-25	WOS:000251940300008
J	Kim, JY; Omori, E; Matsumoto, K; Nunez, G; Ninomiya-Tsuji, J				Kim, Jae-Young; Omori, Emily; Matsumoto, Kunihiro; Nunez, Gabriel; Ninomiya-Tsuji, Jun			TAK1 is a central mediator of NOD2 signaling in epidermal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTESTINAL EPITHELIAL-CELLS; TOLL-LIKE RECEPTORS; CROHNS-DISEASE; MURAMYL DIPEPTIDE; INNATE IMMUNITY; PROTEIN-KINASE; ACTIVATION; PATHWAYS; RECOGNITION	Muramyl dipeptide (MDP) is a peptidoglycan moiety derived from commensal and pathogenic bacteria, and a ligand of its intracellular sensor NOD2. Mutations in NOD2 are highly associated with Crohn disease, which is characterized by dysregulated inflammation in the intestine. However, the mechanism linking abnormality of NOD2 signaling and inflammation has yet to be elucidated. Here we show that transforming growth factor beta-activated kinase 1 (TAK1) is an essential intermediate of NOD2 signaling. We found that TAK1 deletion completely abolished MDP-NOD2 signaling, activation of NF-kappa B and MAPKs, and subsequent induction of cytokines/chemokines in keratinocytes. NOD2 and its downstream effector RICK associated with and activated TAK1. TAK1 deficiency also abolished MDP-induced NOD2 expression. Because mice with epidermis-specific deletion of TAK1 develop severe inflammatory conditions, we propose that TAK1 and NOD2 signaling are important for maintaining normal homeostasis of the skin, and its ablation may impair the skin barrier function leading to inflammation.	[Kim, Jae-Young; Omori, Emily; Ninomiya-Tsuji, Jun] N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA; [Matsumoto, Kunihiro] Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Nagoya, Aichi 4648602, Japan; [Nunez, Gabriel] Univ Michigan, Ctr Comprehens Canc, Dept Pathol, Ann Arbor, MI 48109 USA; [Matsumoto, Kunihiro] Japan Sci & Technol, Solut Oriented Res Sci & Technol, Tokyo, Japan	University of North Carolina; North Carolina State University; Nagoya University; University of Michigan System; University of Michigan; Japan Science & Technology Agency (JST)	Ninomiya-Tsuji, J (corresponding author), N Carolina State Univ, Dept Environm & Mol Toxicol, Campus Box 7633, Raleigh, NC 27695 USA.	Jun_Tsuji@ncsu.edu	Nuñez, Gabriel/A-7160-2014	Kim, Jae-Young/0000-0001-6700-1372; Ninomiya-Tsuji, Jun/0000-0002-5584-0176	NIGMS NIH HHS [R01 GM068812, R01 GM068812-04, GM 068812] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068812] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; ABBOTT DW, 2007, MOL CELL BIOL; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Chen CM, 2004, J BIOL CHEM, V279, P25876, DOI 10.1074/jbc.M400682200; Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Eckmann L, 2005, IMMUNITY, V22, P661, DOI 10.1016/j.immuni.2005.06.004; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; Hugot JP, 2006, ANN NY ACAD SCI, V1072, P9, DOI 10.1196/annals.1326.011; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Inohara N, 1998, J BIOL CHEM, V273, P12296, DOI 10.1074/jbc.273.20.12296; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kelsall B, 2005, NAT MED, V11, P383, DOI 10.1038/nm0405-383; Kishida S, 2005, GENES CELLS, V10, P447, DOI 10.1111/j.1365-2443.2005.00852.x; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Kitamura T, 1998, INT J HEMATOL, V67, P351; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2003, NAT IMMUNOL, V4, P652, DOI 10.1038/ni0703-652; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Lu CF, 2005, J BIOL CHEM, V280, P16278, DOI 10.1074/jbc.M410114200; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Nenci A, 2006, HUM MOL GENET, V15, P531, DOI 10.1093/hmg/ddi470; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Pauleau AL, 2003, MOL CELL BIOL, V23, P7531, DOI 10.1128/MCB.23.21.7531-7539.2003; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rosenstiel P, 2003, GASTROENTEROLOGY, V124, P1001, DOI 10.1053/gast.2003.50157; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Voss E, 2006, J BIOL CHEM, V281, P2005, DOI 10.1074/jbc.M511044200; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Windheim M, 2007, BIOCHEM J, V404, P179, DOI 10.1042/BJ20061704	46	75	81	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					137	144		10.1074/jbc.M704746200	http://dx.doi.org/10.1074/jbc.M704746200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17965022	Green Accepted, hybrid			2022-12-25	WOS:000251940300016
J	Supekova, L; Supek, F; Lee, J; Chen, S; Gray, N; Pezacki, JP; Schlapbach, A; Schultz, PG				Supekova, Lubica; Supek, Frantisek; Lee, Jongkook; Chen, Shawn; Gray, Nathanael; Pezacki, John P.; Schlapbach, Achim; Schultz, Peter G.			Identification of human kinases involved in hepatitis C virus replication by small interference RNA library screening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACCINIA-RELATED KINASE-1; SRC FAMILY KINASES; TYROSINE KINASES; DISRUPTION; ACTIVATION; GENE; PHOSPHORYLATION; MATURATION; INHIBITORS; REPORTER	The propagation of the hepatitis C virus (HCV) is a complex process that requires both host and viral proteins. To facilitate identification of host cell factors that are required for HCV replication, we screened a panel of small interference RNAs that preferentially target human protein kinases using an HCV replicon expressing the firefly luciferase gene as a genetic reporter. Small interference RNAs specific for three human kinases, Csk, Jak1, and Vrk1, were identified that reproducibly reduce viral RNA and viral protein levels in HCV replicon-bearing cells. Treatment of replicon cells with a small molecule inhibitor of Csk also resulted in a significant reduction in HCV RNA and proteins, further supporting a role for Csk in HCV replication. The effects of siRNAs targeting eight kinases known to be negatively regulated by Csk were then examined; knock down of one of these kinases, Fyn, resulted in up-regulation of the HCV replicon, suggesting that Csk mediates its effect on HCV replication through Fyn. This conclusion was further corroborated by demonstration that replicon cells treated with Csk inhibitor contained lower levels of the phosphorylated form of Fyn than control cells.	[Supekova, Lubica; Lee, Jongkook; Schultz, Peter G.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Supek, Frantisek; Schultz, Peter G.] Genom Inst Novartis Res Fdn, Dept Drug Discovery, San Diego, CA 92121 USA; [Gray, Nathanael] Harvard Med Sch, Dana Farber Canc Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Pezacki, John P.] Steacie Inst Mol Sci, Ottawa, ON K1A 0R6, Canada; [Schlapbach, Achim] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland	Scripps Research Institute; Novartis; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; National Research Council Canada; Novartis	Schultz, PG (corresponding author), 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schultz@scripps.edu	Chen, Shawn/K-3585-2012	Chen, Shawn/0000-0002-6678-3293; Schlapbach, Achim/0000-0001-8137-8889; Lee, Jongkook/0000-0003-0739-7963				Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Barcia R, 2002, ARCH BIOCHEM BIOPHYS, V399, P1, DOI 10.1006/abbi.2001.2746; Blanco S, 2006, FEBS J, V273, P2487, DOI 10.1111/j.1742-4658.2006.05256.x; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Chan L, 2004, BIOORG MED CHEM LETT, V14, P797, DOI 10.1016/j.bmcl.2003.10.068; Chu JJH, 2007, P NATL ACAD SCI USA, V104, P3520, DOI 10.1073/pnas.0611681104; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Hirsch AJ, 2005, J VIROL, V79, P11943, DOI 10.1128/JVI.79.18.11943-11951.2005; Ihle JN, 1995, ADV IMMUNOL, V60, P1, DOI 10.1016/S0065-2776(08)60582-9; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; Ishii N, 2006, J VIROL, V80, P4510, DOI 10.1128/JVI.80.9.4510-4520.2006; Klein NP, 1999, EMBO J, V18, P5019, DOI 10.1093/emboj/18.18.5019; Liang Y, 2006, J VIROL, V80, P3349, DOI 10.1128/JVI.80.7.3349-3359.2006; Lin K, 2006, ANTIMICROB AGENTS CH, V50, P1813, DOI 10.1128/AAC.50.5.1813-1822.2006; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lopez-Borges S, 2000, ONCOGENE, V19, P3656, DOI 10.1038/sj.onc.1203709; Lund TC, 1997, J VIROL, V71, P6677, DOI 10.1128/JVI.71.9.6677-6682.1997; Lundin M, 2003, J VIROL, V77, P5428, DOI 10.1128/JVI.77.9.5428-5438.2003; Macdonald A, 2005, J GEN VIROL, V86, P1035, DOI 10.1099/vir.0.80734-0; Macdonald A, 2004, J GEN VIROL, V85, P721, DOI 10.1099/vir.0.19691-0; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; Murray EM, 2003, J VIROL, V77, P2928, DOI 10.1128/JVI.77.5.2928-2935.2003; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; Rakic B, 2006, CHEM BIOL, V13, P23, DOI 10.1016/j.chembiol.2005.10.006; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; Sarcar B, 2004, VIROLOGY, V322, P51, DOI 10.1016/j.virol.2004.01.008; Sevilla A, 2004, J BIOL CHEM, V279, P27458, DOI 10.1074/jbc.M401009200; Thomas RM, 2004, IMMUNITY, V20, P181, DOI 10.1016/S1074-7613(04)00023-8; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Valbuena A, 2006, MOL CELL BIOL, V26, P4782, DOI 10.1128/MCB.00069-06; Vrolijk JM, 2003, J VIROL METHODS, V110, P201, DOI 10.1016/S0166-0934(03)00134-4; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; Ye J, 2003, P NATL ACAD SCI USA, V100, P15865, DOI 10.1073/pnas.2237238100; Yi MK, 2002, VIROLOGY, V304, P197, DOI 10.1006/viro.2002.1652	38	83	88	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					29	36		10.1074/jbc.M703988200	http://dx.doi.org/10.1074/jbc.M703988200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17951261	hybrid			2022-12-25	WOS:000251940300005
J	Morgan, AJ; Galione, A				Morgan, Anthony J.; Galione, Antony			Fertilization and nicotinic acid adenine dinucleotide phosphate induce pH changes in acidic Ca2+ stores in sea urchin eggs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICAL GRANULE EXOCYTOSIS; ENDOPLASMIC-RETICULUM; CONFOCAL MICROSCOPY; RESPIRATORY BURST; YOLK PLATELETS; CALCIUM; NAADP; ACTIVATION; MEMBRANE; ACIDIFICATION	The second messenger nicotinic acid adenine dinucleotide phosphate (NAADP) releases Ca2+ from the acidic Ca2+ stores of many organisms, including those of the sea urchin egg. We investigated whether the pH within the lumen of these acidic organelles changes in response to stimuli. Fertilization activates the egg by Ca2+ release dependent upon NAADP, and accordingly, we report that fertilization also alters organellar pH in a spatio-temporally complex manner. Upon sperm fusion, vesicles deep in the egg center slowly acidify, whereas cortical vesicles undergo a rapid alkalinization. The cortical vesicle alkalinization is independent of exocytosis and cytosolic pH but coincides with the NAADP-dependent fertilization Ca2+ wave. Microinjection of NAADP mimicked the fertilization cortical response, suggesting that it occurred within NAADP-sensitive acidic Ca2+ stores. Our data show that NAADP and physiological stimuli alter the pH within intracellular organelles and suggest that NAADP signals through pH as well as Ca2+.	[Morgan, Anthony J.; Galione, Antony] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Oxford	Morgan, AJ (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	Anthony.morgan@pharm.ox.ac.uk	Galione, Antony/E-5884-2011	Galione, Antony/0000-0002-4132-7646	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Busch GL, 1996, PFLUG ARCH EUR J PHY, V431, P690, DOI 10.1007/BF02253831; Churchill GC, 2000, J BIOL CHEM, V275, P38687, DOI 10.1074/jbc.M005827200; Churchill GC, 2003, CURR BIOL, V13, P125, DOI 10.1016/S0960-9822(03)00002-2; Churchill GC, 2001, J BIOL CHEM, V276, P11223, DOI 10.1074/jbc.M009335200; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; DEITS T, 1985, J BIOL CHEM, V260, P7882; FAGOTTO F, 1994, J CELL BIOL, V125, P1047, DOI 10.1083/jcb.125.5.1047; FAGOTTO F, 1994, J CELL SCI, V107, P3325; FISHKIND DJ, 1990, DEV BIOL, V142, P439, DOI 10.1016/0012-1606(90)90366-Q; FOERDER CA, 1978, P NATL ACAD SCI USA, V75, P3183, DOI 10.1073/pnas.75.7.3183; Galione A, 2005, CELL CALCIUM, V38, P273, DOI 10.1016/j.ceca.2005.06.031; Haley SA, 2004, MOL BIOL CELL, V15, P2084, DOI 10.1091/mbc.E03-11-0843; HEINECKE JW, 1992, J BIOL CHEM, V267, P7959; Kawai A, 2007, AUTOPHAGY, V3, P154, DOI 10.4161/auto.3634; Leckie C, 2003, J BIOL CHEM, V278, P12247, DOI 10.1074/jbc.M210770200; LEE HC, 1983, DEV BIOL, V98, P446, DOI 10.1016/0012-1606(83)90374-3; Lim D, 2001, FASEB J, V15, P2257, DOI 10.1096/fj.01-0157com; Lopez-Godinez J, 2003, BIOCHEM BIOPH RES CO, V301, P13, DOI 10.1016/S0006-291X(02)02979-0; MALLYA SK, 1992, J CELL BIOL, V117, P1211, DOI 10.1083/jcb.117.6.1211; Matese JC, 1997, DEV BIOL, V186, P16, DOI 10.1016/S0012-1606(97)98585-7; Matese JC, 1998, ZYGOTE, V6, P55, DOI 10.1017/S0967199400005086; MCPHERSON SM, 1992, J CELL BIOL, V116, P1111, DOI 10.1083/jcb.116.5.1111; MOHRI T, 1990, CELL STRUCT FUNCT, V15, P309, DOI 10.1247/csf.15.309; MORGAN AJ, 2006, METHODS CALCIUM SIGN, P265; Morgan AJ, 2007, BIOCHEM J, V402, P301, DOI 10.1042/BJ20060759; Papp S, 2003, J CELL BIOL, V160, P475, DOI 10.1083/jcb.200207136; Renstrom E, 2002, J BIOL CHEM, V277, P26717, DOI 10.1074/jbc.C200314200; SAITO K, 1995, BIOCHEM BIOPH RES CO, V215, P828, DOI 10.1006/bbrc.1995.2538; Sardet C, 2002, DEV BIOL, V241, P1, DOI 10.1006/dbio.2001.0474; Schomer B, 1998, DEV BIOL, V203, P1, DOI 10.1006/dbio.1998.9044; SHAPIRO BM, 1991, SCIENCE, V252, P533, DOI 10.1126/science.1850548; Smith RM, 2002, TRAFFIC, V3, P397, DOI 10.1034/j.1600-0854.2002.30603.x; Song JL, 2006, DEV BIOL, V300, P385, DOI 10.1016/j.ydbio.2006.07.041; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; SWANN K, 1986, J CELL BIOL, V103, P2333, DOI 10.1083/jcb.103.6.2333; TERASAKI M, 1995, J CELL SCI, V108, P2293; TERASAKI M, 1991, J CELL BIOL, V114, P929, DOI 10.1083/jcb.114.5.929; Wessel GM, 2000, DEV GROWTH DIFFER, V42, P507; WHALLEY T, 1995, J CELL BIOL, V131, P1183, DOI 10.1083/jcb.131.5.1183; Whitaker M, 2006, PHYSIOL REV, V86, P25, DOI 10.1152/physrev.00023.2005; Wong JL, 2004, DEV CELL, V7, P801, DOI 10.1016/j.devcel.2004.10.014	41	36	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37730	37737		10.1074/jbc.M704630200	http://dx.doi.org/10.1074/jbc.M704630200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17959608	hybrid			2022-12-25	WOS:000251833600049
J	Coddou, C; Acuna-Castillo, C; Bull, P; Huidobro-Toro, JP				Coddou, Claudio; Acuna-Castillo, Claudio; Bull, Paulina; Huidobro-Toro, J. Pablo			Dissecting the facilitator and inhibitor allosteric metal sites of the P2X(4) receptor channel - Critical roles of Cys(132) for zinc potentiation and Asp(138) for copper inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL MODULATION; BINDING SITE; NEURONAL EXCITABILITY; HISTIDINE-RESIDUES; CELL-SURFACE; RAT-BRAIN; SUBUNITS; ZN2+; IDENTIFICATION; DETERMINANTS	Zinc and copper are atypical modulators of ligand-gated ionic channels in the central nervous system. We sought to identify the amino acids of the rat P2X(4) receptor involved in trace metal interaction, specifically in the immediate linear vicinity of His(140), a residue previously identified as being critical for copper-induced inhibition of the ATP-evoked currents. Site-directed mutagenesis replaced conspicuous amino acids located within the extracellular domain region between Thr(123) and Thr(146) for alanines. cDNAs for the wild-type and the receptor mutants were expressed in Xenopus laevis oocytes and examined by the two-electrode technique. Cys(132), but not Cys(126), proved crucial for zinc-induced potentiation of the receptor activity, but not for copper-induced inhibition. Zinc inhibited in a concentration-dependent manner the ATP-gated currents of the C132A mutant. Likewise, Asp(138), but not Asp(131) was critical for copper and zinc inhibition; moreover, mutant D138A was 20-fold more reactive to zinc potentiation than wild-type receptors. Asp(129), Asp131, and Thr(133) had minor roles in metal modulation. We conclude that this region of the P2X4 receptor has a pocket for trace metal coordination with two distinct and separate facilitator and inhibitor metal allosteric sites. In addition, Cys132 does not seem to participate exclusively as a structural receptor channel folding motif but plays a role as a ligand for zinc modulation highlighting the role of trace metals in neuronal excitability.	[Coddou, Claudio; Bull, Paulina; Huidobro-Toro, J. Pablo] Pontificia Univ Catolica Chile, Ctr Regulac Celular & Patol JV Luco, Inst Milenio Biol Fundamental & Aplicada MIFAB, Lab Nucleotidos,Dept Fisiol, Santiago 6513677, Chile; [Bull, Paulina] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Santiago 6513677, Chile; [Acuna-Castillo, Claudio] Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Santiago 9170019, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad de Santiago de Chile	Huidobro-Toro, JP (corresponding author), Pontificia Univ Catolica Chile, Fac Biol Sci, Dept Physiol, Nucleotide Res Lab, Casilla 114-D, Santiago, Chile.	jphuid@bio.puc.cl	Acuña-Castillo, Claudio/AAI-7090-2021	Acuña-Castillo, Claudio/0000-0003-3607-6077				Acuna-Castillo C, 2000, J NEUROCHEM, V74, P1529, DOI 10.1046/j.1471-4159.2000.0741529.x; Acuna-Castillo C, 2007, J NEUROCHEM, V101, P17, DOI 10.1111/j.1471-4159.2006.04343.x; Aitken A, 1999, MOL BIOTECHNOL, V12, P241, DOI 10.1385/MB:12:3:241; ASSAF S, 1984, NATURE, V208, P734; Baranano DE, 2001, TRENDS NEUROSCI, V24, P99, DOI 10.1016/S0166-2236(00)01716-1; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; BLOOMENTHAL AB, 1994, MOL PHARMACOL, V46, P1156; Clyne JD, 2002, J PHYSIOL-LONDON, V539, P347, DOI 10.1113/jphysiol.2001.013244; Clyne JD, 2002, J NEUROSCI, V22, P3873, DOI 10.1523/JNEUROSCI.22-10-03873.2002; Coddou C, 2003, J BIOL CHEM, V278, P36777, DOI 10.1074/jbc.M305177200; Coddou C, 2003, EUR J PHARMACOL, V472, P49, DOI 10.1016/S0014-2999(03)01864-8; Coddou C, 2002, J NEUROCHEM, V80, P626, DOI 10.1046/j.0022-3042.2001.00732.x; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Ennion SJ, 2002, MOL PHARMACOL, V61, P303, DOI 10.1124/mol.61.2.303; Fountain SJ, 2007, NATURE, V448, P200, DOI 10.1038/nature05926; Hershfinkel M, 2001, P NATL ACAD SCI USA, V98, P11749, DOI 10.1073/pnas.201193398; Hirzel K, 2006, NEURON, V52, P679, DOI 10.1016/j.neuron.2006.09.035; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; KARDOS J, 1989, NEUROSCI LETT, V103, P139, DOI 10.1016/0304-3940(89)90565-X; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 1999, J NEUROSCI, V19, P7289, DOI 10.1523/JNEUROSCI.19-17-07289.1999; Lorca RA, 2005, J NEUROCHEM, V95, P499, DOI 10.1111/j.1471-4159.2005.03387.x; MA JY, 1993, BRAIN RES, V607, P222; Mathie A, 2006, PHARMACOL THERAPEUT, V111, P567, DOI 10.1016/j.pharmthera.2005.11.004; Nagaya N, 2005, J BIOL CHEM, V280, P25982, DOI 10.1074/jbc.M504545200; Nicke A, 2005, J NEUROCHEM, V92, P925, DOI 10.1111/j.1471-4159.2004.02939.x; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Palma E, 1998, P NATL ACAD SCI USA, V95, P10246, DOI 10.1073/pnas.95.17.10246; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Silberberg SD, 2007, NEURON, V54, P263, DOI 10.1016/j.neuron.2007.03.020; Soto F, 1996, P NATL ACAD SCI USA, V93, P3684, DOI 10.1073/pnas.93.8.3684; Tittle RK, 2007, J BIOL CHEM, V282, P19526, DOI 10.1074/jbc.M701604200; Torres GE, 1999, J BIOL CHEM, V274, P6653, DOI 10.1074/jbc.274.10.6653; Trombley PQ, 1996, J NEUROPHYSIOL, V76, P2536, DOI 10.1152/jn.1996.76.4.2536; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Vial C, 2004, TRENDS PHARMACOL SCI, V25, P487, DOI 10.1016/j.tips.2004.07.008; Xiong KM, 1999, J NEUROPHYSIOL, V81, P2088, DOI 10.1152/jn.1999.81.5.2088; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yan ZH, 2005, MOL PHARMACOL, V67, P1078, DOI 10.1124/mol.104.010108	40	38	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36879	36886		10.1074/jbc.M706925200	http://dx.doi.org/10.1074/jbc.M706925200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17962187	hybrid			2022-12-25	WOS:000251646000013
J	Gerits, N; Mikalsen, T; Kostenko, S; Shiryaev, A; Johannessen, M; Moens, U				Gerits, Nancy; Mikalsen, Theresa; Kostenko, Sergiy; Shiryaev, Alexey; Johannessen, Mona; Moens, Ugo			Modulation of F-actin rearrangement by the cyclic AMP/cAMP-dependent protein kinase (PKA) pathway is mediated by MAPK-activated protein kinase 5 and requires PKA-induced nuclear export of MK5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; SUBCELLULAR-LOCALIZATION; SIGNALING PATHWAYS; GENE-TRANSCRIPTION; NEURITE OUTGROWTH; ENDOTHELIAL-CELLS; BINDING-PROTEIN; P38; CAMP; AMP	The MAPK-activated protein kinases belong to the Ca2+/ calmodulin-dependent protein kinases. Within this group, MK2, MK3, and MK5 constitute three structurally related enzymes with distinct functions. Few genuine substrates for MK5 have been identified, and the only known biological role is in ras-induced senescence and in tumor suppression. Here we demonstrate that activation of cAMP-dependent protein kinase (PKA) or ectopic expression of the catalytic subunit C alpha in PC12 cells results in transient nuclear export of MK5, which requires the kinase activity of both C alpha and MK5 and the ability of C alpha to enter the nucleus. C alpha and MK5, but not MK2, interact in vivo, and C alpha increases the kinase activity of MK5. Moreover, C alpha augments MK5 phosphorylation, but not MK2, whereas MK5 does not seem to phosphorylate C alpha. Activation of PKA can induce actin filament accumulation at the plasma membrane and formation of actin-based filopodia. We demonstrate that small interfering RNA-triggered depletion of MK5 interferes with PKA-induced F-actin rearrangement. Moreover, cytoplasmic expression of an activated MK5 variant is sufficient to mimic PKA-provoked F-actin remodeling. Our results describe a novel interaction between the PKA pathway and MAPK signaling cascades and suggest that MK5, but not MK2, is implicated in PKA-induced microfilament rearrangement.	[Gerits, Nancy; Mikalsen, Theresa; Kostenko, Sergiy; Shiryaev, Alexey; Johannessen, Mona; Moens, Ugo] Univ Tromso, Fac Med, Dept Microbiol & Virol, N-9037 Tromso, Norway	UiT The Arctic University of Tromso	Moens, U (corresponding author), Univ Tromso, Fac Med, Dept Microbiol & Virol, N-9037 Tromso, Norway.	ugom@fagmed.uit.no	Kostenko, Sergiy/Q-6251-2017	Kostenko, Sergiy/0000-0002-3677-9859				Aberg E, 2006, J BIOL CHEM, V281, P35499, DOI 10.1074/jbc.M606225200; Azuma N, 2001, AM J PHYSIOL-HEART C, V280, pH189, DOI 10.1152/ajpheart.2001.280.1.H189; Bok J, 2003, J NEUROSCI, V23, P777; Chaturvedi D, 2006, MOL CELL BIOL, V26, P4586, DOI 10.1128/MCB.01422-05; Culbert AA, 2006, J BIOL CHEM, V281, P23658, DOI 10.1074/jbc.M513646200; Dalton GD, 2006, NEUROPEPTIDES, V40, P23, DOI 10.1016/j.npep.2005.10.002; DAY RN, 1989, J BIOL CHEM, V264, P431; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Gerits N, 2007, TRANSGENIC RES, V16, P281, DOI 10.1007/s11248-006-9052-0; Han J, 1999, NAT CELL BIOL, V1, pE39, DOI 10.1038/10032; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; HOUBEN R, 2005, J CARCINOGEGEN, V20, P23; Houslay M.D., 2006, SCI STKE, V2006, ppe32; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huot J, 1998, J CELL BIOL, V143, P1361, DOI 10.1083/jcb.143.5.1361; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; Imajo M, 2006, IUBMB LIFE, V58, P312, DOI 10.1080/15216540600746393; Johannessen M, 2004, CELL SIGNAL, V16, P1187, DOI 10.1016/j.cellsig.2004.03.009; JOHANNESSEN M, 2005, TRENDS CELLULAR SIGN, P41; Johannessen M, 2007, J BIOL CHEM, V282, P14777, DOI 10.1074/jbc.M610669200; Kant S, 2006, J BIOL CHEM, V281, P35511, DOI 10.1074/jbc.M606693200; Kayyali US, 2002, J BIOL CHEM, V277, P42596, DOI 10.1074/jbc.M205863200; Kim HS, 2006, EXP MOL MED, V38, P85, DOI 10.1038/emm.2006.10; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Krens SFG, 2006, FEBS LETT, V580, P4984, DOI 10.1016/j.febslet.2006.08.025; Larsen JK, 1997, AM J PHYSIOL-LUNG C, V273, pL930, DOI 10.1152/ajplung.1997.273.5.L930; Ma SM, 2007, BBA-MOL CELL RES, V1773, P912, DOI 10.1016/j.bbamcr.2007.02.006; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Moens MJU, 2007, FRONT BIOSCI-LANDMRK, V12, P1814; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Neufeld B, 2000, J BIOL CHEM, V275, P20239, DOI 10.1074/jbc.C901040199; New L, 2003, MOL BIOL CELL, V14, P2603, DOI 10.1091/mbc.E02-08-0538; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; Ni H, 1998, BIOCHEM BIOPH RES CO, V243, P492, DOI 10.1006/bbrc.1998.8135; Paliga AJM, 2005, BIOL CELL, V97, P629, DOI 10.1042/BC20040146; Pearson GW, 2006, MOL CELL BIOL, V26, P3039, DOI 10.1128/MCB.26.8.3039-3047.2006; Pichon S, 2004, J CELL SCI, V117, P2569, DOI 10.1242/jcs.01110; Rousseau S, 2006, CELL SIGNAL, V18, P1897, DOI 10.1016/j.cellsig.2006.02.006; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Schafer C, 1998, J BIOL CHEM, V273, P24173, DOI 10.1074/jbc.273.37.24173; Schumacher S, 2004, EMBO J, V23, P4770, DOI 10.1038/sj.emboj.7600467; Seternes OM, 2004, EMBO J, V23, P4780, DOI 10.1038/sj.emboj.7600489; Seternes OM, 2002, MOL CELL BIOL, V22, P6931, DOI 10.1128/MCB.22.20.6931-6945.2002; Shi Y, 2003, MOL CELL BIOL, V23, P7732, DOI 10.1128/MCB.23.21.7732-7741.2003; Shimomura A, 1998, J NEUROCHEM, V70, P1029; Sithanandam G, 1996, MOL CELL BIOL, V16, P868; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Thiel G, 2005, J NEUROCHEM, V92, P321, DOI 10.1111/j.1471-4159.2004.02882.x; Thyssen G, 2006, MOL CELL BIOL, V26, P8857, DOI 10.1128/MCB.01031-06; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200; Whitmarsh AJ, 2007, BBA-MOL CELL RES, V1773, P1285, DOI 10.1016/j.bbamcr.2006.11.011; Wu R, 2007, J BIOL CHEM, V282, P21598, DOI 10.1074/jbc.M611316200; Yao J, 2004, TRAFFIC, V5, P1006, DOI 10.1111/j.1600-0854.2004.00240.x; Zheng CL, 2006, J BIOL CHEM, V281, P37215, DOI 10.1074/jbc.M603622200	64	48	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37232	37243		10.1074/jbc.M704873200	http://dx.doi.org/10.1074/jbc.M704873200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17947239	hybrid			2022-12-25	WOS:000251646000049
J	Geoghegan, JC; Valdes, PA; Orem, NR; Deleault, NR; Williamson, RA; Harris, BT; Supattapone, S				Geoghegan, James C.; Valdes, Pablo A.; Orem, Nicholas R.; Deleault, Nathan R.; Williamson, R. Anthony; Harris, Brent T.; Supattapone, Surachai			Selective incorporation of polyanionic molecules into hamster prions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; HIGHLY STRUCTURED RNAS; IN-VITRO CONVERSION; NUCLEIC-ACID; NUCLEOCAPSID PROTEIN; ACRIDINE-ORANGE; LIPID-MEMBRANES; CYCLIC AMPLIFICATION; SEEDING SPECIFICITY; INCUBATION PERIOD	The central pathogenic event of prion disease is the conformational conversion of a host protein, PrPC, into a pathogenic isoform, PrPSc. We previously showed that the protein misfolding cyclic amplification (PMCA) technique can be used to form infectious prion molecules de novo from purified native PrPC molecules in an autocatalytic process requiring accessory polyanions (Deleault, N. R., Harris, B. T., Rees, J. R., and Supattapone, S. (2007) Proc. Natl. Acad. Sci. U. S. A. 104, 9741-9746). Here we investigated the molecular mechanism by which polyanionic molecules facilitate infectious prion formation in vitro. In a PMCA reaction lacking PrPSc template seed, synthetic poly(A) RNA molecules induce hamster (Ha) PrPC to adopt a protease-sensitive, detergent-insoluble conformation reactive against antibodies specific for PrPSc. During PMCA, labeled nucleic acids form nuclease-resistant complexes with HaPrP molecules. Strikingly, purified HaPrP(C) molecules subjected to PMCA selectively incorporate an similar to 1 -2.5-kb subset of [P-32] poly(A) RNA molecules from a heterogeneous mixture ranging in size from similar to 0.1 to > 6 kb. Neuropathological analysis of scrapie-infected hamsters using the fluorescent dye acridine orange revealed that RNA molecules co-localize with large extracellular HaPrP aggregates. These findings suggest that polyanionic molecules such as RNA may become selectively incorporated into stable complexes with PrP molecules during the formation of native hamster prions.	Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; Dartmouth Med Sch, Dept Pathol, Hanover, NH 03755 USA; Dartmouth Med Sch, Dept Med, Hanover, NH 03755 USA; Scripps Res Inst, La Jolla, CA 92037 USA	Dartmouth College; Dartmouth College; Dartmouth College; Scripps Research Institute	Supattapone, S (corresponding author), Dartmouth Med Sch, Dept Biochem, 7200 Vail Bldg, Hanover, NH 03755 USA.	supattapone@dartmouth.edu			NINDS NIH HHS [R01 NS055875-03, R01 NS046478-06, R01 NS055875, R01 NS046478] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055875, R01NS046478] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adler V, 2003, J MOL BIOL, V332, P47, DOI 10.1016/S0022-2836(03)00919-7; AKOWITZ A, 1994, NUCLEIC ACIDS RES, V22, P1101, DOI 10.1093/nar/22.6.1101; AKOWITZ A, 1993, ARCH VIROL, V130, P301, DOI 10.1007/BF01309662; Apetri AC, 2002, J BIOL CHEM, V277, P44589, DOI 10.1074/jbc.C200507200; Apetri AC, 2006, J AM CHEM SOC, V128, P11673, DOI 10.1021/ja063880b; Bell JE, 1997, NEUROPATH APPL NEURO, V23, P26, DOI 10.1111/j.1365-2990.1997.tb01182.x; Ben-Zaken O, 2003, J BIOL CHEM, V278, P40041, DOI 10.1074/jbc.M301152200; Bera A, 2007, BIOCHEMISTRY-US, V46, P1320, DOI 10.1021/bi0620050; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Bosque PJ, 2000, J VIROL, V74, P4377, DOI 10.1128/JVI.74.9.4377-4386.2000; BRANDES G, 1990, HISTOCHEM J, V22, P106, DOI 10.1007/BF01885789; BRUCE ME, 1993, BRIT MED BULL, V49, P822, DOI 10.1093/oxfordjournals.bmb.a072649; Carlson GA, 1996, CURR TOP MICROBIOL, V207, P35; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; CAUGHEY B, 1994, J VIROL, V68, P2135, DOI 10.1128/JVI.68.4.2135-2141.1994; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; Critchley P, 2004, BIOCHEM BIOPH RES CO, V313, P559, DOI 10.1016/j.bbrc.2003.12.004; DebBurman SK, 1997, P NATL ACAD SCI USA, V94, P13938, DOI 10.1073/pnas.94.25.13938; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Derrington E, 2002, CR BIOL, V325, P17, DOI 10.1016/S1631-0691(02)01388-4; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; GABIZON R, 1987, P NATL ACAD SCI USA, V84, P4017, DOI 10.1073/pnas.84.12.4017; Gabus C, 2001, J BIOL CHEM, V276, P19301, DOI 10.1074/jbc.M009754200; Gabus C, 2001, J MOL BIOL, V307, P1011, DOI 10.1006/jmbi.2001.4544; Ginsberg SD, 1999, ANN NEUROL, V45, P174, DOI 10.1002/1531-8249(199902)45:2<174::AID-ANA7>3.0.CO;2-E; Ginsberg SD, 1998, ACTA NEUROPATHOL, V96, P487, DOI 10.1007/s004010050923; Ginsberg SD, 1997, ANN NEUROL, V41, P200, DOI 10.1002/ana.410410211; Glatzel M, 2005, ARCH NEUROL-CHICAGO, V62, P545, DOI 10.1001/archneur.62.4.545; Hetz C, 2007, J BIOL CHEM, V282, P12725, DOI 10.1074/jbc.M611909200; Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010; Horwich A, 2002, J CLIN INVEST, V110, P1221, DOI 10.1172/JCI200216781; Jackson GS, 1999, BBA-PROTEIN STRUCT M, V1431, P1, DOI 10.1016/S0167-4838(99)00038-2; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Kazlauskaite J, 2005, BIOCHEM SOC SYMP, V72, P211, DOI 10.1042/bss0720211; Kazlauskaite J, 2003, BIOCHEMISTRY-US, V42, P3295, DOI 10.1021/bi026872q; King CY, 2001, J MOL BIOL, V307, P1247, DOI 10.1006/jmbi.2001.4542; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Kuwata K, 2002, BIOCHEMISTRY-US, V41, P12277, DOI 10.1021/bi026129y; Leblanc P, 2004, J MOL BIOL, V337, P1035, DOI 10.1016/j.jmb.2004.02.007; Liu ML, 2007, MOL CELL BIOCHEM, V294, P197, DOI 10.1007/s11010-006-9260-1; Lloyd SE, 2001, P NATL ACAD SCI USA, V98, P6279, DOI 10.1073/pnas.101130398; MAI JK, 1984, J HISTOCHEM CYTOCHEM, V32, P97, DOI 10.1177/32.1.6197440; Manolakou K, 2001, P NATL ACAD SCI USA, V98, P7402, DOI 10.1073/pnas.121172098; Moroncini G, 2004, P NATL ACAD SCI USA, V101, P10404, DOI 10.1073/pnas.0403522101; Moscardini M, 2002, J MOL BIOL, V318, P149, DOI 10.1016/S0022-2836(02)00092-X; Nandi PK, 2004, J MOL BIOL, V344, P827, DOI 10.1016/j.jmb.2004.09.080; Nandi PK, 2001, ARCH VIROL, V146, P327, DOI 10.1007/s007050170178; Nandi PK, 1999, ARCH VIROL, V144, P1751, DOI 10.1007/s007050050702; Nandi PK, 2002, J MOL BIOL, V322, P153, DOI 10.1016/S0022-2836(02)00750-7; Novitskaya V, 2006, J BIOL CHEM, V281, P15536, DOI 10.1074/jbc.M601349200; Pergami P, 1999, BIOCHEM BIOPH RES CO, V264, P972, DOI 10.1006/bbrc.1999.1430; PINTO A, 1990, ARCH PATHOL LAB MED, V114, P585; Proske D, 2002, CHEMBIOCHEM, V3, P717, DOI 10.1002/1439-7633(20020802)3:8<717::AID-CBIC717>3.0.CO;2-C; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Raeber AJ, 1999, P NATL ACAD SCI USA, V96, P3987, DOI 10.1073/pnas.96.7.3987; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Saborio GP, 1999, BIOCHEM BIOPH RES CO, V258, P470, DOI 10.1006/bbrc.1999.0660; Sanghera N, 2002, J MOL BIOL, V315, P1241, DOI 10.1006/jmbi.2001.5322; Shaked GM, 2001, J BIOL CHEM, V276, P14324, DOI 10.1074/jbc.M007815200; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; SNOW AD, 1990, LAB INVEST, V63, P601; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; Stephenson DA, 2000, GENOMICS, V69, P47, DOI 10.1006/geno.2000.6320; Swietnicki W, 1997, J BIOL CHEM, V272, P27517, DOI 10.1074/jbc.272.44.27517; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; TOPALOGLU H, 1989, ANAT REC, V224, P88, DOI 10.1002/ar.1092240111; Lima LMTR, 2006, BIOCHEMISTRY-US, V45, P9180, DOI 10.1021/bi060532d; Van Everbroeck B, 1999, J HISTOCHEM CYTOCHEM, V47, P1465; Vasan S, 2006, NEUROCHEM RES, V31, P629, DOI 10.1007/s11064-006-9063-5; Warner RG, 2002, J BIOL CHEM, V277, P18421, DOI 10.1074/jbc.M110406200; WEISSMANN C, 1991, NATURE, V352, P679, DOI 10.1038/352679a0; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; Yuan J, 2006, J BIOL CHEM, V281, P34848, DOI 10.1074/jbc.M602238200; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zeiler B, 2003, BIOTECHNOL APPL BIOC, V37, P173, DOI 10.1042/BA20020087; Zou WQ, 2002, J BIOL CHEM, V277, P43942, DOI 10.1074/jbc.M203611200	82	78	79	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36341	36353		10.1074/jbc.M704447200	http://dx.doi.org/10.1074/jbc.M704447200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17940287	Green Accepted, hybrid			2022-12-25	WOS:000251458300025
J	L'Hoste, S; Poet, M; Duranton, C; Belfodil, R; Barriere, HE; Rubera, I; Tauc, M; Poujeol, C; Barhanin, J; Poujeol, P				L'Hoste, Sebastien; Poet, Mallorie; Duranton, Christophe; Belfodil, Radia; Barriere, Herv e; Rubera, Isabelle; Tauc, Michel; Poujeol, Chantal; Barhanin, Jacques; Poujeol, Phillipe			Role of TASK2 in the control of apoptotic volume decrease in proximal kidney cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBULAR EPITHELIAL-CELLS; SMOOTH-MUSCLE CELLS; K+ CHANNELS; CHLORIDE CHANNELS; PRIMARY CULTURES; CYCLOSPORINE-A; POTASSIUM CHANNELS; NITRIC-OXIDE; HIGH GLUCOSE; TUMOR-CELLS	Apoptotic volume decrease (AVD) is prerequisite to apoptotic events that lead to cell death. In a previous study, we demonstrated in kidney proximal cells that the TASK2 channel was involved in the K+ efflux that occurred during regulatory volume decrease. The aim of the present study was to determine the role of the TASK2 channel in the regulation of AVD and apoptosis phenomenon. For this purpose renal cells were immortalized from primary cultures of proximal convoluted tubules (PCT) from wild type and TASK2 knock-out mice (task2(-/-)). Apoptosis was induced by staurosporine, cyclosporin A, or tumor necrosis factor alpha. Cell volume, K+ conductance, caspase-3, and intracellular reactive oxygen species (ROS) levels were monitored during AVD. In wild type PCT cells the K+ conductance activated during AVD exhibited characteristics of TASK2 currents. In task2(-/-) PCT cells, AVD and caspase activation were reduced by 59%. Whole cell recordings indicated that large conductance calcium-activated K+ currents inhibited by iberiotoxin (BK channels) partially compensated for the deletion of TASK2 K+ currents in the task2(-/-) PCT cells. This result explained the residual AVD measured in these cells. In both cell lines, apoptosis was mediated via intracellular ROS increase. Moreover AVD, K+ conductances, and caspase-3 were strongly impaired by ROS scavenger N-acetylcysteine. In conclusion, the main K+ channels involved in staurosporine, cyclosporin A, and tumor necrosis factor-alpha-induced AVD are TASK2 K+ channels in proximal wild type cells and iberiotoxin-sensitive BK channels in proximal task2(-/-) cells. Both K+ channels could be activated by ROS production.	Univ Nice Sophia Antipolis, CNRS, UMR 6548, F-06108 Nice 2, France; CNRS, Inst Pharmacol, F-06560 Valbonne Sophia Antipoli, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS)	Poujeol, P (corresponding author), Univ Nice Sophia Antipolis, CNRS, UMR 6548, F-06108 Nice 2, France.	Philippe.POUJEOL@unice.fr	DURANTON, CHRISTOPHE/E-9582-2019; Tauc, Michel/F-1530-2013	DURANTON, CHRISTOPHE/0000-0003-1127-2346; Tauc, Michel/0000-0002-8383-9818; RUBERA, Isabelle/0000-0002-4267-6207				Allen DA, 2003, FASEB J, V17, P908, DOI 10.1096/fj.02-0130fje; Alonso MM, 2003, ONCOGENE, V22, P3759, DOI 10.1038/sj.onc.1206435; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Baek SM, 2003, J LAB CLIN MED, V142, P178, DOI 10.1016/S0022-2143(03)00111-2; Bailey MA, 2006, KIDNEY INT, V70, P51, DOI 10.1038/sj.ki.5000388; Bakker RC, 2002, NEPHROL DIAL TRANSPL, V17, P1181, DOI 10.1093/ndt/17.7.1181; Barlow RS, 2000, AM J PHYSIOL-HEART C, V279, pH475, DOI 10.1152/ajpheart.2000.279.2.H475; Barriere H, 2003, J GEN PHYSIOL, V122, P177, DOI 10.1085/jgp.200308820; Barriere H, 2003, J MEMBRANE BIOL, V193, P153, DOI 10.1007/s00232-003-2014-z; BEAUVAIS F, 1995, J LEUKOCYTE BIOL, V57, P851, DOI 10.1002/jlb.57.6.851; Belfodil R, 2003, AM J PHYSIOL-RENAL, V284, pF812, DOI 10.1152/ajprenal.00238.2002; Bock J, 2002, BIOCHEM BIOPH RES CO, V295, P526, DOI 10.1016/S0006-291X(02)00695-2; Bortner CD, 1998, BIOCHEM PHARMACOL, V56, P1549, DOI 10.1016/S0006-2952(98)00225-1; Burg ED, 2006, J MEMBRANE BIOL, V209, P3, DOI 10.1007/s00232-005-0838-4; Chien CT, 2001, J AM SOC NEPHROL, V12, P973, DOI 10.1681/ASN.V125973; COCAPRADOS M, 1995, AM J PHYSIOL-CELL PH, V268, pC572, DOI 10.1152/ajpcell.1995.268.3.C572; DESMET P, 1995, PFLUG ARCH EUR J PHY, V430, P936, DOI 10.1007/BF01837407; Duprat F, 2005, J PHYSIOL-LONDON, V562, P235, DOI 10.1113/jphysiol.2004.071266; DUPRAT F, 1995, P NATL ACAD SCI USA, V92, P11796, DOI 10.1073/pnas.92.25.11796; Erkan E, 2007, J AM SOC NEPHROL, V18, P1199, DOI 10.1681/ASN.2006040407; Gil J, 2003, FREE RADICAL BIO MED, V35, P1500, DOI 10.1016/j.freeradbiomed.2003.08.022; Gomez-Angelats M, 2000, CELL TISSUE RES, V301, P33, DOI 10.1007/s004410000216; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HALLIWELL B, 1999, FREE RADICALS BIOL; Healy E, 1998, KIDNEY INT, V54, P1955, DOI 10.1046/j.1523-1755.1998.00202.x; Hughes FM, 1997, J BIOL CHEM, V272, P30567, DOI 10.1074/jbc.272.48.30567; Ichikawa D, 2006, BIOCHEM BIOPH RES CO, V351, P93, DOI 10.1016/j.bbrc.2006.10.010; Justo P, 2003, J AM SOC NEPHROL, V14, P3072, DOI 10.1097/01.ASN.0000099383.57934.0E; KNOBLAUCH C, 1989, AM J PHYSIOL, V256, pC252, DOI 10.1152/ajpcell.1989.256.2.C252; Krick S, 2002, AM J PHYSIOL-HEART C, V282, pH184, DOI 10.1152/ajpheart.2002.282.1.H184; Krick S, 2001, AM J PHYSIOL-LUNG C, V281, pL887, DOI 10.1152/ajplung.2001.281.4.L887; Krick S, 2001, AM J PHYSIOL-CELL PH, V280, pC970, DOI 10.1152/ajpcell.2001.280.4.C970; Kruidering M, 1997, J PHARMACOL EXP THER, V280, P638; L'Hoste S, 2007, AM J PHYSIOL-RENAL, V292, pF628, DOI 10.1152/ajprenal.00132.2006; LOPES AG, 1988, P NATL ACAD SCI USA, V85, P2873, DOI 10.1073/pnas.85.8.2873; Lu L, 2006, PROG RETIN EYE RES, V25, P515, DOI 10.1016/j.preteyeres.2006.07.004; Lu SP, 2007, FREE RADICAL BIO MED, V42, P936, DOI 10.1016/j.freeradbiomed.2006.11.027; Lu T, 2006, CIRC RES, V99, P607, DOI 10.1161/01.RES.0000243147.41792.93; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Montague JW, 1999, STEROIDS, V64, P563, DOI 10.1016/S0039-128X(99)00034-3; Nietsch HH, 2000, J BIOL CHEM, V275, P20556, DOI 10.1074/jbc.M002535200; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Okada Y, 2001, COMP BIOCHEM PHYS A, V130, P377, DOI 10.1016/S1095-6433(01)00424-X; Okada Y, 2001, J PHYSIOL-LONDON, V532, P3, DOI 10.1111/j.1469-7793.2001.0003g.x; Pedersen SF, 1999, EXP CELL RES, V252, P63, DOI 10.1006/excr.1999.4615; Remillard CV, 2004, AM J PHYSIOL-LUNG C, V286, pL49, DOI 10.1152/ajplung.00041.2003; Sato T, 2004, J IMMUNOL, V173, P285, DOI 10.4049/jimmunol.173.1.285; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; Shimizu T, 2004, P NATL ACAD SCI USA, V101, P6770, DOI 10.1073/pnas.0401604101; Tang XD, 2004, NAT STRUCT MOL BIOL, V11, P171, DOI 10.1038/nsmb725; TAUC M, 1990, BIOCHIM BIOPHYS ACTA, V1052, P278, DOI 10.1016/0167-4889(90)90222-Y; Thevenod F, 2003, NEPHRON PHYSIOL, V93, P87, DOI DOI 10.1159/000070241; Trimarchi JR, 2002, AM J PHYSIOL-CELL PH, V282, pC588, DOI 10.1152/ajpcell.00365.2001; Warth R, 2004, P NATL ACAD SCI USA, V101, P8215, DOI 10.1073/pnas.0400081101; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114	55	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36692	36703		10.1074/jbc.M703933200	http://dx.doi.org/10.1074/jbc.M703933200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17947235	hybrid			2022-12-25	WOS:000251458300062
J	Aerts, S; van Helden, J; Sand, O; Hassan, BA				Aerts, Stein; van Helden, Jacques; Sand, Olivier; Hassan, Bassem A.			Fine-Tuning Enhancer Models to Predict Transcriptional Targets across Multiple Genomes	PLOS ONE			English	Article							CIS-REGULATORY MODULES; FACTOR-BINDING SITES; PRONEURAL GENE; DROSOPHILA; DISCOVERY; MOTIFS; IDENTIFICATION; BROWSER; CLUSTERS; ELEMENTS	Networks of regulatory relations between transcription factors (TF) and their target genes (TG)-implemented through TF binding sites (TFBS)- are key features of biology. An idealized approach to solving such networks consists of starting from a consensus TFBS or a position weight matrix (PWM) to generate a high accuracy list of candidate TGs for biological validation. Developing and evaluating such approaches remains a formidable challenge in regulatory bioinformatics. We perform a benchmark study on 34 Drosophila TFs to assess existing TFBS and cis-regulatory module (CRM) detection methods, with a strong focus on the use of multiple genomes. Particularly, for CRM-modelling we investigate the addition of orthologous sites to a known PWM to construct phyloPWMs and we assess the added value of phylogenentic footprinting to predict contextual motifs around known TFBSs. For CRM-prediction, we compare motif conservation with network-level conservation approaches across multiple genomes. Choosing the optimal training and scoring strategies strongly enhances the performance of TG prediction for more than half of the tested TFs. Finally, we analyse a 35(th) TF, namely Eyeless, and find a significant overlap between predicted TGs and candidate TGs identified by microarray expression studies. In summary we identify several ways to optimize TF-specific TG predictions, some of which can be applied to all TFs, and others that can be applied only to particular TFs. The ability to model known TF-TG relations, together with the use of multiple genomes, results in a significant step forward in solving the architecture of gene regulatory networks.	[Aerts, Stein; Hassan, Bassem A.] Vlaams Inst Biotechnol VIB, Dept Mol & Dev Genet, Neurogenet Lab, Leuven, Belgium; [Aerts, Stein; Hassan, Bassem A.] KU Leuven Sch Med, Dept Human Genet, Leuven, Belgium; [van Helden, Jacques; Sand, Olivier] Univ Libre Bruxelles, Dept Mol Biol, Serv Conformat Macromol Biol & Bioinformat, Brussels, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; Universite Libre de Bruxelles	Aerts, S (corresponding author), Vlaams Inst Biotechnol VIB, Dept Mol & Dev Genet, Neurogenet Lab, Leuven, Belgium.	stein.aerts@med.kuleuven.be; bassem.hassan@med.kuleuven.be	van Helden, Jacques/D-8590-2013; Aerts, Stein/A-1100-2009; Hassan, Bassem A/D-5221-2012	van Helden, Jacques/0000-0002-8799-8584; Aerts, Stein/0000-0002-8006-0315; Hassan, Bassem A/0000-0001-9533-4908; Sand, Olivier/0000-0003-1465-1640	FWO; VIB; University of Leuven; European Communities [LSHG-CT-2003-503265]; Belgian Fonds de la Recherche Fondamentale Collective; Fonds d'Encouragement a la Recherche	FWO(FWO); VIB; University of Leuven(KU Leuven); European Communities(European Commission); Belgian Fonds de la Recherche Fondamentale Collective(Fonds de la Recherche Scientifique - FNRS); Fonds d'Encouragement a la Recherche	This research was funded by an FWO (Fund for Scientific Research, Flanders) postdoctoral fellowship (to SA) as well as VIB, a Concerted Research Action (GOA) grant and an Impuls grant from University of Leuven (to BAH). BioSapiens Network of excellence funded under the sixth Framework program of the European Communities (LSHG-CT-2003-503265 to JvH). Linux clusters were used from KUL and SMBCC, the latter funded by the Belgian Fonds de la Recherche Fondamentale Collective and the Fonds d'Encouragement a la Recherche.	Adryan B, 2006, BIOINFORMATICS, V22, P1532, DOI 10.1093/bioinformatics/btl143; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Aerts S, 2003, NUCLEIC ACIDS RES, V31, P1753, DOI 10.1093/nar/gkg268; Bailey TL, 2003, BIOINFORMATICS, V19, pII16, DOI 10.1093/bioinformatics/btg1054; Bergman CM, 2005, BIOINFORMATICS, V21, P1747, DOI 10.1093/bioinformatics/bti173; Berman BP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r61; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Chan BY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-262; Chang LW, 2006, GENOME RES, V16, P405, DOI 10.1101/gr.4303406; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; DAVIDSON EH, 2001, GENOMIC REGULATORY S, P261; Eddy SR, 2004, NAT BIOTECHNOL, V22, P1315, DOI 10.1038/nbt1004-1315; Emberly E, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-57; Frith MC, 2003, NUCLEIC ACIDS RES, V31, P3666, DOI 10.1093/nar/gkg540; Gallo SM, 2006, BIOINFORMATICS, V22, P381, DOI 10.1093/bioinformatics/bti794; Halfon MS, 2002, GENOME RES, V12, P1019, DOI 10.1101/gr.228902; Hassan BA, 2000, NEURON, V25, P549, DOI 10.1016/S0896-6273(00)81059-4; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Johansson O, 2003, BIOINFORMATICS, V19, pi169, DOI 10.1093/bioinformatics/btg1021; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; King DC, 2007, GENOME RES, V17, P775, DOI 10.1101/gr.5592107; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lifanov AP, 2003, GENOME RES, V13, P579, DOI 10.1101/gr.668403; Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199; Montgomery SB, 2006, BIOINFORMATICS, V22, P637, DOI 10.1093/bioinformatics/btk027; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Ochoa-Espinosa A, 2005, P NATL ACAD SCI USA, V102, P4960, DOI 10.1073/pnas.0500373102; Ostrin EJ, 2006, GENOME RES, V16, P466, DOI 10.1101/gr.4673006; Philippakis AA, 2006, PLOS COMPUT BIOL, V2, P439, DOI 10.1371/journal.pcbi.0020053; Pritsker M, 2004, GENOME RES, V14, P99; Rajewsky N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-30; Rebeiz M, 2002, P NATL ACAD SCI USA, V99, P9888, DOI 10.1073/pnas.152320899; Schroeder MD, 2004, PLOS BIOL, V2, P1396, DOI 10.1371/journal.pbio.0020271; Segal E, 2005, J COMPUT BIOL, V12, P822, DOI 10.1089/cmb.2005.12.822; Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067; Siepel A., 2005, STAT METHODS MOL EVO; Sinha S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-129; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Sun Y, 1998, DEVELOPMENT, V125, P3731; Taverner NV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-210; Thijs G, 2002, J COMPUT BIOL, V9, P447, DOI 10.1089/10665270252935566; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Zhang TY, 2006, DEVELOPMENT, V133, P4881, DOI 10.1242/dev.02669; zur Lage PI, 2004, DEV CELL, V7, P687, DOI 10.1016/j.devcel.2004.09.015	51	24	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1115	10.1371/journal.pone.0001115	http://dx.doi.org/10.1371/journal.pone.0001115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17973026	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459000003
J	Sibilio, L; Martayan, A; Setini, A; Lo Monaco, E; Tremante, E; Butler, RH; Giacomini, P				Sibilio, Leonardo; Martayan, Aline; Setini, Andrea; Lo Monaco, Elisa; Tremante, Elisa; Butler, Richard H.; Giacomini, Patrizio			A single bottleneck in HLA-C assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-I MOLECULES; CELL-SURFACE EXPRESSION; HEAVY-CHAINS FREE; PEPTIDE BINDING; CRYSTAL-STRUCTURE; OPEN CONFORMERS; MHC; TAP; POLYMORPHISM; RECEPTOR	Poor assembly of class I major histocompatibility HLA-C heavy chains results in their intracellular accumulation in two forms: free of and associated with their light chain subunit (beta(2)-microglobulin). Both intermediates are retained in the endoplasmic reticulum by promiscuous and HLA-dedicated chaperones and are poorly associated with peptide antigens. In this study, the eight serologically defined HLA-C alleles and the interlocus recombinant HLA-B46 allele ( sharing the HLA-C-specific motif KYRV at residues 66-76 of the alpha 1-domain alpha-helix) were compared with a large series of HLA-B and HLA-A alleles. Pulse-labeling experiments with HLA-C transfectants and HLA homozygous cell lines demonstrated that KYRV alleles accumulate as free heavy chains because of both poor assembly and post-assembly instability. Reactivity with antibodies to mapped linear epitopes, co-immunoprecipitation experiments, and molecular dynamics simulation studies additionally showed that the KYRV motif confers association to the HLA-dedicated chaperones TAP and tapasin as well as reduced plasticity and unfolding in the peptide-binding groove. Finally, in vitro assembly experiments in cell extracts of the T2 and 721.220 mutant cell lines demonstrated that HLA-Cw1 retains the ability to form a peptide-receptive interface despite a lack of TAP and functional tapasin, respectively. In the context of the available literature, these results indicate that a single locus-specific biosynthetic bottleneck renders HLA-C peptide-selective ( rather than peptide-unreceptive) and a preferential natural killer cell ligand.	[Sibilio, Leonardo; Martayan, Aline; Setini, Andrea; Lo Monaco, Elisa; Tremante, Elisa; Giacomini, Patrizio] Ctr Ric Sperimentale, Regina Elena Natl Canc Res Inst, Immunol Lab, I-00158 Rome, Italy; [Butler, Richard H.] CNR, Inst Cell Biol, I-00016 Monterotondo Scalo Rome, Italy	Consiglio Nazionale delle Ricerche (CNR)	Giacomini, P (corresponding author), Ctr Ric Sperimentale, Regina Elena Natl Canc Res Inst, Immunol Lab, Via Messi Oro 156, I-00158 Rome, Italy.	giacomini@ifo.it	Giacomini, Patrizio/K-5217-2016; Tremante, Elisa/K-5288-2018	Giacomini, Patrizio/0000-0001-6109-1709; Tremante, Elisa/0000-0002-8584-9913; SETINI, Andrea/0000-0001-8098-6671				Andersen MH, 1999, TISSUE ANTIGENS, V54, P185, DOI 10.1034/j.1399-0039.1999.540210.x; ANDERSON KS, 1993, J IMMUNOL, V151, P3407; Arosa FA, 2007, TRENDS IMMUNOL, V28, P115, DOI 10.1016/j.it.2007.01.002; BAAS EJ, 1992, J EXP MED, V176, P147, DOI 10.1084/jem.176.1.147; Barber LD, 1996, J EXP MED, V184, P735, DOI 10.1084/jem.184.2.735; BENJAMIN RJ, 1992, IMMUNOGENETICS, V37, P73; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; BRODSKY FM, 1979, IMMUNOL REV, V47, P3, DOI 10.1111/j.1600-065X.1979.tb00288.x; Caley RRP, 1999, HUM IMMUNOL, V60, P743, DOI 10.1016/S0198-8859(99)00022-1; Colonna M, 2000, IMMUNOL TODAY, V21, P428, DOI 10.1016/S0167-5699(00)01697-2; Falk CS, 1997, IMMUNOL RES, V16, P203, DOI 10.1007/BF02786363; FALK K, 1993, P NATL ACAD SCI USA, V90, P12005, DOI 10.1073/pnas.90.24.12005; Fan QR, 2001, NAT IMMUNOL, V2, P452, DOI 10.1038/87766; Giacomini P, 1997, TISSUE ANTIGENS, V50, P555, DOI 10.1111/j.1399-0039.1997.tb02913.x; GILLET AC, 1990, EUR J IMMUNOL, V20, P759, DOI 10.1002/eji.1830200408; Giorda E, 2003, CANCER RES, V63, P4119; Grandea AG, 1997, IMMUNOGENETICS, V46, P477, DOI 10.1007/s002510050308; GRANDEA AG, 1995, SCIENCE, V270, P105, DOI 10.1126/science.270.5233.105; GREENWOOD R, 1994, J IMMUNOL, V153, P5525; Groothuis TAM, 2005, IMMUNOL REV, V207, P60, DOI 10.1111/j.0105-2896.2005.00305.x; Hansen TH, 2005, IMMUNOL REV, V207, P100, DOI 10.1111/j.0105-2896.2005.00315.x; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; HILL A, 1993, IMMUNOGENETICS, V37, P95; Hulsmeyer M, 2002, J BIOL CHEM, V277, P47844, DOI 10.1074/jbc.M206392200; Lee N, 1998, J IMMUNOL, V160, P4951; Lewis JW, 1998, EUR J IMMUNOL, V28, P3214, DOI 10.1002/(SICI)1521-4141(199810)28:10<3214::AID-IMMU3214>3.3.CO;2-3; Lewis JW, 1998, CURR BIOL, V8, P717, DOI 10.1016/S0960-9822(98)70280-5; MCCUTCHEON JA, 1995, J EXP MED, V181, P2085, DOI 10.1084/jem.181.6.2085; MIZUNO S, 1989, IMMUNOGENETICS, V29, P323, DOI 10.1007/BF00352842; NEEFJES JJ, 1988, EUR J IMMUNOL, V18, P801, DOI 10.1002/eji.1830180522; Neisig A, 1998, J IMMUNOL, V160, P171; Paquet ME, 2002, INT IMMUNOL, V14, P347, DOI 10.1093/intimm/14.4.347; PeaceBrewer AL, 1996, IMMUNITY, V4, P505, DOI 10.1016/S1074-7613(00)80416-1; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; Roder G, 2006, ACTA CRYSTALLOGR D, V62, P1300, DOI 10.1107/S0907444906027636; Sernee MF, 1998, MOL IMMUNOL, V35, P177, DOI 10.1016/S0161-5890(98)00026-1; Setini A, 1996, HUM IMMUNOL, V46, P69, DOI 10.1016/0198-8859(96)00011-0; SHIMIZU Y, 1988, P NATL ACAD SCI USA, V85, P227, DOI 10.1073/pnas.85.1.227; Sibilio L, 2005, J IMMUNOL, V175, P6651, DOI 10.4049/jimmunol.175.10.6651; Smith KD, 1997, IMMUNOL RES, V16, P243, DOI 10.1007/BF02786393; STEINLE A, 1994, TISSUE ANTIGENS, V44, P268, DOI 10.1111/j.1399-0039.1994.tb02394.x; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; Turnquist HR, 2000, EUR J IMMUNOL, V30, P3021, DOI 10.1002/1521-4141(200010)30:10<3021::AID-IMMU3021>3.0.CO;2-U; Yu YYL, 1999, J IMMUNOL, V163, P4427; Zacharias M, 2004, BIOPHYS J, V87, P2203, DOI 10.1529/biophysj.104.044743; ZEMMOUR J, 1992, J EXP MED, V176, P937, DOI 10.1084/jem.176.4.937	47	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1267	1274		10.1074/jbc.M708068200	http://dx.doi.org/10.1074/jbc.M708068200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17956861	hybrid			2022-12-25	WOS:000252282700009
J	Boos, D; Kuffer, C; Lenobel, R; Korner, R; Stemmann, O				Boos, Dominik; Kuffer, Christian; Lenobel, Rene; Koerner, Roman; Stemmann, Olaf			Phosphorylation-dependent binding of cyclin B1 to a Cdc6-like domain of human separase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; ESCHERICHIA-COLI; XENOPUS-OOCYTES; MEIOSIS-I; COMPLEX; SECURIN; PROTEIN; PROGRESSION; INHIBITION; ANAPHASE	Sister chromatids are held together by the ring-shaped cohesin complex, which likely entraps both DNA- double strands in its middle. This tie is resolved in anaphase when separase, a giant protease, becomes active and cleaves the kleisin subunit of cohesin. Premature activation of separase and, hence, chromosome missegregation are prevented by at least two inhibitory mechanisms. Although securin has long been appreciated as a direct inhibitor of separase, surprisingly its loss has basically no phenotype in mammals. Phosphorylation-dependent binding of Cdk1 constitutes an alternative way to inhibit vertebrate separase. Its importance is illustrated by the premature loss of cohesion when Cdk1-resistant separase is expressed in mammalian cells without or with limiting amounts of securin. Here, we demonstrate that crucial inhibitory phosphorylations occur within a region of human separase that is also shown to make direct contact with the cyclin B1 subunit of Cdk1. This region exhibits a weak homology to Saccharomyces cerevisiae Cdc6 of similar Cdk1 binding behavior, thereby establishing phosphoserine/threonine- mediated binding of partners as a conserved characteristic of B-type cyclins. In contrast to the Cdc6-like domain, the previously identified serine 1126 phosphorylation is fully dispensable for Cdk1 binding to separase fragments. This suggests that despite its in vivo relevance, it promotes complex formation indirectly, possibly by inducing a conformational change in full-length separase.	[Boos, Dominik; Kuffer, Christian; Stemmann, Olaf] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany; [Lenobel, Rene; Koerner, Roman] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany	Max Planck Society; Max Planck Society	Stemmann, O (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Am Klopferspitz 18, D-82152 Martinsried, Germany.	stemmann@biochem.mpg.de	LENOBEL, René/AAD-5606-2020; Kuffer, Christian CK/D-9314-2015; Körner, Roman/G-8565-2011	Kuffer, Christian CK/0000-0003-3798-8959; Körner, Roman/0000-0001-9285-9290; Stemmann, Olaf/0000-0003-3044-2515; Lenobel, Rene/0000-0001-7387-0056; Boos, Dominik/0000-0003-0018-4375				Archambault V, 2003, MOL BIOL CELL, V14, P4592, DOI 10.1091/mbc.E03-06-0384; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bourne Y, 2000, STRUCT FOLD DES, V8, P841, DOI 10.1016/S0969-2126(00)00175-1; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Elsasser S, 1996, MOL BIOL CELL, V7, P1723, DOI 10.1091/mbc.7.11.1723; Gorr IH, 2005, MOL CELL, V19, P135, DOI 10.1016/j.molcel.2005.05.022; Gorr IH, 2006, NAT CELL BIOL, V8, P1035, DOI 10.1038/ncb1467; Holland AJ, 2007, J BIOL CHEM, V282, P24623, DOI 10.1074/jbc.M702545200; Holland AJ, 2006, J CELL SCI, V119, P3325, DOI 10.1242/jcs.03083; Huang XX, 2005, MOL BIOL CELL, V16, P4725, DOI 10.1091/mbc.E05-03-0190; Ivanov D, 2005, CELL, V122, P849, DOI 10.1016/j.cell.2005.07.018; Ivanov D, 2007, MOL CELL, V27, P300, DOI 10.1016/j.molcel.2007.07.002; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Ji JY, 2005, DEVELOPMENT, V132, P1875, DOI 10.1242/dev.01780; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kudo NR, 2006, CELL, V126, P135, DOI 10.1016/j.cell.2006.05.033; Kumada K, 2006, J CELL BIOL, V172, P835, DOI 10.1083/jcb.200511126; Li M, 2007, MOL CELL BIOL, V27, P3481, DOI 10.1128/MCB.02088-06; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Lu KP, 1996, NATURE, V380, P544; Mei JJ, 2001, CURR BIOL, V11, P1197, DOI 10.1016/S0960-9822(01)00325-6; Mimura S, 2004, NATURE, V431, P1118, DOI 10.1038/nature03024; Mirgorodskaya OA, 2000, RAPID COMMUN MASS SP, V14, P1226, DOI 10.1002/1097-0231(20000730)14:14<1226::AID-RCM14>3.0.CO;2-V; Papi M, 2005, NAT CELL BIOL, V7, P1029, DOI 10.1038/ncb1303; Patra D, 1999, J BIOL CHEM, V274, P36839, DOI 10.1074/jbc.274.52.36839; Peter M, 2001, NAT CELL BIOL, V3, P83, DOI 10.1038/35050607; Pfleghaar K, 2005, PLOS BIOL, V3, P2127, DOI 10.1371/journal.pbio.0030416; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Taieb FE, 2001, CURR BIOL, V11, P508, DOI 10.1016/S0960-9822(01)00145-2; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Wang ZY, 2001, MOL ENDOCRINOL, V15, P1870, DOI 10.1210/me.15.11.1870; Wirth KG, 2006, J CELL BIOL, V172, P847, DOI 10.1083/jcb.200506119	39	26	26	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					816	823		10.1074/jbc.M706748200	http://dx.doi.org/10.1074/jbc.M706748200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17974570	hybrid			2022-12-25	WOS:000252128100021
J	Bai, P; Houten, SM; Huber, A; Schreiber, V; Watanabe, M; Kiss, B; de Murcia, G; Auwerx, J; Menissier-de Murcia, J				Bai, Peter; Houten, Sander M.; Huber, Aline; Schreiber, Valerie; Watanabe, Mitsuhiro; Kiss, Borbala; de Murcia, Gilbert; Auwerx, Johan; Menissier-de Murcia, Josiane			Peroxisome proliferator-activated receptor (PPAR)-2 controls adipocyte differentiation and adipose tissue function through the regulation of the activity of the retinoid x receptor/PPAR gamma heterodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(ADP-RIBOSE) POLYMERASE-2 PARP-2; PPAR-GAMMA; GENE-EXPRESSION; INHIBITORS; CELLS; PROTEIN; ALPHA; BETA; PREADIPOCYTES; TRANSCRIPTION	The peroxisome proliferator-activated receptor-gamma (PPAR gamma, NR1C3) in complex with the retinoid X receptor (RXR) plays a central role in white adipose tissue (WAT) differentiation and function, regulating the expression of key WAT proteins. In this report we show that poly(ADP-ribose) polymerase-2 (PARP-2), also known as an enzyme participating in the surveillance of the genome integrity, is a member of the PPAR gamma/ RXR transcription machinery. PARP-2(-/)-mice accumulate less WAT, characterized by smaller adipocytes. In the WAT of PARP-2(-/-)mice the expression of a number of PPAR target genes is reduced despite the fact that PPAR gamma 1 and -gamma 2 are expressed at normal levels. Consistent with this, PARP-2(-/)-mouse embryonic fibroblasts fail to differentiate to adipocytes. In transient transfection assays, PARP-2 small interference RNA decreases basal activity and ligand-dependent activation of PPAR gamma, whereas PARP-2 overexpression enhances the basal activity of PPAR gamma, although it does not change the maximal ligand-dependent activation. In addition, we show a DNA-dependent interaction of PARP-2 and PPAR gamma/RXR heterodimer by chromatin immunoprecipitation. In combination, our results suggest that PARP-2 is a novel cofactor of PPAR gamma activity.	[Bai, Peter; Huber, Aline; Schreiber, Valerie; Kiss, Borbala; de Murcia, Gilbert; Menissier-de Murcia, Josiane] CNRS, Ecole Super Biotechnol Strasbourg, Dept Integrite Genom, UMR 7175, F-67412 Illkirch Graffenstaden, France; [Houten, Sander M.; Watanabe, Mitsuhiro; Auwerx, Johan] Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Bai, Peter] Univ Debrecen, Med & Hlth Sci Ctr, Dept Med Chem, H-4032 Debrecen, Hungary; [Houten, Sander M.] Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Auwerx, Johan] Inst Clin Souris, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Debrecen; University of Amsterdam; Academic Medical Center Amsterdam	Bai, P (corresponding author), CNRS, Ecole Super Biotechnol Strasbourg, Dept Integrite Genom, UMR 7175, BP 10413, F-67412 Illkirch Graffenstaden, France.	baip@dote.hu	Bai, Peter/C-8005-2014; Schreiber, Valérie/M-5007-2016; Auwerx, Johan/ABE-9307-2021; Houten, Sander/Y-3599-2019	Schreiber, Valérie/0000-0003-0507-639X; Houten, Sander/0000-0002-6167-9147; Auwerx, Johan/0000-0002-5065-5393	NIDDK NIH HHS [DK067320] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067320] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; AMRI EZ, 1995, J BIOL CHEM, V270, P2367, DOI 10.1074/jbc.270.5.2367; Balint BL, 2005, MOL CELL BIOL, V25, P5648, DOI 10.1128/MCB.25.13.5648-5663.2005; Boulias K, 2005, EMBO J, V24, P2624, DOI 10.1038/sj.emboj.7600728; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cock TA, 2004, EMBO REP, V5, P142, DOI 10.1038/sj.embor.7400082; Dantzer F, 2004, MOL CELL BIOL, V24, P1595, DOI 10.1128/MCB.24.4.1595-1607.2004; Dantzer F, 2006, P NATL ACAD SCI USA, V103, P14854, DOI 10.1073/pnas.0604252103; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Gurnell M, 2005, BEST PRACT RES CL EN, V19, P501, DOI 10.1016/j.beem.2005.10.001; Huber A, 2004, DNA REPAIR, V3, P1103, DOI 10.1016/j.dnarep.2004.06.002; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; JANSSEN OE, 1989, EUR J BIOCHEM, V180, P595, DOI 10.1111/j.1432-1033.1989.tb14686.x; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Knouff C, 2004, ENDOCR REV, V25, P899, DOI 10.1210/er.2003-0036; Kofler J, 2006, J CEREBR BLOOD F MET, V26, P135, DOI 10.1038/sj.jcbfm.9600173; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Maeda Y, 2006, J BIOL CHEM, V281, P9600, DOI 10.1074/jbc.M510435200; Maquoi E, 2002, DIABETES, V51, P1093, DOI 10.2337/diabetes.51.4.1093; Mayeur GL, 2005, J BIOL CHEM, V280, P10827, DOI 10.1074/jbc.M413336200; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Meder VS, 2005, J CELL SCI, V118, P211, DOI 10.1242/jcs.01606; Miyamoto T, 1999, MOL CELL BIOL, V19, P2644; Mota RA, 2005, LAB INVEST, V85, P1250, DOI 10.1038/labinvest.3700326; Motojima K, 1998, J BIOL CHEM, V273, P16710, DOI 10.1074/jbc.273.27.16710; Nirodi C, 2001, J BIOL CHEM, V276, P9366, DOI 10.1074/jbc.M009897200; Oliver AW, 2004, NUCLEIC ACIDS RES, V32, P456, DOI 10.1093/nar/gkh215; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Popoff I, 2002, J PHARMACOL EXP THER, V303, P1145, DOI 10.1124/jpet.102.039768; Prins JB, 1997, DIABETES, V46, P1939, DOI 10.2337/diabetes.46.12.1939; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Saladin R, 1999, CELL GROWTH DIFFER, V10, P43; Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005; Sartorius CA, 2000, J MOL ENDOCRINOL, V24, P165, DOI 10.1677/jme.0.0240165; Saxena A, 2002, HUM MOL GENET, V11, P2319, DOI 10.1093/hmg/11.19.2319; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; SMULSON ME, 1995, J BIOL CHEM, V270, P119, DOI 10.1074/jbc.270.1.119; Tee MK, 2004, MOL BIOL CELL, V15, P1262, DOI 10.1091/mbc.E03-06-0360; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Tramontano F, 2005, J CELL BIOCHEM, V94, P58, DOI 10.1002/jcb.20295; Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; VUDAC N, 1995, J CLIN INVEST, V96, P741, DOI 10.1172/JCI118118; Yelamos J, 2006, EMBO J, V25, P4350, DOI 10.1038/sj.emboj.7601301	52	86	90	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37738	37746		10.1074/jbc.M701021200	http://dx.doi.org/10.1074/jbc.M701021200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17951580	Green Published, hybrid			2022-12-25	WOS:000251833600050
J	Broere, N; Hillesheim, J; Tuo, B; Jorna, H; Houtsmuller, AB; Shenolikar, S; Weinman, EJ; Donowitz, M; Seidler, U; de Jonge, HR; Hogema, BM				Broere, Nellie; Hillesheim, Jutta; Tuo, Biguang; Jorna, Huub; Houtsmuller, Adriaan B.; Shenolikar, Shirish; Weinman, Edward J.; Donowitz, Mark; Seidler, Ursula; de Jonge, Hugo R.; Hogema, Boris M.			Cystic fibrosis transmembrane conductance regulator activation is reduced in the small intestine of Na+/H+ exchanger 3 regulatory factor 1 (NHERF-1)-but not NHERF-2-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PDZ DOMAIN INTERACTIONS; APICAL MEMBRANE; ION-TRANSPORT; ANCHORING PROTEIN; CHLORIDE CHANNEL; PLASMA-MEMBRANE; BINDING MOTIF; C-TERMINUS; IN-VIVO; CFTR	Binding of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel to the Na+/H+ exchanger 3 regulatory factor 1 (NHERF-1) and NHERF-2 scaffolding proteins has been shown to affect its localization and activation. We have for the first time studied the physiological role of these proteins in CFTR regulation in native tissue by determining CFTR-dependent chloride current in NHERF-1-and NHERF-2-deficient mice. The cAMP-and cGMP-activated chloride current and the basal chloride current in basolaterally permeabilized jejunum were reduced by similar to 30% in NHERF-1-deficient mice but not in NHERF-2-deficient mice. The duodenal bicarbonate secretion was affected in a similar way, whereas no significant differences in CFTR activity were observed in ileum. CFTR abundance as determined by Western blotting was unaltered in jejunal epithelial cells and brush border membranes of NHERF-1 and NHERF-2 mutant mice. However, semi-quantitative detection of CFTR by confocal microscopy showed that the level of apically localized CFTR in jejunal crypts was reduced by similar to 35% in NHERF-1-deficient and NHERF-1/ 2 double deficient mice but not in NHERF-2 null mice. Together our results indicate that NHERF-1 is required for full activation of CFTR in murine duodenal and jejunal mucosa and that NHERF-1 affects the local distribution of CFTR in or near the plasma membrane. These studies provide the first evidence in native intestinal epithelium that NHERF-1 but not NHERF-2 is involved in the formation of CFTR-containing functional complexes that serve to position CFTR in the crypt apical membrane and/ or to optimize its function as a cAMP-and cGMP-regulated anion channel.	[Broere, Nellie; Jorna, Huub; Donowitz, Mark; de Jonge, Hugo R.; Hogema, Boris M.] Erasmus Univ, Med Ctr, Dept Biochem, NL-3015 GE Rotterdam, Netherlands; [Hillesheim, Jutta; Tuo, Biguang; Seidler, Ursula] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; [Houtsmuller, Adriaan B.] Erasmus Univ, Med Ctr, Opt Image Ctr, Josephine Nefkens Inst, Rotterdam, Netherlands; [Shenolikar, Shirish] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Weinman, Edward J.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Weinman, Edward J.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Weinman, Edward J.] Univ Maryland, Sch Med, Dept Vet Affairs Med Ctr, Med Serv, Baltimore, MD 21201 USA; [Broere, Nellie; Jorna, Huub; Donowitz, Mark; de Jonge, Hugo R.; Hogema, Boris M.] Johns Hopkins Univ, Sch Med, Dept Physiol & Med, Div Gastroenterol, Baltimore, MD 21205 USA	Erasmus University Rotterdam; Erasmus MC; Hannover Medical School; Erasmus University Rotterdam; Erasmus MC; Duke University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University	Hogema, BM (corresponding author), Erasmus Univ, Med Ctr, Dept Biochem, Dr Molewaterplein 50,Ee634b, NL-3015 GE Rotterdam, Netherlands.	B.Hogema@ErasmusMC.nl	Seidler, Ursula/HII-8049-2022	Seidler, Ursula/0000-0002-9600-2769	NIDDK NIH HHS [R24 DK64388, R01 DK61765, R01 DK26523, P01 DK072084, DK55881] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061765, R01DK026523, P01DK072084, R24DK064388, R01DK055881] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; Bates IR, 2006, BIOPHYS J, V91, P1046, DOI 10.1529/biophysj.106.084830; Benharouga M, 2003, J BIOL CHEM, V278, P22079, DOI 10.1074/jbc.M301030200; Bijvelds MJC, 2005, AM J PHYSIOL-GASTR L, V289, pG870, DOI 10.1152/ajpgi.00226.2005; Capuano P, 2005, PFLUG ARCH EUR J PHY, V449, P392, DOI 10.1007/s00424-004-1351-9; Cha B, 2005, J BIOL CHEM, V280, P16642, DOI 10.1074/jbc.M500505200; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Claass A, 2000, J HISTOCHEM CYTOCHEM, V48, P831, DOI 10.1177/002215540004800611; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; French PJ, 1996, J CLIN INVEST, V98, P1304, DOI 10.1172/JCI118917; Fujii N, 2007, BIOORG MED CHEM LETT, V17, P549, DOI 10.1016/j.bmcl.2006.10.006; Gisler SM, 2003, KIDNEY INT, V64, P1733, DOI 10.1046/j.1523-1755.2003.00266.x; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Haggie PM, 2004, J BIOL CHEM, V279, P5494, DOI 10.1074/jbc.M312445200; Hillesheim J, 2007, PFLUG ARCH EUR J PHY, V454, P575, DOI 10.1007/s00424-007-0239-x; Hwang JI, 2000, J BIOL CHEM, V275, P16632, DOI 10.1074/jbc.M001410200; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; KNOWLES MR, 1995, HUM GENE THER, V6, P445, DOI 10.1089/hum.1995.6.4-445; Lee JH, 2007, J BIOL CHEM, V282, P10414, DOI 10.1074/jbc.M610857200; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; MARKERT T, 1995, J CLIN INVEST, V96, P822, DOI 10.1172/JCI118128; Milewski MI, 2001, J CELL SCI, V114, P719; Morales FC, 2004, P NATL ACAD SCI USA, V101, P17705, DOI 10.1073/pnas.0407974101; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Ostedgaard LS, 2003, P NATL ACAD SCI USA, V100, P1937, DOI 10.1073/pnas.2627982100; PRINCE LS, 1994, P NATL ACAD SCI USA, V91, P5192, DOI 10.1073/pnas.91.11.5192; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Raghuram V, 2003, P NATL ACAD SCI USA, V100, P9620, DOI 10.1073/pnas.1633250100; RATCLIFF R, 1993, NAT GENET, V4, P35, DOI 10.1038/ng0593-35; REDDY MM, 1994, J MEMBRANE BIOL, V140, P57; Schreiber R, 2004, J MEMBRANE BIOL, V199, P85, DOI 10.1007/s00232-004-0679-6; Seidler U, 2001, JOP, V2, P247; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Sun F, 2000, J BIOL CHEM, V275, P14360, DOI 10.1074/jbc.275.19.14360; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Thelin WR, 2005, J PHYSIOL-LONDON, V567, P13, DOI 10.1113/jphysiol.2005.091041; Thiagarajah JR, 2003, CURR OPIN PHARMACOL, V3, P594, DOI 10.1016/j.coph.2003.06.012; VAANDRAGER AB, 1991, AM J PHYSIOL, V261, pG958, DOI 10.1152/ajpgi.1991.261.6.G958; VANDOMMELEN FS, 1986, BIOCHEM J, V236, P771, DOI 10.1042/bj2360771; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Weinman EJ, 2003, FEBS LETT, V536, P141, DOI 10.1016/S0014-5793(03)00043-7; Weinman EJ, 1998, J CLIN INVEST, V101, P2199, DOI 10.1172/JCI204; Yun CC, 2002, J BIOL CHEM, V277, P7676, DOI 10.1074/jbc.M107768200; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423	51	41	41	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37575	37584		10.1074/jbc.M704878200	http://dx.doi.org/10.1074/jbc.M704878200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17947234	hybrid			2022-12-25	WOS:000251833600033
J	Montalbano, J; Jin, WX; Sheikh, MS; Huang, Y				Montalbano, JoAnne; Jin, Weixin; Sheikh, M. Saeed; Huang, Ying			RBEL1 is a novel gene that encodes a nucleocytoplasmic ras superfamily GTP-binding protein and is overexpressed in breast cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAN/TC4 GTPASE; NUCLEAR; P53; FAMILY; IDENTIFICATION; STABILIZES; EXPRESSION; TRANSPORT; PROLINE; PATHWAY	Rab family proteins are generally known as regulators of protein transport and trafficking. A number of Rab proteins have been implicated in cancer development and/ or progression. Here we report the identification of a novel Rab- like protein, which we have named RBEL1 ((R) under bara (b) under bar- (l) under bar ike protein 1) for its higher similarity to the Rab subfamily members. We have characterized two isoforms of RBEL1 including the predominant RBEL1A and the less abundant RBEL1B that results from alternative splicing. Both isoforms harbor conserved N-terminal guanine trinucleotide phosphate (GTP) binding domains and, accordingly, are capable of binding to GTP. Both isoforms contain variable C termini and exhibit differential subcellular localization patterns. Unlike known Rabs that are mostly cytosolic, RBEL1B predominantly resides in the nucleus, whereas RBEL1A is localized primarily to the cytosol. Interestingly, a point mutation affecting RBEL1B GTP binding also alters the ability of mutant protein to accumulate in the nucleus, suggesting GTP binding potential to be important for RBEL1B nuclear localization. Our results also indicate that RBEL1A is overexpressed in about 67% of primary breast tumors. Thus, RBEL1A and RBEL1B are novel Rab- like proteins that localize in the nucleus and cytosol and may play an important role in breast tumorigenesis.	[Montalbano, JoAnne; Jin, Weixin; Sheikh, M. Saeed; Huang, Ying] SUNY Syracuse, Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Huang, Y (corresponding author), SUNY Syracuse, Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA.	huangy@upstate.edu			NATIONAL CANCER INSTITUTE [R21CA113868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK062136, R21DK067271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES014489] Funding Source: NIH RePORTER; NCI NIH HHS [CA113868] Funding Source: Medline; NIDDK NIH HHS [DK062136, DK067271] Funding Source: Medline; NIEHS NIH HHS [ES014489] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Cheng KW, 2005, CANCER RES, V65, P2516, DOI 10.1158/0008-5472.CAN-05-0573; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Corcoran CA, 2005, ONCOGENE, V24, P1634, DOI 10.1038/sj.onc.1208353; Darchen F, 2000, BIOCHIMIE, V82, P375, DOI 10.1016/S0300-9084(00)00219-4; Dumas JJ, 1999, STRUCTURE, V7, P413, DOI 10.1016/S0969-2126(99)80054-9; Erdman RA, 2000, J BIOL CHEM, V275, P3848, DOI 10.1074/jbc.275.6.3848; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; He H, 2002, GENE EXPRESSION, V10, P231, DOI 10.3727/000000002783992406; Huang Y, 2001, CANCER RES, V61, P6918; HUANG Y, 1995, ONCOGENE, V11, P1255; JORCYK C, 2002, CANCER RES, V62, P5325; KAPLAN JB, 1994, ONCOL RES, V6, P611; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Lounsbury KM, 1996, J BIOL CHEM, V271, P32834, DOI 10.1074/jbc.271.51.32834; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Luo XQ, 2005, CANCER RES, V65, P10725, DOI 10.1158/0008-5472.CAN-05-1132; Luo XQ, 2003, ONCOGENE, V22, P7247, DOI 10.1038/sj.onc.1207010; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Melen K, 1996, J BIOL CHEM, V271, P23478, DOI 10.1074/jbc.271.38.23478; Mitra RS, 2003, ONCOGENE, V22, P6243, DOI 10.1038/sj.onc.1206534; Ossareh-Nazari B, 2001, TRAFFIC, V2, P684, DOI 10.1034/j.1600-0854.2001.21002.x; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Quimby BB, 2003, CURR OPIN CELL BIOL, V15, P338, DOI 10.1016/S0955-0674(03)00046-2; Quimby BB, 2001, CELL MOL LIFE SCI, V58, P1766, DOI 10.1007/PL00000816; RICHARDS SA, 1995, J BIOL CHEM, V270, P14405, DOI 10.1074/jbc.270.24.14405; Rong R, 2004, ONCOGENE, V23, P8216, DOI 10.1038/sj.onc.1207901; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Tompkins V, 2006, CELL CYCLE, V5, P641; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Yao RS, 2003, NEOPLASIA, V5, P41, DOI 10.1016/S1476-5586(03)80016-7; Ye KQ, 2000, CELL, V103, P919, DOI 10.1016/S0092-8674(00)00195-1; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175; Zhu WJ, 2001, EMBO J, V20, P5999, DOI 10.1093/emboj/20.21.5999	37	26	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37640	37649		10.1074/jbc.M704760200	http://dx.doi.org/10.1074/jbc.M704760200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17962191	hybrid			2022-12-25	WOS:000251833600040
J	Devlin, AM; Singh, R; Wade, RE; Innis, SM; Bottiglieri, T; Lentz, SR				Devlin, Angela M.; Singh, Ranji; Wade, Rachel E.; Innis, Sheila M.; Bottiglieri, Teodoro; Lentz, Steven R.			Hypermethylation of Fads2 and altered hepatic fatty acid and phospholipid metabolism in mice with hyperhomocysteinemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTATHIONINE BETA-SYNTHASE; DENSITY LIPOPROTEIN SECRETION; PLASMA HIGH-DENSITY; S-ADENOSYLHOMOCYSTEINE; ENDOTHELIAL DYSFUNCTION; VASCULAR DYSFUNCTION; N-METHYLTRANSFERASE; HOMOCYSTEINE; METHYLATION; DEFICIENT	Alterations in lipid metabolism may play a role in the vascular pathology associated with hyperhomocysteinemia (HHcy). Homocysteine is linked to lipid metabolism through the methionine cycle and the synthesis of phosphatidylcholine ( PC) by phosphatidylethanolamine (PE) methyltransferase, which is responsible for the synthesis of 20-40% of liver PC. The goal of the present study was to determine if the reduced methylation capacity in HHcy is associated with alterations in liver phospholipid and fatty acid metabolism. Mice heterozygous for disruption of cystathionine beta-synthase (Cbs(+/-)) fed a diet to induce HHcy (HH diet) had higher (p < 0.001) plasma total homocysteine (30.8 +/- 4.4 mu M, mean +/- S.E.) than C57BL/6 mice (Cbs(+/+)) fed the HH diet (7.0 +/- 1.1 mu M) or Cbs(+/+)mice fed a control diet (2.3 +/- 0.3 mu M). Mild and moderate HHcy was accompanied by lower adenosylmethionine/adenosylhomocysteine ratios (p < 0.05), higher PE ( p < 0.05) and PE/PC ratios (p < 0.01), lower PE methyltransferase activity ( p < 0.001), and higher linoleic acid ( p < 0.05) and lower arachidonic acid ( p < 0.05) in PE. Mice with moderate HHcy also had higher linoleic acid and alpha-linolenic acid (p < 0.05) and lower arachidonic acid and docosahexaenoic acid ( p < 0.05) in liver PC. The first step in the desaturation and elongation of linoleic acid and linolenic acid to arachidonic acid and docosahexaenoic acid, respectively, is catalyzed by Delta(6)-desaturase (encoded by Fads2). We found hypermethylation of the Fads2 promoter (p < 0.01), lower Fads2 mRNA ( p < 0.05), and lower Delta(6)-desaturase activity ( p < 0.001) in liver from mice with HHcy. These findings suggest that methylation silencing of liver Fads2 expression and changes in liver fatty acids may contribute to the pathology of HHcy.	[Devlin, Angela M.; Singh, Ranji; Wade, Rachel E.; Innis, Sheila M.] Univ British Columbia, Dept Pediat, Nutr Res Program, Child & Family Res Inst, Vancouver, BC V6H 3N1, Canada; [Bottiglieri, Teodoro] Baylor Inst Metab Dis, Dallas, TX 75226 USA; [Lentz, Steven R.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52246 USA; [Lentz, Steven R.] Vet Affairs Med Ctr, Iowa City, IA 52246 USA	Child & Family Research Institute; University of British Columbia; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Devlin, AM (corresponding author), Univ British Columbia, Dept Paediat, Nutr Res Program, 4500 Oak St,Mailbox 65, Vancouver, BC V6H 3N1, Canada.	angela.devlin@ubc.ca		Devlin, Angela/0000-0002-1390-6587; Lentz, Steven/0000-0002-8885-4718	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063943, P01HL062984] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL063943, HL 62984, HL63943] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bellamy MF, 1998, CIRCULATION, V98, P1848, DOI 10.1161/01.CIR.98.18.1848; BOTTIGLIERI T, 1990, BIOMED CHROMATOGR, V4, P239, DOI 10.1002/bmc.1130040606; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calvisi DF, 2007, J CLIN INVEST, V117, P2713, DOI 10.1172/JCI31457; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Dayal S, 2005, CIRCULATION, V112, P737, DOI 10.1161/CIRCULATIONAHA.104.529248; Dayal S, 2001, CIRC RES, V88, P1203, DOI 10.1161/hh1101.092180; De Vriese AS, 2004, CIRCULATION, V109, P2331, DOI 10.1161/01.CIR.0000129138.08493.4D; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Devlin AM, 2004, BLOOD, V103, P2624, DOI 10.1182/blood-2003-09-3078; Devlin AM, 2005, J BIOL CHEM, V280, P25506, DOI 10.1074/jbc.M504815200; Dupont JM, 2004, ANAL BIOCHEM, V333, P119, DOI 10.1016/j.ab.2004.05.007; Eberhardt RT, 2000, J CLIN INVEST, V106, P483, DOI 10.1172/JCI8342; FINKELSTEIN JD, 1990, J NUTR BIOCHEM, V1, P228, DOI 10.1016/0955-2863(90)90070-2; Fleming I, 2006, HYPERTENSION, V47, P629, DOI 10.1161/01.HYP.0000208597.87957.89; FOLCH J, 1957, J BIOL CHEM, V226, P497; GARG ML, 1988, BIOCHEM J, V249, P351, DOI 10.1042/bj2490351; Herrmann W, 2001, CLIN CHEM LAB MED, V39, P739, DOI 10.1515/CCLM.2001.123; Innis SM, 2002, J LIPID RES, V43, P1529, DOI 10.1194/jlr.M200120-JLR200; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Lentz SR, 1996, J CLIN INVEST, V98, P24, DOI 10.1172/JCI118771; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liao D, 2006, CIRC RES, V99, P598, DOI 10.1161/01.RES.0000242559.42077.22; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallamaci F, 2002, KIDNEY INT, V61, P609, DOI 10.1046/j.1523-1755.2002.00144.x; Mikael LG, 2006, CIRC RES, V98, P564, DOI 10.1161/01.RES.0000204825.66410.0b; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Namekata K, 2004, J BIOL CHEM, V279, P52961, DOI 10.1074/jbc.M406820200; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Noga AA, 2003, J BIOL CHEM, V278, P21851, DOI 10.1074/jbc.M301982200; RIDGWAY ND, 1992, METHOD ENZYMOL, V209, P366; RIDGWAY ND, 1988, J BIOL CHEM, V263, P16856; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; UBBINK JB, 1991, J CHROMATOGR-BIOMED, V565, P441, DOI 10.1016/0378-4347(91)80407-4; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; Wang H, 2003, BLOOD, V101, P3901, DOI 10.1182/blood-2002-08-2606; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Woo CWH, 2005, AM J PHYSIOL-ENDOC M, V288, pE1002, DOI 10.1152/ajpendo.00518.2004; YAO ZM, 1988, J BIOL CHEM, V263, P2998; YAO ZM, 1989, J BIOL CHEM, V264, P11373; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200	46	61	63	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37082	37090		10.1074/jbc.M704256200	http://dx.doi.org/10.1074/jbc.M704256200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17971455	hybrid			2022-12-25	WOS:000251646000035
J	Maruyama, Y; Ogura, T; Mio, K; Kiyonaka, S; Kato, K; Mori, Y; Sato, C				Maruyama, Yuusuke; Ogura, Toshihiko; Mio, Kazuhiro; Kiyonaka, Shigeki; Kato, Kenta; Mori, Yasuo; Sato, Chikara			Three-dimensional reconstruction using transmission electron microscopy reveals a swollen, bell-shaped structure of transient receptor potential melastatin type 2 cation channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOMATIC PARTICLE PICKUP; ADP-RIBOSE; HYDROGEN-PEROXIDE; SODIUM-CHANNEL; CALCIUM INFLUX; NEURAL-NETWORK; TRPM2; ACTIVATION; LTRPC2; FAMILY	Transient receptor potential melastatin type 2 (TRPM2) is a redox-sensitive, calcium-permeable cation channel activated by various signals, such as adenosine diphosphate ribose ( ADPR) acting on the ADPR pyrophosphatase (ADPRase) domain, and cyclic ADPR. Here, we purified the FLAG-tagged tetrameric TRPM2 channel, analyzed it using negatively stained electron microscopy, and reconstructed the three-dimensional structure at 2.8-nm resolution. This multimodal sensor molecule has a bell-like shape of 18 nm in width and 25 nm in height. The overall structure is similar to another multimodal sensor channel, TRP canonical type 3 (TRPC3). In both structures, the small extracellular domain is a dense half-dome, whereas the large cytoplasmic domain has a sparse, double-layered structure with multiple internal cavities. However, a unique square prism protuberance was observed under the cytoplasmic domain of TRPM2. The FLAG epitope, fused at the C terminus of the ADPRase domain, was assigned by the antibody to a position close to the protuberance. This indicates that the agonist-binding ADPRase domain and the ion gate in the transmembrane region are separately located in the molecule.	[Maruyama, Yuusuke; Ogura, Toshihiko; Mio, Kazuhiro; Sato, Chikara] Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Maruyama, Yuusuke; Sato, Chikara] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan; [Ogura, Toshihiko] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Kiyonaka, Shigeki; Kato, Kenta; Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Dept Synth Chem & Biol Chem, Kyoto 6158510, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; Japan Science & Technology Agency (JST); Kyoto University	Sato, C (corresponding author), Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Umezono 1-1-4, Tsukuba, Ibaraki 3058568, Japan.	ti-sato@aist.go.jp	Mio, Kazuhiro/L-7488-2018; Kiyonaka, Shigeki/AAM-7303-2021; Ogura, Toshihiko/M-4089-2018; Sato, Chikara/M-7183-2016	Mio, Kazuhiro/0000-0002-1655-8231; Sato, Chikara/0000-0001-5543-4496				Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; FRANK J, 2006, 3 DIMENSTIONAL ELECT; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Grubisha O, 2006, J BIOL CHEM, V281, P14057, DOI 10.1074/jbc.M513741200; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; HARAUZ G, 1986, OPTIK, V73, P146; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Heiner I, 2003, BIOCHEM J, V371, P1045, DOI 10.1042/BJ20021975; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Inamura K, 2003, J MEMBRANE BIOL, V191, P201, DOI 10.1007/s00232-002-1057-x; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Kraft R, 2004, AM J PHYSIOL-CELL PH, V286, pC129, DOI 10.1152/ajpcell.00331.2003; Kuhn FJP, 2004, J BIOL CHEM, V279, P46431, DOI 10.1074/jbc.M407263200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; McHugh D, 2003, J BIOL CHEM, V278, P11002, DOI 10.1074/jbc.M210810200; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Mio K, 2005, BIOCHEM BIOPH RES CO, V333, P768, DOI 10.1016/j.bbrc.2005.05.181; Mio K, 2007, J MOL BIOL, V367, P373, DOI 10.1016/j.jmb.2006.12.043; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nagamine K, 1998, GENOMICS, V54, P124, DOI 10.1006/geno.1998.5551; Nishida M, 2003, EMBO J, V22, P4677, DOI 10.1093/emboj/cdg457; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Ogura T, 2004, J STRUCT BIOL, V145, P63, DOI 10.1016/S1047-8477(03)00139-4; Ogura T, 2004, J STRUCT BIOL, V146, P344, DOI 10.1016/j.jsb.2004.01.007; Ogura T, 2001, J STRUCT BIOL, V136, P227, DOI 10.1006/jsbi.2002.4442; Ogura T, 2006, J STRUCT BIOL, V156, P371, DOI 10.1016/j.jsb.2006.05.016; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Perraud AL, 2003, J BIOL CHEM, V278, P1794, DOI 10.1074/jbc.M205601200; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Sato C, 2004, J MOL BIOL, V336, P155, DOI 10.1016/j.jmb.2003.11.024; Sato C, 1998, J STRUCT BIOL, V121, P314, DOI 10.1006/jsbi.1998.3990; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; Shen BW, 2003, J MOL BIOL, V332, P385, DOI 10.1016/S0022-2836(03)00954-9; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Tong Q, 2006, J BIOL CHEM, V281, P9076, DOI 10.1074/jbc.M510422200; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Uemura T, 2005, BIOCHEM BIOPH RES CO, V328, P1232, DOI 10.1016/j.bbrc.2005.01.086; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Vazquez G, 2001, P NATL ACAD SCI USA, V98, P11777, DOI 10.1073/pnas.201238198; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Yazawa M, 2007, NATURE, V448, P78, DOI 10.1038/nature05928; Zhang W, 2003, J BIOL CHEM, V278, P16222, DOI 10.1074/jbc.M300298200; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	54	56	60	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36961	36970		10.1074/jbc.M705694200	http://dx.doi.org/10.1074/jbc.M705694200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17940282	hybrid			2022-12-25	WOS:000251646000022
J	Nechifor, R; Murataliev, M; Wilson, KS				Nechifor, Roxana; Murataliev, Marat; Wilson, Kevin S.			Functional interactions between the G ' subdomain of bacterial translation factor EF-G and ribosomal protein L7/L12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR-G; MESSENGER-RNA TRANSLOCATION; C-TERMINAL DOMAIN; ESCHERICHIA-COLI; FACTOR TU; STRUCTURAL BASIS; GUANOSINE TRIPHOSPHATE; CONFORMATIONAL-CHANGES; GTPASE ACTIVATION; CRYSTAL-STRUCTURE	Protein L7/L12 of the bacterial ribosome plays an important role in activating the GTP hydrolytic activity of elongation factor G (EF-G), which promotes ribosomal translocation during protein synthesis. Previously, we cross-linked L7/L12 from two residues (209 and 231) flanking alpha-helixA(G ') in theG ' subdomain of Escherichia coli EF-G. Here we report kinetic studies on the functional effects of mutating three neighboring glutamic acid residues ( 224, 228, and 231) to lysine, either singly or in combination. Two single mutations ( E224K and E228K), both within helix A(G '), caused large defects in GTP hydrolysis and smaller defects in ribosomal translocation. Removal of L7/L12 from the ribosome strongly reduced the activities of wild type EF-G but had no effect on the activities of the E224K and E228K mutants. Together, these results provide evidence for functionally important interactions between helix A(G ') of EF-G and L7/L12 of the ribosome.	[Nechifor, Roxana; Murataliev, Marat; Wilson, Kevin S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of Alberta	Wilson, KS (corresponding author), Univ Alberta, Dept Biochem, 3-31 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	s.wilson@ualberta.ca						Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Bargis-Surgey P, 1999, EUR J BIOCHEM, V262, P606, DOI 10.1046/j.1432-1327.1999.00434.x; BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BROT N, 1974, P NATL ACAD SCI USA, V71, P89, DOI 10.1073/pnas.71.1.89; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; CUNDLIFFE E, 1989, RIBOSOME STRUCTURE F, P479; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; Datta PP, 2005, MOL CELL, V20, P723, DOI 10.1016/j.molcel.2005.10.028; Daviter T, 2003, J MOL BIOL, V332, P689, DOI 10.1016/S0022-2836(03)00947-1; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; ECCLESTON JF, 1982, J BIOL CHEM, V257, P5046; Feinberg JS, 2006, RNA, V12, P580, DOI 10.1261/rna.2290706; Gao HX, 2007, CELL, V129, P929, DOI 10.1016/j.cell.2007.03.050; HAMEL E, 1972, J BIOL CHEM, V247, P805; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; Helgstrand M, 2007, J MOL BIOL, V365, P468, DOI 10.1016/j.jmb.2006.10.025; Jorgensen R, 2003, NAT STRUCT BIOL, V10, P379, DOI 10.1038/nsb923; Katunin VI, 2002, BIOCHEMISTRY-US, V41, P12806, DOI 10.1021/bi0264871; KIRSEBOM LA, 1986, EUR J BIOCHEM, V156, P669, DOI 10.1111/j.1432-1033.1986.tb09630.x; KISCHA K, 1971, NATURE-NEW BIOL, V233, P62, DOI 10.1038/newbio233062a0; Kothe U, 2004, J MOL BIOL, V336, P1011, DOI 10.1016/j.jmb.2003.12.080; LOCKWOOD AH, 1974, J BIOL CHEM, V249, P1213; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; Nechifor R, 2007, J MOL BIOL, V368, P1412, DOI 10.1016/j.jmb.2007.03.009; Pan DL, 2007, MOL CELL, V25, P519, DOI 10.1016/j.molcel.2007.01.014; PARISI B, 1967, J MOL BIOL, V28, P295, DOI 10.1016/S0022-2836(67)80011-1; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; ROHRBACH MS, 1976, BIOCHEMISTRY-US, V15, P4565, DOI 10.1021/bi00666a003; Savelsbergh A, 2005, EMBO J, V24, P4316, DOI 10.1038/sj.emboj.7600884; Savelsbergh A, 2000, J BIOL CHEM, V275, P890, DOI 10.1074/jbc.275.2.890; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Sergiev PV, 2005, FEBS LETT, V579, P5439, DOI 10.1016/j.febslet.2005.09.010; Studer SM, 2003, J MOL BIOL, V327, P369, DOI 10.1016/S0022-2836(03)00146-3; Uchiumi T, 2002, J BIOL CHEM, V277, P3857, DOI 10.1074/jbc.M107730200; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Wilden B, 2006, P NATL ACAD SCI USA, V103, P13670, DOI 10.1073/pnas.0606099103; Wilson KS, 2004, J MOL BIOL, V337, P15, DOI 10.1016/j.jmb.2004.01.013	39	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36998	37005		10.1074/jbc.M707179200	http://dx.doi.org/10.1074/jbc.M707179200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17932030	hybrid			2022-12-25	WOS:000251646000026
J	Cohen, O; Kronman, C; Lazar, A; Velan, B; Shafferman, A				Cohen, Ofer; Kronman, Chanoch; Lazar, Arie; Velan, Baruch; Shafferman, Avigdor			Controlled concealment of exposed clearance and immunogenic domains by site-specific polyethylene glycol attachment to acetylcholinesterase hypolysine mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT HUMAN ACETYLCHOLINESTERASE; CIRCULATORY RESIDENCE TIME; HUMAN BUTYRYLCHOLINESTERASE; BOVINE ACETYLCHOLINESTERASE; CHEMICAL-MODIFICATION; N-GLYCOSYLATION; SIALYLATION; EXPRESSION; PEGYLATION; SUBUNIT	Cholinesterases are efficient scavengers of organophosphates and are currently being developed as drugs for treatment against poisoning by such compounds. Recombinant ChE bioscavengers have very short circular longevity, a limitation that can be overcome by complex post-translation manipulations or by chemical modification such as polyethylene glycol conjugation. Series of multiple Lys-Ala mutants of human acetylcholinesterase were prepared allowing the generation of homogenous and well defined polyethylene-glycol conjugated AChEs with either one, two, three, four, or five appended polyethylene glycol ( PEG) moieties/molecule. The rank order of circulatory longevity of these molecules was dependent on the number of PEG appendages up to a certain threshold: 5 = 4 > 3 > 2 > 1 > 0. Hypolysine acetylcholinesterases ( AChEs) carrying the same number of PEGs, and therefore with identical masses, allowed us to demonstrate that circulatory longevity correlates with the predicted extent of concealment of the AChE surface. Furthermore, circulatory profiles of high number and low number PEG-AChEs differing in their sialic acid contents demonstrate a direct relationship between PEG loading and the effective seclusion of AChE from the hepatic asialoglycoprotein receptor clearance system. Finally, an inverse relationship is found between the extent of PEG loading and the ability of the human acetylcholinesterase to elicit specific anti-HuAChE antibodies. In conclusion, these findings suggest that for the extension of circulatory longevity, protein surface domain concealment exerted by polyethylene glycol attachment is at least as important as its effect on size enlargement and highlights the role of PEG attachment in masking interactions between biomolecules and their cognate receptors.	Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-74100 Ness Ziona, Israel; Israel Inst Biol Res, Dept Biotechnol, IL-74100 Ness Ziona, Israel		Shafferman, A (corresponding author), Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-74100 Ness Ziona, Israel.	avigdors@iibr.gov.il						Chilukuri N, 2005, CHEM-BIOL INTERACT, V157, P115, DOI 10.1016/j.cbi.2005.10.013; Chitlaru T, 2002, BIOCHEM J, V363, P619, DOI 10.1042/0264-6021:3630619; Chitlaru T, 2001, BIOCHEM J, V354, P613, DOI 10.1042/0264-6021:3540613; Chitlaru T, 1998, BIOCHEM J, V336, P647, DOI 10.1042/bj3360647; Cohen O, 2004, BIOCHEM J, V378, P117, DOI 10.1042/BJ20031305; Cohen O, 2001, BIOCHEM J, V357, P795, DOI 10.1042/0264-6021:3570795; COHEN O, 2004, Patent No. 0147002; Cohen O, 2006, MOL PHARMACOL, V70, P1121, DOI 10.1124/mol.106.026179; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FISCHER M, 1993, CELL MOL NEUROBIOL, V13, P25, DOI 10.1007/BF00712987; KRONMAN C, 1992, GENE, V121, P295, DOI 10.1016/0378-1119(92)90134-B; KRONMAN C, 1995, BIOCHEM J, V311, P959, DOI 10.1042/bj3110959; Kronman C, 2000, J BIOL CHEM, V275, P29488, DOI 10.1074/jbc.M004298200; Kronman C, 2007, TOXICOLOGY, V233, P40, DOI 10.1016/j.tox.2006.08.036; Kryger G, 2000, ACTA CRYSTALLOGR D, V56, P1385, DOI 10.1107/S0907444900010659; Laub PB, 1996, J PHARM SCI, V85, P393, DOI 10.1021/js9503744; Lee H, 2003, PHARMACEUT RES, V20, P818, DOI 10.1023/A:1023402123119; Lenz DE, 2005, CHEM-BIOL INTERACT, V157, P205, DOI 10.1016/j.cbi.2005.10.025; Long DL, 2006, EXP HEMATOL, V34, P697, DOI 10.1016/j.exphem.2006.02.011; Mendelson I, 1998, BIOCHEM J, V334, P251, DOI 10.1042/bj3340251; Natarajan A, 2005, BIOCONJUGATE CHEM, V16, P113, DOI 10.1021/bc0498121; Onda M, 2003, BIOCONJUGATE CHEM, V14, P480, DOI 10.1021/bc020069r; Raveh L, 1997, TOXICOL APPL PHARM, V145, P43, DOI 10.1006/taap.1997.8160; RAVEH L, 1993, BIOCHEM PHARMACOL, V45, P37; Saxena A, 1998, MOL PHARMACOL, V53, P112, DOI 10.1124/mol.53.1.112; SHAFFERMAN A, 1992, J BIOL CHEM, V267, P17640; VELAN B, 1991, J BIOL CHEM, V266, P23977; Yamamoto Y, 2003, NAT BIOTECHNOL, V21, P546, DOI 10.1038/nbt812	28	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35491	35501		10.1074/jbc.M704785200	http://dx.doi.org/10.1074/jbc.M704785200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17932038	hybrid			2022-12-25	WOS:000251458100008
J	Reyes-Juarez, JL; Juarez-Rubi, R; Rodriguez, G; Zarain-Herzberg, A				Reyes-Juarez, Jose Luis; Juarez-Rubi, Raul; Rodriguez, Gabriela; Zarain-Herzberg, Angel			Transcriptional analysis of the human cardiac calsequestrin gene in cardiac and skeletal myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; CALCIUM-RELEASE CHANNEL; MUSCLE DEVELOPMENT; MYOCARDIN FAMILY; EXPRESSION; ENHANCER; ACTIVATION; MEF2; PROTEINS; TARGET	Calsequestrin is the main calcium-binding protein inside the sarcoplasmic reticulum of striated muscle. In mammals, the cardiac calsequestrin gene (casq2) mainly expresses in cardiac muscle and to a minor extent in slow-twitch skeletal muscle and it is not expressed in non-muscle tissues. This work is the first study on the transcriptional regulation of the casq2 gene in cardiac and skeletal muscle cells. The sequence of the casq2 genes proximal promoter ( 180 bp) of mammals and avians is highly conserved and contains one TATA box, one CArG box, one E-box, and one myocyte enhancer factor 2 (MEF-2) site. We cloned the human casq2 gene 5 '-regulatory region into aluciferase reporter expression vector. By functional assays we showed that a construct containing the first 288 bp of promoter was up-regulated during myogenic differentiation of Sol8 cells and had higher transcriptional activity compared with longer constructs. In neonatal rat cardiac myocytes, the larger construct containing 3.2 kb showed the highest transcriptional activity, demonstrating that the first 288 bp are sufficient to confer muscle specificity, whereas distal sequences may act as a cardiac-specific enhancer. Electrophoretic mobility shift assay studies demonstrated that the proximal MEF-2 and CArG box sequences were capable of binding MEF-2 and serum response factor, respectively, whereas the E-box did not show binding properties. Functional studies demonstrated that site-directed mutagenesis of the proximal MEF-2 and CArG box sites significantly decreased the transcription of the gene in cardiac and skeletal muscle cells, indicating that they are important to drive cardiac and skeletal muscle-specific transcription of the casq2 gene.	Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim & Biol Mol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Zarain-Herzberg, A (corresponding author), Apartado Postal 70-159, Mexico City 04510, DF, Mexico.	zarain@servidor.unam.mx		Reyes Juarez, Jose L/0000-0002-0524-9257				ARAI M, 1991, GENE, V109, P275, DOI 10.1016/0378-1119(91)90621-H; Azakie A, 2005, AM J PHYSIOL-CELL PH, V289, pC1522, DOI 10.1152/ajpcell.00126.2005; Balza RO, 2006, J BIOL CHEM, V281, P6498, DOI 10.1074/jbc.M509487200; Beard NA, 2004, PROG BIOPHYS MOL BIO, V85, P33, DOI 10.1016/j.pbiomolbio.2003.07.001; Beard NA, 2002, BIOPHYS J, V82, P310, DOI 10.1016/S0006-3495(02)75396-4; Belaguli NS, 2000, MOL CELL BIOL, V20, P7550, DOI 10.1128/MCB.20.20.7550-7558.2000; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Beylkin DH, 2006, DEV BIOL, V294, P541, DOI 10.1016/j.ydbio.2006.02.049; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Bodmer R, 1998, DEV GENET, V22, P181, DOI 10.1002/(SICI)1520-6408(1998)22:3<181::AID-DVG1>3.0.CO;2-2; Chen CY, 1996, DEV GENET, V19, P119, DOI 10.1002/(SICI)1520-6408(1996)19:2<119::AID-DVG3>3.0.CO;2-C; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Dai YS, 2002, J BIOL CHEM, V277, P24390, DOI 10.1074/jbc.M202490200; Dhar M, 1997, J BIOL CHEM, V272, P18490, DOI 10.1074/jbc.272.29.18490; di Barletta MR, 2006, CIRCULATION, V114, P1012, DOI 10.1161/CIRCULATIONAHA.106.623793; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Frank KF, 2001, BASIC RES CARDIOL, V96, P636, DOI 10.1007/s003950170016; Franzini-Armstrong C, 1999, BIOPHYS J, V77, P1528, DOI 10.1016/S0006-3495(99)77000-1; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Kontula K, 2005, CARDIOVASC RES, V67, P379, DOI 10.1016/j.cardiores.2005.04.027; LaPointe MC, 2005, PEPTIDES, V26, P944, DOI 10.1016/j.peptides.2004.08.028; Lehnart SE, 1998, ANN NY ACAD SCI, V853, P220, DOI 10.1111/j.1749-6632.1998.tb08270.x; Lemonnier M, 2004, J BIOL CHEM, V279, P55651, DOI 10.1074/jbc.M411082200; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; Meissner JD, 2007, J CELL PHYSIOL, V211, P138, DOI 10.1002/jcp.20916; Molkentin JD, 1996, J MOL CELL CARDIOL, V28, P1211, DOI 10.1006/jmcc.1996.0112; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Morin S, 2005, J BIOL CHEM, V280, P32272, DOI 10.1074/jbc.M507640200; Nelson TJ, 2005, J MOL CELL CARDIOL, V39, P479, DOI 10.1016/j.yjmcc.2005.05.004; Park HJ, 2003, J BIOL CHEM, V278, P16176, DOI 10.1074/jbc.M300120200; Park HJ, 2004, J BIOL CHEM, V279, P18026, DOI 10.1074/jbc.M311553200; Park KW, 1998, GENE, V217, P25, DOI 10.1016/S0378-1119(98)00372-2; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Postma AV, 2002, CIRC RES, V91, pE21, DOI 10.1161/01.RES.0000038886.18992.6B; Sato Y, 1998, J BIOL CHEM, V273, P28470, DOI 10.1074/jbc.273.43.28470; Terentyev D, 2006, CIRC RES, V98, P1151, DOI 10.1161/01.RES.0000220647.93982.08; vonHarsdorf R, 1997, J CLIN INVEST, V100, P1294, DOI 10.1172/JCI119643; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; Wang DZ, 2004, CURR OPIN GENET DEV, V14, P558, DOI 10.1016/j.gde.2004.08.003; WANG GS, 1994, J BIOL CHEM, V269, P30595; Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Yang A, 2004, AM J PHYSIOL-HEART C, V287, pH1096, DOI 10.1152/ajpheart.00079.2004; YANO K, 1994, MOL CELL BIOCHEM, V135, P61, DOI 10.1007/BF00925961; Zhang XM, 2004, J BIOL CHEM, V279, P55626, DOI 10.1074/jbc.M405945200	48	13	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35554	35563		10.1074/jbc.M707788200	http://dx.doi.org/10.1074/jbc.M707788200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17938175	hybrid			2022-12-25	WOS:000251458100015
J	Hammer, MM; Wehrman, TS; Blau, HM				Hammer, Mark M.; Wehrman, Tom S.; Blau, Helen M.			A novel enzyme complementation-based assay for monitoring G-protein-coupled receptor internalization	FASEB JOURNAL			English	Article						GPCR signaling; ligand binding; high-throughput screening	CELLS; ENDOCYTOSIS; FUSION; SPECIFICITY; ACTIVATION; BINDING; SYSTEM; MUSCLE; GENE; RAT	G-protein-coupled receptor ( GPCR) signaling is involved in a wide range of physiological processes and diseases, and around one- half of currently used drugs target GPCRs. Assays for the signaling of GPCRs have suffered from drawbacks, including low signal- to- noise, temporally transient signals, and difficulty in applying a single assay to a wide range of GPCRs. We have developed a set of assays for G-protein-coupled receptor signaling based on beta-galactosidase enzyme complementation in live mammalian cells. We previously described an assay for GPCR activation by monitoring the binding of beta-arrestin to the receptor. Here we describe a second assay that monitors the internalization of GPCRs to endosomes, an event that follows receptor activation and is critical in desensitizing and resensitizing the receptor. We show that both assays display high signal- to- noise ratios with low variability and are quantitative for a wide range of GPCRs. EC(50)s obtained with these assays closely match results reported in the literature. Finally, we show that these assays are readily adapted to high- throughput chemical screens. Thus, these two assays for monitoring G- protein- coupled receptor activation and internalization should prove valuable in basic biological studies as well as in high- throughput screens.	DiscoverRx Corp, Fremont, CA USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Baxter Lab Genet Pharmacol, Stanford, CA USA	Stanford University	Blau, HM (corresponding author), Baxter Lab, CCSR 4215, 269 Campus Dr, Stanford, CA 94305 USA.	hblau@stanford.edu	Hammer, Mark/AAR-9625-2020	Hammer, Mark/0000-0002-1700-7984	NIA NIH HHS [AG024987, AG020961, AG009521, T32 AG0259] Funding Source: Medline; NICHD NIH HHS [HD018179] Funding Source: Medline; NIGMS NIH HHS [T32 GM08412] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG009521, R01AG020961, R01AG009521, T32AG000259, R01AG024987] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Blakely BT, 2000, NAT BIOTECHNOL, V18, P218, DOI 10.1038/72686; Blatner NR, 2004, J BIOL CHEM, V279, P53818, DOI 10.1074/jbc.M408408200; Borgland SL, 2003, J BIOL CHEM, V278, P18776, DOI 10.1074/jbc.M300525200; Charlton CA, 2000, DEV BIOL, V221, P112, DOI 10.1006/dbio.2000.9654; Charlton CA, 1997, J CELL BIOL, V138, P331, DOI 10.1083/jcb.138.2.331; Conchon S, 1997, J BIOL CHEM, V272, P25566, DOI 10.1074/jbc.272.41.25566; Davis P.B., 1990, AM J PHYSIOL, V258, P71; Evans NA, 2001, J NEUROCHEM, V77, P476, DOI 10.1046/j.1471-4159.2001.00269.x; Gudermann T, 1996, ANNU REV PHARMACOL, V36, P429; Haasen D, 2006, METHOD ENZYMOL, V414, P121, DOI 10.1016/S0076-6879(06)14008-2; Mohler WA, 1996, P NATL ACAD SCI USA, V93, P12423, DOI 10.1073/pnas.93.22.12423; Penn RB, 2001, J BIOL CHEM, V276, P32648, DOI 10.1074/jbc.M104143200; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; RAGGENBASS M, 1989, P NATL ACAD SCI USA, V86, P750, DOI 10.1073/pnas.86.2.750; Ridley SH, 2001, J CELL SCI, V114, P3991; Rossi F, 1997, P NATL ACAD SCI USA, V94, P8405, DOI 10.1073/pnas.94.16.8405; Seet LF, 2001, J BIOL CHEM, V276, P42445, DOI 10.1074/jbc.M105917200; ULLMANN A, 1967, J MOL BIOL, V24, P339, DOI 10.1016/0022-2836(67)90341-5; van Koppen CJ, 2004, MOL PHARMACOL, V66, P365, DOI 10.1124/mol.104.003822; VASILE E, 1983, J CELL BIOL, V96, P1677, DOI 10.1083/jcb.96.6.1677; VONDEGENFELD G, 2007, FASEB J, V21; Wangemann P, 1999, J MEMBRANE BIOL, V170, P67, DOI 10.1007/s002329900538; Wehrman TS, 2006, P NATL ACAD SCI USA, V103, P19063, DOI 10.1073/pnas.0605218103; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Wehrman TS, 2005, NAT METHODS, V2, P521, DOI 10.1038/NMETH771; Wolkers WF, 2003, BBA-BIOMEMBRANES, V1612, P154, DOI 10.1016/S0005-2736(03)00114-7; Yan YX, 2002, J BIOMOL SCREEN, V7, P451, DOI 10.1177/108705702237677; Yang JT, 1996, J CELL BIOL, V135, P829, DOI 10.1083/jcb.135.3.829	28	26	27	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2007	21	14					3827	3834		10.1096/fj.07-8777com	http://dx.doi.org/10.1096/fj.07-8777com			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	236DP	17942829				2022-12-25	WOS:000251283500007
J	Paaijmans, KP; Wandago, MO; Githeko, AK; Takken, W				Paaijmans, Krijn P.; Wandago, Moses O.; Githeko, Andrew K.; Takken, Willem			Unexpected High Losses of Anopheles gambiae Larvae Due to Rainfall	PLOS ONE			English	Article							SENSU-STRICTO DIPTERA; AQUATIC STAGES; CULICIDAE LARVAE; CLIMATE-CHANGE; GILES COMPLEX; SURVIVORSHIP; TEMPERATURE; ARABIENSIS; HABITATS; SURVIVAL	Background. Immature stages of the malaria mosquito Anopheles gambiae experience high mortality, but its cause is poorly understood. Here we study the impact of rainfall, one of the abiotic factors to which the immatures are frequently exposed, on their mortality. Methodology/Principal Findings. We show that rainfall significantly affected larval mosquitoes by flushing them out of their aquatic habitat and killing them. Outdoor experiments under natural conditions in Kenya revealed that the additional nightly loss of larvae caused by rainfall was on average 17.5% for the youngest (L1) larvae and 4.8% for the oldest (L4) larvae; an additional 10.5% (increase from 0.9 to 11.4%) of the L1 larvae and 3.3% (from 0.1 to 3.4%) of the L4 larvae were flushed away and larval mortality increased by 6.9% (from 4.6 to 11.5%) and 1.5% (from 4.1 to 5.6%) for L1 and L4 larvae, respectively, compared to nights without rain. On rainy nights, 1.3% and 0.7% of L1 and L4 larvae, respectively, were lost due to ejection from the breeding site. Conclusions/Significance. This study demonstrates that immature populations of malaria mosquitoes suffer high losses during rainfall events. As these populations are likely to experience several rain showers during their lifespan, rainfall will have a profound effect on the productivity of mosquito breeding sites and, as a result, on the transmission of malaria. These findings are discussed in the light of malaria risk and changing rainfall patterns in response to climate change.	[Paaijmans, Krijn P.; Wandago, Moses O.; Takken, Willem] Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands; [Githeko, Andrew K.] Kenya Govt Med Res Ctr, Climate & Human Hlth Res Unit, Kisumu, Kenya	Wageningen University & Research; Kenya Medical Research Institute	Paaijmans, KP (corresponding author), Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands.	krijn@paaijmans.nl	Paaijmans, Krijn/ABC-9928-2020		Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO) [WB93-409]	Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by the Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO; WB93-409).	ANIEDU I, 1993, INSECT SCI APPL, V14, P39, DOI 10.1017/S1742758400013370; Bayoh MN, 2004, MED VET ENTOMOL, V18, P174, DOI 10.1111/j.0269-283X.2004.00495.x; Bayoh MN, 2003, B ENTOMOL RES, V93, P375, DOI 10.1079/BER2003259; BAYOH MN, 2001, STUDIES DEV SURVIVAL, P134; Breman JG, 2001, AM J TROP MED HYG, V64, P1; Charlwood JD, 1996, J MED ENTOMOL, V33, P202, DOI 10.1093/jmedent/33.2.202; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Edillo FE, 2004, J MED ENTOMOL, V41, P333, DOI 10.1603/0022-2585-41.3.333; Fillinger U, 2004, TROP MED INT HEALTH, V9, P1274, DOI 10.1111/j.1365-3156.2004.01335.x; Gillies M, 1987, PUBL S AFRI CAN I ME, V55, P1; Gillies M. T., 1968, PUBL S AFR I MED RES, V54, P343; Gimnig JE, 2002, J MED ENTOMOL, V39, P162, DOI 10.1603/0022-2585-39.1.162; Gimnig JE, 2001, J MED ENTOMOL, V38, P282, DOI 10.1603/0022-2585-38.2.282; Hulme M, 2001, CLIM RES, V17, P145, DOI 10.3354/cr017145; JEPSON WF, 1947, B ENTOMOL RES, V38, P177, DOI 10.1017/S0007485300030273; Koenraadt CJM, 2004, ACTA TROP, V90, P141, DOI 10.1016/j.actatropica.2003.11.007; Koenraadt CJM, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-20; Koenraadt CJM, 2003, MED VET ENTOMOL, V17, P61, DOI 10.1046/j.1365-2915.2003.00409.x; Lines J., 1995, INSECTS CHANGING ENV, P157; LYIMO EO, 1992, ENTOMOL EXP APPL, V63, P265, DOI 10.1007/BF00192775; MARTENS WJM, 1995, GLOBAL ENVIRON CHANG, V5, P195, DOI 10.1016/0959-3780(95)00051-O; McMichael A J., 1996, CLIMATE CHANGE HUMAN, P297; Miller JR, 2007, NATURWISSENSCHAFTEN, V94, P195, DOI 10.1007/s00114-006-0178-y; Mutuku FM, 2006, AM J TROP MED HYG, V74, P54, DOI 10.4269/ajtmh.2006.74.54; Okogun Godwin R. A., 2005, Journal of Vector Borne Diseases, V42, P1; Robert V, 1999, PARASITE, V6, P195; Romoser WS, 1999, J AM MOSQUITO CONTR, V15, P194; ROMOSER WS, 1994, J AM MOSQUITO CONTR, V10, P10; RUSSELL PF, 1946, PRACTICAL MALARIOLOG, P555; Schneider P, 2000, MED VET ENTOMOL, V14, P165, DOI 10.1046/j.1365-2915.2000.00204.x; SERVICE MW, 1971, B WORLD HEALTH ORGAN, V45, P169; SERVICE MW, 1977, J MED ENTOMOL, V13, P535, DOI 10.1093/jmedent/13.4-5.535; SERVICE MW, 1973, B ENTOMOL RES, V62, P359, DOI 10.1017/S0007485300003862; SERVICE MW, 1993, MOSQUITO ECOLOGY FIE, P988; Shaman J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000331; Timmermann S. E., 1993, Bulletin of the Society for Vector Ecology, V18, P174; Tuno N, 2005, J MED ENTOMOL, V42, P270, DOI 10.1603/0022-2585(2005)042[0270:SOAGSS]2.0.CO;2; Tuno N, 2004, J MED ENTOMOL, V41, P810, DOI 10.1603/0022-2585-41.4.810; Tuno N, 2007, J VECTOR ECOL, V32, P112, DOI 10.3376/1081-1710(2007)32[112:IVIDAA]2.0.CO;2; *WHO, 2005, WHOHTMMAL20051102, P293	40	154	159	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1146	10.1371/journal.pone.0001146	http://dx.doi.org/10.1371/journal.pone.0001146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987125	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459000029
J	Margineantu, DH; Emerson, CB; Diaz, D; Hockenbery, DM				Margineantu, Daciana H.; Emerson, Christine B.; Diaz, Dolores; Hockenbery, David M.			Hsp90 Inhibition Decreases Mitochondrial Protein Turnover	PLOS ONE			English	Article								Background. Cells treated with hsp90 inhibitors exhibit pleiotropic changes, including an expansion of the mitochondrial compartment, accompanied by mitochondrial fragmentation and condensed mitochondrial morphology, with ultimate compromise of mitochondrial integrity and apoptosis. Findings. We identified several mitochondrial oxidative phosphorylation complex subunits, including several encoded by mtDNA, that are upregulated by hsp90 inhibitors, without corresponding changes in mRNA abundance. Post-transcriptional accumulation of mitochondrial proteins observed with hsp90 inhibitors is also seen in cells treated with proteasome inhibitors. Detailed studies of the OSCP subunit of mitochondrial F1F0-ATPase revealed the presence of mono- and polyubiquitinated OSCP in mitochondrial fractions. We demonstrate that processed OSCP undergoes retrotranslocation to a trypsin-sensitive form associated with the outer mitochondrial membrane. Inhibition of proteasome or hsp90 function results in accumulation of both correctly targeted and retrotranslocated mitochondrial OSCP. Conclusions. Cytosolic turnover of mitochondrial proteins demonstrates a novel connection between mitochondrial and cytosolic compartments through the ubiquitin-proteasome system. Analogous to defective protein folding in the endoplasmic reticulum, a mitochondrial unfolded protein response may play a role in the apoptotic effects of hsp90 and proteasome inhibitors.	[Margineantu, Daciana H.; Emerson, Christine B.; Diaz, Dolores; Hockenbery, David M.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Margineantu, Daciana H.; Emerson, Christine B.; Diaz, Dolores; Hockenbery, David M.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Hockenbery, DM (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	dhockenb@fhcrc.org			NIH [104402]; Amgen Interdisciplinary Fellowship Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056761] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amgen Interdisciplinary Fellowship Fund(Amgen); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH (RO1 grant # 104402) and Amgen Interdisciplinary Fellowship Fund.	Abu-Farha M, 2005, BIOCHEM CELL BIOL, V83, P620, DOI 10.1139/o05-045; Blagosklonny MV, 2001, LEUKEMIA, V15, P1537, DOI 10.1038/sj.leu.2402257; Chillaron J, 2000, MOL BIOL CELL, V11, P217, DOI 10.1091/mbc.11.1.217; Chiosis G, 2001, CHEM BIOL, V8, P289, DOI 10.1016/S1074-5521(01)00015-1; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Elkabetz Y, 2004, J BIOL CHEM, V279, P3980, DOI 10.1074/jbc.M309938200; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hanson BJ, 2001, J BIOL CHEM, V276, P16296, DOI 10.1074/jbc.M011162200; Hua GQ, 2007, J BIOL CHEM, V282, P20553, DOI 10.1074/jbc.M703196200; Jarosch E, 2003, INT REV CYTOL, V223, P39; Jeon HB, 2007, BIOCHEM BIOPH RES CO, V357, P731, DOI 10.1016/j.bbrc.2007.04.015; Kawai A, 2006, BIOCHEM BIOPH RES CO, V351, P71, DOI 10.1016/j.bbrc.2006.09.168; Liao W, 2006, J CELL BIOCHEM, V99, P1085, DOI 10.1002/jcb.20996; Lopez-Maderuelo MD, 2001, FEBS LETT, V490, P23, DOI 10.1016/S0014-5793(01)02130-5; Mancini M, 1997, J CELL BIOL, V138, P449, DOI 10.1083/jcb.138.2.449; Mancini M, 1998, ANN SURG ONCOL, V5, P287, DOI 10.1007/BF02303787; Mancini R, 2000, FASEB J, V14, P769, DOI 10.1096/fasebj.14.5.769; Maor R, 2007, MOL CELL PROTEOMICS, V6, P601, DOI 10.1074/mcp.M600408-MCP200; Marcu MG, 2002, MOL CELL BIOL, V22, P8506, DOI 10.1128/MCB.22.24.8506-8513.2002; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Minnnaugh EG, 2004, MOL CANCER THER, V3, P551; Morrish F, 2003, GENE DEV, V17, P240, DOI 10.1101/gad.1032503; Munster PN, 2002, CANCER RES, V62, P3132; Nimmanapalli R, 2003, BLOOD, V102, P269, DOI 10.1182/blood-2002-12-3718; PAVLICA RJ, 1990, BIOCHIM BIOPHYS ACTA, V1022, P115, DOI 10.1016/0005-2736(90)90407-F; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prescott M, 1997, FEBS LETT, V411, P97, DOI 10.1016/S0014-5793(97)00670-4; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; SCALETTAR BA, 1991, P NATL ACAD SCI USA, V88, P8057, DOI 10.1073/pnas.88.18.8057; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; Sirk DP, 2003, CYTOM PART A, V56A, P15, DOI 10.1002/cyto.a.10084; Smith V, 2002, ANTICANCER RES, V22, P1993; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Tateishi Y, 2006, MOL CELL BIOL, V26, P7966, DOI 10.1128/MCB.00713-06; Thompson WE, 2003, BIOL REPROD, V69, P254, DOI 10.1095/biolreprod.102.010975; Weekes J, 2003, PROTEOMICS, V3, P208, DOI 10.1002/pmic.200390029; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Zhang H, 2004, J MOL MED, V82, P488, DOI 10.1007/s00109-004-0549-9; Zhao M, 2000, LEUKEMIA, V14, P374, DOI 10.1038/sj.leu.2401680	42	118	119	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1066	10.1371/journal.pone.0001066	http://dx.doi.org/10.1371/journal.pone.0001066			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957250	Green Submitted, Green Published, gold			2022-12-25	WOS:000207458500013
J	Abboud, S; Karhunen, PJ; Lutjohann, D; Goebeler, S; Luoto, T; Friedrichs, S; Lehtimaki, T; Pandolfo, M; Laaksonen, R				Abboud, Sherine; Karhunen, Pekka J.; Luetjohann, Dieter; Goebeler, Sirkka; Luoto, Teemu; Friedrichs, Silvia; Lehtimaki, Terho; Pandolfo, Massimo; Laaksonen, Reijo			Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Gene Is a Risk Factor of Large-Vessel Atherosclerosis Stroke	PLOS ONE			English	Article								Background/Purpose. Genetic variation in proprotein convertase subtilisin/kexin type 9 (PCSK9) gene has been recently identified as an important determinant of plasma LDL-cholesterol and severity of coronary heart disease. We studied whether the PCSK9 gene is linked to the risk of ischemic stroke (IS) and with the development of intracranial atherosclerosis. Methods/Results. The pivotal E670G polymorphism, tagging an important haplotype of the PCSK9 gene, was genotyped in two independent studies. The Belgium Stroke Study included 237 middle aged (45-60) Belgian patients, with small-vessel occlusion (SVO) and large-vessel atherosclerosis stroke (LVA), and 326 gender and ethnicity matched controls (>60 yrs) without a history of stroke. In multivariate analysis the minor allele (G) carriers appeared as a significant predictor of LVA (OR = 3.52, 95% CI 1.25-9.85; p = 0.017). In a Finnish crossectional population based consecutive autopsy series of 604 males and females (mean age 62.5 years), G-allele carriers tended to have more severe allele copy number-dependent (p = 0.095) atherosclerosis in the circle of Willis and in its branches. Conclusion. Our findings in this unique combination of clinical and autopsy data, provide evidence that PCSK9 gene associates with the risk of LVA stroke subtype, and suggest that the risk is mediated by the severity of intracranial atherosclerosis.	[Abboud, Sherine; Pandolfo, Massimo; Laaksonen, Reijo] Univ Libre Bruxelles, Erasme Hosp, Dept Neurol, Lab Expt Neurol, Brussels, Belgium; [Karhunen, Pekka J.; Goebeler, Sirkka; Luoto, Teemu] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Karhunen, Pekka J.; Goebeler, Sirkka; Luoto, Teemu] Tampere Univ Hosp, Res Unit Lab Ctr, Tampere, Finland; [Luetjohann, Dieter; Friedrichs, Silvia] Univ Bonn, Dept Clin Pharmacol, D-5300 Bonn, Germany; [Abboud, Sherine; Lehtimaki, Terho; Laaksonen, Reijo] Tampere Univ Hosp, Dept Clin Chem, Lab Atherosclerosis Genet, Tampere, Finland; [Abboud, Sherine; Lehtimaki, Terho; Laaksonen, Reijo] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland	Universite Libre de Bruxelles; Tampere University; Tampere University; Tampere University Hospital; University of Bonn; Tampere University; Tampere University Hospital; Tampere University	Abboud, S (corresponding author), Univ Libre Bruxelles, Erasme Hosp, Dept Neurol, Lab Expt Neurol, Brussels, Belgium.	shabboud@ulb.ac.be	Lehtimäki, Terho/AAD-1094-2022; Luoto, Teemu/W-6468-2018; Laaksonen, Reijo/D-6323-2014; Pandolfo, Massimo/B-2853-2010	Lehtimäki, Terho/0000-0002-2555-4427; Luoto, Teemu/0000-0002-7329-3284; 	Erasme Funds; FNRS; Emil Aaltonen Foundation; Tampere University Hospital; Finnish Cultural Foundation; Finnish Foundation for Cardiovascular Research; Yrjo Jahnsson Foundation	Erasme Funds; FNRS(Fonds de la Recherche Scientifique - FNRS); Emil Aaltonen Foundation; Tampere University Hospital; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Foundation for Cardiovascular Research; Yrjo Jahnsson Foundation	Erasme Funds, FNRS, Emil Aaltonen Foundation, Medical Research Fund of Tampere University Hospital, the Pirkanmaa Regional Fund of the Finnish Cultural Foundation, the Finnish Foundation for Cardiovascular Research, and the Yrjo Jahnsson Foundation	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Berge KE, 2006, ARTERIOSCL THROM VAS, V26, P1094, DOI 10.1161/01.ATV.0000204337.81286.1c; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Chen SN, 2005, J AM COLL CARDIOL, V45, P1611, DOI 10.1016/j.jacc.2005.01.051; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Evans D, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-66; Flossmann E, 2004, STROKE, V35, P212, DOI 10.1161/01.STR.0000107187.84390.AA; HUMPHRIES SE, 2006, J MED GENET; Jerrard-Dunne P, 2003, STROKE, V34, P1364, DOI 10.1161/01.STR.0000069723.17984.FD; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Naoumova RP, 2005, ARTERIOSCL THROM VAS, V25, P2654, DOI 10.1161/01.ATV.0000190668.94752.ab; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Polychronopoulos P, 2002, J NEUROL SCI, V195, P117, DOI 10.1016/S0022-510X(01)00691-8; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Schulz UGR, 2004, STROKE, V35, P819, DOI 10.1161/01.STR.0000121646.23955.0f; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Wardlaw JM, 2005, J NEUROL NEUROSUR PS, V76, P617, DOI 10.1136/jnnp.2004.039982; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	22	53	81	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1043	10.1371/journal.pone.0001043	http://dx.doi.org/10.1371/journal.pone.0001043			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940607	Green Published, gold, Green Submitted			2022-12-25	WOS:000207456100011
J	Seizova-Cajic, T; Smith, JL; Taylor, JL; Gandevia, SC				Seizova-Cajic, Tatjana; Smith, Janette L.; Taylor, Janet L.; Gandevia, Simon C.			Proprioceptive Movement Illusions Due to Prolonged Stimulation: Reversals and Aftereffects	PLOS ONE			English	Article								Background. Adaptation to constant stimulation has often been used to investigate the mechanisms of perceptual coding, but the adaptive processes within the proprioceptive channels that encode body movement have not been well described. We investigated them using vibration as a stimulus because vibration of muscle tendons results in a powerful illusion of movement. Methodology/Principal Findings. We applied sustained 90 Hz vibratory stimulation to biceps brachii, an elbow flexor and induced the expected illusion of elbow extension (in 12 participants). There was clear evidence of adaptation to the movement signal both during the 6-min long vibration and on its cessation. During vibration, the strong initial illusion of extension waxed and waned, with diminishing duration of periods of illusory movement and occasional reversals in the direction of the illusion. After vibration there was an aftereffect in which the stationary elbow seemed to move into flexion. Muscle activity shows no consistent relationship with the variations in perceived movement. Conclusion. We interpret the observed effects as adaptive changes in the central mechanisms that code movement in direction-selective opponent channels.	[Seizova-Cajic, Tatjana] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Smith, Janette L.; Taylor, Janet L.; Gandevia, Simon C.] Prince Wales Med Res Inst, Sydney, NSW, Australia	University of Sydney; Prince Wales Medical Research Institute	Seizova-Cajic, T (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.	tseizova-cajic@psy.unsw.edu.au	Taylor, Janet L/C-9667-2011; Seizova-Cajic, Tatjana/A-5916-2016; Gandevia, Simon C/D-5009-2011; Smith, Janette L/C-2833-2008; Seizova-Cajic, Tatjana/E-9946-2010	Taylor, Janet L/0000-0001-8976-5162; Seizova-Cajic, Tatjana/0000-0002-8319-4095; Gandevia, Simon C/0000-0002-1345-3821; Smith, Janette L/0000-0001-8896-1188; 	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the National Health and Medical Research Council of Australia (SCG, JLT, JLS).	BARLOW HB, 1963, NATURE, V200, P1345, DOI 10.1038/2001345a0; Bergenheim M, 2000, EXP BRAIN RES, V134, P301, DOI 10.1007/s002210000471; Blakemore C., 2010, VISION CODING EFFICI, P363, DOI 10.1017/cbo9780511626197.034; Clifford C.W.G., 2005, FITTING MIND WORLD A; Clifford CWG, 2005, FITTING MIND WORLD A, P47; Desmurget M, 2000, EXP BRAIN RES, V134, P363, DOI 10.1007/s002210000473; DiZio P, 2002, HUM FAC ER, P751; FELDMAN AG, 1982, NEUROSCI LETT, V31, P147, DOI 10.1016/0304-3940(82)90107-0; GANDEVIA SC, 1985, BRAIN, V108, P965, DOI 10.1093/brain/108.4.965; GANDEVIA SC, 1996, HDB PHYSIOL 12, P128; GILHODES JC, 1986, EXP BRAIN RES, V61, P395; GOLDSTEIN A, 1959, J EXP PSYCHOL, V54, P457; GOODWIN GM, 1972, BRAIN, V95, P705, DOI 10.1093/brain/95.4.705; HELSON H, 1948, PSYCHOL REV, V55, P297, DOI 10.1037/h0056721; Kito T, 2006, BRAIN RES, V1114, P75, DOI 10.1016/j.brainres.2006.07.062; Kline K, 2004, VISION RES, V44, P2653, DOI 10.1016/j.visres.2004.05.030; Koffka K, 1935, PRINCIPLES GESTALT P; LACKNER JR, 1979, AVIAT SPACE ENVIR MD, V50, P346; MATHER G, 1980, PERCEPTION, V9, P379, DOI 10.1068/p090379; Mather G, 1998, MOTION AFTEREFFECT, P157; MATHER G, 1998, MOTION AFTEREFFECT; MATTHEWS PBC, 1982, ANNU REV NEUROSCI, V5, P189, DOI 10.1146/annurev.ne.05.030182.001201; Purves D, 1996, P NATL ACAD SCI USA, V93, P3693, DOI 10.1073/pnas.93.8.3693; Ribot-Ciscar E, 1998, BRAIN RES, V791, P167, DOI 10.1016/S0006-8993(98)00092-4; Ribot-Ciscar E, 1998, NEUROSCI LETT, V258, P147, DOI 10.1016/S0304-3940(98)00732-0; ROLL JP, 1982, EXP BRAIN RES, V47, P177; ROLL JP, 1980, ARCH ITAL BIOL, V118, P51; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Wade NJ., 1998, NATURAL HIST VISION; Wierzbicka MM, 1998, J NEUROPHYSIOL, V79, P143, DOI 10.1152/jn.1998.79.1.143; Wohlgemuth A., 1911, AFTER EFFECT SEEN MO, V1; [No title captured]	32	37	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1037	10.1371/journal.pone.0001037	http://dx.doi.org/10.1371/journal.pone.0001037			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940601	gold, Green Published			2022-12-25	WOS:000207456100005
J	Lin, K; Rockliffe, N; Johnson, GG; Sherrington, PD; Pettitt, AR				Lin, K.; Rockliffe, N.; Johnson, G. G.; Sherrington, P. D.; Pettitt, A. R.			Hsp90 inhibition has opposing effects on wild-type and mutant p53 and induces p21 expression and cytotoxicity irrespective of p53/ATM status in chronic lymphocytic leukaemia cells	ONCOGENE			English	Article						p53; ATM; chronic lymphocytic leukaemia; Hsp90	ENDOTHELIAL GROWTH-FACTOR; GENE MUTATION STATUS; IN-VITRO; PURINE ANALOGS; HEAT-SHOCK-PROTEIN-90 HSP90; DISEASE PROGRESSION; PROTEIN EXPRESSION; ZAP-70 EXPRESSION; INDUCED APOPTOSIS; DRUG-RESISTANCE	In chronic lymphocytic leukaemia ( CLL), mutation/ deletion of TP53 is strongly associated with early disease progression, resistance to chemotherapy and short patient survival. Consequently, there is a pressing need to develop novel treatment protocols for this high- risk patient group. The present study was performed to evaluate Hsp90 inhibition as a possible therapeutic approach for such patients. Primary CLL cells of defined ataxia telangiectasia mutated ( ATM)/ p53 status were incubated with the Hsp90 inhibitor geldanamycin ( GA) and analysed by western blotting for the expression of p53, p21, MDM2 and Akt. GA downregulated overexpressed mutant p53 protein ( an oncogene) and upregulated wild- type ( wt) p53 ( a tumour suppressor). The upregulation of wt p53 by GA was independent of ATM and was accompanied by downregulation of Akt and the active form of MDM2, indicating a possible mechanism. GA also produced a p53/ ATM- independent increase in the levels of p21 - a potent inducer of cell- cycle arrest. In- vitro cytotoxicity studies showed that GA killed cultured CLL cells in a dose- and time- dependent fashion irrespective of their p53/ ATM status and more effectively than normal blood mononuclear cells. In summary, our findings reveal important consequences of inhibiting Hsp90 in CLL cells and strongly support the therapeutic evaluation of Hsp90 inhibitors in poor- prognosis patients with p53 defects.	[Lin, K.; Rockliffe, N.; Sherrington, P. D.; Pettitt, A. R.] Univ Liverpool, Dept Haematol, Sch Canc Studies, Div Haematol, Liverpool L69 3GA, Merseyside, England; [Lin, K.; Johnson, G. G.; Sherrington, P. D.; Pettitt, A. R.] Royal Liverpool & Broadgreen Univ Hosp Trust, Dept Haematol, Liverpool, Merseyside, England	University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; University of Liverpool	Pettitt, AR (corresponding author), Univ Liverpool, Dept Haematol, Sch Canc Studies, Div Haematol, 2nd Floor Duncan Bldg,Daulby St, Liverpool L69 3GA, Merseyside, England.	A.R.Pettitt@liverpool.ac.uk	lin, ke/GZM-8300-2022					BARTEK J, 1991, ONCOGENE, V6, P1699; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Bernstein C, 2002, MUTAT RES-REV MUTAT, V511, P145, DOI 10.1016/S1383-5742(02)00009-1; Blagosklonny MV, 1996, P NATL ACAD SCI USA, V93, P8379, DOI 10.1073/pnas.93.16.8379; Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Cadwell C, 2001, GENE, V277, P15, DOI 10.1016/S0378-1119(01)00696-5; Carter A, 2006, LEUKEMIA, V20, P737, DOI 10.1038/sj.leu.2404120; Castro JE, 2005, BLOOD, V106, P2506, DOI 10.1182/blood-2005-03-1099; Catovsky D, 2004, BLOOD, V104, p8A, DOI 10.1182/blood.V104.11.13.13; Chen HJ, 2000, BLOOD, V96, P3181; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Choi HJ, 2006, GLYCOBIOLOGY, V16, P573, DOI 10.1093/glycob/cwj105; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Cordone I, 1998, BLOOD, V91, P4342, DOI 10.1182/blood.V91.11.4342.411k39_4342_4349; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; DOHNER H, 1995, BLOOD, V85, P1580, DOI 10.1182/blood.V85.6.1580.bloodjournal8561580; ELROUBY S, 1993, BLOOD, V82, P3452; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Fujita N, 2002, J BIOL CHEM, V277, P10346, DOI 10.1074/jbc.M106736200; GINE E, 2005, LEUK LYMPHOMA S1, V46, pS89; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; HARVEY M, 1995, NAT GENET, V9, P305, DOI 10.1038/ng0395-305; IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B; Jascur T, 2005, MOL CELL, V17, P237, DOI 10.1016/j.molcel.2004.11.049; Jones DT, 2004, BLOOD, V103, P1855, DOI 10.1182/blood-2003-05-1603; Jones DT, 2003, BLOOD, V101, P3174, DOI 10.1182/blood-2002-07-2143; Jones GG, 2004, ONCOGENE, V23, P1911, DOI 10.1038/sj.onc.1207318; Kamat CD, 2007, CANCER LETT, V249, P209, DOI 10.1016/j.canlet.2006.08.017; KIESER A, 1994, ONCOGENE, V9, P963; Kim E, 2004, J CELL BIOCHEM, V93, P878, DOI 10.1002/jcb.20271; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lens D, 1997, BRIT J HAEMATOL, V99, P848, DOI 10.1046/j.1365-2141.1997.4723278.x; Li RZ, 1998, ONCOGENE, V16, P3269, DOI 10.1038/sj.onc.1201867; Lin K, 2002, BLOOD, V100, P1404, DOI 10.1182/blood-2001-11-0066; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; LOTEM J, 1993, BLOOD, V82, P1092, DOI 10.1182/blood.V82.4.1092.bloodjournal8241092; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Matas D, 2001, EMBO J, V20, P4163, DOI 10.1093/emboj/20.15.4163; Morabito F, 1997, HAEMATOLOGICA, V82, P16; Muller L, 2004, J BIOL CHEM, V279, P48846, DOI 10.1074/jbc.M407687200; Nagata Y, 1999, ONCOGENE, V18, P6037, DOI 10.1038/sj.onc.1202978; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Orchard JA, 2004, LANCET, V363, P105, DOI 10.1016/S0140-6736(03)15260-9; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Oscier DG, 2002, BLOOD, V100, P1177, DOI 10.1182/blood.V100.4.1177.h81602001177_1177_1184; Pettitt AR, 1999, BRIT J HAEMATOL, V105, P986, DOI 10.1046/j.1365-2141.1999.01448.x; Pettitt AR, 1999, BRIT J HAEMATOL, V106, P1049; Pettitt AR, 2000, BRIT J HAEMATOL, V109, P800, DOI 10.1046/j.1365-2141.2000.02068.x; Pettitt AR, 2001, BLOOD, V98, P814, DOI 10.1182/blood.V98.3.814; Rassenti LZ, 2004, NEW ENGL J MED, V351, P893, DOI 10.1056/NEJMoa040857; Romanov VV, 2005, ONCOGENE, V24, P6855, DOI 10.1038/sj.onc.1208895; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Sepehrnia B, 1996, J BIOL CHEM, V271, P15084, DOI 10.1074/jbc.271.25.15084; SILBER R, 1994, BLOOD, V84, P3440; Smith V, 2005, CANCER CHEMOTH PHARM, V56, P126, DOI 10.1007/s00280-004-0947-2; Stankovic T, 2002, BLOOD, V99, P300, DOI 10.1182/blood.V99.1.300; STILGENBAUER S, 2005, LEUK LYMPHOMA S1, V46, pS6; Sturm I, 2003, CELL DEATH DIFFER, V10, P477, DOI 10.1038/sj.cdd.4401194; Thornton PD, 2004, HEMATOL J, V5, P47, DOI 10.1038/sj.thj.6200325; Uziel T, 1996, GENOMICS, V33, P317, DOI 10.1006/geno.1996.0201; Valganon M, 2005, BRIT J HAEMATOL, V129, P53, DOI 10.1111/j.1365-2141.2005.05405.x; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Walerych D, 2004, J BIOL CHEM, V279, P48836, DOI 10.1074/jbc.M407601200; Wang CG, 2003, J BIOL CHEM, V278, P2066, DOI 10.1074/jbc.M206697200; WATTEL E, 1994, BLOOD, V84, P3148, DOI 10.1182/blood.V84.9.3148.3148; Whitesell L, 1998, MOL CELL BIOL, V18, P1517, DOI 10.1128/MCB.18.3.1517; Workman P, 2004, CANCER LETT, V206, P149, DOI 10.1016/j.canlet.2003.08.032; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhang H, 2004, J MOL MED, V82, P488, DOI 10.1007/s00109-004-0549-9; Zhang Y, 2004, J BIOL CHEM, V279, P42545, DOI 10.1074/jbc.M314213200; Zhang Z, 2004, J BIOL CHEM, V279, P16000, DOI 10.1074/jbc.M312264200	76	57	58	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2008	27	17					2445	2455		10.1038/sj.onc.1210893	http://dx.doi.org/10.1038/sj.onc.1210893			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286KN	17982489				2022-12-25	WOS:000254844900009
J	Sadayappan, S; Finley, N; Howarth, JW; Osinska, H; Klevitsky, R; Lorenz, JN; Rosevear, PR; Robbins, J				Sadayappan, Sakthivel; Finley, Natosha; Howarth, Jack W.; Osinska, Hanna; Klevitsky, Raisa; Lorenz, John N.; Rosevear, Paul R.; Robbins, Jeffrey			Role of the acidic N ' region of cardiac troponin I in regulating myocardial function	FASEB JOURNAL			English	Article						muscle; transgenic mouse model; contractility; heart	KINASE-A PHOSPHORYLATION; HYPERTROPHIC CARDIOMYOPATHY; CONFORMATIONAL EXCHANGE; TERMINAL EXTENSION; INTERACTION SITES; HEART; DOMAIN; EXPRESSION; MUSCLE; STIMULATION	Cardiac troponin I (cTnI) phosphorylation modulates myocardial contractility and relaxation during beta-adrenergic stimulation. cTnI differs from the skeletal isoform in that it has a cardiac specific N' extension of 32 residues (N' extension). The role of the acidic N' region in modulating cardiac contractility has not been fully defined. To test the hypothesis that the acidic N' region of cTnI helps regulate myocardial function, we generated cardiac-specific transgenic mice in which residues 2-11 (cTnI(Delta 2-11)) were deleted. The hearts displayed significantly decreased contraction and relaxation under basal and P-adrenergic stress compared to nontransgenic hearts, with a reduction in maximal Ca2+-dependent force and maximal Ca2+- activated Mg2+-ATPase activity. However, Ca2+ sensitivity of force development and cTnI-Ser(23/24) phosphorylation were not affected. Chemical shift mapping shows that both cTnI and cTnI(Delta 2-11) interact with the N lobe of cardiac troponin C (cTnC) and that phosphorylation at Ser(23/24) weakens these interactions. These observations suggest that residues 2-11 of cTnI, comprising the acidic N' region, do not play a direct role in the calcium-induced transition in the cardiac regulatory or N lobe of cTnC. We hypothesized that phosphorylation at Ser(23/24) induces a large conformational change positioning the conserved acidic N region to compete with actin for the inhibitory region of cTnI. Consistent with this hypothesis, deletion of the conserved acidic N' region results in a decrease in myocardial contractility in the cTnI(Delta 2-11) mice demonstrating the importance of acidic N' region in regulating myocardial contractility and mediating the response of the heart to beta-AR stimulation.	[Sadayappan, Sakthivel; Osinska, Hanna; Klevitsky, Raisa; Robbins, Jeffrey] Childrens Hosp, Med Ctr, Dept Pediat, Div Mol Cardivasc Biol, Cincinnati, OH 45229 USA; [Lorenz, John N.] Univ Cincinnati, Dept Med, Cincinnati, OH 45221 USA	Cincinnati Children's Hospital Medical Center; University of Cincinnati	Robbins, J (corresponding author), Childrens Hosp, Med Ctr, Dept Pediat, Div Mol Cardivasc Biol, MLC 7020,Burnet Ave, Cincinnati, OH 45229 USA.	jeff.robbins@cchmc.org		Sadayappan, Sakthivel/0000-0003-2006-7678	NHLBI NIH HHS [HL-83334, P50 HL052318, P50 HL074728-010004, P50 HL074728, HL-69799, P01 HL041496-090007, P01 HL022619-200019, P50 HL077101, P01 HL022619, P50 HL077101-010005, HL-52318, R01 HL061638-06, R01 HL061638, R01 HL056370, P01 HL069779-01, HL-56370, P01 HL069779, P01 HL069779-06A17077, R01 HL056370-04, HL-60546] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022619, R01HL061638, P50HL074728, P01HL069779, P50HL052318, R01HL060546, P01HL041496, R01HL083334, P50HL077101, R01HL056370] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abbott MB, 2000, J BIOL CHEM, V275, P20610, DOI 10.1074/jbc.M909252199; Abbott MB, 2000, FEBS LETT, V469, P168, DOI 10.1016/S0014-5793(00)01271-0; Abbott MB, 2001, BIOCHEMISTRY-US, V40, P5992, DOI 10.1021/bi0100642; Arad M, 2005, CIRCULATION, V112, P2805, DOI 10.1161/CIRCULATIONAHA.105.547448; Barbato JC, 2005, J BIOL CHEM, V280, P6602, DOI 10.1074/jbc.M408525200; Chandra M, 1997, BIOCHEMISTRY-US, V36, P13305, DOI 10.1021/bi9710129; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; El-Armouche A, 2006, CIRCULATION, V114, P670, DOI 10.1161/CIRCULATIONAHA.106.636845; FCNTZKC RC, 1999, J PHYSL, V517, P143; Fewell JG, 1998, J CLIN INVEST, V101, P2630, DOI 10.1172/JCI2825; Finley N, 1999, FEBS LETT, V453, P107, DOI 10.1016/S0014-5793(99)00693-6; Gaponenko V, 1999, J BIOL CHEM, V274, P16681, DOI 10.1074/jbc.274.24.16681; Haworth RS, 2004, CIRC RES, V95, P1091, DOI 10.1161/01.RES.0000149299.34793.3c; Holthauzen LMF, 2004, J BIOL CHEM, V279, P15204, DOI 10.1074/jbc.M308904200; Howarth JW, 2007, J MOL BIOL, V373, P706, DOI 10.1016/j.jmb.2007.08.035; James J, 2000, CIRC RES, V87, P805, DOI 10.1161/01.RES.87.9.805; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; KRANIAS EG, 1982, NATURE, V298, P182, DOI 10.1038/298182a0; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; Krenz M, 2007, J BIOL CHEM, V282, P24057, DOI 10.1074/jbc.M704574200; Layland J, 2004, J PHYSIOL-LONDON, V556, P835, DOI 10.1113/jphysiol.2004.061176; Murakami K, 2005, J MOL BIOL, V352, P178, DOI 10.1016/j.jmb.2005.06.067; MURPHY AM, 1991, BIOCHEMISTRY-US, V30, P707, DOI 10.1021/bi00217a018; Murphy RT, 2004, LANCET, V363, P371, DOI 10.1016/S0140-6736(04)15468-8; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; SAGGIN L, 1989, J BIOL CHEM, V264, P16299; Sakthivel S, 2005, J BIOL CHEM, V280, P703, DOI 10.1074/jbc.M409513200; Sanbe A, 2005, CIRCULATION, V111, P2330, DOI 10.1161/01.CIR.0000164234.24957.75; SASSE S, 1993, CIRC RES, V72, P932, DOI 10.1161/01.RES.72.5.932; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Takimoto E, 2004, CIRC RES, V94, P496, DOI 10.1161/01.RES.0000117307.57798.F5; Turnbull L, 2002, J PHYSIOL-LONDON, V542, P911, DOI 10.1113/jphysiol.2002.022707; Ward DG, 2004, BIOCHEMISTRY-US, V43, P5772, DOI 10.1021/bi036310m; Ward DG, 2004, BIOCHEMISTRY-US, V43, P4020, DOI 10.1021/bi036128l; Ward DG, 2003, BIOCHEMISTRY-US, V42, P10324, DOI 10.1021/bi034495r; Ward DG, 2002, J BIOL CHEM, V277, P41795, DOI 10.1074/jbc.M206744200	36	22	23	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2008	22	4					1246	1257		10.1096/fj.07-9458com	http://dx.doi.org/10.1096/fj.07-9458com			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	282PZ	17984178	Green Accepted			2022-12-25	WOS:000254581000029
J	Maiti, A; Hait, NC; Beckman, MJ				Maiti, Aparna; Hait, Nitai C.; Beckman, Matthew J.			Extracellular calcium-sensing receptor activation induces vitamin D receptor levels in proximal kidney HK-2G cells by a mechanism that requires phosphorylation of p38 alpha MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; 25-HYDROXYVITAMIN D-3-1-ALPHA-HYDROXYLASE; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; 1,25-DIHYDROXYVITAMIN D-3; 1-ALPHA-HYDROXYLASE GENE; PARATHYROID-GLANDS; ALPHA-HYDROXYLASE; EXPRESSION; P38; HYPERCALCEMIA	In hypocalcaemia, elevated parathyroid hormone transitorily down-regulates the kidney vitamin D receptor, which returns to normal levels with the rise in serum extracellular calcium [Ca2+](e). In this study, we investigated the mechanism that underlies VDR increase in kidney in association with elevated [Ca2+](e). Examination of MAP kinase signals in a proximal tubule human kidney (HK-2G) epithelial cell line showed that treatment of [Ca2+](e) in the culture medium elevated phosphorylation of both ERK and p38 MAPKs. Blockade of p38 phosphorylation with SB203580 or SB202190 in turn abolished [Ca2+](e)-mediated VDR protein increase, while treatment with PD98059 and U0126, specifically blocked ERK phosphorylation, but had no effect on VDR stimulation by [Ca2+](e). Furthermore, SB203580 treatment potently repressed [Ca2+](e)-mediated activation of VDR promoter. We also demonstrate that si-RNA knock down of p38 alpha completely diminished high [Ca2+](e)-mediated VDR induction. Direct CaSR involvement was demonstrated by using an si-RNA of CaSR that impeded [Ca2+](e)-mediated induction of VDR. In conclusion, a high extracellular [Ca2+](e) concentration in the physiological range is capable of directly increasing renal proximal VDR expression, and the induction mechanism requires activation of the CaSR and signal mediation by the p38 alpha MAP kinase pathway.	[Maiti, Aparna; Beckman, Matthew J.] Virginia Commonwealth Univ, Dept Orthopaed Surg, Richmond, VA 23298 USA; [Hait, Nitai C.; Beckman, Matthew J.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Beckman, MJ (corresponding author), Virginia Commonwealth Univ, Dept Biochem, 1112 E Clay St, Richmond, VA 23298 USA.	mjbeckma@vcu.edu						Anderson PH, 2004, J STEROID BIOCHEM, V89-90, P111, DOI 10.1016/j.jsbmb.2004.03.089; Armbrecht HJ, 2003, AM J PHYSIOL-RENAL, V284, pF1032, DOI 10.1152/ajprenal.00306.2002; Bajwa A, 2005, ARCH BIOCHEM BIOPHYS, V438, P182, DOI 10.1016/j.abb.2005.04.016; Barletta F, 2004, AM J PHYSIOL-ENDOC M, V286, pE598, DOI 10.1152/ajpendo.00214.2003; Beckman MJ, 2002, ARCH BIOCHEM BIOPHYS, V401, P44, DOI 10.1016/S0003-9861(02)00010-3; Berndt TJ, 2005, AM J PHYSIOL-RENAL, V289, pF1170, DOI 10.1152/ajprenal.00072.2005; Bland R, 1999, ENDOCRINOLOGY, V140, P2027, DOI 10.1210/en.140.5.2027; BRENT GA, 1988, J CLIN ENDOCR METAB, V67, P944, DOI 10.1210/jcem-67-5-944; Brenza HL, 1998, P NATL ACAD SCI USA, V95, P1387, DOI 10.1073/pnas.95.4.1387; BRINGHURST FR, 1993, ENDOCRINOLOGY, V132, P2090, DOI 10.1210/en.132.5.2090; Bronner F, 2001, ScientificWorldJournal, V1, P919; Brown AJ, 2007, NAT CLIN PRACT ENDOC, V3, P134, DOI 10.1038/ncpendmet0394; Brown EM, 2007, NAT CLIN PRACT ENDOC, V3, P122, DOI 10.1038/ncpendmet0388; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Chattopadhyay N, 1996, ENDOCR REV, V17, P289, DOI 10.1210/er.17.4.289; CHEN TH, 1994, J BONE MINER RES, V9, P293; Daniel C, 2004, BIOCHEM BIOPH RES CO, V324, P1220, DOI 10.1016/j.bbrc.2004.09.191; Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101; Eyers PA, 1998, CHEM BIOL, V5, P321, DOI 10.1016/S1074-5521(98)90170-3; Friedman PA, 1996, ENDOCRINOLOGY, V137, P13, DOI 10.1210/en.137.1.13; Fukagawa M, 2002, NEPHRON, V92, P41, DOI 10.1159/000065376; FUKASE M, 1984, ENDOCRINOLOGY, V114, P1203, DOI 10.1210/endo-114-4-1203; Gao XH, 2002, INT J BIOCHEM CELL B, V34, P921, DOI 10.1016/S1357-2725(01)00165-0; Garfia B, 2002, J AM SOC NEPHROL, V13, P2945, DOI 10.1097/01.ASN.0000037676.54018.CB; HANLEY DA, 1978, J CLIN INVEST, V62, P1247, DOI 10.1172/JCI109245; Healy KD, 2005, P NATL ACAD SCI USA, V102, P4724, DOI 10.1073/pnas.0501312102; Healy KD, 2003, P NATL ACAD SCI USA, V100, P9733, DOI 10.1073/pnas.1633774100; Hendrix I, 2005, J MOL ENDOCRINOL, V34, P237, DOI 10.1677/jme.1.01654; HENRY HL, 1985, ENDOCRINOLOGY, V116, P503, DOI 10.1210/endo-116-2-503; HORIUCHI N, 1977, ENDOCRINOLOGY, V101, P969, DOI 10.1210/endo-101-3-969; Huening M, 2002, MOL ENDOCRINOL, V16, P2052, DOI 10.1210/me.2001-0260; IIDA K, 1995, P NATL ACAD SCI USA, V92, P6112, DOI 10.1073/pnas.92.13.6112; Kifor O, 2001, AM J PHYSIOL-RENAL, V280, pF291, DOI 10.1152/ajprenal.2001.280.2.F291; Kim MS, 2007, MOL CELL ENDOCRINOL, V265, P168, DOI 10.1016/j.mce.2006.12.014; Kim YH, 2003, BIOCHEM BIOPH RES CO, V304, P729, DOI 10.1016/S0006-291X(03)00661-2; Langman CB, 2000, CURR OPIN PEDIATR, V12, P135, DOI 10.1097/00008480-200004000-00009; Locatelli F, 2007, MINI-REV MED CHEM, V7, P591; Mackey SL, 1996, MOL ENDOCRINOL, V10, P298, DOI 10.1210/me.10.3.298; MacLeod RJ, 2003, AM J PHYSIOL-ENDOC M, V284, pE435, DOI 10.1152/ajpendo.00143.2002; MATSUMOTO T, 1987, AM J PHYSIOL, V253, pE503, DOI 10.1152/ajpendo.1987.253.5.E503; Murayama A, 2004, EMBO J, V23, P1598, DOI 10.1038/sj.emboj.7600157; NAVEHMANY T, 1990, J CLIN INVEST, V86, P1313, DOI 10.1172/JCI114840; Nemoto S, 1998, J BIOL CHEM, V273, P16415, DOI 10.1074/jbc.273.26.16415; Omdahl JL, 2002, ANNU REV NUTR, V22, P139, DOI 10.1146/annurev.nutr.22.120501.150216; Qi XM, 2002, J BIOL CHEM, V277, P25884, DOI 10.1074/jbc.M203039200; Rodriguez ME, 2007, AM J PHYSIOL-RENAL, V292, pF1390, DOI 10.1152/ajprenal.00262.2006; ROGERS KV, 1995, ENDOCRINOLOGY, V136, P499, DOI 10.1210/en.136.2.499; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Saito H, 2005, J BIOL CHEM, V280, P2543, DOI 10.1074/jbc.M408903200; Shinki T, 1997, P NATL ACAD SCI USA, V94, P12920, DOI 10.1073/pnas.94.24.12920; Suda T, 1994, Curr Opin Nephrol Hypertens, V3, P59, DOI 10.1097/00041552-199401000-00008; Sugden PH, 1997, CELL SIGNAL, V9, P337, DOI 10.1016/S0898-6568(96)00191-X; Tfelt-Hansen J, 2005, CRIT REV CL LAB SCI, V42, P35, DOI 10.1080/10408360590886606; Tfelt-Hansen J, 2004, ENDOCRINOLOGY, V145, P1211, DOI 10.1210/en.2003-0749; Tourian L, 2004, J CELL SCI, V117, P6459, DOI 10.1242/jcs.01573; TTELHANSEN J, 2003, AM J PHYSIOL-ENDOC M, V285, pE329; WEISINGER JR, 1989, J BONE MINER RES, V4, P929; Yamaguchi T, 2000, BIOCHEM BIOPH RES CO, V279, P363, DOI 10.1006/bbrc.2000.3955; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; Yano S, 2004, CELL CALCIUM, V35, P257, DOI 10.1016/j.ceca.2003.10.008; Ye CP, 2004, J NEUROSCI RES, V75, P491, DOI 10.1002/jnr.10875; Zehnder D, 1999, J AM SOC NEPHROL, V10, P2465	62	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					175	183		10.1074/jbc.M707269200	http://dx.doi.org/10.1074/jbc.M707269200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17974568	hybrid			2022-12-25	WOS:000251940300020
J	Hill, WG; Butterworth, MB; Wang, H; Edinger, RS; Lebowitz, J; Peters, KW; Frizzell, RA; Johnson, JP				Hill, Warren G.; Butterworth, Michael B.; Wang, Huamin; Edinger, Robert S.; Lebowitz, Jonathan; Peters, Kathryn W.; Frizzell, Raymond A.; Johnson, John P.			The epithelial sodium channel (ENaC) traffics to apical membrane in lipid rafts in mouse cortical collecting duct cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; CANINE KIDNEY-CELLS; 1A REGULATES ENAC; PLASMA-MEMBRANE; SYNTAXIN 1A; CHOLESTEROL CONTENT; NA+ TRANSPORT; MICRODOMAINS; CAVEOLIN; LOCALIZATION	We previously showed that ENaC is present in lipid rafts in A6 cells, a Xenopus kidney cell line. We now demonstrate that ENaC can be detected in lipid rafts in mouse cortical collecting duct (MPKCCD14) cells by detergent insolubility, buoyancy on density gradients using two distinct approaches, and colocalization with caveolin 1. Less than 30% of ENaC subunits were found in raft fractions. The channel subunits also colocalized on sucrose gradients with known vesicle targeting and fusion proteins syntaxin 1A, Vamp 2, and SNAP23. Hormonal stimulation of ENaC activity by either forskolin or aldosterone, short or long term, did not alter the lipid raft distribution of ENaC. Methyl-beta-cyclodextrin added apically to MPKCCD14 cells resulted in a slow decline in amiloride-sensitive sodium transport with short circuit current reductions of 38.1 +/- 9.6% after 60 min. The slow decline in ENaC activity in response to apical cyclodextrin was identical to the rate of decline seen when protein synthesis was inhibited by cycloheximide. Apical biotinylation of MPKCCD14 cells confirmed the loss of ENaC at the cell surface following cyclodextrin treatment. Acute stimulation of the recycling pool of ENaC was unaffected by apical cyclodextrin application. Expression of dominant negative caveolin isoforms (CAV1-eGFP and CAV3-DGV) which disrupt caveolae, reduced basal ENaC currents by 72.3 and 78.2%, respectively; but, as with cyclodextrin, the acute response to forskolin was unaffected. We conclude that ENaC is present in and regulated by lipid rafts. The data are consistent with a model in which rafts mediate the constitutive apical delivery of ENaC.	[Hill, Warren G.] Beth Israel Deaconess Med Ctr, Harvard Med Sch, Dept Med, Div Matrix Biol, Boston, MA 02215 USA; [Butterworth, Michael B.; Peters, Kathryn W.; Frizzell, Raymond A.; Johnson, John P.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Wang, Huamin; Edinger, Robert S.; Lebowitz, Jonathan; Johnson, John P.] Univ Pittsburgh, Dept Med, Div Renal & Electrolyte, Lab Epithelial Cell Biol, Pittsburgh, PA 15261 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Johnson, JP (corresponding author), Univ Pittsburgh, Div Renal & Electrolyte, 935 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	Johnson@dom.pitt.edu	Hill, Warren/AAM-1917-2020	Hill, Warren/0000-0002-2772-7264; Butterworth, Michael/0000-0002-2173-8333	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK048217, R01DK054814, R01DK043955, R01DK047874, R01DK048217, R01DK057718] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK43955, DK57718, DK54814, DK48217, DK47874] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bacia K, 2004, BIOPHYS J, V87, P1034, DOI 10.1529/biophysj.104.040519; Balut C, 2006, AM J PHYSIOL-CELL PH, V290, pC87, DOI 10.1152/ajpcell.00184.2005; Butterworth MB, 2005, AM J PHYSIOL-RENAL, V289, pF969, DOI 10.1152/ajprenal.00390.2003; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Butterworth MB, 2001, AM J PHYSIOL-CELL PH, V280, pC752, DOI 10.1152/ajpcell.2001.280.4.C752; Chamberlain LH, 2002, J BIOL CHEM, V277, P49750, DOI 10.1074/jbc.M206936200; Condliffe SB, 2004, J BIOL CHEM, V279, P10085, DOI 10.1074/jbc.M313592200; Condliffe SB, 2003, J BIOL CHEM, V278, P12796, DOI 10.1074/jbc.M210772200; CORNELIUS F, 1995, BBA-BIOMEMBRANES, V1235, P205, DOI 10.1016/0005-2736(95)80006-2; Cornelius F, 2001, BIOCHEMISTRY-US, V40, P8842, DOI 10.1021/bi010541g; Edinger RS, 2006, J BIOL CHEM, V281, P9110, DOI 10.1074/jbc.M509232200; Frindt G, 2007, AM J PHYSIOL-RENAL, V292, pF1190, DOI 10.1152/ajprenal.00399.2006; Hansen GH, 2000, J BIOL CHEM, V275, P5136, DOI 10.1074/jbc.275.7.5136; Hanwell D, 2002, J BIOL CHEM, V277, P9772, DOI 10.1074/jbc.M110904200; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Hill WG, 2005, AM J PHYSIOL-CELL PH, V289, pC33, DOI 10.1152/ajpcell.00046.2005; Hill WG, 2002, J BIOL CHEM, V277, P33541, DOI 10.1074/jbc.C200309200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Ishikawa Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1303, DOI 10.1152/ajpcell.00211.2005; Kowalski MP, 2004, J IMMUNOL, V172, P418, DOI 10.4049/jimmunol.172.1.418; Lafont F, 1999, P NATL ACAD SCI USA, V96, P3734, DOI 10.1073/pnas.96.7.3734; Laude AJ, 2004, MOL MEMBR BIOL, V21, P193, DOI 10.1080/09687680410001700517; Li XH, 2001, J PHYSIOL-LONDON, V537, P537, DOI 10.1111/j.1469-7793.2001.00537.x; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Martens JR, 2004, TRENDS PHARMACOL SCI, V25, P16, DOI 10.1016/j.tips.2003.11.007; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Pearce D, 2003, CELL PHYSIOL BIOCHEM, V13, P13, DOI 10.1159/000070245; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pol A, 2001, J CELL BIOL, V152, P1057, DOI 10.1083/jcb.152.5.1057; Pottosin II, 2007, PFLUG ARCH EUR J PHY, V454, P235, DOI 10.1007/s00424-007-0208-4; Prince LS, 1999, AM J PHYSIOL-CELL PH, V276, pC1346, DOI 10.1152/ajpcell.1999.276.6.C1346; Qi JJ, 1999, J BIOL CHEM, V274, P30345, DOI 10.1074/jbc.274.43.30345; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; Ros-Baro A, 2001, P NATL ACAD SCI USA, V98, P12050, DOI 10.1073/pnas.211341698; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; Salaun C, 2004, TRAFFIC, V5, P255, DOI 10.1111/j.1600-0854.2004.0162.x; Saxena SK, 2006, BIOCHEM BIOPH RES CO, V343, P1279, DOI 10.1016/j.bbrc.2006.03.093; Shibata Erwin F, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS34, DOI 10.1111/j.1540-8167.2006.00387.x; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; Shlyonsky VG, 2003, AM J PHYSIOL-RENAL, V284, pF182, DOI 10.1152/ajprenal.00216.2002; Slimane TA, 2003, MOL BIOL CELL, V14, P611, DOI 10.1091/mbc.E02-08-0528; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Tillman TS, 2003, CELL BIOCHEM BIOPHYS, V38, P161, DOI 10.1385/CBB:38:2:161; Toselli M, 2005, BIOPHYS J, V89, P2443, DOI 10.1529/biophysj.105.065623; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; Watson RT, 2001, J CELL BIOL, V154, P829, DOI 10.1083/jcb.200102078; West TA, 2005, CELL PHYSIOL BIOCHEM, V16, P263, DOI 10.1159/000089852; Yang N, 2004, J BIOL CHEM, V279, P20898, DOI 10.1074/jbc.M400625200; Yarbrough TL, 2002, CIRC RES, V90, P443, DOI 10.1161/hh0402.105177; YEAGLE PL, 1988, BIOCHEMISTRY-US, V27, P6449, DOI 10.1021/bi00417a037; Zheng XJ, 2003, J INVEST DERMATOL, V121, P1487, DOI 10.1111/j.1523-1747.2003.12614.x	56	49	51	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37402	37411		10.1074/jbc.M704084200	http://dx.doi.org/10.1074/jbc.M704084200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17932048	hybrid			2022-12-25	WOS:000251833600014
J	Kato, S; Yoshida, M; Kato-Yamada, Y				Kato, Shigeyuki; Yoshida, Masasuke; Kato-Yamada, Yasuyuki			Role of the epsilon subunit of thermophilic F-1-ATPase as a sensor for ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; POLYMERASE CHAIN-REACTION; ESCHERICHIA-COLI; ALPHA(3)BETA(3)GAMMA COMPLEX; ENDOGENOUS INHIBITOR; GENERAL-METHOD; BINDS ATP; SYNTHASE; GAMMA; F1-ATPASE	The epsilon subunit of F-1-ATPase from the thermophilic Bacillus PS3 (TF1) has been shown to bind ATP. The precise nature of the regulatory role of ATP binding to the epsilon subunit remains to be determined. To address this question, 11 mutants of the epsilon subunit were prepared, in which one of the basic or acidic residues was substituted with alanine. ATP binding to these mutants was tested by gel- filtration chromatography. Among them, four mutants that showed no ATP binding were selected and reconstituted with the alpha(3) beta(3) gamma complex of TF1. The ATPase activity of the resulting alpha(3)beta(3)gamma epsilon complexes was measured, and the extent of inhibition by the mutant epsilon subunits was compared in each case. With one exception, weaker binding of ATP correlated with greater inhibition of ATPase activity. These results clearly indicate that ATP binding to the epsilon subunit plays a regulatory role and that ATP binding may stabilize the ATPase- active form of TF1 by fixing the epsilon subunit into the folded conformation.	[Kato, Shigeyuki; Kato-Yamada, Yasuyuki] St Paul Univ, Coll Sci, Dept Life Sci, Tokyo 1718501, Japan; [Kato-Yamada, Yasuyuki] St Paul Univ, Coll Sci, Dept Frontier Project Adaptat & Evolut Extremophi, Tokyo 1718501, Japan; [Yoshida, Masasuke] Tokyo Inst Technol, Chem Resource Lab, Yokohama, Kanagawa 2268503, Japan	Rikkyo University; Rikkyo University; Tokyo Institute of Technology	Kato, S (corresponding author), St Paul Univ, Coll Sci, Dept Life Sci, 3-34-1 Nishi Ikebukuro, Tokyo 1718501, Japan.	katoyama@rikkyo.ac.jp						Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Hara KY, 2001, J BIOL CHEM, V276, P23969, DOI 10.1074/jbc.M009303200; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hisabori T, 1997, EUR J BIOCHEM, V247, P1158, DOI 10.1111/j.1432-1033.1997.01158.x; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Iino R, 2005, J BIOL CHEM, V280, P40130, DOI 10.1074/jbc.M506160200; Iizuka S, 2006, BIOCHEM BIOPH RES CO, V349, P1368, DOI 10.1016/j.bbrc.2006.09.001; Kato Y, 1997, J BIOL CHEM, V272, P24906, DOI 10.1074/jbc.272.40.24906; Kato-Yamada Y, 1999, J BIOL CHEM, V274, P33991, DOI 10.1074/jbc.274.48.33991; Kato-Yamada Y, 2005, FEBS LETT, V579, P6875, DOI 10.1016/j.febslet.2005.11.036; Kato-Yamada Y, 2003, J BIOL CHEM, V278, P36013, DOI 10.1074/jbc.M306140200; Kato-Yamada Y, 2000, J BIOL CHEM, V275, P35746, DOI 10.1074/jbc.M006575200; Kinosita K Jr, 2000, Essays Biochem, V35, P3; LAGET PP, 1979, ARCH BIOCHEM BIOPHYS, V197, P83, DOI 10.1016/0003-9861(79)90222-4; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; MATSUI T, 1995, BBA-BIOENERGETICS, V1231, P139, DOI 10.1016/0005-2728(95)00070-Y; Matsui T, 1997, J BIOL CHEM, V272, P8215, DOI 10.1074/jbc.272.13.8215; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Ono S, 2003, BBA-BIOENERGETICS, V1607, P35, DOI 10.1016/j.bbabio.2003.08.006; ORT DR, 1992, ANNU REV PLANT PHYS, V43, P269, DOI 10.1146/annurev.pp.43.060192.001413; RICHTER ML, 1987, J BIOL CHEM, V262, P15037; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; SMITH JB, 1975, J SUPRAMOL STR CELL, V3, P248, DOI 10.1002/jss.400030307; Stiggall D L, 1979, Methods Enzymol, V55, P308; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Watanabe YH, 2002, J BIOL CHEM, V277, P5804, DOI 10.1074/jbc.M109349200; Yagi H, 2007, P NATL ACAD SCI USA, V104, P11233, DOI 10.1073/pnas.0701045104; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	35	35	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37618	37623		10.1074/jbc.M707509200	http://dx.doi.org/10.1074/jbc.M707509200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17933866	hybrid			2022-12-25	WOS:000251833600037
J	Poltermann, S; Kunert, A; von der Heide, M; Eck, R; Hartmann, A; Zipfel, PF				Poltermann, Sophia; Kunert, Anja; von der Heide, Monika; Eck, Raimund; Hartmann, Andrea; Zipfel, Peter F.			Gpm1p is a factor H-, FHL-1-, and plasminogen-binding surface protein of Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL; COMPLEMENT ACTIVATION; BORRELIA-BURGDORFERI; VIRULENCE FACTORS; SERUM RESISTANCE; IMMUNE EVASION; IDENTIFICATION; MORPHOGENESIS; CONSTRUCTION; ACQUISITION	The human pathogenic yeast Candida albicans utilizes host complement regulators for immune evasion. Here we identify the first fungal protein that binds Factor H and FHL-1. By screening a protein array of 4088 proteins of Saccharomyces cerevisiae, phosphoglycerate mutase (ScGpm1p) was identified as a Factor H-and FHL-1-binding protein. The homologous C. albicans Gpm1p (CaGpm1p) was cloned and recombinantly expressed as a 36-kDa His-tagged protein. Purified CaGpm1p binds the host complement regulators Factor H and FHL-1, but not C4BP. The CaGpm1p binding regions in the host proteins were localized; FHL-1 binds via short consensus repeats (SCRs) 6 and 7, and Factor H utilizes two contact regions that are located in SCRs 6 and 7 and in SCRs 19 and 20. In addition, recombinant CaGpm1p binds plasminogen via lysine residues. CaGpm1p is a surface protein as demonstrated by immunostaining and flow cytometry. A C. albicans gpm1(-/)-mutant strain was generated that did not grow on glucose-supplemented but on ethanol-and glycerol-supplemented medium. Reduced binding of Factor H and plasminogen to the null mutant strain is in agreement with the presence of additional binding proteins. Attached to CaGpm1p, each of the three host plasma proteins is functionally active. Factor H and FHL-1 show cofactor activity for cleavage of C3b, and bound plasminogen is converted by urokinase-type plasminogen activator to proteolytically active plasmin. Thus, the surface-expressed CaGpm1p is a virulence factor that utilizes the host Factor H, FHL-1, and plasminogen for immune evasion and degradation of extracellular matrices.	[Poltermann, Sophia; Kunert, Anja; von der Heide, Monika; Eck, Raimund; Hartmann, Andrea; Zipfel, Peter F.] Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, D-07745 Jena, Germany; [Zipfel, Peter F.] Univ Jena, D-07743 Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Zipfel, PF (corresponding author), Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Beutenbergstr 11a, D-07745 Jena, Germany.	peter.zipfel@hki-jena.de						Alitalo A, 2001, INFECT IMMUN, V69, P3685, DOI 10.1128/IAI.69.6.3685-3691.2001; BECKSAGUE C, 1993, AM J PUBLIC HEALTH, V83, P1739, DOI 10.2105/AJPH.83.12.1739; Bergmann S, 2005, THROMB HAEMOSTASIS, V94, P304, DOI 10.1160/TH05-05-0369; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Crowe JD, 2003, MOL MICROBIOL, V47, P1637, DOI 10.1046/j.1365-2958.2003.03390.x; Diaz A, 1997, J IMMUNOL, V158, P3779; EDWARDS JE, 1991, NEW ENGL J MED, V324, P1060, DOI 10.1056/NEJM199104113241511; Fernandez-Arenas E, 2004, PROTEOMICS, V4, P3007, DOI 10.1002/pmic.200400929; FISHERHOCH SP, 1995, CLIN INFECT DIS, V21, P897, DOI 10.1093/clinids/21.4.897; FONZI WA, 1993, GENETICS, V134, P717; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Johnsson E, 1998, J IMMUNOL, V161, P4894; Kotarsky H, 1998, J IMMUNOL, V160, P3349; Kozel TR, 1996, INFECT IMMUN, V64, P3360, DOI 10.1128/IAI.64.8.3360-3368.1996; Kraiczy P, 2006, MOL IMMUNOL, V43, P31, DOI 10.1016/j.molimm.2005.06.016; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; KUHN S, 1995, GENE, V162, P225, DOI 10.1016/0378-1119(95)00360-I; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Meri T, 2004, INFECT IMMUN, V72, P6633, DOI 10.1128/IAI.72.11.6633-6641.2004; Meri T, 2002, INFECT IMMUN, V70, P5185, DOI 10.1128/IAI.70.9.5185-5192.2002; Motshwene P, 2003, BIOCHEM J, V369, P357, DOI 10.1042/BJ20021352; Neeleman C, 1999, INFECT IMMUN, V67, P4517, DOI 10.1128/IAI.67.9.4517-4524.1999; Nombela C, 2006, TRENDS MICROBIOL, V14, P15, DOI 10.1016/j.tim.2005.11.009; Oppermann M, 2006, CLIN EXP IMMUNOL, V144, P342, DOI 10.1111/j.1365-2249.2006.03071.x; Pardo M, 2000, ELECTROPHORESIS, V21, P2651, DOI 10.1002/1522-2683(20000701)21:13&lt;2651::AID-ELPS2651&gt;3.0.CO;2-3; Pardo M, 2000, ELECTROPHORESIS, V21, P3396, DOI 10.1002/1522-2683(20001001)21:16<3396::AID-ELPS3396>3.0.CO;2-J; PFALLER M, 1992, EUR J CLIN MICROBIOL, V11, P287, DOI 10.1007/BF01962067; Pitarch A, 2002, MOL CELL PROTEOMICS, V1, P967, DOI 10.1074/mcp.M200062-MCP200; Ram S, 1998, J EXP MED, V188, P671, DOI 10.1084/jem.188.4.671; Ram S, 1999, MOL IMMUNOL, V36, P915, DOI 10.1016/S0161-5890(99)00114-5; RODICIO R, 1987, MOL GEN GENET, V206, P133, DOI 10.1007/BF00326548; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Rooney PJ, 2002, CELL MICROBIOL, V4, P127, DOI 10.1046/j.1462-5822.2002.00179.x; Schaller M, 2005, MYCOSES, V48, P365, DOI 10.1111/j.1439-0507.2005.01165.x; Stoiber H, 1997, ANNU REV IMMUNOL, V15, P649, DOI 10.1146/annurev.immunol.15.1.649; SWOBODA RK, 1994, MOL MICROBIOL, V13, P663, DOI 10.1111/j.1365-2958.1994.tb00460.x; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Zhang MX, 1998, INFECT IMMUN, V66, P4845, DOI 10.1128/IAI.66.10.4845-4850.1998; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971	40	101	102	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37537	37544		10.1074/jbc.M707280200	http://dx.doi.org/10.1074/jbc.M707280200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17959597	hybrid			2022-12-25	WOS:000251833600029
J	Goto, Y; Hattori, A; Mizutani, S; Tsujimoto, M				Goto, Yoshikuni; Hattori, Akira; Mizutani, Shigehiko; Tsujimoto, Masafumi			Asparatic acid 221 is critical in the calcium-induced modulation of the enzymatic activity of human aminopeptidase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUROMYCIN-SENSITIVE AMINOPEPTIDASE; C-TERMINAL DOMAIN; MOLECULAR-CLONING; CDNA CLONING; EXOPEPTIDASE SPECIFICITY; METALLOPEPTIDASE FAMILY; OXYTOCINASE SUBFAMILY; CATALYTIC-ACTIVITY; GENOMIC STRUCTURE; ANGIOTENSIN-IV	Aminopeptidase A (APA) plays an important role in the regulation of blood pressure by mediating angiotensin II degradation in the renin-angiotensin system. The Ca2+-induced modulation of enzymatic activity is the most characteristic feature of APA among the M1 family of aminopeptidases. In this study, we used site-directed mutagenesis for any residues responsible for the Ca2+ modulation of human APA. Alignment of sequences of the M1 family members led to the identification of Asp-221 as a significant residue of APA among the family members. Replacement of Asp-221 with Asn or Gln resulted in a loss of Ca2+ responsiveness toward synthetic substrates. These enzymes were also unresponsive to Ca2+ when peptide hormones, such as angiotensin II, cholecystokinin-8, neurokinin B, and kallidin, were employed as substrates. These results suggest that the negative charge of Asp-221 is essential for Ca2+ modulation of the enzymatic activity of APA and causes preferential cleavage of acidic amino acid at the N-terminal end of substrate peptides.	[Goto, Yoshikuni; Hattori, Akira; Tsujimoto, Masafumi] RIKEN, Lab Cellular Biochem, Wako, Saitama 3510198, Japan; [Mizutani, Shigehiko] Nagoya Univ, Sch Med, Dept Med Sci Proteases, Nagoya, Aichi 4668550, Japan	RIKEN; Nagoya University	Tsujimoto, M (corresponding author), RIKEN, Lab Cellular Biochem, Wako, Saitama 3510198, Japan.	tsujimot@riken.jp						Albiston AL, 2001, J BIOL CHEM, V276, P48623, DOI 10.1074/jbc.C100512200; CONSTAM DB, 1995, J BIOL CHEM, V270, P26931, DOI 10.1074/jbc.270.45.26931; DANIELSEN EM, 1980, BIOCHEM J, V189, P591, DOI 10.1042/bj1890591; Diaz-Perales A, 2005, J BIOL CHEM, V280, P14310, DOI 10.1074/jbc.M413222200; Fujiwara H, 2004, BIOCHEM BIOPH RES CO, V313, P962, DOI 10.1016/j.bbrc.2003.12.024; FUNK CD, 1987, P NATL ACAD SCI USA, V84, P667; Goto Y, 2006, FEBS LETT, V580, P1833, DOI 10.1016/j.febslet.2006.02.041; Goto Y, 2006, J BIOL CHEM, V281, P23503, DOI 10.1074/jbc.M603191200; Hattori A, 1999, J BIOCHEM-TOKYO, V125, P931, DOI 10.1093/oxfordjournals.jbchem.a022371; Hesp JR, 1997, BIOCHEMISTRY-US, V36, P3000, DOI 10.1021/bi962401q; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; Huber G, 1999, J NEUROCHEM, V72, P1215, DOI 10.1046/j.1471-4159.1999.0721215.x; Iturrioz X, 2000, BIOCHEMISTRY-US, V39, P3061, DOI 10.1021/bi9925726; Iturrioz X, 2001, BIOCHEMISTRY-US, V40, P14440, DOI 10.1021/bi011409j; Kyrieleis OJP, 2005, J MOL BIOL, V349, P787, DOI 10.1016/j.jmb.2005.03.070; LI L, 1993, GENOMICS, V17, P657, DOI 10.1006/geno.1993.1386; Maruyama M, 2007, J BIOL CHEM, V282, P20088, DOI 10.1074/jbc.M702650200; Migaud M, 1996, PEPTIDES, V17, P601, DOI 10.1016/0196-9781(96)00036-8; NANUS DM, 1993, P NATL ACAD SCI USA, V90, P7069, DOI 10.1073/pnas.90.15.7069; Ofner LD, 2002, BIOCHEM J, V362, P191, DOI 10.1042/0264-6021:3620191; OLSEN J, 1988, FEBS LETT, V238, P307, DOI 10.1016/0014-5793(88)80502-7; Osada T, 2001, MOL ENDOCRINOL, V15, P960, DOI 10.1210/me.15.6.960; Osada T, 2001, MOL ENDOCRINOL, V15, P882, DOI 10.1210/me.15.6.882; Piesse C, 2002, GENE, V292, P129, DOI 10.1016/S0378-1119(02)00650-9; Reaux A, 1999, P NATL ACAD SCI USA, V96, P13415, DOI 10.1073/pnas.96.23.13415; Rogi T, 1996, J BIOL CHEM, V271, P56, DOI 10.1074/jbc.271.1.56; Rozenfeld R, 2004, J BIOL CHEM, V279, P43285, DOI 10.1074/jbc.M404369200; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Sato Y, 2004, BIOL PHARM BULL, V27, P772, DOI 10.1248/bpb.27.772; Schomburg L, 1999, EUR J BIOCHEM, V265, P415, DOI 10.1046/j.1432-1327.1999.00753.x; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; SHIPP MA, 1993, BLOOD, V82, P1052, DOI 10.1182/blood.V82.4.1052.bloodjournal8241052; Tanioka T, 2003, J BIOL CHEM, V278, P32275, DOI 10.1074/jbc.M305076200; TAYLOR A, 1993, FASEB J, V7, P290, DOI 10.1096/fasebj.7.2.8440407; Thunnissen MMGM, 2001, NAT STRUCT BIOL, V8, P131, DOI 10.1038/84117; Tsujimoto M, 2005, BBA-PROTEINS PROTEOM, V1751, P9, DOI 10.1016/j.bbapap.2004.09.011; Vazeux G, 1996, J BIOL CHEM, V271, P9069, DOI 10.1074/jbc.271.15.9069; Vazeux G, 1998, BIOCHEM J, V334, P407, DOI 10.1042/bj3340407; Vazeux G, 1997, BIOCHEM J, V327, P883, DOI 10.1042/bj3270883; WANG J, 1998, HDB PROTEOLYTIC ENZY, P1002; WANG JY, 1993, P NATL ACAD SCI USA, V90, P1222, DOI 10.1073/pnas.90.4.1222; WRIGHT JW, 1990, J HYPERTENS, V8, P969, DOI 10.1097/00004872-199010000-00013; WU Q, 1990, P NATL ACAD SCI USA, V87, P993, DOI 10.1073/pnas.87.3.993	43	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37074	37081		10.1074/jbc.M707251200	http://dx.doi.org/10.1074/jbc.M707251200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17932029	hybrid			2022-12-25	WOS:000251646000034
J	Koski, MK; Hieta, R; Bollner, C; Kivirikko, KI; Myllyharju, J; Wierenga, RK				Koski, M. Kristian; Hieta, Reija; Bollner, Claudia; Kivirikko, Kari I.; Myllyharju, Johanna; Wierenga, Rik K.			The active site of an algal prolyl 4-hydroxylase has a large structural plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING DOMAIN; CRYSTAL-STRUCTURE; PROTEIN; HYDROXYLASE; FAMILY; HIF; IDENTIFICATION; DIOXYGENASES; INHIBITION; REVEALS	Prolyl 4-hydroxylases (P4Hs) are 2-oxoglutarate dioxygenases that catalyze the hydroxylation of peptidyl prolines. They play an important role in collagen synthesis, oxygen homeostasis, and plant cell wall formation. We describe four structures of a P4H from the green alga Chlamydomonas reinhardtii, two of the apoenzyme at 1.93 and 2.90 angstrom resolution, one complexed with the competitive inhibitor Zn2+, and one with Zn2+ and pyridine 2,4-dicarboxylate (which is an analogue of 2-oxoglutarate) at 1.85 angstrom resolution. The structures reveal the double-stranded beta-helix core fold (jellyroll motif), typical for 2-oxoglutarate dioxygenases. The catalytic site is at the center of an extended shallow groove lined by two flexible loops. Mutagenesis studies together with the crystal-lographic data indicate that this groove participates in the binding of the proline-rich peptide-substrates. It is discussed that the algal P4H and the catalytic domain of collagen P4Hs have notable structural similarities, suggesting that these enzymes form a separate structural subgroup of P4Hs different from the hypoxia-inducible factor P4Hs. Key structural differences between these two subgroups are described. These studies provide first insight into the structure-function relationships of the collagen P4Hs, which unlike the hypoxia-inducible factor P4Hs use proline-rich peptides as their substrates.	[Koski, M. Kristian; Hieta, Reija; Bollner, Claudia; Kivirikko, Kari I.; Myllyharju, Johanna; Wierenga, Rik K.] Univ Oulu, Bioctr Oulu, Collagen Res Unit, FIN-90014 Oulu, Finland; [Koski, M. Kristian; Wierenga, Rik K.] Univ Oulu, Dept Biochem, FIN-90014 Oulu, Finland; [Hieta, Reija; Bollner, Claudia; Kivirikko, Kari I.; Myllyharju, Johanna] Univ Oulu, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland	University of Oulu; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu	Wierenga, RK (corresponding author), Univ Oulu, Bioctr Oulu, Collagen Res Unit, POB 3000, FIN-90014 Oulu, Finland.	rik.wierenga@oulu.fi		Hieta, Reija/0000-0001-5724-6253				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Choi KO, 2005, MOL PHARMACOL, V68, P1803, DOI 10.1124/mol.105.015271; Clifton IJ, 2003, J BIOL CHEM, V278, P20843, DOI 10.1074/jbc.M213054200; Clifton IJ, 2001, EUR J BIOCHEM, V268, P6625, DOI 10.1046/j.0014-2956.2001.02617.x; CLITTON IJ, 2006, J INORG BIOCHEM, V100, P644; Dann CE, 2002, P NATL ACAD SCI USA, V99, P15351, DOI 10.1073/pnas.202614999; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Eriksson M, 1999, J BIOL CHEM, V274, P22131, DOI 10.1074/jbc.274.32.22131; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hieta R, 2003, J BIOL CHEM, V278, P34966, DOI 10.1074/jbc.M303624200; Hieta R, 2002, J BIOL CHEM, V277, P23965, DOI 10.1074/jbc.M201865200; Hirsila M, 2005, FASEB J, V19, P1308, DOI 10.1096/fj.04-3399fje; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaelin WG, 2005, BIOCHEM BIOPH RES CO, V338, P627, DOI 10.1016/j.bbrc.2005.08.165; Keskiaho K, 2007, PLANT CELL, V19, P256, DOI 10.1105/tpc.106.042739; Kivirikko K. I., 1992, POSTTRANSLATIONAL MO, P1; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Kukkola L, 2003, J BIOL CHEM, V278, P47685, DOI 10.1074/jbc.M306806200; Lee C, 2003, J BIOL CHEM, V278, P7558, DOI 10.1074/jbc.M210385200; Lloyd MD, 1999, J MOL BIOL, V287, P943, DOI 10.1006/jmbi.1999.2594; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myllyharju J, 1999, EMBO J, V18, P306, DOI 10.1093/emboj/18.2.306; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 1997, EMBO J, V16, P1173, DOI 10.1093/emboj/16.6.1173; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Pekkala M, 2004, J BIOL CHEM, V279, P52255, DOI 10.1074/jbc.M410007200; Ratcliffe PJ, 2006, CLIN MED, V6, P573, DOI 10.7861/clinmedicine.6-6-573; Taylor MS, 2001, GENE, V275, P125, DOI 10.1016/S0378-1119(01)00633-3; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Tiainen P, 2005, J BIOL CHEM, V280, P1142, DOI 10.1074/jbc.M411109200; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561; Yuasa K, 2005, PLANT J, V41, P81, DOI 10.1111/j.1365-313X.2004.02279.x; Zhang ZH, 2002, FEBS LETT, V517, P7, DOI 10.1016/S0014-5793(02)02520-6; Zhang ZH, 2000, NAT STRUCT BIOL, V7, P127	48	48	49	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37112	37123		10.1074/jbc.M706554200	http://dx.doi.org/10.1074/jbc.M706554200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17940281	hybrid			2022-12-25	WOS:000251646000038
J	Kumasaka, T; Yamamoto, M; Furuichi, M; Nakasako, M; Teh, AH; Kimura, M; Yamaguchi, I; Ueki, T				Kumasaka, Takashi; Yamamoto, Masaki; Furuichi, Makio; Nakasako, Masayoshi; Teh, Aik-Hong; Kimura, Makoto; Yamaguchi, Isamu; Ueki, Tatzuo			Crystal structures of blasticidin S deaminase (BSD) - Implications for dynamic properties of catalytic zinc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTIDINE DEAMINASE; ASPERGILLUS-TERREUS; TRICHROMATIC CONCEPT; BINDING; ENZYME; PURIFICATION; GENE	The set of blasticidin S (BS) and blasticidin S deaminase (BSD) is a widely used selectable marker for gene transfer experiments. BSD is a member of the cytidine deaminase (CDA) family; it is a zinc-dependent enzyme with three cysteines and one water molecule as zinc ligands. The crystal structures of BSD were determined in six states (i.e. native, substrate-bound, product-bound, cacodylate-bound, substrate-bound E56Q mutant, and R90K mutant). In the structures, the zinc position and coordination structures vary. The substrate-bound structure shows a large positional and geometrical shift of zinc with a double-headed electron density of the substrate that seems to be assigned to the amino and hydroxyl groups of the substrate and product, respectively. In this intermediate-like structure, the steric hindrance of the hydroxyl group pushes the zinc into the triangular plane consisting of three cysteines with a positional shift of similar to 0.6 A, and the fifth ligand water approaches the opposite direction of the substrate with a shift of 0.4 angstrom. Accordingly, the zinc coordination is changed from tetrahedral to trigonal bipyramidal, and its coordination distance is extended between zinc and its intermediate. The shift of zinc and the recruited water is also observed in the structure of the inactivated E56Q mutant. This novel observation is different in two-cysteine cytidine deaminase Escherichia coli CDA and might be essential for the reaction mechanism in BSD, since it is useful for the easy release of the product by charge compensation and for the structural change of the substrate.	[Kumasaka, Takashi; Teh, Aik-Hong; Ueki, Tatzuo] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Kumasaka, Takashi; Teh, Aik-Hong; Kimura, Makoto; Yamaguchi, Isamu] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Life Sci, Kanagawa 2268501, Japan; [Kumasaka, Takashi; Yamamoto, Masaki; Furuichi, Makio] RIKEN SPring8 Ctr, Sayo, Hyogo 6795148, Japan; [Nakasako, Masayoshi] Keio Univ, Fac Sci & Technol, Dept Phys, Kanagawa 2238522, Japan; [Kimura, Makoto; Yamaguchi, Isamu] RIKEN Wako Inst, Wako, Saitama 3510198, Japan	Japan Synchrotron Radiation Research Institute; Tokyo Institute of Technology; RIKEN; Keio University; RIKEN	Kumasaka, T (corresponding author), Japan Synchrotron Radiat Res Inst, SPring 8, Sayo, Hyogo 6795198, Japan.	kumasaka@spring8.or.jp	Teh, Aik Hong/D-3075-2013; Nakasako, Masayoshi/C-5673-2014; Yamamoto, Masaki/B-7844-2015; Kumasaka, Takashi/D-7428-2018; Kimura, Makoto/I-6906-2014	Teh, Aik Hong/0000-0001-6365-574X; Yamamoto, Masaki/0000-0002-1311-1768; Kumasaka, Takashi/0000-0001-9289-1557; Kimura, Makoto/0000-0001-5310-2893				Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARLOW DC, 1999, BIOCHEMISTRY-US, V38, P1335; CHAKRABARTI P, 1989, BIOCHEMISTRY-US, V28, P6081, DOI 10.1021/bi00440a052; Christianson DW, 1999, ANNU REV BIOCHEM, V68, P33, DOI 10.1146/annurev.biochem.68.1.33; Chung SJ, 2005, J MED CHEM, V48, P658, DOI 10.1021/jm0496279; Coleman JE, 1998, CURR OPIN CHEM BIOL, V2, P222, DOI 10.1016/S1367-5931(98)80064-1; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Fabris D, 1999, INORG CHEM, V38, P1322, DOI 10.1021/ic9809963; Hansen JL, 2003, J MOL BIOL, V330, P1061, DOI 10.1016/S0022-2836(03)00668-5; Johansson E, 2002, BIOCHEMISTRY-US, V41, P2563, DOI 10.1021/bi011849a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kimura M, 2000, J BIOCHEM, V127, P955, DOI 10.1093/oxfordjournals.jbchem.a022711; KIMURA M, 1994, BBA-GENE STRUCT EXPR, V1219, P653, DOI 10.1016/0167-4781(94)90224-0; Kimura M, 2002, BIOCHEM BIOPH RES CO, V290, P421, DOI 10.1006/bbrc.2001.6184; KIMURA M, 1994, MOL GEN GENET, V242, P121, DOI 10.1007/BF00391004; Kleifeld O, 2003, NAT STRUCT BIOL, V10, P98, DOI 10.1038/nsb889; Korkhin Y, 1998, J MOL BIOL, V278, P967, DOI 10.1006/jmbi.1998.1750; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kumasaka T, 2002, STRUCTURE, V10, P1205, DOI 10.1016/S0969-2126(02)00830-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; MERRIT EA, 1991, ACTA CRYSTALLOGR D, V50, P869; MULLER WEG, 1979, CANCER RES, V39, P1102; Nakasako M, 1999, ACTA CRYSTALLOGR D, V55, P547, DOI 10.1107/S0907444998011809; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; REIZER J, 1994, PROTEIN SCI, V3, P853; Sanghani PC, 2002, BIOCHEMISTRY-US, V41, P15189, DOI 10.1021/bi026705q; Shih P, 1996, BIOCHEMISTRY-US, V35, P4697, DOI 10.1021/bi952357z; Snider MJ, 2000, BIOCHEMISTRY-US, V39, P9746, DOI 10.1021/bi000914y; STEUART CD, 1971, NATURE-NEW BIOL, V233, P109, DOI 10.1038/newbio233109a0; STEWART JJP, 1990, J COMPUT AID MOL DES, V4, P1, DOI 10.1007/BF00128336; TAKEUCHI S, 1958, J ANTIBIOT, V11, P1; Teh AH, 2006, BIOCHEMISTRY-US, V45, P7825, DOI 10.1021/bi060345f; WILSON DK, 1994, NAT STRUCT BIOL, V1, P691, DOI 10.1038/nsb1094-691; Xiang SB, 1996, BIOCHEMISTRY-US, V35, P1335, DOI 10.1021/bi9525583; Xiang SB, 1997, BIOCHEMISTRY-US, V36, P4768, DOI 10.1021/bi963091e; Xie KF, 2004, P NATL ACAD SCI USA, V101, P8114, DOI 10.1073/pnas.0400493101; YAMAGUCHI I, 1986, PESTIC BIOCHEM PHYS, V25, P54, DOI 10.1016/0048-3575(86)90031-3; YAMAGUCHI I, 1975, J ANTIBIOT, V28, P7, DOI 10.7164/antibiotics.28.7; Yamamoto M, 1998, J SYNCHROTRON RADIAT, V5, P222, DOI 10.1107/S0909049597014738; Yoshida H., 1997, J CHEM SOFTWARE, V3, P147	46	15	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37103	37111		10.1074/jbc.M704476200	http://dx.doi.org/10.1074/jbc.M704476200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17959604	hybrid			2022-12-25	WOS:000251646000037
J	Seki, A; Hanaoka, M; Akimoto, Y; Masuda, S; Iwasaki, H; Tanaka, K				Seki, Asako; Hanaoka, Mitsumasa; Akimoto, Yuki; Masuda, Susumu; Iwasaki, Hideo; Tanaka, Kan			Induction of a group 2 sigma factor, RPOD3, by high light and the underlying mechanism in Synechococcus elongatus PCC 7942	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; STRAIN PCC 7002; RNA-POLYMERASE; POSITIVE REGULATION; ESCHERICHIA-COLI; GENES; EXPRESSION; IDENTIFICATION; CYANOBACTERIA; TRANSCRIPTION	Among the sigma(70) family bacterial sigma factors, group 2 sigma factors have similar promoter recognition specificity to group 1 (principal) sigma factors and express and function under specific environmental and physiological conditions. In general, the cyanobacterial genome encodes more than four group 2 sigma factors, and the unicellular Synechococcus elongatus PCC 7942 (Synechococcus) has five group 2 sigma factors (RpoD2 - 6). In this study, we analyzed expression of group 2 sigma factors of Synechococcus at both mRNA and protein levels, and we showed that the rpoD3 expression was activated only by high light (1,500 mu mol photons m(-2) s(-1)) among the various stress conditions examined. After high light shift, rpoD3 mRNA accumulated transiently within the first 5 min and diminished subsequently, whereas RpoD3 protein increased gradually during the first several hours. We also found that the rpoD3 deletion mutant rapidly lost viability under the same conditions. Analysis of the rpoD3 promoter structure revealed the presence of an HLR1 (high light-responsive element 1) sequence, which was suggested to be responsible for the high light-induced transcription under the control of the Nb1S (histidine kinase)-RpaB ( response regulator) two-component system (Kappell, A. D., and van Waasbergen, L. G. (2007) Arch. Microbiol. 187, 337 - 342), at +6 to +23 with respect to the transcriptional start site. Here we demonstrated that recombinant RpaB protein specifically bound to HLR1 of the rpoD3 and hliA genes in vitro, and overexpression of a truncated RpaB variant harboring only the phosphoreceiver domain derepressed the transcription in vivo. Thus, we have concluded that phosphorylated RpaB are repressing the rpoD3 and hliA transcription under normal growth conditions, and the RpaB dephosphorylation induced by high light stress results in transcriptional derepression.	[Seki, Asako; Hanaoka, Mitsumasa; Masuda, Susumu; Tanaka, Kan] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Akimoto, Yuki; Iwasaki, Hideo] Waseda Univ, Grad Sch Sci & Engn, Shinjuku Ku, Dept Elect Engn & Biosci, Tokyo 1698555, Japan	University of Tokyo; Waseda University	Tanaka, K (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	kntanaka@iam.u-tokyo.ac.jp	Hanaoka, Mitsumasa/M-9904-2015; Tanaka, Kan/E-3724-2015	Tanaka, Kan/0000-0001-7560-7884; Goto, Asako/0000-0002-0002-2619; Iwasaki, Hideo/0000-0002-3754-4955				Ashby MK, 2006, MICROBIOL MOL BIOL R, V70, P472, DOI 10.1128/MMBR.00046-05; Ashby MK, 2002, FEMS MICROBIOL LETT, V214, P25; Ashby MK, 1999, FEMS MICROBIOL LETT, V181, P253, DOI 10.1016/S0378-1097(99)00547-9; BlondeletRouault MH, 1997, GENE, V190, P315, DOI 10.1016/S0378-1119(97)00014-0; BRAHAMSHA B, 1992, J BACTERIOL, V174, P7273, DOI 10.1128/jb.174.22.7273-7282.1992; Buck M, 2006, BIOCHEM SOC T, V34, P1067, DOI 10.1042/BST0341067; Caslake LF, 1997, MICROBIOL-SGM, V143, P3807, DOI 10.1099/00221287-143-12-3807; Goto-Seki A, 1999, MOL MICROBIOL, V34, P473, DOI 10.1046/j.1365-2958.1999.01608.x; Gruber TM, 1998, ARCH MICROBIOL, V169, P211, DOI 10.1007/s002030050563; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Gusa AA, 2006, J BACTERIOL, V188, P4620, DOI 10.1128/JB.00198-06; Head CG, 1998, J MOL BIOL, V281, P857, DOI 10.1006/jmbi.1998.1985; Hsiao HY, 2004, J BACTERIOL, V186, P3882, DOI 10.1128/JB.186.12.3882-3888.2004; Imamura S, 2006, J BIOL CHEM, V281, P2668, DOI 10.1074/jbc.M509639200; Imamura S, 2003, FEBS LETT, V554, P357, DOI 10.1016/S0014-5793(03)01188-8; Kaneko T, 1997, PLANT CELL PHYSIOL, V38, P1171, DOI 10.1093/oxfordjournals.pcp.a029103; Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205; Kanesaki Y, 2002, BIOCHEM BIOPH RES CO, V290, P339, DOI 10.1006/bbrc.2001.6201; Kappell AD, 2007, ARCH MICROBIOL, V187, P337, DOI 10.1007/s00203-007-0213-1; Kappell AD, 2006, ARCH MICROBIOL, V186, P403, DOI 10.1007/s00203-006-0154-0; Khudyakov IY, 2001, J BACTERIOL, V183, P6667, DOI 10.1128/JB.183.22.6667-6675.2001; Kutsuna S, 1998, J BACTERIOL, V180, P2167, DOI 10.1128/JB.180.8.2167-2174.1998; Li W, 2007, J BACTERIOL, V189, P5413, DOI 10.1128/JB.00432-07; Los DA, 1997, MOL MICROBIOL, V25, P1167, DOI 10.1046/j.1365-2958.1997.5641912.x; Murata N, 2006, J EXP BOT, V57, P235, DOI 10.1093/jxb/erj005; Muro-Pastor AM, 2001, J BACTERIOL, V183, P1090, DOI 10.1128/JB.183.3.1090-1095.2001; Nair U, 2002, J BACTERIOL, V184, P3530, DOI 10.1128/JB.184.13.3530-3538.2002; Osanai T, 2005, J BIOL CHEM, V280, P30653, DOI 10.1074/jbc.M505043200; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; Sugita C, 2007, PHOTOSYNTH RES, V93, P55, DOI 10.1007/s11120-006-9122-4; Suzuki I, 2000, EMBO J, V19, P1327, DOI 10.1093/emboj/19.6.1327; TANAKA K, 1992, BIOSCI BIOTECH BIOCH, V56, P1113, DOI 10.1271/bbb.56.1113; TANAKA K, 1992, BIOCHIM BIOPHYS ACTA, V1132, P94, DOI 10.1016/0167-4781(92)90060-D; TANAKA K, 1993, P NATL ACAD SCI USA, V90, P3511, DOI 10.1073/pnas.90.8.3511; Tsinoremas NF, 1996, EMBO J, V15, P2488, DOI 10.1002/j.1460-2075.1996.tb00606.x; Tu CJ, 2004, J BACTERIOL, V186, P3889, DOI 10.1128/JB.186.12.3889-3902.2004; Tuominen I, 2006, FEBS LETT, V580, P319, DOI 10.1016/j.febslet.2005.11.082; Zhou YN, 1998, J BACTERIOL, V180, P1154, DOI 10.1128/JB.180.5.1154-1158.1998	39	44	45	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36887	36894		10.1074/jbc.M707582200	http://dx.doi.org/10.1074/jbc.M707582200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17977831	hybrid			2022-12-25	WOS:000251646000014
J	Pichiule, P; Chavez, JC; Schmidt, AM; Vannucci, SJ				Pichiule, Paola; Chavez, Juan Carlos; Schmidt, Ann Marie; Vannucci, Susan J.			Hypoxia-inducible factor-1 mediates neuronal expression of the receptor for advanced glycation end products following hypoxia/ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE RECEPTOR; NEURITE OUTGROWTH; ALZHEIMERS-DISEASE; FOCAL ISCHEMIA; BRAIN-INJURY; RAGE; ACTIVATION; S100B; MOUSE; AMPHOTERIN	Activation of the receptor for advanced glycation endproducts (RAGE) by its multiple ligands can trigger diverse signaling pathways with injurious or pro-survival consequences. In this study, we show that Rage mRNA and protein levels were stimulated in the mouse brain after experimental stroke and systemic hypoxia. In both cases, RAGE expression was primarily associated with neurons. Activation of RAGE-dependent pathway(s) post-ischemia appears to have a neuroprotective role because mice genetically deficient for RAGE exhibited increased infarct size 24 h after injury. Up-regulation of RAGE expression was also observed in primary neurons subjected to hypoxia or oxygen-glucose deprivation, an in vitro model of ischemia. Treatment of neurons with low concentrations of S100B decreased neuronal death after oxygen-glucose deprivation, and this effect was abolished by a neutralizing antibody against RAGE. Conversely, high concentrations of exogenous S100B had a cytotoxic effect that seems to be RAGE-independent. As an important novel finding, we demonstrate that hypoxic stimulation of RAGE expression is mediated by the transcription factor hypoxia-inducible factor-1. This conclusion is supported by the finding that HIF-1 alpha down-regulation by Cre-mediated excision drastically decreased RAGE induction by hypoxia or desferrioxamine. In addition, we showed that the mouse RAGE promoter region contains at least one functional HIF-1 binding site, located upstream of the proposed transcription start site. A luciferase reporter construct containing this RAGE promoter fragment was activated by hypoxia, and mutation at the potential HIF-1 binding site decreased hypoxia-dependent promoter activation. Specific binding of HIF-1 to this putative HRE in hypoxic cells was detected by chromatin immunoprecipitation assay.	Columbia Univ, Dept Pediat, New York, NY 10032 USA; Columbia Univ, Dept Surg, New York, NY 10032 USA; Cornell Univ, Coll Med, Burke Med Res Inst, White Plains, NY 10605 USA; Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA	Columbia University; Columbia University; Cornell University; Cornell University	Vannucci, SJ (corresponding author), Columbia Univ, Morgan Stanley Childrens Hosp New York, Dept Pediat, 3959 Broadway,CHN 10-24, New York, NY 10032 USA.	sv2020@columbia.edu						Ahlemeyer B, 2000, BRAIN RES, V858, P121, DOI 10.1016/S0006-8993(99)02438-5; Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Bergeron M, 1999, EUR J NEUROSCI, V11, P4159, DOI 10.1046/j.1460-9568.1999.00845.x; Bianchi R, 2007, J LEUKOCYTE BIOL, V81, P108, DOI 10.1189/jlb.0306198; Bierhaus A, 2004, J CLIN INVEST, V114, P1741, DOI 10.1172/JCI200418058; BRETT J, 1993, AM J PATHOL, V143, P1699; Bucciarelli LG, 2006, CIRCULATION, V113, P1226, DOI 10.1161/CIRCULATIONAHA.105.575993; Businaro R, 2006, J NEUROSCI RES, V83, P897, DOI 10.1002/jnr.20785; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Chavez JC, 2000, J APPL PHYSIOL, V89, P1937, DOI 10.1152/jappl.2000.89.5.1937; Chavez JC, 2002, J NEUROSCI, V22, P8922; Chavez JC, 2006, J NEUROSCI, V26, P9471, DOI 10.1523/JNEUROSCI.2838-06.2006; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Ding KH, 2006, BIOCHEM BIOPH RES CO, V340, P1091, DOI 10.1016/j.bbrc.2005.12.107; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Hanford LE, 2004, J BIOL CHEM, V279, P50019, DOI 10.1074/jbc.M409782200; Harashima A, 2006, BIOCHEM J, V396, P109, DOI 10.1042/BJ20051573; Hirsila M, 2005, FASEB J, V19, P1308, DOI 10.1096/fj.04-3399fje; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Huttunen HJ, 2002, J BIOL CHEM, V277, P38635, DOI 10.1074/jbc.M202515200; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Kogel D, 2004, NEUROSCIENCE, V127, P913, DOI 10.1016/j.neuroscience.2004.06.013; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Li JF, 1997, J BIOL CHEM, V272, P16498, DOI 10.1074/jbc.272.26.16498; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Lue LF, 2001, EXP NEUROL, V171, P29, DOI 10.1006/exnr.2001.7732; Luth HJ, 2005, CEREB CORTEX, V15, P211, DOI 10.1093/cercor/bhh123; Ma L, 2003, BRAIN RES, V966, P167, DOI 10.1016/S0006-8993(02)04149-5; Matsui T, 2002, J CEREBR BLOOD F MET, V22, P711, DOI 10.1097/00004647-200206000-00010; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Ponath G, 2007, J NEUROIMMUNOL, V184, P214, DOI 10.1016/j.jneuroim.2006.12.011; Ratcliffe PJ, 2006, CLIN MED, V6, P573, DOI 10.7861/clinmedicine.6-6-573; Rong LL, 2005, RESTOR NEUROL NEUROS, V23, P355; Rong LL, 2004, FASEB J, V18, P1818, DOI 10.1096/fj.04-1900com; Rong LL, 2004, FASEB J, V18, P1812, DOI 10.1096/fj.04-1899com; Ryan HE, 2000, CANCER RES, V60, P4010; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shanmugam N, 2003, J BIOL CHEM, V278, P34834, DOI 10.1074/jbc.M302828200; Sorci G, 2003, MOL CELL BIOL, V23, P4870, DOI 10.1128/MCB.23.14.4870-4881.2003; Tadin D, 2006, J NEUROSCI, V26, P11403, DOI 10.1523/JNEUROSCI.2592-06.2006; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Toth C, 2006, NEUROBIOL DIS, V23, P445, DOI 10.1016/j.nbd.2006.03.015; Vannucci SJ, 2001, J CEREBR BLOOD F MET, V21, P52, DOI 10.1097/00004647-200101000-00007; Vincent AM, 2007, ENDOCRINOLOGY, V148, P548, DOI 10.1210/en.2006-0073; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yan SF, 2003, CIRC RES, V93, P1159, DOI 10.1161/01.RES.0000103862.26506.3D; Yasuda Y, 2004, BRAIN RES, V1021, P20, DOI 10.1016/j.brainres.2004.06.015; Zhang LQ, 2004, J CLIN INVEST, V113, P85, DOI 10.1172/JCI200418336	54	81	83	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36330	36340		10.1074/jbc.M706407200	http://dx.doi.org/10.1074/jbc.M706407200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17942394	hybrid			2022-12-25	WOS:000251458300024
J	Wang, Y; Fu, X; Gaiser, S; Kottgen, M; Kramer-Zucker, A; Walz, G; Wegierski, T				Wang, Yan; Fu, Xiao; Gaiser, Stephanie; Koettgen, Michael; Kramer-Zucker, Albrecht; Walz, Gerd; Wegierski, Tomasz			OS-9 regulates the transit and polyubiquitination of TRPV4 in the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; SHAKER POTASSIUM CHANNEL; MICE LACKING TRPV4; QUALITY-CONTROL; VANILLOID RECEPTOR; ION-CHANNEL; VR-OAC; DOMAIN; PROTEIN; GENE	Transient receptor potential (TRP) proteins constitute a family of cation-permeable channels that are formed by homo- or heteromeric assembly of four subunits. Despite recent progress in the identification of protein domains required for the formation of tetramers, the mechanisms governing TRP channel assembly, and biogenesis in general, remain largely elusive. In particular, little is known about the involvement of regulatory proteins in these processes. Here we report that OS-9, a ubiquitously expressed endoplasmic reticulum (ER)-associated protein, interacts with the cytosolic N-terminal tail of TRPV4. Using a combination of co-expression and knockdown approaches we have found that OS-9 impedes the release of TRPV4 from the ER and reduces its amount at the plasma membrane. Consistent with these in vitro findings, OS-9 protected zebrafish embryos against the detrimental effects of TRPV4 expression in vivo. A detailed analysis of the underlying mechanisms revealed that OS-9 preferably binds TRPV4 monomers and other ER-localized, immature variants of TRPV4 and attenuates their polyubiquitination. Thus, OS-9 regulates the secretory transport of TRPV4 and appears to protect TRPV4 subunits from the precocious ubiquitination and ER-associated degradation. Our data suggest that OS-9 functions as an auxiliary protein for TRPV4 maturation.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Univ Hosp, Div Renal, D-79106 Freiburg, Germany	Johns Hopkins University; Johns Hopkins University; University of Freiburg	Wegierski, T (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	wegierski@med1.ukl.uni-freiburg.de	Wegierski, Tomasz/AAG-3284-2020	Wegierski, Tomasz/0000-0003-2635-8580; Kottgen, Michael/0000-0003-2406-5039				Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200; Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Chang Q, 2004, J BIOL CHEM, V279, P54304, DOI 10.1074/jbc.M406222200; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cormier JH, 2005, MOL CELL, V19, P717, DOI 10.1016/j.molcel.2005.08.029; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Engelke M, 2002, FEBS LETT, V523, P193, DOI 10.1016/S0014-5793(02)02971-X; Erler I, 2004, J BIOL CHEM, V279, P34456, DOI 10.1074/jbc.M404778200; Erler I, 2006, J BIOL CHEM, V281, P38396, DOI 10.1074/jbc.M607756200; Friedmann E, 2002, J BIOL CHEM, V277, P35274, DOI 10.1074/jbc.M201044200; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; GREEN WN, 1995, TRENDS NEUROSCI, V18, P280, DOI 10.1016/0166-2236(95)93915-K; Guler AD, 2002, J NEUROSCI, V22, P6408; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Kimura Y, 1998, J BIOCHEM-TOKYO, V123, P876; KOPITO RR, 1999, PHYSIOL REV, V79, P167; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Litovchick L, 2002, J BIOL CHEM, V277, P34413, DOI 10.1074/jbc.M203986200; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Nakayama T, 1999, FEBS LETT, V453, P77, DOI 10.1016/S0014-5793(99)00700-0; Sato S, 1998, J BIOL CHEM, V273, P7189, DOI 10.1074/jbc.273.13.7189; Schaefer M, 2005, PFLUG ARCH EUR J PHY, V451, P35, DOI 10.1007/s00424-005-1467-6; Schulteis CT, 1998, J BIOL CHEM, V273, P26210, DOI 10.1074/jbc.273.40.26210; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Su YA, 1996, MOL CARCINOGEN, V15, P270, DOI 10.1002/(SICI)1098-2744(199604)15:4<270::AID-MC4>3.0.CO;2-K; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Wegierski T, 2006, EMBO J, V25, P5659, DOI 10.1038/sj.emboj.7601429; WESTERFIELD M, 1995, ZABRAFISH BOOK GUIDE; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	45	48	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36561	36570		10.1074/jbc.M703903200	http://dx.doi.org/10.1074/jbc.M703903200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17932042	hybrid			2022-12-25	WOS:000251458300049
J	Bylund, DB				Bylund, David B.			Selecting selectivities and the neuropharmacology of antidepressant drug action - A commentary	FASEB JOURNAL			English	Editorial Material							REUPTAKE INHIBITORS; DEPRESSION; SYSTEMS; ADULTS; BRAIN		Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Bylund, DB (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, 985800 Nebraska Med Ctr, Omaha, NE 68198 USA.	dbylund@unmc.edu	Bylund, David/A-9344-2009					Burke WJ, 2004, J CLIN PSYCHIAT, V65, P37; Bylund DB, 2007, NEUROCHEM INT, V51, P246, DOI 10.1016/j.neuint.2007.06.025; Kratochvil CJ, 2006, J CHILD ADOL PSYCHOP, V16, P11, DOI 10.1089/cap.2006.16.11; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Murrin LC, 2007, BIOCHEM PHARMACOL, V73, P1225, DOI 10.1016/j.bcp.2007.01.028; Pathak Sanjeev, 2005, Curr Psychiatry Rep, V7, P429, DOI 10.1007/s11920-005-0063-y; RICHELSON E, 1984, J PHARMACOL EXP THER, V230, P94; Shaw AM, 2007, EUR J PHARMACOL, V555, P30, DOI 10.1016/j.ejphar.2006.10.004; Williams M, 2005, BIOCHEM PHARMACOL, V70, P1707, DOI 10.1016/j.bcp.2005.08.019	9	0	0	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2007	21	13					3417	3418		10.1096/fj.07-1102ufm-A	http://dx.doi.org/10.1096/fj.07-1102ufm-A			3	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	225KW	17967928				2022-12-25	WOS:000250517800003
J	Pearce, VP; Sherrell, J; Lou, Z; Kopelovich, L; Wright, WE; Shay, JW				Pearce, V. P.; Sherrell, J.; Lou, Z.; Kopelovich, L.; Wright, W. E.; Shay, J. W.			Immortalization of epithelial progenitor cells mediated by resveratrol	ONCOGENE			English	Article						telomerase; p53; progesterone; breast epithelial; aging	BREAST-CANCER CELLS; TELOMERASE ACTIVITY; IN-VITRO; P53 PROTEIN; ACTIVATION; EXPRESSION; NEUROBLASTOMA; LOCALIZATION; MAINTENANCE; SENESCENCE	Within the hierarchy of epithelial stem cells, normal progenitor cells may express regulated telomerase during renewal cycles of proliferation and differentiation. Discontinuous telomerase activity may promote increased renewal capacity of progenitor cells, while deregulated/ continuous telomerase activity may promote immortalization when differentiation and/ or senescent pathways are compromised. In the present work, we show that resveratrol activates, while progesterone inactivates, continuous telomerase activity within 24 h in subpopulations of human Li - Fraumeni syndrome- derived breast epithelial cells. Resveratrol results in immortalization of mixed progenitor cells with mutant p53, but not human epithelial cells with wild type p53. Our results demonstrate the potential for renewing progenitor cells with mutant p53 to immortalize after continuous telomerase expression when exposed to certain environmental compounds. Understanding the effects of telomerase modulators on endogenous telomerase activity in progenitor cells is relevant to the role of immortalization in the initiation and progression of cancer subtypes.	[Pearce, V. P.; Lou, Z.; Wright, W. E.; Shay, J. W.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Pearce, V. P.] Univ N Texas, Dept Pharmacol & Neurosci, UNT Hlth Sci Ctr Ft Worth, Ft Worth, TX USA; [Sherrell, J.] Univ Arizona, Sch Dent, Phoenix, AZ USA; [Kopelovich, L.] NCI, Div Canc Prevent, Bethesda, MD 20892 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of North Texas System; University of North Texas Health Science Center; University of Arizona; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Shay, JW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Jerry.Shay@UTSouthwestern.edu	Shay, Jerry W/F-7878-2011		DIVISION OF CANCER PREVENTION AND CONTROL [N01CN005106] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R03CA075907, P50CA070907] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA070907, P50 CA75907, N01CN43301, N01-CN43301, CN-05106] Funding Source: Medline	DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bankfalvi A, 2004, MODERN PATHOL, V17, P1051, DOI 10.1038/modpathol.3800082; Bayne S, 2005, MOL CELL ENDOCRINOL, V240, P11, DOI 10.1016/j.mce.2005.05.009; Bhat KPL, 2002, ANN NY ACAD SCI, V957, P210, DOI 10.1111/j.1749-6632.2002.tb02918.x; Bhat KPL, 2001, ANTIOXID REDOX SIGN, V3, P1041, DOI 10.1089/152308601317203567; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Conneely OM, 2003, J MAMMARY GLAND BIOL, V8, P205, DOI 10.1023/A:1025952924864; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; Dimri G, 2005, BREAST CANCER RES, V7, P171, DOI 10.1186/bcr1275; Dong CK, 2005, CRIT REV ONCOL HEMAT, V54, P85, DOI 10.1016/j.critrevonc.2004.12.005; Dong ZG, 2003, MUTAT RES-FUND MOL M, V523, P145, DOI 10.1016/S0027-5107(02)00330-5; Fridriksdottir AJR, 2005, J MAMMARY GLAND BIOL, V10, P61, DOI 10.1007/s10911-005-2541-6; Gusman J, 2001, CARCINOGENESIS, V22, P1111, DOI 10.1093/carcin/22.8.1111; Hahn WC, 2004, CANCER CELL, V6, P215, DOI 10.1016/j.ccr.2004.09.007; Holt SE, 1999, J CELL PHYSIOL, V180, P10, DOI 10.1002/(SICI)1097-4652(199907)180:1<10::AID-JCP2>3.0.CO;2-D; Kim H, 2002, BIOCHEM J, V365, P765, DOI 10.1042/BJ20011848; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lanzilli G, 2006, INT J ONCOL, V28, P641; Le Corre L, 2005, MOL NUTR FOOD RES, V49, P462, DOI 10.1002/mnfr.200400094; Lebeau J, 2002, ANTICANCER RES, V22, P2161; Leonhardt SA, 2002, EXP BIOL MED, V227, P969, DOI 10.1177/153537020222701104; Leslie KK, 2005, GYNECOL ONCOL, V96, P32, DOI 10.1016/j.ygyno.2004.09.057; Li XT, 2003, J BIOL CHEM, V278, P39261, DOI 10.1074/jbc.R300024200; Lim CS, 1999, MOL ENDOCRINOL, V13, P366, DOI 10.1210/me.13.3.366; Masutomi K, 2003, CANCER LETT, V194, P163, DOI 10.1016/S0304-3835(02)00703-6; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Miloso M, 1999, NEUROSCI LETT, V264, P141, DOI 10.1016/S0304-3940(99)00194-9; Moll UM, 1996, MOL CELL BIOL, V16, P1126; Mote PA, 2002, BREAST CANCER RES TR, V72, P163, DOI 10.1023/A:1014820500738; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Ostermeyer AG, 1996, P NATL ACAD SCI USA, V93, P15190, DOI 10.1073/pnas.93.26.15190; Petersen OW, 2003, CELL PROLIFERAT, V36, P33, DOI 10.1046/j.1365-2184.36.s.1.4.x; Rambhatla L., 2001, J BIOMED BIOTECHNOL, V1, P28, DOI DOI 10.1155/S1110724301000079; Saeki Y, 1997, J MOL MED-JMM, V75, P50, DOI 10.1007/s001090050086; SHAY JW, 1995, MOL CELL BIOL, V15, P425, DOI 10.1128/MCB.15.1.425; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Signorelli P, 2005, J NUTR BIOCHEM, V16, P449, DOI 10.1016/j.jnutbio.2005.01.017; Stampfer MR, 2003, ONCOGENE, V22, P5238, DOI 10.1038/sj.onc.1206667; Stingl J, 2005, J MAMMARY GLAND BIOL, V10, P49, DOI 10.1007/s10911-005-2540-7; Sun W, 1999, CANCER RES, V59, P6118; Tabata Y, 2002, J STEROID BIOCHEM, V82, P217, DOI 10.1016/S0960-0760(02)00157-7; Tanaka M, 1998, AM J PATHOL, V153, P1985, DOI 10.1016/S0002-9440(10)65712-4; TRASK DK, 1990, P NATL ACAD SCI USA, V87, P2319, DOI 10.1073/pnas.87.6.2319; Wang Z, 2000, CANCER RES, V60, P5376; Williams CD, 2001, J CLIN ENDOCR METAB, V86, P3912, DOI 10.1210/jc.86.8.3912; Yaswen P, 2002, INT J BIOCHEM CELL B, V34, P1382, DOI 10.1016/S1357-2725(02)00047-X; Yu CC, 2001, BIOCHEM J, V355, P459, DOI 10.1042/0264-6021:3550459; Zhivotovsky B, 2004, NAT REV MOL CELL BIO, V5, P752, DOI 10.1038/nrm1443	47	31	32	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2008	27	17					2365	2374		10.1038/sj.onc.1210886	http://dx.doi.org/10.1038/sj.onc.1210886			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286KN	17968319	Green Accepted			2022-12-25	WOS:000254844900001
J	Wiencke, JK; Zheng, S; Morrison, Z; Yeh, RF				Wiencke, J. K.; Zheng, S.; Morrison, Z.; Yeh, R-F			Differentially expressed genes are marked by histone 3 lysine 9 trimethylation in human cancer cells	ONCOGENE			English	Article						chromatin immunoprecipitation; histone methylation; histone acetylation; tiling array; homeobox; histone code	MAMMALIAN CHROMATIN; METHYLATION PATTERNS; DNA METHYLATION; STEM-CELLS; OTX2; H3; TRANSCRIPTION; LEUKEMIA; BRAIN; MEDULLOBLASTOMAS	Histone H3 lysine 9 trimethylation ( H3K9Me3) has been associated with transcriptional repression, but recent findings implicate this chromatin modi. cation in transcriptional activation and mRNA elongation by RNA polymerase II. Here, we applied immunoprecipitation ( IP) with a custom DNA tiling microarray containing many transcription factors important in development and cancer ( for example homeotic genes; N 683 total genes) to explore the relationship between H3K9Me3 and other histone modi. cations with the differential expression of genes. Cancer cell lines derived from different tissues ( 2 leukemia, 2 medulloblastoma) were characterized with IP antibodies to H3K9Me3, H3K4 dimethylation ( H3K4Me2) and H3K9 acetylation ( H3K9Ac). MV4- 11 is known to over-express the HOXA9 and MEIS1 genes, whereas D283 overexpresses the OTX2 homeobox gene. Gene expression was assessed by Affymetrix U133 array. Mapping the number and size of histone markings demonstrated significant colocalization of H3K9Ac and H3K4Me2 with H3K9Me3, indicating a pattern of putative 'activating' and 'repressive' markings. The median site size was 600 - 821 bp and 72 - 95% or 53 - 80% of chromatin signal sites were located within 1 kb or 500 bp of transcription start sites ( TSS), respectively. A relatively small number of genes displayed additional H3K9Me3 sites in the 50- region distant from the TSS. Comparing genes with modi. cation sites to those without sites in their promoters confirmed the positive associations of H3K9Ac and H3K4Me2 with gene expression and revealed that H3K9Me3 is associated with active genes rather than being a repressive marking as previously thought. The positive regulatory effect of all three types of modi. cations were quantitatively correlated with site size, and applied to absolute gene expression within a single cell line as well as relative expression among pairs of cell lines. Extended patterns of H3K9Me3 upstream of some genes ( for example HOXA9 and OTX2) may result from the action of multiple promoter elements. We found an inverse relationship between promoter DNA hypermethylation and H3K9Me3 in three studied genes ( HOXA9, TMS1, RASSF1A). The localization of H3K9Me3 downstream of the TSSs of expressed genes and not within promoter regions of hypermethylated and silenced genes is consistent with the proposed coupling of H3K9Me3 with RNA polymerase II. Our results indicate a need for revising aspects of the histone code involving H3 lysine methylation. Awareness of H3K9Me3 as a mark of gene activity, not repression, is especially important for the classification of human cancer using chromatin and histone profiles.	[Wiencke, J. K.; Zheng, S.; Morrison, Z.] Univ Calif San Francisco, Dept Neurol Surg, Lab Neuro & Mol Epidemiol Ambulatory Care, San Francisco, CA 94143 USA; [Yeh, R-F] Univ Calif San Francisco, Dept Epidemiol & Biostat, Ctr Bioinformat & Mol Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wiencke, JK (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, Lab Neuro & Mol Epidemiol Ambulatory Care, AC-34,1 Irving St,Box 441, San Francisco, CA 94143 USA.	john.wiencke@ucsf.edu		Morrison, Zachary/0000-0001-9282-7248	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002, R01ES006717] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES06717, ES000002] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Acampora D, 2005, BRAIN RES BULL, V66, P410, DOI 10.1016/j.brainresbull.2005.02.005; Annabi B, 2005, J NEUROCHEM, V94, P906, DOI 10.1111/j.1471-4159.2005.03256.x; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Arslan MA, 2006, CURR CANCER DRUG TAR, V6, P623, DOI 10.2174/156800906778742479; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Boon K, 2005, CANCER RES, V65, P703; Boon K, 2003, ONCOGENE, V22, P7687, DOI 10.1038/sj.onc.1207043; Canaani E, 2004, BRIT J CANCER, V90, P756, DOI 10.1038/sj.bjc.6601639; Chomez P, 2001, CANCER RES, V61, P5544; de Haas T, 2006, J NEUROPATH EXP NEUR, V65, P176, DOI 10.1097/01.jnen.0000199576.70923.8a; Eissenberg JC, 2006, CURR OPIN GENET DEV, V16, P184, DOI 10.1016/j.gde.2006.02.004; Fossat N, 2005, DEV DYNAM, V233, P154, DOI 10.1002/dvdy.20287; Gregory RI, 2004, TRENDS CELL BIOL, V14, P695, DOI 10.1016/j.tcb.2004.10.002; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Kimura J, 2005, J NEUROSCI, V25, P5097, DOI 10.1523/JNEUROSCI.0239-05.2005; Kondo Y, 2003, MOL CELL BIOL, V23, P206, DOI 10.1128/MCB.23.1.206-215.2003; Kondo Y, 2004, P NATL ACAD SCI USA, V101, P7398, DOI 10.1073/pnas.0306641101; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Miao F, 2005, MOL CELL BIOL, V25, P4650, DOI 10.1128/MCB.25.11.4650-4661.2005; Milne TA, 2005, CANCER RES, V65, P11367, DOI 10.1158/0008-5472.CAN-05-1041; Minc E, 2000, CYTOGENET CELL GENET, V90, P279, DOI 10.1159/000056789; Nguyen CT, 2002, CANCER RES, V62, P6456; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Rath MF, 2006, J NEUROCHEM, V97, P556, DOI 10.1111/j.1471-4159.2006.03773.x; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Rozovskaia T, 2001, ONCOGENE, V20, P874, DOI 10.1038/sj.onc.1204174; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tijink BM, 2006, CLIN CANCER RES, V12, P6064, DOI 10.1158/1078-0432.CCR-06-0910; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Vernay B, 2005, J NEUROSCI, V25, P4856, DOI 10.1523/JNEUROSCI.5158-04.2005; Wu R, 2005, MOL BIOL CELL, V16, P2872, DOI 10.1091/mbc.e04-11-0997; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zhao W, 2005, J BIOCHEM, V137, P431, DOI 10.1093/jb/mvi048	42	74	75	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2008	27	17					2412	2421		10.1038/sj.onc.1210895	http://dx.doi.org/10.1038/sj.onc.1210895			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286KN	17968314				2022-12-25	WOS:000254844900006
J	Asangani, IA; Rasheed, SAK; Nikolova, DA; Leupold, JH; Colburn, NH; Post, S; Allgayer, H				Asangani, I. A.; Rasheed, S. A. K.; Nikolova, D. A.; Leupold, J. H.; Colburn, N. H.; Post, S.; Allgayer, H.			MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer	ONCOGENE			English	Article						pdcd4; miR-21; post-transcriptional regulation; invasion; CAM assay	GENE-EXPRESSION; MICRO-RNA; TRANSFORMATION; TRANSLATION; CELLS; INHIBITION; INITIATION; GROWTH; MA-3	Tumor-suppressor Pdcd4 inhibits transformation and invasion and is downregulated in cancers. So far, it has not been studied as to whether miRNAs, suppressing target expression by binding to the 3'-UTR, regulate Pdcd4 or invasion. The present study was conducted to investigate the regulation of Pdcd4, and invasion/intravasation, by miRNAs. A bioinformatics search revealed a conserved target-site for miR-21 within the Pdcd4-3'UTR at 228-249 nt. In 10 colorectal cell lines, an inverse correlation of miR-21 and Pdcd4-protein was observed. Transfection of Colo206f-cells with miR-21 significantly suppressed a luciferase-reporter containing the Pdcd4-3'-UTR, whereas transfection of RKO with anti-miR-21 increased activity of this construct. This was abolished when a construct mutated at the miR-21/nt228-249 target site was used instead. Anti-miR-21-transfected RKO cells showed an increase of Pdcd4-protein and reduced invasion. Moreover, these cells showed reduced intra-vasation and lung metastasis in a chicken-embryo-metastasis assay. In contrast, overexpression of miR-21 in Colo206f significantly reduced Pdcd4-protein amounts and increased invasion, while Pdcd4-mRNA was unaltered. Resected normal/tumor tissues of 22 colorectal cancer patients demonstrated an inverse correlation between miR-21 and Pdcd4-protein. This is the first study to show that Pdcd4 is negatively regulated by miR-21. Furthermore, it is the first report to demonstrate that miR-21 induces invasion/intravasation/metastasis.	[Asangani, I. A.; Rasheed, S. A. K.; Nikolova, D. A.; Leupold, J. H.; Allgayer, H.] Heidelberg Univ, Med Fac Mannheim, Dept Expt Surg & Mol Oncol Solid Tumors, Collaborat Unit,German Canc Res Ctr, D-68167 Mannheim, Germany; [Asangani, I. A.; Rasheed, S. A. K.; Nikolova, D. A.; Leupold, J. H.; Allgayer, H.] DKFZ Heidelberg, Mannheim, Germany; [Colburn, N. H.] NCI, Basic Res Lab, Gene Regulat Sect, Frederick, MD 21701 USA; [Post, S.] Heidelberg Univ, Med Fac Mannheim, Dept Surg, D-6800 Mannheim, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Ruprecht Karls University Heidelberg	Allgayer, H (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Expt Surg & Mol Oncol Solid Tumors, Collaborat Unit,German Canc Res Ctr, D-68167 Mannheim, Germany.	heike.allgayer@chir.ma.uni-heidelberg.de	Vickers, Michael M/E-4095-2010; Rasheed, Suhail Ahmed Kabeer/P-1257-2019	Rasheed, Suhail Ahmed Kabeer/0000-0002-7674-7560; asangani, irfan/0000-0001-5381-1702	NATIONAL CANCER INSTITUTE [ZIABC010026, Z01BC010026] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Bitomsky N, 2004, ONCOGENE, V23, P7484, DOI 10.1038/sj.onc.1208064; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen Y, 2003, J PATHOL, V200, P640, DOI 10.1002/path.1378; Cmarik JL, 1999, P NATL ACAD SCI USA, V96, P14037, DOI 10.1073/pnas.96.24.14037; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Goke R, 2004, ANN NY ACAD SCI, V1014, P220, DOI 10.1196/annals.1294.024; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Kang MJ, 2002, BIOCHEM BIOPH RES CO, V293, P617, DOI 10.1016/S0006-291X(02)00264-4; Lankat-Buttgereit B, 2004, MOL CELL ENDOCRINOL, V214, P149, DOI 10.1016/j.mce.2003.10.058; Leupold JH, 2007, ONCOGENE, V26, P4550, DOI 10.1038/sj.onc.1210234; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Mudduluru G, 2007, CANCER-AM CANCER SOC, V110, P1697, DOI 10.1002/cncr.22983; Onishi Y, 1998, GENE, V215, P453, DOI 10.1016/S0378-1119(98)00313-8; Palamarchuk A, 2005, CANCER RES, V65, P11282, DOI 10.1158/0008-5472.CAN-05-3469; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Schlichter U, 2001, ONCOGENE, V20, P231, DOI 10.1038/sj.onc.1204071; Shibahara K, 1995, GENE, V166, P297, DOI 10.1016/0378-1119(95)00607-9; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433; Zakowicz H, 2005, RNA, V11, P261, DOI 10.1261/rna.7191905; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang ZH, 2001, ONCOGENE, V20, P4450, DOI 10.1038/sj.onc.1204588; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200; Zijlstra A, 2002, CANCER RES, V62, P7083	39	1492	1621	6	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 3	2008	27	15					2128	2136		10.1038/sj.onc.1210856	http://dx.doi.org/10.1038/sj.onc.1210856			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	283FE	17968323				2022-12-25	WOS:000254621300003
J	Pacienza, N; Pozner, RG; Bianco, GA; D'Atri, LP; Croci, DO; Negrotto, S; Malaver, E; Gomez, RM; Rabinovich, GA; Schattner, M				Pacienza, Natalia; Pozner, Roberto G.; Bianco, German A.; D'Atri, Lina P.; Croci, Diego O.; Negrotto, Soledad; Malaver, Elisa; Gomez, Ricardo M.; Rabinovich, Gabriel A.; Schattner, Mirta			The immunoregulatory glycan-binding protein galectin-1 triggers human platelet activation	FASEB JOURNAL			English	Article						lectin; P-selectin; inflammation; hemostasis	CELL-ADHESION; P-SELECTIN; EXTRACELLULAR-MATRIX; MEMBRANE-VESICLES; DENDRITIC CELLS; TUMOR-CELLS; MICROPARTICLES; INHIBITION; EXPRESSION; SURFACE	Platelet activation is a critical process during inflammation, thrombosis, and cancer. Here, we show that galectin-1, an endogenous lectin with immunoregulatory properties, plays a key role in human platelet activation and function. Galectin-1 binds to human platelets in a carbohydrate-dependent manner and synergizes with ADP or thrombin to induce platelet aggregation and ATP release. Furthermore, galectin-1 induces F-actin polymerization, up-regulation of P-selectin, and GPIIIa expression; promotes shedding of microvesicles; and triggers conformational changes in GPIIb/IIIa. In addition, exposure to this lectin favors the generation of leukocyte-platelet aggregates. A further mechanistic analysis revealed the involvement of Ca2+ and cyclic nucleotide-dependent pathways in galectin-1-mediated control of platelet activation. Finally, expression of endogenous galectin-1 in human platelets contributes to ADP-induced aggregation. Our study reveals a novel unrecognized role for galectin-1 in the control of platelet physiology with potential implications in thrombosis, inflammation, and metastasis.	[Bianco, German A.; Croci, Diego O.; Rabinovich, Gabriel A.] Inst Biol & Med Expt, Natl Res Council, CONICET, RA-1428 Buenos Aires, DF, Argentina; [Pacienza, Natalia; Pozner, Roberto G.; Negrotto, Soledad; Malaver, Elisa; Schattner, Mirta] Natl Acad Med Buenos Aires, Hematol Res Inst, RA-1428 Buenos Aires, DF, Argentina; [Gomez, Ricardo M.] Natl Univ La Plata, Inst Biochem & Mol Biol, Dept Sci Biol, La Plata, Buenos Aires, Argentina; [Rabinovich, Gabriel A.] Univ Buenos Aires, Fac Exact & Nat Sci, Dept Biol Chem, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Buenos Aires National Academy of Medicine; IIHEMA - Instituto de Investigaciones Hematologicas; National University of La Plata; University of Buenos Aires	Rabinovich, GA (corresponding author), Inst Biol & Med Expt, Natl Res Council, CONICET, Vuelta Obligado 2490, RA-1428 Buenos Aires, DF, Argentina.	gabyrabi@ciudad.com.ar; mschattner@hematologia.anm.edu.ar	Croci, Diego/AAJ-5709-2021; Gomez, Ricardo M/AAG-9555-2019	Croci, Diego/0000-0002-8623-0645; Gomez, Ricardo M/0000-0002-4001-519X; Pacienza, Natalia/0000-0002-6124-5269				ABRAMS CS, 1990, BLOOD, V75, P128; Afshar-Kharghan V, 2006, CURR OPIN HEMATOL, V13, P34, DOI 10.1097/01.moh.0000190107.54790.de; Amirkhosravi A, 2003, THROMB HAEMOSTASIS, V90, P549, DOI 10.1160/TH03-02-0102; Bakewell SJ, 2003, P NATL ACAD SCI USA, V100, P14205, DOI 10.1073/pnas.2234372100; Barrionuevo P, 2007, J IMMUNOL, V178, P436, DOI 10.4049/jimmunol.178.1.436; Biro E, 2005, J THROMB HAEMOST, V3, P2754, DOI 10.1111/j.1538-7836.2005.01646.x; BODE AP, 1985, THROMB RES, V39, P49, DOI 10.1016/0049-3848(85)90121-5; Brill A, 2005, CARDIOVASC RES, V67, P30, DOI 10.1016/j.cardiores.2005.04.007; Caine GJ, 2002, NEOPLASIA, V4, P465, DOI 10.1038/sj.neo.7900263; Camby I, 2002, J NEUROPATH EXP NEUR, V61, P585, DOI 10.1093/jnen/61.7.585; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Croce K, 2007, CURR OPIN HEMATOL, V14, P55, DOI 10.1097/00062752-200701000-00011; De Cicco M, 2004, CRIT REV ONCOL HEMAT, V50, P187, DOI 10.1016/j.critrevonc.2003.10.003; Falanga Anna, 2003, Clin Adv Hematol Oncol, V1, P673; Falati S, 2003, J EXP MED, V197, P1585, DOI 10.1084/jem.20021868; Fulcher JA, 2006, J IMMUNOL, V177, P216, DOI 10.4049/jimmunol.177.1.216; Garin MI, 2007, BLOOD, V109, P2058, DOI 10.1182/blood-2006-04-016451; Geng JG, 2004, CURR MED CHEM, V11, P2153, DOI 10.2174/0929867043364720; GU MJ, 1994, J CELL SCI, V107, P175; Hartwig JH, 2006, SEMIN HEMATOL, V43, pS94, DOI 10.1053/j.seminhematol.2005.11.004; He J, 2006, LAB INVEST, V86, P578, DOI 10.1038/labinvest.3700420; He JL, 2004, J BIOL CHEM, V279, P4705, DOI 10.1074/jbc.M311183200; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hu H, 2003, THROMB HAEMOSTASIS, V90, P679, DOI 10.1160/TH03-05-0274; Jain S, 2007, P NATL ACAD SCI USA, V104, P9024, DOI 10.1073/pnas.0700625104; Jurk K, 2005, SEMIN THROMB HEMOST, V31, P381, DOI 10.1055/s-2005-916671; La M, 2003, AM J PATHOL, V163, P1505, DOI 10.1016/S0002-9440(10)63507-9; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Liu FT, 2002, BBA-GEN SUBJECTS, V1572, P263, DOI 10.1016/S0304-4165(02)00313-6; MARCUS AJ, 1993, FASEB J, V7, P516, DOI 10.1096/fasebj.7.6.8472890; McEver RP, 2001, THROMB HAEMOSTASIS, V86, P746; Merten M, 2000, CIRCULATION, V102, P1931, DOI 10.1161/01.CIR.102.16.1931; Merten M, 1999, CIRCULATION, V99, P2577, DOI 10.1161/01.CIR.99.19.2577; Moiseeva EP, 2003, BIOCHEM BIOPH RES CO, V310, P1010, DOI 10.1016/j.bbrc.2003.09.112; Palumbo JS, 2005, BLOOD, V105, P178, DOI 10.1182/blood-2004-06-2272; PEARLSTEIN E, 1984, CANCER RES, V44, P3884; Pereira J, 2006, THROMB HAEMOSTASIS, V95, P94, DOI 10.1160/TH05-05-0310; Perone MJ, 2006, J IMMUNOL, V177, P5278, DOI 10.4049/jimmunol.177.8.5278; Rabinovich G, 1999, J EXP MED, V190, P385, DOI 10.1084/jem.190.3.385; Rabinovich GA, 2002, CELL DEATH DIFFER, V9, P661, DOI 10.1038/sj.cdd.4401009; Rabinovich GA, 1998, J IMMUNOL, V160, P4831; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Rabinovich GA, 1999, IMMUNOLOGY, V97, P100; Rubinstein N, 2004, CANCER CELL, V5, P241, DOI 10.1016/S1535-6108(04)00024-8; Santucci L, 2003, GASTROENTEROLOGY, V124, P1381, DOI 10.1016/S0016-5085(03)00267-1; Saussez S, 2007, HEAD NECK-J SCI SPEC, V29, P874, DOI 10.1002/hed.20559; SCHATTNER M, 1993, BLOOD, V82, P3045; Schwarz UR, 2001, BIOCHEM PHARMACOL, V62, P1153, DOI 10.1016/S0006-2952(01)00760-2; Scott Ken, 2004, Glycoconjugate Journal, V19, P467; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Silvestre MM, 2005, J RENIN-ANGIO-ALDO S, V6, pS1, DOI 10.1177/14703203050060010101; SIMS PJ, 1988, J BIOL CHEM, V263, P18205; Stowell SR, 2007, BLOOD, V109, P219, DOI 10.1182/blood-2006-03-007153; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Timoshenko AV, 2003, MOL CELL BIOCHEM, V250, P139, DOI 10.1023/A:1024952727159; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Toscano MA, 2007, CYTOKINE GROWTH F R, V18, P57, DOI 10.1016/j.cytogfr.2007.01.006; Toscano MA, 2006, J IMMUNOL, V176, P6323, DOI 10.4049/jimmunol.176.10.6323; van den Goor JM, 2003, J THORAC CARDIOV SUR, V126, P1101, DOI 10.1016/S0022-5223(03)01031-6; van der Leij J, 2007, MOL IMMUNOL, V44, P506, DOI 10.1016/j.molimm.2006.02.011; VANDENBRULE FA, 1995, BIOCHEM BIOPH RES CO, V209, P760, DOI 10.1006/bbrc.1995.1564; Vespa GNR, 1999, J IMMUNOL, V162, P799; Wagner DD, 2005, ARTERIOSCL THROM VAS, V25, P1321, DOI 10.1161/01.ATV.0000166521.90532.44; WIEDMER T, 1991, BLOOD, V78, P2880	66	56	57	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2008	22	4					1113	1123		10.1096/fj.07-9524com	http://dx.doi.org/10.1096/fj.07-9524com			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	282PZ	17984174				2022-12-25	WOS:000254581000017
J	Levchenko, T; Veitonmaeki, N; Lundkvist, A; Gerhardt, H; Ming, Y; Berggren, K; Kvanta, A; Carlsson, R; Holmgren, L				Levchenko, Tetyana; Veitonmaeki, Niina; Lundkvist, Andrea; Gerhardt, Holger; Ming, Yue; Berggren, Kristina; Kvanta, Anders; Carlsson, Roland; Holmgren, Lars			Therapeutic antibodies targeting angiomotin inhibit angiogenesis in vivo	FASEB JOURNAL			English	Article						angiostatin; neoplasia; vascular/ocular disease; migration	ENDOTHELIAL-CELL MIGRATION; FIBROBLAST GROWTH-FACTOR; TRANSGENIC BALB/C MICE; ENDOGENOUS INHIBITORS; MACULAR DEGENERATION; ANGIOSTATIN; CANCER; PROTEIN; NEOVASCULARIZATION; PROGRESSION	We have previously shown that angiomotin (Amot) mediates angiostatin inhibition of endothelial migration and tube formation in vitro. A crucial role of angiomotin in regulating endothelial cell motility is indicated by the findings that knockdown of Amot in zebrafish reduces the number of filopodia of endothelial tip cells and severely impairs the migration of intersegmental vessels. In addition, targeting angiomotin using DNA vaccination inhibits angiogenesis and tumor growth in vivo. In this report, we have generated antibodies that, similar to angiostatin, bind to angiomotin on the endothelial cell surface. These antibodies inhibited FGF-2 and vascular endothelial growth factor (VEGF) -induced endothelial migration in the Boyden chamber assay. Furthermore, the anti-Amot B06 antibody significantly reduced the number of endothelial filopodia and inhibited vessel migration during retinal angiogenesis in vivo. We also show that systemic or local treatment with this antibody inhibits pathological blood vessel formation associated with tumor growth or laser-induced choroid neovascularization of the eye. These findings provide a rationale for using angiomotin antibodies for specifically targeting endothelial migration in angiogenesis-dependent diseases.-Levchenko, T., Veitonmaki, N, Lundkvist, A., Gerhardt, H., Ming, Y., Berggren, K, Kvanta, A., Carlsson, R., Hohngren, L. Therapeutic antibodies targeting angiomotin inhibit angiogenesis in vivo.	[Levchenko, Tetyana; Veitonmaeki, Niina; Holmgren, Lars] Karolinska Inst, St Eriks Eye Hosp, Canc Ctr Karolinska, Dept Pathol & Oncol, Stockholm, Sweden; [Ming, Yue; Kvanta, Anders] Karolinska Inst, St Eriks Eye Hosp, Dept Clin Neurosci, Sect Ophthalmol & Vis, Stockholm, Sweden; [Veitonmaeki, Niina; Berggren, Kristina; Carlsson, Roland] BioInvent Int AB, Lund, Sweden; [Lundkvist, Andrea; Gerhardt, Holger] Canc Res UK, Vasc Biol Lab, London, England	Karolinska Institutet; Karolinska Institutet; Cancer Research UK	Holmgren, L (corresponding author), Karolinska Inst, Dept Pathol & Oncol, Canc Ctr Karolinska, SE-17176 Stockholm, Sweden.	lars.holmgren@ki.se	Gerhardt, Holger/G-4610-2011; Gerhardt, Holger/G-4610-2011	Gerhardt, Holger/0000-0002-3030-0384; Tegnebratt, Tetyana/0000-0003-4298-2295; Gerhardt, Holger/0000-0001-9228-7472				Aase K, 2007, GENE DEV, V21, P2055, DOI 10.1101/gad.432007; Bastaki M, 1997, ARTERIOSCL THROM VAS, V17, P454, DOI 10.1161/01.ATV.17.3.454; Beerepoot LV, 2003, CLIN CANCER RES, V9, P4025; Berglin L, 2003, INVEST OPHTH VIS SCI, V44, P403, DOI 10.1167/iovs.02-0180; Bratt A, 2005, J BIOL CHEM, V280, P34859, DOI 10.1074/jbc.M503915200; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Claesson-Welsh L, 1998, P NATL ACAD SCI USA, V95, P5579, DOI 10.1073/pnas.95.10.5579; Di Carlo E, 1999, LAB INVEST, V79, P1261; Ebrahem Q, 2006, P NATL ACAD SCI USA, V103, P13480, DOI 10.1073/pnas.0601552103; Ernkvist M, 2006, FEBS J, V273, P2000, DOI 10.1111/j.1742-4658.2006.05216.x; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gerhardt H, 2005, EXP SUPPL, V94, P3; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Greenwald RB, 2003, ADV DRUG DELIVER REV, V55, P217, DOI 10.1016/S0169-409X(02)00180-1; Holmgren L, 2006, P NATL ACAD SCI USA, V103, P9208, DOI 10.1073/pnas.0603110103; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Iruela-Arispe ML, 1999, CIRCULATION, V100, P1423, DOI 10.1161/01.CIR.100.13.1423; KUNDRA V, 1995, J CELL BIOL, V130, P725, DOI 10.1083/jcb.130.3.725; Kvanta A, 2006, ACTA OPHTHALMOL SCAN, V84, P282, DOI 10.1111/j.1600-0420.2006.00659.x; Levchenko T, 2004, ONCOGENE, V23, P1469, DOI 10.1038/sj.onc.1207264; Levchenko T, 2003, J CELL SCI, V116, P3803, DOI 10.1242/jcs.00694; Melani C, 2003, BLOOD, V102, P2138, DOI 10.1182/blood-2003-01-0190; Meneses PI, 2001, GENE THER, V8, P646, DOI 10.1038/sj.gt.3301423; Mizukami Y, 2005, NAT MED, V11, P992, DOI 10.1038/nm1294; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; OReilly MS, 1996, NAT MED, V2, P689, DOI 10.1038/nm0696-689; PASSANITI A, 1992, LAB INVEST, V67, P519; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rovero S, 2000, J IMMUNOL, V165, P5133, DOI 10.4049/jimmunol.165.9.5133; Sato Y, 2006, ENDOTHELIUM-J ENDOTH, V13, P147, DOI 10.1080/1062332060069110; Soderlind E, 2000, NAT BIOTECHNOL, V18, P852, DOI 10.1038/78458; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Veitonmaki N, 2003, FASEB J, V17, P764, DOI 10.1096/fj.02-0599-fje; Wahl ML, 2005, J CELL BIOCHEM, V96, P242, DOI 10.1002/jcb.20480; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Wood W, 2002, INT J BIOCHEM CELL B, V34, P726, DOI 10.1016/S1357-2725(01)00172-8	37	26	31	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2008	22	3					880	889		10.1096/fj.07-9509com	http://dx.doi.org/10.1096/fj.07-9509com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17984175				2022-12-25	WOS:000254143700026
J	Forgacs, E; Cartwright, S; Sakamoto, T; Sellers, JR; Corrie, JET; Webb, MR; White, HD				Forgacs, Eva; Cartwright, Suzanne; Sakamoto, Takeshi; Sellers, James R.; Corrie, John E. T.; Webb, Martin R.; White, Howard D.			Kinetics of ADP dissociation from the trail and lead heads of actomyosin V following the power stroke	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN-V; PROCESSIVE MYOSIN; WORKING STROKE; NECK LENGTH; MECHANISM; BINDING; ACTIN; MOTOR; ANALOGS; MUSCLE	Myosin V is a cellular motor protein, which transports cargos along actin filaments. It moves processively by 36-nm steps that require at least one of the two heads to be tightly bound to actin throughout the catalytic cycle. To elucidate the kinetic mechanism of processivity, we measured the rate of product release from the double-headed myosin V-HMM using a new ATP analogue, 3'-(7-diethylaminocoumarin-3-carbonylamino)-3'-deoxy-ATP (deac-aminoATP), which undergoes a 20-fold increase in fluorescence emission intensity when bound to the active site of myosin V (Forgacs, E., Cartwright, S., Kovacs, M., Sakamoto, T., Sellers, J. R., Corrie, J. E. T., Webb, M. R., and White, H. D. ( 2006) Biochemistry 45, 13035-13045). The kinetics of ADP and deac-aminoADP dissociation from actomyosin V-HMM, following the power stroke, were determined using double-mixing stopped-flow fluorescence. These used either deac-aminoATP as the substrate with ADP or ATP chase or alternatively ATP as the substrate with either a deac-aminoADP or deac-aminoATP chase. Both sets of experiments show that the observed rate of ADP or deac-aminoADP dissociation from the trail head of actomyosin V-HMM is the same as from actomyosin V-S1. The dissociation of ADP from the lead head is decreased by up to 250-fold.	[Forgacs, Eva; Cartwright, Suzanne; White, Howard D.] Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA; [Corrie, John E. T.; Webb, Martin R.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Sakamoto, Takeshi; Sellers, James R.] NHLBI, Natl Inst Hlth, Lab Mol Physiol, Bethesda, MD 20892 USA	Eastern Virginia Medical School; MRC National Institute for Medical Research; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	White, HD (corresponding author), Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA.	whitehd@evms.edu		Webb, Martin/0000-0002-0134-9621	MRC [MC_U117512742, MC_U117532185] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004229, ZIAHL001786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000209] Funding Source: NIH RePORTER; Medical Research Council [MC_U117512742, MC_U117532185] Funding Source: Medline; NIBIB NIH HHS [EB00209] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; Burgess SA, 2002, BIOPHYS J, V82, p15A; Cremo CR, 2001, J BIOL CHEM, V276, P41465, DOI 10.1074/jbc.M107103200; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; Dunn AR, 2007, NAT STRUCT MOL BIOL, V14, P246, DOI 10.1038/nsmb1206; Eccleston JF, 2001, PRACT APPROACH SER, P201; Forgacs E, 2006, BIOCHEMISTRY-US, V45, P13035, DOI 10.1021/bi060712n; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Olivares AO, 2006, J BIOL CHEM, V281, P31326, DOI 10.1074/jbc.M603898200; Purcell TJ, 2005, P NATL ACAD SCI USA, V102, P13873, DOI 10.1073/pnas.0506441102; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Smith DA, 2004, BIOPHYS J, V87, P442, DOI 10.1529/biophysj.103.037788; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Steffen W, 2003, P NATL ACAD SCI USA, V100, P6434, DOI 10.1073/pnas.1231998100; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; Vale RD, 2003, J CELL BIOL, V163, P445, DOI 10.1083/jcb.200308093; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Webb MR, 2004, BIOCHEMISTRY-US, V43, P14463, DOI 10.1021/bi0486334; White HD, 2003, BIOPHYS J, V84, p116A; Wu XF, 1997, J CELL SCI, V110, P847	30	38	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					766	773		10.1074/jbc.M704313200	http://dx.doi.org/10.1074/jbc.M704313200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17965414	hybrid			2022-12-25	WOS:000252128100015
J	Becker, T; Pfannschmidt, S; Guiard, B; Stojanovski, D; Milenkovic, D; Kutik, S; Pfanner, N; Meisinger, C; Wiedemann, N				Becker, Thomas; Pfannschmidt, Sylvia; Guiard, Bernard; Stojanovski, Diana; Milenkovic, Dusanka; Kutik, Stephan; Pfanner, Nikolaus; Meisinger, Chris; Wiedemann, Nils			Biogenesis of the mitochondrial TOM complex - Mim1 promotes insertion and assembly of signal-anchored receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT CHANNEL; TRANSLOCATION CONTACT SITES; OUTER-MEMBRANE; PREPROTEIN TRANSLOCASE; PRESEQUENCE TRANSLOCASE; INTERMEMBRANE SPACE; ADP/ATP CARRIER; CORE COMPLEX; YEAST; MORPHOLOGY	The translocase of the outer membrane (TOM complex) is the central entry gate for nuclear-encoded mitochondrial precursor proteins. All Tom proteins are also encoded by nuclear genes and synthesized as precursors in the cytosol. The channel-forming beta-barrel protein Tom40 is targeted to mitochondria via Tom receptors and inserted into the outer membrane by the sorting and assembly machinery (SAM complex). A further outer membrane protein, Mim1, plays a less defined role in assembly of Tom40 into the TOM complex. The three receptors Tom20, Tom22, and Tom70 are anchored in the outermembrane by a single transmembrane alpha-helix, located at the N terminus in the case of Tom20 and Tom70 (signal-anchored) or in the C-terminal portion in the case of Tom22(tail-anchored). Insertion of the precursor of Tom22 into the outermembrane requires pre-existing Tom receptors while the import pathway of the precursors of Tom20 and Tom70 is only poorly understood. We report that Mim1 is required for efficient membrane insertion and assembly of Tom20 and Tom70, but not Tom22. We show that Mim1 associates with SAM core components to a large SAM complex, explaining its role in late steps of the assembly pathway of Tom40. We conclude that Mim1 is not only required for biogenesis of the beta-barrel protein Tom40 but also for membrane insertion and assembly of signal-anchored Tom receptors. Thus, Mim1 plays an important role in the efficient assembly of the mitochondrial TOM complex.	[Becker, Thomas; Pfannschmidt, Sylvia; Stojanovski, Diana; Milenkovic, Dusanka; Kutik, Stephan; Pfanner, Nikolaus; Meisinger, Chris; Wiedemann, Nils] Univ Freiburg, Zentrum Biochem & Mol Zellforschung, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Guiard, Bernard] CNRS, Ctr Mol Genet, F-91190 Gif Sur Yvette, France; [Kutik, Stephan] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany	University of Freiburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Freiburg	Pfanner, N (corresponding author), Univ Freiburg, Zentrum Biochem & Mol Zellforschung, Inst Biochem & Mol Biol, Hermann Herder Strasse 7, D-79104 Freiburg, Germany.	nikolaus.pfanner@biochemie.uni-freiburg.de	Pfanner, Nikolaus/AAV-7878-2021; Becker, Thomas/AAS-9404-2020; Meisinger, Chris/J-1110-2014	Meisinger, Chris/0000-0002-8326-3548; Wiedemann, Nils/0000-0001-8305-6728; Stojanovski, Diana/0000-0002-0199-3222				Ahting U, 2005, J BIOL CHEM, V280, P48, DOI 10.1074/jbc.M410905200; Becker L, 2005, J MOL BIOL, V353, P1011, DOI 10.1016/j.jmb.2005.09.019; Beilharz T, 2003, J BIOL CHEM, V278, P8219, DOI 10.1074/jbc.M212725200; Berger KH, 1997, J CELL BIOL, V136, P545, DOI 10.1083/jcb.136.3.545; Boldogh IR, 2003, MOL BIOL CELL, V14, P4618, DOI 10.1091/mbc.E03-04-0225; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; BURGESS SM, 1994, J CELL BIOL, V126, P1375, DOI 10.1083/jcb.126.6.1375; Burri L, 2006, FEBS J, V273, P1507, DOI 10.1111/j.1742-4658.2006.05171.x; Chacinska A, 2003, EMBO J, V22, P5370, DOI 10.1093/emboj/cdg532; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000; Coonrod EM, 2007, TRAFFIC, V8, P500, DOI 10.1111/j.1600-0854.2007.00550.x; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; Dekker PJT, 1998, MOL CELL BIOL, V18, P6515, DOI 10.1128/MCB.18.11.6515; Dembowski M, 2001, J BIOL CHEM, V276, P17679, DOI 10.1074/jbc.M009653200; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Endo T, 2003, J CELL SCI, V116, P3259, DOI 10.1242/jcs.00667; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hoogenraad NJ, 2002, BBA-MOL CELL RES, V1592, P97, DOI 10.1016/S0167-4889(02)00268-9; Hoppins SC, 2004, J BIOL CHEM, V279, P12396, DOI 10.1074/jbc.M313037200; Humphries AD, 2005, J BIOL CHEM, V280, P11535, DOI 10.1074/jbc.M413816200; Ishikawa D, 2004, J CELL BIOL, V166, P621, DOI 10.1083/jcb.200405138; Johnson AE, 2004, NAT STRUCT MOL BIOL, V11, P113, DOI 10.1038/nsmb0204-113; Kanaji S, 2000, J CELL BIOL, V151, P277, DOI 10.1083/jcb.151.2.277; KEIL P, 1993, FEBS LETT, V321, P197, DOI 10.1016/0014-5793(93)80107-6; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Kondo-Okamoto N, 2003, J BIOL CHEM, V278, P48997, DOI 10.1074/jbc.M308436200; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Krimmer T, 2001, J CELL BIOL, V152, P289, DOI 10.1083/jcb.152.2.289; Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Meisinger C, 2007, EMBO J, V26, P2229, DOI 10.1038/sj.emboj.7601673; Meisinger C, 2006, J BIOL CHEM, V281, P22819, DOI 10.1074/jbc.M602679200; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Milenkovic D, 2004, J BIOL CHEM, V279, P22781, DOI 10.1074/jbc.C400120200; MILLAR DG, 1993, J BIOL CHEM, V268, P18403; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Motz C, 2002, J MOL BIOL, V323, P729, DOI 10.1016/S0022-2836(02)00995-6; Nakamura Y, 2004, J BIOL CHEM, V279, P21223, DOI 10.1074/jbc.M314156200; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Pfanner N, 2004, NAT STRUCT MOL BIOL, V11, P1044, DOI 10.1038/nsmb852; Prokisch H, 2000, MOL BIOL CELL, V11, P2961, DOI 10.1091/mbc.11.9.2961; Rapaport D, 2003, EMBO REP, V4, P948, DOI 10.1038/sj.embor.embor937; Ryan MT, 1999, J BIOL CHEM, V274, P20619, DOI 10.1074/jbc.274.29.20619; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHLOSSMANN J, 1995, J BIOL CHEM, V270, P27116, DOI 10.1074/jbc.270.45.27116; SCHNEIDER H, 1991, SCIENCE, V254, P1659, DOI 10.1126/science.1661031; Sesaki H, 2004, J BIOL CHEM, V279, P28298, DOI 10.1074/jbc.M401363200; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; Sherman EL, 2005, MOL BIOL CELL, V16, P4172, DOI 10.1091/mbc.E05-03-0187; SHORE GC, 1995, EUR J BIOCHEM, V227, P9, DOI 10.1111/j.1432-1033.1995.tb20354.x; SIKORSKI RS, 1989, GENETICS, V122, P19; Stojanovski D, 2007, METHOD CELL BIOL, V80, P783, DOI 10.1016/S0091-679X(06)80036-1; Suzuki H, 2002, J CELL SCI, V115, P1895; Suzuki H, 2004, J BIOL CHEM, V279, P50619, DOI 10.1074/jbc.M408604200; Szklarz LKS, 2005, J MOL BIOL, V351, P206, DOI 10.1016/j.jmb.2005.05.068; Truscott KN, 2002, MOL CELL BIOL, V22, P7780, DOI 10.1128/MCB.22.22.7780-7789.2002; van der Laan M, 2006, CURR BIOL, V16, P2271, DOI 10.1016/j.cub.2006.10.025; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; Waizenegger T, 2004, EMBO REP, V5, P704, DOI 10.1038/sj.embor.7400183; Waizenegger T, 2003, J BIOL CHEM, V278, P42064, DOI 10.1074/jbc.M305736200; Waizengger T, 2005, EMBO REP, V6, P57, DOI 10.1038/sj.embor.7400318; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wiedemann N, 2001, EMBO J, V20, P951, DOI 10.1093/emboj/20.5.951; Wiedemann N, 2004, J BIOL CHEM, V279, P18188, DOI 10.1074/jbc.M400050200; YAFFE MP, 1989, J BIOL CHEM, V264, P21091	75	112	113	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					120	127		10.1074/jbc.M706997200	http://dx.doi.org/10.1074/jbc.M706997200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17974559	hybrid			2022-12-25	WOS:000251940300014
J	Tan, AHM; Goh, SYP; Wong, SC; Lam, KP				Tan, Andy Hee-Meng; Goh, Sharon Yun-Pei; Wong, Siew-Cheng; Lam, Kong-Peng			T helper cell-specific regulation of inducible costimulator expression via distinct mechanisms mediated by T-bet and GATA-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-3; ICOS EXPRESSION; MOLECULE ICOS; TH2 DIFFERENTIATION; IMMUNE-RESPONSES; GENE-EXPRESSION; FAMILY-MEMBER; LINEAGE; PROTEIN; IL-4	Inducible costimulator (ICOS) expression is critical for T cell mediated immunity. We showed previously that T cell receptor and CD28 coengagement up-regulate ICOS expression in activated T cells via the induction of NFATc2. Here, we examined the regulation of ICOS expression by Th-specific transcription factors T-bet and GATA-3. Overexpression of T-bet or GATA-3 alone could enhance, and NFATc2 could further synergize with either of them to increase, icos transcription. Although T-bet acted on the icos promoter, GATA-3 operated via an icos 3'-untranslated region element. Interestingly, NFATc2 was found to bind promiscuously the icos promoter in developing Th0, Th1, and Th2 cells but became selectively associated with T-bet at the promoter and with GATA-3 at the 3'-untranslated region in fully differentiated Th1 and Th2 cells, respectively. Collectively, our results reveal a temporally evolving circuit in which the non-selectively expressed NFATc2 cooperates with Th-restricted T-bet or GATA-3 to direct transcription of a costimulatory gene via distinct regulatory elements in different Th cells undergoing differentiation.	[Tan, Andy Hee-Meng; Goh, Sharon Yun-Pei; Wong, Siew-Cheng; Lam, Kong-Peng] Agcy Sci Technol & Res, Singapore Immunol Network Lab Immune Reg, Singapore 138648, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Lam, KP (corresponding author), Agcy Sci Technol & Res, Singapore Immunol Network Lab Immune Reg, 8A Biomed Grove, Immunos Level 3, Singapore 138648, Singapore.	lam_kong_peng@immunol.a-star.edu.sg	Lam, Kong-Peng/G-5374-2012	Lam, Kong-Peng/0000-0002-1316-4333				Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Dong C, 2000, ARTHRITIS RES, V2, P179, DOI 10.1186/ar85; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Glimcher LH, 2000, GENE DEV, V14, P1693; Gonzalo JA, 2001, NAT IMMUNOL, V2, P597, DOI 10.1038/89739; HECHT TT, 1983, J IMMUNOL, V131, P1049; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; HO SN, 1995, J BIOL CHEM, V270, P19898, DOI 10.1074/jbc.270.34.19898; Hofmann A, 1996, P NATL ACAD SCI USA, V93, P5185, DOI 10.1073/pnas.93.11.5185; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwai H, 2002, J IMMUNOL, V169, P4332, DOI 10.4049/jimmunol.169.8.4332; Kopf M, 2000, J EXP MED, V192, P53, DOI 10.1084/jem.192.1.53; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Lohning M, 2003, J EXP MED, V197, P181, DOI 10.1084/jem.20020632; Mak TW, 2003, NAT IMMUNOL, V4, P765, DOI 10.1038/ni947; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nurieva RI, 2003, IMMUNITY, V18, P801, DOI 10.1016/S1074-7613(03)00144-4; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ozkaynak E, 2001, NAT IMMUNOL, V2, P591, DOI 10.1038/89731; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Rao A, 2000, BRIT MED BULL, V56, P969, DOI 10.1258/0007142001903634; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rottman JB, 2001, NAT IMMUNOL, V2, P605, DOI 10.1038/89750; Scales HE, 2004, EUR J IMMUNOL, V34, P2854, DOI 10.1002/eji.200324364; Scott BG, 2004, J NEUROIMMUNOL, V153, P16, DOI 10.1016/j.jneuroim.2004.04.019; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; SIEGEL MD, 1995, J BIOL CHEM, V270, P24548, DOI 10.1074/jbc.270.41.24548; Sperling AI, 2001, NAT IMMUNOL, V2, P573, DOI 10.1038/89709; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Tan AHM, 2006, J BIOL CHEM, V281, P28666, DOI 10.1074/jbc.M604081200; Taylor PA, 2005, BLOOD, V105, P3372, DOI 10.1182/blood-2004-10-3869; Tesciuba AG, 2001, J IMMUNOL, V167, P1996, DOI 10.4049/jimmunol.167.4.1996; TONY HP, 1985, J EXP MED, V162, P1695, DOI 10.1084/jem.162.5.1695; Usui Y, 2006, EUR J IMMUNOL, V36, P3071, DOI 10.1002/eji.200636138; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Villegas EN, 2002, J IMMUNOL, V169, P937, DOI 10.4049/jimmunol.169.2.937; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wassink L, 2004, J IMMUNOL, V173, P1779, DOI 10.4049/jimmunol.173.3.1779; Wong SC, 2003, BLOOD, V102, P1381, DOI 10.1182/blood-2002-08-2416; Yagi J, 2003, J IMMUNOL, V171, P783, DOI 10.4049/jimmunol.171.2.783; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhou M, 2003, IMMUNOL RES, V28, P25, DOI 10.1385/IR:28:1:25	57	29	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					128	136		10.1074/jbc.M707693200	http://dx.doi.org/10.1074/jbc.M707693200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17986443	hybrid			2022-12-25	WOS:000251940300015
J	Ilic, MZ; East, CJ; Rogerson, FM; Fosang, AJ; Handley, CJ				Ilic, Mirna Z.; East, Charlotte J.; Rogerson, Fraser M.; Fosang, Amanda J.; Handley, Christopher J.			Distinguishing aggrecan loss from aggrecan proteolysis in ADAMTS-4 and ADAMTS-5 single and double deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ARTICULAR-CARTILAGE; HUMAN SYNOVIAL-FLUID; CHONDROITIN SULFATE; EXTRACELLULAR-MATRIX; IN-VIVO; CLEAVAGE; DEGRADATION; CATABOLISM; PROTEOGLYCAN; ACTIVATION	Aggrecan loss from mouse cartilage is predominantly because of ADAMTS-5 activity; however, the relative contribution of other proteolytic and nonproteolytic processes to this loss is not clear. This is the first study to compare aggrecan loss with aggrecan processing in mice with single and double deletions of ADAMTS-4 and -5 activity (Delta cat). Cartilage explants harvested from single and double ADAMTS-4 and -5 Delta cat mice were cultured with or without interleukin (IL)-1 alpha or retinoic acid and analyzed for (i) the kinetics of 35S-labeled aggrecan loss, (ii) the pattern of S-35-labeled aggrecan fragments released into the media and retained in the matrix, (iii) the pattern of total aggrecan fragments released into the media and retained in the matrix, and (iv) specific cleavage sites within the interglobular and chondroitin sulfate-2 domains. The loss of radiolabeled aggrecan from ADAMTS-4/-5 Delta cat cartilage was less than that from ADAMTS-4, ADAMTS-5, or wild-type cartilage under nonstimulated conditions. IL-1 alpha and retinoic acid stimulated radiolabeled aggrecan loss from wild-type and ADAMTS-4 Delta cat cartilage, but there was little effect on ADAMTS-5 cartilage. Proteolysis of aggrecan contributed most to its loss in wild-type, ADAMTS-4, and ADAMTS-5 Delta cat cartilage explants. The pattern of proteolytic processing of aggrecan in these cultures was consistent with that occurring in cartilage pathologies. Retinoic acid, but not IL-1 alpha, stimulated radiolabeled aggrecan loss from ADAMTS-4/-5 Delta cat cartilage explants. Even though there was a 300% increase in aggrecan loss from ADAMTS-4/-5 Delta cat cartilage stimulated with retinoic acid, the loss was not associated with aggrecanase cleavage but with the release of predominantly intact aggrecan consistent with the phenotype of the ADAMTS4/-5 Delta cat mouse. Our results show that chondrocytes have additional mechanism for the turnover of aggrecan and that when proteolytic mechanisms are blocked by ablation of aggrecanase activity, nonproteolytic mechanisms compensate to maintain cartilage homeostasis.	[Ilic, Mirna Z.; Handley, Christopher J.] La Trobe Univ, Sch Human Biosci & Muscuoskeletal Res Ctr, Melbourne, Vic 3086, Australia; [East, Charlotte J.; Rogerson, Fraser M.; Fosang, Amanda J.] Univ Melbourne, Royal Melbourne Hosp, Murdoch Childrens Res Inst, Dept Paediat,Arthritis Res Grp, Parkville, Vic 3052, Australia	La Trobe University; Murdoch Children's Research Institute; Royal Melbourne Hospital; University of Melbourne	Ilic, MZ (corresponding author), La Trobe Univ, Sch Human Biosci, Melbourne, Vic 3086, Australia.	m.ilic@latrobe.edu.au		Fosang, Amanda/0000-0002-5523-5427				Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; CAMPBELL MA, 1984, ARCH BIOCHEM BIOPHYS, V234, P275, DOI 10.1016/0003-9861(84)90350-3; Collins-Racie LA, 2004, MATRIX BIOL, V23, P219, DOI 10.1016/j.matbio.2004.05.004; COUCHMAN JR, 1984, NATURE, V307, P650, DOI 10.1038/307650a0; East CJ, 2007, J BIOL CHEM, V282, P8632, DOI 10.1074/jbc.M605750200; Flannery CR, 2002, J BIOL CHEM, V277, P42775, DOI 10.1074/jbc.M205309200; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Gao G, 2002, J BIOL CHEM, V277, P11034, DOI 10.1074/jbc.M107443200; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Glasson SS, 2004, ARTHRITIS RHEUM-US, V50, P2547, DOI 10.1002/art.20558; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; HANDLEY CJ, 1979, BIOCHIM BIOPHYS ACTA, V582, P234, DOI 10.1016/0304-4165(79)90387-8; ILIC MZ, 1995, ARCH BIOCHEM BIOPHYS, V322, P22, DOI 10.1006/abbi.1995.1431; Ilic MZ, 1998, J BIOL CHEM, V273, P17451, DOI 10.1074/jbc.273.28.17451; Ilic MZ, 2000, MATRIX BIOL, V19, P257, DOI 10.1016/S0945-053X(00)00069-X; ILIC MZ, 1992, ARCH BIOCHEM BIOPHYS, V294, P115, DOI 10.1016/0003-9861(92)90144-L; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kuno K, 2000, FEBS LETT, V478, P241, DOI 10.1016/S0014-5793(00)01854-8; Little CB, 2005, ARTHRITIS RHEUM-US, V52, P1461, DOI 10.1002/art.21022; Little CB, 2005, OSTEOARTHR CARTILAGE, V13, P162, DOI 10.1016/j.joca.2004.10.014; LOHMANDER LS, 1993, ARTHRITIS RHEUM, V36, P1214; LOULAKIS P, 1992, BIOCHEM J, V284, P589, DOI 10.1042/bj2840589; Malfait AM, 2002, J BIOL CHEM, V277, P22201, DOI 10.1074/jbc.M200431200; Miwa HE, 2006, MATRIX BIOL, V25, P534, DOI 10.1016/j.matbio.2006.07.004; NG CK, 1992, ARCH BIOCHEM BIOPHYS, V298, P70, DOI 10.1016/0003-9861(92)90095-E; OEGEMA TR, 1979, J BIOL CHEM, V254, P1312; Patwari P, 2005, OSTEOARTHR CARTILAGE, V13, P269, DOI 10.1016/j.joca.2004.10.023; Poon CJ, 2005, J BIOL CHEM, V280, P23615, DOI 10.1074/jbc.M412145200; Pratta MA, 2003, ARTHRITIS RHEUM, V48, P119, DOI 10.1002/art.10726; Pratta MA, 2000, J BIOL CHEM, V275, P39096, DOI 10.1074/jbc.M006201200; ROGERSON F, 2007, T ORTHOP RES SOC SAN, V32, P82; Roughley PJ, 2003, BIOCHEM J, V375, P183, DOI 10.1042/BJ20030609; SANDY JD, 1992, J CLIN INVEST, V89, P1512, DOI 10.1172/JCI115742; SANDY JD, 1991, J BIOL CHEM, V266, P8683; Sandy JD, 2001, BIOCHEM J, V358, P615, DOI 10.1042/0264-6021:3580615; SANDY JD, 1989, BIOCHEM J, V258, P875, DOI 10.1042/bj2580875; Somerville RPT, 2003, J BIOL CHEM, V278, P9503, DOI 10.1074/jbc.M211009200; Song RH, 2007, ARTHRITIS RHEUM-US, V56, P575, DOI 10.1002/art.22334; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Struglics A, 2006, OSTEOARTHR CARTILAGE, V14, P898, DOI 10.1016/j.joca.2006.02.016; Struglics A, 2006, OSTEOARTHR CARTILAGE, V14, P101, DOI 10.1016/j.joca.2005.07.018; Sztrolovics R, 2002, BIOCHEM J, V362, P473, DOI 10.1042/0264-6021:3620473; Tchetina EV, 2005, J RHEUMATOL, V32, P876; Tester AM, 1999, MATRIX BIOL, V18, P65, DOI 10.1016/S0945-053X(99)00004-9; Tortorella M, 2000, J BIOL CHEM, V275, P25791, DOI 10.1074/jbc.M001065200; Tortorella MD, 2000, J BIOL CHEM, V275, P18566, DOI 10.1074/jbc.M909383199; Tortorella MD, 2005, ARCH BIOCHEM BIOPHYS, V444, P34, DOI 10.1016/j.abb.2005.09.018; Tortorella MD, 2002, MATRIX BIOL, V21, P499, DOI 10.1016/S0945-053X(02)00069-0; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; Tortorella MD, 2001, OSTEOARTHR CARTILAGE, V9, P539, DOI 10.1053/joca.2001.0427; Vankemmelbeke MN, 2003, EUR J BIOCHEM, V270, P2394, DOI 10.1046/j.1432-1033.2003.03607.x; Vankemmelbeke MN, 2001, EUR J BIOCHEM, V268, P1259, DOI 10.1046/j.1432-1327.2001.01990.x; WALCZ E, 1994, GENOMICS, V22, P364, DOI 10.1006/geno.1994.1396; Wang P, 2004, J BIOL CHEM, V279, P15434, DOI 10.1074/jbc.M312797200; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200; Zeng WL, 2006, BBA-GEN SUBJECTS, V1760, P517, DOI 10.1016/j.bbagen.2006.01.013	56	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37420	37428		10.1074/jbc.M703184200	http://dx.doi.org/10.1074/jbc.M703184200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17938173	hybrid			2022-12-25	WOS:000251833600016
J	Li, YP; Zhang, ZL; Robinson, GE; Palli, SR				Li, Yiping; Zhang, Zhaolin; Robinson, Gene E.; Palli, Subba R.			Identification and characterization of a juvenile hormone response element and its binding proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL ECDYSONE RECEPTOR; METHOPRENE-TOLERANT GENE; DROSOPHILA-MELANOGASTER; KINASE-C; LOCUSTA-MIGRATORIA; FOLLICLE CELLS; ESTERASE GENE; CHORISTONEURA-FUMIFERANA; INSECTICIDE RESISTANCE; RHODNIUS-PROLIXUS	Juvenile hormones (JH) regulate a wide variety of developmental and physiological processes in insects. Comparison of microarray data on JH-induced genes in the fruit fly, Drosophila melanogaster, L57 cells and in the honey bee, Apis mellifera, identified 16 genes that are induced in both species. Analysis of promoter regions of these 16 D. melanogaster genes identified DmJHRE1 (D. melanogaster JH response element 1). In L57 cells, the reporter gene regulated by DmJHRE1 was induced by JH III. Two proteins (FKBP39 and Chd64) that bind to DmJHRE1 were identified. FKBP39 and Chd64 double-stranded RNA inhibited JH III induction of a reporter gene regulated by DmJHRE1. FKBP39 and Chd64 proteins expressed in yeast bound to DmJHRE1. Two-hybrid and pulldown assays showed that these two proteins interact with each other as well as with ecdysone receptor, ultraspiracle, and methoprene- tolerant protein. Developmental expression profiles and JH induction of mRNA for FKBP39 and Chd64 proteins and their interaction with proteins known to be involved in both JH (methoprene-tolerant protein) and ecdysteroid action (ecdysone receptor and ultraspiracle) suggest that these proteins probably play important roles in cross- talk between JH and ecdysteroids.	[Li, Yiping; Zhang, Zhaolin; Palli, Subba R.] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA; [Robinson, Gene E.] Univ Illinois, Dept Entomol, Program Neurosci, Urbana, IL 61801 USA	University of Kentucky; University of Illinois System; University of Illinois Urbana-Champaign	Palli, SR (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.	rpalli@uky.edu	Zhang, Zhaolin/E-6183-2012; PALLI, SUBBA REDDY/AAU-8289-2020	PALLI, SUBBA REDDY/0000-0002-0873-3247	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070559] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM070559-02, R01 GM070559] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALNEMRI ES, 1994, J BIOL CHEM, V269, P30828; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Berger EM, 2005, VITAM HORM, V73, P175, DOI 10.1016/S0083-6729(05)73006-5; BERGER EM, 1992, DEV BIOL, V151, P410, DOI 10.1016/0012-1606(92)90181-F; BOWNES M, 1987, EUR J BIOCHEM, V164, P709, DOI 10.1111/j.1432-1033.1987.tb11184.x; BOWNES M, 1989, J INSECT PHYSIOL, V35, P409, DOI 10.1016/0022-1910(89)90115-7; CHERBAS L, 1991, GENE DEV, V5, P120, DOI 10.1101/gad.5.1.120; Cherbas L, 1997, GENETICS, V145, P349; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Davidson B, 2001, DEV GENES EVOL, V211, P190, DOI 10.1007/s004270100143; DOBENS L, 1991, MOL CELL BIOL, V11, P1846, DOI 10.1128/MCB.11.4.1846; Dubrovsky EB, 2002, INSECT BIOCHEM MOLEC, V32, P1555, DOI 10.1016/S0965-1748(02)00076-0; Dubrovsky EB, 2000, DEV BIOL, V224, P486, DOI 10.1006/dbio.2000.9800; Feng QL, 1999, MOL CELL ENDOCRINOL, V148, P95, DOI 10.1016/S0303-7207(98)00228-7; GLINKA AV, 1995, BIOCHEM MOL BIOL INT, V35, P323; Godlewski J, 2006, BIOCHEM BIOPH RES CO, V342, P1305, DOI 10.1016/j.bbrc.2006.02.097; HENRICH VC, 2005, COMPREHENSIVE MOL IN, V3, P243; Hirai M, 1998, INSECT BIOCHEM MOLEC, V28, P181, DOI 10.1016/S0965-1748(97)00116-1; Hu X, 2003, MOL ENDOCRINOL, V17, P716, DOI 10.1210/me.2002-0287; IYENGAR AR, 1995, DEV BIOL, V170, P314, DOI 10.1006/dbio.1995.1217; Jones G, 1997, P NATL ACAD SCI USA, V94, P13499, DOI 10.1073/pnas.94.25.13499; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; Kethidi DR, 2006, MOL CELL ENDOCRINOL, V247, P127, DOI 10.1016/j.mce.2005.12.016; Kethidi DR, 2005, J INSECT PHYSIOL, V51, P393, DOI 10.1016/j.jinsphys.2004.12.007; Kethidi DR, 2004, J BIOL CHEM, V279, P19634, DOI 10.1074/jbc.M311647200; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Maki A, 2004, BIOCHEM BIOPH RES CO, V320, P262, DOI 10.1016/j.bbrc.2004.05.156; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Palli SR, 2005, VITAM HORM, V73, P59, DOI 10.1016/S0083-6729(05)73003-X; Panguluri SK, 2006, FEBS J, V273, P5550, DOI 10.1111/j.1742-4658.2006.05545.x; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pursley S, 2000, INSECT BIOCHEM MOLEC, V30, P839, DOI 10.1016/S0965-1748(00)00056-4; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; Riddiford LM, 1996, ARCH INSECT BIOCHEM, V32, P271, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;271::AID-ARCH2&gt;3.0.CO;2-W; SEVALA VL, 1993, INVERTEBR REPROD DEV, V23, P189, DOI 10.1080/07924259.1993.9672314; SEVALA VL, 1989, EXPERIENTIA, V45, P355, DOI 10.1007/BF01957476; SEVALA VL, 1995, INSECT BIOCHEM MOLEC, V25, P267, DOI 10.1016/0965-1748(94)00065-P; Sinha S, 2006, P NATL ACAD SCI USA, V103, P16352, DOI 10.1073/pnas.0607448103; Song QS, 1997, INSECT BIOCHEM MOLEC, V27, P973, DOI 10.1016/S0965-1748(97)00080-5; Swevers L, 1996, INSECT BIOCHEM MOLEC, V26, P217, DOI 10.1016/0965-1748(95)00097-6; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; Truman JW, 2006, SCIENCE, V312, P1385, DOI 10.1126/science.1123652; VENKATARAMAN V, 1994, DEV GENET, V15, P391, DOI 10.1002/dvg.1020150502; Whitfield CW, 2006, P NATL ACAD SCI USA, V103, P16068, DOI 10.1073/pnas.0606909103; Wilson TG, 1998, P NATL ACAD SCI USA, V95, P14040, DOI 10.1073/pnas.95.24.14040; Wilson TG, 2006, GENETICS, V172, P253, DOI 10.1534/genetics.105.046631; WILSON TG, 1986, DEV BIOL, V118, P190, DOI 10.1016/0012-1606(86)90087-4; Wilson TG, 1996, ARCH INSECT BIOCHEM, V32, P641, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;641::AID-ARCH35&gt;3.0.CO;2-A; Wilson TG, 2006, MOL GENET GENOMICS, V276, P294, DOI 10.1007/s00438-006-0138-4; Wu Y, 2006, MECH DEVELOP, V123, P530, DOI 10.1016/j.mod.2006.05.005; Xu Y, 2002, EUR J BIOCHEM, V269, P6026, DOI 10.1046/j.1432-1033.2002.03293.x; YAMAMOTO K, 1988, SCIENCE, V239, P916, DOI 10.1126/science.3124270; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Zhang JZ, 1996, GENE, V175, P193, DOI 10.1016/0378-1119(96)00147-3; Zhang JZ, 1996, MOL CELL ENDOCRINOL, V122, P15, DOI 10.1016/0303-7207(96)03884-1; Zhou S, 2006, INSECT BIOCHEM MOLEC, V36, P726, DOI 10.1016/j.ibmb.2006.06.004; Zhou S, 2002, MOL CELL ENDOCRINOL, V190, P177, DOI 10.1016/S0303-7207(01)00602-5; Zhu HN, 2002, ANAL CHEM, V74, P1687, DOI 10.1021/ac010853p	60	80	87	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37605	37617		10.1074/jbc.M704595200	http://dx.doi.org/10.1074/jbc.M704595200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17956872	hybrid, Green Accepted			2022-12-25	WOS:000251833600036
J	Liu, YV; Hubbi, ME; Pan, F; McDonald, KR; Mansharamani, M; Cole, RN; Liu, JO; Semenza, GL				Liu, Ye V.; Hubbi, Maimon E.; Pan, Fan; McDonald, Karin R.; Mansharamani, Malini; Cole, Robert N.; Liu, Jun O.; Semenza, Gregg L.			Calcineurin promotes hypoxia-inducible factor 1 alpha expression by dephosphorylating RACK1 and blocking RACK1 dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; FACTOR 1-ALPHA; TRANSCRIPTIONAL ACTIVITY; CYCLOSPORINE-A; SCAFFOLD PROTEIN; BINDING-PROTEIN; HIF-ALPHA; HIF-1-ALPHA; DEGRADATION; INHIBITION	Oxygen homeostasis represents an essential organizing principle of metazoan evolution and biology. Hypoxia-inducible factor 1 (HIF-1) is a master regulator of transcriptional responses to changes in O-2 concentration. HIF-1 is a heterodimer of HIF-1 alpha and HIF-1 beta subunits. O-2-dependent degradation of the HIF- 1 alpha subunit is mediated by prolyl hydroxylase, von Hippel-Lindau protein (VHL)/Elongin-C E3 ubiquitin ligase, and the proteasome. O-2-independent degradation of HIF- 1 alpha is regulated by the competition of RACK1 and HSP90 for binding to HIF- 1 alpha. RACK1 binding results in the recruitment of the Elongin-C E3 ubiquitin ligase, leading to VHL-independent ubiquitination and degradation of HIF- 1 alpha. In this report, we show that calcineurin inhibits the ubiquitination and proteasomal degradation of HIF- 1 alpha. Calcineurin is a serine/threonine phosphatase that is activated by calcium and calmodulin. The phosphatase activity of calcineurin is required for its regulation of HIF- 1 alpha. RACK1 binds to the catalytic domain of calcineurin and is required for HIF- 1 alpha degradation induced by the calcineurin inhibitor cyclosporine A. Elongin-C and HIF- 1 alpha each bind to RACK1 and dimerization of RACK1 is required to recruit Elongin-C to HIF-1 alpha. Phosphorylation of RACK1 promotes its dimerization and dephosphorylation by calcineurin inhibits dimerization. Serine 146 within the dimerization domain is phosphorylated and mutation of serine 146 impairs RACK1 dimerization and HIF- 1 alpha degradation. These results indicate that intracellular calcium levels can regulate HIF- 1 alpha expression by modulating calcineurin activity and RACK1 dimerization.	[Liu, Ye V.; Hubbi, Maimon E.; McDonald, Karin R.; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn, Baltimore, MD 21205 USA; [Liu, Ye V.; McDonald, Karin R.; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Hubbi, Maimon E.] Johns Hopkins Univ, Sch Med, Grad Training Program Cellular & Mol Med, Baltimore, MD 21205 USA; [Pan, Fan; Liu, Jun O.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Mass Spectrometry Proteom Facil, Baltimore, MD 21205 USA; [Mansharamani, Malini; Cole, Robert N.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Semenza, GL (corresponding author), Broadway Res Bldg,Suite 671,733 N Broadway, Baltimore, MD 21205 USA.	gsemenza@jhmi.edu		Hubbi, Maimon/0000-0001-9763-287X	NHLBI NIH HHS [N01-HV28180, N01HV28180, N01 HV028180] Funding Source: Medline; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; D'Angelo G, 2003, J BIOL CHEM, V278, P15406, DOI 10.1074/jbc.M211293200; Ebert BL, 1998, MOL CELL BIOL, V18, P4089, DOI 10.1128/MCB.18.7.4089; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huai Q, 2002, P NATL ACAD SCI USA, V99, P12037, DOI 10.1073/pnas.192206699; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Hui AS, 2006, FASEB J, V20, P466, DOI 10.1096/fj.05-5086com; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Ivan M, 2001, CURR OPIN GENET DEV, V11, P27, DOI 10.1016/S0959-437X(00)00152-0; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kiely PA, 2006, MOL CELL BIOL, V26, P4041, DOI 10.1128/MCB.01868-05; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Kong XG, 2006, FEBS LETT, V580, P6182, DOI 10.1016/j.febslet.2006.10.019; Koulmann N, 2006, AM J RESP CRIT CARE, V174, P699, DOI 10.1164/rccm.200512-1976OC; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Licht AH, 2006, BLOOD, V107, P584, DOI 10.1182/blood-2005-07-3033; Lin X, 1999, J BIOL CHEM, V274, P36125, DOI 10.1074/jbc.274.51.36125; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu YV, 2007, CELL CYCLE, V6, P656, DOI 10.4161/cc.6.6.3981; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Patterson RL, 2004, P NATL ACAD SCI USA, V101, P2328, DOI 10.1073/pnas.0308567100; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Semenza GL, 2006, EXPERT OPIN THER TAR, V10, P267, DOI 10.1517/14728222.10.2.267; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Sun L, 1998, IMMUNITY, V8, P703, DOI 10.1016/S1074-7613(00)80575-0; Thornton C, 2004, J BIOL CHEM, V279, P31357, DOI 10.1074/jbc.M402316200; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang J, 2006, CIRC RES, V98, P1528, DOI 10.1161/01.RES.0000227551.68124.98; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; Yuan GX, 2005, J BIOL CHEM, V280, P4321, DOI 10.1074/jbc.M407706200	51	120	131	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37064	37073		10.1074/jbc.M705015200	http://dx.doi.org/10.1074/jbc.M705015200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17965024	hybrid, Green Accepted			2022-12-25	WOS:000251646000033
J	Puca, A; Fiume, G; Palmieri, C; Trimboli, F; Olimpico, F; Scala, G; Quinto, I				Puca, Antimina; Fiume, Giuseppe; Palmieri, Camillo; Trimboli, Francesca; Olimpico, Francesco; Scala, Giuseppe; Quinto, Ileana			I kappa B-alpha represses the transcriptional activity of the HIV-1 Tat transactivator by promoting its nuclear export	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEOLYSIS-RESISTANT INHIBITOR; LONG TERMINAL REPEAT; TYPE-1 TAT; EXPRESSION; BINDING; PROTEIN; SIGNAL; ACTIVATION; GENE	The long terminal repeat of human immunodeficiency virus, type 1 (HIV-1) contains an NF-kappa B enhancer and is potently inhibited by I kappa B-alpha S32/36A, a proteolysis-resistant inhibitor of NF-kappa B transacting factors. The evidence that NF-kappa B is dispensable for HIV-1 expression raises the question of whether I kappa B-alpha represses the HIV-1 transcription by mechanisms distinct from NF-kappa B inhibition. Here, we report that I kappa B-alpha negatively regulates the HIV-1 expression and replication in an NF-kappa B-independent manner by directly binding to Tat, which results in the nuclear export and cytoplasmic sequestration of the viral transactivator. The sequence of I kappa B-alpha required for Tat inhibition spans from amino acids 72 to 287 and includes the nuclear localization signal, the carboxyl-terminal nuclear export signal, and the binding site for the arginine-rich domain of Tat. This novel mechanism of cross-talk between Tat and I kappa B-alpha provides further insights into the mechanisms of HIV-1 regulation and could assist in the development of novel strategies for AIDS therapy.	[Palmieri, Camillo; Trimboli, Francesca; Scala, Giuseppe; Quinto, Ileana] Univ Catanzaro Magna Graecia, Dept Expt & Clin Med, I-88100 Catanzaro, Italy; [Puca, Antimina; Fiume, Giuseppe; Olimpico, Francesco; Scala, Giuseppe; Quinto, Ileana] Univ Naples Federico II, Dept Biochem & Med Biotechnol, I-80131 Naples, Italy	Magna Graecia University of Catanzaro; University of Naples Federico II	Quinto, I (corresponding author), Univ Catanzaro Magna Graecia, Dept Expt & Clin Med, Biosci Bldg,Viale Europa Germaneto, I-88100 Catanzaro, Italy.	quinto@unicz.it	SCALA, GIUSEPPE/A-3280-2009; Trimboli, Francesca/Y-1143-2019; Palmieri, Camillo/A-3195-2009	Trimboli, Francesca/0000-0002-1766-9179; Palmieri, Camillo/0000-0001-6707-4723; FIUME, Giuseppe/0000-0002-5414-6190; QUINTO, Ileana/0000-0001-8212-8515				Ambrosino C, 1997, J BIOL CHEM, V272, P14883, DOI 10.1074/jbc.272.23.14883; ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Asin S, 1999, J VIROL, V73, P3893, DOI 10.1128/JVI.73.5.3893-3903.1999; Bachelerie F, 1997, J CELL SCI, V110, P2883; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Benkirane M, 1998, J BIOL CHEM, V273, P24898, DOI 10.1074/jbc.273.38.24898; BERKHOUT B, 1989, CELL, V59, P273, DOI 10.1016/0092-8674(89)90289-4; BERKHOUT B, 1992, J VIROL, V66, P139, DOI 10.1128/JVI.66.1.139-149.1992; Bossis G, 2002, FEBS LETT, V516, P257, DOI 10.1016/S0014-5793(02)02566-8; Brady J, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-69; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Brussel A, 2003, J VIROL, V77, P10119, DOI 10.1128/JVI.77.18.10119-10124.2003; BUONAGURO L, 1992, J VIROL, V66, P7159, DOI 10.1128/JVI.66.12.7159-7167.1992; Carlotti F, 1999, J BIOL CHEM, V274, P37941, DOI 10.1074/jbc.274.53.37941; Chen BK, 1997, J VIROL, V71, P5495, DOI 10.1128/JVI.71.7.5495-5504.1997; Coiras M, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-56; DAYTON AI, 1986, CELL, V44, P941, DOI 10.1016/0092-8674(86)90017-6; DeLuca C, 1996, J VIROL, V70, P5183, DOI 10.1128/JVI.70.8.5183-5193.1996; Demarchi F, 1996, J VIROL, V70, P4427, DOI 10.1128/JVI.70.7.4427-4437.1996; FISHER AG, 1986, NATURE, V320, P367, DOI 10.1038/320367a0; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Harhaj E, 1996, VIROLOGY, V216, P284, DOI 10.1006/viro.1996.0062; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; HERRMANN CH, 1995, J VIROL, V69, P1612, DOI 10.1128/JVI.69.3.1612-1620.1995; Hiscott J, 2001, J CLIN INVEST, V107, P143, DOI 10.1172/JCI11918; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hotttiger MO, 1998, J VIROL, V72, P8252, DOI 10.1128/JVI.72.10.8252-8256.1998; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; JEANG KT, 1993, J VIROL, V67, P6224, DOI 10.1128/JVI.67.10.6224-6233.1993; Johnson C, 1999, EMBO J, V18, P6682, DOI 10.1093/emboj/18.23.6682; KASHANCHI F, 1994, NATURE, V367, P295, DOI 10.1038/367295a0; Kwon H, 1998, J BIOL CHEM, V273, P7431, DOI 10.1074/jbc.273.13.7431; LEONARD J, 1989, J VIROL, V63, P4919, DOI 10.1128/JVI.63.11.4919-4924.1989; Li XG, 2001, BIOCHEM BIOPH RES CO, V286, P587, DOI 10.1006/bbrc.2001.5442; LIU JS, 1992, J VIROL, V66, P3883, DOI 10.1128/JVI.66.6.3883-3887.1992; Liu WM, 2001, NAT IMMUNOL, V2, P939, DOI 10.1038/ni1001-939; Mallardo M, 1996, J BIOL CHEM, V271, P20820, DOI 10.1074/jbc.271.34.20820; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Marzio G, 1998, P NATL ACAD SCI USA, V95, P13519, DOI 10.1073/pnas.95.23.13519; MCELHINNY JA, 1995, J VIROL, V69, P1500, DOI 10.1128/JVI.69.3.1500-1509.1995; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Pereira LA, 2000, NUCLEIC ACIDS RES, V28, P663, DOI 10.1093/nar/28.3.663; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Prigent M, 2000, J BIOL CHEM, V275, P36441, DOI 10.1074/jbc.M004751200; Quinto I, 1999, J BIOL CHEM, V274, P17567, DOI 10.1074/jbc.274.25.17567; Quinto I, 2004, J BIOL CHEM, V279, P1720, DOI 10.1074/jbc.M309375200; Raha T, 2005, PLOS BIOL, V3, P221, DOI 10.1371/journal.pbio.0030044; Rodriguez MS, 1999, J BIOL CHEM, V274, P9108, DOI 10.1074/jbc.274.13.9108; Sachdev S, 2000, MOL CELL BIOL, V20, P1571, DOI 10.1128/MCB.20.5.1571-1582.2000; Sachdev S, 1998, MOL CELL BIOL, V18, P2524, DOI 10.1128/MCB.18.5.2524; SCALA G, 1994, J EXP MED, V179, P961, DOI 10.1084/jem.179.3.961; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Tam WF, 2000, MOL CELL BIOL, V20, P2269, DOI 10.1128/MCB.20.6.2269-2284.2000; Turpin P, 1999, J BIOL CHEM, V274, P6804, DOI 10.1074/jbc.274.10.6804; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; WESTENDORP MO, 1994, J VIROL, V68, P4177, DOI 10.1128/JVI.68.7.4177-4185.1994; Wu Yuntao, 2004, Retrovirology, V1, P13, DOI 10.1186/1742-4690-1-13; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	63	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37146	37157		10.1074/jbc.M705815200	http://dx.doi.org/10.1074/jbc.M705815200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17942396	hybrid			2022-12-25	WOS:000251646000041
J	Shao, W; Yeretssian, G; Doiron, K; Hussain, SN; Saleh, M				Shao, Wei; Yeretssian, Garabet; Doiron, Karine; Hussain, Sabah N.; Saleh, Maya			The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAS-INDUCED APOPTOSIS; INTERLEUKIN-1-BETA CONVERTING-ENZYME; INFLAMMATORY CELL-DEATH; ENERGY-METABOLISM; HUMAN-NEUTROPHILS; PROTEOME ANALYSIS; MICE DEFICIENT; CLEAVAGE; ACTIVATION; SEPSIS	Caspase-1 is an essential effector of inflammation, pyroptosis, and septic shock. Few caspase-1 substrates have been identified to date, and these substrates do not account for its wide range of actions. To understand the function of caspase-1, we initiated the systematic identification of its cellular substrates. Using the diagonal gel proteomic approach, we identified 41 proteins that are directly cleaved by caspase-1. Among these were chaperones, cytoskeletal and translation machinery proteins, and proteins involved in immunity. A series of unexpected proteins along the glycolysis pathway were also identified, including aldolase, triose-phosphate isomerase, glyceraldehyde-3-phosphate dehydrogenase, alpha-enolase, and pyruvate kinase. With the exception of the latter, the identified glycolysis enzymes were specifically cleaved in vitro by recombinant caspase-1, but not caspase-3. The enzymatic activity of wild-type glyceraldehyde-3-phosphate dehydrogenase, but not a non-cleavable mutant, was dampened by caspase-1 processing. In vivo, stimuli that fully activated caspase-1, including Salmonella typhimurium infection and septic shock, caused a pronounced processing of these proteins in the macrophage and diaphragm muscle, respectively. Notably, these stimuli inhibited glycolysis in wildtype cells compared with caspase-1-deficient cells. The systematic characterization of caspase-1 substrates identifies the glycolysis pathway as a caspase-1 target and provides new insights into its function during pyroptosis and septic shock.	McGill Univ, Ctr Hlth, Dept Biochem, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Med, Div Crit Care, Montreal, PQ H3A 1A1, Canada; McGill Univ, Ctr Study Host Resistance, Montreal, PQ H3A 1A1, Canada	McGill University; McGill University; McGill University	Saleh, M (corresponding author), McGill Univ, Ctr Hlth, Dept Biochem, Rm M11-41,687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	maya.saleh@mcgill.ca	Hussain, Sabah/ABC-5315-2021	Saleh, Maya/0000-0003-1538-9146				BORREGAARD N, 1982, J CLIN INVEST, V70, P550, DOI 10.1172/JCI110647; Brockstedt E, 1998, J BIOL CHEM, V273, P28057, DOI 10.1074/jbc.273.43.28057; Browne KA, 2000, J BIOL CHEM, V275, P39262, DOI 10.1074/jbc.C000622200; Byun Y, 2001, CELL DEATH DIFFER, V8, P443, DOI 10.1038/sj.cdd.4400840; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Demontis S, 2006, CELL DEATH DIFFER, V13, P335, DOI 10.1038/sj.cdd.4401744; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gerner C, 2000, J BIOL CHEM, V275, P39018, DOI 10.1074/jbc.M006495200; GU Y, 1995, J BIOL CHEM, V270, P18715, DOI 10.1074/jbc.270.32.18715; Haji-Michael PG, 1999, METABOLISM, V48, P779, DOI 10.1016/S0026-0495(99)90179-8; Hussain SNA, 1998, MOL CELL BIOCHEM, V179, P125, DOI 10.1023/A:1006864021783; Kawaguchi T, 2001, J BIOL CHEM, V276, P28554, DOI 10.1074/jbc.M101396200; KELLETT DN, 1966, J PHARM PHARMACOL, V18, P199, DOI 10.1111/j.2042-7158.1966.tb07853.x; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Mashima T, 1997, ONCOGENE, V14, P1007, DOI 10.1038/sj.onc.1200919; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Monack DM, 2001, MICROBES INFECT, V3, P1201, DOI 10.1016/S1286-4579(01)01480-0; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Prasad S, 1998, INT J ONCOL, V13, P757; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Saleh M, 2007, CELL DEATH DIFFER, V14, P1559, DOI 10.1038/sj.cdd.4402203; Sarkar A, 2006, AM J RESP CRIT CARE, V174, P1003, DOI 10.1164/rccm.200604-546OC; Scott AM, 2007, CELL DEATH DIFFER, V14, P23, DOI 10.1038/sj.cdd.4402026; SIMCHOWITZ L, 1979, ARTHRITIS RHEUM, V22, P755, DOI 10.1002/art.1780220711; Swanson MS, 2005, AUTOPHAGY, V1, P174, DOI 10.4161/auto.1.3.2067; Thiede B, 2001, J BIOL CHEM, V276, P26044, DOI 10.1074/jbc.M101062200; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Van Damme P, 2005, NAT METHODS, V2, P771, DOI 10.1038/NMETH792; van de Water B, 2000, J BIOL CHEM, V275, P25805, DOI 10.1074/jbc.M001680200; WEISDORF DJ, 1982, BLOOD, V60, P888; WEISDORF DJ, 1982, INFLAMMATION, V6, P245, DOI 10.1007/BF00916406	40	249	254	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36321	36329		10.1074/jbc.M708182200	http://dx.doi.org/10.1074/jbc.M708182200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17959595	hybrid			2022-12-25	WOS:000251458300023
J	Yang, YB; Yin, C; Pandey, A; Abbott, D; Sassetti, C; Kelliher, MA				Yang, Yibin; Yin, Catherine; Pandey, Amit; Abbott, Derek; Sassetti, Christopher; Kelliher, Michelle A.			NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR; INNATE IMMUNE-RESPONSES; NF-KAPPA-B; HOST RECOGNITION; PEPTIDOGLYCAN; MACROPHAGES; SYSTEMS; PROTEIN; MYD88; TLR4	The Rip2 kinase contains a caspase recruitment domain and has been implicated in the activation of the transcriptional factor NF-kappa B downstream of Toll-like receptors, Nod-like receptors, and the T cell receptor. Although Rip2 has been linked to Nod signaling, how Nod-Rip2 proteins mediate NF-kappa B activation has remained unclear. We find Rip2 required for Nod2-mediated NF-kappa B activation and to a lesser extent mitogen-activated protein kinase activation. We demonstrate that Rip2 and I kappa B kinase-gamma become stably polyubiquitinated upon treatment of cells with the NOD2 ligand, muramyl dipeptide. We also demonstrate a requirement for the E2-conjugating enzyme Ubc13, the E3 ubiquitin ligase Traf6, and the ubiquitin-activated kinase Tak1 in Nod2-mediated NF-kappa B activation. Rip2 polyubiquitination is also stimulated when macrophages are infected with live Mycobacterium tuberculosis but not when infected with heat-killed bacteria. Consistent with our data linking Rip2 to NOD and not Toll-like receptor signaling, M. tuberculosis-induced Rip2 polyubiquitination appears MyD88-independent. Collectively, these data reveal that the NOD2 pathway is ubiquitin-regulated and that Rip2 employs a ubiquitin-dependent mechanism to achieve NF-kappa B activation.	Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Case Western Reserve University	Kelliher, MA (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, 364 Plantat St, Worcester, MA 01605 USA.	michelle.kelliher@umassmed.edu		Abbott, Derek/0000-0003-4387-8094	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064282] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034; Fremond CM, 2004, J CLIN INVEST, V114, P1790, DOI 10.1172/JCI200421027; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hise AG, 2007, J IMMUNOL, V178, P1068, DOI 10.4049/jimmunol.178.2.1068; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Mazzaccaro RJ, 1996, P NATL ACAD SCI USA, V93, P11786, DOI 10.1073/pnas.93.21.11786; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Means TK, 2001, J IMMUNOL, V166, P4074, DOI 10.4049/jimmunol.166.6.4074; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Shi SP, 2005, J IMMUNOL, V175, P3318, DOI 10.4049/jimmunol.175.5.3318; Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143; Teitelbaum R, 1999, P NATL ACAD SCI USA, V96, P15190, DOI 10.1073/pnas.96.26.15190	25	180	191	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36223	36229		10.1074/jbc.M703079200	http://dx.doi.org/10.1074/jbc.M703079200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17947236	hybrid			2022-12-25	WOS:000251458300012
J	Mora, L; Heurgue-Hamard, V; de Zamaroczy, M; Kervestin, S; Buckingham, RH				Mora, Liliana; Heurgue-Hamard, Valerie; de Zamaroczy, Miklos; Kervestin, Stephanie; Buckingham, Richard H.			Methylation of bacterial release factors RF1 and RF2 is required for normal translation termination in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED GGQ MOTIF; ESCHERICHIA-COLI; FACTOR-II; NUCLEOTIDE-SEQUENCE; MESSENGER-RNA; STOP CODONS; AMINO-ACID; GENE; EXPRESSION; MUTATIONS	Bacterial release factors RF1 and RF2 are methylated on the Gln residue of a universally conserved tripeptide motif GGQ, which interacts with the peptidyl transferase center of the large ribosomal subunit, triggering hydrolysis of the ester bond in peptidyl-tRNA and releasing the newly synthesized polypeptide from the ribosome. In vitro experiments have shown that the activity of RF2 is stimulated by Gln methylation. The viability of Escherichia coli K12 strains depends on the integrity of the release factor methyltransferase PrmC, because K12 strains are partially deficient in RF2 activity due to the presence of a Thr residue at position 246 instead of Ala. Here, we study in vivo RF1 and RF2 activity at termination codons in competition with programmed frameshifting and the effect of the Ala-246 -> Thr mutation. PrmC inactivation reduces the specific termination activity of RF1 and RF2(Ala-246) by similar to 3- to 4-fold. The mutation Ala-246 -> Thr in RF2 reduces the termination activity in cells similar to 5-fold. After correction for the decrease in level of RF2 due to the autocontrol of RF2 synthesis, the mutation Ala-246 -> Thr reduced RF2 termination activity by similar to 10-fold at UGA codons and UAA codons. PrmC inactivation had no effect on cell growth in rich media but reduced growth considerably on poor carbon sources. This suggests that the expression of some genes needed for optimal growth under such conditions can become growth limiting as a result of inefficient translation termination.	Inst Biol Physicochim, CNRS, UPR 9073, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS)	Buckingham, RH (corresponding author), Inst Biol Physicochim, CNRS, UPR 9073, 13 Rue Pierre & Marie Curie, F-75005 Paris, France.	richard.buckingham@ibpc.fr		Buckingham, Richard/0000-0002-8567-4500; HEURGUE-HAMARD, VALERIE/0000-0003-1576-7231				ADAMSKI FM, 1994, J MOL BIOL, V238, P302, DOI 10.1006/jmbi.1994.1293; Arkov AL, 1998, J BACTERIOL, V180, P2744, DOI 10.1128/JB.180.10.2744-2748.1998; Bachmann B.J., 1987, ESCHERICHIA COLI SAL, P1190; Collier J, 2002, MOL MICROBIOL, V45, P745, DOI 10.1046/j.1365-2958.2002.03045.x; COULONDRE C, 1977, J MOL BIOL, V117, P525, DOI 10.1016/0022-2836(77)90056-0; CRAIGEN WJ, 1986, NATURE, V322, P273, DOI 10.1038/322273a0; CRAIGEN WJ, 1985, P NATL ACAD SCI USA, V82, P3616, DOI 10.1073/pnas.82.11.3616; CURRAN JF, 1988, J MOL BIOL, V203, P75, DOI 10.1016/0022-2836(88)90092-7; CURRAN JF, 1989, J MOL BIOL, V209, P65, DOI 10.1016/0022-2836(89)90170-8; Dahlgren A, 2004, BIOCHIMIE, V86, P431, DOI 10.1016/j.biochi.2004.06.009; Dincbas-Renqvist V, 2000, EMBO J, V19, P6900, DOI 10.1093/emboj/19.24.6900; ELLIOTT T, 1989, J BACTERIOL, V171, P3948, DOI 10.1128/jb.171.7.3948-3960.1989; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; Graille M, 2005, MOL CELL, V20, P917, DOI 10.1016/j.molcel.2005.10.025; HAMILTON CM, 1989, J BACTERIOL, V171, P4617, DOI 10.1128/jb.171.9.4617-4622.1989; Heurgue-Hamard V, 2005, J BIOL CHEM, V280, P2439, DOI 10.1074/jbc.M407252200; Heurgue-Hamard V, 2002, EMBO J, V21, P769, DOI 10.1093/emboj/21.4.769; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Jin HN, 2002, EMBO J, V21, P4357, DOI 10.1093/emboj/cdf424; Kaczanowska M, 2004, J BACTERIOL, V186, P3046, DOI 10.1128/JB.186.10.3046-3055.2004; KAWAKAMI K, 1990, P NATL ACAD SCI USA, V87, P8432, DOI 10.1073/pnas.87.21.8432; KAWAKAMI K, 1988, J BACTERIOL, V170, P5378, DOI 10.1128/jb.170.11.5378-5381.1988; Kisselev L, 2003, EMBO J, V22, P175, DOI 10.1093/emboj/cdg017; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li X, 2007, MOL MICROBIOL, V63, P116, DOI 10.1111/j.1365-2958.2006.05498.x; Liu MZ, 2005, J BIOL CHEM, V280, P15921, DOI 10.1074/jbc.M414050200; Miller J.H., 1972, EXPT MOL GENETICS; Mora L, 2003, MOL MICROBIOL, V47, P267, DOI 10.1046/j.1365-2958.2003.03301.x; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Nakahigashi K, 2002, P NATL ACAD SCI USA, V99, P1473, DOI 10.1073/pnas.032488499; NEIDHARDT FC, 1977, J BACTERIOL, V129, P378, DOI 10.1128/JB.129.1.378-387.1977; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Polevoda B, 2006, J BIOL CHEM, V281, P2562, DOI 10.1074/jbc.M507651200; POOLE ES, 1995, EMBO J, V14, P151, DOI 10.1002/j.1460-2075.1995.tb06985.x; RYDEN SM, 1984, MOL GEN GENET, V193, P38, DOI 10.1007/BF00327411; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SINGER M, 1989, MICROBIOL REV, V53, P1; STORMO GD, 1986, NUCLEIC ACIDS RES, V14, P6661, DOI 10.1093/nar/14.16.6661; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Trobro S, 2007, MOL CELL, V27, P758, DOI 10.1016/j.molcel.2007.06.032; Uno M, 1996, BIOCHIMIE, V78, P935, DOI 10.1016/S0300-9084(97)86715-6; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; WEISS RB, 1984, J BACTERIOL, V158, P362, DOI 10.1128/JB.158.1.362-364.1984	46	45	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35638	35645		10.1074/jbc.M706076200	http://dx.doi.org/10.1074/jbc.M706076200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17932046	hybrid			2022-12-25	WOS:000251458100024
J	Kelley, DJ; Farhoud, M; Meyerand, ME; Nelson, DL; Ramirez, LF; Dempsey, RJ; Wolf, AJ; Alexander, AL; Davidson, RJ				Kelley, Daniel J.; Farhoud, Mohammed; Meyerand, M. Elizabeth; Nelson, David L.; Ramirez, Lincoln F.; Dempsey, Robert J.; Wolf, Alan J.; Alexander, Andrew L.; Davidson, Richard J.			Creating Physical 3D Stereolithograph Models of Brain and Skull	PLOS ONE			English	Article								The human brain and skull are three dimensional (3D) anatomical structures with complex surfaces. However, medical images are often two dimensional (2D) and provide incomplete visualization of structural morphology. To overcome this loss in dimension, we developed and validated a freely available, semi-automated pathway to build 3D virtual reality (VR) and hand-held, stereolithograph models. To evaluate whether surface visualization in 3D was more informative than in 2D, undergraduate students (n = 50) used the Gillespie scale to rate 3D VR and physical models of both a living patient-volunteer's brain and the skull of Phineas Gage, a historically famous railroad worker whose misfortune with a projectile tamping iron provided the first evidence of a structure-function relationship in brain. Using our processing pathway, we successfully fabricated human brain and skull replicas and validated that the stereolithograph model preserved the scale of the VR model. Based on the Gillespie ratings, students indicated that the biological utility and quality of visual information at the surface of VR and stereolithograph models were greater than the 2D images from which they were derived. The method we developed is useful to create VR and stereolithograph 3D models from medical images and can be used to model hard or soft tissue in living or preserved specimens. Compared to 2D images, VR and stereolithograph models provide an extra dimension that enhances both the quality of visual information and utility of surface visualization in neuroscience and medicine.	[Kelley, Daniel J.; Alexander, Andrew L.; Davidson, Richard J.] Waisman Ctr Mental Retardat & Human Dev, Waisman Lab Brain Imaging & Behav, Madison, WI USA; [Kelley, Daniel J.] Univ Wisconsin, Sch Med & Publ Hlth, Med Scientist Training Program, Madison, WI USA; [Kelley, Daniel J.] Univ Wisconsin, Neurosci Training Program, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Kelley, Daniel J.] Univ Wisconsin, Howard Hughes Med Inst, Teaching Fellows Program, Wisconsin Program Sci Teaching,Dept Bacteriol, Madison, WI 53706 USA; [Farhoud, Mohammed] Univ Wisconsin, Paul P Carbone Comprehens Canc Ctr, Madison, WI USA; [Farhoud, Mohammed; Wolf, Alan J.] Univ Wisconsin, Ctr Biotechnol, Biol New Media Ctr, Madison, WI 53705 USA; [Meyerand, M. Elizabeth; Alexander, Andrew L.] Univ Wisconsin, Dept Med Phys, Madison, WI 53706 USA; [Nelson, David L.] Univ Wisconsin, Coll Agr & Life Sci, Dept Biochem, Madison, WI USA; [Ramirez, Lincoln F.; Dempsey, Robert J.] Univ Wisconsin, Dept Neurol Surg, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kelley, DJ (corresponding author), Waisman Ctr Mental Retardat & Human Dev, Waisman Lab Brain Imaging & Behav, Madison, WI USA.	djkelley@wisc.edu	Wolf, Alan J/G-9822-2011	Wolf, Alan J/0000-0002-9576-477X; Davidson, Richard/0000-0002-8506-4964	Studies to Advance Autism Research and Treatment [U54MH066398]; National Institute of Mental Health [P50-MH069315]; National Institutes of Health [P30 HD03352]; National Science Foundation [0411278]; Howard Hughes Medical Institute Professors Program [2006-0516]; National Science Foundation for Course, Curriculum, and Lab Improvement; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH066398, P50MH069315] Funding Source: NIH RePORTER	Studies to Advance Autism Research and Treatment; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute Professors Program(Howard Hughes Medical Institute); National Science Foundation for Course, Curriculum, and Lab Improvement; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a Studies to Advance Autism Research and Treatment grant U54MH066398 Project IV (RJD), a center grant P50-MH069315 to RJD from the US National Institute of Mental Health, a core grant P30 HD03352 (MM Seltzer) from the National Institutes of Health, and National Science Foundation award 0411278 (DLN and AJW). The survey work was exempt from review with IRB protocol #2006-0516 (November 2006) of the Wisconsin Program for Scientific Teaching, which is supported by the Howard Hughes Medical Institute Professors Program awarded to Dr. Jo Handelsman, and by a grant from the National Science Foundation for Course, Curriculum, and Lab Improvement, awarded to JH and Sarah M. Miller.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Chen JCT, 1999, NEUROSURGERY, V45, P883, DOI 10.1097/00006123-199910000-00031; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; D'Urso PS, 1999, NEUROSURGERY, V44, P1084, DOI 10.1097/00006123-199905000-00080; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Eftekhar Behzad, 2005, BMC Med Educ, V5, P15, DOI 10.1186/1472-6920-5-15; Gering DT, 2001, J MAGN RESON IMAGING, V13, P967, DOI 10.1002/jmri.1139; Lukic IK, 2003, LANCET, V362, P2110, DOI 10.1016/S0140-6736(03)15114-8; McGurk M, 1997, ANN ROY COLL SURG, V79, P169; Meakin JR, 2004, BRIT J RADIOL, V77, P504, DOI 10.1259/bjr/50012454; Muller A, 2003, J CRANIOFAC SURG, V14, P899; NOORANI R, 2006, RAPID PROTOTYPING PR, pR21; Panchaphongsaphak B, 2005, ST HEAL T, V111, P378; Pevsner J, 2002, TRENDS NEUROSCI, V25, P217, DOI 10.1016/S0166-2236(00)02121-4; RAMACHANDRAN P, 2001, FREE TOOL CFD DATA V; Ratiu PF, 2004, NEW ENGL J MED, V351, pE21, DOI 10.1056/NEJMicm031024; Wurm G, 2004, SURG NEUROL, V62, P510, DOI 10.1016/j.surneu.2004.01.025; Wurm G, 2004, J NEUROSURG, V100, P139, DOI 10.3171/jns.2004.100.1.0139	18	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1119	10.1371/journal.pone.0001119	http://dx.doi.org/10.1371/journal.pone.0001119			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971879	Green Submitted, Green Published, gold			2022-12-25	WOS:000207458700033
J	Nathavitharana, R; Coronel, J; Moore, DAJ				Nathavitharana, Ruvandhi; Coronel, Jorge; Moore, David A. J.			Solar Disinfection of MODS Mycobacterial Cultures in Resource-Poor Settings	PLOS ONE			English	Article								Introduction. Safe disposal of TB culture material in which the infectious burden of clinical samples has been greatly amplified is an important challenge in resource-limited settings. The bactericidal capacity of solar cookers has been demonstrated previously for conventional bacteria and contaminated clinical waste. We investigated the use of a simple solar cooker for the sterilization of mycobacterial broth cultures from the microscopic observation drug susceptibility assay (MODS). Methods. Simulated TB culture materials were prepared by inoculating 24-well MODS plates with 500 mu L of a known concentration of Mycobacterium bovis BCG. In a series of experiments, samples were simultaneously placed inside a box-type solar cooker and control box and removed at timepoints between 15 minutes and 6 hours. Quantitative cultures were performed using retrieved samples to determine sterilization effect. Results. All cultures from the control box were positive at or within 1-4 logs of inoculation concentration. Simulated culture plates at concentrations from 10(3) colony-forming-units (CFU)/ml to 10(7) CFU/ml were completely sterilized after only one hour of cooker exposure, at temperatures between 50-102 degrees C. At 10(9) CFU/ml (far in excess of diagnostic cultures), it was only possible to recover mycobacterial growth in plates removed after 15 minutes. By 30 minutes all plates were effectively sterilized. Discussion. Solar disinfection provides a very effective, safe and low-cost alternative to conventional equipment used for disposal of mycobacterial culture material. Effect of climatic conditions and optimal operating procedure remain to be defined.	[Nathavitharana, Ruvandhi; Moore, David A. J.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis & Immun, London, England; [Nathavitharana, Ruvandhi; Moore, David A. J.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Wellcome Ctr Clin Trop Med, London, England; [Coronel, Jorge; Moore, David A. J.] Univ Peruana Cayetano Heredia, Lab Invest Enfermedades Infecciosas, Lima, Peru; [Moore, David A. J.] Asociac Benef PRISMA, Lima, Peru	Imperial College London; Imperial College London; Universidad Peruana Cayetano Heredia	Nathavitharana, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis & Immun, London, England.	rrn01@imperial.ac.uk		Coronel, Jorge/0000-0002-4580-6716	Wellcome Trust [078067]	Wellcome Trust(Wellcome TrustEuropean Commission)	Funding: This study was supported by a Student Elective Prize from the Wellcome Trust. DAJM is supported by the Wellcome Trust (grant number 078067).	Chitnis V, 2003, LANCET, V362, P1285, DOI 10.1016/S0140-6736(03)14610-7; Conroy RM, 1996, LANCET, V348, P1695, DOI 10.1016/S0140-6736(96)02309-4; Doig C, 2002, J CLIN PATHOL, V55, P778, DOI 10.1136/jcp.55.10.778; Moore DAJ, 2004, J CLIN MICROBIOL, V42, P4432, DOI 10.1128/JCM.42.10.4432-4437.2004; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; RILEY RL, 1976, AM REV RESPIR DIS, V113, P413; RILEY RL, 1989, AM REV RESPIR DIS, V139, P1286, DOI 10.1164/ajrccm/139.5.1286; WHO (World Health Organization), 2006, WHO TUB FACT SHEET	8	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1100	10.1371/journal.pone.0001100	http://dx.doi.org/10.1371/journal.pone.0001100			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971863	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000207458700017
J	Witt, MJ; Godley, BJ				Witt, Matthew J.; Godley, Brendan J.			A Step Towards Seascape Scale Conservation: Using Vessel Monitoring Systems (VMS) to Map Fishing Activity	PLOS ONE			English	Article								Background. Conservation of marine ecosystems will require a holistic understanding of fisheries with concurrent spatial patterns of biodiversity. Methodology/Principal Findings. Using data from the UK Government Vessel Monitoring System (VMS) deployed on UK-registered large fishing vessels we investigate patterns of fisheries activity on annual and seasonal scales. Analysis of VMS data shows that regions of the UK European continental shelf (i.e. Western Channel and Celtic Sea, Northern North Sea and the Goban Spur) receive consistently greater fisheries pressure than the rest of the UK continental shelf fishing zone. Conclusions/Significance. VMS provides a unique and independent method from which to derive patterns of spatially and temporally explicit fisheries activity. Such information may feed into ecosystem management plans seeking to achieve sustainable fisheries while minimising putative risk to non-target species (e.g. cetaceans, seabirds and elasmobranchs) and habitats of conservation concern. With multilateral collaboration VMS technologies may offer an important solution to quantifying and managing ecosystem disturbance, particularly on the high-seas.	[Witt, Matthew J.; Godley, Brendan J.] Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England	University of Exeter	Godley, BJ (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England.	b.j.godley@ex.ac.uk	Witt, Matthew J/C-2279-2008; Witt, Matthew/V-3318-2018; godley, brendan j/A-6139-2009; godley, brendan/O-1959-2019	Witt, Matthew/0000-0002-9498-5378; godley, brendan j/0000-0003-3845-0034; godley, brendan/0000-0003-3845-0034	Natural Environment Research Council [NER/S/A/2004/12980]; European Social Fund	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Social Fund(European Social Fund (ESF))	MJW is supported by a Natural Environment Research Council PhD studentship (NER/S/A/2004/12980) at the University of Exeter (Cornwall Campus). BJG receives funding from the European Social Fund.	Bearhop S, 2001, CONDOR, V103, P802, DOI 10.1650/0010-5422(2001)103[0802:AVIGSD]2.0.CO;2; Bowen BW, 2005, MOL ECOL, V14, P2389, DOI 10.1111/j.1365-294X.2005.02598.x; Carranza A, 2006, BIOL CONSERV, V131, P52, DOI 10.1016/j.biocon.2006.02.003; *COMM EUR COMM, 2004, 7242004 COMM EUR COM; Connor D.W., 2006, UKSEAMAP MAPPING SEA, V3rd ed.; Croxall JP, 2005, SCIENCE, V307, P249, DOI 10.1126/science.1106042; Deng R, 2005, CAN J FISH AQUAT SCI, V62, P611, DOI 10.1139/F04-219; *DEP ENV FOOD RUR, 2004, EXPL MEM S W TERR WA; *DEP ENV FOOD RUR, 2005, SAT MON UK FISH BOAT; *DEP ENV FOOD RUR, 2005, SAT MON NOT GUID; *DEP ENV FOOD RUR, 2005, CHART PROGR INT ASS; Gallaway BJ, 2003, N AM J FISH MANAGE, V23, P581, DOI 10.1577/1548-8675(2003)023<0581:DOASEL>2.0.CO;2; Gilkinson KD, 2005, ICES J MAR SCI, V62, P925, DOI 10.1016/j.icesjms.2005.03.009; Hall MA, 2000, MAR POLLUT BULL, V41, P204, DOI 10.1016/S0025-326X(00)00111-9; HAMMOND PS, 1995, 922UK27 LIFE EUR COM; HAMMOND PS, 2007, FINAL REPORT SMALL C; Huthnance JM, 2001, DEEP-SEA RES PT II, V48, P2979, DOI 10.1016/S0967-0645(01)00030-3; LEFEVRE J, 1986, ADV MAR BIOL, V23, P163; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Lewison RL, 2003, ECOL APPL, V13, P743, DOI 10.1890/1051-0761(2003)013[0743:EFBAEO]2.0.CO;2; *MAR FISH AG, 2005, UK SEA FISH STAT 200; Mills CM, 2007, ICES J MAR SCI, V64, P248, DOI 10.1093/icesjms/fsl026; MOLENARR EJ, 2000, ORG FAA; Murawski SA, 2005, ICES J MAR SCI, V62, P1150, DOI 10.1016/j.icesjms.2005.04.005; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; NORTHRIDGE S, 2006, 1735R07D M ELL PARTN; Pauly D, 2003, SCIENCE, V302, P1359, DOI 10.1126/science.1088667; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Phillips RA, 2006, BIOL CONSERV, V129, P336, DOI 10.1016/j.biocon.2005.10.046; Reid J.B., 2003, ATLAS CETACEAN DISTR; Sims DW, 2003, MAR ECOL PROG SER, V248, P187, DOI 10.3354/meps248187; Stone C.J., 1995, ATLAS SEABIRD DISTRI; Votier SC, 2004, NATURE, V427, P727, DOI 10.1038/nature02315; Zeller D, 2005, FISH FISH, V6, P156, DOI 10.1111/j.1467-2979.2005.00177.x	34	117	123	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1111	10.1371/journal.pone.0001111	http://dx.doi.org/10.1371/journal.pone.0001111			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971874	gold, Green Published, Green Submitted			2022-12-25	WOS:000207458700028
J	Beniac, DR; Devarennes, SL; Andonov, A; He, R; Booth, TF				Beniac, Daniel R.; deVarennes, Shauna L.; Andonov, Anton; He, Runtao; Booth, Tim F.			Conformational Reorganization of the SARS Coronavirus Spike Following Receptor Binding: Implications for Membrane Fusion	PLOS ONE			English	Article								The SARS coronavirus (SARS-CoV) spike is the largest known viral spike molecule, and shares a similar function with all class 1 viral fusion proteins. Previous structural studies of membrane fusion proteins have largely used crystallography of static molecular fragments, in isolation of their transmembrane domains. In this study we have produced purified, irradiated SARS-CoV virions that retain their morphology, and are fusogenic in cell culture. We used cryo-electron microscopy and image processing to investigate conformational changes that occur in the entire spike of intact virions when they bind to the viral receptor, angiotensin-converting enzyme 2 (ACE2). We have shown that ACE2 binding results in structural changes that appear to be the initial step in viral membrane fusion, and precisely localized the receptor-binding and fusion core domains within the entire spike. Furthermore, our results show that receptor binding and subsequent membrane fusion are distinct steps, and that each spike can bind up to three ACE2 molecules. The SARS-CoV spike provides an ideal model system to study receptor binding and membrane fusion in the native state, employing cryo-electron microscopy and single-particle image analysis.	[Beniac, Daniel R.; deVarennes, Shauna L.; Andonov, Anton; He, Runtao; Booth, Tim F.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Div Viral Dis, Winnipeg, MB, Canada; [Andonov, Anton; He, Runtao; Booth, Tim F.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	Public Health Agency of Canada; University of Manitoba	Booth, TF (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Div Viral Dis, Winnipeg, MB, Canada.	tim_booth@phac-aspc.gc.ca	Andonov, Anton/AAJ-6955-2021		Public Health Agency of Canada; Chief Scientist, Health Canada	Public Health Agency of Canada; Chief Scientist, Health Canada	Funding was provided by the Public Health Agency of Canada and in part by a grant from the office of the Chief Scientist, Health Canada.	Baker KA, 1999, MOL CELL, V3, P309, DOI 10.1016/S1097-2765(00)80458-X; Beniac DR, 2006, NAT STRUCT MOL BIOL, V13, P751, DOI 10.1038/nsmb1123; Booth TF, 2005, J INFECT DIS, V191, P1472, DOI 10.1086/429634; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Chen L, 2001, STRUCTURE, V9, P255, DOI 10.1016/S0969-2126(01)00581-0; COLLINS AR, 1982, VIROLOGY, V119, P358, DOI 10.1016/0042-6822(82)90095-2; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Damico RL, 1998, P NATL ACAD SCI USA, V95, P2580, DOI 10.1073/pnas.95.5.2580; Dimitrov DS, 2003, CELL, V115, P652, DOI 10.1016/S0092-8674(03)00976-0; Dimitrov DS, 2004, NAT REV MICROBIOL, V2, P109, DOI 10.1038/nrmicro817; Duquerroy S, 2005, VIROLOGY, V335, P276, DOI 10.1016/j.virol.2005.02.022; Dutch RE, 2000, BIOSCIENCE REP, V20, P597; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Fenouillet E, 2007, ANTIOXID REDOX SIGN, V9, P1009, DOI 10.1089/ars.2007.1639; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Hakansson-McReynolds S, 2006, J BIOL CHEM, V281, P11965, DOI 10.1074/jbc.M601174200; Hernandez LD, 1997, J CELL BIOL, V139, P1455, DOI 10.1083/jcb.139.6.1455; Hofmann H, 2004, TRENDS MICROBIOL, V12, P466, DOI 10.1016/j.tim.2004.08.008; Hwang WC, 2006, J BIOL CHEM, V281, P34610, DOI 10.1074/jbc.M603275200; KEMBLE GW, 1992, J VIROL, V66, P4940, DOI 10.1128/JVI.66.8.4940-4950.1992; Kobe B, 1999, P NATL ACAD SCI USA, V96, P4319, DOI 10.1073/pnas.96.8.4319; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li WH, 2006, J VIROL, V80, P4211, DOI 10.1128/JVI.80.9.4211-4219.2006; Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Malashkevich VN, 1999, P NATL ACAD SCI USA, V96, P2662, DOI 10.1073/pnas.96.6.2662; Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; Petit CM, 2007, VIROLOGY, V360, P264, DOI 10.1016/j.virol.2006.10.034; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prabakaran P, 2006, J BIOL CHEM, V281, P15829, DOI 10.1074/jbc.M600697200; Rao PV, 1998, J VIROL, V72, P3278, DOI 10.1128/JVI.72.4.3278-3288.1998; SAUTER NK, 1992, BIOCHEMISTRY-US, V31, P9609, DOI 10.1021/bi00155a013; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Supekar VM, 2004, P NATL ACAD SCI USA, V101, P17958, DOI 10.1073/pnas.0406128102; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8; Wentworth DE, 2001, J VIROL, V75, P9741, DOI 10.1128/JVI.75.20.9741-9752.2001; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Xiao XD, 2003, BIOCHEM BIOPH RES CO, V312, P1159, DOI 10.1016/j.bbrc.2003.11.054; Xu YH, 2004, J BIOL CHEM, V279, P49414, DOI 10.1074/jbc.M408782200; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322; Yin HS, 2005, P NATL ACAD SCI USA, V102, P9288, DOI 10.1073/pnas.0503989102; Zhao X, 2000, P NATL ACAD SCI USA, V97, P14172, DOI 10.1073/pnas.260499197	46	35	36	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1082	10.1371/journal.pone.0001082	http://dx.doi.org/10.1371/journal.pone.0001082			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957264	gold, Green Published, Green Submitted			2022-12-25	WOS:000207458500027
J	Plachetzki, DC; Degnan, BM; Oakley, TH				Plachetzki, David C.; Degnan, Bernard M.; Oakley, Todd H.			The Origins of Novel Protein Interactions during Animal Opsin Evolution	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; MAXIMUM-LIKELIHOOD; MOLECULAR PHYLOGENY; ADAPTIVE EVOLUTION; SEQUENCE ALIGNMENT; GENE DUPLICATION; TREE SELECTION; VISUAL CELLS; PHOTORECEPTORS; RHODOPSIN	Background. Biologists are gaining an increased understanding of the genetic bases of phenotypic change during evolution. Nevertheless, the origins of phenotypes mediated by novel protein-protein interactions remain largely undocumented. Methodology/Principle Findings. Here we analyze the evolution of opsin visual pigment proteins from the genomes of early branching animals, including a new class of opsins from Cnidaria. We combine these data with existing knowledge of the molecular basis of opsin function in a rigorous phylogenetic framework. We identify adaptive amino acid substitutions in duplicated opsin genes that correlate with a diversification of physiological pathways mediated by different protein-protein interactions. Conclusions/Significance. This study documents how gene duplication events early in the history of animals followed by adaptive structural mutations increased organismal complexity by adding novel protein-protein interactions that underlie different physiological pathways. These pathways are central to vision and other photo-reactive phenotypes in most extant animals. Similar evolutionary processes may have been at work in generating other metazoan sensory systems and other physiological processes mediated by signal transduction.	[Plachetzki, David C.; Oakley, Todd H.] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA; [Degnan, Bernard M.] Univ Queensland, Sch Integrat Biol, Brisbane, Qld, Australia	University of California System; University of California Santa Barbara; University of Queensland	Oakley, TH (corresponding author), Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA.	oakley@lifesci.ucsb.edu	Oakley, Todd/A-5419-2008	Oakley, Todd/0000-0002-4478-915X; Degnan, Bernard/0000-0001-7573-8518	US National Science Foundation [DEB-0710406, DEB-0643840]; Australian Research Council	US National Science Foundation(National Science Foundation (NSF)); Australian Research Council(Australian Research Council)	This work was supported by US National Science Foundation grants DEB-0710406 to DCP and THO and DEB-0643840 to THO, and Australian Research Council grants to BMD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; Arendt D, 2003, INT J DEV BIOL, V47, P563; ARENDT D, 2001, T ROYAL SOC LONDON B, P1545; Bachner-Melman R, 2005, PLOS GENET, V1, P394, DOI 10.1371/journal.pgen.0010042; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; Dunlap JC, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P371, DOI 10.1002/352760510X.ch18; Durand D, 2006, J COMPUT BIOL, V13, P320, DOI 10.1089/cmb.2006.13.320; EAKIN RM, 1962, P NATL ACAD SCI USA, V48, P826, DOI 10.1073/pnas.48.5.826; EAKIN RM, 1979, AM ZOOL, V19, P647; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gehring W, 2003, J MOL EVOL, V57, pS286, DOI 10.1007/s00239-003-0038-8; Gomez MD, 2000, J NEUROSCI, V20, P5254, DOI 10.1523/JNEUROSCI.20-14-05254.2000; Grens A, 1996, DEV BIOL, V180, P473, DOI 10.1006/dbio.1996.0321; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; Huelsenbeck JP, 1997, SYST BIOL, V46, P69, DOI 10.2307/2413636; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kojima D, 1997, J BIOL CHEM, V272, P22979, DOI 10.1074/jbc.272.37.22979; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Koyanagi M, 2002, FEBS LETT, V531, P525, DOI 10.1016/S0014-5793(02)03616-5; Leys SP, 2002, J COMP PHYSIOL A, V188, P199, DOI 10.1007/s00359-002-0293-y; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Lynch VJ, 2004, P ROY SOC B-BIOL SCI, V271, P2201, DOI 10.1098/rspb.2004.2848; Marin EP, 2000, J BIOL CHEM, V275, P1930, DOI 10.1074/jbc.275.3.1930; NIELSEN R, 2001, PACIFIC S BIOCOMPUTI, P576; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Halloran DM, 2006, J MOL EVOL, V63, P87, DOI 10.1007/s00239-005-0215-z; Ohno S., 1970, EVOLUTION GENE DUPLI; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Peterson KJ, 2005, P NATL ACAD SCI USA, V102, P9547, DOI 10.1073/pnas.0503660102; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Raible F, 2006, DEV BIOL, V300, P461, DOI 10.1016/j.ydbio.2006.08.070; RAMBAUT A, 1997, COMPUTER AP IN PRESS; Rambaut A., 2003, TRACER MCMC TRACE AN; Rockman MV, 2005, PLOS BIOL, V3, P2208, DOI 10.1371/journal.pbio.0030387; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Spaethe J, 2005, J EXP BIOL, V208, P2347, DOI 10.1242/jeb.01634; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Su CY, 2006, SCIENCE, V311, P1617, DOI 10.1126/science.1123802; Suga H, 1999, J MOL EVOL, V48, P646, DOI 10.1007/PL00006508; SWOFFORD DL, 2002, PAUP; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Telford MJ, 2006, CURR BIOL, V16, pR981, DOI 10.1016/j.cub.2006.10.048; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Thornton JW, 2000, ANNU REV GENOM HUM G, V1, P41, DOI 10.1146/annurev.genom.1.1.41; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Velarde RA, 2005, INSECT BIOCHEM MOLEC, V35, P1367, DOI 10.1016/j.ibmb.2005.09.001; Wilkinson M, 2007, TRENDS ECOL EVOL, V22, P114, DOI 10.1016/j.tree.2007.01.002; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1; Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852; Zheng Y, 2007, J EXP ZOOL PART B, V308B, P85, DOI 10.1002/jez.b.21140	68	84	84	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1054	10.1371/journal.pone.0001054	http://dx.doi.org/10.1371/journal.pone.0001054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940617	gold, Green Published, Green Submitted			2022-12-25	WOS:000207456100021
J	Wiesner, C; Winsauer, G; Resch, U; Hoeth, M; Schmid, JA; Van Hengel, J; Van Roy, F; Binder, BR; De Martin, R				Wiesner, C.; Winsauer, G.; Resch, U.; Hoeth, M.; Schmid, J. A.; Van Hengel, J.; Van Roy, F.; Binder, B. R.; De Martin, R.			alpha-Catulin, a Rho signalling component, can regulate NF-kappa B through binding to IKK-beta, and confers resistance to apoptosis	ONCOGENE			English	Article						Rho; alpha-catulin; IKK-beta; NF-kappa B	SERUM RESPONSE FACTOR; ENDOTHELIAL-CELLS; TRANSCRIPTION FACTORS; ADHESION COMPLEX; EPITHELIAL-CELLS; PROTEIN-RHO; CATENIN; ACTIVATION; ACTIN; IDENTIFICATION	Rho GTPases regulate diverse cellular functions including adhesion, cytokinesis and motility, as well as the activity of the transcription factors NF-kappa B, serum response factor and C/EBP. alpha-Catulin, an alpha-catenin-related protein that shares structural similarities with cytoskeletal linker proteins, facilitates Rho signalling by serving as a scaffold for the Rho-specific guanine nucleotide exchange factor Lbc. We report here that alpha-catulin also interacts with a key component of the NF-kappa B signalling pathway, namely the I kappa B kinase (IKK)-beta. In co-immunoprecipitations, alpha-catulin can bind IKK-beta and Lbc. Ectopic expression of alpha-catulin augmented NF-kappa B activity, promoted cell migration and increased resistance to apoptosis, whereas knockdown experiments showed the opposite effects. Together, these features suggest that alpha-catulin has tumorigenic potential.	[Wiesner, C.; Winsauer, G.; Resch, U.; Hoeth, M.; Schmid, J. A.; Binder, B. R.; De Martin, R.] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, A-1090 Vienna, Austria; [Van Hengel, J.; Van Roy, F.] Univ Ghent VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium; [Van Hengel, J.; Van Roy, F.] Univ Ghent, Dept Mol Biol, B-9000 Ghent, Belgium	Medical University of Vienna; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	De Martin, R (corresponding author), Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Lazarettg 19, A-1090 Vienna, Austria.	rainer.demartin@meduniwien.ac.at	van Roy, Frans M/C-6123-2009; Schmid, Johannes A./C-7659-2009	van Roy, Frans M/0000-0003-4358-1039; Schmid, Johannes A./0000-0002-6586-3507; Resch, Ulrike/0000-0002-8380-9555; Wiesner, Christoph/0000-0002-3281-0695				Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; BEG AA, 1996, SCIENCE, V274, P784; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Brock A. L., 2005, Molecular & Cellular Biomechanics, V2, P135; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; de Martin R, 2000, ARTERIOSCL THROM VAS, V20, pE83; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Dutt P, 2004, CELL SIGNAL, V16, P201, DOI 10.1016/S0898-6568(03)00132-3; Ebner K, 2003, BLOOD, V102, P192, DOI 10.1182/blood-2002-12-3753; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gietz RD, 1997, MOL CELL BIOCHEM, V172, P67, DOI 10.1023/A:1006859319926; Hippenstiel S, 2002, BIOCHEM PHARMACOL, V64, P971, DOI 10.1016/S0006-2952(02)01162-0; Hofer-Warbinek R, 2004, CELL DEATH DIFFER, V11, P1317, DOI 10.1038/sj.cdd.4401502; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; ITOH M, 1993, J CELL BIOL, V121, P491, DOI 10.1083/jcb.121.3.491; Janssens B, 1999, BBA-GENE STRUCT EXPR, V1447, P341, DOI 10.1016/S0167-4781(99)00170-0; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Merdek KD, 2004, MOL CELL BIOL, V24, P2410, DOI 10.1128/MCB.24.6.2410-2422.2004; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; Montaner S, 1999, J BIOL CHEM, V274, P8506, DOI 10.1074/jbc.274.13.8506; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Park B, 2002, J BIOL CHEM, V277, P45361, DOI 10.1074/jbc.M202447200; PATERSON HF, 1990, J CELL BIOL, V111, P1001, DOI 10.1083/jcb.111.3.1001; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Sulciner DJ, 1996, MOL CELL BIOL, V16, P7115; Surpili MJ, 2003, BIOCHEMISTRY-US, V42, P15369, DOI 10.1021/bi034575v; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Whitehead LP, 1999, MOL CELL BIOL, V19, P7759; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; ZHANG JC, 1995, J THORAC CARDIOV SUR, V109, P1059, DOI 10.1016/S0022-5223(95)70188-5; Zhang JS, 1998, GENOMICS, V54, P149, DOI 10.1006/geno.1998.5458; ZHENG Y, 1995, J BIOL CHEM, V270, P9031, DOI 10.1074/jbc.270.16.9031	43	29	31	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR 3	2008	27	15					2159	2169		10.1038/sj.onc.1210863	http://dx.doi.org/10.1038/sj.onc.1210863			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	283FE	17952117				2022-12-25	WOS:000254621300006
J	Fukunaga-Kalabis, M; Martinez, G; Telson, SM; Liu, ZJ; Balint, K; Juhasz, I; Elder, DE; Perbal, B; Herlyn, M				Fukunaga-Kalabis, M.; Martinez, G.; Telson, S. M.; Liu, Z-J; Balint, K.; Juhasz, I.; Elder, D. E.; Perbal, B.; Herlyn, M.			Downregulation of CCN3 expression as a potential mechanism for melanoma progression	ONCOGENE			English	Article						melanoma; CCN3; matricellular protein; matrix metalloproteinase	BREAST-CANCER CELLS; MATRIX-METALLOPROTEINASE; MALIGNANT-MELANOMA; INVASION; MIGRATION; GROWTH; LINES; GENE; PROLIFERATION; COMMUNICATION	Coculture of human melanocytes with keratinocytes upregulates CCN3, a matricellular protein critical to maintenance of normal homeostasis of melanocytes in the skin. CCN3 affects two fundamental features of melanocyte physiology: it inhibits melanocyte proliferation and stimulates their adhesion to the basement membrane. Here we report that expression of CCN3 is downregulated in advanced melanomas. Aggressive melanoma cell lines did not respond to treatment with CCN3 inducers, such as interleukin-1 beta (IL-beta), while less aggressive melanoma cell lines responded similarly to melanocytes. Immunostaining analyses revealed that CCN3 was present in melanoma cells close to the epidermal-dermal interface, but not in melanoma cells that had invaded deep into the dermis or had metastasized to lymph nodes. Contrary to our expectations, overexpression of CCN3 in 1205Lu metastatic melanoma cells did not affect their adhesion to collagen IV. However, CCN3 decreased the transcription and activation of matrix metalloproteinases and suppressed the invasion of 1205Lu melanoma cells. These results suggest that the lack of CCN3 in advanced melanoma cells contributes to their invasive phenotype. Whereas major matricellular proteins, such as osteopontin, tenascin or secreted protein acidic and rich in cysteine (SPARC), are strongly upregulated in melanoma cells; CCN3 is the first member of this family that is downregulated.	[Fukunaga-Kalabis, M.; Martinez, G.; Telson, S. M.; Liu, Z-J; Balint, K.; Herlyn, M.] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA; [Juhasz, I.] Univ Debrecen, Med & Hlth Sci Ctr, Dept Dermatol & Venerol, Debrecen, Hungary; [Elder, D. E.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Perbal, B.] Univ Paris 7D, Lab Oncol Virale & Mol, Paris, France	The Wistar Institute; University of Debrecen; University of Pennsylvania; UDICE-French Research Universities; Universite Paris Cite	Herlyn, M (corresponding author), Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, 3601 Spruce St, Philadelphia, PA 19104 USA.	herlynm@wistar.org	Balint, Klara/ABB-8816-2021		NCI NIH HHS [R01 CA047159, CA76674, R01 CA080999, CA25874, CA80999, P30 CA010815, CA47159, R01 CA076674, P01 CA025874, CA10815] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA025874, R01CA080999, R01CA076674, P30CA010815, R01CA047159] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Benini S, 2005, ONCOGENE, V24, P4349, DOI 10.1038/sj.onc.1208620; BRESLOW A, 1970, ANN SURG, V172, P902, DOI 10.1097/00000658-197011000-00017; CLARK WH, 1991, BRIT J CANCER, V64, P631, DOI 10.1038/bjc.1991.375; Denkert C, 2002, CLIN EXP METASTAS, V19, P79, DOI 10.1023/A:1013857325012; Fukunaga-Kalabis M, 2006, J CELL BIOL, V175, P563, DOI 10.1083/jcb.200602132; Gilles C, 1998, CANCER RES, V58, P5529; Glukhova L, 2001, CANCER GENET CYTOGEN, V130, P105, DOI 10.1016/S0165-4608(01)00477-0; Gupta N, 2001, J CLIN PATHOL-MOL PA, V54, P293, DOI 10.1136/mp.54.5.293; Haass NK, 2004, J MOL HISTOL, V35, P309; Haass NK, 2005, PIGM CELL RES, V18, P150, DOI 10.1111/j.1600-0749.2005.00235.x; HERLYN M, 1991, CANCER RES, V51, P4853; Hofmann UB, 1999, BRIT J CANCER, V81, P774, DOI 10.1038/sj.bjc.6690763; Hsu MY, 1998, AM J PATHOL, V153, P1435, DOI 10.1016/S0002-9440(10)65730-6; Hsu MY, 1996, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 1, NO 2, APRIL 1996, P188; Kalembeyi I, 2003, INT J CANCER, V105, P53, DOI 10.1002/ijc.11037; Kleer CG, 2004, NEOPLASIA, V6, P179, DOI 10.1593/neo.03316; Kuphal S, 2005, CANCER METAST REV, V24, P195, DOI 10.1007/s10555-005-1572-1; Lake AC, 2003, AM J PATHOL, V162, P219, DOI 10.1016/S0002-9440(10)63813-8; Laurent M, 2003, FASEB J, V17, P1919, DOI 10.1096/fj.02-1023fje; MAILLARDM, 2001, MOL PATHOL, V54, P275; Manara MC, 2002, AM J PATHOL, V160, P849, DOI 10.1016/S0002-9440(10)64908-5; Massi D, 1999, HUM PATHOL, V30, P339, DOI 10.1016/S0046-8177(99)90014-X; Matic M, 2002, J INVEST DERMATOL, V118, P110, DOI 10.1046/j.0022-202x.2001.01623.x; McCallum L, 2006, BLOOD, V108, P1716, DOI 10.1182/blood-2006-04-016113; Nguyen N, 2006, CANCER RES, V66, P2658, DOI 10.1158/0008-5472.CAN-05-2082; Perbal B, 2003, J CLIN PATHOL-MOL PA, V56, P80, DOI 10.1136/mp.56.2.80; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Philip S, 2001, J BIOL CHEM, V276, P44926, DOI 10.1074/jbc.M103334200; Planque N, 2006, J CELL BIOCHEM, V99, P105, DOI 10.1002/jcb.20887; Robert G, 2006, CANCER RES, V66, P7516, DOI 10.1158/0008-5472.CAN-05-3189; Satyamoorthy K, 1997, MELANOMA RES, V7, pS35; Seftor REB, 1999, CANCER METAST REV, V18, P359, DOI 10.1023/A:1006317125454; Tanimura S, 2003, BIOCHEM BIOPH RES CO, V304, P801, DOI 10.1016/S0006-291X(03)00670-3; Welch DR, 2000, CANCER RES, V60, P1552; Zhou YW, 2005, J INVEST DERMATOL, V124, P1044, DOI 10.1111/j.0022-202X.2005.23680.x	35	58	58	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2008	27	18					2552	2560		10.1038/sj.onc.1210896	http://dx.doi.org/10.1038/sj.onc.1210896			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	289LW	17968313	Green Accepted			2022-12-25	WOS:000255057000005
J	Jadeski, L; Mataraza, JM; Jeong, HW; Li, ZG; Sacks, DB				Jadeski, Lorraine; Mataraza, Jennifer M.; Jeong, Ha-Won; Li, Zhigang; Sacks, David B.			IQGAP1 stimulates proliferation and enhances tumorigenesis of human breast epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-CADHERIN; RHO-GTPASES; CANCER METASTASIS; BINDING PROTEIN; INVASION FRONTS; RAS ACTIVATION; CDC42; CALMODULIN; EXPRESSION; LINES	The scaffold protein IQGAP1 integrates signaling pathways and participates in diverse cellular activities. IQGAP1 is overexpressed in a number of human solid neoplasms, but its functional role in tumorigenesis has not been previously evaluated. Here we report that IQGAP1 contributes to neoplastic transformation of human breast epithelial cells. The amount of IQGAP1 in breast carcinoma is greater than that in normal tissue, with highly metastatic breast epithelial cells expressing the highest levels. Overexpression of IQGAP1 enhances proliferation of MCF-7 breast epithelial cells. Reduction of endogenous IQGAP1 by RNA interference impairs both serum-dependent and anchorage-independent growth of MCF-7 cells. Consistent with these in vitro observations, immortalized MCF-7 cells overexpressing IQGAP1 form invasive tumors in immunocompromised mice, whereas tumors derived from MCF-7 cells with stable knockdown of IQGAP1 are smaller and less invasive. In vitro analysis with selected IQGAP1 mutant constructs and a chemical inhibitor suggests that actin, Cdc42/Rac1, and the mitogen-activated protein kinase pathway contribute to the mechanism by which IQGAP1 increases cell invasion. Collectively, our data reveal that IQGAP1 enhances mammary tumorigenesis, suggesting that it may be a target for therapeutic intervention.	[Jadeski, Lorraine; Mataraza, Jennifer M.; Jeong, Ha-Won; Li, Zhigang; Sacks, David B.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Jadeski, Lorraine] Univ Guelph, Dept Human Biol & Nutr Sci, Guelph, ON N1G 2W1, Canada	Harvard University; Brigham & Women's Hospital; University of Guelph	Sacks, DB (corresponding author), Brigham & Womens Hosp, Dept Pathol, Thorn 530,75 Francis St, Boston, MA 02115 USA.	dsacks@rics.bwh.harvard.edu		Sacks, David/0000-0003-3100-0735				BAGULEY BC, 1989, EUR J CANCER CLIN ON, V25, P263, DOI 10.1016/0277-5379(89)90018-7; Balenci L, 2006, CANCER RES, V66, P9074, DOI 10.1158/0008-5472.CAN-06-0761; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bertucci F, 2004, ONCOGENE, V23, P1377, DOI 10.1038/sj.onc.1207262; Bourguignon LYW, 2005, J BIOL CHEM, V280, P11961, DOI 10.1074/jbc.M411985200; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; Brown MD, 2007, J BIOL CHEM, V282, P30265, DOI 10.1074/jbc.M702537200; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; COX AD, 1994, METHOD ENZYMOL, V238, P277; Dong PX, 2006, CANCER LETT, V243, P120, DOI 10.1016/j.canlet.2005.11.024; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fidler IJ, 2002, SEMIN CANCER BIOL, V12, P89, DOI 10.1006/scbi.2001.0416; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Jadeski LC, 1999, AM J PATHOL, V155, P1381, DOI 10.1016/S0002-9440(10)65240-6; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jeong HW, 2007, J BIOL CHEM, V282, P20752, DOI 10.1074/jbc.M700487200; Jiang WG, 1996, BRIT J SURG, V83, P437, DOI 10.1002/bjs.1800830404; JOYAL JL, 1994, J BIOL CHEM, V269, P30039; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Kulasingam V, 2007, MOL CELL PROTEOMICS, V6, P1997, DOI 10.1074/mcp.M600465-MCP200; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; Lin M, 2004, BREAST CANCER RES TR, V84, P49, DOI 10.1023/B:BREA.0000018424.43445.f3; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Mataraza JM, 2007, CELL SIGNAL, V19, P1857, DOI 10.1016/j.cellsig.2007.04.011; Mataraza JM, 2003, J BIOL CHEM, V278, P41237, DOI 10.1074/jbc.M304838200; Mataraza JM, 2003, BIOCHEM BIOPH RES CO, V305, P315, DOI 10.1016/S0006-291X(03)00759-9; Mateer SC, 2003, CELL MOTIL CYTOSKEL, V55, P147, DOI 10.1002/cm.10118; Miyoshi T, 2005, PATHOL INT, V55, P419, DOI 10.1111/j.1440-1827.2005.01847.x; Nabeshima K, 2002, CANCER LETT, V176, P101, DOI 10.1016/S0304-3835(01)00742-X; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; SACKS DB, 1992, ARCH BIOCHEM BIOPHYS, V299, P275, DOI 10.1016/0003-9861(92)90275-2; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Sokol SY, 2001, J BIOL CHEM, V276, P48425, DOI 10.1074/jbc.M107975200; Sugimoto N, 2001, J HUM GENET, V46, P21, DOI 10.1007/s100380170119; Sun WY, 2004, CANCER LETT, V212, P83, DOI 10.1016/j.canlet.2004.03.023; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Takemoto H, 2001, INT J CANCER, V91, P783, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1121>3.0.CO;2-Z; Vadlamudi RK, 2000, J BIOL CHEM, V275, P36238, DOI 10.1074/jbc.M002138200; von Lintig FC, 2000, BREAST CANCER RES TR, V62, P51, DOI 10.1023/A:1006491619920; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60	65	112	129	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1008	1017		10.1074/jbc.M708466200	http://dx.doi.org/10.1074/jbc.M708466200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17981797	hybrid			2022-12-25	WOS:000252128100040
J	Carter, JM; Demizieux, L; Campenot, RB; Vance, DE; Vance, JE				Carter, Jodi M.; Demizieux, Laurent; Campenot, Robert B.; Vance, Dennis E.; Vance, Jean E.			Phosphatidylcholine biosynthesis via CTP: Phosphocholine cytidylyltransferase beta 2 facilitates neurite outgrowth and branching	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; CYCLIN-DEPENDENT KINASE-5; MEMBRANE PHOSPHOLIPID-SYNTHESIS; RAT SYMPATHETIC NEURONS; PC12 CELLS; PHEOCHROMOCYTOMA CELLS; AXONAL REGENERATION; ACTIVATION; SYSTEM; CONE	Hallmarks of neuronal differentiation are neurite sprouting, extension, and branching. We previously showed that increased expression of CTP: phosphocholine cytidylyltransferase beta 2 (CT beta 2), an isoform of a key phosphatidylcholine ( PC) biosynthetic enzyme, accompanies neurite outgrowth ( Carter, J. M., Waite, K. A., Campenot, R. B., Vance, J. E., and Vance, D. E. (2003) J. Biol. Chem. 278, 44988 - 44994). CT beta 2 mRNA is highly expressed in the brain. We show that CT beta 2 is abundant in axons of rat sympathetic neurons and retinal ganglion cells. We used RNA silencing to decrease CT beta 2 expression in PC12 cells differentiated by nerve growth factor. In CT beta 2-silenced cells, numbers of primary and secondary neurites were markedly reduced, suggesting that CT beta 2 facilitates neurite outgrowth and branching. However, the length of individual neurites was significantly increased, and the total amount of neuronal membrane was unchanged. Neurite branching of PC12 cells is known to be inhibited by activation of Akt and promoted by the Akt inhibitor LY294002. Our experiments showed that LY294002 increases neurite sprouting and branching in control PC12 cells but not in CT beta 2-deficient cells. CT beta 2 was not phosphorylated in vitro by Akt. However, inhibition of Cdk5 by roscovitine blocked CT beta 2 phosphorylation and reduced neurite outgrowth and branching. These results highlight the importance of CT beta 2 in neurons for promoting neurite outgrowth and branching and represent the first identification of a lipid biosynthetic enzyme that facilitates these functions.	[Carter, Jodi M.; Demizieux, Laurent; Vance, Dennis E.; Vance, Jean E.] Univ Alberta, Canadian Inst Hlth Res Grp Mol Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Carter, Jodi M.; Vance, Dennis E.; Vance, Jean E.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada; [Campenot, Robert B.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2S2, Canada; [Demizieux, Laurent; Vance, Jean E.] Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Vance, JE (corresponding author), Univ Alberta, Canadian Inst Hlth Res Grp Mol Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada.	jean.vance@ualberta.ca		Carter, Jodi/0000-0002-5973-0732				Acebes A, 2000, TRENDS NEUROSCI, V23, P557, DOI 10.1016/S0166-2236(00)01646-5; Araki W, 1997, P NATL ACAD SCI USA, V94, P11946, DOI 10.1073/pnas.94.22.11946; Ashery U, 1996, NEURON, V16, P641, DOI 10.1016/S0896-6273(00)80083-5; CAMPENOT RB, 1982, DEV BIOL, V93, P1, DOI 10.1016/0012-1606(82)90232-9; Carter JM, 2003, J BIOL CHEM, V278, P44988, DOI 10.1074/jbc.M307336200; COVIELLA ILG, 1992, J NEUROCHEM, V59, P338, DOI 10.1111/j.1471-4159.1992.tb08909.x; de Chaves EP, 2001, J BIOL CHEM, V276, P36207, DOI 10.1074/jbc.M104282200; DECHAVES EP, 1995, J CELL BIOL, V128, P913, DOI 10.1083/jcb.128.5.913; DEVRIES GH, 1983, J NEUROCHEM, V40, P1189, DOI 10.1111/j.1471-4159.1983.tb08114.x; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Fu AKY, 2005, P NATL ACAD SCI USA, V102, P15224, DOI 10.1073/pnas.0507678102; Fujita H, 2002, J BIOL CHEM, V277, P45428, DOI 10.1074/jbc.M208090200; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hahn CM, 2005, NEUROSCIENCE, V134, P449, DOI 10.1016/j.neuroscience.2005.04.020; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Hayashi H, 2004, J BIOL CHEM, V279, P14009, DOI 10.1074/jbc.M313828200; Higuchi M, 2003, GENES CELLS, V8, P657, DOI 10.1046/j.1365-2443.2003.00663.x; HORWITZ J, 1991, J NEUROCHEM, V56, P509, DOI 10.1111/j.1471-4159.1991.tb08179.x; Jackowski S, 2004, MOL CELL BIOL, V24, P4720, DOI 10.1128/MCB.24.11.4720-4733.2004; Jackson TR, 1996, J CELL SCI, V109, P289; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Ledesma MD, 1999, EMBO J, V18, P1761, DOI 10.1093/emboj/18.7.1761; Lykidis A, 1998, J BIOL CHEM, V273, P14022, DOI 10.1074/jbc.273.22.14022; Lykidis A, 1999, J BIOL CHEM, V274, P26992, DOI 10.1074/jbc.274.38.26992; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Marszalek JR, 2004, J BIOL CHEM, V279, P23882, DOI 10.1074/jbc.M313460200; Namgung U, 2004, MOL CELL NEUROSCI, V25, P422, DOI 10.1016/j.mcn.2003.11.005; Namikawa K, 2000, J NEUROSCI, V20, P2875; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; PELECH SL, 1981, J BIOL CHEM, V256, P8283; Pooler AM, 2005, NEUROSCIENCE, V134, P207, DOI 10.1016/j.neuroscience.2005.03.050; Ridsdale R, 2001, J BIOL CHEM, V276, P49148, DOI 10.1074/jbc.M103566200; SAVCI V, 1995, J NEUROCHEM, V64, P378; Smith DS, 2001, CELL GROWTH DIFFER, V12, P277; Stern CA, 2001, J NEUROSCI, V21, P1434, DOI 10.1523/JNEUROSCI.21-05-01434.2001; STROSZNAJDER J, 1979, BIOCHIM BIOPHYS ACTA, V574, P48, DOI 10.1016/0005-2760(79)90083-3; Szebenyi G, 1998, J NEUROSCI, V18, P7930; TANAKA T, 1987, BIOCHIM BIOPHYS ACTA, V922, P85, DOI 10.1016/0005-2760(87)90248-7; VANCE DE, 1984, TRENDS BIOCHEM SCI, V9, P17, DOI 10.1016/0968-0004(84)90041-0; VANCE JE, 1994, J NEUROCHEM, V62, P329; VANCE JE, 1991, J CELL BIOL, V115, P1061, DOI 10.1083/jcb.115.4.1061; WANG YL, 1993, J BIOL CHEM, V268, P5899; Watanabe H, 2004, J BIOL CHEM, V279, P37870, DOI 10.1074/jbc.M402610200; WIEPRECHT M, 1994, FEBS LETT, V353, P221, DOI 10.1016/0014-5793(94)01040-4; Yang J, 1999, TRENDS CELL BIOL, V9, P207, DOI 10.1016/S0962-8924(99)01577-9; ZHOU X, 1992, J LIPID RES, V33, P1233	47	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					202	212		10.1074/jbc.M706531200	http://dx.doi.org/10.1074/jbc.M706531200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17981805	hybrid			2022-12-25	WOS:000251940300023
J	McColl, G; Killilea, DW; Hubbard, AE; Vantipalli, MC; Melov, S; Lithgow, GJ				McColl, Gawain; Killilea, David W.; Hubbard, Alan E.; Vantipalli, Maithili C.; Melov, Simon; Lithgow, Gordon J.			Pharmacogenetic analysis of lithium-induced delayed aging in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPEROXIDE DISMUTASE/CATALASE MIMETICS; GLYCOGEN-SYNTHASE KINASE-3; PROGRAMMED CELL-DEATH; LIFE-SPAN; C-ELEGANS; CALORIC RESTRICTION; HUNTINGTONS-DISEASE; ABC TRANSPORTERS; OXIDATIVE STRESS; BODY-SIZE	Lithium (Li+) has been used to treat mood affect disorders, including bipolar, for decades. This drug is neuroprotective and has several identified molecular targets. However, it has a narrow therapeutic range and the one or more underlying mechanisms of its therapeutic action are not understood. Here we describe a pharmacogenetic study of Li+ in the nematode Caenorhabditis elegans. Exposure to Li+ at clinically relevant concentrations throughout adulthood increases survival during normal aging (up to 46% median increase). Longevity is extended via a novel mechanism with altered expression of genes encoding nucleosome-associated functions. Li+ treatment results in reduced expression of the worm ortholog of LSD-1 (T08D10.2), a histone demethylase; knockdown by RNA interference of T08D10.2 is sufficient to extend longevity (similar to 25% median increase), suggesting Li+ regulates survival by modulating histone methylation and chromatin structure.	[McColl, Gawain; Vantipalli, Maithili C.; Melov, Simon; Lithgow, Gordon J.] Buck Inst Age Res, Novato, CA 94945 USA; [Killilea, David W.] Childrens Hosp Oakland, Res Inst, Ctr Nutr & Metabol, Oakland, CA 94609 USA; [Hubbard, Alan E.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	Buck Institute for Research on Aging; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California Berkeley	McColl, G (corresponding author), Mental Hlth Res Inst Victoria, 155 Oak St, Parkville, Vic 3052, Australia.	gmccoll@mhri.edu.au	Melov, Simon/AAC-9469-2020; McColl, Gawain/Y-8959-2018	McColl, Gawain/0000-0002-6347-6722; Melov, Simon/0000-0001-8554-2834; Killilea, David/0000-0002-8929-6527	NIA NIH HHS [R01 AG022868-03, R01 AG022868-05, R01 AG021069-03, R01 AG022868, P30 AG 025708, R01 AG021069-02, R01 AG018679, AG 21069, R01 AG024385, R01 AG021069-05, R01 AG022868-01, R01 AG022868-02, R01 AG021069, R01 AG022868-04, R01 AG021069-04, P30 AG025708, AG 22868, R01 AG021069-01] Funding Source: Medline; NINDS NIH HHS [NS 050789-01, R03 NS050789] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS050789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024385, P30AG025708, R01AG018679, R01AG021069, R01AG022868] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		An JH, 2005, P NATL ACAD SCI USA, V102, P16275, DOI 10.1073/pnas.0508105102; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Berger Z, 2005, HUM MOL GENET, V14, P3003, DOI 10.1093/hmg/ddi331; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; CADE JFJ, 1949, MED J AUSTRALIA, V2, P349, DOI 10.5694/j.1326-5377.1949.tb36912.x; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; Chen G, 1999, J NEUROCHEM, V72, P879, DOI 10.1046/j.1471-4159.1999.720879.x; Chen RW, 1999, J BIOL CHEM, V274, P6039, DOI 10.1074/jbc.274.10.6039; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; Evason K, 2005, SCIENCE, V307, P258, DOI 10.1126/science.1105299; Flemming AJ, 2000, P NATL ACAD SCI USA, V97, P5285, DOI 10.1073/pnas.97.10.5285; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hirose T, 2003, DEVELOPMENT, V130, P1089, DOI 10.1242/dev.00330; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HOLM S, 1979, SCAND J STAT, V6, P65; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Inoue K, 2003, BIOCHEM J, V374, P21, DOI 10.1042/BJ20030827; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Keaney M, 2003, FREE RADICAL BIO MED, V34, P277, DOI 10.1016/S0891-5849(02)01290-X; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Killilea DW, 2003, ANTIOXID REDOX SIGN, V5, P507, DOI 10.1089/152308603770310158; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Masuda CA, 2001, J BIOL CHEM, V276, P37794; McColl G, 2005, FASEB J, V19, P1716, DOI 10.1096/fj.04-2447fje; McKay JP, 2004, GENETICS, V166, P161, DOI 10.1534/genetics.166.1.161; Mellor J, 2006, TRENDS GENET, V22, P320, DOI 10.1016/j.tig.2006.03.008; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Mudher A, 2004, MOL PSYCHIATR, V9, P522, DOI 10.1038/sj.mp.4001483; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Nonaka S, 1998, J PHARMACOL EXP THER, V286, P539; Perez M, 2003, J ALZHEIMERS DIS, V5, P301, DOI 10.3233/JAD-2003-5405; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Pettitt J, 2002, J CELL SCI, V115, P857; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Pletcher SD, 1999, J EVOLUTION BIOL, V12, P430, DOI 10.1046/j.1420-9101.1999.00058.x; PRICE LH, 1994, NEW ENGL J MED, V331, P591; Ryves WJ, 2001, BIOCHEM BIOPH RES CO, V280, P720, DOI 10.1006/bbrc.2000.4169; Sadri-Vakili G, 2006, NAT CLIN PRACT NEURO, V2, P330, DOI 10.1038/ncpneuro0199; Sampayo JN, 2003, AGING CELL, V2, P319, DOI 10.1046/j.1474-9728.2003.00063.x; Sheps JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r15; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9; Voisine C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000504; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; Watase K, 2007, PLOS MED, V4, P836, DOI 10.1371/journal.pmed.0040182; WONG A, 1995, GENETICS, V139, P1247; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; Zhao ZY, 2004, J MOL BIOL, V344, P409, DOI 10.1016/j.jmb.2004.09.052	61	143	164	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					350	357		10.1074/jbc.M705028200	http://dx.doi.org/10.1074/jbc.M705028200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17959600	hybrid, Green Accepted			2022-12-25	WOS:000251940300039
J	Palkowitsch, L; Leidner, J; Ghosh, S; Marienfeld, RB				Palkowitsch, Lysann; Leidner, Julia; Ghosh, Sankar; Marienfeld, Ralf B.			Phosphorylation of serine 68 in the I kappa B kinase (IKK)-binding domain of NEMO interferes with the structure of the IKK complex and tumor necrosis factor-alpha-induced NF-kappa B activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING DOMAIN; PHOSPHATASE 2A; ACTIVATION; BETA; GAMMA; OLIGOMERIZATION; CELLS; UBIQUITINATION; SUBUNIT; TAX	The I kappa B-Kinase (IKK) complex is a multisubunit protein complex crucial for signal-induced phosphorylation of the I kappa B proteins and thus controls the activity of the transcription factor NF-kappa B. Besides the two kinases IKK alpha and IKK beta, the IKK complex contains NEMO/IKK gamma, an additional subunit with regulatory and adaptor functions. NEMO not only confers structural stability to the IKK complex but also participates in the activation process of the IKK complex by linking the IKK subunits to upstream activators. In this study we analyze the IKK beta-mediated phosphorylation of the IKK-binding domain of NEMO. In vitro, IKK beta phosphorylates three serine residues in the domain of NEMO at positions 43, 68, and 85. However, mutational analysis revealed that only the phosphorylation of serine 68 in the center of the IKK-binding domain plays an essential role for the formation and the function of the IKK complex. Thus, Ser(68) phosphorylation attenuates the amino-terminal dimerization of NEMO as well as the IKK beta-NEMO interaction. In contrast, the NEMO-IKK alpha interaction was only mildly affected by the phosphorylation of Ser68. However, functional analysis revealed that Ser68 phosphorylation primarily affects the activity of IKK alpha. Furthermore, in complementation experiments of NEMO-deficient murine embryonic fibroblasts, a S68A-NEMO mutant enhanced, whereas a S68E mutant decreased, TNF-alpha-induced NF-kappa B activity, thus emphasizing the inhibitory role of the Ser68 phosphorylation on the signal-induced NF-kappa B activity. Finally, we provide evidence that the protein phosphatase PP2A is involved in the regulation of the Ser(68)-based mechanism. In summary, we provide evidence for a signal-induced phosphorylation-dependent alteration of the IKK complex emphasizing the dynamic nature of this multisubunit kinase complex.	[Palkowitsch, Lysann; Leidner, Julia; Marienfeld, Ralf B.] Univ Ulm, Inst Physiol Chem, D-89081 Ulm, Germany; [Ghosh, Sankar] Yale Univ, Sch Med, Dept Immunobiol, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Ulm University; Yale University	Marienfeld, RB (corresponding author), Univ Ulm, Inst Physiol Chem, Albert Einstein Allee 11, D-89081 Ulm, Germany.	ralf.marienfeld@uni-ulm.de						Agou F, 2004, J BIOL CHEM, V279, P54248, DOI 10.1074/jbc.M406423200; Agou F, 2002, J BIOL CHEM, V277, P17464, DOI 10.1074/jbc.M201964200; Carter RS, 2003, J BIOL CHEM, V278, P19642, DOI 10.1074/jbc.M301705200; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fontan E, 2007, FEBS J, V274, P2540, DOI 10.1111/j.1742-4658.2007.05788.x; Fu DX, 2003, J BIOL CHEM, V278, P1487, DOI 10.1074/jbc.M210631200; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Huang GJ, 2002, FEBS LETT, V531, P494, DOI 10.1016/S0014-5793(02)03590-1; Huang TT, 2002, MOL CELL BIOL, V22, P5813, DOI 10.1128/MCB.22.16.5813-5825.2002; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Kray AE, 2005, J BIOL CHEM, V280, P35974, DOI 10.1074/jbc.M506093200; Lamsoul I, 2005, MOL CELL BIOL, V25, P10391, DOI 10.1128/MCB.25.23.10391-10406.2005; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Luedde T, 2005, J CLIN INVEST, V115, P849, DOI 10.1172/JCI200523493; Marienfeld R, 2003, J BIOL CHEM, V278, P19852, DOI 10.1074/jbc.M301945200; Marienfeld RB, 2006, MOL CELL BIOL, V26, P9209, DOI 10.1128/MCB.00478-06; May MJ, 2002, J BIOL CHEM, V277, P45992, DOI 10.1074/jbc.M206494200; O'Mahony A, 2000, MOL CELL BIOL, V20, P1170, DOI 10.1128/MCB.20.4.1170-1178.2000; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Prajapati S, 2002, J BIOL CHEM, V277, P24331, DOI 10.1074/jbc.M201393200; Quirling M, 2004, J BIOL CHEM, V279, P37452, DOI 10.1074/jbc.M312119200; Schmidt-Supprian M, 2004, J IMMUNOL, V173, P1612, DOI 10.4049/jimmunol.173.3.1612; Schmidt-Supprian M, 2003, IMMUNITY, V19, P377, DOI 10.1016/S1074-7613(03)00237-1; Schomer-Miller B, 2006, J BIOL CHEM, V281, P15268, DOI 10.1074/jbc.M513793200; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Solt LA, 2007, J BIOL CHEM, V282, P8724, DOI 10.1074/jbc.M609613200; Tarassishin L, 2001, BIOCHEM BIOPH RES CO, V285, P555, DOI 10.1006/bbrc.2001.5197; Tegethoff S, 2003, MOL CELL BIOL, V23, P2029, DOI 10.1128/MCB.23.6.2029-2041.2003; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Yamamoto Y, 2000, MOL CELL BIOL, V20, P3655, DOI 10.1128/MCB.20.10.3655-3666.2000; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	37	59	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					76	86		10.1074/jbc.M708856200	http://dx.doi.org/10.1074/jbc.M708856200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17977820	hybrid			2022-12-25	WOS:000251940300010
J	Landau, M; Herz, K; Padan, E; Ben-Tal, N				Landau, Meytal; Herz, Katia; Padan, Etana; Ben-Tal, Nir			Model structure of the Na+/H+ exchanger 1 (NHE1) - Functional and clinical implications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; ESCHERICHIA-COLI; TRANSMEMBRANE SEGMENT; MEMBRANE-PROTEINS; STRUCTURE PREDICTION; SEQUENCE ALIGNMENT; TOPOLOGY MODEL; ACID-RESIDUES; ANTIPORTER; NHAA	Eukaryotic Na+/H+ exchangers are transmembrane proteins that are vital for cellular homeostasis and play key roles in pathological conditions such as cancer and heart diseases. Using the crystal structure of the Na+/H+ antiporter from Escherichia coli (EcNhaA) as a template, we predicted the three-dimensional structure of human Na+/H+ exchanger 1 (NHE1). Modeling was particularly challenging because of the extremely low sequence identity between these proteins, but the model structure is supported by evolutionary conservation analysis and empirical data. It also revealed the location of the binding site of NHE inhibitors; which we validated by conducting mutagenesis studies with EcNhaA and its specific inhibitor 2-aminoperimidine. The model structure features a cluster of titratable residues that are evolutionarily conserved and are located in a conserved region in the center of the membrane; we suggest that they are involved in the cation binding and translocation. We also suggest a hypothetical alternating-access mechanism that involves conformational changes.	[Landau, Meytal; Ben-Tal, Nir] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel; [Herz, Katia; Padan, Etana] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biochem, IL-91904 Jerusalem, Israel	Tel Aviv University; Hebrew University of Jerusalem	Ben-Tal, N (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel.	bental@ashtoret.tau.ac.il	Landau, Meytal/AAF-3479-2021; Landau, Meytal/J-3075-2012	Landau, Meytal/0000-0002-1743-3430; Landau, Meytal/0000-0002-1743-3430; Ben-Tal, Nir/0000-0001-6901-832X				Adamian L, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-13; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Briggs JAG, 2001, PROTEINS, V44, P370, DOI 10.1002/prot.1102; Counillon L, 1997, BIOCHEMISTRY-US, V36, P2951, DOI 10.1021/bi9615405; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dibrov P, 2005, FEBS LETT, V579, P373, DOI 10.1016/j.febslet.2004.11.098; Ding J, 2006, J BIOL CHEM, V281, P29817, DOI 10.1074/jbc.M606152200; Fleishman SJ, 2006, CURR OPIN STRUC BIOL, V16, P496, DOI 10.1016/j.sbi.2006.06.003; Fleishman SJ, 2004, MOL CELL, V15, P879, DOI 10.1016/j.molcel.2004.08.016; Forrest LR, 2006, BIOPHYS J, V91, P508, DOI 10.1529/biophysj.106.082313; Galili L, 2004, J BIOL CHEM, V279, P23104, DOI 10.1074/jbc.M400288200; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Hurwitz N, 2006, PHILOS T R SOC B, V361, P465, DOI 10.1098/rstb.2005.1804; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Kaim G, 1997, BIOCHEMISTRY-US, V36, P9185, DOI 10.1021/bi970831q; Kozachkov L, 2007, BIOCHEMISTRY-US, V46, P2419, DOI 10.1021/bi602393s; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Mayrose I, 2005, J MOL EVOL, V60, P345, DOI 10.1007/s00239-004-0183-8; Murtazina R, 2001, EUR J BIOCHEM, V268, P4674, DOI 10.1046/j.1432-1327.2001.02391.x; Olami Y, 1997, J BIOL CHEM, V272, P1761, DOI 10.1074/jbc.272.3.1761; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; RIMON A, 1995, J BIOL CHEM, V270, P26813, DOI 10.1074/jbc.270.45.26813; Sato Y, 2005, J BIOCHEM, V138, P425, DOI 10.1093/jb/mvi132; Shrode LD, 1998, AM J PHYSIOL-CELL PH, V275, pC431, DOI 10.1152/ajpcell.1998.275.2.C431; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Slepkov ER, 2005, J BIOL CHEM, V280, P17863, DOI 10.1074/jbc.M409608200; Tang CL, 2003, J MOL BIOL, V334, P1043, DOI 10.1016/j.jmb.2003.10.025; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; WAKABAYASHI S, 1992, P NATL ACAD SCI USA, V89, P2424, DOI 10.1073/pnas.89.6.2424; Yohannan S, 2004, P NATL ACAD SCI USA, V101, P959, DOI 10.1073/pnas.0306077101	38	106	109	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37854	37863		10.1074/jbc.M705460200	http://dx.doi.org/10.1074/jbc.M705460200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17981808	hybrid			2022-12-25	WOS:000251833600061
J	Ochiai, A; Itoh, T; Maruyama, Y; Kawamata, A; Mikami, B; Hashimoto, W; Murata, K				Ochiai, Akihito; Itoh, Takafumi; Maruyama, Yukie; Kawamata, Akiko; Mikami, Bunzo; Hashimoto, Wataru; Murata, Kousaku			A novel structural fold in polysaccharide lyases - Bacillus subtilis family 11 rhamnogalacturonan lyase YesW with an eight-bladed beta-propeller	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP GL1 XANTHAN; REFINED 3-DIMENSIONAL STRUCTURE; CHONDROITIN AC LYASE; PRIMARY-CELL WALLS; CRYSTAL-STRUCTURE; PECTATE LYASE; PLANT-CELL; ERWINIA-CHRYSANTHEMI; ANGSTROM RESOLUTION; PECTIC POLYSACCHARIDE	Rhamnogalacturonan (RG) lyase produced by plant pathogenic and saprophytic microbes plays an important role in degrading plant cell walls. An extracellular RG lyase YesW from saprophytic Bacillus subtilis is a member of polysaccharide lyase family 11 and cleaves glycoside bonds in polygalacturonan as well as RG type-I through a beta-elimination reaction. Crystal structures of YesW and its complex with galacturonan disaccharide, a reaction product analogue, were determined at 1.4 and 2.5 angstrom resolutions with final R-factors of 16.4% and 16.6%, respectively. The enzyme is composed of an eight-bladed beta-propeller with a deep cleft in the center as a basic scaffold, and its structural fold has not been seen in polysaccharide lyases analyzed thus far. Structural analysis of the disaccharide-bound YesW and a site-directed mutagenesis study suggested that Arg-452 and Lys-535 stabilize the carboxyl group of the acidic polysaccharide molecule and Tyr-595 makes a stack interaction with the sugar pyranose ring. In addition to amino acid residues binding to the disaccharide, one calcium ion, which is coordinated by Asp-401, Glu-422, His-363, and His-399, may mediate the enzyme activity. This is, to our knowledge, the first report of a new structural category with a beta-propeller fold in polysaccharide lyases and provides structural insights into substrate binding by RG lyase.	[Ochiai, Akihito; Itoh, Takafumi; Maruyama, Yukie; Kawamata, Akiko; Hashimoto, Wataru; Murata, Kousaku] Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Kyoto 6110011, Japan; [Mikami, Bunzo] Kyoto Univ, Lab Appl Struct Biol, Grad Sch Agr, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Murata, K (corresponding author), Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Kyoto 6110011, Japan.	kmurata@kais.kyoto-u.ac.jp						Akita M, 2001, ACTA CRYSTALLOGR D, V57, P1786, DOI 10.1107/S0907444901014482; BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P12067, DOI 10.1073/pnas.182431199; Coutinho PM, 1999, ROY SOC CH, P3; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DARVILL AG, 1978, PLANT PHYSIOL, V62, P418, DOI 10.1104/pp.62.3.418; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; de Vries RP, 2003, APPL MICROBIOL BIOT, V61, P10, DOI 10.1007/s00253-002-1171-9; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fethiere J, 1999, J MOL BIOL, V288, P635, DOI 10.1006/jmbi.1999.2698; Hasegawa H, 2005, APPL ENVIRON MICROB, V71, P4655, DOI 10.1128/AEM.71.8.4655-4663.2005; Hashimoto W, 2003, J BIOL CHEM, V278, P7663, DOI 10.1074/jbc.M208100200; Herron SR, 2003, J BIOL CHEM, V278, P12271, DOI 10.1074/jbc.M209306200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huang WJ, 2003, J MOL BIOL, V328, P623, DOI 10.1016/S0022-2836(03)00345-0; Huang WJ, 1999, J MOL BIOL, V294, P1257, DOI 10.1006/jmbi.1999.3292; Hugouvieux-Cotte-Pattat N, 2004, MOL MICROBIOL, V51, P1361, DOI 10.1046/j.1365-2958.2003.03908.x; HugouvieuxCottePattat N, 1996, ANNU REV MICROBIOL, V50, P213, DOI 10.1146/annurev.micro.50.1.213; Itoh T, 2006, J MOL BIOL, V360, P573, DOI 10.1016/j.jmb.2006.04.047; Jenkins J, 2004, J BIOL CHEM, V279, P9139, DOI 10.1074/jbc.M311390200; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kazemi-Pour N, 2004, PROTEOMICS, V4, P3177, DOI 10.1002/pmic.200300814; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; Li SL, 2001, J BIOL CHEM, V276, P41407, DOI 10.1074/jbc.M106634200; Lietzke SE, 1996, PLANT PHYSIOL, V111, P73, DOI 10.1104/pp.111.1.73; LINHARDT RJ, 1986, APPL BIOCHEM BIOTECH, V12, P135; Lunin VV, 2004, J MOL BIOL, V337, P367, DOI 10.1016/j.jmb.2003.12.071; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; Maruyama Y, 2005, J MOL BIOL, V350, P974, DOI 10.1016/j.jmb.2005.05.055; Maruyama Y, 2007, BIOCHEMISTRY-US, V46, P781, DOI 10.1021/bi0619775; Mayans O, 1997, STRUCTURE, V5, P677, DOI 10.1016/S0969-2126(97)00222-0; McDonough MA, 2004, FEBS LETT, V565, P188, DOI 10.1016/j.febslet.2004.03.094; McKie VA, 2001, BIOCHEM J, V355, P167, DOI 10.1042/0264-6021:3550167; MCNEIL M, 1980, PLANT PHYSIOL, V66, P1128, DOI 10.1104/pp.66.6.1128; MCNEIL M, 1984, ANNU REV BIOCHEM, V53, P625, DOI 10.1146/annurev.bi.53.070184.003205; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NOVOA D, 2004, ACTA CRYSTALLOGR D, V0060; Ochiai A, 2006, ACTA CRYSTALLOGR F, V62, P438, DOI 10.1107/S1744309106011894; Ochiai A, 2007, APPL ENVIRON MICROB, V73, P3803, DOI 10.1128/AEM.00147-07; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Osawa T, 2005, J MOL BIOL, V345, P1111, DOI 10.1016/j.jmb.2004.10.081; Pages S, 2003, J BACTERIOL, V185, P4727, DOI 10.1128/JB.185.16.4727-4733.2003; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PICKERSGILL R, 1994, NAT STRUCT BIOL, V1, P717, DOI 10.1038/nsb1094-717; Pickersgill R, 1998, J BIOL CHEM, V273, P24660, DOI 10.1074/jbc.273.38.24660; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Shaya D, 2006, J BIOL CHEM, V281, P15525, DOI 10.1074/jbc.M512055200; SIBANDA BL, 1985, NATURE, V316, P170, DOI 10.1038/316170a0; Smith NL, 2005, P NATL ACAD SCI USA, V102, P17652, DOI 10.1073/pnas.0504782102; Soriano M, 2005, CURR MICROBIOL, V50, P114, DOI 10.1007/s00284-004-4382-8; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thakur BR, 1997, CRIT REV FOOD SCI, V37, P47, DOI 10.1080/10408399709527767; Thomas LM, 2002, ACTA CRYSTALLOGR D, V58, P1008, DOI 10.1107/S0907444902005851; van Santen Y, 1999, J BIOL CHEM, V274, P30474, DOI 10.1074/jbc.274.43.30474; Vitali J, 1998, PLANT PHYSIOL, V116, P69, DOI 10.1104/pp.116.1.69; Xiong JP, 2004, J BIOL CHEM, V279, P40252, DOI 10.1074/jbc.C400362200; Yamasaki M, 2005, J MOL BIOL, V352, P11, DOI 10.1016/j.jmb.2005.06.075; Yamasaki M, 2004, J BIOL CHEM, V279, P31863, DOI 10.1074/jbc.M402466200; YODER MD, 1995, PLANT PHYSIOL, V107, P349, DOI 10.1104/pp.107.2.349; YODER MD, 1993, STRUCTURE, V1, P241, DOI 10.1016/0969-2126(93)90013-7; Yoon HJ, 1999, J MOL BIOL, V290, P505, DOI 10.1006/jmbi.1999.2883; Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509; Zhou Y, 2006, PROTEINS, V65, P643, DOI 10.1002/prot.21139	70	23	24	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37134	37145		10.1074/jbc.M704663200	http://dx.doi.org/10.1074/jbc.M704663200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17947240	hybrid			2022-12-25	WOS:000251646000040
J	Abhyankar, MM; Urekar, C; Reddi, PP				Abhyankar, Mayuresh M.; Urekar, Craig; Reddi, Prabhakara P.			A novel CpG-free vertebrate insulator silences the testis-specific SP-10 gene in somatic tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERMATID-SPECIFIC TRANSCRIPTION; TRANSGENIC MICE DEMONSTRATE; ENHANCER-BLOCKING ACTIVITY; BETA-GLOBIN DOMAIN; CHROMATIN INSULATOR; NUCLEAR-MATRIX; CTCF; MOUSE; PROMOTER; ELEMENT	Regulation of cell type-specific gene transcription is central to cellular differentiation and development. During spermatogenesis, a number of testis- specific genes are expressed in a precise spatiotemporal order. How these genes remain silent in the somatic tissues is not well understood. Our previous studies using the round spermatid-specific mouse SP-10 gene, which codes for an acrosomal protein, revealed that its proximal promoter acts as an insulator and prevents expression in the somatic tissues. Here we report that the insulator tethers the SP-10 gene to the nuclear matrix in somatic tissues, sequestering the core promoter in the process, thus preventing transcription. In round spermatids where the SP-10 gene is expressed, this tethering is released. TAR DNA-binding protein of 43 kDa (TDP-43), previously shown to interact with the SP-10 insulator, was found to be in the 2 M NaCl- insoluble nuclear matrix fraction. TDP-43 prevented enhancer-promoter interactions when artificially recruited between the two by Gal4 strategy. Knockdown of TDP-43 using small interfering RNA released the enhancer- blocking effect of the SP-10 insulator in a stable cell culture model. Mutation of TDP-43 binding sites abolished this effect. Finally, a 50-bp subfragment of the SP-10 insulator, which includes TDP-43 binding sites, functioned as a minimal insulator in transgenic mice and silenced an otherwise ectopically expressed transgene in somatic tissues. The SP-10 insulator lacks CpG dinucleotides or CTCF binding sites. Thus, the present study characterized a novel vertebrate insulator in a physiological context and showed for the first time how a testis-specific gene is silenced in the somatic tissues by an insulator.	Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia	Reddi, PP (corresponding author), Univ Virginia, Sch Med, Dept Pathol, POB 800904, Charlottesville, VA 22908 USA.	ppr5s@virginia.edu	Reddi, Prabhakara/AAY-8092-2020	Reddi, Prabhakara/0000-0003-4891-8964	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036239, R29HD036239] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 36239] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Acharya KK, 2006, DEV BIOL, V295, P781, DOI 10.1016/j.ydbio.2006.04.443; Antes TJ, 2001, BIOCHEMISTRY-US, V40, P6731, DOI 10.1021/bi0100743; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Dix DJ, 1996, DEV BIOL, V174, P310, DOI 10.1006/dbio.1996.0076; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Geusz ME, 1997, CURR BIOL, V7, P758, DOI 10.1016/S0960-9822(06)00334-4; Geyer CB, 2004, BIOL REPROD, V71, P837, DOI 10.1095/biolreprod.104.028969; Gilbert N, 2005, INT REV CYTOL, V242, P283; Hancock R, 2000, CHROMOSOMA, V109, P219, DOI 10.1007/s004120000077; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; HOGAN B, 1994, MANIPULATING MOUSE E, P226; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; IKAWA M, 1995, DEV GROWTH DIFFER, V37, P455, DOI 10.1046/j.1440-169X.1995.t01-2-00012.x; Istrail S, 2005, P NATL ACAD SCI USA, V102, P4954, DOI 10.1073/pnas.0409624102; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; Kim M, 2006, J BIOL CHEM, V281, P34288, DOI 10.1074/jbc.M607168200; LANGFORD KG, 1991, J BIOL CHEM, V266, P15559; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; LI QL, 1994, BLOOD, V84, P1399; Li SH, 2006, REPRODUCTION, V132, P493, DOI 10.1530/rep.1.01183; Li SM, 1998, J BIOL CHEM, V273, P31191, DOI 10.1074/jbc.273.47.31191; MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815; MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Reddi PP, 1999, BIOL REPROD, V61, P1256, DOI 10.1095/biolreprod61.5.1256; Reddi PP, 2003, DEV BIOL, V262, P173, DOI 10.1016/S0012-1606(03)00349-X; Robinett CC, 1997, MOL CELL BIOL, V17, P2866, DOI 10.1128/MCB.17.5.2866; ROBINSON MO, 1989, P NATL ACAD SCI USA, V86, P8437, DOI 10.1073/pnas.86.21.8437; Saitoh N, 2000, EMBO J, V19, P2315, DOI 10.1093/emboj/19.10.2315; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; SCHMIDT EV, 1990, MOL CELL BIOL, V10, P4406, DOI 10.1128/MCB.10.8.4406; Smith AD, 2006, P NATL ACAD SCI USA, V103, P6275, DOI 10.1073/pnas.0508169103; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Yusufzai TM, 2004, P NATL ACAD SCI USA, V101, P8620, DOI 10.1073/pnas.0402938101; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; ZAMBROWICZ BP, 1993, P NATL ACAD SCI USA, V90, P5071, DOI 10.1073/pnas.90.11.5071	46	89	93	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36143	36154		10.1074/jbc.M705811200	http://dx.doi.org/10.1074/jbc.M705811200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17932037	hybrid			2022-12-25	WOS:000251458300004
J	Ignatova, Z; Thakur, AK; Wetzel, R; Gierasch, LM				Ignatova, Zoya; Thakur, Ashwani K.; Wetzel, Ronald; Gierasch, Lila M.			In-cell aggregation of a polyglutamine-containing chimera is a multistep process initiated by the flanking sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN AGGREGATION; FIBRIL FORMATION; HUNTINGTIN; TOXICITY; DISEASE; BINDING; VITRO; NEURODEGENERATION; FIBRILLOGENESIS; PROTOFIBRILS	Toxicity in amyloid diseases is intimately linked to the nature of aggregates, with early oligomeric species believed to be more cytotoxic than later fibrillar aggregates. Yet mechanistic understanding of how aggregating species evolve with time is currently lacking. We have explored the aggregation process of a chimera composed of a globular protein (cellular retinoic acid-binding protein, CRABP) and huntingtin exon 1 with polyglutamine tracts either above (Q53) or below (Q20) the pathological threshold using Escherichia coli cells as a model intracellular environment. Previously we showed that fusion of the huntingtin exon 1 sequence with > 40Q led to structural perturbation and decreased stability of CRABP (Ignatova, Z., and Gierasch, L. M. (2006) J. Biol. Chem. 281, 12959-12967). Here we report that the Q53 chimera aggregates in cells via a multistep process: early stage aggregates are spherical and detergent-soluble, characteristics of prefibrillar aggregates, and appear to be dominated structurally by CRABP, in that they can promote aggregation of a CRABP variant but not oligoglutamine aggregation, and the CRABP domain is relatively sequestered based on its protection from proteolysis. Late stage aggregates appear to be dominated by polyGln; they are fibrillar, detergent-resistant, capable of seeding aggregation of oligoglutamine but not the CRABP variant, and show relative protection of the polyglutamine-exon1 domain from proteolysis. These results point to an evolution of the dominant sequences in intracellular aggregates and may provide molecular insight into origins of toxic prefibrillar aggregates.	Max Planck Inst Biochem, D-82152 Martinsried, Germany; Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15206 USA	Max Planck Society; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ignatova, Z (corresponding author), Max Planck Inst Biochem, Am Klopferspitz 18, D-82152 Martinsried, Germany.	ignatova@biochem.mpg.de; gierasch@biochem.umass.edu	Wetzel, Ronald/G-7453-2011; Thakur, Ashwani Kumar/AAL-5784-2021; Gierasch, Lila M/D-1494-2009	Ignatova, Zoya/0000-0002-9478-8825	NIA NIH HHS [R01 AG019322] Funding Source: Medline; NIGMS NIH HHS [R01 GM027616] Funding Source: Medline; NIH HHS [DP1 OD000945-02, DP1 OD000945] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019322] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000945] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Berthelier V, 2006, METHOD ENZYMOL, V413, P313, DOI 10.1016/S0076-6879(06)13016-5; Bhattacharyya AM, 2005, P NATL ACAD SCI USA, V102, P15400, DOI 10.1073/pnas.0501651102; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Bulone D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000111; Carrio M, 2005, J MOL BIOL, V347, P1025, DOI 10.1016/j.jmb.2005.02.030; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Crick SL, 2006, P NATL ACAD SCI USA, V103, P16764, DOI 10.1073/pnas.0608175103; de Chiara C, 2005, J MOL BIOL, V354, P883, DOI 10.1016/j.jmb.2005.09.083; DELEEUW AM, 1990, J NEUROCYTOL, V19, P253, DOI 10.1007/BF01217303; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Ellisdon AM, 2007, J MOL BIOL, V368, P595, DOI 10.1016/j.jmb.2007.02.058; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Gonzalez-Montalban N, 2007, BIOCHEM BIOPH RES CO, V355, P637, DOI 10.1016/j.bbrc.2007.01.192; Griffin BA, 2000, METHOD ENZYMOL, V327, P565; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Ignatova Z, 2006, J BIOL CHEM, V281, P12959, DOI 10.1074/jbc.M511523200; Ignatova Z, 2005, BIOCHEMISTRY-US, V44, P7266, DOI 10.1021/bi047404e; Ignatova Z, 2004, P NATL ACAD SCI USA, V101, P523, DOI 10.1073/pnas.0304533101; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kheterpal I, 2001, BIOCHEMISTRY-US, V40, P11757, DOI 10.1021/bi010805z; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lee HJ, 2002, J BIOL CHEM, V277, P48976, DOI 10.1074/jbc.M208192200; Li PW, 2007, NAT STRUCT MOL BIOL, V14, P381, DOI 10.1038/nsmb1234; Masino L, 2004, J MOL BIOL, V344, P1021, DOI 10.1016/j.jmb.2004.09.065; Masino L, 2002, FEBS LETT, V513, P267, DOI 10.1016/S0014-5793(02)02335-9; Myers SL, 2006, RAPID COMMUN MASS SP, V20, P1628, DOI 10.1002/rcm.2482; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; OBERG K, 1994, BIOCHEMISTRY-US, V33, P2628, DOI 10.1021/bi00175a035; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Tanaka M, 2003, J BIOL CHEM, V278, P34717, DOI 10.1074/jbc.M209852200; Vitalis A, 2007, BIOPHYS J, V93, P1923, DOI 10.1529/biophysj.107.110080; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Wang XL, 2006, PROTEINS, V63, P297, DOI 10.1002/prot.20761; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	53	56	56	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36736	36743		10.1074/jbc.M703682200	http://dx.doi.org/10.1074/jbc.M703682200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17942400	hybrid, Green Accepted			2022-12-25	WOS:000251458300066
J	Gonzalez-Rey, E; Martinez-Romero, R; O'Valle, F; Aguilar-Quesada, R; Conde, C; Delgado, M; Oliver, FJ				Gonzalez-Rey, Elena; Martinez-Romero, Ruben; O'Valle, Francisco; Aguilar-Quesada, Rocio; Conde, Carmen; Delgado, Mario; Javier Oliver, F.			Therapeutic Effect of a Poly(ADP-Ribose) Polymerase-1 Inhibitor on Experimental Arthritis by Downregulating Inflammation and Th1 Response	PLOS ONE			English	Article								Poly(ADP-ribose) polymerase-1 (PARP-1) synthesizes and transfers ADP ribose polymers to target proteins, and regulates DNA repair and genomic integrity maintenance. PARP-1 also plays a crucial role in the progression of the inflammatory response, and its inhibition confers protection in several models of inflammatory disorders. Here, we investigate the impact of a selective PARP-1 inhibitor in experimental arthritis. PARP-1 inhibition with 5-aminoisoquinolinone (AIQ) significantly reduces incidence and severity of established collagen-induced arthritis, completely abrogating joint swelling and destruction of cartilage and bone. The therapeutic effect of AIQ is associated with a striking reduction of the two deleterious components of the disease, i.e. the Th1-driven autoimmune and inflammatory responses. AIQ downregulates the production of various inflammatory cytokines and chemokines, decreases the antigen-specific Th1-cell expansion, and induces the production of the antiinflammatory cytokine IL-10. Our results provide evidence of the contribution of PARP-1 to the progression of arthritis and identify this protein as a potential therapeutic target for the treatment of rheumatoid arthritis.	[Gonzalez-Rey, Elena; Martinez-Romero, Ruben; Aguilar-Quesada, Rocio; Delgado, Mario; Javier Oliver, F.] CSIC, Inst Parasitol & Biomed, Granada, Spain; [O'Valle, Francisco] Univ Granada, Dept Pathol, Sch Med, Granada, Spain; [Conde, Carmen] Hosp Clin Univ, Res Lab, Santiago De Compostela, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Granada; Complexo Hospitalario Universitario de Santiago de Compostela	Oliver, FJ (corresponding author), CSIC, Inst Parasitol & Biomed, Granada, Spain.	joliver@ipb.csic.es	OValle, Francisco/AAA-9151-2019; Oliver, Javier/S-1725-2018; Conde, Carmen/ABA-2396-2021; Delgado, Mario/P-1524-2016; GONZALEZ-REY, ELENA/L-3296-2014	Oliver, Javier/0000-0001-8468-1998; Delgado, Mario/0000-0003-1893-5982; GONZALEZ-REY, ELENA/0000-0003-3917-9020; Conde, Carmen/0000-0001-5717-5483; Aguilar-Quesada, Rocio/0000-0003-3125-6634	Junta de Andalucia [CTS870];  [SAF 2003-01217];  [RNIHG c03/02];  [PI050972];  [SAF2006-01089];  [FIS G03/152]	Junta de Andalucia(Junta de Andalucia); ; ; ; ; 	Funding: This work has been supported by grants CTS870 from Junta de Andalucia to MD, SAF 2003-01217, RNIHG c03/02, PI050972, SAF2006-01089 and FIS G03/152 to FJO.	Andreone TL, 2003, J IMMUNOL, V170, P2113, DOI 10.4049/jimmunol.170.4.2113; Anthony DD, 1999, CLIN EXP RHEUMATOL, V17, P240; Brand DD, 2003, SPRINGER SEMIN IMMUN, V25, P3, DOI 10.1007/s00281-003-0127-1; Chiarugi A, 2002, BRIT J PHARMACOL, V137, P761, DOI 10.1038/sj.bjp.0704934; Cuzzocrea S, 2002, BIOCHEM PHARMACOL, V63, P293, DOI 10.1016/S0006-2952(01)00864-4; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Delgado M, 2001, NAT MED, V7, P563, DOI 10.1038/87887; Di Paola R, 2004, EUR J PHARMACOL, V492, P203, DOI 10.1016/j.ejphar.2004.03.033; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Garcia-Vicuna R, 2004, ARTHRITIS RHEUM-US, V50, P3866, DOI 10.1002/art.20615; Goronzy JJ, 2005, CURR OPIN IMMUNOL, V17, P468, DOI 10.1016/j.coi.2005.07.020; Goronzy JJ, 2005, IMMUNOL REV, V204, P55, DOI 10.1111/j.0105-2896.2005.00245.x; Ha HC, 2004, P NATL ACAD SCI USA, V101, P5087, DOI 10.1073/pnas.0306895101; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Hur JW, 2006, RHEUMATOLOGY, V45, P711, DOI 10.1093/rheumatology/kei262; KASAMA T, 1995, J CLIN INVEST, V95, P2868, DOI 10.1172/JCI117993; Koch AE, 2005, ARTHRITIS RHEUM, V52, P710, DOI 10.1002/art.20932; Mabley JG, 2001, INFLAMM RES, V50, P561, DOI 10.1007/PL00000234; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Pascual M, 2003, ARTHRITIS RHEUM, V48, P638, DOI 10.1002/art.10864; Scott DL, 2006, NEW ENGL J MED, V355, P704, DOI 10.1056/NEJMct055183; Scott GS, 2004, J PHARMACOL EXP THER, V310, P1053, DOI 10.1124/jpet.103.063214; SEKI N, 1988, J IMMUNOL, V140, P1477; Suarez-Pinzon WL, 2003, DIABETES, V52, P1683, DOI 10.2337/diabetes.52.7.1683; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; Szabo C, 2006, NITRIC OXIDE-BIOL CH, V14, P169, DOI 10.1016/j.niox.2005.06.008; Tremoulet AH, 2006, EXPERT OPIN INV DRUG, V15, P1427, DOI 10.1517/13543784.15.11.1427; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Walmsley M, 1996, ARTHRITIS RHEUM-US, V39, P495, DOI 10.1002/art.1780390318	29	32	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1071	10.1371/journal.pone.0001071	http://dx.doi.org/10.1371/journal.pone.0001071			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971849	gold, Green Published, Green Submitted			2022-12-25	WOS:000207458700002
J	Parker, JDK; Bradley, BA; Mooers, AO; Quarmby, LM				Parker, Jeremy D. K.; Bradley, Brian A.; Mooers, Arne O.; Quarmby, Lynne M.			Phylogenetic Analysis of the Neks Reveals Early Diversification of Ciliary-Cell Cycle Kinases	PLOS ONE			English	Article								Background. NIMA-related kinases (Neks) have been studied in diverse eukaryotes, including the fungus Aspergillus and the ciliate Tetrahymena. In the former, a single Nek plays an essential role in cell cycle regulation; in the latter, which has more than 30 Neks in its genome, multiple Neks regulate ciliary length. Mammalian genomes encode an intermediate number of Neks, several of which are reported to play roles in cell cycle regulation and/or localize to centrosomes. Previously, we reported that organisms with cilia typically have more Neks than organisms without cilia, but were unable to establish the evolutionary history of the gene family. Methodology/Principle Findings. We have performed a large-scale analysis of the Nek family using Bayesian techniques, including tests of alternate topologies. We find that the Nek family had already expanded in the last common ancestor of eukaryotes, a ciliated cell which likely expressed at least five Neks. We suggest that Neks played an important role in the common ancestor in regulating cilia, centrioles, and centrosomes with respect to mitotic entry, and that this role continues today in organisms with cilia. Organisms that lack cilia generally show a reduction in the number of Nek clades represented, sometimes associated with lineage specific expansion of a single clade, as has occurred in the plants. Conclusion/Significance. This is the first rigorous phylogenetic analysis of a kinase family across a broad array of phyla. Our findings provide a coherent framework for the study of Neks and their roles in coordinating cilia and cell cycle progression.	[Parker, Jeremy D. K.; Bradley, Brian A.; Quarmby, Lynne M.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Mooers, Arne O.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Quarmby, LM (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	quarmby@sfu.ca		Parker, Jeremy/0000-0001-8319-5891; Quarmby, Lynne/0000-0001-6661-680X	Natural Sciences and Engineering Research Council of Canada (NSERC); Michael Smith Foundation for Health Research	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant to LMQ. BAB was supported by fellowships from NSERC and the Michael Smith Foundation for Health Research. Neither of these agencies had any role in any aspect of this study or the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bahe S, 2005, J CELL BIOL, V171, P27, DOI 10.1083/jcb.200504107; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; Bingham J, 2000, BIOINFORMATICS, V16, P660, DOI 10.1093/bioinformatics/16.7.660; Bradley BA, 2005, J CELL SCI, V118, P3317, DOI 10.1242/jcs.02455; Bradley BA, 2004, J EUKARYOT MICROBIOL, V51, P66, DOI 10.1111/j.1550-7408.2004.tb00164.x; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; Chepurnov VA, 2004, INT REV CYTOL, V237, P91; Cloutier M, 2005, FEBS LETT, V579, P4659, DOI 10.1016/j.febslet.2005.07.036; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Erickson HP, 2007, BIOESSAYS, V29, P668, DOI 10.1002/bies.20601; Feige E, 2006, BBA-MOL CELL RES, V1763, P272, DOI 10.1016/j.bbamcr.2006.01.009; Fry AM, 2002, ONCOGENE, V21, P6184, DOI 10.1038/sj.onc.1205711; Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Jekely G, 2006, BIOESSAYS, V28, P191, DOI 10.1002/bies.20369; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Liu SM, 2002, DEVELOPMENT, V129, P5839, DOI 10.1242/dev.00173; Lynch M, 2004, TRENDS GENET, V20, P544, DOI 10.1016/j.tig.2004.09.001; Mahjoub MR, 2005, J AM SOC NEPHROL, V16, P3485, DOI 10.1681/ASN.2005080824; Mahjoub MR, 2004, MOL BIOL CELL, V15, P5172, DOI 10.1091/mbc.E04-07-0571; Mahjoub MR, 2002, J CELL SCI, V115, P1759; Marshall WF, 2006, CURR BIOL, V16, pR604, DOI 10.1016/j.cub.2006.07.012; Mayor T, 2002, J CELL SCI, V115, P3275; Miller SL, 2005, MOL ENDOCRINOL, V19, P939, DOI 10.1210/me.2004-0443; MILLER SL, 2007, ONCOGENE; Noguchi K, 2004, J BIOL CHEM, V279, P32716, DOI 10.1074/jbc.M404104200; Nohynkova E, 2006, EUKARYOT CELL, V5, P753, DOI 10.1128/EC.5.4.753-761.2006; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; O'Connell MJ, 2003, TRENDS CELL BIOL, V13, P221, DOI 10.1016/S0962-8924(03)00056-4; OSMANI AH, 1991, CELL, V67, P283, DOI 10.1016/0092-8674(91)90180-7; OTTO EA, 2007, J AM SOC NE IN PRESS; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pazour GJ, 2004, J AM SOC NEPHROL, V15, P2528, DOI 10.1097/01.ASN.0000141055.57643.E0; Qin HM, 2007, CURR BIOL, V17, P193, DOI 10.1016/j.cub.2006.12.040; Quarmby LM, 2005, J CELL SCI, V118, P5161, DOI 10.1242/jcs.02681; Quarmby LM, 2005, J CELL BIOL, V169, P707, DOI 10.1083/jcb.200503053; Rellos P, 2007, J BIOL CHEM, V282, P6833, DOI 10.1074/jbc.M609721200; Richards TA, 2005, NATURE, V436, P1113, DOI 10.1038/nature03949; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Tan BCM, 2004, J BIOL CHEM, V279, P9321, DOI 10.1074/jbc.M311477200; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TUCKER RW, 1979, CELL, V17, P527, DOI 10.1016/0092-8674(79)90261-7; Upadhya P, 2000, P NATL ACAD SCI USA, V97, P217, DOI 10.1073/pnas.97.1.217; Wloga D, 2006, MOL BIOL CELL, V17, P2799, DOI 10.1091/mbc.E05-05-0450; Yin MJ, 2003, J BIOL CHEM, V278, P52454, DOI 10.1074/jbc.M308080200; Yissachar N, 2006, FEBS LETT, V580, P6489, DOI 10.1016/j.febslet.2006.10.069; Zhang H, 1996, J MICROSC-OXFORD, V181, P186, DOI 10.1046/j.1365-2818.1996.110390.x	55	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1076	10.1371/journal.pone.0001076	http://dx.doi.org/10.1371/journal.pone.0001076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957258	Green Published, gold			2022-12-25	WOS:000207458500021
J	French, CA; Ramirez, CL; Kolmakova, J; Hickman, TT; Cameron, MJ; Thyne, ME; Kutok, JL; Toretsky, JA; Tadavarthy, AK; Kees, UR; Fletcher, JA; Aster, JC				French, C. A.; Ramirez, C. L.; Kolmakova, J.; Hickman, T. T.; Cameron, M. J.; Thyne, M. E.; Kutok, J. L.; Toretsky, J. A.; Tadavarthy, A. K.; Kees, U. R.; Fletcher, J. A.; Aster, J. C.			BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells	ONCOGENE			English	Article						BRD3-NUT; t(15;19); t(9;15); NUT midline carcinoma	BROMODOMAIN PROTEIN; AGGRESSIVE CARCINOMA; S-PHASE; P-TEFB; REARRANGEMENT; INTERACTS; EXPORT; BINDS; CRM1	An unusual group of carcinomas, here termed nuclear protein in testis (NUT) midline carcinomas (NMC), are characterized by translocations that involve NUT, a novel gene on chromosome 15. In about 2/3rds of cases, NUT is fused to BRD4 on chromosome 19. Using a candidate gene approach, we identified two NMCs harboring novel rearrangements that result in the fusion of NUT to BRD3 on chromosome 9. The BRD3-NUT fusion gene encodes a protein composed of two tandem chromatin-binding bromodomains, an extra-terminal domain, a bipartite nuclear localization sequence, and almost the entirety of NUT that is highly homologous to BRD4-NUT. The function of NUT is unknown, but here we show that NUT contains nuclear localization and export sequences that promote nuclear-cytoplasmic shuttling via a leptomycin-sensitive pathway. In contrast, BRD3-NUT and BRD4-NUT are strictly nuclear, implying that the BRD moiety retains NUT in the nucleus via interactions with chromatin. Consistent with this idea, FRAP studies show that BRD4, BRD4-NUT and BRD3-NUT have significantly slower rates of lateral nuclear diffusion than that of NUT. To investigate the functional role of BRD-NUT fusion proteins in NMCs, we investigated the effects of siRNA-induced BRD3-NUT and BRD4-NUT withdrawal. Silencing of these proteins in NMC cell lines resulted in squamous differentiation and cell cycle arrest. Together, these data suggest that BRD-NUT fusion proteins contribute to carcinogenesis by associating with chromatin and interfering with epithelial differentiation.	[French, C. A.; Hickman, T. T.; Cameron, M. J.; Thyne, M. E.; Kutok, J. L.; Fletcher, J. A.; Aster, J. C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [French, C. A.; Hickman, T. T.; Cameron, M. J.; Thyne, M. E.; Kutok, J. L.; Fletcher, J. A.; Aster, J. C.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Ramirez, C. L.] Harvard Univ, Sch Med, Dept Biol, Cambridge, MA 02138 USA; [Ramirez, C. L.] Harvard Univ, Sch Med, Dept Biomed Sci, Cambridge, MA 02138 USA; [Kolmakova, J.] Boston Univ, Sch Med, Boston, MA 02215 USA; [Toretsky, J. A.] Georgetown Univ, Lombardi Comprehens Canc Ctr & Pediat, Dept Oncol, Washington, DC 20057 USA; [Tadavarthy, A. K.] Allina Hosp & Clin, Minneapolis, MN USA; [Kees, U. R.] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Kees, U. R.] Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Harvard University; Boston University; Georgetown University; Telethon Kids Institute; University of Western Australia; University of Western Australia	French, CA (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	Cfrench@partners.org		Hickman, Tyler/0000-0003-2623-3251; Ramirez, Cherie/0000-0002-0397-6872				Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Farina A, 2004, MOL CELL BIOL, V24, P9059, DOI 10.1128/MCB.24.20.9059-9069.2004; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; French CA, 2004, J CLIN ONCOL, V22, P4135, DOI 10.1200/JCO.2004.02.107; French CA, 2003, CANCER RES, V63, P304; French CA, 2001, AM J PATHOL, V159, P1987, DOI 10.1016/S0002-9440(10)63049-0; Haruki N, 2005, J MED GENET, V42, P558, DOI 10.1136/jmg.2004.029686; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; KEES UR, 1991, AM J PEDIAT HEMATOL, V13, P459; Maruyama T, 2002, MOL CELL BIOL, V22, P6509, DOI 10.1128/MCB.22.18.6509-6520.2002; MERTENS F, 2006, PEDIAT BLOOD CA 0102; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Ottinger M, 2006, J VIROL, V80, P10772, DOI 10.1128/JVI.00804-06; Toretsky JA, 2003, AM J CLIN ONCOL-CANC, V26, P300, DOI 10.1097/00000421-200306000-00019; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029	15	285	347	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR 3	2008	27	15					2237	2242		10.1038/sj.onc.1210852	http://dx.doi.org/10.1038/sj.onc.1210852			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	283FE	17934517				2022-12-25	WOS:000254621300014
J	Cordeaux, Y; Briddon, SJ; Alexander, SPH; Kellam, B; Hill, SJ				Cordeaux, Y.; Briddon, S. J.; Alexander, S. P. H.; Kellam, B.; Hill, S. J.			Agonist-occupied A(3) adenosine receptors exist within heterogeneous complexes in membrane microdomains of individual living cells	FASEB JOURNAL			English	Article						fluorescence correlation spectroscopy; GPCRs; confocal imaging	FLUORESCENCE CORRELATION SPECTROSCOPY; G-PROTEIN; MOLECULAR-CLONING; PHOSPHOLIPASE-C; A(1) RECEPTOR; INTRACELLULAR CALCIUM; LIPID RAFTS; CHO-CELLS; ACTIVATION; PHARMACOLOGY	G protein-coupled receptors are known to be organized within different membrane compartments or microdomains of individual cells. Here, we have used a fluorescent A(3) adenosine receptor (A(3)-AR) agonist, ABEA-X-BY630, and the technique of fluorescence correlation spectroscopy (FCS) to investigate the diffusional characteristics of functional agonist-occupied A(3)-AR complexes in single living cells. In Chinese hamster ovary cells expressing the human A(3)-AR, the fluorescent A(3)-AR agonist was able to inhibit forskolin-stimulated [H-3]cAMP production (pEC(50)=8.57), and this was antagonized by the A(3)-selective antagonist MRS1220 (pK(B)=9.32). The fluorescent ligand also stimulated phosphoinositide hydrolysis (pEC(50)=7.34). Ligand binding to the A(3)-AR on the membranes of single cells and subsequent increases in single cell [Ca2+](i) were monitored simultaneously in real time using confocal microscopy. FCS measurements in small-membrane microdomains (similar to 0.2 mu m(2)) revealed two agonist-occupied A(3)-AR components with differing diffusion characteristics (diffusion coefficients=2.65 x 10(-8) and 1.19x10(-9) cm(2)/s, respectively). The binding of ligand to these two components was reduced from 5.1 and 14.9 to 2.6 and 3.3 receptors/mu m(2), respectively, by MRS1220 (100 nM). These data provide direct evidence for at least two populations of agonist-occupied A(3)-receptor complexes, showing different motilities within the membrane of single living cells.	[Cordeaux, Y.; Briddon, S. J.; Alexander, S. P. H.; Hill, S. J.] Queens Med Ctr, Sch Med, Inst Cell Signalling, Sch Biomed Sci, Nottingham NG7 2UH, England; [Kellam, B.] Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham, England	University of Nottingham; University of Nottingham	Hill, SJ (corresponding author), Queens Med Ctr, Sch Med, Inst Cell Signalling, Sch Biomed Sci, C Floor, Nottingham NG7 2UH, England.	stephen.hill@nottingham.ac.uk	Kellam, Barrie/AAE-2960-2019; Hill, Stephen J/M-6243-2018; Hill, Stephen/N-6753-2013; Alexander, Steve P/B-8105-2009	Hill, Stephen J/0000-0002-4424-239X; Hill, Stephen/0000-0002-4424-239X; Alexander, Steve P/0000-0003-4417-497X; Kellam, Barrie/0000-0003-0030-9908; Briddon, Stephen/0000-0001-8514-0827	Wellcome Trust [57199, 66817] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abbracchio MP, 1995, MOL PHARMACOL, V48, P1038; ALVAREZ R, 1990, ANAL BIOCHEM, V187, P98, DOI 10.1016/0003-2697(90)90423-7; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Baker JG, 2003, MOL PHARMACOL, V64, P1357, DOI 10.1124/mol.64.6.1357; Briddon SJ, 2004, P NATL ACAD SCI USA, V101, P4673, DOI 10.1073/pnas.0400420101; Charest PG, 2007, CELL SIGNAL, V19, P32, DOI 10.1016/j.cellsig.2006.05.020; Cordeaux Y, 2004, BRIT J PHARMACOL, V143, P705, DOI 10.1038/sj.bjp.0705925; Cordeaux Y, 2000, MOL PHARMACOL, V58, P1075, DOI 10.1124/mol.58.5.1075; Daly CJ, 2003, PHARMACOL THERAPEUT, V100, P101, DOI 10.1016/j.pharmthera.2003.08.001; Dickenson JM, 1998, EUR J PHARMACOL, V355, P85, DOI 10.1016/S0014-2999(98)00468-3; DICKENSON JM, 1995, EUR J PHARM-MOLEC PH, V288, P393, DOI 10.1016/0922-4106(95)90055-1; Fishman P, 2003, CURR TOP MED CHEM, V3, P463, DOI 10.2174/1568026033392147; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Gessi S, 2004, CLIN CANCER RES, V10, P5895, DOI 10.1158/1078-0432.CCR-1134-03; Gessi S, 2004, MOL PHARMACOL, V65, P711, DOI 10.1124/mol.65.3.711; Gines S, 2001, MOL PHARMACOL, V59, P1314, DOI 10.1124/mol.59.5.1314; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Insel PA, 2005, ANN NY ACAD SCI, V1047, P166, DOI 10.1196/annals.1341.015; Kenakin T, 2001, FASEB J, V15, P598, DOI 10.1096/fj.00-0438rev; Klotz KN, 1998, N-S ARCH PHARMACOL, V357, P1; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Livingston M, 2004, INFLAMM RES, V53, P171, DOI 10.1007/s00011-004-1248-2; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maddock HL, 2003, EUR J PHARMACOL, V477, P235, DOI 10.1016/j.ejphar.2003.08.024; Madi L, 2004, CLIN CANCER RES, V10, P4472, DOI 10.1158/1078-0432.CCR-03-0651; MARSH KA, 1994, BRIT J PHARMACOL, V112, P934, DOI 10.1111/j.1476-5381.1994.tb13170.x; Meseth U, 1999, BIOPHYS J, V76, P1619, DOI 10.1016/S0006-3495(99)77321-2; MEYERHOF W, 1991, FEBS LETT, V284, P155, DOI 10.1016/0014-5793(91)80674-R; Middleton RJ, 2007, J MED CHEM, V50, P782, DOI 10.1021/jm061279i; Middleton RJ, 2005, CURR OPIN CHEM BIOL, V9, P517, DOI 10.1016/j.cbpa.2005.08.016; Miquel M Raquel, 2005, Mol Imaging, V4, P40; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; PALMER TM, 1995, J BIOL CHEM, V270, P16895, DOI 10.1074/jbc.270.28.16895; PEAKMAN MC, 1995, BRIT J PHARMACOL, V115, P801, DOI 10.1111/j.1476-5381.1995.tb15004.x; Pramanik A, 2004, CURR PHARM BIOTECHNO, V5, P205, DOI 10.2174/1389201043377002; Pramanik A, 2001, BIOCHEMISTRY-US, V40, P10839, DOI 10.1021/bi010514q; Ralevic V, 1998, PHARMACOL REV, V50, P413; RAMKUMAR V, 1993, J BIOL CHEM, V268, P16887; Rigler R, 1999, P NATL ACAD SCI USA, V96, P13318, DOI 10.1073/pnas.96.23.13318; SALVATORE CA, 1993, P NATL ACAD SCI USA, V90, P10365, DOI 10.1073/pnas.90.21.10365; Schwille P, 2001, CELL BIOCHEM BIOPHYS, V34, P383, DOI 10.1385/CBB:34:3:383; Selbie LA, 1998, TRENDS PHARMACOL SCI, V19, P87, DOI 10.1016/S0165-6147(97)01166-8; Shneyvays V, 2001, J MOL CELL CARDIOL, V33, P1249, DOI 10.1006/jmcc.2001.1387; Zhong ZH, 2001, DIABETOLOGIA, V44, P1184, DOI 10.1007/s001250100608; ZHOU QY, 1992, P NATL ACAD SCI USA, V89, P7432, DOI 10.1073/pnas.89.16.7432	48	60	65	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2008	22	3					850	860		10.1096/fj.07-8180com	http://dx.doi.org/10.1096/fj.07-8180com			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17959910				2022-12-25	WOS:000254143700023
J	Martin, DDO; Vilas, GL; Prescher, JA; Rajaiah, G; Falck, JR; Bertozzi, CR; Berthiaume, LG				Martin, Dale D. O.; Vilas, Gonzalo L.; Prescher, Jennifer A.; Rajaiah, Gurram; Falck, John R.; Bertozzi, Carolyn R.; Berthiaume, Luc G.			Rapid detection, discovery, and identification of post-translationally myristoylated proteins during apoptosis using a bio-orthogonal azidomyristate analog	FASEB JOURNAL			English	Article						fatty acylation; myristoylation; Staudinger ligation; cell death; triaryphosphine	N-MYRISTOYLTRANSFERASE; SUBSTRATE-SPECIFICITY; ACID; ACTIVATION; LOCALIZATION; CLEAVAGE; CELLS; PALMITOYLATION; MITOCHONDRIA; TRANSDUCTION	Myristoylation is the attachment of the 14-carbon fatty acid myristate to the N-terminal glycine residue of proteins. Typically a co-translational modification, myristoylation of proapoptotic cysteinyl-aspartyl proteases (caspase)-cleaved Bid and PAK2 was also shown to occur post-translationally and is essential for their proper localization and proapoptotic function. Progress in the identification and characterization of myristoylated proteins has been impeded by the long exposure times required to monitor incorporation of radioactive myristate into proteins (typically 1-3 months). Consequently, we developed a nonradioactive detection methodology in which a bio-orthogonal azidomyristate analog is specifically incorporated co- or post-translationally into proteins at N-terminal glycines, chemoselectively ligated to tagged triarylphosphines and detected by Western blotting with short exposure times (seconds to minutes). This represents over a million-fold signal amplification in comparison to using radioactive labeling methods. Using rational prediction analysis to recognize putative internal myristoylation sites in caspase-cleaved proteins combined with our nonradioactive chemical detection method, we identify 5 new post-translationally myristoylatable proteins (PKC epsilon, CD-IC2, Bap31, MST3, and the catalytic subunit of glutamate cysteine ligase). We also demonstrate that 15 proteins undergo post-translational myristoylation in apoptotic Jurkat T cells. This suggests that post-translational myristoylation of caspase-cleaved proteins represents a novel mechanism widely used to regulate cell death.	[Martin, Dale D. O.; Vilas, Gonzalo L.; Berthiaume, Luc G.] Univ Alberta, Fac Med & Dent, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada; [Prescher, Jennifer A.; Bertozzi, Carolyn R.] Univ Calif Berkeley, HHMI, Dept Chem, Berkeley, CA 94720 USA; [Rajaiah, Gurram; Falck, John R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Alberta; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Texas System; University of Texas Southwestern Medical Center Dallas	Berthiaume, LG (corresponding author), Univ Alberta, Fac Med & Dent, Dept Cell Biol, Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	luc.berthiaume@ualberta.ca	Falck, John R/B-3030-2011; Martin, Dale/L-6351-2015	Falck, John R/0000-0002-9219-7845; Berthiaume, Luc/0000-0003-0926-059X	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM031278, GM31278] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031278] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Armah DA, 1999, J BIOL CHEM, V274, P5931, DOI 10.1074/jbc.274.9.5931; Basu A, 2002, J BIOL CHEM, V277, P41850, DOI 10.1074/jbc.M205997200; BERTHIAUME L, 1994, J BIOL CHEM, V269, P6498; Bologna G, 2004, PROTEOMICS, V4, P1626, DOI 10.1002/pmic.200300783; Botta D, 2004, FREE RADICAL BIO MED, V37, P632, DOI 10.1016/j.freeradbiomed.2004.05.027; DEICHAITE I, 1993, J BIOL CHEM, V268, P13738; DEVADAS B, 1992, J BIOL CHEM, V267, P7224; Ducker CE, 2005, MOL CANCER RES, V3, P463, DOI 10.1158/1541-7786.MCR-05-0037; Eisenhaber F, 2003, NUCLEIC ACIDS RES, V31, P3631, DOI 10.1093/nar/gkg537; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Galbiati F, 1996, BIOCHEM J, V313, P717, DOI 10.1042/bj3130717; Giang DG, 1998, J BIOL CHEM, V273, P6595, DOI 10.1074/jbc.273.12.6595; Granville DJ, 1998, FEBS LETT, V437, P5, DOI 10.1016/S0014-5793(98)01193-4; Hang HC, 2007, J AM CHEM SOC, V129, P2744, DOI 10.1021/ja0685001; Huang CYF, 2002, J BIOL CHEM, V277, P34367, DOI 10.1074/jbc.M202468200; Kho Y, 2004, P NATL ACAD SCI USA, V101, P12479, DOI 10.1073/pnas.0403413101; Lane JD, 2001, J CELL BIOL, V153, P1415, DOI 10.1083/jcb.153.7.1415; Laughlin ST, 2006, METHOD ENZYMOL, V415, P230, DOI 10.1016/S0076-6879(06)15015-6; Luchansky SJ, 2003, METHOD ENZYMOL, V362, P249; Maurer-Stroh S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r21; McCabe JB, 1999, MOL BIOL CELL, V10, P3771, DOI 10.1091/mbc.10.11.3771; McCabe JB, 2001, MOL BIOL CELL, V12, P3601, DOI 10.1091/mbc.12.11.3601; NADLER MJS, 1993, BIOCHEMISTRY-US, V32, P9250, DOI 10.1021/bi00086a034; Ng FWH, 1998, J BIOL CHEM, V273, P3140, DOI 10.1074/jbc.273.6.3140; PAIGE LA, 1990, BIOCHEMISTRY-US, V29, P10566, DOI 10.1021/bi00498a021; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Resh MD, 2004, SUB CELL BIOCHEM, V37, P217; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Saxon E, 2002, J AM CHEM SOC, V124, P14893, DOI 10.1021/ja027748x; Selvakumar P, 2006, FEBS LETT, V580, P2021, DOI 10.1016/j.febslet.2006.02.076; Sprung R, 2005, J PROTEOME RES, V4, P950, DOI 10.1021/pr050033j; Stegert MR, 2005, MOL CELL BIOL, V25, P11019, DOI 10.1128/MCB.25.24.11019-11029.2005; TOWLER DA, 1987, J BIOL CHEM, V262, P1030; Utsumi T, 2003, FEBS LETT, V539, P37, DOI 10.1016/S0014-5793(03)00180-7; Utsumi T, 2001, J BIOL CHEM, V276, P10505, DOI 10.1074/jbc.M006134200; Vilas GL, 2006, P NATL ACAD SCI USA, V103, P6542, DOI 10.1073/pnas.0600824103; Wyllie AH, 1997, BRIT MED BULL, V53, P451; Wyllie AH, 1999, BRIT J CANCER, V80, P34; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zhao Y, 2000, MOL BIOL CELL, V11, P721, DOI 10.1091/mbc.11.2.721	41	80	82	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2008	22	3					797	806		10.1096/fj.07-9198com	http://dx.doi.org/10.1096/fj.07-9198com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17932026	Green Accepted			2022-12-25	WOS:000254143700018
J	Wu, F; Yu, J; Gehring, H				Wu, Fang; Yu, Jing; Gehring, Heinz			Inhibitory and structural studies of novel coenzyme-substrate analogs of human histidine decarboxylase	FASEB JOURNAL			English	Article						mammalian histidine decarboxylase; pyridoxylsubstrate analogs; binding specificity of histidine decarboxylase; histamine	MAST-CELL LINE; ORNITHINE-DECARBOXYLASE; DOPA DECARBOXYLASE; ENZYME-INHIBITORS; ACTIVATION; DERIVATIVES; N-(4-PYRIDOXYL)AMINES; INDUCTION; RESIDUES; ISOFORMS	Histamine, a biogenic amine with important biological functions, is produced from histidine by histidine decarboxylase (HDC), a pyridoxal 5'-phosphate-dependent enzyme. HDC is thus a potential target to attenuate histamine production in certain pathological states. Targeting mammalian HDC with novel inhibitors and elucidating the structural basis of their specificity for HDC are challenging tasks, because the three-dimensional structure of mammalian HDC is still unknown. In the present study, we designed, synthesized, and tested potentially membrane-permeable pyridoxyl-substrate conjugates as inhibitors for human (h) HDC and modeled an active site of hHDC, which is compatible with the experimental data. The most potent inhibitory compound among nine tested structural variants was the pyridoxyl-histidine methyl ester conjugate (PHME), indicating that the binding site of hHDC does not tolerate groups other than the imidazole side chain of histidine. PHME inhibited 60% of the fraction of 12-O-tetradecanoylphorbol-13-acetate-induced newly synthesized HDC in human HMC-1 cells at 200 mu M and was also inhibitory in cell extracts. The proposed model of hHDC, containing phosphopyridoxyl-histidine in the active site, revealed the binding specificity of HDC toward its substrate and the structure-activity relationship of the designed and investigated compounds.-Wu, F., Yu, J ., Gehring, H. Inhibitory and structural studies of novel coenzyme-substrate analogs of hHDC.	[Wu, Fang; Gehring, Heinz] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland; [Yu, Jing] Univ Basel, Inst Mol Pharm, Basel, Switzerland	University of Zurich; University of Basel	Gehring, H (corresponding author), Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	gehring@bioc.uzh.ch	Wu, Fang/B-1945-2008	Wu, Fang/0000-0002-4194-2243; , jingyu/0000-0002-6646-9341				Bertoldi M, 2001, EUR J BIOCHEM, V268, P2975, DOI 10.1046/j.1432-1327.2001.02187.x; Burkhard P, 2001, NAT STRUCT BIOL, V8, P963, DOI 10.1038/nsb1101-963; Dartsch C, 1998, REGUL PEPTIDES, V77, P33, DOI 10.1016/S0167-0115(98)00045-7; DEGRAW JI, 1977, J MED CHEM, V20, P1671, DOI 10.1021/jm00222a027; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Facchini A, 2003, NUTR CANCER, V47, P104, DOI 10.1207/s15327914nc4701_13; Fleming JV, 2000, MOL CELL BIOL, V20, P4932, DOI 10.1128/MCB.20.13.4932-4947.2000; Fleming JV, 2004, BIOCHEM J, V379, P253, DOI 10.1042/BJ20031525; Fleming JV, 2003, J BIOL CHEM, V278, P686, DOI 10.1074/jbc.M210718200; Furuta K, 2007, J BIOL CHEM, V282, P13438, DOI 10.1074/jbc.M609943200; HAMMAR L, 1979, AGENTS ACTIONS, V9, P314, DOI 10.1007/BF01970654; HELLER JS, 1975, BIOCHIM BIOPHYS ACTA, V403, P197, DOI 10.1016/0005-2744(75)90022-4; KAMETANI T, 1972, J MED CHEM, V15, P203, DOI 10.1021/jm00272a021; KELLEY JL, 1977, J MED CHEM, V20, P506, DOI 10.1021/jm00214a009; KHOMUTOV RM, 1971, BIOCHEM J, V124, P99, DOI 10.1042/bj1240099; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; KUMAGAI H, 1969, AGR BIOL CHEM TOKYO, V33, P1210, DOI 10.1080/00021369.1969.10859449; LEVINE RJ, 1966, BIOCHEM PHARMACOL, V15, P841, DOI 10.1016/0006-2952(66)90161-4; Maeda K, 1998, EXP HEMATOL, V26, P325; Mattsson M, 1982, Agents Actions, V12, P176, DOI 10.1007/BF01965137; Medina MA, 2003, CRIT REV BIOCHEM MOL, V38, P23, DOI 10.1080/713609209; Mehta PK, 2000, ADV ENZYMOL RAMB, V74, P129; Moya-Garcia AA, 2005, BIOESSAYS, V27, P57, DOI 10.1002/bies.20174; OGIER G, 1993, BIOCHEM PHARMACOL, V45, P1631, DOI 10.1016/0006-2952(93)90304-F; ROBSON LC, 1980, VITAMIN B6 METABOLIS, P205; Rodriguez-Caso C, 2003, CELL MOL LIFE SCI, V60, P1760, DOI 10.1007/s00018-003-3135-3; SAKAMOTO Y, 1985, AGENTS ACTIONS, V17, P32, DOI 10.1007/BF01966677; Seiler N, 2003, CURR DRUG TARGETS, V4, P537, DOI 10.2174/1389450033490885; SMISSMAN EE, 1972, J MED CHEM, V15, P681, DOI 10.1021/jm00276a031; Tanaka S, 1998, J BIOL CHEM, V273, P8177, DOI 10.1074/jbc.273.14.8177; TANAKA S, 1995, BBA-PROTEIN STRUCT M, V1253, P9, DOI 10.1016/0167-4838(95)00185-W; Tang L, 2005, J BIOL CHEM, V280, P31220, DOI 10.1074/jbc.M500805200; TAYLOR RJ, 1973, BIOCHEM PHARMACOL, V22, P2299, DOI 10.1016/0006-2952(73)90011-7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Watanabe T, 2002, CHEM REC, V2, P369, DOI 10.1002/tcr.10036; WATANABE T, 1990, TRENDS PHARMACOL SCI, V11, P363; Wu F, 2007, MOL CANCER THER, V6, P1831, DOI 10.1158/1535-7163.MCT-07-0045; YAMAMOTO J, 1993, BIOCHIM BIOPHYS ACTA, V1216, P431, DOI 10.1016/0167-4781(93)90011-2; ZHANG Z, 1991, P NATL ACAD SCI USA, V88, P10407, DOI 10.1073/pnas.88.23.10407; ZHANG ZM, 1992, ARCH BIOCHEM BIOPHYS, V294, P394, DOI 10.1016/0003-9861(92)90701-W; Zhao CM, 2003, REGUL PEPTIDES, V114, P21, DOI 10.1016/S0167-0115(03)00063-6	41	22	22	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2008	22	3					890	897		10.1096/fj.07-9566com	http://dx.doi.org/10.1096/fj.07-9566com			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17965265				2022-12-25	WOS:000254143700027
J	Acebron, SP; Fernandez-Saiz, V; Taneva, SG; Moro, F; Muga, A				Acebron, Sergio P.; Fernandez-Saiz, Vanesa; Taneva, Stefka G.; Moro, Fernando; Muga, Arturo			DnaJ recruits DnaK to protein aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE DNAK; ESCHERICHIA-COLI DNAK; FINGER-LIKE DOMAIN; SUBSTRATE-BINDING; HSP70 CHAPERONES; INTERDOMAIN COMMUNICATION; MITOCHONDRIAL HSP70; PEPTIDE BINDING; MECHANISM; SPECIFICITY	Thermal stress might lead to protein aggregation in the cell. Reactivation of protein aggregates depends on Hsp100 and Hsp70 chaperones. We focus in this study on the ability of DnaK, the bacterial representative of the Hsp70 family, to interact with different aggregated model substrates. Our data indicate that DnaK binding to large protein aggregates is mediated by DnaJ, and therefore it depends on its affinity for the cochaperone. Mutations in the structural region of DnaK known as the "latch" decrease the affinity of the chaperone for DnaJ, resulting in a defective activity as protein aggregate-removing agent. As expected, the chaperone activity is recovered when DnaJ concentration is raised to overcome the lower affinity of the mutant for the cochaperone, suggesting that a minimum number of aggregate-bound DnaK molecules is necessary for its efficient reactivation. Our results provide the first experimental evidence of DnaJ-mediated recruiting of ATP-DnaK molecules to the aggregate surface.	[Acebron, Sergio P.; Fernandez-Saiz, Vanesa; Taneva, Stefka G.; Moro, Fernando; Muga, Arturo] Univ Basque Country, Fac Ciencia & Tecnol, Dept Bioquim & Biol Mol, Unidad Biofis,CSIC,Euskal Henriko Unibertsitatea, E-48080 Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika	Muga, A (corresponding author), Univ Basque Country, Fac Ciencia & Tecnol, Dept Bioquim & Biol Mol, Unidad Biofis,CSIC,Euskal Henriko Unibertsitatea, POB 644, E-48080 Bilbao, Spain.	arturo.muga@ehu.es	Moro Pérez, Fernando/P-3891-2015; Muga, Arturo/N-1174-2014; Fernandez, Vanesa/ABD-6688-2021	Moro Pérez, Fernando/0000-0002-3568-3388; Muga, Arturo/0000-0003-0345-6882; Fernandez-Saiz, Vanesa/0000-0002-7139-8680				ANG D, 1989, J BACTERIOL, V171, P2748, DOI 10.1128/jb.171.5.2748-2755.1989; Ben-Zvi A, 2004, J BIOL CHEM, V279, P37298, DOI 10.1074/jbc.M405627200; Ben-Zvi AP, 2001, J STRUCT BIOL, V135, P84, DOI 10.1006/jsbi.2001.4352; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; BUKAU B, 1990, EMBO J, V9, P4027, DOI 10.1002/j.1460-2075.1990.tb07624.x; Craig EA, 2006, REV PHYSIOL BIOCH P, V156, P1, DOI 10.1007/s10254-005-0001-8; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Feifel B, 1998, J BIOL CHEM, V273, P11999, DOI 10.1074/jbc.273.20.11999; Fernandez-Saiz V, 2006, J BIOL CHEM, V281, P7479, DOI 10.1074/jbc.M512744200; Gamer J, 1996, EMBO J, V15, P607, DOI 10.1002/j.1460-2075.1996.tb00393.x; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Ha JH, 1997, J BIOL CHEM, V272, P27796, DOI 10.1074/jbc.272.44.27796; Han WJ, 2004, FEBS LETT, V563, P146, DOI 10.1016/S0014-5793(04)00290-X; Han WJ, 2003, J BIOL CHEM, V278, P19038, DOI 10.1074/jbc.M300756200; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Horst M, 1996, PROTEIN SCI, V5, P759; Hu SM, 2002, ARCH BIOCHEM BIOPHYS, V407, P135, DOI 10.1016/S0003-9861(02)00515-5; Jiang JW, 2003, BIOCHEMISTRY-US, V42, P5748, DOI 10.1021/bi034270g; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Karzai AW, 1996, J BIOL CHEM, V271, P11236, DOI 10.1074/jbc.271.19.11236; Kelley WL, 1999, CURR BIOL, V9, pR305, DOI 10.1016/S0960-9822(99)80185-7; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Landry SJ, 2003, STRUCTURE, V11, P1465, DOI 10.1016/j.str.2003.11.012; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Laufen T., 1998, MOL CHAPERONES PROTE, P241; Lewandowska A, 2007, J MOL BIOL, V371, P800, DOI 10.1016/j.jmb.2007.05.057; LIBEREK K, 1988, P NATL ACAD SCI USA, V85, P6632, DOI 10.1073/pnas.85.18.6632; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Lu Z, 1998, J BIOL CHEM, V273, P5970, DOI 10.1074/jbc.273.10.5970; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mayer MP, 1999, J MOL BIOL, V289, P1131, DOI 10.1006/jmbi.1999.2844; Mehl AF, 2001, BIOCHEM BIOPH RES CO, V282, P562, DOI 10.1006/bbrc.2001.4567; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Moro F, 2006, PROTEIN SCI, V15, P223, DOI 10.1110/ps.051732706; Moro F, 2004, J BIOL CHEM, V279, P19600, DOI 10.1074/jbc.M400921200; Moro F, 2003, FEBS LETT, V533, P119, DOI 10.1016/S0014-5793(02)03752-3; Pierpaoli EV, 1998, J BIOL CHEM, V273, P6643, DOI 10.1074/jbc.273.12.6643; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Schlieker C, 2004, FEBS LETT, V578, P351, DOI 10.1016/j.febslet.2004.11.051; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Slepenkov SV, 2002, BIOCHEMISTRY-US, V41, P12224, DOI 10.1021/bi0263208; Suh WC, 1999, J BIOL CHEM, V274, P30534, DOI 10.1074/jbc.274.43.30534; Szabo A, 1996, EMBO J, V15, P408, DOI 10.1002/j.1460-2075.1996.tb00371.x; Tomoyasu T, 1998, MOL MICROBIOL, V30, P567, DOI 10.1046/j.1365-2958.1998.01090.x; WALL D, 1995, J BIOL CHEM, V270, P2139, DOI 10.1074/jbc.270.5.2139; WAWRZYNOW A, 1995, J BIOL CHEM, V270, P19307, DOI 10.1074/jbc.270.33.19307; Weibezahn J, 2005, BIOL CHEM, V386, P739, DOI 10.1515/BC.2005.086; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; WOOS KM, 1992, J BIOL CHEM, V267, P20429; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zietkiewicz S, 2006, J BIOL CHEM, V281, P7022, DOI 10.1074/jbc.M507893200; Zietkiewicz S, 2004, J BIOL CHEM, V279, P44376, DOI 10.1074/jbc.M402405200; ZYLICZ M, 1985, J BIOL CHEM, V260, P7591	60	39	39	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1381	1390		10.1074/jbc.M706189200	http://dx.doi.org/10.1074/jbc.M706189200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17984091	hybrid			2022-12-25	WOS:000252282700021
J	Kennedy, EJ; Ghosh, G; Pillus, L				Kennedy, Eileen J.; Ghosh, Gourisankar; Pillus, Lorraine			Identification of functionally distinct regions that mediate biological activity of the protein kinase a homolog Tpk2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CATALYTIC SUBUNITS; CRYSTAL-STRUCTURE; TYROSINE KINASE; BCR-ABL; SUBSTRATE; YEAST; MECHANISMS; RESISTANCE; INHIBITION	Kinases regulate key signaling processes that are increasingly implicated in development and disease. Kinase modulators have become important therapeutic tools and often target catalytic domains that are among the most structurally and functionally conserved regions of these enzymes. Such therapies lose efficacy as mutations conferring resistance arise. Because interactions between distinct and often distant regions of kinases can be critical, we took an unbiased genetic approach to identify sites within the protein kinase A homolog Tpk2 that contribute to its biological activity. Because many of these map outside the conserved core, this approach should be broadly useful in identifying new, more kinase-specific therapeutic targets.	[Kennedy, Eileen J.; Ghosh, Gourisankar] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Pillus, Lorraine] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Pillus, Lorraine] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Ghosh, G (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman dr,MC 0375, La Jolla, CA 92093 USA.	gghosh@ucsd.edu; lpillus@ucsd.edu		Kennedy, Eileen/0000-0001-5610-1677				Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; Amberg DC., 2005, METHODS YEAST GENETI; Arena S, 2005, CELL MOL LIFE SCI, V62, P2092, DOI 10.1007/s00018-005-5205-1; Bockmuhl DP, 2001, MOL MICROBIOL, V42, P1243, DOI 10.1046/j.1365-2958.2001.02688.x; Bode AM, 2005, PROG NUCLEIC ACID RE, V79, P237, DOI 10.1016/S0079-6603(04)79005-4; Bolte M, 2003, MICROBIOL-SGM, V149, P1205, DOI 10.1099/mic.0.26062-0; Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102; CAMERON S, 1988, CELL, V53, P555, DOI 10.1016/0092-8674(88)90572-7; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Conlan RS, 2001, J MOL BIOL, V309, P1007, DOI 10.1006/jmbi.2001.4742; Deininger Michael, 2005, J Natl Compr Canc Netw, V3, P757; Deminoff SJ, 2006, GENETICS, V173, P1909, DOI 10.1534/genetics.106.059238; DENIS CL, 1991, J BIOL CHEM, V266, P17932; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GIBBS CS, 1991, J BIOL CHEM, V266, P8923; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HANKS SK, 1991, METHOD ENZYMOL A, V200, P38, DOI 10.1016/0076-6879(91)00126-H; Herberg FW, 1999, BIOCHEMISTRY-US, V38, P6352, DOI 10.1021/bi982672w; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Iyer GH, 2005, J MOL BIOL, V351, P1110, DOI 10.1016/j.jmb.2005.06.011; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; JOHNSON KE, 1987, J BIOL CHEM, V262, P8636; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; KEMP BE, 1977, J BIOL CHEM, V252, P4888; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Morris HR, 2005, ANN MED, V37, P86, DOI 10.1080/07853890510007269; Niswender CM, 2002, J BIOL CHEM, V277, P28916, DOI 10.1074/jbc.M203327200; Pan XW, 2002, MOL CELL BIOL, V22, P3981, DOI 10.1128/MCB.22.12.3981-3993.2002; Pan XW, 1999, MOL CELL BIOL, V19, P4874; Pricl S, 2005, MOL CANCER THER, V4, P1167, DOI 10.1158/1535-7163.MCT-05-0101; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Robertson LS, 2000, P NATL ACAD SCI USA, V97, P5984, DOI 10.1073/pnas.100113397; Robertson LS, 1998, P NATL ACAD SCI USA, V95, P13783, DOI 10.1073/pnas.95.23.13783; Rosati S, 2005, CURR TOP MICROBIOL, V294, P91; Rubenstein EM, 2007, EUKARYOT CELL, V6, P571, DOI 10.1128/EC.00026-07; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shaltiel S, 1998, P NATL ACAD SCI USA, V95, P484, DOI 10.1073/pnas.95.2.484; SIKORSKI RS, 1995, GENE, V155, P51, DOI 10.1016/0378-1119(94)00915-F; Smith CM, 1999, PROG BIOPHYS MOL BIO, V71, P313, DOI 10.1016/S0079-6107(98)00059-5; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; VERON M, 1993, P NATL ACAD SCI USA, V90, P10618, DOI 10.1073/pnas.90.22.10618; WICHERT VG, 2005, Z GASTROENTEROL, V43, P1329; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wrobleski ST, 2005, CURR TOP MED CHEM, V5, P1005, DOI 10.2174/1568026054985894; Zahringer H, 1998, EUR J BIOCHEM, V255, P544, DOI 10.1046/j.1432-1327.1998.2550544.x; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005; ZOLLER MJ, 1991, GENE, V99, P171, DOI 10.1016/0378-1119(91)90124-T	58	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1084	1093		10.1074/jbc.M704028200	http://dx.doi.org/10.1074/jbc.M704028200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17971450	hybrid			2022-12-25	WOS:000252128100048
J	Page, RM; Baumann, K; Tomioka, M; Perez-Revuelta, BI; Fukumori, A; Jacobsen, H; Flohr, A; Luebbers, T; Ozmen, L; Steiner, H; Haass, C				Page, Richard M.; Baumann, Karlheinz; Tomioka, Masanori; Perez-Revuelta, Blanca I.; Fukumori, Akio; Jacobsen, Helmut; Flohr, Alexander; Luebbers, Thomas; Ozmen, Laurence; Steiner, Harald; Haass, Christian			Generation of A beta(38) and A beta(42) is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and gamma-secretase modulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; AMYLOID PRECURSOR PROTEIN; IN-VIVO; BETA-PEPTIDE; A-BETA-42; INHIBITOR; DEPOSITION; ENDOPROTEOLYSIS; CONFORMATION; MRK-560	Alzheimer disease amyloid beta-peptide ( A beta) is generated via proteolytic processing of the beta-amyloid precursor protein by beta-and gamma-secretase. gamma-Secretase can be blocked by selective inhibitors but can also be modulated by a subset of non-steroidal anti-inflammatory drugs, including sulindac sulfide. These drugs selectively reduce the generation of the aggregation-prone 42-amino acid A beta(42) and concomitantly increase the levels of the rather benign A beta(38). Here we show that A beta(42) and A beta(38) generation occur independently from each other. The amount of A beta(42) produced by cells expressing 10 different familial Alzheimer disease (FAD)-associated mutations in presenilin (PS) 1, the catalytic subunit of gamma-secretase, appeared to correlate with the respective age of onset in patients. However, A beta(38) levels did not show a negative correlation with the age of onset. Modulation of gamma-secretase activity by sulindac sulfide reduced A beta(42) in the case of wild type PS1 and two FAD-associated PS1 mutations (M146L and A285V). The remaining eight PS1 FAD mutants showed either no reduction of A beta(42) or only rather subtle effects. Strikingly, even the mutations that showed no effect on A beta(42) levels allowed a robust increase of A beta(38) upon treatment with sulindac sulfide. Similar observations were made for fenofibrate, a compound known to increase A beta(42) and to decrease A beta(38). For mutants that predominantly produce A beta(42), the ability of fenofibrate to further increase A beta(42) levels became diminished, whereas A beta(38) levels were altered to varying extents for all mutants analyzed. Thus, we conclude that A beta(38) and A beta(42) production do not depend on each other. Using an independent non-steroidal anti-inflammatory drug derivative, we obtained similar results for PS1 as well as for PS2. These in vitro results were confirmed by in vivo experiments in transgenic mice expressing the PS2 N141I FAD mutant. Our findings therefore have strong implications on the selection of transgenic mouse models used for screening of the A beta(42)-lowering capacity of gamma-secretase modulators. Furthermore, human patients with certain PS mutations may not respond to gamma-secretase modulators.	[Baumann, Karlheinz; Jacobsen, Helmut; Flohr, Alexander; Luebbers, Thomas; Ozmen, Laurence] F Hoffmann La Roche & Co Ltd, Div Pharmaceut, Preclin CNS Res, CH-4070 Basel, Switzerland; [Page, Richard M.; Tomioka, Masanori; Perez-Revuelta, Blanca I.; Fukumori, Akio; Steiner, Harald; Haass, Christian] Univ Munich, Lab Neurodegenerat Dis Res, Dept Biochem,Munich & Adolf Butenandt Inst, Ctr Integrated Protein Sci, D-80336 Munich, Germany	Roche Holding; University of Munich	Baumann, K (corresponding author), F Hoffmann La Roche & Co Ltd, Div Pharmaceut, Preclin CNS Res, CH-4070 Basel, Switzerland.	karlheinz.baumann@roche.com; hsteiner@med.uni-muenchen.de; chaass@med.uni-muenchen.de		Flohr, Alexander/0000-0001-6847-5780				Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Best JD, 2006, J PHARMACOL EXP THER, V317, P786, DOI 10.1124/jpet.105.100271; Best JD, 2007, J PHARMACOL EXP THER, V320, P552, DOI 10.1124/jpet.106.114330; Churcher I, 2006, BIOORG MED CHEM LETT, V16, P280, DOI 10.1016/j.bmcl.2005.10.009; CHURCHER J, 2004, Patent No. 0121995; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Czirr E, 2007, J BIOL CHEM, V282, P24504, DOI 10.1074/jbc.M700618200; Duering M, 2005, NEUROBIOL AGING, V26, P785, DOI 10.1016/j.neurobiolaging.2004.08.002; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Fukumori A, 2006, BIOCHEMISTRY-US, V45, P4907, DOI 10.1021/bi052412w; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hannam J. C., 2006, Piperidines and related compounds for treatment of Alzheimer ' s disease, Patent No. [WO2006/043064A1, 2006043064]; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hyde LA, 2005, BEHAV BRAIN RES, V160, P344, DOI 10.1016/j.bbr.2004.12.017; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Narlawar R, 2006, J MED CHEM, V49, P7588, DOI 10.1021/jm0610200; Ozmen L, 2005, NEURODEGENER DIS, V2, P284, DOI 10.1159/000092314; PINEIRO JLC, 2004, Patent No. 0116404; Richards JG, 2003, J NEUROSCI, V23, P8989; Shirotani K, 2007, NEUROBIOL DIS, V27, P102, DOI 10.1016/j.nbd.2007.04.011; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Takahashi Y, 2003, J BIOL CHEM, V278, P18664, DOI 10.1074/jbc.M301619200; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Weggen S, 2003, J BIOL CHEM, V278, P30748, DOI 10.1074/jbc.M304824200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weggen S, 2003, J BIOL CHEM, V278, P31831, DOI 10.1074/jbc.M303592200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yan Q, 2003, J NEUROSCI, V23, P7504	34	139	147	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					677	683		10.1074/jbc.M708754200	http://dx.doi.org/10.1074/jbc.M708754200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	17962197	hybrid			2022-12-25	WOS:000252128100004
J	Matsumura, T; Okamoto, K; Iwahara, SI; Hori, H; Takahashi, Y; Nishino, T; Abe, Y				Matsumura, Tomohiro; Okamoto, Ken; Iwahara, Shin-Ichiro; Hori, Hiroyuki; Takahashi, Yuriko; Nishino, Takeshi; Abe, Yasuko			Dimer-oligomer interconversion of wild-type and mutant rat 2-Cys peroxiredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; TRYPAREDOXIN PEROXIDASE; SUPEROXIDE-DISMUTASE; ANTIOXIDANT PROTEIN; ESCHERICHIA-COLI; UP-REGULATION; C-MYC; THIOREDOXIN; EXPRESSION; AHPC	Rat heme-binding protein 23 (HBP23)/peroxiredoxin (Prx I) belongs to the 2-Cys peroxiredoxin type I family and exhibits peroxidase activity coupled with reduced thioredoxin (Trx) as an electron donor. We analyzed the dimer-oligomer interconversion of wild-type and mutant HBP23/Prx I by gel filtration and found that the C52S and C173S mutants existed mostly as decamers, whereas the wild type was a mixture of various forms, favoring the decamer at higher protein concentration and lower ionic salt concentration and in the presence of dithiothreitol. The C83S mutant was predominantly dimeric, in agreement with a previous crystallographic analysis (Hirotsu, S., Abe, Y., Okada, K., Nagahara, N., Hori, H., Nishino, T., and Hakoshima, T.(1999) Proc. Natl. Acad. Sci. U. S. A. 96, 12333-12338). X-ray diffraction analysis of the decameric C52S mutant revealed a toroidal structure (diameter, similar to 130 angstrom; inside diameter, similar to 55 angstrom; thickness, similar to 45 angstrom). In contrast to human Prx I, which was recently reported to exist predominantly as the decamer with Cys(83)-Cys(83) disulfide bonds at all dimer-dimer interfaces, rat HBP23/Prx I has a Cys(83)-Cys(83) disulfide bond at only one dimer-dimer interface (S-S separation of similar to 2.1 angstrom), whereas the interactions at the other interfaces (mean S-S separation of 3.6 angstrom) appear to involve hydrophobic and van der Waals forces. This finding is consistent with gel filtration analyses showing that the protein readily interconverts between dimer and oligomeric forms. The C83S mutant exhibited similar peroxidase activity to the wild type, which is exclusively dimeric, in the Trx/Trx reductase system. Athigher concentrations, where the protein was mostly decameric, less efficient attack of reduced Trx was observed in a [C-14] iodoacetamide incorporation experiment. We suggest that the dimer-decamer interconversion may have a regulatory role.	[Matsumura, Tomohiro; Okamoto, Ken; Iwahara, Shin-Ichiro; Hori, Hiroyuki; Takahashi, Yuriko; Nishino, Takeshi; Abe, Yasuko] Nippon Med Sch, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1138602, Japan	Nippon Medical School	Abe, Y (corresponding author), Nippon Med Sch, Dept Biochem & Mol Biol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	y.abe@nms.ac.jp	Okamoto, Ken/AAC-8604-2020; Hori, Hiroyuki/AAB-3911-2021					ABE Y, 1987, ARCH BIOCHEM BIOPHYS, V253, P241, DOI 10.1016/0003-9861(87)90657-6; Alphey MS, 2000, J MOL BIOL, V300, P903, DOI 10.1006/jmbi.2000.3881; Andoh T, 2003, J BIOL CHEM, V278, P885, DOI 10.1074/jbc.M209914200; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chauhan R, 2001, BIOCHEM J, V354, P209, DOI 10.1042/0264-6021:3540209; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Egler RA, 2005, ONCOGENE, V24, P8038, DOI 10.1038/sj.onc.1208821; Georgiou G, 2003, SCIENCE, V300, P592, DOI 10.1126/science.1084976; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hirotsu S, 1999, J STRUCT BIOL, V126, P80, DOI 10.1006/jsbi.1999.4088; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; HOLMGREN A, 1975, P NATL ACAD SCI USA, V72, P2305, DOI 10.1073/pnas.72.6.2305; Immenschuh S, 2003, J HISTOCHEM CYTOCHEM, V51, P1621, DOI 10.1177/002215540305101206; Immenschuh S, 1999, HEPATOLOGY, V30, P118, DOI 10.1002/hep.510300142; IWAHARA S, 1995, BIOCHEMISTRY-US, V34, P13398, DOI 10.1021/bi00041a017; IYER KS, 1973, J BIOL CHEM, V248, P707; Jang HH, 2006, FEBS LETT, V580, P351, DOI 10.1016/j.febslet.2005.12.030; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Jung H, 2001, J BIOL CHEM, V276, P15504, DOI 10.1074/jbc.M009620200; KALEBIC T, 1991, P NATL ACAD SCI USA, V88, P986, DOI 10.1073/pnas.88.3.986; KALLIS GB, 1980, J BIOL CHEM, V255, P261; Kato M, 2006, HISTOL HISTOPATHOL, V21, P729, DOI 10.14670/HH-21.729; Kato S, 2005, ACTA NEUROPATHOL, V110, P101, DOI 10.1007/s00401-005-1019-3; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kitano K, 1999, J BIOCHEM, V126, P313, DOI 10.1093/oxfordjournals.jbchem.a022451; Kitano K, 2005, PROTEINS, V59, P644, DOI 10.1002/prot.20412; Konig J, 2003, J BIOL CHEM, V278, P24409, DOI 10.1074/jbc.M301145200; Koo KH, 2002, ARCH BIOCHEM BIOPHYS, V397, P312, DOI 10.1006/abbi.2001.2700; Kristensen P, 1999, BIOCHEM BIOPH RES CO, V262, P127, DOI 10.1006/bbrc.1999.1107; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; Lee WS, 2007, J BIOL CHEM, V282, P22011, DOI 10.1074/jbc.M610330200; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Matsumoto A, 1999, FEBS LETT, V443, P246, DOI 10.1016/S0014-5793(98)01736-0; Montemartini M, 1999, EUR J BIOCHEM, V264, P516, DOI 10.1046/j.1432-1327.1999.00656.x; Mu ZM, 2002, J BIOL CHEM, V277, P43175, DOI 10.1074/jbc.M206066200; Nagahara N, 2007, J BIOL CHEM, V282, P1561, DOI 10.1074/jbc.M605931200; Nakamura H, 1996, INT IMMUNOL, V8, P603, DOI 10.1093/intimm/8.4.603; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Uwayama J, 2006, BIOCHEM BIOPH RES CO, V339, P226, DOI 10.1016/j.bbrc.2005.10.192; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m	47	58	58	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					284	293		10.1074/jbc.M705753200	http://dx.doi.org/10.1074/jbc.M705753200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17974571	hybrid			2022-12-25	WOS:000251940300032
J	Darnell, GA; Schroder, WA; Antalis, TM; Lambley, E; Major, L; Gardner, J; Birrell, G; Cid-Arregui, A; Suhrbier, A				Darnell, Grant A.; Schroder, Wayne A.; Antalis, Toni M.; Lambley, Eleanore; Major, Lee; Gardner, Joy; Birrell, Geoff; Cid-Arregui, Angel; Suhrbier, Andreas			Human Papillomavirus E7 requires the protease calpain to degrade the retinoblastoma protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; CERVICAL-CANCER CELLS; RNA INTERFERENCE; TUMOR-SUPPRESSOR; E7 PROTEIN; HELA-CELLS; ACTIVATION; MECHANISMS; INHIBITION; EXPRESSION	Cervical cancers transformed by high risk human papilloma virus (HPV) express the E7 oncoprotein, which accelerates the degradation of the retinoblastoma protein (Rb). Here we show that the E7-mediated degradation of Rb requires the calcium-activated cysteine protease, calpain. E7 bound and activated mu-calpain and promoted cleavage at Rb-810, with mutation of this residue preventing E7-mediated degradation. The calpain cleavage product, Rb1-810, was unable to mediate cell cycle arrest but retained the ability to repress E6/E7 transcription. E7 also promoted the accelerated proteasomal degradation of Rb1-810. Calpain inhibitors reduced the viability of HPV-transformed cells and synergized with cisplatin. Calpain, thus, emerges as a central player in E7-mediated degradation of Rb and represents a potential new drug target for the treatment of HPV-associated lesions.	[Darnell, Grant A.; Schroder, Wayne A.; Lambley, Eleanore; Major, Lee; Gardner, Joy; Suhrbier, Andreas] Queensland Inst Med Res, Immunovirol Lab, Brisbane, Qld 4029, Australia; [Antalis, Toni M.] Univ Maryland, Sch Med, Ctr Vasc Biol & Inflammat Dis, Dept Physiol, Baltimore, MD 21201 USA; [Birrell, Geoff] Queensland Inst Med Res, Radiat Biol & Oncol Lab, Brisbane, Qld 4029, Australia; [Cid-Arregui, Angel] Deutsch Krebsforschungszentrum, D-69012 Heidelberg, Germany	QIMR Berghofer Medical Research Institute; University System of Maryland; University of Maryland Baltimore; QIMR Berghofer Medical Research Institute; Helmholtz Association; German Cancer Research Center (DKFZ)	Suhrbier, A (corresponding author), Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia.	Suhrbier@qimr.edu.au	Cid-Arregui, Angel/ABC-5812-2021; Cid-Arregui, Angel/AAP-5299-2020	Cid-Arregui, Angel/0000-0003-1433-2922; Suhrbier, Andreas/0000-0001-8986-9025; Birrell, Geoff/0000-0002-6593-1514	NATIONAL CANCER INSTITUTE [R01CA098369, P30CA134274] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA134274, R01 CA098369] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Antalis TM, 1998, J EXP MED, V187, P1799, DOI 10.1084/jem.187.11.1799; Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Banerjee NS, 2006, J VIROL, V80, P6517, DOI 10.1128/JVI.02499-05; Boyer SN, 1996, CANCER RES, V56, P4620; Carragher NO, 2006, CURR PHARM DESIGN, V12, P615, DOI 10.2174/138161206775474314; Chen PL, 1996, P NATL ACAD SCI USA, V93, P465, DOI 10.1073/pnas.93.1.465; Cid-Arregui A, 2003, J VIROL, V77, P4928, DOI 10.1128/JVI.77.8.4928-4937.2003; Darnell GA, 2005, J VIROL, V79, P4246, DOI 10.1128/JVI.79.7.4246-4256.2005; Darnell GA, 2003, MOL CELL BIOL, V23, P6520, DOI 10.1128/MCB.23.18.6520-6532.2003; Downing S, 2003, MOL CARCINOGEN, V38, P130, DOI 10.1002/mc.10154; duPont Nefertiti C, 2006, Clin Adv Hematol Oncol, V4, P279; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Fernandez-Montalvan A, 2006, BIOL CHEM, V387, P617, DOI 10.1515/BC.2006.079; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Garnett GP, 2006, VACCINE, V24, P178, DOI 10.1016/j.vaccine.2006.05.116; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gonzalez SL, 2001, J VIROL, V75, P7583, DOI 10.1128/JVI.75.16.7583-7591.2001; Guan N, 2006, INT J ONCOL, V29, P655; Hall AHS, 2003, J VIROL, V77, P6066, DOI 10.1128/JVI.77.10.6066-6069.2003; Hebner CM, 2006, REV MED VIROL, V16, P83, DOI 10.1002/rmv.488; Helt AM, 2003, CARCINOGENESIS, V24, P159, DOI 10.1093/carcin/24.2.159; Jang JS, 1999, INT J MOL MED, V4, P487; Kubbutat MHG, 1997, MOL CELL BIOL, V17, P460, DOI 10.1128/MCB.17.1.460; Liu X, 2006, J BIOL CHEM, V281, P578, DOI 10.1074/jbc.M508455200; Longworth MS, 2004, MICROBIOL MOL BIOL R, V68, P362, DOI 10.1128/MMBR.68.2.362-372.2004; Lowy DR, 2006, J CLIN INVEST, V116, P1167, DOI 10.1172/JCI28607; Mailhes John B, 2002, Cell Chromosome, V1, P2, DOI 10.1186/1475-9268-1-2; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; Niu XY, 2006, INT J GYNECOL CANCER, V16, P743, DOI 10.1111/j.1525-1438.2006.00384.x; Postovit LM, 2002, BIOCHEM BIOPH RES CO, V297, P294, DOI 10.1016/S0006-291X(02)02187-3; Psyrri A, 2004, CANCER RES, V64, P3079, DOI 10.1158/0008-5472.CAN-03-3739; Putral LN, 2005, MOL PHARMACOL, V68, P1311, DOI 10.1124/mol.105.014191; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Rojas-Espaillat LA, 2005, CURR OPIN ONCOL, V17, P485, DOI 10.1097/01.cco.0000174049.14515.8d; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; Scheffner M, 2003, SEMIN CANCER BIOL, V13, P59, DOI 10.1016/S1044-579X(02)00100-1; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Tremper-Wells B, 2005, J BIOL CHEM, V280, P2165, DOI 10.1074/jbc.M410591200; Volbracht C, 2005, J NEUROCHEM, V93, P1280, DOI 10.1111/j.1471-4159.2005.03122.x; Wang J, 2001, ONCOGENE, V20, P4740, DOI 10.1038/sj.onc.1204655; Wesierska-Gadek J, 2002, INT J CANCER, V101, P128, DOI 10.1002/ijc.10580; Yamato K, 2006, CANCER GENE THER, V13, P234, DOI 10.1038/sj.cgt.7700891	43	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37492	37500		10.1074/jbc.M706860200	http://dx.doi.org/10.1074/jbc.M706860200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17977825	hybrid			2022-12-25	WOS:000251833600024
J	Hernandez, J; Matter-Sadzinski, L; Skowronska-Krawczyk, D; Chiodini, F; Alliod, C; Ballivet, M; Matter, JM				Hernandez, Julio; Matter-Sadzinski, Lidia; Skowronska-Krawczyk, Dorota; Chiodini, Florence; Alliod, Christine; Ballivet, Marc; Matter, Jean-Marc			Highly conserved sequences mediate the dynamic interplay of basic helix-loop-helix proteins regulating retinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL GANGLION-CELLS; CENTRAL-NERVOUS-SYSTEM; DOMAIN-DNA COMPLEX; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; RECEPTOR PROMOTER; ZEBRAFISH RETINA; SONIC HEDGEHOG; CHICK RETINA; BHLH	The atonal homolog 5 (ATH5) protein is central to the transcriptional network regulating the specification of retinal ganglion cells, and its expression comes under the spatiotemporal control of several basic helix-loop-helix (bHLH) proteins in the course of retina development. Monitoring the in vivo occupancy of the ATH5 promoter by the ATH5, Ngn2, and NeuroM proteins and analyzing the DNA motifs they bind, we show that three evolutionarily conserved E-boxes are required for the bHLH proteins to control the different phases of ATH5 expression. E-box 4 mediates the activity of Ngn2, ATH5, and NeuroM along the pathway leading to the conversion of progenitors into newborn neurons. E-box 1, by mediating the antagonistic effects of Ngn2 and HES1 in proliferating progenitors, controls the expansion of the ATH5 expression domain in early retina. E-box 2 is required for the positive feedback by ATH5 that underlies the up-regulation of ATH5 expression when progenitors are going through their last cell cycle. The combinatorial nature of the regulation of the ATH5 promoter suggests that the bHLH proteins involved have no assigned E-boxes but use a common set at which they either cooperate or compete to finely tune ATH5 expression as development proceeds.	[Hernandez, Julio; Chiodini, Florence; Alliod, Christine; Ballivet, Marc; Matter, Jean-Marc] Univ Geneva, Sch Med, Dept Biochem, CH-1211 Geneva, Switzerland; [Matter-Sadzinski, Lidia; Skowronska-Krawczyk, Dorota; Matter, Jean-Marc] Univ Geneva, Sch Med, Dept Ophthalmol, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Matter, JM (corresponding author), 30 Quai Ernest-Ansermet, CH-1211 Geneva, Switzerland.	Jean-Marc.Matter@biochem.unige.ch						Brown NL, 1998, DEVELOPMENT, V125, P4821; Brown NL, 2001, DEVELOPMENT, V128, P2497; Brzezinski JA, 2005, INVEST OPHTH VIS SCI, V46, P2540, DOI 10.1167/iovs.04-1123; Castro DS, 2006, DEV CELL, V11, P831, DOI 10.1016/j.devcel.2006.10.006; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HOGAN BLM, 1986, J EMBRYOL EXP MORPH, V97, P95; Hutcheson DA, 2005, DEVELOPMENT, V132, P829, DOI 10.1242/dev.01653; Inoue T, 2002, DEVELOPMENT, V129, P831; Kanekar S, 1997, NEURON, V19, P981, DOI 10.1016/S0896-6273(00)80391-8; Kay JN, 2005, DEVELOPMENT, V132, P2573, DOI 10.1242/dev.01831; Kay JN, 2001, NEURON, V30, P725, DOI 10.1016/S0896-6273(01)00312-9; Lee HY, 2005, DEV BIOL, V284, P464, DOI 10.1016/j.ydbio.2005.06.010; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; Martinez-Morales JR, 2005, DEV CELL, V8, P565, DOI 10.1016/j.devcel.2005.01.022; Masai I, 2000, NEURON, V27, P251, DOI 10.1016/S0896-6273(00)00034-9; MATTER JM, 1995, J NEUROSCI, V15, P5919; Matter-Sadzinski L, 2005, DEVELOPMENT, V132, P3907, DOI 10.1242/dev.01960; Matter-Sadzinski L, 2001, DEVELOPMENT, V128, P217; MATTERSADZINSKI L, 1992, EMBO J, V11, P4529, DOI 10.1002/j.1460-2075.1992.tb05554.x; McCabe KL, 1999, DEVELOPMENT, V126, P5713; Neumann CJ, 2000, SCIENCE, V289, P2137, DOI 10.1126/science.289.5487.2137; PRADA C, 1991, EUR J NEUROSCI, V3, P559, DOI 10.1111/j.1460-9568.1991.tb00843.x; Roztocil T, 1997, DEVELOPMENT, V124, P3263; Roztocil T, 1998, J BIOL CHEM, V273, P15131, DOI 10.1074/jbc.273.24.15131; Shimizu T, 1997, EMBO J, V16, P4689, DOI 10.1093/emboj/16.15.4689; Skowronska-Krawczyk D, 2005, MOL CELL BIOL, V25, P10029, DOI 10.1128/MCB.25.22.10029-10039.2005; Skowronska-Krawczyk D, 2004, DEVELOPMENT, V131, P4447, DOI 10.1242/dev.01302; Stenkamp DL, 2003, DEV BIOL, V258, P349, DOI 10.1016/S0012-1606(03)00121-0; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; WEINTRAUB H, 1994, GENE DEV, V8, P2203, DOI 10.1101/gad.8.18.2203; Zhang XM, 2001, DEVELOPMENT, V128, P943	32	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37894	37905		10.1074/jbc.M703616200	http://dx.doi.org/10.1074/jbc.M703616200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17971452	hybrid			2022-12-25	WOS:000251833600065
J	King-Scott, J; Nowak, E; Mylonas, E; Panjikar, S; Roessle, M; Svergun, DI; Tucker, PA				King-Scott, Jack; Nowak, Elzbieta; Mylonas, Efstratios; Panjikar, Santosh; Roessle, Manfred; Svergun, Dmitri I.; Tucker, Paul A.			The structure of a full-length response regulator from Mycobacterium tuberculosis in a stabilized three-dimensional domain-swapped, activated state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; 2-COMPONENT SYSTEM; CRYSTAL-STRUCTURE; MOLECULAR CHARACTERIZATION; BIOLOGICAL MACROMOLECULES; CONFORMATIONAL-CHANGES; SOLUTION SCATTERING; RECEIVER DOMAIN; PROTEINS; BINDING	The full-length, two-domain response regulator RegX3 from Mycobacterium tuberculosis is a dimer stabilized by three-dimensional domain swapping. Dimerization is known to occur in the OmpR/ PhoB subfamily of response regulators upon activation but has previously only been structurally characterized for isolated receiver domains. The RegX3 dimer has a bipartite intermolecular interface, which buries 2357 A 2 per monomer. The two parts of the interface are between the two receiver domains (dimerization interface) and between a composite receiver domain and the effector domain of the second molecule (interdomain interface). The structure provides support for the importance of threonine and tyrosine residues in the signal transduction mechanism. These residues occur in an active-like conformation stabilized by lanthanum ions. In solution, RegX3 exists as both a monomer and a dimer in a concentration-dependent equilibrium. The dimer in solution differs from the active form observed in the crystal, resembling instead the model of the inactive full-length response regulator PhoB.	[King-Scott, Jack; Nowak, Elzbieta; Mylonas, Efstratios; Panjikar, Santosh; Roessle, Manfred; Svergun, Dmitri I.; Tucker, Paul A.] EMBL Hamburg Outstation, D-22603 Hamburg, Germany; [Svergun, Dmitri I.] Russian Acad Sci, Inst Crystallog, Moscow 117333, Russia	European Molecular Biology Laboratory (EMBL); Russian Academy of Sciences; FSRC Crystallography & Photonics RAS	Tucker, PA (corresponding author), EMBL Hamburg Outstation, C-O DESY,Notkestr 85, D-22603 Hamburg, Germany.	tucker@embl-hamburg.de	Panjikar, Santosh/D-2709-2012; Mylonas, Efstratios/AAC-4948-2022	Panjikar, Santosh/0000-0001-7429-3879; Svergun, Dmitri/0000-0003-0830-5696; Mylonas, Efstratios/0000-0003-4476-3010; Rossle, Manfred/0000-0003-4196-0430				Anand GS, 2000, PROTEIN SCI, V9, P898, DOI 10.1110/ps.9.5.898; Bachhawat P, 2005, STRUCTURE, V13, P1353, DOI 10.1016/j.str.2005.06.006; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BELLSOLELL L, 1994, J MOL BIOL, V238, P489, DOI 10.1006/jmbi.1994.1308; Bent CJ, 2004, J BACTERIOL, V186, P2872, DOI 10.1128/JB.186.9.2872-2879.2004; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNAN RG, 1993, CELL, V74, P773, DOI 10.1016/0092-8674(93)90456-Z; Buckler DR, 2002, STRUCTURE, V10, P153, DOI 10.1016/S0969-2126(01)00706-7; Cole ST, 2001, LEPROSY REV, V72, P449; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COWTAN KD, 1993, ACTA CRYSTALLOGR D, V49, P148, DOI 10.1107/S0907444992007698; DELANO WL, 2002, PYMOLL USERS MANUAL; Djordjevic S, 1998, P NATL ACAD SCI USA, V95, P1381, DOI 10.1073/pnas.95.4.1381; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friedland N, 2007, BIOCHEMISTRY-US, V46, P6733, DOI 10.1021/bi602546q; Glover RT, 2007, J BACTERIOL, V189, P5495, DOI 10.1128/JB.00190-07; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; HARLOCKER SL, 1995, J BIOL CHEM, V270, P26849, DOI 10.1074/jbc.270.45.26849; Himpens S, 2000, MICROBIOL-SGM, V146, P3091, DOI 10.1099/00221287-146-12-3091; Jeon Y, 2001, J BIOL CHEM, V276, P40873, DOI 10.1074/jbc.M104855200; KADNER RJ, 1993, J BIOENERG BIOMEMBR, V25, P637; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kondo H, 1997, NAT STRUCT BIOL, V4, P28, DOI 10.1038/nsb0197-28; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Lewis RJ, 2000, J MOL BIOL, V297, P757, DOI 10.1006/jmbi.2000.3598; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; MartinezHackert E, 1997, J MOL BIOL, V269, P301, DOI 10.1006/jmbi.1997.1065; Morth JP, 2005, FEBS LETT, V579, P4145, DOI 10.1016/j.febslet.2005.06.043; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nowak E, 2006, J BIOL CHEM, V281, P9659, DOI 10.1074/jbc.M512004200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Parish T, 2003, MICROBIOL-SGM, V149, P1423, DOI 10.1099/mic.0.26245-0; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; Robinson VL, 2003, J BACTERIOL, V185, P4186, DOI 10.1128/JB.185.14.4186-4194.2003; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schymkowitz JWH, 2001, NAT STRUCT BIOL, V8, P888, DOI 10.1038/nsb1001-888; SIMON G, 1995, MOL MICROBIOL, V17, P971, DOI 10.1111/j.1365-2958.1995.mmi_17050971.x; Sola M, 1999, J MOL BIOL, V285, P675, DOI 10.1006/jmbi.1998.2326; STOCK AM, 1988, COLD SPRING HARB SYM, V53, P49, DOI 10.1101/SQB.1988.053.01.009; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Toro-Roman A, 2005, PROTEIN SCI, V14, P3077, DOI 10.1110/ps.051722805; Toro-Roman A, 2005, J MOL BIOL, V349, P11, DOI 10.1016/j.jmb.2005.03.059; TORRIANI AM, 1990, BIOESSAYS, V12, P371, DOI 10.1002/bies.950120804; VOLKMAN BF, 1995, BIOCHEMISTRY-US, V34, P1413, DOI 10.1021/bi00004a036; WANNER BL, 1993, J CELL BIOCHEM, V51, P47, DOI 10.1002/jcb.240510110; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wosten MMSM, 1999, J BIOL CHEM, V274, P27185, DOI 10.1074/jbc.274.38.27185	60	32	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37717	37729		10.1074/jbc.M705081200	http://dx.doi.org/10.1074/jbc.M705081200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17942407	hybrid			2022-12-25	WOS:000251833600048
J	Minshall, N; Reiter, MH; Weil, D; Standart, N				Minshall, Nicola; Reiter, Marie Helene; Weil, Dominique; Standart, Nancy			CPEB interacts with an ovary-specific eIF4E and 4E-T in early Xenopus oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; CAP-DEPENDENT TRANSLATION; ELEMENT-BINDING PROTEIN; DEAD BOX HELICASE; P-BODY FORMATION; CYTOPLASMIC POLYADENYLATION; POLY(A)-BINDING PROTEIN; PROCESSING BODIES; DROSOPHILA CUP; BALBIANI BODY	CPEB (cytoplasmic polyadenylation element-binding protein) is an important regulator of translation in oocytes and neurons. Although previous studies of CPEB in late Xenopus oocytes involve the eIF4E-binding protein maskin as the key factor for the repression of maternal mRNA, a second mechanism must exist, since maskin is absent earlier in oogenesis. Using co-immunoprecipitation and gel filtration assays, we show that CPEB specifically interacts, via protein/protein interactions, with the RNA helicase Xp54, the RNA-binding proteins P100(Pat1) and RAP55, the eIF4E-binding protein 4E-T, and an eIF4E protein. Remarkably, these CPEB complex proteins have been characterized, in one or more organism, as P-body, maternal, or neuronal granule components. We do not detect interactions with eIF4E1a, the canonical cap-binding factor, eIF4G, or eIF4A or with proteins expressed late in oogenesis, including maskin, PARN, and 4E-BP1. The eIF4E protein was identified as eIF4E1b, a close homolog of eIF4E1a, whose expression is restricted to oocytes and early embryos. Although eIF4E1b possesses all residues required for cap and eIF4G binding, it binds m(7)GTP weakly, and in pull-down assays, rather than binding eIF4G, it binds 4E-T, in a manner independent of the consensus eIF4E-binding site, YSKEELL. Wild type and Y-A mutant 4E-T (which binds eIF4E1b but not eIF4E1a), when tethered to a reporter mRNA, represses its translation in a cap-dependent manner, and injection of eIF4E1b antibody accelerates meiotic maturation. Altogether, our data suggest that CPEB, partnered with several highly conserved RNA-binding partners, inhibits protein synthesis in oocytes using a novel pairing of 4E-T and eIF4E1b.	[Minshall, Nicola; Reiter, Marie Helene; Standart, Nancy] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Weil, Dominique] Inst Andre Lwoff, CNRS, FRE 2937, F-94801 Villejuif, France	University of Cambridge; Centre National de la Recherche Scientifique (CNRS)	Minshall, N (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	nms@mole.bio.cam.ac.uk	WEIL, Dominique/AAE-4214-2020	WEIL, Dominique/0000-0001-7630-1772; Schernthaner-Reiter, Marie Helene/0000-0002-7972-7610	Biotechnology and Biological Sciences Research Council [BB/C514766/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Audhya A, 2005, J CELL BIOL, V171, P267, DOI 10.1083/jcb.200506124; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Barnard DC, 2005, MOL CELL BIOL, V25, P7605, DOI 10.1128/MCB.25.17.7605-7615.2005; Barnard DC, 2004, CELL, V119, P641, DOI 10.1016/j.cell.2004.10.029; Barros TP, 2005, J CELL BIOL, V170, P1039, DOI 10.1083/jcb.200504097; Boag PR, 2005, DEVELOPMENT, V132, P4975, DOI 10.1242/dev.02060; Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159; Chekulaeva M, 2006, CELL, V124, P521, DOI 10.1016/j.cell.2006.01.031; Cho PF, 2005, CELL, V121, P411, DOI 10.1016/j.cell.2005.02.024; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Colegrove-Otero LJ, 2005, MOL CELL BIOL, V25, P9028, DOI 10.1128/MCB.25.20.9028-9039.2005; Colegrove-Otero LJ, 2005, CRIT REV BIOCHEM MOL, V40, P21, DOI 10.1080/10409230590918612; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Copeland PR, 2001, RNA, V7, P875, DOI 10.1017/S1355838201010020; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Cox RT, 2003, DEVELOPMENT, V130, P1579, DOI 10.1242/dev.00365; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Dostie J, 2000, EMBO J, V19, P3142, DOI 10.1093/emboj/19.12.3142; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Evdokimova V, 2006, CELL CYCLE, V5, P1143, DOI 10.4161/cc.5.11.2784; Evsikov AV, 2006, GENE DEV, V20, P2713, DOI 10.1101/gad.1471006; Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039; Fraser CS, 1999, J BIOL CHEM, V274, P196, DOI 10.1074/jbc.274.1.196; Gorgoni B, 2005, RNA, V11, P1030, DOI 10.1261/rna.7281305; Gray NK, 2000, EMBO J, V19, P4723, DOI 10.1093/emboj/19.17.4723; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Hernandez G, 2005, MECH DEVELOP, V122, P529, DOI 10.1016/j.mod.2004.11.011; Houston DW, 2000, CURR TOP DEV BIOL, V50, P155, DOI 10.1016/S0070-2153(00)50008-8; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; JACKSON RJ, 2007, SCI STKE, V367, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Joshi B, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-48; Joshi B, 2004, EUR J BIOCHEM, V271, P2189, DOI 10.1111/j.1432-1033.2004.04149.x; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Kloc M, 2004, CURR TOP DEV BIOL, V59, P1, DOI 10.1016/S0070-2153(04)59001-4; Kwak JE, 2004, P NATL ACAD SCI USA, V101, P4407, DOI 10.1073/pnas.0400779101; Ladomery M, 1997, NUCLEIC ACIDS RES, V25, P965, DOI 10.1093/nar/25.5.965; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Mansfield JH, 2002, DEVELOPMENT, V129, P197; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; McKendrick L, 2001, MOL CELL BIOL, V21, P3632, DOI 10.1128/MCB.21.11.3632-3641.2001; Meijer HA, 2007, BIOL CELL, V99, P239, DOI 10.1042/BC20060112; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Minshall N, 1999, RNA, V5, P27, DOI 10.1017/S1355838299981220; Minshall N, 2001, RNA, V7, P1728, DOI 10.1017/S135583820101158X; Minshall N, 2004, NUCLEIC ACIDS RES, V32, P1325, DOI 10.1093/nar/gkh303; MURRAY MT, 1992, P NATL ACAD SCI USA, V89, P11, DOI 10.1073/pnas.89.1.11; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; O'Brien LL, 2005, MOL BIOL CELL, V16, P2836, DOI 10.1091/mbc.e04-10-0926; Okumura F, 2007, GENE DEV, V21, P255, DOI 10.1101/gad.1521607; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pepling ME, 2007, P NATL ACAD SCI USA, V104, P187, DOI 10.1073/pnas.0609923104; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; Robalino J, 2004, J BIOL CHEM, V279, P10532, DOI 10.1074/jbc.M313688200; Roper K, 2007, J CELL SCI, V120, P1081, DOI 10.1242/jcs.03407; ROTHER RP, 1992, EUR J BIOCHEM, V206, P673, DOI 10.1111/j.1432-1033.1992.tb16973.x; Rouget C, 2006, J BIOL CHEM, V281, P28687, DOI 10.1074/jbc.M601116200; Rouhana L, 2005, RNA, V11, P1117, DOI 10.1261/rna.2630205; Schmitt A, 2002, J CELL SCI, V115, P2457; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Squirrell JM, 2006, MOL BIOL CELL, V17, P336, DOI 10.1091/mbc.E05-09-0874; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; Tanaka KJ, 2006, J BIOL CHEM, V281, P40096, DOI 10.1074/jbc.M609059200; Theis M, 2003, P NATL ACAD SCI USA, V100, P9602, DOI 10.1073/pnas.1133424100; Thom G, 2003, BIOCHEM J, V370, P91, DOI 10.1042/BJ20021462; Thompson B, 2007, TRANSLATIONAL CONTRO, V48, P507; Villaescusa JC, 2006, GENE, V367, P101, DOI 10.1016/j.gene.2005.09.026; Wakiyama M, 2001, BIOSCI BIOTECH BIOCH, V65, P232, DOI 10.1271/bbb.65.232; Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039; Weston A, 2006, NUCLEIC ACIDS RES, V34, P3082, DOI 10.1093/nar/gkl409; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Wilhelm JE, 2003, J CELL BIOL, V163, P1197, DOI 10.1083/jcb.200309088; Wilhelm JE, 2005, DEV CELL, V9, P675, DOI 10.1016/j.devcel.2005.09.015; Yang WH, 2006, RNA, V12, P547, DOI 10.1261/rna.2302706; Zuberek J, 2007, RNA, V13, P691, DOI 10.1261/rna.453107	88	125	135	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37389	37401		10.1074/jbc.M704629200	http://dx.doi.org/10.1074/jbc.M704629200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17942399	hybrid			2022-12-25	WOS:000251833600013
J	Thaminy, S; Newcomb, B; Kim, J; Gatbonton, T; Foss, E; Simon, J; Bedalov, A				Thaminy, Safia; Newcomb, Benjamin; Kim, Jessica; Gatbonton, Tonibelle; Foss, Eric; Simon, Julian; Bedalov, Antonio			Hst3 is regulated by Mec1-dependent proteolysis and controls the S phase checkpoint and sister chromatid cohesion by deacetylating histone H3 at lysine 56	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION STRESS; CELL-CYCLE; H3K56 ACETYLATION; RTT109; MRC1; IDENTIFICATION; FORK	The SIR2 homologues HST3 and HST4 have been implicated in maintenance of genome integrity in the yeast Saccharomyces cerevisiae. We find that Hst3 has NAD-dependent histone deacetylase activity in vitro and that it functions during S phase to deacetylate the core domain of histone H3 at lysine 56 (H3K56). In response to genotoxic stress, Hst3 undergoes rapid Mec1-dependent phosphorylation and is targeted for ubiquitin-mediated proteolysis, thus providing a mechanism for the previously observed checkpoint-dependent accumulation of Ac-H3K56 at sites of DNA damage. Loss of Hst3-mediated regulation of H3K56 acetylation results in a defect in the S phase DNA damage checkpoint. The pathway that regulates H3K56 acetylation acts in parallel with the Rad9 pathway to transmit a DNA damage signal from Mec1 to Rad53. We also observe that loss of Hst3 function impairs sister chromatid cohesion (SCC). Both S phase checkpoint and SCC defects are phenocopied by H3K56 point mutants. Our findings demonstrate that Hst3-regulated H3K56 acetylation safeguards genome stability by controlling the S phase DNA damage response and promoting SCC.	[Thaminy, Safia; Newcomb, Benjamin; Kim, Jessica; Gatbonton, Tonibelle; Foss, Eric; Simon, Julian; Bedalov, Antonio] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Simon, Julian] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA; [Bedalov, Antonio] Univ Washington, Dept Med, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Bedalov, A (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N, Seattle, WA 98109 USA.	abedalov@fhcrc.org			NHLBI NIH HHS [HL04211] Funding Source: Medline; NIDDK NIH HHS [DK56465] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL004211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Foss EJ, 2001, GENETICS, V157, P567; Foss EJ, 2000, COLD SPRING HARB SYM, V65, P347, DOI 10.1101/sqb.2000.65.347; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Ozdemir A, 2005, J BIOL CHEM, V280, P25949, DOI 10.1074/jbc.C500181200; RECHT J, 2006, MOL CELL, V130, P6988; Redon C, 2006, GENETICS, V172, P67, DOI 10.1534/genetics.105.046128; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Verreault A, 2003, MOL CELL, V11, P283, DOI 10.1016/S1097-2765(03)00052-2; Warren CD, 2004, MOL BIOL CELL, V15, P1724, DOI 10.1091/mbc.E03-09-0637; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011	30	61	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37805	37814		10.1074/jbc.M706384200	http://dx.doi.org/10.1074/jbc.M706384200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17977840	hybrid			2022-12-25	WOS:000251833600056
J	Wu, RF; Ma, ZY; Myers, DP; Terada, LS				Wu, Ru Feng; Ma, Zhenyi; Myers, David P.; Terada, Lance S.			HIV-1 Tat activates dual Nox pathways leading to independent activation of ERK and JNK MAP kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR ENDOTHELIAL-CELLS; AMINO-TERMINAL KINASE; FOCAL ADHESION; FLK-1/KDR RECEPTOR; NAD(P)H OXIDASE; KAPOSIS-SARCOMA; GROWTH-FACTOR; PROTEIN; AIDS; DIFFERENTIATION	Human immunodeficiency virus, type 1 Tat is known to exert pleiotropic effects on the vascular endothelium through mitogen-activated protein (MAP) kinases, although the signaling pathways leading to MAP kinase activation are incompletely understood. We focused on proximal pathways potentially governing downstream MAP kinase activity by Tat. Within 2 min, Tat activated both Ras and Rho GTPases in endothelial cells, leading to ERK phosphorylation by 10 min. Notably, Rac1 was necessary for downstream activation of RhoA and both Rac1 and RhoA acted upstream of the Ras/ERK cassette. Antioxidants and the oxidase inhibitor diphenylene iodonium blocked ERK phosphorylation, but specific interference with the canonical Nox2 oxidase had no effect on ERK. Instead, knock down of the novel oxidase Nox4 completely suppressed Tat-dependent Ras and ERK activation downstream of Rac1 and RhoA. Conversely, interference with Rac1, PAK1, and Nox2 blocked JNK phosphorylation, whereas RhoA(N19) and Nox4 knock down did not. Further, knock down of Nox2, but not Nox4, blocked Tat-induced cytoskeletal rearrangement, whereas knock down of Nox4, but not Nox2, blocked Tat-dependent proliferation. Rac1, therefore, bifurcates Tat signaling, leading to concurrent but separate Nox4-dependent Ras/ERK activation, and Nox2-dependent JNK activation. Tat signaling, therefore, provides an example of Nox-specific differential control of MAP kinase pathways.	[Wu, Ru Feng; Ma, Zhenyi; Myers, David P.; Terada, Lance S.] Univ Texas SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Terada, LS (corresponding author), UT SW Med Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	lance.terada@utsouthwestern.edu		Terada, Lance/0000-0001-7441-9734	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061897, R01HL067256] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL067256, R01 HL061897, R01 HL61897] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Albini A, 1996, NAT MED, V2, P1371, DOI 10.1038/nm1296-1371; Avraham HK, 2004, J IMMUNOL, V173, P6228, DOI 10.4049/jimmunol.173.10.6228; Baliga RS, 2005, AM J PHYSIOL-HEART C, V289, pH1373, DOI 10.1152/ajpheart.00304.2005; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Dubrovsky T, 1998, NEUROLOGY, V51, P560, DOI 10.1212/WNL.51.2.560; ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0; Furst R, 2005, CIRC RES, V96, P43, DOI 10.1161/01.RES.0000151983.01148.06; Ganju RK, 1998, J VIROL, V72, P6131, DOI 10.1128/JVI.72.7.6131-6137.1998; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Glasgow BJ, 1997, OPHTHALMOLOGY, V104, P753, DOI 10.1016/S0161-6420(97)30237-1; Gorin Y, 2003, AM J PHYSIOL-RENAL, V285, pF219, DOI 10.1152/ajprenal.00414.2002; Gu Y, 2003, J BIOL CHEM, V278, P17210, DOI 10.1074/jbc.M210314200; Gu Y, 2002, EXP CELL RES, V272, P62, DOI 10.1006/excr.2001.5404; Gu Y, 2001, VIROLOGY, V286, P62, DOI 10.1006/viro.2001.0998; Hsue PY, 2004, CIRCULATION, V109, P316, DOI 10.1161/01.CIR.0000114520.38748.AA; Li J, 2006, MOL BIOL CELL, V17, P3978, DOI 10.1091/mbc.E05-06-0532; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Mitola S, 2000, J VIROL, V74, P344, DOI 10.1128/JVI.74.1.344-353.2000; NEWSOME DA, 1984, AM J OPHTHALMOL, V98, P590, DOI 10.1016/0002-9394(84)90245-9; Park IW, 2001, J IMMUNOL, V167, P2766, DOI 10.4049/jimmunol.167.5.2766; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Tabib A, 2000, CORONARY ARTERY DIS, V11, P41, DOI 10.1097/00019501-200002000-00008; Terada LS, 2006, J CELL BIOL, V174, P615, DOI 10.1083/jcb.200605036; Terada LS, 2000, AM J MED SCI, V320, P379, DOI 10.1097/00000441-200012000-00005; Toschi E, 2006, MOL BIOL CELL, V17, P1985, DOI 10.1091/mbc.E05-08-0717; Urbinati C, 2005, J CELL SCI, V118, P3949, DOI 10.1242/jcs.02518; Wu RF, 2005, J CELL BIOL, V171, P893, DOI 10.1083/jcb.200507004; Wu RF, 2004, J VIROL, V78, P779, DOI 10.1128/JVI.78.2.779-789.2004; Xu YX, 2002, J BIOL CHEM, V277, P28051, DOI 10.1074/jbc.M202665200; Zietz C, 1996, AM J PATHOL, V149, P1887	34	53	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37412	37419		10.1074/jbc.M704481200	http://dx.doi.org/10.1074/jbc.M704481200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17940286	hybrid			2022-12-25	WOS:000251833600015
J	Chupreta, S; Brevig, H; Bai, LC; Merchant, JL; Iniguez-Lluhi, JA				Chupreta, Sergey; Brevig, Holly; Bai, Longchuan; Merchant, Juanita L.; Iniguez-Lluhi, Jorge A.			Sumoylation-dependent control of homotypic and heterotypic synergy by the kruppel-type zinc finger protein ZBP-89	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR ZBP-89; E3 LIGASE ACTIVITY; GENE-EXPRESSION; GLUCOCORTICOID-RECEPTOR; REGULATE TRANSCRIPTION; VIMENTIN GENE; PHOSPHOENOLPYRUVATE CARBOXYKINASE; SUBNUCLEAR LOCALIZATION; SUMO-1 MODIFICATION; MODIFIER-1 SUMO-1	The Kruppel-like transcription factor ZBP-89 is a sswequence-specific regulator that plays key roles in cellular growth and differentiation especially in endodermal and germ cell lineages. ZBP-89 shares with other members of the Sp-like family an overlapping sequence specificity for GC-rich sequences in the regulatory regions of multiple genes. Defining the mechanisms that govern the intrinsic function of ZBP-89 as well as its competitive and non-competitive functional interactions with other regulators is central to understand how ZBP- 89 exerts its biological functions. We now describe that post-translational modification of ZBP-89 by multiple small ubiquitin-like modifier (SUMO) isoforms occurs at two conserved synergy control motifs flanking the DNA binding domain. Functionally sumoylation did not directly alter the ability of ZBP-89 to compete with other Sp-like factors from individual sites. At promoters bearing multiple response elements, however, this modification inhibited the functional cooperation between ZBP-89 and Sp1. Analysis of the properties of ZBP-89 in cellular contexts devoid of competing factors indicated that although on its own it behaves as a modest activator it potently synergizes with heterologous activators such as the glucocorticoid receptor. Notably we found that when conjugated to ZBP-89, SUMO exerts a strong inhibitory effect on such synergistic interactions through a critical conserved functional surface. By regulating higher order functional interactions, sumoylation provides a reversible post-translational mechanism to control the activity of ZBP-89.	Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Iniguez-Lluhi, JA (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA.	iniguez@umich.edu	Merchant, Juanita/AAF-8277-2019	Merchant, Juanita/0000-0002-6559-8184; Iniguez-Lluhi, Jorge/0000-0001-7010-089X	NIDDK NIH HHS [P30 DK034933-219001, R01 DK55732, P30 DK034933, R01 DK061656, R01 DK055732-05, R01 DK055732, DK61656-01, P60 DK20572] Funding Source: Medline; NIGMS NIH HHS [T32 GM007767] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK061656, R01DK055732, P60DK020572, R01DK061656, P30DK034933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antoine K, 2005, MOL CELL BIOCHEM, V271, P215, DOI 10.1007/s11010-005-6417-2; Bai LC, 2000, J BIOL CHEM, V275, P30725, DOI 10.1074/jbc.M004249200; Bai LC, 2003, NUCLEIC ACIDS RES, V31, P7264, DOI 10.1093/nar/gkg929; Bai LG, 2001, MOL CELL BIOL, V21, P4670, DOI 10.1128/MCB.21.14.4670-4683.2001; Bohren KM, 2004, J BIOL CHEM, V279, P27233, DOI 10.1074/jbc.M402273200; Boopathi E, 2004, J BIOL CHEM, V279, P35242, DOI 10.1074/jbc.M403160200; Cassuto H, 2005, J BIOL CHEM, V280, P33873, DOI 10.1074/jbc.M504119200; Cheng PY, 2000, BIOCHEMISTRY-US, V39, P4347, DOI 10.1021/bi992298f; Chun TH, 2003, CIRC RES, V92, P1201, DOI 10.1161/01.RES.0000076893.70898.36; Chupreta S, 2005, MOL CELL BIOL, V25, P4272, DOI 10.1128/MCB.25.10.4272-4282.2005; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Hasegawa T, 1997, J BIOL CHEM, V272, P4915, DOI 10.1074/jbc.272.8.4915; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Holmstrom S, 2003, P NATL ACAD SCI USA, V100, P15758, DOI 10.1073/pnas.2136933100; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149; JANTZEN HM, 1987, CELL, V49, P29, DOI 10.1016/0092-8674(87)90752-5; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Jones MC, 2006, P NATL ACAD SCI USA, V103, P16272, DOI 10.1073/pnas.0603002103; Komatsu T, 2004, MOL ENDOCRINOL, V18, P2451, DOI 10.1210/me.2004-0173; Law DJ, 2006, MAMM GENOME, V17, P999, DOI 10.1007/s00335-006-0052-4; Law DJ, 2006, NUCLEIC ACIDS RES, V34, P1342, DOI 10.1093/nar/gkl022; Law DJ, 1998, MAMM GENOME, V9, P165, DOI 10.1007/s003359900711; Law GL, 1998, J BIOL CHEM, V273, P19955, DOI 10.1074/jbc.273.32.19955; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Li XG, 2006, DEVELOPMENT, V133, P3641, DOI 10.1242/dev.02540; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Malo MS, 2006, AM J PHYSIOL-GASTR L, V290, pG737, DOI 10.1152/ajpgi.00394.2005; Merchant JL, 1996, MOL CELL BIOL, V16, P6644; MULLER M, 1991, MOL ENDOCRINOL, V5, P1498, DOI 10.1210/mend-5-10-1498; Nishida T, 2000, EUR J BIOCHEM, V267, P6423, DOI 10.1046/j.1432-1327.2000.01729.x; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; Park H, 2003, BLOOD, V101, P894, DOI 10.1182/blood-2002-03-0680; Passantino R, 1998, J BIOL CHEM, V273, P484, DOI 10.1074/jbc.273.1.484; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rosendorff A, 2006, P NATL ACAD SCI USA, V103, P5308, DOI 10.1073/pnas.0601066103; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sapetschnig A, 2002, EMBO J, V21, P5206, DOI 10.1093/emboj/cdf510; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Spengler ML, 2006, J BIOL CHEM, V281, P5567, DOI 10.1074/jbc.M600035200; STRAHLE U, 1988, EMBO J, V7, P3389, DOI 10.1002/j.1460-2075.1988.tb03212.x; Su HL, 2002, GENE, V296, P65, DOI 10.1016/S0378-1119(02)00843-0; Subramanian L, 2003, J BIOL CHEM, V278, P9134, DOI 10.1074/jbc.M210440200; Wang XHL, 2004, J BIOL CHEM, V279, P34191, DOI 10.1074/jbc.M403455200; Wei HJ, 2006, J BIOL CHEM, V281, P16664, DOI 10.1074/jbc.M513135200; Wieczorek E, 2000, J BIOL CHEM, V275, P12879, DOI 10.1074/jbc.275.17.12879; Wu YZ, 2007, GENES CELLS, V12, P905, DOI 10.1111/j.1365-2443.2007.01104.x; Yamada A, 2001, J BIOL CHEM, V276, P18082, DOI 10.1074/jbc.M008387200; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Ye S, 1999, FEBS LETT, V450, P268, DOI 10.1016/S0014-5793(99)00509-8; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Zhang XP, 2003, NUCLEIC ACIDS RES, V31, P2900, DOI 10.1093/nar/gkg380	57	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36155	36166		10.1074/jbc.M708130200	http://dx.doi.org/10.1074/jbc.M708130200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17940278	hybrid			2022-12-25	WOS:000251458300005
J	Soundararajan, R; Wang, J; Melters, D; Pearce, D				Soundararajan, Rama; Wang, Jian; Melters, Daniel; Pearce, David			Differential activities of glucocorticoid-induced leucine zipper protein isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-TRANSPORT; CELL-DEATH; TRANSCRIPTIONAL REGULATOR; T-LYMPHOCYTES; KAPPA-B; GILZ; GENE; TSC-22; DOMAIN; ACTIVATION	Glucocorticoid-induced leucine zipper protein (GILZ) is expressed in both epithelial and immune tissues and modulates a variety of cellular functions, including proliferation and epithelial sodium channel (ENaC) activity. A number of reports have described various GILZ activities, focusing on a single isoform with molecular mass of similar to 17 kDa, now termed GILZ1. In GILZ immunoblots using a newly developed antiserum, we detected multiple species in extracts from cultured kidney cells. Mass spectrometric analysis revealed that one of these represented a previously uncharacterized distinct isoform of GILZ, GILZ2. Rapid amplification of cDNA ends was used to clone cDNAs corresponding to four isoforms, which, in addition to GILZ1 and GILZ2, included new isoforms GILZ3 and GILZ4. Heterologous expression of these four GILZ isoforms in cultured cells revealed striking functional differences. Notably, GILZ1 was the only isoform that significantly stimulated ENaC-mediated Na+ current in a kidney collecting duct cell line, although GILZ2 and GILZ3 also stimulated ENaC surface expression in HEK 293 cells. GILZ1 and GILZ3, and to a lesser extent GILZ2, inhibited ERK phosphorylation. Interestingly, GILZ4, which had no effect on either ENaC or ERK, potently suppressed cellular proliferation, as did GILZ1, but not GILZ2 or GILZ3. Finally, rat and mouse tissues all expressed multiple GILZ species but varied in the relative abundance of each. These data suggest that multiple GILZ isoforms are expressed in most cells and tissues and that these play distinct roles in regulating key cellular functions, including proliferation and ion transport. Furthermore, GILZ inhibition of ERK appears to play an essential role in stimulation of cell surface ENaC but not in inhibition of proliferation.	Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pearce, D (corresponding author), 600 16th St,Rm N274H Genentech Hall Mission Bay C, San Francisco, CA 94107 USA.	dpearce@medsfgh.ucsf.edu		Melters, Daniel/0000-0003-4809-0562	NIDDK NIH HHS [K01-DK078679-01, R01-DK51151] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051151, K01DK078679] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Asselin-Labat ML, 2005, MOL ENDOCRINOL, V19, P1752, DOI 10.1210/me.2004-0206; Asselin-Labat ML, 2004, BLOOD, V104, P215, DOI 10.1182/blood-2003-12-4295; Ayroldi E, 2002, MOL CELL BIOL, V22, P7929, DOI 10.1128/MCB.22.22.7929-7941.2002; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724; Bell LM, 2000, J BIOL CHEM, V275, P25262, DOI 10.1074/jbc.M002076200; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Berrebi D, 2003, BLOOD, V101, P729, DOI 10.1182/blood-2002-02-0538; Bhalla V, 2006, AM J PHYSIOL-RENAL, V291, pF714, DOI 10.1152/ajprenal.00061.2006; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Di Marco B, 2007, NUCLEIC ACIDS RES, V35, P517, DOI 10.1093/nar/gkl1080; Dohrmann CE, 1999, MECH DEVELOP, V84, P147, DOI 10.1016/S0925-4773(99)00055-6; Fiol DF, 2005, P NATL ACAD SCI USA, V102, P927, DOI 10.1073/pnas.0408956102; Fiol DF, 2007, FEBS J, V274, P109, DOI 10.1111/j.1742-4658.2006.05569.x; Franchimont D, 2002, J IMMUNOL, V168, P2212, DOI 10.4049/jimmunol.168.5.2212; Hino S, 2000, BIOCHEM BIOPH RES CO, V278, P659, DOI 10.1006/bbrc.2000.3840; Inoue J, 2007, CANCER SCI, V98, P268, DOI 10.1111/j.1349-7006.2007.00389.x; Jay P, 1996, BIOCHEM BIOPH RES CO, V222, P821, DOI 10.1006/bbrc.1996.0825; Kikonyogo A, 2001, P NATL ACAD SCI USA, V98, P11199, DOI 10.1073/pnas.201268998; Levine B, 2007, DEV BIOL, V305, P217, DOI 10.1016/j.ydbio.2007.02.013; Liu WH, 1996, MOL ENDOCRINOL, V10, P1399, DOI 10.1210/me.10.11.1399; Meijer OC, 2000, J NEUROENDOCRINOL, V12, P245; Nakashiro K, 1998, CANCER RES, V58, P549; Pearce D, 2003, CELL PHYSIOL BIOCHEM, V13, P13, DOI 10.1159/000070245; Riccardi C, 2000, THERAPIE, V55, P165; Riccardi C, 1999, CELL DEATH DIFFER, V6, P1182, DOI 10.1038/sj.cdd.4400609; Robert-Nicoud M, 2001, P NATL ACAD SCI USA, V98, P2712, DOI 10.1073/pnas.051603198; SHIBANUMA M, 1992, J BIOL CHEM, V267, P10219; SILLARD R, 1993, EUR J BIOCHEM, V216, P429, DOI 10.1111/j.1432-1033.1993.tb18160.x; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Soundararajan R, 2005, J BIOL CHEM, V280, P39970, DOI 10.1074/jbc.M508658200; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Takai Daiya, 2003, In Silico Biology, V3, P235; TREISMAN JE, 1995, DEVELOPMENT, V121, P2835; Vogel P, 1996, BBA-GENE STRUCT EXPR, V1309, P200, DOI 10.1016/S0167-4781(96)00177-7; Waldegger S, 1997, P NATL ACAD SCI USA, V94, P4440, DOI 10.1073/pnas.94.9.4440; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X	40	59	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36303	36313		10.1074/jbc.M707287200	http://dx.doi.org/10.1074/jbc.M707287200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17956870	hybrid			2022-12-25	WOS:000251458300021
J	You, Z; Omura, S; Ikeda, H; Cane, DE; Jogl, G				You, Zheng; Omura, Satoshi; Ikeda, Haruo; Cane, David E.; Jogl, Gerwald			Crystal structure of the non-heme iron dioxygenase PtIH in pentalenolactone biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KETOGLUTARATE-DEPENDENT DIOXYGENASE; SPIN FE(IV) COMPLEX; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; 2-OXOGLUTARATE OXYGENASES; STREPTOMYCES-AVERMITILIS; ACTIVATION; ENZYMES; CRYSTALLOGRAPHY; IDENTIFICATION; INTERMEDIATE	The non-heme iron dioxygenase PtlH from the soil organism Streptomyces avermitilis is a member of the iron(II)/alpha-ketoglutarate- dependent dioxygenase superfamily and catalyzes an essential reaction in the biosynthesis of the sesquiterpenoid antibiotic pentalenolactone. To investigate the structural basis for substrate recognition and catalysis, we have determined the x-ray crystal structure of PtlH in several complexes with the cofactors iron, alpha-ketoglutarate, and the non-reactive enantiomer of the substrate, ent-1-deoxypentalenicacid, in four different crystal forms to up to 1.31 angstrom resolution. The overall structure of PtlH forms a double stranded barrel helix fold, and the cofactor-binding site for iron and alpha-ketoglutarate is similar to other double-stranded barrel helix fold enzymes. Additional secondary structure elements that contribute to the substrate-binding site in PtlH are not conserved in other double-stranded barrel helix fold enzymes. Binding of the substrate enantiomer induces a reorganization of the monoclinic crystal lattice leading to a disorder-order transition of a C-terminal alpha-helix. The newly formed helix blocks the major access to the active site and effectively traps the bound substrate. Kinetic analysis of wild type and site directed mutant proteins confirms a critical function of two arginine residues in substrate binding, while simulated docking of the enzymatic reaction product reveals the likely orientation of bound substrate.	Brown Univ, Dept Mol & Cell Biol, Providence, RI 02912 USA; Brown Univ, Dept Biochem, Providence, RI 02912 USA; Brown Univ, Dept Chem, Providence, RI 02912 USA; Brown Univ, Dept Biochem, Providence, RI 02912 USA; Kitasato Inst, Minato Ku, Tokyo 1088642, Japan; Kitasato Univ, Kitasato Inst Life Sci, Sagamihara, Kanagawa 2288555, Japan	Brown University; Brown University; Brown University; Brown University; Kitasato University	Jogl, G (corresponding author), Brown Univ, Dept Mol & Cell Biol, Box G-E129, Providence, RI 02912 USA.	Gerwald_Jogl@brown.edu	Jogl, Gerwald/AAJ-5783-2021	Jogl, Gerwald/0000-0002-5465-5315	NIGMS NIH HHS [R01 GM030301-25, R37 GM030301, R01 GM030301-27, R01 GM030301, R01 GM030301-26, GM30301] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030301, R37GM030301] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Borowski T, 2004, CHEM-EUR J, V10, P1031, DOI 10.1002/chem.200305306; CANE DE, 1989, ARCH BIOCHEM BIOPHYS, V270, P50, DOI 10.1016/0003-9861(89)90006-4; CANE DE, 1994, BIOCHEMISTRY-US, V33, P6524, DOI 10.1021/bi00187a020; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DUSZENKO M, 1982, BIOCHIM BIOPHYS ACTA, V714, P344, DOI 10.1016/0304-4165(82)90343-9; ENGLISH AR, 1957, ANTIBIOT ANNU, P682; Frohlich KU, 1996, ARCH MICROBIOL, V165, P179, DOI 10.1007/s002030050313; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hewitson KS, 2005, PHILOS T R SOC A, V363, P807, DOI 10.1098/rsta.2004.1540; Hoffart LM, 2006, P NATL ACAD SCI USA, V103, P14738, DOI 10.1073/pnas.0604005103; Hogan DA, 2000, J BIOL CHEM, V275, P12400, DOI 10.1074/jbc.275.17.12400; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Ikeda M, 2001, EUR J PHARMACOL, V411, P45, DOI 10.1016/S0014-2999(00)00894-3; Jogl G, 2001, ACTA CRYSTALLOGR D, V57, P1127, DOI 10.1107/S0907444901006783; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KELLERSC.W, 1972, ARCH MIKROBIOL, V84, P301, DOI 10.1007/BF00409079; Kershaw NJ, 2005, CHEM COMMUN, P4251, DOI 10.1039/b505964j; Koe BK, 1957, ANTIBIOT ANNU, P672; Koehntop KD, 2005, J BIOL INORG CHEM, V10, P87, DOI 10.1007/s00775-005-0624-x; MAURER KH, 1983, J BACTERIOL, V153, P930, DOI 10.1128/JB.153.2.930-936.1983; MAURER RH, 1986, J ANTIBIOT, V39, P266; McDonough MA, 2005, J BIOL CHEM, V280, P41101, DOI 10.1074/jbc.M507528200; Muller I, 2004, BIOCHEMISTRY-US, V43, P3075, DOI 10.1021/bi035752v; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAKAGAWA A, 1985, J ANTIBIOT, V38, P1114, DOI 10.7164/antibiotics.38.1114; OKAZAKI T, 1979, Annual Report of Sankyo Research Laboratories, V31, P94; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Price JC, 2003, J AM CHEM SOC, V125, P13008, DOI 10.1021/ja037400h; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; TAKAHASHI S, 1983, J ANTIBIOT, V36, P226, DOI 10.7164/antibiotics.36.226; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tetzlaff CN, 2006, BIOCHEMISTRY-US, V45, P6179, DOI 10.1021/bi060419n; You Z, 2006, J AM CHEM SOC, V128, P6566, DOI 10.1021/ja061469i	40	23	27	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36552	36560		10.1074/jbc.M706358200	http://dx.doi.org/10.1074/jbc.M706358200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17942405	Green Accepted, hybrid			2022-12-25	WOS:000251458300048
J	Ferdous, Z; Wei, VM; Iozzo, R; Hook, M; Grande-Allen, KJ				Ferdous, Zannatul; Wei, Victoria Mariko; Iozzo, Renato; Hoeoek, Magnus; Grande-Allen, Kathryn Jane			Decorin-transforming growth factor-beta interaction regulates matrix organization and mechanical characteristics of three-dimensional collagen matrices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT SKIN FIBROBLASTS; SMOOTH-MUSCLE-CELLS; EXTRACELLULAR-MATRIX; PROTEOGLYCANS; EXPRESSION; BIGLYCAN; TENDON; OVEREXPRESSION; FIBRILS; FETAL	The small leucine-rich proteoglycan decorin has been demonstrated to be a key regulator of collagen fibrillogenesis; decorin deficiencies lead to irregularly shaped collagen fibrils and weakened material behavior in postnatal murine connective tissues. In an in vitro investigation of the contributions of decorin to tissue organization and material behavior, model tissues were engineered by seeding embryonic fibroblasts, harvested from 12.5-13.5 days gestational aged decorin null (Dcn(-/-)) or wild-type mice, within type I collagen gels. The resulting three-dimensional collagen matrices were cultured for 4 weeks under static tension. The collagen matrices seeded with Dcn(-/-) cells exhibited greater contraction, cell density, ultimate tensile strength, and elastic modulus than those seeded with wild-type cells. Ultrastructurally, the matrices seeded with Dcn(-/-) cells contained a greater density of collagen. The decorin-null tissues contained more biglycan than control tissues, suggesting that this related proteoglycan compensated for the absence of decorin. The effect of transforming growth factor-beta(TGF-beta), which is normally sequestered by decorin, was also investigated in this study. The addition of TGF-beta 1 to the matrices seeded with wild-type cells improved their contraction and mechanical strength, whereas blocking TGF-beta 1 in the Dcn(-/-) cell-seeded matrices significantly reduced the collagen gel contraction. These results indicate that the inhibitory interaction between decorin and TGF-beta 1 significantly influenced the matrix organization and material behavior of these in vitro model tissues.	Rice Univ, Dept Bioengn, Houston, TX 77005 USA; Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; Texas A&M Univ Syst Hlth Sci Ctr, Inst Biosci & Biotechnol, Ctr Extracellular Matrix Biol, Houston, TX 77030 USA	Rice University; Jefferson University; Jefferson University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Grande-Allen, KJ (corresponding author), Rice Univ, MS 142,POB 1892, Houston, TX 77251 USA.	grande@rice.edu	Grande-Allen, Kathryn/P-4042-2014; Iozzo, Renato/AAS-1980-2020; Ferdous, Zannatul/GZA-6825-2022	Grande-Allen, Kathryn/0000-0003-1533-3767; Ferdous, Zannatul/0000-0002-6007-2183; Iozzo, Renato/0000-0002-5908-5112	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R03EB005444] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Alberts B, 2002, MOL BIOL CELL; Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Ameye L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0848com; Anaguchi Y, 2005, CLIN BIOMECH, V20, P959, DOI 10.1016/j.clinbiomech.2005.05.012; Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; Bates SJ, 2006, J BONE JOINT SURG AM, V88A, P2465, DOI 10.2106/JBJS.E.00143; Bhide VM, 2005, J BIOL CHEM, V280, P23103, DOI 10.1074/jbc.M410060200; BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616; Bittner K, 1996, BIOCHEM J, V314, P159, DOI 10.1042/bj3140159; CHEN WYJ, 1989, J CELL SCI, V94, P577; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; DeLuca A, 1996, J BIOL CHEM, V271, P18961, DOI 10.1074/jbc.271.31.18961; Derwin KA, 2001, J ORTHOP RES, V19, P269, DOI 10.1016/S0736-0266(00)00032-2; Droguett R, 2006, MATRIX BIOL, V25, P332, DOI 10.1016/j.matbio.2006.04.004; Ellis IR, 1998, CYTOKINE, V10, P281, DOI 10.1006/cyto.1997.0294; Ellis IR, 1996, EXP CELL RES, V228, P326, DOI 10.1006/excr.1996.0332; Evans CH, 1999, SPORTS MED, V28, P71, DOI 10.2165/00007256-199928020-00001; Fischer JW, 2001, ARTERIOSCL THROM VAS, V21, P777, DOI 10.1161/01.ATV.21.5.777; GHAHARY A, 1993, J LAB CLIN MED, V122, P465; Grande-Allen KJ, 2004, GLYCOBIOLOGY, V14, P621, DOI 10.1093/glycob/cwh076; Grassl ED, 2003, J BIOMED MATER RES A, V66A, P550, DOI 10.1002/jbm.a.10589; Grinnell F, 2006, EXP CELL RES, V312, P86, DOI 10.1016/j.yexcr.2005.010.001; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Gupta V, 2007, TISSUE ENG, V13, P41, DOI 10.1089/ten.2006.0091; Hakkinen L, 2000, LAB INVEST, V80, P1869, DOI 10.1038/labinvest.3780197; Hay E.D., 1991, CELL BIOL EXTRACELLU, DOI 10.1007/978-1-4615-3770-0; Imai K, 1997, BIOCHEM J, V322, P809, DOI 10.1042/bj3220809; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Jarvelainen H, 2004, ARTERIOSCL THROM VAS, V24, P67, DOI 10.1161/01.ATV.0000107026.98626.3b; Kaji T, 2000, J BIOL CHEM, V275, P1463, DOI 10.1074/jbc.275.2.1463; Kinsella MG, 2004, CRIT REV EUKAR GENE, V14, P203, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i3.40; Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Lara S L, 2001, Methods Mol Biol, V171, P271; Liao J, 2007, J BIOMECH, V40, P390, DOI 10.1016/j.jbiomech.2005.12.011; Malmstrom J, 2004, MOL CELL PROTEOMICS, V3, P466, DOI 10.1074/mcp.M300108-MCP200; Markmann A, 2000, MATRIX BIOL, V19, P631, DOI 10.1016/S0945-053X(00)00097-4; MAUVIEL A, 1993, J CELL BIOCHEM, V53, P288, DOI 10.1002/jcb.240530404; Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216; Miura T, 2006, BIOCHEM BIOPH RES CO, V340, P675, DOI 10.1016/j.bbrc.2005.12.060; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Nomura Y, 2006, CONNECT TISSUE RES, V47, P249, DOI 10.1080/03008200600846606; NUSGENS B, 1984, COLLAGEN REL RES, V4, P351; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; PELTONEN J, 1991, J INVEST DERMATOL, V97, P240, DOI 10.1111/1523-1747.ep12480289; Petridou S, 2000, INVEST OPHTH VIS SCI, V41, P89; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; RIIKONEN T, 1995, J BIOL CHEM, V270, P376, DOI 10.1074/jbc.270.1.376; Robinson PS, 2005, J BIOMECH ENG-T ASME, V127, P181, DOI 10.1115/1.1835363; Scherping SC, 1997, CONNECT TISSUE RES, V36, P1, DOI 10.3109/03008209709160209; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Seidler DG, 2006, J BIOL CHEM, V281, P26408, DOI 10.1074/jbc.M602853200; Seidler DG, 2005, BIOCHEM BIOPH RES CO, V332, P1162, DOI 10.1016/j.bbrc.2005.04.175; Shafritz T. Alex, 1994, Wound Repair and Regeneration, V2, P270, DOI 10.1046/j.1524-475X.1994.20407.x; Sigel AV, 1996, J MOL CELL CARDIOL, V28, P1921, DOI 10.1006/jmcc.1996.0185; Uria JA, 1998, J BIOL CHEM, V273, P9769, DOI 10.1074/jbc.273.16.9769; VOGEL KG, 1987, COLLAGEN REL RES, V7, P105; Wagenseil JE, 2003, J BIOMECH ENG-T ASME, V125, P719, DOI 10.1115/1.1614818; Walsh AJL, 2004, SPINE, V29, P156, DOI 10.1097/01.BRS.0000107231.67854.9F; Zen AAH, 2003, MATRIX BIOL, V22, P251, DOI 10.1016/S0945-053X(03)00018-0; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776	64	108	108	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35887	35898		10.1074/jbc.M705180200	http://dx.doi.org/10.1074/jbc.M705180200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17942398	hybrid			2022-12-25	WOS:000251458100050
J	Yang, GH; Gao, P; Zhang, H; Huang, SJ; Zheng, ZL				Yang, Guohua; Gao, Peng; Zhang, Hua; Huang, Shanjin; Zheng, Zhi-Liang			A Mutation in MRH2 Kinesin Enhances the Root Hair Tip Growth Defect Caused by Constitutively Activated ROP2 Small GTPase in Arabidopsis	PLOS ONE			English	Article							DYNAMIC ACTIN CYTOSKELETON; F-ACTIN; CELL EXPANSION; CORTICAL MICROTUBULES; PROTEIN; MORPHOGENESIS; FUSION; SWITCH; GENE; POLYMERIZATION	Root hair tip growth provides a unique model system for the study of plant cell polarity. Transgenic plants expressing constitutively active (CA) forms of ROP (Rho-of-plants) GTPases have been shown to cause the disruption of root hair polarity likely as a result of the alteration of actin filaments (AF) and microtubules (MT) organization. Towards understanding the mechanism by which ROP controls the cytoskeletal organization during root hair tip growth, we have screened for CA-rop2 suppressors or enhancers using CA1-1, a transgenic line that expresses CA-rop2 and shows only mild disruption of tip growth. Here, we report the characterization of a CA-rop2 enhancer (cae1-1 CA1-1) that exhibits bulbous root hairs. The cae1-1 mutation on its own caused a waving and branching root hair phenotype. CAE1 encodes the root hair growth-related, ARM domain-containing kinesin-like protein MRH2 (and thus cae1-1 was renamed to mrh2-3). Cortical MT displayed fragmentation and random orientation in mrh2 root hairs. Consistently, the MT-stabilizing drug taxol could partially rescue the wavy root hair phenotype of mrh2-3, and the MT-depolymerizing drug Oryzalin slightly enhanced the root hair tip growth defect in CA1-1. Interestingly, the addition of the actin-depolymerizing drug Latrunculin B further enhanced the Oryzalin effect. This indicates that the cross-talk of MT and AF organization is important for the mrh2-3 CA1-1 phenotype. Although we did not observe an apparent effect of the MRH2 mutation in AF organization, we found that mrh2-3 root hair growth was more sensitive to Latrunculin B. Moreover, an ARM domain-containing MRH2 fragment could bind to the polymerized actin in vitro. Therefore, our genetic analyses, together with cell biological and pharmacological evidence, suggest that the plant-specific kinesin-related protein MRH2 is an important component that controls MT organization and is likely involved in the ROP2 GTPase-controlled coordination of AF and MT during polarized growth of root hairs.	[Yang, Guohua; Gao, Peng; Zheng, Zhi-Liang] CUNY, Lehman Coll, Dept Biol Sci, Bronx, NY USA; [Zhang, Hua; Huang, Shanjin] Chinese Acad Sci, Key Lab Photosynth & Environm Mol Physiol, Ctr Signal Transduct & Metabol, Inst Bot, Beijing, Peoples R China; [Zheng, Zhi-Liang] CUNY Grad Sch & Univ Ctr, Plant Sci PhD Subprogram, New York, NY USA	City University of New York (CUNY) System; Lehman College (CUNY); Chinese Academy of Sciences; Institute of Botany, CAS; City University of New York (CUNY) System; City University of New York (CUNY) Graduate School	Zheng, ZL (corresponding author), CUNY, Lehman Coll, Dept Biol Sci, Bronx, NY USA.	zhiliang.zheng@lehman.cuny.edu	Huang, Shanjin/M-4112-2017	Huang, Shanjin/0000-0001-9517-2515	NIH-SCORE [S06GM008225, 12]; Chinese Academy of Sciences through its Hundred Talent Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008225] Funding Source: NIH RePORTER	NIH-SCORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Academy of Sciences through its Hundred Talent Program(Chinese Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from NIH-SCORE (S06GM008225, Project Number 12, to Z-LZ) and the Chinese Academy of Sciences through its Hundred Talent Program ( to SH).	Baluska F, 2000, DEV BIOL, V227, P618, DOI 10.1006/dbio.2000.9908; Bao YQ, 2001, PLANT J, V28, P145, DOI 10.1046/j.1365-313X.2001.01142.x; Bibikova TN, 1999, PLANT J, V17, P657, DOI 10.1046/j.1365-313X.1999.00415.x; Bisgrove SR, 2004, PLANT PHYSIOL, V136, P3855, DOI 10.1104/pp.104.051037; Bloch D, 2005, MOL BIOL CELL, V16, P1913, DOI 10.1091/mbc.E04-07-0562; Carol RJ, 2005, NATURE, V438, P1013, DOI 10.1038/nature04198; Carol RJ, 2002, PHILOS T ROY SOC B, V357, P815, DOI 10.1098/rstb.2002.1092; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chen CB, 2002, DEVELOPMENT, V129, P2401; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; Dong CH, 2001, PLANT CELL, V13, P1333, DOI 10.1105/tpc.13.6.1333; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fu Y, 2005, CELL, V120, P687, DOI 10.1016/j.cell.2004.12.026; Fu Y, 2002, PLANT CELL, V14, P777, DOI 10.1105/tpc.001537; Grierson Claire, 2002, Arabidopsis Book, V1, pe0060, DOI 10.1199/tab.0060; Gu Y, 2005, J CELL BIOL, V169, P127, DOI 10.1083/jcb.200409140; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; Huang S, 2005, PLANT CELL, V17, P486, DOI 10.1105/tpc.104.028555; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jones MA, 2002, PLANT CELL, V14, P763, DOI 10.1105/tpc.010359; Jones MA, 2006, PLANT J, V45, P83, DOI 10.1111/j.1365-313X.2005.02609.x; Jones MA, 2007, J EXP BOT, V58, P1261, DOI 10.1093/jxb/erl279; Ketelaar T, 2003, PLANT CELL, V15, P285, DOI 10.1105/tpc.007039; Kovar DR, 2000, PLANT J, V24, P625, DOI 10.1046/j.1365-313x.2000.00907.x; Lee YRJ, 2004, PLANT PHYSIOL, V136, P3877, DOI 10.1104/pp.104.052621; Lee YRJ, 2001, PLANT CELL, V13, P2427, DOI 10.1105/tpc.13.11.2427; Li H, 2001, PLANT PHYSIOL, V126, P670, DOI 10.1104/pp.126.2.670; LLOYD CW, 1987, CELL MOTIL CYTOSKEL, V8, P27, DOI 10.1002/cm.970080105; Lu L, 2005, MOL BIOL CELL, V16, P811, DOI 10.1091/mbc.E04-05-0400; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Mao TL, 2005, PLANT PHYSIOL, V138, P654, DOI 10.1104/pp.104.052456; Marc J, 1998, PLANT CELL, V10, P1927, DOI 10.1105/tpc.10.11.1927; Martin SG, 2005, DEV CELL, V8, P479, DOI 10.1016/j.devcel.2005.02.008; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Molendijk AJ, 2001, EMBO J, V20, P2779, DOI 10.1093/emboj/20.11.2779; Motes CM, 2005, PROTOPLASMA, V226, P109, DOI 10.1007/s00709-005-0124-4; Muller S, 2006, CURR BIOL, V16, P888, DOI 10.1016/j.cub.2006.03.034; Nibau C, 2006, TRENDS PLANT SCI, V11, P309, DOI 10.1016/j.tplants.2006.04.003; Oppenheimer DG, 1997, P NATL ACAD SCI USA, V94, P6261, DOI 10.1073/pnas.94.12.6261; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Preuss ML, 2004, PLANT PHYSIOL, V136, P3945, DOI 10.1104/pp.104.052340; Ramachandran S, 2000, PLANT PHYSIOL, V124, P1637, DOI 10.1104/pp.124.4.1637; Ren HY, 1997, PLANT CELL, V9, P1445, DOI 10.1105/tpc.9.8.1445; Richardson DN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-18; Ringli C, 2002, PLANT PHYSIOL, V129, P1464, DOI 10.1104/pp.005777; Samaj J, 2006, TRENDS PLANT SCI, V11, P594, DOI 10.1016/j.tplants.2006.10.002; Sheahan MB, 2004, PLANT PHYSIOL, V136, P3968, DOI 10.1104/pp.104.049411; Sieberer BJ, 2005, NEW PHYTOL, V167, P711, DOI 10.1111/j.1469-8137.2005.01506.x; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Van Bruaene N, 2004, PLANT PHYSIOL, V136, P3905, DOI 10.1104/pp.103.031591; Voigt B, 2005, EUR J CELL BIOL, V84, P595, DOI 10.1016/j.ejcb.2004.11.011; Wang QM, 2004, LETT ORG CHEM, V1, P93, DOI 10.2174/1570178043488770; Whittington AT, 2001, NATURE, V411, P610, DOI 10.1038/35079128; Xin ZY, 2005, PLANT PHYSIOL, V139, P1350, DOI 10.1104/pp.105.068064; Xu J, 2005, CURR OPIN PLANT BIOL, V8, P613, DOI 10.1016/j.pbi.2005.09.003; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Yang ZB, 2002, PLANT CELL, V14, pS375, DOI 10.1105/tpc.001065; Yi KX, 2005, PLANT PHYSIOL, V138, P1071, DOI 10.1104/pp.104.055665; Ying G, 2004, CURR OPIN PLANT BIOL, V7, P527, DOI 10.1016/j.pbi.2004.07.006; Zheng ZL, 2000, TRENDS PLANT SCI, V5, P298, DOI 10.1016/S1360-1385(00)01654-X; Zheng ZL, 2000, PLANT MOL BIOL, V44, P1, DOI 10.1023/A:1006402628948; Zhong RQ, 2002, PLANT CELL, V14, P3101, DOI 10.1105/tpc.005801	63	54	60	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1074	10.1371/journal.pone.0001074	http://dx.doi.org/10.1371/journal.pone.0001074			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957256	Green Published, gold			2022-12-25	WOS:000207458500019
J	Rao, PR; Makhijani, K; Shashidhara, LS				Rao, P. R.; Makhijani, K.; Shashidhara, L. S.			Human APC sequesters beta-catenin even in the absence of GSK-3 beta in a Drosophila model	ONCOGENE			English	Article						colon cancer; adenomatous polyposis coli; Shaggy/GSK-3 beta; Armadillo; Wnt; wingless	HOMEOTIC GENE; PHOSPHORYLATION; EXPRESSION; BINDING; COMPLEX	There have been conflicting reports on the requirement of GSK- 3 beta- mediated phosphorylation of the tumor suppressor adenomatous polyposis coli ( APC) vis-a-vis its ability to bind and degrade beta- catenin. Using a unique combination of loss of function for Shaggy/ GSK- 3 beta and a gain of function for human APC in Drosophila, we show that misexpressed human APC ( hAPC) can still sequester Armadillo/beta- catenin. In addition, human APC could suppress gain of Wnt/ Wingless phenotypes associated with loss of Shaggy/ GSK- 3 beta activity, suggesting that sequestered Armadillo/beta- catenin is non- functional. Based on these studies, we propose that binding per se of b- catenin by APC does not require phosphorylation by GSK- 3 beta.	[Rao, P. R.; Makhijani, K.; Shashidhara, L. S.] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Rao, PR (corresponding author), Ctr Cellular & Mol Biol, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.	prashanth21676@gmail.com		Rao, Prashanth Ramesh/0000-0002-6877-6214; , Kalpana/0000-0001-7795-891X				Bajpai R, 2004, DEVELOPMENT, V131, P1007, DOI 10.1242/dev.00980; Bhandari P, 2001, ONCOGENE, V20, P6871, DOI 10.1038/sj.onc.1204849; BRAND AH, 1993, DEVELOPMENT, V118, P401; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Liu J, 2006, J MOL BIOL, V360, P133, DOI 10.1016/j.jmb.2006.04.064; Mohit P, 2003, DEVELOPMENT, V130, P1537, DOI 10.1242/dev.00393; Neumann CJ, 1997, DEVELOPMENT, V124, P871; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; PERRIMON N, 1989, DEV BIOL, V135, P287, DOI 10.1016/0012-1606(89)90180-2; Rubinfeld B, 2001, J BIOL CHEM, V276, P39037, DOI 10.1074/jbc.M105148200; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Seo E, 2007, BIOCHEM BIOPH RES CO, V357, P81, DOI 10.1016/j.bbrc.2007.03.117; Shashidhara LS, 1999, DEV BIOL, V212, P491, DOI 10.1006/dbio.1999.9341; SIMMONDS AJ, 1995, NATURE, V376, P424, DOI 10.1038/376424a0; von Kries JP, 2000, NAT STRUCT BIOL, V7, P800; Xing Y, 2004, MOL CELL, V15, P523, DOI 10.1016/j.molcel.2004.08.001; XU T, 1993, DEVELOPMENT, V117, P1223; Zilian O, 1999, DEVELOPMENT, V126, P5409	19	5	5	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2008	27	17					2488	2493		10.1038/sj.onc.1210890	http://dx.doi.org/10.1038/sj.onc.1210890			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286KN	17968317				2022-12-25	WOS:000254844900013
J	Danik, SB; Rosner, G; Lader, J; Gutstein, DE; Fishman, GI; Morley, GE				Danik, Stephan B.; Rosner, Gregg; Lader, Joshua; Gutstein, David E.; Fishman, Glenn I.; Morley, Gregory E.			Electrical remodeling contributes to complex tachyarrhythmias in connexin43-deficient mouse hearts	FASEB JOURNAL			English	Article						gap junction channels; ion channel remodeling	ISOLATED RABBIT HEART; VENTRICULAR-FIBRILLATION; POTASSIUM CURRENT; SLOW CONDUCTION; MICE; EXPRESSION; JUNCTION; ACTIVATION; MECHANISMS; DYNAMICS	Loss of connexin43 (Cx43) gap junction channels in the heart results in a marked increase in the incidence of spontaneous and inducible polymorphic ventricular tachyarrhythmias (PVTs). The mechanisms resulting in this phenotype remain unclear. We hypothesized that uncoupling promotes regional ion channel remodeling, thereby increasing electrical heterogeneity and facilitating the development of PVT. In isolated-perfused control hearts, programmed electrical stimulation elicited infrequent monomorphic ventricular tachyarrhythmias (MVT), and dominant frequencies (DFs) during MVT were similar in the right ventricle (RV) and left ventricle (LV). Moreover, conduction properties, action potential durations (APDs), and repolarizing current densities were similar in RV and LV myocytes. In contrast, PVT was common in Cx43 conditional knockout (OCKO) hearts, and arrhythmias were characterized by significantly higher DFs in the RV compared to the LV. APDs in OCKO myocytes were significantly shorter than those from chamber-matched controls, with RV OCKO myocytes being most affected. APD shortening was associated with higher levels of sustained current in myocytes from both chambers as well as higher levels of the inward rectifier current only in RV myocytes. Thus, alterations in cell-cell coupling lead to regional changes in potassium current expression, which in this case facilitates the development of reentrant arrhythmias. We propose a new mechanistic link between electrical uncoupling and ion channel remodeling. These findings may be relevant not only in cardiac tissue but also to other organ systems where gap junction remodeling is known to occur.	[Danik, Stephan B.; Rosner, Gregg; Lader, Joshua; Gutstein, David E.; Fishman, Glenn I.; Morley, Gregory E.] NYU, Sch Med, Leon H Charney Div Cardiol, New York, NY 10016 USA	New York University	Morley, GE (corresponding author), NYU, Sch Med, Leon H Charney Div Cardiol, 522 1St Ave,8th Floor,Smilow Bldg, New York, NY 10016 USA.	gregory.morley@nyumc.org		Fishman, Glenn/0000-0002-2366-8527	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082727, R01HL076751, R01HL064757] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL64757, R01 HL082727-03, HL76751, R01 HL076751-01A1, HL82727, R01 HL082727, R01 HL076751-03, R01 HL064757-09, R01 HL064757, R01 HL076751-04, R01 HL076751, R01 HL076751-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chen J, 2000, CIRC RES, V86, P86, DOI 10.1161/01.RES.86.1.86; Danik SB, 2004, CIRC RES, V95, P1035, DOI 10.1161/01.RES.0000148664.33695.2a; Gray RA, 1998, NATURE, V392, P75, DOI 10.1038/32164; GRAY RA, 1995, SCIENCE, V270, P1222, DOI 10.1126/science.270.5239.1222; Guo WN, 2005, CIRC RES, V97, P1342, DOI 10.1161/01.RES.0000196559.63223.aa; Gutstein DE, 2005, AM J PHYSIOL-HEART C, V289, pH1091, DOI 10.1152/ajpheart.00095.2005; Gutstein DE, 2003, AM J PHYSIOL-HEART C, V285, pH1091, DOI 10.1152/ajpheart.00100.2003; Gutstein DE, 2001, CELL COMMUN ADHES, V8, P345, DOI 10.3109/15419060109080751; Gutstein DE, 2001, CIRC RES, V88, P333, DOI 10.1161/01.RES.88.3.333; Iacobas DA, 2005, BBA-BIOMEMBRANES, V1711, P183, DOI 10.1016/j.bbamem.2004.12.002; Iacobas DA, 2005, PHYSIOL GENOMICS, V20, P211, DOI 10.1152/physiolgenomics.00229.2003; IBARRA J, 1991, BIOPHYS J, V60, P1534, DOI 10.1016/S0006-3495(91)82187-7; Jalife J, 2000, ANNU REV PHYSIOL, V62, P25, DOI 10.1146/annurev.physiol.62.1.25; Kaprielian R, 2002, AM J PHYSIOL-HEART C, V283, pH1157, DOI 10.1152/ajpheart.00518.2001; Kardami E, 2007, PROG BIOPHYS MOL BIO, V94, P245, DOI 10.1016/j.pbiomolbio.2007.03.009; Lerner DL, 2000, CIRCULATION, V101, P547, DOI 10.1161/01.CIR.101.5.547; Libbus I, 2003, J CARDIOVASC ELECTR, V14, P394, DOI 10.1046/j.1540-8167.2003.02436.x; Mandapati R, 1998, CIRCULATION, V98, P1688, DOI 10.1161/01.CIR.98.16.1688; Morley GE, 2005, P NATL ACAD SCI USA, V102, P4126, DOI 10.1073/pnas.0500881102; Morley GE, 1999, J CARDIOVASC ELECTR, V10, P1361, DOI 10.1111/j.1540-8167.1999.tb00192.x; Nerbonne JM, 2002, J CARDIOVASC ELECTR, V13, P406, DOI 10.1046/j.1540-8167.2002.00406.x; Noujaim SF, 2007, J PHYSIOL-LONDON, V578, P315, DOI 10.1113/jphysiol.2006.121475; Patel PM, 2001, J CARDIOVASC ELECTR, V12, P570, DOI 10.1046/j.1540-8167.2001.00570.x; Petkova-Kirova PS, 2006, AM J PHYSIOL-HEART C, V290, pH2098, DOI 10.1152/ajpheart.00097.2005; Rose J, 2005, AM J PHYSIOL-HEART C, V288, pH2077, DOI 10.1152/ajpheart.00526.2003; Rubart M, 2005, J CLIN INVEST, V115, P2305, DOI 10.1172/JCI26381; Samie FH, 2001, CIRC RES, V89, P1216, DOI 10.1161/hh2401.100818; Tamaddon HS, 2000, CIRC RES, V87, P929, DOI 10.1161/01.RES.87.10.929; Trepanier-Boulay W, 2001, CIRC RES, V89, P437, DOI 10.1161/hh1701.095644; Vaidya D, 1999, CIRC RES, V85, P174, DOI 10.1161/01.RES.85.2.174; Vaidya D, 2001, CIRC RES, V88, P1196, DOI 10.1161/hh1101.091107; van Rijen HVM, 2004, CIRCULATION, V109, P1048, DOI 10.1161/01.CIR.0000117402.70689.75; Warren M, 2003, J CARDIOVASC ELECTR, V14, P621, DOI 10.1046/j.1540-8167.2003.03006.x; Wickenden AD, 1999, CIRC RES, V85, P1067	34	50	53	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2008	22	4					1204	1212		10.1096/fj.07-8974com	http://dx.doi.org/10.1096/fj.07-8974com			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	282PZ	17984180	Green Accepted			2022-12-25	WOS:000254581000025
J	Wang, QW; Pang, S				Wang, Qiuwei; Pang, Shen			An intercellular adhesion molecule-3 (ICAM-3)- grabbing nonintegrin (DC-SIGN) efficiently blocks HIV viral budding	FASEB JOURNAL			English	Article						gp120; viral production	IMMUNODEFICIENCY-VIRUS TYPE-1; DENDRITIC CELLS; TRANS-ENHANCEMENT; LANGERHANS CELLS; T-CELLS; INFECTION; BINDING; EXPRESSION; RECEPTORS; TRANSMISSION	Efficient inhibition of the HIV infection, life cycle at the stages of viral infection, reverse transcription, and post-translational processing has been extensively studied. However, efficient inhibition of HIV assembly and budding has not been reported. Here, we report that dendritic cell-specific intercellular adhesion molecule-3 (ICAM-3) -grabbing nonintegrin (DC-SIGN) and its related protein, DC-SIGNR, effectively block HIV budding from infected cells. Cotransfection of DC-SIGN or DC-SIGNR with HIV demonstrated 95-99.5% inhibition of viral production from host cells. DC-SIGN or DC-SIGNR can also effectively inhibit 90-95% of HIV generation from infected cells. DC-SIGN efficiently reduces the amount of gp120 present on the cell plasma membrane, and completely strips off gp120 from the virions produced by the host cells, suggesting that blockage of HIV budding is due to internalization of gp120 by DC-SIGN.	[Wang, Qiuwei; Pang, Shen] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Pang, S (corresponding author), Univ Calif Los Angeles, Sch Dent, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	spang@ucla.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047722] Funding Source: NIH RePORTER; NIAID NIH HHS [AI047722] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Balzarini J, 2007, MOL PHARMACOL, V71, P3, DOI 10.1124/mol.106.030155; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Baribaud F, 2001, VIROLOGY, V286, P1, DOI 10.1006/viro.2001.0975; Boggiano C, 2007, J VIROL, V81, P2519, DOI 10.1128/JVI.01661-06; CAMERON PU, 1992, CLIN EXP IMMUNOL, V88, P226, DOI 10.1111/j.1365-2249.1992.tb03066.x; Chow YH, 2002, J ACQ IMMUN DEF SYND, V30, P1, DOI 10.1097/00126334-200205010-00001; CURTIS BM, 1992, P NATL ACAD SCI USA, V89, P8356, DOI 10.1073/pnas.89.17.8356; EARL PL, 1993, AIDS RES HUM RETROV, V9, P589, DOI 10.1089/aid.1993.9.589; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Granelli-Piperno A, 1998, J VIROL, V72, P2733, DOI 10.1128/JVI.72.4.2733-2737.1998; Granelli-Piperno A, 1999, CURR BIOL, V9, P21, DOI 10.1016/S0960-9822(99)80043-8; GranelliPiperno A, 1996, J EXP MED, V184, P2433, DOI 10.1084/jem.184.6.2433; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; Jameson B, 2002, J VIROL, V76, P1866, DOI 10.1128/JVI.76.4.1866-1875.2002; Kawamura T, 2003, P NATL ACAD SCI USA, V100, P8401, DOI 10.1073/pnas.1432450100; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; MCILROY D, 1995, J VIROL, V69, P4737, DOI 10.1128/JVI.69.8.4737-4745.1995; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Moris A, 2004, BLOOD, V103, P2648, DOI 10.1182/blood-2003-07-2532; Mummidi S, 2001, J BIOL CHEM, V276, P33196, DOI 10.1074/jbc.M009807200; Nabatov AA, 2006, FEBS J, V273, P4944, DOI 10.1111/j.1742-4658.2006.05491.x; Pang S, 2000, J VIROL, V74, P10994, DOI 10.1128/JVI.74.23.10994-11000.2000; Patterson S, 2001, J VIROL, V75, P6710, DOI 10.1128/JVI.75.14.6710-6713.2001; Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398; POPE M, 1995, J EXP MED, V182, P2045, DOI 10.1084/jem.182.6.2045; Rubbert A, 1998, J IMMUNOL, V160, P3933; Smed-Sorensen A, 2005, J VIROL, V79, P8861, DOI 10.1128/JVI.79.14.8861-8869.2005; Snyder GA, 2005, J VIROL, V79, P4589, DOI 10.1128/JVI.79.8.4589-4598.2005; Soilleux EJ, 2000, J IMMUNOL, V165, P2937, DOI 10.4049/jimmunol.165.6.2937; Steinman RM, 2003, CURR TOP MICROBIOL, V276, P1; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; Wang QC, 2004, CHINESE MED J-PEKING, V117, P1395; Wang QW, 2007, AIDS RES HUM RETROV, V23, P508, DOI 10.1089/aid.2006.0119; Wu L, 2004, VIROLOGY, V318, P17, DOI 10.1016/j.virol.2003.09.028; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Zaitseva M, 1997, NAT MED, V3, P1369, DOI 10.1038/nm1297-1369; Zheng JY, 2006, JAIDS-J ACQ IMM DEF, V43, P127, DOI 10.1097/01.qai.0000228149.17669.08	37	4	4	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2008	22	4					1055	1064		10.1096/fj.07-9443com	http://dx.doi.org/10.1096/fj.07-9443com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	282PZ	17962491	Bronze			2022-12-25	WOS:000254581000011
J	Norling, LV; Sampaio, ALF; Cooper, D; Perretti, M				Norling, Lucy V.; Sampaio, Andre L. F.; Cooper, Dianne; Perretti, Mauro			Inhibitory control of endothelial galectin-1 on in vitro and in vivo lymphocyte trafficking	FASEB JOURNAL			English	Article						small interfering RNA; homing; delayed-type hypersensitivity	CELL-INTERACTIONS; IL-10 PRODUCTION; EXPRESSION; ADHESION; INFLAMMATION; NEUTROPHILS; LEUKOCYTES; RESOLUTION; INDUCTION; MIGRATION	Galectin-1 (Gal-1) is a beta-galactoside-binding protein, the expression of which is increased in endothelial cells on exposure to proinflammatory stimuli. Through binding of several receptors (CD7, CD45, and CD43) Gal-1 is known to induce apoptosis of activated T lymphocytes, an effect thought to mediate the beneficial effects it exerts in various inflammatory models. The data presented here highlights another function for Gal-1, that of a negative regulator of T-cell recruitment to the endothelium under both physiological and pathophysiological conditions. We have shown, using siRNA to knockdown Gal-1 in endothelial cells, that endogenous Gal-1 limits T-cell capture, rolling, and adhesion to activated endothelial cells under flow. Furthermore, the reverse effect is observed when exogenous human recombinant Gal-1 is added to activated endothelial monolayers whereby a dramatic reduction in lymphocyte recruitment is seen. These findings are corroborated by studies in Gal-1 nun mice in which homing of wild-type (WT) T lymphocytes is significantly increased to mesenteric lymph nodes and to the inflamed paw in a model of delayed-type hypersensitivity. In conclusion, mimicking endothelial Gal-1 actions would be a novel strategy for controlling aberrant T-cell trafficking, hence for the development of innovative anti-inflammatory therapeutics.	[Norling, Lucy V.; Sampaio, Andre L. F.; Cooper, Dianne; Perretti, Mauro] The London, Queen Mary Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England	University of London; Queen Mary University London	Perretti, M (corresponding author), The London, Queen Mary Sch Med & Dent, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	m.perretti@qmul.ac.uk	Norling, Lucy/W-9523-2019; Norling, Lucy/AAO-4645-2020	Norling, Lucy/0000-0001-5316-9115	Arthritis Research UK [18103] Funding Source: Medline; Versus Arthritis [18103] Funding Source: Medline	Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis)		BAUM LG, 1995, GLYCOCONJUGATE J, V12, P63, DOI 10.1007/BF00731870; Baum LG, 2003, CLIN IMMUNOL, V109, P295, DOI 10.1016/j.clim.2003.08.003; Baum LG, 2002, IMMUNITY, V16, P5, DOI 10.1016/S1074-7613(02)00265-0; Cao TV, 2004, MICROCIRCULATION, V11, P615, DOI 10.1080/10739680490503438; Cinamon G, 2001, NAT IMMUNOL, V2, P515, DOI 10.1038/88710; Colnot C, 1998, DEV DYNAM, V211, P306, DOI 10.1002/(SICI)1097-0177(199804)211:4<306::AID-AJA2>3.0.CO;2-L; Gil CD, 2006, INFLAMM RES, V55, P99, DOI 10.1007/s00011-005-0059-4; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; Hayhoe RPG, 2006, BLOOD, V107, P2123, DOI 10.1182/blood-2005-08-3099; He J, 2006, LAB INVEST, V86, P578, DOI 10.1038/labinvest.3700420; He JL, 2004, J BIOL CHEM, V279, P4705, DOI 10.1074/jbc.M311183200; HILGENBERG L, 1995, J CELL SCI, V108, P51; La M, 2003, AM J PATHOL, V163, P1505, DOI 10.1016/S0002-9440(10)63507-9; Nguyen JT, 2001, J IMMUNOL, V167, P5697, DOI 10.4049/jimmunol.167.10.5697; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Nolte MA, 2002, IMMUNOLOGY, V106, P299, DOI 10.1046/j.1365-2567.2002.01443.x; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Perretti M, 1996, NAT MED, V2, P1259, DOI 10.1038/nm1196-1259; POIRIER F, 1993, DEVELOPMENT, V119, P1229; Rabinovich G, 1999, J EXP MED, V190, P385, DOI 10.1084/jem.190.3.385; Rabinovich GA, 2000, EUR J IMMUNOL, V30, P1331, DOI 10.1002/(SICI)1521-4141(200005)30:5<1331::AID-IMMU1331>3.3.CO;2-8; Rabinovich GA, 1999, IMMUNOLOGY, V97, P100; Rao RM, 2004, J EXP MED, V200, P713, DOI 10.1084/jem.20040499; Rittner HL, 2001, ANESTHESIOLOGY, V95, P500, DOI 10.1097/00000542-200108000-00036; Santucci L, 2003, GASTROENTEROLOGY, V124, P1381, DOI 10.1016/S0016-5085(03)00267-1; Santucci L, 2000, HEPATOLOGY, V31, P399, DOI 10.1002/hep.510310220; Schreiber TH, 2007, BLOOD, V109, P1381, DOI 10.1182/blood-2006-07-032995; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Stowell SR, 2007, BLOOD, V109, P219, DOI 10.1182/blood-2006-03-007153; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; van der Leij J, 2004, J PATHOL, V204, P511, DOI 10.1002/path.1671; van der Leij J, 2007, MOL IMMUNOL, V44, P506, DOI 10.1016/j.molimm.2006.02.011	35	80	81	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2008	22	3					682	690		10.1096/fj.07-9268com	http://dx.doi.org/10.1096/fj.07-9268com			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17965266				2022-12-25	WOS:000254143700007
J	Zhang, W; Wang, D; Volk, E; Bellen, HJ; Hiesinger, PR; Quiocho, FA				Zhang, Wei; Wang, Dong; Volk, Elzi; Bellen, Hugo J.; Hiesinger, Peter Robin; Quiocho, Florante A.			V-ATPase V-o sector subunit a1 in neurons is a target of calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APICAL SECRETION; LATE STEP; VACUOLAR; RECOGNITION; EXPRESSION; PROTEINS; TRIGGERS; RELEASE; FUSION	The V-o complex forms the proteolipid pore of a vesicular ATPase that acidifies vesicles. In addition, an independent function in membrane fusion has been suggested in vacuolar fusion in yeast and synaptic vesicle exocytosis in fly neurons. Evidence for a direct role in secretion has also recently been presented in mouse and worm. The molecular mechanisms of how the V-o components might act or are regulated are largely unknown. Here we report the identification and characterization of a calmodulin-binding site in the large cytosolic N-terminal region of the Drosophila protein V100, the neuron-specific V-o subunit a1. V100 forms a tight complex with calmodulin in a Ca2+- dependent manner. Mutations in the calmodulin-binding site in Drosophila lead to a loss of calmodulin recruitment to synapses. Neuronal expression of a calmodulin-binding deficient V100 uncovers an incomplete rescue at low levels and cellular toxicity at high levels. Our results suggest a vesicular ATPase V-o-dependent function of calmodulin at synapses.	[Wang, Dong; Volk, Elzi; Hiesinger, Peter Robin] Univ Texas, SW Med Ctr, Dept Physiol & Green Ctr, Div Syst Biol, Dallas, TX 75390 USA; [Zhang, Wei; Quiocho, Florante A.] Baylor Coll Med, Howard Hughes Med Inst, Verna Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Dept Human Mol Genet & Neurosci, Houston, TX 77030 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Howard Hughes Medical Institute	Hiesinger, PR (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol & Green Ctr, Div Syst Biol, Dallas, TX 75390 USA.	robin.hiesinger@utsouthwestern.edu; faq@bcm.tmc.edu	Wang, Dong/F-8316-2010	Bellen, Hugo/0000-0001-5992-5989	NATIONAL EYE INSTITUTE [R01EY018884] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY018884] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bayer MJ, 2003, J CELL BIOL, V162, P211, DOI 10.1083/jcb.200212004; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; COHEN P, 1988, CALMODULIN MOL ASPEC; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; ISRAEL M, 1987, J NEUROCHEM, V49, P975, DOI 10.1111/j.1471-4159.1987.tb00989.x; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Liegeois S, 2007, GENETICS, V175, P709, DOI 10.1534/genetics.106.066035; Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1995, NAT STRUCT BIOL, V2, P943, DOI 10.1038/nsb1195-943; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Morel N, 2001, J NEUROCHEM, V79, P485, DOI 10.1046/j.1471-4159.2001.00611.x; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Perzov N, 2002, J EXP BIOL, V205, P1209; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Pujol N, 2001, J BIOL CHEM, V276, P11913, DOI 10.1074/jbc.M009451200; PUTKEY JA, 1985, J BIOL CHEM, V260, P4704; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; STEINHARDT RA, 1982, NATURE, V295, P154, DOI 10.1038/295154a0; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; VANELDIK LJ, 1998, CALMODULIN SIGNAL TR; Wickner W, 2000, ANNU REV BIOCHEM, V69, P247, DOI 10.1146/annurev.biochem.69.1.247; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	35	25	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					294	300		10.1074/jbc.M708058200	http://dx.doi.org/10.1074/jbc.M708058200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17933871	hybrid, Green Accepted			2022-12-25	WOS:000251940300033
J	Bawa-Khalfe, T; Cheng, JK; Wang, ZX; Yeh, ETH				Bawa-Khalfe, Tasneem; Cheng, Jinke; Wang, Zhengxin; Yeh, Edward T. H.			Induction of the SUMO-specific protease 1 transcription by the androgen receptor in prostate cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN D1; RESPONSE ELEMENTS; DEPENDENT TRANSCRIPTION; DIFFERENTIAL REGULATION; HISTONE DEACETYLASE-1; STRUCTURAL BASIS; GENE-REGULATION; DNA-BINDING; EXPRESSION; OVEREXPRESSION	Prostate cancer, the most frequently diagnosed carcinoma in males, is readily modulated via the transcriptional activity of androgen receptors. Our recent publication reported that androgen receptor-dependent transcription is significantly elevated with expression of the human sentrin/SUMO-specific protease (SENP1) in the androgen-sensitive human prostate cancer cell line (LNCaP). In situ hybridization studies indicated an elevation of SENP1 message in prostatic intraepithelial neoplasia and prostate cancer lesions as compared with normal prostate epithelia. This study aimed to delineate the mechanism for the regulation of SENP1 message and to determine the pathophysiological consequence of SENP1 induction with respect to prostate cancer. Real-time PCR confirmed the elevation of SENP1 mRNA in prostate cancer cells as compared with normal prostate epithelial cells. Chronic androgen exposure of LNCaP cells prompted an enhancement in the SENP1 transcript selectively. This androgen-mediated augmentation of SENP1 was absent with co-administration of the androgen receptor antagonist bicalutamide and in androgen receptor-negative prostate cancer PC-3 cells, indicating an androgen receptor-dependent event. Activation of the androgen receptor was required for binding an identified androgen response element and positively regulating SENP1 promoter activity. Abrogation of elevated SENP1 mRNA in prostate cancer cells significantly decreased androgen-mediated cell growth. Because increased SENP1 expression directly modulated androgen receptor-dependent cell proliferation and transcription, SENP1 could play an important role in prostate carcinogenesis.	[Wang, Zhengxin; Yeh, Edward T. H.] Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA; [Bawa-Khalfe, Tasneem; Yeh, Edward T. H.] Univ Texas Hlth Sci Ctr, Res Ctr Cardiovasc Dis, Brown Fdn Inst Mol Med Prevent Human Dis, Houston, TX 77030 USA; [Cheng, Jinke; Yeh, Edward T. H.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Yeh, ETH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Cardiol, 1515 Holcombe Blvd,Unit 449, Houston, TX 77030 USA.	etyeh@mdanderson.org			NCI NIH HHS [F32 CA110620] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA110620] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Burnstein KL, 2005, J CELL BIOCHEM, V95, P657, DOI 10.1002/jcb.20460; Callewaert L, 2004, MOL ENDOCRINOL, V18, P1438, DOI 10.1210/me.2003-0313; Chauchereau A, 2003, J BIOL CHEM, V278, P12335, DOI 10.1074/jbc.M207148200; Chen Y, 1998, ONCOGENE, V16, P1913, DOI 10.1038/sj.onc.1201719; Cheng JK, 2006, NEOPLASIA, V8, P667, DOI 10.1593/neo.06445; Cheng JK, 2005, J BIOL CHEM, V280, P14492, DOI 10.1074/jbc.M412185200; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; Claessens F, 2001, J STEROID BIOCHEM, V76, P23, DOI 10.1016/S0960-0760(00)00154-0; Comstock CES, 2007, BRIT J CANCER, V96, P970, DOI 10.1038/sj.bjc.6603615; David G, 2002, J BIOL CHEM, V277, P23658, DOI 10.1074/jbc.M203690200; Dehm SM, 2005, EXPERT REV ANTICANC, V5, P63, DOI 10.1586/14737140.5.1.63; Drobnjak M, 2000, CLIN CANCER RES, V6, P1891; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Gong LM, 1997, J BIOL CHEM, V272, P28198, DOI 10.1074/jbc.272.45.28198; Gong LM, 1999, FEBS LETT, V448, P185, DOI 10.1016/S0014-5793(99)00367-1; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; Halkidou K, 2003, ONCOGENE, V22, P2466, DOI 10.1038/sj.onc.1206342; He Y, 2007, CANCER RES, V67, P8188, DOI 10.1158/0008-5472.CAN-07-0418; Heemers HV, 2007, CANCER RES, V67, P3422, DOI 10.1158/0008-5472.CAN-06-2836; Jacques C, 2005, J CLIN ENDOCR METAB, V90, P2314, DOI 10.1210/jc.2004-1337; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Liu GZ, 2003, J BIOL CHEM, V278, P14956, DOI 10.1074/jbc.M212229200; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Nelson CC, 1999, MOL ENDOCRINOL, V13, P2090, DOI 10.1210/me.13.12.2090; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; Reid KJ, 2001, J BIOL CHEM, V276, P2943, DOI 10.1074/jbc.M009170200; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Richter E, 2007, PROSTATE CANCER P D, V10, P114, DOI 10.1038/sj.pcan.4500936; Scherr D, 2003, UROLOGY, V61, P14, DOI 10.1016/S0090-4295(02)02395-6; Sentis S, 2005, MOL ENDOCRINOL, V19, P2671, DOI 10.1210/me.2005-0042; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Shen LN, 2006, BIOCHEM J, V397, P279, DOI 10.1042/BJ20052030; Stacey DW, 2003, CURR OPIN CELL BIOL, V15, P158, DOI 10.1016/S0955-0674(03)00008-5; Stanbrough M, 2001, P NATL ACAD SCI USA, V98, P10823, DOI 10.1073/pnas.191235898; Wang Chenguang, 2004, Cancer Treat Res, V119, P217; Wu Q, 2004, J MOL ENDOCRINOL, V32, P595, DOI 10.1677/jme.0.0320595; Yamaguchi T, 2005, MOL CELL BIOL, V25, P5171, DOI 10.1128/MCB.25.12.5171-5182.2005; Yamashita D, 2004, GENES CELLS, V9, P1017, DOI 10.1111/j.1365-2443.2004.00786.x; Zhang LQ, 2003, CANCER RES, V63, P4552	43	68	77	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37341	37349		10.1074/jbc.M706978200	http://dx.doi.org/10.1074/jbc.M706978200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17932034	hybrid			2022-12-25	WOS:000251833600008
J	Jun, DJ; Kim, J; Jung, SY; Song, R; Noh, JH; Park, YS; Ryu, SH; Kim, JH; Kong, YY; Chung, JM; Kim, KT				Jun, Dong-Jae; Kim, Jaeyoon; Jung, Sang-Yong; Song, Ran; Noh, Ji-Hyun; Park, Yong-Soo; Ryu, Sung-Ho; Kim, Joung-Hun; Kong, Young-Yun; Chung, Jun-Mo; Kim, Kyong-Tai			Extracellular ATP mediates necrotic cell swelling in SN4741 dopaminergic neurons through P2X(7) receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALA POLYMORPHISM; ACTIVATION; RELEASE; APOPTOSIS; DEATH; IMPAIRS; NEUROPROTECTION; DIFFERENTIATION; ANTAGONISTS; MODULATION	Extracellular ATP has recently been identified as an important regulator of cell death in response to pathological insults. When SN4741 cells, which are dopaminergic neurons derived from the substantia nigra of transgenic mouse embryos, are exposed to ATP, cell death occurs. This cell death is associated with prominent cell swelling, loss of ER integrity, the formation of many large cytoplasmic vacuoles, and subsequent cytolysis and DNA release. In addition, the cleavage of caspase-3, a hallmark of apoptosis, is induced by ATP treatment. However, caspase inhibitors do not overcome ATP-induced cell death, indicating that both necrosis and apoptosis are associated with ATP-induced cell death and suggesting that a necrotic event might override the apoptotic process. In this study we also found that P2X(7) receptors (P2X(7)Rs) are abundantly expressed in SN4741 cells, and both ATP-induced swelling and cell death are reversed by pretreatment with the P2X(7)Rs antagonist, KN62, or by knock-down of P2X(7)Rs with small interfering RNAs. Therefore, extracellular ATP release from injured tissues may act as an accelerating factor in necrotic SN4741 dopaminergic cell death via P2X(7)Rs.	[Jun, Dong-Jae; Kim, Jaeyoon; Jung, Sang-Yong; Song, Ran; Park, Yong-Soo; Ryu, Sung-Ho; Kim, Joung-Hun; Kong, Young-Yun; Kim, Kyong-Tai] Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Pohang 790784, South Korea; [Noh, Ji-Hyun; Chung, Jun-Mo] Ewha Womans Univ, Coll Nat Sci, Dept Life Sci, Seoul 20750, South Korea	Pohang University of Science & Technology (POSTECH); Ewha Womans University	Kim, KT (corresponding author), POSTECH, Dept Life Sci, San-31,Hyoja-Dong,Nam-Gu, Pohang 790784, South Korea.	ktk@postech.ac.kr	Park, Yongsoo/G-9285-2014	Park, Yongsoo/0000-0001-8336-8051; Ryu, Sung Ho/0000-0003-0913-3048; KIM, KYONG-TAI/0000-0001-7292-2627				Adriouch S, 2002, J IMMUNOL, V169, P4108, DOI 10.4049/jimmunol.169.8.4108; Amadio S, 2002, NEUROPHARMACOLOGY, V42, P489, DOI 10.1016/S0028-3908(01)00197-6; Anderson CM, 2006, TRENDS NEUROSCI, V29, P257, DOI 10.1016/j.tins.2006.03.003; Armstrong JN, 2002, J NEUROSCI, V22, P5938; Banfi C, 2005, J MOL CELL CARDIOL, V39, P929, DOI 10.1016/j.yjmcc.2005.09.002; Baraldi PG, 2004, CURR TOP MED CHEM, V4, P1707, DOI 10.2174/1568026043387223; Beigi R, 1999, AM J PHYSIOL-CELL PH, V276, pC267, DOI 10.1152/ajpcell.1999.276.1.C267; Cavaliere F, 2005, NEUROBIOL DIS, V18, P100, DOI 10.1016/j.nbd.2004.09.001; Colomar A, 2003, J BIOL CHEM, V278, P30732, DOI 10.1074/jbc.M304534200; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Deuchars SA, 2001, J NEUROSCI, V21, P7143, DOI 10.1523/JNEUROSCI.21-18-07143.2001; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; DIVIRGILIO F, 1988, BIOCHEM J, V256, P959, DOI 10.1042/bj2560959; Duan SM, 2003, J NEUROSCI, V23, P1320, DOI 10.1523/JNEUROSCI.23-04-01320.2003; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; FILIPPINI A, 1990, P NATL ACAD SCI USA, V87, P8267, DOI 10.1073/pnas.87.21.8267; Formigli L, 2000, J CELL PHYSIOL, V182, P41, DOI 10.1002/(SICI)1097-4652(200001)182:1<41::AID-JCP5>3.0.CO;2-7; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gu B, 1998, BLOOD, V92, P946; Gu BJ, 2004, J BIOL CHEM, V279, P31287, DOI 10.1074/jbc.M313902200; Gu BJ, 2001, J BIOL CHEM, V276, P11135, DOI 10.1074/jbc.M010353200; Humphreys BD, 1998, MOL PHARMACOL, V54, P22, DOI 10.1124/mol.54.1.22; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; Le Feuvre R, 2002, EUR J PHARMACOL, V447, P261, DOI 10.1016/S0014-2999(02)01848-4; Le Stunff H, 2004, J BIOL CHEM, V279, P16918, DOI 10.1074/jbc.M313064200; Lee H, 2005, J BIOL CHEM, V280, P28556, DOI 10.1074/jbc.M411253200; Liang LH, 2005, AM J PHYSIOL-CELL PH, V288, pC240, DOI 10.1152/ajpcell.00532.2004; Mackenzie AB, 2005, J BIOL CHEM, V280, P33968, DOI 10.1074/jbc.M502705200; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Marcus AJ, 2003, J PHARMACOL EXP THER, V305, P9, DOI 10.1124/jpet.102.043729; MINTA A, 1989, J BIOL CHEM, V264, P19449; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Morale MC, 2006, NEUROSCIENCE, V138, P869, DOI 10.1016/j.neuroscience.2005.07.060; MURGIA M, 1993, J BIOL CHEM, V268, P8199; Namgung U, 2000, J NEUROSCI, V20, P6442, DOI 10.1523/JNEUROSCI.20-17-06442.2000; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Okada Y, 2001, J PHYSIOL-LONDON, V532, P3, DOI 10.1111/j.1469-7793.2001.0003g.x; Park YS, 2006, ENDOCRINOLOGY, V147, P1349, DOI 10.1210/en.2005-0959; PEARSON JD, 1979, NATURE, V281, P384, DOI 10.1038/281384a0; Robson SC, 1997, J EXP MED, V185, P153, DOI 10.1084/jem.185.1.153; Sluyter R, 2004, J IMMUNOL, V172, P3399, DOI 10.4049/jimmunol.172.6.3399; Solini A, 2007, AM J PHYSIOL-RENAL, V292, pF1537, DOI 10.1152/ajprenal.00440.2006; Son JH, 1999, J NEUROSCI, V19, P10, DOI 10.1523/JNEUROSCI.19-01-00010.1999; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Torres GE, 1999, J BIOL CHEM, V274, P6653, DOI 10.1074/jbc.274.10.6653; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Virginio C, 1997, NEUROPHARMACOLOGY, V36, P1285, DOI 10.1016/S0028-3908(97)00141-X; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Wiley JS, 2003, J BIOL CHEM, V278, P17108, DOI 10.1074/jbc.M212759200; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Zeng YS, 2000, NEUROSCI RES, V37, P113, DOI 10.1016/S0168-0102(00)00107-3; Zholos A, 2005, J GEN PHYSIOL, V125, P197, DOI 10.1085/jgp.200409161	54	67	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37350	37358		10.1074/jbc.M707915200	http://dx.doi.org/10.1074/jbc.M707915200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17962183	hybrid			2022-12-25	WOS:000251833600009
J	Jurkowski, TP; Anspach, N; Kulishova, L; Nellen, W; Jeltsch, A				Jurkowski, Tomasz P.; Anspach, Nils; Kulishova, Liliya; Nellen, Wolfgang; Jeltsch, Albert			The M.EcoRV DNA-(adenine N-6)-methyltransferase uses DNA bending for recognition of an expanded EcoDam recognition site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-SPECIFIC RECOGNITION; SCANNING FORCE MICROSCOPY; DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; ADENINE METHYLTRANSFERASE; MODIFICATION METHYLASE; ECORV; BINDING; ENZYME; RESTRICTION	The M. EcoRV DNA methyltransferase recognizes GATATC sites. It is related to EcoDam, which methylates GATC sites. The DNA binding domain of M. EcoRV is similar to that of EcoDam suggesting a similar mechanism of DNA recognition. We show that amino acid residue Lys(11) of M. EcoRV is involved in recognition of Gua(1) and Arg(128) contacts the Gua in base pair 6. These residues correspond to Lys(9) and Arg(124) in EcoDam, which recognize the Gua residues in both strands of the Dam recognition sequence, indicating that M. EcoRV and EcoDam make similar contacts to outermost base pairs of their recognition sequences and M. EcoRV recognizes its target site as an expanded GATC site. In contrast to EcoDam, M. EcoRV considerably bends the DNA (59 +/- 4 degrees) suggesting indirect readout of the AT-rich inner sequence. Recognition of an expanded target site by DNA bending is a new principle for changing DNA recognition specificity of proteins during molecular evolution. R128A is inefficient in DNA bending and binding, whereas K11A bends DNA with relaxed sequence specificity. These results suggest a temporal order of the formation of protein-DNA contacts in which the Gua(6)-Arg(128) contact forms early followed by DNA bending and, finally, the formation of the Lys(11)-Gua(1) contact.	[Jurkowski, Tomasz P.; Jeltsch, Albert] Jacobs Univ, Sch Sci & Engn, Biochem Lab, D-28759 Bremen, Germany; [Kulishova, Liliya] Jacobs Univ, Sch Sci & Engn, BioRec Program, D-28759 Bremen, Germany; [Anspach, Nils; Nellen, Wolfgang] Univ Kassel, Genet Abt, CINSaT, D-34132 Kassel, Germany	Jacobs University; Jacobs University; Universitat Kassel	Jeltsch, A (corresponding author), Jacobs Univ, Sch Sci & Engn, Biochem Lab, Campus Ring 1, D-28759 Bremen, Germany.	a.jeltsch@jacobs-university.de	Kulishova, Liliya/M-8942-2016; Kulishova, Liliya/AAE-8903-2019; Jeltsch, Albert/O-7404-2014	Kulishova, Liliya/0000-0003-2077-564X; Kulishova, Liliya/0000-0003-2077-564X; Jeltsch, Albert/0000-0001-6113-9290; Jurkowski, Tomasz/0000-0002-2012-0240				Allan BW, 1999, J BIOL CHEM, V274, P19269, DOI 10.1074/jbc.274.27.19269; Beck C, 2002, BIOCHEMISTRY-US, V41, P14103, DOI 10.1021/bi025979a; Beck C, 2001, BIOCHEMISTRY-US, V40, P10956, DOI 10.1021/bi0155450; Bonin M, 2001, BIOL CHEM, V382, P1157, DOI 10.1515/BC.2001.145; Bonin M, 2000, RNA, V6, P563, DOI 10.1017/S1355838200992318; Cal S, 1997, J BIOL CHEM, V272, P490; Cal S, 1996, J BIOL CHEM, V271, P1008, DOI 10.1074/jbc.271.2.1008; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; CHENG XD, 1995, ANNU REV BIOPH BIOM, V24, P293, DOI 10.1146/annurev.bb.24.060195.001453; Dubey AK, 1997, NUCLEIC ACIDS RES, V25, P2025, DOI 10.1093/nar/25.10.2025; Fersht A., 1999, STRUCTURE MECH PROTE; Friedrich T, 1998, BIOL CHEM, V379, P475, DOI 10.1515/bchm.1998.379.4-5.475; Garcia RA, 1996, P NATL ACAD SCI USA, V93, P7618, DOI 10.1073/pnas.93.15.7618; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; Gowher H, 2000, J MOL BIOL, V303, P93, DOI 10.1006/jmbi.2000.4127; HAGERMAN PJ, 1990, ANNU REV BIOCHEM, V59, P755, DOI 10.1146/annurev.biochem.59.1.755; Horton JR, 2005, CELL, V121, P349, DOI 10.1016/j.cell.2005.02.021; Jeltsch A, 1998, J MOL BIOL, V275, P747, DOI 10.1006/jmbi.1997.1492; Jeltsch A, 1999, J MOL BIOL, V285, P1121, DOI 10.1006/jmbi.1998.2389; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; Jeltsch Albert, 2002, Methods Mol Biol, V182, P85; Klaue Y, 2003, RNA, V9, P839, DOI 10.1261/rna.2167603; LAUSTER R, 1987, FEBS LETT, V220, P167, DOI 10.1016/0014-5793(87)80897-9; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Liebert K, 2007, J BIOL CHEM, V282, P22848, DOI 10.1074/jbc.M700926200; NWOSU VU, 1988, NUCLEIC ACIDS RES, V16, P3705, DOI 10.1093/nar/16.9.3705; Pingoud A, 2001, NUCLEIC ACIDS RES, V29, P3705, DOI 10.1093/nar/29.18.3705; Rasko T, 2000, NUCLEIC ACIDS RES, V28, P3083, DOI 10.1093/nar/28.16.3083; Roth M, 1998, J BIOL CHEM, V273, P17333, DOI 10.1074/jbc.273.28.17333; Roth M, 2000, BIOL CHEM, V381, P269, DOI 10.1515/BC.2000.035; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Singer B, 1997, CHEM RES TOXICOL, V10, P713, DOI 10.1021/tx970011e; STOVER T, 1993, J BIOL CHEM, V268, P8645; Surby MA, 1996, BIOCHEMISTRY-US, V35, P2201, DOI 10.1021/bi951883n; SZCZELKUN MD, 1995, BIOCHEMISTRY-US, V34, P10724, DOI 10.1021/bi00034a004; TRAVERS AA, 1989, ANNU REV BIOCHEM, V58, P427, DOI 10.1146/annurev.biochem.58.1.427; Urig S, 2002, J MOL BIOL, V319, P1085, DOI 10.1016/S0022-2836(02)00371-6; WINKLER FK, 1993, EMBO J, V12, P1781, DOI 10.1002/j.1460-2075.1993.tb05826.x; Yang Z, 2003, NAT STRUCT BIOL, V10, P849, DOI 10.1038/nsb973	39	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36942	36952		10.1074/jbc.M706933200	http://dx.doi.org/10.1074/jbc.M706933200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17977824	hybrid			2022-12-25	WOS:000251646000020
J	Thakur, AS; Robin, G; Guncar, G; Saunders, NFW; Newman, J; Martin, JL; Kobe, B				Thakur, Anil S.; Robin, Gautier; Guncar, Gregor; Saunders, Neil F. W.; Newman, Janet; Martin, Jennifer L.; Kobe, Bostjan			Improved Success of Sparse Matrix Protein Crystallization Screening with Heterogeneous Nucleating Agents	PLOS ONE			English	Article								Background. Crystallization is a major bottleneck in the process of macromolecular structure determination by X-ray crystallography. Successful crystallization requires the formation of nuclei and their subsequent growth to crystals of suitable size. Crystal growth generally occurs spontaneously in a supersaturated solution as a result of homogenous nucleation. However, in a typical sparse matrix screening experiment, precipitant and protein concentration are not sampled extensively, and supersaturation conditions suitable for nucleation are often missed. Methodology/Principal Findings. We tested the effect of nine potential heterogenous nucleating agents on crystallization of ten test proteins in a sparse matrix screen. Several nucleating agents induced crystal formation under conditions where no crystallization occurred in the absence of the nucleating agent. Four nucleating agents: dried seaweed; horse hair; cellulose and hydroxyapatite, had a considerable overall positive effect on crystallization success. This effect was further enhanced when these nucleating agents were used in combination with each other. Conclusions/Significance. Our results suggest that the addition of heterogeneous nucleating agents increases the chances of crystal formation when using sparse matrix screens.	[Thakur, Anil S.; Guncar, Gregor; Saunders, Neil F. W.; Martin, Jennifer L.; Kobe, Bostjan] Univ Queensland, Sch Mol & Microbial Sci, Brisbane, Qld, Australia; [Robin, Gautier; Martin, Jennifer L.; Kobe, Bostjan] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Robin, Gautier; Martin, Jennifer L.; Kobe, Bostjan] Univ Queensland, Australian Res Council ARC, Special Res Ctr Funct & Appl Genom, Brisbane, Qld, Australia; [Newman, Janet] Commonwealth Sci & Ind Res Org, Mol & Hlth Technol, Parkville, Vic, Australia	University of Queensland; University of Queensland; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Kobe, B (corresponding author), Univ Queensland, Sch Mol & Microbial Sci, Brisbane, Qld, Australia.	b.kobe@uq.edu.au	Newman, Janet M/D-1857-2011; Kobe, Bostjan/D-1292-2009; Saunders, Neil/B-5325-2010; Martin, Jennifer L./A-6039-2010	Newman, Janet M/0000-0003-2666-3219; Kobe, Bostjan/0000-0001-9413-9166; Saunders, Neil/0000-0003-2139-6107; Guncar, Gregor/0000-0003-4500-6951; Martin, Jennifer L./0000-0002-9225-8863	Australian Research Council (ARC)	Australian Research Council (ARC)(Australian Research Council)	Funding: This work was supported by an Australian Research Council (ARC) grant to JLM and BK. BK is an ARC Federation Fellow and a National Health and Medical Research Council (NHMRC) Honorary Research Fellow. JLM is an NHMRC Senior Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asherie N, 2004, METHODS, V34, P266, DOI 10.1016/j.ymeth.2004.03.028; Bergfors T, 2003, J STRUCT BIOL, V142, P66, DOI 10.1016/S1047-8477(03)00039-X; Bodenstaff ER, 2002, ACTA CRYSTALLOGR D, V58, P1901, DOI 10.1107/S0907444902016608; Cacciuto A, 2004, NATURE, V428, P404, DOI 10.1038/nature02397; Chayen NE, 2006, P NATL ACAD SCI USA, V103, P597, DOI 10.1073/pnas.0504860102; CHAYEN NE, 1990, J APPL CRYSTALLOGR, V23, P297, DOI 10.1107/S0021889890003260; Chayen NE, 2001, J MOL BIOL, V312, P591, DOI 10.1006/jmbi.2001.4995; D'Arcy A, 2003, ACTA CRYSTALLOGR D, V59, P1343, DOI 10.1107/S0907444903009430; D'Arcy A, 2007, ACTA CRYSTALLOGR D, V63, P550, DOI 10.1107/S0907444907007652; Dale GE, 2003, J STRUCT BIOL, V142, P88, DOI 10.1016/S1047-8477(03)00041-8; EDWARDS AM, 1994, NAT STRUCT BIOL, V1, P195, DOI 10.1038/nsb0394-195; Fermani S, 2001, J CRYST GROWTH, V224, P327, DOI 10.1016/S0022-0248(01)00797-7; Georgieva DG, 2007, ACTA CRYSTALLOGR D, V63, P564, DOI 10.1107/S0907444907007810; Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001; HEMMING SA, 1995, J MOL BIOL, V246, P308, DOI 10.1006/jmbi.1994.0086; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; MCPHERSON A, 1988, SCIENCE, V239, P385, DOI 10.1126/science.239.4838.385; McPherson A, 2004, METHODS, V34, P254, DOI 10.1016/j.ymeth.2004.03.019; MCPHERSON A, 1987, J CRYST GROWTH, V85, P206, DOI 10.1016/0022-0248(87)90224-7; McPherson A., 1999, CRYSTALLIZATION BIOL; Pechkova E, 2002, J CELL BIOCHEM, V85, P243, DOI 10.1002/jcb.10123; PUNZI JS, 1991, J APPL CRYSTALLOGR, V24, P406, DOI 10.1107/S0021889891001644; Rong L, 2004, J SYNCHROTRON RADIAT, V11, P27, DOI 10.1107/S0909049503023525; Sanjoh A, 2001, J CRYST GROWTH, V232, P618, DOI 10.1016/S0022-0248(01)01057-0; Yoshizaki I, 2001, ACTA CRYSTALLOGR D, V57, P1621, DOI 10.1107/S0907444901013610	25	47	50	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1091	10.1371/journal.pone.0001091	http://dx.doi.org/10.1371/journal.pone.0001091			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971854	Green Submitted, Green Published, gold			2022-12-25	WOS:000207458700008
J	Cojoc, D; Difato, F; Ferrari, E; Shahapure, RB; Laishram, J; Righi, M; Di Fabrizio, EM; Torre, V				Cojoc, Dan; Difato, Francesco; Ferrari, Enrico; Shahapure, Rajesh B.; Laishram, Jummi; Righi, Massimo; Di Fabrizio, Enzo M.; Torre, Vincent			Properties of the Force Exerted by Filopodia and Lamellipodia and the Involvement of Cytoskeletal Components	PLOS ONE			English	Article								During neuronal differentiation, lamellipodia and filopodia explore the environment in search for the correct path to the axon's final destination. Although the motion of lamellipodia and filopodia has been characterized to an extent, little is known about the force they exert. In this study, we used optical tweezers to measure the force exerted by filopodia and lamellipodia with a millisecond temporal resolution. We found that a single filopodium exerts a force not exceeding 3 pN, whereas lamellipodia can exert a force up to 20 pN. Using metabolic inhibitors, we showed that no force is produced in the absence of actin polymerization and that development of forces larger than 3 pN requires microtubule polymerization. These results show that actin polymerization is necessary for force production and demonstrate that not only do neurons process information, but they also act on their environment exerting forces varying from tenths pN to tens of pN.	[Cojoc, Dan; Ferrari, Enrico; Di Fabrizio, Enzo M.] Ist Nazl Fis Mat, Lab Nazl Tecnol Avanzate & Nanosci TASC, CNR, Trieste, Italy; [Difato, Francesco; Shahapure, Rajesh B.; Laishram, Jummi; Righi, Massimo; Torre, Vincent] Int Sch Adv Studies SISSA ISAS, Trieste, Italy; [Di Fabrizio, Enzo M.] Magna Graecia Univ Catanzaro, Catanzaro, Italy; [Cojoc, Dan] CBM, LANADA Lab, Trieste, Italy; [Torre, Vincent] Int Sch Adv Studies, Italian Inst Technol, Unit, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Padua; International School for Advanced Studies (SISSA); Magna Graecia University of Catanzaro; International School for Advanced Studies (SISSA); Istituto Italiano di Tecnologia - IIT	Cojoc, D (corresponding author), Ist Nazl Fis Mat, Lab Nazl Tecnol Avanzate & Nanosci TASC, CNR, Area Sci Pk Basovizza, Trieste, Italy.	cojoc@tasc.infm.it; torre@sissa.it	Ferrari, Enrico/N-2400-2019	Ferrari, Enrico/0000-0002-9102-7422; difato, francesco/0000-0001-6404-588X	EU [NEURO, BINASP]; Italian Government [FIRB]; CIPE/FVG [GRAND]	EU(European Commission); Italian Government; CIPE/FVG	This work was partially supported by the EU grants NEURO and BINASP, by a FIRB grant from the Italian Government and by the GRAND grant from CIPE/FVG.	ALETTA JM, 1988, J NEUROSCI, V8, P1425; Ashkin A, 1997, P NATL ACAD SCI USA, V94, P4853, DOI 10.1073/pnas.94.10.4853; Atilgan E, 2006, BIOPHYS J, V90, P65, DOI 10.1529/biophysj.105.071480; Bayer MW, 2007, J COMP NEUROL, V500, P850, DOI 10.1002/cne.21228; BOVOLENTA P, 1987, J NEUROSCI, V7, P1447; BRAY D, 1978, P NATL ACAD SCI USA, V75, P5226, DOI 10.1073/pnas.75.10.5226; Bustamante C, 2000, NAT REV MOL CELL BIO, V1, P130, DOI 10.1038/35040072; Cojoc D, 2004, JPN J APPL PHYS 1, V43, P3910, DOI 10.1143/JJAP.43.3910; DAI JW, 1995, BIOPHYS J, V68, P988, DOI 10.1016/S0006-3495(95)80274-2; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; du Roure O, 2005, P NATL ACAD SCI USA, V102, P2390, DOI 10.1073/pnas.0408482102; Dufresne ER, 2001, REV SCI INSTRUM, V72, P1810, DOI 10.1063/1.1344176; Footer MJ, 2007, P NATL ACAD SCI USA, V104, P2181, DOI 10.1073/pnas.0607052104; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Gallo G, 2000, J NEUROBIOL, V44, P159, DOI 10.1002/1097-4695(200008)44:2<159::AID-NEU6>3.0.CO;2-H; Ghashghaei HT, 2007, NAT REV NEUROSCI, V8, P141, DOI 10.1038/nrn2074; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Gittes F, 1998, OPT LETT, V23, P7, DOI 10.1364/OL.23.000007; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; GOMEZ TM, 1994, J NEUROSCI, V14, P5959; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; Grunwald IC, 2002, CURR OPIN NEUROBIOL, V12, P250, DOI 10.1016/S0959-4388(02)00323-9; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Howard J., 2001, MECH MOTOR PROTEINS; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Liu AP, 2006, BIOPHYS J, V91, P4064, DOI 10.1529/biophysj.106.090852; Marcy Y, 2004, P NATL ACAD SCI USA, V101, P5992, DOI 10.1073/pnas.0307704101; Mogilner A, 2006, CURR OPIN CELL BIOL, V18, P32, DOI 10.1016/j.ceb.2005.11.001; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Mongiu AK, 2007, J CELL SCI, V120, P1113, DOI 10.1242/jcs.03384; Myers KA, 2006, NEUROSCIENTIST, V12, P107, DOI 10.1177/1073858405283428; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Pralle A, 1999, MICROSC RES TECHNIQ, V44, P378, DOI 10.1002/(SICI)1097-0029(19990301)44:5<378::AID-JEMT10>3.0.CO;2-Z; Prass M, 2006, J CELL BIOL, V174, P767, DOI 10.1083/jcb.200601159; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Solecki DJ, 2006, J NEUROSCI, V26, P10624, DOI 10.1523/JNEUROSCI.4060-06.2006; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164	43	107	108	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1072	10.1371/journal.pone.0001072	http://dx.doi.org/10.1371/journal.pone.0001072			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957254	Green Published, gold, Green Submitted			2022-12-25	WOS:000207458500017
J	Wang, Y; Barbacioru, CC; Shiffman, D; Balasubramanian, S; Iakoubova, O; Tranquilli, M; Albornoz, G; Blake, J; Mehmet, NN; Ngadimo, D; Poulter, K; Chan, F; Samaha, RR; Elefteriades, JA				Wang, Yulei; Barbacioru, Catalin C.; Shiffman, Dov; Balasubramanian, Sriram; Iakoubova, Olga; Tranquilli, Maryann; Albornoz, Gonzalo; Blake, Julie; Mehmet, Necip N.; Ngadimo, Dewi; Poulter, Karen; Chan, Frances; Samaha, Raymond R.; Elefteriades, John A.			Gene Expression Signature in Peripheral Blood Detects Thoracic Aortic Aneurysm	PLOS ONE			English	Article								Background. Thoracic aortic aneurysm (TAA) is usually asymptomatic and associated with high mortality. Adverse clinical outcome of TAA is preventable by elective surgical repair; however, identifying at-risk individuals is difficult. We hypothesized that gene expression patterns in peripheral blood cells may correlate with TAA disease status. Our goal was to identify a distinct gene expression signature in peripheral blood that may identify individuals at risk for TAA. Methods and Findings. Whole genome gene expression profiles from 94 peripheral blood samples (collected from 58 individuals with TAA and 36 controls) were analyzed. Significance Analysis of Microarray (SAM) identified potential signature genes characterizing TAA vs. normal, ascending vs. descending TAA, and sporadic vs. familial TAA. Using a training set containing 36 TAA patients and 25 controls, a 41-gene classification model was constructed for detecting TAA status and an overall accuracy of 78+/-66% was achieved. Testing this classifier on an independent validation set containing 22 TAA samples and 11 controls yielded an overall classification accuracy of 78%. These 41 classifier genes were further validated by TaqMan (R) real-time PCR assays. Classification based on the TaqMan (R) data replicated the microarray results and achieved 80% classification accuracy on the testing set. Conclusions. This study identified informative gene expression signatures in peripheral blood cells that can characterize TAA status and subtypes of TAA. Moreover, a 41-gene classifier based on expression signature can identify TAA patients with high accuracy. The transcriptional programs in peripheral blood leading to the identification of these markers also provide insights into the mechanism of development of aortic aneurysms and highlight potential targets for therapeutic intervention. The classifier genes identified in this study, and validated by TaqMan (R) real-time PCR, define a set of promising potential diagnostic markers, setting the stage for a blood-based gene expression test to facilitate early detection of TAA.	[Wang, Yulei; Barbacioru, Catalin C.; Blake, Julie; Mehmet, Necip N.; Poulter, Karen; Chan, Frances; Samaha, Raymond R.] Appl Biosyst Inc, Foster City, CA 94404 USA; [Shiffman, Dov; Iakoubova, Olga] Celera, Alameda, CA USA; [Balasubramanian, Sriram; Ngadimo, Dewi] Celera Genom, San Francisco, CA USA; [Tranquilli, Maryann; Albornoz, Gonzalo; Elefteriades, John A.] Yale Univ, Sch Med, Sect Cardiothorac Surg, New Haven, CT USA	Thermo Fisher Scientific; Applied Biosystems; Yale University	Samaha, RR (corresponding author), Appl Biosyst Inc, 850 Lincoln Ctr Dr, Foster City, CA 94404 USA.	Raymond.Samaha@appliedbiosystems.com; john.elefteriades@yale.edu		Wang, Yulei/0000-0002-9057-9786	Yale University School of Medicine; Applied Biosystems; Celera	Yale University School of Medicine; Applied Biosystems; Celera	This work was supported by Yale University School of Medicine, Applied Biosystems and Celera.	Achiron A, 2004, Clin Dev Immunol, V11, P299, DOI 10.1080/17402520400001603; Achiron A, 2004, ANN NEUROL, V55, P410, DOI 10.1002/ana.20008; Albornoz G, 2006, ANN THORAC SURG, V82, P1400, DOI 10.1016/j.athoracsur.2006.04.098; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Baranzini SE, 2005, PLOS BIOL, V3, P166, DOI 10.1371/journal.pbio.0030002; Batliwalla FM, 2005, GENES IMMUN, V6, P388, DOI 10.1038/sj.gene.6364209; Bomprezzi R, 2003, HUM MOL GENET, V12, P2191, DOI 10.1093/hmg/ddg221; Chittenden TW, 2006, CIRCULATION, V114, P1811, DOI 10.1161/CIRCULATIONAHA.106.628396; Cho RJ, 2000, TRENDS GENET, V16, P409, DOI 10.1016/S0168-9525(00)02065-5; Coady MA, 1997, J THORAC CARDIOV SUR, V113, P476, DOI 10.1016/S0022-5223(97)70360-X; Coady MA, 1999, ARCH SURG-CHICAGO, V134, P361, DOI 10.1001/archsurg.134.4.361; Curci JA, 2004, J CLIN INVEST, V114, P168, DOI 10.1172/JCI200422309; DAPUNT OE, 1994, ANN THORAC SURG, V58, P689, DOI 10.1016/0003-4975(94)90729-3; Davis VA, 2001, J SURG RES, V101, P152, DOI 10.1006/jsre.2001.6281; Dawson J, 2007, J VASC SURG, V45, P350, DOI 10.1016/j.jvs.2006.09.049; Efron B., 1994, INTRO BOOTSTRAP; Guo DC, 2001, CIRCULATION, V103, P2461; Hasham SN, 2004, ANN EMERG MED, V43, P79, DOI 10.1016/S0196-0644(03)00818-7; Hasham SN, 2003, CIRCULATION, V107, P3184, DOI 10.1161/01.CIR.0000078634.33124.95; Henderson EL, 1999, CIRCULATION, V99, P96, DOI 10.1161/01.CIR.99.1.96; Huber TS, 2000, SHOCK, V13, P425, DOI 10.1097/00024382-200006000-00002; Ivanov VN, 2002, J BIOL CHEM, V277, P4932, DOI 10.1074/jbc.M108233200; Kakko S, 2003, J THORAC CARDIOV SUR, V126, P106, DOI 10.1016/S0022-5223(03)00037-0; Koullias G, 2005, J THORAC CARDIOV SUR, V130, P677, DOI 10.1016/j.jtcvs.2005.02.052; Koullias GJ, 2004, ANN THORAC SURG, V78, P2106, DOI 10.1016/j.athoracsur.2004.05.088; Lin CL, 2006, NEUROL RES, V28, P721, DOI 10.1179/016164106X152007; Ma J, 2003, J MOL CELL CARDIOL, V35, P993, DOI 10.1016/S0022-2828(03)00179-2; Mandel M, 2004, CLIN EXP IMMUNOL, V138, P164, DOI 10.1111/j.1365-2249.2004.02587.x; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Middleton RK, 2007, J VASC SURG, V45, P574, DOI 10.1016/j.jvs.2006.11.020; Ocana E, 2003, ATHEROSCLEROSIS, V170, P39, DOI 10.1016/S0021-9150(03)00282-X; Oslund LJP, 1999, ARTERIOSCL THROM VAS, V19, P2847, DOI 10.1161/01.ATV.19.12.2847; Pan JH, 2003, J VASC SURG, V37, P628, DOI 10.1067/mva.2003.74; Patino WD, 2005, P NATL ACAD SCI USA, V102, P3423, DOI 10.1073/pnas.0408032102; Schonbeck U, 2002, AM J PATHOL, V161, P499, DOI 10.1016/S0002-9440(10)64206-X; Shimizu K, 2004, J CLIN INVEST, V114, P300, DOI 10.1172/JCI200419855; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Sorlie T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-127; Suhara T, 2002, MOL CELL BIOL, V22, P680, DOI 10.1128/MCB.22.2.680-691.2002; Tang PCY, 2005, FASEB J, V19, P1528, DOI 10.1096/fj.05-3671fje; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Timofeeva AV, 2006, ANN NY ACAD SCI, V1091, P319, DOI 10.1196/annals.1378.077; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uyemura K, 1996, J CLIN INVEST, V97, P2130, DOI 10.1172/JCI118650; Van Kien PK, 2005, CIRCULATION, V112, P200, DOI 10.1161/CIRCULATIONAHA.104.506345; Verschuren L, 2005, ANTIOXID REDOX SIGN, V7, P1195, DOI 10.1089/ars.2005.7.1195; Walton LJ, 1999, CIRCULATION, V100, P48, DOI 10.1161/01.CIR.100.1.48; Wung Shu-Fen, 2004, J Cardiovasc Nurs, V19, P409; Xiong WF, 2006, J VASC SURG, V44, P1061, DOI 10.1016/j.jvs.2006.06.036	49	69	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1050	10.1371/journal.pone.0001050	http://dx.doi.org/10.1371/journal.pone.0001050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940614	Green Published, gold, Green Submitted			2022-12-25	WOS:000207456100018
J	Arany, PR; Rane, SG; Roberts, AB				Arany, P. R.; Rane, S. G.; Roberts, A. B.			Smad3 deficiency inhibits v-ras-induced transformation by suppression of JNK MAPK signaling and increased farnesyl transferase inhibition	ONCOGENE			English	Article						TGF-beta 1; Smad3; JNK MAPK; Ras; malignant transformation; farnesyl transferase inhibition	GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX; KINASE; PROTEIN; GROWTH-FACTOR-BETA-1; PHOSPHORYLATION; MECHANISM; CELLS; OVEREXPRESSION; TRANSDUCTION	The ability of transforming growth factor-beta ( TGF- beta) to modulate various effects on distinct cell lineages has been a central feature of its multi- faceted nature. The purpose of this study was to access the effects of deletion of a key TGF- beta signal transducer, Smad3, on MAPK activation and v- Ras(Ha)- transformation of primary mouse embryonic. broblasts ( MEFs). We observe reduced TGF- beta 1 and v- ras(Ha) mediated activation of the JNK and ERK MAPK pathway upon ablation of Smad3. Further, Smad3-deficient MEFs demonstrate resistance to v- ras(Ha)- induced transformation while the absence of Smad3 results in increased inhibition of farnesyl transferase activity. Taken together, these observations demonstrate that the absence of Smad3 protects. broblasts from oncogenic transformation by ( i) augmenting farnesyl transferase inhibition and ( ii) suppressing the Ras - JNK MAPK pathway. These results provide new insights into the molecular mechanisms involved in v- Ras(Ha) oncogene- induced mesenchymal phenotypic transformation.	[Arany, P. R.; Rane, S. G.; Roberts, A. B.] NCI, NIH, Lab Cell Regulat & Carcinogenesis, Bethesda, MD 20892 USA; [Rane, S. G.] NIDDK, NIH, Diabet Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Arany, PR (corresponding author), Harvard Univ, Harvard Sch Dent Med, 188 Longwood Ave,REB 203, Boston, MA 02115 USA.	arany@fas.harvard.edu; ranes@mail.nih.gov	Arany, Praveen/S-5329-2019	Arany, Praveen/0000-0002-6116-2340	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK055107, ZIADK055107, Z01DK055106, ZIADK055106] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arany PR, 2006, P NATL ACAD SCI USA, V103, P9250, DOI 10.1073/pnas.0602473103; Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bost F, 1999, MOL CELL BIOL, V19, P1938; Brassard DL, 2002, EXP CELL RES, V273, P138, DOI 10.1006/excr.2001.5440; Byfield SD, 2004, TRENDS CELL BIOL, V14, P107; COX AD, 1992, MOL CELL BIOL, V12, P2606, DOI 10.1128/MCB.12.6.2606; COX AD, 1994, J BIOL CHEM, V269, P19203; Egeblad M, 2005, COLD SH Q B, V70, P383, DOI 10.1101/sqb.2005.70.007; FILMUS J, 1992, ONCOGENE, V7, P521; Fong LG, 2006, SCIENCE, V311, P1621, DOI 10.1126/science.1124875; Hayashida T, 2003, FASEB J, V17, P1576, DOI 10.1096/fj.03-0037fje; KATO K, 1992, P NATL ACAD SCI USA, V89, P6403, DOI 10.1073/pnas.89.14.6403; Kennedy NJ, 2003, GENE DEV, V17, P629, DOI 10.1101/gad.1062903; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Laping NJ, 2007, CLIN CANCER RES, V13, P3087, DOI 10.1158/1078-0432.CCR-06-1811; Lebowitz PF, 1998, ONCOGENE, V17, P1439, DOI 10.1038/sj.onc.1202175; Lehmann K, 2000, GENE DEV, V14, P2610, DOI 10.1101/gad.181700; MASSAGUE J, 1992, CELL, V69, P1067, DOI 10.1016/0092-8674(92)90627-O; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Matsuura I, 2005, BIOCHEMISTRY-US, V44, P12546, DOI 10.1021/bi050560g; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Park BJ, 2000, CANCER RES, V60, P3031; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Prendergast GC, 2001, NAT REV CANCER, V1, P162, DOI 10.1038/35101096; PRENDERGAST GC, 1994, MOL CELL BIOL, V14, P4193, DOI 10.1128/MCB.14.6.4193; Radisky DC, 2007, J CELL BIOCHEM, V101, P830, DOI 10.1002/jcb.21186; ROBERTS AB, 1980, P NATL ACAD SCI-BIOL, V77, P3494, DOI 10.1073/pnas.77.6.3494; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; ROOP DR, 1986, NATURE, V323, P822, DOI 10.1038/323822a0; Saha D, 2001, J BIOL CHEM, V276, P29531, DOI 10.1074/jbc.M100069200; Santibanez JF, 2003, INT J CANCER, V107, P715, DOI 10.1002/ijc.11457; Santibanez JF, 2002, FEBS LETT, V520, P171, DOI 10.1016/S0014-5793(02)02760-6; Sekimoto G, 2007, CANCER RES, V67, P5090, DOI 10.1158/0008-5472.CAN-06-4629; Ten Dijke Peter, 1994, Progress in Growth Factor Research, V5, P55, DOI 10.1016/0955-2235(94)90017-5; Ventura JJ, 2004, MOL CELL, V15, P269, DOI 10.1016/j.molcel.2004.06.007; Vijayachandra K, 2003, CANCER RES, V63, P3447; Wisdom R, 2005, ONCOGENE, V24, P7043, DOI 10.1038/sj.onc.1208870; Yamagata H, 2005, CANCER RES, V65, P157; Yoshida K, 2005, AM J PATHOL, V166, P1029, DOI 10.1016/S0002-9440(10)62324-3; Yue JB, 2001, PHARMACOL THERAPEUT, V91, P1, DOI 10.1016/S0163-7258(01)00143-7	44	15	16	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2008	27	17					2507	2512		10.1038/sj.onc.1210889	http://dx.doi.org/10.1038/sj.onc.1210889			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286KN	17952112				2022-12-25	WOS:000254844900016
J	Kivi, N; Greco, D; Auvinen, P; Auvinen, E				Kivi, N.; Greco, D.; Auvinen, P.; Auvinen, E.			Genes involved in cell adhesion, cell motility and mitogenic signaling are altered due to HPV 16 E5 protein expression	ONCOGENE			English	Article						HPV; papillomavirus; E5; microarray; cell adhesion; cell motility	HUMAN-PAPILLOMAVIRUS TYPE-16; GROWTH-FACTOR RECEPTOR; MATRIX METALLOPROTEINASES; CYCLE PROGRESSION; EPITHELIAL-CELLS; E7 GENE; TRANSFORMATION; IMMORTALIZATION; TRANSDUCTION; INVASION	We investigated the effects of the human papillomavirus type 16 E5 oncogene on cellular gene expression in human epithelial cells using cDNA microarray. In a genome-wide microarray assay, the expression of 179 genes was found to be significantly altered due to E5 expression. The expression of lamin A/C was downregulated at protein level. The expression of protein kinase C-delta and phosphoinositide-3-kinase proteins was found to be upregulated. We also observed increased motility of E5-expressing cells. We conclude that the E5 protein affects several cellular pathways involved in cell adhesion, cell motility and mitogenic signaling. These alterations may together lead to inhibition of apoptosis and facilitate the establishment of persistent infection in the epithelium.	[Kivi, N.; Auvinen, E.] Univ Helsinki, Haartman Inst, Dept Virol, FIN-00014 Helsinki, Finland; [Kivi, N.; Auvinen, E.] Univ Helsinki, Cent Hosp, FIN-00014 Helsinki, Finland; [Greco, D.; Auvinen, P.] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Kivi, N (corresponding author), Univ Helsinki, Haartman Inst, Dept Virol, PO 21,Haartmaninkatu 3, FIN-00014 Helsinki, Finland.	niina.kivi@helsinki.fi	Auvinen, Petri/AAP-8117-2021; Greco, Dario/T-7113-2019; Auvinen, Petri/D-5044-2009	Greco, Dario/0000-0001-9195-9003; Auvinen, Petri/0000-0002-3947-4778; Auvinen, Eeva/0000-0002-2094-985X				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Auvinen E, 2004, ARCH VIROL, V149, P1745, DOI 10.1007/s00705-004-0325-8; BAND V, 1990, P NATL ACAD SCI USA, V87, P463, DOI 10.1073/pnas.87.1.463; BOUVARD V, 1994, VIROLOGY, V203, P73, DOI 10.1006/viro.1994.1456; Bravo IG, 2005, ARCH VIROL, V150, P231, DOI 10.1007/s00705-004-0420-x; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Buness A, 2005, BIOINFORMATICS, V21, P554, DOI 10.1093/bioinformatics/bti052; Burgert HG, 2002, CURR TOP MICROBIOL, V269, P273; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; CASTRONOVO V, 1993, INVAS METAST, V13, P1; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chen SL, 1996, ARCH VIROL, V141, P791, DOI 10.1007/BF01718155; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; CONRAD M, 1993, J VIROL, V67, P6170, DOI 10.1128/JVI.67.10.6170-6178.1993; Czech MP, 2003, ANNU REV PHYSIOL, V65, P791, DOI 10.1146/annurev.physiol.65.092101.142522; DEMETER LM, 1992, CANCER RES, V52, P1561; DiMaio D, 1998, ANNU REV MICROBIOL, V52, P397, DOI 10.1146/annurev.micro.52.1.397; Duerst RJ, 2003, VIRAL IMMUNOL, V16, P475, DOI 10.1089/088282403771926300; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Fehrmann F, 2003, J VIROL, V77, P2819, DOI 10.1128/JVI.77.5.2819-2831.2003; Genther SM, 2003, J VIROL, V77, P2832, DOI 10.1128/JVI.77.5.2832-2842.2003; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; HALBERT CL, 1991, J VIROL, V65, P473, DOI 10.1128/JVI.65.1.473-478.1991; HAWLEYNELSON P, 1989, EMBO J, V8, P3905, DOI 10.1002/j.1460-2075.1989.tb08570.x; Hojilla CV, 2003, BRIT J CANCER, V89, P1817, DOI 10.1038/sj.bjc.6601327; Ivetac I, 2005, MOL BIOL CELL, V16, P2218, DOI 10.1091/mbc.e04-09-0799; Kim SH, 2006, CELL MOL LIFE SCI, V63, P930, DOI 10.1007/s00018-005-5561-x; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; LEECHANACHAI P, 1992, ONCOGENE, V7, P19; Leykauf K, 2004, J GEN VIROL, V85, P1427, DOI 10.1099/vir.0.79844-0; McCormack SJ, 1997, ONCOGENE, V15, P265, DOI 10.1038/sj.onc.1201186; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; MUNGER K, 1989, J VIROL, V63, P4417; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; O'Brien V, 1998, J GEN VIROL, V79, P1833, DOI 10.1099/0022-1317-79-8-1833; OELZE I, 1995, J VIROL, V69, P4489, DOI 10.1128/JVI.69.7.4489-4494.1995; PIM D, 1992, ONCOGENE, V7, P27; Pisani P, 2002, INT J CANCER, V97, P72, DOI 10.1002/ijc.1571; Rajeevan MS, 2001, J MOL DIAGN, V3, P26, DOI 10.1016/S1525-1578(10)60646-0; Sayama K, 2002, J BIOL CHEM, V277, P40390, DOI 10.1074/jbc.M112423200; Schreiber K, 2004, ONCOGENE, V23, P3972, DOI 10.1038/sj.onc.1207507; Shiomi T, 2003, CANCER METAST REV, V22, P145, DOI 10.1023/A:1023039230052; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stoppler MC, 1996, VIROLOGY, V223, P251, DOI 10.1006/viro.1996.0475; STRAIGHT SW, 1993, J VIROL, V67, P4521, DOI 10.1128/JVI.67.8.4521-4532.1993; Thomsen P, 1999, BBA-MOL CELL RES, V1452, P285, DOI 10.1016/S0167-4889(99)00132-9; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P10515; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; VALLE GF, 1995, J GEN VIROL, V76, P1239, DOI 10.1099/0022-1317-76-5-1239; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Werner JA, 2002, CLIN EXP METASTAS, V19, P275, DOI 10.1023/A:1015531319087; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; Williams SMG, 2005, CANCER RES, V65, P6534, DOI 10.1158/0008-5472.CAN-05-0083; Zhang BY, 2002, J VIROL, V76, P220, DOI 10.1128/JVI.76.1.220-231.2002	55	51	53	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2008	27	18					2532	2541		10.1038/sj.onc.1210916	http://dx.doi.org/10.1038/sj.onc.1210916			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	289LW	17982485				2022-12-25	WOS:000255057000003
J	Adriouch, S; Bannas, P; Schwarz, N; Fliegert, R; Guse, AH; Seman, M; Haag, F; Koch-Nolte, F				Adriouch, Sahil; Bannas, Peter; Schwarz, Nicole; Fliegert, Ralf; Guse, Andreas H.; Seman, Michel; Haag, Friedrich; Koch-Nolte, Friedrich			ADP-ribosylation at R125 gates the P2X7 ion channel by presenting a covalent ligand to its nucleotide binding site	FASEB JOURNAL			English	Article						post-translational modification; purinoceptors; ADP-ribosyltransferases; leukocyte ecto-enzymes	CELL-SURFACE-PROTEINS; P2X(7) RECEPTOR; BACTERIAL TOXINS; DIPHTHERIA-TOXIN; T-CELLS; ATP; RIBOSYLTRANSFERASE; PURINOCEPTOR; LYMPHOCYTES; ACTIVATION	ADP-ribosylation is a post-translational modification regulating protein function in which amino acid-specific ADP-ribosyltransferases (ARTs) transfer ADP-ribose from NAD onto specific target proteins. Attachment of the bulky ADP-ribose usually inactivates the target by sterically blocking its interaction with other proteins. P2X7, an ATP-gated ion channel with important roles in inflammation and cell death, in contrast, is activated by ADP-ribosylation. Here, we report the structural basis for this gating and present the first molecular model for the activation of a target protein by ADP-ribosylation. We demonstrate that the ecto-enzyme ART2.2 ADP-ribosylates P2X7 at arginine 125 in a prominent, cysteine-rich region at the interface of 2 receptor subunits. ADP-ribose shares an adenine-ribonculeotide moiety with ATP. Our results indicate that ADP-ribosylation of R125 positions this common chemical framework to fit into the nucleotide-binding site of P2X7 and thereby gates the channel.	[Adriouch, Sahil; Bannas, Peter; Schwarz, Nicole; Haag, Friedrich; Koch-Nolte, Friedrich] Univ Hamburg, Hosp Eppendorf, Ctr Diagnost, Inst Immunol, D-20246 Hamburg, Germany; [Fliegert, Ralf; Guse, Andreas H.] Univ Hamburg, Hosp Eppendorf, Inst Biochem & Mol Biol 1, D-20246 Hamburg, Germany; [Adriouch, Sahil; Seman, Michel] Univ Rouen, Fac Med & Pharm, INSERM, U 519, Rouen, France	University of Hamburg; University of Hamburg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie	Koch-Nolte, F (corresponding author), Univ Hamburg, Hosp Eppendorf, Ctr Diagnost, Inst Immunol, Martinistr 52, D-20246 Hamburg, Germany.	nolte@uke.uni-hamburg.de	ADRIOUCH, Sahil/G-8999-2012	ADRIOUCH, Sahil/0000-0002-0265-7773; Bannas, Peter/0000-0002-7102-534X; Koch-Nolte, Friedrich/0000-0003-1730-6674				Adriouch S, 2005, CELL IMMUNOL, V236, P72, DOI 10.1016/j.cellimm.2005.08.011; Adriouch S, 2002, J IMMUNOL, V169, P4108, DOI 10.4049/jimmunol.169.8.4108; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Aktories K, 2000, BACTERIAL PROTEIN TO; Bannas P, 2005, BLOOD, V105, P3663, DOI 10.1182/blood-2004-08-3325; Cabrini G, 2005, J IMMUNOL, V175, P82, DOI 10.4049/jimmunol.175.1.82; Clyne JD, 2002, J NEUROSCI, V22, P3873, DOI 10.1523/JNEUROSCI.22-10-03873.2002; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Corda D, 2003, EMBO J, V22, P1953, DOI 10.1093/emboj/cdg209; Coutinho-Silva R, 2003, IMMUNITY, V19, P403, DOI 10.1016/S1074-7613(03)00235-8; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Domenighini M, 1996, MOL MICROBIOL, V21, P667, DOI 10.1046/j.1365-2958.1996.321396.x; Ennion SJ, 2002, MOL PHARMACOL, V61, P303, DOI 10.1124/mol.61.2.303; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Ferrero E, 2000, CHEM IMMUNOL, V75, P1; Ganesan AK, 1999, J BIOL CHEM, V274, P9503, DOI 10.1074/jbc.274.14.9503; GRIMALDI JC, 1995, J IMMUNOL, V155, P811; Gudipaty L, 2003, AM J PHYSIOL-CELL PH, V285, pC286, DOI 10.1152/ajpcell.00070.2003; Haag F, 2007, PURINERG SIGNAL, V3, P71, DOI 10.1007/s11302-006-9038-7; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; HONJO T, 1968, J BIOL CHEM, V243, P3553; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; Kawamura H, 2005, J IMMUNOL, V174, P1971, DOI 10.4049/jimmunol.174.4.1971; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Koch-Nolte F, 1999, J IMMUNOL, V163, P6014; KochNolte F, 1996, J BIOL CHEM, V271, P7686, DOI 10.1074/jbc.271.13.7686; Krebs C, 2005, J IMMUNOL, V174, P3298, DOI 10.4049/jimmunol.174.6.3298; Kunerth S, 2003, CELL SIGNAL, V15, P783, DOI 10.1016/S0898-6568(03)00015-9; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; Lund FE, 1998, IMMUNOL REV, V161, P79, DOI 10.1111/j.1600-065X.1998.tb01573.x; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Margarit SM, 2006, STRUCTURE, V14, P1219, DOI 10.1016/j.str.2006.05.022; Moreschi I, 2006, J BIOL CHEM, V281, P31419, DOI 10.1074/jbc.M606625200; Mueller-Dieckmann C, 2002, J MOL BIOL, V322, P687, DOI 10.1016/S0022-2836(02)00818-5; Nagaya N, 2005, J BIOL CHEM, V280, P25982, DOI 10.1074/jbc.M504545200; Nemoto E, 1996, J IMMUNOL, V157, P3341; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Okazaki IJ, 1998, J BIOL CHEM, V273, P23617, DOI 10.1074/jbc.273.37.23617; Paone G, 2002, P NATL ACAD SCI USA, V99, P8231, DOI 10.1073/pnas.122238899; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Schuber F, 2004, CURR MOL MED, V4, P249, DOI 10.2174/1566524043360708; Seman M, 2003, IMMUNITY, V19, P571, DOI 10.1016/S1074-7613(03)00266-8; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Stojilkovic SS, 2005, ANN NY ACAD SCI, V1048, P116, DOI 10.1196/annals.1342.011; Sun JJ, 2004, NAT STRUCT MOL BIOL, V11, P868, DOI 10.1038/nsmb818; VANDEKERCKHOVE J, 1988, J BIOL CHEM, V263, P696; Vial C, 2004, TRENDS PHARMACOL SCI, V25, P487, DOI 10.1016/j.tips.2004.07.008; Yates SP, 2006, TRENDS BIOCHEM SCI, V31, P123, DOI 10.1016/j.tibs.2005.12.007; Young MT, 2007, MOL PHARMACOL, V71, P92, DOI 10.1124/mol.106.030163; ZANOVELLO P, 1990, J IMMUNOL, V145, P1545; Zolkiewska A, 2005, PHYSIOLOGY, V20, P374, DOI 10.1152/physiol.00028.2005	53	100	105	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2008	22	3					861	869		10.1096/fj.07-9294com	http://dx.doi.org/10.1096/fj.07-9294com			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17928361				2022-12-25	WOS:000254143700024
J	Bednarek, R; Boncela, J; Smolarczyk, K; Cierniewska-Cieslak, A; Wyroba, E; Cierniewski, CS				Bednarek, Radoslaw; Boncela, Joanna; Smolarczyk, Katarzyna; Cierniewska-Cieslak, Aleksandra; Wyroba, Elzbieta; Cierniewski, Czeslaw S.			Ku80 as a novel receptor for thymosin beta 4 that mediates its intracellular activity different from G-actin sequestering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; ENDOTHELIAL-CELLS; BETA-4 GENE; METASTASIS; BINDING; PROTEIN; AUTOANTIGEN; EXPRESSION; DNA; OVEREXPRESSION	Our data demonstrate that increased intracellular expression of thymosin beta 4 (T beta 4) is necessary and sufficient to induce plasminogen activator inhibitor type 1 (PAI-1) gene expression in endothelial cells. To describe the mechanism of this effect, we produced T beta 4 mutants with impaired functional motifs and tested their intracellular location and activity. Cytoplasmic distributions of T beta 4((AcSDKPT/4A)), T beta 4((KLKKTET/7A)), and T beta 4((K16A)) mutants fused with green fluorescent protein did not differ significantly from those of wild-type T beta 4. Overexpression of T beta 4, T beta 4((AcSDKPT/4A)), and T beta 4((K16A)) affected intracellular formation of actin filaments. As expected, T beta 4((K16A)) uptake by nuclei was impaired. On the other hand, overexpression of T beta 4((KLKKTET/7A)) resulted in developing the actin filament network typical of adhering cells, indicating that the mutant lacked the actin binding site. The mechanism by which intracellular T beta 4 induced the PAI-1 gene did not depend upon the N-terminal tetrapeptide AcSDKP and depended only partially on its ability to bind G-actin or enter the nucleus. Both T beta 4 and T beta 4((AcSDKPT/4A)) induced the PAI-1 gene to the same extent, whereas mutants T beta 4((KLKKTET/7A)) and T beta 4((K16A)) retained about 60% of the original activity. By proteomic analysis, the Ku80 subunit of ATP-dependent DNA helicase II was found to be associated with T beta 4. Ku80 and T beta 4 consistently co-immunoprecipitated in a complex from endothelial cells. Co-transfection of endothelial cells with the Ku80 deletion mutants and T beta 4 showed that the C-terminal arm domain of Ku80 is directly involved in this interaction. Furthermore, down-regulation of Ku80 by specific short interference RNA resulted in dramatic reduction in PAI-1 expression at the level of both mRNA and protein synthesis. These data suggest that Ku80 functions as a novel receptor for T beta 4 and mediates its intracellular activity.	[Cierniewska-Cieslak, Aleksandra; Cierniewski, Czeslaw S.] Med Univ Lodz, Dept Mol & Med Biophys, PL-92215 Lodz, Poland; [Bednarek, Radoslaw; Boncela, Joanna; Smolarczyk, Katarzyna; Cierniewski, Czeslaw S.] Polish Acad Sci, Ctr Med Biol, PL-93232 Lodz, Poland; [Wyroba, Elzbieta] Polish Acad Sci, M Nencki Inst Expt Biol, PL-02093 Warsaw, Poland	Medical University Lodz; Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Cierniewski, CS (corresponding author), Med Univ Lodz, Dept Mol & Med Biophys, 6-8 Mazowiecka St, PL-92215 Lodz, Poland.	cciern@zdn.am.lodz.pl	Bednarek, Radoslaw/AAC-9267-2019; Wyroba, Elzbieta/R-7525-2016; Boncela, Joanna/AAU-4481-2020; Bednarek, Radoslaw/Q-2649-2016; Wyroba, Elzbieta/P-4434-2019; Krol, Aleksandra/S-9277-2016	Bednarek, Radoslaw/0000-0003-4505-9498; Boncela, Joanna/0000-0001-8419-7012; Bednarek, Radoslaw/0000-0003-4505-9498; Krol, Aleksandra/0000-0003-0033-1099				Adam L, 2000, BIOCHEM BIOPH RES CO, V267, P692, DOI 10.1006/bbrc.1999.1978; Al-Nedawi KNI, 2004, BLOOD, V103, P1319, DOI 10.1182/blood-2003-04-1015; Bertinato J, 2003, GENE, V302, P53, DOI 10.1016/S0378111902010892; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Boncela J, 2006, J BIOL CHEM, V281, P1066, DOI 10.1074/jbc.M506303200; Bouis Diane, 2001, Angiogenesis, V4, P91, DOI 10.1023/A:1012259529167; Cha HJ, 2003, J NATL CANCER I, V95, P1674, DOI 10.1093/jnci/djg100; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Dierks H, 2001, J BIOL CHEM, V276, P37472, DOI 10.1074/jbc.M101502200; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; EMEIS JJ, 1988, BLOOD, V71, P1669; Ghosh RN, 2000, BIOTECHNIQUES, V29, P170, DOI 10.2144/00291pf01; Giffin W, 1996, NATURE, V380, P265, DOI 10.1038/380265a0; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; Golla R, 1997, CELL MOTIL CYTOSKEL, V38, P187, DOI 10.1002/(SICI)1097-0169(1997)38:2<187::AID-CM7>3.0.CO;2-4; Grant D S, 1999, Angiogenesis, V3, P125, DOI 10.1023/A:1009041911493; GRANT DS, 1995, J CELL SCI, V108, P3685; GRILLON C, 1990, FEBS LETT, V274, P30, DOI 10.1016/0014-5793(90)81322-F; GROTE J, 2006, BMC MOL BIOL, V48, P1; Gullo C, 2006, BBA-REV CANCER, V1765, P223, DOI 10.1016/j.bbcan.2006.01.001; HALL AK, 1991, INT J CANCER, V48, P672, DOI 10.1002/ijc.2910480507; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kobayashi T, 2002, AM J PATHOL, V160, P869, DOI 10.1016/S0002-9440(10)64910-3; Koutrafouri V, 2001, BBA-GEN SUBJECTS, V1568, P60, DOI 10.1016/S0304-4165(01)00200-8; LIU ES, 1991, NUCLEIC ACIDS RES, V19, P5425, DOI 10.1093/nar/19.19.5425; Lynch EM, 2001, AM J PHYSIOL-CELL PH, V280, pC897, DOI 10.1152/ajpcell.2001.280.4.C897; Malinda KM, 1999, J INVEST DERMATOL, V113, P364, DOI 10.1046/j.1523-1747.1999.00708.x; Malinda KM, 1997, FASEB J, V11, P474, DOI 10.1096/fasebj.11.6.9194528; MIMORI T, 1990, P NATL ACAD SCI USA, V87, P1777, DOI 10.1073/pnas.87.5.1777; MOLL T, 1995, J BIOL CHEM, V270, P3849, DOI 10.1074/jbc.270.8.3849; Monferran S, 2004, EMBO J, V23, P3758, DOI 10.1038/sj.emboj.7600403; Morio T, 1999, IMMUNITY, V11, P339, DOI 10.1016/S1074-7613(00)80109-0; Muller C, 2005, CELL CYCLE, V4, P438, DOI 10.4161/cc.4.3.1565; Munakata Y, 2005, BLOOD, V106, P3449, DOI 10.1182/blood-2005-02-0536; Myung K, 2004, MOL CELL BIOL, V24, P5050, DOI 10.1128/MCB.24.11.5050-5059.2004; Niu M, 2000, CELL ADHES COMMUN, V7, P311, DOI 10.3109/15419060009015002; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Paasinen-Sohns A, 2000, J CELL BIOL, V151, P801, DOI 10.1083/jcb.151.4.801; Philp D, 2003, FASEB J, V17, P385, DOI 10.1096/fj.03-0244fje; Philp D, 2003, FASEB J, V17, P2103, DOI 10.1096/fj.03-0121fje; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sosne G, 2002, EXP EYE RES, V74, P293, DOI 10.1006/exer.2001.1125; Sosne G, 2001, EXP EYE RES, V72, P605, DOI 10.1006/exer.2000.0985; Swiatkowska M, 2005, FEBS J, V272, P5821, DOI 10.1111/j.1742-4658.2005.04979.x; SYLVIE M, 2004, J MOL BIOL, V26, P503; Tang YQ, 2002, INFECT IMMUN, V70, P6524, DOI 10.1128/IAI.70.12.6524-6533.2002; Teoh G, 1998, J CLIN INVEST, V101, P1379; Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang WS, 2004, ONCOGENE, V23, P6666, DOI 10.1038/sj.onc.1207888; Wang WS, 2003, ONCOGENE, V22, P3297, DOI 10.1038/sj.onc.1206404; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Xie D, 2002, INT J ONCOL, V21, P499; YAMAMOTO T, 1993, BIOCHEM BIOPH RES CO, V193, P706, DOI 10.1006/bbrc.1993.1682; Yarmola EG, 2001, J BIOL CHEM, V276, P45555, DOI 10.1074/jbc.M105723200; Young JD, 1999, NAT MED, V5, P1424	57	33	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1534	1544		10.1074/jbc.M707539200	http://dx.doi.org/10.1074/jbc.M707539200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17984099	hybrid			2022-12-25	WOS:000252282700038
J	Martin, L; Fluhrer, R; Reiss, K; Kremmer, E; Saftig, P; Haass, C				Martin, Lucas; Fluhrer, Regina; Reiss, Karina; Kremmer, Elisabeth; Saftig, Paul; Haass, Christian			Regulated intramembrane proteolysis of Bri2 (Itm2b) by ADAM10 and SPPL2a/SPPL2b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE ACTIVITY; FAMILIAL BRITISH DEMENTIA; SIGNAL PEPTIDE PEPTIDASE; INTRACELLULAR DOMAIN; PRESENILIN HOMOLOGS; CRYSTAL-STRUCTURE; PROTEASE ACTIVITY; SERINE PROTEASES; AMYLOID PEPTIDE; TNF-ALPHA	Presenilin, the catalytic component of the gamma-secretase complex, type IV prepilin peptidases, and signal peptide peptidase (SPP) are the founding members of the family of intramembrane-cleaving GXGD aspartyl proteases. SPP-like (SPPL) proteases, such as SPPL2a, SPPL2b, SPPL2c, and SPPL3, also belong to the GXGD family. In contrast to gamma-secretase, for which numerous substrates have been identified, very few in vivo substrates are known for SPP and SPPLs. Here we demonstrate that Bri2 (Itm2b), a type II-oriented transmembrane protein associated with familial British and Danish dementia, undergoes regulated intramembrane proteolysis. In addition to the previously described ectodomain processing by furin and related proteases, we now describe that the Bri2 protein, similar to gamma-secretase substrates, undergoes an additional cleavage by ADAM10 in its ectodomain. This cleavage releases a soluble variant of Bri2, the BRICHOS domain, which is secreted into the extracellular space. Upon this shedding event, a membrane-bound Bri2 N-terminal fragment remains, which undergoes intramembrane proteolysis to produce an intracellular domain as well as a secreted low molecular weight C-terminal peptide. By expressing all known SPP/SPPL family members as well as their loss of function variants, we demonstrate that selectively SPPL2a and SPPL2b mediate the intramembrane cleavage, whereas neither SPP nor SPPL3 is capable of processing the Bri2 N-terminal fragment.	[Martin, Lucas; Fluhrer, Regina; Haass, Christian] Univ Munich, Ctr Integrated Prot Sci Munich, Dept Biochem, Lab Neurodegenerat Dis Res, D-80336 Munich, Germany; [Martin, Lucas; Fluhrer, Regina; Haass, Christian] Univ Munich, Adolf Butenandt Inst, Dept Biochem, Lab Neurodegenerat Dis Res, D-80336 Munich, Germany; [Reiss, Karina; Saftig, Paul] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany; [Kremmer, Elisabeth] Gesell Strahlenforsch, Forschungszentrum, Inst Mol Immunol, D-81377 Munich, Germany	University of Munich; University of Munich; University of Kiel	Haass, C (corresponding author), Univ Munich, Ctr Integrated Prot Sci Munich, Dept Biochem, Lab Neurodegenerat Dis Res, D-80336 Munich, Germany.	chaass@med.uni-muenchen.de	Saftig, Paul/A-7966-2010; Fluhrer, Regina/F-2642-2011; Reiss, Karina/B-3175-2010					Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Choi SI, 2003, FASEB J, V17, P373, DOI 10.1096/fj.03-0730fje; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Grigorenko AP, 2002, BIOCHEMISTRY-MOSCOW+, V67, P826, DOI 10.1023/A:1016365227942; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Haass C, 2002, TRENDS CELL BIOL, V12, P556, DOI 10.1016/S0962-8924(02)02394-2; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kim SH, 2002, J BIOL CHEM, V277, P1872, DOI 10.1074/jbc.M108739200; Kim SH, 1999, NAT NEUROSCI, V2, P984, DOI 10.1038/14783; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; LaPointe CF, 2000, J BIOL CHEM, V275, P1502, DOI 10.1074/jbc.275.2.1502; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lemieux MJ, 2007, P NATL ACAD SCI USA, V104, P750, DOI 10.1073/pnas.0609981104; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; PLANT GT, 1990, BRAIN, V113, P721, DOI 10.1093/brain/113.3.721; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Wang YC, 2007, P NATL ACAD SCI USA, V104, P2098, DOI 10.1073/pnas.0611080104; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7	51	119	127	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1644	1652		10.1074/jbc.M706661200	http://dx.doi.org/10.1074/jbc.M706661200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17965014	Green Published, hybrid			2022-12-25	WOS:000252282700051
J	Moustafa-Bayoumi, M; Alhaj, MA; El-Sayed, O; Wisel, S; Chotani, MA; Abouelnaga, ZA; Hassona, MDH; Rigatto, K; Morris, M; Nuovo, G; Zweier, JL; Goldschmidt-Clermont, P; Hassanain, H				Moustafa-Bayoumi, Moustafa; Alhaj, Mazin A.; El-Sayed, Osama; Wisel, Sheik; Chotani, Maqsood A.; Abouelnaga, Zeinb A.; Hassona, Mohamed D. H.; Rigatto, Katya; Morris, Mariana; Nuovo, Gerard; Zweier, Jay L.; Goldschmidt-Clermont, Pascal; Hassanain, Hamdy			Vascular hypertrophy and hypertension caused by transgenic overexpression of profilin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; ACTIN POLYMERIZATION; MOLECULAR REGULATION; CAROTID ARTERIES; DIFFERENTIATION; ACTIVATION; DISEASE; KINASE; RHO; CYTOSKELETON	We have overexpressed either the cDNA of human profilin 1 or expressed the mutant (88R/L) in the blood vessels of transgenic FVB/ N mice. Reverse transcription- PCR indicated selective overexpression of profilin 1 and 88R/L in vascular smooth muscle cells. Polyproline binding showed increased profilin 1 and 88R/L proteins in transgenic mice compared with control (similar to 30%, p < 0.05). Rhodamine- phalloidin staining revealed increase stress fiber formation in vascular smooth muscle cells of profilin 1 compared with 88R/L and control. Hematoxylin and eosin staining showed clear signs of vascular hypertrophy in the aorta of profilin 1 mice versus 88R/L and control. However, there were no differences between 88R/L and control mice. Western blotting confirmed the activation of the hypertrophic signaling cascades in aortas of profilin 1 mice. Phospho- ERK1/2 was significantly higher in profilin 1 than 88R/L and control (512.3 and 361.7%, respectively, p < 0.05). Profilin 1 mice had significant increases in phospho-JNK as compared with 88R/L and control (371.4 and 346%, respectively, p < 0.05). However, there were no differences between 88R/L and control mice in both kinases. There was a significant increase in ROCK II kinase in the aorta of profilin 1 mice compared with controls (> 400%, p < 0.05). Tail cuff and circadian monitoring of blood pressure showed significant increases in systolic and mean arterial blood pressures of profilin 1 mice starting at age 6 months compared with controls (similar to 25 mm Hg, p< 0.05). These results suggest that increased actin polymerization in blood vessels triggers activation of the hypertrophic signaling cascades and results in elevation of blood pressure at advanced age.	[Moustafa-Bayoumi, Moustafa; Hassona, Mohamed D. H.] Calif State Polytech Univ Pomona, Dept Kinesiol & Hlth Promot, Pomona, CA 91768 USA; [Alhaj, Mazin A.; Chotani, Maqsood A.; Abouelnaga, Zeinb A.; Hassona, Mohamed D. H.; Nuovo, Gerard; Zweier, Jay L.; Hassanain, Hamdy] Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Alhaj, Mazin A.; Abouelnaga, Zeinb A.; Hassanain, Hamdy] Dept Anesthesiol, Columbus, OH 43210 USA; [El-Sayed, Osama] Dept Cardiol, Dept Surg, Columbus, OH 43210 USA; [Wisel, Sheik] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Moustafa-Bayoumi, Moustafa; Hassona, Mohamed D. H.] Wright State Univ, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA; [Rigatto, Katya; Morris, Mariana] Univ Miami, Miller Sch Med, Miami, FL 33136 USA	California State University System; California State Polytechnic University Pomona; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Wright State University Dayton; University of Miami	Hassanain, H (corresponding author), Ohio State Univ, Med Ctr, Dorothy M Davis Heart & Lung Res Inst, Dept Anesthesiol, 473 W 12th Ave, Columbus, OH 43210 USA.	hamdy.hassanain@osumc.edu	Chotani, Maqsood/E-2891-2011					Amerongen GPV, 2001, ARTERIOSCL THROM VAS, V21, P300, DOI 10.1161/01.ATV.21.3.300; BAUMBACH GL, 1989, HYPERTENSION, V13, P968, DOI 10.1161/01.HYP.13.6.968; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; DENG LY, 1991, AM J PHYSIOL, V271, pH1171; FOLKOW B, 1982, PHYSIOL REV, V62, P347, DOI 10.1152/physrev.1982.62.2.347; GALLAGHER SR, 1999, CURRENT PROTOCOLS MO, V2, DOI DOI 10.12B.11-10.12B.15; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; GOLDSCHMIDTCLER.PJ, 1991, CURR OPIN BIOL, V2, P669; HAARER BK, 1990, CELL MOTIL CYTOSKEL, V17, P71, DOI 10.1002/cm.970170202; Hannigan GE, 2007, CIRC RES, V100, P1408, DOI 10.1161/01.RES.0000265233.40455.62; Heerkens EHJ, 2007, HYPERTENSION, V49, P1, DOI 10.1161/01.HYP.0000252753.63224.3b; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hogan B., 1986, MANIPULATING MOUSE E, P17; Hu YH, 1997, ARTERIOSCL THROM VAS, V17, P2808, DOI 10.1161/01.ATV.17.11.2808; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Korenbaum E, 1998, BIOCHEMISTRY-US, V37, P9274, DOI 10.1021/bi9803675; Langille BL, 1996, CAN J PHYSIOL PHARM, V74, P834, DOI 10.1139/cjpp-74-7-834; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Merrill DC, 1996, J CLIN INVEST, V97, P1047, DOI 10.1172/JCI118497; Moldovan NI, 1997, CURR BIOL, V7, P24, DOI 10.1016/S0960-9822(06)00024-8; Nuovo GJ, 1998, DIAGN MOL PATHOL, V7, P267, DOI 10.1097/00019606-199810000-00006; NUOVO GJ, 1997, PCR SITU HYBRIDIZATI, P271; Owens GK, 1997, AGENT ACTION SUPPL, V48, P3; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Owens GK, 1996, J HYPERTENS, V14, pS55; OWENS GK, 1995, PHYSIOL REV, V75, P487; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pyles JM, 1997, CIRC RES, V81, P904; Rolfe BE, 2005, ATHEROSCLEROSIS, V183, P1, DOI 10.1016/j.atherosclerosis.2005.04.023; Ruwhof C, 2000, CARDIOVASC RES, V47, P23, DOI 10.1016/S0008-6363(00)00076-6; Salmon ED, 1989, CURR OPIN CELL BIOL, V1, P541, DOI 10.1016/0955-0674(89)90018-5; Schiffrin EL, 2001, CURR OPIN NEPHROL HY, V10, P617, DOI 10.1097/00041552-200109000-00011; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; Seasholtz TM, 2001, CIRC RES, V89, P488, DOI 10.1161/hh1801.096337; Simon G, 2004, J HYPERTENS, V22, P3, DOI 10.1097/00004872-200401000-00002; Suetsugu S, 1999, FEBS LETT, V457, P470, DOI 10.1016/S0014-5793(99)01086-8; THERIOT JA, 1993, CELL, V75, P835, DOI 10.1016/0092-8674(93)90527-W; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; WANG LC, 1996, CIRC RES, V78, P799; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Yang CS, 2000, J CELL BIOL, V150, P1001, DOI 10.1083/jcb.150.5.1001	44	38	42	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37632	37639		10.1074/jbc.M703227200	http://dx.doi.org/10.1074/jbc.M703227200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17942408	hybrid			2022-12-25	WOS:000251833600039
J	Neale, EJ; Rong, HL; Cockcroft, CJ; Sivaprasadarao, A				Neale, Edward J.; Rong, Honglin; Cockcroft, Christopher J.; Sivaprasadarao, Asipu			Mapping the membrane-aqueous border for the voltage-sensing domain of a potassium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT K+ CHANNEL; FOCUSED ELECTRIC-FIELD; ION CHANNELS; GATING PORE; TRANSMEMBRANE MOVEMENT; CHARGE MOVEMENT; SODIUM-CHANNELS; LIPID-BILAYER; SENSOR; DISPLACEMENT	Voltage-sensing domains (VSDs) play diverse roles in biology. As integral components, they can detect changes in the membrane potential of a cell and couple these changes to activity of ion channels and enzymes. As independent proteins, homologues of the VSD can function as voltage-dependent proton channels. To sense voltage changes, the positively charged fourth transmembrane segment, S4, must move across the energetically unfavorable hydrophobic core of the bilayer, which presents a barrier to movement of both charged species and protons. To reduce the barrier to S4 movement, it has been suggested that aqueous crevices may penetrate the protein, reducing the extent of total movement. To investigate this hypothesis in a system containing fully functional channels in a native environment with an intact membrane potential, we have determined the contour of the membrane-aqueous border of the VSD of KvAP in Escherichia coli by examining the chemical accessibility of introduced cysteines. The results revealed the contour of the membrane-aqueous border of the VSD in its activated conformation. The water-inaccessible regions of S1 and S2 correspond to the standard width of the membrane bilayer (similar to 28 angstrom), but those of S3 and S4 are considerably shorter (>= 40%), consistent with aqueous crevices pervading both the extracellular and intracellular ends. One face of S3b and the entire S3a were water-accessible, reducing the water-inaccessible region of S3 to just 10 residues, significantly shorter than for S4. The results suggest a key role for S3 in reducing the distance S4 needs to move to elicit gating.	[Neale, Edward J.; Rong, Honglin; Cockcroft, Christopher J.; Sivaprasadarao, Asipu] Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Sivaprasadarao, A (corresponding author), Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, 6 44d Garstang Bldg, Leeds LS2 9JT, W Yorkshire, England.	a.sivaprasadarao@leeds.ac.uk		Sivaprasadarao, Asipu/0000-0002-6755-3502	Wellcome Trust [076280, 076280/Z/04/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ahern CA, 2005, NEURON, V48, P25, DOI 10.1016/j.neuron.2005.08.020; Ahern CA, 2004, TRENDS NEUROSCI, V27, P303, DOI 10.1016/j.tins.2004.03.008; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bogdanov M, 2002, EMBO J, V21, P2107, DOI 10.1093/emboj/21.9.2107; Bond PJ, 2007, P NATL ACAD SCI USA, V104, P2631, DOI 10.1073/pnas.0606822104; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; de Gier JW, 2001, MOL MICROBIOL, V40, P314, DOI 10.1046/j.1365-2958.2001.02392.x; Elliott DJS, 2004, EMBO J, V23, P4717, DOI 10.1038/sj.emboj.7600484; Freites JA, 2005, P NATL ACAD SCI USA, V102, P15059, DOI 10.1073/pnas.0507618102; Gandhi CS, 2003, NEURON, V40, P515, DOI 10.1016/S0896-6273(03)00646-9; Gonzalez C, 2005, P NATL ACAD SCI USA, V102, P5020, DOI 10.1073/pnas.0501051102; Grisshammer Reinhard, 2005, Journal of Structural and Functional Genomics, V6, P159, DOI 10.1007/s10969-005-1917-6; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Islas LD, 2001, J GEN PHYSIOL, V117, P69, DOI 10.1085/jgp.117.1.69; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jones PC, 1996, MOL MEMBR BIOL, V13, P53, DOI 10.3109/09687689609160575; Krylov AV, 2001, J GEN PHYSIOL, V118, P333, DOI 10.1085/jgp.118.4.333; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Sands ZA, 2007, STRUCTURE, V15, P235, DOI 10.1016/j.str.2007.01.004; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Sokolov S, 2005, NEURON, V47, P183, DOI 10.1016/j.neuron.2005.06.012; Sokolov S, 2007, NATURE, V446, P76, DOI 10.1038/nature05598; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; TiwariWoodruff SK, 1997, BIOPHYS J, V72, P1489, DOI 10.1016/S0006-3495(97)78797-6; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253	42	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37597	37604		10.1074/jbc.M706437200	http://dx.doi.org/10.1074/jbc.M706437200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17951256	Green Accepted, hybrid			2022-12-25	WOS:000251833600035
J	Tachibana, C; Biddick, R; Law, GL; Young, ET				Tachibana, Christine; Biddick, Rhiannon; Law, G. Lynn; Young, Elton T.			A poised initiation complex is activated by SNF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; YEAST SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; TRANSCRIPTION ACTIVATION; GENE-EXPRESSION; BUDDING YEAST; IN-VIVO; DROSOPHILA-MELANOGASTER; GLUCONEOGENIC ENZYMES; ADR1-DEPENDENT GENES	Snf1, the yeast AMP kinase homolog, is essential for derepression of glucose-repressed genes that are activated by Adr1. Although required for Adr1 DNA binding, the precise role of Snf1 is unknown. Deletion of histone deacetylase genes allowed constitutive promoter binding of Adr1 and Cat8, another activator of glucose-repressed genes. In repressed conditions, at the Adr1- and Cat8-dependent ADH2 promoter, partial chromatin remodeling had occurred, and the activators recruited a partial preinitiation complex that included RNA polymerase II. Transcription did not occur, however, unless Snf1 was activated, suggesting a Snf1-dependent event that occurs after RNA polymerase II recruitment. Glucose regulation persisted because shifting to low glucose increased expression. Glucose repression could be completely relieved by combining the three elements of 1) chromatin perturbation by mutation of histone deacetylases, 2) activation of Snf1, and 3) the addition of an Adr1 mutant that by itself confers only weak constitutive activity.	[Tachibana, Christine; Biddick, Rhiannon; Law, G. Lynn; Young, Elton T.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Young, ET (corresponding author), Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA.	ety@u.washington.edu			NIDDK NIH HHS [DK67276] Funding Source: Medline; NIGMS NIH HHS [GM26079, T32 GM07270] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026079, T32GM007270] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Agricola E, 2004, BIOCHEMISTRY-US, V43, P8878, DOI 10.1021/bi049577+; Agricola E, 2006, MOL MICROBIOL, V62, P1433, DOI 10.1111/j.1365-2958.2006.05451.x; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Charbon G, 2004, MOL CELL BIOL, V24, P4083, DOI 10.1128/MCB.24.10.4083-4091.2004; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; CIRIACY M, 1979, MOL GEN GENET, V176, P427, DOI 10.1007/BF00333107; COLLART M, 1993, CURRENT PROTOCOLS MO; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; Cosma MP, 2001, MOL CELL, V7, P1213, DOI 10.1016/S1097-2765(01)00266-0; Cross FR, 1997, YEAST, V13, P647, DOI 10.1002/(SICI)1097-0061(19970615)13:7<647::AID-YEA115>3.0.CO;2-#; DENIS CL, 1992, MOL CELL BIOL, V12, P1507, DOI 10.1128/MCB.12.4.1507; Dombek KM, 1997, MOL CELL BIOL, V17, P1450, DOI 10.1128/MCB.17.3.1450; DOMBEK KM, 1993, MOL CELL BIOL, V13, P4391, DOI 10.1128/MCB.13.7.4391; Ducker CE, 2000, EMBO J, V19, P400, DOI 10.1093/emboj/19.3.400; ESTRUCH F, 1992, GENETICS, V132, P639; Featherstone M, 2002, CURR OPIN GENET DEV, V12, P149, DOI 10.1016/S0959-437X(02)00280-0; Fry CJ, 2002, SCIENCE, V295, P1847, DOI 10.1126/science.1070260; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Haurie V, 2001, J BIOL CHEM, V276, P76, DOI 10.1074/jbc.M008752200; HEDGES D, 1995, MOL CELL BIOL, V15, P1915; Hiesinger M, 2001, CURR GENET, V39, P68, DOI 10.1007/s002940000182; Hong SP, 2007, J BIOL CHEM, V282, P16838, DOI 10.1074/jbc.M700146200; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Kingston R., 1997, CURRENT PROTOCOLS MO; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kuchin S, 2000, P NATL ACAD SCI USA, V97, P7916, DOI 10.1073/pnas.140109897; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Lo WS, 2001, SCIENCE, V293, P1142, DOI 10.1126/science.1062322; Ludin K, 1998, P NATL ACAD SCI USA, V95, P6245, DOI 10.1073/pnas.95.11.6245; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; Nath N, 2003, MOL CELL BIOL, V23, P3909, DOI 10.1128/MCB.23.11.3909-3917.2003; NEIGEBORN L, 1984, GENETICS, V108, P845; NEIGEBORN L, 1987, GENETICS, V115, P247; OBRIEN T, 1993, MOL CELL BIOL, V13, P3456, DOI 10.1128/MCB.13.6.3456; Qian OY, 1999, GENETICS, V152, P89; Rahner A, 1996, NUCLEIC ACIDS RES, V24, P2331, DOI 10.1093/nar/24.12.2331; RandezGil F, 1997, MOL CELL BIOL, V17, P2502, DOI 10.1128/MCB.17.5.2502; ROUGVIE AE, 1990, MOL CELL BIOL, V10, P6041, DOI 10.1128/MCB.10.11.6041; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Sanz P, 2000, MOL CELL BIOL, V20, P1321, DOI 10.1128/MCB.20.4.1321-1328.2000; Sarma NJ, 2007, GENETICS, V175, P1127, DOI 10.1534/genetics.106.068932; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shirra MK, 1999, GENETICS, V152, P73; Shirra MK, 2001, MOL CELL BIOL, V21, P5710, DOI 10.1128/MCB.21.17.5710-5722.2001; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Sloan JS, 1999, J BIOL CHEM, V274, P37575, DOI 10.1074/jbc.274.53.37575; Song WJ, 1996, MOL CELL BIOL, V16, P115; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; Tachibana C, 2005, MOL CELL BIOL, V25, P2138, DOI 10.1128/MCB.25.6.2138-2146.2005; THOMPSONJAEGER S, 1991, GENETICS, V129, P697; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; TU JL, 1995, EMBO J, V14, P5939, DOI 10.1002/j.1460-2075.1995.tb00282.x; Van Driessche B, 2005, FEBS LETT, V579, P5318, DOI 10.1016/j.febslet.2005.08.057; Verdone L, 2002, EMBO J, V21, P1101, DOI 10.1093/emboj/21.5.1101; Verdone L, 1996, MOL CELL BIOL, V16, P1978; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200; Young ET, 2002, J BIOL CHEM, V277, P38095, DOI 10.1074/jbc.M206158200; Zhang HS, 2007, P NATL ACAD SCI USA, V104, P8833, DOI 10.1073/pnas.0701666104	69	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37308	37315		10.1074/jbc.M707363200	http://dx.doi.org/10.1074/jbc.M707363200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17974563	hybrid			2022-12-25	WOS:000251833600005
J	Chichili, GR; Rodgers, W				Chichili, Gurunadh R.; Rodgers, William			Clustering of membrane raft proteins by the actin cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; CELL ANTIGEN RECEPTOR; LIPID RAFTS; PLASMA-MEMBRANE; LIVING CELLS; TYROSINE KINASE; MICRODOMAINS; DOMAINS; SEGREGATION; ACTIVATION	Cell membranes are laterally organized into functionally discrete domains that include the cholesterol-dependent membrane "rafts." However, how membrane domains are established and maintained remains unresolved and controversial but often requires the actin cytoskeleton. In this study, we used fluorescence resonance energy transfer to measure the role of the actin cytoskeleton in the co-clustering of membrane raft-associated fluorescent proteins (FPs) and FPs targeted to the nonraft membrane fraction. By fitting the fluorescence resonance energy transfer data to an isothermal binding equation, we observed a specific co-clustering of raft-associated donor and acceptor probes that was sensitive to latrunculin B (Lat B), which disrupts the actin cytoskeleton. Conversely, treating with jasplakinolide to enhance actin polymerization increased co-clustering of the raft-associated FPs over that of the nonraft probes. We also observed by immunoblotting experiments that the actindependent co-clustering coincided with regulation of the raft-associated Src family kinase Lck. Specifically, Lat B decreased the phosphorylation of the C-terminal regulatory tyrosine of Lck (Tyr505), and combining the Lat B with filipin further decreased the Tyr505 phosphorylation. Furthermore, the Lat B-dependent changes in Lck regulation required CD45 because no significant changes occurred in treated T cells lacking CD45 expression. These data define a role for the actin cytoskeleton in promoting co-clustering of raft-associated proteins and show that this property is important toward regulating raft-associated signaling proteins such as Lck.	Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Rodgers, W (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, MS 45,825 NE 13th St, Oklahoma City, OK 73104 USA.	william-rodgers@omrf.org			NIGMS NIH HHS [R01 GM070001] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070001] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bodin S, 2005, J CELL SCI, V118, P759, DOI 10.1242/jcs.01648; BOLARD J, 1986, BIOCHIM BIOPHYS ACTA, V864, P257, DOI 10.1016/0304-4157(86)90002-X; Bray D, 1998, ANNU REV BIOPH BIOM, V27, P59, DOI 10.1146/annurev.biophys.27.1.59; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Cherukuri A, 2001, IMMUNITY, V14, P657, DOI 10.1016/S1074-7613(01)00156-X; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Davidson D, 2003, MOL CELL BIOL, V23, P2017, DOI 10.1128/MCB.23.6.2017-2028.2003; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; Hope HR, 1996, MOL BIOL CELL, V7, P843, DOI 10.1091/mbc.7.6.843; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Jordan S, 2003, J IMMUNOL, V171, P78, DOI 10.4049/jimmunol.171.1.78; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kusumi A, 1996, CURR OPIN CELL BIOL, V8, P566, DOI 10.1016/S0955-0674(96)80036-6; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Liu AP, 2006, BIOPHYS J, V91, P4064, DOI 10.1529/biophysj.106.090852; Lo W, 1998, BIOTECHNIQUES, V25, P94, DOI 10.2144/98251st05; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nishimura SY, 2006, BIOPHYS J, V90, P927, DOI 10.1529/biophysj.105.070524; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pentcheva T, 2001, J IMMUNOL, V166, P6625, DOI 10.4049/jimmunol.166.11.6625; Pohl J, 2004, BIOCHEMISTRY-US, V43, P4179, DOI 10.1021/bi035743m; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Press W.H., 2007, NUMERICAL RECIPES AR, P720; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Rodgers W, 2005, TRENDS IMMUNOL, V26, P97, DOI 10.1016/j.it.2004.11.016; Rodgers W, 2002, BIOTECHNIQUES, V32, P1044, DOI 10.2144/02325st05; RODGERS W, 1993, BIOCHEMISTRY-US, V32, P12591, DOI 10.1021/bi00210a007; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; Rodgers W, 2001, EXP CELL RES, V267, P173, DOI 10.1006/excr.2001.5253; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; SAKO Y, 1994, J CELL BIOL, V125, P1251, DOI 10.1083/jcb.125.6.1251; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Shogomori H, 2005, J BIOL CHEM, V280, P18931, DOI 10.1074/jbc.M500247200; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sohn HW, 2006, P NATL ACAD SCI USA, V103, P8143, DOI 10.1073/pnas.0509858103; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	55	97	101	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36682	36691		10.1074/jbc.M702959200	http://dx.doi.org/10.1074/jbc.M702959200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17947241	hybrid			2022-12-25	WOS:000251458300061
J	Makarava, N; Lee, CI; Ostapchenko, VG; Baskakov, IV				Makarava, Natallia; Lee, Cheng-I; Ostapchenko, Valeriy G.; Baskakov, Ilia V.			Highly promiscuous nature of prion polymerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; CELL-FREE CONVERSION; IN-VITRO CONVERSION; SPECIES-BARRIER; AMYLOID FIBRILS; ALPHA-SYNUCLEIN; SCRAPIE INFECTIVITY; SEEDING SPECIFICITY; INCUBATION-TIME; MOLECULAR-BASIS	The primary structure of the prion protein (PrP) is believed to be the key factor in regulating the species barrier of prion transmission. Because the strength of the species barrier was found to be affected by the prion strain, the extent to which the barrier can indeed be attributed to differences in the PrP primary structures of either donor and acceptor species remains unclear. In this study, we exploited the intrinsic property of PrP to polymerize spontaneously into disease-related amyloid conformations in the absence of a strain-specified template and analyzed polymerization of mouse and hamster full-length recombinant PrPs. Unexpectedly, we found no evidence of species specificity in cross-seeding polymerization assays. Even when both recombinant PrP variants were present in mixtures, preformed mouse or hamster fibrils displayed no selectivity in elongation reactions and consumed equally well both homologous and heterologous substrates. Analysis of individual fibrils revealed that fibrils can elongate in a bidirectional or unidirectional manner. Our work revealed that, in the absence of a cellular environment, post-translational modifications, or strain-specified conformational constraints, PrP fibrils are intrinsically promiscuous and capable of utilizing heterologous PrP variants as a substrate in a highly efficient manner. This study suggests that amyloid structures are capable of accommodating local perturbations arising because of a mismatch in amino acid sequences and highlights the promiscuous nature of the self-propagating activity of amyloid fibrils.	Univ Maryland, Inst Biotechnol, Ctr Med Biotechnol, Baltimore, MD 21201 USA; Univ Maryland, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Baskakov, IV (corresponding author), Univ Maryland, Inst Biotechnol, Ctr Med Biotechnol, 725 W Lombard St, Baltimore, MD 21201 USA.	Baskakov@umbi.umd.edu		Ostapchenko, Valeriy/0000-0002-3629-7702	NINDS NIH HHS [NS045585] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045585] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adjou KT, 2007, J COMP PATHOL, V137, P78, DOI 10.1016/j.jcpa.2007.03.007; Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; Barron RM, 2005, J GEN VIROL, V86, P859, DOI 10.1099/vir.0.80525-0; BISHOP MF, 1984, BIOPHYS J, V46, P631, DOI 10.1016/S0006-3495(84)84062-X; Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; Bocharova OV, 2006, J BIOL CHEM, V281, P2373, DOI 10.1074/jbc.M510840200; Bocharova OV, 2005, BIOCHEMISTRY-US, V44, P6776, DOI 10.1021/bi050251q; Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Breydo L, 2005, BIOCHEMISTRY-US, V44, P15534, DOI 10.1021/bi051369+; Cancellotti E, 2007, BBA-MOL BASIS DIS, V1772, P673, DOI 10.1016/j.bbadis.2006.10.013; CHANDLER RL, 1961, LANCET, V1, P1378; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Dickinson A. G., 1976, Slow virus diseases of animals and man,, P209; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Galuske RAW, 2004, CLIN NEUROPATHOL, V23, P113; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Haik S, 2002, ACTA NEUROPATHOL, V103, P516; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; Horiuchi M, 2000, P NATL ACAD SCI USA, V97, P5836, DOI 10.1073/pnas.110523897; Jean L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000652; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; KIMBERLIN RH, 1979, J GEN VIROL, V42, P107, DOI 10.1099/0022-1317-42-1-107; KIMBERLIN RH, 1978, J GEN VIROL, V39, P487, DOI 10.1099/0022-1317-39-3-487; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; KIMBERLIN RH, 1989, J GEN VIROL, V70, P2017, DOI 10.1099/0022-1317-70-8-2017; Kirby L, 2003, J GEN VIROL, V84, P1013, DOI 10.1099/vir.0.18903-0; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; Langedijk JPM, 2006, J MOL BIOL, V360, P907, DOI 10.1016/j.jmb.2006.05.042; Lee LYL, 2007, J AM CHEM SOC, V129, P1644, DOI 10.1021/ja0667413; MIYAZONO M, 1992, ACTA NEUROPATHOL, V83, P333, DOI 10.1007/BF00713522; Morales R, 2007, BBA-MOL BASIS DIS, V1772, P681, DOI 10.1016/j.bbadis.2006.12.006; Nonno R, 2006, PLOS PATHOG, V2, P112, DOI 10.1371/journal.ppat.0020012; Novitskaya V, 2006, J BIOL CHEM, V281, P15536, DOI 10.1074/jbc.M601349200; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; PATTISON IH, 1968, RES VET SCI, V9, P408; PATTISON IH, 1961, J COMP PATHOL THERAP, V71, P101, DOI 10.1016/S0368-1742(61)80013-1; PRIOLA SA, 1994, J VIROL, V68, P4873, DOI 10.1128/JVI.68.8.4873-4878.1994; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Race R, 1998, NATURE, V392, P770, DOI 10.1038/33834; Rochet JC, 2000, BIOCHEMISTRY-US, V39, P10619, DOI 10.1021/bi001315u; SCOTT M, 1993, CELL, V73, P979, DOI 10.1016/0092-8674(93)90275-U; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Scott Michael, 2004, VVolume 41, P435; Sun Y, 2007, J BIOL CHEM, V282, P9090, DOI 10.1074/jbc.M608623200; Tahiri-Alaoui A, 2006, J BIOL CHEM, V281, P34171, DOI 10.1074/jbc.M606606200; Takahashi M, 1996, VIRCHOWS ARCH, V429, P383; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6; WILSON DR, 1950, J COMP PATHOL THERAP, V60, P267, DOI 10.1016/S0368-1742(50)80025-5; Yan JM, 2007, AM J PATHOL, V171, P172, DOI 10.2353/ajpath.2007.060576	54	24	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36704	36713		10.1074/jbc.M704926200	http://dx.doi.org/10.1074/jbc.M704926200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17940285	hybrid			2022-12-25	WOS:000251458300063
J	Sharif-Askari, E; Gaucher, D; Halwani, R; Ma, J; Jao, K; Abdallah, A; Haddad, EK; Sekaly, RP				Sharif-Askari, Ehssan; Gaucher, Denis; Halwani, Rabih; Ma, Jennifer; Jao, Kevin; Abdallah, Ali; Haddad, Elias K.; Sekaly, Rafick-Pierre			P56(Lck) tyrosine kinase enhances the assembly of death-inducing signaling complex during fas-mediated apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; CELL-DEATH; ACTIVATION; PROTEIN; LCK; CD95; CASPASE-8; CLEAVAGE; RELEASE; PALMITOYLATION	Although the death-inducing signaling complex (DISC) is rapidly assembled, several lines of evidence suggest that formation of this complex is not the first consequence of cell surface CD95 (Fas) stimulation but rather a later step in this process. Activation of Fas triggers a cascade of signaling events that culminate in cellular apoptosis. Tyrosine kinases are critical effectors in T cell activation. However, their functional involvement in death receptor-mediated apoptosis is unknown. Here, we used p56(Lck)-deficient cells to show that CD95-induced cell death is highly dependent on p56(Lck) activity and its localization within plasma membrane. We found that p56Lck acts upstream of the mitochondria; in the absence of p56(Lck), Bid cleavage and the release of cytochrome c were severely impaired. Moreover, p56(Lck)-deficient cells or cells expressing an inactive form of p56(Lck) displayed defective formation of the DISC post CD95 stimulation. In vivo reconstitution of thymocytes from p56(lck)-deficient mice, which are resistant to apoptosis, with p56(Lck) restored Fas-mediated cell death. Our results support a novel model whereby sensitivity to apoptosis is regulated through quantitative changes in the stoichiometry of DISC components triggered by p56(Lck) activation and localization.	CHUM St Luc, Ctr Rech, Immunol Lab, Montreal, PQ H2X 1P1, Canada; Univ Montreal, Dept Med, Montreal, PQ H3T 3J7, Canada; Univ Montreal, Dept Microbiol & Immunol, Immunol Lab, Montreal, PQ H3T 1J4, Canada; Univ Montreal, INSERM, CR CHUM, U743, Montreal, PQ H2X 1P1, Canada; McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montreal; McGill University	Sekaly, RP (corresponding author), CHUM St Luc, Ctr Rech, Immunol Lab, Campus St Luc Pavillon Edouard Asselin 264,Blvd R, Montreal, PQ H2X 1P1, Canada.	rafick-pierre.sekaly@umontreal.ca	Halwani, Rabih/AAN-1568-2021	Halwani, Rabih/0000-0002-6516-7771				Adrain C, 2001, EMBO J, V20, P6627, DOI 10.1093/emboj/20.23.6627; Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Aouad SM, 2004, J IMMUNOL, V172, P2316, DOI 10.4049/jimmunol.172.4.2316; Arch RH, 1999, ANNU REV CELL DEV BI, V15, P113, DOI 10.1146/annurev.cellbio.15.1.113; Atkinson EA, 1996, J BIOL CHEM, V271, P5968, DOI 10.1074/jbc.271.11.5968; Belka C, 2003, ONCOGENE, V22, P176, DOI 10.1038/sj.onc.1206103; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Chakrabandhu K, 2007, EMBO J, V26, P209, DOI 10.1038/sj.emboj.7601456; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Clement MV, 1996, EMBO J, V15, P216, DOI 10.1002/j.1460-2075.1996.tb00352.x; Cremesti A, 2001, J BIOL CHEM, V276, P23954, DOI 10.1074/jbc.M101866200; Daigle I, 2002, NAT MED, V8, P61, DOI 10.1038/nm0102-61; DILLON PJ, 1990, BIOTECHNIQUES, V9, P298; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; EISCHEN CM, 1994, J IMMUNOL, V153, P1947; Eramo A, 2004, EUR J IMMUNOL, V34, P1930, DOI 10.1002/eji.200324786; Feig C, 2007, EMBO J, V26, P221, DOI 10.1038/sj.emboj.7601460; Gajate C, 2005, J BIOL CHEM, V280, P11641, DOI 10.1074/jbc.M411781200; Gajate C, 2001, BLOOD, V98, P3860, DOI 10.1182/blood.V98.13.3860; Gajate C, 2007, BLOOD, V109, P711, DOI 10.1182/blood-2006-04-016824; Gomez-Angelats M, 2001, J BIOL CHEM, V276, P44944, DOI 10.1074/jbc.M104919200; GonzalezGarcia A, 1997, J IMMUNOL, V158, P4104; Gruber C, 2004, BIOCHEM PHARMACOL, V67, P1859, DOI 10.1016/j.bcp.2004.01.026; Hawash IY, 2002, J BIOL CHEM, V277, P5683, DOI 10.1074/jbc.M110002200; Henkler F, 2005, J CELL BIOL, V168, P1087, DOI 10.1083/jcb.200501048; Heyninck K, 2006, ONCOGENE, V25, P1693, DOI 10.1038/sj.onc.1209157; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Jones RG, 2002, J EXP MED, V196, P335, DOI 10.1084/jem.20020307; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Latinis KM, 1996, BLOOD, V87, P871, DOI 10.1182/blood.V87.3.871.bloodjournal873871; Legembre P, 2006, J IMMUNOL, V176, P716, DOI 10.4049/jimmunol.176.2.716; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lincoln JE, 2006, INVEST OPHTH VIS SCI, V47, P2172, DOI 10.1167/iovs.05-1167; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Malorni W, 2007, APOPTOSIS, V12, P941, DOI 10.1007/s10495-007-0757-1; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Misra RS, 2007, J BIOL CHEM, V282, P19365, DOI 10.1074/jbc.M610610200; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; Muppidi JR, 2004, NAT IMMUNOL, V5, P182, DOI 10.1038/ni1024; Nicolau DV, 2006, MOL CELL BIOL, V26, P313, DOI 10.1128/MCB.26.1.313-323.2006; PENNINGER J, 1993, SCIENCE, V260, P358, DOI 10.1126/science.8469988; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Rohn JL, 1998, ONCOGENE, V17, P2811, DOI 10.1038/sj.onc.1202393; Ruiz-Ruiz C, 1999, J IMMUNOL, V163, P4737; RuizRuiz MD, 1997, EUR J IMMUNOL, V27, P1442, DOI 10.1002/eji.1830270622; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Samraj AK, 2006, ONCOGENE, V25, P186, DOI 10.1038/sj.onc.1209034; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scaffidi C, 1999, CURR OPIN IMMUNOL, V11, P277, DOI 10.1016/S0952-7915(99)80045-4; Schlottmann KE, 1996, J LEUKOCYTE BIOL, V60, P546, DOI 10.1002/jlb.60.4.546; SCHRAVEN B, 1995, FEBS LETT, V368, P491, DOI 10.1016/0014-5793(95)00720-T; Sharif-Askari E, 2001, EMBO J, V20, P3101, DOI 10.1093/emboj/20.12.3101; Shaw AS, 2006, NAT IMMUNOL, V7, P1139, DOI 10.1038/ni1405; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Szabo I, 1996, J BIOL CHEM, V271, P20465, DOI 10.1074/jbc.271.34.20465; Varadhachary AS, 1999, J IMMUNOL, V163, P4772; VEILLETTE A, 1992, ONCOGENE, V7, P971; Zhang J, 2004, CELL MOL IMMUNOL, V1, P186	64	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					36048	36056		10.1074/jbc.M706007200	http://dx.doi.org/10.1074/jbc.M706007200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17932036	hybrid			2022-12-25	WOS:000251458100064
J	Li, W; Ashok, M; Li, JH; Yang, H; Sama, AE; Wang, HC				Li, Wei; Ashok, Mala; Li, Jianhua; Yang, Huan; Sama, Andrew E.; Wang, Haichao			A Major Ingredient of Green Tea Rescues Mice from Lethal Sepsis Partly by Inhibiting HMGB1	PLOS ONE			English	Article							GROUP BOX-1 PROTEIN; TOLL-LIKE RECEPTOR-2; CECAL LIGATION; PROINFLAMMATORY CYTOKINE; STIMULATES MACROPHAGES; PLASMA-MEMBRANE; NITRIC-OXIDE; LIPID RAFTS; RELEASE; PUNCTURE	Background. The pathogenesis of sepsis is mediated in part by bacterial endotoxin, which stimulates macrophages/monocytes to sequentially release early (e.g., TNF, IL-1, and IFN-gamma) and late (e.g., HMGB1) pro-inflammatory cytokines. Our recent discovery of HMGB1 as a late mediator of lethal sepsis has prompted investigation for development of new experimental therapeutics. We previously reported that green tea brewed from the leaves of the plant Camellia sinensis is effective in inhibiting endotoxin-induced HMGB1 release. Methods and Findings. Here we demonstrate that its major component, (-)-epigallocatechin-3-gallate (EGCG), but not catechin or ethyl gallate, dose-dependently abrogated HMGB1 release in macrophage/monocyte cultures, even when given 2-6 hours post LPS stimulation. Intraperitoneal administration of EGCG protected mice against lethal endotoxemia, and rescued mice from lethal sepsis even when the first dose was given 24 hours after cecal ligation and puncture. The therapeutic effects were partly attributable to: 1) attenuation of systemic accumulation of proinflammatory mediator (e.g., HMGB1) and surrogate marker (e.g., IL-6 and KC) of lethal sepsis; and 2) suppression of HMGB1-mediated inflammatory responses by preventing clustering of exogenous HMGB1 on macrophage cell surface. Conclusions. Taken together, these data suggest a novel mechanism by which the major green tea component, EGCG, protects against lethal endotoxemia and sepsis.	[Li, Wei; Ashok, Mala; Sama, Andrew E.; Wang, Haichao] NYU, Sch Med, N Shore Univ Hosp, Dept Emergency Med, Manhasset, NY 11030 USA; [Li, Jianhua; Yang, Huan; Wang, Haichao] Feinstein Inst Med Res, Manhasset, NY USA	New York University; Northwell Health; North Shore University Hospital; Northwell Health	Wang, HC (corresponding author), NYU, Sch Med, N Shore Univ Hosp, Dept Emergency Med, Manhasset, NY 11030 USA.	hwang@nshs.edu	Wang, Haichao/AAU-2237-2021; Wang, Haichao/K-6310-2012	Wang, Haichao/0000-0002-0211-9000; Wang, Haichao/0000-0002-0211-9000; Li, Wei/0000-0002-7941-7022	National Institute of General Medical Sciences [R01GM063075, R01GM070817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070817, R01GM063075] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institute of General Medical Sciences grants (R01GM063075 and R01GM070817, to H. W.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Agnello D, 2002, CYTOKINE, V18, P231, DOI 10.1006/cyto.2002.0890; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Angus DC, 2007, CRIT CARE MED, V35, P1061, DOI 10.1097/01.CCM.0000259534.68873.2A; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; Chen GQ, 2005, J LIPID RES, V46, P623, DOI 10.1194/jlr.C400018-JLR200; Chen GQ, 2004, J LEUKOCYTE BIOL, V76, P994, DOI 10.1189/jlb.0404242; Chen XT, 2006, MED HYPOTHESES, V66, P660, DOI 10.1016/j.mehy.2005.09.025; Crespy V, 2004, J NUTR, V134, p3431S, DOI 10.1093/jn/134.12.3431S; DINARELLO CA, 1991, IMMUNOL TODAY, V12, P404, DOI 10.1016/0167-5699(91)90142-G; Elbling L, 2005, FASEB J, V19, P807, DOI 10.1096/fj.04-2915fje; ESKANDARI MK, 1992, J IMMUNOL, V148, P2724; Fink MP, 1996, INTENS CARE MED, V22, P158, DOI 10.1007/BF01720723; Frei B, 2003, J NUTR, V133, p3275S, DOI 10.1093/jn/133.10.3275S; Fujimura Y, 2004, FEBS LETT, V556, P204, DOI 10.1016/S0014-5793(03)01432-7; Gaini S, 2007, CRIT CARE, V11, DOI 10.1186/cc5715; GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F; Heuer JG, 2004, CRIT CARE MED, V32, P1570, DOI 10.1097/01.CCM.0000129488.54282.1A; Hong J, 2002, CANCER RES, V62, P7241; Ichikawa D, 2004, BIOL PHARM BULL, V27, P1353, DOI 10.1248/bpb.27.1353; IVANOV S, 2007, BLOOD IN PRESS; Kokkola R, 2005, SCAND J IMMUNOL, V61, P1, DOI 10.1111/j.0300-9475.2005.01534.x; Li JH, 2004, J IMMUNOL METHODS, V289, P211, DOI 10.1016/j.jim.2004.04.019; Li W, 2007, J IMMUNOL, V178, P3856, DOI 10.4049/jimmunol.178.6.3856; Lyu SY, 2005, ARCH PHARM RES, V28, P573, DOI 10.1007/BF02977761; Mercer-Jones MA, 1999, INFLAMMATION, V23, P305; O'Connor KA, 2003, CYTOKINE, V24, P254, DOI 10.1016/j.cyto.2003.08.001; Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Park JS, 2003, AM J PHYSIOL-CELL PH, V284, pC870, DOI 10.1152/ajpcell.00322.2002; Powers KA, 2006, J EXP MED, V203, P1951, DOI 10.1084/jem.20060943; Rendon-Mitchell B, 2003, J IMMUNOL, V170, P3890, DOI 10.4049/jimmunol.170.7.3890; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Rogers J, 2005, EXP BIOL MED, V230, P645; Sappington PL, 2002, GASTROENTEROLOGY, V123, P790, DOI 10.1053/gast.2002.35391; Tachibana H, 2004, BIOFACTORS, V21, P383, DOI 10.1002/biof.552210174; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Tang DL, 2007, J LEUKOCYTE BIOL, V81, P741, DOI 10.1189/jlb.0806540; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Triantafilou M, 2004, J BIOL CHEM, V279, P40882, DOI 10.1074/jbc.M400466200; Triantafilou M, 2002, J CELL SCI, V115, P2603; Ueno H, 2004, AM J RESP CRIT CARE, V170, P1310, DOI 10.1164/rccm.200402-188OC; Ulloa L, 2002, P NATL ACAD SCI USA, V99, P12351, DOI 10.1073/pnas.192222999; VILLA P, 1995, CLIN DIAGN LAB IMMUN, V2, P549, DOI 10.1128/CDLI.2.5.549-553.1995; Vincent JL, 2000, AM J RESP CRIT CARE, V161, P1781, DOI 10.1164/ajrccm.161.6.9812004; Vita JA, 2003, J NUTR, V133, p3293S, DOI 10.1093/jn/133.10.3293S; Vyas D, 2005, AM J PHYSIOL-REG I, V289, pR1048, DOI 10.1152/ajpregu.00312.2005; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang HC, 2006, J NUTR, V136, P360, DOI 10.1093/jn/136.2.360; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Yang CS, 1998, CANCER EPIDEM BIOMAR, V7, P351; Yang CS, 2000, J NUTR, V130, P2409, DOI 10.1093/jn/130.10.2409; Yang FJ, 1998, J NUTR, V128, P2334, DOI 10.1093/jn/128.12.2334; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yin KS, 2005, SHOCK, V24, P396, DOI 10.1097/01.shk.0000175556.03300.c6; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82	58	114	127	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1153	10.1371/journal.pone.0001153	http://dx.doi.org/10.1371/journal.pone.0001153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987129	Green Published, gold			2022-12-25	WOS:000207459000035
J	Theveneau, E; Duband, JL; Altabef, M				Theveneau, Eric; Duband, Jean-Loup; Altabef, Muriel			Ets-1 Confers Cranial Features on Neural Crest Delamination	PLOS ONE			English	Article								Neural crest cells (NCC) have the particularity to invade the environment where they differentiate after separation from the neuroepithelium. This process, called delamination, is strikingly different between cranial and trunk NCCs. If signalings controlling slow trunk delamination start being deciphered, mechanisms leading to massive and rapid cranial outflow are poorly documented. Here, we show that the chick cranial NCCs delamination is the result of two events: a substantial cell mobilization and an epithelium to mesenchyme transition (EMT). We demonstrate that ets-1, a transcription factor specifically expressed in cranial NCCs, is responsible for the former event by recruiting massively cranial premigratory NCCs independently of the S-phase of the cell cycle and by leading the gathered cells to straddle the basal lamina. However, it does not promote the EMT process alone but can cooperate with snail-2 (previously called slug) to this event. Altogether, these data lead us to propose that ets-1 plays a pivotal role in conferring specific cephalic characteristics on NCC delamination.	[Theveneau, Eric; Duband, Jean-Loup; Altabef, Muriel] Univ Paris 06, Dev Biol Lab, UMR 7622, Paris, France; [Theveneau, Eric; Duband, Jean-Loup; Altabef, Muriel] CNRS, Dev Biol Lab, UMR 7622, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Altabef, M (corresponding author), Univ Paris 06, Dev Biol Lab, UMR 7622, Paris, France.	Muriel.Altabef@snv.jussieu.fr		Duband, Jean-Loup/0000-0002-1831-6420; Theveneau, Eric/0000-0001-6510-5717	CNRS; Universite P. et M. Curie; Association pour la Recherche contre le Cancer [ARC 5590]; Ministere de la Recherche; ARC	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite P. et M. Curie; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); ARC(Australian Research Council)	This work was supported by the CNRS, the Universite P. et M. Curie, and the Association pour la Recherche contre le Cancer (ARC 5590). ET is a recipient of doctoral fellowships from the Ministere de la Recherche and from ARC.	Basch ML, 2006, NATURE, V441, P218, DOI 10.1038/nature04684; Burstyn-Cohen T, 2004, DEVELOPMENT, V131, P5327, DOI 10.1242/dev.01424; Burstyn-Cohen T, 2002, DEV CELL, V3, P383, DOI 10.1016/S1534-5807(02)00221-6; Chen ZQ, 1997, CANCER RES, V57, P2013; Cheung M, 2005, DEV CELL, V8, P179, DOI 10.1016/j.devcel.2004.12.010; CHRYSOGELOS S, 1989, J BIOL CHEM, V264, P1232; del Barrio MG, 2002, DEVELOPMENT, V129, P1583; Delannoy-Courdent A, 1998, J CELL SCI, V111, P1521; Dottori M, 2001, DEVELOPMENT, V128, P4127; Duband JL, 1995, ACTA ANAT, V154, P63; DUBAND JL, 1991, J CELL SCI, V98, P517; Fafeur V, 1997, CELL GROWTH DIFFER, V8, P655; Giudicelli F, 2001, GENE DEV, V15, P567, DOI 10.1101/gad.189801; GRAHAM A, 1993, DEVELOPMENT, V119, P233; Graham A, 1996, MOL CELL NEUROSCI, V8, P76, DOI 10.1006/mcne.1996.0046; GRAHAM A, 1994, NATURE, V372, P684, DOI 10.1038/372684a0; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hirsinger E, 1997, DEVELOPMENT, V124, P4605; Iwasaka C, 1996, J CELL PHYSIOL, V169, P522, DOI 10.1002/(SICI)1097-4652(199612)169:3<522::AID-JCP12>3.3.CO;2-Q; Kalcheim C, 2005, INT J DEV BIOL, V49, P105, DOI 10.1387/ijdb.041949ck; Knecht AK, 2002, NAT REV GENET, V3, P453, DOI 10.1038/nrg819; Le Douarin NM, 1999, NEURAL CREST, V2; Lelievre E, 2001, INT J BIOCHEM CELL B, V33, P391, DOI 10.1016/S1357-2725(01)00025-5; Liu JP, 1998, DEVELOPMENT, V125, P5055; Marcelle C, 1997, DEVELOPMENT, V124, P3955; MAROULAKOU IG, 1994, ONCOGENE, V9, P1551; MAVROTHALASSITIS G, 1994, ONCOGENE, V9, P425; Meyer D, 1997, INT J DEV BIOL, V41, P607; NAKAGAWA S, 1995, DEVELOPMENT, V121, P1321; Nakagawa S, 1998, DEVELOPMENT, V125, P2963; Nieto MA, 2001, MECH DEVELOP, V105, P27, DOI 10.1016/S0925-4773(01)00394-X; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Paumelle R, 2002, ONCOGENE, V21, P2309, DOI 10.1038/sj.onc.1205297; Pietri T, 2003, DEV DYNAM, V227, P309, DOI 10.1002/dvdy.10299; QUEVA C, 1993, ONCOGENE, V8, P2511; Rottinger E, 2004, DEVELOPMENT, V131, P1075, DOI 10.1242/dev.01000; Sela-Donenfeld D, 1999, DEVELOPMENT, V126, P4749; Sela-Donenfeld D, 2000, DEVELOPMENT, V127, P4845; Sementchenko VI, 2000, ONCOGENE, V19, P6533, DOI 10.1038/sj.onc.1204034; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Shoval I, 2007, DEVELOPMENT, V134, P491, DOI 10.1242/dev.02742; Tahtakran SA, 2003, GENE EXPR PATTERNS, V3, P455, DOI 10.1016/S1567-133X(03)00065-6; Taki M, 2006, INT J ONCOL, V28, P487; Tanaka H, 2004, J AM SOC NEPHROL, V15, P3083, DOI 10.1097/01.ASN.0000145459.54236.D3; Tanaka K, 1998, J CELL PHYSIOL, V176, P235, DOI 10.1002/(SICI)1097-4652(199808)176:2<235::AID-JCP2>3.0.CO;2-P; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Tucker RP, 2001, DEV DYNAM, V222, P115, DOI 10.1002/dvdy.1171; VANDENBUNDER B, 1989, DEVELOPMENT, V107, P265; WANG CY, 1992, J EXP MED, V175, P1391, DOI 10.1084/jem.175.5.1391; WILKINSON DG, 1992, SITU HYBRIDISATION P, P939; Zhang JL, 2003, J BIOL CHEM, V278, P29901, DOI 10.1074/jbc.M303909200; Zhao JJ, 1998, DEVELOPMENT, V125, P1899	53	92	92	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1142	10.1371/journal.pone.0001142	http://dx.doi.org/10.1371/journal.pone.0001142			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987123	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459000025
J	Kurata, H; Tanaka, T; Ohnishi, F				Kurata, Hiroyuki; Tanaka, Takayuki; Ohnishi, Fumitaka			Mathematical Identification of Critical Reactions in the Interlocked Feedback Model	PLOS ONE			English	Article								Dynamic simulations are necessary for understanding the mechanism of how biochemical networks generate robust properties to environmental stresses or genetic changes. Sensitivity analysis allows the linking of robustness to network structure. However, it yields only local properties regarding a particular choice of plausible parameter values, because it is hard to know the exact parameter values in vivo. Global and firm results are needed that do not depend on particular parameter values. We propose mathematical analysis for robustness (MAR) that consists of the novel evolutionary search that explores all possible solution vectors of kinetic parameters satisfying the target dynamics and robustness analysis. New criteria, parameter spectrum width and the variability of solution vectors for parameters, are introduced to determine whether the search is exhaustive. In robustness analysis, in addition to single parameter sensitivity analysis, robustness to multiple parameter perturbation is defined. Combining the sensitivity analysis and the robustness analysis to multiple parameter perturbation enables identifying critical reactions. Use of MAR clearly identified the critical reactions responsible for determining the circadian cycle in the Drosophila interlocked circadian clock model. In highly robust models, while the parameter vectors are greatly varied, the critical reactions with a high sensitivity are uniquely determined. Interestingly, not only the per-tim loop but also the dclk-cyc loop strongly affect the period of PER, although the dclk-cyc loop hardly changes its amplitude and it is not potentially influential. In conclusion, MAR is a powerful method to explore wide parameter space without human-biases and to link a robust property to network architectures without knowing the exact parameter values. MAR identifies the reactions critically responsible for determining the period and amplitude in the interlocked feedback model and suggests that the circadian clock intensively evolves or designs the kinetic parameters so that it creates a highly robust cycle.	[Kurata, Hiroyuki; Tanaka, Takayuki; Ohnishi, Fumitaka] Kyushu Inst Technol, Dept Biosci & Bioinformat, Fukuoka, Japan	Kyushu Institute of Technology	Kurata, H (corresponding author), Kyushu Inst Technol, Dept Biosci & Bioinformat, Fukuoka, Japan.	kurata@bio.kyutech.ac.jp			The Ministry of Education, Science, Sports and Culture [18300098]	The Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding: The Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (B), 2006, 18300098	Alves R, 2000, BIOINFORMATICS, V16, P786, DOI 10.1093/bioinformatics/16.9.786; Bagheri N, 2007, BIOINFORMATICS, V23, P358, DOI 10.1093/bioinformatics/btl627; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; El-Samad H, 2005, P NATL ACAD SCI USA, V102, P2736, DOI 10.1073/pnas.0403510102; ESHELMAN LJ, 1993, FDN GENETIC ALGORITH, V2, P187; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Kimura S, 2004, BIOINFORMATICS, V20, P1646, DOI 10.1093/bioinformatics/bth122; Kurata H, 2005, GENOME RES, V15, P590, DOI 10.1101/gr.3463705; Kurata H, 2003, NUCLEIC ACIDS RES, V31, P4071, DOI 10.1093/nar/gkg461; Kurata H, 2006, PLOS COMPUT BIOL, V2, P663, DOI 10.1371/journal.pcbi.0020059; Leloup JC, 2000, BIOESSAYS, V22, P84; Ma L, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-38; Ono I., 1997, P 7 ICGA, P246; SAVAGEAU MA, 1971, NATURE, V229, P542, DOI 10.1038/229542a0; SAVAGEAU MA, 1971, ARCH BIOCHEM BIOPHYS, V145, P612, DOI 10.1016/S0003-9861(71)80021-8; Smolen P, 2001, J NEUROSCI, V21, P6644, DOI 10.1523/JNEUROSCI.21-17-06644.2001; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Suri V, 2000, J NEUROSCI, V20, P7547; Ueda HR, 2001, J THEOR BIOL, V210, P401, DOI 10.1006/jtbi.2000.2226	22	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1103	10.1371/journal.pone.0001103	http://dx.doi.org/10.1371/journal.pone.0001103			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971866	Green Submitted, Green Published, gold			2022-12-25	WOS:000207458700020
J	Smith, CM; Gill, MB; May, JS; Stevenson, PG				Smith, Christopher M.; Gill, Michael B.; May, Janet S.; Stevenson, Philip G.			Murine Gammaherpesvirus-68 Inhibits Antigen Presentation by Dendritic Cells	PLOS ONE			English	Article								Dendritic cells (DCs) play a central role in initiating adaptive immunity. Murine gammaherpesvirus-68 (MHV-68), like many persistent viruses, infects DCs during normal host colonization. It therefore provides a means to understanding what host and viral genes contribute to this aspect of pathogenesis. The infected DC phenotype is likely to depend on whether viral gene expression is lytic or latent and whether antigen presentation is maintained. For MHV-68, neither parameter has been well defined. Here we show that MHV-68 infects immature but not mature bone marrow-derived DCs. Infection was predominantly latent and these DCs showed no obvious defect in antigen presentation. Lytically infected DCs were very different. These down-regulated CD86 and MHC class I expression and presented a viral epitope poorly to CD8(+) T cells. Antigen presentation improved markedly when the MHV-68 K3 gene was disrupted, indicating that K3 fulfils an important function in infected DCs. MHV-68 infects only a small fraction of the DCs present in lymphoid tissue, so K3 expression is unlikely to compromise significantly global CD8(+) T cell priming. Instead it probably helps to maintain lytic gene expression in DCs once CD8(+) T cell priming has occurred.	[Smith, Christopher M.; Gill, Michael B.; May, Janet S.; Stevenson, Philip G.] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England	University of Cambridge	Stevenson, PG (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England.	pgs27@cam.ac.uk	Stevenson, Philip/F-6651-2011; Stevenson, Philip g/F-9688-2014	Stevenson, Philip g/0000-0002-3520-5060	C.J. Martin fellowship; Wellcome Trust [GR076956MA]; Cancer Research UK [C19612/A6189]; Medical Research Council [G0400427, G9800903]; MRC [G0400427] Funding Source: UKRI	C.J. Martin fellowship(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CMS was supported by a C.J. Martin fellowship and PGS by a Wellcome Trust Senior Clinical Research Fellowship (GR076956MA). This work was also supported by grants from Cancer Research UK (C19612/A6189) and the Medical Research Council (G0400427 and G9800903).	Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Belz GT, 2007, P NATL ACAD SCI USA, V104, P6341, DOI 10.1073/pnas.0609990104; Bennett NJ, 2005, PLOS BIOL, V3, P638, DOI 10.1371/journal.pbio.0030120; BHARDWAJ N, 1994, J CLIN INVEST, V94, P797, DOI 10.1172/JCI117399; Boname JM, 2004, IMMUNITY, V20, P305, DOI 10.1016/S1074-7613(04)00047-0; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; Coleman HM, 2005, J GEN VIROL, V86, P561, DOI 10.1099/vir.0.80565-0; Coleman HM, 2003, J VIROL, V77, P13093, DOI 10.1128/JVI.77.24.13093-13105.2003; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Davenport MG, 1999, J VIROL, V73, P3154, DOI 10.1128/JVI.73.4.3154-3161.1999; De Lima BD, 2004, J VIROL, V78, P5103, DOI 10.1128/JVI.78.10.5103-5112.2004; EFSTATHIOU S, 1990, J GEN VIROL, V71, P1365, DOI 10.1099/0022-1317-71-6-1365; EFSTATHIOU S, 1990, J GEN VIROL, V71, P1355, DOI 10.1099/0022-1317-71-6-1355; Flano E, 2000, J IMMUNOL, V165, P1074, DOI 10.4049/jimmunol.165.2.1074; Flano E, 2005, J IMMUNOL, V175, P3225, DOI 10.4049/jimmunol.175.5.3225; Fowler P, 2003, J GEN VIROL, V84, P3405, DOI 10.1099/vir.0.19594-0; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Gill MB, 2006, J GEN VIROL, V87, P1465, DOI 10.1099/vir.0.81760-0; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000347; Gillet L, 2006, J GEN VIROL, V87, P3515, DOI 10.1099/vir.0.82313-0; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; Hochreiter R, 2007, J GEN VIROL, V88, P1896, DOI 10.1099/vir.0.82931-0; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Husain SM, 1999, P NATL ACAD SCI USA, V96, P7508, DOI 10.1073/pnas.96.13.7508; Ishido S, 2000, IMMUNITY, V13, P365, DOI 10.1016/S1074-7613(00)00036-4; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; KOZUCH O, 1993, ACTA VIROL, V37, P101; Kushnir N, 1998, J IMMUNOL, V160, P1774; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; Liu LZ, 1999, J IMMUNOL, V163, P868; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; MACATONIA SE, 1989, J EXP MED, V169, P1255, DOI 10.1084/jem.169.4.1255; Marques S, 2003, J VIROL, V77, P7308, DOI 10.1128/JVI.77.13.7308-7318.2003; Martinez-Guzman D, 2003, J VIROL, V77, P10488, DOI 10.1128/JVI.77.19.10488-10503.2003; May JS, 2005, J VIROL, V79, P3459, DOI 10.1128/JVI.79.6.3459-3467.2005; Moorman NJ, 2003, J VIROL, V77, P10295, DOI 10.1128/JVI.77.19.10295-10303.2003; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Rainbow L, 1997, J VIROL, V71, P5915, DOI 10.1128/JVI.71.8.5915-5921.1997; Rappocciolo G, 2006, J IMMUNOL, V176, P1741, DOI 10.4049/jimmunol.176.3.1741; Rice J, 2002, EUR J IMMUNOL, V32, P3481, DOI 10.1002/1521-4141(200212)32:12<3481::AID-IMMU3481>3.0.CO;2-J; Rosa GT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000560; Skepper JN, 2001, J VIROL, V75, P5697, DOI 10.1128/JVI.75.12.5697-5702.2001; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Stevenson PG, 2004, CURR OPIN IMMUNOL, V16, P456, DOI 10.1016/j.coi.2004.05.002; Stevenson PG, 2002, NAT IMMUNOL, V3, P733, DOI 10.1038/ni818; Stevenson PG, 1999, EUR J IMMUNOL, V29, P1059, DOI 10.1002/(SICI)1521-4141(199904)29:04<1059::AID-IMMU1059>3.0.CO;2-L; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P2347, DOI 10.1099/0022-1317-73-9-2347; Taylor JL, 2005, J VIROL, V79, P15099, DOI 10.1128/JVI.79.24.15099-15106.2005; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Yin Y, 2003, SCIENCE, V301, P1371, DOI 10.1126/science.1088902	51	29	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1048	10.1371/journal.pone.0001048	http://dx.doi.org/10.1371/journal.pone.0001048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940612	Green Published, gold, Green Submitted			2022-12-25	WOS:000207456100016
J	Ohmori, K; Endo, Y; Yoshida, Y; Ohata, H; Taya, Y; Enari, M				Ohmori, K.; Endo, Y.; Yoshida, Y.; Ohata, H.; Taya, Y.; Enari, M.			Monomeric but not trimeric clathrin heavy chain regulates p53-mediated transcription	ONCOGENE			English	Article						clathrin heavy chain; gene transcription; monomer; p53; tumor suppressor	UBIQUITIN LIGASE; TUMOR-SUPPRESSOR; MITOTIC SPINDLE; P53; PROTEIN; MDM2; IDENTIFICATION; DEGRADATION; EXPRESSION; SUPERHELIX	Tumor suppressor p53 protein is the transcription factor responsible for various genes including DNA repair, growth arrest, apoptosis and antiangiogenesis. Recently, we showed that clathrin heavy chain (CHC), which was originally identified as a cytosolic protein regulating endocytosis, is present in nuclei and functions as a coactivator for p53. Here, we determined the detailed p53-binding site of CHC and a CHC deletion mutant containing this region (CHC833-1406) behaved as a monomer in cells. Monomeric CHC833-1406 still had a higher ability to transactivate p53 than wild-type CHC although this CHC mutant no longer had endocytic function. Moreover, similar to wild-type CHC, monomeric CHC enhances p53-mediated transcription through the recruitment of histone acetyltransferase p300. Immunofluorescent microscopic analysis exhibited that CHC833-1406 is predominantly localized in nuclei, suggesting that there may be a certain regulatory domain for nuclear export in the C-terminus of CHC. Thus, the trimerization domain of CHC is not necessary for the transactivation of p53 target genes and these data provide further evidence that nuclear CHC plays a role distinct from clathrin-mediated endocytosis.	[Ohmori, K.; Endo, Y.; Yoshida, Y.; Ohata, H.; Taya, Y.; Enari, M.] Japan Sci & Technol Agcy, SORST, Chuo Ku, Tokyo 1040045, Japan; [Ohmori, K.; Endo, Y.; Yoshida, Y.; Ohata, H.; Taya, Y.; Enari, M.] Natl Canc Ctr, Res Inst, Div Radiol, Chuo Ku, Tokyo 1040045, Japan; [Ohmori, K.] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba, Japan	Japan Science & Technology Agency (JST); National Cancer Center - Japan; University of Tokyo	Enari, M (corresponding author), Natl Canc Ctr, Res Inst, Div Radiol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	ytaya@gan2.res.ncc.go.jp; menari@gan2.res.ncc.go.jp	Enari, Masato/E-5507-2014	Enari, Masato/0000-0003-4293-3848				Barth M, 2004, J CELL SCI, V117, P2051, DOI 10.1242/jcs.01062; Bourdon JC, 2003, CELL DEATH DIFFER, V10, P397, DOI 10.1038/sj.cdd.4401243; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen CY, 2002, EMBO J, V21, P6072, DOI 10.1093/emboj/cdf594; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Dell'Angelica EC, 2001, TRENDS CELL BIOL, V11, P315, DOI 10.1016/S0962-8924(01)02043-8; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; ENARI M, 1953, GENE DEV, V20, P1087; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Kim HL, 2000, EXP MOL MED, V32, P222, DOI 10.1038/emm.2000.36; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; KIRCHHAUSEN T, 1981, CELL, V23, P755, DOI 10.1016/0092-8674(81)90439-6; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kumar S, 2006, MOL CELL ENDOCRINOL, V246, P147, DOI 10.1016/j.mce.2005.11.028; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Lafer EM, 2002, TRAFFIC, V3, P513, DOI 10.1034/j.1600-0854.2002.30801.x; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Linke SP, 2003, CANCER RES, V63, P2596; Ljungman M, 2000, NEOPLASIA, V2, P208, DOI 10.1038/sj.neo.7900073; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Nakamura Y, 2006, CANCER SCI, V97, P633, DOI 10.1111/j.1349-7006.2006.00214.x; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Prives C, 1999, J PATHOL, V187, P112; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; Royle SJ, 2006, J CELL SCI, V119, P4071, DOI 10.1242/jcs.03192; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Seo YR, 2002, ONCOGENE, V21, P731, DOI 10.1038/sj.onc.1205129; Tarapore P, 2002, ONCOGENE, V21, P6234, DOI 10.1038/sj.onc.1205707; Vecchi M, 2001, J CELL BIOL, V153, P1511, DOI 10.1083/jcb.153.7.1511; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wakeham DE, 2003, EMBO J, V22, P4980, DOI 10.1093/emboj/cdg511; Ybe JA, 1999, NATURE, V399, P371, DOI 10.1038/20708; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Ziegler E. C., 2005, SCI STKE, pre6, DOI DOI 10.1126/STKE.2842005RE6	42	21	22	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR 3	2008	27	15					2215	2227		10.1038/sj.onc.1210854	http://dx.doi.org/10.1038/sj.onc.1210854			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	283FE	17952123				2022-12-25	WOS:000254621300012
J	D'Addario, C; Ming, Y; Ogren, SO; Terenius, L				D'Addario, Claudio; Ming, Yu; Ogren, Sven-Ove; Terenius, Lars			The role of acetaldehyde in mediating effects of alcohol on expression of endogenous opioid system genes in a neuroblastoma cell line	FASEB JOURNAL			English	Article						ethanol; gene expression; opioid peptides/receptors; 4-methylpyrazole	MESSENGER-RNA LEVELS; CHRONIC DAILY ETHANOL; GROWTH-INHIBITION; RAT PITUITARY; RECEPTOR; PROOPIOMELANOCORTIN; CONSUMPTION; PROTEIN; WITHDRAWAL; QUANTIFICATION	Ethanol (EtOH) alters neural activity through interaction with various neurotransmitters and neuromodulators. The endogenous opioid system seems to play a key role in the activities of EtOH, since the opioid antagonist naltrexone (ReVia (R)) attenuates craving. We have investigated the tran criptional regulation of opioid system genes in response to EtOH exposure for up to 96 h in human neuroblastoma SH-SY5Y cells using quantitative real-time polymerase chain reaction. We observed a significant decrease in the expression of opioid peptide precursors (proopiomelanocortin, proenkephalin, and prodynorphin) and of the kappa opioid receptor after 48 and 72 h of EtOH exposure (10 and 40 mM). These alterations were not present when the EtOH metabolism was blocked by 4-methylpyrazole. To evaluate whether the effects evoked by EtOH were possibly due to the first product of EtOH metabolism, cells were exposed to 0.4 mM acetaldehyde. We observed the same pattern of changes for prodynorphin, proenkephalin, and the kappa opioid receptor as after 72 h exposure to EtOH. These results contribute to our understanding of EtOH action at a cellular level and provide evidence of the role of acetaldehyde in mediating some of the EtOH-induced effects.	[D'Addario, Claudio; Ming, Yu; Terenius, Lars] Karolinska Inst, Dept Clin Neurosci, S-17176 Stockholm, Sweden; [D'Addario, Claudio; Ogren, Sven-Ove] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	D'Addario, C (corresponding author), Karolinska Inst, Dept Clin Neurosci, CMM L8 01, S-17176 Stockholm, Sweden.	claudio.daddario@ki.se	DAddario, Claudio/A-5970-2010	Ogren, Sven Ove/0000-0003-2573-5276; d'addario, claudio/0000-0002-1275-098X				ANGELOGIANNI P, 1993, NEUROENDOCRINOLOGY, V57, P106, DOI 10.1159/000126348; Asher O, 2002, J PHARMACOL EXP THER, V301, P66, DOI 10.1124/jpet.301.1.66; Beadles-Bohling AS, 2005, BRAIN RES, V1046, P77, DOI 10.1016/j.brainres.2005.03.043; Boyadjieva N, 1997, ALCOHOL CLIN EXP RES, V21, P477; Chen CP, 2004, J NEUROCHEM, V88, P1547, DOI 10.1046/j.1471-4159.2003.02300.x; Chumakova OV, 2000, B EXP BIOL MED+, V130, P921, DOI 10.1007/BF02682270; Cowen M. S., 2006, CNS & Neurological Disorders-Drug Targets, V5, P233, DOI 10.2174/187152706776359646; Cowen MS, 2001, ALCOHOL CLIN EXP RES, V25, P1126, DOI 10.1111/j.1530-0277.2001.tb02326.x; DAVE JR, 1986, ENDOCRINOLOGY, V118, P280, DOI 10.1210/endo-118-1-280; Deitrich RA, 2004, J STUD ALCOHOL, V65, P557, DOI 10.15288/jsa.2004.65.557; Faingold CL, 1998, PROG NEUROBIOL, V55, P509, DOI 10.1016/S0301-0082(98)00027-6; GIANOULAKIS C, 1988, ENDOCRINOLOGY, V122, P817, DOI 10.1210/endo-122-3-817; GRAFSTROM RC, 1994, CARCINOGENESIS, V15, P985, DOI 10.1093/carcin/15.5.985; Hall FS, 2001, PSYCHOPHARMACOLOGY, V154, P43, DOI 10.1007/s002130000622; Holownia A, 1997, NEUROTOXICOL TERATOL, V19, P141, DOI 10.1016/S0892-0362(96)00226-7; Holownia A, 1999, BRAIN RES, V833, P202, DOI 10.1016/S0006-8993(99)01529-2; Holownia A, 1996, ALCOHOL, V13, P93, DOI 10.1016/0741-8329(95)02019-5; Jope RS, 1998, J NEUROCHEM, V70, P763; Koob GF, 1998, ALCOHOL CLIN EXP RES, V22, P3, DOI 10.1097/00000374-199802000-00001; Koob GF, 2003, ALCOHOL CLIN EXP RES, V27, P232, DOI 10.1097/01.ALC.0000057122.36127.C2; Kovacs KM, 2005, ALCOHOL CLIN EXP RES, V29, P730, DOI 10.1097/01.ALC.0000164361.62346.D6; Kuriyama K, 1987, Alcohol Alcohol Suppl, V1, P685; Lamarche F, 2004, CELL BIOL TOXICOL, V20, P361, DOI 10.1007/s10565-004-0087-9; Lin MCM, 1997, FASEB J, V11, P1145, DOI 10.1096/fasebj.11.13.9367349; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo J, 1997, BRAIN RES, V770, P139, DOI 10.1016/S0006-8993(97)00762-2; Lyon E, 2001, CLIN CHEM, V47, P844; Maas JW, 2005, J NEUROSCI, V25, P4118, DOI 10.1523/JNEUROSCI.4273-04.2005; Muhlbauer E, 2003, EUR J PHARMACOL, V459, P121, DOI 10.1016/S0014-2999(02)02855-8; Narahashi T, 2001, ALCOHOL CLIN EXP RES, V25, p182S, DOI 10.1111/j.1530-0277.2001.tb02394.x; NICHOLLS R, 1992, INT J BIOCHEM, V24, P1899, DOI 10.1016/0020-711X(92)90285-9; NYLANDER I, 1994, ALCOHOL CLIN EXP RES, V18, P1272, DOI 10.1111/j.1530-0277.1994.tb00118.x; Oswald LM, 2004, PHYSIOL BEHAV, V81, P339, DOI 10.1016/j.physbeh.2004.02.008; PASTORCIC M, 1994, MOL CELL NEUROSCI, V5, P580, DOI 10.1006/mcne.1994.1071; Peoples RW, 1996, ANNU REV PHARMACOL, V36, P185, DOI 10.1146/annurev.pa.36.040196.001153; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poplawski MM, 2005, ALCOHOL CLIN EXP RES, V29, P648, DOI 10.1097/01.ALC.0000158834.11252.2E; Quertemont E, 2005, ALCOHOL CLIN EXP RES, V29, P221, DOI 10.1097/01.ALC.0000156185.39073.D2; Quertemont E, 2004, TRENDS PHARMACOL SCI, V25, P130, DOI 10.1016/j.tips.2004.01.001; Rao MN, 1999, METABOLISM, V48, P797, DOI 10.1016/S0026-0495(99)90182-8; Rasmussen DD, 2002, ALCOHOL CLIN EXP RES, V26, P535, DOI 10.1097/00000374-200204000-00015; Rasmussen DD, 2000, ALCOHOL CLIN EXP RES, V24, P1836, DOI 10.1097/00000374-200012000-00013; Ray LA, 2004, ALCOHOL CLIN EXP RES, V28, P1789, DOI 10.1097/01.ALC.0000148114.34000.B9; Roberts AJ, 2001, ALCOHOL CLIN EXP RES, V25, P1249, DOI 10.1111/j.1530-0277.2001.tb02344.x; Rosin A, 1999, NEUROSCI LETT, V275, P1, DOI 10.1016/S0304-3940(99)00675-8; Sarkola T, 2002, ALCOHOL CLIN EXP RES, V26, P239, DOI 10.1111/j.1530-0277.2002.tb02530.x; Scott HC, 1998, ALCOHOL CLIN EXP RES, V22, P2111, DOI 10.1111/j.1530-0277.1998.tb05924.x; SEIZINGER BR, 1984, J PHARMACOL EXP THER, V230, P455; SINGH NP, 1995, MUTAT RES-DNA REPAIR, V337, P9, DOI 10.1016/0921-8777(95)00006-6; Thibault C, 2000, MOL PHARMACOL, V58, P1593, DOI 10.1124/mol.58.6.1593; Turner RT, 1998, ALCOHOL CLIN EXP RES, V22, P1591, DOI 10.1097/00000374-199810000-00031; Uddin S, 1996, ALCOHOL CLIN EXP RES, V20, P556, DOI 10.1111/j.1530-0277.1996.tb01092.x; Wallington CL, 2002, BRAIN RES, V944, P73, DOI 10.1016/S0006-8993(02)02720-8; WHITFIELD JB, 1994, ALCOHOL CLIN EXP RES, V18, P238, DOI 10.1111/j.1530-0277.1994.tb00007.x; Wilke N, 2000, J PHARMACOL EXP THER, V292, P173; WINKLER A, 1995, ALCOHOL ALCOHOLISM, V30, P231; Worst TJ, 2005, ALCOHOL ALCOHOLISM, V40, P63, DOI 10.1093/alcalc/agh119; Xuei X, 2006, MOL PSYCHIATR, V11, P1016, DOI 10.1038/sj.mp.4001882; Yoshimura M, 2006, ALCOHOL CLIN EXP RES, V30, P1824, DOI 10.1111/j.1530-0277.2006.00219.x; Zhou Y, 2000, ALCOHOL CLIN EXP RES, V24, P1575, DOI 10.1111/j.1530-0277.2000.tb04577.x; ZIMMERMAN BT, 1995, ALCOHOL CLIN EXP RES, V19, P434, DOI 10.1111/j.1530-0277.1995.tb01527.x	61	22	22	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2008	22	3					662	670		10.1096/fj.07-8346com	http://dx.doi.org/10.1096/fj.07-8346com			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	17934066				2022-12-25	WOS:000254143700005
J	Goldfeder, MB; Oliveira, CC				Goldfeder, Mauricio B.; Oliveira, Carla C.			Cwc24p, a novel Saccharomyces cerevisiae nuclear ring finger protein, affects pre-snoRNA U3 splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL NUCLEOLAR RNA; 18S RIBOSOMAL-RNA; EXOSOME SUBUNIT RRP43P; BOX-C/D SNORNP; MESSENGER-RNA; PRP19P-ASSOCIATED COMPLEX; PRP19-ASSOCIATED COMPLEX; SPLICEOSOME ACTIVATION; YEAST; BIOGENESIS	U3 snoRNA is transcribed from two intron-containing genes in yeast, snR17A and snR17B. Although the assembly of the U3 snoRNP has not been precisely determined, at least some of the core box C/D proteins are known to bind pre-U3 co-transcriptionally, thereby affecting splicing and 3 '-end processing of this snoRNA. We identified the interaction between the box C/D assembly factor Nop17p and Cwc24p, a novel yeast RING finger protein that had been previously isolated in a complex with the splicing factor Cef1p. Here we show that, consistent with the protein interaction data, Cwc24p localizes to the cell nucleus, and its depletion leads to the accumulation of both U3 pre-snoRNAs. U3 snoRNA is involved in the early cleavages of 35 S pre-rRNA, and the defective splicing of pre-U3 detected in cells depleted of Cwc24p causes the accumulation of the 35 S precursor rRNA. These results led us to the conclusion that Cwc 24p is involved in pre-U3 snoRNA splicing, indirectly affecting pre-rRNA processing.	[Goldfeder, Mauricio B.; Oliveira, Carla C.] Univ Sao Paulo, Inst Chem, Dept Biochem, BR-05508900 Sao Paulo, Brazil	Universidade de Sao Paulo	Oliveira, CC (corresponding author), Univ Sao Paulo, Inst Chem, Dept Biochem, 748 Av Prof Lineu Prestes, BR-05508900 Sao Paulo, Brazil.	ccoliv@iq.usp.br	Oliveira, Carla C/F-2323-2011	Oliveira, Carla C/0000-0002-1098-9241				Arenas JE, 1997, P NATL ACAD SCI USA, V94, P11798, DOI 10.1073/pnas.94.22.11798; Bachellerie JP, 1997, TRENDS BIOCHEM SCI, V22, P257, DOI 10.1016/S0968-0004(97)01057-8; BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; BELTRAME M, 1995, EMBO J, V14, P4350, DOI 10.1002/j.1460-2075.1995.tb00109.x; Bleichert F, 2006, P NATL ACAD SCI USA, V103, P9464, DOI 10.1073/pnas.0603673103; Cahill NM, 2002, EMBO J, V21, P3816, DOI 10.1093/emboj/cdf376; Chan SP, 2005, J BIOL CHEM, V280, P31190, DOI 10.1074/jbc.M505060200; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Chen CH, 2006, RNA, V12, P765, DOI 10.1261/rna.2292106; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Clery A, 2007, MOL CELL BIOL, V27, P1191, DOI 10.1128/MCB.01287-06; Combs DJ, 2006, MOL CELL BIOL, V26, P523, DOI 10.1128/MCB.26.2.523-534.2006; Dez C, 2002, MOL CELL BIOL, V22, P7053, DOI 10.1128/MCB.22.20.7053-7065.2002; Dobryn HC, 2004, RNA, V10, P308, DOI 10.1261/rna.5970404; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Fatica A, 2002, MOL CELL, V9, P341, DOI 10.1016/S1097-2765(02)00458-6; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giorgi C, 2001, EMBO J, V20, P6856, DOI 10.1093/emboj/20.23.6856; Gonzales FA, 2005, J MOL BIOL, V346, P437, DOI 10.1016/j.jmb.2004.11.071; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Granneman S, 2003, NUCLEIC ACIDS RES, V31, P1877, DOI 10.1093/nar/gkg300; Hall DB, 2006, MOL CELL BIOL, V26, P3672, DOI 10.1128/MCB.26.9.3672-3679.2006; HUGHES JMX, 1991, EMBO J, V10, P4231, DOI 10.1002/j.1460-2075.1991.tb05001.x; James P, 1996, GENETICS, V144, P1425; Kufel J, 2000, MOL CELL BIOL, V20, P5415, DOI 10.1128/MCB.20.15.5415-5424.2000; Kufel J, 2003, NUCLEIC ACIDS RES, V31, P6788, DOI 10.1093/nar/gkg904; Kufel J, 2003, J BIOL CHEM, V278, P2147, DOI 10.1074/jbc.M208856200; Lafontaine DLJ, 2000, MOL CELL BIOL, V20, P2650, DOI 10.1128/MCB.20.8.2650-2659.2000; Lafontaine DLJ, 1999, RNA, V5, P455, DOI 10.1017/S135583829998192X; LI HV, 1990, MOL CELL BIOL, V10, P1145, DOI 10.1128/MCB.10.3.1145; Martin A, 2002, J BIOL CHEM, V277, P17743, DOI 10.1074/jbc.M200762200; MAXWELL ES, 1995, ANNU REV BIOCHEM, V64, P897, DOI 10.1146/annurev.bi.64.070195.004341; Morlando M, 2004, EMBO J, V23, P2392, DOI 10.1038/sj.emboj.7600254; Morrissey JP, 1997, CHROMOSOMA, V105, P515, DOI 10.1007/BF02510488; Mougin A, 1996, RNA, V2, P1079; Nazar RN, 2004, IUBMB LIFE, V56, P457, DOI 10.1080/15216540400010867; Nicoloso M, 1996, J MOL BIOL, V260, P178, DOI 10.1006/jmbi.1996.0391; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Ohi MD, 2005, MOL CELL BIOL, V25, P451, DOI 10.1128/MCB.25.1.451-460.2005; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Ohi MD, 2002, RNA, V8, P798, DOI 10.1017/S1355838202025050; Oliveira CC, 2002, NUCLEIC ACIDS RES, V30, P4186, DOI 10.1093/nar/gkf545; Pleiss JA, 2007, PLOS BIOL, V5, P745, DOI 10.1371/journal.pbio.0050090; Preti M, 2006, BIOCHEM BIOPH RES CO, V351, P468, DOI 10.1016/j.bbrc.2006.10.053; Rudra D, 2007, MOL CELL BIOL, V27, P4815, DOI 10.1128/MCB.02062-06; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHIMMANG T, 1989, EMBO J, V8, P4015, DOI 10.1002/j.1460-2075.1989.tb08584.x; Sharma K, 1999, MOL CELL BIOL, V19, P6012; Sherman F, 1986, LAB COURSE MANUAL ME; Stevens SW, 2001, RNA, V7, P1543; TOLLERVEY D, 1991, EMBO J, V10, P573, DOI 10.1002/j.1460-2075.1991.tb07984.x; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; Tollervey D, 1997, CURR OPIN CELL BIOL, V9, P337, DOI 10.1016/S0955-0674(97)80005-1; Tsai WY, 1999, J BIOL CHEM, V274, P9455, DOI 10.1074/jbc.274.14.9455; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Warner JR, 2001, CELL, V107, P133, DOI 10.1016/S0092-8674(01)00531-1; Watkins NJ, 2004, MOL CELL, V16, P789, DOI 10.1016/j.molcel.2004.11.012; Watkins NJ, 2002, MOL CELL BIOL, V22, P8342, DOI 10.1128/MCB.22.23.8342-8352.2002; Wu P, 1998, J BIOL CHEM, V273, P16453, DOI 10.1074/jbc.273.26.16453; Zanchin NIT, 1997, MOL CELL BIOL, V17, P5001, DOI 10.1128/MCB.17.9.5001; Zanchin NIT, 1999, MOL CELL BIOL, V19, P1518	68	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2644	2653		10.1074/jbc.M707885200	http://dx.doi.org/10.1074/jbc.M707885200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	17974558	hybrid			2022-12-25	WOS:000252622300021
J	Ferguson, BJ; Alexander, C; Rossi, SW; Liiv, I; Rebane, A; Worth, CL; Wong, J; Laan, M; Peterson, P; Jenkinson, EJ; Anderson, G; Scott, HS; Cooke, A; Rich, T				Ferguson, Brian J.; Alexander, Clare; Rossi, Simona W.; Liiv, Ingrid; Rebane, Ana; Worth, Catherine L.; Wong, Joyce; Laan, Martti; Peterson, Paert; Jenkinson, Eric J.; Anderson, Graham; Scott, Hamish S.; Cooke, Anne; Rich, Tina			AIRE's CARD revealed, a new structure for central tolerance provokes transcriptional plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOIMMUNE REGULATOR PROTEIN; CREB-BINDING-PROTEIN; NUCLEAR-BODIES; SUBCELLULAR-LOCALIZATION; FUNCTIONAL DOMAINS; THYMIC EXPRESSION; EPITHELIAL-CELLS; GENE; PML; PATHWAY	Developing T cells encounter peripheral self-antigens in the thymus in order to delete autoreactive clones. It is now known that the autoimmune regulator protein ( AIRE), which is expressed in thymic medullary epithelial cells, plays a key role in regulating the thymic transcription of these peripheral tissue-specific antigens. Mutations in the AIRE gene are associated with a severe multiorgan autoimmune syndrome ( APECED), and autoimmune reactivities are manifest in AIRE-deficient mice. Functional AIRE protein is expressed as distinct nuclear puncta, although no structural basis existed to explain their relevance to disease. In addressing the cell biologic basis for APECED, we made the unexpected discovery that an AIRE mutation hot spot lies in a caspase recruitment domain. Combined homology modeling and in vitro data now show how APECED mutations influence the activity of this transcriptional regulator. We also provide novel in vivo evidence for AIRE's association with a global transcription cofactor, which may underlie AIRE's focal, genome-wide, alteration of the transcriptome.	[Ferguson, Brian J.; Alexander, Clare; Cooke, Anne; Rich, Tina] Univ Cambridge, Dept Pathol, Div Immunol & Cellular Pathol, Cambridge CB2 1QP, England; [Rossi, Simona W.; Jenkinson, Eric J.; Anderson, Graham] Univ Birmingham, MRC, Ctr Immune Regulat, Inst Biomed Res, Birmingham B15 2TT, W Midlands, England; [Liiv, Ingrid; Rebane, Ana; Laan, Martti; Peterson, Paert] Univ Tartu, EE-50411 Tartu, Estonia; [Worth, Catherine L.; Wong, Joyce] Univ Cambridge, Dept Biochem, Cambridge CB2 1QP, England; [Scott, Hamish S.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	University of Cambridge; University of Birmingham; University of Tartu; University of Cambridge; Walter & Eliza Hall Institute	Rich, T (corresponding author), Univ Glasgow, Inst Comparat Med, Glasgow G61 1QH, Lanark, Scotland.	T.Rich@vet.gla.ac.uk	Cooke, Anne/S-4763-2019; Cooke, Anne/E-8709-2012; Scott, Hamish/B-2122-2009; Rebane, Ana/D-4279-2013; Laan, Martti/J-5031-2014; Peterson, Pärt/A-5788-2009	Cooke, Anne/0000-0003-3327-6081; Scott, Hamish/0000-0002-5813-631X; Rebane, Ana/0000-0001-6051-1361; Laan, Martti/0000-0002-0448-8627; Peterson, Pärt/0000-0001-6755-791X; anderson, graham/0000-0002-2917-4085; Worth, Catherine/0000-0002-1796-9606; Ferguson, Brian/0000-0002-6873-1032; Rossi, Simona W/0000-0002-8212-0502	MRC [G0401620] Funding Source: UKRI; Medical Research Council [G0401620] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Akiyoshi H, 2004, J BIOL CHEM, V279, P33984, DOI 10.1074/jbc.M400702200; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Blechschmidt K, 1999, GENOME RES, V9, P158; Chin RK, 2003, NAT IMMUNOL, V4, P1121, DOI 10.1038/ni982; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DeVoss J, 2006, J EXP MED, V203, P2727, DOI 10.1084/jem.20061864; Doucas V, 1999, P NATL ACAD SCI USA, V96, P2627, DOI 10.1073/pnas.96.6.2627; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Gavanescu I, 2007, P NATL ACAD SCI USA, V104, P4583, DOI 10.1073/pnas.0700259104; Grotzinger T, 1996, MOL CELL BIOL, V16, P1150; Halonen M, 2004, HUM MUTAT, V23, P245, DOI 10.1002/humu.20003; Hamazaki Y, 2007, NAT IMMUNOL, V8, P304, DOI 10.1038/ni1438; Heino M, 1999, BIOCHEM BIOPH RES CO, V257, P821, DOI 10.1006/bbrc.1999.0308; Johnnidis JB, 2005, P NATL ACAD SCI USA, V102, P7233, DOI 10.1073/pnas.0502670102; Kwok RPS, 2006, MOL REPROD DEV, V73, P885, DOI 10.1002/mrd.20440; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Maul GG, 2000, J STRUCT BIOL, V129, P278, DOI 10.1006/jsbi.2000.4239; McManus KJ, 2006, PLOS COMPUT BIOL, V2, P1271, DOI 10.1371/journal.pcbi.0020139; Milovic-Holm K, 2007, EMBO J, V26, P391, DOI 10.1038/sj.emboj.7601504; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Negorev DG, 2006, J VIROL, V80, P8019, DOI 10.1128/JVI.02164-05; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; PEARSON W, 1997, COMPUT APPL BIOSCI, P325; Pitkanen J, 2005, BIOCHEM BIOPH RES CO, V333, P944, DOI 10.1016/j.bbrc.2005.05.187; Pitkanen J, 2001, J BIOL CHEM, V276, P19597, DOI 10.1074/jbc.M008322200; Pitkanen J, 2000, J BIOL CHEM, V275, P16802, DOI 10.1074/jbc.M908944199; Ponting CP, 2002, ANNU REV BIOPH BIOM, V31, P45, DOI 10.1146/annurev.biophys.31.082901.134314; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Ramsey C, 2002, HUM MOL GENET, V11, P3299, DOI 10.1093/hmg/11.26.3299; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Sternsdorf T, 1997, IMMUNOBIOLOGY, V198, P307, DOI 10.1016/S0171-2985(97)80051-4; Su MA, 2004, CURR OPIN IMMUNOL, V16, P746, DOI 10.1016/j.coi.2004.09.009; Tang J, 2005, CANCER BIOL THER, V4, P645, DOI 10.4161/cbt.4.6.1729; Taubert R, 2007, EUR J IMMUNOL, V37, P838, DOI 10.1002/eji.200636962; Topham CM, 1997, PROTEIN ENG, V10, P7, DOI 10.1093/protein/10.1.7; Varadaraj A, 2007, J PATHOL, V211, P471, DOI 10.1002/path.2126; Venanzi ES, 2004, CURR OPIN IMMUNOL, V16, P197, DOI 10.1016/j.coi.2004.01.008; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; WORTH CL, 2007, IN PRESS J BIOINFORM; Zhu MZ, 2006, J CLIN INVEST, V116, P2964, DOI 10.1172/JCI28326	52	67	68	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1723	1731		10.1074/jbc.M707211200	http://dx.doi.org/10.1074/jbc.M707211200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17974569	hybrid, Green Accepted			2022-12-25	WOS:000252282700059
J	Chen, S; Hu, T; Zhang, J; Chen, J; Chen, K; Ding, J; Jiang, H; Shen, X				Chen, Shuai; Hu, Tiancen; Zhang, Jian; Chen, Jing; Chen, Kaixian; Ding, Jianping; Jiang, Hualiang; Shen, Xu			Mutation of Gly-11 on the dimer interface results in the complete crystallographic dimer dissociation of severe acute respiratory syndrome coronavirus 3C-like protease - Crystal structure with molecular dynamics simulations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COV MAIN PROTEINASE; SUBSTRATE-SPECIFICITY; ENZYMATIC-ACTIVITY; M-PRO; SARS; DIMERIZATION; PURIFICATION; INHIBITOR; DESIGN; SYSTEM	SARS-CoV 3C-like protease (3CL(pro)) is an attractive target for anti-severe acute respiratory syndrome (SARS) drug discovery, and its dimerization has been extensively proved to be indispensable for enzymatic activity. However, the reason why the dissociated monomer is inactive still remains unclear due to the absence of the monomer structure. In this study, we showed that mutation of the dimer-interface residue Gly-11 to alanine entirely abolished the activity of SARS-CoV 3CL(pro). Subsequently, we determined the crystal structure of this mutant and discovered a complete crystallographic dimer dissociation of SARS-CoV 3CL(pro). The mutation might shorten the alpha-helix A' of domain I and cause a mis-oriented N-terminal finger that could not correctly squeeze into the pocket of another monomer during dimerization, thus destabilizing the dimer structure. Several structural features essential for catalysis and substrate recognition are severely impaired in the G11A monomer. Moreover, domain III rotates dramatically against the chymotrypsin fold compared with the dimer, from which we proposed a putative dimerization model for SARS-CoV 3CL(pro). As the first reported monomer structure for SARS-CoV 3CL(pro), the crystal structure of G11A mutant might provide insight into the dimerization mechanism of the protease and supply direct structural evidence for the incompetence of the dissociated monomer.	[Chen, Shuai; Hu, Tiancen; Zhang, Jian; Chen, Jing; Chen, Kaixian; Jiang, Hualiang; Shen, Xu] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Ding, Jianping] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, State Key Lab Mol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Jiang, H (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.	hljiang@mail.shcnc.ac.cn; xshen@mail.shcnc.ac.cn	Zhang, Jian/GXA-1303-2022	Zhang, Jian/0000-0002-6558-791X; ding, jian ping/0000-0001-7029-7346				Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrila J, 2006, BIOCHEMISTRY-US, V45, P14908, DOI 10.1021/bi0616302; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen H, 2006, J BIOL CHEM, V281, P13894, DOI 10.1074/jbc.M510745200; Chen S, 2005, ACTA PHARMACOL SIN, V26, P99, DOI 10.1111/j.1745-7254.2005.00010.x; Chen S, 2005, J BIOL CHEM, V280, P164, DOI 10.1074/jbc.M408211200; Chou CY, 2004, BIOCHEMISTRY-US, V43, P14958, DOI 10.1021/bi0490237; Ding L, 2005, ANAL BIOCHEM, V343, P159, DOI 10.1016/j.ab.2005.04.027; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan KQ, 2005, BIOCHEM BIOPH RES CO, V329, P934, DOI 10.1016/j.bbrc.2005.02.061; Fan KQ, 2004, J BIOL CHEM, V279, P1637, DOI 10.1074/jbc.M310875200; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P6212, DOI 10.1073/pnas.0400762101; Gao F, 2003, FEBS LETT, V553, P451, DOI 10.1016/S0014-5793(03)01091-3; Graziano V, 2006, BIOCHEMISTRY-US, V45, P14632, DOI 10.1021/bi061746y; Graziano V, 2006, FEBS LETT, V580, P2577, DOI 10.1016/j.febslet.2006.04.004; Hsu MF, 2005, J BIOL CHEM, V280, P31257, DOI 10.1074/jbc.M502577200; Hsu WC, 2005, J BIOL CHEM, V280, P22741, DOI 10.1074/jbc.M502556200; Huang CK, 2004, BIOCHEMISTRY-US, V43, P4568, DOI 10.1021/bi036022q; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee TW, 2005, J MOL BIOL, V353, P1137, DOI 10.1016/j.jmb.2005.09.004; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shi JH, 2006, FEBS J, V273, P1035, DOI 10.1111/j.1742-4658.2006.05130.x; Shi JH, 2004, J BIOL CHEM, V279, P24765, DOI 10.1074/jbc.M311744200; Sun HF, 2003, PROTEIN EXPRES PURIF, V32, P302, DOI 10.1016/j.pep.2003.08.016; Tan JZ, 2005, J MOL BIOL, V354, P25, DOI 10.1016/j.jmb.2005.09.012; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wei P, 2006, BIOCHEM BIOPH RES CO, V339, P865, DOI 10.1016/j.bbrc.2005.11.102; Xu T, 2005, ACTA CRYSTALLOGR F, V61, P964, DOI 10.1107/S1744309105033257; Xue XY, 2007, J MOL BIOL, V366, P965, DOI 10.1016/j.jmb.2006.11.073; Yang HT, 2003, P NATL ACAD SCI USA, V100, P13190, DOI 10.1073/pnas.1835675100; Zheng KW, 2007, PROTEINS, V66, P467, DOI 10.1002/prot.21160	40	57	58	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					554	564		10.1074/jbc.M705240200	http://dx.doi.org/10.1074/jbc.M705240200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17977841	hybrid, Green Published			2022-12-25	WOS:000251940300060
J	Scott, DA; Hickerson, SM; Vickers, TJ; Beverley, SM				Scott, David A.; Hickerson, Suzanne M.; Vickers, Tim J.; Beverley, Stephen M.			The role of the mitochondrial glycine cleavage complex in the metabolism and virulence of the protozoan parasite Leishmania major	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUCTASE-THYMIDYLATE SYNTHASE; ONE-CARBON METABOLISM; DIHYDROFOLATE-REDUCTASE; SERINE HYDROXYMETHYLTRANSFERASE; SUBCELLULAR-LOCALIZATION; AMASTIGOTE VIRULENCE; FOLATE COENZYMES; P-PROTEIN; GENE; DECARBOXYLASE	For the human pathogen Leishmania major, a key metabolic function is the synthesis of thymidylate, which requires 5,10-methylenetetrahydrofolate (5,10-CH2-THF). 5,10-CH2-THF can be synthesized from glycine by the mitochondrial glycine cleavage complex (GCC). Bioinformatic analysis revealed the four subunits of the GCC in the L. major genome, and the role of the GCC in parasite metabolism and virulence was assessed through studies of the P subunit (glycine decarboxylase (GCVP)). First, a tagged GCVP protein was expressed and localized to the parasite mitochondrion. Second, a gcvP(-) mutant was generated and shown to lack significant GCC activity using an indirect in vivo assay after incorporation of label from [2-C-14] glycine into DNA. The gcvP(-) mutant grew poorly in the presence of excess glycine or minimal serine; these studies also established that L. major promastigotes require serine for optimal growth. Although gcvP(-) promastigotes and amastigotes showed normal virulence in macrophage infections in vitro, both forms of the parasite showed substantially delayed replication and lesion pathology in infections of both genetically susceptible or resistant mice. These data suggest that, as the physiology of the infection site changes during the course of infection, so do the metabolic constraints on parasite replication. This conclusion has great significance to the interpretation of metabolic requirements for virulence. Last, these studies call attention in trypanosomatid protozoa to the key metabolic intermediate 5,10-CH2-THF, situated at the junction of serine, glycine, and thymidylate metabolism. Notably, genome-based predictions suggest the related parasite Trypanosoma brucei is totally dependent on the GCC for 5,10-CH2-THF synthesis.	[Scott, David A.; Hickerson, Suzanne M.; Vickers, Tim J.; Beverley, Stephen M.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Beverley, SM (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, Campus Box 8230, 660 S Euclid Ave, St Louis, MO 63110 USA.	beverley@borcim.wustl.edu		Scott, David/0000-0002-8668-2449; Beverley, Stephen/0000-0001-5319-0811	NIAID NIH HHS [AI 21903, R37 AI021903, R01 AI021903-26, R01 AI021903] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI021903, R01AI021903] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bauwe H, 2003, J EXP BOT, V54, P1523, DOI 10.1093/jxb/erg171; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Berman J, 2006, T ROY SOC TROP MED H, V100, pS41, DOI 10.1016/j.trstmh.2006.02.009; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bogdan C, 2000, J EXP MED, V191, P2121, DOI 10.1084/jem.191.12.2121; Capul AA, 2007, INFECT IMMUN, V75, P4629, DOI 10.1128/IAI.00735-07; Chandok MR, 2003, CELL, V113, P469, DOI 10.1016/S0092-8674(03)00350-7; Chaudhary K, 2005, NAT BIOTECHNOL, V23, P1089, DOI 10.1038/nbt0905-1089; Christensen KE, 2006, BIOESSAYS, V28, P595, DOI 10.1002/bies.20420; Chu E, 2003, CANCER CHEMOTH PHARM, V52, pS80, DOI 10.1007/s00280-003-0625-9; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; COOMBS GH, 1986, PARASITOLOGY, V92, P13, DOI 10.1017/S0031182000063411; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Engel N, 2007, PLANT PHYSIOL, V144, P1328, DOI 10.1104/pp.107.099317; Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103; Gagnon D, 2006, MOL BIOCHEM PARASIT, V150, P63, DOI 10.1016/j.molbiopara.2006.06.009; GARRETT CE, 1984, MOL BIOCHEM PARASIT, V11, P257, DOI 10.1016/0166-6851(84)90070-7; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; HAMMOND DJ, 1984, MOL BIOCHEM PARASIT, V13, P243, DOI 10.1016/0166-6851(84)90117-8; Hardy LW, 1997, EXP PARASITOL, V87, P157, DOI 10.1006/expr.1997.4207; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; Hong PC, 2000, INFECT IMMUN, V68, P4102, DOI 10.1128/IAI.68.7.4102-4107.2000; HORNE DW, 1992, J NUTR, V122, P2204, DOI 10.1093/jn/122.11.2204; HORNE DW, 1989, ARCH BIOCHEM BIOPHYS, V270, P729, DOI 10.1016/0003-9861(89)90556-0; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; Kastanos EK, 1997, BIOCHEMISTRY-US, V36, P14956, DOI 10.1021/bi971610n; Klessig DF, 2004, CELL, V119, P445, DOI 10.1016/j.cell.2004.10.007; KNIGHTON DR, 1994, NAT STRUCT BIOL, V1, P186, DOI 10.1038/nsb0394-186; Lira R, 1999, J INFECT DIS, V180, P564, DOI 10.1086/314896; Luo MZ, 1997, PLANT MOL BIOL, V33, P709, DOI 10.1023/A:1005798207693; McConville MJ, 2007, TRENDS PARASITOL, V23, P368, DOI 10.1016/j.pt.2007.06.009; McNeil JB, 1996, GENETICS, V142, P371; MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L; Melchior D, 2004, J ANIM SCI, V82, P1091; Nagarajan L, 1997, J BIOL CHEM, V272, P4444, DOI 10.1074/jbc.272.7.4444; Nakai T, 2005, EMBO J, V24, P1523, DOI 10.1038/sj.emboj.7600632; Nare B, 1997, J BIOL CHEM, V272, P13883, DOI 10.1074/jbc.272.21.13883; Neuburger M, 1996, J BIOL CHEM, V271, P9466, DOI 10.1074/jbc.271.16.9466; Opperdoes FR, 2007, TRENDS PARASITOL, V23, P149, DOI 10.1016/j.pt.2007.02.004; Payne SH, 2006, EUKARYOT CELL, V5, P272, DOI 10.1128/EC.5.2.272-276.2006; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Piper MD, 2000, J BIOL CHEM, V275, P30987, DOI 10.1074/jbc.M004248200; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; SACKS DL, 1984, SCIENCE, V223, P1417, DOI 10.1126/science.6701528; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schirch L. V., 1984, FOLATES PTERINS CHEM, V1, P399; Spath GF, 2000, P NATL ACAD SCI USA, V97, P9258, DOI 10.1073/pnas.160257897; Spath GF, 2001, EXP PARASITOL, V99, P97, DOI 10.1006/expr.2001.4656; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196; SWAFFORD JR, 1990, 12 P C EL MICR, P610; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; WALKER JL, 1986, J BIOL CHEM, V261, P2214; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Zhang K, 2005, MOL MICROBIOL, V55, P1566, DOI 10.1111/j.1365-2958.2005.04493.x; Zufferey R, 2003, J BIOL CHEM, V278, P44708, DOI 10.1074/jbc.M308063200	61	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					155	165		10.1074/jbc.M708014200	http://dx.doi.org/10.1074/jbc.M708014200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17981801	hybrid, Green Accepted			2022-12-25	WOS:000251940300018
J	Hatakeyama, T; Unno, H; Kouzuma, Y; Uchida, T; Eto, S; Hidemura, H; Kato, N; Yonekura, M; Kusunoki, M				Hatakeyama, Tomomitsu; Unno, Hideaki; Kouzuma, Yoshiaki; Uchida, Tatsuya; Eto, Seiichiro; Hidemura, Haruki; Kato, Norihisa; Yonekura, Masami; Kusunoki, Masami			C-type lectin-like carbohydrate recognition of the hemolytic lectin CEL-III containing ricin-type beta-trefoil folds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVERTEBRATE CUCUMARIA-ECHINATA; MARINE INVERTEBRATE; LIGAND-BINDING; CRYSTAL-STRUCTURE; B-CHAIN; PROTEINS; DOMAIN; SEEDS	CEL-III is a Ca2+ dependent hemolytic lectin, isolated from the marine invertebrate Cucumaria echinata. The three-dimensional structure of CEL-III/GalNAc and CEL-III/ methyl alpha-galactoside complexes was solved by x-ray crystallographic analysis. In these complexes, five carbohydrate molecules were found to be bound to two carbohydrate-binding domains (domains 1 and 2) located in the N-terminal 2/3 portion of the polypeptide and that contained beta-trefoil folds similar to ricin B-chain. The 3-OH and 4-OH of bound carbohydrate molecules were coordinated with Ca2+ located at the subdomains 1 alpha, 1 gamma, 2 alpha, 2 beta, and 2 gamma, simultaneously forming hydrogen bond networks with nearby amino acid side chains, which is similar to carbohydrate binding in C-type lectins. The binding of carbohydrates was further stabilized by aromatic amino acid residues, such as tyrosine and tryptophan, through a stacking interaction with the hydrophobic face of carbohydrates. The importance of amino acid residues in the carbohydrate-binding sites was confirmed by the mutational analyses. The orientation of bound GalNAc and methyl alpha-galactoside was similar to the galactose moiety of lactose bound to the carbohydrate-binding site of the ricin B-chain, although the ricin B-chain does not require Ca2+ ions for carbohydrate binding. The binding of the carbohydrates induced local structural changes in carbohydrate-binding sites in subdomains 2 alpha and 2 beta. Binding of GalNAc also induced a slight change in the main chain structure of domain 3, which could be related to the conformational change upon binding of specific carbohydrates to induce oligomerization of the protein.	[Hatakeyama, Tomomitsu; Unno, Hideaki; Eto, Seiichiro; Hidemura, Haruki] Nagasaki Univ, Fac Engn, Dept Appl Chem, Nagasaki 8528521, Japan; [Kouzuma, Yoshiaki; Kato, Norihisa; Yonekura, Masami] Ibaraki Univ, Coll Agr, Dept Res Biol Sci, Ibaraki 3000393, Japan; [Uchida, Tatsuya; Kusunoki, Masami] Osaka Univ, Inst Prot Res, Res Ctr Struct & Funct Proteom, Suita, Osaka 5650871, Japan	Nagasaki University; Ibaraki University; Osaka University	Hatakeyama, T (corresponding author), Nagasaki Univ, Fac Engn, Dept Appl Chem, 1-14 Bunkyo-machi, Nagasaki 8528521, Japan.	thata@nagasaki-u.ac.jp	Hideaki, UNNO/ABG-9471-2020	Hideaki, UNNO/0000-0001-5917-269X; Hatakeyama, Tomomitsu/0000-0002-9505-1980				Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; ARAKI T, 1987, BIOCHIM BIOPHYS ACTA, V911, P191, DOI 10.1016/0167-4838(87)90008-2; Armstrong PB, 1996, J BIOL CHEM, V271, P14717, DOI 10.1074/jbc.271.25.14717; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fivaz M, 1999, TRENDS CELL BIOL, V9, P212, DOI 10.1016/S0962-8924(99)01567-6; FUNATSU G, 1979, AGR BIOL CHEM TOKYO, V43, P2221, DOI 10.1080/00021369.1979.10863794; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Hatakeyama T, 1997, J BIOCHEM, V121, P63; HATAKEYAMA T, 1995, J BIOL CHEM, V270, P3560, DOI 10.1074/jbc.270.8.3560; Hatakeyama T, 1999, J BIOCHEM, V125, P277, DOI 10.1093/oxfordjournals.jbchem.a022284; HATAKEYAMA T, 1994, J BIOCHEM, V116, P209, DOI 10.1093/oxfordjournals.jbchem.a124495; Hatakeyama T, 1996, J BIOL CHEM, V271, P16915, DOI 10.1074/jbc.271.28.16915; Hazes B, 1996, PROTEIN SCI, V5, P1490, DOI 10.1002/pro.5560050805; KIMURA M, 1993, BIOSCI BIOTECH BIOCH, V57, P166, DOI 10.1271/bbb.57.166; KONSKA G, 1994, J BIOCHEM-TOKYO, V116, P519, DOI 10.1093/oxfordjournals.jbchem.a124555; Kouzuma Y, 2003, J BIOCHEM, V134, P395, DOI 10.1093/jb/mvg157; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEPPLA SH, 2006, COMPREHENSIVE SOURCE, P323; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakano M, 1999, BBA-PROTEIN STRUCT M, V1435, P167, DOI 10.1016/S0167-4838(99)00212-5; Ng KKS, 2002, J BIOL CHEM, V277, P16088, DOI 10.1074/jbc.M200493200; Oda T, 1997, J BIOCHEM, V121, P560; Oda T, 1999, J BIOCHEM, V125, P713, DOI 10.1093/oxfordjournals.jbchem.a022341; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; PARKER MW, 1994, NATURE, V367, P292, DOI 10.1038/367292a0; Poget SF, 2001, BIOCHEMISTRY-US, V40, P10966, DOI 10.1021/bi002698z; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Rossjohn J, 1998, J STRUCT BIOL, V121, P92, DOI 10.1006/jsbi.1997.3947; Satoh F, 2002, J NAT TOXINS, V11, P297; Shrive AK, 2003, J MOL BIOL, V331, P509, DOI 10.1016/S0022-2836(03)00761-7; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Sugawara H, 2004, J BIOL CHEM, V279, P45219, DOI 10.1074/jbc.M408840200; Tateno H, 2003, J BIOL CHEM, V278, P40455, DOI 10.1074/jbc.M306836200; Uchida T, 2004, J BIOL CHEM, V279, P37133, DOI 10.1074/jbc.M404065200; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0	41	34	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37826	37835		10.1074/jbc.M705604200	http://dx.doi.org/10.1074/jbc.M705604200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17977832	hybrid			2022-12-25	WOS:000251833600058
J	Spira, D; Stypmann, J; Tobin, DJ; Petermann, I; Mayer, C; Hagemann, S; Vasiljeva, O; Gunther, T; Schule, R; Peters, C; Reinheckel, T				Spira, Daniel; Stypmann, Joerg; Tobin, Desmond J.; Petermann, Ivonne; Mayer, Christian; Hagemann, Sascha; Vasiljeva, Olga; Guenther, Thomas; Schuele, Roland; Peters, Christoph; Reinheckel, Thomas			Cell type-specific functions of the lysosomal protease cathepsin L in the heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAIR FOLLICLE MORPHOGENESIS; DILATED CARDIOMYOPATHY; CYSTEINE PROTEASES; MICE DEFICIENT; MOUSE; PEPTIDE; SECRETION; ECHOCARDIOGRAPHY; DIFFERENTIATION; KERATINOCYTE	Deficiency of the lysosomal cysteine protease cathepsin L (Ctsl) in mice results in a phenotype affecting multiple tissues, including thymus, epidermis, and hair follicles, and in the heart develops as a progressive dilated cardiomyopathy (DCM). To understand the role of Ctsl in the maintenance of regular heart morphology and function, it is critical to determine whether the DCM in Ctsl(-/-) mice is primarily because of the lack of Ctsl expression and activity in the cardiomyocytes or is caused by the additional extracardiac pathologies. Cardiomyocyte-specific expression of Ctsl in Ctsl(-/-) mice, using an alpha-myosin heavy chain promoter-Ctsl transgene, results in improved cardiac contraction, normal mRNA expression of atrionatriuretic peptide, normal heart weight, and regular ultrastructure of cardiomyocytes. Epithelial expression of cathepsin L2 (CTSL2) by a K14 promoter-CTSL2-transgene resulted in rescue of the Ctsl(-/-) hair loss phenotype. In these mice, cardiac atrionatriuretic peptide expression and end systolic heart dimensions were also significantly attenuated. However, cardiac contraction was not improved, and increased heart weight as well as the typical changes in lysosomal ultrastructure of Ctsl(-/-) hearts persisted. Myocardial fibrosis was detected in all Ctsl(-/-) mice irrespective of transgene-mediated cardiac Ctsl expression or extracardiac CTSL2 expression. Expression of collagen 1 was not enhanced in Ctsl(-/-) hearts, but a reduced collagenolytic activity suggests a role for Ctsl in collagen turnover by cardiac fibroblasts. We conclude that the DCM of Ctsl(-/-) mice is primarily caused by absence of the protease in cardiomyocytes, whereas the complex gross phenotype of Ctsl-deficient mice, i.e. the fur defect, results in additional stress to the heart.	[Spira, Daniel; Petermann, Ivonne; Mayer, Christian; Hagemann, Sascha; Vasiljeva, Olga; Peters, Christoph; Reinheckel, Thomas] Univ Freiburg, Inst Mol Med & Zellforsch, D-79104 Freiburg, Germany; [Stypmann, Joerg] Univ Klinikum Munster, Med Klin & Poliklin C Kardiol & Angiol, Klin Forsch Munster, D-48149 Munster, Germany; [Stypmann, Joerg] Univ Klinikum Munster, Klin Forsch Munster, Interdisziplinaren Zentrums, Zen Projektgrp Kleintierdiag 4A, D-48149 Munster, Germany; [Tobin, Desmond J.] Univ Bradford, Sch Life Sci, Bradford BD7 1DP, W Yorkshire, England; [Guenther, Thomas; Schuele, Roland] Univ Frauenklin, D-79106 Freiburg, Germany; [Guenther, Thomas; Schuele, Roland] Klinikum Albert Ludwigs Univ Freiburg, Zentrum Klin Forsch, D-79106 Freiburg, Germany	University of Freiburg; University of Munster; University of Munster; University of Bradford; University of Freiburg; University of Freiburg	Reinheckel, T (corresponding author), Univ Freiburg, Inst Mol Med & Zellforsch, Stefan Meier Str 17, D-79104 Freiburg, Germany.	thomas.reinheckel@uniklinikfreiburg.freiburg.de	Reinheckel, Thomas/AAL-9761-2021; Tobin, Desmond/A-5228-2009	Reinheckel, Thomas/0000-0001-9866-9105; Vasiljeva, Olga/0000-0003-3648-5460; Tobin, Desmond/0000-0003-4566-9392; Gunther, Thomas/0000-0003-3903-9490				Aikawa R, 2002, J BIOL CHEM, V277, P18979, DOI 10.1074/jbc.M201257200; BARRETT AJ, 1992, ANN NY ACAD SCI, V674, P1; Benavides F, 2002, AM J PATHOL, V161, P693, DOI 10.1016/S0002-9440(10)64225-3; Bestvater F, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-16; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Everts V, 2006, J BONE MINER RES, V21, P1399, DOI 10.1359/JBMR.060614; Felbor U, 2000, EMBO J, V19, P1187, DOI 10.1093/emboj/19.6.1187; FIGULLA HR, 1991, CARDIOLOGY, V78, P282, DOI 10.1159/000174795; Friedrichs B, 2003, J CLIN INVEST, V111, P1733, DOI 10.1172/JCI200315990; Frosch BA, 1999, APMIS, V107, P28, DOI 10.1111/j.1699-0463.1999.tb01523.x; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Guertl B, 2000, INT J EXP PATHOL, V81, P349, DOI 10.1046/j.1365-2613.2000.00186.x; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; GULICK J, 1991, J BIOL CHEM, V266, P9180; Hagemann S, 2004, EUR J CELL BIOL, V83, P775, DOI 10.1078/0171-9335-00404; Honey K, 2002, J EXP MED, V195, P1349, DOI 10.1084/jem.20011904; Hughes SE, 2005, HEART, V91, P257, DOI 10.1136/hrt.2004.040337; Hughes SE, 2004, HISTOPATHOLOGY, V44, P412, DOI 10.1111/j.1365-2559.2004.01835.x; Langenickel T, 2000, AM J PHYSIOL-HEART C, V278, pH1500, DOI 10.1152/ajpheart.2000.278.5.H1500; Linke M, 2002, BIOL CHEM, V383, P773, DOI 10.1515/BC.2002.081; Loennechen JP, 2001, AM J PHYSIOL-HEART C, V280, pH2902, DOI 10.1152/ajpheart.2001.280.6.H2902; MACIEWICZ RA, 1988, BIOCHEM J, V256, P433, DOI 10.1042/bj2560433; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; MOWRY RW, 1958, LAB INVEST, V7, P566; Muntener K, 2004, J BIOL CHEM, V279, P41012, DOI 10.1074/jbc.M405333200; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Petermann I, 2006, FASEB J, V20, P1266, DOI 10.1096/fj.05-5517fje; Potts W, 2004, INT J EXP PATHOL, V85, P85, DOI 10.1111/j.0959-9673.2004.00373.x; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Reinheckel T, 2005, J CELL SCI, V118, P3387, DOI 10.1242/jcs.02469; Reinheckel T, 2001, BIOL CHEM, V382, P735, DOI 10.1515/BC.2001.089; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Shimomura H, 2001, JPN CIRC J, V65, P965, DOI 10.1253/jcj.65.965; Strauch OF, 2003, PEDIATR RES, V54, P701, DOI 10.1203/01.PDR.0000084085.65972.3F; Stypmann J, 2002, P NATL ACAD SCI USA, V99, P6234, DOI 10.1073/pnas.092637699; Stypmann J, 2006, BASIC RES CARDIOL, V101, P281, DOI 10.1007/s00395-006-0591-6; Stypmann J, 2006, INT J CARDIOVAS IMAG, V22, P353, DOI 10.1007/s10554-005-9052-9; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Tobin DJ, 2002, AM J PATHOL, V160, P1807, DOI 10.1016/S0002-9440(10)61127-3; Towbin JA, 2002, NATURE, V415, P227, DOI 10.1038/415227a; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Urbich C, 2005, NAT MED, V11, P206, DOI 10.1038/nm1182; Yasothornsrikul S, 2003, P NATL ACAD SCI USA, V100, P9590, DOI 10.1073/pnas.1531542100; YOSHIMURA M, 1993, CIRCULATION, V87, P464, DOI 10.1161/01.CIR.87.2.464	49	43	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37045	37052		10.1074/jbc.M703447200	http://dx.doi.org/10.1074/jbc.M703447200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17942402	hybrid			2022-12-25	WOS:000251646000031
J	Torres-Bacete, J; Nakamaru-Ogiso, E; Matsuno-Yagi, A; Yagi, T				Torres-Bacete, Jesus; Nakamaru-Ogiso, Eiko; Matsuno-Yagi, Akemi; Yagi, Takao			Characterization of the NuoM (ND4) subunit in Escherichia coli NDH-1 - Conserved charged residues essential for energy-coupled activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-QUINONE OXIDOREDUCTASE; HEREDITARY OPTIC NEUROPATHY; MITOCHONDRIAL COMPLEX-I; MEMBRANE DOMAIN SUBUNIT; UBIQUINONE REDUCTASE-ACTIVITY; CONVERTING NIFE HYDROGENASES; AEROBIC RESPIRATORY-CHAIN; PARACOCCUS-DENITRIFICANS; PROTEIN-STRUCTURE; SUBMITOCHONDRIAL PARTICLES	The proton-translocating NADH-quinone ( Q) oxidoreductase (NDH-1) from Escherichia coli is composed of two segments: a peripheral arm and a membrane arm. The membrane arm contains 7 hydrophobic subunits. Of these subunits, NuoM, a homolog of the mitochondrial ND4 subunit, is proposed to be involved in proton translocation and Q-binding. Therefore, we conducted site-directed mutation of 15 amino acid residues of NuoM and investigated their properties. In all mutants, the assembly of the whole enzyme seemed intact. Mutation of highly conserved Glu(144) and Lys(234) leads to almost total elimination of energy-transducing NDH-1 activities as well as increased production of superoxide radicals. Their NADH dehydrogenase activities were almost normal. Because these two residues are predicted to be located in the transmembrane segments of NuoM, the results strongly suggest that they participate in proton translocation. Although it is hypothesized that His interacts with a Q head group, mutations at four His moderately inhibited NDH-1 activities and had almost no effect on the K-m values for Q or IC50 values of capsaicin-40, a competitive inhibitor for the Q binding site. The data suggest that these His are not involved in the catalytic Q-binding. Functional roles of NuoM and advantages of NDH-1 research as a model for mitochondrial complex I study have been discussed.	[Torres-Bacete, Jesus; Nakamaru-Ogiso, Eiko; Matsuno-Yagi, Akemi; Yagi, Takao] Scripps Res Inst, Dept Mol & Expt Med, Div Biochem, La Jolla, CA 92037 USA	Scripps Research Institute	Yagi, T (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, Div Biochem, La Jolla, CA 92037 USA.	yagi@scripps.edu		Torres, Jesus/0000-0003-3410-6930	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033712] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM033712] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramson J, 2000, NAT STRUCT BIOL, V7, P910; Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; Baranova EA, 2007, J STRUCT BIOL, V159, P238, DOI 10.1016/j.jsb.2007.01.009; Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026; Branden M, 2002, BIOCHEMISTRY-US, V41, P10794, DOI 10.1021/bi026093; Cardol P, 2006, EUKARYOT CELL, V5, P1460, DOI 10.1128/EC.00118-06; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430; CHOMYN A, 1985, NATURE, V314, P591; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Clason T, 2007, J STRUCT BIOL, V159, P433, DOI 10.1016/j.jsb.2007.05.002; Di Bernardo S, 2000, BIOCHEMISTRY-US, V39, P9411; Di Bernardo S, 2001, FEBS LETT, V508, P385, DOI 10.1016/S0014-5793(01)03111-8; Fillingame RH, 1999, SCIENCE, V286, P1687, DOI 10.1126/science.286.5445.1687; Fisher N, 2000, J MOL BIOL, V296, P1153, DOI 10.1006/jmbi.2000.3509; Friedrich T, 1998, BBA-BIOENERGETICS, V1365, P215, DOI 10.1016/S0005-2728(98)00070-X; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Ghelli A, 1997, J BIOCHEM, V121, P746; Gong X, 2003, J BIOL CHEM, V278, P25731, DOI 10.1074/jbc.M302361200; GRAY KA, 1994, BIOCHEMISTRY-US, V33, P723, DOI 10.1021/bi00169a014; Guenebaut V, 1998, J MOL BIOL, V276, P105, DOI 10.1006/jmbi.1997.1518; HAN AL, 1988, ARCH BIOCHEM BIOPHYS, V267, P490, DOI 10.1016/0003-9861(88)90055-0; Hedderich R, 2005, J MOL MICROB BIOTECH, V10, P92, DOI 10.1159/000091557; Hedderich R, 2004, J BIOENERG BIOMEMBR, V36, P65, DOI 10.1023/B:JOBB.0000019599.43969.33; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hirst J, 2005, BIOCHEM SOC T, V33, P525, DOI 10.1042/BST0330525; Hofhaus G, 1996, J BIOL CHEM, V271, P13155, DOI 10.1074/jbc.271.22.13155; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Kao MC, 2004, J BIOL CHEM, V279, P32360, DOI 10.1074/jbc.M403885200; Kao MC, 2004, BIOCHEMISTRY-US, V43, P3750, DOI 10.1021/bi049927s; Kao MC, 2003, BIOCHEMISTRY-US, V42, P4534, DOI 10.1021/bi034166z; Kao MC, 2002, BIOCHEMISTRY-US, V41, P4377, DOI 10.1021/bi025525d; Kervinen M, 2004, BIOCHEMISTRY-US, V43, P773, DOI 10.1021/bi0355903; KIKUNO R, 1985, FEBS LETT, V189, P85, DOI 10.1016/0014-5793(85)80847-4; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Lunardi J, 1998, BBA-MOL BASIS DIS, V1407, P114, DOI 10.1016/S0925-4439(98)00036-2; Majander A, 1996, EUR J BIOCHEM, V239, P201, DOI 10.1111/j.1432-1033.1996.0201u.x; Marella M, 2007, J BIOL CHEM, V282, P24146, DOI 10.1074/jbc.M701819200; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Mathiesen C, 2003, FEBS LETT, V549, P7, DOI 10.1016/S0014-5793(03)00767-1; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; Messner KR, 1999, J BIOL CHEM, V274, P10119, DOI 10.1074/jbc.274.15.10119; MILLER MJ, 1990, P NATL ACAD SCI USA, V87, P4900, DOI 10.1073/pnas.87.13.4900; Mitaku S, 2002, BIOINFORMATICS, V18, P608, DOI 10.1093/bioinformatics/18.4.608; Mitaku S, 1999, PROTEIN ENG, V12, P953, DOI 10.1093/protein/12.11.953; Murai M, 2007, BIOCHEMISTRY-US, V46, P6409, DOI 10.1021/bi7003697; MURPHY E, 1985, EMBO J, V4, P3357, DOI 10.1002/j.1460-2075.1985.tb04089.x; Nakamaru-Ogiso E, 2005, J BIOL CHEM, V280, P301, DOI 10.1074/jbc.M410377200; Nakamaru-Ogiso E, 2003, FEBS LETT, V549, P43, DOI 10.1016/S0014-5793(03)00766-X; Nakamaru-Ogiso E, 2003, BIOCHEMISTRY-US, V42, P746, DOI 10.1021/bi0269660; Park JS, 2007, BBA-MOL BASIS DIS, V1772, P533, DOI 10.1016/j.bbadis.2007.01.009; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Remacle C, 2006, P NATL ACAD SCI USA, V103, P4771, DOI 10.1073/pnas.0509501103; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; Satoh T, 1996, BBA-BIOENERGETICS, V1273, P21, DOI 10.1016/0005-2728(95)00131-X; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Steuber J, 2003, J BIOL CHEM, V278, P26817, DOI 10.1074/jbc.M301682200; Takano S, 1996, BIOCHEMISTRY-US, V35, P9120, DOI 10.1021/bi9605853; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Valiyaveetil FI, 1997, J BIOL CHEM, V272, P32635, DOI 10.1074/jbc.272.51.32635; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; YAGI T, 1993, J BIOENERG BIOMEMBR, V25, P339, DOI 10.1007/BF00762459; YAGI T, 1986, ARCH BIOCHEM BIOPHYS, V250, P302, DOI 10.1016/0003-9861(86)90731-9; YAGI T, 1990, ARCH BIOCHEM BIOPHYS, V281, P305, DOI 10.1016/0003-9861(90)90448-8; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1; Yano T, 1999, J BIOL CHEM, V274, P28606, DOI 10.1074/jbc.274.40.28606	72	71	73	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36914	36922		10.1074/jbc.M707855200	http://dx.doi.org/10.1074/jbc.M707855200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17977822	hybrid			2022-12-25	WOS:000251646000017
J	Wu, G; Ortiz-Flores, G; Ortiz-Lopez, A; Ort, DR				Wu, Guosheng; Ortiz-Flores, Guadalupe; Ortiz-Lopez, Adriana; Ort, Donald R.			A point mutation in atpC1 raises the redox potential of the Arabidopsis chloroplast ATP synthase gamma-subunit regulatory disulfide above the range of thioredoxin modulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLING FACTOR REDUCTION; ENERGY-DEPENDENT CHANGES; THIOL MODULATION; ACTIVATION; CONFORMATION; LEAVES; PHOTOPHOSPHORYLATION; PHOTOSYNTHESIS; DEACTIVATION; DOMAIN	The light-dependent regulation of chloroplast ATP synthase activity depends on an intricate but ill defined interplay between the proton electrochemical potential across the thylakoid membrane and thioredoxin-mediated redox modulation of a cysteine bridge located on the ATP synthase gamma-subunit. The abnormal light-dependent regulation of the chloroplast ATP synthase in the Arabidopsis thaliana cfq (coupling factor quick recovery) mutant was caused by a point mutation (G to A) in the atpC1 gene, which caused an amino acid substitution (E244K) in the vicinity of the redox modulation domain in the gamma-subunit of ATP synthase. Equilibrium redox titration revealed that this mutation made the regulatory sulfhydryl group energetically much more difficult to reduce relative to the wild type (i.e. raised the E-m,E-7.9 by 39 mV). Enzymatic studies using isolated chloroplasts showed significantly lower light-induced ATPase and ATP synthase activity in the mutant compared with the wild type. The lower ATP synthesis capacity in turn restricted overall rates of leaf photosynthesis in the cfq mutant under low light. This work provides in situ validation of the concept that thioredoxin-dependent reduction of the gamma-subunit regulatory disulfide modulates the proton electrochemical potential energy requirement for activation of the chloroplast ATP synthase and that the activation state of the ATP synthase can limit leaf level photosynthesis.	[Wu, Guosheng; Ortiz-Flores, Guadalupe; Ortiz-Lopez, Adriana; Ort, Donald R.] Univ Illinois, Dept Plant Biol, Inst Genom Biol 1406, Urbana, IL 61801 USA; [Ortiz-Lopez, Adriana; Ort, Donald R.] USDA ARS, Photosynth Res Unit, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA)	Ort, DR (corresponding author), Univ Illinois, Dept Plant Biol, Inst Genom Biol 1406, 1206 W Gregory Dr, Urbana, IL 61801 USA.	d-ort@uiuc.edu						CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Chung DW, 2006, PLANT PHYSIOL, V142, P88, DOI 10.1104/pp.106.084483; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dal Bosco C, 2004, J BIOL CHEM, V279, P1060, DOI 10.1074/jbc.M308435200; DAVENPORT JW, 1981, J BIOL CHEM, V256, P8947; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; GABRYS H, 1994, PLANT PHYSIOL, V104, P769, DOI 10.1104/pp.104.2.769; GAO F, 1995, J BIOL CHEM, V270, P9763, DOI 10.1074/jbc.270.17.9763; Gong P, 2006, PHOTOSYNTH RES, V88, P133, DOI 10.1007/s11120-006-9041-4; GRAAN T, 1984, J BIOL CHEM, V259, P4003; HANGARTER RP, 1987, J BIOL CHEM, V262, P13513; Hightower KE, 1996, BIOCHEMISTRY-US, V35, P4846, DOI 10.1021/bi952913p; HUTCHISON RS, 1995, METHOD ENZYMOL, V252, P220; Hutchison RS, 2000, BIOCHEMISTRY-US, V39, P6679, DOI 10.1021/bi0001978; INOHARA N, 1991, J BIOL CHEM, V266, P7333; KETCHAM SR, 1984, J BIOL CHEM, V259, P7286; KLEEFELD S, 1990, BIOCHIM BIOPHYS ACTA, V1019, P11, DOI 10.1016/0005-2728(90)90119-O; KOMATSUTAKAKI M, 1992, J BIOL CHEM, V267, P2360; Konno H, 2000, BIOCHEM J, V352, P783, DOI 10.1042/0264-6021:3520783; KRAMER DM, 1990, PHOTOSYNTH RES, V26, P213, DOI 10.1007/BF00033134; KRAMER DM, 1989, BIOCHIM BIOPHYS ACTA, V976, P28, DOI 10.1016/S0005-2728(89)80186-0; Leakey ADB, 2006, PLANT PHYSIOL, V140, P779, DOI 10.1104/pp.105.073957; LEES WJ, 1993, J ORG CHEM, V58, P642, DOI 10.1021/jo00055a016; McCarty RE, 2005, J BIOENERG BIOMEMBR, V37, P289, DOI 10.1007/s10863-005-8640-7; MIKI J, 1988, FEBS LETT, V232, P221, DOI 10.1016/0014-5793(88)80421-6; MILLS JD, 1982, FEBS LETT, V144, P63, DOI 10.1016/0014-5793(82)80569-3; MORONEY JV, 1984, J BIOL CHEM, V259, P7281; MORONEY JV, 1982, J BIOL CHEM, V257, P5910; NALIN CM, 1984, J BIOL CHEM, V259, P7275; NOCTOR G, 1988, BIOCHIM BIOPHYS ACTA, V935, P53, DOI 10.1016/0005-2728(88)90107-7; ORT DR, 1992, ANNU REV PLANT PHYS, V43, P269, DOI 10.1146/annurev.pp.43.060192.001413; ORTIZLOPEZ A, 1991, PLANT PHYSIOL, V96, P1018, DOI 10.1104/pp.96.4.1018; Richter ML, 2005, J BIOENERG BIOMEMBR, V37, P467, DOI 10.1007/s10863-005-9493-9; Richter ML, 2004, PHOTOSYNTH RES, V79, P319, DOI 10.1023/B:PRES.0000017157.08098.36; RICHTER ML, 1987, J BIOL CHEM, V262, P15037; Samra HS, 2006, J BIOL CHEM, V281, P31041, DOI 10.1074/jbc.M603315200; SCHUMANN J, 1985, J BIOL CHEM, V260, P1817; WERDAN K, 1975, BIOCHIM BIOPHYS ACTA, V396, P276, DOI 10.1016/0005-2728(75)90041-9; WHITMARSH J, 1984, ARCH BIOCHEM BIOPHYS, V231, P378, DOI 10.1016/0003-9861(84)90401-6; WOLOSIUK RA, 1977, NATURE, V266, P565, DOI 10.1038/266565a0	40	38	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36782	36789		10.1074/jbc.M707007200	http://dx.doi.org/10.1074/jbc.M707007200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17959606	hybrid			2022-12-25	WOS:000251646000002
J	Rajagopalan, L; Greeson, JN; Xia, A; Liu, H; Sturm, A; Raphael, RM; Davidson, AL; Oghalai, JS; Pereira, FA; Brownell, WE				Rajagopalan, Lavanya; Greeson, Jennifer N.; Xia, Anping; Liu, Haiying; Sturm, Angela; Raphael, Robert M.; Davidson, Amy L.; Oghalai, John S.; Pereira, Fred A.; Brownell, William E.			Tuning of the outer hair cell motor by membrane cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; LATERAL WALL; AUDITORY DYSFUNCTION; VOLTAGE-DEPENDENCE; SUGAR TRANSPORTER; PRESTIN; PROTEIN; EXPRESSION; ELECTROMOTILITY; CHLORPROMAZINE	Cholesterol affects diverse biological processes, in many cases by modulating the function of integral membrane proteins. We observed that alterations of cochlear cholesterol modulate hearing in mice. Mammalian hearing is powered by outer hair cell (OHC) electromotility, a membrane-based motor mechanism that resides in the OHC lateral wall. We show that membrane cholesterol decreases during maturation of OHCs. To study the effects of cholesterol on hearing at the molecular level, we altered cholesterol levels in the OHC wall, which contains the membrane protein prestin. We show a dynamic and reversible relationship between membrane cholesterol levels and voltage dependence of prestin-associated charge movement in both OHCs and prestin-transfected HEK 293 cells. Cholesterol levels also modulate the distribution of prestin within plasma membrane microdomains and affect prestin self-association in HEK 293 cells. These findings indicate that alterations in membrane cholesterol affect prestin function and functionally tune the outer hair cell.	Baylor Coll Med, Huffington Ctr Aging & Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA; WM Keck Ctr Interdisciplinary Biosci Training, Houston, TX 77005 USA; Rice Univ, Dept Bioengn, Houston, TX 77005 USA; Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Rice University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Brownell, WE (corresponding author), Baylor Coll Med, Huffington Ctr Aging & Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	brownell@bcm.tmc.edu		Pereira, Fred/0000-0003-2100-0280	NIDCD NIH HHS [DC008134, K08 DC006671-04, R21 DC008134, F32 DC000354, R01 DC000354-20, F31 DC007563-01, K08 DC006671, DC07563-01, R21 DC008134-02, R01 DC009622, DC00354, R01 DC000354, DC006671] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009622, K08DC006671, R21DC008134, F31DC007563, R01DC000354, F32DC000354] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Addona GH, 2003, BBA-BIOMEMBRANES, V1609, P177, DOI 10.1016/S0005-2736(02)00685-5; Addona GH, 1998, BBA-BIOMEMBRANES, V1370, P299, DOI 10.1016/S0005-2736(97)00280-0; Adler HJ, 2003, HEARING RES, V184, P27, DOI 10.1016/S0378-5955(03)00192-8; Albert AD, 2005, PROG LIPID RES, V44, P99, DOI 10.1016/j.plipres.2005.02.001; Allende D, 2004, TRENDS BIOCHEM SCI, V29, P325, DOI 10.1016/j.tibs.2004.04.002; Barenholz Y, 2004, SUB CELL BIOCHEM, V37, P167; Barenholz Y, 2002, PROG LIPID RES, V41, P1, DOI 10.1016/S0163-7827(01)00016-9; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; BOESZEBATTAGLIA K, 1990, J BIOL CHEM, V265, P20727; Brownell WE, 2006, SPR HDB AUD, V27, P313; Brownell WE, 2000, CELL AND MOLECULAR BIOLOGY OF THE EAR, P69; Brownell WE, 2001, ANNU REV BIOMED ENG, V3, P169, DOI 10.1146/annurev.bioeng.3.1.169; Burger K, 2000, CELL MOL LIFE SCI, V57, P1577, DOI 10.1007/PL00000643; Chattopadhyay A, 2005, BIOCHEM BIOPH RES CO, V327, P1036, DOI 10.1016/j.bbrc.2004.12.102; de Monvel JB, 2006, BIOPHYS J, V91, P364, DOI 10.1529/biophysj.105.076331; DING JP, 1991, HEARING RES, V56, P19, DOI 10.1016/0378-5955(91)90149-4; Evans MB, 2006, OTOL NEUROTOL, V27, P609, DOI 10.1097/01.mao.0000226286.19295.34; Farrell B, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041930; Geleoc GSG, 1999, NAT NEUROSCI, V2, P713, DOI 10.1038/11174; Greeson JN, 2006, BRAIN RES, V1091, P140, DOI 10.1016/j.brainres.2006.02.084; Hajdu P, 2003, PFLUG ARCH EUR J PHY, V445, P674, DOI 10.1007/s00424-002-0974-y; Hinzpeter A, 2007, J BIOL CHEM, V282, P2423, DOI 10.1074/jbc.M608251200; IWASA KH, 1991, NEUROSCI LETT, V133, P171, DOI 10.1016/0304-3940(91)90562-8; IWASA KH, 1993, BIOPHYS J, V65, P492, DOI 10.1016/S0006-3495(93)81053-1; JONES OT, 1988, BIOCHEMISTRY-US, V27, P2364, DOI 10.1021/bi00407a018; KAKEHATA S, 1995, BIOPHYS J, V68, P2190, DOI 10.1016/S0006-3495(95)80401-7; Kalinec F, 1997, HEARING RES, V110, P141, DOI 10.1016/S0378-5955(97)00076-2; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Liao ZJ, 2005, J ACOUST SOC AM, V118, P3737, DOI 10.1121/1.2118387; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Lucero HA, 2004, ARCH BIOCHEM BIOPHYS, V426, P208, DOI 10.1016/j.abb.2004.03.020; Ludwig J, 2001, P NATL ACAD SCI USA, V98, P4178, DOI 10.1073/pnas.071613498; Lue AJC, 2001, OTOLARYNG HEAD NECK, V125, P71, DOI 10.1067/mhn.2001.116446; Marcucci R, 2005, J THROMB HAEMOST, V3, P929, DOI 10.1111/j.1538-7836.2005.01310.x; MORIZONO T, 1985, ACTA OTO-LARYNGOL, V99, P516, DOI 10.3109/00016488509182255; MORIZONO T, 1978, ANN OTO RHINOL LARYN, V87, P804, DOI 10.1177/000348947808700607; Murdock DR, 2005, BIOPHYS J, V89, P4090, DOI 10.1529/biophysj.105.069872; NAKAZAWA K, 1995, HEARING RES, V82, P93; Navaratnam D, 2005, BIOPHYS J, V89, P3345, DOI 10.1529/biophysj.105.068759; NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9; Nguyen TVN, 1998, OTOLARYNG HEAD NECK, V119, P14, DOI 10.1016/S0194-5998(98)70167-6; Niemela PS, 2007, PLOS COMPUT BIOL, V3, P304, DOI 10.1371/journal.pcbi.0030034; Oghalai JS, 2004, HEARING RES, V198, P59, DOI 10.1016/j.heares.2004.03.013; Oghalai JS, 1999, HEARING RES, V135, P19, DOI 10.1016/S0378-5955(99)00077-5; Oghalai JS, 1998, J NEUROSCI, V18, P48; Oghalai JS, 2000, SCIENCE, V287, P658, DOI 10.1126/science.287.5453.658; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Oliver D, 1999, J PHYSIOL-LONDON, V519, P791, DOI 10.1111/j.1469-7793.1999.0791n.x; OLLILA OHS, 2008, J STRUCT BIOL; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Preyer S, 2001, HEARING RES, V152, P139, DOI 10.1016/S0378-5955(00)00245-8; Pucadyil TJ, 2006, PROG LIPID RES, V45, P295, DOI 10.1016/j.plipres.2006.02.002; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Rajagopalan L, 2006, J NEUROSCI, V26, P12727, DOI 10.1523/JNEUROSCI.2734-06.2006; Rajendran L, 2003, P NATL ACAD SCI USA, V100, P8241, DOI 10.1073/pnas.1331629100; Rankin SE, 1997, BIOPHYS J, V73, P2446, DOI 10.1016/S0006-3495(97)78273-0; Raphael RM, 2000, BIOPHYS J, V78, P2844, DOI 10.1016/S0006-3495(00)76827-5; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; Rybalchenko V, 2003, J PHYSIOL-LONDON, V547, P873, DOI 10.1113/jphysiol.2002.036434; SAITO T, 1986, ARCH OTO-RHINO-LARYN, V243, P242, DOI 10.1007/BF00464438; SANTI PA, 1994, J HISTOCHEM CYTOCHEM, V42, P705, DOI 10.1177/42.6.8189033; Santos-Sacchi J, 2004, J MEMBRANE BIOL, V200, P83, DOI 10.1007/s00232-004-0699-2; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 2001, J PHYSIOL-LONDON, V531, P661, DOI 10.1111/j.1469-7793.2001.0661h.x; Santos-Sacchi J, 1998, J PHYSIOL-LONDON, V510, P225, DOI 10.1111/j.1469-7793.1998.225bz.x; Scanlon SM, 2001, BIOCHEMISTRY-US, V40, P10507, DOI 10.1021/bi010730z; SHEHATA WE, 1991, ACTA OTO-LARYNGOL, V111, P707, DOI 10.3109/00016489109138403; SIKORA MA, 1986, ACTA OTO-LARYNGOL, V102, P372, DOI 10.3109/00016488609119420; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SONG JB, 1993, BIOPHYS J, V64, P1967, DOI 10.1016/S0006-3495(93)81566-2; Starke-Peterkovic T, 2006, BIOPHYS J, V90, P4060, DOI 10.1529/biophysj.105.074666; Sturm AK, 2007, OTOLARYNG HEAD NECK, V136, P434, DOI 10.1016/j.otohns.2006.10.030; Suckfull M, 2001, THER APHER, V5, P377, DOI 10.1046/j.1526-0968.2001.00369.x; Syka J, 2007, NEUROSCI LETT, V411, P112, DOI 10.1016/j.neulet.2006.10.032; TAMI TA, 1985, OTOLARYNG HEAD NECK, V93, P235, DOI 10.1177/019459988509300221; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Wu M, 1998, J MEMBRANE BIOL, V166, P111, DOI 10.1007/s002329900453; Yu N, 2006, BRAIN RES, V1095, P51, DOI 10.1016/j.brainres.2006.04.017; Zhang PC, 2001, NATURE, V413, P428, DOI 10.1038/35096578; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng J, 2006, J BIOL CHEM, V281, P19916, DOI 10.1074/jbc.M513854200	84	81	81	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36659	36670		10.1074/jbc.M705078200	http://dx.doi.org/10.1074/jbc.M705078200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17933870	Green Accepted, hybrid			2022-12-25	WOS:000251458300059
J	Ryo, A; Hirai, A; Nishi, M; Liou, YC; Perrem, K; Lin, SC; Hirano, H; Lee, SW; Aoki, I				Ryo, Akihide; Hirai, Akiko; Nishi, Mayuko; Liou, Yih-Cherng; Perrem, Kilian; Lin, Sheng-Cai; Hirano, Hisashi; Lee, Sam W.; Aoki, Ichiro			A suppressive role of the prolyl isomerase Pin1 in cellular apoptosis mediated by the death-associated protein Daxx	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER; ACTIVATION; INHIBITION; MACHINERY; ADAPTER; ALPHA; CELLS; LINKS; PML; JNK	The death-associated protein Daxx is a multifunctional factor that regulates a variety of cellular processes, including transcription and apoptosis. Several previous reports have indicated that Daxx is induced upon oxidative stress and is then subjected to phosphorylation-based functional modification. However, the precise molecular events underlying these phosphorylation events remain largely unknown. We report in our current study that the peptidyl-prolyl isomerase Pin1 is highly overexpressed in malignant human gliomas and inhibits Daxx-mediated cellular apoptosis. The targeted inhibition of Pin1 by small interfering RNA in A172 glioblastoma cells significantly enhances the apoptotic response induced by hydrogen peroxide or stimulatory Fas antibodies. This is in turn accompanied by the increased induction of Daxx and the activation of the apoptosis signal-regulating kinase 1/c-Jun N-terminal kinase pathway. Furthermore, Pin1 binds to the phosphorylated Ser(178)-Pro motif in the Daxx protein, and Pin1 overexpression results in the rapid degradation of Daxx via the ubiquitin-proteasome pathway. Moreover, a Daxx-S178A mutant, which cannot interact with Pin1, demonstrates higher proapoptotic activity and is refractory to Pin1-mediated antiapoptotic effects. We further found that the expression levels of Pin1 inversely correlate with the degree of Daxx nuclear accumulation in human glioblastoma tissues. These results together indicate that Pin1-mediated prolyl isomerization plays an important role in the negative regulation of Daxx and thereby inhibits the oxidative stress-induced cellular apoptotic response, particularly in malignant tumor cells where Pin1 is often overexpressed.	Yokohama City Univ, Sch Med, Dept Pathol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; Beaumont Hosp, Mol Oncol Lab, Dept Pathol, Royal Coll Surg Ireland, Dublin 9, Ireland; Xiamen Univ, Sch Life Sci, Key Lab Minist Educ Cell Biol, Xiamen 361005, Peoples R China; Yokohama City Univ, Int Grad Sch Arts & Sci, Yokohama, Kanagawa 2300045, Japan; Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA	Yokohama City University; National University of Singapore; Royal College of Surgeons - Ireland; Xiamen University; Yokohama City University; Harvard University; Massachusetts General Hospital; Harvard University	Ryo, A (corresponding author), Yokohama City Univ, Sch Med, Dept Pathol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	aryo@yokohama-cu.ac.jp	Lin, SC/G-4666-2010					Becker EBE, 2006, NEURON, V49, P655, DOI 10.1016/j.neuron.2006.01.034; Bremer E, 2006, TRENDS MOL MED, V12, P382, DOI 10.1016/j.molmed.2006.06.002; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Charette SJ, 2000, MOL CELL BIOL, V20, P7602, DOI 10.1128/MCB.20.20.7602-7612.2000; Duan L, 2004, CLIN CANCER RES, V10, P234, DOI 10.1158/1078-0432.CCR-1004-2; Guha A, 2004, CURR OPIN NEUROL, V17, P655, DOI 10.1097/00019052-200412000-00004; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Khelifi AF, 2005, CELL DEATH DIFFER, V12, P724, DOI 10.1038/sj.cdd.4401559; Kitagawa D, 2006, EMBO J, V25, P3286, DOI 10.1038/sj.emboj.7601212; Kwon JE, 2006, J BIOL CHEM, V281, P12664, DOI 10.1074/jbc.M600204200; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; Pathan N, 2001, NEOPLASIA, V3, P550, DOI 10.1038/sj.neo.7900213; Rodriguez-Nieto S, 2006, CURR PHARM DESIGN, V12, P4411, DOI 10.2174/138161206779010495; Ryo A, 2003, J CELL SCI, V116, P773, DOI 10.1242/jcs.00276; Ryo A, 2006, J BIOL CHEM, V281, P4117, DOI 10.1074/jbc.M507026200; Ryo A, 2005, CLIN CANCER RES, V11, P7523, DOI 10.1158/1078-0432.CCR-05-0457; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Salomoni P, 2006, TRENDS CELL BIOL, V16, P97, DOI 10.1016/j.tcb.2005.12.002; Sasaki T, 2006, PATHOL RES PRACT, V202, P357, DOI 10.1016/j.prp.2005.12.007; Song JJ, 2004, J BIOL CHEM, V279, P30573, DOI 10.1074/jbc.M404512200; Torii S, 1999, EMBO J, V18, P6037, DOI 10.1093/emboj/18.21.6037; Tsuruta F, 2002, J BIOL CHEM, V277, P14040, DOI 10.1074/jbc.M108975200; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116	31	50	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36671	36681		10.1074/jbc.M704145200	http://dx.doi.org/10.1074/jbc.M704145200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17938171	hybrid			2022-12-25	WOS:000251458300060
J	Youard, ZA; Mislin, GLA; Majcherczyk, PA; Schalk, IJ; Reimmann, C				Youard, Zeb A.; Mislin, Gaeetan L. A.; Majcherczyk, Paul A.; Schalk, Isabelle J.; Reimmann, Cornelia			Pseudomonas fluorescens CHA0 produces enantio-pyochelin, the optical antipode of the pseudomonas aeruginosa siderophore pyochelin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; IN-VITRO RECONSTITUTION; SALICYLATE BIOSYNTHESIS; BURKHOLDERIA-CEPACIA; IRON-TRANSPORT; RECEPTOR; FERRIPYOCHELIN; AGENTS; GENES; FUNGI	The siderophore pyochelin is made by a thiotemplate mechanism from salicylate and two molecules of cysteine. In Pseudomonas aeruginosa, the first cysteine residue is converted to its D-isoform during thiazoline ring formation whereas the second cysteine remains in its L-configuration, thus determining the stereochemistry of the two interconvertible pyochelin diastereoisomers as 4 ' R, 2 '' R, 4 '' R (pyochelin I) and 4 ' R, 2 ' S, 4 '' R (pyochelin II). Pseudomonas fluorescens CHA0 was found to make a different stereoisomeric mixture, which promoted growth under iron limitation in strain CHA0 and induced the expression of its biosynthetic genes, but was not recognized as a siderophore and signaling molecule by P. aeruginosa. Reciprocally, pyochelin promoted growth and induced pyochelin gene expression in P. aeruginosa, but was not functional in P. fluorescens. The structure of the CHA0 siderophore was determined by mass spectrometry, thin-layer chromatography, NMR, polarimetry, and chiral HPLC as enantio-pyochelin, the optical antipode of the P. aeruginosa siderophore pyochelin. Enantio-pyochelin was chemically synthesized and confirmed to be active in CHA0. Its potential biosynthetic pathway in CHA0 is discussed.	Univ Strasbourg 1, CNRS, UMR7175, LC1,ESBS, F-67400 Illkirch Graffenstaden, France; Univ Lausanne, Dept Microbiol Fondamentale, Quartier UNIL Sorge, CH-1015 Lausanne, Switzerland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Lausanne	Reimmann, C (corresponding author), Univ Lausanne, Dept Microbiol Fondamentale, Quartier UNIL Sorge, Batiment Biophore, CH-1015 Lausanne, Switzerland.	Cornelia.Reimmann@unil.ch						ANKENBAUER RG, 1994, J BACTERIOL, V176, P307, DOI 10.1128/JB.176.2.307-319.1994; ANKENBAUER RG, 1988, J BACTERIOL, V170, P5344, DOI 10.1128/jb.170.11.5344-5351.1988; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; BERGERON RJ, 1985, J BIOL CHEM, V260, P7936; Bergeron RJ, 2001, J MED CHEM, V44, P2469, DOI 10.1021/jm010019s; BERGERON RJ, 1991, J MED CHEM, V34, P2072, DOI 10.1021/jm00111a023; BLONDEAU P, 1967, CAN J CHEMISTRY, V45, P49, DOI 10.1139/v67-009; Budzikiewicz H, 2004, PROG CH ORG NAT PROD, V87, P81; BUDZIKIEWICZ H, 2003, PROGR CHEM ORGANIC N, V87; CARMI R, 1994, J NAT PROD, V57, P1200, DOI 10.1021/np50111a002; Castignetti D, 1997, CURR MICROBIOL, V34, P250, DOI 10.1007/s002849900178; Cobessi D, 2005, J MOL BIOL, V352, P893, DOI 10.1016/j.jmb.2005.08.004; COX CD, 1980, J BACTERIOL, V142, P581, DOI 10.1128/JB.142.2.581-587.1980; COX CD, 1979, J BACTERIOL, V137, P357, DOI 10.1128/JB.137.1.357-364.1979; COX CD, 1981, P NATL ACAD SCI-BIOL, V78, P4256, DOI 10.1073/pnas.78.7.4256; Cuiv PO, 2004, J BACTERIOL, V186, P2996, DOI 10.1128/JB.186.10.2996-3005.2004; Darling P, 1998, INFECT IMMUN, V66, P874, DOI 10.1128/IAI.66.2.874-877.1998; DRECHSEL H, 1992, BIOMETALS, V5, P141, DOI 10.1007/BF01061320; FARINHA MA, 1990, FEMS MICROBIOL LETT, V58, P221; Gaille C, 2003, J BIOL CHEM, V278, P16893, DOI 10.1074/jbc.M212324200; Gaille C, 2002, J BIOL CHEM, V277, P21768, DOI 10.1074/jbc.M202410200; GUERINOT ML, 1994, ANNU REV MICROBIOL, V48, P743, DOI 10.1146/annurev.mi.48.100194.003523; HEINRICHS DE, 1993, J BACTERIOL, V175, P5882, DOI 10.1128/JB.175.18.5882-5889.1993; Hutt AJ, 1996, J ANTIMICROB CHEMOTH, V37, P7, DOI 10.1093/jac/37.1.7; Hutt Andrew J., 2007, Drug Metabolism and Drug Interactions, V22, P79; Ino A, 2001, TETRAHEDRON, V57, P1897, DOI 10.1016/S0040-4020(01)00012-6; KEEL C, 1989, PHYTOPATHOLOGY, V79, P584, DOI 10.1094/Phyto-79-584; Kobayashi S, 1998, J ANTIBIOT, V51, P328, DOI 10.7164/antibiotics.51.328; Laville J, 1998, J BACTERIOL, V180, P3187, DOI 10.1128/JB.180.12.3187-3196.1998; LIU PV, 1978, INFECT IMMUN, V22, P878, DOI 10.1128/IAI.22.3.878-890.1978; Meyer JM, 2000, ARCH MICROBIOL, V174, P135, DOI 10.1007/s002030000188; Michel L, 2005, MOL MICROBIOL, V58, P495, DOI 10.1111/j.1365-2958.2005.04837.x; Michel L, 2007, MICROBIOL-SGM, V153, P1508, DOI 10.1099/mic.0.2006/002915-0; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Mislin GLA, 2006, J MOL BIOL, V357, P1437, DOI 10.1016/j.jmb.2006.01.080; MULLER G, 1985, J BIOL CHEM, V26, P13921; Munzinger M, 1999, BIOMETALS, V12, P189, DOI 10.1023/A:1009259118034; NEILANDS JB, 1981, J BIOL CHEM, V256, P3831; Patel HM, 2001, BIOCHEMISTRY-US, V40, P9023, DOI 10.1021/bi010519n; Patel HM, 2003, BIOCHEMISTRY-US, V42, P10514, DOI 10.1021/bi034840c; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Phoebe CH, 2001, J ANTIBIOT, V54, P56; Quadri LEN, 1999, BIOCHEMISTRY-US, V38, P14941, DOI 10.1021/bi991787c; Reimmann C, 1998, MICROBIOL-UK, V144, P3135, DOI 10.1099/00221287-144-11-3135; Reimmann C, 2001, J BACTERIOL, V183, P813, DOI 10.1128/JB.183.3.813-820.2001; RINEHART KL, 1995, J ORG CHEM, V60, P2786, DOI 10.1021/jo00114a029; Sambrook J, 2001, MOL CLONING LAB MANU; Sasaki T, 2002, J ANTIBIOT, V55, P249, DOI 10.7164/antibiotics.55.249; Schlegel K, 2004, BIOMETALS, V17, P409, DOI 10.1023/B:BIOM.0000029437.42633.73; Schlegel K, 2006, Z NATURFORSCH C, V61, P263; SCHNIDER U, 1995, J BACTERIOL, V177, P5387, DOI 10.1128/jb.177.18.5387-5392.1995; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; SERINO L, 1995, MOL GEN GENET, V249, P217, DOI 10.1007/BF00290369; Serino L, 1997, J BACTERIOL, V179, P248, DOI 10.1128/jb.179.1.248-257.1997; SHINDO K, 1989, J ANTIBIOT, V42, P1526, DOI 10.7164/antibiotics.42.1526; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SOKOL PA, 1986, J CLIN MICROBIOL, V23, P560, DOI 10.1128/JCM.23.3.560-562.1986; STANISICH VA, 1972, GENET RES, V19, P91, DOI 10.1017/S0016672300014294; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tseng CF, 2006, J BIOL INORG CHEM, V11, P419, DOI 10.1007/s00775-006-0088-7; VOISARD C, 1994, MOLECULAR ECOLOGY OF RHIZOSPHERE MICROORGANISMS, P67, DOI 10.1002/9783527615810.ch6; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; WINKELMANN G, 1979, FEBS LETT, V97, P43, DOI 10.1016/0014-5793(79)80048-4; WINKELMANN G, 1981, FEMS MICROBIOL LETT, V11, P237, DOI 10.1016/0378-1097(81)90068-9; YE RW, 1995, J BACTERIOL, V177, P3606, DOI 10.1128/jb.177.12.3606-3609.1995; Zamri A, 2000, TETRAHEDRON, V56, P9397, DOI 10.1016/S0040-4020(00)00875-9; Zamri A, 2000, TETRAHEDRON, V56, P249, DOI 10.1016/S0040-4020(99)00946-1	67	87	91	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2007	282	49					35546	35553		10.1074/jbc.M707039200	http://dx.doi.org/10.1074/jbc.M707039200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OW	17938167	hybrid			2022-12-25	WOS:000251458100014
J	Nancarrow, DJ; Handoko, HY; Stark, MS; Whiteman, DC; Hayward, NK				Nancarrow, Derek J.; Handoko, Herlina Y.; Stark, Mitchell S.; Whiteman, David C.; Hayward, Nicholas K.			SiDCoN: A Tool to Aid Scoring of DNA Copy Number Changes in SNP Chip Data	PLOS ONE			English	Article								The recent application of genome-wide, single nucleotide polymorphism (SNP) microarrays to investigate DNA copy number aberrations in cancer has provided unparalleled sensitivity for identifying genomic changes. In some instances the complexity of these changes makes them difficult to interpret, particularly when tumour samples are contaminated with normal (stromal) tissue. Current automated scoring algorithms require considerable manual data checking and correction, especially when assessing uncultured tumour specimens. To address these limitations we have developed a visual tool to aid in the analysis of DNA copy number data. Simulated DNA Copy Number (SiDCoN) is a spreadsheet-based application designed to simulate the appearance of B-allele and logR plots for all known types of tumour DNA copy number changes, in the presence or absence of stromal contamination. The system allows the user to determine the level of stromal contamination, as well as specify up to 3 different DNA copy number aberrations for up to 5000 data points (representing individual SNPs). This allows users great flexibility to assess simple or complex DNA copy number combinations. We demonstrate how this utility can be used to estimate the level of stromal contamination within tumour samples and its application in deciphering the complex heterogeneous copy number changes we have observed in a series of tumours. We believe this tool will prove useful to others working in the area, both as a training tool, and to aid in the interpretation of complex copy number changes.	[Nancarrow, Derek J.; Handoko, Herlina Y.; Stark, Mitchell S.; Whiteman, David C.; Hayward, Nicholas K.] Queensland Inst Med Res, Herston, Qld 4006, Australia	QIMR Berghofer Medical Research Institute	Nancarrow, DJ (corresponding author), Queensland Inst Med Res, Bramston Terrace, Herston, Qld 4006, Australia.	derekN@qimr.edu.au	Stark, Mitchell/K-3874-2019; hayward, nicholas k/C-1367-2015; Stark, Mitchell/K-6794-2019; Whiteman, David C/P-2728-2014; Stark, Mitchell S/E-3542-2010; hayward, nick/AAV-8802-2020; , Herlina/F-4193-2015	hayward, nicholas k/0000-0003-4760-1033; Stark, Mitchell/0000-0002-4510-2161; Whiteman, David C/0000-0003-2563-9559; Stark, Mitchell S/0000-0002-4510-2161; , Herlina/0000-0003-3153-2248	United States National Cancer Institute [CA 001833-03]; Queensland Cancer Fund; National Health and Medical Research Council (NHMRC) of Australia [199600]; National Health and Medical Research Council of Australia; NATIONAL CANCER INSTITUTE [R01CA001833] Funding Source: NIH RePORTER	United States National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Queensland Cancer Fund; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This research was supported by grant number CA 001833-03 from the United States National Cancer Institute, the Queensland Cancer Fund and the National Health and Medical Research Council (NHMRC) of Australia (Program no. 199600). David Whiteman is supported by Senior Research Fellowships from the National Health and Medical Research Council of Australia. The funding bodies played no role in the design or conduct of the study; the collection, management, analysis, or interpretation of the data; or the preparation, review, or approval of the manuscript.	Andersen CL, 2007, CARCINOGENESIS, V28, P38, DOI 10.1093/carcin/bgl086; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Gibbs JR, 2006, PLOS GENET, V2, P1511, DOI 10.1371/journal.pgen.0020150; Huang J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-83; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152	7	30	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1093	10.1371/journal.pone.0001093	http://dx.doi.org/10.1371/journal.pone.0001093			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971856	Green Published, gold, Green Submitted			2022-12-25	WOS:000207458700010
J	Genovesi, S; Leita, L; Sequi, P; Andrighetto, I; Sorgato, MC; Bertoli, A				Genovesi, Sacha; Leita, Liviana; Sequi, Paolo; Andrighetto, Igino; Sorgato, M. Catia; Bertoli, Alessandro			Direct Detection of Soil-Bound Prions	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; SCRAPIE; TRANSMISSION; PROTEIN; FATE; ADSORPTION; EXTRACTION; INFECTION; SHEEP; DEER	Scrapie and chronic wasting disease are contagious prion diseases affecting sheep and cervids, respectively. Studies have indicated that horizontal transmission is important in sustaining these epidemics, and that environmental contamination plays an important role in this. In the perspective of detecting prions in soil samples from the field by more direct methods than animal-based bioassays, we have developed a novel immuno-based approach that visualises in situ the major component (PrPSc) of prions sorbed onto agricultural soil particles. Importantly, the protocol needs no extraction of the protein from soil. Using a cell-based assay of infectivity, we also report that samples of agricultural soil, or quartz sand, acquire prion infectivity after exposure to whole brain homogenates from prion-infected mice. Our data provide further support to the notion that prion-exposed soils retain infectivity, as recently determined in Syrian hamsters intracerebrally or orally challanged with contaminated soils. The cell approach of the potential infectivity of contaminated soil is faster and cheaper than classical animal-based bioassays. Although it suffers from limitations, e. g. it can currently test only a few mouse prion strains, the cell model can nevertheless be applied in its present form to understand how soil composition influences infectivity, and to test prion-inactivating procedures.	[Genovesi, Sacha; Sorgato, M. Catia; Bertoli, Alessandro] Univ Padua, Dipartimento Chim Biol, Padua, Italy; [Leita, Liviana] Ist Sperimentale Nutr Piante, Gorizia, Italy; [Sequi, Paolo] Ist Sperimentale Nutr Piante, Rome, Italy; [Andrighetto, Igino] Ist Zooprofilatt Sperimentale Venezie, Legnaro, Italy; [Sorgato, M. Catia] CNR Ist Neurosci, Padua, Italy	University of Padua; IZS delle Venezie; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Bertoli, A (corresponding author), Univ Padua, Dipartimento Chim Biol, Padua, Italy.	alessandro.bertoli@unipd.it	Andrighetto, Igino/ABF-4296-2020; Bertoli, Alessandro/C-1903-2014	BERTOLI, ALESSANDRO/0000-0003-1202-0191	Prin 2006, Ministero dell'Universita e della Ricerca (MCS); RIFAFERT, Ministero delle Politiche Agricole e Forestali (LL)	Prin 2006, Ministero dell'Universita e della Ricerca (MCS)(Ministry of Education, Universities and Research (MIUR)); RIFAFERT, Ministero delle Politiche Agricole e Forestali (LL)	This work was supported by grants Prin 2006, Ministero dell'Universita e della Ricerca (MCS), and RIFAFERT, Ministero delle Politiche Agricole e Forestali (LL).	Aguzzi A, 2006, NAT REV MICROBIOL, V4, P765, DOI 10.1038/nrmicro1492; Aringhieri R, 2001, EUR J SOIL SCI, V52, P449, DOI 10.1046/j.1365-2389.2001.00404.x; Belay ED, 2004, EMERG INFECT DIS, V10, P977, DOI 10.3201/eid1006.031082; Brini M, 2005, MOL BIOL CELL, V16, P2799, DOI 10.1091/mbc.E04-10-0915; Brown P, 1998, LANCET, V351, P1146, DOI 10.1016/S0140-6736(05)79115-7; BROWN P, 1991, LANCET, V337, P269, DOI 10.1016/0140-6736(91)90873-N; Carter D. L., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P413; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Chung HH, 2004, CHEMOSPHERE, V57, P1383, DOI 10.1016/j.chemosphere.2004.09.025; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Connan H, 2007, J THERM ANAL CALORIM, V88, P115, DOI 10.1007/s10973-006-8108-y; Cooke CM, 2007, ENVIRON SCI TECHNOL, V41, P811, DOI 10.1021/es0618189; Cooke CM, 2007, SOIL BIOL BIOCHEM, V39, P1181, DOI 10.1016/j.soilbio.2006.12.030; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; Fries GF, 1996, SCI TOTAL ENVIRON, V185, P93, DOI 10.1016/0048-9697(96)05045-0; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; Hoinville LJ, 1996, REV SCI TECH OIE, V15, P827, DOI 10.20506/rst.15.3.959; Hui CA, 2004, REV ENVIRON CONTAM T, V183, P115; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Leita L, 2006, SOIL BIOL BIOCHEM, V38, P1638, DOI 10.1016/j.soilbio.2005.11.018; Ma X, 2007, ENVIRON SCI TECHNOL, V41, P2324, DOI 10.1021/es062122i; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; MaWhinney S, 2006, EMERG INFECT DIS, V12, P1527, DOI 10.3201/eid1210.060019; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Palsson P. A., 1979, Slow transmissible diseases of the nervous system. Volume 1., P357; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rao MA, 2007, SOIL BIOL BIOCHEM, V39, P493, DOI 10.1016/j.soilbio.2006.08.020; Revault M, 2005, BBA-GEN SUBJECTS, V1724, P367, DOI 10.1016/j.bbagen.2005.05.005; Rigou P, 2006, ENVIRON SCI TECHNOL, V40, P1497, DOI 10.1021/es0516965; Ryder S, 2004, RES VET SCI, V76, P211, DOI 10.1016/j.rvsc.2003.11.007; Seeger H, 2005, SCIENCE, V310, P324, DOI 10.1126/science.1118829; Seidel B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000435; Shaw LJ, 1999, APPL SOIL ECOL, V11, P217, DOI 10.1016/S0929-1393(98)00149-8; Sigurdson CJ, 2007, BBA-MOL BASIS DIS, V1772, P610, DOI 10.1016/j.bbadis.2006.10.010; Sigurdson CJ, 1999, J GEN VIROL, V80, P2757, DOI 10.1099/0022-1317-80-10-2757; Vasina EN, 2005, BIOMACROMOLECULES, V6, P3425, DOI 10.1021/bm050492d; Weissmann C, 2002, P NATL ACAD SCI USA, V99, P16378, DOI 10.1073/pnas.172403799; WOLF DC, 1989, J ENVIRON QUAL, V18, P39, DOI 10.2134/jeq1989.00472425001800010007x	41	26	26	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1069	10.1371/journal.pone.0001069	http://dx.doi.org/10.1371/journal.pone.0001069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957252	Green Submitted, Green Published, gold			2022-12-25	WOS:000207458500015
J	Shinde, AV; Bystroff, C; Wang, C; Vogelezang, MG; Vincent, PA; Hynes, RO; Van De Water, L				Shinde, Arti V.; Bystroff, Christopher; Wang, Chunyu; Vogelezang, Mariette G.; Vincent, Peter A.; Hynes, Richard O.; Van De Water, Livingston			Identification of the peptide sequences within the EIIIA (EDA) segment of fibronectin that mediate integrin alpha 9 beta 1-dependent cellular activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVELY SPLICED SEGMENTS; CRYSTAL-STRUCTURE; III REPEAT; EMBRYONIC FIBRONECTINS; EXTRACELLULAR-MATRIX; ADHESION MOLECULE-1; PLASMA FIBRONECTIN; CYCLE PROGRESSION; RAT FIBRONECTIN; MESSENGER-RNA	Alternative splicing of the fibronectin (FN) gene transcript provides an efficient mechanism for generating functionally appropriate forms of this adhesive glycoprotein in situ. Cellular FNs that include the EIIIA and/or EIIIB FN-III segments are prominently expressed during embryogenesis, wound healing, tumor progression, and inflammation. However, the roles of this domain in altering overall FN protein structure and regulating cellular function remain unclear. We previously reported that two integrins, alpha 9 beta 1 and alpha 4 beta 1, ligate the EIIIA segment (Liao, Y. F., Gotwals, P. J., Koteliansky, V. E., Sheppard, D., and Van De Water, L. (2002) J. Biol. Chem. 277, 14467 - 14474) and that the epitopes for function-blocking monoclonal antibodies lie within the C-C' loop of EIIIA (Liao, Y. F., Wieder, K. G., Classen, J. M., and Van De Water, L. (1999) J. Biol. Chem. 274, 17876 - 17884). We have now performed site-directed mutagenesis within the EIIIA segment and carried out cell adhesion assays on these mutant EIIIAs. We find that the Asp(41) and Gly(42) residues within the C-C' loop of EIIIA are necessary for integrin alpha 9 beta 1 binding. Synthetic peptides based on the predicted important amino acid sequence from the C-C' loop encode sufficient information to completely inhibit alpha 9 beta 1-mediated cell adhesion. We also report that EIIIA promotes filopodial formation in alpha 9 beta 1-expressing cells accompanied by Cdc42 activation. Our data provide a cellular activity for the EIIIA segment, evidence for conformational lability, and peptide sequences for probing EIIIA functions in vitro and in vivo.	[Shinde, Arti V.; Van De Water, Livingston] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; [Vincent, Peter A.] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Bystroff, Christopher; Wang, Chunyu] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Wang, Chunyu] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Hynes, Richard O.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Hynes, Richard O.] Howard Hughes Med Inst, Ctr Canc Res, Cambridge, MA 02139 USA	Albany Medical College; Albany Medical College; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Van De Water, L (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, MC-165, Albany, NY 12208 USA.	vandewl@mail.amc.edu	Wang, Chunyu/AAH-5952-2019	Wang, Chunyu/0000-0001-5165-7959; Van De Water, Livingston/0000-0002-3825-9224	NHLBI NIH HHS [P01 HL 066105] Funding Source: Medline; NIGMS NIH HHS [R01 GM056442, GM 56442] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056442] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Astrof S, 2004, MOL CELL BIOL, V24, P8662, DOI 10.1128/MCB.24.19.8662-8670.2004; Astrof S, 2007, DEV BIOL, V311, P11, DOI 10.1016/j.ydbio.2007.07.005; Bloom L, 1999, MOL BIOL CELL, V10, P1521, DOI 10.1091/mbc.10.5.1521; Bourdoulous S, 1998, J CELL BIOL, V143, P267, DOI 10.1083/jcb.143.1.267; BROWN LF, 1993, AM J PATHOL, V142, P793; Bystroff C, 1998, J MOL BIOL, V281, P565, DOI 10.1006/jmbi.1998.1943; CARNEMOLLA B, 1992, J BIOL CHEM, V267, P24689; Coito AJ, 1997, AM J PATHOL, V150, P1757; Copie V, 1998, J MOL BIOL, V277, P663; Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1; DUBIN D, 1995, ARTERIOSCL THROM VAS, V15, P1958, DOI 10.1161/01.ATV.15.11.1958; Dugina V, 2001, J CELL SCI, V114, P3285; ERICKSON HP, 1994, P NATL ACAD SCI USA, V91, P10114, DOI 10.1073/pnas.91.21.10114; Eto B, 2000, J BIOL CHEM, V275, P34922, DOI 10.1074/jbc.M001953200; FFRENCHCONSTANT C, 1995, EXP CELL RES, V221, P261, DOI 10.1006/excr.1995.1374; FFRENCHCONSTANT C, 1989, J CELL BIOL, V109, P903, DOI 10.1083/jcb.109.2.903; Fukuda T, 2002, CANCER RES, V62, P5603; Gehris AL, 1997, DEV BIOL, V190, P191, DOI 10.1006/dbio.1997.8693; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; GLUKHOVA MA, 1989, J CELL BIOL, V109, P357, DOI 10.1083/jcb.109.1.357; GUAN JL, 1990, J CELL BIOL, V110, P833, DOI 10.1083/jcb.110.3.833; HINO K, 1995, ARTHRITIS RHEUM-US, V38, P678, DOI 10.1002/art.1780380516; Hocking DC, 1996, J CELL BIOL, V133, P431, DOI 10.1083/jcb.133.2.431; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Hynes RO, 1999, P NATL ACAD SCI USA, V96, P2588, DOI 10.1073/pnas.96.6.2588; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Hynes RO, 1990, FIBRONECTINS; JARNAGIN WR, 1994, J CELL BIOL, V127, P2037, DOI 10.1083/jcb.127.6.2037; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Liao YF, 2002, J BIOL CHEM, V277, P14467, DOI 10.1074/jbc.M201100200; Liao YF, 1999, J BIOL CHEM, V274, P17876, DOI 10.1074/jbc.274.25.17876; Litvinovich SV, 1998, J MOL BIOL, V280, P245, DOI 10.1006/jmbi.1998.1863; MAIN AL, 1992, CELL, V71, P671, DOI 10.1016/0092-8674(92)90600-H; Manabe R, 1997, J CELL BIOL, V139, P295, DOI 10.1083/jcb.139.1.295; Manabe R, 1999, J BIOL CHEM, V274, P5919, DOI 10.1074/jbc.274.9.5919; Muro AF, 2003, J CELL BIOL, V162, P149, DOI 10.1083/jcb.200212079; Niimi T, 2001, J BIOMOL NMR, V21, P281, DOI 10.1023/A:1012947209393; OSBORN L, 1994, J CELL BIOL, V124, P601, DOI 10.1083/jcb.124.4.601; OYAMA F, 1989, J BIOL CHEM, V264, P10331; PAGANI F, 1991, J CELL BIOL, V113, P1223, DOI 10.1083/jcb.113.5.1223; PALMER EL, 1993, J CELL BIOL, V123, P1289, DOI 10.1083/jcb.123.5.1289; PETERS DMP, 1990, J CELL BIOL, V111, P249, DOI 10.1083/jcb.111.1.249; Peters JH, 2002, OSTEOARTHR CARTILAGE, V10, P831, DOI 10.1053/joca.2002.0845; Peters JH, 1996, CELL ADHES COMMUN, V4, P103, DOI 10.3109/15419069609010766; PETERSEN TE, 1983, P NATL ACAD SCI-BIOL, V80, P137, DOI 10.1073/pnas.80.1.137; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Saito S, 1999, J BIOL CHEM, V274, P30756, DOI 10.1074/jbc.274.43.30756; Schenk S, 2003, TRENDS CELL BIOL, V13, P366, DOI 10.1016/S0962-8924(03)00129-6; SCHWARZBAUER JE, 1987, EMBO J, V6, P2573, DOI 10.1002/j.1460-2075.1987.tb02547.x; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Singh P, 2004, J INVEST DERMATOL, V123, P1176, DOI 10.1111/j.0022-202X.2004.23485.x; Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485; Staniszewska I, 2007, CIRC RES, V100, P1308, DOI 10.1161/01.RES.0000266662.98355.66; Takahashi H, 2000, J BIOL CHEM, V275, P23589, DOI 10.1074/jbc.M003526200; Tan K, 1998, STRUCTURE, V6, P793, DOI 10.1016/S0969-2126(98)00080-X; Tan MH, 2004, BLOOD, V104, P11, DOI 10.1182/blood-2003-09-3363; Vlahakis NE, 2005, J BIOL CHEM, V280, P4544, DOI 10.1074/jbc.M412816200; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wang CY, 2004, J MOL BIOL, V342, P525, DOI 10.1016/j.jmb.2004.07.001; WANG JH, 1995, P NATL ACAD SCI USA, V92, P5714, DOI 10.1073/pnas.92.12.5714; XIA P, 1995, EXP CELL RES, V217, P517, DOI 10.1006/excr.1995.1117; XIA P, 1994, EXP CELL RES, V213, P253, DOI 10.1006/excr.1994.1197; YOKOSAKI Y, 1994, J BIOL CHEM, V269, P26691; Yokosaki Y, 1998, J BIOL CHEM, V273, P11423, DOI 10.1074/jbc.273.19.11423; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539; Zhu XL, 2002, BIOL REPROD, V66, P1193, DOI 10.1095/biolreprod66.4.1193	71	84	92	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2858	2870		10.1074/jbc.M708306200	http://dx.doi.org/10.1074/jbc.M708306200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	17967897	hybrid			2022-12-25	WOS:000252622300043
J	Li, DH; Tang, HY; Speicher, DW				Li, Donghai; Tang, Hsin-Yao; Speicher, David W.			A structural model of the erythrocyte spectrin heterodimer initiation site determined using homology modeling and chemical cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-CELL SPECTRIN; PROTEIN-PROTEIN INTERACTIONS; MASS-SPECTROMETRY; ALPHA-SPECTRIN; CRYSTAL-STRUCTURE; BETA-SPECTRIN; SWISS-MODEL; DOCKING; SEQUENCE; ELECTROSTATICS	Spectrin assembles into an anti-parallel heterodimeric flexible rod-like molecule through a multistep process initiated by a high affinity interaction between discrete complementary homologous motifs or "repeats" near the actin binding domain. Attempts to determine crystallographic structures of this critical dimer initiation complex have so far been unsuccessful. Therefore, in this study we determined the subunit-subunit docking interface and a plausible medium resolution structure of the heterodimer initiation site using homology modeling coupled with structural refinement based on experimentally determined distance constraints. Intramolecular and intermolecular cross-links formed by the "zero length" cross-linking reagent, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide were identified after trypsin digestion of cross-linked heterodimer complex using liquid chromatography-tandem mass spectrometry analysis. High confidence assignment of cross-linked peptides was facilitated by determination of cross-linked peptide masses with an uncertainty of a few parts per million using a high sensitivity linear ion trap mass spectrometer equipped with a Fourier-transform ion cyclotron resonance detector. Six interchain cross-links distinguished between alternative docking models, and these distance constraints, as well as three intrachain crosslinks, were used to further refine an initial homology-based structure. The final model is consistent with all available physical data, including protease protection experiments, isothermal titration calorimetry analyses, and location of a common polymorphism that destabilizes dimerization. This model supports the hypothesis that initial docking of the correct alpha and beta repeats from among many very similar repeats in both subunits is driven primarily by long range electrostatic interactions.	[Li, Donghai; Tang, Hsin-Yao; Speicher, David W.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	The Wistar Institute	Speicher, DW (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	speicher@wistar.org		Tang, Hsin-Yao/0000-0003-1838-018X	NCI NIH HHS [CA 10815] Funding Source: Medline; NHLBI NIH HHS [HL 38794, R01 HL038794] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038794] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Begg GE, 2000, J BIOL CHEM, V275, P3279, DOI 10.1074/jbc.275.5.3279; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen R, 2003, PROTEINS, V51, P397, DOI 10.1002/prot.10334; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; DeLano WL, 2002, PYMOL USERS MANUAL; Delaunay J, 2007, BLOOD REV, V21, P1, DOI 10.1016/j.blre.2006.03.005; El-Shafey A, 2006, PROTEIN SCI, V15, P429, DOI 10.1110/ps.051685706; FLOOD G, 1995, J MOL BIOL, V252, P227, DOI 10.1006/jmbi.1995.0490; Flood G, 1997, EUR BIOPHYS J BIOPHY, V25, P431, DOI 10.1007/s002490050057; Gallagher PG, 2004, SEMIN HEMATOL, V41, P142, DOI 10.1053/j.seminhematol.2004.01.003; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Harper SL, 2001, BIOCHEMISTRY-US, V40, P9935, DOI 10.1021/bi0107795; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kalkhof S, 2005, ANAL CHEM, V77, P495, DOI 10.1021/ac0487294; Kusunoki H, 2004, J MOL BIOL, V344, P495, DOI 10.1016/j.jmb.2004.09.019; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li DH, 2007, BIOCHEMISTRY-US, V46, P10585, DOI 10.1021/bi7007905; Mandell JG, 2001, PROTEIN ENG, V14, P105, DOI 10.1093/protein/14.2.105; MOHANDAS N, 1993, SEMIN HEMATOL, V30, P171; Mohindas N, 2006, TRANSFUS CLIN BIOL, V13, P29, DOI 10.1016/j.tracli.2006.02.017; NASH GB, 1993, BIORHEOLOGY, V30, P397; SAHR KE, 1990, J BIOL CHEM, V265, P4434; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schilling B, 2003, J AM SOC MASS SPECTR, V14, P834, DOI 10.1016/S1044-0305(03)00327-1; Sinz A, 2003, J MASS SPECTROM, V38, P1225, DOI 10.1002/JMS.559; SPEICHER DW, 1992, J BIOL CHEM, V267, P14775; SPEICHER DW, 1984, NATURE, V311, P177, DOI 10.1038/311177a0; SPEICHER DW, 1993, J BIOL CHEM, V268, P4227; Speicher K D, 2000, J Biomol Tech, V11, P74; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSU WT, 2000, BRIT J HAEMATOL, V104, P2; Ursitti JA, 1996, J BIOL CHEM, V271, P6636, DOI 10.1074/jbc.271.12.6636; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wilmotte R, 1997, BLOOD, V90, P4188, DOI 10.1182/blood.V90.10.4188; WILMOTTE R, 1993, J CLIN INVEST, V91, P2091, DOI 10.1172/JCI116432; WINKELMANN JC, 1990, J BIOL CHEM, V265, P11827; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097; Ylanne J, 2001, STRUCTURE, V9, P597, DOI 10.1016/S0969-2126(01)00619-0; Young MM, 2000, P NATL ACAD SCI USA, V97, P5802, DOI 10.1073/pnas.090099097	43	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1553	1562		10.1074/jbc.M706981200	http://dx.doi.org/10.1074/jbc.M706981200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17977835	hybrid			2022-12-25	WOS:000252282700040
J	Keramaris, E; Ruzhynsky, VA; Callaghan, SM; Wong, E; Davis, RJ; Flavell, R; Slack, RS; Park, DS				Keramaris, Elizabeth; Ruzhynsky, Vladamir A.; Callaghan, Steve M.; Wong, Estelle; Davis, Roger J.; Flavell, Richard; Slack, Ruth S.; Park, David S.			Required roles of Bax and JNKs in central and peripheral nervous system death of retinoblastoma-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL PHOSPHORYLATION; ACTIVATED PROTEIN-KINASES; CYCLIN-DEPENDENT KINASES; JUN NH2-TERMINAL KINASE; C-JUN; CELL-DEATH; SIGNAL-TRANSDUCTION; PARKINSONS-DISEASE; CORTICAL-NEURONS; TUMOR-SUPPRESSOR	Retinoblastoma-deficient mice show massive neuronal damage and deficits in both CNS and PNS tissue. Previous work in the field has shown that death is regulated through distinct processes where CNS tissue undergoes death regulated by the tumor suppressor p53 and the apoptosome component, APAF1. Death in the PNS, however, is independent of p53 and reliant on the death protease, caspase 3. In the present study, we more carefully delineated the common and distinct mechanisms of death regulation by examining the stress-activated kinases, JNK2 and 3, the conserved Bcl-2 member Bax, and the relationship among these elements including p53. By use of genetic modeling, we show that death in various regions of the CNS and DRGs of the PNS is reliant on Bax. In the CNS, Bax acts downstream of p53. The relevance of the JNKs is more complex, however. Surprisingly, JNK3 deficiency by itself does not inhibit c-Jun phosphorylation and instead, aggravates death in both CNS and PNS tissue. However, JNK2/3 double deficiency blocks death due to Rb loss in both the PNS and CNS. Importantly, the relationships between JNKs, p53, and Bax exhibit regional differences. In the medulla region of the hindbrain in the CNS, JNK2/3 deficiency blocks p53 activation. Moreover, Bax deficiency does not affect c-Jun phosphorylation. This indicates that a JNK- p53-Bax pathway is central in the hindbrain. However, in the diencephalon regions of the forebrain (thalamus), Bax deficiency blocks c-Jun activation, indicating that a Bax-JNK pathway of death is more relevant. In the DRGs of the PNS, a third pathway is present. In this case, a JNK- Bax pathway, independent of p53, regulates damage. Accordingly, our results show that a death regulator Bax is common to death in both PNS and CNS tissue. However, it is regulated by or itself regulates different effectors including the JNKs and p53 depending upon the specific region of the nervous system.	[Keramaris, Elizabeth; Ruzhynsky, Vladamir A.; Callaghan, Steve M.; Wong, Estelle; Slack, Ruth S.; Park, David S.] Univ Ottawa, Ottawa Hlth Res Inst, Dept Cellular Mol Med Neurosci E, Ottawa, ON K1H 8M5, Canada; [Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Dept Biochem & Mol Biol, Worcester, MA 01605 USA; [Flavell, Richard] Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA	University of Ottawa; Ottawa Hospital Research Institute; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; Yale University	Park, DS (corresponding author), Univ Ottawa, Ottawa Hlth Res Inst, Dept Cellular Mol Med Neurosci E, Ottawa, ON K1H 8M5, Canada.	dpark@uottawa.ca		Slack, Ruth/0000-0002-1552-2835; Davis, Roger/0000-0002-0130-1652; Park, David/0000-0002-4490-3784				Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Cregan SP, 1999, J NEUROSCI, V19, P7860; Crocker SJ, 2001, P NATL ACAD SCI USA, V98, P13385, DOI 10.1073/pnas.231177098; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Ferguson KL, 2002, EMBO J, V21, P3337, DOI 10.1093/emboj/cdf338; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Ghahremani MH, 2002, J BIOL CHEM, V277, P35586, DOI 10.1074/jbc.M204362200; Giovanni A, 2000, J BIOL CHEM, V275, P11553, DOI 10.1074/jbc.275.16.11553; Guo Z, 2001, CANCER RES, V61, P8395; Harris CA, 2002, J NEUROSCI, V22, P103, DOI 10.1523/JNEUROSCI.22-01-00103.2002; Hayley S, 2004, J NEUROSCI, V24, P2045, DOI 10.1523/JNEUROSCI.4564-03.2004; Herdegen T, 2001, ONCOGENE, V20, P2424, DOI 10.1038/sj.onc.1204387; Herdegen T, 1998, J NEUROSCI, V18, P5124, DOI 10.1523/JNEUROSCI.18-14-05124.1998; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kuan CY, 2003, P NATL ACAD SCI USA, V100, P15184, DOI 10.1073/pnas.2336254100; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Lipinski MM, 2001, EMBO J, V20, P3402, DOI 10.1093/emboj/20.13.3402; Macleod KF, 1996, EMBO J, V15, P6178, DOI 10.1002/j.1460-2075.1996.tb01006.x; MINDEN A, 1994, MOL CELL BIOL, V14, P6683, DOI 10.1128/MCB.14.10.6683; Morris EJ, 2001, ADV CANCER RES, V82, P1, DOI 10.1016/S0065-230X(01)82001-7; Morris EJ, 2001, J NEUROSCI, V21, P5017, DOI 10.1523/JNEUROSCI.21-14-05017.2001; Mulligan G, 1998, TRENDS GENET, V14, P223, DOI 10.1016/S0168-9525(98)01470-X; Oliva AA, 2006, J NEUROSCI, V26, P9462, DOI 10.1523/JNEUROSCI.2625-06.2006; Pan HC, 1998, MOL CELL, V2, P283, DOI 10.1016/S1097-2765(00)80273-7; Park DS, 1996, J BIOL CHEM, V271, P21898, DOI 10.1074/jbc.271.36.21898; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Simpson MTW, 2001, J NEUROSCI, V21, P7089, DOI 10.1523/JNEUROSCI.21-18-07089.2001; Slack RS, 1996, DEV GENET, V18, P81, DOI 10.1002/(SICI)1520-6408(1996)18:1<81::AID-DVG9>3.0.CO;2-Y; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Ziebold U, 2001, GENE DEV, V15, P386, DOI 10.1101/gad.858801	40	9	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					405	415		10.1074/jbc.M701552200	http://dx.doi.org/10.1074/jbc.M701552200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17984095	hybrid			2022-12-25	WOS:000251940300045
J	Schuler, T; Mesic, I; Madry, C; Bartholomaus, I; Laube, B				Schueler, Thomas; Mesic, Ivana; Madry, Christian; Bartholomaeus, Ingo; Laube, Bodo			Formation of NR1/NR2 and NR1/NR3 heterodimers constitutes the initial step in N-methyl-D-aspartate receptor assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; LIGAND-BINDING PROPERTIES; NMDA RECEPTOR; MOLECULAR DETERMINANTS; MUTATIONAL ANALYSIS; SURFACE EXPRESSION; ZN2+ MODULATION; TERMINAL DOMAIN; SUBUNIT; NR1	N-Methyl-D-aspartate (NMDA) receptors are tetrameric protein complexes composed of the glycine-binding NR1 subunit with a glutamate-binding NR2 and/or glycine-binding NR3 subunit. Tri-heteromeric receptors containing NR1, NR2, and NR3 subunits reconstitute channels, which differ strikingly in many properties from the respective glycine- and glutamate-gated NR1/NR2 complexes and the NR1/NR3 receptors gated by glycine alone. Therefore, an accurate oligomerization process of the different subunits has to assure proper NMDA receptor assembly, which has been assumed to occur via the oligomerization of homodimers. Indeed, using fluorescence resonance energy transfer analysis of differentially fluorescence-tagged subunits and blue native polyacrylamide gel electrophoresis after metabolic labeling and affinity purification revealed that the NR1 subunit is capable of forming homo-oligomeric aggregates. In contrast, both the NR2 and the NR3 subunits formed homo- and hetero-oligomers only in the presence of the NR1 subunit indicating differential roles of the subunits in NMDA receptor assembly. However, co-expression of the NR3A subunit with an N-terminal domain-deleted NR1 subunit (NR1(Delta NTD)) abrogating NR1 homo-oligomerization did not affect NR1/NR3A receptor stoichiometry or function. Hence, homo-oligomerization of the NR1 subunit is not essential for proper NR1/NR3 receptor assembly. Because identical results were obtained for NR1(Delta NTD)/NR2 NMDA receptors (Madry, C., Mesic, I., Betz, H., and Laube, B. ( 2007) Mol. Pharmacol., 72, 1535-1544) and NR1-containing hetero-oligomers are readily formed, we assume that heterodimerization of the NR1 with an NR3 or NR2 subunit, which is followed by the subsequent association of two heterodimers, is the key step in determining proper NMDA receptor subunit assembly and stoichiometry.	[Schueler, Thomas; Mesic, Ivana; Madry, Christian; Bartholomaeus, Ingo; Laube, Bodo] Max Planck Inst Hirnforsch, D-60528 Frankfurt, Germany; [Schueler, Thomas; Mesic, Ivana; Laube, Bodo] Tech Univ Darmstadt, AG Mol & Zellulare Neurophysiol, D-64287 Darmstadt, Germany	Max Planck Society; Technical University of Darmstadt	Laube, B (corresponding author), Max Planck Inst Hirnforsch, D-60528 Frankfurt, Germany.	laube@mpih-frankfurt.mpg.de	Madry, Christian/ABA-8050-2021	Madry, Christian/0000-0002-0522-7197				Al-Hallaq RA, 2002, MOL PHARMACOL, V62, P1119, DOI 10.1124/mol.62.5.1119; Atlason PT, 2007, J BIOL CHEM, V282, P25299, DOI 10.1074/jbc.M702778200; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Choi YB, 2001, J NEUROSCI, V21, P392, DOI 10.1523/JNEUROSCI.21-02-00392.2001; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Hall RA, 1997, J BIOL CHEM, V272, P4135, DOI 10.1074/jbc.272.7.4135; Herin GA, 2004, EUR J PHARMACOL, V500, P101, DOI 10.1016/j.ejphar.2004.07.015; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; Laube B, 2000, J PHYSIOL-LONDON, V522, P215, DOI 10.1111/j.1469-7793.2000.t01-1-00215.x; LAUBE B, 1993, FEBS LETT, V335, P331, DOI 10.1016/0014-5793(93)80412-N; Laube B, 1998, J NEUROSCI, V18, P2954; LAUBE B, 1995, J PHYSIOL-LONDON, V483, P613, DOI 10.1113/jphysiol.1995.sp020610; Leuschner WD, 1999, J BIOL CHEM, V274, P16907, DOI 10.1074/jbc.274.24.16907; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Madry C, 2007, MOL PHARMACOL, V72, P1535, DOI 10.1124/mol.107.040071; Madry C, 2007, BIOCHEM BIOPH RES CO, V354, P102, DOI 10.1016/j.bbrc.2006.12.153; Matsuda S, 2005, J BIOL CHEM, V280, P20021, DOI 10.1074/jbc.M410513200; Meddows E, 2001, J BIOL CHEM, V276, P18795, DOI 10.1074/jbc.M101382200; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Papadakis M, 2004, J BIOL CHEM, V279, P14703, DOI 10.1074/jbc.M313446200; Perez-Otano I, 2001, J NEUROSCI, V21, P1228; Qiu S, 2005, J BIOL CHEM, V280, P24923, DOI 10.1074/jbc.M413915200; Sadtler S, 2003, J BIOL CHEM, V278, P16782, DOI 10.1074/jbc.M213077200; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; Stephenson FA, 2006, BIOCHEM SOC T, V34, P877, DOI 10.1042/BST0340877; Tichelaar W, 2004, J MOL BIOL, V344, P435, DOI 10.1016/j.jmb.2004.09.048; Zimmermann T, 2002, FEBS LETT, V531, P245, DOI 10.1016/S0014-5793(02)03508-1	37	71	74	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2008	283	1					37	46		10.1074/jbc.M703539200	http://dx.doi.org/10.1074/jbc.M703539200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	245MV	17959602	hybrid			2022-12-25	WOS:000251940300006
J	Ali, N; Knauper, V				Ali, Nazim; Knaeuper, Vera			Phorbol ester-induced shedding of the prostate cancer marker transmembrane protein with epidermal growth factor and two follistatin motifs 2 is mediated by the disintegrin and metalloproteinase-17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; FACTOR-RECEPTOR; IN-VITRO; TISSUE INHIBITOR; BREAST-CANCER; UP-REGULATION; NUDE-MICE; CLEAVAGE; EGFR; TACE	The transmembrane protein with epidermal growth factor and two follistatin motifs 2 (TMEFF2) is expressed in prostate and brain and shed from the cell surface in a metalloproteinase-dependent fashion. Neither the sheddase(s) responsible for TMEFF2 shedding nor the physiological significance or activity of the soluble TMEFF2 ectodomain (TMEFF2-ECD) has been identified. In the present study we present new evidence that a disintegrin and metalloproteinase-17 (ADAM17) is responsible for phorbol 12-myristate 13-acetate-induced release of TMEFF2-ECD using small interfering RNA to ablate ADAM17 expression or by inhibiting enzymatic activity. A single well shedding assay monitoring the release of alkaline phosphatase-tagged TMEFF2-ECD into medium and the generation of 22- and 14-kDa C-terminal fragments in lysates were dependent on ADAM17 activity. A gamma-secretase inhibitor prevented the formation of a 10-kDa fragment in cell lysates, thus establishing TMEFF2 as a novel substrate for regulated intramembrane proteolysis. We assigned proliferation-inducing activity to TMEFF2. Inhibition of TMEFF2 shedding using synthetic metalloproteinase inhibitors or small interfering RNA targeting TMEFF2 expression yielded a statistically significant reduction of cell proliferation in the lymph node-derived prostate cancer cells (LNCaPs) and a human embryonic kidney (HEK293) cell line overexpressing TMEFF2. The TMEFF2-ECD was able to induce ERK1/2 phosphorylation in an epidermal growth factor receptor(or ErbB1)-dependent manner in HEK293 cells. Our data suggest that TMEFF2 contributes to cell proliferation in an ADAM17-dependent autocrine fashion in cells expressing this protein.	[Ali, Nazim; Knaeuper, Vera] Cardiff Univ, Sch Dent, Metalloproteinase Res Grp, Matrix Biol & Tissue Repair Res Unit, Cardiff CF14 4XY, Wales	Cardiff University	Knauper, V (corresponding author), Cardiff Univ, Sch Dent, Metalloproteinase Res Grp, Matrix Biol & Tissue Repair Res Unit, Heath Pk, Cardiff CF14 4XY, Wales.	KnauperV@cf.ac.uk		Ali, Nazim/0000-0002-0088-5115; Knauper, Vera/0000-0002-3965-9924				Adam RM, 1999, ENDOCRINOLOGY, V140, P5866, DOI 10.1210/en.140.12.5866; Afar DEH, 2004, MOL CANCER THER, V3, P921; Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Anders L, 2006, MOL CELL BIOL, V26, P3917, DOI 10.1128/MCB.26.10.3917-3934.2006; Angelucci A, 2006, ENDOCR-RELAT CANCER, V13, P197, DOI 10.1677/erc.1.01100; Arribas J, 2006, CANCER METAST REV, V25, P57, DOI 10.1007/s10555-006-7889-6; Baselga J, 2001, EUR J CANCER, V37, pS18, DOI 10.1016/S0959-8049(00)00404-4; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Borrell-Pages M, 2003, EMBO J, V22, P1114, DOI 10.1093/emboj/cdg111; Chen Q, 2006, CANCER LETT, V244, P274, DOI 10.1016/j.canlet.2005.12.027; Dempsey Peter J, 2002, Mol Interv, V2, P136, DOI 10.1124/mi.2.3.136; Dong JY, 2005, MOL BIOL CELL, V16, P2984, DOI 10.1091/mbc.E04-11-0994; Dong JY, 1999, P NATL ACAD SCI USA, V96, P6235, DOI 10.1073/pnas.96.11.6235; Ehlers MRW, 1996, BIOCHEMISTRY-US, V35, P9549, DOI 10.1021/bi9602425; El Sheikh SS, 2004, NEOPLASIA, V6, P846, DOI 10.1593/neo.04379; Endres K, 2005, FEBS J, V272, P5808, DOI 10.1111/j.1742-4658.2005.04976.x; Eto K, 2006, BIOCHEM BIOPH RES CO, V350, P263, DOI 10.1016/j.bbrc.2006.09.028; Fedak PWM, 2004, CIRCULATION, V110, P2401, DOI 10.1161/01.CIR.0000134959.83967.2D; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Ge WT, 2006, J BIOL CHEM, V281, P7406, DOI 10.1074/jbc.M510687200; Gery S, 2002, ONCOGENE, V21, P4739, DOI 10.1038/sj.onc.1205142; Glynne-Jones E, 2001, INT J CANCER, V94, P178, DOI 10.1002/ijc.1450; Grasso AW, 1997, ONCOGENE, V15, P2705, DOI 10.1038/sj.onc.1201447; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hojilla CV, 2007, J CELL SCI, V120, P1050, DOI 10.1242/jcs.003335; Horie M, 2000, GENOMICS, V67, P146, DOI 10.1006/geno.2000.6228; Horiuchi K, 2005, DEV BIOL, V283, P459, DOI 10.1016/j.ydbio.2005.05.004; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Hynes NE, 2006, CANCER CELL, V10, P7, DOI 10.1016/j.ccr.2006.06.012; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Karan D, 2003, INT J ONCOL, V23, P1365; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Kuefer R, 2006, NEOPLASIA, V8, P319, DOI 10.1593/neo.05682; Liang GN, 2000, CANCER RES, V60, P4907; Lin H, 2003, LIFE SCI, V73, P1617, DOI 10.1016/S0024-3205(03)00514-9; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; McCulloch DR, 2000, MOL CELL ENDOCRINOL, V167, P11, DOI 10.1016/S0303-7207(00)00305-1; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Mohler JL, 2002, PROSTATE, V51, P247, DOI 10.1002/pros.10086; Mosesson Y, 2004, SEMIN CANCER BIOL, V14, P262, DOI 10.1016/j.semcancer.2004.04.005; Murphy G, 2003, BIOCHEM SOC SYMP, V70, P65, DOI 10.1042/bss0700065; Nakamura H, 2004, CANCER RES, V64, P876, DOI 10.1158/0008-5472.CAN-03-3502; Peduto L, 2006, ONCOGENE, V25, P5462, DOI 10.1038/sj.onc.1209536; Peduto L, 2005, CANCER RES, V65, P9312, DOI 10.1158/0008-5472.CAN-05-1063; Quayle SN, 2006, GENOMICS, V87, P633, DOI 10.1016/j.ygeno.2005.12.004; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Reiss K, 2006, PHARMACOL THERAPEUT, V111, P985, DOI 10.1016/j.pharmthera.2006.02.009; Reiss K, 2006, J BIOL CHEM, V281, P21735, DOI 10.1074/jbc.M602663200; Sahebjam S, 2007, ARTHRITIS RHEUM, V56, P905, DOI 10.1002/art.22427; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin Umut, 2006, V327, P99; Santiago-Josefat B, 2007, J BIOL CHEM, V282, P8325, DOI 10.1074/jbc.M608826200; Siegel DA, 2006, J NEUROCHEM, V98, P34, DOI 10.1111/j.1471-4159.2006.03801.x; Singh RJR, 2005, CARDIOVASC RES, V67, P39, DOI 10.1016/j.cardiores.2005.02.020; Smith BL, 2004, BRIT J CANCER, V91, P1190, DOI 10.1038/sj.bjc.6602090; Smookler DS, 2006, J IMMUNOL, V176, P721, DOI 10.4049/jimmunol.176.2.721; Sternlicht MD, 2005, DEVELOPMENT, V132, P3923, DOI 10.1242/dev.01966; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; Uchida T, 1999, BIOCHEM BIOPH RES CO, V266, P593, DOI 10.1006/bbrc.1999.1873; Vicentini C, 2003, J CANCER RES CLIN, V129, P165, DOI 10.1007/s00432-003-0420-3; Vincent B, 2001, J BIOL CHEM, V276, P37743; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Xia WM, 2003, J CELL SCI, V116, P2839, DOI 10.1242/jcs.00651; Yamazaki S, 2003, J CELL BIOL, V163, P469, DOI 10.1083/jcb.200307035; Yazici S, 2005, PROSTATE, V65, P203, DOI 10.1002/pros.20283; Young J, 2001, P NATL ACAD SCI USA, V98, P265, DOI 10.1073/pnas.011415298; Zhao LC, 2001, J BIOL CHEM, V276, P30631, DOI 10.1074/jbc.M103748200; Zhao XY, 2005, CANCER RES, V65, P2846, DOI 10.1158/0008-5472.CAN-04-4019	73	30	32	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37378	37388		10.1074/jbc.M702170200	http://dx.doi.org/10.1074/jbc.M702170200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17942404	hybrid, Green Accepted			2022-12-25	WOS:000251833600012
J	Bluem, R; Schmidt, E; Corvey, C; Karas, M; Schlicksupp, A; Kirsch, J; Kuhse, J				Bluem, Raphael; Schmidt, Enrico; Corvey, Carsten; Karas, Michael; Schlicksupp, Andrea; Kirsch, Joachim; Kuhse, Jochen			Components of the translational machinery are associated with juvenile glycine receptors and are redistributed to cytoskeleton upon aging and synaptic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR 1A; RAT SPINAL-CORD; POSTSYNAPTIC DENSITY; SPLICE VARIANTS; FACTOR 1-ALPHA; GEPHYRIN; PROTEIN; IDENTIFICATION; EXPRESSION; ACTIN	The translation eukaryotic elongation factor 1 alpha(eEF1A) is a monomeric GTPase involved in protein synthesis. In addition, this protein is thought to participate in other cellular functions such as actin bundling, cell cycle regulation, and apoptosis. Here we show that eEF1A is associated with the alpha 2 subunit of the inhibitory glycine receptor in pulldown experiments with rat brain extracts. Moreover, additional proteins involved in translation like ribosomal S6 protein and p70 ribosomal S6 protein kinase as well as ERK1/2 and calcineurin were identified in the same pulldown approaches. Glycine receptor activation in spinal cordneurons cultured for 1 week resulted in an increased phosphorylation of ribosomal S6 protein. Immunocytochemistry showed that eEF1A and ribosomal S6 protein are localized in the soma, dendrites, and at synapses of cultured hippocampal and spinal cord neurons. Consistent with our biochemical data, immunoreactivities of both proteins were partially overlapping with glycine receptor immunoreactivity in cultured spinal cord and hippocampal neurons. After 5 weeks in culture, eEF1A immunoreactivity was redistributed to the cytoskeleton in about 45% of neurons. Interestingly, the degree of redistribution could be increased at earlier stages of in vitro differentiation by inhibition of either the ERK1/2 pathway or glycine receptors and simultaneousN-methyl-D-aspartate receptor activation. Our findings suggest a functional coupling of eEF1A with both inhibitory and excitatory receptors, possibly involving the ERK-signaling pathway.	[Bluem, Raphael; Schmidt, Enrico; Schlicksupp, Andrea; Kirsch, Joachim; Kuhse, Jochen] Univ Heidelberg, Dept Anat & Cell Biol, D-69120 Heidelberg, Germany; [Corvey, Carsten; Karas, Michael] Univ Frankfurt, Dept Pharmaceut Chem, D-60438 Frankfurt, Germany	Ruprecht Karls University Heidelberg; Goethe University Frankfurt	Kuhse, J (corresponding author), Univ Heidelberg, Dept Anat & Cell Biol, Neuenheimer Feld 307, D-69120 Heidelberg, Germany.	jochen.kuhse@urz.uni-heidelberg.de	Kuhse, Jochen/T-3864-2019					Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Blackstone C, 1999, CELL CALCIUM, V26, P181, DOI 10.1054/ceca.1999.0071; Bunai F, 2006, J BIOCHEM, V140, P393, DOI 10.1093/jb/mvj169; Cho SJ, 2004, NEUROSCI LETT, V366, P29, DOI 10.1016/j.neulet.2004.05.036; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Dresbach T, 2003, MOL CELL NEUROSCI, V23, P279, DOI 10.1016/S1044-7431(03)00015-0; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Giustetto M, 2003, P NATL ACAD SCI USA, V100, P13680, DOI 10.1073/pnas.1835674100; Gong R, 2006, J BIOL CHEM, V281, P18802, DOI 10.1074/jbc.M512524200; GRENNINGLOH G, 1990, EMBO J, V9, P771, DOI 10.1002/j.1460-2075.1990.tb08172.x; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; HOCH W, 1989, NEURON, V3, P339, DOI 10.1016/0896-6273(89)90258-4; HONGBROWN LQ, 2004, AM J PHYSIOL, V287, P482; KELLY PT, 1978, J CELL BIOL, V79, P173, DOI 10.1083/jcb.79.1.173; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; KIRSCH J, 1995, J NEUROSCI, V15, P4148; McClatchy DB, 2006, NEUROCHEM RES, V31, P975, DOI 10.1007/s11064-006-9103-1; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Moore RC, 2000, CELL MOTIL CYTOSKEL, V45, P279, DOI 10.1002/(SICI)1097-0169(200004)45:4<279::AID-CM4>3.3.CO;2-W; Newbery HJ, 2007, J BIOL CHEM, V282, P28951, DOI 10.1074/jbc.M703962200; Pauly T, 2005, NEUROSCIENCE, V131, P99, DOI 10.1016/j.neuroscience.2004.10.039; PFEIFFER F, 1981, BRAIN RES, V226, P273, DOI 10.1016/0006-8993(81)91099-4; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Reid T, 1999, J BIOL CHEM, V274, P33587, DOI 10.1074/jbc.274.47.33587; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Ruest LB, 2002, J BIOL CHEM, V277, P5418, DOI 10.1074/jbc.M110685200; Sabatini DM, 1999, SCIENCE, V284, P1161, DOI 10.1126/science.284.5417.1161; SHEPHERD JCW, 1989, P NATL ACAD SCI USA, V86, P7520, DOI 10.1073/pnas.86.19.7520; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; SHIINA N, 1994, SCIENCE, V266, P282, DOI 10.1126/science.7939665; Yoshida M, 2004, J NEUROBIOL, V60, P166, DOI 10.1002/neu.20003	33	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37783	37793		10.1074/jbc.M708301200	http://dx.doi.org/10.1074/jbc.M708301200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17965018	hybrid			2022-12-25	WOS:000251833600054
J	Wang, HB; Xie, HR; Sun, XF; Tranguch, S; Zhang, H; Jia, XX; Wang, DZ; Das, SK; Desvergne, B; Wahli, W; DuBois, RN; Dey, SK				Wang, Haibin; Xie, Huirong; Sun, Xiaofei; Tranguch, Susanne; Zhang, Hao; Jia, Xiangxu; Wang, Dingzhi; Das, Sanjoy K.; Desvergne, Beatrice; Wahli, Walter; DuBois, Raymond N.; Dey, Sudhansu K.			Stage-specific integration of maternal and embryonic peroxisome proliferator-activated receptor delta signaling is critical to pregnancy success	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIIMPLANTATION MOUSE UTERUS; TARGETED DISRUPTION; TROPHOBLAST DIFFERENTIATION; MICE LACKING; PLACENTAL DEVELOPMENT; TRANSCRIPTION FACTOR; DEFICIENT MICE; GROWTH-FACTOR; EGF-RECEPTOR; PPAR-DELTA	Successful pregnancy depends on well coordinated developmental events involving both maternal and embryonic components. Although a host of signaling pathways participate in implantation, decidualization, and placentation, whether there is a common molecular link that coordinates these processes remains unknown. By exploiting genetic, molecular, pharmacological, and physiological approaches, we show here that the nuclear transcription factor peroxisome proliferator-activated receptor (PPAR)delta plays a central role at various stages of pregnancy, whereas maternal PPAR delta is critical to implantation and decidualization, and embryonic PPAR delta is vital for placentation. Using trophoblast stem cells, we further elucidate that a reciprocal relationship between PPAR delta-AKT and leukemia inhibitory factor-STAT3 signaling pathways serves as a cell lineage sensor to direct trophoblast cell fates during placentation. This novel finding of stage-specific integration of maternal and embryonic PPAR delta signaling provides evidence that PPAR delta is a molecular link that coordinates implantation, decidualization, and placentation crucial to pregnancy success. This study is clinically relevant because deferral of on time implantation leads to spontaneous pregnancy loss, and defective trophoblast invasion is one cause of preeclampsia in humans.	[Wang, Haibin; Xie, Huirong; Sun, Xiaofei; Tranguch, Susanne; Zhang, Hao; Jia, Xiangxu; Das, Sanjoy K.; Dey, Sudhansu K.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Sun, Xiaofei; Dey, Sudhansu K.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Tranguch, Susanne; DuBois, Raymond N.; Dey, Sudhansu K.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Wang, Dingzhi; DuBois, Raymond N.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Das, Sanjoy K.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Div Reprod & Dev Biol, Nashville, TN 37232 USA; [Desvergne, Beatrice; Wahli, Walter] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Lausanne	Dey, SK (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.	sk.dey@vanderbilt.edu	Wahli, Walter/I-3194-2019; DuBois, Raymond N./AAX-8869-2020; Wahli, Walter/B-1398-2009; Desvergne, Beatrice/C-8892-2016	Wahli, Walter/0000-0002-5966-9089; Tranguch, Susanne/0000-0001-9496-7260; Desvergne, Beatrice/0000-0001-5483-288X	NCI NIH HHS [P01 CA77839] Funding Source: Medline; NICHD NIH HHS [HD12304, HD37830, HD050315] Funding Source: Medline; NIDA NIH HHS [F31 DA021062, DA06668] Funding Source: Medline; NIEHS NIH HHS [ES07814] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD012304, R03HD050315, R01HD012304, R01HD037830] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA006668, R01DA006668, F31DA021062] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Barak Y, 2007, PPAR RES, V2007, DOI 10.1155/2007/12781; Chakraborty I, 1996, J MOL ENDOCRINOL, V16, P107, DOI 10.1677/jme.0.0160107; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Coan PM, 2006, DEV DYNAM, V235, P3280, DOI 10.1002/dvdy.20981; Dahl KDC, 2005, MOL CELL BIOL, V25, P10479, DOI 10.1128/MCB.25.23.10479-10491.2005; Daikoku T, 2007, CANCER RES, V67, P5285, DOI 10.1158/0008-5472.CAN-07-0828; Das SK, 1997, DEV GENET, V21, P44, DOI 10.1002/(SICI)1520-6408(1997)21:1&lt;44::AID-DVG5&gt;3.0.CO;2-8; DAS SK, 1994, DEVELOPMENT, V120, P1071; Davis S, 1999, CURR TOP MICROBIOL, V237, P173; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Duval D, 2000, FASEB J, V14, P1577, DOI 10.1096/fj.14.11.1577; Fowler KJ, 2000, GENOME RES, V10, P30; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Gupta RA, 2004, NAT MED, V10, P245, DOI 10.1038/nm993; GURTNER GC, 1995, GENE DEV, V9, P1, DOI 10.1101/gad.9.1.1; Halder JB, 2000, GENESIS, V26, P213, DOI 10.1002/(SICI)1526-968X(200003)26:3<213::AID-GENE7>3.0.CO;2-M; Hizaki H, 1999, P NATL ACAD SCI USA, V96, P10501, DOI 10.1073/pnas.96.18.10501; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; KWEE L, 1995, DEVELOPMENT, V121, P489; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; LEE SST, 1995, MOL CELL BIOL, V15, P3012; LESCISIN KR, 1988, GENE DEV, V2, P1639, DOI 10.1101/gad.2.12a.1639; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lim H, 1999, GENE DEV, V13, P1561, DOI 10.1101/gad.13.12.1561; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Ma W, 2001, MOL ENDOCRINOL, V15, P1983, DOI 10.1210/me.15.11.1983; Matsumoto H, 2002, J BIOL CHEM, V277, P29260, DOI 10.1074/jbc.M203996200; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Nadra K, 2006, MOL CELL BIOL, V26, P3266, DOI 10.1128/MCB.26.8.3266-3281.2006; Natale DRC, 2006, METH MOLEC MED, V121, P275; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; Robb L, 2005, P NATL ACAD SCI USA, V102, P16333, DOI 10.1073/pnas.0508023102; Roberts AW, 2001, P NATL ACAD SCI USA, V98, P9324, DOI 10.1073/pnas.161271798; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Scherle PA, 2000, J BIOL CHEM, V275, P37086, DOI 10.1074/jbc.M006168200; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Song H, 2002, DEVELOPMENT, V129, P2879; Takahashi T, 2006, J BIOL CHEM, V281, P37117, DOI 10.1074/jbc.M608202200; Takahashi Y, 2003, EMBO J, V22, P372, DOI 10.1093/emboj/cdg057; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Tanaka M, 1997, DEV BIOL, V190, P55, DOI 10.1006/dbio.1997.8685; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Wang DZ, 2006, P NATL ACAD SCI USA, V103, P19069, DOI 10.1073/pnas.0607948103; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang HB, 2004, J BIOL CHEM, V279, P10649, DOI 10.1074/jbc.M312203200; Wang XH, 2002, DEVELOPMENT, V129, P4125; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; WARE CB, 1995, DEVELOPMENT, V121, P1283; Yan JL, 2001, DEV BIOL, V235, P422, DOI 10.1006/dbio.2001.0300; Yang ZM, 1997, BIOL REPROD, V56, P368, DOI 10.1095/biolreprod56.2.368; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505	64	48	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37770	37782		10.1074/jbc.M706577200	http://dx.doi.org/10.1074/jbc.M706577200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17965409	hybrid			2022-12-25	WOS:000251833600053
J	Danfelter, M; Onnerfjord, P; Heinegard, D				Danfelter, Mikael; Onnerfjord, Patrik; Heinegard, Dick			Fragmentation of proteins in cartilage treated with interleukin-1 - Specific cleavage of type IX collagen by matrix metalloproteinase 13 releases the NC4 domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC MATRIX PROTEIN; MULTIPLE EPIPHYSEAL DYSPLASIA; RICH REPEAT PROTEOGLYCANS; NECROSIS-FACTOR-ALPHA; CROSS-LINKING SITES; II COLLAGEN; OSTEOARTHRITIC CARTILAGE; SUBSTRATE-SPECIFICITY; RHEUMATOID-ARTHRITIS; EXTRACELLULAR-MATRIX	Degradation of bovine nasal cartilage induced by interleukin-1 (IL-1) was used to study catabolic events in the tissue over 16 days. Culture medium was fractionated by two-dimensional electrophoresis (isoelectric focusing and SDS-PAGE). Identification of components by peptide mass fingerprinting revealed released fragments representing the NC4 domain of the type IX collagen alpha 1 chain at days 12 and 16. A novel peptide antibody against a near N-terminal epitope of the NC4 domain confirmed the finding and indicated the presence of one of the fragments already at day 9. Mass spectrometric analysis of the two most abundant fragments revealed that the smallest one contained almost the entire NC4 domain cleaved between arginine 258 and isoleucine 259 in the sequence-ETCNELPAR(258)-COOHNH2-ITP-. A larger fragment contained the NC4 domain and the major part of the COL3 domain with a cleavage site between glycine 400 and threonine 401 in COL3(-RGPPGPPGPPGPSG(400)-COOH NH2-TIG-). The presence of multiple collagen alpha 1 (IX) N-terminal sequences demonstrates that the released molecules were cleaved at sites very close to the original N terminus either prior to or due to IL-1 treatment. Matrix metalloproteinase 13(MMP-13) is active and cleaves fibromodulin in the time interval studied. Cartilage explants treated with MMP-13 were shown to release collagen alpha 1 (IX) fragments with the same sizes and with the same cleavage sites as those obtained upon IL-1 treatment. These data describe cleavage by an MMP-13 activity toward non-collagenous and triple helix domains. These potentially important degradation events precede the major loss of type II collagen.	[Danfelter, Mikael; Onnerfjord, Patrik; Heinegard, Dick] Lund Univ, Dept Expt Med Sci, BMC, SE-22184 Lund, Sweden	Lund University	Heinegard, D (corresponding author), Lund Univ, Dept Expt Med Sci, BMC, Plan C12, SE-22184 Lund, Sweden.	dick.heinegard@med.lu.se	Onnerfjord, Patrik/R-3131-2019	Onnerfjord, Patrik/0000-0002-2345-2937	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR050926] Funding Source: NIH RePORTER; NIAMS NIH HHS [U01 AR050926] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aurich M, 2006, ARTHRITIS RHEUM-US, V54, P244, DOI 10.1002/art.21535; Billinghurst RC, 2000, ARTHRITIS RHEUM, V43, P664, DOI 10.1002/1529-0131(200003)43:3<664::AID-ANR24>3.0.CO;2-D; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Borden P, 1996, J BIOL CHEM, V271, P23577, DOI 10.1074/jbc.271.38.23577; Briggs MD, 2002, HUM MUTAT, V19, P465, DOI 10.1002/humu.10066; Budde B, 2005, MOL CELL BIOL, V25, P10465, DOI 10.1128/MCB.25.23.10465-10478.2005; Carlsen S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1989; Dahlberg L, 2000, ARTHRITIS RHEUM, V43, P673, DOI 10.1002/1529-0131(200003)43:3<673::AID-ANR25>3.0.CO;2-8; Deng SJ, 2000, J BIOL CHEM, V275, P31422, DOI 10.1074/jbc.M004538200; Diab M, 1996, BIOCHEM J, V314, P327, DOI 10.1042/bj3140327; Eyre DR, 2004, J BIOL CHEM, V279, P2568, DOI 10.1074/jbc.M311653200; FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070; Fosang AJ, 1996, FEBS LETT, V380, P17, DOI 10.1016/0014-5793(95)01539-6; GOLDBERG RL, 1995, ORTHOPAEDIC RES SOC, P125; Hagg R, 1997, J BIOL CHEM, V272, P20650, DOI 10.1074/jbc.272.33.20650; Hagg R, 1998, J CELL BIOL, V142, P285, DOI 10.1083/jcb.142.1.285; Heathfield TF, 2004, J BIOL CHEM, V279, P6286, DOI 10.1074/jbc.M307765200; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; Hu K, 2006, ARTHRITIS RHEUM-US, V54, P2891, DOI 10.1002/art.22040; Johansson N, 1997, DEV DYNAM, V208, P387, DOI 10.1002/(SICI)1097-0177(199703)208:3<387::AID-AJA9>3.0.CO;2-E; Kapyla J, 2004, J BIOL CHEM, V279, P51677, DOI 10.1074/jbc.M409412200; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Kojima T, 2001, ARTHRITIS RHEUM, V44, P120, DOI 10.1002/1529-0131(200101)44:1<120::AID-ANR16>3.0.CO;2-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leeman MF, 2002, CRIT REV BIOCHEM MOL, V37, P149, DOI 10.1080/10409230290771483; Lorenzo P, 2001, J BIOL CHEM, V276, P12201, DOI 10.1074/jbc.M010932200; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Monfort J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1873; MONFORT J, 2006, ARTHRITIS RES THER, V8, P1; Mwale F, 2002, J BONE MINER RES, V17, P275, DOI 10.1359/jbmr.2002.17.2.275; Mwale F, 2000, DEV DYNAM, V218, P648, DOI 10.1002/1097-0177(200008)218:4<648::AID-DVDY1022>3.0.CO;2-P; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Neuhold LA, 2001, J CLIN INVEST, V107, P35, DOI 10.1172/JCI10564; NINOMIYA Y, 1984, P NATL ACAD SCI-BIOL, V81, P3014, DOI 10.1073/pnas.81.10.3014; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OKADA Y, 1989, FEBS LETT, V244, P473, DOI 10.1016/0014-5793(89)80586-1; Olsen BR, 1997, INT J BIOCHEM CELL B, V29, P555, DOI 10.1016/S1357-2725(96)00100-8; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pihlajamaa T, 2004, J BIOL CHEM, V279, P24265, DOI 10.1074/jbc.M402865200; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; SAKLATVALA J, 1984, BIOCHEM J, V224, P461, DOI 10.1042/bj2240461; SAKLATVALA J, 1986, NATURE, V322, P547, DOI 10.1038/322547a0; SAKLATVALA J, 1983, BIOCHEM J, V215, P385, DOI 10.1042/bj2150385; Sarioglu H, 2000, ELECTROPHORESIS, V21, P2209, DOI 10.1002/1522-2683(20000601)21:11<2209::AID-ELPS2209>3.0.CO;2-T; SAXNE T, 1988, ARTHRITIS RHEUM, V31, P1041, DOI 10.1002/art.1780310816; SAXNE T, 1988, J AUTOIMMUN, V1, P373, DOI 10.1016/0896-8411(88)90007-8; SAXNE T, 2006, RHEUMATOID ARTHRITIS, P301; StahleBackdahl M, 1997, LAB INVEST, V76, P717; Sztrolovics R, 1999, BIOCHEM J, V339, P571, DOI 10.1042/0264-6021:3390571; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDERREST M, 1985, J BIOL CHEM, V260, P220; VASIOS G, 1988, J BIOL CHEM, V263, P2324; VAUGHAN L, 1988, J CELL BIOL, V106, P991, DOI 10.1083/jcb.106.3.991; WU JJ, 1992, J BIOL CHEM, V267, P23007	56	26	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36933	36941		10.1074/jbc.M702491200	http://dx.doi.org/10.1074/jbc.M702491200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17951262	hybrid			2022-12-25	WOS:000251646000019
J	Doyle, SL; Jefferies, CA; Feighery, C; O'Neill, LAJ				Doyle, Sarah L.; Jefferies, Caroline A.; Feighery, Con; O'Neill, Luke A. J.			Signaling by Toll-like receptors 8 and 9 requires Bruton's tyrosine kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED AGAMMAGLOBULINEMIA; NF-KAPPA-B; BINDING PROTEIN; ACTIVATION; BTK; PHOSPHORYLATION; DOMAIN; GENE; DNA; MECHANISMS	Toll-like receptors (TLRs) are a primary surveillance system for the detection of pathogens and are crucial to the activation of host defense. TLR7 and TLR8 sense single-stranded RNA from viruses or host ribonucleoproteins and synthetic imidazoquinolines such as R848, whereas TLR9 senses unmethylated CpG motifs in viral and bacterial DNA and in host DNA. Here we report the endogenous interaction between Brutons's tyrosine kinase (Btk) and human TLR8 and TLR9 in the monocytic cell line THP1. We also show that R848, single-stranded RNA, and CpGB-DNA activate Btk in THP1 cells as shown by phosphorylation of the tyrosine 223 residue of Btk and also by increased autokinase activity. We demonstrate that Btk is required for NF kappa B activation, participating in the pathway to increased phosphorylation of p65 on serine 536 activated by TLR8 and TLR9. Finally we demonstrate that peripheral blood mononuclear cells from patients with X-linked agammaglobulinaemia (XLA) that have dysfunctional Btk are impaired in the induction of interleukin-6 by CpGB-DNA. This study therefore establishes Btk as a key signaling molecule that interacts with and acts downstream of TLR8 and TLR9. Lack of functioning Btk in XLA patients downstream of TLR8 and TLR9 might explain the susceptibility of XLA patients to viral infections.	[Doyle, Sarah L.; Feighery, Con; O'Neill, Luke A. J.] Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland; [Feighery, Con] Univ Dublin Trinity Coll, Dept Immunol, Dublin 2, Ireland; [Jefferies, Caroline A.] Royal Coll Surgeons Ireland, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin; Royal College of Surgeons - Ireland	Doyle, SL (corresponding author), Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland.	Sarah.Doyle@tcd.ie	Doyle, Sarah/C-1453-2014; Jefferies, Caroline/AAI-1543-2021	Jefferies, Caroline/0000-0002-8879-6722; O'Neill, Luke/0000-0002-4333-2748; Doyle, Sarah/0000-0002-6294-9380				BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BRADLEY LAD, 1994, HUM MOL GENET, V3, P79, DOI 10.1093/hmg/3.1.79; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Chuang TH, 2000, EUR CYTOKINE NETW, V11, P372; Dasari P, 2005, CELL IMMUNOL, V236, P140, DOI 10.1016/j.cellimm.2005.08.020; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Hashimoto S, 1996, BLOOD, V88, P561, DOI 10.1182/blood.V88.2.561.bloodjournal882561; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Horwood NJ, 2006, J IMMUNOL, V176, P3635, DOI 10.4049/jimmunol.176.6.3635; Jefferies CA, 2004, IMMUNOL LETT, V92, P15, DOI 10.1016/j.imlet.2003.11.017; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Kurosaki T, 1997, CURR OPIN IMMUNOL, V9, P309, DOI 10.1016/S0952-7915(97)80075-1; Latz E, 2004, J ENDOTOXIN RES, V10, P406, DOI 10.1179/096805104225006525; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; LEDERMAN HM, 1985, MEDICINE, V64, P145, DOI 10.1097/00005792-198505000-00001; MCKINNEY RE, 1987, REV INFECT DIS, V9, P334; Moore ML, 2004, J VIROL, V78, P5584, DOI 10.1128/JVI.78.11.5584-5590.2004; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; Sanna PP, 2000, J VIROL, V74, P9813, DOI 10.1128/JVI.74.21.9813-9817.2000; Schlaepfer E, 2006, J IMMUNOL, V176, P2888, DOI 10.4049/jimmunol.176.5.2888; Schmitz ML, 2001, TRENDS BIOCHEM SCI, V26, P186, DOI 10.1016/S0968-0004(00)01753-9; Sochorova K, 2007, BLOOD, V109, P2553, DOI 10.1182/blood-2006-07-037960; Stiehm ER, 2006, PEDIATRICS, V117, P184, DOI 10.1542/peds.2004-2773; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Winkelstein JA, 2006, MEDICINE, V85, P193, DOI 10.1097/01.md.0000229482.27398.ad; Zheng M, 2002, P NATL ACAD SCI USA, V99, P8944, DOI 10.1073/pnas.132605599; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	33	96	105	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36953	36960		10.1074/jbc.M707682200	http://dx.doi.org/10.1074/jbc.M707682200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17932028	Green Published, hybrid			2022-12-25	WOS:000251646000021
J	Han, GS; Siniossoglou, S; Carman, GM				Han, Gil-Soo; Siniossoglou, Symeon; Carman, George M.			The cellular functions of the yeast lipin homolog pah1p are dependent on its phosphatidate phosphatase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIACYLGLYCEROL PYROPHOSPHATE PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID BIOSYNTHESIS; ESCHERICHIA-COLI; SUBCELLULAR-LOCALIZATION; GENETIC-REGULATION; SHUTTLE VECTORS; SEQUENCE MOTIF; METABOLISM; ACID	The Saccharomyces cerevisiae PAH1-encoded Mg2+-dependent phosphatidate phosphatase (PAP1, 3-sn-phosphatidate phosphohydrolase, EC 3.1.3.4) catalyzes the dephosphorylation of phosphatidate to yield diacylglycerol and Pi. This enzyme plays a major role in the synthesis of triacylglycerols and phospholipids in S. cerevisiae. PAP1 contains the DXDX(T/V) catalytic motif (DIDGT at residues 398-402) that is shared by the mammalian fat-regulating protein lipin 1 and the superfamily of haloacid dehalogenase-like proteins. The yeast enzyme also contains a conserved glycine residue (Gly(80)) that is essential for the fat-regulating function of lipin 1 in a mouse model. In this study, we examined the roles of the putative catalytic motif and the conserved glycine for PAP1 activity by a mutational analysis. The PAP1 activities of the D398E and D400E mutant enzymes were reduced by > 99.9%, and the activity of the G80R mutant enzyme was reduced by 98%. The mutant PAH1 alleles whose products lacked PAP1 activity were nonfunctional in vivo and failed to complement the pah1 Delta mutant phenotypes of temperature sensitivity, respiratory deficiency, nuclear/endoplasmic reticulum membrane expansion, derepression of INO1 expression, and alterations in lipid composition. These results demonstrated that the PAP1 activity of the PAH1 gene product is essential for its roles in lipid metabolism and cell physiology.	[Han, Gil-Soo; Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; [Han, Gil-Soo; Carman, George M.] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Siniossoglou, Symeon] Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust, Cambridge CB2 2XY, England	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Cambridge; Wellcome Trust Sanger Institute	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu			Medical Research Council [G0701446] Funding Source: Medline; NIGMS NIH HHS [R01 GM028140, GM-28140] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140, R01GM028140] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Carman GM, 1996, J BIOL CHEM, V271, P13293, DOI 10.1074/jbc.271.23.13293; Carman GM, 1997, BBA-LIPID LIPID MET, V1348, P45, DOI 10.1016/S0005-2760(97)00095-7; Chen M, 2007, BBA-MOL CELL BIOL L, V1771, P310, DOI 10.1016/j.bbalip.2006.05.017; Collet JF, 1999, J BIOL CHEM, V274, P33985, DOI 10.1074/jbc.274.48.33985; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; CULBERTSON MR, 1975, GENETICS, V80, P23; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; English D, 1996, CHEM PHYS LIPIDS, V80, P117, DOI 10.1016/0009-3084(96)02549-2; ESKO JD, 1980, J BIOL CHEM, V255, P4474; Faulkner A, 1999, J BIOL CHEM, V274, P14831, DOI 10.1074/jbc.274.21.14831; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Furneisen JM, 2000, BBA-MOL CELL BIOL L, V1484, P71, DOI 10.1016/S1388-1981(99)00202-4; Greenberg ML, 1996, MICROBIOL REV, V60, P1; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2004, J BIOL CHEM, V279, P5338, DOI 10.1074/jbc.M311779200; Han GS, 2001, J BIOL CHEM, V276, P10126, DOI 10.1074/jbc.M011421200; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Hemrika W, 1997, P NATL ACAD SCI USA, V94, P2145, DOI 10.1073/pnas.94.6.2145; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HOSAKA K, 1984, BIOCHIM BIOPHYS ACTA, V796, P110; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huijbregts RPH, 2000, TRAFFIC, V1, P195, DOI 10.1034/j.1600-0854.2000.010301.x; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; Kooijman EE, 2003, TRAFFIC, V4, P162, DOI 10.1034/j.1600-0854.2003.00086.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li GL, 2007, BBA-MOL CELL BIOL L, V1771, P432, DOI 10.1016/j.bbalip.2006.06.007; LIN YP, 1989, J BIOL CHEM, V264, P8641; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; LOPES JM, 1991, NUCLEIC ACIDS RES, V19, P1687, DOI 10.1093/nar/19.7.1687; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; Neuwald AF, 1997, PROTEIN SCI, V6, P1764, DOI 10.1002/pro.5560060817; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; PERRELLA FW, 1988, ANAL BIOCHEM, V174, P437, DOI 10.1016/0003-2697(88)90042-5; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Rose MD., 1990, METHODS YEAST GENETI; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Shemesh T, 2003, BIOPHYS J, V85, P3813, DOI 10.1016/S0006-3495(03)74796-1; SIKORSKI RS, 1989, GENETICS, V122, P19; Sorger D, 2003, APPL MICROBIOL BIOT, V61, P289, DOI 10.1007/s00253-002-1212-4; Stukey J, 1997, PROTEIN SCI, V6, P469; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Toke DA, 1999, BIOCHEMISTRY-US, V38, P14606, DOI 10.1021/bi991472x; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Wu WI, 1996, J BIOL CHEM, V271, P1868, DOI 10.1074/jbc.271.4.1868; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f	69	125	139	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37026	37035		10.1074/jbc.M705777200	http://dx.doi.org/10.1074/jbc.M705777200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17971454	hybrid			2022-12-25	WOS:000251646000029
J	Huang, L; Yu, YY; Kirschke, CP; Gertz, ER; Lloyd, KKC				Huang, Liping; Yu, Yan Yiu; Kirschke, Catherine P.; Gertz, Erik R.; Lloyd, Kent K. C.			Znt7 (Slc30a7)-deficient mice display reduced body zinc status and body fat accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LETHAL MILK; FUNCTIONAL-CHARACTERIZATION; MAMMALIAN ZINC; ALKALINE-PHOSPHATASES; CONFERS RESISTANCE; EPITHELIAL-CELLS; LIV-1 SUBFAMILY; TRANSPORTER; GENE; DEFICIENCY	In vitro studies have demonstrated that ZNT7 is involved in transporting the cytoplasmic zinc into the Golgi apparatus of the cell for zinc storage or to be incorporated into newly synthesized zinc-requiring enzymes/proteins. To evaluate the physiological role of ZNT7, we created a mouse model of Znt7 deficiency by a gene-trap approach. Znt7-deficient mice were zinc-deficient based on their low zinc content in serum, liver, bone, kidney, and small intestine. In embryonic fibroblasts isolated from Znt7-deficient mice, cellular zinc was similar to 50% that of wild-type controls. Znt7-deficient mice also displayed some classic manifestations of dietary zinc deficiency, such as reduced food intake and poor body weight gain. However, the mutant mice did not show any sign of hair abnormality and dermatitis that are commonly associated with dietary zinc deficiency. A radioactive feeding study suggested that Znt7-deficient mice had reduced zinc absorption in the gut resulting in decreased zinc accumulations in other organs in the body. The poor growth found in Znt7-deficient mice could not be corrected by feeding the mutant mice with a diet containing 6-fold higher zinc (180 mg/kg) than the suggested adequate intake amount (30 mg/kg). Furthermore, the reduced body weight gain of the mutant mice was largely due to the decrease in body fat accumulation. We conclude that ZNT7 has essential functions in dietary zinc absorption and in regulation of body adiposity.	[Huang, Liping; Yu, Yan Yiu; Kirschke, Catherine P.; Gertz, Erik R.] Univ Calif Davis, USDA, Agr Res Serv, Western Human Nutr Res Ctr, Davis, CA 95616 USA; [Huang, Liping; Yu, Yan Yiu] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Lloyd, Kent K. C.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Huang, Liping] Univ Calif Davis, Rowe Program Genet, Davis, CA 95616 USA	United States Department of Agriculture (USDA); University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Huang, L (corresponding author), Univ Calif Davis, USDA, Agr Res Serv, Western Human Nutr Res Ctr, 430 W Hlth Sci Dr, Davis, CA 95616 USA.	liping.huang@ars.usda.gov						ACKLAND ML, 1992, J NUTR, V122, P1214, DOI 10.1093/jn/122.6.1214; Andree KB, 2004, J NUTR, V134, P1716, DOI 10.1093/jn/134.7.1716; Andrews GK, 2004, GENESIS, V40, P74, DOI 10.1002/gene.20067; BURGUNDER JM, 1984, J HERED, V75, P480; Chi ZH, 2006, NEUROREPORT, V17, P1807, DOI 10.1097/01.wnr.0000239968.06438.c5; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chimienti F, 2005, BIOMETALS, V18, P313, DOI 10.1007/s10534-005-3687-9; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; DASILVA FDF, 2001, BIOL CHEM ELEMENTS, P315; DAVIES NT, 1980, BRIT J NUTR, V43, P189, DOI 10.1079/BJN19800078; DICKIE MM, 1969, MOUSE NEWS LETT, V41, P30; Eder K, 2000, J ANIM PHYSIOL AN N, V83, P65, DOI 10.1046/j.1439-0396.2000.00230.x; Eng BH, 1998, J MEMBRANE BIOL, V166, P1, DOI 10.1007/s002329900442; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Gaither LA, 2000, J BIOL CHEM, V275, P5560, DOI 10.1074/jbc.275.8.5560; Gaither LA, 2001, J BIOL CHEM, V276, P22258, DOI 10.1074/jbc.M101772200; Hall AG, 2005, J PEDIATR GASTR NUTR, V41, P72, DOI 10.1097/01.mpg.0000166800.54085.9c; Huang LP, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-10; Huang LP, 2005, J BIOL CHEM, V280, P15456, DOI 10.1074/jbc.M412188200; Huang LP, 2002, J BIOL CHEM, V277, P26389, DOI 10.1074/jbc.M200462200; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; HURLEY LS, 1981, JOHNS HOPKINS MED J, V148, P1; Inoue K, 2002, HUM MOL GENET, V11, P1775, DOI 10.1093/hmg/11.15.1775; Jackson KA, 2007, J BIOL CHEM, V282, P10423, DOI 10.1074/jbc.M610535200; JACKSON MJ, 1981, BRIT J NUTR, V46, P15, DOI 10.1079/BJN19810005; Kelleher SL, 2005, AM J PHYSIOL-CELL PH, V288, pC1042, DOI 10.1152/ajpcell.00471.2004; Kirschke CP, 2003, J BIOL CHEM, V278, P4096, DOI 10.1074/jbc.M207644200; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; LEE DY, 1992, J NUTR, V122, P2233, DOI 10.1093/jn/122.11.2233; MacDonald RS, 2000, J NUTR, V130, p1500S, DOI 10.1093/jn/130.5.1500S; McMahon RJ, 1998, P NATL ACAD SCI USA, V95, P4841, DOI 10.1073/pnas.95.9.4841; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Norii T, 2005, J NUTR SCI VITAMINOL, V51, P433, DOI 10.3177/jnsv.51.433; Palmiter RD, 2004, P NATL ACAD SCI USA, V101, P4918, DOI 10.1073/pnas.0401022101; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Palmiter RD, 1996, EMBO J, V15, P1784, DOI 10.1002/j.1460-2075.1996.tb00527.x; PILETZ JE, 1978, AM J CLIN NUTR, V31, P560, DOI 10.1093/ajcn/31.4.560; Prasad AS, 1996, ANN INTERN MED, V125, P142, DOI 10.7326/0003-4819-125-2-199607150-00012; PRASAD AS, 1985, ANNU REV NUTR, V5, P341, DOI 10.1146/annurev.nu.05.070185.002013; PRASAD AS, 1985, J PHARMACOL-PARIS, V16, P344; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; SMITH KT, 1980, J NUTR, V110, P316, DOI 10.1093/jn/110.2.316; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Taylor KM, 2005, FEBS LETT, V579, P427, DOI 10.1016/j.febslet.2004.12.006; Taylor KM, 2004, BIOCHEM J, V377, P131, DOI 10.1042/BJ20031183; Taylor KM, 2003, BIOCHEM J, V375, P51, DOI 10.1042/BJ20030478; Valentine RA, 2007, J BIOL CHEM, V282, P14389, DOI 10.1074/jbc.M701752200; VanWouwe JP, 1996, BIOL TRACE ELEM RES, V55, P71, DOI 10.1007/BF02784169; Wang FD, 2004, J BIOL CHEM, V279, P24631, DOI 10.1074/jbc.M400680200; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; York B, 1996, MAMM GENOME, V7, P677, DOI 10.1007/s003359900204; Yu YY, 2007, J HISTOCHEM CYTOCHEM, V55, P223, DOI 10.1369/jhc.6A7032.2006	59	71	74	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					37053	37063		10.1074/jbc.M706631200	http://dx.doi.org/10.1074/jbc.M706631200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17954933	hybrid			2022-12-25	WOS:000251646000032
J	Iben, LG; Olson, RE; Balanda, LA; Jayachandra, S; Robertson, BJ; Hay, V; Corradi, J; Prasad, CVC; Zaczek, R; Albright, CF; Toyn, JH				Iben, Lawrence G.; Olson, Richard E.; Balanda, Lynn A.; Jayachandra, Sukhanya; Robertson, Barbara J.; Hay, Vanessa; Corradi, John; Prasad, C. V. C.; Zaczek, Robert; Albright, Charles F.; Toyn, Jeremy H.			Signal peptide peptidase and gamma-secretase share equivalent inhibitor binding pharmacology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ALZHEIMERS-DISEASE; ACTIVE-SITE; INTRAMEMBRANE PROTEOLYSIS; TRANSMEMBRANE DOMAIN; PRESENILIN HOMOLOGS; ASPARTIC PROTEASE; ZETA-CLEAVAGE; IDENTIFICATION	The enzyme gamma-secretase has long been considered a potential pharmaceutical target for Alzheimer disease. Presenilin ( the catalytic subunit of gamma-secretase) and signal peptide peptidase (SPP) are related transmembrane aspartyl proteases that cleave transmembrane substrates. SPP and gamma-secretase are pharmacologically similar in that they are targeted by many of the same small molecules, including transition state analogs, non-transition state inhibitors, and amyloid beta-peptide modulators. One difference between presenilin and SPP is that the proteolytic activity of presenilin functions only within a multisubunit complex, whereas SPP requires no additional protein cofactors for activity. In this study, gamma-secretase inhibitor radioligands were used to evaluate SPP and gamma-secretase inhibitor binding pharmacology. We found that the SPP enzyme exhibited distinct binding sites for transition state analogs, non-transition state inhibitors, and the nonsteroidal anti-inflammatory drug sulindac sulfide, analogous to those reported previously for gamma-secretase. In the course of this study, cultured cells were found to contain an abundance of SPP binding activity, most likely contributed by several of the SPP family proteins. The number of SPP binding sites was in excess of gamma-secretase binding sites, making it essential to use selective radioligands for evaluation of gamma-secretase binding under these conditions. This study provides further support for the idea that SPP is a useful model of inhibitory mechanisms and structure in the SPP/presenilin protein family.	[Iben, Lawrence G.; Olson, Richard E.; Prasad, C. V. C.; Zaczek, Robert; Albright, Charles F.; Toyn, Jeremy H.] Bristol Myers Squibb Res & Dev, Dept Neurosci Drug Discovery, Wallingford, CT 06492 USA; [Balanda, Lynn A.; Jayachandra, Sukhanya; Robertson, Barbara J.; Corradi, John] Bristol Myers Squibb Res & Dev, Dept Appl Biotechnol, Wallingford, CT 06492 USA; [Hay, Vanessa] Bristol Myers Squibb Res & Dev, Dept Appl Biotechnol, Pennington, NJ 08534 USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Toyn, JH (corresponding author), Bristol Myers Squibb Res & Dev, Dept Neurosci Drug Discovery, 5 Res Pkwy, Wallingford, CT 06492 USA.	jeremy.toyn@bms.com		Corradi, John/0000-0003-3456-4974				Barten DM, 2005, J PHARMACOL EXP THER, V312, P635, DOI 10.1124/jpet.104.075408; Barten Donna M, 2006, Drugs R D, V7, P87, DOI 10.2165/00126839-200607020-00003; Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Berezovska O, 2003, J NEUROSCI, V23, P4560; Clarke EE, 2006, J BIOL CHEM, V281, P31279, DOI 10.1074/jbc.M605051200; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; GRIGORENKO AP, 2002, BIOKHIMIYA, V67, P995; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Martoglio B, 2003, HUM MOL GENET, V12, pR201, DOI 10.1093/hmg/ddg303; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Nyborg AC, 2004, J BIOL CHEM, V279, P43148, DOI 10.1074/jbc.M405879200; Nyborg AC, 2004, J BIOL CHEM, V279, P15153, DOI 10.1074/jbc.M309305200; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Prasad CVC, 2007, BIOORG MED CHEM LETT, V17, P4006, DOI 10.1016/j.bmcl.2007.04.082; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; SEITTERT D, 2000, J BIOL CHEM, V275, P34086; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Tian GC, 2003, J BIOL CHEM, V278, P28968, DOI 10.1074/jbc.M300905200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wu CM, 2004, BIOCHEM BIOPH RES CO, V322, P585, DOI 10.1016/j.bbrc.2004.07.160; Yagishita S, 2006, BIOCHEMISTRY-US, V45, P3952, DOI 10.1021/bi0521846; Yan XX, 2004, J NEUROSCI, V24, P2942, DOI 10.1523/JNEUROSCI.0092-04.2004; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200; Zhao GJ, 2004, J BIOL CHEM, V279, P50647, DOI 10.1074/jbc.C400473200	47	24	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2007	282	51					36829	36836		10.1074/jbc.M707002200	http://dx.doi.org/10.1074/jbc.M707002200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	241GX	17932033	hybrid			2022-12-25	WOS:000251646000007
J	Wende, AR; Schaeffer, PJ; Parker, GJ; Zechner, C; Han, DH; Chen, MM; Hancock, CR; Lehman, JJ; Huss, JM; McClain, DA; Holloszy, JO; Kelly, DP				Wende, Adam R.; Schaeffer, Paul J.; Parker, Glendon J.; Zechner, Christoph; Han, Dong-Ho; Chen, May M.; Hancock, Chad R.; Lehman, John J.; Huss, Janice M.; McClain, Donald A.; Holloszy, John O.; Kelly, Daniel P.			A role for the transcriptional coactivator PGC-1 alpha in muscle refueling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; MESSENGER-RNA EXPRESSION; HUMAN SKELETAL-MUSCLE; FATTY-ACID OXIDATION; GENE-EXPRESSION; ENERGY-METABOLISM; MITOCHONDRIAL BIOGENESIS; HEPATIC GLUCONEOGENESIS; GAMMA COACTIVATOR-1; GLUCOSE-TRANSPORT	The transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1 alpha(PGC-1 alpha) has been identified as an inducible regulator of mitochondrial function. Skeletal muscle PGC-1 alpha expression is induced post-exercise. Therefore, we sought to determine its role in the regulation of muscle fuel metabolism. Studies were performed using conditional, muscle-specific, PGC-1 alpha gain-of-function and constitutive, generalized, loss-of-function mice. Forced expression of PGC-1 alpha increased muscle glucose uptake concomitant with augmentation of glycogen stores, a metabolic response similar to post-exercise recovery. Induction of muscle PGC-1 alpha expression prevented muscle glycogen depletion during exercise. Conversely, PGC-1 alpha-deficient animals exhibited reduced rates of muscle glycogen repletion post-exercise. PGC-1 alpha was shown to increase muscle glycogen stores via several mechanisms including stimulation of glucose import, suppression of glycolytic flux, and by down-regulation of the expression of glycogen phosphorylase and its activating kinase, phosphorylase kinase alpha. These findings identify PGC-1 alpha as a critical regulator of skeletal muscle fuel stores.	Washington Univ, Sch Med, Cardiovasc Res Ctr, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Univ Utah, Sch Med, Vet Affairs Med Ctr, Salt Lake City, UT 84112 USA; Univ Utah, Sch Med, Div Endocrinol, Salt Lake City, UT 84112 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Kelly, DP (corresponding author), Washington Univ, Sch Med, Cardiovasc Res Ctr, 660 S Euclid Ave, St Louis, MO 63110 USA.	dkelly@im.wustl.edu	Hancock, Chad R./X-4803-2018; Wende, Adam/AFG-8878-2022; Kelly, Daniel/ABG-2056-2021; Zechner, Christoph/AAW-7249-2021	Hancock, Chad R./0000-0002-1578-5301; Wende, Adam/0000-0002-5536-4675; Zechner, Christoph/0000-0002-2829-9935; McClain, Don/0000-0002-3310-2359	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020579, P30DK052574, P30DK056341, R01DK045416, R01DK074700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG000425] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL007275] Funding Source: Medline; NIA NIH HHS [R01 AG000425] Funding Source: Medline; NIDDK NIH HHS [R01 DK045416, P30 DK052574, P60 DK020579, R01 DK074700, P30 DK056341-06, P30 DK056341-07, P30 DK056341] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Al-Khalili L, 2005, DIABETOLOGIA, V48, P1173, DOI 10.1007/s00125-005-1741-3; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; BARNARD RJ, 1992, FASEB J, V6, P3238, DOI 10.1096/fasebj.6.14.1426762; Booth FW, 2002, J PHYSIOL-LONDON, V543, P399, DOI 10.1113/jphysiol.2002.019265; Brooks GA, 1998, COMP BIOCHEM PHYS B, V120, P89, DOI 10.1016/S0305-0491(98)00025-X; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; Burke L M, 1999, Curr Opin Clin Nutr Metab Care, V2, P515, DOI 10.1097/00075197-199911000-00015; CHI MMY, 1983, AM J PHYSIOL, V244, pC276, DOI 10.1152/ajpcell.1983.244.3.C276; COGGAN AR, 1991, SPORTS MED, V11, P102, DOI 10.2165/00007256-199111020-00003; DOUEN AG, 1990, J BIOL CHEM, V265, P13427; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; Gasa R, 2000, J BIOL CHEM, V275, P26396, DOI 10.1074/jbc.M002427200; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Ghersa P, 1998, GENE THER, V5, P1213, DOI 10.1038/sj.gt.3300713; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; HANSEN PA, 1994, J APPL PHYSIOL, V76, P979, DOI 10.1152/jappl.1994.76.2.979; Hargreaves M, 2004, P NUTR SOC, V63, P217, DOI 10.1079/PNS2004344; Hawley JA, 2002, CLIN EXP PHARMACOL P, V29, P218, DOI 10.1046/j.1440-1681.2002.03623.x; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Holloszy JO, 1998, FRONT BIOSCI, V3, pD1011, DOI DOI 10.2741/A342; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; KARLSSON J, 1971, J APPL PHYSIOL, V31, P203, DOI 10.1152/jappl.1971.31.2.203; Kelley DE, 2002, ANN NY ACAD SCI, V967, P135; Koval JA, 1998, AM J PHYSIOL-ENDOC M, V274, pE304, DOI 10.1152/ajpendo.1998.274.2.E304; LAWRENCE JC, 1983, J BIOL CHEM, V258, P710; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mortensen O. H., 2006, AM J PHYSIOL-ENDOC M, V291, pE807, DOI DOI 10.1152/AJPENDO.00591.2005; Mourtzakis M, 2006, J APPL PHYSIOL, V100, P1822, DOI 10.1152/japplphysiol.00571.2005; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Nielsen JN, 2004, P NUTR SOC, V63, P233, DOI 10.1079/PNS2004348; Nielsen JN, 2003, ACTA PHYSIOL SCAND, V178, P309, DOI 10.1046/j.1365-201X.2003.01165.x; Norrbom J, 2004, J APPL PHYSIOL, V96, P189, DOI 10.1152/japplphysiol.00765.2003; ODoherty RM, 1996, J APPL PHYSIOL, V81, P789, DOI 10.1152/jappl.1996.81.2.789; Passonneau J.V., 1972, FLEXIBLE SYSTEM ENZY; PASSONNEAU JV, 1974, ANAL BIOCHEM, V60, P405, DOI 10.1016/0003-2697(74)90248-6; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, J CLIN ENDOCR METAB, V89, P4656, DOI 10.1210/jc.2004-0408; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; REN JM, 1993, J BIOL CHEM, V268, P16113; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; SAKS VA, 1985, J BIOL CHEM, V260, P7757; Sambandam N, 2006, AM J PHYSIOL-HEART C, V290, pH87, DOI 10.1152/ajpheart.00285.2005; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; TANNER JW, 1992, BIOCHEM J, V282, P99, DOI 10.1042/bj2820099; Taylor EB, 2005, AM J PHYSIOL-ENDOC M, V289, pE960, DOI 10.1152/ajpendo.00237.2005; Terada S, 2004, AM J PHYSIOL-ENDOC M, V286, pE208, DOI 10.1152/ajpendo.00051.2003; Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1; Trimmer JK, 2002, J APPL PHYSIOL, V93, P233, DOI 10.1152/japplphysiol.01050.2001; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; WILKINSON DA, 1994, J MOL BIOL, V235, P974, DOI 10.1006/jmbi.1994.1051; Wu PF, 1998, BIOCHEM J, V329, P197, DOI 10.1042/bj3290197; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	72	193	209	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2007	282	50					36642	36651		10.1074/jbc.M707006200	http://dx.doi.org/10.1074/jbc.M707006200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	238OY	17932032	hybrid			2022-12-25	WOS:000251458300057
J	Rosell, R; Skrzypski, M; Jassem, E; Taron, M; Bartolucci, R; Sanchez, JJ; Mendez, P; Chaib, I; Perez-Roca, L; Szymanowska, A; Rzyman, W; Puma, F; Kobierska-Gulida, G; Farabi, R; Jassem, J				Rosell, Rafael; Skrzypski, Marcin; Jassem, Ewa; Taron, Miquel; Bartolucci, Roberta; Javier Sanchez, Jose; Mendez, Pedro; Chaib, Imane; Perez-Roca, Laia; Szymanowska, Amelia; Rzyman, Witold; Puma, Francesco; Kobierska-Gulida, Grazyna; Farabi, Raffaele; Jassem, Jacek			BRCA1: A Novel Prognostic Factor in Resected Non-Small-Cell Lung Cancer	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; ZINC-FINGER GENE; PROTEIN EXPRESSION; EXCISION-REPAIR; DNA-REPAIR; CISPLATIN; ERCC1; INACTIVATION; CHEMOTHERAPY; THIOREDOXIN	Background. Although early-stage non-small-cell lung cancer (NSCLC) is considered a potentially curable disease following complete resection, patients have a wide spectrum of survival according to stage (IB, II, IIIA). Within each stage, gene expression profiles can identify patients with a higher risk of recurrence. We hypothesized that altered mRNA expression in nine genes could help to predict disease outcome: excision repair cross-complementing 1 (ERCC1), myeloid zinc finger 1 (MZF1) and Twist1 (which regulate N-cadherin expression), ribonucleotide reductase subunit M1 (RRM1), thioredoxin-1 (TRX1), tyrosyl-DNA phosphodiesterase (Tdp1), nuclear factor of activated T cells (NFAT), BRCA1, and the human homolog of yeast budding uninhibited by benzimidazole (BubR1). Methodology and Principal Findings. We performed real-time quantitative polymerase chain reaction (RT-QPCR) in frozen lung cancer tissue specimens from 126 chemonaive NSCLC patients who had undergone surgical resection and evaluated the association between gene expression levels and survival. For validation, we used paraffin-embedded specimens from 58 other NSCLC patients. A strong inter-gene correlation was observed between expression levels of all genes except NFAT. A Cox proportional hazards model indicated that along with disease stage, BRCA1 mRNA expression significantly correlated with overall survival (hazard ratio [HR], 1.98 [95% confidence interval (CI), 1.11-6]; P = 0.02). In the independent cohort of 58 patients, BRCA1 mRNA expression also significantly correlated with survival (HR, 2.4 [95% CI, 1.01-5.92]; P = 0.04). Conclusions. Overexpression of BRCA1 mRNA was strongly associated with poor survival in NSCLC patients, and the validation of this finding in an independent data set further strengthened this association. Since BRCA1 mRNA expression has previously been linked to differential sensitivity to cisplatin and antimicrotubule drugs, BRCA1 mRNA expression may provide additional information for customizing adjuvant antimicrotubule-based chemotherapy, especially in stage IB, where the role of adjuvant chemotherapy has not been clearly demonstrated.	[Rosell, Rafael; Skrzypski, Marcin; Taron, Miquel; Mendez, Pedro; Chaib, Imane; Perez-Roca, Laia] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Badalona, Spain; [Skrzypski, Marcin; Jassem, Ewa; Szymanowska, Amelia; Rzyman, Witold; Kobierska-Gulida, Grazyna; Jassem, Jacek] Med Univ Gdansk, Gdansk, Poland; [Javier Sanchez, Jose] Autonomous Univ Madrid, E-28049 Madrid, Spain; [Bartolucci, Roberta; Puma, Francesco; Farabi, Raffaele] Azienda Osped Santa Maria, Terni, Italy	Catalan Institute of Oncology; Hospital Germans Trias i Pujol; Fahrenheit Universities; Medical University Gdansk; Autonomous University of Madrid	Rosell, R (corresponding author), Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Badalona, Spain.	rrosell@ico.scs.es		Skrzypski, Marcin/0000-0002-4391-4318; Puma, Francesco/0000-0002-6861-168X; Jassem, Ewa/0000-0003-4239-4776; Rzyman, Witold/0000-0002-9044-7791	Spanish Lung Cancer Group; Medical University of Gdansk; Spanish Ministry of Health [FIS 05/1621]	Spanish Lung Cancer Group; Medical University of Gdansk(Medical University Gdansk); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	The research reported here was funded by the Spanish Lung Cancer Group and the Medical University of Gdansk. It was partially funded by the Spanish Ministry of Health grant FIS 05/1621. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NR, 2006, CANCER RES, V66, P3365, DOI 10.1158/0008-5472.CAN-05-3401; Bae I, 2005, CELL CYCLE, V4, P1641, DOI 10.4161/cc.4.11.2152; Barthelmes HU, 2004, J BIOL CHEM, V279, P55618, DOI 10.1074/jbc.M405042200; Chabalier C, 2006, CELL CYCLE, V5, P1001, DOI 10.4161/cc.5.9.2726; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Cobo M, 2007, J CLIN ONCOL, V25, P2747, DOI 10.1200/JCO.2006.09.7915; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; Endoh H, 2004, J CLIN ONCOL, V22, P811, DOI 10.1200/JCO.2004.04.109; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Furuta T, 2002, CANCER RES, V62, P4899; Grushko TA, 2004, CLIN CANCER RES, V10, P499, DOI 10.1158/1078-0432.CCR-0976-03; HROMAS R, 1991, J BIOL CHEM, V266, P14183; Interthal H, 2005, EMBO J, V24, P2224, DOI 10.1038/sj.emboj.7600694; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Kakolyris S, 2001, CLIN CANCER RES, V7, P3087; LAUSEN B, 1992, BIOMETRICS, V48, P73, DOI 10.2307/2532740; Le Mee S, 2005, EXP CELL RES, V302, P129, DOI 10.1016/j.yexcr.2004.08.028; Liu CY, 2007, LUNG CANCER, V55, P303, DOI 10.1016/j.lungcan.2006.10.019; Lord RVN, 2002, CLIN CANCER RES, V8, P2286; Lu Y, 2006, PLOS MED, V3, P2229, DOI 10.1371/journal.pmed.0030467; Marsit CJ, 2004, ONCOGENE, V23, P1000, DOI 10.1038/sj.onc.1207256; Metzger R, 1998, J CLIN ONCOL, V16, P309, DOI 10.1200/JCO.1998.16.1.309; Moorehead RA, 2000, BIOCHEM PHARMACOL, V59, P337, DOI 10.1016/S0006-2952(99)00333-0; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Nakamura H, 2004, ANTIOXID REDOX SIGN, V6, P15, DOI 10.1089/152308604771978309; NEVINS JR, 2007, NAT REV GENET; Niedernhofer LJ, 2007, NEW ENGL J MED, V356, P2538; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Parmigiani G, 2004, CLIN CANCER RES, V10, P2922, DOI 10.1158/1078-0432.CCR-03-0490; Potapova O, 1997, J BIOL CHEM, V272, P14041, DOI 10.1074/jbc.272.22.14041; Potti A, 2006, NEW ENGL J MED, V355, P570, DOI 10.1056/NEJMoa060467; Quinn JE, 2003, CANCER RES, V63, P6221; Rice JC, 1998, ONCOGENE, V17, P1807, DOI 10.1038/sj.onc.1202086; Rosell R, 2004, CLIN CANCER RES, V10, p4215S, DOI 10.1158/1078-0432.CCR-040006; Rosell R, 2003, ONCOGENE, V22, P3548, DOI 10.1038/sj.onc.1206419; Shichiri M, 2002, CANCER RES, V62, P13; Strauss GM, 2005, HEMATOL ONCOL CLIN N, V19, P263, DOI 10.1016/j.hoc.2005.02.008; Taron M, 2004, HUM MOL GENET, V13, P2443, DOI 10.1093/hmg/ddh260; Wachters FM, 2005, LUNG CANCER-J IASLC, V50, P211, DOI 10.1016/j.lungcan.2005.06.013; Welsh SJ, 2002, CANCER RES, V62, P5089; Wisnivesky JP, 2004, CHEST, V126, P761, DOI 10.1378/chest.126.3.761; Yan QW, 2006, BIOCHEM PHARMACOL, V71, P761, DOI 10.1016/j.bcp.2005.12.015; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Yoshida T, 2005, ANN NY ACAD SCI, V1055, P1, DOI 10.1196/annals.1323.002; ZHAO R, 1995, ANTI-CANCER DRUG, V6, P657, DOI 10.1097/00001813-199510000-00005; Zheng Z, 2007, NEW ENGL J MED, V356, P800, DOI 10.1056/NEJMoa065411	47	164	180	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1129	10.1371/journal.pone.0001129	http://dx.doi.org/10.1371/journal.pone.0001129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987116	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459000013
J	Zhang, XH; Tseng, H				Zhang, Xiaohong; Tseng, Hung			Basonuclin-Null Mutation Impairs Homeostasis and Wound Repair in Mouse Corneal Epithelium	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; RIBOSOMAL-RNA GENES; NUCLEAR-LOCALIZATION; MURINE CORNEAL; STEM-CELLS; EXPRESSION; KERATINOCYTES; TRANSCRIPTION; ADHERENS; PHOSPHORYLATION	At least two cellular processes are required for corneal epithelium homeostasis and wound repair: cell proliferation and cell-cell adhesion. These processes are delicately balanced to ensure the maintenance of normal epithelial function. During wound healing, these processes must be reprogrammed in coordination to achieve a rapid re-epithelialization. Basonuclin (Bnc1) is a cell-type-specific transcription factor expressed mainly in the proliferative keratinocytes of stratified epithelium (e.g., corneal epithelium, epidermis and esophageal epithelium) and the gametogenic cells in testis and ovary. Our previous work suggested that basonuclin could regulate transcription of ribosomal RNA genes (rDNA) and genes involved in chromatin structure, transcription regulation, cell-cell junction/communication, ion-channels and intracelllular transportation. However, basonuclin's role in keratinocytes has not been demonstrated in vivo. Here we show that basonuclin-null mutation disrupts corneal epithelium homeostasis and delays wound healing by impairing cell proliferation. In basonuclin-null cornea epithelium, RNA polymerase I (Pol I) transcription is perturbed. This perturbation is unique because it affects transcripts from a subset of rDNA. Basonuclin-null mutation also perturbs RNA polymerase II (Pol II) transcripts from genes encoding chromatin structure proteins histone 3 and HMG2, transcription factor Gli2, gap-junction protein connexin 43 and adheren E-cadherin. In most cases, a concerted change in mRNA and protein level is observed. However, for E-cadherin, despite a notable increase in its mRNA level, its protein level was reduced. In conclusion, our study establishes basonuclin as a regulator of corneal epithelium homeostasis and maintenance. Basonuclin likely coordinates functions of a subset of ribosomal RNA genes (rDNA) and a group of protein coding genes in cellular processes critical for the regulation of cell proliferation.	[Zhang, Xiaohong; Tseng, Hung] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Tseng, Hung] Univ Penn, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Tseng, H (corresponding author), Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA.	htsengpe@mail.med.upenn.edu			National Eye Institute [EY13637]; NATIONAL EYE INSTITUTE [R01EY013637] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding: This work was supported by a National Eye Institute grant (EY13637). The funding agency has no role in the design, conduct and report of this study.	Anderson SC, 2002, INVEST OPHTH VIS SCI, V43, P978; Ban Y, 2003, EXP EYE RES, V76, P663, DOI 10.1016/S0014-4835(03)00054-X; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Birger Y, 2006, DIFFERENTIATION, V74, P19, DOI 10.1111/j.1432-0436.2006.00054.x; CHEN JJY, 1990, INVEST OPHTH VIS SCI, V31, P1301; Chung EH, 1999, INVEST OPHTH VIS SCI, V40, P1952; Collinson JM, 2002, DEV DYNAM, V224, P432, DOI 10.1002/dvdy.10124; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Danjo Y, 1998, J CELL SCI, V111, P3323; Davis J, 2003, J CELL SCI, V116, P2157, DOI 10.1242/jcs.00441; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; Dwivedi DJ, 2005, INVEST OPHTH VIS SCI, V46, P3623, DOI 10.1167/iovs.05-0028; Green H, 2005, MOL B INT U, P207; Hanakawa Y, 2002, J INVEST DERMATOL, V119, P27, DOI 10.1046/j.1523-1747.2002.01780.x; HUANG AJW, 1991, INVEST OPHTH VIS SCI, V32, P96; Iuchi S, 1997, P NATL ACAD SCI USA, V94, P7948, DOI 10.1073/pnas.94.15.7948; Iuchi S, 1999, P NATL ACAD SCI USA, V96, P9628, DOI 10.1073/pnas.96.17.9628; Lavker RM, 2004, EXP EYE RES, V78, P433, DOI 10.1016/j.exer.2003.09.008; Louet JF, 2006, P NATL ACAD SCI USA, V103, P17868, DOI 10.1073/pnas.0608711103; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; Ma J, 2006, DEVELOPMENT, V133, P2053, DOI 10.1242/dev.02371; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; O'Malley BW, 2006, SCIENCE, V313, P1749, DOI 10.1126/science.1132509; Orsulic S, 2000, J CELL SCI, V113, P1793; Orsulic S, 1999, J CELL SCI, V112, P1237; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Qian JC, 2006, DEV DYNAM, V235, P1984, DOI 10.1002/dvdy.20827; Romano RA, 2004, GENOMICS, V83, P821, DOI 10.1016/j.ygeno.2003.11.009; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P2577, DOI 10.1167/iovs.04-0001; Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; STEPP MA, 1993, INVEST OPHTH VIS SCI, V34, P1829; Sugrue SP, 1997, EXP EYE RES, V64, P11, DOI 10.1006/exer.1996.0175; Sun TT, 2004, J INVEST DERM SYMP P, V9, P202, DOI 10.1111/j.1087-0024.2004.09311.x; Swamynathan SK, 2007, MOL CELL BIOL, V27, P182, DOI 10.1128/MCB.00846-06; Tian QJ, 2001, DEVELOPMENT, V128, P407; Tseng H, 1999, DIFFERENTIATION, V65, P221, DOI 10.1046/j.1432-0436.1999.6540221.x; TSENG H, 1994, J CELL BIOL, V126, P495, DOI 10.1083/jcb.126.2.495; TSENG H, 1992, P NATL ACAD SCI USA, V89, P10311, DOI 10.1073/pnas.89.21.10311; Tseng H, 1998, FRONT BIOSCI, V3, pD985; TSENG H, 1999, J CELL SCI, P112; Tseng H, 2006, BIOESSAYS, V28, P719, DOI 10.1002/bies.20430; TSENG SCG, 1989, EYE, V3, P141, DOI 10.1038/eye.1989.22; Vanhoutteghem A, 2004, P NATL ACAD SCI USA, V101, P3468, DOI 10.1073/pnas.0400268101; Vanhoutteghem A, 2006, P NATL ACAD SCI USA, V103, P12423, DOI 10.1073/pnas.0605086103; Wang JW, 2006, BIOCHEM BIOPH RES CO, V348, P1261, DOI 10.1016/j.bbrc.2006.07.198; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Zantek ND, 1999, CELL GROWTH DIFFER, V10, P629; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018; Zhang L, 2003, MOL VIS, V9, P584; Zhang SL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000902; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449; Zieske JD, 2004, INT J DEV BIOL, V48, P903, DOI 10.1387/ijdb.041860jz	54	29	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1087	10.1371/journal.pone.0001087	http://dx.doi.org/10.1371/journal.pone.0001087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971852	Green Published, Green Submitted, gold			2022-12-25	WOS:000207458700006
J	Tran-Hung, L; Tran-Thi, N; Aboudharam, G; Raoult, D; Drancourt, M				Tran-Hung, Lam; Tran-Thi, Ny; Aboudharam, Gerard; Raoult, Didier; Drancourt, Michel			A New Method to Extract Dental Pulp DNA: Application to Universal Detection of Bacteria	PLOS ONE			English	Article								Background. Dental pulp is used for PCR-based detection of DNA derived from host and bacteremic microorganims. Current protocols require odontology expertise for proper recovery of the dental pulp. Dental pulp specimen exposed to laboratory environment yields contaminants detected using universal 16S rDNA-based detection of bacteria. Methodology/Principal Findings. We developed a new protocol by encasing decontaminated tooth into sterile resin, extracting DNA into the dental pulp chamber itself and decontaminating PCR reagents by filtration and double restriction enzyme digestion. Application to 16S rDNA-based detection of bacteria in 144 teeth collected in 86 healthy people yielded a unique sequence in only 14 teeth (9.7%) from 12 individuals (14%). Each individual yielded a unique 16S rDNA sequence in 1-2 teeth per individual. Negative controls remained negative. Bacterial identifications were all confirmed by amplification and sequencing of specific rpoB sequence. Conclusions/Significance. The new protocol prevented laboratory contamination of the dental pulp. It allowed the detection of bacteria responsible for dental pulp colonization from blood and periodontal tissue. Only 10% such samples contained 16S rDNA. It provides a new tool for the retrospective diagnostic of bacteremia by allowing the universal detection of bacterial DNA in animal and human, contemporary or ancient tooth. It could be further applied to identification of host DNA in forensic medicine and anthropology.	[Tran-Hung, Lam; Tran-Thi, Ny; Aboudharam, Gerard; Raoult, Didier; Drancourt, Michel] Univ Aix Marseille 2, CNRS UMR 6020, IFR 48, Unite Rickettsies,Fac Med, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Raoult, D (corresponding author), Univ Aix Marseille 2, CNRS UMR 6020, IFR 48, Unite Rickettsies,Fac Med, Marseille, France.	Didier.Raoult@gmail.com	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974; Tran-Hung, Lam/0000-0002-9598-7543	Unite des Rickettsies	Unite des Rickettsies	Unite des Rickettsies	Aboudharam G, 2004, EUR J CLIN MICROBIOL, V23, P920, DOI 10.1007/s10096-004-1244-z; Aboudharam G, 2004, MICROB PATHOGENESIS, V36, P349, DOI 10.1016/j.micpath.2004.02.002; Aboudharam G, 2000, MICROB PATHOGENESIS, V28, P249, DOI 10.1006/mpat.1999.0343; Berger P, 2005, RES MICROBIOL, V156, P967, DOI 10.1016/j.resmic.2005.05.008; Borst A, 2004, EUR J CLIN MICROBIOL, V23, P289, DOI 10.1007/s10096-004-1100-1; CALVO F, 2001, ANTHROPO, V1, P21; DELIVANIS PD, 1981, ORAL SURG ORAL MED O, V52, P430, DOI 10.1016/0030-4220(81)90344-3; Doyuk E, 2002, J INFECTION, V45, P39, DOI 10.1053/jinf.2002.1004; Drancourt M, 2005, J INFECT DIS, V191, P607, DOI 10.1086/427041; Drancourt M, 2005, NAT REV MICROBIOL, V3, P23, DOI 10.1038/nrmicro1063; Drancourt M, 2004, MICROBIOL-SGM, V150, P263, DOI 10.1099/mic.0.26885-0; Drancourt M, 1998, P NATL ACAD SCI USA, V95, P12637, DOI 10.1073/pnas.95.21.12637; Fernandez-Baca V, 2001, J HOSP INFECT, V49, P173, DOI 10.1053/jhin.2001.1053; Gilbert MTP, 2004, MICROBIOL-SGM, V150, P341, DOI 10.1099/mic.0.26594-0; Gilbert MTP, 2003, AM J HUM GENET, V72, P32, DOI 10.1086/345378; GLICK M, 1991, ORAL SURG ORAL MED O, V71, P733, DOI 10.1016/0030-4220(91)90284-J; GLICK M, 1989, J AM DENT ASSOC, V119, P649, DOI 10.1016/S0002-8177(89)95019-8; Grahn N, 2003, FEMS MICROBIOL LETT, V219, P87, DOI 10.1016/S0378-1097(02)01190-4; Hoffmann H, 2003, APPL ENVIRON MICROB, V69, P5306, DOI 10.1128/AEM.69.9.5306-5318.2003; HOSHINO E, 1992, INT ENDOD J, V25, P2, DOI 10.1111/j.1365-2591.1992.tb00941.x; HUGHES MS, 1994, J CLIN MICROBIOL, V32, P2007, DOI 10.1128/JCM.32.8.2007-2008.1994; Kim BN, 2002, EUR J CLIN MICROBIOL, V21, P419, DOI 10.1007/s10096-002-0738-9; Kim KS, 2003, FEMS MICROBIOL LETT, V226, P299, DOI 10.1016/S0378-1097(03)00618-9; La VD, 2004, CLIN INFECT DIS, V39, P1391, DOI 10.1086/424884; Leonard H, 2005, LANCET, V366, P1584, DOI 10.1016/S0140-6736(05)67631-3; Mollet C, 1997, MOL MICROBIOL, V26, P1005, DOI 10.1046/j.1365-2958.1997.6382009.x; Papagrigorakis MJ, 2006, INT J INFECT DIS, V10, P206, DOI 10.1016/j.ijid.2005.09.001; RAND KH, 1990, MOL CELL PROBE, V4, P445, DOI 10.1016/0890-8508(90)90003-I; Raoult D, 2000, P NATL ACAD SCI USA, V97, P12800, DOI 10.1073/pnas.220225197; RESTAGNO G, 1995, PRENATAL DIAG, V15, P672, DOI 10.1002/pd.1970150715; Rocas IN, 2004, J ENDODONT, V30, P504, DOI 10.1097/00004770-200407000-00011; Rothman RE, 2002, J INFECT DIS, V186, P1677, DOI 10.1086/345367; Rudbeck L, 2005, AM J PHYS ANTHROPOL, V128, P424, DOI 10.1002/ajpa.20294; Rupf S, 2000, ENDOD DENT TRAUMATOL, V16, P269; Sambrook J., 2002, MOL CLONING LAB MANU; SEIFERT H, 1993, CLIN INFECT DIS, V17, P632, DOI 10.1093/clinids/17.4.632; TZIAFAS D, 1989, J ENDODONT, V15, P591, DOI 10.1016/S0099-2399(89)80157-8; WAGES JM, 1994, BIOTECHNIQUES, V16, P1014; Wiechmann I, 2005, AM J PHYS ANTHROPOL, V126, P48, DOI 10.1002/ajpa.10276; WOODWARD SR, 1994, PCR METH APPL, V3, P244	40	17	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1062	10.1371/journal.pone.0001062	http://dx.doi.org/10.1371/journal.pone.0001062			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957246	gold, Green Published, Green Submitted			2022-12-25	WOS:000207458500009
J	Kolla, RV; Chintalapati, S; Sabet, M; Santelli, E; Liddington, RC; David, M; Fierer, J; Guiney, D; Rickert, RC				Kolla, Ravi V.; Chintalapati, Suresh; Sabet, Mojgan; Santelli, Eugenio; Liddington, Robert C.; David, Michael; Fierer, Joshua; Guiney, Donald; Rickert, Robert C.			Complement C3d Conjugation to Anthrax Protective Antigen Promotes a Rapid, Sustained, and Protective Antibody Response	PLOS ONE			English	Article								B. anthracis is the causative agent of anthrax. Pathogenesis is primarily mediated through the exotoxins lethal factor and edema factor, which bind protective antigen (PA) to gain entry into the host cell. The current anthrax vaccine (AVA, Biothrax (TM)) consists of aluminum-adsorbed cell-free filtrates of unencapsulated B. anthracis, wherein PA is thought to be the principle target of neutralization. In this study, we evaluated the efficacy of the natural adjuvant, C3d, versus alum in eliciting an anti-PA humoral response and found that C3d conjugation to PA and emulsion in incomplete Freund's adjuvant (IFA) imparted superior protection from anthrax challenge relative to PA in IFA or PA adsorbed to alum. Relative to alum-PA, immunization of mice with C3d-PA/IFA augmented both the onset and sustained production of PA-specific antibodies, including neutralizing antibodies to the receptor-binding portion (domain 4) of PA. C3d-PA/IFA was efficacious when administered either i.p. or s.c., and in adolescent mice lacking a fully mature B cell compartment. Induction of PA-specific antibodies by C3d-PA/IFA correlated with increased efficiency of germinal center formation and plasma cell generation. Importantly, C3d-PA immunization effectively protected mice from intranasal challenge with B. anthracis spores, and was approximately 10-fold more effective than alum-PA immunization or PA/IFA based on dose challenge. These data suggest that incorporation of C3d as an adjuvant may overcome shortcomings of the currently licensed aluminum-based vaccine, and may confer protection in the early days following acute anthrax exposure.	[Kolla, Ravi V.; Chintalapati, Suresh; Santelli, Eugenio; Liddington, Robert C.; Rickert, Robert C.] Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, La Jolla, CA USA; [Sabet, Mojgan; Guiney, Donald] Univ Calif San Diego, Dept Med, Div Infect Dis, San Diego, CA 92103 USA; [David, Michael] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Fierer, Joshua] San Diego Vet Affairs Med Ctr, Dept Med, San Diego, CA USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Rickert, RC (corresponding author), Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, La Jolla, CA USA.	robert@burnham.org	, jfierer/W-2823-2019		NIH [AI41649, AI59363, AI055789]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI055789, R01AI041649, R21AI059363] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI41649 and AI59363 (to RCR) and AI055789 (to RCL).	Berthold I, 2005, VACCINE, V23, P1993, DOI 10.1016/j.vaccine.2004.10.014; Brey RN, 2005, ADV DRUG DELIVER REV, V57, P1266, DOI 10.1016/j.addr.2005.01.028; Carroll MC, 1997, CURR OPIN IMMUNOL, V9, P64, DOI 10.1016/S0952-7915(97)80160-4; Chabot DJ, 2004, VACCINE, V23, P43, DOI 10.1016/j.vaccine.2004.05.029; Cherukuri A, 2001, J IMMUNOL, V167, P163, DOI 10.4049/jimmunol.167.1.163; Cozine CL, 2005, CURR OPIN IMMUNOL, V17, P298, DOI 10.1016/j.coi.2005.04.007; Del Nagro CJ, 2005, J IMMUNOL, V175, P5379, DOI 10.4049/jimmunol.175.8.5379; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Fang YF, 1998, J IMMUNOL, V160, P5273; Fischer MB, 1998, J IMMUNOL, V160, P2619; Flick-Smith HC, 2002, INFECT IMMUN, V70, P1653, DOI 10.1128/IAI.70.3.1653-1656.2002; GORSE GJ, 2006, VACCINE; Green TD, 2001, VACCINE, V20, P242, DOI 10.1016/S0264-410X(01)00266-3; Haas KM, 2004, J IMMUNOL, V172, P5833, DOI 10.4049/jimmunol.172.10.5833; Haas KM, 2002, IMMUNITY, V17, P713, DOI 10.1016/S1074-7613(02)00483-1; Hannan J, 2002, BIOCHEM SOC T, V30, P983, DOI 10.1042/bst0300983; Henson SE, 2001, J IMMUNOL METHODS, V258, P97, DOI 10.1016/S0022-1759(01)00471-9; Hess MW, 2000, BLOOD, V95, P2617, DOI 10.1182/blood.V95.8.2617.008k20_2617_2623; HogenEsch H, 2002, VACCINE, V20, pS34, DOI 10.1016/S0264-410X(02)00169-X; Hughes MA, 2005, INFECT IMMUN, V73, P7535, DOI 10.1128/IAI.73.11.7535-7540.2005; Jendrek S, 2003, VACCINE, V21, P3011, DOI 10.1016/S0264-410X(03)00109-9; Joellenbeck LM, 2002, ANTHRAX VACCINE IS I; Jordan MB, 2004, SCIENCE, V304, P1808, DOI 10.1126/science.1089926; Koch M, 2005, VIROLOGY, V340, P277, DOI 10.1016/j.virol.2005.06.034; Leppla SH, 2002, J CLIN INVEST, V110, P141, DOI [10.1172/JCI200216204, 10.1172/JCI0216204]; Liddington R, 1999, J APPL MICROBIOL, V87, P282, DOI 10.1046/j.1365-2672.1999.00888.x; Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.0818-9641.2004.01286.x; Mikszta JA, 2005, J INFECT DIS, V191, P278, DOI 10.1086/426865; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Nemazee D, 2006, NATURE, V441, pE4, DOI 10.1038/nature04875; Oliver AM, 1999, J IMMUNOL, V162, P7198; Oncu Serkan, 2003, Med Sci Monit, V9, pRA276; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Rickert RC, 2005, CURR OPIN IMMUNOL, V17, P237, DOI 10.1016/j.coi.2005.03.001; Rosovitz MJ, 2003, J BIOL CHEM, V278, P30936, DOI 10.1074/jbc.M301154200; Sabet M, 2006, FEMS IMMUNOL MED MIC, V47, P369, DOI 10.1111/j.1574-695X.2006.00096.x; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Sever JL, 2002, PHARMACOEPIDEM DR S, V11, P189, DOI 10.1002/pds.712; Suradhat S, 2001, VET IMMUNOL IMMUNOP, V83, P79, DOI 10.1016/S0165-2427(01)00369-5; Takahashi K, 1997, J IMMUNOL, V159, P1557; Turnbull PCB, 2000, CURR OPIN INFECT DIS, V13, P113, DOI 10.1097/00001432-200004000-00004; 2000, MMWR MORB MORTAL WKL, V49, P341	43	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2007	2	10							e1044	10.1371/journal.pone.0001044	http://dx.doi.org/10.1371/journal.pone.0001044			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10HW	17940608	Green Published, gold, Green Submitted			2022-12-25	WOS:000207456100012
J	Sales, KJ; Boddy, SC; Jabbour, HN				Sales, K. J.; Boddy, S. C.; Jabbour, H. N.			F-prostanoid receptor alters adhesion, morphology and migration of endometrial adenocarcinoma cells	ONCOGENE			English	Article						PGF(2 alpha); FP receptor; focal adhesions; morphology; migration; chemotaxis	GONADOTROPIN-RELEASING-HORMONE; ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR RECEPTOR; N-TERMINAL KINASE; C-SRC; TYROSINE PHOSPHORYLATION; CYCLOOXYGENASE ENZYMES; SIGNAL-TRANSDUCTION; COUPLED RECEPTORS; EXPRESSION	Cellular adhesion to extracellular matrix is a central phenomenon for the maintenance of tissue integrity and cellular movement. Collectively, these processes are regulated by a fine- tuned balance between the formation and loosening of adhesive contacts, a process involving integrins, and the elevation and diminution of cytoplasmic signalling molecules. We demonstrate that prostaglandin ( PG) F-2 alpha stimulation rapidly increases the capacity of Ishikawa cells stably expressing the F- prostanoid receptor ( FPS) to adhere to vitronectin. Coincident with this elevation in matrix adhesion, we demonstrate a profound PGF(2 alpha)- induced alteration in cytoskeletal remodelling, characterized by polymerization of the actin cytoskeleton and recruitment of focal adhesion kinase at focal adhesions and enhanced cell migration. Moreover, we show that these PGF2a- induced alterations in adhesion and morphology on vitronectin and migration could be abolished by cultivating FPS cells in the presence of integrin alpha v beta 3 antibody or alpha v beta 3- directed tetrapeptide arg - gly - asp - ser or inhibition of FP receptor signalling with the FP receptor antagonist, chemical disruptors of the phospholipase C-beta, protein kinase A, c- Src and epidermal growth factor receptor kinase pathways or inhibition of the monomeric G proteins Rho, Rac and CDC42. These results reveal a mechanism by which prostanoids regulate cell movement, which may be relevant to pathologies of the endometrium.	[Sales, K. J.; Boddy, S. C.; Jabbour, H. N.] Queens Med Res Inst, MRC, MRC Human Reprod Sci Unit, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Edinburgh	Jabbour, HN (corresponding author), Queens Med Res Inst, MRC, MRC Human Reprod Sci Unit, 47 Little France Crescent,Old Dalkeith Rd, Edinburgh EH16 4TJ, Midlothian, Scotland.	h.jabbour@hrsu.mrc.ac.uk		Sales, Kurt/0000-0002-9880-5143	Medical Research Council [MC_U127684438, U.1276.00.004.00002.01/2(61014)] Funding Source: Medline; MRC [MC_U127684438] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Benard O, 2001, J BIOL CHEM, V276, P4554, DOI 10.1074/jbc.M006995200; Brakebusch C, 2002, J CLIN INVEST, V109, P999, DOI 10.1172/JCI200215468; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Cruet S, 1999, GYNECOL ONCOL, V75, P254, DOI 10.1006/gyno.1999.5572; Damsky CH, 1991, CURR OPIN CELL BIOL, V3, P777, DOI 10.1016/0955-0674(91)90049-5; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; Davidson L, 2004, J BIOL CHEM, V279, P11906, DOI 10.1074/jbc.M310784200; Davidson L, 2004, J BIOL CHEM, V279, P1980, DOI 10.1074/jbc.M309827200; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; Fujino H, 2000, J BIOL CHEM, V275, P29907, DOI 10.1074/jbc.M003467200; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Griffin BW, 1999, J PHARMACOL EXP THER, V290, P1278; Harris D, 2002, ENDOCRINOLOGY, V143, P1018, DOI 10.1210/en.143.3.1018; Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918; Jaaro H, 1997, P NATL ACAD SCI USA, V94, P3742, DOI 10.1073/pnas.94.8.3742; Jabbour HN, 2005, ENDOCRINOLOGY, V146, P4657, DOI 10.1210/en.2005-0804; Jabbour HN, 2004, TRENDS ENDOCRIN MET, V15, P398, DOI 10.1016/j.tem.2004.08.006; LEFKOWITZ RJ, 1993, CELL, V74, P409, DOI 10.1016/0092-8674(93)80042-D; LESSEY BA, 1994, J CLIN ENDOCR METAB, V79, P643, DOI 10.1210/jc.79.2.643; Levi NL, 1998, MOL ENDOCRINOL, V12, P815, DOI 10.1210/me.12.6.815; Liapis H, 1997, HUM PATHOL, V28, P443, DOI 10.1016/S0046-8177(97)90033-2; LUMSDEN MA, 1983, BRIT J OBSTET GYNAEC, V90, P1135, DOI 10.1111/j.1471-0528.1983.tb06460.x; LUNDSTROM V, 1978, AM J OBSTET GYNECOL, V130, P640, DOI 10.1016/0002-9378(78)90320-4; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Luttrell LM, 1997, ADV SEC MESS PHOSPH, V31, P263; MORINO N, 1995, J BIOL CHEM, V270, P269, DOI 10.1074/jbc.270.1.269; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Pierce KL, 1999, J BIOL CHEM, V274, P35944, DOI 10.1074/jbc.274.50.35944; PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cellbio.7.1.275; RodriguezFernandez JL, 1996, J BIOL CHEM, V271, P27895, DOI 10.1074/jbc.271.44.27895; Sales KJ, 2004, MOL ENDOCRINOL, V18, P1533, DOI 10.1210/me.2004-0022; Sales KJ, 2005, CANCER RES, V65, P7707, DOI 10.1158/0008-5472.CAN-05-0101; Sales KJ, 2003, PROSTAG OTH LIPID M, V71, P97, DOI 10.1016/S1098-8823(03)00050-9; Sales KJ, 2004, J CLIN ENDOCR METAB, V89, P986, DOI 10.1210/jc.2003-031434; Sales KJ, 2003, REPRODUCTION, V126, P559, DOI 10.1530/rep.0.1260559; Sales KJ, 2007, ENDOCRINOLOGY, V148, P3635, DOI 10.1210/en.2006-1517; Schlaepfer DD, 1997, J BIOL CHEM, V272, P13189, DOI 10.1074/jbc.272.20.13189; SEGER R, 1994, J BIOL CHEM, V269, P25699; SINGH EJ, 1975, AM J OBSTET GYNECOL, V121, P1003, DOI 10.1016/0002-9378(75)90927-8; Slack BE, 1998, P NATL ACAD SCI USA, V95, P7281, DOI 10.1073/pnas.95.13.7281; WEINER TM, 1993, LANCET, V342, P1024, DOI 10.1016/0140-6736(93)92881-S; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007	43	31	33	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 10	2008	27	17					2466	2477		10.1038/sj.onc.1210883	http://dx.doi.org/10.1038/sj.onc.1210883			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286KN	17968320	Green Accepted			2022-12-25	WOS:000254844900011
J	Perazzona, B; Lin, H; Sun, T; Wang, Y; Arlinghaus, R				Perazzona, B.; Lin, H.; Sun, T.; Wang, Y.; Arlinghaus, R.			Kinase domain mutants of Bcr enhance Bcr-Abl oncogenic effects	ONCOGENE			English	Article						BCR-ABL; CML; BCR kinase-defective BCR	NEGATIVE REGULATOR; TYROSINE KINASE; GENE ENCODES; P160 BCR; C-ABL; ONCOPROTEIN; LEUKEMIA; TRANSFORMATION; EXPRESSION; PROTEIN	Bcr-Abl acquires its transforming ability through its upregulated Abl tyrosine kinase activity. Bcr is a phosphoprotein with a novel serine/threonine kinase activity encoded by its first exon. In chronic myelogenous leukemia (CML) cells, Bcr-Abl phosphorylates Bcr on tyrosine residues reducing its kinase activity. Overexpression of BCR in BCR-ABL + cells produces a phosphoserine form of Bcr, which inhibits the oncogenic effects of BCR-ABL. To investigate the inhibitory effects of Bcr on Bcr-Abl, we expressed BCR/GFP in TonB210 cells, which contain a tetracycline-inducible BCR-ABL. In nude mice injected with cell clones of TonB210/BCR/GFP, tumor formation was delayed, and tumors were 50% smaller compared with the TonB210/GFP. In addition, TonB210/BCR/GFP cells had little colony-forming ability in soft agar compared with TonB210/GFP cells. In contrast, a point mutant of BCR (Y360F), which disrupts its kinase activity, not only blocked Bcr's inhibitory effects but also enhanced the oncogenic effects of Bcr-Abl in a solid tumor model and in soft agar colony assays. Similar effects were observed with a second BCR kinase domain mutant, S354A. These results indicate that the inhibitory function of Bcr directed toward Bcr-Abl requires its kinase function.	[Perazzona, B.; Lin, H.; Sun, T.; Wang, Y.; Arlinghaus, R.] Univ Texas MD Anderson Canc Ctr, Unit 951, Dept Mol Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Arlinghaus, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Unit 951, Dept Mol Pathol, 7435 Fannin St, Houston, TX 77030 USA.	rarlingh@mdanderson.org			NATIONAL CANCER INSTITUTE [P01CA049639] Funding Source: NIH RePORTER; NCI NIH HHS [CA49639, P01 CA049639, P01 CA049639-150024] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; Arlinghaus RB, 2002, ONCOGENE, V21, P8560, DOI 10.1038/sj.onc.1206083; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; GUO JQ, 1994, BLOOD, V83, P3629; Hawk N, 2002, CANCER RES, V62, P386; Klucher KM, 1998, BLOOD, V91, P3927, DOI 10.1182/blood.V91.10.3927.3927_3927_3934; LI WJ, 1989, ONCOGENE, V4, P127; Lin F, 2001, ONCOGENE, V20, P1873, DOI 10.1038/sj.onc.1204409; Ling XY, 2003, CANCER RES, V63, P298; LIU J, 1996, MOL CELL BIOL, V3, P998; LIU JX, 1993, ONCOGENE, V8, P101; LU D, 1993, BLOOD, V82, P1257; Mahon GM, 2003, CURR BIOL, V13, P437, DOI 10.1016/S0960-9822(03)00090-3; MARU Y, 1991, CELL, V67, P459, DOI 10.1016/0092-8674(91)90521-Y; MCWHIRTER JR, 1993, MOL CELL BIOL, V13, P7587, DOI 10.1128/MCB.13.12.7587; Moravcova J, 2005, NEOPLASMA, V52, P119; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; PENDERGAST AM, 1991, CELL, V66, P161, DOI 10.1016/0092-8674(91)90148-R; Ress A, 2005, EMBO REP, V6, P1095, DOI 10.1038/sj.embor.7400536; SAWYERS CL, 1992, CELL, V70, P901, DOI 10.1016/0092-8674(92)90241-4; STAM K, 1987, MOL CELL BIOL, V7, P1955, DOI 10.1128/MCB.7.5.1955; Wu Y, 1999, ONCOGENE, V18, P4416, DOI 10.1038/sj.onc.1202828; Xie SH, 2002, ONCOGENE, V21, P7137, DOI 10.1038/sj.onc.1205942	23	3	4	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 3	2008	27	15					2208	2214		10.1038/sj.onc.1210851	http://dx.doi.org/10.1038/sj.onc.1210851			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	283FE	17934518	Green Accepted			2022-12-25	WOS:000254621300011
J	Nagata, M; Kaito, C; Sekimizu, K				Nagata, Makiko; Kaito, Chikara; Sekimizu, Kazuhisa			Phosphodiesterase activity of CvfA is required for virulence in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EAL DOMAIN PROTEIN; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; GENE-EXPRESSION; 2',3'-CYCLIC PHOSPHODIESTERASE; HD DOMAIN; DI-GMP; SYSTEM; AGR; IDENTIFICATION	We previously identified the cvfA gene (SA1129) as a novel virulence regulator in Staphylococcus aureus using the silkworm infection model. The cvfA gene, which is conserved among various pathogenic bacteria, contributes to the expression of the agr locus, a global virulence regulator that controls the expression of genes encoding various exoproteins, such as hemolysin. CvfA protein has a transmembrane domain, an RNA binding domain (KH domain), and a metal-dependent phosphohydrolase domain (HD domain). We report here the purification of recombinant CvfA protein from a membrane fraction of Escherichia coli by measuring its phosphodiesterase activity. Purified CvfA protein hydrolyzed the phosphodiester linkage of 2 ', 3 '-cyclic AMP, 2 ', 3 '-cyclic GMP, and 2 ', 3 '-cyclic phosphate at the 3 '-terminal of RNA in the presence of Mn2+. CvfA mutant proteins with amino acid substitutions in the HD domain had significantly decreased phosphodiesterase activity. Furthermore, mutated cvfA genes encoding proteins with low phosphodiesterase activity did not complement the decreased hemolysin production or the attenuated killing ability against silkworms in the cvfA deletion mutant. These results suggest that the phosphodiesterase activity of CvfA protein is required for virulence in S. aureus.	[Nagata, Makiko; Kaito, Chikara; Sekimizu, Kazuhisa] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Sekimizu, K (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 3-1-7 Chome, Tokyo 1130033, Japan.	sekimizu@mol.f.u-tokyo.ac.jp	Kaito, Chikara/W-1815-2019; Kaito, Chikara/G-1248-2017	Kaito, Chikara/0000-0002-2895-3386; Kaito, Chikara/0000-0002-2895-3386				Ades SE, 2004, CURR OPIN MICROBIOL, V7, P157, DOI 10.1016/j.mib.2004.02.010; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; CHEUNG AL, 1992, P NATL ACAD SCI USA, V89, P6462, DOI 10.1073/pnas.89.14.6462; Crossly KB, 1997, STAPHYLOCOCCI HUMAN; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Fabret C, 2002, MOL MICROBIOL, V46, P25, DOI 10.1046/j.1365-2958.2002.03140.x; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fournier B, 2001, MOL MICROBIOL, V41, P247, DOI 10.1046/j.1365-2958.2001.02515.x; Giraudo AT, 1997, ARCH MICROBIOL, V168, P53, DOI 10.1007/s002030050469; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Hisert KB, 2005, MOL MICROBIOL, V56, P1234, DOI 10.1111/j.1365-2958.2005.04632.x; Hunt A, 2006, MICROBIOL-SGM, V152, P2895, DOI 10.1099/mic.0.29152-0; Inoue R, 2001, MOL GENET GENOMICS, V266, P564, DOI 10.1007/s004380100564; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Kaito C, 2006, MOL MICROBIOL, V62, P1601, DOI 10.1111/j.1365-2958.2006.05480.x; Kennell D, 2002, J BACTERIOL, V184, P4645, DOI 10.1128/JB.184.17.4645-4657.2002; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Li SL, 1997, BIOTECHNIQUES, V23, P588, DOI 10.2144/97234bm05; Li ZW, 1998, P NATL ACAD SCI USA, V95, P2856, DOI 10.1073/pnas.95.6.2856; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Matsumoto Y, 2007, INFECT IMMUN, V75, P1964, DOI 10.1128/IAI.01552-06; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; TAO L, 1992, GENE, V120, P105, DOI 10.1016/0378-1119(92)90016-I; Tischler AD, 2005, INFECT IMMUN, V73, P5873, DOI 10.1128/IAI.73.9.5873-5882.2005; Traber K, 2006, MOL MICROBIOL, V59, P1519, DOI 10.1111/j.1365-2958.2006.04986.x; Trulzsch K, 2001, MICROBIOL-UK, V147, P203; Turko IV, 1998, J BIOL CHEM, V273, P6460, DOI 10.1074/jbc.273.11.6460; TYC K, 1987, J BIOL CHEM, V262, P12994; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; VANDENESCH F, 1991, J BACTERIOL, V173, P6313, DOI 10.1128/jb.173.20.6313-6320.1991; Yakunin AF, 2004, J BIOL CHEM, V279, P36819, DOI 10.1074/jbc.M405120200; Yarwood JM, 2001, J BACTERIOL, V183, P1113, DOI 10.1128/JB.183.4.1113-1123.2001	40	52	54	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2176	2184		10.1074/jbc.M705309200	http://dx.doi.org/10.1074/jbc.M705309200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	17951247	hybrid			2022-12-25	WOS:000252501000045
J	Yoshimochi, T; Fujikane, R; Kawanami, M; Matsunaga, F; Ishino, Y				Yoshimochi, Takehiro; Fujikane, Ryosuke; Kawanami, Miyuki; Matsunaga, Fujihiko; Ishino, Yoshizumi			The GINS complex from Pyrococcus furiosus stimulates the MCM helicase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MINICHROMOSOME MAINTENANCE PROTEIN; DNA-REPLICATION; CRYSTAL-STRUCTURE; INITIATION; ORGANIZATION; POLYMORPHISM; ASSOCIATION; CDC6/ORC1; CDC45	Pyrococcus furiosus, a hyperthermophilic Archaea, has homologs of the eukaryotic MCM (mini-chromosome maintenance) helicase and GINS complex. The MCM and GINS proteins are both essential factors to initiate DNA replication in eukaryotic cells. Many biochemical characterizations of the replication-related proteins have been reported, but it has not been proved that the homologs of each protein are also essential for replication in archaeal cells. Here, we demonstrated that the P. furiosus GINS complex interacts with P. furiosus MCM. A chromatin immunoprecipitation assay revealed that the GINS complex is detected preferentially at the oriC region on Pyrococcus chromosomal DNA during the exponential growth phase but not in the stationary phase. Furthermore, the GINS complex stimulates both the ATPase and DNA helicase activities of MCM in vitro. These results strongly suggest that the archaeal GINS is involved in both the initiation and elongation processes of DNA replication in P. furiosus, as observed in eukaryotic cells.	[Ishino, Yoshizumi] BIRD Japan Sci & Technol Agcy, Higashi Ku, Fukuoka 8128581, Japan; [Yoshimochi, Takehiro; Fujikane, Ryosuke; Kawanami, Miyuki; Matsunaga, Fujihiko; Ishino, Yoshizumi] Kyushu Univ, Fac Agr, Dept Genet Resources Technol, Fukuoka 8128581, Japan	Kyushu University	Ishino, Y (corresponding author), BIRD Japan Sci & Technol Agcy, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	ishino@agr.kyushu-u.ac.jp		Fujikane, Ryosuke/0000-0002-6621-3848; Ishino, Yoshizumi/0000-0001-9419-0826				Barry ER, 2006, MICROBIOL MOL BIOL R, V70, P876, DOI 10.1128/MMBR.00029-06; Boskovic J, 2007, EMBO REP, V8, P678, DOI 10.1038/sj.embor.7401002; Carpentieri F, 2002, J BIOL CHEM, V277, P12118, DOI 10.1074/jbc.M200091200; Chang YP, 2007, P NATL ACAD SCI USA, V104, P12685, DOI 10.1073/pnas.0705558104; Chen YJ, 2005, J MOL BIOL, V346, P389, DOI 10.1016/j.jmb.2004.11.076; Choi JM, 2007, GENE DEV, V21, P1316, DOI 10.1101/gad.1548107; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Costa A, 2006, J STRUCT BIOL, V156, P210, DOI 10.1016/j.jsb.2006.04.001; De Falco M, 2007, EMBO REP, V8, P99, DOI 10.1038/sj.embor.7400870; Fletcher RJ, 2005, J BIOL CHEM, V280, P42405, DOI 10.1074/jbc.M509773200; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Fujita M, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-22; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gomez-Llorente Y, 2005, J BIOL CHEM, V280, P40909, DOI 10.1074/jbc.M509760200; Grainge I, 2003, NUCLEIC ACIDS RES, V31, P4888, DOI 10.1093/nar/gkg662; Haugland GT, 2006, NUCLEIC ACIDS RES, V34, P6337, DOI 10.1093/nar/gkl864; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; KARMADA K, 2007, NAT STRUCT MOL BIOL, V14, P388; Kelman Z, 1999, P NATL ACAD SCI USA, V96, P14783, DOI 10.1073/pnas.96.26.14783; Kubota Y, 2003, GENE DEV, V17, P1141, DOI 10.1101/gad.1070003; Labib K, 2007, TRENDS CELL BIOL, V17, P271, DOI 10.1016/j.tcb.2007.04.002; Liu LD, 2001, J BIOL CHEM, V276, P45484, DOI 10.1074/jbc.M106391200; Makarova KS, 2005, NUCLEIC ACIDS RES, V33, P4626, DOI 10.1093/nar/gki775; Marinsek N, 2006, EMBO REP, V7, P539, DOI 10.1038/sj.embor.7400649; Masuda T, 2003, GENES CELLS, V8, P145, DOI 10.1046/j.1365-2443.2003.00621.x; Matsunaga F, 2001, P NATL ACAD SCI USA, V98, P11152, DOI 10.1073/pnas.191387498; Matsunaga F, 2007, NUCLEIC ACIDS RES, V35, P3214, DOI 10.1093/nar/gkm212; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; ORLANDO V, 1993, CELL, V75, P1187, DOI 10.1016/0092-8674(93)90328-N; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pape T, 2003, EMBO REP, V4, P1079, DOI 10.1038/sj.embor.7400010; Shechter DF, 2000, J BIOL CHEM, V275, P15049, DOI 10.1074/jbc.M000398200; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Tercero JA, 2000, EMBO J, V19, P2082, DOI 10.1093/emboj/19.9.2082; UEMORI T, 1993, NUCLEIC ACIDS RES, V21, P259, DOI 10.1093/nar/21.2.259; YABUUCHI H, 2007, EMBO J, V8, P99	38	55	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1601	1609		10.1074/jbc.M707654200	http://dx.doi.org/10.1074/jbc.M707654200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17986447	hybrid			2022-12-25	WOS:000252282700046
J	Galkin, A; Moncada, S				Galkin, Alexander; Moncada, Salvador			S-nitrosation of mitochondrial complex I depends on its structural conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE REDUCTASE; ACTIVE/DE-ACTIVE TRANSITION; NITRIC-OXIDE; CATALYTIC-PROPERTIES; ELECTRON-TRANSPORT; PERSISTENT INHIBITION; OXYGEN-CONSUMPTION; RELAXING FACTOR; RAT-HEART; PEROXYNITRITE	Nitric oxide is known to cause persistent inhibition of mitochondrial respiration as a result of S-nitrosation of NADH: ubiquinone oxidoreductase (complex I) (Clementi, E., Brown, G. C., Feelisch, M., and Moncada, S. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 7631-7636). Little is known about whether such nitrosation occurs in physiological conditions and, if so, what are the possible cellular mechanisms. We have now found that the conformational state (active/deactive transition (Vinogradov, A. D. (1998) Biochim. Biophys. Acta 1364, 169-185)) of mitochondrial complex I is an important factor for the interaction of the enzyme with nitrosothiols and peroxynitrite. Only the deactivated, idle form of complex I was susceptible to inhibition by nitrosothiols and peroxynitrite. In contrast, the active form of the enzyme was insensitive to such treatment. Neither form of complex I was inhibited by nitric oxide itself. Our data suggest that the process of active/deactive transition plays an important role in the regulation of complex I activity and cellular respiration by nitric oxide. The implications of this finding for hypoxic or pathophysiological conditions in vivo are discussed.	[Galkin, Alexander; Moncada, Salvador] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England	University of London; University College London	Galkin, A (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	a.galkin@ucl.ac.uk						AKAIKE T, 1993, BIOCHEMISTRY-US, V32, P827, DOI 10.1021/bi00054a013; Alvarez B, 1999, J BIOL CHEM, V274, P842, DOI 10.1074/jbc.274.2.842; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; Beltran B, 2000, BRIT J PHARMACOL, V129, P953, DOI 10.1038/sj.bjp.0703147; Borutaite V, 2000, BBA-BIOENERGETICS, V1459, P405, DOI 10.1016/S0005-2728(00)00178-X; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Burwell LS, 2006, BIOCHEM J, V394, P627, DOI 10.1042/BJ20051435; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Cassina A, 1996, ARCH BIOCHEM BIOPHYS, V328, P309, DOI 10.1006/abbi.1996.0178; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; CUDD A, 1982, J BIOL CHEM, V257, P1443; Dahm CC, 2006, J BIOL CHEM, V281, P10056, DOI 10.1074/jbc.M512203200; Gavrikova EV, 1999, FEBS LETT, V455, P36, DOI 10.1016/S0014-5793(99)00850-9; Giustarini D, 2005, ANTIOXID REDOX SIGN, V7, P930, DOI 10.1089/ars.2005.7.930; GOSTIMSKAYA IS, BIOCH BIOPHYS ACTA, V1757, P1155; GRANGER DL, 1982, J CELL BIOL, V95, P527, DOI 10.1083/jcb.95.2.527; Grivennikova VG, 2001, J BIOL CHEM, V276, P9038, DOI 10.1074/jbc.M009661200; HAYES JE, 1954, J BIOL CHEM, V207, P225; HUGHES MN, 1968, J CHEM SOC A, V2, P450; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Konorev EA, 2000, FREE RADICAL BIO MED, V28, P1671, DOI 10.1016/S0891-5849(00)00281-1; KOTLYAR AB, 1990, BIOCHIM BIOPHYS ACTA, V1019, P151, DOI 10.1016/0005-2728(90)90137-S; KOTLYAR AB, 1984, BIOCHIM BIOPHYS ACTA, V784, P24, DOI 10.1016/0167-4838(84)90168-7; Lizasoain I, 1996, BIOCHEM J, V314, P877, DOI 10.1042/bj3140877; Maklashina E, 2003, BBA-BIOENERGETICS, V1606, P95, DOI 10.1016/S0005-2728(03)00087-2; Maklashina E, 2004, FEBS LETT, V556, P64, DOI 10.1016/S0014-5793(03)01369-3; Maklashina E, 2002, BBA-BIOENERGETICS, V1556, P6, DOI 10.1016/S0005-2728(02)00280-3; Maklashina E. O., 1994, Biokhimiya, V59, P946; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Monnet X, 2006, CARDIOVASC RES, V70, P391, DOI 10.1016/j.cardiores.2005.07.005; Orsi A, 2000, BIOCHEM J, V346, P407, DOI 10.1042/0264-6021:3460407; Palacios-Callender M, 2004, P NATL ACAD SCI USA, V101, P7630, DOI 10.1073/pnas.0401723101; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Pearce LL, 2005, NITRIC OXIDE-BIOL CH, V13, P254, DOI 10.1016/j.niox.2005.07.010; RADI R, 1991, J BIOL CHEM, V266, P4244; RADI R, 1994, ARCH BIOCHEM BIOPHYS, V308, P89, DOI 10.1006/abbi.1994.1013; Riobo NA, 2001, BIOCHEM J, V359, P139, DOI 10.1042/0264-6021:3590139; STADLER J, 1991, AM J PHYSIOL, V260, P910; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Tao LM, 2004, BIOCHEMISTRY-US, V43, P4028, DOI 10.1021/bi035924o; Tompkins AJ, 2006, BBA-MOL BASIS DIS, V1762, P223, DOI 10.1016/j.bbadis.2005.10.001; Vinogradov AD, 1998, BBA-BIOENERGETICS, V1364, P169, DOI 10.1016/S0005-2728(98)00026-7; Vinogradov AD, 2001, IUBMB LIFE, V52, P129, DOI 10.1080/15216540152845920; Vinogradov AD, 1999, BIOCHEMISTRY-MOSCOW+, V64, P136; Vogel R, 2004, CURR OPIN NEUROL, V17, P179, DOI 10.1097/00019052-200404000-00016; White MY, 2006, PROTEOMICS, V6, P6221, DOI 10.1002/pmic.200600219	47	100	104	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37448	37453		10.1074/jbc.M707543200	http://dx.doi.org/10.1074/jbc.M707543200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17956863	hybrid			2022-12-25	WOS:000251833600019
J	Yang, T; Allen, PD; Pessah, IN; Lopez, JR				Yang, Tianzhong; Allen, Paul D.; Pessah, Isaac N.; Lopez, Jose R.			Enhanced excitation-coupled calcium entry in myotubes is associated with expression of RyR1 malignant hyperthermia mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE MUSCLE FIBRES; OPERATED CA2+ ENTRY; SKELETAL-MUSCLE; RYANODINE RECEPTOR; DIHYDROPYRIDINE RECEPTOR; POTASSIUM CONTRACTURES; CHARGE MOVEMENT; CHANNEL; FIBERS; INFLUX	Myotubes expressing wild type RyR1 (WT) or RyR1 with one of three malignant hyperthermia mutations R615C, R2163C, and T4826I (MH) were exposed sequentially to 60 mM KCl in Ca2+-replete and Ca2+-free external buffers (Ca+ and Ca-, respectively) with 3 min of rest between exposures. Although the maximal peak amplitude of the Ca2+ transients during K+ depolarization was similar for WT and MH in both external buffers, the rate of decay of the sustained phase of the transient during K+ depolarization (decay rate) in Ca+ was 50% slower for MH. This difference was eliminated in Ca-, and the relative decay rates were faster for both genotypes than in Ca+. The integrated Ca2+ transient in Ca- compared with Ca+ was reduced by 50-60% for MH and 20% for WT. The decay rate was not affected by [ K+] x [ Cl-] product or NiCl2 (2 mM) supplementation of Ca-. The addition of La2+ (0.1mM), or SKF 96365 (20 mu M) to Ca+ significantly accelerated decay rates for both WT and MH, but their effect was significantly greater in MH. Nifedipine (1 mu M) had no effect, suggesting that the mechanism for this difference was not a reduction in L-type Ca2+ channel Ca2+ current. These data strongly suggest: 1) the decay rate in skeletal myotubes is related in part to Ca2+ entry through the ECCE channel; 2) the MH mutations enhance ECCE compared with wild type; and 3) the increased Ca2+ entry might play a significant role in the pathophysiology of MH.	[Yang, Tianzhong; Allen, Paul D.; Lopez, Jose R.] Brigham & Womens Hosp, Dept Anesthesiol & Perioperat & Pain Med, Boston, MA 02115 USA; [Pessah, Isaac N.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95606 USA; [Lopez, Jose R.] Inst Venezolano Invest Cient, Ctr Biofis & Bioquim, Caracas 21827, Venezuela	Harvard University; Brigham & Women's Hospital; University of California System; University of California Davis; Venezuelan Institute Science Research	Allen, PD (corresponding author), Brigham & Womens Hosp, Dept Anesthesiol & Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA.	pdallen@partners.org	Tuluc, Petronel/C-2527-2011; Pessah, Isaac N/K-7985-2017	Pessah, Isaac N/0000-0002-8149-588X				ANDERSON K, 1994, AM J PHYSIOL, V266, pC462, DOI 10.1152/ajpcell.1994.266.2.C462; ARMSTRONG CM, 1972, BIOCHIM BIOPHYS ACTA, V267, P605, DOI 10.1016/0005-2728(72)90194-6; BARRETT JN, 1978, SCIENCE, V200, P1270, DOI 10.1126/science.96524; BEAM KG, 1989, ANN NY ACAD SCI, V560, P127, DOI 10.1111/j.1749-6632.1989.tb24090.x; BERRIDGE MJ, 1995, BIOESSAYS, V17, P491, DOI 10.1002/bies.950170605; BIANCHI CP, 1959, J GEN PHYSIOL, V42, P803, DOI 10.1085/jgp.42.4.803; CAPUTO C, 1967, J GEN PHYSIOL, V50, P2177, DOI 10.1085/jgp.50.9.2177; CAPUTO C, 1994, J PHYSIOL-LONDON, V481, P119, DOI 10.1113/jphysiol.1994.sp020423; CHEN W, 1991, J PHYSIOL-LONDON, V444, P579, DOI 10.1113/jphysiol.1991.sp018895; Cherednichenko G, 2004, P NATL ACAD SCI USA, V101, P15793, DOI 10.1073/pnas.0403485101; FISCHMAN DA, 1967, J GEN PHYSIOL, V50, P1709, DOI 10.1085/jgp.50.6.1709; Flucher BE, 1996, P NATL ACAD SCI USA, V93, P8101, DOI 10.1073/pnas.93.15.8101; Fraefel C, 1996, J VIROL, V70, P7190, DOI 10.1128/JVI.70.10.7190-7197.1996; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Gallant EM, 1996, MUSCLE NERVE, V19, P68, DOI 10.1002/(SICI)1097-4598(199601)19:1<68::AID-MUS9>3.3.CO;2-0; GALLANT EM, 1982, NEUROSCI LETT, V28, P181, DOI 10.1016/0304-3940(82)90149-5; GALLANT EM, 1992, AM J PHYSIOL, V262, P422; GONZALEZSERRATOS H, 1982, NATURE, V298, P292, DOI 10.1038/298292a0; GOODMAN FR, 1974, ARCH INT PHARMACOD T, V209, P14; Grabner M, 1999, J BIOL CHEM, V274, P21913, DOI 10.1074/jbc.274.31.21913; HODGKIN AL, 1960, J PHYSIOL-LONDON, V153, P386, DOI 10.1113/jphysiol.1960.sp006541; HODGKIN AL, 1959, J PHYSIOL-LONDON, V148, P127, DOI 10.1113/jphysiol.1959.sp006278; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Hurne AM, 2005, J BIOL CHEM, V280, P36994, DOI 10.1074/jbc.M506441200; Jurkat-Rott K, 2000, MUSCLE NERVE, V23, P4, DOI 10.1002/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D; Kurebayashi N, 2001, J PHYSIOL-LONDON, V533, P185, DOI 10.1111/j.1469-7793.2001.0185b.x; Leung YM, 1999, JPN J PHARMACOL, V81, P253, DOI 10.1254/jjp.81.253; Lopez JR, 2000, ANESTHESIOLOGY, V92, P1799, DOI 10.1097/00000542-200006000-00040; LORKOVIC H, 1962, AM J PHYSIOL, V202, P440, DOI 10.1152/ajplegacy.1962.202.3.440; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Ma JJ, 2003, CELL CALCIUM, V33, P375, DOI 10.1016/S0143-4160(03)00050-2; MARTY I, 1994, P NATL ACAD SCI USA, V91, P2270, DOI 10.1073/pnas.91.6.2270; Nelson Thomas E., 2002, Current Molecular Medicine (Hilversum), V2, P347, DOI 10.2174/1566524023362429; Ong HL, 2007, J BIOL CHEM, V282, P27556; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Protasi F, 1998, J CELL BIOL, V140, P831, DOI 10.1083/jcb.140.4.831; RIOS E, 1987, NATURE, V325, P717, DOI 10.1038/325717a0; RIOS E, 1991, PHYSIOL REV, V71, P849, DOI 10.1152/physrev.1991.71.3.849; Robinson LC, 2006, CURR BIOL, V16, pR548, DOI 10.1016/j.cub.2006.06.036; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; SCHNEIDER MF, 1973, NATURE, V242, P244, DOI 10.1038/242244a0; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; TANABE T, 1993, ANN NY ACAD SCI, V707, P81, DOI 10.1111/j.1749-6632.1993.tb38044.x; Treves S, 2005, NEUROMUSCULAR DISORD, V15, P577, DOI 10.1016/j.nmd.2005.06.008; Wang Y, 2000, AM J PHYSIOL-CELL PH, V278, pC619, DOI 10.1152/ajpcell.2000.278.3.C619; Yang TZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1591, DOI 10.1152/ajpcell.00133.2006; Yang TZ, 2003, J BIOL CHEM, V278, P25722, DOI 10.1074/jbc.M302165200	48	47	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2007	282	52					37471	37478		10.1074/jbc.M701379200	http://dx.doi.org/10.1074/jbc.M701379200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	243YQ	17942409	hybrid			2022-12-25	WOS:000251833600022
J	Zak, PJ; Stanton, AA; Ahmadi, S				Zak, Paul J.; Stanton, Angela A.; Ahmadi, Sheila			Oxytocin Increases Generosity in Humans	PLOS ONE			English	Article							STRONG RECIPROCITY; EVOLUTION; COOPERATION; RESPONSES; INTERACT; ALTRUISM; NETWORKS; FAIRNESS; BRAIN; TRUST	Human beings routinely help strangers at costs to themselves. Sometimes the help offered is generous-offering more than the other expects. The proximate mechanisms supporting generosity are not well-understood, but several lines of research suggest a role for empathy. In this study, participants were infused with 40 IU oxytocin (OT) or placebo and engaged in a blinded, one-shot decision on how to split a sum of money with a stranger that could be rejected. Those on OT were 80% more generous than those given a placebo. OT had no effect on a unilateral monetary transfer task dissociating generosity from altruism. OT and altruism together predicted almost half the interpersonal variation in generosity. Notably, OT had twofold larger impact on generosity compared to altruism. This indicates that generosity is associated with both altruism as well as an emotional identification with another person.	[Zak, Paul J.] Claremont Grad Univ, Ctr Neuroecon Studies, Claremont, CA 91711 USA; [Zak, Paul J.] Claremont Grad Univ, Dept Econ, Claremont, CA USA; [Zak, Paul J.] Loma Linda Univ, Med Ctr, Dept Neurol, Loma Linda, CA USA; [Stanton, Angela A.] Chapman Univ, Argyros Sch Business & Econ, Orange, CA USA; [Ahmadi, Sheila] Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol, Los Angeles, CA 90095 USA	Claremont Colleges; Claremont Graduate School; Claremont Colleges; Claremont Graduate School; Loma Linda University; Chapman University System; Chapman University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zak, PJ (corresponding author), Claremont Grad Univ, Ctr Neuroecon Studies, Claremont, CA 91711 USA.	paul.zak@cgu.edu	Stanton, Angela A/H-8039-2015	Stanton, Angela A/0000-0003-4619-419X	Seaver Institute; John Templeton Foundation	Seaver Institute; John Templeton Foundation	PJZ thanks the Seaver Institute and the John Templeton Foundation for financial support. Neither the Seaver Institute nor the John Templeton Foundation had a role in the conduct of this study.	Alexander R., 2008, ESSAYS PEDAGOGY; ANDREONI J, 1990, ECON J, V100, P464, DOI 10.2307/2234133; [Anonymous], EMPATHY; AQUINAS T, 1999, AQUINAS SELECTED WRI; Batson CD, 2003, PERS SOC PSYCHOL B, V29, P1190, DOI 10.1177/0146167203254600; BATSON CD, 2002, ALTRUISM ALTRUISTIC; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; Brooks A. C., 2005, GIFTS TIME MONEY ROL; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; CARTER CS, 2006, ATTACHMENT BONDING N; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; Decety J, 2006, CURR DIR PSYCHOL SCI, V15, P54, DOI 10.1111/j.0963-7214.2006.00406.x; Domes G, 2007, BIOL PSYCHIAT, V61, P731, DOI 10.1016/j.biopsych.2006.07.015; EISENBERG N, 2004, HDB EMOTION; Eisenberger NI, 2004, TRENDS COGN SCI, V8, P294, DOI 10.1016/j.tics.2004.05.010; Evans JJ, 1997, EUR J ENDOCRINOL, V137, P559, DOI 10.1530/eje.0.1370559; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Fraley RC, 2000, J PERS SOC PSYCHOL, V78, P350, DOI 10.1037/0022-3514.78.2.350; Frank R. H., 1988, PASSIONS REASON; Freedman LJ, 2000, J COMP NEUROL, V421, P172; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Glazer A, 1996, AM ECON REV, V86, P1019; Grafen A, 2007, P R SOC B, V274, P713, DOI 10.1098/rspb.2006.0140; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Heinrichs M, 2003, BIOL PSYCHIAT, V54, P1389, DOI 10.1016/S0006-3223(03)00465-7; Hume David, ENQUIRY CONCERNING P; Insel TR, 1997, AM J PSYCHIAT, V154, P726; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; LARSEN RJ, 1987, J RES PERS, V21, P1, DOI 10.1016/0092-6566(87)90023-7; Liu Y, 2003, NEUROSCIENCE, V121, P537, DOI 10.1016/S0306-4522(03)00555-4; LOUP F, 1991, BRAIN RES, V555, P220, DOI 10.1016/0006-8993(91)90345-V; Macedo S, 2006, PRIMATES AND PHILOSOPHERS: HOW MORALITY EVOLVED, P1; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Morgane PJ, 2005, PROG NEUROBIOL, V75, P143, DOI 10.1016/j.pneurobio.2005.01.001; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Oosterbeek H, 2004, EXP ECON, V7, P171, DOI 10.1023/B:EXEC.0000026978.14316.74; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; RABIN M, 1993, AM ECON REV, V83, P1281; Sally D, 2002, J LAW ECON ORGAN, V18, P455, DOI 10.1093/jleo/18.2.455; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; SCHERVISH PG, 2002, INT J VOLUNTARY NONP, V13, P47; Smith Adam, THEORY MORAL SENTIME; Sober E., 1999, OTHERS EVOLUTION PSY; Sober E, 2002, ALTRUISM ALTRUISTIC; Tankersley D, 2007, NAT NEUROSCI, V10, P150, DOI 10.1038/nn1833; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; van Veelen M, 2006, J THEOR BIOL, V242, P790, DOI 10.1016/j.jtbi.2006.04.022; Verbalis JG, 1999, FRONT NEUROENDOCRIN, V20, P146, DOI 10.1006/frne.1999.0178; Xiao E, 2005, P NATL ACAD SCI USA, V102, P7398, DOI 10.1073/pnas.0502399102; Zak P. J., 2007, RENAISSANCE BEHAV EC; Zak PJ, 2004, ANN NY ACAD SCI, V1032, P224, DOI 10.1196/annals.1314.025; Zak PJ, 2005, HORM BEHAV, V48, P522, DOI 10.1016/j.yhbeh.2005.07.009; Zak PJ, 2005, BEHAV BRAIN SCI, V28, P368; 2006, GIVING US; GENEROSITY	60	474	492	3	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2007	2	11							e1128	10.1371/journal.pone.0001128	http://dx.doi.org/10.1371/journal.pone.0001128			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IZ	17987115	Green Published, gold			2022-12-25	WOS:000207459000012
J	Le Mandat Schultz, A; Bonnard, A; Barreau, F; Aigrain, Y; Pierre-Louis, C; Berrebi, D; Peuchmaur, M				Le Mandat Schultz, Aurelie; Bonnard, Arnaud; Barreau, Frederick; Aigrain, Yves; Pierre-Louis, Coralie; Berrebi, Dominique; Peuchmaur, Michel			Expression of TLR-2, TLR-4, NOD2 and pNF-kappa B in a Neonatal Rat Model of Necrotizing Enterocolitis	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; PLATELET-ACTIVATING-FACTOR; EPIDERMAL GROWTH-FACTOR; INNATE IMMUNITY; ENDOTOXIN; APOPTOSIS; NECROSIS; INJURY; MILK; GUT	Background. The etiology of necrotizing enterocolitis (NEC) results from a combination of several risk factors that act synergistically and occurs in the same circumstances as those which lead to innate immunity activation. Pattern recognition molecules could be an important player in the initiation of an exaggerated inflammatory response leading to intestinal injury in NEC. Methodology/Principal Findings. We specifically evaluated intestinal epithelial cell (IEC) expression of Toll-like receptor 2 (TLR-2), TLR-4, NOD2 and phosphorylated NF-kappa B (pNF-kappa B) after mucosal injury in a rat model of NEC induced by prematurity, systemic hypoxia, and a rich protein formula. In the control group (group 1), neonatal rats were full-term and breast-fed; in the experimental groups, rat pups were preterm at day 21 of gestation and rat-milk fed (group 2) or hand-gavaged with a protein rich formula after a hypoxia-reoxygenation procedure (group 3). Morphological mucosal changes in the small bowel were scored on hematoxylin-and eosin-stained sections. Immunohistochemistry was performed on frozen tissue sections using anti TLR-2 and active pNF-kappa B p65 antibodies. Real-time RT-PCR was performed to assess mRNA expression of NOD2, TLR-2 and TLR-4. Proliferation and apoptosis were studied in paraffin sections using anti Ki-67 and caspase-3 antibodies, respectively. The combination of immaturity, protein rich formula and a hypoxia-reoxygenation procedure induces pathological mucosal damage consistent with NEC. There was an overexpression of TLR-2, and pNF-kappa B in IECs that was correlated with the severity of mucosal damage, together with an increase of apoptotic IECs and markedly impaired proliferation. In addition, these immunological alterations appeared before severe mucosal damage. TLR-2 mRNA were also increased in NEC together with TLR-4 mRNA using real-time RT-PCR whereas NOD2 expression was unchanged. Conclusions/Significance. These results show that this rat model of NEC induced mucosal injury, leading to a highly responsive IEC phenotype and suggesting that alterations in the innate immune system participates in the pathogenesis of NEC and are enhanced by prematurity.	[Le Mandat Schultz, Aurelie; Bonnard, Arnaud; Aigrain, Yves; Pierre-Louis, Coralie; Berrebi, Dominique; Peuchmaur, Michel] Univ Paris 07, EA3102, Paris, France; [Le Mandat Schultz, Aurelie; Bonnard, Arnaud; Aigrain, Yves] Hop Robert Debre, AP HP, Serv Chirurg Pediat, F-75019 Paris, France; [Aigrain, Yves] AP HP, Ecole Chirurg, Paris, France; [Pierre-Louis, Coralie; Berrebi, Dominique; Peuchmaur, Michel] Hop Robert Debre, AP HP, Serv Anat & Cytol Pathol, F-75019 Paris, France; [Barreau, Frederick] Hop Robert Debre, INSERM, U843, F-75019 Paris, France; [Barreau, Frederick] Univ Paris Diderot, UMR S843, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Berrebi, D (corresponding author), Univ Paris 07, EA3102, Paris, France.	dominique.berrebi@rdb.ap-hop-paris.fr	berrebi, dominique/B-1419-2014		APHP; Universite Paris 7	APHP; Universite Paris 7	Funding: APHP and Universite Paris 7	BARLOW B, 1974, J PEDIATR SURG, V9, P587, DOI 10.1016/0022-3468(74)90093-1; Bernstein IM, 2000, AM J OBSTET GYNECOL, V182, P198, DOI 10.1016/S0002-9378(00)70513-8; Caplan Michael S, 2005, Semin Pediatr Surg, V14, P145, DOI 10.1053/j.sempedsurg.2005.05.002; Caplan MS, 1997, PEDIATR RES, V42, P779, DOI 10.1203/00006450-199712000-00010; Caplan MS, 2001, CURR OPIN PEDIATR, V13, P111, DOI 10.1097/00008480-200104000-00004; Caplan MS, 1999, GASTROENTEROLOGY, V117, P577, DOI 10.1016/S0016-5085(99)70450-6; CAPLAN MS, 1992, PEDIATR RES, V31, P428, DOI 10.1203/00006450-199205000-00002; Chan KL, 2002, J PEDIATR SURG, V37, P1435, DOI 10.1053/jpsu.2002.35407; Claud EC, 2003, PEDIATR RES, V53, P419, DOI 10.1203/01.PDR.0000050141.73528.AD; Dvorak B, 2002, AM J PHYSIOL-GASTR L, V282, pG156, DOI 10.1152/ajpgi.00196.2001; Edelson MB, 1999, PEDIATRICS, V103, P766, DOI 10.1542/peds.103.4.766; Fell JME, 2005, EARLY HUM DEV, V81, P117, DOI 10.1016/j.earlhumdev.2004.10.001; Fusunyan RD, 2001, PEDIATR RES, V49, P589, DOI 10.1203/00006450-200104000-00023; Hackam David J, 2005, Semin Pediatr Surg, V14, P49, DOI 10.1053/j.sempedsurg.2004.10.025; Halpern MD, 2003, J PEDIATR GASTR NUTR, V36, P126, DOI 10.1097/00005176-200301000-00024; Hsueh W, 2003, PEDIATR DEVEL PATHOL, V6, P6, DOI 10.1007/s10024-002-0602-z; Ikeda H, 1998, GUT, V42, P530, DOI 10.1136/gut.42.4.530; Jilling T, 2004, PEDIATR RES, V55, P622, DOI 10.1203/01.PDR.0000113463.70435.74; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; LIU SX, 2007, PEDIAT RES; Liu Y, 2001, INFECT IMMUN, V69, P2788, DOI 10.1128/IAI.69.5.2788-2796.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Nadler EP, 2000, J SURG RES, V92, P71, DOI 10.1006/jsre.2000.5877; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; OKUR H, 1995, J PEDIATR SURG, V30, P1416, DOI 10.1016/0022-3468(95)90395-X; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Zouali H, 2005, DIGEST DIS SCI, V50, P1684, DOI 10.1007/s10620-005-2915-z	32	35	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2007	2	10							e1102	10.1371/journal.pone.0001102	http://dx.doi.org/10.1371/journal.pone.0001102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IW	17971865	Green Published, gold, Green Submitted			2022-12-25	WOS:000207458700019
J	Vogel, H; Kroymann, J; Mitchell-Olds, T				Vogel, Heiko; Kroymann, Juergen; Mitchell-Olds, Thomas			Different Transcript Patterns in Response to Specialist and Generalist Herbivores in the Wild Arabidopsis Relative Boechera divaricarpa	PLOS ONE			English	Article								Background. Plants defend themselves against herbivorous insects, utilizing both constitutive and inducible defenses. Induced defenses are controlled by several phytohormone-mediated signaling pathways. Here, we analyze transcriptional changes in the North American Arabidopsis relative Boechera divaricarpa in response to larval herbivory by the crucifer specialist lepidopteran Plutella xylostella (diamondback moth) and by the generalist lepidopteran Trichoplusia ni (cabbage semilooper), and compare them to wounding and exogenous phytohormone application. Methodology/Principal Findings. We use a custom macroarray constructed from B. divaricarpa herbivory-regulated cDNAs identified by suppression subtractive hybridization and from known stress-responsive A. thaliana genes for transcript profiling after insect herbivory, wounding and in response to jasmonate, salicylate and ethylene. In addition, we introduce path analysis as a novel approach to analyze transcript profiles. Path analyses reveal that transcriptional responses to the crucifer specialist P. xylostella are primarily determined by direct effects of the ethylene and salicylate pathways, whereas responses to the generalist T. ni are influenced by the ethylene and jasmonate pathways. Wound-induced transcriptional changes are influenced by all three pathways, with jasmonate having the strongest effect. Conclusions/Significance. Our results show that insect herbivory is distinct from simple mechanical plant damage, and that different lepidopteran herbivores elicit different transcriptional responses.	[Vogel, Heiko; Kroymann, Juergen; Mitchell-Olds, Thomas] Max Planck Inst Chem Ecol, Dept Genet & Evolut, Jena, Germany; [Vogel, Heiko] Max Planck Inst Chem Ecol, Dept Entomol, Jena, Germany; [Mitchell-Olds, Thomas] Duke Univ, Dept Biol, Durham, NC USA	Max Planck Society; Max Planck Society; Duke University	Kroymann, J (corresponding author), Max Planck Inst Chem Ecol, Dept Genet & Evolut, Jena, Germany.	kroymann@ice.mpg.de	Kroymann, Juergen/B-4317-2013; Kroymann, Juergen/AAY-8562-2021; Mitchell-Olds, Thomas/K-8121-2012	Kroymann, Juergen/0000-0002-4573-6498; Mitchell-Olds, Thomas/0000-0003-3439-9921	Max Planck Society; European Union [QLRT-2000-01097]	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Union(European Commission)	This work was supported by the Max Planck Society and by the European Union (QLRT-2000-01097).	Alborn HT, 1997, SCIENCE, V276, P945, DOI 10.1126/science.276.5314.945; Alborn HT, 2003, J CHEM ECOL, V29, P1357, DOI 10.1023/A:1024209302628; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arondel V, 2000, PLANT SCI, V157, P1, DOI 10.1016/S0168-9452(00)00232-6; Berrocal-Lobo M, 2002, PLANT J, V29, P23, DOI 10.1046/j.1365-313x.2002.01191.x; Bostock RM, 1999, PHYSIOL MOL PLANT P, V55, P99, DOI 10.1006/pmpp.1999.0218; Bostock RM, 2001, EUR J PLANT PATHOL, V107, P103, DOI 10.1023/A:1008703904253; Cameron RK, 2000, PHYSIOL MOL PLANT P, V56, P91, DOI 10.1006/pmpp.2000.0262; Clark AM, 1999, PLANT CELL PHYSIOL, V40, P69, DOI 10.1093/oxfordjournals.pcp.a029476; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Durrant WE, 2000, PLANT CELL, V12, P963, DOI 10.1105/tpc.12.6.963; Ellis C, 2001, PLANT CELL, V13, P1025, DOI 10.1105/tpc.13.5.1025; ESTADA U, 1994, APPL ENVIRON MICROB, V60, P3840, DOI 10.1128/AEM.60.10.3840-3846.1994; Felton GW, 2000, CURR OPIN PLANT BIOL, V3, P309, DOI 10.1016/S1369-5266(00)00086-8; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Feys BJ, 2000, TRENDS GENET, V16, P449, DOI 10.1016/S0168-9525(00)02107-7; Frey M, 2004, PHYTOCHEMISTRY, V65, P1047, DOI 10.1016/j.phytochem.2003.11.021; Frey M, 2000, P NATL ACAD SCI USA, V97, P14801, DOI 10.1073/pnas.260499897; Glazebrook J, 2003, PLANT J, V34, P217, DOI 10.1046/j.1365-313X.2003.01717.x; Glazebrook J, 2001, CURR OPIN PLANT BIOL, V4, P301, DOI 10.1016/S1369-5266(00)00177-1; Halitschke R, 2001, PLANT PHYSIOL, V125, P711, DOI 10.1104/pp.125.2.711; Heckel DG, 1999, P NATL ACAD SCI USA, V96, P8373, DOI 10.1073/pnas.96.15.8373; HILL DS, 1987, CULTURAL INSECT PEST; Howe GA, 1996, PLANT CELL, V8, P2067, DOI 10.1105/tpc.8.11.2067; Hughes P, 2000, J BIOL CHEM, V275, P823, DOI 10.1074/jbc.275.2.823; Iqbal M, 1997, B ENTOMOL RES, V87, P481, DOI 10.1017/S0007485300041341; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Kessler A, 2004, SCIENCE, V305, P665, DOI 10.1126/science.1096931; Koch M, 2001, AM J BOT, V88, P534, DOI 10.2307/2657117; Laudert D, 1998, PLANT J, V15, P675, DOI 10.1046/j.1365-313x.1998.00245.x; Liechti R, 2002, SCIENCE, V296, P1649, DOI 10.1126/science.1071547; Liu YL, 2005, PLANT PHYSIOL, V139, P1545, DOI 10.1104/pp.105.066837; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; McDowell JM, 2000, TRENDS BIOCHEM SCI, V25, P79, DOI 10.1016/S0968-0004(99)01532-7; Mithofer A, 2005, PLANT PHYSIOL, V137, P1160, DOI 10.1104/pp.104.054460; Mori N, 2001, J INSECT PHYSIOL, V47, P749, DOI 10.1016/S0022-1910(00)00171-2; O'Donnell PJ, 1998, PLANT J, V14, P137, DOI 10.1046/j.1365-313X.1998.00110.x; Pare PW, 1997, PLANT PHYSIOL, V114, P1161, DOI 10.1104/pp.114.4.1161; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Pohnert G, 1999, TETRAHEDRON, V55, P11275, DOI 10.1016/S0040-4020(99)00639-0; RASKIN I, 1992, PLANT PHYSIOL, V99, P799, DOI 10.1104/pp.99.3.799; Reymond P, 2004, PLANT CELL, V16, P3132, DOI 10.1105/tpc.104.026120; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Rojo E, 2003, J PLANT GROWTH REGUL, V22, P82, DOI 10.1007/s00344-003-0027-6; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; Seki M, 2001, PLANT CELL, V13, P61, DOI 10.1105/tpc.13.1.61; SHELTON AM, 1991, J ENTOMOL SCI, V26, P17, DOI 10.18474/0749-8004-26.1.17; Shipley B., 2000, CAUSE CORRELATIONS B; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tabashnik BE, 1997, P NATL ACAD SCI USA, V94, P12780, DOI 10.1073/pnas.94.24.12780; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Tamaoki M, 2003, PLANT CELL PHYSIOL, V44, pS81; Thaler JS, 2002, ECOL LETT, V5, P764, DOI 10.1046/j.1461-0248.2002.00388.x; Thomma BPHJ, 2001, CURR OPIN IMMUNOL, V13, P63, DOI 10.1016/S0952-7915(00)00183-7; Titarenko E, 1997, PLANT PHYSIOL, V115, P817, DOI 10.1104/pp.115.2.817; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; Utsugi S, 1998, PLANT MOL BIOL, V38, P565, DOI 10.1023/A:1006072014605; van Poecke RMP, 2002, J EXP BOT, V53, P1793, DOI 10.1093/jxb/erf022; van Wees SCM, 2000, P NATL ACAD SCI USA, V97, P8711, DOI 10.1073/pnas.130425197; Voelckel C, 2004, ECOL LETT, V7, P770, DOI 10.1111/j.1461-0248.2004.00633.x; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Wright S, 1934, ANN MATH STAT, V5, P161, DOI 10.1214/aoms/1177732676; Wright SS, 1921, J AGR RES, V20, P557; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602	66	35	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2007	2	10							e1081	10.1371/journal.pone.0001081	http://dx.doi.org/10.1371/journal.pone.0001081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10IU	17957263	gold, Green Published, Green Submitted			2022-12-25	WOS:000207458500026
J	Martin, D; Galisteo, R; Ji, Y; Montaner, S; Gutkind, JS				Martin, D.; Galisteo, R.; Ji, Y.; Montaner, S.; Gutkind, J. S.			An NF-kappa B gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia	ONCOGENE			English	Article						G proteins; signal transduction; G protein coupled receptors; angiosarcoma; endothelial cell; angiogenesis	PROTEIN-COUPLED-RECEPTOR; HERPESVIRUS; KSHV; CELL; CANCER; ANGIOGENESIS; SURVIVAL; PROMOTE	Kaposi's sarcoma (KS) is the most frequent AIDS-associated malignancy, etiologically linked to the infection with the human herpesvirus 8 (HHV-8/KSHV). This member of the gamma-herpesviridae family encodes 81 open reading frames, several bearing oncogenic potential. A constitutively active virally encoded G protein-coupled receptor (vGPCR) readily induces KS-like lesions when expressed in endothelial cells in vivo, and unmasks the oncogenic potential of other HHV-8 genes in a paracrine fashion. How vGPCR causes endothelial cell transformation is still not fully understood. Using full-genome microarray analysis we show here that the expression of nuclear factor-kappa B (NF-kappa B)regulated genes is a prominent feature triggered by vGPCR in cells expressing this viral oncogene and in cells exposed to vGPCR-induced secretions, thus mimicking its paracrine effect. Indeed, vGPCR activates the NF-kappa B pathway potently, and NF-kappa B activation is a hallmark of both human and experimental KS. Of interest, whereas constitutive NF-kappa B signaling is not sufficient to promote endothelial cells transformation, NF-kappa B function is strictly required for vGPCR-induced direct and paracrine neoplasia. Taken together, these results strongly support the role of NF-kappa B regulated genes in KS pathogenesis, thus providing the rationale for the development of novel mechanism-based therapies for this angioproliferative disease.	[Martin, D.; Galisteo, R.; Gutkind, J. S.] Natl Inst Dent & Craniofacial Res, NIH, Oral & Pharyngeal Canc Branch, Bethesda, MD 20892 USA; [Ji, Y.; Montaner, S.] Univ Maryland, Dept Diagnost Sci & Pathol, Baltimore, MD 21201 USA; [Ji, Y.; Montaner, S.] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Gutkind, JS (corresponding author), Natl Inst Dent & Craniofacial Res, NIH, Oral & Pharyngeal Canc Branch, 30 Convent Dr,Bldg 30,Room 211, Bethesda, MD 20892 USA.	sg39v@nih.gov	Abrams, William R/A-5782-2008; Gutkind, J. Silvio/A-1053-2009; Gutkind, J. Silvio/J-1201-2016	Gutkind, J. Silvio/0000-0002-5150-4482; Martin Izquierdo, Daniel/0000-0002-8880-9087	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; Asou H, 1998, BLOOD, V91, P2475, DOI 10.1182/blood.V91.7.2475.2475_2475_2481; Bais C, 1998, NATURE, V391, P86, DOI 10.1038/34193; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; Bower M, 2006, CURR OPIN INFECT DIS, V19, P14, DOI 10.1097/01.qco.0000200295.30285.13; Cesarman E, 2007, CURR TOP MICROBIOL, V312, P263; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; ENSOLI B, 1989, SCIENCE, V243, P223, DOI 10.1126/science.2643161; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Hamilton TA, 2002, IMMUNOL RES, V25, P229, DOI 10.1385/IR:25:3:229; Heidemann J, 2003, J BIOL CHEM, V278, P8508, DOI 10.1074/jbc.M208231200; Hiscott J, 2006, ONCOGENE, V25, P6844, DOI 10.1038/sj.onc.1209941; Kanegane H, 1997, J INFECT DIS, V176, P254, DOI 10.1086/517260; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Montaner S, 2006, CANCER RES, V66, P168, DOI 10.1158/0008-5472.CAN-05-1026; Montaner S, 2003, CANCER CELL, V3, P23, DOI 10.1016/S1535-6108(02)00237-4; Montaner S, 2001, CANCER RES, V61, P2641; Morris K, 2003, LANCET ONCOL, V4, P5, DOI 10.1016/S1470-2045(03)00969-0; Mutlu AD, 2007, CANCER CELL, V11, P245, DOI 10.1016/j.ccr.2007.01.015; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Rezza G, 1999, J NATL CANCER I, V91, P1468, DOI 10.1093/jnci/91.17.1468; Schwarz M, 2001, J IMMUNOL, V167, P505, DOI 10.4049/jimmunol.167.1.505; SCIACCA FL, 1994, J IMMUNOL, V153, P4816; Sodhi A, 2004, NAT REV MOL CELL BIO, V5, P998, DOI 10.1038/nrm1529; Yang TY, 2000, J EXP MED, V191, P445, DOI 10.1084/jem.191.3.445	27	162	167	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2008	27	13					1844	1852		10.1038/sj.onc.1210817	http://dx.doi.org/10.1038/sj.onc.1210817			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	276NZ	17934524				2022-12-25	WOS:000254150600004
